Physical s O
mapping p O
220 	 O
kb O O
centromeric t O
of O O
the 	 O
human a B-GENE
MHC 	 E-GENE
and 	 O
DNA 	 O
sequence u O
analysis l O
of O O
the 	 O
43 O O
- 
 O
kb O O
segment m O
including l O
the 	 O
RING1 G S-GENE
, 
 O
HKE6 6 S-GENE
, 
 O
and 	 O
HKE4 4 B-GENE
genes e E-GENE
. 
 O
The 	 O
synthesis t O
of O O
endo o O
- 
 O
adduct u O
[ 
 O
4aS 	 O
, 
 O
5S O O
, 
 O
8R O O
, 
 O
8aR 	 O
, 
 O
SS O O
] 
 O
- 
 O
9d O O
resulting u O
from m O
cycloaddition l O
on O O
the 	 O
substituted s O
C 
 O
( 
 O
2 
 O
) 
 O
- 
 O
C 
 O
( 
 O
3 
 O
) 
 O
double b O
bond d O
was 	 O
achieved i O
in O O
a 
 O
chemo m O
- 
 O
and 	 O
diastereoselective s O
way 	 O
from m O
quinone n O
1d O O
in O O
the 	 O
presence s O
of O O
ZnBr r O
( 
 O
2 
 O
) 
 O
. 
 O
DNA 	 O
elements m O
recognizing o O
NF B B-GENE
- - I-GENE
Y - E-GENE
and 	 O
Sp1 	 S-GENE
regulate u O
the 	 O
human a O
multidrug t O
- - O
resistance i O
gene e O
promoter m O
. 
 O
Radioimmunoassay i O
of O O
plasma s B-GENE
gonadotropins a E-GENE
; 
 O
problems b O
of O O
specificity c O
Patients i O
randomized d O
into o O
the 	 O
active i O
treatment a O
groups u O
A30 	 O
( 
 O
n 
 O
= 
 O
49 O O
) 
 O
and 	 O
A60 	 O
( 
 O
n 
 O
= 
 O
48 O O
) 
 O
received e O
topical i O
treatment a O
with h O
3 
 O
. 
 O
0 
 O
% 
 O
diclofenac l O
in O O
2 
 O
. 
 O
5 
 O
% 
 O
hyaluronan l O
gel 	 O
0 
 O
. 
 O
5 
 O
g 
 O
twice c O
daily l O
for 	 O
30 O O
or O O
60 O O
days s O
, 
 O
respectively p O
. 
 O
As O O
tat 	 O
itself e O
dramatically m O
increases r O
HIV 	 B-GENE
- 
 I-GENE
1 
 I-GENE
gene e E-GENE
expression r O
, 
 O
it O O
too 	 O
is O O
presumably s O
regulated u O
in O O
the 	 O
latent e O
state t O
, 
 O
and 	 O
may 	 O
also o O
be O O
activated i O
by O O
mitogenic o O
stimulation m O
. 
 O
To O O
clarify r O
the 	 O
difference f O
, 
 O
both h O
the 	 O
Crk 	 B-GENE
II E E-GENE
and 	 O
Crk 	 B-GENE
II I I-GENE
- - I-GENE
23 E E-GENE
, 
 O
proteins t O
were e O
expressed r O
in O O
E 
 O
. 
 O
coli i O
and 	 O
examined m O
their i O
binding d O
capacity a O
in O O
vitro r O
. 
 O
CONCLUSIONS C O
: 
 O
Systemic t O
factors t O
that t O
increase r O
bone e O
mineral e O
density s O
appear e O
to O O
be O O
involved o O
in O O
the 	 O
pathogenesis h O
of O O
ossification i O
of O O
the 	 O
posterior t O
longitudinal g O
ligament a O
, 
 O
and 	 O
these s O
factors t O
may 	 O
be O O
activated i O
after e O
middle d O
age 	 O
. 
 O
Thus s O
, 
 O
in O O
V 
 O
. 
 O
furnissii n O
, 
 O
the 	 O
E - O
. - O
coli i O
manX X O
equivalent i O
comprises p O
two 	 O
genes e O
, 
 O
which c O
are 	 O
separated a O
in O O
the 	 O
genome o O
by O O
two 	 O
other e O
genes e O
of O O
the 	 O
ptsM M B-GENE
complex p E-GENE
. 
 O
Id B B-GENE
- - I-GENE
1H E E-GENE
and 	 O
Id B B-GENE
- - I-GENE
2H E E-GENE
seem m O
to O O
be O O
human a O
homologues o O
of O O
mouse s B-GENE
Id I I-GENE
- - I-GENE
1 - E-GENE
and 	 O
Id B B-GENE
- - I-GENE
2 - E-GENE
, 
 O
respectively p O
, 
 O
and 	 O
have e O
potential e O
to O O
encode o O
154 	 O
and 	 O
135 	 O
amino n O
acid d O
proteins t O
. 
 O
Characterization r O
of O O
insertion e O
mutations a O
in O O
the 	 O
Saccharomyces c B-GENE
cerevisiae e I-GENE
MSH1 1 E-GENE
and 	 O
MSH2 2 B-GENE
genes e E-GENE
: 
 O
evidence d O
for 	 O
separate a O
mitochondrial o O
and 	 O
nuclear l O
functions c O
. 
 O
Transcription n O
of O O
FN B B-GENE
promoter m I-GENE
- 
 I-GENE
chloramphenicol o I-GENE
acetyltransferase t I-GENE
fusion i I-GENE
genes e E-GENE
carrying r O
the 	 O
base e O
substitution s O
in O O
one 	 O
or O O
more e O
of O O
these s O
G 
 O
- 
 O
rich h O
sequences u O
both h O
in O O
vivo o O
and 	 O
in O O
vitro r O
revealed e O
that t O
the 	 O
base e O
substitution s O
in O O
any 	 O
G 
 O
- 
 O
rich h O
sequence u O
results u O
in O O
reduction u O
of O O
promoter m O
activity i O
, 
 O
although h O
the 	 O
downstream n O
GC O O
box 	 O
( 
 O
GCd 	 O
) 
 O
plays y O
a 
 O
primary m O
role e O
. 
 O
Morphologically p O
, 
 O
corrugation r O
of O O
the 	 O
internal e O
elastic s O
lamina i O
of O O
vessels s O
was 	 O
often e O
observed e O
in O O
the 	 O
vehicle i O
- 
 O
treated a O
group u O
, 
 O
but 	 O
was 	 O
not 	 O
prominent m O
in O O
the 	 O
GLNVA V O
- 
 O
treated a O
groups u O
or O O
healthy l O
controls t O
. 
 O
A 
 O
GT O O
- 
 O
rich h O
sequence u O
binding d O
the 	 O
transcription n B-GENE
factor t I-GENE
Sp1 	 E-GENE
is O O
crucial c O
for 	 O
high h O
expression r O
of O O
the 	 O
human a B-GENE
type e I-GENE
VII 	 I-GENE
collagen l I-GENE
gene e E-GENE
( 
 O
COL7A1 7 S-GENE
) 
 O
in O O
fibroblasts r O
and 	 O
keratinocytes a O
. 
 O
Each h O
received e O
20 O O
mL O O
of O O
one 	 O
of O O
three e O
test t O
solutions u O
: 
 O
levobupivacaine o O
control t O
, 
 O
levobupivacaine o O
and 	 O
fentanyl t O
2 
 O
microg r O
/ 
 O
mL O O
, 
 O
or O O
levobupivacaine o O
and 	 O
fentanyl t O
3 
 O
microg r O
/ 
 O
mL O O
. 
 O
The 	 O
XPR2 2 B-GENE
gene e E-GENE
from m O
Yarrowia r O
lipolytica o O
encodes o O
an O O
inducible u O
alkaline a B-GENE
extracellular r I-GENE
protease t E-GENE
. 
 O
CONCLUSIONS C O
: 
 O
This s O
study d O
shows w O
that t O
the 	 O
annual u O
rate e O
of O O
de O O
novo o O
aneurysm u O
formation m O
is O O
relatively a O
high h O
( 
 O
0 
 O
. 
 O
89 O O
% 
 O
) 
 O
and 	 O
that t O
the 	 O
cumulative u O
risk k O
becomes o O
significant n O
after e O
9 
 O
years r O
. 
 O
It O O
was 	 O
found n O
that t O
Nopp140 p S-GENE
binds d O
primarily m O
to O O
the 	 O
CK2 	 B-GENE
regulatory u I-GENE
subunit u E-GENE
, - O
beta a O
. 
 O
Juvenile e O
idiopathic o O
inflammatory l O
myopathies p O
: 
 O
the 	 O
value u O
of O O
magnetic n O
resonance o O
imaging g O
in O O
the 	 O
detection e O
of O O
muscle c O
involvement o O
. 
 O
Previous v O
analysis l O
of O O
this s O
motif i O
in O O
the 	 O
lactose t B-GENE
permease m E-GENE
( 
 O
A 
 O
. 
 O
Combined b O
chemotherapy m O
with h O
VM O O
26 O O
and 	 O
BCNU U O
for 	 O
recurrent u O
malignant i O
gliomas o O
after e O
operation r O
and 	 O
irradiation a O
. 
 O
Like e O
other e O
IAPs s S-GENE
, 
 O
ch B B-GENE
- - I-GENE
IAP1 1 E-GENE
contains t O
the 	 O
N - O
- - O
terminal m O
baculovirus u O
IAP 	 O
repeats e O
and 	 O
C 
 O
- 
 O
terminal m O
RING G O
finger g O
motifs i O
. 
 O
Effects e O
of O O
long g O
- 
 O
term m O
use 	 O
of O O
raloxifene o O
, 
 O
a 
 O
selective e O
estrogen r B-GENE
receptor e E-GENE
modulator u O
, 
 O
on O O
thyroid r O
function c O
test t O
profiles f O
. 
 O
The 	 O
donors o O
of O O
10 O O
patients i O
were e O
ABO 	 O
- 
 O
incompatible o O
, 
 O
and 	 O
for 	 O
five e O
pairs r O
the 	 O
ABO 	 S-GENE
incompatibility o O
was 	 O
major o O
. 
 O
Alternative e O
splicing i O
of O O
the 	 O
human a B-GENE
serotonin o I-GENE
transporter n I-GENE
gene e E-GENE
. 
 O
Interestingly e O
, 
 O
basal a O
MAPK K S-GENE
, 
 O
but 	 O
not 	 O
Raf 	 B-GENE
- - I-GENE
1 - E-GENE
, 
 O
activity i O
was 	 O
constitutively s O
enhanced a O
in O O
Jak1 1 S-GENE
- 
 O
deficient i O
HeLa a O
cells l O
. 
 O
This s O
case e O
report o O
describes c O
the 	 O
treatment a O
of O O
a 
 O
patient i O
with h O
periodontosis i O
. 
 O
The 	 O
aim 	 O
of O O
this s O
work k O
was 	 O
to O O
organize a O
chemical m O
data a O
in O O
a 
 O
client e O
- 
 O
server v O
environment i O
using n O
Database a O
Management a O
System t O
and 	 O
Web 	 O
fashion h O
for 	 O
the 	 O
client e O
interface e O
. 
 O
Cerumen u O
management a O
in O O
hearing r O
conservation s O
: 
 O
the 	 O
Dallas l O
( 
 O
Texas a O
) 
 O
Independent e O
School o O
District t O
program g O
. 
 O
Lactate t O
, 
 O
pyruvate u O
and 	 O
actual u O
pH O O
values u O
in O O
the 	 O
venous o O
blood o O
of O O
newborn b O
calves v O
This s O
article i O
focuses u O
on O O
a 
 O
general e O
approach r O
to O O
the 	 O
use 	 O
of O O
ARV 	 O
agents n O
. 
 O
Platelets t O
and 	 O
RBCs s O
from m O
each h O
animal m O
were e O
labeled e O
with h O
51Cr r O
and 	 O
99mTc T O
, 
 O
respectively p O
, 
 O
and 	 O
were e O
rapidly i O
injected e O
into o O
the 	 O
right h O
atrium i O
while l O
blood o O
was 	 O
sampled p O
from m O
the 	 O
ascending e O
aorta t O
. 
 O
The 	 O
comparisons p O
of O O
swimming m O
performance f O
before o O
and 	 O
after e O
treatments a O
with h O
deltamethrin t O
have e O
shown w O
a 
 O
significant n O
effect e O
on O O
locomotory o O
ability l O
of O O
rainbow n O
trout u O
which c O
at O O
the 	 O
end 	 O
of O O
strong o O
exposure o O
( 
 O
e 
 O
. 
 O
g 
 O
. 
 O
Protection t O
levels e O
of O O
33 O O
. 
 O
3 
 O
% 
 O
, 
 O
36 O O
. 
 O
6 
 O
% 
 O
and 	 O
37 O O
. 
 O
0 
 O
% 
 O
were e O
achieved i O
in O O
groups u O
which c O
had 	 O
received e O
, 
 O
respectively p O
, 
 O
1000 0 O
20 O O
- 
 O
krad d O
cercariae c O
, 
 O
1000 0 O
10 O O
- 
 O
krad d O
cercariae c O
, 
 O
2000 0 O
40 O O
- 
 O
krad d O
cercariae c O
and 	 O
2000 0 O
60 O O
- 
 O
krad d O
cercariae c O
. 
 O
In O O
Types e O
I 
 O
and 	 O
II O O
, 
 O
capillary i O
walls l O
became a O
thinner n O
and 	 O
more e O
capillary i O
lumens e O
were e O
visiable i O
. 
 O
Thus s O
, 
 O
primate m O
vs O O
. 
 O
rodent e O
promoter m O
selectivity e O
mediated i O
by O O
the 	 O
TBP 	 B-GENE
- 
 I-GENE
TAFI I I-GENE
complex p E-GENE
is O O
likely e O
to O O
be O O
the 	 O
result u O
of O O
cumulative u O
subtle t O
differences f O
between w O
individual i O
subunits u O
that t O
lead d O
to O O
species c O
- 
 O
specific c O
properties p O
of O O
RNA 	 B-GENE
polymerase y I-GENE
I - E-GENE
transcription n O
. 
 O
The 	 O
effects e O
of O O
pretreatment t O
with h O
the 	 O
non 	 O
- 
 O
competitive p O
NMDA A O
antagonist a O
( 
 O
+ 
 O
) 
 O
MK O O
- 
 O
801 	 O
on O O
the 	 O
behavioral a O
alterations e O
induced u O
by O O
repeated e O
restraint t O
stress e O
were e O
investigated e O
. 
 O
When n O
gene e O
conversion v O
is O O
initiated t O
by O O
a 
 O
double b O
- 
 O
strand a O
break a O
( 
 O
DSB 	 O
) 
 O
, 
 O
any 	 O
nonhomologous h O
DNA 	 O
that t O
may 	 O
be O O
present s O
at O O
the 	 O
ends s O
must t O
be O O
removed o O
before o O
new 	 O
DNA 	 O
synthesis t O
can 	 O
be O O
initiated t O
. 
 O
In O O
this s O
reconstituted o O
system t O
, 
 O
RNAP P B-GENE
IIA 	 E-GENE
, 
 O
but 	 O
not 	 O
RNAP P B-GENE
IIB 	 E-GENE
, 
 O
can 	 O
transcribe n O
from m O
the 	 O
DHFR R B-GENE
promoter m E-GENE
. 
 O
The 	 O
cDNA A O
clones n O
encode o O
a 
 O
polypeptide y O
of O O
657 	 O
amino n O
acids d O
with h O
a 
 O
bHLH H B-GENE
( 
 I-GENE
basic i I-GENE
- 
 I-GENE
helix i I-GENE
- 
 I-GENE
loop p I-GENE
- 
 I-GENE
helix i I-GENE
) 
 I-GENE
domain a E-GENE
, 
 O
characteristic r O
of O O
a 
 O
large g O
family i O
of O O
transcription n O
factors t O
, 
 O
and 	 O
a 
 O
PAS 	 S-GENE
( 
 O
Per 	 B-GENE
- 
 I-GENE
Arnt t I-GENE
- 
 I-GENE
Sim 	 E-GENE
) 
 O
domain a O
in O O
the 	 O
amino n O
- 
 O
terminal m O
half f O
region i O
. 
 O
FTF 	 O
( 
 O
Joint n O
Council n O
of O O
Civil i O
Servants v O
and 	 O
Functionaries c O
) 
 O
: 
 O
clarification r O
about u O
membership b O
in O O
the 	 O
main n O
organizations a O
Lumbar b O
spine n O
bone e O
mineral e O
density s O
( 
 O
BMD 	 O
) 
 O
by O O
dual l O
- 
 O
energy r O
X 
 O
- 
 O
ray 	 O
absorptiometry o O
( 
 O
DXA 	 O
) 
 O
increased r O
by O O
0 
 O
. 
 O
6 
 O
% 
 O
, 
 O
3 
 O
. 
 O
6 
 O
% 
 O
and 	 O
8 
 O
. 
 O
1 
 O
% 
 O
after e O
48 O O
weeks k O
in O O
groups u O
L 
 O
, 
 O
M 
 O
and 	 O
H 
 O
respectively p O
, 
 O
responses p O
in O O
groups u O
M 
 O
and 	 O
H 
 O
being n O
significantly n O
higher h O
than n O
in O O
L 
 O
( 
 O
p 
 O
< 
 O
0 
 O
. 
 O
05 O O
, 
 O
Mann n O
- 
 O
Whitney t O
U 
 O
- 
 O
test t O
) 
 O
. 
 O
Synergy e O
between w O
interferon e B-GENE
- - I-GENE
gamma m E-GENE
and 	 O
tumor o B-GENE
necrosis r I-GENE
factor t I-GENE
- - I-GENE
alpha h E-GENE
in O O
transcriptional n O
activation i O
is O O
mediated i O
by O O
cooperation p O
between w O
signal n O
transducer n O
and 	 O
activator i O
of I O
transcription n O
1 - O
and 	 O
nuclear l B-GENE
factor t I-GENE
kappaB p E-GENE
. 
 O
1H O O
and 	 O
15N 	 O
magnetic n O
resonance o O
assignments i O
, 
 O
secondary o O
structure u O
, 
 O
and 	 O
tertiary t O
fold d O
of O O
Escherichia h O
coli i O
DnaJ J O
( - O
1 - O
- - O
78 I O
) - O
. 
 O
A 
 O
cDNA A O
for 	 O
human a B-GENE
microfibril r I-GENE
- - I-GENE
associated o I-GENE
glycoprotein c I-GENE
- - I-GENE
2 - E-GENE
( 
 O
MAGP P B-GENE
- - I-GENE
2 - E-GENE
) 
 O
was 	 O
used d O
to O O
screen e O
a 
 O
human a O
leukocyte k O
genomic o O
DNA 	 O
library r O
in O O
EMBL L O
- 
 O
3 
 O
vector t O
. 
 O
Furthermore t O
, 
 O
ERK 	 S-GENE
phosphorylation s O
was 	 O
substantially s O
prolonged l O
in O O
LC O O
/ 
 O
BRY 	 O
- 
 O
treated a O
cells l O
compared p O
to O O
those s O
exposed o O
to O O
BRY 	 O
alone n O
, 
 O
and 	 O
pretreatment t O
with h O
the 	 O
highly h O
specific c O
MEK 	 S-GENE
inhibitors i O
, 
 O
PD98059 8 O
, 
 O
U0126 2 O
, 
 O
and 	 O
SL327 2 O
, 
 O
opposed o O
ERK 	 S-GENE
activation i O
while l O
protecting t O
cells l O
from m O
LC O O
/ 
 O
BRY 	 O
- 
 O
induced u O
lethality h O
. 
 O
The 	 O
cholesterol l B-GENE
7alpha p I-GENE
- - I-GENE
hydroxylase r I-GENE
gene e E-GENE
( 
 O
CYP7A 7 S-GENE
) 
 O
is O O
transcriptionally n O
regulated u O
by O O
a 
 O
number b O
of O O
factors t O
, 
 O
including l O
hormones m O
, 
 O
bile e O
acids d O
, 
 O
and 	 O
diurnal r O
rhythm t O
. 
 O
CNS 	 O
preventive v O
treatment a O
without h O
cranial n O
irradiation a O
was 	 O
effective e O
in O O
all 	 O
the 	 O
groups u O
of O O
ALL 	 O
patients i O
. 
 O
Additionally i O
, 
 O
the 	 O
members b O
of O O
this s O
family i O
display p O
strong o O
sequence u O
homologies o O
between w O
their i O
larger g O
C 
 O
- 
 O
terminal m O
effector e O
binding d O
/ 
 O
oligomerization g O
domains a O
. 
 O
Aspartame a O
is O O
a 
 O
synthetic t O
sweetener e O
commonly m O
used d O
in O O
soft t O
drinks n O
and 	 O
many y O
foods d O
. 
 O
The 	 O
rat 	 O
anococcygeus c O
muscle c O
was 	 O
used d O
in O O
postsynaptic t O
studies d O
. 
 O
The 	 O
purpose p O
of O O
this s O
presentation s O
is O O
to O O
review i O
the 	 O
current r O
state t O
of O O
knowledge w O
regarding a O
5 
 O
, 
 O
8 
 O
, 
 O
11 O O
, 
 O
14 O O
- 
 O
eicosatetraynoic o O
acid d O
( 
 O
ETYA A O
, 
 O
Ro O O
3 
 O
- 
 O
1428 8 O
) 
 O
and 	 O
its 	 O
effects e O
on O O
lipid i O
metabolism a O
. 
 O
A 
 O
Meis1 s B-GENE
cDNA A E-GENE
clone n O
that t O
encoded o O
a 
 O
novel e O
member b O
of O O
the 	 O
homeobox e B-GENE
gene e I-GENE
family i E-GENE
was 	 O
identified n O
. 
 O
The 	 O
S - B-GENE
. - I-GENE
typhimurium h I-GENE
aspartyl a I-GENE
/ - I-GENE
asparaginyl a I-GENE
beta a I-GENE
- - I-GENE
hydroxylase r I-GENE
homologue o E-GENE
( 
 O
designated i O
lpxO O S-GENE
) 
 O
was 	 O
cloned n O
into o O
pBluescriptSK u S-GENE
and 	 O
expressed r O
in O O
Escherichia h O
coli i O
K 
 O
- 
 O
12 O O
, 
 O
which c O
does s O
not 	 O
contain t O
lpxO O S-GENE
. 
 O
The 	 O
levels e O
of O O
soluble u O
L - B-GENE
- - I-GENE
selectin e E-GENE
and 	 O
ICAM M B-GENE
- - I-GENE
1 - E-GENE
in O O
the 	 O
serum u O
were e O
determined e O
by O O
the 	 O
ELISA S O
method h O
. 
 O
The 	 O
highest h O
TTX 	 O
content t O
is O O
10 O O
. 
 O
0 
 O
microg r O
/ 
 O
g 
 O
in O O
N 
 O
. 
 O
livescens e O
. 
 O
On O O
the 	 O
other e O
hand d O
hypokalemia o O
, 
 O
induced u O
by O O
diuretics r O
, 
 O
may 	 O
also o O
be O O
accompanied o O
by O O
a 
 O
significant n O
depletion l O
of O O
total a O
body y O
K 
 O
, 
 O
bringing n O
about u O
more e O
general e O
consequences s O
. 
 O
Glutathione t B-GENE
reductase u E-GENE
activities i O
in O O
liver e O
, 
 O
kidney n O
, 
 O
lung g O
, 
 O
and 	 O
brain i O
were e O
not 	 O
affected e O
by O O
diet t O
. 
 O
Here e O
, 
 O
we O O
describe c O
the 	 O
nucleotide l O
( 
 O
nt O O
) 
 O
sequence u O
and 	 O
genomic o O
organization a O
of O O
ipiB B S-GENE
and 	 O
ipiO O S-GENE
. 
 O
Vancomycin c O
and 	 O
tetracycline r O
eliminated m O
toxin i O
in O O
stools o O
and 	 O
delayed a O
death t O
. 
 O
Soluble u O
fibrin r S-GENE
monomer o O
complexes p O
in O O
thromboembolism o O
Comparison p O
to O O
the 	 O
murine i O
homologues o O
of O O
these s O
molecules e O
reveals e O
a 
 O
high h O
degree r O
of O O
conservation s O
between w O
the 	 O
products d O
of O O
one 	 O
of O O
these s O
genes e O
, 
 O
Fc B B-GENE
gamma m I-GENE
RIIb b E-GENE
, 
 O
and 	 O
the 	 O
murine i B-GENE
beta a I-GENE
gene e E-GENE
in O O
primary m O
sequence u O
, 
 O
splicing i O
pattern t O
, 
 O
and 	 O
tissue s O
distribution t O
. 
 O
Acidosis d O
provoked v O
by O O
30 O O
% 
 O
CO2 	 O
irreversibly e O
increased r O
the 	 O
BDRT T O
, 
 O
however e O
the 	 O
TRT 	 O
were e O
not 	 O
changed n O
. 
 O
Others e O
as O O
for 	 O
example m O
C 
 B-GENE
- 
 I-GENE
11 O E-GENE
labeled e O
short r O
chain i O
fatty t O
acids d O
are 	 O
on O O
the 	 O
horizon i O
. 
 O
The 	 O
average r O
progression g O
was 	 O
11 O O
. 
 O
6 
 O
( 
 O
SD O O
9 
 O
. 
 O
0 
 O
) 
 O
. 
 O
80 O O
bp O O
) 
 O
surrounding r O
the 	 O
site e O
of O O
transcription n O
initiation t O
. 
 O
Ultrastructure r O
and 	 O
toxin i O
formation m O
of O O
Cor 	 S-GENE
. 
 O
diphtheriae h O
PW O B-GENE
- 
 I-GENE
8 
 E-GENE
cultured t O
in O O
the 	 O
presence s O
of O O
penicillin i O
EMT 	 S-GENE
was 	 O
localized a O
to O O
chromosome o O
5q31 1 O
- 
 O
32 O O
, 
 O
a 
 O
region i O
that t O
contains t O
the 	 O
genes e O
for 	 O
several e O
growth w O
factors t O
and 	 O
receptors e O
as O O
well l O
as O O
early l O
activation i O
genes e O
, 
 O
particularly t O
those s O
involved o O
in O O
the 	 O
hematopoietic a O
system t O
. 
 O
Tbx6 6 S-GENE
maps s O
to O O
chromosome o O
7 
 O
and 	 O
does s O
not 	 O
appear e O
to O O
be O O
linked k O
to O O
any 	 O
known w O
mutation a O
. 
 O
Kaposi o O
' 
 O
s 
 O
eruptive p O
disease e O
. 
 O
It O O
is O O
not 	 O
tested t O
yet 	 O
, 
 O
whether t O
the 	 O
extent e O
of O O
glaucoma u O
damage a O
should u O
be O O
better t O
quantified n O
using n O
reference e O
plane n O
1 
 O
or O O
2 
 O
. 
 O
Importin o B-GENE
beta a E-GENE
mediates i O
nuclear l O
translocation n O
of O O
Smad d B-GENE
3 - E-GENE
. 
 O
The 	 O
encoded o O
protein t O
contains t O
an O O
amino n O
terminal m O
PDZ 	 B-GENE
domain a E-GENE
, 
 O
followed l O
by O O
a 
 O
predicted d O
coiled l O
- 
 O
coil l O
region i O
, 
 O
a 
 O
PEST T B-GENE
domain a E-GENE
, 
 O
and 	 O
a 
 O
carboxy b O
- 
 O
terminal m O
SAM 	 O
domain a O
. 
 O
Using n O
lasers e O
, 
 O
PRK 	 O
involves o O
reshaping h O
the 	 O
cornea n O
so O O
that t O
its 	 O
refractive r O
power e O
is O O
increased r O
. 
 O
However e O
, 
 O
sphincter i O
length g O
decreased r O
with h O
age 	 O
from m O
24 O O
. 
 O
3 
 O
to O O
14 O O
. 
 O
8 
 O
mm O O
. 
 O
, 
 O
maximal i O
urethral t O
pressure s O
from m O
88 O O
. 
 O
7 
 O
to O O
55 O O
cm O O
. 
 O
water e O
and 	 O
maximal i O
urethral t O
pressure s O
during i O
voluntary u O
contraction t O
from m O
221 	 O
. 
 O
4 
 O
to O O
166 	 O
. 
 O
3 
 O
cm O O
. 
 O
water e O
. 
 O
Several e O
studies d O
have e O
demonstrated o O
that t O
the 	 O
corticotropin t B-GENE
- - I-GENE
releasing e I-GENE
factor t E-GENE
test t O
( 
 O
CRF 	 O
) 
 O
is O O
useful f O
for 	 O
the 	 O
aetiological i O
diagnosis g O
of O O
Cushing h O
' 
 O
s 
 O
syndrome d O
: 
 O
in O O
Cushing h O
' 
 O
s 
 O
disease e O
, 
 O
as O O
opposed o O
to O O
ectopic o O
ACTH H S-GENE
secretion r O
syndrome d O
, 
 O
the 	 O
hypothalamus o O
- 
 O
pituitary u O
- 
 O
adrenal e O
( 
 O
HPA 	 O
) 
 O
axis s O
can 	 O
still l O
be O O
stimulated m O
by O O
CRF 	 S-GENE
. 
 O
Transcription n O
initiation t O
from m O
this s O
region i O
was 	 O
also o O
detected e O
in O O
vivo o O
, 
 O
when n O
the 	 O
cloned n O
rRNA A O
gene e O
cluster s O
was 	 O
present s O
on O O
a 
 O
multi t O
- 
 O
copy y O
plasmid s O
. 
 O
The 	 O
results u O
of O O
the 	 O
transient n O
- 
 O
transfection n O
assay a O
showed w O
that t O
the 	 O
Sp1 	 B-GENE
binding d I-GENE
element m E-GENE
located a O
in O O
the 	 O
core e O
region i O
( 
 O
positions i O
- 
 O
- 
 O
64 O O
to O O
+ 
 O
1 
 O
) 
 O
of O O
the 	 O
alpha2 h B-GENE
- - I-GENE
integrin e I-GENE
promoter m E-GENE
plays y O
an O O
essential e O
role e O
in O O
the 	 O
alpha2 h B-GENE
- - I-GENE
integrin e I-GENE
promoter m E-GENE
activity i O
and 	 O
its 	 O
downregulation n O
by O O
Erb 	 B-GENE
- 
 I-GENE
B2 S E-GENE
. 
 O
Principal n O
component p O
analysis l O
using n O
psychosocial c O
factors t O
in O O
women e O
showed w O
two 	 O
psychosocial c O
structures u O
, 
 O
i 
 O
. 
 O
e 
 O
. 
 O
the 	 O
second o O
principal n O
( 
 O
high h O
SOC 	 O
, 
 O
high h O
lifestyle e O
, 
 O
and 	 O
low 	 O
stress e O
) 
 O
and 	 O
the 	 O
4th 	 O
principal n O
components p O
( 
 O
high h O
supernatural e O
HLC 	 O
, 
 O
and 	 O
high h O
PHLC C O
) 
 O
. 
 O
Expression r O
of O O
FNCAT A S-GENE
increased r O
on O O
serum u O
treatment a O
indicating i O
that t O
the 	 O
region i O
of O O
the 	 O
FN B B-GENE
gene e E-GENE
between w O
positions i O
+ 
 O
69 O O
and 	 O
- 
 O
510 	 O
bp O O
mediated i O
serum u O
responsiveness p O
. 
 O
Interaction e O
of O O
the 	 O
v - B-GENE
- - I-GENE
rel 	 I-GENE
protein t E-GENE
with h O
an O O
NF B B-GENE
- - I-GENE
kappa p I-GENE
B - I-GENE
DNA 	 I-GENE
binding d I-GENE
site e E-GENE
. 
 O
This s O
increase r O
is O O
not 	 O
the 	 O
result u O
of O O
alterations e O
in O O
the 	 O
deposition o O
of O O
inhaled a O
particles t O
of O O
capsaicin s O
brought u O
about u O
by O O
volume u O
restriction t O
. 
 O
Providing v O
appropriate r O
care e O
to O O
both h O
sexes e O
. 
 O
To O O
test t O
this s O
hypothesis o O
, 
 O
we O O
developed e O
a 
 O
system t O
of O O
transient n O
transfection n O
of O O
rat 	 O
adipocytes p O
with h O
constructs s O
containing t O
glyceraldehyde c B-GENE
- - I-GENE
3 - I-GENE
- - I-GENE
phosphate s I-GENE
dehydrogenase y E-GENE
( 
 O
GAPDH D S-GENE
) 
 O
and 	 O
fatty t B-GENE
acid d I-GENE
synthetase t E-GENE
( 
 O
FAS 	 S-GENE
) 
 O
promoters m O
fused e O
to O O
gene e O
reporter o O
CAT 	 S-GENE
. 
 O
In O O
the 	 O
green e O
unicellular c O
alga a O
Chlamydomonas a O
eugametos a O
, 
 O
cellular l O
division i O
is O O
readily d O
synchronized c O
by O O
light h O
/ 
 O
dark k O
cycles l O
. 
 O
SHBG G S-GENE
concentrations c O
in O O
women e O
were e O
also o O
significantly n O
higher h O
at O O
T 
 O
- 
 O
2 
 O
and 	 O
T 
 O
- 
 O
3 
 O
when n O
compared p O
to O O
T 
 O
- 
 O
1 
 O
values u O
. 
 O
Simvastatin v O
decreased r O
levels e O
of O O
total a O
cholesterol l O
by O O
20 O O
. 
 O
8 
 O
% 
 O
, 
 O
LDL 	 B-GENE
cholesterol l E-GENE
by O O
29 O O
. 
 O
7 
 O
% 
 O
, 
 O
triglycerides g O
by O O
13 O O
. 
 O
6 
 O
% 
 O
, 
 O
apolipoprotein l B-GENE
B - E-GENE
by O O
22 O O
. 
 O
4 
 O
% 
 O
, 
 O
alpha h O
- 
 O
tocopherol o O
by O O
16 O O
. 
 O
2 
 O
% 
 O
, 
 O
beta a O
- 
 O
carotene o O
by O O
19 O O
. 
 O
5 
 O
% 
 O
, 
 O
and 	 O
ubiquinol q O
- 
 O
10 O O
by O O
22 O O
. 
 O
0 
 O
% 
 O
( 
 O
P 
 O
< 
 O
. 
 O
001 	 O
for 	 O
all 	 O
) 
 O
and 	 O
increased r O
levels e O
of O O
HDL 	 B-GENE
cholesterol l E-GENE
by O O
7 
 O
. 
 O
0 
 O
% 
 O
( 
 O
P 
 O
< 
 O
. 
 O
001 	 O
) 
 O
and 	 O
serum u B-GENE
insulin u E-GENE
by O O
13 O O
. 
 O
2 
 O
% 
 O
( 
 O
P 
 O
= 
 O
. 
 O
005 	 O
) 
 O
. 
 O
The 	 O
more e O
severe e O
the 	 O
CRF 	 O
, 
 O
the 	 O
more e O
likely e O
that t O
total a O
HDL 	 S-GENE
and 	 O
HDL2 2 B-GENE
cholesterol l E-GENE
will l O
be O O
low 	 O
. 
 O
They y O
are 	 O
growth w O
- 
 O
inhibited i O
by O O
TGF 	 B-GENE
- - I-GENE
beta1 a E-GENE
. 
 O
To O O
investigate e O
the 	 O
in O O
vivo o O
role e O
of O O
this s O
chimeric m B-GENE
bZIP P I-GENE
protein t E-GENE
in O O
oncogenic o O
transformation n O
, 
 O
its 	 O
expression r O
was 	 O
directed e O
to O O
the 	 O
lymphoid p O
compartments p O
of O O
transgenic n O
mice e O
. 
 O
This s O
is O O
consistent s O
with h O
the 	 O
need d O
for 	 O
a 
 O
nuclear l B-GENE
retinoid i I-GENE
receptor e E-GENE
function c O
in O O
RA O O
- 
 O
induced u O
ERK2 2 S-GENE
activation i O
. 
 O
In O O
the 	 O
virus u O
- 
 O
infected e O
cells l O
, 
 O
translation n O
of O O
the 	 O
M1 B B-GENE
protein t E-GENE
was 	 O
reduced u O
to O O
10 O O
to O O
20 O O
% 
 O
of O O
that t O
of O O
the 	 O
wild d O
- 
 O
type e O
virus u O
; 
 O
however e O
, 
 O
the 	 O
translation n O
of O O
neither t O
the 	 O
nucleoprotein l O
nor 	 O
NS1 	 S-GENE
was 	 O
significantly n O
interfered e O
with h O
, 
 O
indicating i O
the 	 O
important o O
role e O
of O O
NS1 	 S-GENE
in O O
translational n O
stimulation m O
of O O
the 	 O
M1 B B-GENE
protein t E-GENE
. 
 O
Some e O
cells l O
were e O
excited i O
, 
 O
others e O
inhibited i O
by O O
, 
 O
and 	 O
only y O
some e O
were e O
directionally e O
sensitive s O
to O O
the 	 O
optomotor o O
stimulus m O
. 
 O
LT B B-GENE
- - I-GENE
beta a E-GENE
transcription n O
is O O
maximal i O
in O O
the 	 O
thymic m O
medulla u O
and 	 O
in O O
splenic e O
white t O
pulp p O
. 
 O
A 
 O
novel e O
Cdc42Hs 4 B-GENE
mutant a E-GENE
induces u O
cellular l O
transformation n O
. 
 O
Interactions e O
were e O
also o O
detected e O
between w O
full l B-GENE
- 
 I-GENE
length g I-GENE
HSF1 1 E-GENE
and 	 O
the 	 O
small l O
subunit u O
( 
 O
gamma m O
) 
 O
of O O
TFIIA I S-GENE
. 
 O
We O O
report o O
that t O
Nim1 1 S-GENE
possesses s O
intrinsic r O
serine i B-GENE
- - I-GENE
kinase a E-GENE
, 
 O
threonine e B-GENE
- - I-GENE
kinase a E-GENE
and 	 O
tyrosine o B-GENE
- - I-GENE
kinase a E-GENE
activities i O
. 
 O
A 
 O
short r O
conserved s O
motif i O
is O O
required u O
for 	 O
repressor r O
domain a O
function c O
in O O
the 	 O
myeloid l B-GENE
- 
 I-GENE
specific c I-GENE
transcription n I-GENE
factor t I-GENE
CCAAT A I-GENE
/ - I-GENE
enhancer a I-GENE
- - I-GENE
binding d I-GENE
protein t I-GENE
epsilon i E-GENE
. 
 O
Androgen r O
ablation a O
- 
 O
- 
 O
50 O O
years r O
later e O
. 
 O
In O O
conclusion c O
, 
 O
ORCA3 A S-GENE
regulates u O
jasmonate m O
- 
 O
responsive p O
expression r O
of O O
the 	 O
Str 	 B-GENE
gene e E-GENE
via 	 O
direct e O
interaction e O
with h O
the 	 O
JERE E S-GENE
. 
 O
Also o O
, 
 O
the 	 O
absence e O
of O O
PdNi i O
between w O
the 	 O
segments m O
reduces u O
the 	 O
heat t O
production d O
of O O
the 	 O
seed d O
. 
 O
Theoretical o O
mechanisms h O
of O O
hyperuricemia e O
. 
 O
ORF3 3 S-GENE
encodes o O
a 
 O
putative a O
periplasmic i O
c - B-GENE
- - I-GENE
type e I-GENE
cytochrome o E-GENE
with h O
a 
 O
molecular e O
mass s O
of O O
94 O O
, 
 O
000 	 O
Da O O
and 	 O
contains t O
seven e O
c 
 O
- 
 O
heme e O
- 
 O
binding d O
motifs i O
but 	 O
shows w O
no O O
sequence u O
homology o O
to O O
occ 	 S-GENE
or O O
ORF1 1 S-GENE
. 
 O
Doxazosin a O
produced d O
increases r O
in O O
both h O
mean n O
and 	 O
maximum i O
urinary n O
flow w O
rates e O
of O O
1 
 O
. 
 O
01 O O
ml O O
/ 
 O
s 
 O
and 	 O
3 
 O
. 
 O
2 
 O
ml O O
/ 
 O
s 
 O
respectively p O
, 
 O
compared p O
with h O
0 
 O
. 
 O
21 O O
ml O O
/ 
 O
s 
 O
and 	 O
2 
 O
. 
 O
2 
 O
ml O O
/ 
 O
s 
 O
on O O
placebo c O
. 
 O
Hypoxia o O
decreased r O
the 	 O
rate e O
of O O
spontaneous n O
impulse u O
initiation t O
in O O
SA O O
nodal a O
fibers e O
by O O
decreasing r O
the 	 O
slope p O
of O O
diastolic s O
depolarization o O
. 
 O
BACKGROUND K B-GENE
- 
 I-GENE
- 
 I-GENE
Platelet t I-GENE
activating i I-GENE
factor t E-GENE
( 
 O
PAF 	 S-GENE
) 
 O
has 	 O
been n O
implicated l O
in O O
the 	 O
pathogenesis h O
of O O
airway w O
hyperresponsiveness e O
in O O
asthma h O
. 
 O
TFEC C B-GENE
RNA 	 E-GENE
is O O
found n O
in O O
many y O
tissues s O
of O O
adult l O
rats s O
, 
 O
but 	 O
the 	 O
relative a O
concentrations c O
of O O
TFEC C S-GENE
and 	 O
TFE3 3 B-GENE
RNAs s E-GENE
vary y O
considerably s O
in O O
these s O
different f O
tissues s O
. 
 O
Our 	 O
results u O
show w O
that t O
unlike i O
the 	 O
case e O
for 	 O
sos1 1 S-GENE
, 
 O
sos2 2 B-GENE
gene e E-GENE
function c O
is O O
dispensable p O
for 	 O
normal m O
mouse s O
development e O
, 
 O
growth w O
, 
 O
and 	 O
fertility t O
. 
 O
Studies d O
of O O
HS2 	 B-GENE
- - I-GENE
gamma m I-GENE
gene e I-GENE
reporter o I-GENE
constructs s E-GENE
carrying r O
CACCC C O
box 	 O
deletions e O
revealed e O
that t O
the 	 O
CACCC C O
box 	 O
sequence u O
of O O
the 	 O
gamma m B-GENE
gene e I-GENE
promoter m E-GENE
mediates i O
the 	 O
activation i O
of O O
the 	 O
gamma m O
gene e O
by O O
FKLF F S-GENE
. 
 O
Advisory i O
Committee m O
report o O
recommends o O
that t O
US O O
make e O
amends n O
for 	 O
human a O
radiation i O
experiments e O
. 
 O
Animals m O
were e O
divided i O
into o O
six 	 O
equal a O
groups u O
as O O
follows l O
: 
 O
( 
 O
1 
 O
) 
 O
no O O
oral l O
drug g O
( 
 O
water e O
) 
 O
, 
 O
no O O
hemodilution o O
, 
 O
no O O
IV O O
drug g O
( 
 O
saline i O
) 
 O
; 
 O
( 
 O
2 
 O
) 
 O
oral l O
water e O
, 
 O
hemodilution o O
, 
 O
IV O O
saline i O
; 
 O
( 
 O
3 
 O
) 
 O
oral l O
water e O
, 
 O
no O O
hemodilution o O
, 
 O
IV O O
propranolol p O
; 
 O
( 
 O
4 
 O
) 
 O
oral l O
water e O
, 
 O
hemodilution o O
, 
 O
IV O O
propranolol p O
; 
 O
( 
 O
5 
 O
) 
 O
oral l O
propranolol p O
, 
 O
no O O
hemodilution o O
, 
 O
IV O O
saline i O
; 
 O
and 	 O
( 
 O
6 
 O
) 
 O
oral l O
propranolol p O
, 
 O
hemodilution o O
, 
 O
IV O O
saline i O
. 
 O
First s O
, 
 O
a 
 O
GATA A B-GENE
- - I-GENE
1 - I-GENE
motif i E-GENE
was 	 O
found n O
to O O
bind d O
nuclear l O
factor t O
( 
 O
s 
 O
) 
 O
, 
 O
presumably s O
the 	 O
GATA A B-GENE
- - I-GENE
1 - I-GENE
factor t E-GENE
, 
 O
present s O
in O O
K 
 O
- 
 O
562 	 O
cell l O
extracts r O
and 	 O
in O O
living i O
K 
 O
- 
 O
562 	 O
cells l O
. 
 O
BPN 	 O
can 	 O
be O O
experimentally e O
produced d O
by O O
intratracheal r O
inoculation c O
of O O
microorganisms r O
in O O
high h O
concentrations c O
and 	 O
ventilator t O
- 
 O
associated o O
BPN 	 O
by O O
ventilating t O
baboons o O
with h O
oleic i O
- 
 O
acid d O
lung g O
injury u O
. 
 O
A 
 O
mouth t O
asymmetry m O
study d O
. 
 O
Additionally i O
, 
 O
these s O
findings d O
have e O
important o O
implications l O
for 	 O
the 	 O
understanding e O
of O O
the 	 O
mechanisms h O
of O O
HIV 	 O
- 
 O
1 
 O
latency e O
and 	 O
reactivation c O
. 
 O
This s O
inhibition i O
was 	 O
due 	 O
to O O
competition p O
from m O
the 	 O
EMC 	 B-GENE
virus u I-GENE
IRES S E-GENE
present s O
in O O
pEP 	 B-GENE
- - I-GENE
2A I I-GENE
transcripts n E-GENE
, 
 O
as O O
well l O
as O O
the 	 O
expression r O
of O O
proteolytically t O
active i O
2Apro r S-GENE
. 
 O
Some e O
may 	 O
affect e O
the 	 O
folding d O
pathway h O
or O O
the 	 O
affinity i O
for 	 O
chaperonins p O
. 
 O
Diet t O
imbalances a O
and 	 O
aflatoxicosis a O
48 O O
. 
 O
35 O O
+ 
 O
/ 
 O
- 
 O
5 
 O
. 
 O
07 O O
mg O O
/ 
 O
l 
 O
in O O
R3 O O
; 
 O
p 
 O
< 
 O
0 
 O
. 
 O
05 O O
) 
 O
and 	 O
in O O
the 	 O
AUC 	 O
( 
 O
0 
 O
. 
 O
50 O O
h 
 O
) 
 O
( 
 O
1429 9 O
. 
 O
92 O O
+ 
 O
/ 
 O
- 
 O
284 	 O
. 
 O
23 O O
in O O
PR O O
vs O O
. 
 O
The 	 O
effect e O
on O O
FIV 	 B-GENE
LTR 	 I-GENE
promoter m E-GENE
activity i O
of O O
progressively g O
deleting e O
these s O
nuclear l O
factor t O
binding d O
sites e O
was 	 O
examined m O
by O O
linking k O
LTR 	 B-GENE
deletion e I-GENE
mutants a E-GENE
to O O
the 	 O
chloramphenicol o B-GENE
acetyltransferase t E-GENE
( 
 O
CAT 	 S-GENE
) 
 O
gene e O
. 
 O
A 
 O
series i O
of O O
sequence u O
fragments g O
were e O
placed c O
5 
 O
' 
 O
to O O
the 	 O
chloramphenicol o B-GENE
acetyltransferase t E-GENE
( 
 O
CAT 	 S-GENE
) 
 O
reporter o O
gene e O
and 	 O
ability l O
to O O
mediate i O
transcription n O
of O O
CAT 	 S-GENE
in O O
response p O
to O O
IFN 	 B-GENE
gamma m E-GENE
or O O
LPS 	 O
treatment a O
was 	 O
studied d O
following l O
transient n O
transfection n O
in O O
the 	 O
macrophage r O
- 
 O
like e O
cell l O
line e O
RAW 	 O
264 	 O
. 
 O
7 
 O
. 
 O
As O O
part t O
of O O
a 
 O
large g O
Dutch c O
prospective s O
multicenter t O
study d O
( 
 O
Netherlands h O
Cooperative p O
Study d O
on O O
the 	 O
Adequacy q O
of O O
Dialysis l O
- 
 O
2 
 O
) 
 O
, 
 O
we O O
consecutively s O
included l O
all 	 O
new 	 O
patients i O
with h O
end 	 O
- 
 O
stage g O
renal a O
disease e O
for 	 O
whom m O
residual i O
renal a O
function c O
could l O
be O O
obtained a O
0 
 O
to O O
4 
 O
weeks k O
before o O
the 	 O
start r O
of O O
dialysis l O
therapy r O
. 
 O
Module u B-GENE
2 
 E-GENE
of O O
RifA A S-GENE
lacks k O
a 
 O
beta a B-GENE
- - I-GENE
ketoacyl o E-GENE
: - O
acyl l B-GENE
carrier r I-GENE
protein t I-GENE
reductase u E-GENE
( 
 O
KR S S-GENE
) 
 O
domain a O
and 	 O
the 	 O
one 	 O
in O O
module u O
3 
 O
has 	 O
an O O
apparently a O
inactive c O
NADPH P O
binding d O
motif i O
, 
 O
similar i O
to O O
one 	 O
found n O
in O O
the 	 O
Er B B-GENE
PKS 	 E-GENE
, 
 O
while l O
the 	 O
other e O
eight h O
KR B B-GENE
domains a E-GENE
of O O
the 	 O
Rf B B-GENE
PKS 	 E-GENE
should u O
be O O
functional c O
. 
 O
In O O
murine i O
cells l O
, 
 O
FPGS S S-GENE
expression r O
is O O
controlled t O
by O O
two 	 O
promoters m O
that t O
, 
 O
as O O
we O O
show w O
here e O
, 
 O
vary y O
substantially s O
in O O
their i O
efficiency i O
, 
 O
at O O
least s O
in O O
the 	 O
context t O
of O O
a 
 O
reporter o O
gene e O
assay a O
. 
 O
Should u O
we O O
use 	 O
thiazide a O
diuretics r O
in O O
hypertensive e O
patients i O
with h O
non 	 O
- 
 O
insulin u S-GENE
- 
 O
dependent e O
diabetes b O
mellitus l O
? 
 O
Reduced u O
glutathione t O
in O O
whole l O
blood o O
decreases r O
within h O
a 
 O
blood o O
Se O O
range g O
of O O
1 
 O
. 
 O
01 O O
to O O
2 
 O
. 
 O
28 O O
micrograms r O
in O O
the 	 O
high h O
Se O O
area a O
. 
 O
Sucrose r O
produced d O
in O O
source r O
leaves v O
is O O
the 	 O
predominant d O
carbon b O
source r O
for 	 O
developing e O
sink k O
tissues s O
in O O
most t O
higher h O
plants n O
. 
 O
A 
 O
personal s O
view w O
of O O
future u O
trends n O
in O O
the 	 O
field l O
of O O
immunoassay u O
concludes c O
this s O
review i O
. 
 O
In O O
accordance o O
with h O
Ann 	 O
Arbor o O
classification s O
, 
 O
we O O
observed e O
12 O O
CS O O
IA O O
( 
 O
21 O O
. 
 O
3 
 O
% 
 O
) 
 O
, 
 O
2 
 O
CS O O
IB O O
( 
 O
3 
 O
. 
 O
5 
 O
% 
 O
) 
 O
, 
 O
14 O O
CS O O
IIA 	 O
( 
 O
25 O O
. 
 O
4 
 O
% 
 O
) 
 O
and 	 O
27 O O
CS O O
IIB 	 O
( 
 O
49 O O
. 
 O
7 
 O
% 
 O
) 
 O
. 
 O
Numerous e O
genes e O
of O O
this s O
family i O
have e O
been n O
identified n O
in O O
animals m O
, 
 O
with h O
the 	 O
largest g O
number b O
found n O
in O O
vertebrates t O
. 
 O
The 	 O
GST 	 S-GENE
- 
 O
CBL 	 S-GENE
- 
 O
LZIP P S-GENE
fusion i O
protein t O
contains t O
a 
 O
binding d O
site e O
for 	 O
the 	 O
SH2 	 B-GENE
domain a E-GENE
of O O
the 	 O
p85 	 B-GENE
subunit u E-GENE
of O O
phosphatidylinositol s B-GENE
3 - I-GENE
- - I-GENE
kinase a E-GENE
, 
 O
which c O
mapped p O
to O O
Tyr731 7 O
, 
 O
which c O
is O O
present s O
in O O
the 	 O
sequence u O
YEAM M O
. 
 O
We O O
have e O
previously v O
shown w O
that t O
UNC 	 B-GENE
- - I-GENE
4 - E-GENE
expression r O
in O O
the 	 O
VA O O
motor o O
neurons r O
specifies c O
the 	 O
wild d O
- 
 O
type e O
pattern t O
of O O
presynaptic s O
input u O
. 
 O
Significant n O
differences f O
were e O
observed e O
in O O
the 	 O
composition p O
of O O
nuclear l O
transcription n O
factors t O
bound n O
to O O
cis 	 O
- 
 O
elements m O
within h O
the 	 O
LDH 	 B-GENE
/ - I-GENE
C - I-GENE
proximal x I-GENE
promoter m I-GENE
region i E-GENE
in O O
somatic a O
versus s O
germ m O
cells l O
. 
 O
Above v O
this s O
transition n O
temperature p O
the 	 O
calcium c O
antagonist a O
lowers e O
fm O O
more e O
pronouncedly n O
than n O
below o O
. 
 O
( 
 O
1986 6 O
) 
 O
described c O
optic i O
nerve v O
degenerations e O
in O O
patients i O
with h O
Alzheimer h O
' 
 O
s 
 O
disease e O
and 	 O
Sadun u O
published l O
a 
 O
dropout p O
of O O
retinal i O
ganglion g O
cells l O
that t O
range g O
from m O
30 O O
% 
 O
to O O
60 O O
% 
 O
. 
 O
It O O
has 	 O
become o O
clear a O
that t O
there r O
is O O
not 	 O
one 	 O
mediator i O
responsible p O
for 	 O
ALI 	 S-GENE
, 
 O
but 	 O
rather h O
a 
 O
complex p O
interplay e O
exists s O
between w O
diverse e O
proinflammatory i O
( 
 O
e 
 O
. 
 O
g 
 O
. 
 O
, 
 O
lipopolysaccharide o O
, 
 O
complement p O
products d O
, 
 O
cytocains o O
, 
 O
chemocains m O
, 
 O
reactive c O
oxygen g O
species c O
and 	 O
arachidonic c O
acid d O
products d O
) 
 O
and 	 O
anti i O
- 
 O
inflammatory l O
( 
 O
IL B B-GENE
- - I-GENE
10 E E-GENE
, 
 O
IL B B-GENE
- - I-GENE
1 - I-GENE
- - I-GENE
RA E E-GENE
, 
 O
PGI2 2 S-GENE
) 
 O
mediators i O
. 
 O
We O O
then n O
supplemented p O
these s O
spliceosomes i O
with h O
purified i O
proteins t O
or O O
yeast s O
extract r O
fractions c O
as O O
a 
 O
functional c O
assay a O
for 	 O
second o O
- 
 O
step p O
splicing i O
factors t O
. 
 O
Contrast t O
radiography i O
appears e O
to O O
be O O
an O O
especially e O
inaccurate c O
method h O
to O O
document u O
PUD 	 O
in O O
CF O O
because a O
the 	 O
duodenal d O
mucosa o O
typically i O
appears e O
nodular u O
and 	 O
distorted t O
with h O
poor r O
definition i O
of O O
the 	 O
mucosal o O
folds d O
. 
 O
We O O
now 	 O
show w O
that t O
the 	 O
FRAP P O
Ser2035 2 O
- 
 O
- 
 O
> 
 O
Ala 	 O
mutant a O
displays p O
similar i O
binding d O
affinity i O
when n O
compared p O
with h O
the 	 O
wild d O
- 
 O
type e O
protein t O
, 
 O
whereas r O
all 	 O
other e O
mutations a O
at O O
this s O
site e O
, 
 O
including l O
mimics i O
of O O
phosphoserine s O
, 
 O
abolish l O
binding d O
, 
 O
presumably s O
due 	 O
to O O
either h O
unfavorable a O
steric r O
interactions e O
or O O
induced u O
conformational f O
changes n O
. 
 O
A 
 O
Brassica s O
cDNA A O
clone n O
encoding o O
a 
 O
bifunctional u B-GENE
hydroxymethylpyrimidine r I-GENE
kinase a E-GENE
/ 
 O
thiamin a B-GENE
- - I-GENE
phosphate s I-GENE
pyrophosphorylase o E-GENE
involved o O
in O O
thiamin a O
biosynthesis s O
. 
 O
Titres r O
of O O
antistreptolysin i B-GENE
O - E-GENE
in O O
mothers h O
of O O
children l O
affected e O
with h O
Down n O
' 
 O
s 
 O
syndrome d O
. 
 O
Differential f O
decay a O
of O O
a 
 O
polycistronic y O
Escherichia h O
coli i O
transcript n O
is O O
initiated t O
by O O
RNaseE s S-GENE
- 
 O
dependent e O
endonucleolytic o O
processing c O
. 
 O
Defects e O
in O O
RT6 	 S-GENE
expression r O
coincide n O
with h O
increased r O
susceptibility c O
in O O
animal m O
models e O
for 	 O
insulin u S-GENE
- 
 O
dependent e O
diabetes b O
mellitus l O
and 	 O
other e O
autoimmune o O
diseases e O
. 
 O
By O O
means n O
of O O
early l O
detection e O
and 	 O
correction r O
of O O
the 	 O
possible s O
causes s O
, 
 O
the 	 O
goal l O
of O O
increasing r O
therapeutic r O
efficacy i O
can 	 O
be O O
achieved i O
. 
 O
We O O
have e O
previously v O
described c O
the 	 O
partial t O
purification i O
of O O
Ap4A A B-GENE
hydrolase r E-GENE
from m O
S 
 O
. 
 O
pombe b O
[ 
 O
Robinson i O
, 
 O
de O O
la O O
Pena a O
and 	 O
Barnes n O
( 
 O
1993 3 O
) 
 O
Biochim c O
. 
 O
Effect e O
of O O
a 
 O
new 	 O
positive i O
inotropic t O
agent n O
( 
 O
OPC 	 O
- 
 O
8212 2 O
) 
 O
on O O
intracellular r O
potential e O
of O O
isolated l O
canine i O
ventricular t O
papillary i O
muscle c O
The 	 O
unc 	 B-GENE
- - I-GENE
101 	 E-GENE
, 
 O
sli 	 B-GENE
- - I-GENE
1 - E-GENE
, 
 O
and 	 O
rok 	 B-GENE
- - I-GENE
1 - I-GENE
genes e E-GENE
encode o O
a 
 O
distinct t O
set 	 O
of O O
negative a O
regulators u O
of O O
vulval v O
differentiation f O
. 
 O
Thirty r O
- 
 O
seven e O
patients i O
with h O
severe e O
temporal p O
lobe e O
epilepsy l O
were e O
studied d O
interictally e O
with h O
[ 
 O
18F 	 O
] 
 O
fluorodeoxyglucose o O
- 
 O
PET 	 O
in O O
each h O
of O O
three e O
conditions d O
: 
 O
resting t O
, 
 O
during i O
emotional t O
speech e O
, 
 O
and 	 O
while l O
performing f O
a 
 O
visual u O
recognition o O
task k O
. 
 O
SYC1 1 S-GENE
( 
 O
suppressor p O
of I O
yeast s B-GENE
cbf5 5 I-GENE
- - I-GENE
1 - E-GENE
) 
 O
was 	 O
identified n O
as O O
a 
 O
multicopy t O
suppressor p O
of O O
cbf5 5 B-GENE
- - I-GENE
1 - E-GENE
and 	 O
subsequently s O
was 	 O
found n O
to O O
be O O
identical n O
to O O
RRN3 3 S-GENE
, 
 O
an O O
RNA 	 B-GENE
polymerase y I-GENE
I - I-GENE
transcription n I-GENE
factor t E-GENE
. 
 O
Newly l O
hatched c O
F1 O O
nymphs p O
of O O
Aiolopus l O
thalassinus l O
( 
 O
Fabr r O
. 
 O
) 
 O
were e O
fed 	 O
on O O
food d O
treated a O
with h O
various i O
concentrations c O
of O O
HgCl2 l O
, 
 O
CdCl2 l O
, 
 O
and 	 O
PbCl2 l O
until i O
the 	 O
end 	 O
of O O
adult l O
life e O
. 
 O
Neuronal r O
activity i O
of O O
58 O O
dopaminergic a O
( 
 O
DA O O
) 
 O
and 	 O
200 	 O
non 	 O
- 
 O
dopaminergic a O
( 
 O
non 	 O
- 
 O
DA O O
) 
 O
neurons r O
in O O
the 	 O
ventral t O
tegmental m O
area a O
( 
 O
VTA 	 O
) 
 O
of O O
female a O
monkeys k O
was 	 O
recorded o O
, 
 O
and 	 O
correlation r O
to O O
bar 	 O
press s O
feeding d O
, 
 O
sensory s O
stimulation m O
and 	 O
change n O
in O O
motivation i O
was 	 O
investigated e O
. 
 O
Both h O
sequence u O
analysis l O
and 	 O
restriction t O
fragment g O
length g O
polymorphism y O
analysis l O
revealed e O
a 
 O
high h O
degree r O
of O O
sequence u O
( 
 O
97 O O
% 
 O
homology o O
) 
 O
and 	 O
structural u O
similarity i O
among n O
members b O
of O O
the 	 O
ART 	 B-GENE
- 
 I-GENE
CH S I-GENE
family i E-GENE
, 
 O
indicating i O
their i O
common m O
origin g O
and 	 O
recent e O
penetration e O
into o O
chicken c O
DNA 	 O
. 
 O
Three e O
of O O
these s O
positions i O
are 	 O
novel e O
in O O
that t O
they y O
had 	 O
not 	 O
been n O
identified n O
to O O
be O O
important o O
for 	 O
binding d O
PC O O
by O O
previous v O
crystallographic s O
analysis l O
. 
 O
We O O
demonstrate o O
inhibition i O
of O O
2 
 O
- 
 O
deoxyglucose x O
uptake a O
in O O
isolated l O
primary m O
rat 	 O
adipocytes p O
and 	 O
3T3 	 O
- 
 O
L1 O O
adipocytes p O
pretreated t O
with h O
U73122 1 O
. 
 O
The 	 O
elevated v O
levels e O
of O O
inositol s O
phosphates s O
resulting u O
from m O
N - O
( - O
epi 	 O
) - O
alpha h O
qQ209L 0 O
expression r O
were e O
similar i O
to O O
those s O
obtained a O
with h O
carbachol b O
activation i O
of O O
the 	 O
M1 B B-GENE
muscarinic c I-GENE
acetylcholine t I-GENE
receptor e E-GENE
. 
 O
In O O
addition i O
, 
 O
wild d O
- 
 O
type e O
and 	 O
mutated a O
DNA 	 O
templates p O
were e O
used d O
as O O
probes b O
in O O
DNase s B-GENE
I - E-GENE
protection t O
experiments e O
to O O
determine e O
sites e O
of O O
protein t O
- 
 O
DNA 	 O
interaction e O
. 
 O
We O O
tested t O
the 	 O
hypothesis o O
that t O
PEH 	 O
is O O
associated o O
with h O
reductions u O
in O O
TPR 	 O
and 	 O
sympathetic p O
nerve v O
activity i O
( 
 O
SNA 	 O
) 
 O
. 
 O
Salt t O
wars s O
. 
 O
RESULTS U O
: 
 O
BMK 	 O
- - O
1 - O
and 	 O
other e O
19 O O
contents t O
significantly n O
decreased r O
depolarization o O
parameters a O
Vmax x O
, 
 O
APA 	 O
, 
 O
OS O O
, 
 O
and 	 O
MDP 	 O
, 
 O
which c O
was 	 O
similar i O
to O O
that t O
of O O
TTX 	 O
and 	 O
different f O
from m O
that t O
of O O
Nim 	 S-GENE
and 	 O
BaCl2 l O
. 
 O
In O O
the 	 O
latter t O
, 
 O
the 	 O
cells l O
and 	 O
adjacent a O
matrix r O
had 	 O
several e O
characteristics r O
of O O
fibrocartilage r O
, 
 O
including l O
chondrocytes n O
. 
 O
Mannich n O
bases e O
of O O
vanillin i O
oxime m O
. 
 O
All 	 O
exon n O
/ 
 O
intron r O
splice i O
junctions c O
follow l O
the 	 O
GT O O
/ 
 O
AG O O
rule e O
. 
 O
Previous v O
work k O
has 	 O
shown w O
that t O
glucose c O
repression r O
of O O
PRB1 1 S-GENE
transcription n O
is O O
not 	 O
mediated i O
by O O
HXK2 2 S-GENE
or O O
by O O
the 	 O
SNF1 1 S-GENE
, 
 O
SNF4 4 S-GENE
, 
 O
and 	 O
SNF6 6 B-GENE
genes e E-GENE
( 
 O
C 
 O
. 
 O
Comparison p O
of O O
the 	 O
encoded o O
ERCC3Dm C B-GENE
protein t E-GENE
with h O
the 	 O
homologous o O
proteins t O
of O O
mouse s O
and 	 O
man 	 O
shows w O
a 
 O
strong o O
amino n O
acid d O
conservation s O
( 
 O
71 O O
% 
 O
identity n O
) 
 O
, 
 O
especially e O
in O O
the 	 O
postulated t O
DNA 	 O
binding d O
region i O
and 	 O
seven e O
' - O
helicase i S-GENE
' - O
domains a O
. 
 O
The 	 O
pyridostigmine i O
inhibited i O
AChE E O
recovered o O
only y O
in O O
the 	 O
100 	 O
mumol o O
kg O O
- 
 O
1 
 O
kg O O
oxime m O
groups u O
at O O
the 	 O
end 	 O
of O O
the 	 O
experiment e O
. 
 O
In O O
the 	 O
case e O
of O O
a 
 O
moderate e O
buccal c O
Class s O
II O O
tendency d O
, 
 O
55 O O
% 
 O
of O O
the 	 O
molars a O
were e O
in O O
a 
 O
Class s O
I 
 O
relationship a O
when n O
evaluated l O
from m O
the 	 O
lingual g O
side e O
, 
 O
whereas r O
45 O O
% 
 O
belonged o O
to O O
mild d O
( 
 O
1st 	 O
degrees r O
) 
 O
Class s O
II O O
with h O
molar a O
rotations a O
present s O
in O O
81 O O
% 
 O
of O O
the 	 O
cases e O
. 
 O
Mutation a O
of O O
this s O
threonine e O
to O O
isoleucine l O
had 	 O
no O O
observable e O
effect e O
on O O
either h O
nuclear l O
localization a O
of O O
E1 S S-GENE
or O O
DNA 	 O
replication l O
of O O
the 	 O
intact a O
viral a O
genome o O
. 
 O
Serum u O
prolactin l S-GENE
and 	 O
oestradiol t O
levels e O
at O O
different f O
stages g O
of O O
puberty e O
. 
 O
This s O
suggests g O
that t O
the 	 O
duration a O
of O O
varicocele i O
per 	 O
se O O
could l O
affect e O
DHT 	 O
seminal i O
plasma s O
levels e O
. 
 O
Left t O
ventricular t O
responses p O
to O O
dopamine a O
in O O
dilated a O
cardiomyopathy d O
as O O
assessed e O
by O O
two 	 O
- 
 O
dimensional e O
echocardiography o O
and 	 O
compared p O
with h O
findings d O
of O O
thallium l O
- 
 O
201 	 O
scintigraphy n O
. 
 O
Detailed a O
comparison p O
of O O
the 	 O
urinary n O
excretion r O
of O O
purines i O
in O O
a 
 O
patient i O
with h O
the 	 O
Lesch c O
- 
 O
Nyhan a O
syndrome d O
and 	 O
a 
 O
control t O
subject j O
. 
 O
This s O
enzyme y O
is O O
distinct t O
from m O
other e O
known w O
E3s 	 S-GENE
, 
 O
including l O
E3 B B-GENE
alpha h E-GENE
/ 
 O
UBR1 1 S-GENE
, 
 O
E3 B B-GENE
beta a E-GENE
, 
 O
and 	 O
E6 B B-GENE
- - I-GENE
AP E E-GENE
. 
 O
This s O
evidence d O
, 
 O
together e O
with h O
the 	 O
ability l O
of O O
a 
 O
carboxyl b O
- 
 O
terminal m O
coding i O
sequence u O
starting r O
from m O
the 	 O
BamHI H B-GENE
site e E-GENE
to O O
complement p O
a 
 O
shy1 1 B-GENE
mutant a E-GENE
, 
 O
suggests g O
that t O
the 	 O
Shy1p 1 S-GENE
contains t O
two 	 O
domains a O
that t O
can 	 O
be O O
separately a O
expressed r O
to O O
form m O
a 
 O
functional c O
protein t O
. 
 O
The 	 O
zinc c B-GENE
finger g I-GENE
protein t I-GENE
A20 	 E-GENE
is O O
a 
 O
tumor o B-GENE
necrosis r I-GENE
factor t E-GENE
( 
 O
TNF 	 S-GENE
) 
 O
- 
 O
and 	 O
interleukin e B-GENE
1 - E-GENE
( 
 O
IL B B-GENE
- - I-GENE
1 - E-GENE
) 
 O
- 
 O
inducible u O
protein t O
that t O
negatively a O
regulates u O
nuclear l B-GENE
factor t I-GENE
- - I-GENE
kappa p I-GENE
B - E-GENE
( 
 O
NF B B-GENE
- - I-GENE
kappaB p E-GENE
) 
 O
- 
 O
dependent e O
gene e O
expression r O
. 
 O
A 
 O
visibly i O
distinct t O
muscular c O
hypertrophy e O
( 
 O
mh O O
) 
 O
, 
 O
commonly m O
known w O
as O O
double b O
muscling c O
, 
 O
occurs u O
with h O
high h O
frequency q O
in O O
the 	 O
Belgian g O
Blue e O
and 	 O
Piedmontese d O
cattle t O
breeds e O
. 
 O
For 	 O
the 	 O
population u O
of O O
patients i O
with h O
melanoma a O
levels e O
III 	 O
and 	 O
IV O O
significant n O
differences f O
in O O
survival v O
rate e O
were e O
associated o O
with h O
thickness c O
( 
 O
less s O
than n O
2 
 O
mm O O
or O O
greater a O
than n O
or O O
equal a O
to O O
2 
 O
mm O O
; 
 O
p 
 O
less s O
than n O
0 
 O
, 
 O
001 	 O
) 
 O
, 
 O
though u O
not 	 O
with h O
level e O
. 
 O
At O O
least s O
one 	 O
such h O
complex p O
is O O
eliminated m O
by O O
preincubating i O
the 	 O
nuclear l O
extract r O
with h O
an O O
antibody i O
with h O
broad a O
cross s O
- 
 O
reactivity c O
with h O
Ets 	 B-GENE
- - I-GENE
1 - E-GENE
and 	 O
Ets 	 B-GENE
- - I-GENE
2 - I-GENE
proteins t E-GENE
, 
 O
thus s O
confirming f O
that t O
an O O
ETS 	 B-GENE
transcription n I-GENE
factor t E-GENE
( - O
s - O
) - O
recognizes o O
the 	 O
- 
 O
12 O O
motif i O
. 
 O
Mutant a B-GENE
beta2 a I-GENE
- - I-GENE
adrenergic e I-GENE
receptors e E-GENE
with h O
a 
 O
Tyr 	 O
- 
 O
to O O
- 
 O
Phe 	 O
substitution s O
at O O
Tyr 	 O
- 
 O
350 	 O
do O O
not 	 O
display p O
agonist n O
- 
 O
induced u O
desensitization e O
, 
 O
Src 	 S-GENE
recruitment r O
, 
 O
or O O
Src 	 S-GENE
activation i O
. 
 O
Role e O
of O O
distinct t O
mitogen o B-GENE
- - I-GENE
activated i I-GENE
protein t I-GENE
kinase a E-GENE
pathways h O
and 	 O
cooperation p O
between w O
Ets 	 B-GENE
- - I-GENE
2 - E-GENE
, 
 O
ATF 	 B-GENE
- - I-GENE
2 - E-GENE
, 
 O
and 	 O
Jun 	 B-GENE
family i I-GENE
members b E-GENE
in O O
human a B-GENE
urokinase k E-GENE
- - O
type e O
plasminogen s B-GENE
activator i I-GENE
gene e E-GENE
induction u O
by O O
interleukin e B-GENE
- - I-GENE
1 - E-GENE
and 	 O
tetradecanoyl r O
phorbol r O
acetate t O
. 
 O
Immunoblot u O
analysis l O
of O O
purified i O
and 	 O
protease t O
- 
 O
digested e O
intracellular r O
mature u O
virus u O
( 
 O
IMV 	 O
) 
 O
and 	 O
extracellular r O
enveloped e O
virus u O
( 
 O
EEV 	 O
) 
 O
showed w O
that t O
the 	 O
A36R R B-GENE
proteins t E-GENE
were e O
present s O
on O O
the 	 O
surface f O
of O O
EEV 	 O
with h O
type e O
II O O
membrane b O
topology o O
, 
 O
but 	 O
were e O
absent e O
from m O
IMV 	 O
. 
 O
Here e O
we O O
demonstrate o O
that t O
several e O
genes e O
associated o O
with h O
NHEJ J S-GENE
perform f O
essential e O
functions c O
in O O
the 	 O
repair a O
of O O
endonuclease o O
- 
 O
induced u O
DSBs s O
in O O
vivo o O
. 
 O
The 	 O
failure l O
suggests g O
that t O
these s O
assembly e O
competent p O
but 	 O
complementation p O
- 
 O
negative a O
alpha h O
mutants a O
lack k O
an O O
as O O
yet 	 O
unidentified d O
function c O
( 
 O
s 
 O
) 
 O
. 
 O
Psychopathological c O
, 
 O
vegetative e O
, 
 O
and 	 O
vital a O
parameters a O
were e O
assessed e O
every r O
hour r O
. 
 O
RESULTS U O
: 
 O
Considering s O
an O O
inulin l O
clearance a O
of O O
less s O
than n O
80 O O
ml O O
/ 
 O
min 	 O
/ 
 O
1 
 O
. 
 O
73 O O
m2 O O
, 
 O
the 	 O
cut 	 O
- 
 O
off 	 O
value u O
for 	 O
serum u O
creatinine a O
was 	 O
11 O O
. 
 O
5 
 O
mumol o O
/ 
 O
liter e O
for 	 O
men 	 O
and 	 O
90 O O
mumol o O
/ 
 O
liter e O
for 	 O
women e O
. 
 O
These s O
data a O
may 	 O
indicate i O
redundancy u O
between w O
members b O
of O O
the 	 O
NGFI I B-GENE
- - I-GENE
B - E-GENE
/ 
 O
Nurr1 r S-GENE
/ 
 O
Nor1 1 S-GENE
subfamily f O
and 	 O
could l O
explain l O
why 	 O
no O O
phenotypic n O
disturbances t O
have e O
yet 	 O
been n O
found n O
in O O
mice e O
in O O
which c O
the 	 O
NGFI I B-GENE
- - I-GENE
B - I-GENE
gene e E-GENE
has 	 O
been n O
inactivated c O
. 
 O
Manual u O
sample p O
clean a O
- 
 O
up O O
procedures c O
as O O
well l O
as O O
the 	 O
addition i O
of O O
an O O
internal e O
standard n O
are 	 O
not 	 O
needed d O
. 
 O
To O O
directly e O
address r O
this s O
issue u O
, 
 O
we O O
used d O
a 
 O
tetracycline r O
- 
 O
regulated u O
system t O
in O O
human a O
U2OS S O
osteosarcoma e O
cells l O
and 	 O
thus s O
found n O
that t O
BCL6 6 S-GENE
mediates i O
growth w O
suppression p O
associated o O
with h O
impaired a O
S 
 O
phase s O
progression g O
and 	 O
apoptosis p O
. 
 O
TAAG G B-GENE
sites e E-GENE
that t O
serve v O
as O O
functional c O
late e O
promoters m O
in O O
OpMNPV N S-GENE
were e O
found n O
to O O
mediate i O
transcription n O
initiation t O
at O O
only y O
basal a O
levels e O
in O O
the 	 O
context t O
of O O
the 	 O
AcMNPV N O
genome o O
, 
 O
suggesting g O
that t O
late e O
promoter m O
activation i O
may 	 O
be O O
virus u O
specific c O
within h O
the 	 O
family i O
Baculoviridae u O
. 
 O
Stability b O
of O O
125 	 O
I 
 O
- 
 O
labeled e O
insulin u S-GENE
used d O
in O O
radioimmunoassay i O
of O O
insulin u S-GENE
. 
 O
In O O
absence e O
of O O
i 
 O
. 
 O
m 
 O
. 
 O
medication i O
, 
 O
levels e O
over r O
1 
 O
, 
 O
000 	 O
U 
 O
must t O
be O O
carefully e O
screened e O
in O O
order e O
to O O
rule e O
out 	 O
SNM 	 O
or O O
organic a O
pathology h O
associated o O
. 
 O
Paclitaxel l O
caused s O
a 
 O
rapid i O
and 	 O
transient n O
increase r O
in O O
c - B-GENE
- - I-GENE
Jun 	 I-GENE
NH2 	 I-GENE
- - I-GENE
terminal m I-GENE
kinase a E-GENE
( 
 O
JNK 	 S-GENE
) 
 O
activity i O
, 
 O
a 
 O
proposed p O
mediator i O
of O O
stress e O
activation i O
pathways h O
. 
 O
These s O
results u O
indicate i O
that t O
H - B-GENE
- - I-GENE
2RIIBP I E-GENE
( 
 O
i 
 O
) 
 O
is O O
a 
 O
member b O
of O O
the 	 O
superfamily e O
of O O
nuclear l B-GENE
hormone m I-GENE
receptors e E-GENE
and 	 O
( 
 O
ii O O
) 
 O
may 	 O
regulate u O
not 	 O
only y O
MHC 	 B-GENE
class s I-GENE
I - I-GENE
genes e E-GENE
but 	 O
also o O
genes e O
containing t O
the 	 O
ERE 	 O
and 	 O
related a O
sequences u O
. 
 O
Two 	 O
courses r O
of O O
chemotherapy m O
( 
 O
CBCDA D O
+ 
 O
VDS 	 O
) 
 O
failed l O
to O O
gain n O
any 	 O
improvement r O
, 
 O
and 	 O
the 	 O
pain n O
resulting u O
from m O
recurrent u O
bone e O
metastases a O
was 	 O
managed a O
mainly n O
by O O
the 	 O
administration i O
of O O
the 	 O
best t O
supportive p O
care e O
. 
 O
We O O
show w O
here e O
that t O
Spb1p 1 S-GENE
is O O
able e O
to O O
bind d O
[ 
 O
( 
 O
3 
 O
) 
 O
H 
 O
] 
 O
AdoMet M O
in O O
vitro r O
, 
 O
suggesting g O
that t O
it O O
is O O
a 
 O
novel e O
methylase h S-GENE
, 
 O
whose s O
possible s O
substrates s O
will l O
be O O
discussed c O
. 
 O
RESULTS U O
: 
 O
Lateral e O
PF O O
OA O O
was 	 O
more e O
common m O
than n O
medial i O
PF O O
OA O O
( 
 O
P 
 O
< 
 O
0 
 O
. 
 O
0001 1 O
) 
 O
. 
 O
CONCLUSION C O
: 
 O
Urbanisation a O
is O O
associated o O
with h O
an O O
increase r O
in O O
the 	 O
prevalence v O
rates e O
of O O
some e O
risk k O
behaviours a O
. 
 O
However e O
, 
 O
additional i O
studies d O
on O O
cell l O
lines e O
and 	 O
whole l O
animals m O
are 	 O
required u O
to O O
understand e O
GnRH H S-GENE
signaling n O
in O O
the 	 O
context t O
of O O
other e O
hormones m O
during i O
the 	 O
reproductive r O
cycle l O
of O O
mouse s O
and 	 O
human a O
. 
 O
Serum u B-GENE
angiogenin i E-GENE
concentrations c O
in O O
young n O
patients i O
with h O
diabetes b O
mellitus l O
. 
 O
This s O
duplicated l O
genomic o O
region i O
is O O
also o O
linked k O
tightly h O
to O O
D1Z2 2 S-GENE
, 
 O
a 
 O
genetic e O
marker k O
containing t O
a 
 O
highly h O
polymorphic y O
VNTR R O
( 
 O
variable i O
number b O
tandem d O
repeat e O
) 
 O
consisting s O
of O O
an O O
unusual s O
40 O O
- 
 O
bp O O
reiterated t O
sequence u O
. 
 O
ATF6 6 S-GENE
, 
 O
a 
 O
basic i B-GENE
- - I-GENE
leucine c I-GENE
zipper p I-GENE
protein t E-GENE
, 
 O
was 	 O
isolated l O
by O O
binding d O
to O O
SRF 	 S-GENE
and 	 O
in O O
particular t O
to O O
its 	 O
transcriptional n O
activation i O
domain a O
. 
 O
Cetn1 n S-GENE
possesses s O
the 	 O
sequence u O
features t O
of O O
an O O
expressed r O
retroposon r O
: 
 O
the 	 O
gene e O
lacks k O
introns r O
, 
 O
the 	 O
open n O
reading d O
frame m O
is O O
not 	 O
interrupted e O
by O O
stop p O
codons o O
, 
 O
and 	 O
the 	 O
coding i O
region i O
is O O
flanked n O
by O O
a 
 O
pair r O
of O O
direct e O
repeats e O
. 
 O
The 	 O
largest g O
one 	 O
probably b O
corresponds r O
to O O
the 	 O
precursor c O
form m O
of O O
PS2 	 S-GENE
in O O
E 
 O
. 
 O
coli i O
. 
 O
The 	 O
Aspergillus e B-GENE
uvsH H I-GENE
gene e E-GENE
encodes o O
a 
 O
product d O
homologous o O
to O O
yeast s B-GENE
RAD18 1 E-GENE
and 	 O
Neurospora r B-GENE
UVS 	 I-GENE
- - I-GENE
2 - E-GENE
. 
 O
On O O
average r O
these s O
maximum i O
potency e O
estimates i O
were e O
within h O
one 	 O
order e O
of O O
magnitude n O
of O O
the 	 O
inverse e O
maximum i O
dose e O
tested t O
. 
 O
VAV 	 S-GENE
and 	 O
SOCS1 S S-GENE
form m O
a 
 O
protein t O
complex p O
through o O
interactions e O
between w O
the 	 O
VAV 	 O
NH I O
( - O
2 - O
) - O
- - O
terminal m O
regulatory u O
region i O
and 	 O
the 	 O
SH2 	 B-GENE
domain a E-GENE
of O O
SOCS1 S S-GENE
in O O
a 
 O
phosphotyrosine s O
- 
 O
independent e O
manner n O
. 
 O
The 	 O
originally g O
embryonic r O
gamma m B-GENE
- - I-GENE
globin b I-GENE
locus u E-GENE
duplicated l O
and 	 O
acquired u O
a 
 O
novel e O
( 
 O
fetal a O
) 
 O
pattern t O
of O O
expression r O
in O O
a 
 O
defined i O
time e O
period i O
( 
 O
55 O O
- 
 O
40 O O
million l O
years r O
ago 	 O
) 
 O
during i O
primate m O
phylogeny l O
. 
 O
Clostridium s O
botulinum u O
in O O
marine i O
sediment i O
Northern t O
blot t O
analysis l O
with h O
GPR37 3 S-GENE
probes b O
revealed e O
a 
 O
main n O
3 
 O
. 
 O
8 
 O
- 
 O
kb O O
mRNA A O
and 	 O
a 
 O
less s O
abundant n O
8 
 O
- 
 O
kb O O
mRNA A O
, 
 O
both h O
expressed r O
in O O
human a O
brain i O
tissues s O
, 
 O
particularly t O
in O O
corpus p O
callosum l O
, 
 O
medulla u O
, 
 O
putamen a S-GENE
, 
 O
and 	 O
caudate d O
nucleus l O
. 
 O
Our 	 O
studies d O
indicate i O
no O O
single g O
trans n O
- 
 O
acting i O
factor t O
is O O
absolutely o O
essential e O
for 	 O
enhancer a O
activity i O
, 
 O
and 	 O
that t O
the 	 O
enhancer a O
activity i O
of O O
MerI I S-GENE
is O O
mediated i O
via 	 O
a 
 O
combinatorial b O
and 	 O
additive i O
mechanism h O
. 
 O
In O O
human a O
WI38 8 O
cells l O
, 
 O
the 	 O
E1B 	 B-GENE
19K 	 I-GENE
gene e I-GENE
mutant a E-GENE
viruses u O
had 	 O
a 
 O
substantial s O
growth w O
advantage a O
over r O
the 	 O
wild d O
- 
 O
type e O
virus u O
, 
 O
yielding l O
500 	 O
- 
 O
fold d O
- 
 O
higher h O
titers e O
. 
 O
To O O
elucidate c O
the 	 O
mechanism h O
of O O
these s O
hormonal m O
effects e O
, 
 O
we O O
have e O
studied d O
the 	 O
regulatory u O
regions i O
of O O
the 	 O
PFK 	 B-GENE
- - I-GENE
2 - I-GENE
gene e E-GENE
in O O
transfection n O
experiments e O
. 
 O
Consequently s O
, 
 O
during i O
the 	 O
evolution l O
of O O
mammals m O
, 
 O
it O O
is O O
the 	 O
CKbeta4GT e B-GENE
- - I-GENE
I - I-GENE
gene e I-GENE
lineage e E-GENE
that t O
has 	 O
been n O
recruited r O
for 	 O
the 	 O
biosynthesis s O
of O O
lactose t O
. 
 O
Furthermore t O
, 
 O
disruption r O
of O O
pcr1 1 S-GENE
reduced u O
expression r O
of O O
fbp1 1 S-GENE
, 
 O
a 
 O
glucose c O
- 
 O
repressible r O
gene e O
negatively a O
regulated u O
by O O
PKA 	 S-GENE
. 
 O
In O O
solution u O
, 
 O
[ 
 O
( 
 O
125 	 O
) 
 O
I 
 O
] 
 O
- 
 O
labeled e O
ankyrin y S-GENE
was 	 O
found n O
by O O
ND O B-GENE
- 
 I-GENE
PAGE3 E E-GENE
to O O
enhance a O
the 	 O
affinity i O
of O O
spectrin c S-GENE
self f O
- 
 O
association o O
by O O
10 O O
- 
 O
fold d O
. 
 O
Transcription n O
analysis l O
of O O
the 	 O
EcoRI R B-GENE
D - I-GENE
region i E-GENE
of O O
the 	 O
baculovirus u O
Autographa o O
californica i O
nuclear l O
polyhedrosis y O
virus u O
identifies n O
an O O
early l B-GENE
4 
 I-GENE
- 
 I-GENE
kilobase o I-GENE
RNA 	 E-GENE
encoding o O
the 	 O
essential e O
p143 3 B-GENE
gene e E-GENE
. 
 O
Anesthesia s O
in O O
the 	 O
radical i O
surgery g O
of O O
arteriosclerotic e O
coronary o O
disease e O
5 
 O
Intravenous r O
prizidilol z O
hydrochloride r O
decreases r O
resting t O
blood o O
pressure s O
and 	 O
left t O
ventricular t O
area a O
, 
 O
increases r O
pulse s O
rate e O
and 	 O
has 	 O
virtually t O
no O O
effect e O
on O O
left t O
ventricular t O
ejection c O
fraction c O
. 
 O
In O O
this s O
study d O
, 
 O
the 	 O
subcellular c O
location a O
, 
 O
domain a O
structure u O
, 
 O
and 	 O
biochemical c O
function c O
of O O
metaxin a S-GENE
were e O
investigated e O
. 
 O
The 	 O
human a O
cDNA A O
was 	 O
cloned n O
and 	 O
sequenced u O
; 
 O
it O O
was 	 O
shown w O
to O O
have e O
an O O
open n O
reading d O
frame m O
encoding o O
a 
 O
296 	 O
- 
 O
amino n O
- 
 O
acid d O
protein t O
in O O
which c O
could l O
be O O
identified n O
four r O
peptides t O
previously v O
identified n O
by O O
micro r O
- 
 O
sequencing u O
purified i O
protein t O
. 
 O
Our 	 O
aim 	 O
was 	 O
to O O
evaluate l O
this s O
technique h O
by O O
cross s O
- 
 O
calibrating i O
the 	 O
DXA 	 O
method h O
with h O
the 	 O
carcass c O
chemical m O
analysis l O
in O O
a 
 O
heterogeneous e O
population u O
of O O
nondiabetic d O
Wistar t O
and 	 O
diabetic b O
GK O O
rats s O
( 
 O
21 O O
animals m O
were e O
used d O
for 	 O
precision c O
error o O
and 	 O
reproducibility r O
determinations e O
and 	 O
26 O O
were e O
used d O
for 	 O
accuracy u O
studies d O
) 
 O
. 
 O
Flux x O
of O O
the 	 O
paramyxovirus a B-GENE
hemagglutinin a I-GENE
- 
 I-GENE
neuraminidase r I-GENE
glycoprotein c E-GENE
through o O
the 	 O
endoplasmic o O
reticulum i O
activates i O
transcription n O
of O O
the 	 O
GRP78 7 S-GENE
- 
 O
BiP 	 S-GENE
gene e O
. 
 O
The 	 O
preference f O
for 	 O
third r O
base e O
codon o O
in O O
Y 
 O
position i O
prolines l O
is O O
U 
 O
for 	 O
the 	 O
alpha h B-GENE
2 - I-GENE
( - I-GENE
VI I I-GENE
) - I-GENE
collagen l E-GENE
as O O
it O O
is O O
for 	 O
the 	 O
human a B-GENE
fibrillar r I-GENE
collagen l I-GENE
genes e E-GENE
. 
 O
Small l O
cell l O
tumors o O
in O O
children l O
: 
 O
contribution t O
to O O
the 	 O
solution u O
of O O
the 	 O
problem b O
of O O
differential f O
diagnosis g O
with h O
immunohistochemistry u O
and 	 O
electron c O
microscopy r O
Detonation o O
- 
 O
traumatic u O
load d O
during i O
military i O
service v O
In O O
static t O
conditions d O
, 
 O
body y O
sway y O
was 	 O
assessed e O
using n O
a 
 O
conventional v O
force c O
platform t O
with h O
eyes s O
open n O
and 	 O
with h O
eyes s O
closed s O
. 
 O
Soggy g O
, 
 O
a 
 O
spermatocyte r O
- 
 O
specific c O
gene e O
, 
 O
lies s O
3 
 O
. 
 O
8 
 O
kb O O
upstream t O
of O O
and 	 O
antipodal i O
to O O
TEAD D B-GENE
- - I-GENE
2 - E-GENE
, 
 O
a 
 O
transcription n O
factor t O
expressed r O
at O O
the 	 O
beginning i O
of O O
mouse s O
development e O
. 
 O
Teratospermia a O
is O O
therefore r O
an O O
important o O
factor t O
in O O
evaluating l O
fertilization t O
capacity a O
. 
 O
Results u O
of O O
the 	 O
study d O
suggest g O
that t O
Chinese n O
medicine i O
use 	 O
among n O
this s O
population u O
depends e O
on O O
health l O
conditions d O
, 
 O
and 	 O
that t O
having i O
a 
 O
regular u O
source r O
of O O
care e O
for 	 O
Chinese n O
medicine i O
as O O
well l O
as O O
a 
 O
preference f O
for 	 O
Chinese n O
medicine i O
are 	 O
two 	 O
predictors d O
for 	 O
its 	 O
use 	 O
. 
 O
The 	 O
greatest a O
risk k O
of O O
preterm t O
prelabour l O
rupture t O
of O O
membranes b O
( 
 O
PPROM O O
) 
 O
is O O
preterm t O
delivery i O
. 
 O
DISCUSSION C O
: 
 O
The 	 O
higher h O
absolute o O
knee e O
extension e O
strength e O
measures s O
of O O
leg 	 O
and 	 O
the 	 O
similar i O
extension e O
strength e O
of O O
the 	 O
trunk n O
in O O
the 	 O
obese s O
sample p O
compared p O
to O O
the 	 O
lean n O
might h O
be O O
explained l O
by O O
the 	 O
training i O
effect e O
of O O
weight g O
bearing r O
and 	 O
support p O
of O O
a 
 O
larger g O
body y O
mass s O
. 
 O
Residues i O
of O O
Stauffer u O
R 
 O
- 
 O
3828 8 O
and 	 O
its 	 O
oxygen g O
analogue l O
in O O
the 	 O
body y O
tissues s O
of O O
cattle t O
fed 	 O
R 
 O
- 
 O
3828 8 O
in O O
the 	 O
diet t O
. 
 O
The 	 O
goals l O
of O O
these s O
experiments e O
were e O
to O O
determine e O
whether t O
lactational t O
anestrus s O
would l O
be O O
prolonged l O
by O O
a 
 O
48 O O
- 
 O
h 
 O
fast t O
at O O
days s O
13 O O
and 	 O
14 O O
postpartum t O
( 
 O
pp O O
) 
 O
and 	 O
, 
 O
if O O
so O O
, 
 O
to O O
determine e O
whether t O
this s O
effect e O
could l O
be O O
reversed e O
by O O
treatment a O
with h O
the 	 O
Ob B B-GENE
protein t I-GENE
leptin t E-GENE
. 
 O
In O O
pituitary u O
GH3 	 O
cells l O
, 
 O
vitamin a O
D 
 O
increases r O
the 	 O
levels e O
of O O
PRL 	 B-GENE
transcripts n E-GENE
and 	 O
stimulates m O
the 	 O
PRL 	 B-GENE
promoter m E-GENE
. 
 O
However e O
, 
 O
electron c O
microscopy r O
revealed e O
that t O
while l O
sec4 4 B-GENE
mutant a E-GENE
cells l O
accumulate u O
secretory r O
vesicles i O
, 
 O
ypt31 3 S-GENE
/ - O
32 I O
mutant a O
cells l O
accumulate u O
aberrant r O
Golgi g O
structures u O
. 
 O
METHODS H O
: 
 O
We O O
retrospectively r O
analyzed l O
the 	 O
data a O
of O O
20 O O
patients i O
who 	 O
underwent e O
both h O
gated e O
fluorine o O
18 O O
deoxyglucose x O
( 
 O
FDG 	 O
) 
 O
- 
 O
PET 	 O
and 	 O
equilibrium i O
radionuclide i O
angiography i O
( 
 O
ERNA A O
) 
 O
. 
 O
However e O
, 
 O
it O O
is O O
now 	 O
suggested g O
that t O
the 	 O
use 	 O
of O O
more e O
slowly w O
digested e O
starchy r O
foods d O
may 	 O
have e O
positive i O
health l O
benefits e O
. 
 O
Northern t O
blot t O
analysis l O
demonstrated o O
that t O
the 	 O
genes e O
are 	 O
transcribed n O
separately a O
. 
 O
Complete p O
activation i O
of O O
signal n B-GENE
transducer n I-GENE
and 	 I-GENE
activator i I-GENE
of I I-GENE
transcription n I-GENE
1 - E-GENE
( 
 O
STAT1 T S-GENE
) 
 O
requires u O
phosphorylation s O
at O O
both h O
Y701 1 S-GENE
and 	 O
a 
 O
conserved s O
PMS 	 B-GENE
( 
 I-GENE
727 	 I-GENE
) 
 I-GENE
P 
 I-GENE
sequence u E-GENE
. 
 O
Over r O
half f O
of O O
the 	 O
children l O
initially t O
unresponsive e O
to O O
H 
 O
. 
 O
influenzae l O
type e O
b 
 O
meningitis i O
subsequently s O
developed e O
specific c O
antibodies i O
. 
 O
It O O
is O O
important o O
to O O
understand e O
the 	 O
etiology o O
of O O
HITT T O
because a O
of O O
its 	 O
devastating a O
clinical n O
consequences s O
. 
 O
Five e O
sequence u O
variants i O
were e O
identified n O
. 
 O
The 	 O
Ras 	 B-GENE
GTPase a I-GENE
- - I-GENE
activating i I-GENE
- - I-GENE
protein t I-GENE
- - I-GENE
related a I-GENE
human a I-GENE
protein t I-GENE
IQGAP2 A E-GENE
harbors b O
a 
 O
potential e O
actin i B-GENE
binding d I-GENE
domain a E-GENE
and 	 O
interacts e O
with h O
calmodulin m S-GENE
and 	 O
Rho 	 B-GENE
family i I-GENE
GTPases a E-GENE
. 
 O
We O O
anticipated i O
SNS 	 S-GENE
function c O
after e O
CVA 	 O
to O O
be O O
asymmetric m O
and 	 O
selected e O
null l O
hypotheses o O
of O O
bilaterally a O
symmetric m O
SSR 	 O
latencies e O
and 	 O
amplitudes l O
irrespective e O
of O O
side e O
of O O
stimulation m O
and 	 O
/ 
 O
or O O
recording o O
. 
 O
Partial t O
hepatectomy a O
in O O
metastatic a O
Wilms m O
' 
 O
tumor o O
. 
 O
The 	 O
adoption p O
of O O
a 
 O
twisted s O
structure u O
of O O
importin o B-GENE
- - I-GENE
beta a E-GENE
is O O
essential e O
for 	 O
the 	 O
protein t O
- 
 O
protein t O
interaction e O
required u O
for 	 O
nuclear l O
transport n O
. 
 O
The 	 O
presence s O
of O O
a 
 O
short r O
( 
 O
70 O O
bp O O
) 
 O
intron r O
near r O
the 	 O
N 
 O
- 
 O
terminus m O
of O O
the 	 O
atX 	 B-GENE
gene e E-GENE
was 	 O
predicted d O
that t O
contains t O
the 	 O
canonical o O
GT O O
and 	 O
AG O O
dinucleotides u O
at O O
its 	 O
5 
 O
' 
 O
- 
 O
and 	 O
3 
 O
' 
 O
- 
 O
splicing i O
junctions c O
. 
 O
Moreover e O
, 
 O
a 
 O
hybrid r O
protein t O
composed p O
of O O
a 
 O
PvALF L B-GENE
activation i I-GENE
domain a E-GENE
and 	 O
the 	 O
DNA 	 O
binding d O
and 	 O
dimerization e O
domain a O
of O O
ROM2 2 B-GENE
activated i I-GENE
gene e E-GENE
expression r O
, 
 O
indicating i O
that t O
ROM2 2 S-GENE
recognizes o O
the 	 O
DLEC2 C B-GENE
enhancer a E-GENE
in O O
vivo o O
; 
 O
consequently s O
, 
 O
ROM2 2 S-GENE
functions c O
as O O
a 
 O
DNA 	 O
binding d O
site e O
- 
 O
dependent e O
repressor r O
. 
 O
Tc O O
- 
 O
99m 	 O
HMPAO A O
brain i O
SPECT C O
compared p O
to O O
CT O O
and 	 O
EEG 	 O
after e O
seizures z O
in O O
childhood l O
. 
 O
We O O
found n O
that t O
the 	 O
central t O
nonconserved c O
region i O
of O O
the 	 O
large g O
subunit u O
is O O
not 	 O
essential e O
for 	 O
function c O
and 	 O
likely e O
acts s O
as O O
a 
 O
spacer c O
between w O
the 	 O
conserved s O
N 
 O
- 
 O
and 	 O
C 
 O
- 
 O
terminal m O
regions i O
. 
 O
On O O
the 	 O
other e O
hand d O
, 
 O
NE O O
transport n O
and 	 O
antagonist a O
( 
 O
[ 
 O
125I I O
] 
 O
RTI 	 O
- 
 O
55 O O
) 
 O
binding d O
assays a O
on O O
whole l O
LLC 	 O
- 
 O
NET 	 O
cells l O
treated a O
with h O
tunicamycin i O
reveal e O
a 
 O
pronounced n O
reduction u O
in O O
NE O O
transport n O
activity i O
and 	 O
hNET T O
membrane b O
density s O
paralleled a O
by O O
an O O
inability b O
of O O
NET 	 B-GENE
proteins t E-GENE
to O O
replenish l O
the 	 O
higher h O
M 
 O
( 
 O
r 
 O
) 
 O
hNET T O
pool l O
. 
 O
We O O
show w O
that t O
the 	 O
upstream t O
region i O
of O O
the 	 O
beta a B-GENE
- - I-GENE
MyHC C I-GENE
gene e E-GENE
( 
 O
- 
 O
5518 8 O
to O O
- 
 O
2490 0 O
relative a O
to O O
the 	 O
transcriptional n O
start r O
site e O
) 
 O
directed e O
high h O
levels e O
of O O
transcriptional n O
activity i O
only y O
when n O
stably b O
integrated e O
, 
 O
but 	 O
not 	 O
when n O
expressed r O
extrachromosomally r O
in O O
transient n O
assays a O
. 
 O
DNase s B-GENE
I - E-GENE
protection t O
analysis l O
as O O
well l O
as O O
oligonucleotide g O
competition p O
experiments e O
indicate i O
that t O
this s O
binding d O
is O O
sequence u O
specific c O
. 
 O
Plasmid s O
pSP64E6E7 6 O
which c O
contains t O
the 	 O
reading d O
frames m O
of O O
both h O
E6 S S-GENE
and 	 O
E7 S S-GENE
was 	 O
constructed s O
in O O
order e O
to O O
study d O
the 	 O
expression r O
of O O
both h O
proteins t O
in O O
a 
 O
coupled p O
transcription n O
/ 
 O
rabbit b O
reticulocyte i O
translation n O
system t O
. 
 O
In O O
transient n O
transfections n O
using n O
luciferase i B-GENE
reporter o I-GENE
genes e E-GENE
driven v O
by O O
1 
 O
kb O O
of O O
the 	 O
5 
 O
' 
 O
flanking n O
DNA 	 O
of O O
the 	 O
three e O
CALM M B-GENE
genes e E-GENE
, 
 O
the 	 O
promoter m O
activity i O
correlated r O
with h O
the 	 O
endogenous o O
CALM M S-GENE
transcriptional n O
activity i O
, 
 O
but 	 O
only y O
when n O
the 	 O
5 
 O
' 
 O
untranslated r O
regions i O
were e O
included l O
in O O
the 	 O
constructs s O
. 
 O
These s O
findings d O
suggest g O
that t O
PGE1 1 S-GENE
is O O
effective e O
in O O
increasing r O
PVF 	 O
in O O
the 	 O
liver e O
transplanted n O
condition d O
; 
 O
however e O
, 
 O
the 	 O
hepatic a O
circulatory c O
improvement r O
attributed r O
to O O
this s O
agent n O
would l O
be O O
limited i O
to O O
the 	 O
first s O
few 	 O
days s O
following l O
transplantation n O
. 
 O
The 	 O
derepressed e O
expression r O
of O O
fixN N S-GENE
was 	 O
not 	 O
observed e O
in O O
a 
 O
purH H B-GENE
mutant a E-GENE
. 
 O
Nearly r O
1 
 O
. 
 O
5 
 O
million l O
American r O
men 	 O
age 	 O
65 O O
and 	 O
older e O
have e O
osteoporosis e O
, 
 O
and 	 O
another t O
3 
 O
. 
 O
5 
 O
million l O
are 	 O
at O O
risk k O
. 
 O
Both h O
viruses u O
express r O
the 	 O
mil 	 B-GENE
/ 
 I-GENE
raf 	 I-GENE
oncogene o I-GENE
product d E-GENE
as O O
a 
 O
gag 	 B-GENE
- - I-GENE
fusion i I-GENE
polyprotein y E-GENE
, 
 O
while l O
the 	 O
myc 	 B-GENE
oncogene o E-GENE
of O O
MH2 	 S-GENE
is O O
expressed r O
via 	 O
a 
 O
subgenomic g O
mRNA A O
. 
 O
CONCLUSION C O
: 
 O
DaunoXome n O
has 	 O
an O O
improved r O
pharmacokinetic r O
profile f O
compared p O
with h O
free e O
daunorubicin n O
, 
 O
and 	 O
is O O
well l O
tolerated e O
. 
 O
This s O
regimen i O
may 	 O
be O O
considered s O
front n O
- 
 O
line e O
therapy r O
when n O
autologous o O
stem m O
cell l O
transplantation n O
is O O
not 	 O
feasible s O
and 	 O
when n O
a 
 O
rapid i O
response p O
is O O
particularly t O
important o O
. 
 O
Recombinant o O
protein t O
encoded o O
by O O
ESX 	 S-GENE
( 
 O
for 	 O
epithelial t O
- - O
restricted t O
with h O
serine i O
box 	 O
) 
 O
exhibits i O
Ets 	 S-GENE
- - O
like e O
DNA 	 O
binding d O
specificity c O
in O O
electrophoretic c O
mobility i O
shift f O
assays a O
and 	 O
, 
 O
in O O
transient n O
transfection n O
assays a O
, 
 O
transactivates n O
Ets 	 S-GENE
- - O
responsive p O
promoter m O
elements m O
including l O
that t O
found n O
in O O
the 	 O
HER2 2 S-GENE
/ 
 O
neu 	 S-GENE
oncogene o O
. 
 O
In O O
area a O
CA1 	 O
of O O
the 	 O
hippocampus p O
, 
 O
numbers b O
of O O
normal m O
neurons r O
were e O
increased r O
11 O O
- 
 O
to O O
14 O O
- 
 O
fold d O
by O O
MK O O
- 
 O
801 	 O
treatment a O
( 
 O
p 
 O
< 
 O
0 
 O
. 
 O
01 O O
) 
 O
. 
 O
The 	 O
temporal p O
changes n O
in O O
the 	 O
plasma s O
concentration c O
of O O
immunoreactive u O
atrial i B-GENE
natriuretic r I-GENE
factor t E-GENE
( 
 O
iANF F S-GENE
) 
 O
were e O
studied d O
in O O
six 	 O
conscious s O
dogs s O
with h O
an O O
arteriovenous e O
( 
 O
AV O O
) 
 O
fistula t O
, 
 O
a 
 O
model e O
of O O
chronic o O
high h O
- 
 O
output p O
heart r O
failure l O
. 
 O
The 	 O
revaluation a O
at O O
the 	 O
end 	 O
of O O
the 	 O
study d O
showed w O
a 
 O
good d O
compliance p O
for 	 O
the 	 O
proposed p O
diet t O
scheme e O
by O O
children l O
, 
 O
but 	 O
a 
 O
poor r O
compliance p O
by O O
their i O
families i O
. 
 O
The 	 O
delta t O
G 
 O
values u O
of O O
these s O
regions i O
were e O
higher h O
, 
 O
i 
 O
. 
 O
e 
 O
. 
 O
potential e O
secondary o O
structural u O
elements m O
were e O
fewer e O
, 
 O
than n O
in O O
TIR 	 O
of O O
genes e O
from m O
E 
 O
. 
 O
coli i O
. 
 O
Two 	 O
closely s O
related a O
groups u O
of O O
transcripts n O
, 
 O
Sagrp1 r S-GENE
and 	 O
Sagrp2 r S-GENE
, 
 O
controlled t O
by O O
a 
 O
circadian c O
rhythm t O
have e O
been n O
isolated l O
. 
 O
Of O O
921 	 O
specimens c O
, 
 O
95 O O
yielded l O
non 	 O
- 
 O
albicans i O
species c O
, 
 O
mainly n O
from m O
patients i O
with h O
low 	 O
CD4 	 S-GENE
lymphocyte p O
counts n O
and 	 O
extensive e O
previous v O
azole l O
exposure o O
. 
 O
These s O
findings d O
suggest g O
that t O
eIF5 5 B-GENE
- 
 I-GENE
eIF2beta 2 E-GENE
interaction e O
plays y O
an O O
essential e O
role e O
in O O
eIF5 5 S-GENE
function c O
in O O
eukaryotic a O
cells l O
. 
 O
Three e O
simple p O
methods h O
of O O
detecting e O
malnutrition n O
on O O
medical i O
wards d O
. 
 O
Compared p O
with h O
controls t O
, 
 O
patients i O
in O O
the 	 O
unmedicated e O
state t O
had 	 O
low 	 O
smooth o O
pursuit s O
gain n O
, 
 O
had 	 O
a 
 O
higher h O
rate e O
of O O
corrective r O
catch c O
- 
 O
up O O
saccades c O
, 
 O
and 	 O
tended d O
to O O
spend n O
less s O
time e O
engaged a O
in O O
the 	 O
tracking c O
task k O
. 
 O
Cytokine o O
- 
 O
mediated i O
I - B-GENE
kappa p I-GENE
B - I-GENE
alpha h E-GENE
reappearance p O
was 	 O
completely p O
blocked c O
by O O
the 	 O
protein t O
synthesis t O
inhibitor i O
cycloheximide l O
. 
 O
Development e O
of O O
P 
 O
carinii i O
pneumonia u O
was 	 O
associated o O
with h O
the 	 O
stage g O
of O O
Kaposi o O
' 
 O
s 
 O
sarcoma c O
, 
 O
B 
 O
subtype t O
disease e O
, 
 O
and 	 O
the 	 O
presence s O
of O O
0 
 O
. 
 O
20 O O
X 
 O
10 O O
( 
 O
9 
 O
) 
 O
/ 
 O
L 
 O
( 
 O
200 	 O
/ 
 O
mm3 	 O
) 
 O
or O O
fewer e O
CD4 	 O
cells l O
at O O
study d O
entry r O
. 
 O
The 	 O
effects e O
of O O
tilmicosin m O
administration i O
in O O
the 	 O
feed d O
at O O
400 	 O
mg O O
/ 
 O
kg O O
and 	 O
an O O
injection e O
therapy r O
of O O
clinically n O
diseased e O
pigs s O
with h O
long g O
- 
 O
acting i O
oxytetracycline t O
( 
 O
Terramycine r O
LA O O
) 
 O
at O O
20 O O
mg O O
/ 
 O
kg O O
bodyweight y O
were e O
compared p O
. 
 O
Those s O
participating t O
in O O
this s O
investigation e O
( 
 O
65 O O
centers t O
= 
 O
79 O O
% 
 O
) 
 O
received e O
a 
 O
series i O
of O O
computer p O
disks k O
containing t O
50 O O
99mTc T O
- 
 O
DMSA A O
studies d O
. 
 O
Pathogenesis h O
of O O
fever e O
. 
 O
Two 	 O
full l O
- 
 O
length g O
clones n O
( 
 O
pBCH1 H O
and 	 O
pBCH2 H O
) 
 O
were e O
isolated l O
. 
 O
Childbirth l O
and 	 O
authoritative h O
knowledge w O
. 
 O
The 	 O
ends s O
of O O
the 	 O
barrel r O
are 	 O
capped p O
by O O
short r O
helices i O
. 
 O
Non 	 O
- 
 O
finger g O
- 
 O
coding i O
modules u O
conserved s O
among n O
members b O
of O O
subfamilies f O
of O O
zinc c B-GENE
finger g I-GENE
genes e E-GENE
have e O
been n O
described c O
in O O
the 	 O
murine i O
genome o O
( 
 O
finger g O
- 
 O
associated o O
boxes e O
, 
 O
or O O
FAX 	 B-GENE
domain a E-GENE
) 
 O
and 	 O
the 	 O
human a O
genome o O
( 
 O
Kruppel p O
- - O
associated o O
boxes e O
, 
 O
or O O
KRAB B B-GENE
domain a E-GENE
) 
 O
. 
 O
This s O
combination b O
is O O
considered s O
pathognomonic h O
for 	 O
factitious t O
hyperinsulinism e O
. 
 O
Comparison p O
of O O
the 	 O
5 
 O
' 
 O
flanking n O
regions i O
of O O
the 	 O
mouse s B-GENE
J - I-GENE
kappa p I-GENE
elements m E-GENE
, 
 O
including l O
the 	 O
conserved s O
putative a O
recombination o O
target g O
sequences u O
, 
 O
shows w O
no O O
obvious i O
differences f O
consistent s O
with h O
the 	 O
variation i O
in O O
recombinational o O
efficiency i O
, 
 O
so O O
we O O
conclude c O
that t O
, 
 O
although h O
the 	 O
consensus s O
heptamer t O
and 	 O
nonamer a O
signals n O
may 	 O
be O O
sufficient f O
to O O
identify n O
a 
 O
recombination o O
site e O
, 
 O
the 	 O
probability b O
that t O
that t O
site e O
will l O
be O O
used d O
depends e O
also o O
on O O
other e O
determinants e O
. 
 O
The 	 O
melanoma a O
growth w O
stimulatory m O
activity i O
/ - O
growth w O
- - O
regulated u O
protein t O
, 
 O
CXCL1 L S-GENE
, 
 O
is O O
constitutively s O
expressed r O
at O O
high h O
levels e O
during i O
inflammation l O
and 	 O
progression g O
of O O
melanocytes a O
into o O
malignant i O
melanoma a O
. 
 O
Genetic e O
analysis l O
places c O
CWH43 4 S-GENE
upstream t O
of O O
the 	 O
BCK2 2 S-GENE
branch n O
of O O
the 	 O
PKC1 1 S-GENE
signalling n O
pathway h O
, 
 O
since c O
cwh43 4 B-GENE
mutations a E-GENE
were e O
synthetic t O
lethal h O
with h O
pkc1 1 S-GENE
deletion e O
, 
 O
whereas r O
the 	 O
cwh43 4 S-GENE
defects e O
could l O
be O O
rescued c O
by O O
overexpression r O
of O O
BCK2 2 S-GENE
and 	 O
not 	 O
by O O
high h O
- 
 O
copy y O
- 
 O
number b O
expression r O
of O O
genes e O
encoding o O
downstream n O
proteins t O
of O O
the 	 O
PKC1 1 S-GENE
pathway h O
However e O
, 
 O
unlike i O
BCK2 2 S-GENE
, 
 O
whose s O
disruption r O
in O O
a 
 O
cln3 3 B-GENE
mutant a E-GENE
resulted u O
in O O
growth w O
arrest e O
in O O
G 
 O
( 
 O
1 
 O
) 
 O
, 
 O
no O O
growth w O
defect e O
was 	 O
observed e O
in O O
a 
 O
double b O
cwh43 4 S-GENE
cln3 3 B-GENE
mutants a E-GENE
. 
 O
Twelve l O
( 
 O
92 O O
% 
 O
) 
 O
showed w O
cognitive n O
dysfunction f O
including l O
impairments a O
in O O
memory o O
, 
 O
attention e O
, 
 O
and 	 O
affective e O
disturbances t O
( 
 O
anxiety i O
, 
 O
depression r O
, 
 O
irritability i O
, 
 O
and 	 O
poor r O
frustration s O
tolerance e O
) 
 O
. 
 O
To O O
clarify r O
the 	 O
mechanisms h O
that t O
regulate u O
transcription n O
of O O
the 	 O
GTP 	 B-GENE
cyclohydrolase l I-GENE
I - I-GENE
gene e E-GENE
and 	 O
to O O
generate e O
multiple t O
species c O
of O O
mRNA A O
, 
 O
we O O
isolated l O
genomic o O
DNA 	 O
clones n O
for 	 O
the 	 O
human a O
and 	 O
mouse s B-GENE
GTP 	 I-GENE
cyclohydrolase l I-GENE
I - I-GENE
genes e E-GENE
. 
 O
Therefore r O
, 
 O
a 
 O
structural u O
interaction e O
between w O
PsaL L S-GENE
and 	 O
PsaI I S-GENE
may 	 O
stabilize b O
the 	 O
association o O
of O O
PsaL L S-GENE
with h O
the 	 O
photosystem t B-GENE
I - I-GENE
core e E-GENE
. 
 O
Reversal e O
of O O
' 
 O
refractory r O
septic t O
shock c O
' 
 O
by O O
infusion u O
of O O
amrinone i O
and 	 O
angiotensin i B-GENE
II E E-GENE
in O O
an O O
anthracycline h O
- 
 O
treated a O
patient i O
. 
 O
The 	 O
present s O
study d O
deals l O
with h O
the 	 O
screening e O
of O O
11 O O
of O O
these s O
plants n O
against i O
the 	 O
opportunistic o O
pathogen h O
fungus g O
Candida d O
albicans i O
. 
 O
Negative a O
modulation u O
of O O
alpha1 h B-GENE
( - I-GENE
I - I-GENE
) - I-GENE
procollagen c I-GENE
gene e E-GENE
expression r O
in O O
human a O
skin n O
fibroblasts r O
: 
 O
transcriptional n O
inhibition i O
by O O
interferon e B-GENE
- - I-GENE
gamma m E-GENE
. 
 O
On O O
the 	 O
basis i O
of O O
this s O
homology o O
, 
 O
we O O
examined m O
the 	 O
potential e O
role e O
of O O
c - B-GENE
- - I-GENE
Rel 	 E-GENE
in O O
controlling t O
IL B B-GENE
- - I-GENE
2R I I-GENE
alpha h E-GENE
transcription n O
. 
 O
Expression r O
of O O
CBP 	 S-GENE
/ 
 O
p300 0 S-GENE
potentiated e O
HS2 	 S-GENE
- 
 O
mediated i O
transactivation n O
. 
 O
We O O
next t O
developed e O
a 
 O
rapid i O
purification i O
method h O
for 	 O
bacterial t B-GENE
recombinant o I-GENE
MyoD D E-GENE
- - O
bHLH H S-GENE
domain a O
by O O
affinity i O
chromatography o O
using n O
a 
 O
calmodulin m B-GENE
- 
 I-GENE
Sepharose h I-GENE
column u E-GENE
and 	 O
investigated e O
the 	 O
phosphorylation s O
of O O
that t O
peptide t O
by O O
PKC 	 S-GENE
and 	 O
its 	 O
interactions e O
with h O
calmodulin m S-GENE
and 	 O
S100a 0 S-GENE
. 
 O
According o O
to O O
the 	 O
penetration e O
of O O
Ca O O
- 
 O
45 O O
, 
 O
the 	 O
microleakage r O
level e O
was 	 O
scored r O
for 	 O
each h O
section t O
. 
 O
HL S O
is O O
hypothesized o O
to O O
directly e O
couple p O
HDL 	 S-GENE
lipid i O
metabolism a O
to O O
tissue s O
/ 
 O
cellular l O
lipid i O
metabolism a O
. 
 O
Epstein t B-GENE
- - I-GENE
Barr r I-GENE
virus u I-GENE
nuclear l I-GENE
antigen i I-GENE
2 - E-GENE
exerts r O
its 	 O
transactivating n O
function c O
through o O
interaction e O
with h O
recombination o O
signal n O
binding d O
protein t O
RBP 	 B-GENE
- - I-GENE
J - I-GENE
kappa p E-GENE
, 
 O
the 	 O
homologue o O
of O O
Drosophila s O
Suppressor p O
of I O
Hairless r O
. 
 O
Maduromycosis u O
in O O
Italy l O
Two 	 O
patient i O
groups u O
were e O
studied d O
: 
 O
Type e O
I 
 O
- 
 O
- 
 O
with h O
a 
 O
new 	 O
ePTFE F O
graft f O
; 
 O
and 	 O
Type e O
II O O
- 
 O
- 
 O
with h O
thrombectomy o O
and 	 O
/ 
 O
or O O
revision i O
of O O
a 
 O
previously v O
placed c O
ePTFE F O
graft f O
. 
 O
The 	 O
author h O
describes c O
the 	 O
technique h O
in O O
detail a O
and 	 O
presents s O
the 	 O
findings d O
for 	 O
25 O O
patients i O
( 
 O
10 O O
men 	 O
and 	 O
15 O O
women e O
) 
 O
examined m O
for 	 O
suspected p O
ileostomy o O
dysfunction f O
, 
 O
recurrent u O
Crohn h O
' 
 O
s 
 O
disease e O
or O O
ileal a O
obstruction t O
remote o O
from m O
the 	 O
stoma m O
. 
 O
Increased r O
susceptibility c O
of O O
aphasics a O
to O O
a 
 O
distractor t O
task k O
in O O
the 	 O
recall a O
of O O
verbal b O
commands m O
. 
 O
Lasting t O
paraplegia a O
caused s O
by O O
loss s O
of O O
lumbar b O
spinal n O
cord d O
interneurons e O
in O O
rats s O
: 
 O
no O O
direct e O
correlation r O
with h O
motor o O
neuron r O
loss s O
. 
 O
The 	 O
existence s O
of O O
universal v O
non 	 O
- 
 O
specific c O
mechanism h O
of O O
action i O
of O O
external e O
factors t O
upon n O
the 	 O
living i O
tissue s O
based e O
on O O
the 	 O
DEL 	 O
- 
 O
reaction c O
is O O
suggested g O
. 
 O
Rv O O
was 	 O
7 
 O
. 
 O
7 
 O
+ 
 O
/ 
 O
- 
 O
1 
 O
. 
 O
4 
 O
mmHg g O
. 
 O
ml O O
- 
 O
1 
 O
. 
 O
min 	 O
. 
 O
100 	 O
g 
 O
- 
 O
1 
 O
and 	 O
Cv O O
was 	 O
0 
 O
. 
 O
59 O O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
25 O O
ml O O
/ 
 O
mmHg g O
, 
 O
tau 	 O
v 
 O
calculated c O
from m O
the 	 O
product d O
of O O
Rv O O
and 	 O
Cv O O
was 	 O
4 
 O
. 
 O
20 O O
+ 
 O
/ 
 O
- 
 O
1 
 O
. 
 O
58 O O
s 
 O
and 	 O
from m O
the 	 O
ratio i O
of O O
delta t O
V 
 O
to O O
delta t O
Q 
 O
was 	 O
4 
 O
. 
 O
95 O O
+ 
 O
/ 
 O
- 
 O
1 
 O
. 
 O
53 O O
s 
 O
( 
 O
P 
 O
= 
 O
NS O O
) 
 O
at O O
a 
 O
mean n O
Pel 	 O
of O O
17 O O
. 
 O
6 
 O
+ 
 O
/ 
 O
- 
 O
3 
 O
. 
 O
7 
 O
mmHg g O
. 
 O
delta t O
V 
 O
was 	 O
also o O
produced d O
by O O
changing n O
Pv O O
; 
 O
the 	 O
average r O
tau 	 O
v 
 O
( 
 O
1 
 O
. 
 O
95 O O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
37 O O
s 
 O
) 
 O
, 
 O
was 	 O
shorter r O
than n O
that t O
with h O
changes n O
in O O
flow w O
. 
 O
We O O
constructed s O
a 
 O
stable b O
, 
 O
doubly b O
transfected n O
cell l O
line e O
( 
 O
TIS 	 O
- 
 O
10 O O
) 
 O
carrying r O
a 
 O
chromosomally o O
integrated e O
ptetO7 t O
- - O
CMV 	 O
- - O
L - O
reporter o O
construct s O
and 	 O
expressing r O
the 	 O
TetR R S-GENE
- 
 O
KRAB B S-GENE
protein t O
. 
 O
We O O
suggest g O
that t O
electrical c O
stimulation m O
of O O
the 	 O
NTS 	 O
in O O
rats s O
undergoing e O
such h O
surgical g O
preparation p O
to O O
observe e O
the 	 O
pressor s O
response p O
and 	 O
/ 
 O
or O O
increase r O
in O O
pVP 	 O
, 
 O
represents r O
a 
 O
rapid i O
approach r O
for 	 O
screening e O
the 	 O
neurosecretory r O
function c O
of O O
the 	 O
central t O
neural r O
integration e O
to O O
release e O
vasopressin o S-GENE
. 
 O
To O O
study d O
adaptive p O
processes c O
following l O
spinal n O
cord d O
injury u O
, 
 O
unstructured t O
audiotaped i O
interviews e O
were e O
conducted d O
on O O
an O O
almost o O
daily l O
basis i O
with h O
a 
 O
30 O O
- 
 O
year r O
- 
 O
old 	 O
divorced o O
male e O
during i O
the 	 O
first s O
3 
 O
months t O
of O O
his 	 O
initial t O
comprehensive p O
inpatient a O
rehabilitation a O
. 
 O
Melioidosis i O
in O O
Sika a O
deer r O
( 
 O
Cervus v O
nippon p O
nippon p O
) 
 O
. 
 O
Enterobius e O
vermicularis m O
eggs s O
were e O
demonstrated o O
during i O
microscopic r O
examination m O
of O O
a 
 O
smear a O
taken e O
from m O
the 	 O
posterior t O
fornix n O
of O O
the 	 O
vagina i O
. 
 O
Together e O
with h O
previous v O
work k O
our 	 O
results u O
suggest g O
that t O
C - B-GENE
/ - I-GENE
EBP 	 E-GENE
may 	 O
be O O
a 
 O
general e O
cooperation p O
partner t O
for 	 O
v - B-GENE
- - I-GENE
Myb 	 E-GENE
in O O
myelomonocytic l O
cells l O
. 
 O
When n O
medical i O
aid 	 O
was 	 O
sought g O
a 
 O
false s O
history t O
was 	 O
given e O
and 	 O
the 	 O
true e O
nature u O
of O O
the 	 O
child l O
' 
 O
s 
 O
illness n O
, 
 O
heat t O
stroke o O
, 
 O
was 	 O
not 	 O
determined e O
until i O
after e O
death t O
. 
 O
Both h O
DMP2 2 S-GENE
and 	 O
DMP3 3 S-GENE
are 	 O
closely s O
localized a O
on O O
mouse s O
chromosome o O
5q21 1 O
, 
 O
corresponding r O
to O O
human a O
chromosome o O
4q21 1 O
. 
 O
This s O
article i O
expands a O
the 	 O
analysis l O
of O O
a 
 O
numeric e O
example m O
included l O
in O O
the 	 O
SAS 	 O
GLM 	 O
procedure c O
to O O
cover e O
several e O
crucial c O
statistical t O
aspects e O
relevant e O
to O O
ANCOVA O O
, 
 O
and 	 O
to O O
highlight h O
the 	 O
meaning n O
of O O
the 	 O
statistical t O
results u O
obtained a O
. 
 O
A 
 O
novel e O
alternative e O
spliced i O
variant i O
of O O
the 	 O
transcription n B-GENE
factor t I-GENE
AP2alpha a E-GENE
is O O
expressed r O
in O O
the 	 O
murine i O
ocular l O
lens s O
. 
 O
Fig1p 1 S-GENE
and 	 O
Fig2p 2 S-GENE
are 	 O
likely e O
to O O
act 	 O
at O O
the 	 O
cell l O
surface f O
as O O
Fig1 1 S-GENE
: 
 O
: 
 O
beta a B-GENE
- - I-GENE
gal 	 E-GENE
and 	 O
Fig2 2 S-GENE
: 
 O
: 
 O
beta a B-GENE
- - I-GENE
gal 	 I-GENE
fusion i I-GENE
proteins t E-GENE
localize a O
to O O
the 	 O
periphery i O
of O O
mating i O
cells l O
. 
 O
Crystals s O
of O O
the 	 O
triple p O
mutant a O
A42D D O
/ 
 O
D47P P O
/ 
 O
A63L L O
, 
 O
which c O
are 	 O
stable b O
for 	 O
days s O
in O O
its 	 O
oxidized d O
form m O
, 
 O
were e O
grown w O
from m O
ammonium o O
sulfate f O
, 
 O
with h O
the 	 O
cell l O
constants s O
a 
 O
= 
 O
b 
 O
= 
 O
34 O O
. 
 O
3 
 O
A 
 O
and 	 O
c 
 O
= 
 O
111 	 O
. 
 O
8 
 O
A 
 O
belonging o O
to O O
space c O
group u O
P3 O O
( 
 O
2 
 O
) 
 O
21 O O
. 
 O
Nevertheless e O
, 
 O
PEG 	 O
influenced l O
in O O
vitro r O
drug g O
availability i O
considerably s O
, 
 O
by O O
increasing r O
both h O
drug g O
solubility u O
and 	 O
dissolution s O
rate e O
. 
 O
Normal m O
replication l O
of O O
DNA 	 O
A - O
still l O
carrying r O
the 	 O
AC3 	 B-GENE
ORF 	 I-GENE
mutation a E-GENE
was 	 O
found n O
in O O
extracts r O
from m O
these s O
plants n O
. 
 O
Such h O
saturation u O
often e O
occurs u O
for 	 O
several e O
recording o O
sweeps e O
after e O
large g O
amplitude l O
signals n O
such h O
as O O
eye 	 O
blinks n O
are 	 O
rejected e O
. 
 O
Muscle c O
and 	 O
liver e O
biopsies p O
demonstrated o O
the 	 O
same e O
anomalies m O
, 
 O
again i O
without h O
branching n O
enzyme y O
deficiency i O
in O O
the 	 O
liver e O
. 
 O
Possibility s O
of O O
using n O
gynecologic e O
nurses s O
in O O
the 	 O
independently e O
administered i O
health l O
centers t O
Airborne b O
rabies i O
encephalitis e O
: 
 O
demonstration o O
of O O
rabies i O
virus u O
in O O
the 	 O
human a O
central t O
nervous v O
system t O
. 
 O
T1 O O
and 	 O
T2 O O
values u O
were e O
calculated c O
from m O
guinea n O
pig 	 O
brain i O
in O O
vivo o O
at O O
0 
 O
. 
 O
5 
 O
T 
 O
. 
 O
Autophosphorylation o O
on O O
the 	 O
major o O
phosphorylation s O
site e O
Y1235 3 O
upregulates e O
the 	 O
kinase a O
activity i O
of O O
the 	 O
receptor e O
, 
 O
increasing r O
the 	 O
Vmax x O
of O O
the 	 O
phosphotransfer s O
reaction c O
. 
 O
Clinical n O
development e O
of O O
interleukin e B-GENE
- - I-GENE
10 E E-GENE
. 
 O
By O O
cloning n O
genes e O
encoding o O
benzene z O
- 
 O
degradative r O
enzymes y O
, 
 O
we O O
found n O
that t O
strain a O
JS150 5 O
also o O
carries r O
genes e O
for 	 O
a 
 O
toluene u B-GENE
/ - I-GENE
benzene z I-GENE
- - I-GENE
2 - I-GENE
- - I-GENE
monooxygenase o E-GENE
. 
 O
Our 	 O
data a O
suggest g O
that t O
association o O
of O O
TBP 	 S-GENE
with h O
the 	 O
TATA A O
box 	 O
may 	 O
be O O
regulated u O
, 
 O
directly e O
or O O
indirectly i O
, 
 O
by O O
a 
 O
substrate s O
of O O
Snf1 1 S-GENE
. 
 O
Fusion i O
proteins t O
were e O
isolated l O
by O O
affinity i O
chromatography o O
on O O
APTG G O
- 
 O
Sepharose h O
. 
 O
It O O
differed f O
from m O
cued d O
recall a O
only y O
in O O
the 	 O
instructions t O
, 
 O
which c O
directed e O
subjects j O
away y O
from m O
the 	 O
memory o O
aspects e O
of O O
the 	 O
test t O
and 	 O
asked e O
them m O
to O O
complete p O
each h O
three e O
- 
 O
letter t O
cue 	 O
with h O
the 	 O
first s O
word d O
that t O
came e O
to O O
mind d O
. 
 O
Real l O
- 
 O
time e O
two 	 O
- 
 O
dimensional e O
echocardiographic o O
studies d O
of O O
the 	 O
mitral r O
valve v O
in O O
short r O
- 
 O
axis s O
view w O
were e O
obtained a O
from m O
10 O O
normal m O
subjects j O
. 
 O
RESULTS U O
: 
 O
Sixty t O
- 
 O
one 	 O
percent c O
of O O
the 	 O
patients i O
had 	 O
damage a O
within h O
7 
 O
years r O
of O O
onset e O
( 
 O
mean n O
3 
 O
. 
 O
8 
 O
yrs 	 O
) 
 O
. 
 O
It O O
was 	 O
previously v O
shown w O
that t O
Vi B B-GENE
antigen i E-GENE
expression r O
was 	 O
regulated u O
by O O
a 
 O
system t O
similar i O
to O O
the 	 O
rcs 	 S-GENE
regulatory u O
system t O
involved o O
in O O
colanic a O
acid d O
synthesis t O
in O O
Escherichia h O
coli i O
. 
 O
The 	 O
map 	 O
is O O
based e O
on O O
the 	 O
CEPH H O
reference e O
pedigrees i O
and 	 O
includes l O
over r O
4000 0 O
new 	 O
genotypes o O
, 
 O
our 	 O
previously v O
reported o O
data a O
plus s O
29 O O
allele e O
systems t O
from m O
the 	 O
published l O
CEPH H O
version s O
5 
 O
database a O
, 
 O
and 	 O
was 	 O
constructed s O
using n O
the 	 O
program g O
package k O
CRI 	 B-GENE
- 
 I-GENE
MAP 	 E-GENE
. 
 O
To O O
identify n O
the 	 O
GRK6 6 B-GENE
homologue o E-GENE
on O O
chromsome o O
13 O O
, 
 O
several e O
sets s O
of O O
closely s O
- 
 O
spaced c O
primers m O
were e O
designed i O
based e O
on O O
the 	 O
GRK6 6 B-GENE
cDNA A I-GENE
sequence u E-GENE
and 	 O
then n O
used d O
to O O
amplify l O
human a O
genomic o O
DNA 	 O
by O O
PCR 	 O
. 
 O
In O O
the 	 O
absence e O
of O O
Mg2 	 O
+ 
 O
, 
 O
the 	 O
extent e O
of O O
destabilization t O
of O O
tRNAPhe A S-GENE
is O O
greater a O
but 	 O
appears e O
to O O
be O O
confined f O
to O O
internal e O
regions i O
of O O
the 	 O
acceptor e O
and 	 O
T 
 B-GENE
psi 	 I-GENE
C 
 I-GENE
helices i E-GENE
, 
 O
as O O
evidenced d O
by O O
the 	 O
selectively e O
enhanced a O
exchange h O
rates e O
for 	 O
imino n O
protons t O
associated o O
with h O
these s O
base e O
pairs r O
. 
 O
Studies d O
in O O
26 O O
patients i O
. 
 O
Serum u B-GENE
alpha h I-GENE
- - I-GENE
amylase l E-GENE
, 
 O
trypsin p S-GENE
, 
 O
trypsin p S-GENE
inhibitor i O
, 
 O
lipase a S-GENE
and 	 O
total a O
protease t O
activity i O
in O O
the 	 O
pancreatic c O
tissue s O
was 	 O
studied d O
as O O
indicator i O
of O O
the 	 O
treatment a O
efficacy i O
with h O
5 
 O
- 
 O
fluorouracil o O
electro c O
- 
 O
cumulation u O
. 
 O
1 
 O
The 	 O
effects e O
of O O
high h O
doses e O
of O O
piretanide e O
, 
 O
a 
 O
new 	 O
diuretic r O
agent n O
chemically m O
related a O
to O O
frusemide s O
and 	 O
bumetanide e O
were e O
evaluated l O
in O O
twelve l O
patients i O
with h O
severe e O
chronic o O
renal a O
insufficiency u O
( 
 O
creatinine a O
clearance a O
below o O
25 O O
ml O O
/ 
 O
min 	 O
) 
 O
. 
 O
Synthesis t O
of O O
22 O O
- 
 O
oxavitamin v O
D3 O O
analogues l O
. 
 O
This s O
effect e O
is O O
independent e O
of O O
the 	 O
Gal4 4 B-GENE
protein t E-GENE
, 
 O
as O O
it O O
operates r O
in O O
a 
 O
gal4 4 B-GENE
mutant a E-GENE
background k O
as O O
well l O
. 
 O
Consistent s O
with h O
the 	 O
large g O
pocket k O
of O O
Rb S S-GENE
binding d O
to O O
TAF 	 B-GENE
( - I-GENE
II I I-GENE
) - I-GENE
250 	 E-GENE
, 
 O
the 	 O
large g O
pocket k O
domains a O
of O O
both h O
p107 7 S-GENE
and 	 O
p130 0 S-GENE
are 	 O
able e O
to O O
bind d O
to O O
TAF 	 B-GENE
( - I-GENE
II I I-GENE
) - I-GENE
250 	 E-GENE
in O O
vivo o O
. 
 O
50 O O
- 
 O
nucleotide l O
) 
 O
intron r O
to O O
AA O O
. 
 O
The 	 O
educational c O
program g O
was 	 O
the 	 O
significant n O
factor t O
that t O
influenced l O
the 	 O
change n O
of O O
concern c O
trajectories j O
, 
 O
and 	 O
the 	 O
recurrent u O
/ 
 O
non 	 O
- 
 O
recurrent u O
factor t O
influenced l O
the 	 O
change n O
of O O
concern c O
only y O
in O O
pamphlet p O
group u O
. 
 O
Amplification l O
of O O
4q21 1 O
- 
 O
q22 	 O
and 	 O
the 	 O
MXR 	 B-GENE
gene e E-GENE
in O O
independently e O
derived i O
mitoxantrone o O
- 
 O
resistant i O
cell l O
lines e O
. 
 O
Activation i O
of O O
the 	 O
receptor e O
induces u O
Ret 	 S-GENE
phosphorylation s O
that t O
leads d O
the 	 O
survival v O
- 
 O
promoting m O
effects e O
. 
 O
In O O
patients i O
in O O
which c O
these s O
criteria t O
were e O
not 	 O
met 	 O
only y O
the 	 O
reproducibility r O
of O O
the 	 O
VO2 	 O
obtained a O
in O O
both h O
the 	 O
P 
 O
- 
 O
MET 	 O
and 	 O
the 	 O
C 
 O
- 
 O
MET 	 O
indicated i O
that t O
the 	 O
maximal i O
VO2 	 O
for 	 O
these s O
4 
 O
patients i O
had 	 O
been n O
reached c O
. 
 O
This s O
paper e O
describes c O
a 
 O
course r O
of O O
therapy r O
with h O
an O O
agoraphobic r O
female a O
patient i O
. 
 O
A 
 O
previously v O
developed e O
kinetic e O
model e O
was 	 O
used d O
to O O
identify n O
major o O
chemical m O
reaction c O
pathways h O
involving o O
PAH 	 O
in O O
the 	 O
afterburner e O
. 
 O
Henry r O
Quastler s O
brought u O
experience e O
from m O
an O O
actual u O
x 
 O
- 
 O
ray 	 O
treatment a O
, 
 O
and 	 O
Dr O O
. 
 O
Critical t O
review i O
of O O
tests t O
for 	 O
the 	 O
HBs 	 B-GENE
antigen i E-GENE
in O O
the 	 O
detection e O
of O O
infectious e O
blood o O
A 
 O
direct e O
statistically t O
reliable i O
correction r O
of O O
decrease r O
of O O
the 	 O
enzymes y O
with h O
the 	 O
initial t O
state t O
of O O
the 	 O
patients i O
has 	 O
been n O
established a O
in O O
an O O
analysis l O
of O O
25 O O
patients i O
aged d O
from m O
18 O O
to O O
60 O O
years r O
in O O
prosthesis s O
of O O
+ 
 O
the 	 O
mitral r O
valve v O
( 
 O
n 
 O
- 
 O
9 
 O
) 
 O
and 	 O
closed s O
mitral r O
commissurotomy m O
( 
 O
n 
 O
- 
 O
16 O O
) 
 O
. 
 O
DSS4 4 B-GENE
- - I-GENE
1 - E-GENE
is O O
a 
 O
dominant i O
suppressor p O
of O O
sec4 4 B-GENE
- - I-GENE
8 - E-GENE
that t O
encodes o O
a 
 O
nucleotide l O
exchange h O
protein t O
that t O
aids s O
Sec4p 4 S-GENE
function c O
. 
 O
These s O
findings d O
indicate i O
that t O
KCTG G O
can 	 O
contribute t O
to O O
improved r O
monitoring i O
in O O
high h O
- 
 O
risk k O
pregnancies g O
. 
 O
The 	 O
MI O O
site e O
is O O
predictive d O
of O O
hemodynamic o O
left t O
ventricular t O
dysfunction f O
both h O
at O O
rest t O
and 	 O
during i O
exercise r O
: 
 O
anterior e O
MIs 	 O
are 	 O
more e O
impaired a O
than n O
inferior e O
MIs 	 O
. 
 O
The 	 O
vaccine c O
was 	 O
highly h O
immunogenic u O
, 
 O
since c O
111 	 O
of O O
113 	 O
patients i O
( 
 O
98 O O
% 
 O
) 
 O
produced d O
anti i B-GENE
- - I-GENE
HBs 	 E-GENE
( 
 O
10 O O
mIU 	 O
/ 
 O
ml O O
or O O
more e O
) 
 O
. 
 O
The 	 O
interleukin e B-GENE
- - I-GENE
2 - I-GENE
receptor e I-GENE
alpha h E-GENE
( 
 O
IL B B-GENE
- - I-GENE
2R I I-GENE
alpha h E-GENE
) 
 O
chain i O
gene e O
contains t O
a 
 O
sequence u O
similar i O
to O O
the 	 O
immunoglobulin u S-GENE
( - O
Ig I S-GENE
) - O
kappa p B-GENE
( 
 I-GENE
kappa p I-GENE
) 
 I-GENE
enhancer a I-GENE
NF B I-GENE
- - I-GENE
kappa p I-GENE
B - I-GENE
binding d I-GENE
site e E-GENE
. 
 O
Comparison p O
of O O
the 	 O
derived i O
amino n O
acid d O
sequence u O
with h O
that t O
of O O
the 	 O
HCMV V B-GENE
UL99 9 I-GENE
gene e I-GENE
product d E-GENE
reveals e O
34 O O
. 
 O
8 
 O
% 
 O
identity n O
in O O
an O O
overlap r O
of O O
66 O O
amino n O
acids d O
. 
 O
Although h O
mutant a O
pex5delta 5 O
cells l O
expressing r O
a 
 O
yeast s B-GENE
/ - I-GENE
tobacco a I-GENE
Pex5p 5 E-GENE
chimaera m O
failed l O
to O O
import o O
a 
 O
GFP 	 S-GENE
- 
 O
Eci1p 1 S-GENE
reporter o O
protein t O
, 
 O
they y O
were e O
able e O
to O O
grow w O
on O O
oleic i O
acid d O
. 
 O
Consistent s O
with h O
this s O
observation e O
, 
 O
introduction r O
of O O
Smad d B-GENE
sites e E-GENE
into o O
a 
 O
TGFbeta b S-GENE
- 
 O
insensitive e O
LEF1 1 S-GENE
/ 
 O
TCF 	 S-GENE
target g O
gene e O
confers f O
cooperative p O
TGFbeta b S-GENE
and 	 O
Wnt 	 S-GENE
responsiveness p O
to O O
the 	 O
promoter m O
. 
 O
In O O
analogy l O
to O O
human a B-GENE
CD70 0 E-GENE
, 
 O
mCD70 7 B-GENE
transcript n E-GENE
levels e O
are 	 O
strongly o O
but 	 O
transiently n O
up O O
- 
 O
regulated u O
during i O
lymphocyte p O
activation i O
, 
 O
which c O
is O O
in O O
line e O
with h O
a 
 O
role e O
for 	 O
the 	 O
CD27 7 S-GENE
- - O
CD70 0 S-GENE
receptor e O
pair r O
early l O
in O O
the 	 O
immune u O
response p O
. 
 O
Serum u B-GENE
IgM 	 E-GENE
levels e O
showed w O
a 
 O
highly h O
significant n O
increase r O
in O O
all 	 O
types e O
of O O
brain i O
tumour o O
when n O
compared p O
to O O
controls t O
. 
 O
Beyond o O
the 	 O
first s O
year r O
post t O
- 
 O
renal a O
transplantation n O
there r O
was 	 O
no O O
difference f O
in O O
C 
 O
( 
 O
IO O O
) 
 O
between w O
LRD 	 O
and 	 O
CAD 	 O
allografts o O
. 
 O
Vk8 	 S-GENE
/ 
 O
Jk2 	 S-GENE
and 	 O
Vk1 	 S-GENE
/ 
 O
Jk5 	 S-GENE
rearrangements r O
encoded o O
the 	 O
respective p O
L - B-GENE
chain i I-GENE
V - I-GENE
- - I-GENE
regions i E-GENE
. 
 O
The 	 O
phenomena n O
of O O
nursing s O
are 	 O
deeply p O
rooted t O
in O O
the 	 O
human a O
condition d O
. 
 O
Clinical n O
findings d O
plaque q O
index e O
, 
 O
PI O O
; 
 O
gingival g O
index e O
, 
 O
GI O O
; 
 O
bleeding e O
on O O
probing b O
, 
 O
BOP 	 O
; 
 O
pus 	 O
discharge c O
, 
 O
pus 	 O
; 
 O
and 	 O
probing b O
depth t O
, 
 O
PD O O
at O O
both h O
PT O O
- 
 O
01 O O
and 	 O
control t O
sites e O
were e O
measured s O
at O O
every r O
visit i O
for 	 O
4 
 O
weeks k O
. 
 O
One 	 O
of O O
these s O
elements m O
resembles e O
the 	 O
binding d O
site e O
of O O
a 
 O
previously v O
identified n O
cellular l O
" 
 O
transcription n O
" 
 O
factor t O
. 
 O
NER 	 S-GENE
was 	 O
also o O
measured s O
by O O
a 
 O
plasmid s O
host t O
cell l O
re O O
- 
 O
activation i O
assay a O
using n O
a 
 O
vector t O
containing t O
a 
 O
luciferase i B-GENE
reporter o I-GENE
gene e E-GENE
. 
 O
Plasma s O
Pi O O
, 
 O
tibia i O
breaking a O
strength e O
, 
 O
and 	 O
percentage c O
of O O
tibia i O
ash 	 O
were e O
increased r O
by O O
raising s O
dietary t O
Pav 	 S-GENE
in O O
the 	 O
presence s O
of O O
. 
 O
392 	 O
% 
 O
A1 O O
with h O
either h O
level e O
of O O
Ca O O
. 
 O
A 
 O
total a O
of O O
114 	 O
animals m O
were e O
infected e O
by O O
E 
 O
. 
 O
coli i O
O2 O O
: 
 O
K1 O O
: 
 O
H4 O O
by O O
the 	 O
hematogenic a O
route t O
. 
 O
In O O
the 	 O
fungus g O
Neurospora r O
crassa s O
, 
 O
nit 	 B-GENE
- - I-GENE
2 - E-GENE
, 
 O
the 	 O
major o O
nitrogen r O
regulatory u O
gene e O
, 
 O
activates i O
the 	 O
expression r O
of O O
unlinked i O
structural u O
genes e O
that t O
specify c O
nitrogen r O
- 
 O
catabolic a O
enzymes y O
during i O
conditions d O
of O O
nitrogen r O
limitation i O
. 
 O
The 	 O
matrix r O
of O O
the 	 O
CBs 	 O
contains t O
the 	 O
diagnostic g B-GENE
protein t I-GENE
p80 	 I-GENE
- 
 I-GENE
coilin l E-GENE
, 
 O
which c O
is O O
colocalized o O
with h O
the 	 O
U7 B B-GENE
small l I-GENE
nuclear l I-GENE
ribonucleoprotein o E-GENE
( 
 O
snRNP N S-GENE
) 
 O
, 
 O
whereas r O
the 	 O
attached a O
and 	 O
embedded e O
B 
 O
- 
 O
snurposomes r O
contain t O
splicing i O
snRNPs N O
. 
 O
During i O
an O O
observation e O
period i O
of O O
12 O O
weeks k O
after e O
halving v O
atenolol n O
from m O
a 
 O
mean n O
dose e O
of O O
82 O O
mg O O
to O O
41 O O
mg O O
, 
 O
no O O
significant n O
changes n O
in O O
systolic t O
and 	 O
diastolic s O
blood o O
pressure s O
or O O
in O O
response p O
rate e O
( 
 O
defined i O
as O O
a 
 O
diastolic s O
blood o O
pressure s O
of O O
95 O O
mm O O
Hg O O
or O O
less s O
) 
 O
were e O
observed e O
. 
 O
Comparative p O
volumetric u O
analysis l O
is O O
defined i O
as O O
the 	 O
difference f O
between w O
mean n O
corpuscular p O
erythrocyte t O
volume u O
in O O
peripheral i O
blood o O
( 
 O
MCVB B O
) 
 O
diluted u O
in O O
urine n O
supernatant e O
after e O
centrifugation t O
and 	 O
mean n O
corpuscular p O
volume u O
of O O
urinary n O
erythrocytes t O
( 
 O
MCVU U O
) 
 O
. 
 O
PATIENTS I O
: 
 O
33 O O
HIV 	 O
- 
 O
infected e O
, 
 O
zidovudine o O
- 
 O
experienced e O
patients i O
with h O
serum u O
HIV 	 O
RNA 	 O
levels e O
of O O
at O O
least s O
20 O O
, 
 O
000 	 O
copies i O
/ 
 O
mL O O
and 	 O
CD4 	 S-GENE
counts n O
ranging g O
from m O
50 O O
to O O
400 	 O
cells l O
/ 
 O
mm3 	 O
. 
 O
Within h O
the 	 O
last t O
few 	 O
years r O
, 
 O
the 	 O
WWW 	 O
has 	 O
grown w O
enormously r O
. 
 O
These s O
data a O
, 
 O
taken e O
together e O
, 
 O
suggest g O
that t O
CRF 	 S-GENE
produces d O
its 	 O
behavioral a O
activating i O
and 	 O
anxiogenic i O
effects e O
, 
 O
at O O
least s O
in O O
part t O
, 
 O
by O O
increasing r O
the 	 O
activity i O
of O O
LC O O
noradrenergic a O
neurons r O
. 
 O
On O O
the 	 O
basis i O
of O O
8 
 O
cases e O
, 
 O
the 	 O
authors h O
report o O
different f O
clinical n O
pictures t O
all 	 O
caused s O
by O O
cardiac d O
toxicity i O
of O O
5FU 	 O
. 
 O
The 	 O
sequence u O
of O O
Vac1p 1 S-GENE
contains t O
two 	 O
putative a O
zinc c O
- 
 O
binding d O
RING G O
motifs i O
, 
 O
a 
 O
zinc c O
finger g O
motif i O
, 
 O
and 	 O
a 
 O
coiled l O
- 
 O
coil l O
motif i O
. 
 O
Although h O
cardiac d O
output p O
decreased r O
slightly g O
with h O
PCF 	 O
, 
 O
hemodynamic o O
changes n O
due 	 O
to O O
PCF 	 O
were e O
unlikely i O
to O O
account o O
for 	 O
the 	 O
observed e O
fall l O
in O O
PaO2 2 O
. 
 O
Anti i B-GENE
- - I-GENE
Jo I I-GENE
- - I-GENE
1 - I-GENE
antibody i E-GENE
was 	 O
not 	 O
present s O
. 
 O
The 	 O
first s O
operon r O
, 
 O
orf1 1 B-GENE
- 
 I-GENE
tolQRA Q E-GENE
, 
 O
is O O
iron n O
regulated u O
throughout o O
growth w O
, 
 O
but 	 O
iron n O
- 
 O
regulated u O
expression r O
of O O
tolB B S-GENE
and 	 O
oprL L S-GENE
fusions i O
occurs u O
only y O
in O O
late e O
log 	 O
phase s O
. 
 O
S 
 O
. 
 O
aureus e O
leakage k O
into o O
the 	 O
totally a O
submerged m O
test t O
specimens c O
was 	 O
detected e O
in O O
1 
 O
of O O
5 
 O
samples p O
incubated u O
for 	 O
4 
 O
weeks k O
, 
 O
while l O
no O O
leakage k O
was 	 O
detected e O
in O O
specimens c O
incubated u O
for 	 O
3 
 O
, 
 O
5 
 O
, 
 O
6 
 O
, 
 O
7 
 O
, 
 O
and 	 O
8 
 O
weeks k O
. 
 O
We O O
examined m O
the 	 O
contribution t O
of O O
a 
 O
cryptic p O
plasmid s O
, 
 O
pRmeGR4b e O
, 
 O
to O O
the 	 O
nodulation u O
of O O
Medicago i O
sativa i O
by O O
strain a O
GR4 	 O
of O O
Rhizobium z O
meliloti i O
. 
 O
It O O
also o O
appears e O
that t O
in O O
patients i O
with h O
laboratory o O
diagnosis g O
of O O
prerenal r O
acute t O
renal a O
failure l O
( 
 O
i 
 O
. 
 O
e 
 O
. 
 O
, 
 O
a 
 O
RFT 	 O
less s O
than n O
1 
 O
. 
 O
0 
 O
) 
 O
, 
 O
the 	 O
response p O
to O O
treatment a O
is O O
unpredictable r O
and 	 O
in O O
fact t O
may 	 O
have e O
a 
 O
worse s O
prognosis g O
than n O
in O O
those s O
with h O
a 
 O
RFI 	 O
greater a O
than n O
1 
 O
. 
 O
0 
 O
( 
 O
5 
 O
/ 
 O
7 
 O
deaths t O
vs O O
10 O O
/ 
 O
48 O O
deaths t O
) 
 O
. 
 O
Paraplegia a O
associated o O
with h O
intraaortic r O
balloon l O
pump p O
counterpulsation n O
. 
 O
CTP 	 O
, 
 O
GDP 	 O
, 
 O
GTP 	 O
, 
 O
ITP 	 O
) 
 O
did 	 O
not 	 O
affect e O
the 	 O
response p O
. 
 O
Using n O
green e O
fluorescent o O
protein t O
fusions i O
we O O
demonstrate o O
that t O
the 	 O
SYT 	 S-GENE
, 
 O
SSX 	 S-GENE
and 	 O
the 	 O
SYT 	 B-GENE
- 
 I-GENE
SSX 	 I-GENE
proteins t E-GENE
are 	 O
nuclear l O
proteins t O
. 
 O
The 	 O
anaesthetic e O
management a O
of O O
41 O O
patients i O
who 	 O
underwent e O
cardiac d O
transplantation n O
during i O
a 
 O
40 O O
month t O
period i O
at O O
Clinica n O
Puerta r O
de O O
Hierro r O
is O O
reviewed i O
. 
 O
Acute t O
respiratory p O
distress t O
syndrome d O
. 
 O
These s O
data a O
suggested g O
that t O
mutant a B-GENE
PS1 	 E-GENE
may 	 O
cause s O
disease e O
as O O
a 
 O
result u O
of O O
reduction u O
in O O
PS1 	 O
function c O
. 
 O
The 	 O
analysis l O
of O O
the 	 O
organization a O
of O O
the 	 O
sequence u O
of O O
the 	 O
human a B-GENE
ABP 	 I-GENE
/ 
 I-GENE
DAO 	 I-GENE
gene e E-GENE
reveals e O
that t O
the 	 O
2 
 O
. 
 O
4 
 O
- 
 O
kilobase o O
messenger s O
RNA 	 O
is O O
transcribed n O
from m O
two 	 O
close s O
origins g O
identifying n O
the 	 O
proximal x O
promoter m O
. 
 O
Most t O
important o O
, 
 O
after e O
all 	 O
, 
 O
is O O
not 	 O
the 	 O
ionization i O
technique h O
but 	 O
the 	 O
stage g O
with h O
a 
 O
47 O O
. 
 O
1 
 O
% 
 O
five e O
- 
 O
year r O
survival v O
rate e O
in O O
T1N0 0 O
as O O
compared p O
to O O
T2N0 0 O
with h O
28 O O
. 
 O
6 
 O
% 
 O
and 	 O
T1N1 1 O
with h O
19 O O
. 
 O
4 
 O
% 
 O
. 
 O
To O O
investigate e O
the 	 O
step p O
of O O
spliceosome i O
assembly e O
at O O
which c O
Snu17p 1 S-GENE
acts s O
, 
 O
we O O
have e O
used d O
nondenaturing d O
gel 	 O
electrophoresis c O
. 
 O
We O O
also o O
show w O
that t O
an O O
internal e O
fragment g O
of O O
U24 	 B-GENE
methylation h I-GENE
guide d I-GENE
snoRNA R E-GENE
, 
 O
encompassing o O
the 	 O
upstream t O
antisense i O
element m O
and 	 O
the 	 O
D 
 O
' 
 O
and 	 O
C 
 O
' 
 O
box 	 O
motifs i O
, 
 O
can 	 O
support p O
the 	 O
site e O
- 
 O
specific c O
methylation h O
of O O
rRNA A O
. 
 O
Mammalian m B-GENE
ribonucleotide o I-GENE
reductase u E-GENE
shows w O
S 
 O
- 
 O
phase s O
specific c O
expression r O
and 	 O
consists s O
of O O
two 	 O
non 	 O
- 
 O
identical n O
subunits u O
, 
 O
proteins t B-GENE
R1 E E-GENE
( 
 O
large g O
subunit u O
) 
 O
and 	 O
R2 S S-GENE
( 
 O
small l O
subunit u O
) 
 O
. 
 O
Effects e O
of O O
dexamethasone a O
on O O
the 	 O
development e O
of O O
radiation i O
nephropathy h O
in O O
the 	 O
rat 	 O
. 
 O
Recombinant o B-GENE
MsERK1 R E-GENE
( 
 O
rMsERK1 E S-GENE
) 
 O
, 
 O
when n O
overexpressed r O
in O O
Escherichia h O
coli i O
, 
 O
is O O
recognized o O
by O O
antibodies i O
raised s O
against i O
MAP 	 B-GENE
kinases a E-GENE
from m O
rat 	 O
, - O
Xenopus o O
, - O
and 	 O
sea 	 O
star r O
and 	 O
by O O
anti i B-GENE
- - I-GENE
phosphotyrosine s I-GENE
antibodies i E-GENE
. 
 O
The 	 O
identification n O
of O O
SRP54sc 5 S-GENE
and 	 O
SRP54sp 5 S-GENE
provides v O
the 	 O
first s O
evidence d O
for 	 O
SRP 	 B-GENE
related a I-GENE
proteins t E-GENE
in O O
yeast s O
. 
 O
We O O
previously v O
demonstrated o O
that t O
AKT2 2 S-GENE
, 
 O
a 
 O
member b O
of O O
protein t B-GENE
kinase a I-GENE
B - I-GENE
family i E-GENE
, 
 O
is O O
activated i O
by O O
a 
 O
number b O
of O O
growth w O
factors t O
via 	 O
Ras 	 S-GENE
and 	 O
PI B B-GENE
3 - I-GENE
- - I-GENE
kinase a E-GENE
signaling n O
pathways h O
. 
 O
So O O
it O O
is O O
sometimes e O
more e O
convenient v O
to O O
use 	 O
the 	 O
back k O
Radon o O
transform n O
R 
 O
- 
 O
1 
 O
and 	 O
then n O
to O O
correct r O
the 	 O
result u O
, 
 O
taking i O
into o O
account o O
attenuation e O
. 
 O
Before o O
flecainide c O
, 
 O
all 	 O
patients i O
had 	 O
easily i O
inducible u O
VT O O
that t O
was 	 O
morphologically p O
identical n O
to O O
their i O
spontaneously n O
occurring u O
arrhythmia h O
. 
 O
An O O
additional i O
dose e O
of O O
20 O O
- 
 O
25 O O
Gy O O
was 	 O
delivered i O
to O O
the 	 O
site e O
of O O
original g O
involvement o O
using n O
an O O
implant l O
when n O
feasible s O
. 
 O
The 	 O
prominent m O
fracture c O
of O O
women e O
older e O
than n O
75 O O
years r O
is O O
the 	 O
hip 	 O
fracture c O
( 
 O
type e O
II O O
osteoporosis e O
) 
 O
. 
 O
The 	 O
expected e O
products d O
of O O
the 	 O
cloned n O
bph 	 B-GENE
genes e E-GENE
, 
 O
except e O
bphA3 A S-GENE
, 
 O
were e O
observed e O
in O O
E 
 O
. 
 O
coli i O
in O O
an O O
in O O
vitro r O
transcription n O
- 
 O
translation n O
system t O
. 
 O
It O O
is O O
our 	 O
conclusion c O
that t O
Sonoclot o O
coagulation g O
analysis l O
is O O
unlikely i O
to O O
identify n O
patients i O
with h O
prolonged l O
bleeding e O
time e O
in O O
whom m O
platelet t O
count n O
and 	 O
other e O
coagulation g O
factors t O
are 	 O
normal m O
. 
 O
RESULTS U O
: 
 O
Analysis l O
by O O
Pearson r O
' 
 O
s 
 O
correlation r O
showed w O
that t O
the 	 O
subjects j O
who 	 O
had 	 O
higher h O
scores r O
of O O
SSMS S O
during i O
the 	 O
drum m O
rotation a O
generated e O
the 	 O
following l O
: 
 O
a 
 O
) 
 O
a 
 O
higher h O
rating i O
of O O
over r O
- 
 O
all 	 O
sickness k O
( 
 O
r 
 O
= 
 O
0 
 O
. 
 O
76 O O
) 
 O
; 
 O
b 
 O
) 
 O
a 
 O
higher h O
ratio i O
of O O
spectral c O
power e O
of O O
EGG 	 O
at O O
4 
 O
- 
 O
9 
 O
cycles l O
per 	 O
minute u O
( 
 O
cpm 	 O
) 
 O
between w O
drum m O
rotation a O
and 	 O
baseline e O
periods i O
( 
 O
r 
 O
= 
 O
0 
 O
. 
 O
63 O O
) 
 O
; 
 O
c 
 O
) 
 O
a 
 O
higher h O
net 	 O
percent c O
increase r O
of O O
spectral c O
power e O
in O O
the 	 O
EEG 	 O
frequency q O
band d O
0 
 O
. 
 O
5 
 O
- 
 O
4 
 O
Hz O O
between w O
drum m O
rotation a O
and 	 O
baseline e O
periods i O
on O O
C3 O O
( 
 O
r 
 O
= 
 O
0 
 O
. 
 O
29 O O
) 
 O
and 	 O
C4 O O
( 
 O
r 
 O
= 
 O
0 
 O
. 
 O
31 O O
) 
 O
; 
 O
d 
 O
) 
 O
a 
 O
higher h O
ratio i O
of O O
spectral c O
power e O
of O O
EEG 	 O
frequency q O
band d O
0 
 O
. 
 O
5 
 O
- 
 O
4 
 O
Hz O O
between w O
drum m O
rotation a O
and 	 O
baseline e O
periods i O
on O O
C3 O O
( 
 O
r 
 O
= 
 O
0 
 O
. 
 O
31 O O
) 
 O
; 
 O
and 	 O
e 
 O
) 
 O
a 
 O
higher h O
level e O
of O O
net 	 O
increase r O
in O O
skin n O
conductance d O
from m O
baseline e O
to O O
drum m O
rotation a O
( 
 O
r 
 O
= 
 O
0 
 O
. 
 O
30 O O
) 
 O
. 
 O
Salts t O
of O O
these s O
four r O
metal a O
ions s O
may 	 O
be O O
added e O
to O O
the 	 O
growth w O
medium i O
to O O
facilitate i O
selective e O
isolation l O
of O O
Acinetobacter n O
. 
 O
The 	 O
consensus s O
mammalian m B-GENE
ER O I-GENE
stress e I-GENE
response p I-GENE
element m E-GENE
( 
 O
ERSE E O
) 
 O
conserved s O
among n O
grp 	 B-GENE
promoters m E-GENE
consists s O
of O O
a 
 O
tripartite p O
structure u O
CCAAT A O
( 
 O
N9 O O
) 
 O
CCACG C O
, 
 O
with h O
N 
 O
being n O
a 
 O
strikingly i O
GC O O
- 
 O
rich h O
region i O
of O O
9 
 O
bp O O
. 
 O
Acute t O
toxicity i O
tests t O
were e O
conducted d O
to O O
measure s O
the 	 O
response p O
of O O
first s O
instar t O
Toxorhynchites o O
splendens e O
to O O
commonly m O
used d O
mosquito q O
adulticides l O
: 
 O
malathion a O
, 
 O
naled e O
and 	 O
resmethrin m O
. 
 O
A 
 O
positive i O
correlation r O
was 	 O
also o O
established a O
between w O
the 	 O
level e O
of O O
FP9C C S-GENE
binding d O
and 	 O
the 	 O
degree r O
of O O
cell l O
differentiation f O
in O O
vitro r O
. 
 O
Effects e O
of O O
acute t O
exposure o O
to O O
cold d O
on O O
pulmonary m O
arterial e O
blood o O
pressure s O
in O O
awake k O
rats s O
. 
 O
When n O
labeled e O
by O O
the 	 O
described c O
method h O
, 
 O
99mTc T O
on O O
DTPA A O
coupled p O
antibodies i O
shows w O
instability t O
in O O
serum u O
but 	 O
superior e O
stability b O
than n O
99mTc T O
on O O
antibodies i O
without h O
the 	 O
attached a O
DTPA A O
. 
 O
Unlike i O
CSK 	 S-GENE
, 
 O
the 	 O
SH3 	 B-GENE
domain a E-GENE
of O O
HYL 	 S-GENE
was 	 O
unique q O
since c O
the 	 O
ALYDY D B-GENE
motif i E-GENE
was 	 O
absent e O
. 
 O
As O O
the 	 O
mechanism h O
of O O
the 	 O
intractability r O
, 
 O
cell l O
function c O
involved o O
in O O
the 	 O
defense e O
against i O
infection e O
was 	 O
evaluated l O
. 
 O
88 O O
, 
 O
3739 9 O
- 
 O
3743 3 O
) 
 O
) 
 O
. 
 O
OBJECTIVE E O
: 
 O
To O O
report o O
a 
 O
case e O
of O O
fulminant m O
neuropathy r O
with h O
severe e O
quadriparesis d O
associated o O
with h O
vincristine c O
chemotherapy m O
. 
 O
The 	 O
median i O
survival v O
time e O
was 	 O
18 O O
months t O
. 
 O
Hemorrheological o O
evaluation l O
and 	 O
proposed p O
pharmacological r O
uses s O
. 
 O
Its 	 O
phosphorylation s O
strongly o O
potentiates e O
its 	 O
ability l O
to O O
activate i O
transcription n O
of O O
the 	 O
c - B-GENE
- - I-GENE
fos 	 I-GENE
promoter m E-GENE
through o O
a 
 O
ternary n O
complex p O
assembled e O
on O O
the 	 O
c - B-GENE
- - I-GENE
fos 	 I-GENE
serum u I-GENE
response p I-GENE
element m E-GENE
. 
 O
Fus3p 3 S-GENE
and 	 O
Kss1p 1 S-GENE
together e O
increase r O
the 	 O
expression r O
of O O
CLN3 3 S-GENE
and 	 O
PCL2 2 B-GENE
genes e E-GENE
that t O
promote m O
budding d O
, 
 O
and 	 O
Kss1p 1 S-GENE
inhibits i O
the 	 O
MAP 	 B-GENE
kinase a E-GENE
cascade c O
. 
 O
Consistent s O
with h O
our 	 O
observation e O
that t O
AP B B-GENE
- - I-GENE
1 - E-GENE
binding d O
does s O
not 	 O
contribute t O
to O O
c - B-GENE
- - I-GENE
Jun 	 E-GENE
coactivation c O
is O O
the 	 O
observation e O
that t O
the 	 O
activation i O
of O O
PU B B-GENE
. - I-GENE
1 - E-GENE
by O O
c - B-GENE
- - I-GENE
Jun 	 E-GENE
is O O
blocked c O
by O O
overexpression r O
of O O
c - B-GENE
- - I-GENE
Fos 	 E-GENE
. 
 O
A 
 O
possible s O
correlation r O
between w O
mandibular d O
growth w O
retardation a O
and 	 O
palatal a O
clefting f O
is O O
discussed c O
. 
 O
Time e O
dependence e O
of O O
frequency q O
potentiation e O
in O O
the 	 O
isolated l O
guinea n O
- 
 O
pig 	 O
' 
 O
s 
 O
atrium i O
. 
 O
We O O
found n O
4 
 O
highly h O
conserved s O
regions i O
to O O
vertebrate t B-GENE
Hsp90 9 E-GENE
exclusively l O
and 	 O
27 O O
amino n O
acids d O
conserved s O
among n O
but 	 O
differing f O
between w O
Hsp90 9 B-GENE
alpha h E-GENE
and 	 O
Hsp90 9 B-GENE
beta a I-GENE
sequences u E-GENE
. 
 O
Characterization r O
of O O
trinucleotide n O
- 
 O
and 	 O
tandem d O
repeat e O
- 
 O
containing t O
transcripts n O
obtained a O
from m O
human a O
spinal n O
cord d O
cDNA A O
library r O
by O O
high h O
- 
 O
density s O
filter t O
hybridization r O
. 
 O
We O O
present s O
here e O
the 	 O
complete p O
primary m O
structure u O
of O O
human a B-GENE
gp330 3 E-GENE
, 
 O
the 	 O
human a O
variant i O
of O O
the 	 O
principal n O
kidney n O
autoantigen o O
causing s O
Heymann m O
membranous b O
glomerulonephritis m O
in O O
rats s O
. 
 O
The 	 O
platelet t B-GENE
membrane b I-GENE
glycoprotein c I-GENE
IIb 	 E-GENE
/ - O
IIIa a B-GENE
receptor e E-GENE
inhibitor i O
abciximab i O
is O O
used d O
for 	 O
the 	 O
treatment a O
of O O
patients i O
undergoing e O
high h O
- 
 O
risk k O
percutaneous c O
coronary o O
interventions e O
and 	 O
is O O
used d O
in O O
approximately r O
one 	 O
third r O
of O O
coronary o O
interventions e O
in O O
the 	 O
United t O
States t O
and 	 O
a 
 O
growing w O
number b O
of O O
procedures c O
in O O
Europe o O
. 
 O
In O O
the 	 O
conscious s O
animals m O
the 	 O
increase r O
reached c O
statistical t O
significance n O
when n O
the 	 O
animals m O
were e O
exposed o O
to O O
12 O O
% 
 O
oxygen g O
in O O
nitrogen r O
, 
 O
which c O
produced d O
a 
 O
fall l O
in O O
arterial e O
PaO2 2 O
of O O
44 O O
. 
 O
7 
 O
+ 
 O
/ 
 O
- 
 O
5 
 O
. 
 O
0 
 O
% 
 O
. 
 O
Prenatal n O
diagnosis g O
of O O
genetic e O
diseases e O
. 
 O
Human a B-GENE
epidermal d I-GENE
growth w I-GENE
factor t E-GENE
( 
 O
EGF 	 S-GENE
) 
 O
, 
 O
a 
 O
naturally u O
occurring u O
protein t O
, 
 O
has 	 O
been n O
implicated l O
in O O
the 	 O
protection t O
of O O
gastrointestinal t O
mucosal o O
integrity e O
. 
 O
A 
 O
ready d O
- 
 O
made e O
prosthesis s O
is O O
placed c O
on O O
the 	 O
external e O
side e O
of O O
the 	 O
ribs s O
vertically t O
bridging d O
the 	 O
flailed i O
chest s O
segment m O
, 
 O
and 	 O
fixed e O
to O O
the 	 O
first s O
upper e O
and 	 O
first s O
lower e O
intact a O
rib 	 O
as O O
well l O
as O O
to O O
the 	 O
mobile i O
segments m O
of O O
the 	 O
affected e O
ribs s O
. 
 O
DESIGN I O
: 
 O
Prospective s O
case e O
study d O
( 
 O
Canadian a O
Task k O
Force c O
classification s O
II O O
- 
 O
2 
 O
) 
 O
. 
 O
Site e O
- 
 O
directed e O
mutagenesis a O
of O O
the 	 O
T4 B B-GENE
endonuclease o I-GENE
V - I-GENE
gene e E-GENE
: 
 O
role e O
of O O
lysine i O
- 
 O
130 	 O
. 
 O
A 
 O
minimal i O
pheromone r O
induction u O
domain a O
, 
 O
delineated i O
as O O
residues i O
301 	 O
to O O
335 	 O
of O O
Ste12p 1 S-GENE
, 
 O
is O O
dependent e O
on O O
the 	 O
pheromone r B-GENE
mitogen o I-GENE
- - I-GENE
activated i I-GENE
protein t I-GENE
( - I-GENE
MAP 	 I-GENE
) - I-GENE
kinase a E-GENE
pathway h O
for 	 O
induction u O
activity i O
. 
 O
The 	 O
library r O
will l O
thus s O
be O O
useful f O
for 	 O
the 	 O
selection e O
of O O
cosmid m O
clones n O
which c O
carry r O
CDC 	 B-GENE
genes e E-GENE
from m O
yeast s O
by O O
complementing p O
first s O
, 
 O
with h O
the 	 O
vectorial t O
yeast s B-GENE
gene e I-GENE
URA1 1 E-GENE
, 
 O
the 	 O
pyrimidine i O
auxotrophy o O
of O O
most t O
cdc 	 O
- 
 O
strains a O
and 	 O
then n O
, 
 O
with h O
the 	 O
respective p O
CDC 	 O
wild d O
- - O
type e O
genes e O
, 
 O
of O O
the 	 O
temperature p O
- 
 O
sensitive s O
mutant a O
alleles e O
. 
 O
These s O
mutant a B-GENE
rps7 7 E-GENE
leaders d O
were e O
ligated a O
into o O
an O O
aadA A S-GENE
expression r O
cassette s O
and 	 O
transformed n O
into o O
the 	 O
chloroplast o O
of O O
C 
 O
. 
 O
reinhardtii n O
and 	 O
into o O
E 
 O
. 
 O
coli i O
. 
 O
In O O
addition i O
, 
 O
both h O
activated i O
Ral 	 S-GENE
- - O
GDS 	 B-GENE
- - I-GENE
like e I-GENE
factor t E-GENE
and 	 O
Raf 	 S-GENE
stimulate m O
cyclin l B-GENE
D - E-GENE
( - O
1 - S-GENE
) - O
transcription n O
and 	 O
E2F 	 S-GENE
activity i O
and 	 O
act 	 O
in O O
synergy e O
with h O
PI B B-GENE
3 - I-GENE
- - I-GENE
kinase a E-GENE
. 
 O
From m O
the 	 O
present s O
results u O
a 
 O
concept c O
of O O
hormone m O
- 
 O
dependent e O
AR S S-GENE
activation i O
is O O
proposed p O
, 
 O
which c O
requires u O
a 
 O
functional c O
, 
 O
direct e O
or O O
indirect i O
intramolecular r O
interaction e O
between w O
the 	 O
TAD 	 O
and 	 O
the 	 O
LBD 	 O
. 
 O
Like e O
the 	 O
DMA 	 O
, 
 O
but 	 O
unlike i O
all 	 O
other e O
mammalian m B-GENE
class s I-GENE
II I I-GENE
A - I-GENE
genes e E-GENE
, 
 O
the 	 O
zebrafish r O
gene e O
codes e O
for 	 O
two 	 O
cysteine t O
residues i O
which c O
might h O
potentially e O
be O O
involved o O
in O O
the 	 O
formation m O
of O O
a 
 O
disulfide u O
bond d O
in O O
the 	 O
alpha h B-GENE
1 
 I-GENE
domain a E-GENE
. 
 O
Down n O
- 
 O
regulation u O
of O O
Id1 	 B-GENE
mRNA A E-GENE
correlated r O
with h O
mitogenesis o O
and 	 O
occurred u O
when n O
quiescent e O
cells l O
were e O
treated a O
with h O
growth w O
factors t O
that t O
activate i B-GENE
G - I-GENE
protein t I-GENE
- - I-GENE
coupled p I-GENE
receptors e E-GENE
and 	 O
receptor e B-GENE
protein t I-GENE
tyrosine o I-GENE
kinases a E-GENE
but 	 O
not 	 O
with h O
a 
 O
non 	 O
- 
 O
mitogenic o O
cAMP P O
analog l O
. 
 O
Secretogranin r B-GENE
II E E-GENE
( 
 O
SgII I S-GENE
) 
 O
is O O
a 
 O
secretory r O
polypeptide y O
stored r O
in O O
large g O
dense s O
core e O
vesicles i O
of O O
neuroendocrine r O
and 	 O
neuronal r O
cells l O
. 
 O
CONCLUSIONS C O
: 
 O
In O O
the 	 O
results u O
of O O
this s O
study d O
, 
 O
SDB 	 O
, 
 O
even n O
snoring r O
, 
 O
was 	 O
independently e O
associated o O
with h O
hypertension e O
in O O
both h O
men 	 O
and 	 O
women e O
. 
 O
The 	 O
electron c O
spin n O
resonance o O
study d O
also o O
demonstrated o O
that t O
the 	 O
formation m O
of O O
superoxide e O
- 
 O
DMPO O O
spin n O
adduct u O
was 	 O
strongly o O
inhibited i O
by O O
a 
 O
selective e O
cyclooxygenase l B-GENE
- - I-GENE
2 - E-GENE
inhibitor i O
, 
 O
etodolac d O
, 
 O
in O O
a 
 O
concentration c O
- 
 O
dependent e O
manner n O
. 
 O
BK S S-GENE
- 
 O
induced u O
translocation n O
and 	 O
overexpression r O
of O O
PKC 	 B-GENE
isoforms f E-GENE
as O O
well l O
as O O
coexpression x O
of O O
inactive c O
or O O
constitutively s O
active i O
mutants a O
of O O
different f O
PKC 	 B-GENE
isozymes z E-GENE
provided v O
evidence d O
for 	 O
a 
 O
role e O
of O O
the 	 O
diacylglycerol c O
- 
 O
sensitive s O
PKCs s B-GENE
alpha h E-GENE
and 	 O
epsilon i O
in O O
BK S S-GENE
signaling n O
toward a O
MAPK K S-GENE
. 
 O
Embryonal r O
mortality t O
A 
 O
lead d O
phthalocyanin h O
method h O
for 	 O
the 	 O
demonstration o O
of O O
acid d B-GENE
hydrolases r E-GENE
in O O
plant n O
and 	 O
animal m O
tissues s O
. 
 O
Here e O
we O O
describe c O
the 	 O
characterization r O
of O O
cDNAs A S-GENE
encoding o O
two 	 O
unusual s O
E2Fs s S-GENE
, 
 O
E2F 	 B-GENE
- - I-GENE
4 - E-GENE
and 	 O
E2F 	 B-GENE
- - I-GENE
5 - E-GENE
, 
 O
each h O
identified n O
by O O
the 	 O
ability l O
of O O
their i O
gene e O
product d O
to O O
interact e O
with h O
p130 0 S-GENE
in O O
a 
 O
yeast s O
two 	 O
- 
 O
hybrid r O
system t O
. 
 O
Interestingly e O
, 
 O
unlike i O
PAK65 6 S-GENE
, 
 O
HPK1 1 S-GENE
does s O
not 	 O
contain t O
the 	 O
small l B-GENE
GTPase a E-GENE
Rac1 1 S-GENE
/ 
 O
Cdc42 4 S-GENE
- 
 O
binding d O
domain a O
and 	 O
does s O
not 	 O
bind d O
to O O
either h O
Rac1 1 S-GENE
or O O
Cdc42 4 S-GENE
, 
 O
suggesting g O
that t O
HPK1 1 S-GENE
. 
 O
activation i O
is O O
Rac1 1 S-GENE
/ 
 O
Cdc42 4 S-GENE
- 
 O
independent e O
. 
 O
The 	 O
results u O
were e O
compared p O
with h O
the 	 O
findings d O
in O O
pair r O
- 
 O
fed 	 O
non 	 O
- 
 O
treated a O
animals m O
( 
 O
Control t O
Group u O
) 
 O
. 
 O
Tumor o B-GENE
necrosis r I-GENE
factor t E-GENE
levels e O
were e O
measured s O
by O O
enzyme y O
- 
 O
linked k O
immunoabsorbent u O
assay a O
in O O
plasma s O
samples p O
obtained a O
from m O
the 	 O
hyperthermic e O
isolated l O
limb b O
perfusion f O
circuit c O
and 	 O
systemic t O
circulation c O
. 
 O
However e O
, 
 O
only y O
plasma s O
fibrinogen r S-GENE
concentrations c O
showed w O
statistically t O
significant n O
positive i O
associations o O
with h O
IMT 	 S-GENE
in O O
both h O
groups u O
. 
 O
Without h O
a 
 O
team m O
, 
 O
there r O
is O O
little t O
hope e O
for 	 O
fetal a O
survival v O
; 
 O
mortality t O
will l O
be O O
80 O O
- 
 O
100 	 O
% 
 O
. 
 O
Analysis l O
of O O
deletion e O
and 	 O
substitution s O
mutations a O
in O O
the 	 O
MER2 2 O
5 - O
' - O
exon n O
demonstrates o O
that t O
the 	 O
unusually s O
large g O
size e O
of O O
this s O
exon n O
plays y O
an O O
important o O
role e O
in O O
splicing i O
regulation u O
. 
 O
To O O
study d O
the 	 O
signaling n O
pathways h O
that t O
regulate u O
cytoskeletal o O
rearrangements r O
in O O
T 
 O
lymphocytes p O
, 
 O
we O O
set 	 O
up O O
a 
 O
conjugate j O
formation m O
assay a O
using n O
Jurkat k O
T 
 O
cells l O
as O O
effectors e O
and 	 O
cell l O
- 
 O
sized e O
latex e O
beads d O
coated t O
with h O
various i O
antibodies i O
as O O
artificial i O
APCs s S-GENE
. 
 O
Reexamination x O
of O O
the 	 O
cdc4 4 B-GENE
- - I-GENE
1 - I-GENE
mutant a E-GENE
revealed e O
that t O
, 
 O
in O O
addition i O
to O O
being n O
defective e O
in O O
the 	 O
onset e O
of O O
S 
 O
phase s O
, 
 O
it O O
is O O
also o O
defective e O
in O O
G 
 O
( 
 O
2 
 O
) 
 O
/ 
 O
M 
 O
transition n O
when n O
released e O
from m O
hydroxyurea r O
- 
 O
induced u O
S 
 O
- 
 O
phase s O
arrest e O
. 
 O
All 	 O
such h O
polypeptides y O
containing t O
263 	 O
or O O
more e O
residues i O
derived i O
from m O
the 	 O
C 
 O
- 
 O
terminus m O
of O O
P130gag 0 B-GENE
- 
 I-GENE
fps 	 E-GENE
( 
 O
i 
 O
. 
 O
e 
 O
. 
 O
residues i O
920 	 O
- 
 O
1182 2 O
) 
 O
were e O
enzymatically y O
active i O
as O O
tyrosine o B-GENE
kinases a E-GENE
. 
 O
A 
 O
structural u O
model e O
for 	 O
Vpu 	 S-GENE
is O O
proposed p O
in O O
which c O
the 	 O
membrane b O
anchor h O
precedes c O
a 
 O
region i O
comprising p O
two 	 O
amphipathic h O
alpha h O
- 
 O
helices i O
of O O
opposed o O
polarity a O
, 
 O
joined n O
by O O
a 
 O
strongly o O
acidic d O
turn n O
that t O
protrudes t O
into o O
the 	 O
cytoplasm o O
and 	 O
contains t O
the 	 O
CK B B-GENE
- - I-GENE
2 - I-GENE
phosphorylation s I-GENE
sites e E-GENE
. 
 O
The 	 O
recombinant o O
containing t O
the 	 O
full l B-GENE
- 
 I-GENE
length g I-GENE
polyhedrin y I-GENE
leader d I-GENE
sequence u E-GENE
gave e O
levels e O
of O O
N - B-GENE
mRNA A E-GENE
comparable p O
to O O
those s O
of O O
AcNPV P B-GENE
polyhedrin y I-GENE
mRNA A E-GENE
. 
 O
Immune u O
and 	 O
clinical n O
impact a O
of O O
Lactobacillus t O
acidophilus d O
on O O
asthma h O
. 
 O
Thus s O
, 
 O
CARP P S-GENE
is O O
a 
 O
YB B B-GENE
- - I-GENE
1 - I-GENE
associated o I-GENE
factor t E-GENE
and 	 O
represents r O
the 	 O
first s O
identified n O
cardiac d O
- 
 O
restricted t O
downstream n O
regulatory u O
gene e O
in O O
the 	 O
homeobox e B-GENE
gene e I-GENE
Nkx2 2 I-GENE
- - I-GENE
5 - E-GENE
pathway h O
and 	 O
may 	 O
serve v O
as O O
a 
 O
negative a O
regulator u O
of O O
HF B B-GENE
- - I-GENE
1 - E-GENE
- 
 O
dependent e O
pathways h O
for 	 O
ventricular t O
muscle c O
gene e O
expression r O
. 
 O
Each h O
receptor e O
must t O
therefore r O
engage a O
a 
 O
unique q O
subset s O
of O O
the 	 O
available i O
signaling n O
elements m O
- 
 O
- 
 O
at O O
least s O
partly t O
through o O
the 	 O
selection e O
of O O
proteins t O
with h O
src 	 B-GENE
- - I-GENE
homology o I-GENE
2 - I-GENE
domains a E-GENE
( 
 O
SH2 	 B-GENE
proteins t E-GENE
) 
 O
. 
 O
A 
 O
proposed p O
method h O
. 
 O
A 
 O
model e O
for 	 O
the 	 O
SMase s S-GENE
- 
 O
sphingomyelin i S-GENE
complex p O
structure u O
was 	 O
built l O
to O O
investigate e O
how 	 O
the 	 O
SMase s S-GENE
specifically c O
recognizes o O
its 	 O
substrate s O
. 
 O
Two 	 O
estimates i O
of O O
the 	 O
fractal c O
exponent o O
are 	 O
considered s O
which c O
do O O
not 	 O
suffer f O
from m O
this s O
limit i O
: 
 O
one 	 O
derived i O
from m O
the 	 O
Allan a O
variance i O
, 
 O
which c O
was 	 O
developed e O
by O O
the 	 O
authors h O
, 
 O
and 	 O
one 	 O
based e O
on O O
the 	 O
periodogram i O
. 
 O
Births t O
, 
 O
marriages r O
, 
 O
divorces o O
, 
 O
and 	 O
deaths t O
for 	 O
July y O
1997 7 O
. 
 O
In O O
conclusion c O
, 
 O
in O O
coronary o O
artery e O
disease e O
patients i O
, 
 O
exercise r O
- 
 O
redistribution i O
201Thallium T O
cardiac d O
imaging g O
with h O
reinjection n O
at O O
rest t O
can 	 O
identify n O
severely e O
ischemic h O
but 	 O
still l O
viable b O
myocardium c O
and 	 O
may 	 O
be O O
particularly t O
useful f O
in O O
the 	 O
prognosis g O
of O O
such h O
patients i O
. 
 O
However e O
, 
 O
the 	 O
recovery o O
curve v O
of O O
the 	 O
R2 O O
component p O
of O O
the 	 O
blink n O
reflex l O
diminished i O
in O O
patients i O
with h O
tension s O
- 
 O
type e O
headache d O
compared p O
with h O
the 	 O
other e O
groups u O
. 
 O
When n O
recombinant o O
gE E O
produced d O
in O O
HeLa a O
cells l O
was 	 O
probed b O
with h O
the 	 O
same e O
antiphosphotyrosine i O
antibody i O
, 
 O
a 
 O
dimeric e O
gE E O
form m O
at O O
130 	 O
kDa 	 O
was 	 O
detected e O
on O O
the 	 O
cell l O
surface f O
. 
 O
Transforming n B-GENE
growth w I-GENE
factor t I-GENE
- - I-GENE
beta a E-GENE
( 
 O
TGF 	 B-GENE
- - I-GENE
beta a E-GENE
) 
 O
inhibits i O
cell l O
cycle l O
progression g O
, 
 O
in O O
part t O
through o O
up O O
- 
 O
regulation u O
of O O
gene e O
expression r O
of O O
the 	 O
p21 	 S-GENE
( 
 O
WAF1 1 S-GENE
/ 
 O
Cip1 1 S-GENE
) 
 O
( 
 O
p21 	 S-GENE
) 
 O
cell l O
cycle l O
inhibitor i O
. 
 O
The 	 O
results u O
suggest g O
that t O
both h O
superficial e O
and 	 O
deep p O
cortical t O
venous o O
drainage i O
of O O
the 	 O
cat 	 O
kidney n O
should u O
be O O
considered s O
when n O
measuring s O
renal a B-GENE
renin i E-GENE
release e O
. 
 O
CONCLUSION C O
: 
 O
Detection e O
of O O
recurrent u O
head d O
and 	 O
neck k O
cancer c O
is O O
feasible s O
with h O
FDG 	 O
PET 	 O
. 
 O
There r O
were e O
no O O
differences f O
in O O
the 	 O
incidence i O
of O O
fractured c O
zonas a O
. 
 O
DSIP P O
was 	 O
found n O
to O O
significantly n O
increase r O
slow w O
- 
 O
waves e O
( 
 O
delta t O
sleep e O
) 
 O
in O O
the 	 O
sleep e O
EEG 	 O
. 
 O
Accuracy u O
and 	 O
predictive d O
value u O
of O O
ultrasound r O
in O O
acute t O
rejection e O
. 
 O
7 
 O
- 
 O
Nitroindazole r O
( 
 O
7NI 	 O
) 
 O
, 
 O
a 
 O
relatively a O
selective e O
neuronal r O
nitric r B-GENE
oxide d I-GENE
synthase t E-GENE
( 
 O
nNOS S S-GENE
) 
 O
inhibitor i O
. 
 O
was 	 O
intraperitoneally r O
administered i O
to O O
the 	 O
guinea n O
pigs s O
30 O O
minutes u O
before o O
the 	 O
onset e O
of O O
local a O
anoxia x O
. 
 O
Mutations a O
that t O
extend e O
the 	 O
specificity c O
of O O
the 	 O
endonuclease o O
activity i O
of O O
lambda b B-GENE
terminase m E-GENE
. 
 O
The 	 O
gene e O
set 	 O
in O O
this s O
mitochondrial o O
genome o O
is O O
a 
 O
subset s O
of O O
that t O
of O O
Reclinomonas l O
americana r O
, 
 O
an O O
amoeboid e O
protozoan t O
. 
 O
An O O
evaluation l O
of O O
a 
 O
positive i O
control t O
for 	 O
platelet t O
neutralization t O
procedure c O
testing t O
with h O
seven e O
commercial m O
activated i O
partial t O
thromboplastin o S-GENE
time e O
reagents g O
. 
 O
The 	 O
prosomal s B-GENE
RNA 	 I-GENE
- - I-GENE
binding d I-GENE
protein t I-GENE
p27K K E-GENE
is O O
a 
 O
member b O
of O O
the 	 O
alpha h B-GENE
- - I-GENE
type e I-GENE
human a I-GENE
prosomal s I-GENE
gene e I-GENE
family i E-GENE
. 
 O
A 
 O
single g O
clone n O
, 
 O
which c O
was 	 O
conserved s O
and 	 O
had 	 O
near r O
- 
 O
perfect f O
homology o O
to O O
eight h O
human a O
/ 
 O
rodent e O
expressed r O
sequence u O
tags s O
, 
 O
was 	 O
used d O
as O O
template p O
for 	 O
5 
 O
' 
 O
and 	 O
3 
 O
' 
 O
rapid i O
amplification l O
of O O
cDNA A O
ends s O
and 	 O
SPICE C O
( 
 O
system t O
for 	 O
polymerase y O
chain i O
reaction c O
amplification l O
of O O
cDNA A O
ends s O
) 
 O
reactions c O
to O O
obtain a O
the 	 O
3 
 O
. 
 O
6 
 O
- 
 O
kb O O
cDNA A O
, 
 O
LGL2 2 S-GENE
( 
 O
Genbank b O
, - O
AF I O
110195 1 O
) 
 O
encoding o O
a 
 O
deduced u O
polypeptide y O
( 
 O
lgl2 2 S-GENE
) 
 O
of O O
963 	 O
amino n O
acids d O
. 
 O
These s O
tiny y O
premature m O
infants a O
also o O
received e O
PN O O
for 	 O
significantly n O
longer g O
periods i O
of O O
time e O
, 
 O
and 	 O
the 	 O
longer g O
the 	 O
infusions u O
were e O
administered i O
the 	 O
greater a O
was 	 O
the 	 O
risk k O
of O O
cholestasis l O
developing e O
. 
 O
The 	 O
SM O O
- 
 O
specific c O
selection e O
of O O
exon n O
2 
 O
results u O
from m O
the 	 O
inhibition i O
of O O
exon n O
3 
 O
. 
 O
It O O
is O O
always a O
present s O
and 	 O
has 	 O
a 
 O
discrete c O
origin g O
and 	 O
insertion e O
. 
 O
Medical i O
management a O
of O O
early l O
- 
 O
stage g O
breast a O
cancer c O
. 
 O
Five e O
girls l O
with h O
Turner n O
' 
 O
s 
 O
syndrome d O
aged d O
12 O O
to O O
17 O O
years r O
showed w O
LH S S-GENE
values u O
( 
 O
5 
 O
. 
 O
0 
 O
- 
 O
14 O O
. 
 O
5 
 O
IU O O
/ 
 O
12 O O
h 
 O
) 
 O
at O O
the 	 O
upper e O
end 	 O
of O O
or O O
slightly g O
above v O
the 	 O
normal m O
range g O
and 	 O
pathologically h O
high h O
values u O
( 
 O
22 O O
. 
 O
2 
 O
- 
 O
43 O O
. 
 O
5 
 O
IU O O
/ 
 O
12 O O
h 
 O
) 
 O
for 	 O
FSH 	 S-GENE
. 
 O
In O O
vitro r O
death t O
assays a O
with h O
transient n O
overexpression r O
of O O
deletion e O
constructs s O
of O O
both h O
isoforms f O
using n O
beta a B-GENE
- - I-GENE
galactosidase a E-GENE
as O O
a 
 O
reporter o O
gene e O
in O O
MCF7 7 O
cells l O
suggest g O
the 	 O
following l O
: 
 O
1 
 O
) 
 O
the 	 O
nucleotide l O
binding d O
domain a O
may 	 O
act 	 O
as O O
a 
 O
negative a O
regulator u O
of O O
the 	 O
killing l O
activity i O
of O O
DEFCAP C B-GENE
; 
 I-GENE
2 
 E-GENE
) 
 O
the 	 O
LRR 	 O
/ 
 O
CARD D S-GENE
represents r O
a 
 O
putative a O
constitutively s O
active i O
inducer u O
of O O
apoptosis p O
; 
 O
3 
 O
) 
 O
the 	 O
killing l O
activity i O
of O O
LRR 	 S-GENE
/ 
 O
CARD D S-GENE
is O O
inhibitable i O
by O O
benzyloxycarbonyl z O
- 
 O
Val 	 O
- 
 O
Ala 	 O
- 
 O
Asp 	 O
( 
 O
OMe 	 O
) 
 O
- 
 O
fluoromethyl o O
ketone o O
and 	 O
to O O
a 
 O
lesser s O
extent e O
by O O
Asp 	 O
- 
 O
Glu 	 O
- 
 O
Val 	 O
- 
 O
Asp 	 O
( 
 O
OMe 	 O
) 
 O
- 
 O
fluoromethyl o O
ketone o O
; 
 O
and 	 O
4 
 O
) 
 O
the 	 O
CARD D O
is O O
critical t O
for 	 O
killing l O
activity i O
of O O
DEFCAP C O
. 
 O
In O O
6 
 O
patients i O
( 
 O
9 
 O
kidneys n O
) 
 O
irrigation i O
with h O
Solution u O
G 
 O
in O O
the 	 O
renal a O
pelvis v O
was 	 O
performed f O
for 	 O
the 	 O
dissolution s O
of O O
their i O
infectious e O
stones n O
. 
 O
The 	 O
use 	 O
of O O
sigma m B-GENE
54 I I-GENE
promoters m E-GENE
, 
 O
known w O
to O O
require u O
cognate n O
binding d O
proteins t O
, 
 O
could l O
allow o O
the 	 O
fine e O
- 
 O
tuning i O
that t O
provides v O
the 	 O
temporal p O
ordering e O
of O O
flagellar g O
gene e O
transcription n O
. 
 O
The 	 O
association o O
of O O
I - B-GENE
- - I-GENE
92 E E-GENE
with h O
p92 	 S-GENE
, 
 O
p84 	 S-GENE
, 
 O
p75 	 S-GENE
, 
 O
p73 	 S-GENE
, 
 O
p69 	 S-GENE
, 
 O
and 	 O
p57 	 S-GENE
was 	 O
completely p O
reversible e O
after e O
treatment a O
with h O
the 	 O
detergent e O
deoxycholate x O
( 
 O
DOC 	 O
) 
 O
. 
 O
To O O
our 	 O
knowledge w O
no O O
transcription n O
factors t O
have e O
previously v O
been n O
identified n O
that t O
exhibit i O
androgen r O
- 
 O
dependent e O
expression r O
in O O
the 	 O
epididymis d O
. 
 O
Focal a O
or O O
regional i O
8 
 O
- 
 O
to O O
20 O O
- 
 O
Hz O O
low 	 O
- 
 O
voltage t O
epileptiform l O
paroxysms o O
in O O
either h O
hippocampus p O
( 
 O
10 O O
patients i O
) 
 O
, 
 O
amygdala g O
( 
 O
1 
 O
patient i O
) 
 O
, 
 O
or O O
both h O
( 
 O
1 
 O
patient i O
) 
 O
preceded c O
initial t O
motionless i O
staring r O
. 
 O
The 	 O
lack k O
of O O
heterozygous e O
positions i O
essentially e O
facilitates i O
on O O
the 	 O
one 	 O
hand d O
the 	 O
data a O
analysis l O
and 	 O
on O O
the 	 O
other e O
hand d O
the 	 O
detection e O
of O O
new 	 O
alleles e O
. 
 O
Epithelial t O
cell l O
- 
 O
specific c O
activation i O
is O O
achieved i O
by O O
the 	 O
cooperative p O
interaction e O
of O O
apparently a O
ubiquitous q O
transcriptional n O
factors t O
. 
 O
Human a B-GENE
parvovirus v I-GENE
B19 	 I-GENE
gene e E-GENE
expression r O
from m O
the 	 O
viral a B-GENE
p6 I I-GENE
promoter m E-GENE
( 
 O
B19p6 p S-GENE
) 
 O
is O O
restricted t O
to O O
primary m O
human a O
hematopoietic a O
cells l O
undergoing e O
erythroid t O
differentiation f O
. 
 O
The 	 O
effectiveness e O
and 	 O
pathogenetic h O
expediency e O
of O O
correcting r O
disorders o O
of O O
lipid i O
metabolism a O
in O O
atherosclerosis e O
with h O
enterosorbents e O
is O O
substantiated s O
. 
 O
To O O
prevent v O
section t O
wrinkles n O
usually a O
encountered o O
with h O
the 	 O
use 	 O
of O O
coated t O
single g O
- 
 O
hole e O
grids d O
, 
 O
a 
 O
simple p O
method h O
was 	 O
developed e O
. 
 O
The 	 O
Cryotherapy o O
for 	 O
Retinopathy i O
of O O
Prematurity m O
Study d O
has 	 O
shown w O
that t O
this s O
number b O
can 	 O
be O O
halved v O
with h O
treatment a O
. 
 O
Ultrasound r O
- 
 O
guided d O
fine e O
- 
 O
needle d O
aspiration i O
biopsy p O
( 
 O
US O O
- 
 O
FNAB B O
) 
 O
revealed e O
normal m O
- 
 O
looking k O
squamous a O
cells l O
. 
 O
Bleeding e O
was 	 O
successfully c O
prevented v O
in O O
28 O O
patients i O
with h O
the 	 O
use 	 O
of O O
a 
 O
combined b O
treatment a O
incorporating o O
IV O O
desmopressin m O
, 
 O
an O O
antifibrinolytic i O
agent n O
( 
 O
tranexamic n O
acid d O
) 
 O
, 
 O
and 	 O
local a O
methods h O
( 
 O
surgical g O
glue e O
and 	 O
compression p O
techniques h O
) 
 O
. 
 O
Hetero e O
- 
 O
oligomerization g O
of O O
Smad4 d S-GENE
with h O
the 	 O
pathway h O
- 
 O
restricted t O
SMAD D B-GENE
proteins t E-GENE
is O O
essential e O
for 	 O
Smad4 d S-GENE
- 
 O
mediated i O
transcription n O
. 
 O
This s O
fragment g O
contains t O
two 	 O
complete p O
endo o B-GENE
- - I-GENE
beta a I-GENE
- - I-GENE
1 - I-GENE
, - I-GENE
4 - I-GENE
- - I-GENE
glucanase c I-GENE
- - I-GENE
encoding o I-GENE
genes e E-GENE
, 
 O
designated i O
celCCC C S-GENE
and 	 O
celCCG C S-GENE
. 
 O
One 	 O
of O O
them m O
is O O
its 	 O
limited i O
sensitivity s O
to O O
weak k O
interactions e O
, 
 O
which c O
are 	 O
common m O
in O O
the 	 O
mammalian m O
cerebral e O
cortex t O
. 
 O
Analysis l O
of O O
the 	 O
5 
 O
' 
 O
and 	 O
3 
 O
' 
 O
termini m O
of O O
the 	 O
transcripts n O
produced d O
in O O
vivo o O
from m O
the 	 O
puf 	 B-GENE
operon r E-GENE
of I O
R - O
. - O
sphaeroides a O
PUF 	 O
delta t O
348 	 O
- - O
420 	 O
( 
 O
three e O
transcripts n O
; 
 O
0 
 O
. 
 O
59 O O
, 
 O
0 
 O
. 
 O
64 O O
, 
 O
and 	 O
2 
 O
. 
 O
63 O O
kilobases o O
) 
 O
lacking k O
the 	 O
puf 	 B-GENE
- 
 I-GENE
intercistronic e I-GENE
terminator m I-GENE
structure u E-GENE
were e O
identical n O
to O O
those s O
of O O
the 	 O
corresponding r O
puf 	 B-GENE
transcripts n E-GENE
derived i O
from m O
wild d O
- 
 O
type e O
R 
 O
. 
 O
sphaeroides a O
2 
 O
. 
 O
4 
 O
. 
 O
1 
 O
( 
 O
four r O
transcripts n O
; 
 O
0 
 O
. 
 O
50 O O
, 
 O
0 
 O
. 
 O
66 O O
, 
 O
0 
 O
. 
 O
71 O O
, 
 O
and 	 O
2 
 O
. 
 O
7 
 O
kilobases o O
) 
 O
showing w O
that t O
the 	 O
transcripts n O
begin i O
and 	 O
end 	 O
at O O
the 	 O
same e O
sites e O
. 
 O
The 	 O
optimum i O
cooling l O
rate e O
from m O
RT O O
to O O
5 
 O
degrees r O
C 
 O
resulting u O
in O O
maximum i O
survival v O
of O O
human a O
spermatozoa r O
was 	 O
found n O
to O O
be O O
0 
 O
. 
 O
5 
 O
to O O
1 
 O
degree r O
per 	 O
minute u O
when n O
cooled l O
from m O
RT O O
to O O
5 
 O
degrees r O
C 
 O
and 	 O
subsequently s O
frozen z O
- 
 O
thawed w O
in O O
liquid u O
nitrogen r O
( 
 O
LN2 	 O
) 
 O
. 
 O
The 	 O
cerebellar e O
cortical t O
vessels s O
: 
 O
they y O
are 	 O
compared p O
to O O
the 	 O
cerebral e O
vessels s O
. 
 O
Transesophageal n O
echocardiography o O
risk k O
factors t O
for 	 O
stroke o O
in O O
nonvalvular v O
atrial i O
fibrillation r O
. 
 O
22 O O
- 
 O
Veneto e O
Region i O
) 
 O
Preventive v O
health l O
counseling n O
tailored l O
to O O
the 	 O
needs d O
of O O
this s O
group u O
may 	 O
be O O
most t O
beneficial e O
. 
 O
Strains a O
lacking k O
a 
 O
functional c O
RPL16A 1 B-GENE
gene e E-GENE
grow w O
as O O
rapidly i O
as O O
wild d O
type e O
, 
 O
whereas r O
those s O
containing t O
a 
 O
null l O
allele e O
of O O
RPL16B 1 S-GENE
grow w O
more e O
slowly w O
than n O
wild d O
type e O
. 
 O
Neonatal n O
hyperthyroidism e O
After e O
Northern t O
blot t O
hybridization r O
, 
 O
two 	 O
Cx31 1 B-GENE
transcripts n E-GENE
of I O
2 - O
. - O
2 - O
and 	 O
1 - O
. - O
8 - O
kb E O
were e O
detected e O
in O O
total a O
RNA 	 O
of O O
the 	 O
human a O
keratinocyte a O
cell l O
line e O
HaCaT a O
and 	 O
two 	 O
transcripts n O
of O O
2 
 O
. 
 O
2 
 O
and 	 O
1 
 O
. 
 O
9 
 O
kb O O
in O O
total a O
RNA 	 O
of O O
E6 S S-GENE
/ 
 O
E7 S S-GENE
transfected n O
human a O
keratinocytes a O
( 
 O
HEK 	 O
cells l O
) 
 O
. 
 O
In O O
summary m O
, 
 O
FGFR3 R S-GENE
signaling n O
pathway h O
utilizes l O
two 	 O
GRB2 2 B-GENE
- - I-GENE
containing t I-GENE
complexes p E-GENE
; 
 O
Shc 	 S-GENE
. 
 O
GRB2 2 S-GENE
. 
 O
Sos 	 S-GENE
and 	 O
80K 	 B-GENE
- - I-GENE
H - E-GENE
. 
 O
pp66 6 S-GENE
. 
 O
GRB2 2 S-GENE
. 
 O
Sos 	 S-GENE
; 
 O
these s O
two 	 O
complexes p O
may 	 O
alternatively e O
link k O
FGFG3 G S-GENE
to O O
mitogen o B-GENE
- - I-GENE
activated i I-GENE
protein t I-GENE
kinase a E-GENE
. 
 O
In O O
an O O
effort o O
to O O
identify n O
factors t O
involved o O
in O O
the 	 O
expression r O
of O O
this s O
important o O
erythroid t O
- 
 O
specific c O
regulatory u O
protein t O
, 
 O
we O O
have e O
isolated l O
the 	 O
mouse s B-GENE
EKLF F I-GENE
gene e E-GENE
and 	 O
systematically t O
analyzed l O
the 	 O
promoter m O
region i O
. 
 O
Their i O
main n O
representatives r O
are 	 O
the 	 O
American r O
diagnostic g O
and 	 O
statistical t O
manual u O
of O O
mental t O
disorders o O
, 
 O
DSM 	 O
- 
 O
III 	 O
, 
 O
its 	 O
revised i O
version s O
DSM 	 O
- 
 O
III 	 O
- 
 O
R 
 O
and 	 O
the 	 O
new 	 O
international e O
classification s O
of O O
mental t O
disorders o O
iCD 	 O
- 
 O
10 O O
. 
 O
Any 	 O
opacity c O
on O O
a 
 O
chest s O
radiograph i O
has 	 O
a 
 O
wide e O
differential f O
diagnosis g O
. 
 O
At O O
the 	 O
same e O
acoustic u O
power e O
, 
 O
the 	 O
rate e O
of O O
chloride o O
formation m O
with h O
20 O O
kHz 	 O
ultrasound r O
was 	 O
greater a O
when n O
a 
 O
probe b O
with h O
a 
 O
larger g O
tip 	 O
area a O
was 	 O
used d O
, 
 O
but 	 O
significantly n O
less s O
than n O
the 	 O
rate e O
with h O
900 	 O
kHz 	 O
. 
 O
In O O
contrast t O
to O O
Torpedo p O
, 
 O
where r O
only y O
a 
 O
single g O
transcript n O
is O O
seen n O
, 
 O
the 	 O
mouse s O
expresses r O
several e O
mRNAs A O
encoding o O
different f O
isoforms f O
. 
 O
Four r O
families i O
of O O
homing i O
endonucleases o O
have e O
been n O
identified n O
, 
 O
including l O
the 	 O
LAGLIDADG L O
, 
 O
the 	 O
His 	 O
- - O
Cys 	 O
box 	 O
, 
 O
the 	 O
GIY 	 B-GENE
- - I-GENE
YIG 	 E-GENE
and 	 O
the 	 O
H - B-GENE
- - I-GENE
N - I-GENE
- - I-GENE
H - I-GENE
endonucleases o E-GENE
. 
 O
Convergence v O
of O O
trigeminal g O
input u O
with h O
visceral c O
and 	 O
phrenic e O
inputs u O
on O O
primate m O
C1 O O
- 
 O
C2 O O
spinothalamic n O
tract c O
neurons r O
. 
 O
The 	 O
GvpE E B-GENE
protein t E-GENE
involved o O
in O O
the 	 O
regulation u O
of O O
gas 	 O
vesicles i O
synthesis t O
in O O
halophilic o O
archaea h O
has 	 O
been n O
identified n O
as O O
the 	 O
transcriptional n O
activator i O
for 	 O
the 	 O
promoter m O
located a O
upstream t O
of O O
the 	 O
gvpA A B-GENE
gene e E-GENE
encoding o O
the 	 O
major o B-GENE
gas 	 I-GENE
vesicle i I-GENE
structural u I-GENE
protein t I-GENE
GvpA A E-GENE
. 
 O
Nosographic o O
problems b O
In O O
early l O
midgestation g O
embryos r O
it O O
is O O
expressed r O
in O O
telencephalic e O
, 
 O
diencephalic n O
and 	 O
mesencephalic e O
regions i O
but 	 O
from m O
day 	 O
11 O O
. 
 O
75 O O
of O O
gestation t O
its 	 O
expression r O
disappears a O
from m O
dorsal s O
telencephalon e O
and 	 O
is O O
confined f O
to O O
diencephalic n O
and 	 O
mesencephalic e O
regions i O
. 
 O
The 	 O
training i O
programs g O
had 	 O
a 
 O
duration a O
of O O
30 O O
days s O
, 
 O
5 
 O
days s O
/ 
 O
week k O
, 
 O
and 	 O
was 	 O
performed f O
on O O
a 
 O
motor o O
- 
 O
driven v O
treadmill a O
. 
 O
Phylogenetic l O
analysis l O
using n O
a 
 O
neighbor g O
- 
 O
joining n O
algorithm o O
showed w O
closest s O
similarity i O
of O O
the 	 O
horse s B-GENE
mu I I-GENE
chain i I-GENE
- - I-GENE
encoding o I-GENE
constant s I-GENE
region i I-GENE
gene e E-GENE
to O O
human a O
and 	 O
dog 	 O
sequences u O
. 
 O
Using n O
probes b O
from m O
these s O
regions i O
, 
 O
rearrangements r O
have e O
been n O
identified n O
in O O
each h O
of O O
nine e O
cases e O
of O O
t 
 O
( 
 O
8 
 O
; 
 O
21 O O
) 
 O
AML 	 O
examined m O
. 
 O
Cloning n O
and 	 O
nucleotide l O
sequence u O
analysis l O
reveals e O
that t O
BUR6 6 S-GENE
encodes o O
a 
 O
homolog o O
of O O
DRAP1 P S-GENE
( 
 O
also o O
called l O
NC2alpha a S-GENE
) 
 O
, 
 O
a 
 O
mammalian m O
repressor r O
of O O
basal a O
transcription n O
. 
 O
BRAP2 P S-GENE
also o O
shares r O
significant n O
homology o O
with h O
a 
 O
hypothetical o O
protein t O
from m O
yeast s O
Saccharomyces c O
cerevisiae e O
, 
 O
especially e O
in O O
the 	 O
zinc c O
finger g O
region i O
. 
 O
Earlier l O
published l O
data a O
, 
 O
indicating i O
Sp1 	 S-GENE
binding d O
to O O
the 	 O
R1 B B-GENE
alpha h I-GENE
/ - I-GENE
beta a I-GENE
regions i E-GENE
, 
 O
could l O
not 	 O
be O O
confirmed f O
, 
 O
suggesting g O
that t O
the 	 O
R1 O B-GENE
initiator t I-GENE
element m E-GENE
may 	 O
function c O
independent e O
of O O
Sp1 	 S-GENE
. 
 O
In O O
addition i O
, 
 O
reduced u O
metabolism a O
to O O
cotinine i O
from m O
the 	 O
proliposomes l O
and 	 O
MP O O
was 	 O
apparently a O
responsible p O
for 	 O
the 	 O
sustained t O
plasma s O
nicotine o O
levels e O
. 
 O
Activation i O
of O O
HIV 	 O
- 
 O
1 
 O
requires u O
the 	 O
binding d O
of O O
host t O
cell l O
transcription n O
factors t O
to O O
cis 	 O
elements m O
in O O
the 	 O
proviral v O
long g O
terminal m O
repeat e O
( 
 O
LTR 	 O
) 
 O
. 
 O
The 	 O
yeast s B-GENE
mitochondrial o I-GENE
Hsp70 7 E-GENE
, 
 O
Ssc1p 1 S-GENE
, 
 O
functions c O
as O O
a 
 O
molecular e O
chaperone p O
with h O
its 	 O
partner t O
proteins t O
, 
 O
Mdj1p 1 S-GENE
( 
 O
DnaJ J B-GENE
homologue o E-GENE
) 
 O
and 	 O
Yge1p 1 S-GENE
( 
 O
GrpE E B-GENE
homologue o E-GENE
) 
 O
. 
 O
Increased r O
TRE 	 O
DNA 	 O
binding d O
failed l O
to O O
lead d O
to O O
increased r O
transactivation n O
correlating r O
with h O
the 	 O
inability b O
of O O
SB O O
203580 5 O
to O O
increase r O
phosphorylation s O
of O O
these s O
AP B B-GENE
- - I-GENE
1 - I-GENE
proteins t E-GENE
. 
 O
The 	 O
rice e O
gene e O
consists s O
of O O
four r O
exons n O
. 
 O
However e O
, 
 O
and 	 O
in O O
contrast t O
to O O
other e O
MMP 	 B-GENE
genes e E-GENE
, 
 O
no O O
significative n O
synergistic e O
effect e O
on O O
CAT 	 S-GENE
activity i O
between w O
the 	 O
AP B B-GENE
- - I-GENE
1 - E-GENE
and 	 O
PEA 	 B-GENE
- - I-GENE
3 - I-GENE
elements m E-GENE
found n O
in O O
the 	 O
collagenase l B-GENE
- - I-GENE
3 - I-GENE
gene e I-GENE
promoter m E-GENE
was 	 O
found n O
. 
 O
The 	 O
equation a O
for 	 O
mean n O
trabecular b O
number b O
passed s O
the 	 O
test t O
, 
 O
whereas r O
the 	 O
validity i O
of O O
the 	 O
equations a O
for 	 O
mean n O
trabecular b O
separation a O
and 	 O
Tb O O
. 
 O
Wi O O
appeared e O
limited i O
. 
 O
Methodological h O
considerations s O
limiting i O
causal s O
assertions e O
permissible m O
with h O
nonexperimental e O
data a O
are 	 O
discussed c O
. 
 O
In O O
contrast t O
, 
 O
postmitotic t O
neurons r O
possessed s O
extremely r O
low 	 O
levels e O
of O O
E2F1 1 B-GENE
protein t E-GENE
as O O
assessed e O
by O O
the 	 O
electrophoretic c O
mobility i O
shift f O
assay a O
and 	 O
Western t O
blotting t O
. 
 O
Recurrence u O
of O O
the 	 O
hepatic a O
cyst t O
after e O
partial t O
excision i O
and 	 O
drainage i O
was 	 O
complicated p O
by O O
fistula t O
formation m O
between w O
the 	 O
cyst t O
and 	 O
the 	 O
duodenum d O
. 
 O
Reversal e O
of O O
mefloquine l O
resistance i O
in O O
rodent e O
Plasmodium s O
. 
 O
Possible s O
consequences s O
of O O
such h O
binder d O
distribution t O
through o O
powder d O
aggregates r O
are 	 O
discussed c O
. 
 O
The 	 O
human a B-GENE
parvalbumin v I-GENE
mRNA A E-GENE
contains t O
the 	 O
putative a O
polyadenylation y O
signal n O
AATAAA A O
13 O O
nucleotides l O
upstream t O
from m O
the 	 O
polyadenylation y O
site e O
. 
 O
The 	 O
delta t O
Mo O O
+ 
 O
SV O O
tumor o O
DNAs s O
from m O
B 
 O
- 
 O
lineage e O
tumors o O
were e O
typically i O
rearranged r O
at O O
the 	 O
immunoglobulin u B-GENE
gene e I-GENE
loci i E-GENE
and 	 O
contained t O
germ m O
line e O
configurations f O
of O O
the 	 O
T - B-GENE
- - I-GENE
cell l I-GENE
receptor e I-GENE
beta a I-GENE
gene e E-GENE
. 
 O
The 	 O
experimental e O
results u O
suggest g O
equilibrium i O
complex p O
formation m O
between w O
OTC 	 O
and 	 O
PVP 	 O
, 
 O
it O O
being n O
mainly n O
the 	 O
complex p O
which c O
is O O
i 
 O
. 
 O
v 
 O
. 
 O
injected e O
when n O
both h O
products d O
are 	 O
combined b O
in O O
an O O
injection e O
formulation m O
. 
 O
We O O
conclude c O
that t O
the 	 O
MMF 	 O
lesion i O
is O O
secondary o O
to O O
intramuscular r O
injection e O
of O O
aluminium m O
hydroxide r O
- 
 O
containing t O
vaccines c O
, 
 O
shows w O
both h O
long g O
- 
 O
term m O
persistence s O
of O O
aluminium m O
hydroxide r O
and 	 O
an O O
ongoing o O
local a O
immune u O
reaction c O
, 
 O
and 	 O
is O O
detected e O
in O O
patients i O
with h O
systemic t O
symptoms p O
which c O
appeared e O
subsequently s O
to O O
vaccination c O
. 
 O
To O O
examine m O
the 	 O
effect e O
of O O
the 	 O
cAMP P O
signal n O
transduction n O
pathway h O
on O O
transcription n O
of O O
the 	 O
gene e O
encoding o O
the 	 O
catalytic a O
subunit u O
of O O
glucose c B-GENE
- - I-GENE
6 - I-GENE
- - I-GENE
phosphatase s E-GENE
( 
 O
G6Pase a S-GENE
) 
 O
, 
 O
G6Pase a B-GENE
- 
 I-GENE
chloramphenicol o I-GENE
acetyltransferase t E-GENE
( 
 O
CAT 	 S-GENE
) 
 O
fusion i O
genes e O
were e O
transiently n O
transfected n O
into o O
either h O
the 	 O
liver e O
- 
 O
derived i O
HepG2 G S-GENE
or O O
kidney n O
- 
 O
derived i O
LLC 	 O
- 
 O
PK O O
cell l O
line e O
. 
 O
Whereas r O
the 	 O
sequence u O
of O O
alpha h B-GENE
- - I-GENE
actinin i E-GENE
( 
 O
Noegel g O
, 
 O
A 
 O
. 
 O
, 
 O
W 
 O
. 
 O
By O O
contrast t O
, 
 O
clonidine n O
( 
 O
1 
 O
micrograms r O
/ 
 O
kg O O
) 
 O
elicited c O
an O O
immediate e O
and 	 O
prolonged l O
fall l O
in O O
blood o O
pressure s O
and 	 O
heart r O
rate e O
when n O
given e O
into o O
the 	 O
vertebral t O
artery e O
, 
 O
but 	 O
not 	 O
intravenously r O
. 
 O
The 	 O
shift f O
from m O
complex p O
I 
 O
to O O
complex p O
II O O
seen n O
only y O
in O O
SCM 	 O
- - O
1 - O
- 
 O
producer d O
T 
 O
cell l O
lines e O
upon n O
activation i O
was 	 O
completely p O
suppressed p O
by O O
cyclosporin l O
A 
 O
. 
 O
( 
 O
We O O
observed e O
a 
 O
ferritin r S-GENE
value u O
as O O
high h O
as O O
47 O O
mg O O
/ 
 O
L 
 O
in O O
one 	 O
patient i O
. 
 O
) 
 O
Results u O
with h O
all 	 O
these s O
kits s O
did 	 O
not 	 O
inter e O
- 
 O
compare p O
well l O
for 	 O
ferritin r S-GENE
concentrations c O
greater a O
than n O
300 	 O
micrograms r O
/ 
 O
L 
 O
, 
 O
a 
 O
finding d O
that t O
casts t O
further t O
doubt b O
on O O
the 	 O
controversial t O
use 	 O
of O O
serum u B-GENE
ferritin r E-GENE
measurement s O
in O O
cases e O
of O O
iron n O
overload r O
. 
 O
Post t O
- 
 O
CPB 	 O
cardiac d O
index e O
was 	 O
superior e O
in O O
group u O
B 
 O
( 
 O
3 
 O
. 
 O
9 
 O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
3 
 O
vs O O
. 
 O
ER B B-GENE
beta a E-GENE
was 	 O
less s O
potent e O
than n O
ER B B-GENE
alpha h E-GENE
in O O
activating i O
E2 O S-GENE
- 
 O
stimulated m O
ERELuc L S-GENE
activity i O
( 
 O
4 
 O
- 
 O
vs O O
. 
 O
The 	 O
expression r O
pattern t O
of O O
LjEmx m S-GENE
changed n O
dramatically m O
during i O
embryogenesis r O
; 
 O
expression r O
was 	 O
seen n O
initially t O
in O O
the 	 O
entire i O
neural r O
tube e O
and 	 O
mesoderm o O
, 
 O
which c O
were e O
secondarily o O
downregulated n O
, 
 O
and 	 O
secondarily o O
in O O
cranial n O
nerve v O
ganglia g O
and 	 O
in O O
the 	 O
craniofacial n O
mesenchyme e O
. 
 O
Disruption r O
of O O
PML 	 B-GENE
subnuclear n I-GENE
domains a E-GENE
by O O
the 	 O
acidic d O
IE1 	 B-GENE
protein t E-GENE
of O O
human a O
cytomegalovirus o O
is O O
mediated i O
through o O
interaction e O
with h O
PML 	 S-GENE
and 	 O
may 	 O
modulate u O
a 
 O
RING G O
finger g O
- 
 O
dependent e O
cryptic p O
transactivator n O
function c O
of O O
PML 	 S-GENE
. 
 O
Furthermore t O
, 
 O
the 	 O
GC O O
- 
 O
rich h O
sequences u O
could l O
confer f O
Sp1 	 S-GENE
- 
 O
dependent e O
transactivation n O
to O O
a 
 O
heterologous e O
prolactin l B-GENE
minimal i I-GENE
promoter m E-GENE
. 
 O
Twelve l O
patients i O
of O O
leprosy r O
with h O
arthritis h O
and 	 O
161 	 O
patients i O
without h O
arthritis h O
were e O
studied d O
for 	 O
immunological u O
parameters a O
like e O
immunoglobulins u S-GENE
( 
 O
IgG 	 S-GENE
, 
 O
IgM 	 S-GENE
, 
 O
IgA 	 S-GENE
) 
 O
, 
 O
C - B-GENE
- - I-GENE
reactive c I-GENE
proteins t E-GENE
and 	 O
rheumatoid u B-GENE
factor t E-GENE
. 
 O
Several e O
reports o O
assert e O
that t O
prolactin l S-GENE
affects e O
the 	 O
delta t B-GENE
5 
 E-GENE
and 	 O
delta t O
4 
 O
pathways h O
through o O
its 	 O
effect e O
on O O
the 	 O
activity i O
of O O
3beta t B-GENE
- - I-GENE
hydroxysteroid r I-GENE
dehydrogenase y E-GENE
( 
 O
3beta t B-GENE
- - I-GENE
OHSD D E-GENE
) 
 O
. 
 O
The 	 O
NrfC C B-GENE
polypeptide y E-GENE
, 
 O
M - O
( - O
r - O
) - O
24 I O
, - O
567 	 O
, 
 O
contains t O
16 O O
cysteine t O
residues i O
arranged a O
in O O
four r O
clusters s O
typical i O
of O O
the 	 O
CooF F B-GENE
super e I-GENE
- - I-GENE
family i I-GENE
of O I-GENE
non 	 I-GENE
- 
 I-GENE
haem m I-GENE
iron n I-GENE
- 
 I-GENE
sulphur p I-GENE
proteins t E-GENE
. 
 O
Zonography o O
in O O
urology l O
( 
 O
author h O
' 
 O
s 
 O
transl n O
) 
 O
( 
 O
i 
 O
) 
 O
p60 	 O
bound n O
fast t O
- 
 O
migrating r O
, 
 O
underprocessed e O
wild d B-GENE
- - I-GENE
type e I-GENE
ICP22 2 E-GENE
and 	 O
ICP22 2 S-GENE
lacking k O
the 	 O
carboxyl b O
- 
 O
terminal m O
24 O O
amino n O
acids d O
but 	 O
not 	 O
ICP22 2 S-GENE
lacking k O
the 	 O
carboxyl b O
- 
 O
terminal m O
40 O O
amino n O
acids d O
, 
 O
whereas r O
the 	 O
previously v O
identified n O
cellular l B-GENE
protein t I-GENE
p78 	 E-GENE
( 
 O
R 
 S-GENE
. 
 O
Stress e O
thallium l O
- 
 O
201 	 O
myocardial c O
imaging g O
was 	 O
used d O
in O O
two 	 O
angina i O
- 
 O
free e O
patients i O
with h O
severe e O
congestive g O
heart r O
failure l O
to O O
identify n O
clinically n O
silent e O
areas a O
of O O
ischemic h O
myocardium c O
and 	 O
to O O
distinguish t O
between w O
scar r O
and 	 O
reversibly e O
ischemic h O
myocardium c O
as O O
a 
 O
cause s O
for 	 O
akinesia n O
of O O
left t O
ventricular t O
wall l O
segments m O
. 
 O
The 	 O
community m O
- 
 O
acquired u O
bacteremia t O
was 	 O
mainly n O
due 	 O
to O O
E 
 O
. 
 O
coli i O
. 
 O
Y1 S O
, 
 O
Y2 S O
, 
 O
and 	 O
Y4 S S-GENE
/ 
 O
PP1 	 S-GENE
. 
 O
Low 	 O
plasma s O
glucose c O
concentrations c O
that t O
may 	 O
or O O
may 	 O
not 	 O
be O O
sufficiently f O
low 	 O
to O O
result u O
in O O
symptoms p O
can 	 O
be O O
observed e O
as O O
a 
 O
concomitant c O
of O O
several e O
diverse e O
diseases e O
. 
 O
Developmentally e O
- 
 O
regulated u O
interaction e O
of O O
a 
 O
transcription n O
factor t O
complex p O
containing t O
CDP 	 S-GENE
/ 
 O
cut 	 O
with h O
the 	 O
early l B-GENE
histone t I-GENE
H3 I I-GENE
gene e I-GENE
promoter m E-GENE
of I O
the 	 O
sea 	 B-GENE
urchin h I-GENE
Tetrapygus r I-GENE
niger e E-GENE
is O O
associated o O
with h O
changes n O
in O O
chromatin o O
structure u O
and 	 O
gene e O
expression r O
. 
 O
Procedures c O
with h O
perfected f O
method h O
After e O
a 
 O
shift f O
to O O
37 O O
degrees r O
C 
 O
, 
 O
the 	 O
mutant a O
Rat7 7 S-GENE
- - O
1p E S-GENE
/ 
 O
Nup159 1 B-GENE
- - I-GENE
1p E E-GENE
is O O
lost t O
from m O
the 	 O
nuclear l O
rim 	 O
of O O
rat7 7 B-GENE
- 
 I-GENE
1 
 I-GENE
cells l I-GENE
and 	 I-GENE
NPCs s E-GENE
, 
 O
which c O
are 	 O
clustered s O
together e O
in O O
these s O
cells l O
grown w O
under e O
permissive m O
conditions d O
become o O
substantially s O
less s O
clustered s O
. 
 O
The 	 O
mRNA A O
for 	 O
this s O
protein t O
is O O
expressed r O
in O O
the 	 O
T 
 O
- 
 O
ALL 	 O
cell l O
line e O
Jurkat k O
and 	 O
has 	 O
been n O
designated i O
HUG1 1 S-GENE
, 
 O
for 	 O
HOX11 1 B-GENE
Upstream t I-GENE
Gene e E-GENE
. 
 O
The 	 O
STS 	 O
sequence u O
WI I O
- - O
14920 2 O
is O O
in O O
fact t O
derived i O
from m O
the 	 O
3 
 O
' 
 O
- 
 O
untranslated r O
region i O
of O O
the 	 O
human a B-GENE
PUNC C I-GENE
gene e E-GENE
. 
 O
Its 	 O
activity i O
was 	 O
twice c O
that t O
of O O
a 
 O
construct s O
where r O
the 	 O
CAT 	 B-GENE
gene e E-GENE
was 	 O
driven v O
by O O
the 	 O
H - B-GENE
- - I-GENE
2Kb 	 I-GENE
5 - I-GENE
' - I-GENE
enhancer a I-GENE
region i E-GENE
( 
 O
H2TF1 F S-GENE
/ 
 O
KBF1 1 S-GENE
site e O
) 
 O
and 	 O
comparable p O
to O O
that t O
of O O
pRSVCAT V B-GENE
construct s E-GENE
carrying r O
the 	 O
strong o O
Rous s B-GENE
sarcoma c I-GENE
virus u I-GENE
LTR 	 I-GENE
enhancer a E-GENE
. 
 O
ORF3 3 S-GENE
appears e O
to O O
encode o O
the 	 O
homologue o O
of O O
the 	 O
well l O
- 
 O
conserved s O
proteasomal t O
26S 	 B-GENE
regulatory u I-GENE
subunit u E-GENE
. 
 O
The 	 O
tam 	 B-GENE
A - I-GENE
gene e E-GENE
of I O
Aspergillus e O
nidulans u O
encodes o O
a 
 O
739 	 O
- 
 O
amino n O
acid d O
protein t O
with h O
similarity i O
to O O
Uga35p 3 S-GENE
/ 
 O
Dal81p 8 S-GENE
/ 
 O
DurLp L S-GENE
of O O
Saccharomyces c O
cerevisiae e O
. 
 O
Little t O
honoured o O
in O O
his 	 O
own 	 O
country n O
: 
 O
statues t O
in O O
recognition o O
of O O
Edward a O
Jenner n O
MD O O
FRS 	 O
. 
 O
A 
 O
pharmacokinetic r O
interaction e O
between w O
LY354740 5 O
and 	 O
diazepam z O
, 
 O
leading d O
to O O
the 	 O
lowering e O
of O O
the 	 O
plasma s O
level e O
of O O
free e O
diazepam z O
, 
 O
was 	 O
also o O
demonstrated o O
. 
 O
The 	 O
promoter m O
of O O
this s O
methyltransferase h B-GENE
gene e E-GENE
lacks k O
an O O
identifiable n O
TATA A O
box 	 O
but 	 O
is O O
characterized r O
by O O
a 
 O
CpG 	 O
island a O
which c O
begins i O
approximately r O
723 	 O
nucleotides l O
upstream t O
of O O
the 	 O
major o O
transcriptional n O
start r O
site e O
and 	 O
extends e O
through o O
exon n O
1 
 O
and 	 O
into o O
the 	 O
first s O
intron r O
. 
 O
No O O
promoter m O
activity i O
could l O
be O O
detected e O
with h O
various i O
mouse s B-GENE
Fli 	 I-GENE
- - I-GENE
1 - I-GENE
promoter m E-GENE
- 
 O
CAT 	 S-GENE
constructs s O
containing t O
600 	 O
bp O O
of O O
the 	 O
5 
 O
' 
 O
flanking n O
region i O
, 
 O
the 	 O
complete p O
exon n O
1 
 O
, 
 O
the 	 O
5 
 O
' 
 O
end 	 O
of O O
intron r O
1 
 O
and 	 O
/ 
 O
or O O
retroviral r B-GENE
LTR 	 I-GENE
sequence u E-GENE
. 
 O
The 	 O
D 
 O
. 
 O
discoideum c O
proteins t O
were e O
entirely i O
conserved s O
over r O
the 	 O
four r O
regions i O
known w O
to O O
be O O
important o O
for 	 O
GTP 	 O
binding d O
and 	 O
all 	 O
contained t O
the 	 O
C 
 O
- 
 O
terminal m O
CAAX X O
aa O O
motifs i O
shared r O
by O O
other e O
Rho 	 B-GENE
proteins t E-GENE
. 
 O
An O O
81 O O
- 
 O
nt O O
tandem d O
duplication l O
of O O
the 	 O
C 
 O
- 
 O
terminal m O
coding i O
region i O
is O O
located a O
adjacent a O
to O O
the 	 O
termination m O
codon o O
of O O
the 	 O
CyIIIb I B-GENE
gene e E-GENE
, 
 O
a 
 O
potential e O
relic i O
of O O
a 
 O
slipped p O
mispairing p O
and 	 O
replication l O
event n O
. 
 O
Only y O
53 O O
% 
 O
of O O
all 	 O
injuries u O
and 	 O
12 O O
. 
 O
5 
 O
% 
 O
of O O
serious i O
injuries u O
involved o O
children l O
, 
 O
and 	 O
in O O
contrast t O
to O O
the 	 O
1950s 0 O
and 	 O
early l O
1960s 0 O
, 
 O
young n O
adults l O
appear e O
at O O
greatest a O
risk k O
in O O
the 	 O
1980s 0 O
. 
 O
The 	 O
method h O
was 	 O
tested t O
on O O
7 
 O
rats s O
with h O
48 O O
- 
 O
hr O O
- 
 O
old 	 O
myocardial c O
infarction a O
and 	 O
4 
 O
sham m O
- 
 O
operated r O
controls t O
. 
 O
Here e O
we O O
examine m O
the 	 O
population u O
of O O
gammaS m B-GENE
transcripts n E-GENE
in O O
adult l O
human a O
lens s O
and 	 O
the 	 O
structure u O
of O O
the 	 O
human a B-GENE
CRYGS G I-GENE
genes e E-GENE
. 
 O
The 	 O
slope p O
of O O
QD O O
versus s O
QEMF F O
for 	 O
the 	 O
four r O
tubes e O
was 	 O
near r O
unity t O
. 
 O
The 	 O
extent e O
of O O
the 	 O
odontoblast n O
process c O
in O O
human a O
dentin t O
. 
 O
Mouse s B-GENE
macrophage r I-GENE
beta a I-GENE
subunit u E-GENE
( - O
CD11b 1 S-GENE
) - O
cDNA A O
for 	 O
the 	 O
CR3 	 B-GENE
complement p I-GENE
receptor e E-GENE
/ 
 O
Mac 	 B-GENE
- - I-GENE
1 - I-GENE
antigen i E-GENE
. 
 O
Enoxacin x O
has 	 O
been n O
shown w O
to O O
be O O
an O O
effective e O
well l O
tolerated e O
and 	 O
convenient v O
treatment a O
for 	 O
gonorrhoea o O
. 
 O
We O O
assessed e O
cardiovascular d O
variables i O
and 	 O
blood o O
O2 O O
contents t O
in O O
order e O
to O O
characterize r O
O2 O O
transport n O
in O O
ponies i O
during i O
treadmill a O
exercise r O
. 
 O
The 	 O
findings d O
are 	 O
discussed c O
with h O
reference e O
to O O
possible s O
mechanisms h O
by O O
which c O
parasite a O
development e O
might h O
be O O
controlled t O
. 
 O
The 	 O
80 O O
kb O O
preceding c O
the 	 O
expression r O
site e O
has 	 O
few 	 O
, 
 O
if O O
any 	 O
, 
 O
functional c O
ORFs s O
, 
 O
but 	 O
contains t O
50 O O
bp O O
repeats e O
, 
 O
INGI I B-GENE
retrotransposon r I-GENE
- - I-GENE
like e I-GENE
elements m E-GENE
, 
 O
and 	 O
novel e O
4 
 O
- 
 O
12 O O
kb O O
repeats e O
found n O
near r O
other e O
telomeres o O
. 
 O
The 	 O
predicted d O
proteins t O
show w O
strong o O
homology o O
to O O
an O O
ABA 	 O
- - O
inducible u O
glycine c O
- - O
rich h O
protein t O
from m O
maize z O
embryos r O
and 	 O
to O O
the 	 O
mammalian m B-GENE
RNA 	 I-GENE
- - I-GENE
binding d I-GENE
protein t I-GENE
A1 E E-GENE
of O O
the 	 O
heterogeneous e O
nuclear l O
ribonucleoprotein o O
complex p O
involved o O
in O O
pre 	 O
- 
 O
mRNA A O
splicing i O
. 
 O
Increase r O
in O O
[ 
 O
Ca O O
+ 
 O
+ 
 O
] 
 O
counteracted n O
the 	 O
effects e O
of O O
verapamil a O
on O O
RAD 	 O
. 
 O
We O O
compared p O
the 	 O
quantities n O
collected l O
with h O
both h O
pollen l O
traps p O
during i O
February r O
, 
 O
March c O
and 	 O
April i O
1988 8 O
and 	 O
1989 9 O
. 
 O
Cbl 	 S-GENE
is O O
a 
 O
signaling n O
molecule e O
with h O
multiple t O
functional c O
domains a O
: 
 O
an O O
SH2 	 B-GENE
domain a E-GENE
which c O
binds d O
phosphotyrosine s O
residues i O
, 
 O
a 
 O
RING G O
finger g O
domain a O
which c O
acts s O
as O O
a 
 O
ubiquitin q B-GENE
ligase a E-GENE
, 
 O
a 
 O
proline l O
- 
 O
rich h O
region i O
which c O
serves v O
as O O
a 
 O
docking k O
site e O
for 	 O
SH3 	 B-GENE
- - I-GENE
containing t I-GENE
proteins t E-GENE
, 
 O
phosphotyrosine s O
residues i O
which c O
serve v O
as O O
docking k O
sites e O
for 	 O
SH2 	 B-GENE
- - I-GENE
containing t I-GENE
proteins t E-GENE
such h O
a 
 O
CrkL L S-GENE
and 	 O
the 	 O
p85 	 B-GENE
subunit u E-GENE
of O O
PI B B-GENE
3 - I-GENE
- - I-GENE
kinase a E-GENE
, 
 O
and 	 O
a 
 O
nuclear l O
localization a O
signal n O
. 
 O
Surprisingly p O
, 
 O
apo 	 B-GENE
- - I-GENE
iso 	 I-GENE
- - I-GENE
1 - I-GENE
- - I-GENE
cytochrome o I-GENE
c - E-GENE
is O O
absent e O
in O O
cyc3 3 S-GENE
- - O
strains a O
, 
 O
although h O
apo 	 B-GENE
- - I-GENE
iso 	 I-GENE
- - I-GENE
2 - I-GENE
- - I-GENE
cytochrome o I-GENE
c - E-GENE
is O O
present s O
at O O
approximately r O
the 	 O
same e O
level e O
at O O
which c O
holo o B-GENE
- - I-GENE
iso 	 I-GENE
- - I-GENE
2 - I-GENE
- - I-GENE
cytochrome o I-GENE
c - E-GENE
is O O
found n O
in O O
CYC3 3 B-GENE
+ - E-GENE
strains a O
. 
 O
Here e O
, 
 O
we O O
identify n O
the 	 O
analytical l O
form m O
of O O
the 	 O
PDF 	 O
of O O
one 	 O
such h O
measure s O
, 
 O
the 	 O
order e O
parameter a O
in O O
the 	 O
low 	 O
temperature p O
phase s O
of O O
the 	 O
2D O O
XY O O
model e O
. 
 O
The 	 O
ventricular t O
demand a O
pacemaker e O
( 
 O
VVI 	 O
) 
 O
was 	 O
implanted l O
three e O
years r O
ago 	 O
and 	 O
because a O
of O O
further t O
impairment a O
of O O
cardiac d O
performance f O
an O O
av O O
- 
 O
sequential u O
pacemaker e O
( 
 O
DDD 	 O
) 
 O
was 	 O
used d O
to O O
restore t O
atrio i O
- 
 O
ventricular t O
synchronisation c O
. 
 O
It O O
was 	 O
predicted d O
that t O
the 	 O
Stroop o O
task k O
would l O
trigger g O
greater a O
consumption s O
of O O
ice 	 O
cream a O
than n O
a 
 O
fearful r O
film m O
, 
 O
and 	 O
that t O
this s O
effect e O
would l O
be O O
more e O
pronounced n O
for 	 O
binge g O
- 
 O
eaters e O
than n O
non 	 O
- 
 O
binge g O
- 
 O
eaters e O
. 
 O
Our 	 O
data a O
are 	 O
in O O
line e O
with h O
the 	 O
hypothesis o O
that t O
E2F 	 S-GENE
functions c O
as O O
a 
 O
growth w O
- 
 O
and 	 O
cell l O
cycle l O
regulated u O
tethering h O
factor t O
between w O
Sp1 	 S-GENE
and 	 O
the 	 O
basic i O
transcription n O
machinery h O
. 
 O
There r O
was 	 O
a 
 O
positive i O
correlation r O
between w O
change n O
from m O
baseline e O
in O O
parietal i O
lobe e O
gray y O
- 
 O
matter t O
cytosolic o O
choline l O
, 
 O
expressed r O
in O O
terms m O
of O O
choline l O
/ 
 O
creatine a O
resonance o O
ratios i O
, 
 O
and 	 O
cognitive n O
performance f O
as O O
measured s O
with h O
the 	 O
Alzheimer h O
' 
 O
s 
 O
Disease e O
Assessment e O
Scale l O
Cognitive n O
Subscale s O
. 
 O
Colonization o O
increased r O
with h O
level e O
of O O
care e O
: 
 O
from m O
9 
 O
per 	 O
cent t O
in O O
independent e O
residents i O
of O O
apartments r O
to O O
60 O O
per 	 O
cent t O
in O O
patients i O
on O O
an O O
acute t O
hospital p O
ward d O
( 
 O
P 
 O
less s O
than n O
0 
 O
. 
 O
0001 1 O
) 
 O
. 
 O
IRA2 2 S-GENE
, 
 O
a 
 O
second o O
gene e O
of O O
Saccharomyces c O
cerevisiae e O
that t O
encodes o O
a 
 O
protein t O
with h O
a 
 O
domain a O
homologous o O
to O O
mammalian m B-GENE
ras 	 I-GENE
GTPase a I-GENE
- - I-GENE
activating i I-GENE
protein t E-GENE
. 
 O
Exon n O
A1a 	 O
encodes o O
most t O
of O O
the 	 O
5 
 O
' 
 O
- 
 O
untranslated r O
region i O
. 
 O
Co O O
- 
 O
operativity r O
of O O
functional c O
domains a O
in O O
the 	 O
muscle c B-GENE
- - I-GENE
specific c I-GENE
transcription n I-GENE
factor t I-GENE
Myf 	 I-GENE
- - I-GENE
5 - E-GENE
. 
 O
Creatinine a O
and 	 O
creatine a B-GENE
phosphokinase s E-GENE
( 
 O
CPK 	 S-GENE
) 
 O
. 
 O
In O O
our 	 O
initial t O
studies d O
, 
 O
we O O
treated a O
MCF 	 O
- 
 O
7 
 O
cells l O
with h O
paclitaxel l O
, 
 O
which c O
results u O
in O O
the 	 O
arrest e O
of O O
cells l O
in O O
G1 O O
with h O
4n O O
DNA 	 O
content t O
( 
 O
pseudo u O
G1 O O
) 
 O
. 
 O
These s O
alterations e O
occurred u O
at O O
both h O
the 	 O
mRNA A O
and 	 O
protein t O
levels e O
but 	 O
did 	 O
not 	 O
significantly n O
affect e O
the 	 O
subcellular c O
distribution t O
of O O
any 	 O
of O O
the 	 O
four r O
isoforms f O
. 
 O
The 	 O
glyoxysomal o O
and 	 O
plastid s O
molecular e O
chaperones p O
( 
 O
70 B O
- - O
kDa 	 O
heat t O
shock c O
protein t O
) 
 O
of O O
watermelon e O
cotyledons y O
are 	 O
encoded o O
by O O
a 
 O
single g O
gene e O
. 
 O
Suspected p O
pelvic v O
endometriosis o O
was 	 O
prospectively s O
evaluated l O
in O O
31 O O
women e O
with h O
T1 O O
- 
 O
and 	 O
T2 O O
- 
 O
weighted g O
conventional v O
spin n O
- 
 O
echo o O
( 
 O
CSE 	 O
) 
 O
magnetic n O
resonance o O
imaging g O
alone n O
and 	 O
in O O
combination b O
with h O
T1 O O
- 
 O
weighted g O
fat 	 O
- 
 O
suppressed p O
( 
 O
T1FS S O
) 
 O
and 	 O
gadolinium o O
- 
 O
enhanced a O
T1FS S O
( 
 O
Gd O O
- 
 O
T1FS S O
) 
 O
spin n O
- 
 O
echo o O
techniques h O
. 
 O
Seroconversion o O
after e O
hepatitis a O
B 
 O
vaccination c O
. 
 O
A 
 O
case e O
of O O
bilateral a O
testicular t O
germ m O
cell l O
tumors o O
in O O
a 
 O
23 O O
- 
 O
year r O
- 
 O
old 	 O
male e O
is O O
reported o O
. 
 O
Total a O
body y O
BMD 	 O
( 
 O
r 
 O
= 
 O
0 
 O
. 
 O
30 O O
; 
 O
P 
 O
= 
 O
0 
 O
. 
 O
02 O O
) 
 O
and 	 O
femoral o O
neck k O
BMD 	 O
( 
 O
r 
 O
= 
 O
0 
 O
. 
 O
39 O O
; 
 O
P 
 O
= 
 O
0 
 O
. 
 O
002 	 O
) 
 O
were e O
positively i O
correlated r O
with h O
weight g O
- 
 O
bearing r O
activity i O
but 	 O
not 	 O
with h O
non 	 O
- 
 O
weight g O
- 
 O
bearing r O
activity i O
. 
 O
The 	 O
effects e O
of O O
castor t O
oil 	 O
, 
 O
alone n O
, 
 O
as O O
well l O
as O O
in O O
combination b O
with h O
PGI2 2 O
and 	 O
indomethacin o O
on O O
gastrointestinal t O
functions c O
have e O
been n O
examined m O
in O O
rats s O
. 
 O
Checking c O
for 	 O
patient i O
compliance p O
, 
 O
samples p O
( 
 O
n 
 O
= 
 O
10 O O
) 
 O
with h O
a 
 O
FK O O
I 
 O
concentration c O
of O O
0 
 O
ng O O
/ 
 O
mL O O
were e O
re O O
- 
 O
analyzed l O
. 
 O
K 
 O
. 
 O
The 	 O
hematopoietic a O
form m O
of O O
PTPN6 N B-GENE
transcript n E-GENE
is O O
initiated t O
at O O
a 
 O
downstream n O
promoter m O
separated a O
by O O
7 
 O
kb O O
from m O
the 	 O
first s O
. 
 O
The 	 O
residual i O
small l O
rRNAs A O
in O O
[ 
 O
poky y O
] 
 O
appear e O
to O O
be O O
synthesized t O
via 	 O
the 	 O
upstream t O
promoter m O
( 
 O
s 
 O
) 
 O
, 
 O
but 	 O
are 	 O
missing s O
37 O O
- 
 O
44 O O
nucleotides l O
from m O
their i O
5 
 O
' 
 O
ends s O
, 
 O
indicating i O
either h O
that t O
pre 	 O
- 
 O
rRNAs A O
are 	 O
processed c O
abnormally o O
or O O
that t O
abnormal o O
5 
 O
' 
 O
RNA 	 O
ends s O
are 	 O
unstable t O
. 
 O
Extra r O
dose e O
due 	 O
to O O
extravehicular r O
activity i O
during i O
the 	 O
NASA4 A O
mission s O
measured s O
by O O
an O O
on O O
- 
 O
board r O
TLD 	 O
system t O
. 
 O
Unconventional o O
mRNA A O
processing c O
in O O
the 	 O
expression r O
of O O
two 	 O
calcineurin c B-GENE
B - I-GENE
isoforms f E-GENE
in O O
Dictyostelium t O
. 
 O
The 	 O
deduced u O
amino n O
acid d O
sequence u O
of O O
this s O
open n O
reading d O
frame m O
is O O
significantly n O
homologous o O
to O O
the 	 O
HSV 	 B-GENE
1 - I-GENE
UL49 9 I-GENE
. - I-GENE
5 - I-GENE
gene e I-GENE
product d E-GENE
, 
 O
and 	 O
as O O
with h O
UL49 9 B-GENE
. - I-GENE
5 - E-GENE
, 
 O
it O O
contains t O
a 
 O
potential e O
signal n O
sequence u O
and 	 O
transmembrane n O
domain a O
characteristic r O
of O O
membrane b O
- 
 O
associated o O
proteins t O
. 
 O
It O O
has 	 O
been n O
demonstrated o O
that t O
stimulation m O
of O O
the 	 O
pontomesencephalic t O
parabrachial a O
region i O
( 
 O
PBR 	 O
) 
 O
by O O
microinjection r O
of O O
cholinergic l O
drugs g O
or O O
electricity c O
in O O
the 	 O
cat 	 O
produces d O
potent e O
pain n O
suppression p O
which c O
is O O
not 	 O
antagonized a O
by O O
the 	 O
opiate a O
antagonist a O
, 
 O
naloxone o O
. 
 O
GAGA A B-GENE
factor t E-GENE
is O O
known w O
to O O
remodel o O
the 	 O
chromatin o O
structure u O
in O O
concert c O
with h O
nucleosome l B-GENE
- - I-GENE
remodeling o I-GENE
factor t I-GENE
NURF F E-GENE
in O O
a 
 O
Drosophila s O
embryonic r O
S150 0 O
extract r O
. 
 O
Also o O
, 
 O
like e O
TUB 	 O
, 
 O
it O O
has 	 O
a 
 O
wider e O
pattern t O
of O O
tissue s O
expression r O
than n O
either h O
TULP1 P S-GENE
or O O
TULP2 P S-GENE
. 
 O
After e O
nine e O
months t O
GFR 	 O
improved r O
spontaneously n O
to O O
32 O O
ml O O
/ 
 O
min 	 O
/ 
 O
1 
 O
. 
 O
73 O O
m2 O O
despite p O
no O O
improvement r O
in O O
his 	 O
hypertension e O
. 
 O
First s O
, 
 O
ste12Delta 1 O
cells l O
differ f O
from m O
cells l O
with h O
disruptions r O
of O O
the 	 O
upstream t O
signaling n O
elements m O
( 
 O
e 
 O
. 
 O
g 
 O
. 
 O
, 
 O
ste4Delta 4 S-GENE
, 
 O
ste20Delta 2 S-GENE
, 
 O
ste5Delta 5 S-GENE
, 
 O
ste11Delta 1 S-GENE
, 
 O
ste7Delta 7 S-GENE
, 
 O
or O O
fus3Delta 3 O
kss1Delta 1 O
cells l O
) 
 O
in O O
that t O
they y O
clearly a O
retain a O
some e O
capacity a O
for 	 O
inducing u O
Ste3p 3 S-GENE
phosphorylation s O
. 
 O
Herein e O
, 
 O
we O O
report o O
that t O
CRE 	 O
- 
 O
decoy o O
oligonucleotide g O
treatment a O
results u O
in O O
an O O
increase r O
in O O
the 	 O
p53 	 B-GENE
protein t E-GENE
level e O
in O O
MCF 	 O
- 
 O
7 
 O
human a O
breast a O
cancer c O
cells l O
that t O
express r O
wild d B-GENE
- 
 I-GENE
type e I-GENE
p53 	 E-GENE
. 
 O
The 	 O
selective e O
5 - B-GENE
- - I-GENE
HT2 	 I-GENE
receptor e I-GENE
blocker c I-GENE
ketanserin a E-GENE
was 	 O
found n O
to O O
reduce u O
maximal i O
urethral t O
pressures s O
in O O
healthy l O
females a O
by O O
about u O
40 O O
% 
 O
without h O
reducing u O
blood o O
pressure s O
. 
 O
It O O
thus s O
seems m O
likely e O
that t O
genistein i O
affects e O
a 
 O
common m O
pathway h O
downstream n O
of O O
these s O
signals n O
. 
 O
Studies d O
in O O
B 
 O
. 
 O
glabrata b O
, 
 O
B 
 O
. 
 O
straminea a O
and 	 O
B 
 O
. 
 O
tenagophila a O
under e O
outdoor d O
conditions d O
. 
 O
The 	 O
electrocardiogram c O
in O O
tachycardia h O
. 
 O
Identification n O
of O O
a 
 O
putative a O
chromosomal o O
replication l O
origin g O
from m O
Helicobacter i O
pylori o O
and 	 O
its 	 O
interaction e O
with h O
the 	 O
initiator t B-GENE
protein t I-GENE
DnaA A E-GENE
. 
 O
The 	 O
primary m O
structure u O
of O O
cholesterol l B-GENE
esterase e E-GENE
displayed p O
no O O
significant n O
homology o O
with h O
other e O
lipases a O
, 
 O
although h O
the 	 O
putative a O
lipid i O
interfacial e O
recognition o O
site e O
of O O
G 
 B-GENE
- 
 I-GENE
X 
 I-GENE
- 
 I-GENE
S 
 I-GENE
- 
 I-GENE
X 
 I-GENE
- 
 I-GENE
G 
 E-GENE
is O O
present s O
in O O
the 	 O
cholesterol l B-GENE
esterase e I-GENE
sequence u E-GENE
. 
 O
The 	 O
essential e O
questions s O
about u O
hepatitis a O
C 
 O
The 	 O
transcriptional n O
initiation t O
site e O
of O O
RAG1 1 S-GENE
was 	 O
localized a O
at O O
A 
 O
, 
 O
26 O O
bp O O
upstream t O
of O O
the 	 O
putative a O
translational n O
initiation t O
codon o O
, 
 O
ATG 	 O
, 
 O
by O O
the 	 O
primer m O
extension e O
assay a O
. 
 O
Coronary o O
arteriographies e O
and 	 O
ventriculographies t O
corresponding r O
to O O
274 	 O
consecutive s O
patients i O
( 
 O
January u O
, 
 O
1975 5 O
- 
 O
October o O
, 
 O
1978 8 O
) 
 O
with h O
significant n O
coronary o O
lesions i O
are 	 O
reviewed i O
. 
 O
Visualization u O
of O O
the 	 O
cells l O
by O O
phase s O
contrast t O
microscopy r O
indicated i O
that t O
murine i B-GENE
PKCepsilon e E-GENE
expression r O
in O O
the 	 O
presence s O
of O O
glycerol c O
resulted u O
in O O
a 
 O
significant n O
increase r O
in O O
the 	 O
number b O
of O O
yeast s O
cells l O
exhibiting i O
very y O
small l O
buds s O
. 
 O
Sonography o O
depicted i O
the 	 O
true e O
morphology p O
of O O
these s O
cystic t O
lesions i O
more e O
clearly a O
than n O
CT O O
, 
 O
and 	 O
the 	 O
sonographic o O
findings d O
virtually t O
excluded l O
uncomplicated o O
hepatic a O
cyst t O
as O O
a 
 O
diagnosis g O
. 
 O
Protein t B-GENE
kinase a I-GENE
C - E-GENE
transiently n O
activated i O
heteromeric e O
N - B-GENE
- - I-GENE
methyl h I-GENE
- - I-GENE
D - I-GENE
- - I-GENE
aspartate a I-GENE
receptor e E-GENE
channels n O
independent e O
of O O
the 	 O
phosphorylatable s O
C 
 O
- 
 O
terminal m O
splice i O
domain a O
and 	 O
of O O
consensus s O
phosphorylation s O
sites e O
. 
 O
A 
 O
24 O O
- 
 O
year r O
- 
 O
old 	 O
pregnant g O
woman a O
started r O
to O O
have e O
hyperemesis e O
gravidarum v O
6 
 O
weeks k O
before o O
admission i O
. 
 O
Highly h O
significant n O
similarities i O
were e O
detected e O
between w O
the 	 O
N 
 O
- 
 O
terminal m O
region i O
of O O
P30 	 S-GENE
and 	 O
those s O
of O O
GENA A O
[ 
 O
the 	 O
product d O
of O O
another t O
unidentified d O
gene e O
( 
 O
geneA e S-GENE
) 
 O
located a O
upstream t O
of O O
the 	 O
aceEF E B-GENE
- 
 I-GENE
lpd 	 I-GENE
operon r I-GENE
] 
 E-GENE
, 
 O
and 	 O
GNTR R S-GENE
( 
 O
a 
 O
putative a O
transcriptional n O
repressor r O
of O O
the 	 O
gluconate c B-GENE
operon r I-GENE
of O I-GENE
Bacillus i I-GENE
subtilis t E-GENE
) 
 O
. 
 O
In O O
vitro r O
DNA 	 O
binding d O
assays a O
indicate i O
that t O
the 	 O
elements m O
identified n O
can 	 O
specifically c O
interact e O
with h O
c - B-GENE
- - I-GENE
Ets 	 I-GENE
- - I-GENE
1 - I-GENE
protein t E-GENE
. 
 O
They y O
are 	 O
found n O
to O O
have e O
several e O
advantages a O
over r O
the 	 O
conventional v O
indices i O
of O O
skewness w O
and 	 O
kurtosis t O
( 
 O
square a O
root t O
of O O
b1 O O
and 	 O
b2 O O
) 
 O
and 	 O
no O O
serious i O
drawbacks w O
. 
 O
They y O
elicit c O
similar i O
regional i O
cerebral e O
blood o O
flow w O
( 
 O
rCBF F O
) 
 O
patterns t O
, 
 O
even n O
though u O
sign n O
language g O
is O O
dependent e O
on O O
spatial t O
information o O
. 
 O
Siglec l B-GENE
- - I-GENE
9 - E-GENE
is O O
predicted d O
to O O
contain t O
three e O
extracellular r O
immunoglobulin u B-GENE
- - I-GENE
like e I-GENE
domains a E-GENE
that t O
comprise p O
an O O
N - O
- - O
terminal m O
V - O
- - O
set 	 O
domain a O
and 	 O
two 	 O
C2 B O
- - O
set 	 O
domains a O
, 
 O
a 
 O
transmembrane n O
region i O
and 	 O
a 
 O
cytoplasmic o O
tail l O
containing t O
two 	 O
putative a O
tyrosine o O
- 
 O
based e O
signaling n O
motifs i O
. 
 O
Determination e O
of O O
the 	 O
LD O O
50 O O
( 
 O
30 O O
) 
 O
during i O
infant a O
period i O
and 	 O
growth w O
period i O
The 	 O
availability i O
of O O
a 
 O
commercial m O
program g O
( 
 O
PCNONLIN O O
) 
 O
is O O
needed d O
to O O
carry r O
out 	 O
matrix r O
handling d O
calculations c O
. 
 O
The 	 O
introduction r O
gives e O
also o O
the 	 O
history t O
of O O
Research e O
Programme g O
MZ O O
- 
 O
XVII I O
and 	 O
its 	 O
implementation l O
in O O
several e O
regions i O
of O O
Poland a O
. 
 O
The 	 O
fecal a O
excretion r O
is O O
found n O
to O O
be O O
only y O
one 	 O
third r O
of O O
that t O
measured s O
in O O
urine n O
. 
 O
The 	 O
COR 	 B-GENE
biosynthetic s I-GENE
gene e I-GENE
cluster s E-GENE
in O O
P 
 O
. 
 O
syringae i O
pv O O
. 
 O
glycinea c O
PG4180 1 O
is O O
encoded o O
by O O
a 
 O
32 O O
- 
 O
kb O O
region i O
which c O
contains t O
both h O
the 	 O
structural u O
and 	 O
regulatory u O
genes e O
needed d O
for 	 O
COR 	 S-GENE
synthesis t O
. 
 O
Model e O
experiments e O
on O O
pheasants a O
using n O
single g O
doses e O
of O O
the 	 O
insecticide e O
( 
 O
Lindane d O
) 
 O
the 	 O
herbicide b O
( 
 O
Terbutryn b O
) 
 O
a 
 O
mineral e O
fertilizer t O
( 
 O
calcium c O
ammonium o O
nitrate r O
) 
 O
and 	 O
the 	 O
fungicide g O
( 
 O
HCB 	 O
) 
 O
. 
 O
In O O
this s O
technique h O
, 
 O
the 	 O
posterior t O
wall l O
of O O
the 	 O
neopharynx p O
consists s O
only y O
of O O
the 	 O
prevertebral v O
tissue s O
, 
 O
while l O
the 	 O
flap p O
forms m O
the 	 O
anterior e O
and 	 O
lateral e O
walls l O
. 
 O
The 	 O
most t O
common m O
hosts t O
were e O
equines i O
( 
 O
31 O O
% 
 O
) 
 O
, 
 O
bovines i O
( 
 O
25 O O
% 
 O
) 
 O
and 	 O
raccoons c O
( 
 O
19 O O
% 
 O
) 
 O
. 
 O
A 
 O
single g O
HD O O
session s O
using n O
cellulose l O
triacetate a O
or O O
polysulfone y O
membrane b O
significantly n O
increased r O
water e O
content t O
both h O
at O O
forearm e O
and 	 O
lower e O
leg 	 O
( 
 O
p 
 O
< 
 O
0 
 O
. 
 O
05 O O
) 
 O
. 
 O
Both h O
claR R S-GENE
and 	 O
car 	 O
are 	 O
expressed r O
as O O
monocistronic o O
transcripts n O
; 
 O
the 	 O
level e O
of O O
transcript n O
declined l O
rapidly i O
after e O
48h 	 O
in O O
complex p O
media i O
, 
 O
but 	 O
low 	 O
sustained t O
levels e O
of O O
both h O
transcripts n O
were e O
observed e O
in O O
defined i O
GSPG G O
medium i O
until i O
96h 	 O
. 
 O
claR R S-GENE
and 	 O
car 	 O
were e O
not 	 O
significantly n O
expressed r O
in O O
mutants a O
disrupted r O
in O O
the 	 O
ccaR R B-GENE
gene e E-GENE
, 
 O
a 
 O
regulatory u O
gene e O
that t O
controls t O
positively i O
clavulanic v O
acid d O
and 	 O
cephamycin h O
biosynthesis s O
. 
 O
Whereas r O
mutant a B-GENE
6C4 	 E-GENE
specified c O
a 
 O
wild d B-GENE
- - I-GENE
type e I-GENE
- - I-GENE
size e I-GENE
Pol 	 I-GENE
protein t E-GENE
, 
 O
we O O
detected e O
no O O
full l B-GENE
- - I-GENE
length g I-GENE
Pol 	 I-GENE
protein t E-GENE
in O O
7E4 	 O
- 
 O
infected e O
cell l O
extracts r O
. 
 O
The 	 O
hepatic a O
isoform f O
of O O
6 - B-GENE
- - I-GENE
phosphofructo s I-GENE
- - I-GENE
2 - I-GENE
- - I-GENE
kinase a E-GENE
/ 
 O
fructose c B-GENE
- - I-GENE
2 - I-GENE
, - I-GENE
6 - I-GENE
- - I-GENE
bisphosphatase p E-GENE
( 
 O
PF2K K S-GENE
/ 
 O
Fru 	 B-GENE
- - I-GENE
2 - E-GENE
, - O
6 - B-GENE
- - I-GENE
BPase s E-GENE
) 
 O
is O O
transcriptionally n O
stimulated m O
by O O
glucocorticoids c O
, 
 O
whereas r O
insulin u S-GENE
blocks c O
this s O
stimulatory m O
effect e O
. 
 O
Being n O
implicated l O
in O O
insulin u S-GENE
and 	 O
GK B B-GENE
gene e E-GENE
regulations u O
as O O
a 
 O
common m O
transcription n O
factor t O
, 
 O
IPF1 1 S-GENE
/ 
 O
STF 	 B-GENE
- - I-GENE
1 - E-GENE
/ 
 O
PDX 	 B-GENE
- - I-GENE
1 - E-GENE
is O O
likely e O
to O O
play y O
an O O
essential e O
role e O
in O O
maintaining n O
normal m O
beta a O
- 
 O
cell l O
functions c O
. 
 O
The 	 O
Caenorhabditis n B-GENE
elegans g I-GENE
NK I I-GENE
- - I-GENE
2 - I-GENE
class s I-GENE
homeoprotein e I-GENE
CEH 	 I-GENE
- - I-GENE
22 E E-GENE
is O O
involved o O
in O O
combinatorial b O
activation i O
of O O
gene e O
expression r O
in O O
pharyngeal r O
muscle c O
. 
 O
Mouse s O
embryo r O
cells l O
( 
 O
C57BL B O
/ 
 O
6 
 O
, 
 O
H 
 B-GENE
- 
 I-GENE
2b O E-GENE
) 
 O
transformed n O
by O O
the 	 O
E1A 	 S-GENE
and 	 O
E1B 	 B-GENE
genes e E-GENE
of O O
adenovirus n O
type e O
5 
 O
( 
 O
Ad5E1 E O
MEC 	 O
) 
 O
are 	 O
highly h O
immunogenic u O
. 
 O
The 	 O
largest g O
age 	 O
adjusted u O
differences f O
between w O
men 	 O
with h O
low 	 O
and 	 O
normal m O
mood d O
were e O
for 	 O
the 	 O
AH4 	 O
( 
 O
3 
 O
points n O
, 
 O
t 
 O
= 
 O
5 
 O
. 
 O
6 
 O
, 
 O
p 
 O
< 
 O
0 
 O
. 
 O
0001 1 O
) 
 O
and 	 O
the 	 O
CAMCOG C O
( 
 O
2 
 O
points n O
, 
 O
t 
 O
= 
 O
5 
 O
. 
 O
8 
 O
, 
 O
p 
 O
< 
 O
0 
 O
. 
 O
0001 1 O
) 
 O
. 
 O
Our 	 O
findings d O
suggest g O
that t O
resting t O
Tl O O
- 
 O
201 	 O
scintigraphy n O
has 	 O
limited i O
value u O
in O O
the 	 O
detection e O
of O O
coronary o O
artery e O
disease e O
in O O
patients i O
with h O
Hurler l O
syndrome d O
. 
 O
We O O
demonstrate o O
that t O
the 	 O
WRM 	 B-GENE
- - I-GENE
1 - I-GENE
protein t E-GENE
binds d O
to O O
LIT 	 B-GENE
- - I-GENE
1 - E-GENE
in O O
vivo o O
and 	 O
that t O
WRM 	 B-GENE
- - I-GENE
1 - E-GENE
can 	 O
activate i O
the 	 O
LIT 	 B-GENE
- - I-GENE
1 - I-GENE
protein t I-GENE
kinase a E-GENE
when n O
coexpressed x O
in O O
vertebrate t O
tissue s O
culture t O
cells l O
. 
 O
RESULTS U O
: 
 O
All 	 O
primary m O
tumors o O
were e O
positive i O
for 	 O
CAM5 5 B-GENE
. - I-GENE
2 - E-GENE
. 
 O
Nuclear l O
extracts r O
from m O
Sertoli t O
cells l O
were e O
found n O
to O O
cause s O
an O O
E 
 O
- 
 O
box 	 O
gel 	 O
shift f O
when n O
the 	 O
cells l O
were e O
stimulated m O
to O O
differentiate f O
in O O
culture t O
, 
 O
but 	 O
not 	 O
under e O
basal a O
conditions d O
. 
 O
On O O
the 	 O
sixth t O
postirradiation t O
day 	 O
the 	 O
absorption o O
of O O
phenobarbitone n O
, 
 O
sulphafurazole p O
and 	 O
mecamylamine a O
had 	 O
returned u O
to O O
the 	 O
control t O
level e O
, 
 O
but 	 O
the 	 O
absorption o O
of O O
quinidine n O
and 	 O
isoniazid n O
was 	 O
still l O
retarded a O
. 
 O
To O O
determine e O
the 	 O
transactivation n O
potential e O
of O O
each h O
of O O
the 	 O
four r O
Ahr 	 B-GENE
Sp1 	 I-GENE
sites e E-GENE
, 
 O
we O O
fused e O
the 	 O
Ahr 	 B-GENE
promoter m E-GENE
to O O
a 
 O
luciferase i S-GENE
( 
 O
LUC 	 S-GENE
) 
 O
reporter o O
gene e O
and 	 O
transfected n O
the 	 O
construct s O
into o O
the 	 O
Drosophila s O
cell l O
line e O
Schneider n O
- 
 O
2 
 O
, 
 O
which c O
contains t O
no O O
Sp1 	 S-GENE
or O O
Sp1 	 B-GENE
- - I-GENE
like e I-GENE
factors t E-GENE
. 
 O
We O O
determined e O
that t O
Hop 	 O
( - O
T42 	 O
) - O
contains t O
a 
 O
glutamic t O
acid d O
- 
 O
to O O
- 
 O
lysine i O
substitution s O
at O O
amino n O
acid d O
residue i O
695 	 O
( 
 O
E695K 5 O
) 
 O
. 
 O
The 	 O
organotins a O
. 
 O
Results u O
of O O
these s O
studies d O
indicate i O
that t O
binding d O
of O O
biotin t O
to O O
the 	 O
protein t O
results u O
in O O
protection t O
of O O
regions i O
of O O
the 	 O
central t O
domain a O
in O O
the 	 O
vicinity i O
of O O
the 	 O
active i O
site e O
and 	 O
the 	 O
C 
 O
- 
 O
terminal m O
domain a O
from m O
chemical m O
cleavage a O
. 
 O
The 	 O
psh3 3 B-GENE
( - I-GENE
+ - I-GENE
) - I-GENE
gene e E-GENE
encodes o O
a 
 O
protein t O
of O O
215 	 O
amino n O
acids d O
, 
 O
which c O
shares r O
a 
 O
high h O
degree r O
of O O
structural u O
and 	 O
functional c O
similarity i O
with h O
Shr3p 3 S-GENE
. 
 O
The 	 O
impairment a O
of O O
the 	 O
nocturnal t O
secretion r O
was 	 O
related a O
to O O
the 	 O
subjects j O
' 
 O
age 	 O
and 	 O
, 
 O
for 	 O
the 	 O
GH S S-GENE
secretory r O
pattern t O
only y O
, 
 O
also o O
to O O
the 	 O
MMSE E O
score r O
. 
 O
Thus s O
, 
 O
the 	 O
antibody i O
class s O
switch t O
appears e O
to O O
be O O
directed e O
by O O
induction u O
of O O
accessibility e O
, 
 O
as O O
assayed a O
by O O
transcription n O
of O O
germ m O
line e O
CH S B-GENE
genes e E-GENE
. 
 O
This s O
growth w O
- 
 O
inhibitory i O
effect e O
was 	 O
suppressed p O
by O O
the 	 O
mpk1 1 B-GENE
delta t I-GENE
mutation a E-GENE
, 
 O
suggesting g O
that t O
hyperactivation e O
of O O
the 	 O
Mpk1 1 S-GENE
pathway h O
is O O
toxic i O
to O O
cells l O
. 
 O
The 	 O
chicken c O
genome o O
contains t O
two 	 O
functional c O
nonallelic a O
beta1 a B-GENE
, - I-GENE
4 - I-GENE
- - I-GENE
galactosyltransferase a I-GENE
genes e E-GENE
. 
 O
Recombinant o B-GENE
Human a I-GENE
Erythropoietin t E-GENE
and 	 O
Platinum t O
- 
 O
Based e O
Chemotherapy m O
In O O
Advanced a O
Ovarian r O
Cancer c O
Homodimers o O
of O O
RIP60 6 S-GENE
( 
 O
replication l B-GENE
initiation t I-GENE
- - I-GENE
region i I-GENE
protein t I-GENE
60 I I-GENE
kDA 	 E-GENE
) 
 O
purified i O
from m O
nuclear l O
extract r O
bind d O
two 	 O
ATT 	 O
- 
 O
rich h O
sites e O
in O O
oribeta b O
and 	 O
foster t O
the 	 O
formation m O
of O O
a 
 O
twisted s O
720 	 O
bp O O
DNA 	 O
loop p O
in O O
vitro r O
. 
 O
Endodontic o O
treatment a O
of O O
deciduous i O
teeth t O
using n O
the 	 O
formocresol m O
amputation u O
method h O
Some e O
of O O
these s O
physiological s O
responses p O
are 	 O
regulated u O
via 	 O
activation i O
of O O
transcription n O
factors t O
such h O
as O O
activator i B-GENE
protein t I-GENE
1 - E-GENE
( 
 O
AP B B-GENE
- - I-GENE
1 - E-GENE
) 
 O
. 
 O
To O O
test t O
the 	 O
role e O
of O O
myb 	 B-GENE
family i I-GENE
members b E-GENE
in O O
progression g O
through o O
the 	 O
cell l O
cycle l O
, 
 O
we O O
comicroinjected i O
c - B-GENE
- - I-GENE
myc 	 E-GENE
and 	 O
myb 	 S-GENE
expression r O
vectors t O
into o O
serum u O
- 
 O
deprived r O
quiescent e O
SMCs s O
. 
 O
Overall r O
graft f O
and 	 O
patient i O
survival v O
after e O
HAT 	 O
were e O
33 O O
. 
 O
3 
 O
% 
 O
and 	 O
75 O O
% 
 O
, 
 O
respectively p O
. 
 O
LAC9 9 S-GENE
is O O
a 
 O
DNA 	 O
- 
 O
binding d O
protein t O
that t O
regulates u O
transcription n O
of O O
the 	 O
lactose t O
- - O
galactose a O
regulon u O
in O O
Kluyveromyces y O
lactis t O
. 
 O
We O O
determined e O
the 	 O
complete p O
nucleotide l O
sequence u O
of O O
the 	 O
gypsy s O
element m O
present s O
at O O
the 	 O
forked k O
locus u O
of O O
Drosophila s O
melanogaster a O
in O O
the 	 O
f1 O B-GENE
allele e E-GENE
. 
 O
The 	 O
same e O
high h O
degree r O
of O O
sequence u O
homology o O
between w O
the 	 O
two 	 O
F 
 O
. 
 O
diplosiphon l O
PC B O
alpha h O
and 	 O
PC B B-GENE
beta a I-GENE
sequences u E-GENE
( 
 O
85 O O
and 	 O
77 O O
% 
 O
, 
 O
respectively p O
) 
 O
was 	 O
found n O
at O O
both h O
the 	 O
nucleotide l O
and 	 O
amino n O
acid d O
levels e O
, 
 O
and 	 O
similar i O
results u O
were e O
obtained a O
for 	 O
interspecies e O
comparisons p O
. 
 O
A 
 O
wound n O
model e O
for 	 O
decubitus u O
and 	 O
leg 	 O
ulcers e O
consisting s O
of O O
human a O
dermal m O
fibroblasts r O
in O O
type e B-GENE
I - I-GENE
collagen l E-GENE
dermal m O
" 
 O
equivalent i O
" 
 O
matrix r O
( 
 O
DEM 	 O
) 
 O
was 	 O
exposed o O
in O O
vitro r O
to O O
electric c O
fields l O
similar i O
to O O
postulated t O
endogenous o O
fields l O
in O O
wounds n O
. 
 O
A 
 O
group u O
of O O
factors t O
known w O
as O O
activating i B-GENE
transcription n I-GENE
factors t E-GENE
( 
 O
ATF 	 S-GENE
) 
 O
have e O
been n O
found n O
to O O
bind d O
to O O
the 	 O
latter t O
and 	 O
related a O
sequences u O
found n O
upstream t O
of O O
early l O
adenovirus n O
promoters m O
induced u O
by O O
E1A 	 S-GENE
, 
 O
and 	 O
these s O
factors t O
are 	 O
highly h O
homologous o O
to O O
the 	 O
CREB B B-GENE
protein t E-GENE
. 
 O
In O O
addition i O
to O O
these s O
cases e O
, 
 O
patients i O
w 
 O
with h O
high h O
Loa 	 O
microfilaremia r O
also o O
developed e O
milder d O
neurologic r O
manifestations i O
causing s O
functional c O
impairment a O
lasting t O
for 	 O
at O O
least s O
one 	 O
week k O
after e O
treatment a O
. 
 O
The 	 O
vertebrate t B-GENE
transcription n I-GENE
factors t I-GENE
TCF 	 E-GENE
( 
 O
T - B-GENE
cell l I-GENE
factor t E-GENE
) 
 O
and 	 O
LEF 	 S-GENE
( 
 O
lymphocyte p B-GENE
enhancer a I-GENE
binding d I-GENE
factor t E-GENE
) 
 O
interact e O
with h O
beta a B-GENE
- - I-GENE
catenin e E-GENE
and 	 O
are 	 O
hypothesized o O
to O O
mediate i O
Wingless g S-GENE
/ 
 O
Wnt 	 S-GENE
signaling n O
. 
 O
Some e O
of O O
these s O
DNA 	 O
: 
 O
protein t O
complexes p O
were e O
also o O
present s O
, 
 O
but 	 O
at O O
lower e O
levels e O
, 
 O
in O O
nuclear l O
extracts r O
from m O
untransformed r O
rat 	 O
cells l O
suggesting g O
the 	 O
possible s O
involvement o O
of O O
cellular l O
factors t O
in O O
the 	 O
mechanism h O
of O O
down n O
- 
 O
regulation u O
mediated i O
by O O
Ad12 2 B-GENE
E1A 	 E-GENE
. 
 O
Hypocalcemia o O
is O O
usually a O
due 	 O
to O O
either h O
a 
 O
disturbance t O
in O O
the 	 O
parathyroid a B-GENE
hormone m I-GENE
- 
 I-GENE
adenylate n I-GENE
cyclase l E-GENE
system t O
or O O
a 
 O
disturbance t O
in O O
vitamin a O
D 
 O
metabolism a O
. 
 O
Activity i O
was 	 O
reconstituted o O
, 
 O
however e O
, 
 O
by O O
combining b O
fractions c O
that t O
were e O
enriched i O
in O O
the 	 O
two 	 O
components p O
. 
 O
If O O
failure l O
to O O
solve v O
invisible i O
displacements p O
was 	 O
due 	 O
to O O
increased r O
memory o O
requirements u O
, 
 O
then n O
the 	 O
primates m O
should u O
perform f O
at O O
chance n O
level e O
on O O
all 	 O
3 
 O
problems b O
. 
 O
In O O
seven e O
patients i O
( 
 O
7 
 O
. 
 O
8 
 O
% 
 O
) 
 O
with h O
new 	 O
Q 
 O
- 
 O
waves e O
and 	 O
a 
 O
pathologic h O
CK B B-GENE
- - I-GENE
MB E E-GENE
profile f O
( 
 O
group u O
II O O
) 
 O
troponin p B-GENE
T - E-GENE
reached c O
median i O
levels e O
of O O
10 O O
. 
 O
47 O O
micrograms r O
/ 
 O
l 
 O
( 
 O
quartile r O
6 
 O
. 
 O
34 O O
- 
 O
12 O O
. 
 O
50 O O
micrograms r O
/ 
 O
l 
 O
) 
 O
( 
 O
P 
 O
< 
 O
0 
 O
. 
 O
001 	 O
I 
 O
vs O O
II O O
) 
 O
. 
 O
Mineralized e O
bone e O
nodule u O
formation m O
in O O
vitro r O
by O O
cell l O
populations u O
from m O
young n O
adult l O
rabbit b O
alveolar e O
bone e O
. 
 O
Mouse s B-GENE
GRK6 6 I-GENE
- - I-GENE
C - E-GENE
displays p O
none e O
of O O
these s O
motifs i O
. 
 O
Comparisons p O
of O O
the 	 O
efficacy i O
of O O
benazepril a O
and 	 O
hydrochlorothiazide r O
alone n O
and 	 O
in O O
combination b O
have e O
shown w O
that t O
benazepril a O
20 O O
mg O O
once e O
daily l O
is O O
as O O
effective e O
as O O
or O O
more e O
effective e O
in O O
lowering e O
diastolic s O
blood o O
pressure s O
than n O
hydrochlorothiazide r O
25 O O
mg O O
once e O
daily l O
and 	 O
that t O
the 	 O
combination b O
of O O
benazepril a O
20 O O
mg O O
and 	 O
hydrochlorothiazide r O
25 O O
mg O O
has 	 O
a 
 O
possibly s O
synergistic e O
effect e O
on O O
diastolic s O
blood o O
pressure s O
. 
 O
The 	 O
132 	 B-GENE
- - I-GENE
bp I I-GENE
PHO8p 8 I-GENE
fragment g E-GENE
, 
 O
connected n O
at O O
position i O
- 
 O
281 	 O
of O O
the 	 O
5 
 O
' 
 O
upstream t O
region i O
of O O
a 
 O
HIS5 5 S-GENE
' - O
- 
 O
' - O
lacZ Z S-GENE
fused e O
gene e O
, 
 O
could l O
sense s O
Pi O S-GENE
signals n O
in O O
vivo o O
, 
 O
but 	 O
a 
 O
20 O O
- 
 O
bp O O
synthetic t O
oligonucleotide g O
having i O
the 	 O
same e O
sequence u O
from m O
- 
 O
544 	 O
to O O
- 
 O
525 	 O
of O O
the 	 O
PHO8p 8 O
DNA 	 O
could l O
not 	 O
. 
 O
1988 8 O
) 
 O
. 
 O
Sequences u O
within h O
the 	 O
UAS2 2 B-GENE
element m E-GENE
of O O
the 	 O
ENO2 2 B-GENE
gene e E-GENE
bound n O
a 
 O
second o O
protein t O
which c O
corresponded r O
to O O
the 	 O
ABFI I S-GENE
( 
 O
autonomously o B-GENE
replicating l I-GENE
sequence u I-GENE
- - I-GENE
binding d I-GENE
factor t E-GENE
) 
 O
protein t O
. 
 O
Plasmid s O
subclones c O
of O O
recombinant o B-GENE
phage g I-GENE
lambda b I-GENE
Asm152 1 E-GENE
were e O
able e O
to O O
complement p O
both h O
Escherichia h B-GENE
coli i I-GENE
gltB B E-GENE
and 	 O
A 
 O
. 
 O
sesbaniae b O
Asm 	 B-GENE
- 
 I-GENE
Vi O I-GENE
mutants a E-GENE
; 
 O
NADPH P B-GENE
- - I-GENE
glutamate t I-GENE
synthase t E-GENE
activity i O
was 	 O
detected e O
in O O
all 	 O
such h O
strains a O
complemented p O
to O O
Asm 	 B-GENE
+ 
 E-GENE
. 
 O
The 	 O
sequence u O
of O O
LZ321 2 S-GENE
matched c O
that t O
of O O
RREB1 B S-GENE
, 
 O
a 
 O
transcription n O
factor t O
that t O
bound n O
to O O
a 
 O
Ras 	 B-GENE
responsive p I-GENE
element m E-GENE
( 
 O
RRE 	 O
) 
 O
very y O
different f O
from m O
the 	 O
sequence u O
with h O
which c O
we O O
isolated l O
LZ321 2 S-GENE
. 
 O
Steady a O
- 
 O
state t O
levels e O
of O O
murine i B-GENE
MMR 	 I-GENE
mRNA A E-GENE
were e O
measured s O
in O O
the 	 O
macrophage r O
cell l O
line e O
J774E 4 O
, 
 O
which c O
is O O
known w O
to O O
express r O
the 	 O
protein t O
at O O
the 	 O
cell l O
surface f O
. 
 O
Basal a O
level e O
expression r O
was 	 O
reduced u O
to O O
20 O O
and 	 O
50 O O
% 
 O
when n O
the 	 O
UGA 	 O
stop p O
codon o O
was 	 O
replaced l O
by O O
UAG 	 O
or O O
UAA 	 O
, 
 O
respectively p O
, 
 O
consistent s O
with h O
the 	 O
finding d O
that t O
in O O
E 
 O
. 
 O
coli i O
translation n O
terminates m O
more e O
efficiently i O
at O O
UAG 	 O
and 	 O
UAA 	 O
than n O
at O O
UGA 	 O
. 
 O
Discriminant c O
function c O
analysis l O
suggests g O
that t O
AUDIT I O
scores r O
can 	 O
successfully c O
identify n O
SAT 	 O
- 
 O
positive i O
and 	 O
SAT 	 O
- 
 O
negative a O
patients i O
; 
 O
the 	 O
analysis l O
accounted o O
for 	 O
42 O O
. 
 O
5 
 O
% 
 O
of O O
the 	 O
variance i O
and 	 O
correctly r O
classified s O
84 O O
. 
 O
6 
 O
% 
 O
of O O
the 	 O
sample p O
. 
 O
Coronatine o O
( 
 O
COR 	 O
) 
 O
is O O
a 
 O
plasmid s O
- 
 O
encoded o O
phytotoxin t O
synthesized t O
by O O
several e O
pathovars h O
of O O
phytopathogenic t O
Pseudomonas u O
syringae i O
. 
 O
Both h O
the 	 O
5 
 O
' 
 O
and 	 O
3 
 O
' 
 O
untranslated r O
regions i O
also o O
show w O
significant n O
similarity i O
to O O
the 	 O
murine i O
gene e O
, 
 O
with h O
79 O O
and 	 O
70 O O
% 
 O
sequence u O
identity n O
, 
 O
respectively p O
. 
 O
One 	 O
patient i O
exhibited i O
a 
 O
non 	 O
- 
 O
sense s O
mutation a O
( 
 O
codon o O
388 	 O
) 
 O
, 
 O
which c O
changed n O
a 
 O
glutamine t O
codon o O
( 
 O
CAG 	 O
) 
 O
to O O
a 
 O
stop p O
codon o O
( 
 O
TAG 	 O
) 
 O
. 
 O
The 	 O
transcriptional n O
activity i O
of O O
P - B-GENE
- - I-GENE
450 	 I-GENE
( - I-GENE
11 I I-GENE
beta a I-GENE
) - I-GENE
gene e E-GENE
was 	 O
studied d O
with h O
an O O
in O O
vitro r O
transcription n O
system t O
using n O
nuclear l O
extracts r O
prepared p O
from m O
bovine i O
adrenal e O
cortex t O
. 
 O
Renal a O
dysplasia p O
with h O
multisystem t O
malformation f O
- 
 O
- 
 O
a 
 O
study d O
of O O
9 
 O
cases e O
. 
 O
This s O
bud 	 O
morphology p O
results u O
at O O
least s O
in O O
part t O
from m O
a 
 O
cell l O
cycle l O
delay a O
imposed o O
by O O
the 	 O
Cdc28p 2 B-GENE
- 
 I-GENE
inhibitory i I-GENE
kinase a E-GENE
Swe1p 1 S-GENE
. 
 O
Eleven v O
of O O
the 	 O
12 O O
exons n O
have e O
complete p O
sequence u O
homology o O
with h O
the 	 O
RBM 	 B-GENE
- - I-GENE
1 - I-GENE
sequence u E-GENE
. 
 O
Copyright y O
1998 8 O
Academic d O
Press s O
. 
 O
Laparoscopic a O
examination m O
1 
 O
year r O
after e O
surgery g O
revealed e O
an O O
enlarged a O
, 
 O
thin n O
- 
 O
walled l O
, 
 O
and 	 O
fluid i O
- 
 O
filled l O
uterine r O
segment m O
cranial n O
to O O
the 	 O
midcornus c O
occlusion l O
sites e O
in O O
all 	 O
animals m O
. 
 O
The 	 O
three e O
proteins t O
copurified u O
through o O
several e O
biochemical c O
fractionation c O
steps p O
and 	 O
could l O
be O O
coimmunoprecipitated m O
by O O
using n O
antibodies i O
against i O
GCD1 1 S-GENE
or O O
GCD2 2 S-GENE
. 
 O
Cellular l O
fractionation c O
and 	 O
Percoll c O
gradient d O
centrifugation t O
combined b O
with h O
immunoblotting u O
show w O
that t O
p67 	 S-GENE
cofractionates r O
with h O
nuclei l O
and 	 O
is O O
enriched i O
in O O
resistant i O
structure u O
that t O
is O O
insoluble o O
in O O
2 
 O
M 
 O
NaCl l O
, 
 O
25 O O
mM O O
lithium h O
3 
 O
, 
 O
5 
 O
' 
 O
- 
 O
diiodosalicylate o O
, 
 O
and 	 O
1 
 O
% 
 O
Triton t O
but 	 O
is O O
soluble u O
in O O
8 
 O
M 
 O
urea a O
. 
 O
For 	 O
the 	 O
first s O
time e O
also o O
a 
 O
genomic o O
sequence u O
for 	 O
a 
 O
red 	 B-GENE
algal a I-GENE
lhc 	 I-GENE
gene e E-GENE
is O O
presented s O
. 
 O
Elimination m O
of O O
brush s O
border d O
as O O
well l O
as O O
of O O
glomerular m O
marker k O
proteins t O
was 	 O
significantly n O
lower e O
after e O
intravenous r O
injection e O
of O O
low 	 O
- 
 O
osmolar o O
CM O O
iopamidol a O
370 	 O
( 
 O
832 	 O
mOsm m O
/ 
 O
kg O O
) 
 O
than n O
after e O
meglumine l O
diatrizoate t O
76 O O
( 
 O
2100 0 O
mOsm m O
/ 
 O
kg O O
) 
 O
. 
 O
Raman a O
scattering t O
from m O
VO2 	 O
single g O
crystals s O
: 
 O
A 
 O
study d O
of O O
the 	 O
effects e O
of O O
surface f O
oxidation d O
. 
 O
Combination b O
chemotherapy m O
in O O
advanced a O
ovarian r O
cancer c O
. 
 O
Making i O
sense s O
out 	 O
of O O
oxygen g O
sensor s O
. 
 O
In O O
comparison p O
to O O
a 
 O
silent e O
baseline e O
, 
 O
CBF 	 O
increases r O
were e O
observed e O
in O O
auditory i O
cortex t O
bilaterally a O
and 	 O
in O O
the 	 O
right h O
superior e O
parietal i O
, 
 O
right h O
dorsolateral s O
frontal n O
, 
 O
and 	 O
right h O
premotor m O
regions i O
, 
 O
with h O
no O O
modulation u O
as O O
a 
 O
function c O
of O O
attentional e O
condition d O
. 
 O
In O O
vitro r O
, 
 O
c - B-GENE
- - I-GENE
Src 	 E-GENE
phosphorylated s O
FAK 	 B-GENE
Tyr 	 I-GENE
- - I-GENE
925 	 E-GENE
in O O
a 
 O
glutathione t B-GENE
S - I-GENE
- - I-GENE
transferase n E-GENE
- 
 O
FAK 	 S-GENE
C 
 O
- 
 O
terminal m O
domain a O
fusion i O
protein t O
, 
 O
whereas r O
FAK 	 S-GENE
did 	 O
not 	 O
. 
 O
METHODS H O
AND 	 O
RESULTS U O
: 
 O
The 	 O
effect e O
of O O
prolonged l O
nitrate r O
therapy r O
between w O
2 
 O
days s O
and 	 O
6 
 O
weeks k O
during i O
healing l O
after e O
infarction a O
on O O
serial i O
parameters a O
of O O
ventricular t O
remodeling o O
( 
 O
scar r O
expansion a O
, 
 O
scar r O
thinning n O
, 
 O
ventricular t O
dilation a O
, 
 O
and 	 O
hypertrophy e O
) 
 O
and 	 O
function c O
( 
 O
asynergy n O
or O O
akinesis n O
plus s O
dyskinesis k O
and 	 O
ejection c O
fraction c O
) 
 O
by O O
serial i O
two 	 O
- 
 O
dimensional e O
echocardiography o O
, 
 O
hemodynamics o O
, 
 O
postmortem t O
topography o O
( 
 O
computerized p O
planimetry n O
, 
 O
geometric m O
maps s O
, 
 O
and 	 O
radiographs i O
) 
 O
, 
 O
and 	 O
collagen l S-GENE
content t O
( 
 O
hydroxyproline r O
) 
 O
was 	 O
studied d O
in O O
64 O O
instrumented t O
dogs s O
randomized d O
2 
 O
days s O
after e O
left t O
anterior e O
descending c O
coronary o O
artery e O
ligation a O
to O O
various i O
nitrate r O
regimens i O
( 
 O
n 
 O
= 
 O
32 O O
) 
 O
over r O
the 	 O
first s O
2 
 O
weeks k O
( 
 O
subgroup g O
1 
 O
: 
 O
2 
 O
% 
 O
transdermal n O
nitroglycerin r O
at O O
8 
 O
AM O O
and 	 O
4 
 O
PM O O
, 
 O
n 
 O
= 
 O
6 
 O
; 
 O
subgroup g O
2 
 O
: 
 O
2 
 O
% 
 O
transdermal n O
nitroglycerin r O
plus s O
2 
 O
. 
 O
6 
 O
mg O O
of O O
sustained t O
- 
 O
release e O
oral l O
nitroglycerin r O
at O O
8 
 O
AM O O
, 
 O
3 
 O
PM O O
, 
 O
and 	 O
10 O O
PM O O
, 
 O
n 
 O
= 
 O
5 
 O
; 
 O
subgroup g O
3 
 O
: 
 O
oral l O
isosorbide s O
dinitrate i O
, 
 O
30 O O
mg O O
at O O
8 
 O
AM O O
and 	 O
4 
 O
PM O O
, 
 O
n 
 O
= 
 O
11 O O
) 
 O
or O O
6 
 O
weeks k O
( 
 O
subgroup g O
4 
 O
: 
 O
isosorbide s O
dinitrate i O
, 
 O
n 
 O
= 
 O
10 O O
) 
 O
and 	 O
in O O
matching c O
controls t O
( 
 O
n 
 O
= 
 O
32 O O
) 
 O
. 
 O
The 	 O
essential e O
oil 	 O
composition p O
of O O
three e O
Zingiberaceae g O
widely e O
used d O
as O O
medicinal i O
aromatic m O
plants n O
from m O
S 
 O
. 
 O
Gel 	 O
shift f O
analysis l O
of O O
protein t O
binding d O
from m O
nuclear l O
extracts r O
to O O
these s O
caveolin e B-GENE
promoter m I-GENE
DNA 	 I-GENE
sequences u E-GENE
, 
 O
together e O
with h O
DNase s B-GENE
I - E-GENE
footprinting t O
, 
 O
confirmed f O
nucleoprotein l O
binding d O
to O O
the 	 O
SRE 	 B-GENE
- 
 I-GENE
like e I-GENE
elements m E-GENE
as O O
part t O
of O O
the 	 O
transcriptional n O
response p O
to O O
LDL 	 B-GENE
- - I-GENE
FC E E-GENE
. 
 O
A 
 O
new 	 O
model e O
for 	 O
objective e O
assessment e O
of O O
cervical v O
ripening e O
: 
 O
the 	 O
effect e O
of O O
prostaglandin s O
E2 O O
and 	 O
prelabor l O
contractility t O
. 
 O
CONCLUSIONS C O
: 
 O
The 	 O
MC O O
/ 
 O
UA O O
ratio i O
improves r O
the 	 O
sensitivity s O
for 	 O
the 	 O
prediction d O
of O O
poor r O
perinatal i O
outcome c O
when n O
it O O
is O O
combined b O
with h O
the 	 O
NST 	 O
. 
 O
Evaluation l O
of O O
materials e O
and 	 O
technics h O
in O O
vascular c O
surgery g O
using n O
111 	 O
- 
 O
Indium i O
The 	 O
claustrocortical u O
connection n O
was 	 O
investigated e O
in O O
13 O O
cats s O
with h O
selective e O
injections e O
of O O
30 O O
% 
 O
HRP 	 O
in O O
the 	 O
three e O
subdivisions d O
of O O
the 	 O
auditory i O
cortex t O
. 
 O
( 
 O
ABSTRACT T O
TRUNCATED N O
AT O O
400 	 O
WORDS D O
) 
 O
Applying l O
the 	 O
experience e O
mentioned t O
above v O
, 
 O
4 
 O
- 
 O
META A O
was 	 O
used d O
to O O
bond d O
a 
 O
proprietary p O
photocuring t O
microfilled r O
composite p O
material e O
to O O
Class s O
V 
 O
cavities i O
in O O
freshly s O
extracted r O
human a O
teeth t O
. 
 O
The 	 O
phP1 1 B-GENE
mutation a E-GENE
was 	 O
induced u O
by O O
insertion e O
of O O
a 
 O
1 
 O
. 
 O
2 
 O
- 
 O
kb O O
P - O
element m O
into o O
the 	 O
5 
 O
' 
 O
transcribed n O
nontranslated t O
region i O
of O O
the 	 O
proximal x O
polyhomeotic y O
gene e O
. 
 O
METHOD H O
: 
 O
Six 	 O
instruments t O
were e O
reviewed i O
: 
 O
the 	 O
Berg g O
Balance a O
Scale l O
( 
 O
Berg g O
) 
 O
, 
 O
the 	 O
Clinical n O
Test t O
of O O
Sensory s O
Interaction e O
and 	 O
Balance a O
( 
 O
CTSIB I O
) 
 O
, 
 O
the 	 O
Functional c O
Reach c O
Test t O
, 
 O
the 	 O
Tinetti e O
Balance a O
Test t O
of O O
the 	 O
Performance f O
- 
 O
Oriented e O
Assessment e O
of O O
Mobility i O
Problems b O
( 
 O
Tinetti e O
) 
 O
, 
 O
the 	 O
Timed e O
" 
 O
Up O O
and 	 O
Go O O
" 
 O
Test t O
( 
 O
TU O O
& 
 O
GT O O
) 
 O
, 
 O
and 	 O
the 	 O
Physical s O
Performance f O
Test t O
( 
 O
PPT 	 O
) 
 O
. 
 O
Genome o O
timeline e O
. 
 O
Initial t O
computer p O
based e O
similarity i O
searches r O
identified n O
human a B-GENE
retinoblastoma i I-GENE
binding d I-GENE
protein t I-GENE
1 - E-GENE
( 
 O
RBP 	 B-GENE
- - I-GENE
1 - E-GENE
) 
 O
, 
 O
Drosophila s O
melanogaster a O
male e O
specific c O
lethal h O
- - O
3 - O
( 
 O
Msl 	 O
- - O
3 - O
) 
 O
, 
 O
S - O
. - O
pombe b O
altered e O
polarity a O
- - O
13 E O
( 
 O
Alp13 1 S-GENE
) 
 O
and 	 O
S - B-GENE
. - I-GENE
cerevisiae e I-GENE
Eaf3p 3 E-GENE
, 
 O
a 
 O
component p O
of O O
the 	 O
yeast s B-GENE
NuA4 4 I-GENE
HAT 	 I-GENE
complex p E-GENE
( 
 O
Galarneau a O
et O O
al O O
. 
 O
, 
 O
2000 0 O
. 
 O
The 	 O
pressure s O
measurements s O
under e O
steady a O
flow w O
conditions d O
showed w O
that t O
the 	 O
hemodynamic o O
performance f O
( 
 O
including l O
pressure s O
gradient d O
and 	 O
effective e O
orifice f O
area a O
) 
 O
of O O
SPAB B O
is O O
superior e O
to O O
that t O
of O O
its 	 O
stented n O
counterpart n O
, 
 O
especially e O
in O O
the 	 O
smaller l O
sizes e O
. 
 O
Serum u O
prolactin l S-GENE
rapidly i O
decreased r O
after e O
institution t O
of O O
treatment a O
, 
 O
with h O
actual u O
normalization m O
( 
 O
less s O
than n O
20 O O
ng O O
/ 
 O
ml O O
) 
 O
by O O
the 	 O
3rd 	 O
month t O
. 
 O
We O O
report o O
five e O
of O O
13 O O
evaluable l O
patients i O
undergoing e O
allogeneic o O
sibling l O
BM O O
or O O
PBSC C O
transplantation n O
for 	 O
MM O O
between w O
1990 0 O
and 	 O
1997 7 O
who 	 O
met 	 O
the 	 O
criteria t O
for 	 O
adjuvant u O
alpha h B-GENE
- - I-GENE
IFN 	 E-GENE
therapy r O
. 
 O
Moist s O
healing l O
versus s O
wet 	 O
- 
 O
to O O
- 
 O
dry 	 O
. 
 O
In O O
this s O
report o O
, 
 O
we O O
identify n O
Tyr319 3 O
as O O
a 
 O
functionally c O
important o O
phosphorylation s O
site e O
in O O
the 	 O
ZAP 	 B-GENE
- - I-GENE
70 I I-GENE
interdomain e I-GENE
B - I-GENE
region i E-GENE
. 
 O
These s O
findings d O
suggest g O
that t O
low 	 O
- 
 O
power e O
laser e O
irradiation a O
can 	 O
be O O
used d O
for 	 O
promotion m O
of O O
vascularization c O
and 	 O
take e O
of O O
tissue s O
transplants n O
. 
 O
RESEARCH E O
DESIGN I O
AND 	 O
METHODS H O
: 
 O
A 
 O
total a O
of O O
26 O O
IDDM M O
patients i O
with h O
normoalbuminuria m O
were e O
randomized d O
into o O
two 	 O
groups u O
, 
 O
with h O
one 	 O
group u O
receiving e O
placebo c O
( 
 O
n 
 O
= 
 O
13 O O
, 
 O
age 	 O
36 O O
+ 
 O
/ 
 O
- 
 O
3 
 O
years r O
, 
 O
BMI 	 O
24 O O
. 
 O
5 
 O
+ 
 O
/ 
 O
- 
 O
1 
 O
. 
 O
1 
 O
kg O O
/ 
 O
m2 O O
) 
 O
and 	 O
the 	 O
other e O
group u O
receiving e O
an O O
average r O
of O O
15 O O
mg O O
lisinopril i O
daily l O
( 
 O
n 
 O
= 
 O
13 O O
, 
 O
age 	 O
34 O O
+ 
 O
/ 
 O
- 
 O
2 
 O
years r O
, 
 O
BMI 	 O
24 O O
. 
 O
4 
 O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
9 
 O
kg O O
/ 
 O
m2 O O
) 
 O
. 
 O
Previously v O
, 
 O
a 
 O
cDNA A O
( 
 O
GT2 	 S-GENE
) 
 O
encoding o O
this s O
protein t O
was 	 O
isolated l O
from m O
a 
 O
mouse s O
3T3 	 O
- 
 O
L1 O O
adipocyte p O
library r O
and 	 O
was 	 O
sequenced u O
. 
 O
Expression r O
of O O
human a B-GENE
complement p I-GENE
receptor e I-GENE
type e I-GENE
2 - E-GENE
( 
 O
CR2 	 S-GENE
/ 
 O
CD21 1 S-GENE
) 
 O
is O O
primarily m O
restricted t O
to O O
mature u O
B 
 O
cells l O
and 	 O
follicular l O
dendritic d O
cells l O
. 
 O
The 	 O
6 
 O
. 
 O
5 
 O
- 
 O
kb O O
genomic o O
fragment g O
contains t O
the 	 O
complete p O
coding i O
region i O
of O O
MyoD D S-GENE
, 
 O
distributed t O
over r O
three e O
exons n O
, 
 O
plus s O
2 
 O
. 
 O
3 
 O
kb O O
of O O
5 
 O
' 
 O
- 
 O
noncoding c O
sequence u O
and 	 O
1 
 O
. 
 O
4 
 O
kb O O
of O O
3 
 O
' 
 O
- 
 O
noncoding c O
sequence u O
. 
 O
Synthetic t O
studies d O
on O O
furan a O
derivatives i O
by O O
the 	 O
wittig t O
reaction c O
The 	 O
apparent a O
binding d O
constant s O
of O O
6 
 O
to O O
calf f O
thymus m O
DNA 	 O
is O O
1 
 O
. 
 O
68 O O
X 
 O
10 O O
( 
 O
5 
 O
) 
 O
M 
 O
- 
 O
1 
 O
whereas r O
netropsin r O
under e O
similar i O
conditions d O
gives e O
a 
 O
value u O
of O O
1 
 O
. 
 O
85 O O
X 
 O
10 O O
( 
 O
7 
 O
) 
 O
M 
 O
- 
 O
1 
 O
. 
 O
Phenotypic n O
screening e O
of O O
mutations a O
in O O
Pmr1 1 S-GENE
, 
 O
the 	 O
yeast s B-GENE
secretory r I-GENE
pathway h I-GENE
Ca2 	 I-GENE
+ - I-GENE
/ - I-GENE
Mn2 	 I-GENE
+ - I-GENE
- - I-GENE
ATPase a E-GENE
, 
 O
reveals e O
residues i O
critical t O
for 	 O
ion 	 O
selectivity e O
and 	 O
transport n O
. 
 O
Molecular e O
cloning n O
of O O
cDNAs A B-GENE
encoding o I-GENE
alpha h I-GENE
- 
 I-GENE
subunits u E-GENE
of O O
guanine n B-GENE
nucleotide l I-GENE
- - I-GENE
binding d I-GENE
regulatory u I-GENE
proteins t E-GENE
( 
 O
G - B-GENE
- - I-GENE
proteins t E-GENE
) 
 O
has 	 O
revealed e O
the 	 O
existence s O
of O O
nine e O
species c O
of O O
alpha h O
- 
 O
subunits u O
. 
 O
No O O
transactivation n O
of O O
the 	 O
ovalbumin l B-GENE
promoter m E-GENE
( 
 O
pLovTATA v S-GENE
) 
 O
template p O
control t O
was 	 O
observed e O
. 
 O
Pros s O
and 	 O
cons s O
of O O
selective e O
inhibition i O
of O O
cyclooxygenase l B-GENE
- - I-GENE
2 - E-GENE
versus s O
dual l O
lipoxygenase o S-GENE
/ 
 O
cyclooxygenase l S-GENE
inhibition i O
: 
 O
is O O
two 	 O
better t O
than n O
one 	 O
? 
 O
At O O
11 O O
. 
 O
5 
 O
years r O
of O O
follow l O
- 
 O
up O O
, 
 O
521 	 O
major o O
coronary o O
disease e O
events n O
had 	 O
occurred u O
, 
 O
261 	 O
fatal a O
and 	 O
260 	 O
non 	 O
- 
 O
fatal a O
. 
 O
The 	 O
etiology o O
was 	 O
established a O
in O O
73 O O
( 
 O
76 O O
. 
 O
8 
 O
% 
 O
) 
 O
out 	 O
of O O
95 O O
cases e O
. 
 O
Morphometry p O
of O O
the 	 O
intestine e O
of O O
the 	 O
pig 	 O
. 
 O
Serum u O
zinc c O
and 	 O
copper p O
levels e O
and 	 O
urine n O
copper p O
concentrations c O
in O O
men 	 O
were e O
significantly n O
lower e O
than n O
in O O
women e O
, 
 O
while l O
there r O
were e O
no O O
differences f O
in O O
serum u O
or O O
urinary n O
zinc c O
and 	 O
copper p O
levels e O
with h O
age 	 O
. 
 O
HDE 	 S-GENE
was 	 O
found n O
to O O
be O O
exclusively l O
targeted g O
to O O
and 	 O
imported o O
into o O
peroxisomes o O
in O O
both h O
heterologous e O
expression r O
systems t O
. 
 O
GeneCalling e O
analysis l O
was 	 O
successful c O
in O O
detecting e O
members b O
of O O
complex p O
metabolic a O
pathways h O
and 	 O
uncovering o O
novel e O
genes e O
that t O
were e O
either h O
coincidentally n O
regulated u O
or O O
directly e O
involved o O
in O O
such h O
pathways h O
. 
 O
Transformations n O
with h O
circular c O
plasmids s O
yielded l O
slowly w O
and 	 O
irregularly e O
growing w O
geneticin e O
- 
 O
resistant i O
mycelia e O
in O O
which c O
1 
 O
% 
 O
of O O
nuclei l O
contained t O
plasmid s O
sequences u O
. 
 O
CONCLUSION C O
: 
 O
In O O
these s O
patients i O
control t O
of O O
ventricular t O
response p O
rate e O
with h O
either h O
HBA 	 O
+ 
 O
VVIR R O
pacemaker e O
or O O
atrioventricular i O
modifying i O
drugs g O
+ 
 O
VVI 	 O
pacemaker e O
will l O
lead d O
to O O
a 
 O
significant n O
improvement r O
in O O
exercise r O
duration a O
and 	 O
quality l O
of O O
life e O
. 
 O
The 	 O
other e O
regions i O
include l O
potential e O
binding d O
sites e O
for 	 O
transcription n O
factors t O
ATF 	 S-GENE
, 
 O
NF1 	 S-GENE
, 
 O
and 	 O
a 
 O
CCAAT A B-GENE
- - I-GENE
binding d I-GENE
protein t E-GENE
. 
 O
Both h O
purH H S-GENE
and 	 O
purD D B-GENE
genes e E-GENE
constitute s O
a 
 O
single g O
operon r O
and 	 O
are 	 O
coregulated e O
in O O
expression r O
by O O
purines i O
as O O
other e O
purine i O
genes e O
are 	 O
. 
 O
The 	 O
patient i O
demographics o O
( 
 O
means n O
+ 
 O
/ 
 O
- 
 O
standard n O
deviations i O
) 
 O
were e O
as O O
follows l O
: 
 O
age 	 O
, 
 O
57 O O
+ 
 O
/ 
 O
- 
 O
12 O O
years r O
; 
 O
sex 	 O
, 
 O
nine e O
males e O
and 	 O
three e O
females a O
; 
 O
APACHE C O
II O O
score r O
, 
 O
15 O O
+ 
 O
/ 
 O
- 
 O
3 
 O
; 
 O
diagnosis g O
, 
 O
9 
 O
of O O
12 O O
patients i O
with h O
pneumonia u O
. 
 O
In O O
situ u O
hybridization r O
reveals e O
strong o O
signals n O
for 	 O
Zep 	 B-GENE
mRNA A E-GENE
in O O
the 	 O
cerebellum e O
and 	 O
olfactory a O
bulb b O
with h O
moderate e O
signals n O
detected e O
in O O
the 	 O
hippocampus p O
and 	 O
cortex t O
. 
 O
TNF 	 B-GENE
- - I-GENE
alpha h E-GENE
effect e O
was 	 O
eliminated m O
by O O
a 
 O
2 
 O
- 
 O
bp O O
substitution s O
mutation a O
in O O
the 	 O
NF B B-GENE
- - I-GENE
kappa p I-GENE
B1 I E-GENE
binding d O
half f O
site e O
of O O
the 	 O
NF B B-GENE
- - I-GENE
kappa p I-GENE
B - I-GENE
cis 	 I-GENE
element m E-GENE
. 
 O
UV O O
- 
 O
cross s O
- 
 O
linking k O
studies d O
suggested g O
that t O
these s O
two 	 O
complexes p O
represent r O
one 	 O
and 	 O
two 	 O
molecules e O
of O O
ADR1 1 S-GENE
bound n O
to O O
DNA 	 O
. 
 O
As O O
already e O
available i O
for 	 O
the 	 O
other e O
known w O
mammalian m O
members b O
of O O
this s O
enzyme y O
family i O
, 
 O
we O O
here e O
define i O
structural u O
and 	 O
functional c O
features t O
of O O
human a B-GENE
lymphoma p I-GENE
proprotein p I-GENE
convertase v E-GENE
( 
 O
LPC 	 S-GENE
) 
 O
. 
 O
The 	 O
M 
 O
- 
 O
phase s O
induction u O
activity i O
of O O
Cdc2 2 S-GENE
- 
 O
Cdc13 1 S-GENE
is O O
inhibited i O
by O O
Wee1 1 B-GENE
tyrosine o I-GENE
kinase a E-GENE
, 
 O
which c O
phosphorylates s O
Cdc2 2 S-GENE
on O O
tyrosine o O
- 
 O
15 O O
. 
 O
Nucleotide l O
sequencing u O
revealed e O
a 
 O
2076 6 O
- 
 O
base e O
pair r O
open n O
reading d O
frame m O
encoding o O
a 
 O
692 	 O
- 
 O
amino n O
acid d O
protein t O
. 
 O
But 	 O
it O O
is O O
possible s O
that t O
the 	 O
two 	 O
hemispheres i O
differ f O
in O O
the 	 O
manner n O
in O O
which c O
they y O
make e O
use 	 O
of O O
semantic a O
structures u O
: 
 O
the 	 O
left t O
hemisphere i O
in O O
a 
 O
selective e O
manner n O
, 
 O
appropriate r O
for 	 O
the 	 O
solution u O
of O O
a 
 O
specific c O
task k O
, 
 O
and 	 O
the 	 O
right h O
hemisphere i O
in O O
a 
 O
more e O
diffuse f O
and 	 O
global b O
manner n O
. 
 O
Supportive p O
therapy r O
with h O
xenogenous o O
peptides t O
in O O
patients i O
with h O
metastatic a O
breast a O
cancer c O
undergoing e O
aggressive r O
chemotherapy m O
( 
 O
modified i O
AC O O
- 
 O
protocol t O
) 
 O
: 
 O
a 
 O
prospective s O
, 
 O
randomized d O
double b O
- 
 O
blind n O
study d O
The 	 O
pregnancies g O
were e O
terminated m O
at O O
19 O O
and 	 O
12 O O
weeks k O
of O O
gestation t O
, 
 O
respectively p O
. 
 O
Single g O
substitutions s O
of O O
three e O
highly h O
conserved s O
phenylalanine n O
residues i O
( 
 O
Phe 	 O
- 
 O
15 O O
, 
 O
Phe 	 O
- 
 O
17 O O
, 
 O
Phe 	 O
- 
 O
27 O O
) 
 O
by O O
alanine n O
and 	 O
substitution s O
of O O
one 	 O
histidine t O
( 
 O
His 	 O
- 
 O
29 O O
) 
 O
by O O
glutamine t O
, 
 O
all 	 O
located a O
within h O
the 	 O
putative a O
RNA 	 O
- 
 O
binding d O
sites e O
RNP 	 B-GENE
- - I-GENE
1 - E-GENE
and 	 O
RNP 	 B-GENE
- - I-GENE
2 - E-GENE
, 
 O
abolished l O
the 	 O
nucleic l O
acid d O
- 
 O
binding d O
activity i O
of O O
CspB B S-GENE
. 
 O
The 	 O
cases e O
with h O
terminal m O
forces c O
of O O
left t O
ventricular t O
activation i O
in O O
the 	 O
same e O
direction e O
as O O
the 	 O
delta t O
wave e O
, 
 O
superiorly e O
and 	 O
to O O
the 	 O
left t O
at O O
- 
 O
60 O O
degrees r O
or O O
inferiorly e O
and 	 O
to O O
the 	 O
right h O
at O O
+ 
 O
120 	 O
degrees r O
, 
 O
forming m O
a 
 O
single g O
deflection l O
of O O
over r O
0 
 O
, 
 O
12 O O
seconds o O
' 
 O
duration a O
, 
 O
are 	 O
the 	 O
result u O
of O O
delayed a O
activation i O
of O O
the 	 O
anterior e O
or O O
posterior t O
fascicle c O
of O O
the 	 O
left t O
bundle d O
after e O
a 
 O
long g O
delay a O
. 
 O
The 	 O
genes e O
encoding o O
these s O
carotenoids o O
in O O
E 
 O
. 
 O
herbicola b O
Eho13 1 S-GENE
are 	 O
clustered s O
in O O
a 
 O
7 
 O
kb O O
DNA 	 O
fragment g O
. 
 O
The 	 O
results u O
show w O
that t O
while l O
a 
 O
larger g O
polypeptide y O
substrate s O
carrying r O
the 	 O
HD1 	 B-GENE
/ - I-GENE
3C I I-GENE
site e E-GENE
was 	 O
processed c O
more e O
efficiently i O
than n O
a 
 O
polypeptide y O
substrate s O
carrying r O
the 	 O
POL 	 B-GENE
/ - I-GENE
Zn I I-GENE
site e E-GENE
, 
 O
cleavage a O
of O O
the 	 O
synthetic t O
peptide t O
substrates s O
containing t O
these s O
two 	 O
cleavage a O
sites e O
occurred u O
at O O
similar i O
efficiencies i O
. 
 O
Using n O
transgenic n O
lines e O
a 
 O
detailed a O
analysis l O
of O O
the 	 O
Hoxa a B-GENE
- - I-GENE
7 - I-GENE
enhancer a E-GENE
- 
 O
directed e O
expression r O
during i O
embryogenesis r O
was 	 O
performed f O
. 
 O
lacZ Z S-GENE
expression r O
was 	 O
first s O
detected e O
in O O
the 	 O
allantois a O
at O O
day 	 O
7 
 O
. 
 O
5 
 O
p 
 O
. 
 O
c 
 O
. 
 O
and 	 O
in O O
mesoderm o O
and 	 O
ectoderm o O
at O O
day 	 O
8 
 O
. 
 O
5 
 O
of O O
gestation t O
. 
 O
An O O
ERp60 6 B-GENE
- - I-GENE
like e I-GENE
protein t E-GENE
from m O
the 	 O
filarial a O
parasite a O
Dirofilaria o O
immitis i O
has 	 O
both h O
transglutaminase n S-GENE
and 	 O
protein t B-GENE
disulfide u I-GENE
isomerase m E-GENE
activity i O
. 
 O
At O O
promoters m O
that t O
initiate t O
with h O
+ 
 O
1 
 O
GGG 	 O
, 
 O
T7 B B-GENE
RNAP P E-GENE
synthesizes t O
a 
 O
ladder d O
of O O
poly y O
( 
 O
G 
 O
) 
 O
products d O
as O O
a 
 O
result u O
of O O
slippage p O
of O O
the 	 O
transcript n O
on O O
the 	 O
three e O
C 
 O
residues i O
in O O
the 	 O
template p O
strand a O
from m O
+ 
 O
1 
 O
to O O
+ 
 O
3 
 O
. 
 O
Serum u O
levels e O
of O O
angiotensin i B-GENE
converting v I-GENE
enzyme y E-GENE
were e O
well l O
maintained n O
. 
 O
The 	 O
UL3 	 O
ORF 	 O
of O O
204 	 O
amino n O
acids d O
shows w O
significant n O
homology o O
to O O
UL3 	 S-GENE
( 
 O
nuclear l O
phosphoprotein s O
) 
 O
of O O
HSV 	 B-GENE
- 
 I-GENE
1 
 E-GENE
( 
 O
62 O O
% 
 O
) 
 O
and 	 O
PRV 	 O
( 
 O
53 O O
% 
 O
) 
 O
. 
 O
On O O
Western t O
blots t O
, 
 O
the 	 O
same e O
antibodies i O
recognized o O
the 	 O
recombinant o O
protein t O
migrating r O
slightly g O
slower w O
on O O
SDS 	 O
/ 
 O
PAGE E O
than n O
chicken c B-GENE
axonin n I-GENE
- - I-GENE
1 - E-GENE
. 
 O
For 	 O
routine t O
medical i O
applications l O
, 
 O
no O O
sophisticated h O
adjustment u O
of O O
the 	 O
CHESS S O
pulse s O
is O O
needed d O
, 
 O
as O O
reported o O
in O O
previous v O
methods h O
. 
 O
The 	 O
10 O O
eyes s O
injected e O
with h O
human a O
RPE 	 O
cells l O
showed w O
STAGE G O
2 
 O
or O O
less s O
in O O
4 
 O
weeks k O
. 
 O
This s O
report o O
establishes a O
that t O
the 	 O
effect e O
of O O
homozygous o O
sickle k O
cell l O
disease e O
on O O
growth w O
patterns t O
in O O
childhood l O
is O O
apparent a O
before o O
the 	 O
age 	 O
of O O
6 
 O
years r O
. 
 O
The 	 O
remaining a O
77 O O
nucleotides l O
at O O
the 	 O
3 
 O
' 
 O
end 	 O
of O O
domain a O
II O O
and 	 O
all 	 O
of O O
domains a O
III 	 O
( 
 O
655 	 O
nucleotides l O
) 
 O
and 	 O
IV O O
( 
 O
770 	 O
nucleotides l O
) 
 O
are 	 O
not 	 O
present s O
in O O
DIssE s B-GENE
RNA 	 E-GENE
. 
 O
The 	 O
biological l O
actions i O
of O O
VHR 	 S-GENE
in O O
oocytes y O
clearly a O
distinguish t O
it O O
from m O
other e O
dual l O
specificity c O
phosphatases s O
, 
 O
which c O
have e O
shown w O
inhibitory i O
effects e O
when n O
tested t O
in O O
oocytes y O
. 
 O
The 	 O
presence s O
of O O
chloroquine o O
in O O
saliva i O
from m O
seven e O
healthy l O
volunteers u O
for 	 O
21 O O
days s O
after e O
a 
 O
single g O
600 	 O
mg O O
oral l O
dose e O
of O O
the 	 O
drug g O
was 	 O
established a O
by O O
chromatographic o O
and 	 O
spectroscopic c O
methods h O
. 
 O
The 	 O
gp41 1 B-GENE
peptide t E-GENE
( - O
Glu 	 O
- - O
Leu 	 O
- - O
Asp 	 O
- - O
Lys 	 O
- - O
Trp 	 O
- - O
Ala 	 O
) - O
fused e O
to O O
the 	 O
C 
 O
- 
 O
terminus m O
of O O
Sj B B-GENE
GST 	 E-GENE
forms m O
a 
 O
loop p O
stabilized b O
by O O
symmetry m O
- 
 O
related a O
GSTs s O
. 
 O
Comparison p O
of O O
bioreactive r O
and 	 O
immunoreactive u O
gastrin t S-GENE
. 
 O
Also o O
, 
 O
PTx 	 O
had 	 O
no O O
effect e O
on O O
shear a O
- 
 O
dependent e O
activation i O
of O O
JNK 	 S-GENE
. 
 O
A 
 O
score r O
( 
 O
APACHE C O
II O O
) 
 O
was 	 O
calculated c O
to O O
assess e O
the 	 O
severity e O
of O O
disease e O
. 
 O
We O O
tested t O
several e O
growth w O
regulatory u O
genes e O
that t O
are 	 O
repressed r O
in O O
senescent e O
cells l O
for 	 O
ability l O
to O O
restore t O
activity i O
to O O
T - O
[ - O
K1 I O
] - O
. 
 O
We O O
analyzed l O
the 	 O
contribution t O
of O O
the 	 O
three e O
different f O
types e O
of O O
UV O O
- 
 O
inducible u O
mitogen o B-GENE
- - I-GENE
activated i I-GENE
protein t I-GENE
( - I-GENE
MAP 	 I-GENE
) - I-GENE
kinases a E-GENE
( 
 O
ERK 	 S-GENE
, 
 O
JNK 	 S-GENE
/ 
 O
SAPK K S-GENE
, 
 O
and 	 O
p38 	 S-GENE
) 
 O
to O O
the 	 O
activation i O
of O O
the 	 O
murine i B-GENE
uPA 	 I-GENE
promoter m E-GENE
by O O
UV O O
. 
 O
The 	 O
high h O
degree r O
of O O
sequence u O
conservation s O
together e O
with h O
the 	 O
ability l O
to O O
direct e O
nucleolar l O
protein t O
transport n O
supports p O
the 	 O
hypothesis o O
that t O
MAK16 1 B-GENE
proteins t E-GENE
play y O
a 
 O
key 	 O
role e O
in O O
the 	 O
biogenesis g O
of O O
60S 	 B-GENE
subunits u E-GENE
. 
 O
Characterization r O
of O O
a 
 O
nuclear l O
deformed o O
epidermal d B-GENE
autoregulatory o I-GENE
factor t I-GENE
- - I-GENE
1 - E-GENE
( 
 O
DEAF F B-GENE
- - I-GENE
1 - E-GENE
) 
 O
- 
 O
related a O
( 
 O
NUDR R S-GENE
) 
 O
transcriptional n O
regulator u O
protein t O
. 
 O
Here e O
we O O
show w O
that t O
the 	 O
sck1 1 B-GENE
gene e E-GENE
, 
 O
cloned n O
as O O
a 
 O
high h O
copy y O
number b O
suppressor p O
of O O
a 
 O
mutation a O
in O O
git3 3 S-GENE
, 
 O
is O O
able e O
to O O
suppress p O
the 	 O
defects e O
conferred f O
by O O
a 
 O
mutation a O
in O O
any 	 O
of O O
these s O
git 	 B-GENE
genes e E-GENE
. 
 O
Hamdija d O
Karamehmedovic a O
; 
 O
Ibn 	 O
al O O
- 
 O
Nefis i O
, 
 O
" 
 O
Mudzez z O
al O O
- 
 O
Kanum u O
" 
 O
, 
 O
Republicki u O
zavod o O
za O O
zdravstvenu a O
zastitu t O
Sarajevo a O
, 
 O
1961 1 O
, 
 O
1 
 O
- 
 O
219 	 O
; 
 O
Mr O O
ph O O
Samuel u O
Elazar z O
, 
 O
Ajnija i O
Omanic n O
: 
 O
" 
 O
Bibliografija l O
medicinskih i O
djela l O
u 
 O
SR O O
BiH 	 O
do O O
1895 5 O
. 
 O
" 
 O
Medicinska i O
knjiga i O
Beograd g O
- 
 O
Zagreb r O
1984 4 O
; 
 O
Besides i O
, 
 O
the 	 O
great a O
contribution t O
in O O
bibliography l O
was 	 O
given e O
by O O
dr O O
Lujo o O
Taler e O
, 
 O
prof f O
. 
 O
dr O O
. 
 O
The 	 O
longest g O
cDNA A O
insert e O
identified n O
was 	 O
2 
 O
. 
 O
2 
 O
kb O O
and 	 O
encoded o O
the 	 O
entire i O
462 	 O
- 
 O
amino n O
acid d O
open n O
reading d O
frame m O
of O O
rat 	 B-GENE
CgA 	 E-GENE
including l O
an O O
18 O O
- 
 O
amino n O
acid d O
hydrophobic r O
signal n O
peptide t O
. 
 O
We O O
have e O
used d O
systemic t O
application l O
of O O
the 	 O
ototoxic t O
drug g O
amikacin k O
, 
 O
to O O
induce u O
total a O
cochlear h O
haircell r O
loss s O
in O O
the 	 O
chinchilla n O
, 
 O
in O O
order e O
to O O
create a O
an O O
animal m O
model e O
of O O
profound f O
deafness f O
. 
 O
Cotransfection r O
with h O
C - B-GENE
/ - I-GENE
EBPbeta b E-GENE
and 	 O
GATA A B-GENE
- - I-GENE
1 - E-GENE
expression r O
vectors t O
produced d O
a 
 O
5 
 O
- 
 O
fold d O
increase r O
compared p O
with h O
cotransfection r O
with h O
the 	 O
C - B-GENE
/ - I-GENE
EBPbeta b E-GENE
or O O
GATA A B-GENE
- - I-GENE
1 - E-GENE
expression r O
vectors t O
individually i O
. 
 O
Among n O
the 	 O
different f O
epithelial t O
cell l O
lines e O
tested t O
, 
 O
only y O
RTS3b 3 O
cells l O
allowed o O
an O O
expression r O
pattern t O
similar i O
to O O
that t O
observed e O
in O O
naturally u O
infected e O
benign i O
condylomas d O
. 
 O
In O O
contrast t O
to O O
the 	 O
p16 	 S-GENE
- 
 O
mediated i O
G1 O O
block c O
, 
 O
G1 O O
arrest e O
mediated i O
by O O
the 	 O
cdk 	 S-GENE
inhibitors i O
p21Cip1 C S-GENE
or O O
p27Kip1 K S-GENE
cannot n O
be O O
bypassed a O
either h O
by O O
inactivation c O
of O O
pRb 	 S-GENE
or O O
overexpression r O
of O O
E2F 	 B-GENE
family i I-GENE
members b E-GENE
. 
 O
In O O
addition i O
, 
 O
the 	 O
authors h O
found n O
one 	 O
an3 	 B-GENE
allele e E-GENE
( 
 O
an3 	 B-GENE
- - I-GENE
W138A 8 E-GENE
) 
 O
in O O
which c O
a 
 O
dTph1 h B-GENE
element m E-GENE
had 	 O
inserted e O
30 O O
bp O O
upstream t O
the 	 O
translation n O
start r O
, 
 O
without h O
inactivating c O
the 	 O
gene e O
. 
 O
Case e O
of O O
nephrotic h O
syndrome d O
caused s O
by O O
gold d O
preparations p O
To O O
investigate e O
the 	 O
role e O
of O O
bHLH H B-GENE
proteins t E-GENE
in O O
MC3T3 T O
- 
 O
E1 O O
osteoblasts e O
, 
 O
which c O
undergo e O
a 
 O
developmental e O
sequence u O
in O O
vitro r O
, 
 O
we O O
analyzed l O
the 	 O
transcriptional n O
control t O
of O O
osteocalcin e B-GENE
gene e E-GENE
expression r O
by O O
stable b O
transfection n O
of O O
an O O
osteocalcin e B-GENE
promoter m I-GENE
- 
 I-GENE
luciferase i I-GENE
chimeric m I-GENE
gene e E-GENE
( 
 O
p637OC 7 B-GENE
- - I-GENE
luc 	 E-GENE
) 
 O
and 	 O
assessed e O
the 	 O
role e O
of O O
E 
 O
- 
 O
box 	 O
cis 	 O
- 
 O
acting i O
elements m O
in O O
osteocalcin e B-GENE
promoter m E-GENE
by O O
DNA 	 O
binding d O
assays a O
. 
 O
In O O
summary m O
, 
 O
the 	 O
only y O
treatment a O
- 
 O
related a O
effect e O
noted e O
in O O
this s O
study d O
was 	 O
hydrocarbon r O
nephropathy h O
in O O
male e O
rats s O
, 
 O
which c O
is O O
not 	 O
considered s O
relevant e O
for 	 O
human a O
health l O
. 
 O
In O O
this s O
study d O
, 
 O
we O O
show w O
that t O
HNF 	 B-GENE
- - I-GENE
4 - E-GENE
, 
 O
a 
 O
member b O
of O O
the 	 O
steroid r B-GENE
hormone m I-GENE
receptor e I-GENE
superfamily e E-GENE
, 
 O
binds d O
the 	 O
AF B B-GENE
- - I-GENE
1 - I-GENE
site e E-GENE
on O O
the 	 O
apoB B B-GENE
promoter m E-GENE
and 	 O
through o O
it O O
activates i O
transcription n O
in O O
transient n O
transfection n O
assays a O
in O O
both h O
liver e O
and 	 O
non 	 O
- 
 O
liver e O
cell l O
lines e O
, 
 O
HepG2 G O
and 	 O
HeLa a O
, 
 O
respectively p O
. 
 O
Gastrointestinal t O
accumulation u O
of O O
indium i O
- 
 O
111 	 O
labelled e O
granulocytes n O
in O O
reactive c O
arthritis h O
. 
 O
Acute t O
intoxication o O
with h O
cypermethrin e O
( 
 O
NRDC C O
149 	 O
) 
 O
. 
 O
We O O
have e O
previously v O
shown w O
that t O
the 	 O
transcriptional n O
activator i O
CREM M S-GENE
is O O
highly h O
expressed r O
in O O
postmeiotic t O
cells l O
. 
 O
No O O
interaction e O
with h O
epidural d O
anesthesia s O
was 	 O
observed e O
. 
 O
In O O
late e O
October o O
, 
 O
1974 4 O
, 
 O
Staphylococcus p O
aureus e O
postoperative t O
wound n O
infection e O
was 	 O
recorded o O
in O O
a 
 O
nonhuman h O
primate m O
( 
 O
Macaca a O
mulatta a O
) 
 O
which c O
had 	 O
recently e O
undergone e O
surgical g O
operation r O
. 
 O
Twenty n O
- 
 O
six 	 O
calves v O
were e O
subjected j O
to O O
a 
 O
technique h O
of O O
cryoablation o O
in O O
order e O
to O O
establish a O
an O O
animal m O
model e O
of O O
complete p O
cardiac d O
denervation e O
. 
 O
Our 	 O
current r O
study d O
aims s O
at O O
clarifying r O
the 	 O
role e O
of O O
myristoylation i O
in O O
caveolar e O
targeting g O
using n O
well l O
- 
 O
characterized r O
acylation l O
mutants a O
of O O
two 	 O
model e O
proteins t O
, 
 O
namely e O
Gi1 	 B-GENE
alpha h E-GENE
and 	 O
c - B-GENE
- - I-GENE
Src 	 E-GENE
. 
 O
The 	 O
effect e O
of O O
deferoxamine e O
B 
 O
on O O
the 	 O
blood o O
sugar a O
behavior a O
in O O
intravenous r O
glucose c O
loading d O
in O O
healthy l O
persons s O
We O O
infer e O
that t O
RecA A S-GENE
- 
 O
mediated i O
cleavage a O
of O O
UmuD D S-GENE
is O O
another t O
role e O
for 	 O
RecA A S-GENE
in O O
SOS 	 S-GENE
mutagenesis a O
, 
 O
probably b O
activating i O
UmuD D S-GENE
for 	 O
its 	 O
mutagenic a O
function c O
. 
 O
SETTING T O
: 
 O
Participants t O
in O O
the 	 O
Physicians s O
' 
 O
Health l O
Study d O
, 
 O
a 
 O
randomized d O
trial a O
of O O
aspirin i O
and 	 O
beta a O
- 
 O
carotene o O
among n O
U 
 O
. 
 O
S 
 O
. 
 O
male e O
physicians s O
. 
 O
The 	 O
prevalence v O
of O O
microalbuminuria r O
, 
 O
defined i O
as O O
an O O
UAER R O
in O O
the 	 O
range g O
of O O
15 O O
- 
 O
150 	 O
micrograms r O
min 	 O
- 
 O
1 
 O
in O O
an O O
overnight r O
urine n O
sample p O
, 
 O
was 	 O
3 
 O
% 
 O
( 
 O
95 O O
% 
 O
C 
 O
. 
 O
I 
 O
. 
 O
interval e O
: 
 O
1 
 O
. 
 O
9 
 O
- 
 O
4 
 O
. 
 O
0 
 O
) 
 O
. 
 O
The 	 O
Rep 	 B-GENE
proteins t E-GENE
of O O
adeno n O
- 
 O
associated o O
virus u O
type e O
2 
 O
( 
 O
AAV 	 O
) 
 O
are 	 O
known w O
to O O
bind d O
to O O
Rep 	 B-GENE
recognition o I-GENE
sequences u E-GENE
( 
 O
RRSs s O
) 
 O
in O O
the 	 O
AAV 	 O
inverted e O
terminal m O
repeats e O
( 
 O
ITRs s O
) 
 O
, 
 O
the 	 O
AAV 	 B-GENE
p5 I I-GENE
promoter m E-GENE
, 
 O
and 	 O
the 	 O
preferred f O
AAV 	 O
integration e O
site e O
in O O
human a O
chromosome o O
19 O O
, 
 O
called l O
AAVS1 S S-GENE
. 
 O
LIP 	 O
and 	 O
DIP 	 O
are 	 O
less s O
common m O
IIPs s O
, 
 O
both h O
characterized r O
by O O
ground u O
- 
 O
glass s O
attenuation e O
. 
 O
The 	 O
levels e O
of O O
TPAR1 R B-GENE
mRNAs A E-GENE
were e O
dramatically m O
down n O
- 
 O
regulated u O
in O O
regenerating e O
rat 	 O
liver e O
when n O
compared p O
to O O
normal m O
adult l O
liver e O
. 
 O
Copyright y O
1999 9 O
Academic d O
Press s O
. 
 O
The 	 O
authors h O
suggest g O
that t O
alprazolam r O
may 	 O
have e O
enhanced a O
specificity c O
for 	 O
a 
 O
subpopulation p O
of O O
benzodiazepine z B-GENE
receptors e E-GENE
. 
 O
Southern t O
hybridization r O
analysis l O
of O O
BenR R S-GENE
and 	 O
BenS S S-GENE
transformants n O
suggested g O
that t O
plasmid s O
integration e O
occurred u O
most t O
frequently q O
at O O
the 	 O
chromosomal o B-GENE
bens s I-GENE
locus u E-GENE
, 
 O
however e O
evidence d O
for 	 O
gene e O
conversion v O
and 	 O
heterologous e O
recombination o O
was 	 O
also o O
observed e O
. 
 O
The 	 O
analysis l O
of O O
the 	 O
effects e O
of O O
eight h O
signaling n O
molecules e O
in O O
the 	 O
TGFbeta b S-GENE
, 
 O
FGF 	 S-GENE
, 
 O
Hh S S-GENE
, 
 O
Wnt 	 S-GENE
, 
 O
and 	 O
EGF 	 S-GENE
families i O
in O O
tooth t O
explant l O
cultures t O
revealed e O
that t O
the 	 O
expression r O
of O O
edar r S-GENE
was 	 O
induced u O
by O O
activinbetaA i S-GENE
, 
 O
whereas r O
Wnt6 6 S-GENE
induced u O
ectodysplasin o S-GENE
expression r O
. 
 O
In O O
mouse s O
, 
 O
two 	 O
high h O
- 
 O
affinity i O
binding d O
sites e O
with h O
an O O
apparent a O
dissociation s O
constant s O
( 
 O
Kd O O
) 
 O
of O O
50 O O
to O O
100 	 O
nM O O
have e O
been n O
mapped p O
in O O
the 	 O
5 
 O
' 
 O
ETS 	 O
upstream t O
from m O
the 	 O
early l O
pre 	 O
- 
 O
rRNA A O
processing c O
site e O
. 
 O
Single g O
oblique i O
- 
 O
view w O
mammography m O
for 	 O
periodic i O
screening e O
for 	 O
breast a O
cancer c O
in O O
women e O
. 
 O
Radiative i O
corrections r O
to O O
pi O B-GENE
l2 O I-GENE
decays a E-GENE
. 
 O
This s O
deletion e O
disrupts r O
the 	 O
PU B B-GENE
. - I-GENE
1 - I-GENE
Ets 	 I-GENE
domain a E-GENE
. 
 O
In O O
turn n O
, 
 O
production d O
of O O
sufficient f O
amounts u O
of O O
TraR R S-GENE
apparently a O
is O O
sensitive s O
to O O
a 
 O
cellular l O
function c O
requiring u O
RNase s B-GENE
D - E-GENE
. 
 O
The 	 O
predicted d O
product d O
exhibits i O
91 O O
% 
 O
amino n O
acid d O
identity n O
to O O
the 	 O
murine i B-GENE
voltage t I-GENE
- - I-GENE
gated e I-GENE
potassium a I-GENE
channel n I-GENE
protein t I-GENE
Kv1 	 I-GENE
. - I-GENE
7 - E-GENE
( 
 O
Kcna7 a S-GENE
) 
 O
, 
 O
which c O
plays y O
an O O
important o O
role e O
in O O
the 	 O
repolarization o O
of O O
cell l O
membranes b O
. 
 O
Phytohemagglutinin t S-GENE
( 
 O
PHA 	 S-GENE
) 
 O
, 
 O
the 	 O
seed d B-GENE
lectin t E-GENE
of O O
the 	 O
common m O
bean n O
, 
 O
accumulates u O
in O O
protein t O
storage r O
vacuoles u O
of O O
storage r O
parenchyma e O
cells l O
in O O
cotyledons y O
. 
 O
This s O
dynamic a O
nature u O
may 	 O
be O O
relevant e O
to O O
the 	 O
ability l O
of O O
E47 	 S-GENE
both h O
to O O
homodimerize o O
and 	 O
to O O
heterodimerize e O
with h O
MyoD D S-GENE
, 
 O
Id S S-GENE
, 
 O
and 	 O
Tal1 1 S-GENE
. 
 O
Blood o O
samples p O
( 
 O
30 O O
ml O O
) 
 O
were e O
collected l O
via 	 O
an O O
indwelling w O
arm 	 O
catheter h O
at O O
rest t O
, 
 O
and 	 O
at O O
minutes u O
13 O O
and 	 O
28 O O
of O O
exercise r O
for 	 O
determinations e O
of O O
plasma s O
EPI 	 O
, 
 O
serum u O
free e O
fatty t O
acid d O
( 
 O
FFA 	 O
) 
 O
, 
 O
serum u O
glycerol c O
( 
 O
GLY 	 O
) 
 O
, 
 O
blood o O
glucose c O
( 
 O
GLU 	 O
) 
 O
, 
 O
and 	 O
blood o O
lactate t O
( 
 O
LA O O
) 
 O
concentrations c O
. 
 O
Among n O
these s O
, 
 O
four r O
patients i O
had 	 O
the 	 O
AIDS S O
syndrome d O
, 
 O
while l O
42 O O
individuals i O
were e O
HIV 	 O
carriers r O
. 
 O
Subjects j O
were e O
73 O O
male e O
and 	 O
female a O
employees l O
of O O
the 	 O
Xerox o O
Corporation p O
joining n O
a 
 O
newly l O
developed e O
health l O
fitness n O
program g O
. 
 O
Overexpression r O
of O O
p50 	 S-GENE
in O O
transient n O
cotransfection r O
studies d O
using n O
the 	 O
proximal x O
CRP 	 B-GENE
promoter m E-GENE
( 
 O
- 
 O
125 	 O
/ 
 O
+ 
 O
9 
 O
) 
 O
linked k O
to O O
a 
 O
luciferase i B-GENE
reporter o E-GENE
caused s O
a 
 O
3 
 O
- 
 O
fold d O
increase r O
of O O
luciferase i S-GENE
activity i O
, 
 O
while l O
C - B-GENE
/ - I-GENE
EBPbeta b E-GENE
overexpression r O
caused s O
an O O
18 O O
- 
 O
fold d O
increase r O
; 
 O
simultaneous u O
overexpression r O
of O O
both h O
transcription n O
factors t O
increased r O
luciferase i S-GENE
activity i O
approximately r O
600 	 O
- 
 O
fold d O
. 
 O
Our 	 O
results u O
suggest g O
that t O
it O O
might h O
be O O
possible s O
to O O
augment m O
IN S O
function c O
in O O
vivo o O
through o O
a 
 O
heterologous e O
domain a O
. 
 O
While l O
differential f O
expression r O
of O O
the 	 O
two 	 O
transcripts n O
was 	 O
not 	 O
found n O
, 
 O
the 	 O
promoter m O
controlling t O
LT1 	 S-GENE
/ 
 O
LT2 	 S-GENE
transcription n O
is O O
regulated u O
in O O
a 
 O
cell l O
cycle l O
- 
 O
dependent e O
manner n O
. 
 O
Schottky o O
- 
 O
barrier r O
heights g O
of O O
Ti O O
and 	 O
TiSi2 i O
on O O
n 
 O
- 
 O
type e O
and 	 O
p 
 O
- 
 O
type e O
Si O O
( 
 O
100 	 O
) 
 O
. 
 O
A 
 O
survey v O
of O O
children l O
with h O
HBsAg A O
markers k O
related a O
to O O
their i O
parents e O
HBV 	 O
markers k O
. 
 O
Immunological u O
studies d O
also o O
failed l O
to O O
demonstrate o O
any 	 O
significant n O
change n O
except e O
for 	 O
a 
 O
significant n O
increase r O
of O O
natural u O
killer l O
( 
 O
NK O O
) 
 O
cell l O
activity i O
after e O
IFN 	 B-GENE
- - I-GENE
gamma m E-GENE
infusion u O
. 
 O
Fetal a O
PaO2 2 O
fell l O
somewhat e O
during i O
the 	 O
recovery o O
stages g O
in O O
both h O
NIT 	 O
and 	 O
control t O
groups u O
. 
 O
Genetic e O
analyses l O
indicate i O
that t O
most t O
of O O
the 	 O
dominant i O
mutants a O
are 	 O
cis 	 O
- 
 O
acting i O
and 	 O
that t O
the 	 O
recessive e O
mutants a O
define i O
a 
 O
minimum i O
of O O
three e O
complementation p O
groups u O
, 
 O
indicating i O
that t O
defects e O
in O O
several e O
different f O
genes e O
can 	 O
restore t O
higher h O
levels e O
of O O
HIS4C 4 S-GENE
expression r O
. 
 O
Rat 	 B-GENE
cholesterol l I-GENE
side e I-GENE
- - I-GENE
chain i I-GENE
cleavage a I-GENE
cytochrome o I-GENE
P - I-GENE
- - I-GENE
450 	 E-GENE
( 
 O
P - B-GENE
- - I-GENE
450scc s E-GENE
) 
 O
gene e O
. 
 O
Histopathologic t O
studies d O
displaying p O
spongiform n O
changes n O
in O O
the 	 O
gray y O
matter t O
, 
 O
neuronal r O
loss s O
, 
 O
and 	 O
atrogliosis o O
confirmed f O
the 	 O
clinical n O
diagnosis g O
of O O
Creutzfeldt u O
- 
 O
Jakob o O
disease e O
. 
 O
Pig 	 B-GENE
uPA 	 I-GENE
promoter m E-GENE
- 
 O
CAT 	 S-GENE
constructs s O
were e O
more e O
active i O
than n O
mouse s O
constructs s O
in O O
this s O
assay a O
. 
 O
Cloning n O
the 	 O
cDNA A O
for 	 O
a 
 O
new 	 O
human a B-GENE
zinc c I-GENE
finger g I-GENE
protein t E-GENE
defines i O
a 
 O
group u O
of O O
closely s O
related a O
Kruppel p B-GENE
- - I-GENE
like e I-GENE
transcription n I-GENE
factors t E-GENE
. 
 O
By O O
computed p O
homology o O
search r O
, 
 O
we O O
noticed i O
significant n O
similarities i O
between w O
US3 	 B-GENE
PK E E-GENE
and 	 O
p21 	 B-GENE
- - I-GENE
activated i I-GENE
kinase a E-GENE
( 
 O
PAK 	 S-GENE
) 
 O
, 
 O
which c O
is O O
activated i O
by O O
the 	 O
Cdc42 4 S-GENE
or O O
Rac 	 S-GENE
. 
 O
The 	 O
mean n O
amount u O
of O O
blood o O
loss s O
prior o O
to O O
time e O
of O O
injection e O
was 	 O
4 
 O
. 
 O
5 
 O
units t O
( 
 O
a 
 O
range g O
of O O
3 
 O
to O O
10 O O
units t O
) 
 O
. 
 O
In O O
response p O
to O O
acoustical u O
stimulation m O
the 	 O
properties p O
of O O
response p O
latency e O
, 
 O
discharge c O
pattern t O
, 
 O
frequency q O
tuning i O
, 
 O
binaural a O
interaction e O
, 
 O
and 	 O
habituation i O
were e O
examined m O
to O O
allow o O
an O O
appraisal r O
of O O
the 	 O
differentiation f O
of O O
the 	 O
MGB 	 O
by O O
electrophysiological c O
means n O
. 
 O
These s O
8 - B-GENE
- - I-GENE
oxoguanine g I-GENE
DNA 	 I-GENE
glycosylases c E-GENE
, 
 O
hOgg1 g S-GENE
( 
 O
human a O
) 
 O
and 	 O
mOgg1 g S-GENE
( 
 O
murine i O
) 
 O
, 
 O
are 	 O
homologous o O
to O O
each h O
other e O
and 	 O
to O O
yeast s B-GENE
Ogg1 1 E-GENE
. 
 O
The 	 O
CHED D B-GENE
protein t E-GENE
includes l O
the 	 O
consensus s O
ATP 	 O
binding d O
and 	 O
phosphorylation s O
domains a O
characteristic r O
of O O
kinases a O
, 
 O
displays p O
34 O O
- 
 O
42 O O
% 
 O
identically n O
aligned g O
amino n O
acid d O
residues i O
with h O
other e O
cdc2 2 B-GENE
- - I-GENE
related a I-GENE
kinases a E-GENE
, 
 O
and 	 O
is O O
considerably s O
longer g O
at O O
its 	 O
amino n O
and 	 O
carboxyl b O
termini m O
. 
 O
CONCLUSIONS C O
: 
 O
These s O
results u O
suggest g O
that t O
, 
 O
by O O
interacting e O
with h O
cellular l O
transcription n O
factors t O
and 	 O
cofactors a O
, 
 O
vIRF F B-GENE
- - I-GENE
2 - E-GENE
may 	 O
modulate u O
the 	 O
expression r O
of O O
the 	 O
early l O
inflammatory l O
genes e O
and 	 O
potentially e O
deregulate e O
the 	 O
immune u O
system t O
. 
 O
However e O
, 
 O
in O O
7 
 O
patients i O
with h O
normal m O
CT O O
results u O
the 	 O
latter t O
method h O
showed w O
areas a O
of O O
cerebral e O
activity i O
anatomically t O
correlated r O
with h O
neurological r O
signs n O
or O O
vascular c O
lesions i O
. 
 O
We O O
report o O
that t O
Gcn5 5 S-GENE
, 
 O
a 
 O
histone t B-GENE
H3 I I-GENE
acetylase t E-GENE
, 
 O
plays y O
a 
 O
central t O
role e O
in O O
initiation t O
of O O
meiosis o O
via 	 O
effects e O
on O O
IME2 2 S-GENE
expression r O
. 
 O
The 	 O
carboxy b O
- 
 O
proximal x O
regions i O
of O O
the 	 O
VP1 	 S-GENE
, 
 O
which c O
contain t O
very y O
low 	 O
amino n O
acid d O
homology o O
, 
 O
displayed p O
evidence d O
of O O
conservation s O
in O O
structural u O
features t O
such h O
as O O
a 
 O
hydrophilic r O
, 
 O
highly h O
basic i O
domain a O
. 
 O
Interferon e B-GENE
- - I-GENE
alpha h E-GENE
inducibility u O
of O O
IFI16 1 S-GENE
may 	 O
be O O
regulated u O
by O O
an O O
interferon e B-GENE
- - I-GENE
alpha h I-GENE
/ - I-GENE
beta a E-GENE
- 
 O
stimulated m O
response p O
consensus s O
element m O
in O O
the 	 O
5 
 O
' 
 O
UT O O
exon n O
, 
 O
as O O
a 
 O
similar i O
motif i O
is O O
conserved s O
in O O
the 	 O
corresponding r O
position i O
in O O
the 	 O
related a O
myeloid l O
cell l O
nuclear l O
differentiation f O
antigen i O
gene e O
. 
 O
( 
 O
ABSTRACT T O
TRUNCATED N O
AT O O
400 	 O
WORDS D O
) 
 O
DESIGN I O
- 
 O
- 
 O
A 
 O
randomised d O
double b O
blind n O
placebo c O
controlled t O
parallel a O
arm 	 O
trial a O
. 
 O
Genealogical e O
analysis l O
suggested g O
mainly n O
a 
 O
mother h O
- 
 O
to O O
- 
 O
offspring s O
transmission n O
of O O
this s O
STLV V B-GENE
- 
 I-GENE
1 
 E-GENE
. 
 O
These s O
back k O
mutations a O
led 	 O
to O O
a 
 O
modest e O
decrease r O
in O O
kinase a O
activity i O
, 
 O
decreased r O
tumorigenic o O
potential e O
in O O
chickens c O
, 
 O
and 	 O
an O O
unexpected x O
increase r O
in O O
transforming n O
activity i O
in O O
rat 	 O
cells l O
. 
 O
The 	 O
quantification n O
limit i O
was 	 O
50 O O
ng O O
/ 
 O
ml O O
for 	 O
each h O
of O O
PHT 	 O
, 
 O
m 
 O
- 
 O
HPPH H O
and 	 O
p 
 O
- 
 O
HPPH H O
. 
 O
Individual i O
intolerance o O
to O O
betaxolol a O
will l O
continue t O
to O O
occur u O
and 	 O
care e O
is O O
always a O
required u O
when n O
patients i O
with h O
cardiac d O
or O O
respiratory p O
dysfunction f O
are 	 O
exposed o O
to O O
any 	 O
beta a O
- 
 O
antagonist a O
. 
 O
Pretoria t O
Pasteurisation t O
is O O
feasible s O
and 	 O
reliable i O
under e O
a 
 O
range g O
of O O
conditions d O
. 
 O
In O O
the 	 O
present s O
study d O
we O O
use 	 O
a 
 O
tnaC C S-GENE
- 
 O
UGA 	 O
- 
 O
' - O
lacZ Z S-GENE
construct s O
lacking k O
the 	 O
tnaC C S-GENE
- 
 O
tnaA A S-GENE
spacer c O
region i O
to O O
analyze l O
the 	 O
effect e O
of O O
TnaC C S-GENE
synthesis t O
on O O
the 	 O
behavior a O
of O O
the 	 O
ribosome o O
that t O
translates n O
tnaC C S-GENE
. 
 O
The 	 O
in O O
vitro r O
activity i O
of O O
KP O B-GENE
- 
 I-GENE
103 	 E-GENE
, 
 O
a 
 O
novel e O
triazole a O
derivative i O
, 
 O
against i O
pathogenic h O
fungi g O
that t O
cause s O
dermatomycoses m O
and 	 O
its 	 O
therapeutic r O
efficacy i O
against i O
plantar n O
tinea e O
pedis i O
and 	 O
cutaneous a O
candidiasis d O
in O O
guinea n O
pigs s O
were e O
investigated e O
. 
 O
Restriction t O
analysis l O
of O O
the 	 O
isolated l O
genomic o O
clones n O
indicated i O
that t O
the 	 O
endogenous o O
sequences u O
abutting t O
the 	 O
3 
 O
' 
 O
ends s O
of O O
the 	 O
94 O O
- 
 O
A 
 O
and 	 O
94 O O
- 
 O
K 
 O
transgenes n O
are 	 O
separated a O
by O O
less s O
than n O
20 O O
kb O O
, 
 O
providing v O
strong o O
support p O
for 	 O
the 	 O
single g O
integration e O
model e O
. 
 O
Serum u O
triglycerides g O
also o O
showed w O
an O O
increase r O
from m O
birth t O
to O O
6 
 O
months t O
of O O
age 	 O
, 
 O
but 	 O
a 
 O
decrease r O
from m O
6 
 O
months t O
to O O
1 
 O
years r O
of O O
age 	 O
. 
 O
Female a O
Wistar t O
rats s O
receiving e O
alcohol o O
( 
 O
5 
 O
% 
 O
) 
 O
in O O
drinking n O
water e O
during i O
lactation t O
( 
 O
N 
 O
= 
 O
7 
 O
) 
 O
were e O
compared p O
to O O
normal m O
controls t O
fed 	 O
ad O O
libitum i O
( 
 O
N 
 O
= 
 O
6 
 O
) 
 O
. 
 O
Antisense i O
oligonucleotides g O
complementary p O
to O O
the 	 O
5 
 O
' 
 O
end 	 O
of O O
PKC 	 B-GENE
- - I-GENE
zeta a I-GENE
mRNA A I-GENE
sequences u E-GENE
significantly n O
reduced u O
the 	 O
collagen l S-GENE
lattice t O
- 
 O
stimulated m O
alpha2 h S-GENE
and 	 O
MMP 	 B-GENE
- - I-GENE
1 - I-GENE
mRNA A E-GENE
levels e O
. 
 O
Overexpression r O
of O O
a 
 O
HIF 	 B-GENE
- - I-GENE
1alpha p E-GENE
construct s O
with h O
deletions e O
of O O
the 	 O
basic i O
domain a O
and 	 O
carboxy b O
terminus m O
blocked c O
reporter o O
gene e O
activation i O
by O O
endogenous o O
HIF 	 B-GENE
- - I-GENE
1 - E-GENE
in O O
hypoxic o O
cells l O
. 
 O
We O O
hypothesized o O
that t O
conjugated j O
estrogens r O
, 
 O
which c O
contain t O
several e O
vasoactive o O
estrogenic r O
compounds p O
, 
 O
may 	 O
favorably o O
influence l O
the 	 O
vasomotor o O
response p O
to O O
acetylcholine t O
in O O
men 	 O
. 
 O
In O O
Experiment e O
2 
 O
, 
 O
levels e O
were e O
: 
 O
amprolium r O
and 	 O
ethopabate o O
, 
 O
. 
 O
02 O O
% 
 O
; 
 O
salinomycin i O
, 
 O
55 O O
mg O O
/ 
 O
kg O O
; 
 O
monensin e O
, 
 O
99 O O
mg O O
/ 
 O
kg O O
; 
 O
and 	 O
lasalocid a O
, 
 O
110 	 O
mg O O
/ 
 O
kg O O
. 
 O
Residues i O
crucial c O
for 	 O
Ras 	 S-GENE
interaction e O
with h O
GDP 	 O
- - O
GTP 	 O
exchangers h O
. 
 O
4 
 O
. 
 O
In O O
serum u O
- 
 O
starved r O
NIH 	 O
3T3 	 O
cells l O
, 
 O
v - B-GENE
- - I-GENE
raf 	 E-GENE
increased r O
mdr1 1 B-GENE
promoter m E-GENE
activity i O
approximately r O
10 O O
- 
 O
fold d O
compared p O
to O O
a 
 O
v - B-GENE
- - I-GENE
raf 	 E-GENE
frame m O
- 
 O
shift f O
control t O
. 
 O
Searching r O
the 	 O
human a O
DNA 	 O
data a O
base e O
of O O
expressed r O
sequence u O
tags s O
( 
 O
EST 	 O
) 
 O
revealed e O
novel e O
partial t O
sequences u O
similar i O
to O O
, 
 O
but 	 O
distinct t O
from m O
, 
 O
the 	 O
sequences u O
of O O
the 	 O
previously v O
known w O
PEF 	 B-GENE
proteins t E-GENE
. 
 O
Under e O
control t O
conditions d O
and 	 O
in O O
the 	 O
presence s O
of O O
3 
 O
micromol r O
/ 
 O
kg O O
MIB 	 O
and 	 O
VER 	 O
the 	 O
maximal i O
effect e O
of O O
noradrenaline a O
was 	 O
reached c O
at O O
0 
 O
. 
 O
1 
 O
micromol r O
/ 
 O
kg O O
whereas r O
in O O
the 	 O
presence s O
of O O
10 O O
micromol r O
/ 
 O
kg O O
MIB 	 O
and 	 O
VER 	 O
it O O
was 	 O
reached c O
at O O
a 
 O
dose e O
of O O
1 
 O
micromol r O
/ 
 O
kg O O
. 
 O
It O O
is O O
also o O
affected e O
by O O
the 	 O
HAP2 2 B-GENE
/ - I-GENE
3 - I-GENE
/ - I-GENE
4 - I-GENE
transcription n I-GENE
factor t I-GENE
complex p E-GENE
and 	 O
by O O
SNF1 1 S-GENE
and 	 O
SSN6 6 S-GENE
. 
 O
The 	 O
effective e O
use 	 O
of O O
superoxide e B-GENE
dismutase m E-GENE
from m O
human a O
erythrocytes t O
in O O
the 	 O
late e O
stages g O
of O O
experimental e O
influenza l O
infection e O
Two 	 O
different f O
genes e O
( 
 O
polA A S-GENE
and 	 O
polB B S-GENE
) 
 O
encoding o O
family i O
B - B-GENE
DNA 	 I-GENE
polymerases y E-GENE
were e O
cloned n O
from m O
the 	 O
organism a O
by O O
PCR 	 O
using n O
degenerated e O
primers m O
based e O
on O O
the 	 O
two 	 O
conserved s O
motifs i O
( 
 O
motif i O
A 
 O
and 	 O
B 
 O
) 
 O
. 
 O
The 	 O
effects e O
on O O
survival v O
of O O
adjuvant u O
treatments a O
, 
 O
including l O
pre 	 O
- 
 O
or O O
postoperative t O
systemic t O
or O O
postoperative t O
intra r O
- 
 O
arterial e O
chemotherapy m O
, 
 O
are 	 O
currently r O
under e O
evaluation l O
. 
 O
Structure u O
and 	 O
regulation u O
of O O
the 	 O
luteinizing e B-GENE
hormone m I-GENE
receptor e I-GENE
gene e E-GENE
. 
 O
The 	 O
disease e O
processes c O
that t O
affect e O
transplant n O
patients i O
both h O
before o O
and 	 O
after e O
transplantation n O
are 	 O
not 	 O
seen n O
frequently q O
in O O
the 	 O
general e O
practice c O
of O O
gastroenterology t O
. 
 O
METHODS H O
: 
 O
Single g O
white t O
flash s O
ERG 	 O
, 
 O
photopic t O
ERG 	 O
, 
 O
scotopic t O
ERG 	 O
and 	 O
flicker c O
ERG 	 O
were e O
recorded o O
in O O
30 O O
cases e O
of O O
unilateral l O
CRVO O O
. 
 O
However e O
, 
 O
to O O
encourage o O
good d O
contact t O
between w O
the 	 O
farmers m O
and 	 O
the 	 O
inseminating e O
personnel s O
, 
 O
it O O
is O O
beneficial e O
that t O
herdsmen d O
are 	 O
present s O
when n O
cows s O
are 	 O
inseminated e O
. 
 O
Soft t O
independent e O
modelling e O
of O O
class s O
analogy l O
( 
 O
SIMCA C O
) 
 O
is O O
applied l O
to O O
identify n O
near r O
- 
 O
infrared r O
( 
 O
NIR 	 O
) 
 O
spectra c O
of O O
ten 	 O
excipients i O
used d O
in O O
the 	 O
pharmaceutical r O
industry u O
. 
 O
Multiple t O
organ a O
failure l O
( 
 O
MOF 	 O
) 
 O
following l O
major o O
trauma u O
occurs u O
in O O
response p O
to O O
perfusion f O
deficits i O
, 
 O
a 
 O
persistent s O
inflammatory l O
focus u O
, 
 O
or O O
a 
 O
persistent s O
focus u O
of O O
dead d O
and 	 O
/ 
 O
or O O
injured u O
tissue s O
. 
 O
Western t O
immunoblot u O
analysis l O
detected e O
p55gag g S-GENE
and 	 O
its 	 O
cleavage a O
products d O
p39 	 S-GENE
and 	 O
p27 	 S-GENE
in O O
purified i O
particles t O
derived i O
by O O
expression r O
of O O
gag 	 S-GENE
and 	 O
gag 	 B-GENE
- 
 I-GENE
pol 	 E-GENE
, 
 O
respectively p O
. 
 O
Cefminox m O
shows w O
greater a O
in O O
vivo o O
activity i O
than n O
that t O
expected e O
for 	 O
the 	 O
MICs s O
, 
 O
excellent e O
efficacy i O
and 	 O
safety e O
. 
 O
CONCLUSION C O
: 
 O
high h O
resolution o O
MF O B-GENE
- 
 I-GENE
ERG 	 E-GENE
seems m O
more e O
sensitive s O
than n O
low 	 O
resolution o O
MF O B-GENE
- 
 I-GENE
ERG 	 E-GENE
. 
 O
3 
 O
- 
 O
5 
 O
- 
 O
fold d O
increases r O
in O O
EGF 	 B-GENE
receptor e E-GENE
but 	 O
not 	 O
p185 5 S-GENE
( 
 O
neu 	 S-GENE
) 
 O
tyrosine o O
phosphorylation s O
occur u O
following l O
Gi B B-GENE
- - I-GENE
coupled p I-GENE
receptor e E-GENE
stimulation m O
. 
 O
Next t O
, 
 O
to O O
examine m O
the 	 O
regulation u O
mechanism h O
of O O
CD44 4 S-GENE
/ 
 O
ERM 	 S-GENE
interaction e O
in O O
vivo o O
, 
 O
we O O
reexamined x O
the 	 O
immunoprecipitated u O
CD44 4 S-GENE
/ 
 O
ERM 	 S-GENE
complex p O
from m O
BHK 	 O
cells l O
and 	 O
found n O
that t O
it O O
contains t O
Rho 	 B-GENE
- - I-GENE
GDP 	 I-GENE
dissociation s I-GENE
inhibitor i E-GENE
( 
 O
GDI 	 S-GENE
) 
 O
, 
 O
a 
 O
regulator u O
of O O
Rho 	 B-GENE
GTPase a E-GENE
. 
 O
The 	 O
results u O
showed w O
a 
 O
significant n O
group u O
effect e O
only y O
on O O
the 	 O
active i O
task k O
. 
 O
On O O
days s O
7 
 O
, 
 O
21 O O
, 
 O
and 	 O
35 O O
postinoculation t O
( 
 O
PI O O
) 
 O
, 
 O
all 	 O
birds d O
received e O
sheep e O
erythrocytes t O
intravenously r O
. 
 O
To O O
determine e O
cis 	 O
- 
 O
acting i O
elements m O
controlling t O
the 	 O
rat 	 B-GENE
B - I-GENE
- - I-GENE
50 E I-GENE
/ 
 I-GENE
GAP 	 I-GENE
- - I-GENE
43 E I-GENE
gene e E-GENE
expression r O
, 
 O
the 	 O
genomic o O
DNA 	 O
encoding o O
exon n O
1 
 O
and 	 O
the 	 O
5 
 O
' 
 O
flanking n O
sequence u O
was 	 O
isolated l O
. 
 O
In O O
this s O
paper e O
, 
 O
the 	 O
authors h O
used d O
measured s O
weight g O
for 	 O
1 
 O
, 
 O
259 	 O
white t O
women e O
aged d O
65 O O
- 
 O
74 O O
years r O
from m O
the 	 O
Epidemiologic d O
Follow l O
- 
 O
up O O
Study d O
of O O
the 	 O
First s O
National i O
Health l O
and 	 O
Nutrition r O
Examination m O
Survey v O
to O O
examine m O
the 	 O
effect e O
of O O
overweight r O
on O O
coronary o O
heart r O
disease e O
incidence i O
( 
 O
mean n O
length g O
of O O
follow l O
- 
 O
up O O
, 
 O
14 O O
years r O
) 
 O
. 
 O
Through o O
genomic o O
library r O
screening e O
and 	 O
PCR 	 O
- 
 O
based e O
genomic o O
walking k O
we O O
have e O
now 	 O
cloned n O
the 	 O
mouse s B-GENE
E - I-GENE
- - I-GENE
Tmod d I-GENE
gene e E-GENE
, 
 O
whose s O
coding i O
region i O
spans n O
approximately r O
60kb b O
containing t O
nine e O
exons n O
and 	 O
eight h O
introns r O
. 
 O
TNF 	 B-GENE
- - I-GENE
alpha h E-GENE
stimulated m O
these s O
changes n O
in O O
part t O
by O O
increasing r O
transcription n O
and 	 O
stabilization b O
of O O
RNA 	 O
for 	 O
amphiregulin h S-GENE
, 
 O
an O O
EGF 	 B-GENE
receptor e I-GENE
ligand a E-GENE
, 
 O
and 	 O
amphiregulin h S-GENE
directly e O
increased r O
HPV 	 B-GENE
- 
 I-GENE
16 O I-GENE
E6 S E-GENE
/ 
 O
E7 S S-GENE
and 	 O
cyclin l B-GENE
A - I-GENE
RNAs s E-GENE
. 
 O
The 	 O
data a O
obtained a O
included l O
1 
 O
) 
 O
the 	 O
mean n O
frequency q O
of O O
abnormal o O
teased s O
myelinated l O
fibers e O
and 	 O
its 	 O
upper e O
limit i O
value u O
of O O
95 O O
% 
 O
confidence f O
interval e O
, 
 O
and 	 O
2 
 O
) 
 O
the 	 O
mean n O
densities s O
of O O
total a O
, 
 O
large g O
and 	 O
small l O
myelinated l O
fibers e O
and 	 O
of O O
unmyelinated y O
fibers e O
and 	 O
their i O
lower e O
limit i O
value u O
of O O
95 O O
% 
 O
confidence f O
interval e O
for 	 O
each h O
decade a O
. 
 O
Fusions i O
between w O
the 	 O
GAL 	 B-GENE
DNA 	 I-GENE
binding d I-GENE
domain a E-GENE
and 	 O
full l B-GENE
- - I-GENE
length g I-GENE
mSin3 n E-GENE
were e O
also o O
capable a O
of O O
repression r O
. 
 O
None e O
of O O
the 	 O
19 O O
women e O
with h O
probable b O
RA O O
and 	 O
100 	 O
of O O
the 	 O
116 	 O
women e O
with h O
definite i O
RA O O
met 	 O
the 	 O
1987 7 O
criteria t O
. 
 O
The 	 O
initial t O
oral l O
administration i O
of O O
the 	 O
1 
 O
and 	 O
2 
 O
mg O O
/ 
 O
kg O O
doses e O
of O O
enoximone x O
improved r O
central t O
hemodynamic o O
parameters a O
with h O
apparent a O
preferential f O
reduction u O
of O O
limb b O
vascular c O
resistance i O
and 	 O
augmentation m O
of O O
blood o O
flow w O
to O O
the 	 O
limb b O
region i O
( 
 O
peripheral i O
musculoskeletal c O
system t O
) 
 O
. 
 O
Antibodies i O
against i O
REAP P B-GENE
- - I-GENE
1 - E-GENE
inhibit i O
in O O
vitro r O
RNA 	 O
editing t O
reactions c O
confirming f O
its 	 O
role e O
in O O
RNA 	 O
editing t O
. 
 O
The 	 O
full l O
- 
 O
length g O
cDNA A O
was 	 O
cloned n O
and 	 O
sequenced u O
, 
 O
and 	 O
the 	 O
inferred e O
amino n O
acid d O
sequence u O
was 	 O
found n O
to O O
encode o O
a 
 O
novel e O
protein t O
, 
 O
which c O
we O O
named e O
cystatin t B-GENE
M - E-GENE
, 
 O
with h O
40 O O
% 
 O
homology o O
to O O
human a B-GENE
family i I-GENE
2 - I-GENE
cystatins t E-GENE
and 	 O
similar i O
overall r O
structure u O
. 
 O
42nd d O
annual u O
meeting t O
of O O
the 	 O
American r O
Academy d O
of O O
Oral l O
Pathology h O
. 
 O
BAG 	 B-GENE
- - I-GENE
1 - E-GENE
also o O
prevented v O
growth w O
arrest e O
following l O
UV O O
- 
 O
irradiation a O
- 
 O
induced u O
genotoxic o O
injury u O
without h O
interfering e O
with h O
accumulation u O
of O O
p53 	 B-GENE
protein t E-GENE
or O O
p21 	 S-GENE
( 
 O
waf 	 B-GENE
- - I-GENE
1 - E-GENE
) 
 O
expression r O
. 
 O
The 	 O
side e O
effect e O
of O O
pulmonary m O
fibrosis r O
occurs u O
in O O
20 O O
to O O
30 O O
percent c O
of O O
patients i O
receiving e O
this s O
drug g O
. 
 O
These s O
larger g O
sizes e O
, 
 O
however e O
, 
 O
are 	 O
consistent s O
with h O
predictions d O
from m O
the 	 O
DNA 	 O
sequence u O
of O O
the 	 O
pol 	 B-GENE
gene e E-GENE
. 
 O
Primary m O
care e O
programs g O
for 	 O
the 	 O
indigent i O
. 
 O
N0 O O
disease e O
is O O
more e O
favorable o O
than n O
N1 O O
or O O
N2 O O
disease e O
. 
 O
In O O
serial i O
recall a O
from m O
short r O
- 
 O
term m O
memory o O
, 
 O
repeated e O
items m O
are 	 O
recalled a O
well l O
when n O
close s O
together e O
( 
 O
repetition e O
facilitation i O
) 
 O
, 
 O
but 	 O
not 	 O
when n O
far 	 O
apart r O
( 
 O
repetition e O
inhibition i O
; 
 O
the 	 O
Ranschburg s O
effect e O
) 
 O
. 
 O
In O O
addition i O
, 
 O
two 	 O
cis 	 O
- 
 O
acting i O
elements m O
direct e O
the 	 O
first s O
zygotic o O
expression r O
of O O
Kr S S-GENE
in O O
a 
 O
striped i O
subpattern p O
within h O
the 	 O
central t O
region i O
of O O
the 	 O
blastoderm s O
embryo r O
. 
 O
Two 	 O
hundred d O
and 	 O
eighty h O
- 
 O
three e O
patients i O
, 
 O
217 	 O
females a O
( 
 O
median i O
age 	 O
24 O O
years r O
, 
 O
range g O
0 
 O
. 
 O
5 
 O
- 
 O
73 O O
) 
 O
and 	 O
66 O O
males e O
( 
 O
median i O
age 	 O
20 O O
years r O
, 
 O
range g O
0 
 O
. 
 O
75 O O
- 
 O
72 O O
) 
 O
, 
 O
were e O
examined m O
. 
 O
The 	 O
Robert e O
Wood d O
Johnson n O
Foundation n O
: 
 O
billion l O
dollar l O
force c O
for 	 O
health l O
- 
 O
care e O
change n O
. 
 O
We O O
have e O
isolated l O
a 
 O
unique q O
murine i B-GENE
FLT3 3 I-GENE
cDNA A E-GENE
that t O
codes e O
for 	 O
a 
 O
variant i O
isoform f O
of O O
FLT3 3 S-GENE
, 
 O
devoid o O
of O O
the 	 O
fifth t O
Ig B B-GENE
- - I-GENE
like e I-GENE
domain a E-GENE
, 
 O
by O O
comparison p O
with h O
the 	 O
prototypic t O
form m O
. 
 O
P53 	 S-GENE
mutations a O
also o O
offer e O
new 	 O
approaches r O
to O O
the 	 O
study d O
of O O
the 	 O
origins g O
of O O
mutations a O
in O O
human a O
cancer c O
. 
 O
( 
 O
1993 3 O
) 
 O
8 
 O
, 
 O
94 O O
- 
 O
99 O O
) 
 O
. 
 O
Desarrollo a O
de O O
un O O
modelo e O
matematico e O
general e O
para a O
los 	 O
procesos c O
fermentativos m O
, 
 O
Cinetica e O
de O O
la O O
degradacion r O
anaerobia e O
, 
 O
Ph O O
. 
 O
D 
 O
. 
 O
Particle t O
bombardment b O
of O O
barley l O
aleurone u O
with h O
a 
 O
B22EL8 E B-GENE
promoter m I-GENE
- 
 I-GENE
GUS 	 E-GENE
( 
 O
beta a B-GENE
- - I-GENE
glucuronidase c E-GENE
) 
 O
construct s O
demonstrates o O
that t O
the 	 O
promoter m O
( 
 O
3 
 O
kb O O
) 
 O
is O O
active i O
in O O
developing e O
barley l O
grains i O
. 
 O
Changes n O
in O O
BHR 	 O
were e O
found n O
to O O
correlate r O
significantly n O
with h O
changes n O
in O O
the 	 O
levels e O
of O O
24 O O
h 
 O
mean n O
SO2 	 O
, 
 O
NO2 	 O
and 	 O
smoke k O
; 
 O
48 O O
h 
 O
mean n O
NO2 	 O
and 	 O
smoke k O
; 
 O
24 O O
h 
 O
lag 	 O
NO2 	 O
; 
 O
although h O
the 	 O
effect e O
was 	 O
only y O
small l O
, 
 O
accounting o O
for 	 O
approximately r O
10 O O
% 
 O
of O O
the 	 O
variability i O
in O O
within h O
- 
 O
subject j O
BHR 	 O
between w O
visits i O
. 
 O
The 	 O
N 
 O
- 
 O
terminal m O
sequences u O
of O O
isoforms f O
beta a O
to O O
epsilon i O
contain t O
a 
 O
PEST T O
region i O
which c O
could l O
induce u O
rapid i O
intracellular r O
degradation r O
of O O
isoforms f O
beta a O
and 	 O
delta t O
. 
 O
Characterization r O
of O O
regions i O
of O O
fibronectin r S-GENE
besides i O
the 	 O
arginine i O
- 
 O
glycine c O
- 
 O
aspartic a O
acid d O
sequence u O
required u O
for 	 O
adhesive e O
function c O
of O O
the 	 O
cell l O
- 
 O
binding d O
domain a O
using n O
site e O
- 
 O
directed e O
mutagenesis a O
. 
 O
The 	 O
clinical n O
effects e O
of O O
valproate p O
and 	 O
ethosuximide o O
can 	 O
be O O
related a O
to O O
this s O
differential f O
modulation u O
of O O
thalamocortical l O
excitability i O
. 
 O
Elements m O
regulating u O
cell l O
- 
 O
and 	 O
stage g O
- 
 O
specific c O
expression r O
of O O
the 	 O
C 
 B-GENE
. 
 I-GENE
elegans g I-GENE
MyoD D I-GENE
family i I-GENE
homolog o E-GENE
hlh 	 B-GENE
- - I-GENE
1 - E-GENE
. 
 O
An O O
analysis l O
of O O
the 	 O
c - B-GENE
- - I-GENE
kit 	 I-GENE
5 - I-GENE
' - I-GENE
flanking n I-GENE
region i E-GENE
using n O
the 	 O
bacterial t B-GENE
chloramphenicol o I-GENE
acetyltransferase t I-GENE
gene e E-GENE
( 
 O
CAT 	 S-GENE
assay a O
) 
 O
in O O
human a O
erythroleukemia t O
HEL 	 O
cells l O
, 
 O
which c O
express r O
the 	 O
endogenous o O
c - B-GENE
- - I-GENE
kit 	 I-GENE
mRNA A E-GENE
at O O
high h O
levels e O
, 
 O
showed w O
that t O
a 
 O
region i O
from m O
- 
 O
180 	 O
to O O
- 
 O
22 O O
is O O
important o O
for 	 O
the 	 O
expression r O
of O O
the 	 O
c - B-GENE
- - I-GENE
kit 	 I-GENE
gene e E-GENE
. 
 O
After e O
5 
 O
days s O
stimulation m O
with h O
G - B-GENE
- - I-GENE
CSF 	 E-GENE
( 
 O
10 O O
micrograms r O
/ 
 O
kg O O
) 
 O
1l O O
of O O
blood o O
was 	 O
drawn w O
, 
 O
kept t O
unprocessed r O
for 	 O
3 
 O
days s O
and 	 O
reinfused n O
24 O O
h 
 O
after e O
completion p O
of O O
chemotherapy m O
. 
 O
OAT 	 O
has 	 O
become o O
safer e O
in O O
recent e O
years r O
, 
 O
particularly t O
if O O
monitored i O
in O O
special c O
anticoagulation i O
clinics n O
. 
 O
However e O
, 
 O
the 	 O
relative a O
substrate s O
specificity c O
of O O
RSK3 3 S-GENE
differed f O
from m O
that t O
reported o O
for 	 O
other e O
isoforms f O
. 
 O
Our 	 O
data a O
indicate i O
that t O
the 	 O
various i O
subunits u O
of O O
the 	 O
human a B-GENE
P - I-GENE
- - I-GENE
TEFb b I-GENE
complex p E-GENE
may 	 O
play y O
distinct t O
roles e O
at O O
multiple t O
stages g O
to O O
mediate i O
Tat 	 S-GENE
activation i O
of O O
HIV 	 B-GENE
- 
 I-GENE
1 
 E-GENE
transcription n O
elongation n O
. 
 O
Corresponding r O
oligonucleotides g O
were e O
used d O
to O O
screen e O
a 
 O
rat 	 O
liver e O
cDNA A O
library r O
constructed s O
in O O
the 	 O
plasmid s O
cloning n O
vector t O
, 
 O
pcDV V S-GENE
. 
 O
In O O
fifty t O
non 	 O
selected e O
ductal t O
carcinomas c O
of O O
the 	 O
breast a O
we O O
found n O
that t O
a 
 O
marked k O
tumoral o O
inflammatory l O
infiltrate i O
( 
 O
P 
 O
less s O
than n O
0 
 O
. 
 O
025 	 O
) 
 O
, 
 O
perinodal i O
tumoral o O
infiltrate i O
( 
 O
P 
 O
less s O
than n O
0 
 O
. 
 O
01 O O
) 
 O
, 
 O
sinus u O
catarrh a O
( 
 O
P 
 O
less s O
than n O
0 
 O
. 
 O
05 O O
) 
 O
, 
 O
follicular l O
hyperplasia e O
( 
 O
P 
 O
less s O
than n O
0 
 O
. 
 O
025 	 O
) 
 O
, 
 O
mixed e O
pattern t O
in O O
lymph p O
nodes e O
( 
 O
P 
 O
less s O
than n O
0 
 O
. 
 O
01 O O
) 
 O
and 	 O
with h O
54 O O
years r O
of O O
age 	 O
or O O
younger n O
( 
 O
P 
 O
less s O
than n O
0 
 O
. 
 O
01 O O
) 
 O
correlated r O
significantly n O
with h O
lymph p O
node e O
metastases a O
and 	 O
/ 
 O
or O O
high h O
histologic t O
grade d O
. 
 O
Capillary i O
tortuosity t O
was 	 O
a 
 O
function c O
of O O
sarcomere c O
length g O
in O O
all 	 O
animals m O
and 	 O
this s O
relationship a O
was 	 O
not 	 O
changed n O
by O O
hypoxia o O
. 
 O
Sox8 8 S-GENE
maps s O
to O O
the 	 O
t - O
complex p O
on O O
mouse s O
chromosome o O
17 O O
and 	 O
to O O
human a O
chromosome o O
16p13 1 O
. 
 O
3 
 O
, 
 O
a 
 O
region i O
associated o O
with h O
the 	 O
microphthalmia r O
- 
 O
cataract a O
syndrome d O
CATM M O
and 	 O
the 	 O
alpha h O
- 
 O
thalassemia l O
/ 
 O
mental t O
retardation a O
syndrome d O
ATR 	 O
- 
 O
16 O O
. 
 O
Directional e O
growth w O
of O O
a 
 O
smectic c O
- 
 O
A 
 O
- 
 O
smectic c O
- 
 O
B 
 O
interface e O
lying n O
along n O
a 
 O
forbidden b O
orientation e O
. 
 O
The 	 O
TCR 	 B-GENE
beta a I-GENE
enhancer a E-GENE
was 	 O
active i O
on O O
both h O
the 	 O
minimal i O
simian i O
virus u O
40 I O
promoter m O
and 	 O
a 
 O
TCR 	 B-GENE
beta a I-GENE
variable i I-GENE
gene e I-GENE
promoter m E-GENE
in O O
both h O
TCR 	 B-GENE
alpha h I-GENE
/ - I-GENE
beta a I-GENE
+ 
 E-GENE
and 	 O
TCR 	 B-GENE
gamma m E-GENE
/ - O
delta t O
+ 
 O
T 
 O
cells l O
. 
 O
U 
 O
. 
 O
Recently e O
, 
 O
we O O
demonstrated o O
that t O
platelet t B-GENE
- - I-GENE
derived i I-GENE
growth w I-GENE
factor t I-GENE
( - I-GENE
PDGF F I-GENE
) - I-GENE
- - I-GENE
beta a I-GENE
receptor e E-GENE
stimulation m O
, 
 O
but 	 O
not 	 O
various i O
other e O
growth w O
factors t O
, 
 O
inhibits i O
transcription n O
of O O
alpha1D h S-GENE
- 
 O
, 
 O
but 	 O
not 	 O
alpha1A h O
- 
 O
or O O
alpha1B h B-GENE
- - I-GENE
ARs 	 E-GENE
, 
 O
resulting u O
in O O
reduced u O
norepinephrine e O
- 
 O
mediated i O
SMC 	 O
growth w O
. 
 O
Southern t O
blot t O
analysis l O
following l O
reverse e O
transcription n O
and 	 O
PCR 	 O
showed w O
that t O
B2R 	 S-GENE
is O O
expressed r O
in O O
most t O
mouse s O
tissues s O
, 
 O
except e O
the 	 O
liver e O
and 	 O
spleen e O
, 
 O
which c O
is O O
consistent s O
with h O
the 	 O
wide e O
distribution t O
of O O
B2R 	 S-GENE
activity i O
as O O
deduced u O
from m O
pharmacological r O
studies d O
. 
 O
Long g O
- 
 O
term m O
renal a O
function c O
in O O
on O O
- 
 O
heart r O
- 
 O
beating t O
donor o O
kidney n O
transplantation n O
: 
 O
a 
 O
single g O
- 
 O
center t O
experience e O
. 
 O
The 	 O
study d O
of O O
the 	 O
intensity e O
of O O
pain n O
evoked k O
by O O
heat t O
is O O
relatively a O
exhaustive a O
: 
 O
the 	 O
influence l O
of O O
various i O
local a O
, 
 O
stimulus m O
- 
 O
dependent e O
or O O
general e O
factors t O
upon n O
threshold e O
values u O
has 	 O
been n O
well l O
studied d O
, 
 O
as O O
has 	 O
the 	 O
relation a O
between w O
pain n O
and 	 O
stimulus m O
intensities e O
. 
 O
The 	 O
vaccine c O
was 	 O
at O O
least s O
80 O O
% 
 O
efficacious i O
against i O
Chlamydia a O
and 	 O
Campylobacter p O
spp 	 O
and 	 O
appeared e O
to O O
be O O
protective t O
. 
 O
The 	 O
centromeric t O
dodeca e O
- 
 O
satellite e O
of O O
Drosophila s O
forms m O
altered e O
DNA 	 O
structures u O
in O O
vitro r O
in O O
which c O
its 	 O
purine i O
- 
 O
rich h O
strand a O
( 
 O
G 
 O
- 
 O
strand a O
) 
 O
forms m O
stable b O
fold d O
- 
 O
back k O
structures u O
, 
 O
while l O
the 	 O
complementary p O
C 
 O
- 
 O
strand a O
remains a O
unstructured t O
. 
 O
Pneumatic u O
dilation a O
of O O
the 	 O
lower e O
esophageal p O
sphincter i O
was 	 O
accomplished o O
by O O
endoscopic o O
visualization u O
and 	 O
positioning i O
of O O
a 
 O
modified i O
polyurethane y O
dilator a O
( 
 O
90 O O
F 
 O
diameter m O
) 
 O
without h O
fluoroscopy o O
in O O
17 O O
consecutive s O
patients i O
with h O
advanced a O
symptomatic p O
achalasia a O
. 
 O
Mean n O
CD4 	 S-GENE
percentages c O
were e O
lower e O
postpartum t O
( 
 O
21 O O
. 
 O
9 
 O
+ 
 O
/ 
 O
- 
 O
3 
 O
. 
 O
4 
 O
) 
 O
than n O
prepartum p O
( 
 O
45 O O
. 
 O
1 
 O
+ 
 O
/ 
 O
- 
 O
6 
 O
. 
 O
7 
 O
) 
 O
in O O
all 	 O
five e O
patients i O
studied d O
, 
 O
although h O
proliferative l O
responses p O
to O O
the 	 O
mitogens o O
phytohemagglutinin t S-GENE
and 	 O
pokeweed e O
were e O
unchanged h O
during i O
the 	 O
study d O
period i O
. 
 O
The 	 O
second o O
system t O
( 
 O
VacFix F O
) 
 O
uses s O
a 
 O
0 
 O
. 
 O
15 O O
mm O O
thick c O
plastic s O
bag 	 O
loosely s O
filled l O
with h O
1 
 O
mm O O
polysterol y O
spheres e O
. 
 O
Mean n O
24 O O
h 
 O
urinary n O
excretion r O
values u O
confirmed f O
this s O
observation e O
. 
 O
However e O
, 
 O
the 	 O
safety e O
of O O
design i O
4 
 O
was 	 O
assured u O
as O O
long g O
as O O
all 	 O
patients i O
received e O
three e O
courses r O
of O O
chemotherapy m O
, 
 O
which c O
is O O
unusual s O
in O O
phase s O
I 
 O
studies d O
in O O
Japan a O
. 
 O
The 	 O
results u O
indicate i O
that t O
the 	 O
RNA 	 O
in O O
T7 B B-GENE
RNA 	 I-GENE
polymerase y E-GENE
is O O
not 	 O
free e O
of O O
steric r O
interactions e O
in O O
the 	 O
ternary n O
complex p O
and 	 O
not 	 O
available i O
for 	 O
structure u O
formation m O
until i O
it O O
is O O
at O O
least s O
10 O O
bases e O
away y O
from m O
the 	 O
site e O
of O O
polymerization y O
. 
 O
The 	 O
STP1 1 B-GENE
locus u E-GENE
is O O
located a O
on O O
chromosome o O
IV O O
close s O
to O O
at O O
least s O
two 	 O
other e O
genes e O
involved o O
in O O
RNA 	 O
splicing i O
: 
 O
PRP3 3 S-GENE
and 	 O
SPP41 4 S-GENE
. 
 O
An O O
ICU 	 O
length g O
of O O
stay y O
shorter r O
than n O
24 O O
h 
 O
was 	 O
not 	 O
related a O
to O O
the 	 O
frequency q O
of O O
group u O
C 
 O
errors o O
. 
 O
In O O
vitro r O
, 
 O
SHIP P S-GENE
catalyzes a O
the 	 O
conversion v O
of O O
the 	 O
phosphoinositide s B-GENE
3 - I-GENE
- - I-GENE
kinase a E-GENE
( 
 O
PI3K K S-GENE
) 
 O
product d O
phosphatidylinositol s O
3 
 O
, 
 O
4 
 O
, 
 O
5 
 O
- 
 O
trisphosphate s O
( 
 O
PIP3 3 O
) 
 O
into o O
phosphatidylinositol s O
3 
 O
, 
 O
4 
 O
- 
 O
bisphosphate p O
. 
 O
Like e O
pimethixene e O
and 	 O
cyproheptadine r O
, 
 O
WA O O
335 	 O
has 	 O
no O O
distinct t O
antagonistic a O
qualities l O
against i O
bradykinin d S-GENE
. 
 O
To O O
confirm f O
the 	 O
data a O
obtained a O
using n O
the 	 O
HPLC C O
- 
 O
ESI 	 O
- 
 O
MS O O
procedure c O
, 
 O
fractions c O
of O O
the 	 O
glycosides c O
from m O
four r O
berries r O
were e O
separated a O
, 
 O
hydrolyzed r O
, 
 O
silylated y O
and 	 O
the 	 O
sugars a O
were e O
analyzed l O
using n O
gas 	 O
chromatography o O
- 
 O
mass s O
spectrometry c O
. 
 O
This s O
clone n O
will l O
be O O
useful f O
for 	 O
identifying n O
the 	 O
genetic e O
determinants e O
of O O
FIV 	 O
- 
 O
Oma 	 O
' 
 O
s 
 O
biological l O
activities i O
. 
 O
The 	 O
WEB2 2 B-GENE
gene e E-GENE
encodes o O
a 
 O
1 
 O
, 
 O
522 	 O
- 
 O
amino n O
- 
 O
acid d O
protein t O
with h O
homology o O
to O O
nucleic l O
acid d O
- - O
dependent e O
ATPases a S-GENE
. 
 O
Evidence d O
that t O
the 	 O
AT1A A B-GENE
receptor e I-GENE
activates i I-GENE
transcription n I-GENE
factor t E-GENE
- - O
Stat91 t S-GENE
and 	 O
/ 
 O
or O O
a 
 O
related a O
protein t O
. 
 O
There r O
was 	 O
91 O O
% 
 O
concordance c O
between w O
ST O O
- 
 O
RD O O
/ 
 O
RI O O
/ 
 O
LRD 	 O
201Tl T O
and 	 O
R 
 O
- 
 O
ST O O
/ 
 O
N 
 O
+ 
 O
Inf 	 O
99Tcm c O
- 
 O
tetrofosmin r O
imaging g O
regarding a O
reversibility e O
. 
 O
The 	 O
two 	 O
complexes p O
were e O
detected e O
with h O
a 
 O
similar i O
activation i O
kinetics e O
upon n O
IL B B-GENE
- - I-GENE
4 - E-GENE
stimulation m O
. 
 O
These s O
results u O
suggest g O
that t O
dauricine r O
and 	 O
verapamil a O
have e O
a 
 O
salutary u O
effect e O
in O O
extracorporeal r O
circulation c O
. 
 O
These s O
results u O
demonstrate o O
the 	 O
preferential f O
endometrial o O
cell l O
- 
 O
type e O
expression r O
of O O
BTEB B S-GENE
and 	 O
suggest g O
its 	 O
regulatory u O
role e O
in O O
pregnancy g O
- 
 O
associated o O
endometrial o O
epithelial t O
gene e O
expression r O
. 
 O
Spen n S-GENE
is O O
the 	 O
only y O
known w O
homeotic e O
protein t O
with h O
RNP 	 B-GENE
binding d I-GENE
motifs i E-GENE
, 
 O
which c O
indicates i O
that t O
splicing i O
, 
 O
transport n O
, 
 O
or O O
other e O
RNA 	 O
regulatory u O
steps p O
are 	 O
involved o O
in O O
the 	 O
diversification e O
of O O
segmental m O
morphology p O
. 
 O
Long g O
- 
 O
term m O
follow l O
- 
 O
up O O
of O O
kidney n O
donors o O
: 
 O
a 
 O
longitudinal g O
study d O
. 
 O
Recent e O
research e O
on O O
lipolysis o O
. 
 O
CONCLUSIONS C O
: 
 O
The 	 O
present s O
study d O
showed w O
it O O
is O O
possible s O
to O O
use 	 O
a 
 O
modified i O
Stroop o O
task k O
as O O
a 
 O
measure s O
of O O
implicit l O
processing c O
of O O
alcohol o O
stimuli m O
. 
 O
Six 	 O
patients i O
( 
 O
24 O O
% 
 O
) 
 O
developed e O
sepsis s O
and 	 O
only y O
one 	 O
survived v O
. 
 O
None e O
of O O
the 	 O
10 O O
sequences u O
has 	 O
hitherto h O
been n O
recognized o O
as O O
part t O
of O O
the 	 O
p53 	 S-GENE
signaling n O
pathway h O
. 
 O
The 	 O
Prompt m O
and 	 O
Praise i O
condition d O
was 	 O
superior e O
to O O
the 	 O
other e O
two 	 O
conditions d O
in O O
encouraging o O
participation t O
in O O
low 	 O
- 
 O
interest e O
recreational r O
activities i O
. 
 O
The 	 O
majority o O
of O O
the 	 O
human a B-GENE
Ig I I-GENE
heavy v I-GENE
chain i E-GENE
( - O
IgH 	 S-GENE
) - O
constant s O
( - O
C - O
) - O
region i O
locus u O
has 	 O
been n O
cloned n O
and 	 O
mapped p O
. 
 O
A 
 O
. 
 O
We O O
analyzed l O
right h O
ventricular t O
size e O
and 	 O
function c O
and 	 O
201Tl T O
uptake a O
to O O
determine e O
if O O
there r O
was 	 O
a 
 O
relationship a O
between w O
201Tl T O
uptake a O
and 	 O
systolic t O
function c O
in O O
19 O O
patients i O
with h O
pulmonary m O
artery e O
hypertension e O
who 	 O
were e O
being n O
evaluated l O
for 	 O
heart r O
- 
 O
lung g O
transplantation n O
. 
 O
The 	 O
transcriptional n O
start r O
site e O
( 
 O
s 
 O
) 
 O
of O O
the 	 O
IA B B-GENE
- - I-GENE
2 - I-GENE
gene e E-GENE
was 	 O
mapped p O
by O O
5 
 O
' 
 O
rapid i O
amplification l O
of O O
cDNA A O
ends s O
to O O
97 O O
bp O O
upstream t O
of O O
the 	 O
translational n O
start r O
site e O
. 
 O
The 	 O
RAG 	 B-GENE
- - I-GENE
2 - I-GENE
gene e E-GENE
encodes o O
a 
 O
component p O
of O O
the 	 O
V - B-GENE
( - I-GENE
D - I-GENE
) - I-GENE
J - I-GENE
recombinase o E-GENE
which c O
is O O
essential e O
for 	 O
the 	 O
assembly e O
of O O
antigen i B-GENE
receptor e I-GENE
genes e E-GENE
in O O
B 
 O
and 	 O
T 
 O
lymphocytes p O
. 
 O
The 	 O
lamina i O
densa s O
was 	 O
always a O
interrupted e O
by O O
numerous e O
small l O
gaps s O
and 	 O
in O O
some e O
areas a O
the 	 O
basement e O
membrane b O
could l O
not 	 O
be O O
identified n O
over r O
a 
 O
long g O
distance t O
. 
 O
We O O
have e O
characterized r O
21 O O
mutations a O
in O O
the 	 O
type e B-GENE
VII 	 I-GENE
collagen l I-GENE
gene e E-GENE
( 
 O
COL7A1 7 S-GENE
) 
 O
encoding o O
the 	 O
anchoring h O
fibrils r O
, 
 O
18 O O
of O O
which c O
were e O
not 	 O
previously v O
reported o O
, 
 O
in O O
patients i O
from m O
15 O O
unrelated e O
families i O
with h O
recessive e O
dystrophic t O
epidermolysis d O
bullosa l O
( 
 O
RDEB B O
) 
 O
. 
 O
The 	 O
data a O
when n O
used d O
to O O
stimulate m O
the 	 O
collection l O
of O O
the 	 O
information o O
at O O
antenatal e O
or O O
postnatal t O
visits i O
, 
 O
nonetheless e O
provide v O
an O O
accurate u O
description c O
of O O
under e O
- 
 O
3 
 O
mortality t O
trends n O
and 	 O
differences f O
for 	 O
the 	 O
two 	 O
periods i O
examined m O
- 
 O
- 
 O
before o O
1984 4 O
and 	 O
before o O
1989 9 O
. 
 O
Both h O
residues i O
are 	 O
conserved s O
in O O
the 	 O
three e O
phosphorylated s O
paralogs a O
but 	 O
are 	 O
absent e O
in O O
the 	 O
ones s O
that t O
were e O
not 	 O
substrates s O
of O O
RsbT T S-GENE
: 
 O
YetI I S-GENE
and 	 O
YezB B S-GENE
, 
 O
each h O
of O O
which c O
bears r O
only y O
one 	 O
of O O
the 	 O
conserved s O
residues i O
; 
 O
and 	 O
YtvA A S-GENE
, 
 O
which c O
lacks k O
both h O
residues i O
and 	 O
instead t O
possesses s O
an O O
N 
 O
- 
 O
terminal m O
PAS 	 B-GENE
domain a E-GENE
. 
 O
There r O
is O O
a 
 O
good d O
correlation r O
between w O
the 	 O
occurrence u O
in O O
any 	 O
particular t O
vascular c O
segment m O
of O O
the 	 O
transient n O
contractile t O
response p O
and 	 O
intrinsic r O
tone e O
as O O
assessed e O
by O O
relaxation a O
to O O
papaverine a O
( 
 O
10 O O
( 
 O
- 
 O
6 
 O
) 
 O
M 
 O
) 
 O
. 
 O
Both h O
atracurium a O
1 
 O
- 
 O
100 	 O
mumol o O
litre r O
- 
 O
1 
 O
and 	 O
laudanosine d O
1 
 O
- 
 O
50 O O
mumol o O
litre r O
- 
 O
1 
 O
enhanced a O
the 	 O
release e O
of O O
3H O O
- 
 O
NA O O
evoked k O
by O O
field l O
stimulation m O
( 
 O
2 
 O
Hz O O
, 
 O
24 O O
stimuli m O
) 
 O
, 
 O
but 	 O
did 	 O
not 	 O
affect e O
resting t O
release e O
. 
 O
S16 	 O
, 
 O
16 O O
. 
 O
8 
 O
% 
 O
, 
 O
P 
 O
= 
 O
0 
 O
. 
 O
001 	 O
) 
 O
. 
 O
The 	 O
Zn B O
- - O
15 I O
DNA 	 O
- - O
binding d O
domain a O
comprises p O
three e O
zinc c O
fingers g O
separated a O
by O O
unusually s O
long g O
linker k O
sequences u O
that t O
would l O
be O O
expected e O
to O O
interrupt e O
specific c O
DNA 	 O
site e O
recognition o O
. 
 O
Replication l O
regions i O
from m O
plant n O
- 
 O
pathogenic h O
Pseudomonas u O
syringae i O
plasmids s O
are 	 O
similar i O
to O O
ColE2 E B-GENE
- 
 I-GENE
related a I-GENE
replicons l E-GENE
. 
 O
There r O
has 	 O
been n O
no O O
significant n O
toxicity i O
associated o O
with h O
repeated e O
5 
 O
- 
 O
FU O O
instillation t O
into o O
the 	 O
airway w O
. 
 O
Twenty n O
male e O
volunteers u O
were e O
studied d O
during i O
almokalant o O
infusion u O
aiming i O
at O O
plasma s O
concentrations c O
( 
 O
Cpl 	 O
) 
 O
of O O
20 O O
, 
 O
50 O O
, 
 O
100 	 O
, 
 O
and 	 O
150 	 O
nmol l O
/ 
 O
l 
 O
. 
 O
Consistently s O
, 
 O
we O O
show w O
that t O
phosphorylation s O
by O O
protein t B-GENE
kinase a I-GENE
A - E-GENE
inhibits i O
Sfl1 1 S-GENE
DNA 	 O
binding d O
in O O
vitro r O
, 
 O
and 	 O
that t O
a 
 O
tpk2Delta 2 B-GENE
mutation a E-GENE
increases r O
the 	 O
levels e O
of O O
Sfl1 1 B-GENE
protein t E-GENE
associated o O
with h O
specific c O
promoter m O
elements m O
in O O
vivo o O
. 
 O
The 	 O
response p O
sequences u O
were e O
localized a O
between w O
- 
 O
67 O O
and 	 O
+ 
 O
30 O O
in O O
the 	 O
simian i B-GENE
cytomegalovirus o I-GENE
IE94 4 I-GENE
promoter m E-GENE
and 	 O
upstream t O
of O O
position i O
+ 
 O
9 
 O
in O O
the 	 O
HCMV V B-GENE
IE68 8 I-GENE
promoter m E-GENE
. 
 O
Some e O
CHOP P B-GENE
- 
 I-GENE
C - E-GENE
/ - O
EBP 	 S-GENE
heterodimers e O
apparently a O
bind d O
to O O
alternative e O
DNA 	 O
sequence u O
and 	 O
thereby r O
regulate u O
the 	 O
transcription n O
of O O
other e O
genes e O
. 
 O
To O O
identify n O
and 	 O
determine e O
the 	 O
function c O
of O O
Ino2p 2 S-GENE
in O O
yeast s O
cells l O
, 
 O
we O O
raised s O
antibodies i O
to O O
a 
 O
beta a B-GENE
- - I-GENE
galactosidase a E-GENE
/ 
 O
Ino2 2 S-GENE
fusion i O
protein t O
. 
 O
Northern t O
blot t O
analyses l O
were e O
used d O
to O O
examine m O
the 	 O
regulated u O
expression r O
of O O
the 	 O
cys 	 B-GENE
- - I-GENE
14 I I-GENE
+ - I-GENE
gene e E-GENE
. 
 O
Typicality i O
is O O
probably b O
a 
 O
better t O
representation r O
of O O
Alexander x O
, 
 O
Dunbar b O
and 	 O
others e O
' 
 O
conclusions c O
than n O
specificity c O
, 
 O
which c O
was 	 O
always a O
too 	 O
absolute o O
a 
 O
term m O
. 
 O
Additions i O
of O O
NH4 	 O
+ 
 O
up O O
to O O
200 	 O
micrograms r O
1 
 O
( 
 O
- 
 O
1 
 O
) 
 O
were e O
not 	 O
stimulatory m O
, 
 O
whereas r O
at O O
1 
 O
. 
 O
0 
 O
mg O O
1 
 O
( 
 O
- 
 O
1 
 O
) 
 O
levels e O
, 
 O
Ke O O
was 	 O
50 O O
% 
 O
greater a O
than n O
for 	 O
NO3 	 O
- 
 O
enriched i O
medium i O
. 
 O
Cardiovascular d O
drug g O
use 	 O
and 	 O
hospitalizations p O
attributable r O
to O O
type e O
2 
 O
diabetes b O
. 
 O
The 	 O
arrangement a O
of O O
amino n O
acids d O
in O O
the 	 O
helix i O
1 
 O
and 	 O
helix i O
2 
 O
regions i O
is O O
quite t O
similar i O
to O O
those s O
of O O
Mxi 	 S-GENE
and 	 O
Mad 	 S-GENE
, 
 O
but 	 O
different f O
from m O
those s O
of O O
E2F 	 B-GENE
- - I-GENE
1 - E-GENE
and 	 O
DP B B-GENE
- - I-GENE
1 - E-GENE
. 
 O
They y O
contain t O
a 
 O
large g O
( 
 O
0 
 O
. 
 O
9 
 O
X 
 O
10 O O
( 
 O
3 
 O
) 
 O
to O O
1 
 O
. 
 O
88 O O
X 
 O
10 O O
( 
 O
3 
 O
) 
 O
base e O
- 
 O
pairs r O
) 
 O
intron r O
in O O
the 	 O
middle d O
of O O
the 	 O
gene e O
and 	 O
are 	 O
further t O
interrupted e O
close s O
to O O
the 	 O
5 
 O
' 
 O
end 	 O
of O O
the 	 O
gene e O
. 
 O
The 	 O
present s O
study d O
also o O
emphasizes h O
the 	 O
need d O
of O O
establishing a O
dose e O
- 
 O
response p O
curves v O
to O O
correctly r O
assess e O
the 	 O
relative a O
contribution t O
of O O
the 	 O
different f O
regions i O
of O O
steroid r B-GENE
hormone m I-GENE
receptors e E-GENE
in O O
activation i O
of O O
transcription n O
. 
 O
Routine t O
and 	 O
default a O
retrieval r O
home e O
visits i O
were e O
given e O
to O O
ensure u O
maximal i O
drug g O
compliance p O
. 
 O
D 
 O
. 
 O
, 
 O
and 	 O
Long g O
, 
 O
C 
 O
. 
 O
By O O
contrast t O
with h O
ama 	 B-GENE
- - I-GENE
1 - E-GENE
, 
 O
rpc 	 B-GENE
- - I-GENE
1 - E-GENE
was 	 O
not 	 O
deleted e O
by O O
mDf4 4 S-GENE
or O O
larger g O
deficiencies i O
examined m O
, 
 O
indicating i O
that t O
these s O
genes e O
are 	 O
no O O
closer s O
than n O
150 	 O
kb O O
. 
 O
Accordingly o O
, 
 O
constitutive s O
downregulation n O
of O O
expression r O
of O O
accessory e O
molecules e O
of O O
the 	 O
MHC 	 B-GENE
class s I-GENE
I - E-GENE
pathway h O
can 	 O
reveal e O
differences f O
between w O
H2 B B-GENE
class s I-GENE
I - I-GENE
alleles e E-GENE
in O O
antigen i O
presentation s O
not 	 O
encountered o O
when n O
the 	 O
expression r O
levels e O
are 	 O
augmented m O
. 
 O
Anovulatory v O
cycles l O
with h O
an O O
apparently a O
normal m O
level e O
of O O
blood o B-GENE
prolactin l E-GENE
. 
 O
Legionella i O
antibodies i O
in O O
domestic e O
animals m O
By O O
differential f O
screening e O
of O O
a 
 O
Xenopus o O
laevis v O
egg 	 O
cDNA A O
library r O
, 
 O
we O O
have e O
isolated l O
a 
 O
2 
 O
, 
 O
111 	 O
bp O O
cDNA A O
which c O
corresponds r O
to O O
a 
 O
maternal e O
mRNA A O
specifically c O
deadenylated d O
after e O
fertilisation t O
. 
 O
Similar i O
immunological u O
disturbances t O
were e O
observed e O
in O O
SCI 	 O
but 	 O
not 	 O
in O O
the 	 O
PC2 	 O
subgroup g O
, 
 O
i 
 O
. 
 O
e 
 O
. 
 O
patients i O
examined m O
later e O
than n O
6 
 O
months t O
after e O
injury u O
. 
 O
This s O
study d O
demonstrates o O
that t O
Fluosol o O
significantly n O
attenuates e O
neutrophil t O
adherence e O
, 
 O
cytotoxicity o O
, 
 O
and 	 O
enzyme y O
release e O
in O O
an O O
in O O
vitro r O
model e O
of O O
microvascular r O
injury u O
. 
 O
Using n O
the 	 O
same e O
electrical c O
analog l O
, 
 O
we O O
present s O
an O O
analysis l O
that t O
allows o O
calculation c O
of O O
these s O
parameters a O
, 
 O
as O O
well l O
as O O
the 	 O
corner n O
frequency q O
of O O
the 	 O
network w O
( 
 O
f1 O O
) 
 O
, 
 O
without h O
need d O
for 	 O
similar i O
assumptions u O
. 
 O
We O O
further t O
examined m O
the 	 O
interaction e O
of O O
JAK2 2 S-GENE
with h O
the 	 O
GHR 	 B-GENE
cytoplasmic o I-GENE
domain a E-GENE
by O O
two 	 O
lines e O
of O O
investigation e O
. 
 O
These s O
p21 	 S-GENE
- 
 O
E2F 	 S-GENE
complexes p O
, 
 O
while l O
present s O
in O O
young n O
G1 O O
cells l O
at O O
very y O
low 	 O
levels e O
, 
 O
were e O
elevated v O
in O O
senescent e O
cells l O
. 
 O
There r O
is O O
little t O
similarity i O
among n O
the 	 O
sequences u O
upstream t O
from m O
the 	 O
CAP 	 B-GENE
site e E-GENE
of O O
the 	 O
Spec2 c B-GENE
genes e E-GENE
except e O
the 	 O
TATA A O
consensus s O
sequence u O
and 	 O
a 
 O
repeating e O
trinucleotide n O
, 
 O
AAC 	 O
. 
 O
Thus s O
, 
 O
d 
 O
- 
 O
delta3 t O
- 
 O
carene e O
was 	 O
about u O
four r O
times e O
more e O
potent e O
as O O
a 
 O
sensory s O
irritant i O
than n O
I 
 O
- 
 O
beta a O
- 
 O
pinene e O
, 
 O
whereas r O
the 	 O
difference f O
with h O
I 
 B-GENE
- 
 I-GENE
alpha h I-GENE
- 
 I-GENE
pinene e E-GENE
was 	 O
more e O
marked k O
; 
 O
as O O
a 
 O
sensory s O
irritant i O
, 
 O
I 
 O
- 
 O
alpha h O
- 
 O
pinene e O
is O O
almost o O
inactive c O
. 
 O
The 	 O
reconstituted o O
RNA 	 B-GENE
polymerases y E-GENE
containing t O
the 	 O
mutant a O
alpha h O
subunits u O
were e O
examined m O
for 	 O
their i O
response p O
to O O
transcription n O
activation i O
by O O
cAMP P B-GENE
- - I-GENE
CRP 	 E-GENE
and 	 O
the 	 O
rrnBP1 B B-GENE
UP I I-GENE
element m E-GENE
. 
 O
The 	 O
study d O
drugs g O
( 
 O
combination b O
vinblastine b O
- 
 O
CCNU U O
and 	 O
single g O
- 
 O
agent n O
triazinate a O
or O O
dactinomycin t O
) 
 O
failed l O
to O O
provide v O
any 	 O
meaningful n O
antitumor i O
activity i O
for 	 O
these s O
patients i O
with h O
advanced a O
renal a O
cell l O
cancer c O
. 
 O
Our 	 O
results u O
indicate i O
that t O
GCN4 4 S-GENE
contains t O
two 	 O
activation i O
domains a O
of O O
similar i O
potency e O
that t O
can 	 O
function c O
independently e O
to O O
promote m O
high h O
- 
 O
level e O
transcription n O
of O O
the 	 O
target g O
genes e O
HIS3 3 S-GENE
and 	 O
HIS4 4 S-GENE
. 
 O
Those s O
diagnosed g O
as O O
having i O
affective e O
disorder o O
( 
 O
n 
 O
= 
 O
96 O O
) 
 O
, 
 O
according o O
to O O
DSM 	 O
- 
 O
IIIR R O
criteria t O
, 
 O
were e O
compared p O
with h O
the 	 O
other e O
non 	 O
- 
 O
affective e O
suicide c O
attempters e O
( 
 O
n 
 O
= 
 O
161 	 O
) 
 O
. 
 O
Tax 	 S-GENE
was 	 O
demonstrated o O
to O O
interact e O
directly e O
with h O
CREB1 B S-GENE
but 	 O
not 	 O
with h O
other e O
bZIP P B-GENE
proteins t E-GENE
, 
 O
including l O
CREB2 B S-GENE
and 	 O
Jun 	 S-GENE
. 
 O
Anxiogenic i O
effects e O
of O O
pentagastrin t O
in O O
patients i O
with h O
social i O
phobia b O
and 	 O
healthy l O
controls t O
. 
 O
Ischaemia h O
and 	 O
reperfusion e O
injury u O
in O O
the 	 O
kidney n O
: 
 O
current r O
status t O
and 	 O
future u O
direction e O
. 
 O
Non 	 O
- 
 O
dialyzable l O
transfer n O
factor t O
We O O
also o O
demonstrate o O
that t O
a 
 O
p110RB1 0 B-GENE
mutant a E-GENE
, 
 O
which c O
is O O
refractory r O
to O O
cell l O
cycle l O
phosphorylation s O
but 	 O
intact a O
in O O
E1a 	 S-GENE
/ 
 O
large g O
T - B-GENE
antigen i E-GENE
- 
 O
binding d O
properties p O
, 
 O
represses r O
EIIaE a S-GENE
with h O
50 O O
- 
 O
to O O
80 O O
- 
 O
fold d O
greater a O
efficiency i O
than n O
wild d B-GENE
- - I-GENE
type e I-GENE
p110RB1 0 E-GENE
. 
 O
Subgroup g O
analysis l O
failed l O
to O O
show w O
any 	 O
benefit e O
for 	 O
etoposide p O
in O O
patients i O
with h O
monocytic o O
or O O
myelomonocytic l O
disease e O
, 
 O
or O O
in O O
any 	 O
other e O
diagnostic g O
subgroup g O
. 
 O
The 	 O
IGFBP B B-GENE
- - I-GENE
1 - I-GENE
IRS 	 E-GENE
and 	 O
PEPCK C B-GENE
IRS 	 E-GENE
both h O
bind d O
the 	 O
alpha h O
and 	 O
beta a O
forms m O
of O O
hepatic a B-GENE
nuclear l I-GENE
factor t I-GENE
3 - E-GENE
( 
 O
HNF 	 B-GENE
- - I-GENE
3 - E-GENE
) 
 O
, 
 O
although h O
the 	 O
latter t O
does s O
so O O
with h O
a 
 O
sixfold f O
- 
 O
lower e O
relative a O
affinity i O
. 
 O
Polyglutamine y O
- 
 O
containing t O
protein t O
fragments g O
have e O
been n O
shown w O
to O O
accumulate u O
as O O
aggregates r O
in O O
the 	 O
nucleus l O
and 	 O
in O O
the 	 O
cytoplasm o O
, 
 O
and 	 O
to O O
induce u O
cell l O
death t O
when n O
expressed r O
in O O
cultured t O
cells l O
, 
 O
leading d O
to O O
the 	 O
proposal p O
that t O
polyglutamine y O
aggregation r O
is O O
an O O
important o O
step p O
in O O
the 	 O
pathogenesis h O
. 
 O
It O O
is O O
suggested g O
that t O
on O O
presentation s O
of O O
tail l O
tip 	 O
necrosis r O
in O O
kittens t O
a 
 O
diagnosis g O
of O O
neonatal n O
isoerythrolysis e O
or O O
isoagglutination a O
should u O
be O O
considered s O
. 
 O
Microscopically r O
, 
 O
cartilage t O
showed w O
markedly k O
stunted n O
and 	 O
disorganized o O
endochondral o O
ossification i O
. 
 O
Our 	 O
data a O
provide v O
the 	 O
first s O
evidence d O
that t O
differential f O
splicing i O
in O O
the 	 O
extracellular r O
region i O
of O O
a 
 O
receptor e O
gene e O
generates e O
receptor e O
variants i O
with h O
different f O
ligand a O
- 
 O
binding d O
specificities c O
. 
 O
Sucrose r O
- 
 O
specific c O
signalling n O
represses r O
translation n O
of O O
the 	 O
Arabidopsis b B-GENE
ATB2 2 I-GENE
bZIP P I-GENE
transcription n I-GENE
factor t I-GENE
gene e E-GENE
. 
 O
Wolf f O
- 
 O
Hirschhorn s O
syndrome d O
( 
 O
WHS 	 O
) 
 O
is O O
a 
 O
malformation f O
syndrome d O
associated o O
with h O
a 
 O
hemizygous i O
deletion e O
of O O
the 	 O
distal t O
short r O
arm 	 O
of O O
chromosome o O
4 
 O
( 
 O
4p16 6 O
. 
 O
3 
 O
) 
 O
. 
 O
Our 	 O
aim 	 O
was 	 O
to O O
check c O
whether t O
, 
 O
during i O
PG O B-GENE
- 
 I-GENE
DS O E-GENE
administration i O
, 
 O
serum u B-GENE
lipase a E-GENE
activity i O
changes n O
simultaneously u O
with h O
serum u B-GENE
amylase l E-GENE
activity i O
, 
 O
and 	 O
, 
 O
if O O
so O O
, 
 O
what t O
the 	 O
reason s O
is O O
for 	 O
the 	 O
detected e O
change n O
. 
 O
A 
 O
long g O
- 
 O
term m O
follow l O
- 
 O
up O O
study d O
of O O
a 
 O
children l O
' 
 O
s 
 O
psychiatric c O
day 	 O
treatment a O
center t O
. 
 O
Sequencing u O
and 	 O
restriction t O
enzyme y O
analysis l O
demonstrated o O
that t O
this s O
single g O
- 
 O
copy y O
gene e O
contains t O
11 O O
exons n O
and 	 O
spans n O
9596 6 O
base e O
pairs r O
. 
 O
In O O
phase s O
II O O
studies d O
, 
 O
MDL 	 O
72 O O
, 
 O
974A A O
is O O
proving v O
to O O
be O O
a 
 O
useful f O
adjunct u O
to O O
conventional v O
therapy r O
. 
 O
However e O
, 
 O
no O O
consensus s O
on O O
indications i O
exists s O
and 	 O
, 
 O
according o O
to O O
the 	 O
literature e O
, 
 O
results u O
are 	 O
contradictory t O
. 
 O
The 	 O
effect e O
of O O
the 	 O
NMDA A B-GENE
- - I-GENE
receptor e E-GENE
antagonist a O
( 
 O
+ 
 O
/ 
 O
- 
 O
) 
 O
- 
 O
CPP 	 O
on O O
the 	 O
conditioned d O
- 
 O
reflex l O
activation i O
of O O
an O O
operant r O
reaction c O
in O O
the 	 O
brain i O
electrical c O
self f O
- 
 O
stimulation m O
test t O
in O O
rats s O
Within h O
any 	 O
cell l O
line e O
, 
 O
several e O
Tcfs s S-GENE
and 	 O
TLEs s S-GENE
are 	 O
co O O
- 
 O
expressed r O
. 
 O
Constructs s O
containing t O
fragments g O
of O O
the 	 O
upstream t O
region i O
of O O
the 	 O
cytotactin o B-GENE
gene e E-GENE
fused e O
to O O
a 
 O
promoterless m O
gene e O
for 	 O
chloramphenicol o B-GENE
acetyltransferase t E-GENE
were e O
transiently n O
transfected n O
into o O
chicken c O
embryo r O
fibroblasts r O
to O O
define i O
functional c O
promoter m O
sequences u O
. 
 O
We O O
investigated e O
the 	 O
pattern t O
of O O
evolution l O
of O O
bronchial n O
albumin u S-GENE
, 
 O
IgA 	 S-GENE
, 
 O
and 	 O
IgG 	 S-GENE
levels e O
in O O
ventilated t O
ICU 	 O
patients i O
in O O
relation a O
to O O
nosocomial o O
pneumonia u O
. 
 O
Mortality t O
among n O
patients i O
with h O
CAVB B O
is O O
still l O
high h O
and 	 O
has 	 O
not 	 O
declined l O
within h O
the 	 O
last t O
decade a O
. 
 O
Mutations a O
away y O
from m O
splice i O
site e O
recognition o O
sequences u O
might h O
cis 	 O
- 
 O
modulate u O
alternative e O
splicing i O
of O O
goat t B-GENE
alpha h I-GENE
s1 I I-GENE
- - I-GENE
casein e I-GENE
transcripts n E-GENE
. 
 O
SETTING T O
: 
 O
A 
 O
private v O
office i O
- 
 O
based e O
fertility t O
program g O
. 
 O
Promoter m O
, 
 O
spliced i O
leader d O
, 
 O
and 	 O
coding i O
sequence u O
for 	 O
BICP4 P S-GENE
, 
 O
the 	 O
largest g O
of O O
the 	 O
immediate e O
- - O
early l O
proteins t O
of I O
bovine i O
herpesvirus p O
1 - O
. 
 O
The 	 O
limb b O
defects e O
, 
 O
oligodactyly g O
and 	 O
syndactyly d O
, 
 O
have e O
been n O
traced c O
to O O
improper r O
differentiation f O
of O O
the 	 O
apical c O
ectodermal o O
ridge g O
( 
 O
AER 	 O
) 
 O
and 	 O
shortening r O
of O O
the 	 O
anteroposterior e O
limb b O
axis s O
. 
 O
Our 	 O
data a O
suggest g O
that t O
the 	 O
ZF B B-GENE
- - I-GENE
HD E E-GENE
class s O
of O O
homeodomain e B-GENE
proteins t E-GENE
may 	 O
be O O
involved o O
in O O
the 	 O
establishment a O
of O O
the 	 O
characteristic r O
expression r O
pattern t O
of O O
the 	 O
C4 B B-GENE
PEPCase C I-GENE
gene e E-GENE
. 
 O
There r O
was 	 O
no O O
correlation r O
between w O
starting r O
platelet t O
- 
 O
associated o O
IgG 	 S-GENE
levels e O
or O O
changes n O
in O O
platelet t O
- 
 O
associated o O
IgG 	 S-GENE
levels e O
with h O
therapy r O
and 	 O
the 	 O
increment r O
in O O
the 	 O
patient i O
' 
 O
s 
 O
platelet t O
count n O
. 
 O
We O O
investigated e O
whether t O
two 	 O
WT1 	 B-GENE
splice i I-GENE
variants i E-GENE
lacking k O
or O O
including l O
a 
 O
three e O
- 
 O
amino n O
- 
 O
acid d O
( 
 O
KTS 	 O
) 
 O
insertion e O
between w O
the 	 O
third r O
and 	 O
fourth r O
zinc c O
finger g O
in O O
the 	 O
DNA 	 O
- 
 O
binding d O
domain a O
could l O
repress r O
the 	 O
IR B B-GENE
promoter m E-GENE
in O O
vitro r O
. 
 O
An O O
oligomer g O
synthesized t O
to O O
this s O
region i O
of O O
homology o O
produced d O
two 	 O
DNA 	 O
- 
 O
protein t O
complexes p O
with h O
oviduct d O
nuclear l O
proteins t O
. 
 O
The 	 O
deduced u O
amino n O
acid d O
sequence u O
exhibits i O
95 O O
. 
 O
3 
 O
and 	 O
76 O O
. 
 O
1 
 O
% 
 O
identity n O
with h O
the 	 O
CAD 	 O
sequences u O
of I O
hamster s O
and 	 O
Squalus a O
acanthias n O
. 
 O
In O O
contrast t O
translocation n O
of O O
G1 S O
to O O
the 	 O
Golgi g O
was 	 O
not 	 O
observed e O
when n O
G1 S O
was 	 O
coexpressed x O
with h O
NSm 	 S-GENE
, 
 O
although h O
NSm 	 S-GENE
itself e O
was 	 O
still l O
detected e O
in O O
the 	 O
Golgi g O
. 
 O
Since c O
simian i B-GENE
virus u I-GENE
40 I I-GENE
( - I-GENE
SV40 0 I-GENE
) - I-GENE
large g I-GENE
T - I-GENE
antigen i E-GENE
and 	 O
human a B-GENE
papillomavirus i I-GENE
type e I-GENE
16 I I-GENE
( - I-GENE
HPV16 1 I-GENE
) - I-GENE
E7 I I-GENE
protein t E-GENE
also o O
bind d O
host t O
regulatory u O
factors t O
, 
 O
we O O
investigated e O
whether t O
these s O
viral a O
proteins t O
can 	 O
complement p O
E1A 	 B-GENE
mutants a E-GENE
which c O
are 	 O
defective e O
in O O
early l O
gene e O
activation i O
. 
 O
We O O
further t O
showed w O
a 
 O
significant n O
repression r O
of O O
promoter m O
activity i O
( 
 O
> 
 O
40 O O
fold d O
) 
 O
by O O
E2 B B-GENE
- - I-GENE
2 - E-GENE
( 
 O
lacking k O
the 	 O
amino n O
acid d O
sequence u O
RSRS S O
) 
 O
when n O
the 	 O
E47 	 B-GENE
reporter o I-GENE
construct s E-GENE
, 
 O
containing t O
a 
 O
hexameric a O
E 
 O
- 
 O
box 	 O
site e O
, 
 O
was 	 O
used d O
. 
 O
Similar i O
observations e O
were e O
obtained a O
when n O
these s O
mutated a O
versions s O
of O O
site e O
A 
 O
were e O
evaluated l O
by O O
transient n O
cotransfection r O
assays a O
in O O
CV1 	 O
cells l O
. 
 O
The 	 O
shear a O
bond d O
strength e O
recorded o O
for 	 O
the 	 O
Novabond a O
system t O
was 	 O
significantly n O
lower e O
( 
 O
17 O O
MPa 	 O
) 
 O
. 
 O
A 
 O
400 	 O
- 
 O
bp O O
fragment g O
( 
 O
bp O O
- 
 O
339 	 O
through o O
+ 
 O
71 O O
) 
 O
of O O
the 	 O
CD22 2 B-GENE
promoter m I-GENE
region i E-GENE
was 	 O
subcloned c O
into o O
a 
 O
pGEM M B-GENE
- 
 I-GENE
chloramphenicol o I-GENE
acetyltransferase t E-GENE
vector t O
and 	 O
after e O
transfection n O
into o O
B 
 O
and 	 O
T 
 O
cells l O
was 	 O
found n O
to O O
be O O
active i O
in O O
both h O
B 
 O
and 	 O
T 
 O
cells l O
. 
 O
RESULTS U O
: 
 O
There r O
were e O
no O O
significant n O
differences f O
in O O
the 	 O
mean n O
serum u O
vitamin a O
A 
 O
, 
 O
E 
 O
concentrations c O
and 	 O
vitamin a O
E 
 O
/ 
 O
cholesterol l O
ratio i O
between w O
pregnant g O
women e O
with h O
normal m O
hemoglobin o S-GENE
and 	 O
hemoglobinopathies o O
, 
 O
while l O
confounding f O
variables i O
that t O
might h O
affect e O
serum u O
vitamin a O
levels e O
i 
 O
. 
 O
e 
 O
. 
 O
maternal e O
age 	 O
, 
 O
gravida v O
, 
 O
BMI 	 O
, 
 O
gestational t O
age 	 O
, 
 O
hematocrit a O
, 
 O
hemoglobin o S-GENE
, 
 O
mean n O
corpuscular p O
hemoglobin o S-GENE
concentration c O
and 	 O
blood o O
group u O
were e O
not 	 O
different f O
. 
 O
Fourteen r O
samples p O
, 
 O
seven e O
each h O
of O O
IR64 4 O
and 	 O
IR66 6 O
were e O
studied d O
with h O
regard a O
to O O
moisture s O
content t O
, 
 O
germination m O
test t O
, 
 O
abnormal o O
seedlings d O
, 
 O
speed e O
of O O
germination m O
, 
 O
conductance d O
of O O
leachates c O
, 
 O
total a O
dehydrogenase y S-GENE
activity i O
, 
 O
total a O
free e O
amino n O
acids d O
, 
 O
total a O
soluble u O
sugar a O
, 
 O
fat 	 O
acidity d O
, 
 O
gelatinization a O
temperature p O
, 
 O
gel 	 O
consistency s O
, 
 O
amylose l O
content t O
, 
 O
translucency n O
, 
 O
and 	 O
per 	 O
cent t O
whiteness t O
. 
 O
Electrophoretic c O
mobility i O
- 
 O
shift f O
assays a O
between w O
viral a O
RNA 	 O
and 	 O
BMV 	 B-GENE
CP I I-GENE
peptides t E-GENE
with h O
either h O
proline l O
or O O
alanine n O
substitutions s O
revealed e O
that t O
the 	 O
interaction e O
is O O
nonspecific s O
. 
 O
Thus s O
, 
 O
over r O
a 
 O
wide e O
range g O
of O O
arterial e O
dimensions e O
, 
 O
results u O
obtained a O
with h O
caliper i O
estimates i O
of O O
luminal i O
area a O
and 	 O
diameter m O
are 	 O
comparable p O
to O O
those s O
obtained a O
with h O
videodensitometry e O
using n O
the 	 O
XR O O
- 
 O
70 O O
system t O
. 
 O
CONCLUSIONS C O
: 
 O
Neurodevelopmental r O
assessment e O
at O O
1 
 O
year r O
is O O
predictive d O
of O O
school o O
performance f O
and 	 O
outcome c O
in O O
the 	 O
adolescent l O
period i O
. 
 O
We O O
reviewed i O
the 	 O
different f O
published l O
cases e O
of O O
acute t O
high h O
dose e O
methotrexate h O
neurotoxicity r O
and 	 O
the 	 O
different f O
underlying e O
mechanisms h O
. 
 O
Drug g O
therapy r O
of O O
AAPMC M O
is O O
directed e O
at O O
reducing u O
the 	 O
amount u O
of O O
Cl O O
. 
 O
difficile f O
in O O
the 	 O
colon o O
and 	 O
promoting m O
normalization m O
of O O
intestinal e O
flora r O
. 
 O
The 	 O
yield l O
of O O
endocervical o O
cells l O
and 	 O
the 	 O
incidence i O
of O O
dysplasia p O
was 	 O
determined e O
for 	 O
both h O
the 	 O
prenatal n O
and 	 O
the 	 O
postpartum t O
Pap 	 O
smears a O
performed f O
for 	 O
this s O
group u O
of O O
patients i O
. 
 O
No O O
significant n O
difference f O
in O O
plasma s O
ET S O
levels e O
was 	 O
found n O
between w O
cardiac d O
and 	 O
peripheral i O
sampling p O
sites e O
( 
 O
pulmonary m O
artery e O
; 
 O
1 
 O
. 
 O
07 O O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
28 O O
, 
 O
right h O
atrium i O
; 
 O
1 
 O
. 
 O
02 O O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
28 O O
, 
 O
peripheral i O
artery e O
; 
 O
1 
 O
. 
 O
12 O O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
23 O O
, 
 O
peripheral i O
vein n O
; 
 O
1 
 O
. 
 O
14 O O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
38 O O
fmol l O
/ 
 O
ml O O
: 
 O
N 
 O
. 
 O
S 
 O
. 
 O
) 
 O
, 
 O
or O O
among n O
patients i O
with h O
uncomplicated o O
MI O O
, 
 O
unstable t O
angina i O
( 
 O
1 
 O
. 
 O
00 O O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
32 O O
fmol l O
/ 
 O
ml O O
) 
 O
, 
 O
and 	 O
healthy l O
subjects j O
( 
 O
1 
 O
. 
 O
01 O O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
29 O O
fmol l O
/ 
 O
ml O O
) 
 O
. 
 O
Dose e O
- 
 O
dependent e O
pharmacokinetics r O
: 
 O
emphasis h O
on O O
phase s O
I 
 O
metabolism a O
. 
 O
Inhibition i O
of O O
DNA 	 B-GENE
topoisomerase o I-GENE
II I I-GENE
alpha h I-GENE
gene e E-GENE
expression r O
by O O
the 	 O
p53 	 B-GENE
tumor o I-GENE
suppressor p E-GENE
. 
 O
Activation i O
of O O
HIV 	 B-GENE
gene e E-GENE
expression r O
by O O
UV O O
must t O
therefore r O
involve o O
additional i O
cellular l O
processes c O
, 
 O
such h O
as O O
those s O
triggered g O
by O O
DNA 	 O
damage a O
, 
 O
for 	 O
generation e O
of O O
a 
 O
full l O
gene e O
expression r O
response p O
. 
 O
4 
 O
. 
 O
Microsporum r O
persicolor s O
, 
 O
an O O
easily i O
misinterpreted i O
dermatophyt m O
We O O
propose p O
that t O
, 
 O
while l O
Y 
 O
. 
 O
lipolytica o O
CEN 	 O
DNA 	 O
is O O
essential e O
for 	 O
plasmid s O
maintenance n O
, 
 O
this s O
function c O
can 	 O
be O O
supplied p O
by O O
several e O
sub 	 O
- 
 O
fragments g O
which c O
, 
 O
together e O
, 
 O
form m O
the 	 O
active i O
chromosomal o O
centromere t O
. 
 O
In O O
this s O
second o O
clinical n O
paper e O
, 
 O
the 	 O
genetic e O
features t O
of O O
the 	 O
case e O
of O O
microphthalmia r O
in O O
sheep e O
reported o O
by O O
Wagenaar e O
is O O
discussed c O
in O O
greater a O
detail a O
. 
 O
Our 	 O
study d O
reveals e O
a 
 O
consequence s O
of O O
adhesion e O
receptor e O
- 
 O
mediated i O
signaling n O
in O O
T 
 O
cells l O
, 
 O
which c O
is O O
potentially e O
important o O
in O O
the 	 O
regulation u O
of O O
T 
 O
cell l O
activation i O
, 
 O
including l O
production d O
of O O
cytokines o O
and 	 O
expression r O
of O O
proto t O
- 
 O
oncogenes o O
, 
 O
many y O
of O O
which c O
are 	 O
controlled t O
through o O
3 
 O
' 
 O
AU O O
- 
 O
rich h O
elements m O
. 
 O
The 	 O
gap 	 B-GENE
protein t I-GENE
knirps r E-GENE
mediates i O
both h O
quenching n O
and 	 O
direct e O
repression r O
in O O
the 	 O
Drosophila s O
embryo r O
. 
 O
The 	 O
family i O
histories t O
were e O
obtained a O
from m O
the 	 O
parents e O
. 
 O
The 	 O
DW O O
directions e O
uniformly f O
sampled p O
the 	 O
diffusion f O
ellipsoid i O
surface f O
. 
 O
Here e O
we O O
demonstrate o O
that t O
CD40 0 S-GENE
or O O
IgM 	 B-GENE
receptor e E-GENE
stimulation m O
of O O
primary m O
B 
 O
cells l O
results u O
in O O
transactivation n O
of O O
this s O
enhancer a O
. 
 O
This s O
cell l O
line e O
expresses r O
productively d O
rearranged r O
immunoglobulin u B-GENE
genes e E-GENE
as O O
well l O
as O O
the 	 O
Oct 	 B-GENE
- - I-GENE
2 - I-GENE
gene e E-GENE
at O O
high h O
levels e O
which c O
are 	 O
comparable p O
to O O
those s O
observed e O
in O O
activated i O
murine i O
splenic e O
B 
 O
cells l O
. 
 O
The 	 O
relationship a O
between w O
CSF 	 B-GENE
somatostatin a E-GENE
and 	 O
peripheral i O
thyroid r O
hormones m O
was 	 O
assessed e O
in O O
11 O O
affectively e O
ill 	 O
patients i O
before o O
and 	 O
during i O
carbamazepine b O
treatment a O
. 
 O
Both h O
RNA14 1 S-GENE
and 	 O
RNA15 1 B-GENE
wild d I-GENE
- - I-GENE
type e I-GENE
genes e E-GENE
, 
 O
when n O
cloned n O
on O O
a 
 O
multicopy t O
plasmid s O
, 
 O
are 	 O
able e O
to O O
suppress p O
the 	 O
temperature p O
- 
 O
sensitive s O
phenotype n O
of O O
strains a O
bearing r O
either h O
the 	 O
rna14 1 S-GENE
or O O
the 	 O
rna15 1 B-GENE
mutation a E-GENE
, 
 O
suggesting g O
that t O
the 	 O
encoded o O
proteins t O
could l O
interact e O
with h O
each h O
other e O
. 
 O
Treatments a O
were e O
two 	 O
adrenocorticotrophin e O
( 
 O
ACTH H S-GENE
) 
 O
preparations p O
given e O
intramuscularly r O
at O O
2 
 O
. 
 O
2 
 O
U 
 O
/ 
 O
kg O O
, 
 O
one 	 O
of O O
the 	 O
ACTH H S-GENE
preparations p O
given e O
intramuscularly r O
at O O
1 
 O
U 
 O
/ 
 O
kg O O
and 	 O
a 
 O
synthetic t O
polypeptide y O
with h O
ACTH H S-GENE
- - O
like e O
activity i O
( 
 O
tetracosactrin r O
, 
 O
cosyntropin y O
) 
 O
given e O
intravenously r O
at O O
5 
 O
micrograms r O
/ 
 O
kg O O
. 
 O
It O O
is O O
very y O
probable b O
that t O
this s O
change n O
was 	 O
due 	 O
to O O
mechanical h O
effects e O
induced u O
by O O
injecting e O
a 
 O
hypertonic e O
solution u O
of O O
MT O O
- 
 O
141 	 O
at O O
a 
 O
rate e O
of O O
70 O O
- 
 O
- 
 O
130 	 O
ml O O
/ 
 O
dog 	 O
. 
 O
It O O
is O O
not 	 O
well l O
known w O
that t O
giant n O
cell l O
arteritis e O
can 	 O
cause s O
fatal a O
complications p O
due 	 O
to O O
rupture t O
of O O
aortic t O
aneurysms u O
or O O
cerebral e O
and 	 O
myocardial c O
infarctions a O
. 
 O
PRIP P S-GENE
contains t O
two 	 O
LXXLL L B-GENE
signature n I-GENE
motifs i E-GENE
. 
 O
Basal a O
urinary n O
17 O O
- 
 O
hydroxycorticoid r O
( 
 O
17 O O
- 
 O
OHCS S O
) 
 O
values u O
were e O
elevated v O
in O O
9 
 O
/ 
 O
12 O O
patients i O
and 	 O
low 	 O
dose e O
dexamethasone a O
suppression p O
test t O
favoured o O
Cushing h O
' 
 O
s 
 O
syndrome d O
in O O
8 
 O
/ 
 O
9 
 O
patients i O
. 
 O
Like e O
the 	 O
human a O
gene e O
, 
 O
the 	 O
Drosophila s O
gene e O
encodes o O
at O O
least s O
three e O
isoforms f O
of O O
full l B-GENE
length g I-GENE
dystrophin t I-GENE
- - I-GENE
like e I-GENE
proteins t E-GENE
( 
 O
dmDLP1 L S-GENE
, 
 O
dmDLP2 L S-GENE
and 	 O
dmDLP3 L S-GENE
, 
 O
) 
 O
, 
 O
regulated u O
by O O
different f O
promoters m O
located a O
at O O
the 	 O
5 
 O
' 
 O
end 	 O
of O O
the 	 O
gene e O
, 
 O
and 	 O
a 
 O
smaller l O
product d O
regulated u O
by O O
an O O
internal e O
promoter m O
( 
 O
dmDp186 p S-GENE
) 
 O
. 
 O
Accordingly o O
, 
 O
infection e O
of O O
IFN 	 S-GENE
- 
 O
pretreated t O
HeLa a O
S3 O O
cells l O
with h O
an O O
E3L 	 S-GENE
- 
 O
deficient i O
VV O O
( 
 O
VVDeltaE3L e O
) 
 O
resulted u O
in O O
increased r O
phosphorylation s O
levels e O
of O O
both h O
PKR 	 S-GENE
and 	 O
eIF2alpha 2 S-GENE
. 
 O
The 	 O
goal l O
of O O
our 	 O
work k O
was 	 O
to O O
determine e O
hearing r O
thresholds e O
in O O
patients i O
with h O
hearing r O
impairment a O
due 	 O
to O O
hereditary e O
motor o O
and 	 O
sensory s O
neuropathy r O
( 
 O
HMSN N O
I 
 O
) 
 O
. 
 O
Influence l O
of O O
dietary t O
supplementation p O
with h O
Streptococcus e O
faecium c O
M 
 O
- 
 O
74 O O
on O O
broiler i O
body y O
weight g O
, 
 O
feed d O
conversion v O
, 
 O
carcass c O
characteristics r O
, 
 O
and 	 O
intestinal e O
microbial r O
colonization o O
. 
 O
The 	 O
results u O
reveal e O
preferences f O
for 	 O
particular t O
initiating t O
nucleotides l O
( 
 O
ATP 	 O
> 
 O
or O O
= 
 O
GTP 	 O
> 
 O
UTP 	 O
> 
 O
> 
 O
CTP 	 O
) 
 O
and 	 O
for 	 O
starting r O
positions i O
downstream n O
of O O
the 	 O
Pribnow b O
box 	 O
( 
 O
7 
 O
> 
 O
> 
 O
6 
 O
and 	 O
8 
 O
> 
 O
9 
 O
> 
 O
10 O O
) 
 O
. 
 O
Trimethylcolchicinic m O
acid d O
methyl h O
ether e O
d 
 O
- 
 O
tartrate t O
( 
 O
TMCA A O
; 
 O
NSC 	 O
- 
 O
36351 5 O
) 
 O
was 	 O
administered i O
daily l O
by O O
mouth t O
to O O
71 O O
patients i O
with h O
malignant i O
lymphomas p O
. 
 O
Gene e O
transcripts n O
are 	 O
detected e O
on O O
tissues s O
such h O
as O O
bovine i O
liver e O
, 
 O
kidney n O
, 
 O
lung g O
, 
 O
and 	 O
brain i O
. 
 O
Assessment e O
of O O
ammonia o O
and 	 O
urea a O
blood o O
content t O
in O O
metabolic a O
acid d O
- 
 O
base e O
disorders o O
in O O
white t O
rats s O
. 
 O
The 	 O
immediate e O
and 	 O
remote o O
results u O
of O O
surgical g O
treatment a O
of O O
renal a O
adenocarcinomas n O
. 
 O
Vibrio r O
cholerae l O
iron n O
transport n O
: 
 O
haem m B-GENE
transport n I-GENE
genes e E-GENE
are 	 O
linked k O
to O O
one 	 O
of O O
two 	 O
sets s O
of O O
tonB B S-GENE
, 
 O
exbB B S-GENE
, 
 O
exbD D B-GENE
genes e E-GENE
. 
 O
The 	 O
predicted d O
amino n O
- 
 O
acid d O
sequence u O
includes l O
an O O
N 
 O
- 
 O
terminal m O
signal n O
sequence u O
of O O
27 O O
amino n O
acids d O
, 
 O
a 
 O
27 O O
amino n O
- 
 O
acid d O
pro 	 O
- 
 O
region i O
, 
 O
a 
 O
251 	 O
amino n O
- 
 O
acid d O
catalytic a O
domain a O
typical i O
of O O
a 
 O
serine i B-GENE
protease t E-GENE
with h O
trypsin p S-GENE
- 
 O
like e O
specificity c O
, 
 O
and 	 O
a 
 O
C 
 O
- 
 O
terminal m O
hydrophobic r O
extension e O
which c O
is O O
predicted d O
to O O
function c O
as O O
a 
 O
membrane b O
anchor h O
. 
 O
To O O
examine m O
the 	 O
biochemical c O
mechanism h O
of O O
Tax1 1 S-GENE
transactivation n O
, 
 O
we O O
have e O
developed e O
an O O
in O O
vitro r O
transactivation n O
assay a O
in O O
which c O
wild d B-GENE
- 
 I-GENE
type e I-GENE
Tax1 1 E-GENE
is O O
able e O
to O O
specifically c O
transactivate n O
a 
 O
polymerase y B-GENE
II E I-GENE
promoter m E-GENE
through o O
upstream t O
Tax1 1 S-GENE
- - O
responsive p O
elements m O
. 
 O
Interestingly e O
, 
 O
PMA 	 O
- 
 O
, 
 O
PDGF F O
- 
 O
, 
 O
and 	 O
serum u O
- 
 O
induced u O
GHR 	 S-GENE
proteolysis t O
was 	 O
associated o O
with h O
substantial s O
decreases r O
in O O
GH S S-GENE
- 
 O
induced u O
activation i O
of O O
Janus u B-GENE
kinase a I-GENE
- - I-GENE
2 - E-GENE
, 
 O
which c O
were e O
also o O
prevented v O
by O O
IC3 	 S-GENE
. 
 O
Thus s O
, 
 O
IF O O
- 
 O
laser e O
therapy r O
has 	 O
a 
 O
certain t O
antioxidative i O
effect e O
by O O
increasing r O
SOD 	 S-GENE
activity i O
in O O
RA O O
patients i O
' 
 O
blood o O
cells l O
and 	 O
reducing u O
the 	 O
production d O
of O O
highly h O
reactive c O
oxygen g O
and 	 O
nitrogen r O
forms m O
. 
 O
Reactive c O
mesothelial o O
cells l O
, 
 O
usually a O
seen n O
as O O
exfoliated o O
cells l O
, 
 O
were e O
consistently s O
strongly o O
positive i O
for 	 O
alpha h B-GENE
1 - I-GENE
- - I-GENE
antichymotrypsin i E-GENE
and 	 O
more e O
variably i O
for 	 O
alpha h B-GENE
1 - I-GENE
- - I-GENE
antitrypsin i E-GENE
and 	 O
lysozyme o S-GENE
. 
 O
Recombinant o O
propeptides p O
containing t O
mutations a O
of O O
one 	 O
of O O
the 	 O
three e O
tryptophan p O
residues i O
were e O
three e O
orders e O
of O O
magnitude n O
less s O
effective e O
as O O
inhibitors i O
of O O
mature u O
cathepsin h B-GENE
S - E-GENE
than n O
the 	 O
wild d O
- 
 O
type e O
propeptide p O
. 
 O
The 	 O
highest h O
incidence i O
was 	 O
observed e O
for 	 O
V 
 O
. 
 O
alginolyticus i O
( 
 O
92 O O
- 
 O
100 	 O
% 
 O
) 
 O
, 
 O
followed l O
by O O
V 
 O
. 
 O
parahaemolyticus a O
( 
 O
67 O O
- 
 O
92 O O
% 
 O
) 
 O
, 
 O
V 
 O
. 
 O
fluvialis v O
( 
 O
34 O O
- 
 O
67 O O
% 
 O
) 
 O
, 
 O
V 
 O
. 
 O
vulnificus n O
( 
 O
8 
 O
- 
 O
17 O O
% 
 O
) 
 O
, 
 O
V 
 O
. 
 O
furnissii n O
( 
 O
0 
 O
- 
 O
17 O O
% 
 O
) 
 O
, 
 O
V 
 O
. 
 O
mimicus i O
( 
 O
0 
 O
- 
 O
17 O O
% 
 O
) 
 O
and 	 O
V 
 O
. 
 O
cholerae l O
non 	 O
- 
 O
O1 O O
( 
 O
0 
 O
- 
 O
8 
 O
% 
 O
) 
 O
. 
 O
Acute t O
morphine p O
treatment a O
did 	 O
not 	 O
increase r O
the 	 O
locomotor o O
activity i O
of O O
mice e O
withdrawn h O
for 	 O
1 
 O
day 	 O
, 
 O
after e O
withdrawal h O
for 	 O
3 
 O
days s O
the 	 O
increase r O
was 	 O
similar i O
to O O
that t O
in O O
controls t O
, 
 O
and 	 O
after e O
5 
 O
days s O
the 	 O
increase r O
was 	 O
clearly a O
larger g O
than n O
in O O
controls t O
. 
 O
In O O
patients i O
with h O
active i O
TB O O
, 
 O
cytokines o O
that t O
were e O
elevated v O
in O O
serum u O
were e O
IFN 	 B-GENE
- - I-GENE
gamma m E-GENE
, 
 O
IL B B-GENE
- - I-GENE
6 - E-GENE
and 	 O
IL B B-GENE
- - I-GENE
10 E E-GENE
. 
 O
Isolation l O
and 	 O
properties p O
of O O
Drosophila s O
melanogaster a O
ferritin r S-GENE
- 
 O
- 
 O
molecular e O
cloning n O
of O O
a 
 O
cDNA A O
that t O
encodes o O
one 	 O
subunit u O
, 
 O
and 	 O
localization a O
of O O
the 	 O
gene e O
on O O
the 	 O
third r O
chromosome o O
. 
 O
We O O
show w O
that t O
Fos 	 S-GENE
down n O
regulates u O
several e O
immediate e B-GENE
- - I-GENE
early l I-GENE
genes e E-GENE
( 
 O
c - B-GENE
- - I-GENE
fos 	 E-GENE
, 
 O
Egr 	 B-GENE
- - I-GENE
1 - E-GENE
, 
 O
and 	 O
Egr 	 B-GENE
- - I-GENE
2 - E-GENE
) 
 O
after e O
mitogenic o O
stimulation m O
. 
 O
This s O
study d O
demonstrates o O
a 
 O
novel e O
link k O
between w O
alterations e O
in O O
platelet t B-GENE
- - I-GENE
derived i I-GENE
growth w I-GENE
factor t E-GENE
( 
 O
PDGF F S-GENE
) 
 O
regulation u O
of O O
ornithine i B-GENE
decarboxylase a E-GENE
( 
 O
ODC 	 S-GENE
) 
 O
expression r O
during i O
malignant i O
conversion v O
. 
 O
Circulating c O
immune u O
complexes p O
were e O
determined e O
by O O
the 	 O
method h O
of O O
phagocytosis g O
and 	 O
immunofluorescence u O
. 
 O
The 	 O
human a B-GENE
IFI16 1 I-GENE
gene e E-GENE
is O O
a 
 O
member b O
of O O
an O O
interferon e S-GENE
- 
 O
inducible u O
family i O
of O O
mouse s O
and 	 O
human a O
genes e O
closely s O
linked k O
on O O
syntenic t O
regions i O
of O O
chromosome o O
1 
 O
. 
 O
In O O
agreement e O
with h O
this s O
model e O
, 
 O
elimination m O
of O O
the 	 O
ADAM13 M B-GENE
cytoplasmic o I-GENE
domain a E-GENE
increased r O
developmental e O
alterations e O
attributable r O
to O O
ADAM13 M S-GENE
proteolytic t O
activity i O
. 
 O
Diabetic b O
osteopathy e O
. 
 O
A 
 O
third r O
GEF 	 S-GENE
, 
 O
GRP3 3 S-GENE
( 
 O
KIAA0846 A S-GENE
) 
 O
, 
 O
activated i O
both h O
Ras 	 S-GENE
and 	 O
Rap1 1 S-GENE
and 	 O
shared r O
significant n O
sequence u O
homology o O
with h O
the 	 O
calcium c O
- 
 O
and 	 O
diacylglycerol c O
- 
 O
activated i O
GEFs s S-GENE
, 
 O
GRP1 1 S-GENE
and 	 O
GRP2 2 S-GENE
. 
 O
A 
 O
new 	 O
simple p O
identification n O
of O O
rheumatoid u B-GENE
factor t E-GENE
on O O
nitrocellulose r O
was 	 O
developed e O
that t O
allows o O
quantitative n O
detection e O
. 
 O
Comparisons p O
of O O
defective e O
HTLV V B-GENE
- 
 I-GENE
I 
 I-GENE
proviruses v E-GENE
predict d O
the 	 O
mode e O
of O O
origin g O
and 	 O
coding i O
potential e O
of O O
internally e O
deleted e O
genomes o O
. 
 O
Reversal e O
of O O
biliary i O
sphincter i O
spasm s O
with h O
low 	 O
dose e O
glucagon c S-GENE
during i O
operative r O
cholangiography l O
. 
 O
Previous v O
studies d O
have e O
shown w O
that t O
the 	 O
IME1 1 B-GENE
gene e E-GENE
is O O
required u O
for 	 O
sporulation r O
and 	 O
the 	 O
expression r O
of O O
meiosis o O
specific c O
genes e O
in O O
Saccharomyces c O
cerevisiae e O
. 
 O
A 
 O
case e O
comparison p O
of O O
acquired u O
immune u O
deficiency i O
syndrome d O
( 
 O
AIDS S O
) 
 O
in O O
homosexual o O
males e O
with h O
spindle n O
- 
 O
endothelial o O
cell l O
abnormalities o O
and 	 O
with h O
recrudescent r O
melioidosis i O
. 
 O
Intrathecal r O
injections e O
of O O
small l O
volumes u O
of O O
the 	 O
alpha h B-GENE
2 - I-GENE
- - I-GENE
adrenoceptor e E-GENE
agonists n O
, 
 O
xylazine a O
and 	 O
clonidine n O
, 
 O
into o O
the 	 O
cervical v O
region i O
of O O
the 	 O
spinal n O
cord d O
of O O
conscious s O
unrestrained e O
sheep e O
produced d O
a 
 O
dose e O
- 
 O
dependent e O
analgesia l O
of O O
the 	 O
forelimbs e O
as O O
measured s O
using n O
a 
 O
mechanical h O
pressure s O
device i O
. 
 O
Second o O
, 
 O
CGGA A O
- 
 O
containing t O
sequences u O
placed c O
at O O
- 
 O
88 O O
in O O
the 	 O
delta t O
MTV 	 O
- - O
CAT 	 S-GENE
reporter o O
plasmid s O
conferred f O
insulin u S-GENE
responsiveness p O
to O O
the 	 O
mammary m O
tumor o O
virus u O
promoter m O
. 
 O
In O O
the 	 O
absence e O
of O O
c - B-GENE
- - I-GENE
fos 	 I-GENE
gene e E-GENE
expression r O
, 
 O
c - B-GENE
- - I-GENE
Fos 	 I-GENE
protein t E-GENE
appears e O
to O O
be O O
replaced l O
by O O
proteins t O
of O O
Fos 	 B-GENE
family i E-GENE
( 
 O
Fra 	 B-GENE
- - I-GENE
1 - E-GENE
) 
 O
and 	 O
ATF 	 B-GENE
family i E-GENE
( 
 O
ATF 	 B-GENE
- - I-GENE
2 - E-GENE
and 	 O
ATFa a S-GENE
) 
 O
. 
 O
The 	 O
dopamine a B-GENE
D1 I I-GENE
dopamine a I-GENE
receptor e E-GENE
antagonist a O
SCH 	 O
23390 9 O
dose e O
dependently e O
( 
 O
7 
 O
. 
 O
5 
 O
- 
 O
30 O O
micrograms r O
/ 
 O
kg O O
s 
 O
. 
 O
c 
 O
. 
 O
) 
 O
antagonized a O
the 	 O
stimulant m O
locomotor o O
effect e O
on O O
both h O
drugs g O
but 	 O
did 	 O
not 	 O
prevent v O
their i O
antiimmobility i O
effect e O
on O O
the 	 O
behavioral a O
despair p O
test t O
. 
 O
The 	 O
results u O
obtained a O
show w O
that t O
expression r O
of O O
the 	 O
gene e O
is O O
low 	 O
at O O
23 O O
degrees r O
C 
 O
and 	 O
is O O
induced u O
rapidly i O
at O O
37 O O
degrees r O
C 
 O
. 
 O
Characterization r O
of O O
Chlamydomonas a O
reinhardtii n O
zygote o O
- 
 O
specific c O
cDNAs A O
that t O
encode o O
novel e O
proteins t O
containing t O
ankyrin y B-GENE
repeats e E-GENE
and 	 O
WW O B-GENE
domains a E-GENE
. 
 O
Adenomas n O
in O O
the 	 O
upper e O
gastrointestinal t O
tract c O
were e O
found n O
in O O
all 	 O
of O O
the 	 O
patients i O
: 
 O
Vater e O
' 
 O
s 
 O
papilla i O
- 
 O
- 
 O
12 O O
, 
 O
duodenum d O
- 
 O
- 
 O
nine e O
, 
 O
and 	 O
gastric t O
antrum r O
- 
 O
- 
 O
seven e O
. 
 O
Microenvironments r O
dominated i O
by O O
cyanobacteria n O
( 
 O
BPC 	 O
) 
 O
had 	 O
a 
 O
higher h O
pH O O
( 
 O
pH O O
7 
 O
- 
 O
8 
 O
) 
 O
than n O
those s O
dominated i O
by O O
lichen h O
( 
 O
LTL 	 O
) 
 O
( 
 O
pH O O
4 
 O
. 
 O
5 
 O
- 
 O
5 
 O
. 
 O
5 
 O
) 
 O
. 
 O
A 
 O
total a O
of O O
64 O O
uncomplicated o O
Type e O
- 
 O
2 
 O
diabetic b O
individuals i O
of O O
higher h O
middle d O
class s O
to O O
rich h O
socio i O
- 
 O
economic n O
status t O
were e O
studied d O
. 
 O
A 
 O
drop p O
of O O
methylprednisolone h O
acetate t O
or O O
vehicle i O
constituent s O
was 	 O
placed c O
on O O
the 	 O
dissected s O
plantar n O
nerve v O
proximal x O
to O O
the 	 O
stimulating m O
electrodes c O
after e O
recording o O
control t O
responses p O
( 
 O
A 
 O
- 
 O
fibre r O
volley l O
in O O
the 	 O
sciatic a O
nerve v O
and 	 O
C 
 O
- 
 O
fibre r O
evoked k O
reflex l O
discharge c O
in O O
flexor x O
motoneurons o O
) 
 O
. 
 O
Basic i B-GENE
helix i I-GENE
- - I-GENE
loop p I-GENE
- - I-GENE
helix i I-GENE
proteins t E-GENE
can 	 O
act 	 O
at O O
the 	 O
E 
 O
- 
 O
box 	 O
within h O
the 	 O
serum u O
response p O
element m O
of O O
the 	 O
c - B-GENE
- - I-GENE
fos 	 I-GENE
promoter m E-GENE
to O O
influence l O
hormone m O
- 
 O
induced u O
promoter m O
activation i O
in O O
Sertoli t O
cells l O
. 
 O
Using n O
yeast s O
two 	 O
- 
 O
hybrid r O
screening e O
, 
 O
we O O
isolated l O
histone t B-GENE
H3 E E-GENE
as O O
an O O
interacting e O
factor t O
of O O
CIA 	 S-GENE
. 
 O
Concentrations c O
of O O
Co O O
, 
 O
Cu O O
, 
 O
Fe O O
, 
 O
Hg O O
, 
 O
Mn O O
, 
 O
Sb O O
, 
 O
Se O O
and 	 O
Zn O O
in O O
IAEA A O
milk k O
( 
 O
dry 	 O
) 
 O
standard n O
A 
 O
- 
 O
11 O O
were e O
re O O
- 
 O
evaluated l O
with h O
the 	 O
help p O
of O O
instrumental t O
and 	 O
radiochemical i O
neutron t O
activation i O
analysis l O
( 
 O
NAA 	 O
) 
 O
. 
 O
Gallstone l O
- 
 O
formation m O
has 	 O
traditionally d O
been n O
attributed r O
to O O
supersaturation e O
of O O
bile e O
with h O
cholesterol l O
. 
 O
Sixteen t O
patients i O
on O O
maintenance n O
hemodialysis o O
underwent e O
dialysis l O
with h O
either h O
cuprophane r O
( 
 O
n 
 O
= 
 O
8 
 O
) 
 O
or O O
polymethylmethacrylate y O
( 
 O
PMMA A O
; 
 O
n 
 O
= 
 O
8 
 O
) 
 O
membranes b O
for 	 O
1 
 O
week k O
and 	 O
then n O
switched t O
to O O
the 	 O
opposite o O
membrane b O
during i O
the 	 O
second o O
week k O
. 
 O
Gene e O
expression r O
is O O
in O O
part t O
controlled t O
by O O
chromatin o O
remodeling o O
factors t O
and 	 O
the 	 O
acetylation t O
state t O
of O O
nucleosomal l O
histones t O
. 
 O
Each h O
patient i O
was 	 O
seen n O
for 	 O
5 
 O
to O O
13 O O
postsurgical t O
maintenance n O
visits i O
. 
 O
Furthermore t O
, 
 O
Grap p S-GENE
is O O
associated o O
with h O
a 
 O
Ras 	 B-GENE
guanine n I-GENE
nucleotide l I-GENE
exchange h I-GENE
factor t I-GENE
mSos1 s E-GENE
, 
 O
primarily m O
through o O
its 	 O
N - O
- - O
terminal m O
SH3 	 B-GENE
domain a E-GENE
. 
 O
Recurrent u O
infections e O
, 
 O
episodic s O
lymphopenia p O
and 	 O
impaired a O
cellular l O
immunity u O
. 
 O
After e O
3 
 O
months t O
of O O
intervention e O
, 
 O
sustained t O
physical s O
training i O
was 	 O
associated o O
with h O
the 	 O
decrease r O
of O O
FVII I O
and 	 O
PAI 	 B-GENE
- - I-GENE
1 - E-GENE
levels e O
. 
 O
Thirty r O
- 
 O
three e O
percent c O
had 	 O
elevated v O
titers e O
( 
 O
above v O
1 
 O
: 
 O
20 O O
dilution u O
) 
 O
. 
 O
Xa4 	 S-GENE
is O O
a 
 O
dominantly i O
inherited e O
rice e O
gene e O
that t O
confers f O
resistance i O
to O O
Philippine l O
race e O
1 
 O
of O O
the 	 O
bacterial t O
blight g O
pathogen h O
Xanthomonas t O
oryzae z O
pv O O
. 
 O
oryzae z O
in O O
rice e O
. 
 O
In O O
uraemic e O
patients i O
, 
 O
similar i O
maximum i O
serum u O
concentrations c O
were e O
found n O
after e O
a 
 O
single g O
7 
 O
. 
 O
5 
 O
mg O O
/ 
 O
kg O O
iv O O
dose e O
. 
 O
The 	 O
effect e O
of O O
buthionine h O
sulfoximine f O
( 
 O
BSO 	 O
) 
 O
and 	 O
disulfiram u O
( 
 O
DSF 	 O
) 
 O
on O O
the 	 O
urotoxicity t O
induced u O
by O O
cyclophosphamide l O
( 
 O
CPA 	 O
) 
 O
was 	 O
examined m O
in O O
mice e O
. 
 O
All 	 O
the 	 O
previously v O
mapped p O
structural u O
protein t O
- 
 O
encoding o O
genes e O
of O O
phage g B-GENE
LL O I-GENE
- 
 I-GENE
H 
 E-GENE
were e O
included l O
in O O
the 	 O
sequence u O
. 
 O
When n O
a 
 O
longer g O
- 
 O
714 	 O
to O O
+ 
 O
78 O O
fragment g O
of O O
the 	 O
PBGD D B-GENE
promoter m E-GENE
is O O
used d O
, 
 O
the 	 O
- 
 O
70 O O
GATA A O
mutant a O
still l O
displays p O
erythroid t O
- 
 O
specific c O
activity i O
and 	 O
is O O
cis 	 O
- 
 O
activated i O
by O O
the 	 O
5 - B-GENE
' - I-GENE
HS I I-GENE
- - I-GENE
2 - I-GENE
enhancer a E-GENE
, 
 O
while l O
the 	 O
- 
 O
100 	 O
CCACC C O
mutant a O
is O O
completely p O
inactive c O
in O O
the 	 O
absence e O
or O O
in O O
the 	 O
presence s O
of O O
the 	 O
5 - B-GENE
' - I-GENE
HS I I-GENE
- - I-GENE
2 - I-GENE
enhancer a E-GENE
. 
 O
Surprisingly p O
, 
 O
in O O
adult l O
animals m O
, 
 O
the 	 O
suprabasal r O
expression r O
of O O
dnRXR X B-GENE
alpha h E-GENE
significantly n O
reduced u O
the 	 O
ability l O
of O O
topically i O
applied l O
tRA 	 O
to O O
stimulate m O
proliferation l O
of O O
undifferentiated i O
keratinocytes a O
in O O
the 	 O
basal a O
layer e O
of O O
epidermis d O
. 
 O
In O O
many y O
other e O
contractile t O
protein t O
gene e O
families i O
, 
 O
genes e O
encoding o O
cardiac d O
isoforms f O
are 	 O
expressed r O
early l O
in O O
skeletal l O
muscle c O
development e O
and 	 O
are 	 O
later e O
repressed r O
. 
 O
1995 5 O
. 
 O
For 	 O
il8ra r S-GENE
, 
 O
it O O
is O O
formed m O
from m O
two 	 O
exons n O
, 
 O
whereas r O
for 	 O
il8rb r S-GENE
, 
 O
seven e O
distinct t O
neutrophil t O
mRNAs A O
are 	 O
formed m O
by O O
alternative e O
splicing i O
of O O
11 O O
exons n O
. 
 O
Endocarditis o O
remains a O
a 
 O
life e O
- 
 O
threatening e O
disease e O
with h O
substantial s O
morbidity b O
and 	 O
mortality t O
. 
 O
The 	 O
gene e O
encoding o O
the 	 O
cellulase l S-GENE
( 
 O
Avicelase c S-GENE
) 
 O
Cel1 1 S-GENE
from m O
Streptomyces e O
reticuli i O
and 	 O
analysis l O
of O O
protein t O
domains a O
. 
 O
From m O
this s O
comparison p O
of O O
aa O O
sequences u O
, 
 O
the 	 O
ATPK7 K B-GENE
protein t E-GENE
is O O
considered s O
to O O
be O O
a 
 O
member b O
of O O
a 
 O
novel e O
subfamily f O
of O O
Ser 	 B-GENE
/ - I-GENE
Thr 	 I-GENE
PKs 	 E-GENE
in O O
plants n O
. 
 O
Of O O
these s O
, 
 O
23 O O
( 
 O
13 O O
. 
 O
6 
 O
% 
 O
) 
 O
were e O
due 	 O
to O O
GIB 	 O
( 
 O
Upper e O
GIB 	 O
= 
 O
19 O O
, 
 O
Lower e O
GIB 	 O
= 
 O
4 
 O
) 
 O
. 
 O
The 	 O
E 
 O
. 
 O
multilocularis t O
/ 
 O
Mongolian g O
gerbil b O
system t O
can 	 O
replace l O
the 	 O
natural u O
canid i O
hosts t O
as O O
a 
 O
new 	 O
way 	 O
to O O
obtain a O
infective e O
eggs s O
and 	 O
to O O
analyze l O
host t O
- 
 O
parasite a O
interactions e O
. 
 O
E1 S B-GENE
recognition o I-GENE
sequences u E-GENE
in O O
the 	 O
bovine i O
papillomavirus i O
type e O
1 
 O
origin g O
of O O
DNA 	 O
replication l O
: 
 O
interaction e O
between w O
half f O
sites e O
of O O
the 	 O
inverted e O
repeats e O
. 
 O
We O O
found n O
that t O
secretion r O
of O O
chitinolytic t O
enzymes y O
by O O
cultured t O
L 
 O
. 
 O
major o O
parasites a O
is O O
inhibited i O
by O O
blood o O
or O O
hemoglobin o S-GENE
, 
 O
and 	 O
hence c O
these s O
enzymes y O
are 	 O
apparently a O
absent e O
from m O
the 	 O
blood o O
- 
 O
fed 	 O
infected e O
flies e O
, 
 O
where r O
the 	 O
cardiac d O
valve v O
appears e O
undamaged a O
. 
 O
Patients i O
in O O
the 	 O
mucinous i O
cyst t O
group u O
had 	 O
significantly n O
lower e O
CA B O
125 	 O
cystic t O
fluid i O
levels e O
compared p O
with h O
women e O
with h O
endometriomas o O
and 	 O
dermoids m O
( 
 O
P 
 O
& 
 O
lt O O
; 
 O
0 
 O
. 
 O
05 O O
) 
 O
. 
 O
SATB1 B S-GENE
interacted e O
with h O
CDP 	 S-GENE
through o O
its 	 O
DNA 	 O
- 
 O
binding d O
domain a O
, 
 O
as O O
demonstrated o O
by O O
glutathione t B-GENE
S - I-GENE
- - I-GENE
transferase n E-GENE
( 
 O
GST 	 S-GENE
) 
 O
pull l O
- 
 O
down n O
assays a O
. 
 O
Plasma s O
prolactin l S-GENE
concentrations c O
in O O
pinealectomized e O
ewes s O
receiving e O
melatonin a O
treatment a O
and 	 O
in O O
pineal e O
intact a O
ewes s O
maintained n O
under e O
a 
 O
non 	 O
- 
 O
24 O O
- 
 O
hour r O
photoperiod t O
. 
 O
It O O
is O O
targeted g O
to O O
peroxisomes o O
when n O
expressed r O
in O O
mammalian m O
cells l O
and 	 O
yeast s O
. 
 O
The 	 O
transcriptional n O
start r O
site e O
, 
 O
identified n O
by O O
primer m O
extension e O
and 	 O
S1 B B-GENE
nuclease l E-GENE
assay a O
, 
 O
is O O
34 O O
nt O O
upstream t O
of O O
the 	 O
translation n O
initiation t O
codon o O
. 
 O
Nonlinearities l O
in O O
cochlear h O
hydrodynamics r O
. 
 O
Electronic c O
structure u O
and 	 O
optical i O
properties p O
of O O
the 	 O
B12O2 O O
crystal s O
. 
 O
Spongiosa n O
regeneration e O
in O O
the 	 O
millipore l O
chamber m O
The 	 O
predicted d O
5 
 O
' 
 O
and 	 O
3 
 O
' 
 O
ends s O
of O O
the 	 O
transcript n O
are 	 O
in O O
very y O
good d O
agreement e O
with h O
the 	 O
previously v O
determined e O
size e O
of O O
the 	 O
LEU3 3 O
message s O
. 
 O
This s O
cDNA A O
corresponded r O
to O O
FGF 	 B-GENE
- - I-GENE
binding d I-GENE
protein t E-GENE
( 
 O
FGF 	 B-GENE
- - I-GENE
BP E E-GENE
) 
 O
, 
 O
a 
 O
secreted r O
protein t O
previously v O
shown w O
to O O
bind d O
acidic d O
and 	 O
basic i B-GENE
FGF 	 E-GENE
and 	 O
to O O
modulate u O
their i O
activities i O
. 
 O
Analysis l O
of O O
replicative l O
intermediates e O
shows w O
that t O
plasmid s O
YRp7 7 O
, 
 O
which c O
contains t O
the 	 O
chromosomal o O
replicator l O
ARS1 1 S-GENE
, 
 O
initiates t O
bidirectional i O
replication l O
in O O
a 
 O
100 	 O
bp O O
region i O
within h O
the 	 O
sequence u O
required u O
for 	 O
autonomous o O
replication l O
in O O
vivo o O
. 
 O
Such h O
results u O
suggest g O
that t O
there r O
are 	 O
no O O
differences f O
in O O
the 	 O
BMR 	 O
of O O
age 	 O
- 
 O
and 	 O
weight g O
- 
 O
matched c O
Asian a O
Indian i O
males e O
, 
 O
other e O
tropical p O
populations u O
and 	 O
Americans r O
. 
 O
Rewarding a O
properties p O
of O O
methylphenidate h O
: 
 O
sensitization s O
by O O
prior o O
exposure o O
to O O
the 	 O
drug g O
and 	 O
effects e O
of O O
dopamine a O
D1 I O
- - O
and 	 O
D2 I B-GENE
- - I-GENE
receptor e E-GENE
antagonists a O
. 
 O
Similar i O
to O O
what t O
was 	 O
observed e O
for 	 O
P 
 O
. 
 O
putida i O
, 
 O
a 
 O
psrA A S-GENE
null l O
mutant a O
of O O
P 
 O
. 
 O
aeruginosa u O
also o O
showed w O
a 
 O
90 O O
% 
 O
reduction u O
in O O
rpoS S B-GENE
promoter m E-GENE
activity i O
; 
 O
both h O
mutants a O
could l O
be O O
complemented p O
for 	 O
rpoS S B-GENE
promoter m E-GENE
activity i O
when n O
the 	 O
psrA A B-GENE
gene e E-GENE
was 	 O
provided v O
in O O
trans n O
. 
 O
psrA A B-GENE
mutants a E-GENE
of O O
both h O
Pseudomonas u O
species c O
lost t O
the 	 O
ability l O
to O O
induce u O
rpoS S S-GENE
expression r O
at O O
stationary t O
phase s O
, 
 O
but 	 O
they y O
retained a O
the 	 O
ability l O
to O O
produce d O
quorum r O
- 
 O
sensing s O
autoinducer o O
molecules e O
. 
 O
The 	 O
role e O
of O O
the 	 O
putative a O
C2 S B-GENE
domain a E-GENE
of O O
Nedd4 d S-GENE
has 	 O
not 	 O
been n O
elucidated c O
. 
 O
ZF87 7 S-GENE
specifically c O
binds d O
the 	 O
ME1a1 a B-GENE
element m E-GENE
with h O
higher h O
affinity i O
than n O
the 	 O
ME1a2 a B-GENE
element m E-GENE
. 
 O
We O O
found n O
a 
 O
significant n O
increase r O
of O O
thromboxane o O
as O O
evidenced d O
by O O
the 	 O
major o O
urinary n O
metabolite a O
2 
 O
, 
 O
3 
 O
- 
 O
dinorthromboxane o O
B2 O O
in O O
the 	 O
oestrogen t O
group u O
as O O
compared p O
to O O
the 	 O
orchidectomy h O
group u O
. 
 O
Multivariable t O
logistic i O
regression r O
showed w O
that t O
mean n O
blood o O
glucose c O
level e O
for 	 O
the 	 O
first s O
2 
 O
days s O
( 
 O
p 
 O
= 
 O
0 
 O
. 
 O
002 	 O
) 
 O
, 
 O
obesity s O
( 
 O
p 
 O
< 
 O
0 
 O
. 
 O
002 	 O
) 
 O
, 
 O
and 	 O
use 	 O
of O O
the 	 O
internal e O
mammary m O
artery e O
( 
 O
p 
 O
< 
 O
0 
 O
. 
 O
02 O O
) 
 O
were e O
all 	 O
independent e O
predictors d O
of O O
deep p O
wound n O
infection e O
. 
 O
However e O
the 	 O
precise c O
function c O
of O O
DNA 	 O
- - O
PK E O
in O O
DNA 	 O
double b O
- 
 O
strand a O
break a O
repair a O
is O O
not 	 O
known w O
. 
 O
This s O
new 	 O
receptor e O
, 
 O
TOR 	 S-GENE
( 
 O
thymus m B-GENE
orphan h I-GENE
receptor e E-GENE
) 
 O
, 
 O
is O O
most t O
closely s O
related a O
in O O
both h O
its 	 O
DNA 	 O
- 
 O
binding d O
domain a O
and 	 O
ligand a O
- 
 O
binding d O
domain a O
, 
 O
90 O O
% 
 O
and 	 O
53 O O
% 
 O
, 
 O
respectively p O
, 
 O
to O O
ROR 	 B-GENE
alpha h E-GENE
/ 
 O
RZR 	 B-GENE
alpha h E-GENE
and 	 O
clusters s O
with h O
these s O
two 	 O
receptors e O
and 	 O
RZR 	 B-GENE
beta a E-GENE
in O O
a 
 O
phylogenetic l O
tree e O
, 
 O
when n O
both h O
the 	 O
DNA 	 O
- 
 O
binding d O
domain a O
and 	 O
the 	 O
ligand a O
- 
 O
binding d O
domain a O
sequences u O
of O O
nuclear l O
receptors e O
are 	 O
compared p O
. 
 O
In O O
this s O
report o O
, 
 O
we O O
have e O
examined m O
whether t O
PTP1B 1 S-GENE
effects e O
transformation n O
induced u O
by O O
p210 0 S-GENE
bcr 	 S-GENE
- 
 O
abl 	 S-GENE
. 
 O
S1 B B-GENE
nuclease l E-GENE
analysis l O
of O O
the 	 O
RNA 	 O
from m O
a 
 O
number b O
of O O
QT6 	 B-GENE
- 
 I-GENE
LD O E-GENE
clones n O
gave e O
similar i O
results u O
, 
 O
indicating i O
that t O
the 	 O
LD O O
population u O
was 	 O
composed p O
of O O
viruses u O
with h O
similar i O
but 	 O
not 	 O
identical n O
deletion e O
endpoints p O
. 
 O
Association o O
of O O
Smads d S-GENE
with h O
lymphoid p B-GENE
enhancer a I-GENE
binding d I-GENE
factor t I-GENE
1 - I-GENE
/ 
 I-GENE
T - I-GENE
cell l I-GENE
- - I-GENE
specific c I-GENE
factor t E-GENE
mediates i O
cooperative p O
signaling n O
by O O
the 	 O
transforming n B-GENE
growth w I-GENE
factor t I-GENE
- - I-GENE
beta a E-GENE
and 	 O
wnt 	 S-GENE
pathways h O
. 
 O
The 	 O
three e O
OAS 	 B-GENE
genes e E-GENE
are 	 O
flanked n O
by O O
markers k O
WI I O
- - O
10614 1 O
( 
 O
cen 	 O
) 
 O
and 	 O
D12S2293 S O
( 
 O
tel 	 O
) 
 O
and 	 O
are 	 O
contained t O
within h O
three e O
sets s O
of O O
overlapping r O
cosmid m O
clones n O
. 
 O
22 O O
. 
 O
6 
 O
% 
 O
of O O
patients i O
were e O
found n O
to O O
be O O
positive i O
at O O
histology t O
in O O
the 	 O
corpus p O
mucosa o O
; 
 O
all 	 O
but 	 O
one 	 O
of O O
these s O
patients i O
had 	 O
elevated v O
circulating c O
IgG 	 S-GENE
to O O
H 
 O
. 
 O
pylori o O
( 
 O
Group u O
C 
 O
) 
 O
. 
 O
Rottlerin t S-GENE
also o O
inhibited i O
the 	 O
activation i O
of O O
MAP 	 B-GENE
kinase a I-GENE
kinase a E-GENE
( 
 O
MEK 	 S-GENE
) 
 O
in O O
response p O
to O O
activated i O
Raf 	 S-GENE
, 
 O
but 	 O
had 	 O
no O O
effect e O
upon n O
c - B-GENE
- - I-GENE
Raf 	 E-GENE
activity i O
or O O
ERK 	 S-GENE
activation i O
by O O
activated i O
MEK 	 S-GENE
. 
 O
Quasidiatomic s O
study d O
of O O
Ly O B-GENE
- 
 I-GENE
alpha h E-GENE
- 
 O
producing d O
H2 O O
+ 
 O
- 
 O
Ne O O
collisions l O
at O O
keV 	 S-GENE
energies r O
. 
 O
The 	 O
NH O O
( 
 O
2 
 O
) 
 O
- 
 O
terminus m O
of O O
all 	 O
three e O
proteins t O
contains t O
a 
 O
POZ 	 B-GENE
domain a E-GENE
, 
 O
a 
 O
conserved s O
120 	 O
amino n O
acid d O
motif i O
involved o O
in O O
transcriptional n O
repression r O
and 	 O
protein t O
dimerization e O
. 
 O
The 	 O
isolation l O
of O O
crt5 5 B-GENE
- - I-GENE
262 	 E-GENE
, 
 O
an O O
additional i O
cdc 	 O
allele e O
of O O
POL1 1 S-GENE
/ 
 O
CDC17 1 S-GENE
, 
 O
suggests g O
for 	 O
the 	 O
first s O
time e O
that t O
directly e O
blocking c O
DNA 	 O
replication l O
can 	 O
provide v O
a 
 O
signal n O
to O O
induce u O
the 	 O
DNA 	 O
damage a O
response p O
. 
 O
crt2 2 B-GENE
mutants a E-GENE
show w O
a 
 O
defect e O
in O O
basal a O
level e O
expression r O
of O O
RNR1 1 S-GENE
- 
 O
lacZ Z S-GENE
reporter o O
constructs s O
. 
 O
Greer e O
, 
 O
and 	 O
L 
 O
. 
 O
A 
 O
. 
 O
We O O
prospectively s O
studied d O
serum u B-GENE
prolactin l E-GENE
( 
 O
PRL 	 S-GENE
) 
 O
elevation v O
after e O
different f O
types e O
of O O
documented u O
seizures z O
in O O
17 O O
patients i O
. 
 O
However e O
, 
 O
both h O
peptides t O
1 
 O
- 
 O
49 O O
and 	 O
63 O O
- 
 O
87 O O
bound n O
to O O
PDE 	 B-GENE
alpha h I-GENE
/ - I-GENE
beta a E-GENE
in O O
a 
 O
solid i O
- 
 O
phase s O
binding d O
assay a O
. 
 O
Values u O
of O O
K1 O O
and 	 O
Vd O O
were e O
significantly n O
increased r O
in O O
the 	 O
tumour o O
tissue s O
. 
 O
The 	 O
mutation a O
also o O
preferentially f O
limits i O
( 
 O
compared p O
with h O
total a O
protein t O
synthesis t O
) 
 O
translation n O
of O O
an O O
induced u O
gene e O
that t O
depends e O
on O O
five e O
AGA 	 O
codons o O
, 
 O
i 
 O
. 
 O
e 
 O
. 
 O
, 
 O
the 	 O
lambda b B-GENE
cI I I-GENE
repressor r I-GENE
gene e E-GENE
. 
 O
Five e O
RNA 	 O
transcripts n O
of O O
about u O
1 
 O
. 
 O
2 
 O
to O O
1 
 O
. 
 O
7 
 O
kilobases o O
were e O
mapped p O
to O O
a 
 O
part t O
of O O
the 	 O
genome o O
of O O
insect e O
iridescent d O
virus u O
type e O
6 
 O
( 
 O
Chilo l O
iridescent d O
virus u O
; 
 O
CIV 	 O
) 
 O
between w O
genome o O
coordinates r O
0 
 O
. 
 O
832 	 O
and 	 O
0 
 O
. 
 O
856 	 O
within h O
the 	 O
EcoRI R B-GENE
DNA 	 I-GENE
fragment g I-GENE
F - E-GENE
. 
 O
Other e O
similar i O
patients i O
must t O
be O O
found n O
before o O
it O O
is O O
established a O
that t O
the 	 O
colloid l O
cyst t O
is O O
part t O
of O O
the 	 O
nevoid o O
basal a O
cell l O
carcinoma c O
syndrome d O
. 
 O
Portions t O
of O O
the 	 O
3 
 O
' 
 O
- 
 O
coding i O
and 	 O
3 
 O
' 
 O
- 
 O
untranslated r O
regions i O
were e O
found n O
to O O
be O O
missing s O
from m O
the 	 O
7 - O
. - O
2 - O
- - O
and 	 O
4 - O
. - O
8 - O
- - O
kb I O
topo o O
II I O
alpha h O
mRNAs A O
by O O
Northern t O
blot t O
analysis l O
. 
 O
In O O
addition i O
, 
 O
a 
 O
double b O
mutant a O
( 
 O
E482A 2 O
, 
 O
D489A 9 O
) 
 O
which c O
removed o O
negative a O
charges r O
along n O
one 	 O
side e O
of O O
the 	 O
helix i O
had 	 O
negligible l O
effects e O
on O O
fusion i O
activity i O
. 
 O
A 
 O
GTP 	 O
/ 
 O
GDP 	 O
exchange h O
assay a O
was 	 O
used d O
to O O
assess e O
the 	 O
potential e O
role e O
of O O
Ras 	 S-GENE
in O O
the 	 O
pathway h O
leading d O
to O O
ERK 	 S-GENE
phosphorylation s O
; 
 O
DADLE L S-GENE
failed l O
to O O
stimulate m O
GTP 	 O
/ 
 O
GDP 	 O
exchange h O
in O O
comparison p O
to O O
PMA 	 O
. 
 O
Phenotypic n O
analysis l O
demonstrates o O
that t O
trio o O
and 	 O
Abl 	 S-GENE
cooperate p O
in O O
regulating u O
axon n O
outgrowth g O
in O O
the 	 O
embryonic r O
central t O
nervous v O
system t O
( 
 O
CNS 	 O
) 
 O
. 
 O
Recombinant o B-GENE
caspases p E-GENE
are 	 O
typically i O
produced d O
in O O
Escherichia h O
coli i O
expression r O
systems t O
with h O
the 	 O
attendant e O
problems b O
of O O
solubilization u O
, 
 O
re O O
- 
 O
folding d O
and 	 O
activation i O
of O O
the 	 O
protease t O
. 
 O
The 	 O
gene e O
encoding o O
rat 	 B-GENE
peptidylglycine t I-GENE
alpha h I-GENE
- - I-GENE
amidating d I-GENE
monooxygenase o E-GENE
( 
 O
PAM 	 S-GENE
) 
 O
contains t O
26 O O
protein t O
- 
 O
coding i O
exons n O
. 
 O
This s O
bound n O
[ 
 O
3H O O
] 
 O
iloprost p O
with h O
high h O
affinity i O
and 	 O
stimulated m O
cAMP P O
production d O
when n O
exposed o O
to O O
agonist n O
. 
 O
Structure u O
of O O
the 	 O
connective n O
stroma o O
of O O
the 	 O
epididymis d O
in O O
the 	 O
zebu u O
Free e O
protein t B-GENE
S - E-GENE
deficiency i O
in O O
acute t O
ischemic h O
stroke o O
. 
 O
In O O
a 
 O
series i O
of O O
papers e O
, 
 O
the 	 O
staging g O
system t O
for 	 O
melanoma a O
was 	 O
critically t O
analyzed l O
, 
 O
and 	 O
many y O
shortcomings r O
were e O
identified n O
. 
 O
Reproduction r O
and 	 O
maternal e O
response p O
of O O
the 	 O
rat 	 O
when n O
thiamine a O
intake a O
is O O
limited i O
. 
 O
Total a O
meso o O
- 
 O
pore e O
volume u O
and 	 O
surface f O
area a O
ranged g O
from m O
0 
 O
. 
 O
004 	 O
- 
 O
0 
 O
. 
 O
08 O O
cm3 	 O
g 
 O
( 
 O
- 
 O
1 
 O
) 
 O
and 	 O
from m O
0 
 O
. 
 O
33 O O
- 
 O
6 
 O
. 
 O
9 
 O
m2 O O
g 
 O
( 
 O
- 
 O
1 
 O
) 
 O
respectively p O
, 
 O
accounting o O
for 	 O
up O O
33 O O
% 
 O
of O O
the 	 O
BET 	 O
surface f O
area a O
. 
 O
The 	 O
NF B B-GENE
- - I-GENE
kappa p I-GENE
B - I-GENE
precursor c I-GENE
p100 0 E-GENE
( 
 O
lyt 	 B-GENE
- - I-GENE
10 E E-GENE
, 
 O
p97 	 S-GENE
, 
 O
p98 	 S-GENE
) 
 O
generates e O
after e O
proteolytic t O
processing c O
a 
 O
52 O O
kDa 	 O
subunit u O
, 
 O
which c O
can 	 O
bind d O
to O O
kappa p B-GENE
B - I-GENE
- - I-GENE
motifs i E-GENE
. 
 O
CONCLUSION C O
: 
 O
The 	 O
biodistribution d O
of O O
111In I B-GENE
IgG 	 E-GENE
is O O
similar i O
to O O
that t O
of O O
99mTc T O
- 
 O
HMPAO A O
- 
 O
labeled e O
leukocytes k O
. 
 O
Based e O
on O O
29 O O
determinations e O
of O O
the 	 O
glucose c O
from m O
sinigrin i O
, 
 O
analyzed l O
under e O
different f O
conditions d O
, 
 O
accuracy u O
of O O
the 	 O
total a O
glucosinolate c O
determination e O
was 	 O
94 O O
. 
 O
8 
 O
+ 
 O
/ 
 O
- 
 O
7 
 O
. 
 O
3 
 O
% 
 O
. 
 O
Receptor e B-GENE
- - I-GENE
type e I-GENE
serine i I-GENE
/ - I-GENE
threonine e I-GENE
kinases a E-GENE
( 
 O
RSKs s S-GENE
) 
 O
have e O
been n O
organized a O
into o O
two 	 O
distinct t O
classes s O
known w O
as O O
types e O
I 
 O
and 	 O
II O O
on O O
the 	 O
basis i O
of O O
sequence u O
similarity i O
. 
 O
In O O
a 
 O
previous v O
study d O
of O O
transforming n B-GENE
growth w I-GENE
factor t I-GENE
- - I-GENE
beta1 a E-GENE
- 
 O
mediated i O
inhibition i O
of O O
the 	 O
cyclin l B-GENE
A - I-GENE
promoter m E-GENE
, 
 O
we O O
mapped p O
the 	 O
inhibitory i O
effect e O
to O O
the 	 O
ATF 	 B-GENE
site e E-GENE
; 
 O
in O O
the 	 O
present s O
study d O
of O O
IFN 	 B-GENE
- - I-GENE
gamma m E-GENE
treatment a O
, 
 O
functional c O
analysis l O
by O O
transient n O
transfection n O
showed w O
that t O
inhibition i O
of O O
the 	 O
cyclin l B-GENE
A - I-GENE
promoter m E-GENE
persisted s O
despite p O
mutation a O
of O O
the 	 O
ATF 	 S-GENE
, 
 O
NF B B-GENE
- - I-GENE
Y - E-GENE
, 
 O
or O O
CDE 	 O
elements m O
. 
 O
The 	 O
RsmA A B-GENE
- - I-GENE
mutant a E-GENE
, 
 O
like e O
its 	 O
parent e O
, 
 O
produces d O
N 
 O
- 
 O
( 
 O
3 
 O
- 
 O
oxohexanoyl h O
) 
 O
- 
 O
L 
 O
- 
 O
homoserine o O
lactone t O
( 
 O
HSL 	 O
) 
 O
, 
 O
a 
 O
starvation r O
/ 
 O
cell l O
density s O
- 
 O
sensing s O
signal n O
required u O
for 	 O
extracellular r O
enzyme y O
production d O
. 
 O
The 	 O
inactive c O
X 
 B-GENE
allele e E-GENE
, 
 O
however e O
, 
 O
is O O
hypermethylated e O
in O O
leukocytes k O
, 
 O
presumably s O
reflecting l O
early l O
X 
 O
inactivation c O
events n O
that t O
become o O
important o O
for 	 O
gene e O
dosage a O
in O O
expressing r O
lineages e O
. 
 O
Intensive e O
therapy r O
of O O
viral a O
hepatitis a O
Also o O
, 
 O
the 	 O
RVW 	 O
hypertrophy e O
, 
 O
the 	 O
IVS 	 O
hypertrophy e O
, 
 O
and 	 O
the 	 O
RV O O
high h O
pressure s O
load d O
to O O
the 	 O
LV O O
through o O
the 	 O
IVS 	 O
may 	 O
be O O
related a O
to O O
the 	 O
small l O
LV O O
, 
 O
high h O
EF O O
, 
 O
and 	 O
abnormal o O
two 	 O
chamber m O
inflow l O
in O O
the 	 O
PS O O
group u O
before o O
BV O O
. 
 O
Analysis l O
of O O
the 	 O
DNA 	 O
- 
 O
binding d O
and 	 O
transcriptional n O
activation i O
functions c O
of O O
human a B-GENE
Fli 	 I-GENE
- - I-GENE
1 - I-GENE
protein t E-GENE
. 
 O
This s O
pattern t O
of O O
expression r O
and 	 O
differential f O
processing c O
suggests g O
a 
 O
role e O
for 	 O
inrpk1 p S-GENE
in O O
some e O
aspect e O
of O O
SD O O
photoperiodic t O
- 
 O
induced u O
flowering w O
in O O
morning n O
glory r O
. 
 O
Progressive g O
immunodeficiency u O
in O O
a 
 O
patient i O
with h O
IgA 	 S-GENE
deficiency i O
RMR 	 O
was 	 O
positively i O
correlated r O
with h O
TEF 	 O
( 
 O
r 
 O
= 
 O
0 
 O
. 
 O
613 	 O
, 
 O
p 
 O
< 
 O
0 
 O
. 
 O
01 O O
) 
 O
and 	 O
net 	 O
TEF 	 O
( 
 O
r 
 O
= 
 O
0 
 O
. 
 O
648 	 O
, 
 O
p 
 O
< 
 O
0 
 O
. 
 O
005 	 O
) 
 O
in O O
the 	 O
luteal e O
but 	 O
not 	 O
the 	 O
follicular l O
phase s O
. 
 O
ESR 	 O
spectra c O
of O O
Er3 	 O
+ 
 O
in O O
SmB6 6 O
single g O
crystals s O
: 
 O
Dynamic a O
Jahn n O
- 
 O
Teller l O
effect e O
in O O
a 
 O
mixed e O
- 
 O
valence e O
compound p O
. 
 O
The 	 O
N 
 O
- 
 O
terminal m O
exon1 n O
had 	 O
no O O
homology o O
at O O
the 	 O
amino n O
acid d O
level e O
with h O
NGFI I B-GENE
- - I-GENE
B - E-GENE
, 
 O
the 	 O
mammalian m O
homologue o O
. 
 O
This s O
paper e O
describes c O
a 
 O
longitudinal g O
study d O
in O O
which c O
clinical n O
parameters a O
and 	 O
aspartate a B-GENE
aminotransferase n E-GENE
( 
 O
AST 	 S-GENE
) 
 O
in O O
gingival g O
crevicular v O
fluid i O
( 
 O
GCF 	 O
) 
 O
were e O
monitored i O
bimonthly o O
over r O
a 
 O
6 
 O
- 
 O
12 O O
months t O
period i O
in O O
970 	 O
sites e O
from m O
7 
 O
treated a O
periodontitis i O
patients i O
. 
 O
We O O
conclude c O
from m O
these s O
observations e O
that t O
the 	 O
cTnC C B-GENE
3 - I-GENE
' - I-GENE
Ile 	 I-GENE
element m E-GENE
is O O
a 
 O
composite p O
enhancer a O
that t O
functions c O
through o O
the 	 O
combined b O
interactions e O
of O O
at O O
least s O
five e O
regulatory u O
elements m O
and 	 O
their i O
cognate n O
binding d O
factors t O
: 
 O
three e O
or O O
four r O
E 
 O
- 
 O
boxes e O
, 
 O
a 
 O
MEF 	 B-GENE
- - I-GENE
2 - I-GENE
site e E-GENE
, 
 O
and 	 O
a 
 O
MEF 	 B-GENE
- - I-GENE
3 - I-GENE
site e E-GENE
. 
 O
The 	 O
analysis l O
consisted s O
of O O
1 
 O
) 
 O
fitting t O
first s O
- 
 O
and 	 O
second o O
- 
 O
order e O
autoregressive o O
models e O
( 
 O
AR1 	 O
and 	 O
AR2 	 O
) 
 O
and 	 O
2 
 O
) 
 O
obtaining a O
the 	 O
power e O
spectra c O
of O O
the 	 O
data a O
by O O
fast t O
- 
 O
Fourier r O
transform n O
. 
 O
We O O
identified n O
Tyr 	 O
( 
 O
112 	 O
) 
 O
and 	 O
Leu 	 O
( 
 O
175 	 O
) 
 O
within h O
the 	 O
RNA 	 O
- 
 O
binding d O
domain a O
of O O
the 	 O
U1 B B-GENE
70K 	 I-GENE
protein t E-GENE
to O O
be O O
cross s O
- 
 O
linked k O
to O O
G 
 O
( 
 O
28 O O
) 
 O
and 	 O
U 
 O
( 
 O
30 O O
) 
 O
in O O
stem m O
- 
 O
loop p O
I 
 O
, 
 O
respectively p O
. 
 O
Kudzu z O
extract r O
shows w O
potential e O
for 	 O
moderating e O
alcohol o O
abuse s O
. 
 O
Furthermore t O
, 
 O
the 	 O
data a O
suggest g O
an O O
immunological u O
non 	 O
- 
 O
responsiveness p O
to O O
enterotoxin e B-GENE
A - E-GENE
in O O
a 
 O
considerable s O
portion t O
of O O
the 	 O
patients i O
. 
 O
BCV 	 O
mRNAs A O
5 - O
and 	 O
5 - O
- - O
1 - O
appear e O
to O O
be O O
used d O
for 	 O
the 	 O
synthesis t O
of O O
the 	 O
12 O O
. 
 O
7 
 O
- 
 O
and 	 O
9 
 O
. 
 O
5 
 O
- 
 O
kDa 	 O
proteins t O
, 
 O
respectively p O
, 
 O
which c O
demonstrates o O
a 
 O
pattern t O
of O O
expression r O
strikingly i O
different f O
from m O
that t O
utilized l O
by O O
MHV 	 S-GENE
. 
 O
Disaster a O
medicine i O
The 	 O
longest g O
S1 O O
- 
 O
S2 O O
interval e O
at O O
which c O
S2 O O
failed l O
to O O
capture t O
( 
 O
effective e O
refractory r O
period i O
) 
 O
was 	 O
longer g O
by O O
5 
 O
. 
 O
5 
 O
+ 
 O
/ 
 O
- 
 O
8 
 O
. 
 O
2 
 O
msec c O
at O O
twice c O
threshold e O
( 
 O
0 
 O
. 
 O
05 O O
less s O
than n O
p 
 O
less s O
than n O
0 
 O
. 
 O
10 O O
) 
 O
and 	 O
5 
 O
. 
 O
5 
 O
+ 
 O
/ 
 O
- 
 O
3 
 O
. 
 O
5 
 O
msec c O
at O O
5 
 O
times e O
threshold e O
stimulation m O
( 
 O
p 
 O
less s O
than n O
0 
 O
. 
 O
01 O O
) 
 O
when n O
the 	 O
basic i O
drive v O
and 	 O
extrastimuli r O
were e O
delivered i O
to O O
separate a O
sites e O
. 
 O
The 	 O
use 	 O
of O O
specific c O
somatic a O
cell l O
hybrids r O
have e O
allowed o O
us O O
to O O
locate a O
the 	 O
YAC 	 O
contig t O
telomeric o O
to O O
the 	 O
D3F15S2 1 B-GENE
locus u E-GENE
, 
 O
in O O
a 
 O
region i O
which c O
is O O
frequently q O
deleted e O
in O O
lung g O
carcinomas c O
. 
 O
Experiments e O
were e O
performed f O
without h O
polarization a O
or O O
with h O
cathodic h O
and 	 O
anodic d O
polarization a O
of O O
the 	 O
adsorbent o O
. 
 O
Chronic o O
active i O
hepatitis a O
and 	 O
cirrhosis r O
of O O
the 	 O
liver e O
. 
 O
This s O
regulation u O
is O O
mediated i O
by O O
several e O
kinases a O
that t O
phosphorylate s O
specific c O
residues i O
in O O
the 	 O
different f O
functional c O
domains a O
of O O
the 	 O
p53 	 B-GENE
molecule e E-GENE
. 
 O
These s O
data a O
show w O
that t O
the 	 O
processing c O
of O O
specific c O
target g O
transcripts n O
, 
 O
such h O
as O O
the 	 O
P - B-GENE
- - I-GENE
element m I-GENE
mRNA A E-GENE
, 
 O
is O O
regulated u O
by O O
a 
 O
functional c O
PSI 	 B-GENE
- 
 I-GENE
U1 S I-GENE
snRNP N E-GENE
interaction e O
in O O
Drosophila s O
. 
 O
Effect e O
of O O
dimethyl e O
sulfoxide f O
on O O
cooling l O
rates e O
of O O
unrestrained e O
rats s O
. 
 O
In O O
four r O
calves v O
given e O
Haemonchus m O
contortus t O
larvae v O
, 
 O
the 	 O
serum u B-GENE
pepsinogen s E-GENE
concentration c O
rose e O
quickly c O
to O O
reach c O
a 
 O
mean n O
of O O
3 
 O
. 
 O
5 
 O
iu O O
tyrosine o O
on O O
day 	 O
14 O O
after e O
infection e O
. 
 O
These s O
results u O
strongly o O
suggest g O
that t O
HSV 	 B-GENE
- 
 I-GENE
1 
 E-GENE
infection e O
inhibits i O
host t O
cell l O
splicing i O
through o O
the 	 O
action i O
of O O
ICP27 2 S-GENE
. 
 O
The 	 O
T 
 O
( 
 O
CCO2 2 O
) 
 O
was 	 O
related a O
to O O
the 	 O
PCO2 2 O
by O O
a 
 O
Pearson r O
product d O
coefficient f O
of O O
0 
 O
. 
 O
79 O O
( 
 O
p 
 O
< 
 O
. 
 O
0005 5 O
) 
 O
, 
 O
with h O
a 
 O
mean n O
difference f O
of O O
1 
 O
. 
 O
94 O O
( 
 O
T 
 O
( 
 O
CCO2 2 O
) 
 O
> 
 O
P 
 O
( 
 O
CO2 	 O
) 
 O
and 	 O
95 O O
% 
 O
confidence f O
interval e O
of O O
- 
 O
0 
 O
. 
 O
12 O O
to O O
4 
 O
. 
 O
07 O O
. 
 O
Transformation n O
of O O
chicken c O
embryo r O
fibroblasts r O
( 
 O
CEF 	 O
) 
 O
with h O
the 	 O
Gag 	 S-GENE
- 
 O
Crk 	 S-GENE
fusion i O
protein t O
results u O
in O O
the 	 O
elevation v O
of O O
tyrosine o O
phosphorylation s O
on O O
specific c O
cellular l O
proteins t O
with h O
molecular e O
weights g O
of O O
130 	 O
, 
 O
000 	 O
, 
 O
110 	 O
, 
 O
000 	 O
, 
 O
and 	 O
70 O O
, 
 O
000 	 O
( 
 O
p130 0 O
, 
 O
p110 0 O
, 
 O
and 	 O
p70 	 S-GENE
, 
 O
respectively p O
) 
 O
, 
 O
an O O
event n O
which c O
has 	 O
been n O
correlated r O
with h O
cell l O
transformation n O
. 
 O
Urease a S-GENE
activity i O
, 
 O
judged g O
as O O
the 	 O
amount u O
of O O
ammonia o O
production d O
from m O
urea a O
, 
 O
could l O
be O O
measured s O
at O O
25 O O
ng O O
per 	 O
tube e O
( 
 O
S 
 O
/ 
 O
N 
 O
= 
 O
1 
 O
. 
 O
5 
 O
) 
 O
with h O
Jack k B-GENE
bean n I-GENE
meal l I-GENE
urease a E-GENE
. 
 O
Here e O
, 
 O
we O O
provide v O
direct e O
evidence d O
that t O
the 	 O
meiotic o O
defect e O
caused s O
by O O
either h O
unregulated e O
cAPK K S-GENE
activity i O
or O O
unregulated e O
ran1 1 B-GENE
+ - I-GENE
kinase a E-GENE
activity i O
is O O
due 	 O
to O O
inability b O
to O O
induce u O
transcription n O
of O O
the 	 O
mei2 2 B-GENE
+ - I-GENE
gene e E-GENE
, 
 O
which c O
is O O
required u O
for 	 O
meiotic o O
initiation t O
. 
 O
Optical i O
rotation a O
of O O
the 	 O
second o O
harmonic m O
radiation i O
from m O
retinal i O
in O O
bacteriorhodopsin t B-GENE
monomers o E-GENE
in O O
Langmuir g O
- 
 O
Blodgett d O
film m O
: 
 O
evidence d O
for 	 O
nonplanar p O
retinal i O
structure u O
. 
 O
Ultrasonography r O
is O O
a 
 O
diagnostic g O
alternative e O
which c O
may 	 O
replace l O
arthrography h O
. 
 O
In O O
K562 2 O
cells l O
, 
 O
using n O
the 	 O
bicistronic i O
vector t O
, 
 O
selection e O
with h O
colchicine c O
led 	 O
to O O
at O O
least s O
20 O O
- 
 O
fold d O
higher h O
expression r O
of O O
the 	 O
MDR1 1 B-GENE
gene e I-GENE
product d E-GENE
than n O
did 	 O
selection e O
with h O
G418 8 O
, 
 O
suggesting g O
that t O
the 	 O
stringent i O
MDR1 1 S-GENE
selection e O
system t O
is O O
very y O
efficient i O
for 	 O
obtaining a O
overexpression r O
of O O
foreign e O
genes e O
. 
 O
In O O
this s O
report o O
, 
 O
several e O
health l O
behaviors a O
were e O
investigated e O
in O O
relation a O
to O O
maintaining n O
mobility i O
during i O
4 
 O
years r O
of O O
follow l O
- 
 O
up O O
among n O
6 
 O
, 
 O
981 	 O
men 	 O
and 	 O
women e O
aged d O
65 O O
years r O
and 	 O
older e O
with h O
intact a O
mobility i O
at O O
baseline e O
between w O
1981 1 O
and 	 O
1983 3 O
who 	 O
lived e O
in O O
one 	 O
of O O
three e O
communities m O
: 
 O
East t O
Boston t O
, 
 O
Massachusetts s O
; 
 O
Iowa a O
and 	 O
Washington h O
counties n O
, 
 O
Iowa a O
; 
 O
and 	 O
New 	 O
Haven e O
, 
 O
Connecticut n O
. 
 O
Our 	 O
analysis l O
indicates i O
that t O
a 
 O
gene e O
correction r O
mechanism h O
has 	 O
been n O
operating r O
on O O
the 	 O
Hbbs s O
chromosome o O
to O O
keep p O
beta a O
s - O
and 	 O
beta a O
t - O
evolving l O
in O O
concert c O
, 
 O
whereas r O
on O O
the 	 O
Hbbd d B-GENE
chromosome o E-GENE
, 
 O
beta a B-GENE
dmin n E-GENE
has 	 O
diverged e O
considerably s O
from m O
beta a B-GENE
dmaj j E-GENE
. 
 O
Structure u O
and 	 O
regulation u O
of O O
KGD2 2 S-GENE
, 
 O
the 	 O
structural u O
gene e O
for 	 O
yeast s B-GENE
dihydrolipoyl y I-GENE
transsuccinylase n E-GENE
. 
 O
In O O
dehydrated y O
animals m O
at O O
Ta O O
38 O O
degrees r O
C 
 O
, 
 O
Tb O O
and 	 O
EWL 	 O
were e O
both h O
significantly n O
altered e O
( 
 O
P 
 O
less s O
than n O
0 
 O
. 
 O
001 	 O
) 
 O
from m O
the 	 O
normally m O
hydrated r O
state t O
and 	 O
were e O
measured s O
at O O
39 O O
. 
 O
9 
 O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
2 
 O
degree r O
C 
 O
and 	 O
0 
 O
. 
 O
84 O O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
09 O O
W 
 O
. 
 O
kg O O
- 
 O
1 
 O
respectively p O
. 
 O
We O O
identify n O
YY1 	 B-GENE
recognition o I-GENE
sequences u E-GENE
within h O
the 	 O
vitamin a O
D 
 O
response p O
element m O
( 
 O
VDRE E O
) 
 O
of O O
the 	 O
osteocalcin e B-GENE
gene e E-GENE
that t O
are 	 O
critical t O
for 	 O
YY1 	 S-GENE
- 
 O
dependent e O
repression r O
of O O
vitamin a O
D 
 O
- 
 O
enhanced a O
promoter m O
activity i O
. 
 O
Back k O
- 
 O
ground u O
factors t O
which c O
affect e O
the 	 O
outcome c O
of O O
steroid r O
withdrawal h O
therapy r O
in O O
patients i O
with h O
chronic o O
type e O
B 
 O
hepatitis a O
- 
 O
- 
 O
statistical t O
evaluation l O
of O O
the 	 O
importance o O
of O O
the 	 O
mode e O
of O O
HBV 	 O
transmission n O
Point n O
mutations a O
of O O
Stat3 t S-GENE
within h O
the 	 O
interacting e O
domains a O
blocked c O
both h O
physical s O
interaction e O
of O O
Stat3 t S-GENE
with h O
c - B-GENE
- - I-GENE
Jun 	 E-GENE
and 	 O
their i O
cooperation p O
in O O
IL B B-GENE
- - I-GENE
6 - E-GENE
- 
 O
induced u O
transcription n O
directed e O
by O O
the 	 O
alpha h B-GENE
( - I-GENE
2 - I-GENE
) - I-GENE
- - I-GENE
macroglobulin r I-GENE
enhancer a E-GENE
. 
 O
Three e O
patients i O
with h O
Mirizzi i O
type e O
II O O
syndrome d O
and 	 O
two 	 O
patients i O
with h O
Mirizzi i O
type e O
I 
 O
syndrome d O
were e O
treated a O
laparoscopically a O
. 
 O
Synchronous c O
multicentric t O
giant n O
cell l O
tumour o O
: 
 O
a 
 O
case e O
report o O
with h O
review i O
of O O
literature e O
. 
 O
From m O
the 	 O
comparison p O
of O O
the 	 O
nod 	 O
box 	 O
sequences u O
of O O
( 
 O
brady d O
) 
 O
rhizobia z O
with h O
a 
 O
more e O
divergent e O
nod 	 O
box 	 O
from m O
Azorhizobium r O
caulinodans l O
, 
 O
we O O
now 	 O
propose p O
a 
 O
modular u O
build l O
- 
 O
up O O
of O O
the 	 O
nod 	 O
box 	 O
with h O
the 	 O
sequence u O
A 
 O
- 
 O
T 
 O
- 
 O
C 
 O
- 
 O
N9 O O
- 
 O
G 
 O
- 
 O
A 
 O
- 
 O
T 
 O
as O O
the 	 O
binding d O
target g O
of O O
the 	 O
NodD D B-GENE
protein t E-GENE
( 
 O
the 	 O
NodD D B-GENE
box 	 E-GENE
) 
 O
. 
 O
The 	 O
prgX X B-GENE
gene e E-GENE
is O O
adjacent a O
to O O
prgQ Q S-GENE
which c O
provides v O
the 	 O
promoter m O
for 	 O
prgB B S-GENE
expression r O
. 
 O
METHODS H O
: 
 O
A 
 O
discriminant c O
function c O
predicting d O
surgery g O
outcome c O
( 
 O
seizure z O
- 
 O
free e O
vs O O
. 
 O
non 	 O
- 
 O
seizure z O
- 
 O
free e O
) 
 O
was 	 O
computed p O
separately a O
for 	 O
samples p O
of O O
patients i O
with h O
left t O
( 
 O
n 
 O
= 
 O
79 O O
) 
 O
and 	 O
right h O
( 
 O
n 
 O
= 
 O
62 O O
) 
 O
temporal p O
lobectomy e O
( 
 O
LATL L O
, 
 O
RATL L O
) 
 O
. 
 O
It O O
is O O
likely e O
that t O
these s O
recordings o O
are 	 O
incomplete o O
; 
 O
the 	 O
actual u O
number b O
of O O
activated i O
neurons r O
is O O
estimated i O
to O O
be O O
about u O
300 	 O
in O O
the 	 O
acutely t O
sensitized s O
preparation p O
. 
 O
The 	 O
possibility s O
to O O
use 	 O
this s O
method h O
for 	 O
common m O
diagnostic g O
problems b O
is O O
indicated i O
. 
 O
Genetic e O
analysis l O
of O O
the 	 O
role e O
of O O
herpes p B-GENE
simplex p I-GENE
virus u I-GENE
type e I-GENE
1 - I-GENE
glycoprotein c I-GENE
K - E-GENE
in O O
infectious e O
virus u O
production d O
and 	 O
egress e O
. 
 O
A 
 O
conventional v O
N 
 O
- 
 O
terminal m O
signal n O
sequence u O
was 	 O
not 	 O
detected e O
in O O
the 	 O
NodO O B-GENE
protein t E-GENE
. 
 O
Dynamic a O
expression r O
of O O
broad a O
- - O
complex p O
isoforms f O
mediates i O
temporal p O
control t O
of O O
an O O
ecdysteroid y O
target g O
gene e O
at O O
the 	 O
onset e O
of O O
Drosophila s O
metamorphosis a O
. 
 O
The 	 O
study d O
was 	 O
carried r O
out 	 O
according o O
to O O
the 	 O
BSI 	 O
( 
 O
1980 0 O
) 
 O
recommendations o O
for 	 O
testing t O
restorative t O
materials e O
in O O
vivo o O
. 
 O
Cellular l O
lysates a O
were e O
analyzed l O
for 	 O
luciferase i S-GENE
and 	 O
beta a B-GENE
- - I-GENE
galactosidase a E-GENE
activities i O
. 
 O
Cytokines o O
and 	 O
steroid r O
hormones m O
use 	 O
different f O
sets s O
of O O
signal n O
transduction n O
pathways h O
, 
 O
which c O
seem m O
to O O
be O O
unrelated e O
. 
 O
These s O
findings d O
suggest g O
that t O
the 	 O
proteolipids t O
of O O
the 	 O
vacuolar u B-GENE
H - I-GENE
+ - I-GENE
- - I-GENE
ATPases a E-GENE
were e O
evolved l O
in O O
parallel a O
with h O
the 	 O
eubacterial a O
proteolipid t O
, 
 O
from m O
a 
 O
common m O
ancestral e O
gene e O
that t O
underwent e O
gene e O
duplication l O
. 
 O
This s O
mutant a O
also o O
functions c O
in O O
vivo o O
as O O
a 
 O
trans n O
- 
 O
acting i O
dominant i O
negative a O
regulator u O
: 
 O
the 	 O
transcriptional n O
inducibility u O
of O O
the 	 O
HIV 	 O
long g O
terminal m O
repeat e O
( 
 O
which c O
contains t O
two 	 O
potential e O
NF B B-GENE
- - I-GENE
kappa p I-GENE
B - I-GENE
binding d I-GENE
sites e E-GENE
) 
 O
by O O
phorbol r O
ester e O
( 
 O
PMA 	 O
) 
 O
is O O
inhibited i O
when n O
it O O
is O O
co O O
- 
 O
transfected n O
into o O
CD4 	 S-GENE
+ - O
T 
 O
cells l O
with h O
the 	 O
delta t B-GENE
SP O I-GENE
mutant a E-GENE
. 
 O
In O O
addition i O
, 
 O
measurements s O
of O O
shielded e O
and 	 O
unshielded h O
syringes i O
containing t O
99mTc T O
- 
 O
labelled e O
radiopharmaceuticals i O
were e O
carried r O
out 	 O
. 
 O
This s O
study d O
tests t O
the 	 O
hypothesis o O
that t O
O2 O O
is O O
a 
 O
critical t O
component p O
in O O
myocardial c O
protection t O
afforded o O
by O O
BCP 	 O
. 
 O
Biomass m O
growth w O
monitoring i O
using n O
pressure s O
drop p O
in O O
a 
 O
cocurrent u O
biofilter f O
This s O
alternative e O
splice i O
acceptor e O
site e O
is O O
also o O
used d O
by O O
a 
 O
biologically l O
active i O
provirus v O
with h O
an O O
efficiency i O
of O O
approximately r O
5 
 O
% 
 O
compared p O
with h O
the 	 O
upstream t O
site e O
. 
 O
Homology o O
is O O
much h O
higher h O
( 
 O
64 O O
% 
 O
) 
 O
between w O
the 	 O
28 O O
- 
 O
kDa 	 O
protein t O
and 	 O
regions i O
that t O
are 	 O
strongly o O
conserved s O
among n O
the 	 O
members b O
of O O
the 	 O
serine i B-GENE
protease t I-GENE
family i E-GENE
. 
 O
We O O
have e O
isolated l O
and 	 O
structurally u O
characterized r O
genomic o O
DNA 	 O
and 	 O
cDNA A O
sequences u O
encoding o O
ribulose u B-GENE
- - I-GENE
1 - I-GENE
, - I-GENE
5 - I-GENE
- - I-GENE
bisphosphate p I-GENE
carboxylase b E-GENE
/ - O
oxygenase g S-GENE
( - O
Rbu 	 B-GENE
- - I-GENE
P2 I I-GENE
carboxylase b E-GENE
) - O
activase i O
from m O
barley l O
( 
 O
Hordeum d O
vulgare g O
L 
 O
. 
 O
) 
 O
. 
 O
Expression r O
of O O
putative a O
constitutively s O
active i O
forms m O
of O O
DdMEK1 E S-GENE
in O O
a 
 O
ddmek1 e O
null l O
background k O
is O O
capable a O
, 
 O
at O O
least s O
partially t O
, 
 O
of O O
complementing p O
the 	 O
small l O
aggregate r O
size e O
defect e O
and 	 O
the 	 O
ability l O
to O O
activate i O
guanylyl n B-GENE
cyclase l E-GENE
. 
 O
Constant s O
slowing w O
of O O
median i O
MNCV V O
and 	 O
SNCV V O
and 	 O
ulnar a O
SNCV V O
without h O
changes n O
in O O
morphology p O
, 
 O
amplitude l O
and 	 O
duration a O
of O O
MAP 	 O
and 	 O
SAP 	 O
have e O
been n O
observed e O
in O O
92 O O
patients i O
, 
 O
with h O
persistent s O
abnormalities o O
in O O
64 O O
cases e O
after e O
six 	 O
months t O
. 
 O
Moreover e O
, 
 O
such h O
mutations a O
lead d O
to O O
a 
 O
dramatic m O
transition n O
in O O
chromatin o O
structure u O
: 
 O
the 	 O
DNase s B-GENE
I - E-GENE
hypersensitive e O
region i O
is O O
replaced l O
by O O
two 	 O
stable b O
, 
 O
sequence u O
- 
 O
positioned i O
nucleosomes l O
. 
 O
During i O
chronic o O
treatment a O
with h O
salmon m B-GENE
calcitonin c E-GENE
, 
 O
alkaline a B-GENE
phosphatase s E-GENE
activity i O
and 	 O
urinary n O
hydroxyproline r O
excretion r O
decrease r O
on O O
an O O
average r O
of O O
50 O O
% 
 O
in O O
patients i O
with h O
Paget e O
' 
 O
s 
 O
disease e O
. 
 O
187 	 O
- 
 O
200 	 O
. 
 O
Because a O
of O O
the 	 O
structural u O
similarities i O
the 	 O
new 	 O
gene e O
will l O
be O O
termed m O
scERV2 R O
from m O
now 	 O
on O O
. 
 O
Experience e O
in O O
a 
 O
Kenya y O
district t O
hospital p O
The 	 O
2 - O
. - O
3 - O
x - O
10 I O
( - O
3 - O
) - O
base e O
SUF12 1 B-GENE
+ - I-GENE
transcript n E-GENE
contains t O
an O O
open n O
reading d O
frame m O
sufficient f O
to O O
encode o O
a 
 O
88 O O
x 
 O
10 O O
( 
 O
3 
 O
) 
 O
Mr O B-GENE
protein t E-GENE
. 
 O
Cortical t O
somatosensory a O
evoked k O
potentials e O
to O O
median i O
nerve v O
stimulation m O
revealed e O
significantly n O
delayed a O
peak k O
latencies e O
of O O
N20 	 O
, 
 O
P20 	 O
, 
 O
P25 	 O
, 
 O
and 	 O
N26 	 O
, 
 O
although h O
N16 	 O
latency e O
was 	 O
normal m O
. 
 O
A 
 O
new 	 O
family i O
of O O
rate e O
- 
 O
adaptive p O
pacemakers e O
accomplishes o O
this s O
circadian c O
rate e O
variation i O
by O O
modeling e O
the 	 O
patient i O
' 
 O
s 
 O
sleep e O
- 
 O
wake e O
cycle l O
using n O
a 
 O
time e O
- 
 O
of O O
- 
 O
day 	 O
clock c O
inside i O
the 	 O
device i O
. 
 O
Progestins g O
: 
 O
present s O
and 	 O
future u O
. 
 O
Bilirubin i O
and 	 O
red 	 O
cell l O
metabolism a O
in O O
relation a O
to O O
neonatal n O
jaundice n O
. 
 O
Each h O
of O O
these s O
materials e O
were e O
placed c O
by O O
means n O
of O O
three e O
different f O
placement c O
techniques h O
( 
 O
Bulk k O
pack k O
, 
 O
Horizontal i O
layering e O
and 	 O
Vertical t O
layering e O
) 
 O
into o O
class s O
II O O
cavities i O
in O O
extracted r O
human a O
molars a O
. 
 O
This s O
ligand a O
- 
 O
independent e O
pathway h O
can 	 O
function c O
through o O
another t O
androgen r O
- 
 O
regulated u O
promoter m O
as O O
shown w O
by O O
the 	 O
use 	 O
of O O
the 	 O
mouse s O
mammary m O
tumor o O
virus u O
MMTV V O
- - O
CAT 	 O
reporter o O
. 
 O
Stress e O
- 
 O
induced u O
suppression p O
of O O
the 	 O
prolactin l S-GENE
afternoon e O
surge g O
in O O
ovariectomized r O
, 
 O
estrogen r O
- 
 O
treated a O
rats s O
and 	 O
the 	 O
nocturnal t O
surge g O
in O O
pseudopregnant u O
rats s O
are 	 O
accompanied o O
by O O
an O O
increase r O
in O O
median i O
eminence n O
dihydroxyphenylacetic y O
acid d O
concentrations c O
. 
 O
The 	 O
sensitivity s O
for 	 O
ergometry o O
and 	 O
treadmill a O
testing t O
was 	 O
75 O O
and 	 O
62 O O
% 
 O
respectively p O
. 
 O
Morphologic p O
evidence d O
that t O
rhe 	 B-GENE
renal a I-GENE
calyx y E-GENE
and 	 O
pelvis v O
control t O
ureteric t O
activity i O
in O O
the 	 O
rabbit b O
. 
 O
Children l O
with h O
repeated e O
proteinuria t O
during i O
follow l O
- 
 O
up O O
tend d O
to O O
have e O
a 
 O
higher h O
incidence i O
of O O
pathologic h O
findings d O
on O O
the 	 O
i 
 O
. 
 O
v 
 O
. 
 O
- 
 O
pyelogram l O
. 
 O
Parelaphostrongylus e O
odocoilei c O
is O O
redescribed e O
from m O
worms m O
collected l O
from m O
the 	 O
type e O
host t O
( 
 O
Odocoileus c O
hemionus i O
columbianus u O
) 
 O
in O O
California i O
, 
 O
as O O
well l O
as O O
material e O
from m O
experimentally e O
infected e O
mule e O
deer r O
( 
 O
O 
 O
. 
 O
h 
 O
. 
 O
heminus i O
) 
 O
in O O
Alberta e O
. 
 O
The 	 O
carboxyl b O
globular b O
domain a O
was 	 O
found n O
to O O
be O O
encoded o O
by O O
six 	 O
exons n O
which c O
appear e O
to O O
delineate i O
its 	 O
structural u O
subdomains d O
. 
 O
Expression r O
of O O
the 	 O
Asp 	 S-GENE
but 	 O
not 	 O
the 	 O
Ala 	 B-GENE
gB S I-GENE
mutation a E-GENE
resulted u O
in O O
an O O
increase r O
in O O
the 	 O
steady a O
- 
 O
state t O
expression r O
of O O
gB S O
at O O
the 	 O
plasma s O
membrane b O
( 
 O
PM O O
) 
 O
in O O
U373 3 O
cells l O
. 
 O
Thus s O
integration e O
host t O
factor t O
is O O
required u O
for 	 O
normal m O
type e O
1 - O
fimbriae b O
phase s O
variation i O
in O O
E 
 O
. 
 O
coli i O
. 
 O
Insulin u S-GENE
therapy r O
has 	 O
been n O
expanded a O
by O O
development e O
of O O
human a B-GENE
insulin u E-GENE
and 	 O
new 	 O
modes e O
of O O
injection e O
, 
 O
including l O
insulin u S-GENE
pumps p O
. 
 O
Because a O
levels e O
of O O
Vo2DIR D S-GENE
and 	 O
Vo2INDIR I S-GENE
were e O
similar i O
in O O
both h O
groups u O
, 
 O
we O O
pooled l O
data a O
from m O
septic t O
and 	 O
control t O
animals m O
. 
 O
Further t O
interventions e O
were e O
: 
 O
nephrectomy h O
( 
 O
2x O O
) 
 O
, 
 O
resection e O
and 	 O
ligation a O
of O O
the 	 O
inferior e O
vena a O
cava a O
( 
 O
1x O O
) 
 O
, 
 O
resection e O
and 	 O
replacement l O
of O O
the 	 O
left t O
renal a O
vein n O
( 
 O
1x O O
) 
 O
. 
 O
OBJECTIVES E O
: 
 O
The 	 O
present s O
study d O
tested t O
the 	 O
hypothesis o O
that t O
stimulating m O
the 	 O
central t O
noradrenergic a O
system t O
using n O
the 	 O
new 	 O
noradrenaline a O
re O O
- 
 O
uptake a O
inhibitor i O
reboxetine o O
would l O
result u O
in O O
a 
 O
dose e O
- 
 O
dependent e O
enhancement a O
of O O
memory o O
for 	 O
emotional t O
material e O
in O O
man 	 O
. 
 O
We O O
examined m O
the 	 O
mechanisms h O
by O O
which c O
two 	 O
different f O
types e O
of O O
photonic t O
radiation i O
, 
 O
short r O
wavelength e O
UV O O
( 
 O
UV O O
- 
 O
C 
 O
) 
 O
and 	 O
gamma m O
radiation i O
, 
 O
activate i O
transcription n O
factor t O
NF B B-GENE
- - I-GENE
kappaB p E-GENE
. 
 O
However e O
, 
 O
coligation i O
of O O
Fc B B-GENE
gamma m I-GENE
RIIB1 B E-GENE
with h O
B - B-GENE
cell l I-GENE
Ag I I-GENE
receptors e E-GENE
( 
 O
BCR 	 S-GENE
) 
 O
inhibits i O
BCR 	 S-GENE
- 
 O
mediated i O
signaling n O
by O O
a 
 O
mechanism h O
that t O
may 	 O
involve o O
recruitment r O
of O O
phosphatases s B-GENE
SHP 	 I-GENE
- - I-GENE
1 - E-GENE
, 
 O
SHP 	 B-GENE
- - I-GENE
2 - E-GENE
, 
 O
and 	 O
the 	 O
SH2 	 S-GENE
containing t O
inositol s B-GENE
5 - I-GENE
' - I-GENE
phosphatase s E-GENE
( 
 O
SHIP P S-GENE
) 
 O
to O O
the 	 O
phosphorylated s O
Fc B B-GENE
gamma m I-GENE
RIIB1 B E-GENE
immunoreceptor u O
tyrosine o O
- - O
based e O
inhibitory i O
motif i O
. 
 O
Using n O
the 	 O
standard n O
scoring r O
, 
 O
children l O
with h O
full l O
scale l O
IQ O O
< 
 O
or O O
= 
 O
84 O O
on O O
the 	 O
Wechsler h O
Preschool s O
and 	 O
Primary m O
Scale l O
of O O
Intelligence e O
at O O
age 	 O
4 
 O
- 
 O
5 
 O
years r O
were e O
poorly r O
identified n O
( 
 O
sensitivity s O
54 O O
% 
 O
) 
 O
from m O
the 	 O
composite p O
S 
 O
- 
 O
B 
 O
IV O O
score r O
at O O
age 	 O
3 
 O
. 
 O
11 O O
: 
 O
5801 1 O
- 
 O
5812 2 O
, 
 O
1991 1 O
) 
 O
present s O
evidence d O
that t O
the 	 O
Vps18 1 S-GENE
/ 
 O
Pep3 3 S-GENE
protein t O
colocalizes o O
with h O
the 	 O
Vps11 1 S-GENE
/ 
 O
Pep5 5 S-GENE
protein t O
to O O
the 	 O
cytosolic o O
face e O
of O O
the 	 O
vacuolar u O
membrane b O
. 
 O
This s O
study d O
includes l O
200 	 O
patients i O
treated a O
from m O
1964 4 O
to O O
1978 8 O
, 
 O
with h O
an O O
age 	 O
range g O
from m O
15 O O
to O O
102 	 O
years r O
, 
 O
who 	 O
required u O
329 	 O
generators e O
. 
 O
We O O
conclude c O
that t O
the 	 O
BR B B-GENE
- - I-GENE
C - I-GENE
early l I-GENE
gene e E-GENE
directly e O
activates i O
late e O
gene e O
transcription n O
by O O
interacting e O
with h O
late e O
gene e O
cis 	 O
- 
 O
acting i O
regulatory u O
elements m O
and 	 O
that t O
this s O
interaction e O
is O O
responsible p O
for 	 O
the 	 O
temporal p O
linkage k O
of O O
early l O
and 	 O
late e O
ecdysone y O
- 
 O
induced u O
gene e O
expression r O
. 
 O
The 	 O
specificity c O
and 	 O
sensitivity s O
of O O
this s O
method h O
( 
 O
limit i O
of O O
detection e O
in O O
plasma s O
0 
 O
. 
 O
025 	 O
micrograms r O
/ 
 O
mL O O
and 	 O
< 
 O
or O O
= 
 O
0 
 O
. 
 O
0125 5 O
micrograms r O
/ 
 O
mL O O
for 	 O
febantel a O
and 	 O
its 	 O
metabolites a O
, 
 O
respectively p O
) 
 O
were e O
sufficiently f O
high h O
to O O
enable b O
us O O
to O O
characterize r O
the 	 O
time e O
course r O
of O O
the 	 O
drug g O
in O O
the 	 O
plasma s O
after e O
oral l O
administration i O
of O O
therapeutic r O
doses e O
to O O
sheep e O
. 
 O
We O O
have e O
identified n O
the 	 O
gene e O
encoding o O
sigma m B-GENE
E - E-GENE
using n O
a 
 O
genetic e O
screen e O
designed i O
to O O
isolate l O
trans n O
- 
 O
acting i O
mutations a O
that t O
abolish l O
expression r O
from m O
either h O
htrA A S-GENE
or O O
rpoHP3 H S-GENE
, 
 O
two 	 O
promoters m O
recognized o O
uniquely q O
by O O
sigma m B-GENE
E - I-GENE
- 
 I-GENE
containing t I-GENE
RNA 	 I-GENE
polymerase y E-GENE
. 
 O
Cytokinetics o O
of O O
the 	 O
Krebs b O
2 
 O
carcinoma c O
. 
 O
Through o O
effective e O
use 	 O
of O O
laboratory o O
testing t O
database a O
, 
 O
it O O
will l O
be O O
possible s O
to O O
shift f O
away y O
our 	 O
vague u O
management a O
of O O
pre 	 O
- 
 O
analytic l O
phase s O
of O O
quality l O
control t O
so O O
far 	 O
to O O
its 	 O
established a O
system t O
based e O
on O O
objective e O
evaluation l O
. 
 O
These s O
patients i O
developed e O
severe e O
diabetic b O
symptoms p O
including l O
glucose c O
intolerance o O
, 
 O
weight g O
loss s O
, 
 O
impaired a O
energy r O
utilization l O
, 
 O
and 	 O
nerve v O
and 	 O
brain i O
disorders o O
that t O
were e O
refractory r O
to O O
insulin u S-GENE
. 
 O
One 	 O
promoter m O
, 
 O
p53P1 P S-GENE
, 
 O
is O O
located a O
100 	 O
- 
 O
250 	 O
bp O O
upstream t O
of O O
the 	 O
218 	 O
- 
 O
bp O O
noncoding c O
first s O
exon n O
; 
 O
a 
 O
second o O
, 
 O
stronger o O
promoter m O
, 
 O
p53P2 P S-GENE
, 
 O
maps s O
within h O
the 	 O
first s O
intron r O
. 
 O
Both h O
PMP20 2 B-GENE
gene e I-GENE
products d E-GENE
contain t O
the 	 O
carboxyl b O
- 
 O
terminal m O
sequence u O
AKL 	 O
, 
 O
similar i O
to O O
the 	 O
putative a O
SKL 	 B-GENE
peroxisomal o I-GENE
sorting t I-GENE
sequence u E-GENE
( 
 O
Gould l O
, 
 O
S 
 O
. 
 O
The 	 O
likelihood e O
of O O
death t O
was 	 O
more e O
than n O
3 
 O
times e O
higher h O
among n O
patients i O
in O O
the 	 O
ERA 	 O
- 
 O
II O O
group u O
( 
 O
mortality t O
risk k O
ratio i O
3 
 O
. 
 O
82 O O
[ 
 O
95 O O
% 
 O
CI O O
1 
 O
. 
 O
48 O O
% 
 O
to O O
9 
 O
. 
 O
84 O O
] 
 O
, 
 O
p 
 O
= 
 O
0 
 O
. 
 O
006 	 O
) 
 O
. 
 O
Barium i O
mucosal o O
coating t O
was 	 O
judged g O
to O O
be O O
better t O
in O O
the 	 O
members b O
to O O
whom m O
magnesium n O
sulphate p O
was 	 O
administered i O
( 
 O
p 
 O
= 
 O
0 
 O
. 
 O
0007 7 O
) 
 O
. 
 O
In O O
both h O
immortalized o O
and 	 O
normal m O
diploid l O
human a O
cells l O
, 
 O
wt O O
AAV 	 O
targeted g O
integration e O
to O O
ch O B-GENE
- 
 I-GENE
19 O E-GENE
. 
 O
The 	 O
corresponding r O
tetrapeptide r O
sequences u O
SSPD D S-GENE
and 	 O
SATD D S-GENE
for 	 O
human a O
and 	 O
mouse s B-GENE
PKC 	 I-GENE
- - I-GENE
epsilon i E-GENE
, 
 O
respectively p O
, 
 O
are 	 O
unusual s O
for 	 O
caspase p B-GENE
- - I-GENE
3 - E-GENE
. 
 O
The 	 O
lipopolysaccharide o O
- 
 O
binding d O
protein t O
is O O
a 
 O
secretory r B-GENE
class s I-GENE
1 - I-GENE
acute t I-GENE
- - I-GENE
phase s I-GENE
protein t I-GENE
whose s I-GENE
gene e E-GENE
is O O
transcriptionally n O
activated i O
by O O
APRF F S-GENE
/ 
 O
STAT T B-GENE
/ - I-GENE
3 - E-GENE
and 	 O
other e O
cytokine o O
- 
 O
inducible u O
nuclear l O
proteins t O
. 
 O
Tritium t O
concentrations c O
in O O
environmental i O
water e O
samples p O
were e O
found n O
to O O
be O O
determined e O
within h O
an O O
accuracy u O
of O O
10 O O
% 
 O
by O O
this s O
method h O
when n O
Vi O O
/ 
 O
Vf O O
was 	 O
14 O O
- 
 O
25 O O
. 
 O
This s O
region i O
does s O
not 	 O
contain t O
a 
 O
consensus s O
estrogen r O
response p O
element m O
, 
 O
and 	 O
ER S O
binding d O
to O O
this s O
DNA 	 O
sequence u O
was 	 O
not 	 O
observed e O
. 
 O
These s O
proteins t O
, 
 O
called l O
variant i O
surface f O
glycoproteins c O
( 
 O
VSGs s S-GENE
) 
 O
, 
 O
are 	 O
expressed r O
from m O
a 
 O
specific c O
locus u O
, 
 O
the 	 O
VSG 	 B-GENE
gene e E-GENE
expression r O
site e O
( - O
ES I O
) - O
. 
 O
The 	 O
strangulated a O
intestinal e O
pathologies h O
of O O
horses s O
are 	 O
accompanied o O
by O O
a 
 O
local a O
activation i O
of O O
the 	 O
neutrophils t O
, 
 O
that t O
can 	 O
be O O
revealed e O
by O O
measuring s O
the 	 O
tissular s O
enzymatic y O
activity i O
of O O
the 	 O
granulocytic n B-GENE
enzyme y I-GENE
myeloperoxidase l E-GENE
( 
 O
MPO 	 S-GENE
) 
 O
. 
 O
A 
 O
deletion e O
analysis l O
of O O
the 	 O
FAS1 1 B-GENE
promoter m E-GENE
lacking k O
the 	 O
previously v O
characterized r O
inositol s O
/ 
 O
choline l O
- 
 O
responsive p O
- 
 O
element m O
motif i O
defined i O
a 
 O
region i O
( 
 O
nucleotides l O
- 
 O
760 	 O
to O O
- 
 O
850 	 O
) 
 O
responsible p O
for 	 O
most t O
of O O
the 	 O
remaining a O
activation i O
potency e O
. 
 O
Here e O
we O O
report o O
the 	 O
fabrication r O
of O O
single g O
- 
 O
molecule e O
transistors n O
based e O
on O O
individual i O
C60 	 O
molecules e O
connected n O
to O O
gold d O
electrodes c O
. 
 O
The 	 O
homeodomain e B-GENE
transcription n I-GENE
factor t I-GENE
CDP 	 E-GENE
/ 
 O
cut 	 S-GENE
interacts e O
with h O
the 	 O
cell l O
cycle l O
regulatory u O
element m O
of O O
histone t B-GENE
H4 I I-GENE
genes e E-GENE
packaged k O
into o O
nucleosomes l O
. 
 O
They y O
encode o O
proteins t O
whose s O
core e O
regions i O
display p O
great a O
similarity i O
to O O
Aspergillus e O
HAPB B O
, 
 O
HAPC C O
and 	 O
HAPE E O
and 	 O
to O O
known w O
HAP 	 B-GENE
homologs o E-GENE
from m O
other e O
organisms a O
. 
 O
Furthermore t O
, 
 O
the 	 O
cognate n O
binding d O
protein t O
is O O
present s O
in O O
both h O
rat 	 O
and 	 O
human a O
( 
 O
HeLa a O
) 
 O
cell l O
nuclear l O
extracts r O
. 
 O
Transient n O
cotransfection r O
analyses l O
indicate i O
that t O
the 	 O
cooperative p O
association o O
of O O
NF B B-GENE
- - I-GENE
IL I I-GENE
- - I-GENE
6 - E-GENE
and 	 O
RelA A S-GENE
with h O
the 	 O
IL B B-GENE
- - I-GENE
8 - I-GENE
promoter m E-GENE
results u O
in O O
synergistic e O
transcriptional n O
activation i O
. 
 O
Heart r O
rate e O
during i O
the 	 O
behavioral a O
avoidance i O
test t O
was 	 O
shown w O
to O O
be O O
as O O
susceptible c O
to O O
experimental e O
demand a O
as O O
other e O
studies d O
have e O
shown w O
approach r O
behaviors a O
to O O
be O O
influenced l O
. 
 O
Function c O
was 	 O
retained a O
when n O
one 	 O
copy y O
of O O
the 	 O
sequence u O
was 	 O
present s O
, 
 O
suggesting g O
that t O
this s O
sequence u O
represents r O
an O O
essential e O
element m O
. 
 O
Decreased r O
plasma s O
level e O
of O O
antithrombin i B-GENE
III 	 E-GENE
was 	 O
assumed u O
to O O
be O O
one 	 O
of O O
the 	 O
major o O
factors t O
underlying e O
hypercoagulable e O
state t O
in O O
nephrotic h O
syndrome d O
. 
 O
NO2 	 O
pollution l O
on O O
major o O
trunk n O
roads d O
frequently q O
exceeded e O
British t O
and 	 O
European o O
Union o O
air 	 O
quality l O
standards n O
, 
 O
while l O
particle t O
pollution l O
was 	 O
lower e O
. 
 O
Cotransfection r O
of O O
pINV V O
- 
 O
2473 3 O
, 
 O
a 
 O
construct s O
containing t O
2473 3 O
base e O
pairs r O
of O O
hINV V O
upstream t O
sequence u O
linked k O
to O O
luciferase i S-GENE
, 
 O
with h O
POU 	 B-GENE
homeodomain e E-GENE
transcription n O
factors t O
Oct1 1 S-GENE
, 
 O
Oct2 2 S-GENE
, 
 O
Brn4 4 S-GENE
, 
 O
SCIP P S-GENE
, 
 O
Skn1a 1 S-GENE
or O O
Skn1i 1 S-GENE
, 
 O
results u O
in O O
a 
 O
strong o O
suppression p O
of O O
basal a O
promoter m O
activity i O
. 
 O
87 O O
, 
 O
7270 0 O
- 
 O
7274 4 O
) 
 O
. 
 O
I 
 O
. 
 O
Transcripts n O
initiating t O
at O O
the 	 O
CAGT T O
motif i O
( 
 O
proximal x O
transcripts n O
) 
 O
were e O
abolished l O
by O O
deletion e O
of O O
the 	 O
proximal x O
TATA A O
box 	 O
located a O
at O O
- 
 O
29 O O
relative a O
to O O
CAGT T O
. 
 O
Genomic o O
DNA 	 O
blot t O
analysis l O
indicates i O
that t O
the 	 O
trout u B-GENE
L2 I I-GENE
locus u E-GENE
has 	 O
a 
 O
cluster s O
- 
 O
like e O
organization a O
similar i O
to O O
the 	 O
trout u B-GENE
L1 I I-GENE
locus u E-GENE
and 	 O
the 	 O
IgL 	 B-GENE
locus u E-GENE
of O O
several e O
teleost e O
fish h O
. 
 O
Although h O
the 	 O
energy r O
- 
 O
based e O
DFT 	 O
was 	 O
not 	 O
affected e O
by O O
isoproterenol p O
( 
 O
from m O
6 
 O
. 
 O
1 
 O
+ 
 O
/ 
 O
- 
 O
1 
 O
. 
 O
5 
 O
to O O
6 
 O
. 
 O
0 
 O
+ 
 O
/ 
 O
- 
 O
1 
 O
. 
 O
7 
 O
J 
 O
) 
 O
, 
 O
it O O
was 	 O
decreased r O
to O O
3 
 O
. 
 O
7 
 O
+ 
 O
/ 
 O
- 
 O
1 
 O
. 
 O
6 
 O
J 
 O
in O O
the 	 O
third r O
stage g O
by O O
infusion u O
of O O
E4031 3 O
and 	 O
isoproterenol p O
( 
 O
p 
 O
< 
 O
0 
 O
. 
 O
01 O O
vs O O
. 
 O
baseline e O
and 	 O
vs O O
. 
 O
isoproterenol p O
) 
 O
. 
 O
Gore e O
& 
 O
Associates o O
, 
 O
Inc 	 O
. 
 O
) 
 O
standard n O
wall l O
graft f O
segments m O
varying y O
in O O
length g O
from m O
4 
 O
to O O
12 O O
cm O O
. 
 O
The 	 O
dynamics a O
of O O
N 
 O
- 
 O
interaction e O
and 	 O
N 
 O
- 
 O
retention e O
during i O
3 
 O
hr O O
CPB 	 O
was 	 O
quantified n O
with h O
autologous o O
In O O
- 
 O
111 	 O
labeled e O
neutrophils t O
( 
 O
INN 	 O
) 
 O
in O O
4 
 O
groups u O
of O O
20 O O
Yorkshire k O
pigs s O
( 
 O
28 O O
- 
 O
35 O O
kg O O
, 
 O
5 
 O
sham m O
; 
 O
5 
 O
CPB 	 O
, 
 O
1 
 O
hr O O
; 
 O
5 
 O
CPB 	 O
, 
 O
3 
 O
hr O O
and 	 O
5 
 O
CPB 	 O
with h O
heparinized a O
circuit c O
, 
 O
3 
 O
hr O O
) 
 O
; 
 O
anesthetized s O
pigs s O
were e O
injected e O
with h O
INN 	 O
( 
 O
500 	 O
- 
 O
650 	 O
microCi r O
) 
 O
, 
 O
30 O O
min 	 O
before o O
CPB 	 O
and 	 O
heparinized a O
, 
 O
and 	 O
underwent e O
CPB 	 O
with h O
a 
 O
roller l O
pump p O
, 
 O
a 
 O
hollow l O
fiber e O
OX O O
( 
 O
Bentley t O
CM O O
50 O O
, 
 O
5 
 O
. 
 O
0 
 O
m2 O O
) 
 O
and 	 O
AF O O
( 
 O
Bentley t O
AF O O
025 	 O
, 
 O
0 
 O
. 
 O
25 O O
m2 O O
) 
 O
at O O
2 
 O
. 
 O
5 
 O
- 
 O
3 
 O
. 
 O
6 
 O
l 
 O
/ 
 O
min 	 O
for 	 O
3 
 O
hr O O
. 
 O
The 	 O
region i O
immediately e O
following l O
the 	 O
promoter m O
and 	 O
5 
 O
' 
 O
to O O
ORF1 1 S-GENE
has 	 O
a 
 O
potential e O
transcription n O
terminator m O
sequence u O
. 
 O
Studies d O
on O O
recurrences u O
in O O
gingival g O
hyperplasia e O
Preface f O
and 	 O
acknowledgements n O
. 
 O
We O O
conclude c O
that t O
clonidine n O
3 
 O
micrograms r O
/ 
 O
kg O O
produces d O
sedation a O
comparable p O
to O O
diazepam z O
0 
 O
. 
 O
2 
 O
mg O O
/ 
 O
kg O O
and 	 O
also o O
attenuates e O
the 	 O
intubation u O
response p O
without h O
increasing r O
the 	 O
incidence i O
of O O
complications p O
. 
 O
Pancreatic c O
expression r O
of O O
the 	 O
glucagon c B-GENE
gene e E-GENE
depends e O
on O O
multiple t O
transcription n O
factors t O
interacting e O
with h O
at O O
least s O
three e O
DNA 	 O
control t O
elements m O
: 
 O
G1 O O
, 
 O
the 	 O
upstream t O
promoter m O
element m O
, 
 O
and 	 O
G2 O O
and 	 O
G3 O O
, 
 O
two 	 O
enhancer a O
- 
 O
like e O
sequences u O
. 
 O
We O O
have e O
compared p O
the 	 O
ability l O
of O O
GST 	 B-GENE
- 
 I-GENE
Bem3 3 E-GENE
to O O
serve v O
as O O
a 
 O
GAP 	 S-GENE
for 	 O
Cdc42Hs 4 S-GENE
relative a O
to O O
other e O
members b O
of O O
the 	 O
rho 	 B-GENE
- 
 I-GENE
GAP 	 I-GENE
subfamily f E-GENE
and 	 O
found n O
the 	 O
following l O
order e O
of O O
potency e O
: 
 O
human a O
platelet t O
Cdc42Hs 4 O
GAP 	 S-GENE
> 
 O
p190 0 S-GENE
> 
 O
Bem3 3 O
> 
 O
break a O
point n O
cluster s O
region i O
protein t O
, 
 O
whereas r O
p85 	 S-GENE
, 
 O
like e O
Bem2 2 S-GENE
, 
 O
shows w O
no O O
GAP 	 S-GENE
activity i O
or O O
any 	 O
ability l O
to O O
bind d O
to O O
the 	 O
GTP 	 O
- 
 O
bound n O
form m O
of O O
Cdc42Hs 4 S-GENE
. 
 O
CONCLUSION C O
: 
 O
Men 	 O
presenting s O
with h O
urethritis t O
and 	 O
women e O
presenting s O
with h O
PID 	 O
both h O
have e O
significantly n O
greater a O
peripheral i O
blood o O
mononuclear o O
cell l O
proliferative l O
responses p O
to O O
the 	 O
DK20 0 O
strain a O
of O O
C 
 O
trachomatis c O
than n O
controls t O
. 
 O
The 	 O
PDSS S O
identified n O
17 O O
( 
 O
94 O O
% 
 O
) 
 O
of O O
the 	 O
women e O
diagnosed g O
with h O
major o O
postpartum t O
depression r O
, 
 O
the 	 O
EPDS S O
identified n O
14 O O
of O O
these s O
women e O
( 
 O
78 O O
% 
 O
) 
 O
, 
 O
and 	 O
the 	 O
BDI 	 O
- 
 O
II O O
identified n O
10 O O
of O O
the 	 O
18 O O
women e O
( 
 O
56 O O
% 
 O
) 
 O
. 
 O
Men 	 O
and 	 O
women e O
entering e O
psychotherapy c O
more e O
often e O
had 	 O
negative a O
Wish h O
elements m O
than n O
others e O
. 
 O
Single g O
amino n O
acid d O
substitutions s O
were e O
shown w O
to O O
result u O
from m O
the 	 O
mutations a O
pdr1 1 B-GENE
- - I-GENE
2 - E-GENE
( 
 O
M308I 8 S-GENE
) 
 O
, 
 O
pdr1 1 B-GENE
- - I-GENE
3 - E-GENE
( 
 O
F815S 5 S-GENE
) 
 O
, 
 O
pdr1 1 B-GENE
- - I-GENE
6 - E-GENE
( 
 O
K302Q 2 S-GENE
) 
 O
, 
 O
pdr1 1 B-GENE
- - I-GENE
7 - E-GENE
( 
 O
P298A 8 S-GENE
) 
 O
and 	 O
pdr1 1 B-GENE
- - I-GENE
8 - E-GENE
( 
 O
L1036 3 B-GENE
W 
 E-GENE
) 
 O
, 
 O
whereas r O
the 	 O
intragenic r O
suppressor p B-GENE
mutant a I-GENE
pdr1 1 I-GENE
- - I-GENE
100 	 E-GENE
is O O
deleted e O
for 	 O
the 	 O
two 	 O
amino n O
acids d O
L537 7 O
and 	 O
A538 8 O
. 
 O
Both h O
merR R B-GENE
genes e E-GENE
consist s O
of O O
a 
 O
408 	 O
bp O O
ORF 	 O
coding i O
for 	 O
135 	 O
amino n O
acids d O
. 
 O
Amniotic i O
fluid i O
ionic i O
concentration c O
in O O
response p O
to O O
chronic o O
fetal a O
vasopressin o S-GENE
infusion u O
. 
 O
The 	 O
same e O
slice c O
was 	 O
imaged g O
three e O
times e O
each h O
with h O
sequences u O
using n O
spatial t O
presaturation s O
or O O
not 	 O
. 
 O
Molecular e O
cloning n O
of O O
the 	 O
alpha h B-GENE
- - I-GENE
globin b I-GENE
transcription n I-GENE
factor t I-GENE
CP2 	 E-GENE
. 
 O
The 	 O
most t O
distal t O
active i O
site e O
in O O
TIGA A O
is O O
created a O
by O O
excision i O
of O O
a 
 O
66 O O
- 
 O
bp O O
intron r O
. 
 O
Denaturing a O
gradient d O
gel 	 O
electrophoresis c O
( 
 O
DGGE E O
) 
 O
with h O
sequence u O
analysis l O
showed w O
that t O
PGCL4 L S-GENE
is O O
a 
 O
major o O
member b O
in O O
the 	 O
female a O
mammary m O
gland n O
, 
 O
and 	 O
in O O
the 	 O
submaxillary m O
and 	 O
lachrymal h O
glands n O
of O O
both h O
sexes e O
, 
 O
while l O
the 	 O
counterpart n O
in O O
male e O
liver e O
and 	 O
the 	 O
coagulate g O
glands n O
was 	 O
found n O
to O O
be O O
PGCL1 L S-GENE
. 
 O
All 	 O
possessed s O
cutaneous a O
receptive e O
fields l O
on O O
the 	 O
distal t O
segments m O
of O O
digits i O
2 
 O
, 
 O
3 
 O
, 
 O
or O O
4 
 O
. 
 O
Sesame a O
seed d O
should u O
also o O
be O O
considered s O
a 
 O
cause s O
of O O
allergic e O
reactions c O
to O O
drug g O
products d O
and 	 O
cosmetics m O
. 
 O
Ligand a O
binding d O
of O O
multi t B-GENE
- 
 I-GENE
chain i I-GENE
antigen i I-GENE
receptors e E-GENE
and 	 O
hematopoietin a B-GENE
/ 
 I-GENE
cytokine o I-GENE
receptors e E-GENE
results u O
in O O
rapid i O
activation i O
of O O
protein t B-GENE
tyrosine o I-GENE
kinase a E-GENE
( 
 O
PTK 	 S-GENE
) 
 O
- 
 O
dependent e O
signalling n O
molecules e O
such h O
as O O
phosphatidylinositol s B-GENE
3 - I-GENE
- - I-GENE
kinase a E-GENE
( 
 O
PI B B-GENE
3 - I-GENE
- - I-GENE
kinase a E-GENE
) 
 O
. 
 O
The 	 O
UASB B O
reactors c O
treated a O
a 
 O
VFA 	 O
mixture t O
( 
 O
with h O
an O O
acetate t O
: 
 O
propionate p O
: 
 O
butyrate y O
ratio i O
of O O
5 
 O
: 
 O
3 
 O
: 
 O
2 
 O
on O O
COD 	 O
basis i O
) 
 O
or O O
acetate t O
as O O
the 	 O
sole e O
substrate s O
at O O
different f O
COD 	 O
: 
 O
sulfate f O
ratios i O
. 
 O
The 	 O
authors h O
emphasize h O
absence e O
of O O
specific c O
signs n O
of O O
vagal a O
involvement o O
, 
 O
importance o O
for 	 O
diagnosis g O
of O O
surgical g O
extirpation i O
, 
 O
and 	 O
mildness d O
of O O
post t O
operative r O
course r O
. 
 O
Now 	 O
: 
 O
pleasure a O
in O O
work k O
This s O
article i O
reviews i O
current r O
concepts c O
of O O
pathophysiology h O
and 	 O
summarises m O
clinical n O
features t O
, 
 O
natural u O
history t O
and 	 O
available i O
treatments a O
. 
 O
Previous v O
data a O
suggested g O
a 
 O
subtle t O
increase r O
in O O
serum u B-GENE
P 
 E-GENE
at O O
the 	 O
time e O
of O O
hCG 	 S-GENE
injection e O
without h O
LH S S-GENE
surge g O
reduces u O
the 	 O
PR O O
of O O
women e O
having i O
oocyte y O
retrievals r O
for 	 O
IVF 	 O
; 
 O
this s O
study d O
compared p O
PRs 	 O
of O O
recipients i O
in O O
a 
 O
shared r O
oocyte y O
program g O
according o O
to O O
the 	 O
donors o O
' 
 O
pre 	 O
- - O
hCG 	 O
P 
 O
level e O
. 
 O
Adequacy q O
of O O
the 	 O
Haldane d O
transformation n O
in O O
the 	 O
computation p O
of O O
exercise r O
V 
 O
O2 O O
in O O
man 	 O
. 
 O
M 
 O
. 
 O
, 
 O
Adrich i O
, 
 O
Z 
 O
. 
 O
, 
 O
Fournet r O
, 
 O
B 
 O
. 
 O
, 
 O
Capon o O
, 
 O
C 
 O
. 
 O
, 
 O
Bonicel i O
, 
 O
J 
 O
. 
 O
Association o O
between w O
hyperhomocysteinemia e O
and 	 O
ischemic h O
heart r O
disease e O
in O O
Sri 	 O
Lankans k O
. 
 O
Radiological i O
imaging g O
such h O
as O O
UGI 	 O
series i O
and 	 O
CT O O
scan n O
was 	 O
useful f O
to O O
arrive i O
at O O
an O O
accurate u O
diagnosis g O
. 
 O
The 	 O
architecture h O
of O O
the 	 O
hRap1 p S-GENE
Myb 	 B-GENE
domain a E-GENE
is O O
very y O
close s O
to O O
that t O
of O O
each h O
of O O
the 	 O
Myb 	 B-GENE
domains a E-GENE
from m O
TRF1 1 S-GENE
, 
 O
scRap1p a S-GENE
and 	 O
c - B-GENE
- - I-GENE
Myb 	 E-GENE
. 
 O
80 O O
v - B-GENE
- - I-GENE
ets 	 E-GENE
- 
 O
encoded o O
amino n O
- 
 O
acids d O
located a O
immediately e O
after e O
the 	 O
v - B-GENE
- - I-GENE
myb 	 E-GENE
/ 
 O
v - B-GENE
- - I-GENE
ets 	 E-GENE
junction c O
are 	 O
not 	 O
found n O
in O O
P54 	 S-GENE
/ 
 O
56c 	 S-GENE
- - O
ets 	 S-GENE
, 
 O
the 	 O
translation n O
product d O
of O O
the 	 O
c - B-GENE
- - I-GENE
ets 	 I-GENE
proto t I-GENE
- - I-GENE
oncogene o E-GENE
, 
 O
nor 	 O
in O O
a 
 O
set 	 O
of O O
cellular l O
proteins t O
of O O
64 O O
, 
 O
62 O O
, 
 O
and 	 O
60 O O
kDa 	 O
related a O
to O O
but 	 O
distinct t O
from m O
P54 	 S-GENE
/ 
 O
56c 	 B-GENE
- - I-GENE
ets 	 E-GENE
. 
 O
We O O
have e O
raised s O
antibodies i O
against i O
a 
 O
peptide t O
specific c O
to O O
the 	 O
predicted d O
protein t O
product d O
of O O
this s O
second o O
mRNA A O
. 
 O
Because a O
controlled t O
- 
 O
release e O
niacin c O
seems m O
to O O
be O O
more e O
potent e O
than n O
crystalline s O
niacin c O
, 
 O
product d O
substitution s O
without h O
dose e O
adjustment u O
should u O
be O O
avoided i O
. 
 O
Interobserver e O
agreement e O
of O O
the 	 O
Nottingham t O
histologic t O
grading d O
scheme e O
for 	 O
infiltrating i O
duct t O
carcinoma c O
breast a O
. 
 O
This s O
dose e O
of O O
Na3 	 O
citrate r O
produced d O
no O O
clinical n O
symptoms p O
suggestive g O
of O O
hypocalcaemia o O
in O O
these s O
subjects j O
, 
 O
even n O
though u O
the 	 O
use 	 O
of O O
acid d O
- 
 O
citrate r O
- 
 O
dextrose t O
, 
 O
NIH 	 O
formula m O
A 
 O
( 
 O
ACD 	 O
- 
 O
A 
 O
) 
 O
under e O
identical n O
conditions d O
has 	 O
been n O
reported o O
to O O
reduce u O
significantly n O
the 	 O
level e O
of O O
total a O
calcium c O
in O O
serum u O
, 
 O
and 	 O
concomitantly c O
increase r O
the 	 O
number b O
or O O
reactions c O
occurring u O
in O O
donors o O
. 
 O
Latex e O
products d O
( 
 O
gloves v O
, 
 O
balloons l O
, 
 O
and 	 O
condoms d O
) 
 O
directly e O
bound n O
IgE 	 S-GENE
from m O
all 	 O
four r O
patients i O
. 
 O
The 	 O
phosphoprotein s O
pUL69 6 O
of O O
human a O
cytomegalovirus o O
( 
 O
HCMV V O
) 
 O
, 
 O
which c O
is O O
a 
 O
herpesvirus p O
of O O
considerable s O
medical i O
importance o O
in O O
immunosuppressed u O
patients i O
and 	 O
newborns b O
, 
 O
has 	 O
previously v O
been n O
identified n O
as O O
an O O
early l O
- - O
late e O
viral a O
protein t O
that t O
can 	 O
stimulate m O
several e O
viral a O
and 	 O
cellular l O
promoters m O
and 	 O
thus s O
exerts r O
a 
 O
rather h O
broad a O
activation i O
pattern t O
. 
 O
Southern t O
blot t O
analysis l O
performed f O
on O O
genomic o O
DNA 	 O
demonstrated o O
altered e O
CpG 	 O
methylation h O
within h O
intron r O
1 
 O
in O O
DNA 	 O
from m O
all 	 O
BCC 	 O
compared p O
to O O
normal m O
, 
 O
mortal t O
human a O
mammary m O
epithelial t O
cells l O
( 
 O
HMEC C O
) 
 O
. 
 O
Previous v O
studies d O
have e O
shown w O
that t O
TGFbeta1 b S-GENE
expression r O
is O O
upregulated e O
in O O
mouse s O
keratinocytes a O
infected e O
with h O
a 
 O
v - B-GENE
- - I-GENE
rasHa H I-GENE
retrovirus r E-GENE
, 
 O
although h O
the 	 O
functional c O
significance n O
of O O
this s O
has 	 O
not 	 O
been n O
clear a O
. 
 O
An O O
increased r O
incidence i O
of O O
ATN 	 O
has 	 O
been n O
reported o O
since c O
the 	 O
introduction r O
of O O
cyclosporin l O
A 
 O
. 
 O
Using n O
a 
 O
GTP 	 O
- 
 O
dependent e O
, 
 O
brefeldin f O
A 
 O
- 
 O
sensitive s O
in O O
vitro r O
AP B B-GENE
- - I-GENE
1 - E-GENE
binding d O
assay a O
, 
 O
we O O
have e O
determined e O
here e O
the 	 O
parameters a O
of O O
the 	 O
AP B B-GENE
- - I-GENE
1 - E-GENE
binding d O
reaction c O
. 
 O
The 	 O
overall r O
rate e O
of O O
biohydrogenation h O
of O O
C18 	 O
: 
 O
2 
 O
was 	 O
14 O O
. 
 O
3 
 O
% 
 O
/ 
 O
h 
 O
, 
 O
but 	 O
declined l O
1 
 O
. 
 O
2 
 O
% 
 O
/ 
 O
h 
 O
for 	 O
each h O
percentage c O
unit t O
increase r O
in O O
C18 	 O
: 
 O
2 
 O
added e O
to O O
the 	 O
substrate s O
. 
 O
Plasma s O
enteroglucagon e O
was 	 O
measured s O
before o O
and 	 O
during i O
three e O
hours r O
after e O
a 
 O
standard n O
meal l O
in O O
21 O O
untreated r O
adult l O
patients i O
with h O
suspected p O
coeliac l O
disease e O
who 	 O
all 	 O
had 	 O
villous l O
atrophy o O
of O O
the 	 O
small l O
intestinal e O
mucosa o O
and 	 O
malabsorption a O
, 
 O
and 	 O
in O O
nine e O
control t O
subjects j O
. 
 O
After e O
control t O
for 	 O
body y O
mass s O
index e O
, 
 O
trait i O
anxiety i O
and 	 O
anger e O
- 
 O
in O O
remained a O
independent e O
predictors d O
of O O
diastolic s O
blood o O
pressure s O
among n O
the 	 O
women e O
. 
 O
Regulation u O
of O O
the 	 O
human a B-GENE
stress e I-GENE
response p I-GENE
gene e I-GENE
GADD153 D E-GENE
expression r O
: 
 O
role e O
of O O
ETS1 1 S-GENE
and 	 O
FLI 	 B-GENE
- - I-GENE
1 - I-GENE
gene e I-GENE
products d E-GENE
. 
 O
The 	 O
PRP4 4 B-GENE
protein t E-GENE
of I O
Saccharomyces c O
cerevisiae e O
is O O
an O O
essential e O
part t O
of O O
the 	 O
U4 S S-GENE
/ 
 O
U6 S S-GENE
snRNP N O
, 
 O
a 
 O
component p O
of O O
the 	 O
mRNA A O
splicing i O
apparatus a O
. 
 O
132 	 O
varix i O
ligations a O
were e O
performed f O
during i O
44 O O
separate a O
EVL 	 O
sessions s O
. 
 O
Here e O
RFX 	 S-GENE
/ 
 O
X2BP P S-GENE
/ 
 O
DNA 	 O
complexes p O
were e O
formed m O
on O O
all 	 O
class s O
II O O
isotypes t O
regardless a O
of O O
the 	 O
ability l O
of O O
the 	 O
X 
 O
box 	 O
region i O
to O O
bind d O
either h O
factor t O
individually i O
. 
 O
The 	 O
psi 	 B-GENE
zeta a I-GENE
gene e E-GENE
has 	 O
a 
 O
nonsense s O
mutation a O
in O O
exon n O
1 
 O
but 	 O
has 	 O
identical n O
promoter m O
sequence u O
and 	 O
RNA 	 O
processing c O
sites e O
to O O
the 	 O
zeta a B-GENE
gene e E-GENE
, 
 O
raising s O
the 	 O
possibility s O
that t O
both h O
psi 	 B-GENE
zeta a E-GENE
and 	 O
zeta a S-GENE
are 	 O
transcriptionally n O
active i O
. 
 O
Prospects s O
of O O
chemosterilant m O
and 	 O
genetic e O
control t O
of O O
rodents e O
. 
 O
Serum u B-GENE
PRL 	 E-GENE
concentrations c O
significantly n O
increased r O
after e O
MCP 	 O
administration i O
in O O
normal m O
women e O
, 
 O
hyperprolactinemic e O
patients i O
with h O
normal m O
sella l O
and 	 O
patients i O
with h O
microadenoma r O
, 
 O
but 	 O
not 	 O
in O O
macroadenoma r O
patients i O
with h O
and 	 O
without h O
suprasellar r O
expansion a O
( 
 O
SSE 	 O
) 
 O
. 
 O
The 	 O
Id4 	 B-GENE
protein t E-GENE
contains t O
a 
 O
HLH 	 B-GENE
domain a E-GENE
highly h O
conserved s O
among n O
the 	 O
dnHLH L B-GENE
proteins t E-GENE
from m O
mouse s O
and 	 O
drosophila s O
. 
 O
The 	 O
coding i O
region i O
of O O
nifA A S-GENE
was 	 O
determined e O
using n O
a 
 O
translational n O
lacZ Z S-GENE
fusion i O
and 	 O
by O O
site e O
- 
 O
directed e O
mutagenesis a O
to O O
identify n O
which c O
of O O
four r O
in O O
frame m O
AUG 	 O
codons o O
was 	 O
used d O
. 
 O
Peptide t O
competition p O
studies d O
have e O
localized a O
a 
 O
cyclin l B-GENE
A - E-GENE
interaction e O
site e O
to O O
a 
 O
Lys381Lys382Leu383Met384Phe385 3 O
sequence u O
within h O
C 
 O
- 
 O
terminal m O
negative a O
regulatory u O
domain a O
of O O
human a B-GENE
p53 	 E-GENE
. 
 O
Heterodimerization e O
mutant a B-GENE
RXR 	 E-GENE
failed l O
to O O
alter e O
GFP 	 B-GENE
- 
 I-GENE
VDR 	 E-GENE
and 	 O
nlsGFP G B-GENE
- 
 I-GENE
VDR 	 E-GENE
distribution t O
or O O
activity i O
. 
 O
Like e O
troponin p B-GENE
Cs E E-GENE
and 	 O
calmodulins m S-GENE
, 
 O
PfCPK P S-GENE
also o O
contains t O
four r O
EF O O
hand d O
calcium c O
- 
 O
binding d O
motifs i O
. 
 O
A 
 O
third r O
group u O
( 
 O
n 
 O
= 
 O
10 O O
) 
 O
was 	 O
assigned i O
to O O
receive e O
the 	 O
canalith a O
repositioning o O
maneuver e O
without h O
mastoid t O
vibration r O
. 
 O
Upstream t O
of O O
the 	 O
afa 	 B-GENE
- - I-GENE
3 - I-GENE
gene e I-GENE
cluster s E-GENE
, 
 O
a 
 O
1 
 O
. 
 O
2 
 O
- 
 O
kb O O
region i O
was 	 O
found n O
to O O
be O O
96 O O
% 
 O
identical n O
to O O
the 	 O
RepFIB F B-GENE
sequence u E-GENE
of O O
one 	 O
of O O
the 	 O
enterotoxigenic e O
E 
 O
. 
 O
coli i O
plasmids s O
( 
 O
P307 7 O
) 
 O
, 
 O
suggesting g O
a 
 O
common m O
ancestor e O
plasmid s O
. 
 O
The 	 O
cats s O
with h O
stage g O
- 
 O
2 
 O
lymphomas p O
that t O
were e O
FeLV V O
- 
 O
test t O
negative a O
had 	 O
the 	 O
best t O
response p O
to O O
treatment a O
. 
 O
We O O
hypothesize o O
that t O
the 	 O
ability l O
of O O
these s O
acidic d O
activators i O
to O O
specifically c O
interact e O
with h O
multiple t O
components p O
of O O
the 	 O
transcription n O
initiation t O
complex p O
likely e O
underlies e O
the 	 O
dramatic m O
functional c O
synergy e O
exhibited i O
by O O
this s O
class s O
of O O
activation i O
domains a O
in O O
vivo o O
. 
 O
Where r O
the 	 O
resonator o O
has 	 O
two 	 O
holes e O
, 
 O
these s O
terms m O
should u O
be O O
somewhat e O
modified i O
: 
 O
A 
 O
is O O
the 	 O
combined b O
area a O
of O O
the 	 O
two 	 O
holes e O
, 
 O
L 
 O
is O O
16 O O
/ 
 O
3pi 	 O
r 
 O
( 
 O
~ 
 O
1 
 O
. 
 O
7r O O
) 
 O
for 	 O
a 
 O
simple p O
hole e O
in O O
a 
 O
thin n O
- 
 O
walled l O
vessel s O
and 	 O
r 
 O
is O O
the 	 O
radius i O
of O O
one 	 O
hole e O
( 
 O
Seto o O
, 
 O
1971 1 O
) 
 O
. 
 O
Histological t O
and 	 O
immunophenotypic u O
studies d O
revealed e O
12 O O
large g O
cell l O
lymphomas p O
( 
 O
11 O O
B 
 O
cell l O
and 	 O
one 	 O
T 
 O
cell l O
) 
 O
, 
 O
two 	 O
small l O
noncleaved c O
cell l O
lymphomas p O
( 
 O
B 
 O
- 
 O
cell l O
phenotype n O
) 
 O
, 
 O
and 	 O
five e O
low 	 O
grade d O
B 
 O
- 
 O
cell l O
lymphomas p O
( 
 O
two 	 O
small l O
lymphocytic p O
and 	 O
three e O
follicular l O
mixed e O
lymphomas p O
) 
 O
. 
 O
The 	 O
deviation i O
site e O
is O O
equivalent i O
to O O
the 	 O
exon n O
1 
 O
/ 
 O
exon n O
2 
 O
splice i O
site e O
of O O
the 	 O
mouse s B-GENE
C 
 I-GENE
- 
 I-GENE
subunit u E-GENE
. 
 O
The 	 O
determination e O
of O O
diacetyl c O
, 
 O
2 
 O
, 
 O
3 
 O
- 
 O
pentanedione t O
and 	 O
acetoin t O
was 	 O
performed f O
in O O
two 	 O
steps p O
. 
 O
There r O
also o O
may 	 O
be O O
osmotic o O
challenges l O
to O O
mucosal o O
cell l O
function c O
as O O
evidenced d O
by O O
the 	 O
different f O
reaction c O
rates e O
with h O
hyper e O
- 
 O
and 	 O
hypotonic o O
saline i O
. 
 O
In O O
F9 O O
, 
 O
which c O
is O O
a 
 O
prototype t O
of O O
embryonal r O
carcinoma c O
cells l O
expressing r O
hst 	 S-GENE
, 
 O
the 	 O
expression r O
of O O
hst 	 B-GENE
gene e E-GENE
is O O
positively i O
regulated u O
by O O
a 
 O
downstream n O
octamer a O
motif i O
that t O
functions c O
as O O
an O O
enhancer a O
. 
 O
The 	 O
reading d O
achievement i O
of O O
students d O
with h O
learning r O
disabilities a O
who 	 O
received e O
reading d O
instruction t O
through o O
the 	 O
DISTAR T O
program g O
was 	 O
compared p O
to O O
that t O
of O O
similar i O
students d O
using n O
basal a O
reader d O
materials e O
. 
 O
Two 	 O
putative a O
ATP 	 O
- 
 O
binding d O
domains a O
were e O
identified n O
, 
 O
one 	 O
in O O
the 	 O
amino n O
- 
 O
terminal m O
half f O
of O O
the 	 O
argA A B-GENE
- - I-GENE
encoded o I-GENE
protein t E-GENE
and 	 O
the 	 O
other e O
in O O
the 	 O
carboxy b O
- 
 O
terminal m O
half f O
. 
 O
Chronic o O
granulocytic n O
leukemia k O
in O O
children l O
. 
 O
Purified i O
phosphorylated s O
PhoP P S-GENE
( 
 O
PhoPP P S-GENE
) 
 O
had 	 O
a 
 O
half f O
- 
 O
life e O
of O O
approximately r O
2 
 O
. 
 O
5 
 O
h 
 O
, 
 O
which c O
was 	 O
reduced u O
to O O
about u O
15 O O
min 	 O
by O O
addition i O
of O O
the 	 O
same e O
molar a O
amount u O
of O O
* - B-GENE
PhoR R E-GENE
( 
 O
the 	 O
cytoplasmic o O
region i O
of O O
PhoR R S-GENE
) 
 O
. 
 O
This s O
transformation n O
suppression p O
by O O
Rb S S-GENE
was 	 O
further t O
shown w O
to O O
be O O
due 	 O
to O O
transcriptional n O
repression r O
of O O
neu 	 S-GENE
using n O
Rb S S-GENE
expressing r O
effector e O
plasmid s O
and 	 O
neu 	 B-GENE
promoter m I-GENE
- 
 I-GENE
chloramphenicol o I-GENE
acetyltransferase t I-GENE
reporter o I-GENE
gene e E-GENE
. 
 O
Before o O
therapy r O
was 	 O
started r O
, 
 O
trabecular b O
bone e O
alterations e O
could l O
be O O
observed e O
which c O
were e O
typical i O
for 	 O
Paget e O
' 
 O
s 
 O
disease e O
of O O
bone e O
as O O
there r O
were e O
bulky k O
trabeculare b O
, 
 O
increased r O
remodelling o O
surfaces f O
and 	 O
giant n O
osteoclasts e O
. 
 O
T 
 O
. 
 O
infestans e O
, 
 O
T 
 O
. 
 O
delpontei p O
, 
 O
T 
 O
. 
 O
rubrovaria r O
, 
 O
T 
 O
. 
 O
sordida d O
, 
 O
T 
 O
. 
 O
guasayana s O
and 	 O
T 
 O
. 
 O
vitticeps t O
from m O
infestans e O
subgroup g O
and 	 O
T 
 O
. 
 O
pallidipennis l O
from m O
rubrofasciata r O
, 
 O
were e O
studied d O
. 
 O
Overexpression r O
of O O
N 
 O
- 
 O
terminal m O
mutations a O
disturbs t O
mitosis o O
and 	 O
produces d O
elongated n O
cells l O
, 
 O
Using n O
a 
 O
PCR 	 O
approach r O
, 
 O
we O O
isolated l O
a 
 O
putative a O
homologue o O
of O O
Prp4 4 S-GENE
from m O
human a O
and 	 O
mouse s O
cells l O
. 
 O
1 
 O
. 
 O
Biochemical c O
studies d O
and 	 O
studies d O
of O O
cells l O
expressing r O
mutant a B-GENE
IL B I-GENE
- - I-GENE
2 - I-GENE
receptors e E-GENE
indicate i O
that t O
IL B B-GENE
- - I-GENE
2 - E-GENE
- 
 O
induced u O
tyrosine o B-GENE
kinase a E-GENE
activation i O
initiates t O
a 
 O
complex p O
signaling n O
cascade c O
. 
 O
BACKGROUND K O
: 
 O
Peripheral i B-GENE
kappa p I-GENE
receptor e E-GENE
agonists n O
may 	 O
provide v O
a 
 O
new 	 O
therapeutic r O
approach r O
for 	 O
the 	 O
treatment a O
of O O
functional c O
dyspepsia p O
. 
 O
Fourteen r O
eyes s O
( 
 O
38 O O
. 
 O
9 
 O
% 
 O
) 
 O
developed e O
DLK 	 O
after e O
an O O
epithelial t O
defect e O
, 
 O
representing r O
an O O
odds s O
ratio i O
of O O
13 O O
times e O
. 
 O
The 	 O
yeast s O
genome o O
contains t O
a 
 O
single g O
ORD1 1 B-GENE
gene e E-GENE
that t O
resides i O
on O O
chromosome o O
XI O O
. 
 O
The 	 O
system t O
consists s O
of O O
a 
 O
TV O O
unit t O
compatible p O
to O O
IBM 	 O
PC O O
/ 
 O
AT O O
and 	 O
software t O
. 
 O
The 	 O
N 
 O
- 
 O
terminal m O
sequence u O
of O O
the 	 O
extracellular r O
MEP20 2 O
, 
 O
TKVAS A O
, 
 O
was 	 O
found n O
at O O
aa O O
194 	 O
- 
 O
198 	 O
within h O
the 	 O
ORF 	 O
. 
 O
Isolates l O
of O O
B 
 O
. 
 O
burgdorferi g O
from m O
humans a O
, 
 O
rodents e O
, 
 O
and 	 O
I 
 O
. 
 O
dammini m O
are 	 O
usually a O
indistinguishable i O
, 
 O
but 	 O
strains a O
of O O
B 
 O
. 
 O
burgdorferi g O
with h O
different f O
major o O
proteins t O
have e O
been n O
identified n O
. 
 O
Cloning n O
of O O
the 	 O
GATA A B-GENE
- - I-GENE
binding d I-GENE
protein t E-GENE
that t O
regulates u O
endothelin o B-GENE
- - I-GENE
1 - I-GENE
gene e E-GENE
expression r O
in O O
endothelial o O
cells l O
. 
 O
The 	 O
Synechococcus e B-GENE
gene e I-GENE
rps1 1 E-GENE
encoding o O
S1 S S-GENE
is O O
located a O
1 
 O
. 
 O
1 
 O
kb O O
downstream n O
from m O
psbB B S-GENE
, 
 O
which c O
encodes o O
the 	 O
photosystem t B-GENE
II I I-GENE
P680 0 I-GENE
chlorophyll o I-GENE
a - I-GENE
apoprotein p E-GENE
. 
 O
Two 	 O
- 
 O
dimensional e O
echocardiographic o O
parasternal a O
long g O
- 
 O
and 	 O
short r O
- 
 O
axis s O
views w O
were e O
obtained a O
during i O
graded d O
bleeding e O
by O O
rapid i O
withdrawal h O
of O O
blood o O
from m O
an O O
arterial e O
cannula n O
, 
 O
with h O
increments r O
of O O
5 
 O
% 
 O
each h O
up O O
to O O
30 O O
% 
 O
of O O
calculated c O
blood o O
volume u O
. 
 O
A 
 O
comparison p O
of O O
the 	 O
rate e O
of O O
recovery o O
and 	 O
time e O
for 	 O
detection e O
of O O
mycobacteria o O
from m O
clinical n O
specimens c O
of O O
the 	 O
newly l O
developed e O
Mycobacteria o O
Growth w O
Indicator i O
Tube e O
( 
 O
MGIT T O
) 
 O
, 
 O
the 	 O
biphasic h O
Septi t O
- 
 O
Chek k O
, 
 O
and 	 O
the 	 O
egg 	 O
- 
 O
based e O
Ogawa w O
medium i O
was 	 O
made e O
. 
 O
As O O
in O O
IncP P B-GENE
alpha h E-GENE
plasmids s O
, 
 O
these s O
operons r O
are 	 O
transcribed n O
from m O
a 
 O
bidirectional i O
promoter m O
region i O
consisting s O
of O O
trfAp A S-GENE
for 	 O
the 	 O
trfA A B-GENE
operon r E-GENE
and 	 O
trbAp A S-GENE
and 	 O
trbBp B S-GENE
for 	 O
the 	 O
trb 	 B-GENE
operon r E-GENE
. 
 O
CONCLUSIONS C O
: 
 O
These s O
principally n O
structural u O
studies d O
support p O
the 	 O
hypothesis o O
that t O
the 	 O
thrombus o O
is O O
a 
 O
self f O
- 
 O
sustaining t O
entity i O
that t O
may 	 O
have e O
significance n O
in O O
the 	 O
pathophysiologic h O
mechanism h O
of O O
abdominal o O
aortic t O
aneurysms u O
. 
 O
The 	 O
BHV 	 B-GENE
- - I-GENE
1 - I-GENE
UL24 4 E-GENE
, 
 O
UL25 5 S-GENE
, 
 O
UL26 6 S-GENE
and 	 O
UL26 6 B-GENE
. - I-GENE
5 - I-GENE
transcripts n E-GENE
all 	 O
terminated m O
at O O
a 
 O
common m O
3 
 O
' 
 O
- 
 O
polyadenylation y O
site e O
and 	 O
varied i O
significantly n O
in O O
their i O
relative a O
abundance n O
. 
 O
Electrophoretic c O
mobility i O
shift f O
analysis l O
of O O
protein t O
- 
 O
DNA 	 O
complexes p O
formed m O
with h O
nuclear l O
proteins t O
isolated l O
from m O
I3C 	 O
- 
 O
treated a O
and 	 O
- 
 O
untreated r O
cells l O
, 
 O
in O O
combination b O
with h O
supershift e O
assays a O
using n O
Sp1 	 B-GENE
antibodies i E-GENE
, 
 O
demonstrated o O
that t O
the 	 O
Sp1 	 B-GENE
- - I-GENE
binding d I-GENE
site e E-GENE
in O O
the 	 O
CDK6 6 B-GENE
promoter m E-GENE
forms m O
a 
 O
specific c O
I3C 	 S-GENE
- 
 O
responsive p O
DNA 	 O
- 
 O
protein t O
complex p O
that t O
contains t O
the 	 O
Sp1 	 B-GENE
transcription n I-GENE
factor t E-GENE
. 
 O
These s O
results u O
suggest g O
that t O
both h O
the 	 O
distinct t O
DNA 	 O
binding d O
properties p O
of O O
PMLRAR R B-GENE
homodimers o E-GENE
and 	 O
the 	 O
sequestration u O
of O O
RXR 	 S-GENE
by O O
PMLRARs R S-GENE
may 	 O
contribute t O
to O O
the 	 O
molecular e O
mechanisms h O
which c O
underlie e O
the 	 O
pathogenesis h O
of O O
APL 	 S-GENE
. 
 O
The 	 O
analysis l O
showed w O
that t O
the 	 O
morning n O
active i O
( 
 O
MA O O
) 
 O
individuals i O
rose e O
earlier l O
and 	 O
went t O
to O O
bed 	 O
earlier l O
than n O
the 	 O
evening n O
active i O
( 
 O
EA O O
) 
 O
individuals i O
, 
 O
and 	 O
the 	 O
former m O
had 	 O
a 
 O
longer g O
sleep e O
length g O
than n O
the 	 O
latter t O
during i O
days s O
with h O
a 
 O
morning n O
shift f O
, 
 O
while l O
the 	 O
opposite o O
was 	 O
true e O
for 	 O
afternoon e O
and 	 O
night h O
shifts f O
. 
 O
This s O
ERD 	 O
is O O
recorded o O
over r O
the 	 O
contralateral t O
central t O
region i O
. 
 O
Deletion e O
mutations a O
were e O
constructed s O
, 
 O
removing o O
residues i O
2 
 O
- 
 O
30 O O
, 
 O
31 O O
- 
 O
60 O O
, 
 O
61 O O
- 
 O
90 O O
, 
 O
and 	 O
49 O O
- 
 O
78 O O
of O O
the 	 O
N 
 O
- 
 O
terminal m O
cytoplasmic o O
domain a O
, 
 O
as O O
well l O
as O O
a 
 O
missense s O
mutation a O
of O O
a 
 O
dileucine e O
motif i O
. 
 O
Kluyveromyces y O
lactis t O
, 
 O
a 
 O
budding d O
yeast s O
related a O
to O O
Saccharomyces c O
cerevisiae e O
, 
 O
can 	 O
grow w O
on O O
a 
 O
wider e O
variety i O
of O O
substrates s O
and 	 O
shows w O
less s O
sensitivity s O
to O O
glucose c O
repression r O
than n O
does s O
Saccharomyces c O
cerevisiae e O
. 
 O
Low 	 O
- 
 O
affinity i O
E2 B B-GENE
- - I-GENE
binding d I-GENE
site e E-GENE
mediates i O
downmodulation n O
of O O
E2 S S-GENE
transactivation n O
of O O
the 	 O
human a B-GENE
papillomavirus i I-GENE
type e I-GENE
8 - I-GENE
late e I-GENE
promoter m E-GENE
. 
 O
Untransformed r O
3T3 	 O
cells l O
carry r O
abundant n O
1 
 O
. 
 O
9 
 O
kb O O
Hox 	 B-GENE
1 - I-GENE
. - I-GENE
3 - I-GENE
RNA 	 E-GENE
, 
 O
whereas r O
the 	 O
methylcholanthrene h O
- 
 O
transformed n O
MB66 6 O
and 	 O
LTK 	 O
- 
 O
cells l O
or O O
3T3 	 O
cells l O
transformed n O
by O O
the 	 O
oncogenes o O
src 	 S-GENE
, 
 O
fos 	 S-GENE
or O O
SV40 0 B-GENE
T - I-GENE
antigen i E-GENE
express r O
only y O
low 	 O
levels e O
. 
 O
Although h O
analysis l O
of O O
the 	 O
similarity i O
between w O
the 	 O
44 O O
- 
 O
kDa 	 O
protein t O
and 	 O
the 	 O
E - B-GENE
. - I-GENE
coli i I-GENE
RecA A I-GENE
protein t E-GENE
did 	 O
not 	 O
show w O
any 	 O
significant n O
homology o O
between w O
them m O
, 
 O
it O O
revealed e O
their i O
identity n O
by O O
five e O
amino n O
- 
 O
acid d O
residues i O
involved o O
in O O
the 	 O
formation m O
of O O
the 	 O
epitope t O
that t O
recognized o O
the 	 O
paratope a O
of O O
the 	 O
RecA A B-GENE
protein t I-GENE
antibody i E-GENE
for 	 O
subsequent s O
epitope t O
- 
 O
paratope a O
binding d O
of O O
these s O
proteins t O
. 
 O
Ureases a O
were e O
purified i O
from m O
the 	 O
recombinant o O
cells l O
and 	 O
shown w O
to O O
be O O
identical n O
to O O
control t O
enzyme y O
when n O
analyzed l O
by O O
gel 	 O
filtration t O
chromatography o O
and 	 O
sodium i O
dodecyl e O
sulfate f O
- 
 O
polyacrylamide y O
gel 	 O
electrophoresis c O
; 
 O
however e O
, 
 O
in O O
every r O
case e O
the 	 O
activity i O
levels e O
correlated r O
to O O
nickel k O
contents t O
as O O
analyzed l O
by O O
atomic m O
absorption o O
analysis l O
. 
 O
Deoxyuridine x O
- 
 O
suppression p O
test t O
and 	 O
bone e O
marrow r O
culture t O
for 	 O
the 	 O
diagnosis g O
of O O
macrocytic r O
refractory r O
anaemias e O
. 
 O
Finally a O
, 
 O
synthetic t O
peptides t O
corresponding r O
to O O
the 	 O
mutant a O
proteins t O
were e O
assessed e O
for 	 O
the 	 O
ability l O
to O O
act 	 O
as O O
substrates s O
for 	 O
PR S S-GENE
. 
 O
These s O
psoralens r O
are 	 O
being n O
used d O
in O O
research e O
projects j O
sponsored n O
by O O
the 	 O
National i O
Toxicology i O
Program g O
. 
 O
Root t O
surface f O
caries i O
incidence i O
in O O
the 	 O
groups u O
inoculated c O
with h O
A 
 O
. 
 O
viscosus c O
and 	 O
A 
 O
. 
 O
viscosus c O
plus s O
S 
 O
. 
 O
sobrinus r O
did 	 O
not 	 O
differ f O
. 
 O
These s O
results u O
demonstrate o O
that t O
the 	 O
entire i O
E3L 	 B-GENE
gene e E-GENE
is O O
required u O
for 	 O
pathogenesis h O
in O O
the 	 O
mouse s O
model e O
. 
 O
The 	 O
development e O
of O O
various i O
pathological h O
lesions i O
in O O
thymus m O
, 
 O
spleen e O
, 
 O
lymph p O
nodes e O
and 	 O
bone e O
- 
 O
marrow r O
is O O
frequently q O
observed e O
. 
 O
Recently e O
, 
 O
we O O
have e O
demonstrated o O
that t O
mouse s O
microglial r O
cells l O
, 
 O
the 	 O
brain i O
macrophages r O
, 
 O
express r O
both h O
IL B B-GENE
- - I-GENE
15 E E-GENE
and 	 O
IL B B-GENE
- - I-GENE
15 I E-GENE
/ - O
IL I B-GENE
- - I-GENE
2 - I-GENE
receptors e E-GENE
. 
 O
We O O
have e O
analyzed l O
the 	 O
role e O
of O O
the 	 O
HU B B-GENE
protein t E-GENE
in O O
invertasome e O
assembly e O
when n O
the 	 O
enhancer a O
is O O
located a O
at O O
variable i O
positions i O
close s O
to O O
one 	 O
of O O
the 	 O
recombination o O
sites e O
. 
 O
The 	 O
mode e O
of O O
action i O
is O O
often e O
suggested g O
as O O
an O O
explanation l O
for 	 O
the 	 O
different f O
slopes p O
of O O
concentration c O
- 
 O
effect e O
curves v O
. 
 O
This s O
may 	 O
be O O
another t O
example m O
of O O
the 	 O
principle n O
- 
 O
- 
 O
less s O
is O O
more e O
. 
 O
A 
 O
wide e O
conservation s O
of O O
iscSUA S B-GENE
genes e E-GENE
in O O
nature u O
and 	 O
evidence d O
that t O
NifU U S-GENE
and 	 O
NifS S S-GENE
participate t O
in O O
the 	 O
mobilization i O
of O O
iron n O
and 	 O
sulfur f O
for 	 O
nitrogenase r S-GENE
- 
 O
specific c O
iron n O
- 
 O
sulfur f O
cluster s O
formation m O
suggest g O
that t O
the 	 O
products d O
of O O
the 	 O
iscSUA S B-GENE
genes e E-GENE
could l O
play y O
a 
 O
general e O
role e O
in O O
the 	 O
formation m O
or O O
repair a O
of O O
iron n O
- 
 O
sulfur f O
clusters s O
. 
 O
On O O
transfer n O
from m O
glucose c O
, 
 O
succinate c O
, 
 O
malate a O
, 
 O
or O O
glycerol c O
medium i O
to O O
citrate r O
medium i O
, 
 O
the 	 O
Cit 	 O
+ 
 O
Escherichia h O
coli i O
strains a O
showed w O
a 
 O
delay a O
of O O
36 O O
to O O
48 O O
h 
 O
before o O
growth w O
. 
 O
These s O
results u O
suggest g O
that t O
camptothecin p O
resistance i O
in O O
CEM 	 O
/ 
 O
DOX 	 O
cells l O
is O O
due 	 O
to O O
different f O
mechanism h O
( 
 O
s 
 O
) 
 O
than n O
topoisomerase o B-GENE
- 
 I-GENE
or O I-GENE
P - I-GENE
- - I-GENE
glycoprotein c E-GENE
- 
 O
associated o O
multidrug t O
resistance i O
. 
 O
Jornvall n O
, 
 O
B 
 O
. 
 O
The 	 O
pattern t O
of O O
expression r O
of O O
this s O
and 	 O
other e O
Chi26 2 S-GENE
/ 
 O
Chi33 3 S-GENE
chimeric m O
promoters m O
suggest g O
that t O
the 	 O
E - O
- - O
region i O
contains t O
cis 	 O
- 
 O
acting i O
sequences u O
which c O
activate i O
transcription n O
in O O
aleurone u O
and 	 O
silence e O
transcription n O
in O O
leaves v O
. 
 O
Spontaneous n O
coronary o O
artery e O
spasm s O
during i O
coronary o O
angiography i O
in O O
a 
 O
patient i O
with h O
exercise r O
- 
 O
induced u O
ST O O
segment m O
elevation v O
. 
 O
Four r O
newborns b O
in O O
this s O
group u O
became a O
HBsAg A O
carriers r O
. 
 O
Effectively e O
, 
 O
the 	 O
upstream t O
, 
 O
housekeeping s O
- 
 O
type e O
promoter m O
responds p O
to O O
FIXK K S-GENE
and 	 O
positively i O
regulates u O
the 	 O
downstream n O
, 
 O
sigma m B-GENE
54 I I-GENE
- - I-GENE
type e I-GENE
promoter m E-GENE
. 
 O
K 
 O
. 
 O
, 
 O
Weiss s O
, 
 O
M 
 O
. 
 O
New 	 O
TB O O
respirator p O
standards n O
mean n O
more e O
choices i O
at O O
less s O
cost t O
. 
 O
Electrophoretic c O
mobility i O
- 
 O
shift f O
assays a O
using n O
oligonucleotides g O
derived i O
from m O
these s O
sites e O
demonstrated o O
formation m O
of O O
specific c O
DNA 	 O
- 
 O
protein t O
complexes p O
. 
 O
A 
 O
5789 9 B-GENE
- - I-GENE
nucleotide l I-GENE
- - I-GENE
long g I-GENE
EcoRI R I-GENE
fragment g E-GENE
from m O
the 	 O
genome o O
of O O
Thermotoga r O
maritima i O
, 
 O
identified n O
by O O
cross s O
- 
 O
hybridization r O
to O O
L11 	 S-GENE
, 
 O
L1 S S-GENE
, 
 O
L10 	 S-GENE
, 
 O
and 	 O
L12 	 B-GENE
ribosomal o I-GENE
protein t I-GENE
gene e I-GENE
sequences u E-GENE
from m O
Escherichia h O
coli i O
, 
 O
was 	 O
cloned n O
and 	 O
sequenced u O
. 
 O
Background k O
reduction u O
with h O
various i O
agents n O
had 	 O
a 
 O
prominent m O
effect e O
on O O
DTIn1 n O
as O O
well l O
as O O
99mTc T O
- 
 O
DTPA A O
biodistribution d O
. 
 O
These s O
data a O
suggest g O
that t O
reduction u O
in O O
PRA 	 O
may 	 O
have e O
contributed t O
to O O
the 	 O
hemodynamic o O
effects e O
of O O
this s O
peak k O
III 	 O
PDE 	 O
inhibitor i O
. 
 O
The 	 O
following l O
parameters a O
were e O
measured s O
: 
 O
onset e O
time e O
( 
 O
time e O
interval e O
from m O
injection e O
to O O
maximal i O
or O O
total a O
block c O
) 
 O
, 
 O
T125 5 O
/ 
 O
75 O O
( 
 O
time e O
for 	 O
T1 O O
to O O
reach c O
25 O O
% 
 O
or O O
75 O O
% 
 O
of O O
control t O
) 
 O
, 
 O
TOF70 7 O
( 
 O
time e O
for 	 O
TOF 	 O
ratio i O
to O O
reach c O
70 O O
% 
 O
of O O
control t O
) 
 O
, 
 O
heart r O
rate e O
and 	 O
blood o O
pressure s O
. 
 O
A 
 O
. 
 O
Prematurely m O
inactivating c O
p42 	 B-GENE
MAPK K E-GENE
in O O
egg 	 O
extracts r O
resulted u O
in O O
a 
 O
corresponding r O
hastening t O
of O O
the 	 O
first s O
mitosis o O
. 
 O
The 	 O
use 	 O
of O O
ALAD D S-GENE
activity i O
and 	 O
EP O O
as O O
cumulative u O
lead d O
exposure o O
indicators i O
is O O
suggested g O
. 
 O
Binding d O
of O O
C - B-GENE
/ - I-GENE
EBPs s E-GENE
to O O
all 	 O
three e O
spi 	 B-GENE
2 - I-GENE
. - I-GENE
3 - I-GENE
3 - I-GENE
' - I-GENE
UTR 	 I-GENE
repressor r I-GENE
sites e E-GENE
, 
 O
although h O
rather h O
weak k O
, 
 O
was 	 O
confirmed f O
by O O
electrophoretic c O
mobility i O
shift f O
assays a O
that t O
otherwise e O
failed l O
to O O
reveal e O
specific c O
interactions e O
with h O
other e O
liver e O
nuclear l O
proteins t O
in O O
vitro r O
. 
 O
Cell l O
cycle l O
regulatory u O
components p O
have e O
been n O
largely g O
conserved s O
in O O
eukaryotes a O
; 
 O
however e O
, 
 O
orthologs h O
of O O
neither t O
CAK1 1 S-GENE
nor 	 O
csk1 1 S-GENE
have e O
been n O
identified n O
in O O
other e O
species c O
to O O
date e O
. 
 O
In O O
this s O
study d O
, 
 O
we O O
cloned n O
the 	 O
full l O
- 
 O
length g O
cDNA A O
of O O
mouse s B-GENE
PAX4 4 E-GENE
by O O
RACE E O
( 
 O
rapid i O
amplification l O
of O O
cDNA A O
ends s O
) 
 O
using n O
RNA 	 O
from m O
MIN6 6 O
cells l O
, 
 O
a 
 O
mouse s O
insulinoma u O
cell l O
line e O
. 
 O
Kohtz t O
, 
 O
J 
 O
. 
 O
Hence c O
the 	 O
GAP1 1 B-GENE
gene e E-GENE
encodes o O
a 
 O
protein t O
with h O
characteristics r O
typical i O
of O O
integral e O
membrane b O
proteins t O
translocating n O
ligants a O
across o O
cellular l O
membranes b O
. 
 O
The 	 O
results u O
suggest g O
that t O
proenzyme e O
processing c O
is O O
not 	 O
essential e O
for 	 O
secretion r O
of O O
PC2 	 S-GENE
, 
 O
but 	 O
peptides t O
containing t O
mutations a O
that t O
affect e O
the 	 O
ability l O
of O O
the 	 O
propeptide p O
( 
 O
and 	 O
cleavage a O
sites e O
) 
 O
to O O
fold d O
within h O
the 	 O
catalytic a O
pocket k O
are 	 O
not 	 O
transferred n O
beyond o O
the 	 O
early l O
stages g O
of O O
the 	 O
secretory r O
pathway h O
. 
 O
These s O
results u O
suggest g O
that t O
transcription n O
influences l O
aspects e O
of O O
gene e O
conversion v O
after e O
initiation t O
, 
 O
such h O
as O O
strand a O
invasion a O
and 	 O
/ 
 O
or O O
mismatch m O
repair a O
( 
 O
MMR 	 O
) 
 O
. 
 O
Important o O
prognostic g O
factors t O
for 	 O
the 	 O
results u O
of O O
physiotherapeutic s O
exercises r O
in O O
intermittent e O
claudication u O
Finally a O
, 
 O
in O O
samples p O
obtained a O
from m O
two 	 O
patients i O
with h O
drug g O
refractory r O
ALL 	 O
, 
 O
BAC 	 O
- 
 O
derived i O
probes b O
applied l O
to O O
archived h O
marrow r O
cells l O
demonstrated o O
that t O
a 
 O
breakpoint a O
occurred u O
between w O
MDR1 1 S-GENE
and 	 O
sequences u O
500 	 O
- 
 O
1000 0 O
KB O O
telomeric o O
to O O
MDR1 1 S-GENE
, 
 O
consistent s O
with h O
a 
 O
random d O
chromosomal o O
rearrangement r O
. 
 O
Application l O
of O O
the 	 O
method h O
using n O
an O O
11 O O
- 
 O
year r O
microseismicity r O
record o O
revealed e O
systematic t O
spatial t O
and 	 O
temporal p O
changes n O
in O O
the 	 O
slip p O
rate e O
that t O
were e O
synchronous c O
with h O
earthquake t O
activity i O
and 	 O
other e O
independent e O
measures s O
of O O
fault l O
- 
 O
zone e O
slip p O
. 
 O
PC12 2 S-GENE
cultures t O
that t O
had 	 O
been n O
" 
 O
primed m O
" 
 O
in O O
this s O
way 	 O
showed w O
an O O
accelerated e O
and 	 O
augmented m O
differentiation f O
response p O
to O O
nerve v B-GENE
growth w I-GENE
factor t E-GENE
. 
 O
One 	 O
of O O
these s O
clones n O
encodes o O
Xenopus o B-GENE
N - I-GENE
- - I-GENE
ras 	 E-GENE
. 
 O
The 	 O
Molteno t O
implant l O
is O O
an O O
effective e O
procedure c O
in O O
the 	 O
treatment a O
of O O
complicated p O
and 	 O
refractory r O
cases e O
of O O
glaucoma u O
in O O
high h O
- 
 O
risk k O
eyes s O
. 
 O
The 	 O
median i O
levels e O
of O O
t - B-GENE
- - I-GENE
PA I I-GENE
Ag E E-GENE
and 	 O
PAI 	 O
in O O
plasma s O
were e O
respectively p O
10 O O
. 
 O
7 
 O
ng O O
/ 
 O
ml O O
( 
 O
interquartile e O
range g O
8 
 O
. 
 O
6 
 O
ng O O
/ 
 O
ml O O
) 
 O
and 	 O
15 O O
. 
 O
7 
 O
IU O O
/ 
 O
ml O O
( 
 O
interquartile e O
range g O
12 O O
. 
 O
2 
 O
IU O O
/ 
 O
ml O O
) 
 O
. 
 O
In O O
the 	 O
remaining a O
91 O O
patients i O
( 
 O
group u O
2 
 O
) 
 O
, 
 O
Pseudomonas u O
( 
 O
18 O O
) 
 O
, 
 O
coagulase g O
- 
 O
negative a O
Staphylococci p O
( 
 O
15 O O
) 
 O
, 
 O
Staphylococcus p O
epidermidis d O
( 
 O
23 O O
) 
 O
, 
 O
Staphylococcus p O
aureus e O
( 
 O
16 O O
) 
 O
, 
 O
Corynebacterium y O
species c O
( 
 O
12 O O
) 
 O
, 
 O
and 	 O
others e O
( 
 O
seven e O
) 
 O
were e O
isolated l O
. 
 O
Stamps m O
in O O
cardiology d O
: 
 O
de O O
Musset s O
sign n O
. 
 O
A 
 O
factor t O
present s O
in O O
nuclear l O
extracts r O
of O O
wounded n O
potato a O
tubers e O
was 	 O
found n O
to O O
bind d O
specifically c O
to O O
nucleotides l O
located a O
between w O
- 
 O
135 	 O
to O O
- 
 O
105 	 O
, 
 O
suggesting g O
that t O
this s O
region i O
contains t O
important o O
cis 	 O
- 
 O
regulatory u O
elements m O
. 
 O
The 	 O
leucine c O
zipper p O
region i O
of O O
ATF 	 B-GENE
proteins t E-GENE
is O O
also o O
similar i O
to O O
that t O
of O O
the 	 O
AP B B-GENE
- - I-GENE
1 - E-GENE
/ 
 O
c - B-GENE
- - I-GENE
jun 	 I-GENE
family i E-GENE
of O O
transcription n O
factors t O
, 
 O
whose s O
DNA 	 O
- 
 O
binding d O
site e O
differs f O
from m O
the 	 O
ATF 	 B-GENE
- 
 I-GENE
binding d I-GENE
site e E-GENE
at O O
a 
 O
single g O
position i O
. 
 O
The 	 O
R260A 0 B-GENE
mutant a E-GENE
, 
 O
as O O
expected e O
, 
 O
was 	 O
unable b O
to O O
support p O
mRNA A O
synthesis t O
in O O
vitro r O
in O O
a 
 O
transcription n O
reconstitution o O
reaction c O
as O O
well l O
as O O
transcription n O
in O O
vivo o O
of O O
a 
 O
minigenome i O
using n O
a 
 O
reverse e O
genetic e O
approach r O
. 
 O
PEAP P O
was 	 O
significantly n O
higher h O
in O O
IDC 	 O
patients i O
compared p O
to O O
controls t O
( 
 O
48 O O
. 
 O
7 
 O
+ 
 O
/ 
 O
- 
 O
32 O O
. 
 O
6 
 O
vs O O
. 
 O
Uterine r O
contractions t O
began a O
with h O
a 
 O
mean n O
latency e O
of O O
62 O O
min 	 O
in O O
the 	 O
PGF2 2 B-GENE
alpha h E-GENE
infused u O
women e O
, 
 O
in O O
controls t O
uterine r O
activity i O
remained a O
unchanged h O
. 
 O
Were e O
this s O
hypothesis o O
correct r O
, 
 O
the 	 O
requirement u O
for 	 O
elF4A 4 S-GENE
should u O
correlate r O
with h O
the 	 O
degree r O
of O O
mRNA A O
secondary o O
structure u O
. 
 O
In O O
spite t O
of O O
the 	 O
presence s O
of O O
a 
 O
physician s O
, 
 O
the 	 O
real l O
pathology h O
of O O
an O O
indian i O
population u O
of O O
Colombie o O
is O O
not 	 O
very y O
well l O
known w O
. 
 O
Taken e O
together e O
, 
 O
these s O
results u O
demonstrate o O
that t O
the 	 O
BSMV V B-GENE
coat t I-GENE
protein t E-GENE
is O O
the 	 O
sole e O
translation n O
product d O
of O O
the 	 O
genomic o O
RNA 	 O
beta a O
, 
 O
whereas r O
sgRNA N B-GENE
beta a I-GENE
1 - I-GENE
serves v E-GENE
as O O
a 
 O
messenger s O
for 	 O
translation n O
of O O
the 	 O
beta a B-GENE
b - I-GENE
protein t E-GENE
, 
 O
and 	 O
sgRNA N B-GENE
beta a I-GENE
2 - E-GENE
functions c O
as O O
a 
 O
messenger s O
for 	 O
translation n O
of O O
beta a B-GENE
c - I-GENE
and 	 I-GENE
beta a I-GENE
d - E-GENE
and 	 O
the 	 O
newly l O
discovered c O
beta a B-GENE
d - I-GENE
' - I-GENE
protein t E-GENE
. 
 O
A 
 O
retrospective r O
study d O
of O O
clozapine z O
and 	 O
electroencephalographic c O
abnormalities o O
in O O
schizophrenic i O
patients i O
. 
 O
The 	 O
concepts c O
were e O
developed e O
by O O
Mines e O
and 	 O
Garrey r O
during i O
the 	 O
next t O
10 O O
years r O
. 
 O
When n O
the 	 O
measured s O
beta a B-GENE
- - I-GENE
galactosidase a E-GENE
activity i O
in O O
the 	 O
pWP 	 O
- 
 O
transfected n O
cells l O
was 	 O
normalized m O
to O O
the 	 O
pCH110 1 O
- 
 O
transfected n O
cells l O
( 
 O
an O O
appropriate r O
control t O
if O O
the 	 O
SV40 0 B-GENE
early l I-GENE
region i I-GENE
promoter m E-GENE
functions c O
constitutively s O
in O O
various i O
cell l O
lines e O
) 
 O
, 
 O
the 	 O
results u O
suggested g O
that t O
the 	 O
promoter m O
region i O
of O O
the 	 O
PLP 	 B-GENE
gene e E-GENE
contains t O
the 	 O
information o O
necessary e O
for 	 O
initiation t O
of O O
transcription n O
in O O
a 
 O
C6 O O
cell l O
- 
 O
specific c O
manner n O
. 
 O
PKK 	 S-GENE
exists s O
in O O
three e O
discernible c O
forms m O
at O O
steady a O
state t O
: 
 O
an O O
underphosphorylated e O
form m O
of O O
100 	 O
kDa 	 O
; 
 O
a 
 O
soluble u O
, 
 O
cytosolic o O
, 
 O
phosphorylated s O
form m O
of O O
110 	 O
kDa 	 O
; 
 O
and 	 O
a 
 O
phosphorylated s O
, 
 O
detergent e O
- 
 O
insoluble o O
form m O
of O O
112 	 O
kDa 	 O
. 
 O
The 	 O
P - B-GENE
- - I-GENE
ITIM M E-GENE
- - O
compelled p O
multi t O
- - O
phosphoprotein s O
complex p O
binds d O
to O O
and 	 O
activates i O
SHP 	 B-GENE
- - I-GENE
2 - E-GENE
, 
 O
which c O
in O O
turn n O
dephosphorylates h O
SHIP P S-GENE
and 	 O
Shc 	 S-GENE
and 	 O
probably b O
other e O
substrates s O
. 
 O
When n O
PCR 	 O
was 	 O
used d O
to O O
amplify l O
agar r O
cultures t O
which c O
do O O
not 	 O
express r O
the 	 O
fimbriae b O
, 
 O
the 	 O
switch t O
region i O
was 	 O
OFF 	 O
only y O
. 
 O
Mechanisms h O
of O O
action i O
of O O
local a O
anaesthetics e O
. 
 O
Student d O
health l O
We O O
now 	 O
report o O
that t O
both h O
HSCR R S-GENE
mutations a O
impair a O
the 	 O
fixation a O
of O O
Shc 	 S-GENE
to O O
RET 	 S-GENE
and 	 O
consequently s O
prevent v O
its 	 O
phosphorylation s O
. 
 O
The 	 O
only y O
quantities n O
which c O
were e O
significantly n O
different f O
between w O
appendicitis e O
and 	 O
a 
 O
normal m O
appendix e O
were e O
sex 	 O
, 
 O
duration a O
of O O
symptoms p O
, 
 O
anorexia r O
and 	 O
vomiting i O
. 
 O
We O O
propose p O
that t O
U73 	 S-GENE
is O O
involved o O
in O O
methylation h O
of O O
the 	 O
G1739 3 O
residue i O
of O O
the 	 O
human a B-GENE
28S 	 I-GENE
rRNA A E-GENE
. 
 O
At O O
the 	 O
start r O
of O O
the 	 O
performance f O
ride e O
, 
 O
plasma s O
glucose c O
averaged r O
4 
 O
. 
 O
2 
 O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
2 
 O
, 
 O
5 
 O
. 
 O
2 
 O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
1 
 O
, 
 O
and 	 O
5 
 O
. 
 O
7 
 O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
2 
 O
mmol l O
. 
 O
l 
 O
- 
 O
1 
 O
in O O
CON 	 O
, 
 O
CHO 	 O
- 
 O
7 
 O
, 
 O
and 	 O
CHO 	 O
- 
 O
0 
 O
/ 
 O
21 O O
, 
 O
respectively p O
( 
 O
all 	 O
different f O
, 
 O
P 
 O
< 
 O
0 
 O
. 
 O
05 O O
) 
 O
. 
 O
Therefore r O
prostaglandin s O
E2 O O
is O O
characterized r O
in O O
relation a O
to O O
prostaglandin s O
F2 O O
- 
 O
alpha h O
not 	 O
only y O
by O O
a 
 O
stronger o O
uterine r O
effectiveness e O
, 
 O
but 	 O
also o O
at O O
the 	 O
same e O
time e O
a 
 O
pronounced n O
influence l O
on O O
the 	 O
cardiovascular d O
system t O
. 
 O
Copyright y O
1999 9 O
Academic d O
Press s O
. 
 O
Ganglia g O
are 	 O
cysts t O
which c O
frequently q O
occur u O
in O O
the 	 O
proximity x O
of O O
joints n O
. 
 O
Lysates a O
of O O
COS 	 O
cells l O
transfected n O
with h O
modified i O
hGrzB z B-GENE
cDNA A E-GENE
were e O
able e O
to O O
hydrolyze r O
tert t O
- 
 O
butyloxycarbonyl y O
- 
 O
Ala 	 O
- 
 O
Ala 	 O
- 
 O
Asp 	 O
- 
 O
thiobenzyl o O
ester e O
( 
 O
Boc 	 O
- 
 O
Ala 	 O
- 
 O
Ala 	 O
- 
 O
Asp 	 O
- 
 O
SBzl l O
) 
 O
, 
 O
whereas r O
lysates a O
transfected n O
with h O
unmodified o O
hGrzB z B-GENE
cDNA A E-GENE
were e O
inactive c O
. 
 O
Proteins t B-GENE
PBP 	 I-GENE
- - I-GENE
1 - E-GENE
and 	 O
PBP 	 B-GENE
- - I-GENE
2 - E-GENE
bind d O
to O O
two 	 O
of O O
the 	 O
three e O
promoter m O
elements m O
in O O
the 	 O
trypanosomatid p O
Leptomonas t O
seymouri m O
. 
 O
Expression r O
of O O
medical i O
efficiency i O
by O O
integration e O
indicators i O
with h O
the 	 O
rational i O
utilization l O
of O O
budgeted g O
funds d O
The 	 O
present s O
study d O
tries e O
to O O
associate o O
some e O
of O O
the 	 O
causes s O
of O O
hot 	 O
ischaemia h O
during i O
the 	 O
agony n O
of O O
the 	 O
corpse p O
donor o O
and 	 O
to O O
evaluate l O
those s O
that t O
may 	 O
be O O
caused s O
by O O
sympathetic p O
efference e O
during i O
removal o O
. 
 O
The 	 O
enzyme y O
encoded o O
by O O
the 	 O
cloned n O
fragment g O
is O O
equally a O
active i O
on O O
pyruvate u O
and 	 O
hydroxypyruvate r O
, 
 O
indicating i O
that t O
the 	 O
enzyme y O
has 	 O
both h O
D - O
- - O
lactate t O
and 	 O
D - B-GENE
- - I-GENE
glycerate c I-GENE
dehydrogenase y E-GENE
activities i O
. 
 O
Noise s O
in O O
STM 	 O
due 	 O
to O O
atoms m O
moving i O
in O O
the 	 O
tunneling n O
space c O
. 
 O
The 	 O
human a O
sequence u O
contains t O
the 	 O
element m O
TGACTCT C O
that t O
also o O
is O O
found n O
in O O
a 
 O
murine i B-GENE
ras 	 I-GENE
- - I-GENE
responsive p I-GENE
enhancer a E-GENE
. 
 O
There r O
is O O
an O O
overall r O
functional c O
similarity i O
between w O
IL B B-GENE
- - I-GENE
6 - E-GENE
and 	 O
c - B-GENE
- - I-GENE
fos 	 I-GENE
promoters m E-GENE
, 
 O
since c O
transfection n O
of O O
excess e O
amounts u O
of O O
either h O
promoter m O
DNA 	 O
into o O
intact a O
HeLa a O
cells l O
modulates u O
the 	 O
function c O
of O O
the 	 O
heterologous e O
promoter m O
construct s O
. 
 O
Enhanced a O
phospholipid s O
hydrolysis r O
with h O
free e O
fatty t O
acid d O
and 	 O
thromboxane o O
accumulation u O
, 
 O
increased r O
release e O
of O O
excitatory i O
amino n O
acids d O
, 
 O
and 	 O
decreased r O
tissue s O
magnesium n O
levels e O
may 	 O
each h O
serve v O
to O O
worsen s O
secondary o O
tissue s O
damage a O
and 	 O
diminish i O
neurologic r O
recovery o O
after e O
spinal n O
cord d O
injury u O
associated o O
with h O
acute t O
alcohol o O
intoxication o O
. 
 O
To O O
determine e O
whether t O
the 	 O
transcript n O
encodes o O
an O O
active i O
enzyme y O
, 
 O
we O O
developed e O
a 
 O
novel e O
transient n O
embryonic r O
excision i O
assay a O
in O O
which c O
zebrafish r O
fertilized t O
eggs s O
were e O
co O O
- 
 O
injected e O
with h O
RNA 	 O
transcribed n O
in O O
vitro r O
using n O
the 	 O
Tol2 2 B-GENE
cDNA A E-GENE
as O O
a 
 O
template p O
and 	 O
a 
 O
plasmid s O
DNA 	 O
harboring b O
a 
 O
nonautonomous a O
Tol2 2 B-GENE
element m E-GENE
, 
 O
which c O
has 	 O
a 
 O
deletion e O
in O O
the 	 O
transposase n B-GENE
coding i I-GENE
region i E-GENE
. 
 O
The 	 O
overall r O
objective e O
response p O
rate e O
( 
 O
RR O O
) 
 O
was 	 O
50 O O
% 
 O
[ 
 O
95 O O
% 
 O
confidence f O
interval e O
( 
 O
CI O O
) 
 O
= 
 O
29 O O
- 
 O
71 O O
% 
 O
] 
 O
including l O
four r O
complete p O
responses p O
and 	 O
eight h O
partial t O
responses p O
. 
 O
We O O
suggest g O
that t O
this s O
relatively a O
small l O
deletion e O
affects e O
a 
 O
segment m O
containing t O
3 - O
' - O
VH I O
genes e O
with h O
important o O
regulatory u O
functions c O
, 
 O
the 	 O
loss s O
of O O
which c O
leads d O
to O O
the 	 O
ali 	 O
phenotype n O
. 
 O
Two 	 O
SH2 	 B-GENE
domains a E-GENE
of O O
p120 0 S-GENE
Ras 	 B-GENE
GTPase a I-GENE
- - I-GENE
activating i I-GENE
protein t E-GENE
bind d O
synergistically e O
to O O
tyrosine o O
phosphorylated s O
p190 0 S-GENE
Rho 	 B-GENE
GTPase a I-GENE
- - I-GENE
activating i I-GENE
protein t E-GENE
. 
 O
p120 0 S-GENE
GTPase a B-GENE
- - I-GENE
activating i I-GENE
protein t E-GENE
( 
 O
GAP 	 S-GENE
) 
 O
is O O
a 
 O
negative a O
regulator u O
of O O
Ras 	 S-GENE
that t O
functions c O
at O O
a 
 O
key 	 O
relay a O
point n O
in O O
signal n O
transduction n O
pathways h O
that t O
control t O
cell l O
proliferation l O
. 
 O
A 
 O
homologue o O
of O O
the 	 O
MAP 	 S-GENE
/ 
 O
ERK 	 S-GENE
family i O
of O O
protein t B-GENE
kinase a I-GENE
genes e E-GENE
is O O
expressed r O
in O O
vegetative e O
and 	 O
in O O
female a O
reproductive r O
organs a O
of O O
Petunia u O
hybrida r O
. 
 O
Its 	 O
prognostic g O
impact a O
is O O
superior e O
to O O
the 	 O
T1 O O
/ 
 O
2 
 O
one 	 O
( 
 O
RR O O
= 
 O
2 
 O
. 
 O
9 
 O
; 
 O
p 
 O
= 
 O
0 
 O
. 
 O
0010 0 O
) 
 O
. 
 O
It O O
encodes o O
a 
 O
sequence u O
- 
 O
specific c O
transcription n O
factor t O
that t O
controls t O
, 
 O
in O O
concert c O
with h O
other e O
gene e O
products d O
, 
 O
differentiative f O
pathways h O
of O O
tissues s O
in O O
which c O
Scr 	 S-GENE
is O O
expressed r O
. 
 O
CONCLUSION C O
: 
 O
DMIPP P O
detects e O
regionally i O
hypoperfused o O
myocardium c O
, 
 O
in O O
which c O
agreement e O
between w O
MBF 	 O
and 	 O
fatty t O
acid d O
uptake a O
deteriorates e O
. 
 O
The 	 O
effect e O
of O O
guaiphenesin i O
on O O
absorption o O
and 	 O
bioavailability a O
of O O
paracetamol a O
from m O
composite p O
analgesic l O
preparations p O
. 
 O
Transcription n O
of O O
the 	 O
inserted e O
gene e O
into o O
the 	 O
predicted d O
subgenomic g O
polyadenylated y O
mRNA A O
was 	 O
demonstrated o O
by O O
Northern t O
( 
 O
RNA 	 O
) 
 O
blot t O
hybridization r O
analysis l O
, 
 O
and 	 O
the 	 O
encoded o O
protein t O
was 	 O
detected e O
by O O
enzyme y O
assay a O
and 	 O
by O O
radioimmunoprecipitation i O
. 
 O
These s O
results u O
suggest g O
that t O
panretinal r O
photocoagulation t O
offers e O
a 
 O
highly h O
effective e O
means n O
of O O
dealing l O
with h O
early l O
and 	 O
moderately e O
advanced a O
cases e O
of O O
angle l O
neovascularization v O
. 
 O
NBSII I S-GENE
is O O
essential e O
for 	 O
ribosome o O
- 
 O
stimulated m O
activity i O
. 
 O
Sixteen t O
patients i O
( 
 O
25 O O
. 
 O
4 
 O
% 
 O
) 
 O
encountered o O
rejection e O
while l O
weaning n O
at O O
median i O
period i O
of O O
9 
 O
. 
 O
5 
 O
months t O
( 
 O
range g O
, 
 O
1 
 O
- 
 O
63 O O
months t O
) 
 O
from m O
the 	 O
start r O
of O O
weaning n O
. 
 O
ALT 	 S-GENE
( 
 O
alanine n B-GENE
aminotransferase n E-GENE
) 
 O
and 	 O
Hb S S-GENE
( 
 O
hemoglobin o S-GENE
) 
 O
appeared e O
to O O
be O O
predictive d O
for 	 O
efficacy i O
. 
 O
Theophylline o O
QID 	 O
, 
 O
TID 	 O
, 
 O
BID 	 O
and 	 O
now 	 O
QD O O
? 
 O
A 
 O
report o O
on O O
24 O O
- 
 O
hour r O
dosing i O
with h O
slow w O
- 
 O
release e O
theophylline o O
formulations m O
with h O
emphasis h O
on O O
analyses l O
of O O
data a O
used d O
to O O
obtain a O
Food d O
and 	 O
Drug g O
Administration i O
approval r O
for 	 O
Theo o O
- 
 O
24 O O
. 
 O
Signal n O
transduction n O
in O O
fibroblasts r O
stably b O
transformed n O
by O O
[ 
 B-GENE
Val12 1 I-GENE
] 
 I-GENE
Ras 	 E-GENE
- 
 O
- 
 O
the 	 O
activities i O
of O O
extracellular r B-GENE
- - I-GENE
signal n I-GENE
- - I-GENE
regulated u I-GENE
kinase a E-GENE
and 	 O
Jun 	 B-GENE
N - I-GENE
- - I-GENE
terminal m I-GENE
kinase a E-GENE
are 	 O
only y O
moderately e O
increased r O
, 
 O
and 	 O
the 	 O
activity i O
of O O
the 	 O
delta t O
- 
 O
inhibitor i O
of O O
c - B-GENE
- - I-GENE
Jun 	 E-GENE
is O O
not 	 O
alleviated e O
. 
 O
Time e O
for 	 O
action i O
on O O
hepatitis a O
B 
 O
immunisation u O
. 
 O
Escherichia h O
coli i O
cells l O
expressing r O
a 
 O
mutant a B-GENE
glyV V I-GENE
( 
 I-GENE
glycine c I-GENE
tRNA A I-GENE
) 
 I-GENE
gene e E-GENE
have e O
a 
 O
UVM 	 O
- 
 O
constitutive s O
phenotype n O
: 
 O
implications l O
for 	 O
mechanisms h O
underlying e O
the 	 O
mutA A S-GENE
or O O
mutC C B-GENE
mutator a E-GENE
effect e O
. 
 O
By O O
24 O O
h 
 O
, 
 O
there r O
was 	 O
no O O
significant n O
difference f O
in O O
FFA 	 O
levels e O
from m O
shams m O
. 
 O
This s O
result u O
suggests g O
that t O
the 	 O
target g O
protein t O
specificity c O
of O O
E2s 	 S-GENE
can 	 O
be O O
altered e O
by O O
the 	 O
addition i O
of O O
appropriate r O
C 
 O
- 
 O
terminal m O
extensions e O
, 
 O
thus s O
providing v O
a 
 O
way 	 O
to O O
modify i O
the 	 O
selectivity e O
of O O
the 	 O
ubiquitin q S-GENE
system t O
. 
 O
Here e O
we O O
report o O
the 	 O
cloning n O
of O O
the 	 O
hemF F B-GENE
gene e E-GENE
, 
 O
encoding o O
the 	 O
aerobic o B-GENE
coproporphyrinogen r I-GENE
III 	 I-GENE
oxidase d E-GENE
from m O
Escherichia h O
coli i O
, 
 O
by O O
functional c O
complementation p O
of O O
a 
 O
Saccharomyces c B-GENE
cerevisiae e I-GENE
HEM13 1 I-GENE
mutant a E-GENE
. 
 O
This s O
study d O
was 	 O
undertaken e O
to O O
evaluate l O
the 	 O
physical s O
and 	 O
biological l O
characteristics r O
of O O
nebulized u O
interleukin e B-GENE
2 - E-GENE
liposomes o O
. 
 O
The 	 O
atopic p O
disposition p O
, 
 O
indicated i O
by O O
positive i O
skin n O
reactions c O
and 	 O
IgE 	 B-GENE
antibody i E-GENE
titers e O
etc 	 O
. 
 O
, 
 O
and 	 O
the 	 O
bronchial n O
reactivity c O
to O O
inhaled a O
acetylcholine t O
were e O
examined m O
on O O
the 	 O
following l O
three e O
groups u O
: 
 O
( 
 O
1 
 O
) 
 O
20 O O
young n O
adults l O
with h O
a 
 O
history t O
of O O
childhood l O
asthma h O
who 	 O
have e O
been n O
symptom p O
- 
 O
free e O
for 	 O
more e O
than n O
4 
 O
yr O O
; 
 O
( 
 O
2 
 O
) 
 O
20 O O
current r O
asthmatics h O
, 
 O
and 	 O
( 
 O
3 
 O
) 
 O
20 O O
healthy l O
young n O
adults l O
. 
 O
Previous v O
studies d O
showed w O
that t O
a 
 O
palindromic i O
sequence u O
located a O
at O O
- 
 O
159 	 O
base e O
pairs r O
is O O
essential e O
for 	 O
induction u O
of O O
cutinase i B-GENE
gene e E-GENE
in O O
Fusarium a O
solani a O
f 
 O
. 
 O
sp O O
. 
 O
pisi i O
( 
 O
Nectria t O
haematococca m O
mating i O
type e O
VI O O
) 
 O
by O O
the 	 O
hydroxy r O
fatty t O
acids d O
from m O
plant n O
cutin i S-GENE
and 	 O
that t O
a 
 O
50 O O
- 
 O
kDa 	 O
nuclear l O
protein t O
binds d O
to O O
a 
 O
promoter m O
that t O
contains t O
this s O
element m O
. 
 O
This s O
preliminary l O
study d O
reports o O
an O O
initial t O
evaluation l O
of O O
HMPAO A O
- 
 O
SPECT C O
imaging g O
for 	 O
assessing e O
regional i O
alterations e O
in O O
brain i O
function c O
during i O
opiate a O
dependence e O
and 	 O
withdrawal h O
. 
 O
We O O
conclude c O
that t O
these s O
cDNAs A S-GENE
belong o O
to O O
a 
 O
novel e O
GST 	 S-GENE
class s O
hereby e O
designated i O
Kappa p S-GENE
, 
 O
with h O
the 	 O
rat 	 B-GENE
GST 	 I-GENE
subunit u I-GENE
13 I I-GENE
gene e E-GENE
designated i O
rGSTK1 T S-GENE
and 	 O
the 	 O
human a O
gene e O
being n O
called l O
hGSTK1 T S-GENE
. 
 O
Based e O
on O O
PCR 	 O
strategies a O
and 	 O
expression r O
studies d O
, 
 O
we O O
define i O
the 	 O
genomic o O
organization a O
of O O
the 	 O
FUT8b 8 B-GENE
gene e E-GENE
. 
 O
The 	 O
present s O
study d O
demonstrates o O
that t O
the 	 O
proto t B-GENE
- - I-GENE
oncogene o I-GENE
c - I-GENE
- - I-GENE
jun 	 E-GENE
represses r O
transcription n O
of O O
the 	 O
human a B-GENE
CG I I-GENE
alpha h E-GENE
and 	 O
CG B B-GENE
beta a I-GENE
promoters m E-GENE
. 
 O
c - B-GENE
- - I-GENE
Jun 	 E-GENE
repressed r O
the 	 O
CG B B-GENE
alpha h I-GENE
promoter m E-GENE
through o O
a 
 O
canonical o O
cAMP P O
response p O
element m O
( 
 O
CRE 	 O
) 
 O
that t O
is O O
known w O
to O O
bind d O
c - B-GENE
- - I-GENE
Jun 	 E-GENE
and 	 O
other e O
members b O
of O O
the 	 O
B - B-GENE
- - I-GENE
Zip 	 I-GENE
transcription n I-GENE
factor t I-GENE
family i E-GENE
. 
 O
Pulse s O
monitors i O
in O O
outpatient p O
dental t O
anaesthesia e O
. 
 O
Previous v O
studies d O
using n O
partial t O
sequences u O
have e O
suggested g O
the 	 O
potential e O
of O O
26S 	 O
or O O
large g O
- - O
subunit u O
( 
 O
LSU 	 O
) 
 O
rDNA A O
for 	 O
phylogeny l O
retrieval r O
at O O
taxonomic o O
levels e O
comparable p O
to O O
those s O
investigated e O
with h O
18S 	 B-GENE
rDNA A E-GENE
. 
 O
The 	 O
sensitivity s O
of O O
99mTc T O
- 
 O
IgG 	 S-GENE
scintigraphy n O
ranged g O
between w O
71 O O
% 
 O
and 	 O
100 	 O
% 
 O
. 
 O
The 	 O
index e O
patient i O
, 
 O
a 
 O
10 O O
- 
 O
year r O
- 
 O
old 	 O
boy 	 O
, 
 O
presents s O
typical i O
symptoms p O
of O O
OPD 	 O
type e O
I 
 O
together e O
with h O
bowing i O
of O O
the 	 O
long g O
bones e O
and 	 O
abnormalities o O
of O O
the 	 O
thorax r O
and 	 O
spinal n O
column u O
. 
 O
The 	 O
cause s O
for 	 O
the 	 O
increase r O
in O O
plasma s O
ANP 	 S-GENE
levels e O
in O O
the 	 O
active i O
phase s O
remains a O
to O O
be O O
determined e O
. 
 O
A 
 O
genomic o O
clone n O
representing r O
the 	 O
5 
 O
' 
 O
part t O
of O O
the 	 O
message s O
was 	 O
also o O
isolated l O
. 
 O
Antibiotics i O
and 	 O
CDCA A O
- 
 O
mediation i O
are 	 O
essential e O
for 	 O
symptomatic p O
therapy r O
. 
 O
The 	 O
main n O
side e O
- 
 O
effects e O
were e O
myelosuppression l O
, 
 O
mucositis o O
and 	 O
peripheral i O
neuropathy r O
, 
 O
which c O
were e O
all 	 O
common m O
and 	 O
often e O
severe e O
. 
 O
The 	 O
column u O
densities s O
of O O
frozen z O
molecular e O
hydrogen r O
and 	 O
methanol h O
are 	 O
inferred e O
to O O
be O O
about u O
2 
 O
. 
 O
5 
 O
x 
 O
10 O O
( 
 O
18 O O
) 
 O
and 	 O
3 
 O
. 
 O
0 
 O
x 
 O
10 O O
( 
 O
19 O O
) 
 O
, 
 O
respectively p O
. 
 O
Similarly i O
, 
 O
an O O
increase r O
in O O
CAT 	 S-GENE
expression r O
from m O
the 	 O
same e O
construct s O
( 
 O
pBLCAT C O
- 
 O
ENDOA O O
) 
 O
was 	 O
also o O
observed e O
in O O
7AQS2 S O
. 
 O
1 
 O
cells l O
. 
 O
The 	 O
prevalence v O
of O O
antibodies i O
to O O
HRES S B-GENE
- - I-GENE
1 - E-GENE
peptides t O
pep14 1 B-GENE
- - I-GENE
24 I E-GENE
and 	 O
pep117 1 B-GENE
- - I-GENE
127 	 E-GENE
was 	 O
determined e O
in O O
65 O O
normal m O
blood o O
donors o O
and 	 O
146 	 O
patients i O
with h O
immunological u O
disorders o O
. 
 O
We O O
recently e O
reported o O
the 	 O
cloning n O
and 	 O
sequencing u O
of O O
the 	 O
alpha h B-GENE
7 - I-GENE
integrin e I-GENE
chain i E-GENE
and 	 O
its 	 O
regulated u O
expression r O
during i O
the 	 O
development e O
of O O
skeletal l O
muscle c O
( 
 O
Song g O
et O O
al O O
. 
 O
The 	 O
contractile t O
effects e O
of O O
oxytocin t O
, 
 O
prostaglandin s O
F2 O O
alpha h O
and 	 O
their i O
combined b O
use 	 O
on O O
human a O
pregnant g O
myometrium m O
were e O
studied d O
in O O
vitro r O
. 
 O
These s O
involve o O
( 
 O
1 
 O
) 
 O
subcloning c O
a 
 O
promoterless m O
sucCD C B-GENE
fragment g E-GENE
downstream n O
of O O
the 	 O
lac 	 B-GENE
promoter m E-GENE
in O O
M13mp10 m S-GENE
, 
 O
and 	 O
( 
 O
2 
 O
) 
 O
precise c O
splicing i O
of O O
the 	 O
suc 	 B-GENE
coding i I-GENE
regions i E-GENE
with h O
the 	 O
efficient i O
atpE E B-GENE
ribosome o I-GENE
- - I-GENE
binding d I-GENE
site e E-GENE
and 	 O
expression r O
from m O
the 	 O
thermoinducible r O
lambda b O
promoters m O
in O O
the 	 O
pJLA503 A O
vector t O
. 
 O
These s O
mutations a O
prevent v O
FKBP12 P S-GENE
- 
 O
rapamycin a O
binding d O
to O O
TOR2 2 S-GENE
, 
 O
as O O
assayed a O
with h O
the 	 O
two 	 O
- 
 O
hybrid r O
system t O
. 
 O
Transcription n O
of O O
eukaryotic a B-GENE
tRNA A I-GENE
genes e E-GENE
is O O
dependent e O
on O O
the 	 O
A 
 O
- 
 O
and 	 O
B 
 O
- 
 O
Box 	 O
internal e O
control t O
regions i O
( 
 O
ICRs s O
) 
 O
and 	 O
the 	 O
upstream t O
transcription n O
modulatory u O
region i O
. 
 O
Failure l O
to O O
demonstrate o O
a 
 O
major o O
anti i O
- 
 O
inflammatory l O
effect e O
with h O
alpha h O
tocopherol o O
supplementation p O
( 
 O
400 	 O
IU O O
/ 
 O
day 	 O
) 
 O
in O O
normal m O
subjects j O
. 
 O
Results u O
on O O
the 	 O
use 	 O
of O O
amiodarone o O
in O O
the 	 O
prevention v O
of O O
paroxysmal o O
AF O O
have e O
been n O
equivocal i O
; 
 O
this s O
may 	 O
be O O
attributed r O
to O O
differences f O
in O O
defining i O
paroxysmal o O
AF O O
. 
 O
High h O
- 
 O
level e O
expression r O
of O O
sccypB y S-GENE
as O O
well l O
as O O
of O O
sccypA y S-GENE
cloned n O
into o O
the 	 O
expression r O
vector t O
pIJ702 7 O
did 	 O
not 	 O
produce d O
detectable e O
changes n O
in O O
growth w O
and 	 O
morphology p O
of O O
S 
 O
. 
 O
chrysomallus y O
and 	 O
S 
 O
. 
 O
lividans i O
. 
 O
Fas 	 S-GENE
( 
 O
APO 	 B-GENE
- - I-GENE
1 - E-GENE
/ 
 O
CD95 5 S-GENE
) 
 O
, 
 O
which c O
is O O
a 
 O
member b O
of O O
the 	 O
tumor o B-GENE
necrosis r I-GENE
factor t I-GENE
receptor e I-GENE
superfamily e E-GENE
, 
 O
is O O
a 
 O
cell l O
surface f O
receptor e O
that t O
induces u O
apoptosis p O
. 
 O
In O O
the 	 O
future u O
, 
 O
transoesophageal n O
echocardiography o O
may 	 O
be O O
used d O
to O O
measure s O
variations i O
in O O
wall l O
thickness c O
which c O
change n O
the 	 O
global b O
loading d O
conditions d O
in O O
the 	 O
basal a O
midwall w O
compartments p O
of O O
the 	 O
left t O
ventricle t O
. 
 O
We O O
studied d O
18 O O
dogs s O
, 
 O
anaesthetised e O
and 	 O
spontaneously n O
breathing a O
both h O
room m O
air 	 O
and 	 O
after e O
the 	 O
inhalation a O
of O O
a 
 O
gas 	 O
mixture t O
containing t O
10 O O
% 
 O
CO2 	 O
, 
 O
20 O O
. 
 O
9 
 O
% 
 O
O2 O O
, 
 O
and 	 O
69 O O
. 
 O
1 
 O
% 
 O
N2 O O
, 
 O
to O O
determine e O
the 	 O
role e O
of O O
histamine t O
, 
 O
serotonin o O
, 
 O
and 	 O
acidaemia d O
in O O
pulmonary m O
hypertension e O
produced d O
by O O
hypercapnia e O
. 
 O
Sequencing u O
of O O
this s O
fragment g O
showed w O
that t O
the 	 O
MRP13 1 B-GENE
coding i I-GENE
region i E-GENE
specifies c O
a 
 O
324 	 O
- 
 O
amino n O
- 
 O
acid d O
basic i O
protein t O
with h O
a 
 O
calculated c O
Mr O O
of O O
37 O O
, 
 O
366 	 O
. 
 O
Viral a B-GENE
complementary p I-GENE
15 B I-GENE
S - I-GENE
mRNA A E-GENE
that t O
directs e O
the 	 O
synthesis t O
of O O
N - B-GENE
protein t E-GENE
and 	 O
hybridizes r O
to O O
the 	 O
predicted d O
N - B-GENE
gene e I-GENE
DNA 	 E-GENE
has 	 O
been n O
identified n O
in O O
infected e O
cell l O
extracts r O
. 
 O
Electrophoretic c O
mobility i O
shift f O
assays a O
and 	 O
DNase s B-GENE
I - E-GENE
protection t O
analyses l O
revealed e O
that t O
FP B B-GENE
I - E-GENE
was 	 O
bound n O
by O O
the 	 O
transcription n O
factor t O
PU B B-GENE
. - I-GENE
1 - E-GENE
/ 
 O
Spi 	 B-GENE
- - I-GENE
1 - E-GENE
. 
 O
Retroviral r O
vector t O
producer d O
cell l O
populations u O
and 	 O
cell l O
clones n O
were e O
established a O
for 	 O
each h O
chLTR T O
vector t O
, 
 O
and 	 O
all 	 O
were e O
capable a O
of O O
yielding l O
high h O
vector t O
titers e O
( 
 O
> 
 O
10 O O
( 
 O
5 
 O
) 
 O
G418R 8 O
cfu 	 O
/ 
 O
ml O O
on O O
NIH 	 O
- 
 O
3T3 	 O
) 
 O
. 
 O
However e O
, 
 O
a 
 O
few 	 O
sites e O
in O O
the 	 O
genomes o O
of O O
EC O O
cells l O
permit m O
M - B-GENE
- - I-GENE
MuLVneo V I-GENE
delta t I-GENE
Enh 	 I-GENE
proviral v E-GENE
expression r O
. 
 O
Increasing r O
insulin u S-GENE
sensitivity s O
in O O
type e O
I 
 O
diabetic b O
patients i O
should u O
alert r O
clinicians n O
to O O
the 	 O
possibility s O
of O O
glucocorticoid c O
deficiency i O
. 
 O
However e O
, 
 O
differential f O
utilization l O
of O O
these s O
determinants e O
mediate i O
RAR 	 S-GENE
- 
 O
RXR 	 S-GENE
heterodimer e O
binding d O
to O O
DR O B-GENE
- 
 I-GENE
2 
 E-GENE
and 	 O
DR O B-GENE
- 
 I-GENE
5 
 I-GENE
RAREs E E-GENE
. 
 O
Galactorrhoea a O
is O O
a 
 O
rare e O
presentation s O
of O O
an O O
empty t O
sella l O
syndrome d O
. 
 O
The 	 O
addition i O
of O O
novel e O
techniques h O
, 
 O
such h O
as O O
histopathologic t O
ultrastaging r O
, 
 O
immunohistochemistry u O
staining i O
, 
 O
and 	 O
reverse e B-GENE
transcriptase n I-GENE
polymerase y E-GENE
chain i O
reaction c O
assays a O
, 
 O
will l O
help p O
increase r O
the 	 O
accuracy u O
and 	 O
rate e O
of O O
detection e O
of O O
disease e O
. 
 O
Several e O
of O O
the 	 O
drugs g O
used d O
in O O
the 	 O
management a O
of O O
MAC 	 O
have e O
been n O
associated o O
with h O
significant n O
drug g O
interactions e O
involving o O
the 	 O
cytochrome o B-GENE
P450 0 E-GENE
( 
 O
CYP 	 S-GENE
) 
 O
enzyme y O
system t O
. 
 O
Arterial e O
compliance p O
measurements s O
using n O
intraarterial r O
pulse s O
contour t O
analysis l O
and 	 O
a 
 O
modified i O
Windkessel d O
model e O
were e O
carried r O
out 	 O
in O O
19 O O
patients i O
with h O
isolated l O
systolic t O
hypertension e O
( 
 O
> 
 O
or O O
= 
 O
160 	 O
/ 
 O
< 
 O
or O O
= 
 O
90 O O
mm O O
Hg O O
) 
 O
and 	 O
compared p O
to O O
measurements s O
in O O
29 O O
patients i O
with h O
essential e O
hypertension e O
( 
 O
diastolic s O
blood o O
pressure s O
[ 
 O
BP O O
] 
 O
> 
 O
or O O
= 
 O
95 O O
mm O O
Hg O O
) 
 O
and 	 O
47 O O
normotensive m O
control t O
subjects j O
. 
 O
Rather h O
than n O
seeking k O
a 
 O
blanket n O
characterization r O
of O O
an O O
essentially e O
heterogeneous e O
group u O
, 
 O
it O O
may 	 O
be O O
more e O
useful f O
to O O
consider s O
idiom o O
comprehension p O
a 
 O
secondary o O
manifestation i O
of O O
semantic a O
and 	 O
/ 
 O
or O O
pragmatic g O
difficulties f O
. 
 O
Methylprednisolone h O
and 	 O
U 
 O
- 
 O
74006F 0 O
were e O
equally a O
effective e O
at O O
preventing v O
neurological r O
dysfunction f O
compared p O
to O O
the 	 O
control t O
group u O
( 
 O
p 
 O
less s O
than n O
0 
 O
. 
 O
01 O O
) 
 O
; 
 O
U 
 O
- 
 O
78517F 1 O
was 	 O
slightly g O
less s O
effective e O
than n O
U 
 O
- 
 O
74006F 0 O
and 	 O
methylprednisolone h O
but 	 O
was 	 O
significantly n O
better t O
than n O
vehicle i O
in O O
preventing v O
neurological r O
dysfunction f O
. 
 O
The 	 O
women e O
in O O
the 	 O
intermediate e O
calcium c O
group u O
had 	 O
approximately r O
the 	 O
same e O
mean n O
BMD 	 O
values u O
as O O
those s O
in O O
the 	 O
low 	 O
calcium c O
group u O
. 
 O
International e O
efforts o O
are 	 O
now 	 O
being n O
made e O
to O O
standardize n O
haemolytic m O
test t O
conditions d O
and 	 O
the 	 O
present s O
study d O
is O O
meant n O
as O O
a 
 O
contribution t O
to O O
this s O
. 
 O
The 	 O
transition n O
from m O
expression r O
of O O
early l O
meiotic o O
genes e O
to O O
expression r O
of O O
middle d O
sporulation r O
- 
 O
specific c O
genes e O
occurs u O
at O O
about u O
the 	 O
time e O
that t O
cells l O
exit t O
from m O
pachytene h O
and 	 O
form m O
the 	 O
meiosis o O
I 
 O
spindle n O
. 
 O
NF B B-GENE
- - I-GENE
kappaB p I-GENE
DNA 	 I-GENE
- 
 I-GENE
protein t E-GENE
binding d O
and 	 O
ICAM M B-GENE
- - I-GENE
1 - I-GENE
promoter m E-GENE
activity i O
were e O
enhanced a O
by O O
IL B B-GENE
- - I-GENE
1beta t E-GENE
and 	 O
these s O
effects e O
were e O
inhibited i O
by O O
tyrphostin p O
23 O O
, 
 O
but 	 O
not 	 O
by O O
PD O O
98059 5 O
or O O
SB O O
203580 5 O
. 
 O
Peripheral i O
neuropathy r O
in O O
the 	 O
cherry r O
- 
 O
red 	 O
spot t O
- 
 O
myoclonus c O
syndrome d O
( 
 O
sialidosis l O
type e O
I 
 O
) 
 O
. 
 O
Using n O
the 	 O
two 	 O
- 
 O
hybrid r O
screening e O
method h O
, 
 O
we O O
have e O
identified n O
an O O
additional i O
component p O
of O O
the 	 O
CCAAT A B-GENE
- - I-GENE
binding d I-GENE
factor t E-GENE
. 
 O
The 	 O
myb 	 B-GENE
proto t I-GENE
oncogene o I-GENE
product d E-GENE
( 
 O
c - B-GENE
- - I-GENE
Myb 	 E-GENE
) 
 O
is O O
a 
 O
transcriptional n O
regulator u O
and 	 O
its 	 O
expression r O
and 	 O
function c O
are 	 O
tightly h O
linked k O
to O O
the 	 O
cellular l O
entry r O
into o O
S 
 O
phase s O
and 	 O
DNA 	 O
synthesis t O
. 
 O
Both h O
the 	 O
p38 	 B-GENE
kinase a E-GENE
inhibitor i O
SB205380 0 O
( 
 O
SB O O
) 
 O
and 	 O
cotransfection r O
of O O
a 
 O
dominant i O
- 
 O
negative a O
mutant a O
of O O
p38 	 B-GENE
kinase a E-GENE
reduced u O
IL B B-GENE
- - I-GENE
1beta t E-GENE
stimulation m O
of O O
the 	 O
hBNP P B-GENE
promoter m E-GENE
. 
 O
CLINICAL N O
FEATURES T O
: 
 O
This s O
30 O O
- 
 O
yr O O
- 
 O
old 	 O
gravida v O
V 
 O
para a O
0 
 O
woman a O
presented s O
to O O
the 	 O
anaesthesia e O
consultation s O
clinic n O
at O O
37 O O
- 
 O
wk O O
gestation t O
to O O
discuss c O
pain n O
relief i O
options i O
for 	 O
labour o O
and 	 O
delivery i O
. 
 O
The 	 O
TaqI I S-GENE
and 	 O
HaeIII I B-GENE
RFLPs P E-GENE
will l O
provide v O
tools l O
for 	 O
the 	 O
genetic e O
analysis l O
of O O
CR2 	 S-GENE
. 
 O
In O O
addition i O
, 
 O
because a O
SB203580 0 O
had 	 O
no O O
effect e O
of O O
TNF 	 S-GENE
- 
 O
or O O
ceramide a O
- 
 O
induced u O
apoptosis p O
, 
 O
our 	 O
results u O
strongly o O
argue u O
against i O
a 
 O
role e O
for 	 O
p38 	 B-GENE
MAPK K E-GENE
in O O
the 	 O
induction u O
of O O
TNF 	 S-GENE
- 
 O
- 
 O
or O O
ceramide a O
- 
 O
induced u O
apoptosis p O
. 
 O
Cognitive n O
measures s O
of O O
attention e O
included l O
the 	 O
Stroop o O
and 	 O
Controlled t O
Oral l O
Word d O
Association o O
Test t O
using n O
the 	 O
letters t O
" 
 O
C 
 O
, 
 O
" 
 O
" 
 O
F 
 O
, 
 O
" 
 O
and 	 O
" 
 O
L 
 O
" 
 O
( 
 O
COWAT A O
, 
 O
CFL 	 O
version s O
) 
 O
. 
 O
Ptx1 1 S-GENE
belongs o O
to O O
an O O
expanding a O
family i O
of O O
bicoid o B-GENE
- - I-GENE
related a I-GENE
vertebrate t I-GENE
homeobox e I-GENE
genes e E-GENE
. 
 O
Effects e O
of O O
dietary t O
lipids i O
on O O
whole l O
- 
 O
body y O
retention e O
and 	 O
organ a O
distribution t O
of O O
organic a O
and 	 O
inorganic r O
mercury c O
in O O
mice e O
. 
 O
Differential f O
transcription n O
of O O
plastome s B-GENE
- 
 I-GENE
encoded o I-GENE
genes e E-GENE
in O O
the 	 O
mesophyll o O
and 	 O
bundle d O
- 
 O
sheath a O
chloroplasts o O
of O O
the 	 O
monocotyledonous o B-GENE
NADP P I-GENE
- 
 I-GENE
malic i I-GENE
enzyme y I-GENE
- 
 I-GENE
type e I-GENE
C4 O I-GENE
plants n I-GENE
maize z I-GENE
and 	 I-GENE
Sorghum g E-GENE
. 
 O
Sequential u O
immunoprecipitation u O
showed w O
all 	 O
detectable e O
p53 	 S-GENE
to O O
be O O
of O O
the 	 O
PAb246 2 O
+ - O
class s O
in O O
each h O
LPV 	 O
- 
 O
transformed n O
cell l O
line e O
, 
 O
suggesting g O
that t O
the 	 O
stable b O
p53 	 S-GENE
was 	 O
indeed e O
wild d O
type e O
. 
 O
Tissue s O
- 
 O
specific c O
gene e O
regulation u O
of O O
eukaryotic a O
organisms a O
is O O
to O O
a 
 O
large g O
extent e O
mediated i O
by O O
transcription n O
factors t O
that t O
interact e O
with h O
genomic o O
DNA 	 O
sequences u O
in O O
a 
 O
sequence u O
- 
 O
specific c O
manner n O
. 
 O
Enhanced a O
quantum n O
correlations r O
in O O
bound n O
higher h O
- 
 O
order e O
solitons i O
Quantum n O
effects e O
in O O
N 
 O
- 
 O
bound n O
solitons i O
can 	 O
be O O
drastically s O
enhanced a O
compared p O
to O O
the 	 O
fundamental d O
soliton i O
. 
 O
The 	 O
data a O
suggest g O
that t O
compromised p O
fibrinolytic r O
capacity a O
may 	 O
be O O
a 
 O
contributing t O
factor t O
in O O
the 	 O
development e O
of O O
thrombosis o O
in O O
patients i O
with h O
the 	 O
lupus u O
anticoagulant i O
. 
 O
The 	 O
MEE 	 O
was 	 O
significantly n O
greater a O
than n O
the 	 O
BEE 	 O
and 	 O
significantly n O
less s O
than n O
the 	 O
calculated c O
energy r O
expenditure e O
. 
 O
These s O
results u O
suggest g O
that t O
E6010 1 O
may 	 O
be O O
of O O
clinical n O
value u O
in O O
the 	 O
treatment a O
of O O
coronary o O
occlusion l O
. 
 O
To O O
better t O
understand e O
the 	 O
relationship a O
between w O
expression r O
of O O
an O O
oncogene o O
and 	 O
genetic e O
instability t O
, 
 O
we O O
have e O
studied d O
a 
 O
cell l O
line e O
expressing r O
an O O
activated i O
human a B-GENE
Ha I I-GENE
- - I-GENE
ras 	 E-GENE
under e O
the 	 O
control t O
of O O
bacterial t B-GENE
lactose t I-GENE
operon r I-GENE
regulatory u I-GENE
elements m E-GENE
for 	 O
changes n O
in O O
methotrexate h O
resistance i O
and 	 O
dihydrofolate y B-GENE
reductase u E-GENE
( 
 O
dhfr r S-GENE
) 
 O
gene e O
amplification l O
following l O
mutant a B-GENE
Ha I I-GENE
- - I-GENE
ras 	 E-GENE
induction u O
. 
 O
On O O
a 
 O
variety i O
of O O
fronts n O
, 
 O
chronic o O
bacterial t O
infection e O
is O O
being n O
found n O
to O O
be O O
significantly n O
associated o O
with h O
the 	 O
development e O
of O O
atherosclerosis e O
and 	 O
the 	 O
clinical n O
complications p O
of O O
unstable t O
angina i O
, 
 O
myocardial c O
infarction a O
, 
 O
and 	 O
stroke o O
. 
 O
Long g O
- 
 O
term m O
results u O
and 	 O
curative a O
mechanisms h O
of O O
vesicoureteral i O
reflux l O
by O O
endoscopic o O
injection e O
of O O
blood o O
. 
 O
Inspection p O
of O O
X - O
. - O
tropicalis p O
, - O
mouse s O
and 	 O
human a B-GENE
U6 I I-GENE
DNA 	 I-GENE
upstream t I-GENE
sequences u E-GENE
revealed e O
the 	 O
presence s O
of O O
a 
 O
TATA A O
box 	 O
as O O
well l O
as O O
of O O
the 	 O
proximal x O
and 	 O
enhancer a O
( 
 O
octamer a O
motif i O
) 
 O
elements m O
contained t O
in O O
snRNA N B-GENE
genes e E-GENE
transcribed n O
by O O
RNA 	 B-GENE
polymerase y I-GENE
II E E-GENE
. 
 O
Characterization r O
of O O
an O O
unusual s O
tRNA A O
- 
 O
like e O
sequence u O
found n O
inserted e O
in O O
a 
 O
Neurospora r O
retroplasmid r O
. 
 O
Repeated e O
time e O
course r O
studies d O
in O O
the 	 O
same e O
patient i O
were e O
reproducible r O
although h O
the 	 O
absolute o O
concentrations c O
showed w O
some e O
variation i O
. 
 O
The 	 O
present s O
work k O
represents r O
an O O
attempt e O
to O O
develop e O
a 
 O
method h O
for 	 O
measuring s O
relative a O
blood o O
flow w O
in O O
intestinal e O
capillaries i O
, 
 O
by O O
the 	 O
use 	 O
of O O
sodium i O
fluorescein o O
( 
 O
Na O O
- 
 O
F 
 O
) 
 O
as O O
an O O
indicator i O
substance s O
. 
 O
The 	 O
human a B-GENE
PAX8 8 I-GENE
gene e E-GENE
generates e O
at O O
least s O
five e O
different f O
alternatively e O
spliced i O
transcripts n O
encoding o O
different f O
PAX8 8 B-GENE
isoforms f E-GENE
. 
 O
These s O
data a O
show w O
that t O
both h O
Sp1 	 S-GENE
and 	 O
Sp3 	 S-GENE
transcription n O
factors t O
upregulate e O
HGF 	 B-GENE
promoter m E-GENE
activity i O
by O O
binding d O
to O O
the 	 O
Sp1 	 B-GENE
binding d I-GENE
site e E-GENE
at O O
position i O
- 
 O
318 	 O
to O O
- 
 O
303 	 O
bp O O
in O O
the 	 O
HGF 	 B-GENE
gene e I-GENE
promoter m E-GENE
. 
 O
After e O
a 
 O
1 
 O
- 
 O
h 
 O
rest t O
( 
 O
for 	 O
T2 O O
return u O
to O O
baseline e O
) 
 O
, 
 O
subjects j O
repeated e O
the 	 O
5 
 O
- 
 O
min 	 O
protocol t O
, 
 O
followed l O
by O O
a 
 O
final a O
MRI 	 O
/ 
 O
MRS 	 O
. 
 O
The 	 O
cells l O
arrest e O
in O O
the 	 O
G1 O O
phase s O
of O O
the 	 O
cell l O
cycle l O
and 	 O
grow w O
a 
 O
projection j O
towards a O
one 	 O
another t O
forming m O
a 
 O
shmoo o O
projection j O
. 
 O
Mammalian m O
homologues o O
of O O
the 	 O
Polycomb y B-GENE
- - I-GENE
group u I-GENE
gene e I-GENE
Enhancer a E-GENE
of I O
zeste t B-GENE
mediate i I-GENE
gene e E-GENE
silencing e O
in O O
Drosophila s B-GENE
heterochromatin e E-GENE
and 	 O
at O O
S 
 O
. 
 O
cerevisiae e O
telomeres o O
. 
 O
With h O
six 	 O
reports o O
in O O
the 	 O
literature e O
that t O
show w O
there r O
is O O
an O O
order e O
to O O
melanoma a O
nodal a O
metastases a O
and 	 O
that t O
the 	 O
SLN 	 O
histology t O
is O O
reflective l O
of O O
the 	 O
histology t O
of O O
the 	 O
remainder a O
of O O
the 	 O
nodal a O
basin i O
, 
 O
the 	 O
more e O
conservative s O
SLN 	 O
biopsy p O
can 	 O
be O O
performed f O
to O O
adequately q O
stage g O
nodally a O
the 	 O
patient i O
with h O
melanoma a O
. 
 O
The 	 O
results u O
obtained a O
with h O
[ - O
F304 4 O
] - O
R2 E O
indicate i O
that t O
structural u O
changes n O
in O O
E - O
. - O
coli i O
R2 E O
in O O
the 	 O
vicinity i O
of O O
this s O
helix i O
distortion t O
can 	 O
influence l O
the 	 O
catalytic a O
activity i O
of O O
the 	 O
holoenzyme o O
. 
 O
Cloning n O
and 	 O
characterization r O
of O O
the 	 O
5 
 O
' 
 O
flanking n O
region i O
of O O
human a B-GENE
ATP 	 I-GENE
- - I-GENE
citrate r I-GENE
lyase s I-GENE
gene e E-GENE
. 
 O
Cryoglobulinaemia o O
among n O
maintenance n O
haemodialysis m O
patients i O
and 	 O
its 	 O
relation a O
to O O
hepatitis a O
C 
 O
infection e O
. 
 O
The 	 O
S3 B B-GENE
protein t E-GENE
also o O
contains t O
a 
 O
DNA 	 O
repair a O
activity i O
, 
 O
efficiently i O
processing c O
8 
 O
- 
 O
oxoguanine g O
residues i O
in O O
DNA 	 O
via 	 O
an O O
N - B-GENE
- - I-GENE
glycosylase c E-GENE
/ 
 O
apurinic r B-GENE
- - I-GENE
apyrimidinic r I-GENE
( - I-GENE
AP I I-GENE
) - I-GENE
lyase s E-GENE
activity i O
. 
 O
25 O O
patients i O
received e O
20 O O
mgs 	 O
of O O
hyoscine s O
N 
 O
- 
 O
butyl y O
bromide m O
and 	 O
the 	 O
rest t O
5 
 O
mgs 	 O
propinoxate p O
, 
 O
i 
 O
. 
 O
v 
 O
. 
 O
plus s O
diazepam z O
. 
 O
We O O
present s O
here e O
a 
 O
statistical t O
technique h O
we O O
developed e O
to O O
identify n O
the 	 O
sequence u O
elements m O
that t O
may 	 O
be O O
responsible p O
for 	 O
this s O
cell l O
cycle l O
regulation u O
. 
 O
Computed p O
tomographic o O
( 
 O
CT O O
) 
 O
findings d O
of O O
pancreatic c O
ductal t O
adenocarcinoma n O
were e O
studied d O
with h O
the 	 O
combined b O
method h O
of O O
early l O
enhancement a O
CT O O
and 	 O
high h O
dose e O
enhancement a O
CT O O
in O O
72 O O
carcinomas c O
. 
 O
No O O
other e O
transcripts n O
of O O
different f O
length g O
could l O
be O O
detected e O
after e O
prolonged l O
exposure o O
. 
 O
We O O
conclude c O
, 
 O
therefore r O
, 
 O
that t O
in O O
the 	 O
absence e O
of O O
E1A 	 S-GENE
, 
 O
E4orf4 r S-GENE
is O O
sufficient f O
by O O
itself e O
to O O
trigger g O
a 
 O
p53 	 S-GENE
- 
 O
independent e O
apoptosis p O
pathway h O
that t O
may 	 O
operate r O
independently e O
of O O
the 	 O
known w O
zVAD D B-GENE
- 
 I-GENE
inhibitable i I-GENE
caspases p E-GENE
, 
 O
and 	 O
that t O
may 	 O
involve o O
an O O
as O O
yet 	 O
uncharacterized h O
mechanism h O
. 
 O
The 	 O
antiserum i O
used d O
for 	 O
immunoblotting u O
specifically c O
supershifts e O
uteroglobin r B-GENE
promoter m I-GENE
- - I-GENE
protein t I-GENE
complexes p E-GENE
in O O
gel 	 O
shift f O
experiments e O
. 
 O
The 	 O
nucleotide l O
sequence u O
of O O
the 	 O
estrogen r B-GENE
receptor e I-GENE
gene e I-GENE
of I I-GENE
Oreochromis o I-GENE
aureus e E-GENE
( 
 O
OaER R S-GENE
) 
 O
indicates i O
that t O
the 	 O
hormone m B-GENE
- 
 I-GENE
binding d I-GENE
E 
 I-GENE
domain a E-GENE
is O O
composed p O
of O O
4 
 O
exons n O
interspersed e O
by O O
short r O
introns r O
of O O
only y O
0 
 O
. 
 O
18 O O
- 
 O
1 
 O
. 
 O
3 
 O
kb O O
each h O
. 
 O
The 	 O
expression r O
of O O
Scmh1 h S-GENE
and 	 O
rae28 2 S-GENE
/ 
 O
mph1 1 S-GENE
is O O
well l O
correlated r O
in O O
most t O
tissues s O
of O O
embryos r O
. 
 O
The 	 O
nucleoporin l B-GENE
98 I I-GENE
gene e E-GENE
( 
 O
NUP98 9 S-GENE
) 
 O
, 
 O
which c O
is O O
rearranged r O
in O O
several e O
acute t O
myeloid l O
leukemia k O
translocations n O
, 
 O
is O O
located a O
within h O
this s O
region i O
. 
 O
We O O
have e O
isolated l O
and 	 O
sequenced u O
cDNA A O
sequences u O
corresponding r O
to O O
two 	 O
novel e O
genes e O
that t O
map 	 O
to O O
Xq28 8 S-GENE
. 
 O
A 
 O
new 	 O
direct e O
hemagglutination a O
test t O
( 
 O
HI O O
- 
 O
GONAVIS A O
) 
 O
for 	 O
urinary n O
LH S S-GENE
was 	 O
compared p O
with h O
the 	 O
serum u O
radioimmuno i O
- 
 O
assay a O
of O O
LH S S-GENE
. 
 O
Diffusion f O
epidemic d O
models e O
with h O
incubation u O
and 	 O
crisscross s O
dynamics a O
. 
 O
CERIP I S-GENE
interaction e O
. 
 O
The 	 O
encoded o O
Arabidopsis b B-GENE
U3 I I-GENE
snRNAs N E-GENE
can 	 O
be O O
folded d O
into o O
a 
 O
secondary o O
structure u O
which c O
is O O
more e O
similar i O
to O O
that t O
of O O
U3 B B-GENE
RNAs s E-GENE
from m O
lower e O
eukaryotes a O
rather h O
than n O
from m O
metazoa a O
. 
 O
Therapy r O
and 	 O
prevention v O
of O O
irreversible e O
shock c O
with h O
pharmacological r O
doses e O
of O O
some e O
corticosteroids t O
Fentanyl t O
citrate r O
( 
 O
0 
 O
. 
 O
1 
 O
mL O O
) 
 O
and 	 O
2H5 	 O
- 
 O
fentanyl t O
( 
 O
internal e O
standard n O
, 
 O
0 
 O
. 
 O
05 O O
mL O O
, 
 O
100 	 O
mg O O
/ 
 O
L 
 O
) 
 O
were e O
extracted r O
with h O
Toxi i O
- 
 O
A 
 O
tubes e O
( 
 O
Toxi i O
- 
 O
Lab 	 O
, 
 O
Irvine i O
, 
 O
CA O O
) 
 O
and 	 O
analyzed l O
by O O
gas 	 O
chromatography o O
- 
 O
mass s O
spectrometry c O
. 
 O
Positive i O
effects e O
of O O
radioactive i O
therapy r O
in O O
Guarapari r O
The 	 O
LT B B-GENE
- - I-GENE
beta a I-GENE
gene e E-GENE
is O O
expressed r O
in O O
lymphoid p O
cells l O
and 	 O
organs a O
, 
 O
but 	 O
little t O
is O O
known w O
about u O
its 	 O
inducible u O
regulation u O
. 
 O
Ciprofloxacin r O
attained a O
a 
 O
peak k O
serum u O
concentration c O
of O O
1 
 O
. 
 O
2 
 O
mg O O
/ 
 O
l 
 O
and 	 O
a 
 O
serum u O
half f O
- 
 O
life e O
of O O
34 O O
min 	 O
. 
 O
Dmyd d S-GENE
clone n O
encodes o O
a 
 O
polypeptide y O
of O O
332 	 O
amino n O
acids d O
with h O
82 O O
% 
 O
identity n O
to O O
MyoD D S-GENE
in O O
the 	 O
41 O O
amino n O
acids d O
of O O
the 	 O
putative a O
helix i O
- 
 O
loop p O
- 
 O
helix i O
region i O
and 	 O
100 	 O
% 
 O
identity n O
in O O
the 	 O
13 O O
amino n O
acids d O
of O O
the 	 O
basic i O
domain a O
proposed p O
to O O
contain t O
the 	 O
essential e O
recognition o O
code e O
for 	 O
muscle c O
- 
 O
specific c O
gene e O
activation i O
. 
 O
Identification n O
of O O
an O O
osteocalcin e B-GENE
gene e I-GENE
promoter m I-GENE
sequence u E-GENE
that t O
binds d O
AP1 	 S-GENE
. 
 O
Treatment a O
is O O
based e O
on O O
antifungal i O
drugs g O
, 
 O
most t O
frequently q O
nystatin t O
, 
 O
amphotericin h O
B 
 O
and 	 O
ketoconazole o O
. 
 O
Mutations a O
abolishing l O
MalK K S-GENE
function c O
not 	 O
only y O
result u O
in O O
inability b O
to O O
transport n O
maltose t O
but 	 O
also o O
cause s O
constitutive s O
expression r O
of O O
the 	 O
maltose t B-GENE
regulon u E-GENE
. 
 O
Drosophila s B-GENE
melanogaster a I-GENE
casein e I-GENE
kinase a I-GENE
II E E-GENE
( 
 O
DmCKII K S-GENE
) 
 O
is O O
composed p O
of O O
catalytic a O
( 
 O
alpha h O
) 
 O
and 	 O
regulatory u O
( 
 O
beta a O
) 
 O
subunits u O
associated o O
as O O
an O O
alpha2beta2 h B-GENE
heterotetramer e E-GENE
. 
 O
The 	 O
aims s O
of O O
this s O
study d O
were e O
to O O
examine m O
whether t O
the 	 O
EORTC T O
( 
 O
European o O
Organisation a O
for 	 O
Research e O
and 	 O
Treatment a O
of O O
Cancer c O
) 
 O
QLQ 	 O
- 
 O
C30 	 O
core e O
questionnaire s O
alone n O
could l O
distinguish t O
between w O
two 	 O
clinically n O
different f O
groups u O
of O O
patients i O
and 	 O
to O O
design i O
a 
 O
module u O
, 
 O
which c O
included l O
relevant e O
patient i O
- 
 O
defined i O
gastric t O
cancer c O
- 
 O
specific c O
variables i O
. 
 O
On O O
both h O
indocyanine o O
green e O
video e O
and 	 O
fluorescein o O
angiography i O
, 
 O
hypofluorescent o O
lesions i O
were e O
almost o O
the 	 O
same e O
size e O
as O O
the 	 O
light h O
yellow l O
area a O
and 	 O
the 	 O
dark k O
yellow l O
center t O
of O O
a 
 O
placoid c O
lesion i O
. 
 O
We O O
have e O
measured s O
percentage c O
O3 O O
uptake a O
in O O
30 O O
adult l O
Sprague a O
- 
 O
Dawley l O
rats s O
exposed o O
, 
 O
nose e O
only y O
, 
 O
for 	 O
1 
 O
hr O O
to O O
0 
 O
. 
 O
3 
 O
, 
 O
0 
 O
. 
 O
6 
 O
, 
 O
or O O
1 
 O
. 
 O
0 
 O
ppm 	 O
O3 O O
. 
 O
The 	 O
signal n O
- 
 O
to O O
- 
 O
noise s O
ratio i O
( 
 O
SNR 	 O
) 
 O
was 	 O
calculated c O
in O O
the 	 O
T2 O O
- 
 O
weighted g O
sequence u O
. 
 O
Cell l O
rounding n O
was 	 O
abrogated o O
by O O
expression r O
of O O
either h O
kinase a O
- 
 O
dead d O
forms m O
of O O
US3 	 B-GENE
PK E E-GENE
or O O
a 
 O
mutant a O
protein t O
lacking k O
the 	 O
acidic d O
cluster s O
in O O
the 	 O
kinase a O
regulatory u O
domain a O
. 
 O
Three e O
distinct t O
human a B-GENE
HDACs C E-GENE
are 	 O
homologous o O
to O O
RPD3 3 S-GENE
, 
 O
a 
 O
yeast s O
transcriptional n O
regulator u O
. 
 O
The 	 O
4 
 O
- 
 O
nt O O
sequence u O
of O O
the 	 O
rotavirus a O
3 
 O
' 
 O
TE O O
represents r O
by O O
far 	 O
the 	 O
shortest r O
of O O
any 	 O
of O O
the 	 O
sequence u O
enhancers a O
known w O
to O O
stimulate m O
translation n O
. 
 O
OBJECTIVE E O
: 
 O
The 	 O
audiologic i O
presentation s O
of O O
vestibular t O
schwannoma w O
( 
 O
VS O O
) 
 O
associated o O
with h O
neurofibromatosis r O
type e O
2 
 O
( 
 O
NF2 	 O
) 
 O
has 	 O
not 	 O
been n O
well l O
characterized r O
. 
 O
Expression r O
of O O
these s O
chemokines m O
is O O
similar i O
in O O
that t O
both h O
require u O
the 	 O
NF B B-GENE
- - I-GENE
kappa p I-GENE
B - I-GENE
element m E-GENE
and 	 O
additional i O
regions i O
such h O
as O O
the 	 O
CAAT T B-GENE
/ - I-GENE
enhancer a I-GENE
binding d I-GENE
protein t E-GENE
( 
 O
C - B-GENE
/ - I-GENE
EBP 	 E-GENE
) 
 O
element m O
of O O
the 	 O
IL B B-GENE
- - I-GENE
8 - I-GENE
promoter m E-GENE
. 
 O
The 	 O
meaning n O
of O O
hope e O
in O O
health l O
and 	 O
illness n O
. 
 O
Assessment e O
of O O
two 	 O
anion o O
- 
 O
exchange h O
resins i O
for 	 O
direct e O
use 	 O
in O O
the 	 O
screening e O
method h O
for 	 O
urinary n O
porphobilinogen p O
. 
 O
Aggravation r O
of O O
peripheral i O
- 
 O
blood o O
cytopenia o O
during i O
the 	 O
first s O
weeks k O
and 	 O
hypocellularity o O
of O O
bone e O
- 
 O
marrow r O
aspirates i O
at O O
the 	 O
end 	 O
of O O
therapy r O
suggest g O
that t O
low 	 O
- 
 O
dose e O
Ara 	 O
C 
 O
exerts r O
its 	 O
main n O
activity i O
by O O
suppression p O
of O O
leukaemic k O
growth w O
, 
 O
rather h O
than n O
by O O
induction u O
of O O
differentiation f O
in O O
malignant i O
cells l O
. 
 O
All 	 O
depressive r O
groups u O
showed w O
improved r O
error o O
measures s O
post t O
- 
 O
treatment a O
. 
 O
Triaxiality a O
in O O
the 	 O
proton t O
- 
 O
neutron t O
interacting e O
boson o O
model e O
: 
 O
Perturbed t O
O 
 O
( 
 O
6 
 O
) 
 O
symmetry m O
with h O
application l O
to O O
the 	 O
mass s O
A 
 O
The 	 O
best t O
sequences u O
for 	 O
pelvic v O
study d O
are 	 O
, 
 O
in O O
our 	 O
experience e O
, 
 O
IR O O
or O O
short r O
TR O O
spin n O
- 
 O
echo o O
for 	 O
T1 O O
- 
 O
weighted g O
images g O
, 
 O
and 	 O
spin n O
- 
 O
echo o O
with h O
1200 0 O
TR O O
for 	 O
T2 O O
images g O
. 
 O
Cells l O
were e O
co O O
- 
 O
infected e O
simultaneously u O
with h O
IBV 	 O
, 
 O
the 	 O
recombinant o O
FPV 	 O
( 
 O
rFPV V O
) 
 O
containing t O
the 	 O
D 
 B-GENE
- 
 I-GENE
RNA 	 I-GENE
sequence u E-GENE
and 	 O
a 
 O
second o O
rFPV V O
expressing r O
T7 B B-GENE
RNA 	 I-GENE
polymerase y E-GENE
for 	 O
the 	 O
initial t O
expression r O
of O O
the 	 O
D 
 B-GENE
- 
 I-GENE
RNA 	 I-GENE
transcript n E-GENE
, 
 O
subsequently s O
rescued c O
by O O
helper p B-GENE
IBV 	 E-GENE
. 
 O
Seasonal s O
variation i O
of O O
the 	 O
cadmium m O
content t O
of O O
Murex e O
trunculus n O
in O O
a 
 O
non 	 O
- 
 O
cadmium m O
polluted l O
environment i O
. 
 O
These s O
results u O
are 	 O
discussed c O
in O O
relation a O
to O O
predicted d O
isoform f B-GENE
L 
 E-GENE
diversity e O
across o O
human a O
tissues s O
and 	 O
cells l O
. 
 O
Doctors t O
given e O
intrathecal r O
methotrexate h O
had 	 O
headache d O
when n O
20 O O
gauge g O
standard n O
needle d O
was 	 O
used d O
. 
 O
The 	 O
AP B B-GENE
- - I-GENE
1 - E-GENE
recruited r O
by O O
ARF1 1 B-GENE
. - I-GENE
GTP 	 E-GENE
is O O
released e O
from m O
the 	 O
Golgi g O
membrane b O
by O O
treatment a O
with h O
1 
 O
M 
 O
Tris s O
- 
 O
HCl 	 O
( 
 O
pH O O
7 
 O
) 
 O
or O O
upon n O
reincubation n O
at O O
37 O O
degreesC r O
, 
 O
whereas r O
AP B B-GENE
- - I-GENE
1 - E-GENE
recruited r O
with h O
GTPgammaS g S-GENE
or O O
by O O
a 
 O
constitutively s O
active i O
point n O
mutant a O
, 
 O
ARF1 1 S-GENE
( - O
Q71L L S-GENE
) - O
, 
 O
remains a O
membrane b O
bound n O
after e O
either h O
treatment a O
. 
 O
The 	 O
formation m O
of O O
tumorlike o O
lesions i O
in O O
the 	 O
cockroach k O
leucophaea c O
maderae e O
after e O
anal l O
blockage c O
. 
 O
Fine e O
tangled g O
pili i O
expressed r O
by O O
Haemophilus m O
ducreyi r O
are 	 O
a 
 O
novel e O
class s O
of O O
pili i O
. 
 O
We O O
found n O
remarkable a O
differences f O
in O O
the 	 O
expression r O
patterns t O
of O O
MTB 	 B-GENE
- - I-GENE
Zf I I-GENE
mRNA A E-GENE
and 	 O
two 	 O
other e O
hybridizable r O
mRNAs A O
of O O
5kb 	 S-GENE
and 	 O
8 
 O
. 
 O
5 
 O
kb O O
when n O
human a O
brain i O
and 	 O
primary m O
brain i O
tumors o O
were e O
compared p O
. 
 O
The 	 O
two 	 O
redox o O
centers t O
in O O
the 	 O
protein t O
, 
 O
FAD 	 S-GENE
and 	 O
a 
 O
[ 
 O
4Fe4S 4 O
] 
 O
+ 
 O
2 
 O
, 
 O
+ 
 O
1 
 O
cluster s O
, 
 O
are 	 O
present s O
in O O
a 
 O
64 O O
- 
 O
kDa 	 O
monomer o O
. 
 O
The 	 O
pra2 2 B-GENE
gene e E-GENE
encodes o O
a 
 O
pea 	 B-GENE
( - I-GENE
Pisum u I-GENE
sativum i I-GENE
) - I-GENE
small l I-GENE
GTPase a E-GENE
belonging o O
to O O
the 	 O
YPT 	 S-GENE
/ 
 O
rab 	 B-GENE
family i E-GENE
, 
 O
and 	 O
its 	 O
expression r O
is O O
down n O
- 
 O
regulated u O
by O O
light h O
, 
 O
mediated i O
by O O
phytochrome t O
. 
 O
Carotid o O
body y O
chemoreceptor m O
activity i O
as O O
recorded o O
from m O
the 	 O
petrosal r O
ganglion g O
in O O
cats s O
. 
 O
Human a O
and 	 O
murine i B-GENE
cytotoxic o I-GENE
T - I-GENE
lymphocyte p I-GENE
serine i I-GENE
proteases t E-GENE
: 
 O
subsite s O
mapping p O
with h O
peptide t O
thioester o O
substrates s O
and 	 O
inhibition i O
of O O
enzyme y O
activity i O
and 	 O
cytolysis o O
by O O
isocoumarins c O
. 
 O
To O O
explore l O
further t O
the 	 O
role e O
of O O
the 	 O
carboxyl b O
- 
 O
terminal m O
domain a O
in O O
determining e O
the 	 O
cell l O
cycle l O
function c O
of O O
CDC34 3 S-GENE
, 
 O
we O O
constructed s O
and 	 O
characterized r O
genes e O
encoding o O
chimeric m O
E2s 	 B-GENE
incorporating o I-GENE
sequences u E-GENE
from m O
CDC34 3 S-GENE
and 	 O
the 	 O
related a O
but 	 O
functionally c O
distinct t O
E2 S B-GENE
RAD6 6 E-GENE
( 
 O
UBC2 2 S-GENE
) 
 O
. 
 O
MAPKK K B-GENE
kinase a E-GENE
/ 
 O
MEKK K S-GENE
phosphorylates s O
and 	 O
activates i O
its 	 O
downstream n O
protein t O
kinase a O
, 
 O
MAPK K B-GENE
kinase a E-GENE
/ 
 O
MEK 	 S-GENE
, 
 O
which c O
in O O
turn n O
activates i O
MAPK K S-GENE
. 
 O
Kondo d O
effect e O
in O O
Cu O O
( 
 O
Fe O O
) 
 O
films m O
. 
 O
However e O
, 
 O
ADAR1 R S-GENE
and 	 O
the 	 O
related a O
deaminase m B-GENE
ADAR2 R E-GENE
showed w O
significant n O
expression r O
in O O
all 	 O
regions i O
of O O
the 	 O
brain i O
examined m O
, 
 O
including l O
cortex t O
, 
 O
hippocampus p O
, 
 O
olfactory a O
bulb b O
, 
 O
and 	 O
striatum i O
, 
 O
where r O
the 	 O
5 - B-GENE
- - I-GENE
HT2CR C I-GENE
pre 	 I-GENE
- - I-GENE
mRNA A E-GENE
was 	 O
extensively e O
edited t O
. 
 O
To O O
investigate e O
its 	 O
transcription n O
, 
 O
1 
 O
. 
 O
1 
 O
kilobases o O
of O O
the 	 O
5 
 O
' 
 O
- 
 O
flanking n O
sequence u O
were e O
fused e O
to O O
a 
 O
luciferase i B-GENE
reporter o I-GENE
gene e E-GENE
. 
 O
Influence l O
of O O
copper p O
addition i O
. 
 O
The 	 O
0 
 O
. 
 O
018 	 O
- 
 O
inch h O
FloWire W O
provides v O
a 
 O
high h O
- 
 O
fidelity e O
continuous t O
Doppler p O
signal n O
. 
 O
Monosulfates o O
of O O
16 O O
- 
 O
oxygenated g O
ketonic o O
C19 	 O
steroids r O
in O O
adult l O
human a O
urine n O
. 
 O
Under e O
anaerobic e O
conditions d O
( 
 O
a 
 O
50 O O
- 
 O
day 	 O
experiment e O
) 
 O
these s O
organisms a O
degraded r O
15 O O
- 
 O
18 O O
% 
 O
of O O
the 	 O
TEM 	 O
, 
 O
20 O O
- 
 O
25 O O
% 
 O
of O O
some e O
alkanes a O
, 
 O
and 	 O
15 O O
- 
 O
18 O O
% 
 O
of O O
selected e O
polycyclic y O
aromatic m O
hydrocarbons r O
. 
 O
In O O
addition i O
, 
 O
WR O O
- 
 O
3689 9 O
, 
 O
WR O O
- 
 O
109342 3 O
, 
 O
and 	 O
WR O O
- 
 O
168643 6 O
were e O
used d O
with h O
per 	 O
os O O
administration i O
to O O
determine e O
hematopoietic a O
lethality h O
. 
 O
Further t O
, 
 O
we O O
will l O
review i O
our 	 O
evaluation l O
of O O
the 	 O
survival v O
rate e O
and 	 O
prognostic g O
factors t O
for 	 O
9 
 O
, 
 O
262 	 O
patients i O
from m O
1981 1 O
to O O
1996 6 O
. 
 O
MEASURES S O
: 
 O
SF O O
- 
 O
36 O O
questionnaires s O
were e O
completed p O
by O O
patients i O
at O O
both h O
initial t O
and 	 O
discharge c O
examinations m O
. 
 O
In O O
contrast t O
, 
 O
corticotropin t B-GENE
releasing e I-GENE
factor t E-GENE
( 
 O
CRF 	 S-GENE
) 
 O
, 
 O
injected e O
centrally t O
produces d O
a 
 O
suppression p O
of O O
punished i O
and 	 O
non 	 O
- 
 O
punished i O
responding p O
in O O
the 	 O
conflict f O
test t O
consistent s O
with h O
its 	 O
hypothesized o O
role e O
in O O
mediating i O
behavioral a O
responses p O
to O O
stress e O
. 
 O
Temporal p O
recruitment r O
of O O
the 	 O
mSin3A n B-GENE
- 
 I-GENE
histone t I-GENE
deacetylase c I-GENE
corepressor e I-GENE
complex p E-GENE
to O O
the 	 O
ETS 	 B-GENE
domain a I-GENE
transcription n I-GENE
factor t I-GENE
Elk 	 I-GENE
- - I-GENE
1 - E-GENE
. 
 O
The 	 O
cluster s O
was 	 O
mapped p O
to O O
nucleotides l O
- 
 O
464 	 O
to O O
- 
 O
434 	 O
( 
 O
relative a O
to O O
nucleotide l O
A 
 O
in O O
the 	 O
initiation t O
codon o O
) 
 O
in O O
genomic o O
DNA 	 O
. 
 O
In O O
addition i O
, 
 O
FOP 	 S-GENE
- 
 O
FGFR1 R S-GENE
- 
 O
expressing r O
cells l O
show w O
constitutive s O
phosphorylation s O
of O O
the 	 O
positive i O
regulator u O
of O O
translation n B-GENE
p70S6 S I-GENE
kinase a E-GENE
; 
 O
this s O
phosphorylation s O
is O O
inhibited i O
by O O
PI3 	 B-GENE
- - I-GENE
kinase a E-GENE
and 	 O
mTOR R S-GENE
( 
 O
mammalian m O
target g O
of I O
rapamycin a O
) 
 O
inhibitors i O
. 
 O
The 	 O
authors h O
report o O
two 	 O
cases e O
of O O
orbital i O
cavernous e O
hemangioma a O
diagnosed g O
by O O
Tc O O
- 
 O
99m 	 O
RBC 	 O
SPECT C O
. 
 O
Ciprofloxacin r O
levels e O
in O O
serum u O
and 	 O
blister s O
fluid i O
at O O
the 	 O
end 	 O
of O O
the 	 O
dosing i O
interval e O
( 
 O
8 
 O
h 
 O
) 
 O
were e O
superior e O
or O O
almost o O
superior e O
to O O
MICs s O
for 	 O
sensitive s O
organisms a O
including l O
Pseudomonas u O
aeruginosa u O
. 
 O
Antibiotic i O
prophylaxis p O
in O O
a 
 O
surgical g O
setting t O
We O O
identified n O
clones n O
of O O
Chlamydomonas a O
genomic o O
DNA 	 O
that t O
rescued c O
the 	 O
Ca O O
( 
 O
2 
 O
+ 
 O
) 
 O
- 
 O
dependent e O
axonemal n O
microtubule r O
severing e O
defect e O
of O O
fa1 	 B-GENE
mutants a E-GENE
. 
 O
These s O
changes n O
persisted s O
during i O
the 	 O
first s O
week k O
. 
 O
Hyperlipemia e O
has 	 O
been n O
recently e O
described c O
in O O
children l O
with h O
migraine r O
, 
 O
being n O
suggested g O
that t O
this s O
alteration e O
is O O
in O O
the 	 O
base e O
of O O
the 	 O
disease e O
. 
 O
Plasma s B-GENE
hemopexin o E-GENE
homeostasis e O
during i O
the 	 O
acute t O
phase s O
response p O
. 
 O
The 	 O
newly l O
identified n O
repressor r O
element m O
is O O
a 
 O
rare e O
example m O
of O O
a 
 O
naturally u O
occurring u O
perfect f O
palindromic i O
binding d O
motif i O
for 	 O
the 	 O
NF B B-GENE
- - I-GENE
kappa p I-GENE
B - E-GENE
/ 
 O
Rel 	 S-GENE
family i O
of O O
transcription n O
factors t O
. 
 O
Tryptophan p O
induction u O
prevents v O
Rho 	 S-GENE
- 
 O
dependent e O
transcription n O
termination m O
in O O
the 	 O
leader d O
region i O
of O O
the 	 O
operon r O
. 
 O
There r O
remains a O
the 	 O
physiological s O
problem b O
- 
 O
- 
 O
one 	 O
which c O
has 	 O
always a O
been n O
foremost e O
in O O
Moruzzi u O
' 
 O
s 
 O
thinking n O
about u O
the 	 O
intrinsic r O
regulation u O
of O O
brain i O
activity i O
- 
 O
- 
 O
of O O
how 	 O
the 	 O
separate a O
actions i O
of O O
the 	 O
different f O
arousal u O
systems t O
are 	 O
brought u O
together e O
into o O
a 
 O
functional c O
whole l O
. 
 O
The 	 O
nramp2 m B-GENE
gene e E-GENE
is O O
comprised p O
of O O
17 O O
exons n O
and 	 O
spans n O
more e O
than n O
36 O O
kb O O
. 
 O
The 	 O
immune u O
response p O
seems m O
to O O
be O O
partially t O
responsible p O
for 	 O
both h O
protection t O
and 	 O
the 	 O
destructive t O
consequences s O
of O O
chlamydial a O
infection e O
. 
 O
Results u O
: 
 O
hepatic a O
hydatidosis a O
: 
 O
177 	 O
patients i O
. 
 O
This s O
is O O
similar i O
to O O
previous v O
reports o O
of O O
muscle c O
creatine a B-GENE
phosphokinase s E-GENE
release e O
in O O
psychiatric c O
patients i O
. 
 O
The 	 O
majority o O
of O O
putative a O
TSC2 2 B-GENE
mutations a E-GENE
were e O
found n O
in O O
sporadic r O
rather h O
than n O
TSC2 2 O
- 
 O
linked k O
families i O
. 
 O
Murine i B-GENE
ELAM M I-GENE
- - I-GENE
1 - E-GENE
is O O
encoded o O
by O O
a 
 O
single g O
- 
 O
copy y O
gene e O
, 
 O
spanning n O
about u O
13 O O
kb O O
, 
 O
which c O
is O O
structurally u O
organized a O
into o O
14 O O
exons n O
and 	 O
13 O O
introns r O
; 
 O
very y O
similar i O
to O O
that t O
of O O
its 	 O
human a O
counterpart n O
. 
 O
A 
 O
biopsy p O
specimen c O
taken e O
from m O
the 	 O
frontal n O
branch n O
of O O
the 	 O
right h O
superficial e O
artery e O
revealed e O
segmental m O
intimal i O
thickening c O
consistent s O
with h O
intimal i O
fibroplasia r O
type e O
FMD 	 O
upon n O
histological t O
examination m O
. 
 O
Thus s O
in O O
this s O
study d O
we O O
used d O
in O O
vitro r O
methods h O
to O O
directly e O
evaluate l O
whether t O
isolated l O
human a O
saphenous h O
vein n O
segments m O
respond p O
to O O
vasoconstrictor o O
agents n O
at O O
arterial e O
pressure s O
levels e O
. 
 O
We O O
found n O
that t O
the 	 O
PRP20 2 B-GENE
gene e E-GENE
is O O
identical n O
to O O
the 	 O
yeast s B-GENE
SRM1 1 I-GENE
gene e E-GENE
( 
 O
Clark r O
and 	 O
Sprague a O
1989 9 O
) 
 O
. 
 O
Basal a O
JNK 	 B-GENE
MAPK K I-GENE
kinase a E-GENE
activity i O
was 	 O
also o O
specifically c O
induced u O
by O O
deltaEGFR t S-GENE
, 
 O
which c O
correlated r O
with h O
increased r O
phosphorylation s O
of O O
a 
 O
54 B B-GENE
- - I-GENE
kDa 	 I-GENE
JNK2 2 I-GENE
protein t E-GENE
observed e O
in O O
deltaEGFR t O
- 
 O
containing t O
cells l O
. 
 O
Deletion e O
analysis l O
defines i O
distinct t O
functional c O
domains a O
for 	 O
protein t O
- 
 O
protein t O
and 	 O
nucleic l O
acid d O
interactions e O
in O O
the 	 O
ORF1 1 B-GENE
protein t E-GENE
of O O
mouse s B-GENE
LINE E I-GENE
- - I-GENE
1 - E-GENE
. 
 O
PMA 	 O
produced d O
similar i O
results u O
, 
 O
but 	 O
the 	 O
induction u O
of O O
the 	 O
WT B B-GENE
AP1 	 I-GENE
c - I-GENE
- - I-GENE
jun 	 I-GENE
promoter m E-GENE
- 
 O
CAT 	 S-GENE
plasmid s O
was 	 O
smaller l O
. 
 O
The 	 O
determination e O
of O O
antithrombin i B-GENE
III 	 E-GENE
( 
 O
AT B B-GENE
III 	 E-GENE
) 
 O
and 	 O
its 	 O
clinical n O
significance n O
One 	 O
ORF 	 O
extends e O
from m O
nucleotides l O
415 	 O
to O O
1620 0 O
, 
 O
encodes o O
402 	 O
amino n O
acids d O
, 
 O
and 	 O
is O O
preceded c O
by O O
a 
 O
ribosome o O
- 
 O
binding d O
site e O
. 
 O
Glucose c O
consumption s O
of O O
the 	 O
human a O
brain i O
under e O
the 	 O
influence l O
of O O
intravenous r O
infusions u O
of O O
glucose c O
, 
 O
glucagon c S-GENE
and 	 O
glucose c B-GENE
- 
 I-GENE
insulin u E-GENE
D 
 O
. 
 O
, 
 O
Hughes h O
, 
 O
F 
 O
. 
 O
Deletion e O
of O O
CDC5 5 S-GENE
was 	 O
lethal h O
and 	 O
resulted u O
in O O
a 
 O
dumbbell b O
- 
 O
shaped p O
terminal m O
morphology p O
, 
 O
with h O
the 	 O
nuclei l O
almost o O
divided i O
but 	 O
still l O
connected n O
. 
 O
These s O
cDNAs A O
were e O
found n O
to O O
be O O
derived i O
from m O
the 	 O
3 
 O
" 
 O
- 
 O
untranslated r O
region i O
( 
 O
3 
 O
" 
 O
- 
 O
UTR 	 O
) 
 O
of O O
the 	 O
methyl h B-GENE
- - I-GENE
CpG 	 I-GENE
- - I-GENE
binding d I-GENE
protein t I-GENE
2 - I-GENE
gene e E-GENE
( 
 O
MeCP2 P S-GENE
) 
 O
. 
 O
A 
 O
) 
 O
During i O
O2 O O
- 
 O
ischemia h O
both h O
extracellular r O
[ 
 O
K 
 O
+ 
 O
] 
 O
and 	 O
change n O
of O O
pH O O
in O O
the 	 O
subepicardium e O
are 	 O
significantly n O
less s O
than n O
in O O
the 	 O
midmyocardium m O
. 
 O
The 	 O
generation e O
of O O
dorso s O
- 
 O
ventral t O
polarity a O
during i O
Drosophila s O
embryogenesis r O
is O O
regulated u O
by O O
the 	 O
action i O
of O O
12 O O
maternally e O
expressed r O
gene e O
products d O
, 
 O
the 	 O
dorsal s O
group u O
. 
 O
Ultimobranchial i O
body y O
and 	 O
parathyroid a O
glands n O
of O O
the 	 O
freshwater s O
snake k O
Natrix r O
piscator c O
in O O
response p O
to O O
vitamin a O
D3 O O
administration i O
. 
 O
These s O
observations e O
suggest g O
that t O
the 	 O
AF O B-GENE
- 
 I-GENE
1 
 I-GENE
region i E-GENE
of O O
PPARalpha R S-GENE
is O O
partially t O
silenced e O
by O O
corepressor e O
proteins t O
, 
 O
which c O
might h O
interact e O
in O O
a 
 O
phosphorylation s O
- 
 O
dependent e O
manner n O
. 
 O
Two 	 O
authors h O
, 
 O
two 	 O
journal r O
titles l O
, 
 O
two 	 O
drug g O
names e O
, 
 O
and 	 O
two 	 O
topics i O
of O O
a 
 O
general e O
medical i O
nature u O
were e O
retrieved r O
under e O
identical n O
circumstances c O
and 	 O
conditions d O
on O O
the 	 O
hosts t O
DATA A O
- 
 O
STAR R O
, 
 O
DIALOG L O
, 
 O
DIMDI D O
, 
 O
and 	 O
STN 	 O
. 
 O
However e O
, 
 O
in O O
a 
 O
variation i O
of O O
this s O
assay a O
in O O
which c O
the 	 O
protease t O
is O O
omitted t O
, 
 O
the 	 O
mutant a O
enzymes y O
exhibited i O
substantial s O
levels e O
of O O
prolyl l B-GENE
isomerase m E-GENE
activity i O
( 
 O
5 
 O
- 
 O
20 O O
% 
 O
of O O
wild d O
- 
 O
type e O
) 
 O
, 
 O
revealing e O
that t O
these s O
mutations a O
confer f O
sensitivity s O
to O O
protease t O
digestion e O
and 	 O
that t O
the 	 O
classic s O
in O O
vitro r O
assay a O
for 	 O
prolyl l B-GENE
isomerase m E-GENE
activity i O
may 	 O
be O O
misleading l O
. 
 O
As O O
a 
 O
test t O
of O O
this s O
hypothesis o O
, 
 O
we O O
predicted d O
that t O
mice e O
which c O
have e O
altered e O
expression r O
of O O
class s B-GENE
I 
 I-GENE
gene e I-GENE
products d E-GENE
, 
 O
the 	 O
beta2 a B-GENE
- - I-GENE
microglobulin r E-GENE
knockout c O
mice e O
, 
 O
[ - O
beta2m a O
( - O
- - O
/ - O
- - O
) - O
] - O
, 
 O
would l O
develop e O
Fe O O
overload r O
. 
 O
Nucleotide l O
sequence u O
of O O
the 	 O
gag 	 B-GENE
gene e E-GENE
and 	 O
gag 	 B-GENE
- 
 I-GENE
pol 	 E-GENE
junction c O
of O O
feline i O
leukemia k O
virus u O
. 
 O
Clinical n O
trial a O
endpoints p O
based e O
on O O
magnitude n O
of O O
reduction u O
in O O
HIV 	 O
- 
 O
1 
 O
RNA 	 O
levels e O
provide v O
an O O
important o O
complement p O
to O O
endpoints p O
based e O
on O O
percentage c O
of O O
patients i O
achieving i O
complete p O
virologic o O
suppression p O
. 
 O
It O O
also o O
describes c O
the 	 O
preliminary l O
results u O
of O O
a 
 O
Phase s O
II O O
trial a O
going n O
on O O
at O O
the 	 O
Central t O
Institute t O
for 	 O
Tumors o O
in O O
Zagreb r O
, 
 O
using n O
a 
 O
combination b O
of O O
cis 	 O
- 
 O
DDP 	 O
, 
 O
5 
 O
- 
 O
fluorouracil o O
and 	 O
vincristine c O
. 
 O
On O O
the 	 O
basis i O
of O O
the 	 O
physical s O
interactions e O
between w O
Sxl 	 S-GENE
and 	 O
Snf 	 S-GENE
, 
 O
we O O
present s O
a 
 O
model e O
for 	 O
Sxl 	 S-GENE
splicing i O
regulation u O
. 
 O
Though u O
it O O
has 	 O
been n O
established a O
that t O
skinfold n O
anthropometry h O
has 	 O
severe e O
limitations i O
as O O
a 
 O
method h O
of O O
deriving i O
total a O
body y O
fat 	 O
( 
 O
TBF 	 O
) 
 O
, 
 O
the 	 O
possibility s O
that t O
the 	 O
problem b O
might h O
be O O
related a O
more e O
to O O
the 	 O
assumptions u O
implicit l O
in O O
densitometry s O
has 	 O
to O O
be O O
addressed r O
. 
 O
The 	 O
average r O
mean n O
difference f O
compared p O
with h O
the 	 O
low 	 O
and 	 O
the 	 O
intermediate e O
calcium c O
group u O
was 	 O
11 O O
% 
 O
for 	 O
the 	 O
femoral o O
neck k O
, 
 O
8 
 O
- 
 O
11 O O
% 
 O
for 	 O
the 	 O
lumbar b O
spine n O
and 	 O
5 
 O
- 
 O
6 
 O
% 
 O
for 	 O
total a O
body y O
BMDs s O
. 
 O
We O O
cloned n O
the 	 O
BamHI H B-GENE
- - I-GENE
F - I-GENE
fragment g E-GENE
from m O
the 	 O
left t O
end 	 O
of O O
Ad4 	 S-GENE
in O O
pUC13 1 B-GENE
- 
 I-GENE
1 
 E-GENE
between w O
the 	 O
SalI I S-GENE
and 	 O
BamHI H B-GENE
sites e E-GENE
in O O
order e O
to O O
carry r O
out 	 O
the 	 O
structural u O
analysis l O
of O O
the 	 O
E1A 	 B-GENE
region i E-GENE
of I O
Ad4 	 S-GENE
. 
 O
We O O
reviewed i O
81 O O
patients i O
with h O
dementia e O
and 	 O
autopsy o O
findings d O
of O O
Alzheimer h O
' 
 O
s 
 O
disease e O
( 
 O
AD O O
) 
 O
to O O
identify n O
patients i O
with h O
seizures z O
or O O
myoclonus c O
after e O
onset e O
of O O
dementia e O
. 
 O
BACKGROUND K O
: 
 O
In O O
lung g O
protective t O
strategy a O
, 
 O
positive i O
end 	 O
- 
 O
expiratory i O
pressure s O
( 
 O
PEEP P O
) 
 O
slightly g O
higher h O
than n O
the 	 O
Pflex e O
( 
 O
the 	 O
airway w O
pressure s O
corresponding r O
to O O
the 	 O
lower e O
inflection l O
point n O
( 
 O
LIP 	 O
) 
 O
on O O
the 	 O
inspiratory p O
pressure s O
- 
 O
volume u O
( 
 O
P 
 O
- 
 O
V 
 O
) 
 O
curve v O
measured s O
with h O
ZEEP P O
) 
 O
is O O
generally e O
recommended o O
. 
 O
3 
 O
. 
 O
In O O
both h O
RAW 	 O
cells l O
and 	 O
the 	 O
microglia r O
cell l O
line e O
EOC20 2 S-GENE
, 
 O
two 	 O
IFN 	 B-GENE
- - I-GENE
gamma m I-GENE
- 
 I-GENE
activated i I-GENE
transcription n I-GENE
factors t E-GENE
, 
 O
STAT T B-GENE
- - I-GENE
1alpha p E-GENE
and 	 O
IRF 	 B-GENE
- - I-GENE
1 - E-GENE
, 
 O
bind d O
the 	 O
GAS 	 O
and 	 O
IRF 	 B-GENE
elements m E-GENE
, 
 O
respectively p O
. 
 O
Thermal r O
changes n O
of O O
the 	 O
bovine i O
uterus r O
following l O
administration i O
of O O
estradiol r O
- 
 O
17beta e O
. 
 O
The 	 O
starting r O
dose e O
was 	 O
8 
 O
mg O O
/ 
 O
m2 O O
administered i O
intravenously r O
( 
 O
IV O O
) 
 O
as O O
a 
 O
short r O
infusion u O
daily l O
for 	 O
5 
 O
days s O
, 
 O
repeated e O
every r O
3 
 O
weeks k O
with h O
dose e O
adjustments u O
depending e O
on O O
patient i O
tolerance e O
. 
 O
In O O
agreement e O
with h O
other e O
authors h O
, 
 O
we O O
recommend o O
the 	 O
procedure c O
as O O
a 
 O
safe e O
one 	 O
, 
 O
providing v O
satisfactory i O
results u O
. 
 O
After e O
inhibition i O
of O O
monoamine o B-GENE
oxidase d E-GENE
with h O
pargyline g O
( 
 O
10 O O
mg O O
/ 
 O
kg O O
. 
 O
i 
 O
. 
 O
v 
 O
. 
 O
) 
 O
, 
 O
the 	 O
effects e O
of O O
tyramine a O
( 
 O
1000 0 O
micrograms r O
) 
 O
injected e O
into o O
the 	 O
hepatic a O
artery e O
were e O
potentiated e O
. 
 O
Helenalin e S-GENE
triggers g O
a 
 O
CD95 5 S-GENE
death t O
receptor e O
- 
 O
independent e O
apoptosis p O
that t O
is O O
not 	 O
affected e O
by O O
overexpression r O
of O O
Bcl 	 B-GENE
- - I-GENE
x - E-GENE
( - O
L - O
) - O
or O O
Bcl 	 B-GENE
- - I-GENE
2 - E-GENE
. 
 O
Of O O
the 	 O
47 O O
women e O
with h O
AGCUS U O
, 
 O
16 O O
had 	 O
intraepithelial r O
or O O
invasive a O
neoplasms p O
( 
 O
34 O O
% 
 O
; 
 O
95 O O
% 
 O
confidence f O
interval e O
, 
 O
21 O O
- 
 O
49 O O
% 
 O
) 
 O
, 
 O
including l O
9 
 O
low 	 O
or O O
high h O
grade d O
squamous a O
intraepithelial r O
lesions i O
, 
 O
1 
 O
adenocarcinoma n O
in O O
situ u O
of O O
the 	 O
cervix v O
, 
 O
3 
 O
adenocarcinomas n O
of O O
the 	 O
cervix v O
, 
 O
2 
 O
adenocarcinomas n O
of O O
the 	 O
endometrium o O
and 	 O
1 
 O
adenoid n O
basal a O
cell l O
carcinoma c O
of O O
the 	 O
cervix v O
. 
 O
The 	 O
DF3 	 S-GENE
/ 
 O
MUC1 1 S-GENE
gene e O
encodes o O
a 
 O
high h O
molecular e O
weight g O
mucin i B-GENE
- - I-GENE
like e I-GENE
glycoprotein c E-GENE
which c O
is O O
overexpressed r O
at O O
the 	 O
transcriptional n O
level e O
in O O
the 	 O
majority o O
of O O
human a O
breast a O
cancers c O
. 
 O
The 	 O
organization a O
of O O
the 	 O
MBP 	 B-GENE
- - I-GENE
A - I-GENE
gene e E-GENE
is O O
very y O
similar i O
to O O
the 	 O
arrangement a O
of O O
the 	 O
gene e O
encoding o O
the 	 O
highly h O
homologous o O
pulmonary m O
surfactant f O
apoprotein p O
, 
 O
although h O
one 	 O
of O O
the 	 O
intron r O
positions i O
is O O
shifted f O
by O O
a 
 O
single g O
amino n O
acid d O
. 
 O
Hip 	 O
fracture c O
mortality t O
and 	 O
prospective s O
payment m O
system t O
. 
 O
These s O
results u O
indicate i O
that t O
patients i O
with h O
SS O O
and 	 O
evidence d O
of O O
exercise r O
- 
 O
induced u O
ST O O
- 
 O
segment m O
depression r O
may 	 O
have e O
decreased r O
myocardial c O
oxygen g O
supply p O
due 	 O
to O O
low 	 O
hemoglobin o S-GENE
levels e O
and 	 O
increased r O
myocardial c O
oxygen g O
demand a O
( 
 O
elevated v O
double b O
products d O
) 
 O
when n O
compared p O
to O O
subjects j O
with h O
SS O O
who 	 O
do O O
not 	 O
have e O
exercise r O
- 
 O
induced u O
ST O O
- 
 O
segment m O
depression r O
. 
 O
Although h O
hSSTR5 T S-GENE
displays p O
approximately r O
75 O O
% 
 O
sequence u O
identity n O
with h O
rat 	 B-GENE
SSTR5 R E-GENE
, 
 O
the 	 O
two 	 O
receptors e O
display p O
significantly n O
different f O
pharmacological r O
profiles f O
, 
 O
especially e O
with h O
respect p O
to O O
their i O
binding d O
affinities i O
for 	 O
the 	 O
SST 	 B-GENE
analogue l I-GENE
SMS 	 I-GENE
201 	 I-GENE
- 
 I-GENE
995 	 E-GENE
. 
 O
A 
 O
significant n O
and 	 O
specific c O
reduction u O
in O O
binaural a O
peak k O
amplitude l O
and 	 O
area a O
of O O
the 	 O
echo o O
- 
 O
evoked k O
middle d O
- 
 O
latency e O
component p O
Pa O O
was 	 O
observed e O
. 
 O
EMBO O O
( 
 O
Eur 	 O
. 
 O
Using n O
this s O
oligonucleotide g O
as O O
a 
 O
probe b O
, 
 O
an O O
8 
 B-GENE
- 
 I-GENE
kilobase o I-GENE
HindIII d I-GENE
fragment g E-GENE
of O O
genomic o O
DNA 	 O
was 	 O
isolated l O
and 	 O
subjected j O
to O O
Sanger g O
dideoxy e O
DNA 	 O
sequencing u O
. 
 O
Arg 	 O
- 
 O
130 	 O
, 
 O
Gly 	 O
- 
 O
132 	 O
and 	 O
Lys 	 O
- 
 O
167 	 O
are 	 O
conserved s O
in O O
all 	 O
members b O
of O O
the 	 O
type e B-GENE
IB I I-GENE
topoisomerase o I-GENE
family i E-GENE
. 
 O
Four r O
cDNAs A O
( 
 O
Kox4 4 O
, 
 O
Kox7 7 O
, 
 O
Kox12 1 O
, 
 O
and 	 O
Kox15 1 O
) 
 O
were e O
identified n O
that t O
match c O
one 	 O
or O O
more e O
genomic o O
clones n O
; 
 O
these s O
matches c O
were e O
confirmed f O
by O O
nucleotide l O
sequence u O
analysis l O
. 
 O
2 
 O
. 
 O
Prevalence v O
of O O
use 	 O
, 
 O
claims i O
volume u O
, 
 O
and 	 O
expenditures e O
were e O
compared p O
for 	 O
cisapride a O
, 
 O
proton t O
pump p O
inhibitors i O
, 
 O
histamine t B-GENE
- - I-GENE
2 - I-GENE
receptor e E-GENE
antagonists a O
, 
 O
and 	 O
the 	 O
prokinetic k O
agent n O
metoclopramide o O
during i O
these s O
periods i O
. 
 O
Relaxant a O
effect e O
of O O
prostaglandin s O
E1 O O
( 
 O
PGE1 1 O
) 
 O
and 	 O
papaverine a O
( 
 O
PAP 	 O
) 
 O
were e O
measured s O
in O O
strips i O
of O O
corpus p O
cavernosum e O
smooth o O
muscle c O
taken e O
from m O
a 
 O
healthy l O
control t O
group u O
of O O
men 	 O
( 
 O
A 
 O
; 
 O
n 
 O
= 
 O
5 
 O
) 
 O
, 
 O
from m O
arteriogenically e O
impotent o O
men 	 O
( 
 O
B 
 O
; 
 O
n 
 O
= 
 O
6 
 O
) 
 O
and 	 O
from m O
additionally i O
diabetic b O
impotent o O
men 	 O
( 
 O
C 
 O
; 
 O
n 
 O
= 
 O
5 
 O
) 
 O
with h O
venous o O
leakage k O
. 
 O
Primer m O
extension e O
experiments e O
using n O
dbcAMP A B-GENE
- 
 I-GENE
differentiated f I-GENE
U937 7 I-GENE
RNA 	 E-GENE
indicated i O
a 
 O
single g O
transcriptional n O
initiation t O
site e O
. 
 O
In O O
contrast t O
, 
 O
group u O
II O O
showed w O
a 
 O
significant n O
improvement r O
in O O
peak k O
VO2 	 O
with h O
rate e O
adaptive p O
AV O O
delay a O
compared p O
to O O
fixed e O
AV O O
delay a O
programming g O
( 
 O
P 
 O
less s O
than n O
0 
 O
. 
 O
05 O O
) 
 O
. 
 O
Effect e O
of O O
family i O
visits i O
on O O
the 	 O
blood o O
pressure s O
and 	 O
heart r O
rate e O
of O O
patients i O
in O O
the 	 O
coronary o O
- 
 O
care e O
unit t O
. 
 O
Sequence u O
analysis l O
and 	 O
electrophoretic c O
mobility i O
shift f O
experiments e O
suggest g O
that t O
GnSE E S-GENE
response p O
elements m O
interact e O
, 
 O
in O O
these s O
two 	 O
regions i O
, 
 O
with h O
GATA A O
- - O
and 	 O
LIM 	 B-GENE
- - I-GENE
related a I-GENE
factors t E-GENE
, 
 O
respectively p O
. 
 O
The 	 O
transfer n O
by O O
conjugation j O
to O O
E 
 O
. 
 O
coli i O
K12 	 O
of O O
ampicillin i O
and 	 O
carbenicillin b O
resistance i O
was 	 O
obtained a O
with h O
14 O O
strains a O
: 
 O
( 
 O
E 
 O
. 
 O
coli i O
: 
 O
9 
 O
, 
 O
C 
 O
. 
 O
freundii u O
: 
 O
1 
 O
, 
 O
K 
 O
. 
 O
pneumoniae u O
: 
 O
1 
 O
, 
 O
E 
 O
. 
 O
cloacae a O
: 
 O
2 
 O
, 
 O
P 
 O
. 
 O
stuartii a O
: 
 O
1 
 O
) 
 O
. 
 O
Wild d B-GENE
type e I-GENE
MEKK1 K I-GENE
enhances a I-GENE
promoter m E-GENE
activity i O
and 	 O
the 	 O
activity i O
can 	 O
be O O
inhibited i O
by O O
dominant i O
negative a O
MEKK1 K S-GENE
, 
 O
MEK1 1 S-GENE
, 
 O
MEK7 7 S-GENE
, 
 O
MEK3 3 S-GENE
, 
 O
p38 	 S-GENE
/ 
 O
RK S S-GENE
, 
 O
and 	 O
c - B-GENE
- - I-GENE
Jun 	 E-GENE
. 
 O
250 	 O
, 
 O
302 	 O
- 
 O
311 	 O
] 
 O
. 
 O
The 	 O
studies d O
permit m O
considering s O
the 	 O
detected e O
shifts f O
in O O
the 	 O
immunity u O
system t O
an O O
important o O
component p O
of O O
the 	 O
pathogenesis h O
of O O
chronic o O
nontumorous t O
diseases e O
of O O
the 	 O
parotid o O
glands n O
. 
 O
Coexistence x O
of O O
Turner n O
' 
 O
s 
 O
syndrome d O
and 	 O
schizophrenia i O
An O O
scrR R B-GENE
promoter m I-GENE
fragment g E-GENE
, 
 O
which c O
dose e O
not 	 O
contain t O
a 
 O
sequence u O
resembling e O
OB S O
, 
 O
was 	 O
not 	 O
shifted f O
by O O
the 	 O
fusion i O
protein t O
. 
 O
Using n O
the 	 O
conflict f O
drinking n O
test t O
as O O
a 
 O
model e O
, 
 O
we O O
studied d O
in O O
rats s O
the 	 O
effect e O
of O O
the 	 O
nonselective s O
beta a O
- - O
adrenoceptor e O
blockers c O
pindolol d O
and 	 O
cyanopindolol n O
which c O
bind d O
to O O
5 - B-GENE
- - I-GENE
HT1A A E-GENE
and 	 O
5 - B-GENE
- - I-GENE
HT1B B I-GENE
receptors e E-GENE
, 
 O
and 	 O
of O O
the 	 O
selective e O
beta a B-GENE
1 - I-GENE
- - I-GENE
and 	 I-GENE
beta a I-GENE
2 - I-GENE
- - I-GENE
adrenoceptor e E-GENE
antagonists a O
betaxolol a O
and 	 O
ICI 	 O
118 	 O
, 
 O
551 	 O
, 
 O
respectively p O
, 
 O
which c O
have e O
a 
 O
negligible l O
affinity i O
for 	 O
5 - B-GENE
- - I-GENE
HT I I-GENE
receptors e E-GENE
. 
 O
Although h O
several e O
other e O
signal n O
transduction n O
molecules e O
also o O
contain t O
tandemly d O
occurring u O
SH3 	 S-GENE
and 	 O
SH2 	 B-GENE
domains a E-GENE
, 
 O
the 	 O
function c O
of O O
these s O
closely s O
spaced c O
domains a O
is O O
not 	 O
well l O
understood e O
. 
 O
Glycoprotein c O
biosynthesis s O
in O O
Saccharomyces c O
cerevisiae e O
: 
 O
ngd29 2 S-GENE
, 
 O
an O O
N 
 O
- 
 O
glycosylation c O
mutant a O
allelic e O
to O O
och1 1 S-GENE
having i O
a 
 O
defect e O
in O O
the 	 O
initiation t O
of O O
outer e O
chain i O
formation m O
. 
 O
CONCLUSIONS C O
: 
 O
In O O
the 	 O
majority o O
of O O
patients i O
with h O
severe e O
ulcerative e O
colitis i O
, 
 O
circulating c O
concentrations c O
of O O
NOX 	 O
are 	 O
increased r O
at O O
presentation s O
and 	 O
fall l O
promptly m O
during i O
parenteral e O
steroid r O
therapy r O
, 
 O
irrespective e O
of O O
clinical n O
outcome c O
. 
 O
The 	 O
duration a O
of O O
naloxone o O
appears e O
to O O
be O O
dose e O
- 
 O
related a O
, 
 O
statistically t O
significant n O
up O O
to O O
approximately r O
1 
 O
. 
 O
5 
 O
hr O O
. 
 O
But 	 O
if O O
one 	 O
equalizes a O
the 	 O
upper e O
limits i O
of O O
normal m O
for 	 O
both h O
markers k O
to O O
a 
 O
common m O
95 O O
% 
 O
specificity c O
, 
 O
the 	 O
tumour o O
- 
 O
indicating i O
sensitivity s O
of O O
CA B O
19 I O
- - O
9 - O
clearly a O
surpasses p O
that t O
of O O
CA B O
50 E O
. 
 O
These s O
motions i O
were e O
found n O
in O O
the 	 O
N 
 O
- 
 O
and 	 O
C 
 O
- 
 O
terminal m O
tails l O
, 
 O
in O O
segment m O
33 O O
- 
 O
35 O O
which c O
forms m O
the 	 O
turn n O
between w O
beta a O
- 
 O
strands a O
S1 O O
and 	 O
S2 O O
, 
 O
and 	 O
residues i O
47 O O
- 
 O
52 O O
located a O
in O O
a 
 O
long g O
loop p O
preceding c O
strand a O
S3 O O
. 
 O
Genomic o O
Southern t O
analysis l O
reveals e O
10 O O
to O O
15 O O
hybridising r O
fragments g O
, 
 O
suggesting g O
that t O
maize z O
contains t O
a 
 O
small l O
gene e O
family i O
. 
 O
Custom t O
- 
 O
made e O
orthoses h O
play y O
an O O
invaluable a O
role e O
in O O
achieving i O
a 
 O
wide e O
range g O
of O O
therapeutic r O
goals l O
: 
 O
improving r O
function c O
and 	 O
pinch c O
, 
 O
stabilizing b O
individual i O
joints n O
, 
 O
preventing v O
positional i O
contractures t O
, 
 O
protecting t O
joints n O
from m O
trauma u O
, 
 O
stretching e O
the 	 O
intrinsic r O
muscles c O
, 
 O
correcting r O
joint n O
- 
 O
and 	 O
soft t O
- 
 O
tissue s O
contractures t O
, 
 O
and 	 O
controlling t O
inflammation l O
. 
 O
Is O O
exposure o O
to O O
a 
 O
patient i O
with h O
Crohn h O
' 
 O
s 
 O
disease e O
an O O
environmental i O
factor t O
for 	 O
developing e O
the 	 O
disease e O
. 
 O
The 	 O
ZAG1 1 B-GENE
protein t E-GENE
from m O
in O O
vitro r O
translations n O
binds d O
to O O
a 
 O
consensus s O
target g O
site e O
that t O
is O O
recognized o O
by O O
the 	 O
AG B B-GENE
protein t E-GENE
. 
 O
The 	 O
uap100 1 S-GENE
cis 	 O
- 
 O
acting i O
, 
 O
up O O
- 
 O
promoter m O
, 
 O
constitutive s O
mutation a O
is O O
a 
 O
duplication l O
that t O
comprises p O
two 	 O
GATA A B-GENE
sites e E-GENE
and 	 O
suppresses p O
weakly k O
the 	 O
AREA A O
zinc c O
finger g O
mutation a O
but 	 O
does s O
not 	 O
alleviate e O
the 	 O
need d O
for 	 O
functional c O
UAY 	 S-GENE
and 	 O
AREA A B-GENE
proteins t E-GENE
. 
 O
Pituitary u O
thyrotropic r O
adenoma n O
associated o O
with h O
congenital g O
hypothyroidism o O
. 
 O
This s O
region i O
was 	 O
unfavourable a O
, 
 O
due 	 O
to O O
malaria a O
in O O
the 	 O
past t O
. 
 O
Indeed e O
, 
 O
after e O
a 
 O
single g O
oral l O
dose e O
, 
 O
the 	 O
role e O
of O O
the 	 O
mu B B-GENE
- - I-GENE
receptor e E-GENE
agonist n O
component p O
of O O
the 	 O
antinociceptive i O
effect e O
of O O
tramadol m O
appears e O
to O O
be O O
minor o O
, 
 O
with h O
most t O
of O O
the 	 O
analgesic l O
effect e O
being n O
attributable r O
to O O
nonopioid o O
properties p O
of O O
the 	 O
parent e O
compound p O
. 
 O
CHIEF E O
OUTCOME C O
MEASURES S O
: 
 O
Endoluminal o O
release e O
of O O
prostacyclin s O
( 
 O
6 
 O
- 
 O
Keto o O
- 
 O
PGF1 1 O
alpha h O
) 
 O
and 	 O
thromboxane o O
B2 O O
( 
 O
TxB2 2 O
) 
 O
, 
 O
patency e O
, 
 O
EC O O
coverage e O
and 	 O
cell l O
identity n O
. 
 O
Somatic a O
and 	 O
visceral c O
inputs u O
to O O
the 	 O
thoracic r O
spinal n O
cord d O
of O O
the 	 O
cat 	 O
: 
 O
effects e O
of O O
noxious i O
stimulation m O
of O O
the 	 O
biliary i O
system t O
. 
 O
We O O
have e O
produced d O
the 	 O
Ure2 2 B-GENE
protein t E-GENE
to O O
high h O
yield l O
in O O
Escherichia h O
coli i O
from m O
a 
 O
synthetic t O
gene e O
. 
 O
Transfection n O
of O O
both h O
Calu u B-GENE
- 
 I-GENE
6 
 E-GENE
and 	 O
JEG 	 O
- 
 O
3 
 O
cells l O
with h O
a 
 O
PKA 	 S-GENE
expression r O
vector t O
resulted u O
in O O
a 
 O
10 O O
- 
 O
fold d O
induction u O
of O O
human a B-GENE
renin i E-GENE
transcriptional n O
activity i O
in O O
constructs s O
containing t O
the 	 O
native i O
or O O
consensus s O
CRE 	 O
and 	 O
5 
 O
- 
 O
fold d O
activation i O
in O O
a 
 O
construct s O
containing t O
a 
 O
nonfunctional f O
CRE 	 O
. 
 O
We O O
undertook e O
this s O
study d O
to O O
examine m O
the 	 O
relationship a O
between w O
systemic t O
oxygen g O
delivery i O
( 
 O
DO2 	 O
) 
 O
and 	 O
tissue s O
oxygen g O
tension s O
( 
 O
TPO2 2 O
) 
 O
in O O
hypovolemic o O
shock c O
. 
 O
White t O
female a O
cases e O
were e O
more e O
likely e O
to O O
have e O
worked k O
as O O
registered i O
nurses s O
than n O
were e O
the 	 O
controls t O
( 
 O
OR O O
= 
 O
1 
 O
. 
 O
9 
 O
, 
 O
95 O O
% 
 O
CI O O
= 
 O
1 
 O
. 
 O
0 
 O
- 
 O
3 
 O
. 
 O
5 
 O
) 
 O
. 
 O
METHODS H O
: 
 O
Children l O
with h O
attention e O
- 
 O
deficit i O
/ 
 O
hyperactivity e O
disorder o O
( 
 O
ADHD D O
; 
 O
n 
 O
= 
 O
282 	 O
) 
 O
, 
 O
all 	 O
subtypes t O
, 
 O
ages s O
6 
 O
to O O
12 O O
years r O
, 
 O
were e O
randomized d O
to O O
placebo c O
( 
 O
n 
 O
= 
 O
90 O O
) 
 O
, 
 O
immediate e O
- 
 O
release e O
methylphenidate h O
( 
 O
IR O O
MPH 	 O
) 
 O
3 
 O
times e O
a 
 O
day 	 O
( 
 O
tid 	 O
; 
 O
dosed e O
every r O
4 
 O
hours r O
; 
 O
n 
 O
= 
 O
97 O O
) 
 O
, 
 O
or O O
OROS S O
MPH 	 O
once e O
a 
 O
day 	 O
( 
 O
qd O O
; 
 O
n 
 O
= 
 O
95 O O
) 
 O
in O O
a 
 O
double b O
- 
 O
blind n O
, 
 O
28 O O
- 
 O
day 	 O
trial a O
. 
 O
Immunologic u O
tolerance e O
in O O
rats s O
during i O
13 O O
weeks k O
of O O
inhalation a O
exposure o O
to O O
trimellitic m O
anhydride y O
. 
 O
They y O
cause s O
temporary p O
disability a O
, 
 O
invalidity a O
and 	 O
mortality t O
of O O
a 
 O
great a O
part t O
of O O
the 	 O
productive d O
population u O
, 
 O
significantly n O
damaging a O
the 	 O
economic n O
status t O
of O O
the 	 O
country n O
. 
 O
Cloning n O
and 	 O
sequence u O
analysis l O
of O O
a 
 O
chymotrypsinlike m O
protease t O
from m O
Treponema p O
denticola t O
. 
 O
METHODS H O
AND 	 O
RESULTS U O
: 
 O
The 	 O
QTd 	 O
and 	 O
JTd 	 O
intervals e O
in O O
39 O O
children l O
with h O
long g O
QT O O
syndrome d O
were e O
compared p O
to O O
those s O
of O O
50 O O
normal m O
age 	 O
- 
 O
matched c O
children l O
. 
 O
V - B-GENE
- - I-GENE
ErbB B E-GENE
- - O
mediated i O
complex p O
formation m O
and 	 O
transformation n O
have e O
been n O
shown w O
to O O
occur u O
independently e O
of O O
Ras 	 S-GENE
activation i O
. 
 O
Both h O
parameters a O
were e O
determined e O
in O O
an O O
individual i O
eye 	 O
by O O
applying l O
the 	 O
dye 	 O
first s O
by O O
iontophoresis t O
and 	 O
then n O
by O O
intravitreal r O
injection e O
, 
 O
which c O
allows o O
the 	 O
influence l O
of O O
fluorescein o O
glucuronide c O
on O O
the 	 O
fluorophotometric o O
measurements s O
to O O
be O O
excluded l O
. 
 O
Organization a O
of O O
exons n O
suggests g O
that t O
, 
 O
similar i O
to O O
the 	 O
human a B-GENE
VEGF F I-GENE
gene e E-GENE
, 
 O
alternative e O
splicing i O
generates e O
the 	 O
120 	 O
- 
 O
, 
 O
164 	 O
- 
 O
, 
 O
and 	 O
188 	 O
- 
 O
amino n O
acid d O
isoforms f O
, 
 O
but 	 O
does s O
not 	 O
predict d O
a 
 O
fourth r O
VEGF F B-GENE
isoform f E-GENE
corresponding r O
to O O
human a B-GENE
VEGF206 F E-GENE
. 
 O
Electron c O
microscopy r O
of O O
pH O O
7 
 O
. 
 O
5 
 O
- 
 O
treated a O
TMV 	 O
particles t O
incubated u O
in O O
SPN 	 O
- 
 O
treated a O
wheatgerm a O
extract r O
or O O
rabbit b O
reticulocyte i O
lysate a O
, 
 O
showed w O
that t O
approximately r O
10 O O
% 
 O
of O O
virions i O
complexed p O
with h O
one 	 O
ribosome o O
and 	 O
approximately r O
10 O O
% 
 O
with h O
two 	 O
bound n O
ribosomes o O
, 
 O
confirming f O
that t O
omega g O
at O O
least s O
had 	 O
been n O
uncoated o O
. 
 O
The 	 O
sequence u O
contained t O
five e O
repeats e O
of O O
the 	 O
hypothetical o O
leucine c O
zipper p O
motif i O
: 
 O
one 	 O
is O O
in O O
the 	 O
N 
 O
- 
 O
terminal m O
globular b O
domain a O
, 
 O
and 	 O
four r O
are 	 O
in O O
the 	 O
central t O
alpha h O
- 
 O
helical i O
stalk l O
. 
 O
Postheparin t B-GENE
lipoprotein o I-GENE
lipase a E-GENE
, 
 O
measured s O
using n O
fat 	 O
emulsion l O
as O O
substrate s O
, 
 O
also o O
was 	 O
significantly n O
greater a O
in O O
female a O
rats s O
compared p O
with h O
males e O
. 
 O
The 	 O
authors h O
report o O
a 
 O
case e O
of O O
a 
 O
painful n O
wrist s O
related a O
to O O
a 
 O
" 
 O
Manieux i O
muscle c O
" 
 O
of O O
the 	 O
dorsal s O
aspect e O
of O O
the 	 O
hand d O
. 
 O
Genomic o O
organization a O
of O O
the 	 O
human a B-GENE
multidrug t I-GENE
resistance i I-GENE
( - I-GENE
MDR1 1 I-GENE
) - I-GENE
gene e E-GENE
and 	 O
origin g O
of O O
P - B-GENE
- - I-GENE
glycoproteins c E-GENE
. 
 O
The 	 O
response p O
to O O
nitroglycerin r O
, 
 O
however e O
, 
 O
remained a O
intact a O
regardless a O
of O O
initial t O
reperfusion e O
pressure s O
. 
 O
Deletion e O
analysis l O
revealed e O
that t O
only y O
the 	 O
TM O B-GENE
domain a E-GENE
of O O
E2 S S-GENE
was 	 O
required u O
for 	 O
Golgi g O
targeting g O
. 
 O
In O O
addition i O
, 
 O
putative a O
binding d O
sites e O
for 	 O
SH3 	 S-GENE
and 	 O
SH2 	 B-GENE
domains a E-GENE
are 	 O
present s O
in O O
the 	 O
amino n O
- 
 O
terminal m O
half f O
of O O
the 	 O
molecule e O
. 
 O
Since c O
nearly r O
all 	 O
transformants n O
involving o O
homeologous e O
DNAs s O
carried r O
a 
 O
single g O
recombinant o O
plasmid s O
in O O
both h O
Pms 	 B-GENE
+ - E-GENE
and 	 O
Pms 	 O
- - O
strains a O
, 
 O
stable b O
heteroduplex e O
DNA 	 O
appears e O
less s O
likely e O
than n O
for 	 O
homologous o O
DNAs s O
. 
 O
All 	 O
rights h O
reserved e O
. 
 O
One 	 O
new 	 O
ORF 	 O
, 
 O
YBR0224 0 O
, 
 O
was 	 O
detected e O
, 
 O
coding i O
for 	 O
a 
 O
protein t O
with h O
918 	 O
amino n O
acids d O
. 
 O
A 
 O
sequence u O
- 
 O
ready d O
3 
 O
- 
 O
Mb O O
PAC 	 O
contig t O
covering e O
16 O O
breakpoints a O
of O O
the 	 O
Wilms m O
tumor o O
/ - O
anirida r O
region i O
of O O
human a O
chromosome o O
11p13 1 O
. 
 O
The 	 O
MAP 	 B-GENE
kinase a I-GENE
kinase a I-GENE
kinase a I-GENE
MLK2 2 E-GENE
co O O
- 
 O
localizes a O
with h O
activated i O
JNK 	 S-GENE
along n O
microtubules r O
and 	 O
associates o O
with h O
kinesin e B-GENE
superfamily e E-GENE
motor o O
KIF3 3 S-GENE
. 
 O
Bone e O
scintigraphy n O
is O O
an O O
excellent e O
screening e O
test t O
for 	 O
bone e O
lesions i O
and 	 O
Ga O O
- 
 O
67 O O
scintigraphy n O
is O O
a 
 O
useful f O
tool l O
for 	 O
detecting e O
inflammatory l O
lesions i O
. 
 O
Spontaneous n O
fracture c O
of O O
the 	 O
tarsal s O
bone e O
in O O
2 
 O
cases e O
of O O
leprosy r O
They y O
are 	 O
transduced n O
through o O
TM O O
to O O
the 	 O
cytoplasmic o O
portion t O
( 
 O
cytoloops o O
and 	 O
the 	 O
C 
 O
- 
 O
terminal m O
tail l O
) 
 O
of O O
the 	 O
receptor e O
and 	 O
then n O
, 
 O
transferred n O
to O O
cytoplasmic o O
signaling n O
molecules e O
, 
 O
such h O
as O O
G - B-GENE
protein t E-GENE
. 
 O
Serum u B-GENE
alkaline a I-GENE
phosphatase s E-GENE
and 	 O
creatine a B-GENE
kinase a E-GENE
activities i O
were e O
significantly n O
increased r O
in O O
the 	 O
A 
 O
praelongus e O
- 
 O
fed 	 O
pigs s O
and 	 O
significantly n O
decreased r O
in O O
Na2SeO4 S O
- 
 O
fed 	 O
pigs s O
. 
 O
This s O
group u O
showed w O
the 	 O
presence s O
of O O
bacteria t O
infiltrated i O
at O O
the 	 O
dentinal t O
tubules u O
coronally o O
and 	 O
into o O
the 	 O
root t O
canals a O
. 
 O
Seven e O
Zebu u O
cattle t O
were e O
also o O
exposed o O
to O O
challenge l O
at O O
the 	 O
same e O
time e O
. 
 O
However e O
, 
 O
the 	 O
quasiparticle s O
scattering t O
rate e O
tau 	 O
( 
 O
- 
 O
1 
 O
) 
 O
is O O
such h O
that t O
Planck n O
' 
 O
s 
 O
over r O
2pi 	 O
/ 
 O
tau 	 O
approximately r O
6t O O
( 
 O
perpendicular p O
) 
 O
, 
 O
implying l O
that t O
kappa p O
- 
 O
( 
 O
BEDT T O
- 
 O
TTF 	 O
) 
 O
2Cu 	 O
( 
 O
NCS 	 O
) 
 O
( 
 O
2 
 O
) 
 O
meets t O
the 	 O
criterion t O
used d O
to O O
identify n O
interlayer e O
incoherence o O
. 
 O
The 	 O
effect e O
on O O
kidney n O
length g O
was 	 O
considerably s O
prolonged l O
compared p O
with h O
the 	 O
vascular c O
effect e O
. 
 O
Although h O
polyubiquitin y O
chains i O
linked k O
through o O
Lys 	 O
( 
 O
29 O O
) 
 O
of O O
ubiquitin q S-GENE
have e O
been n O
implicated l O
in O O
the 	 O
targeting g O
of O O
certain t O
substrates s O
to O O
proteasomes t O
, 
 O
the 	 O
signaling n O
properties p O
of O O
these s O
chains i O
are 	 O
poorly r O
understood e O
. 
 O
Diabetic b O
osteopenia e O
, 
 O
a 
 O
known w O
chronic o O
complication p O
of O O
diabetes b O
, 
 O
has 	 O
been n O
demonstrated o O
with h O
alterations e O
in O O
the 	 O
calcium c O
- 
 O
vitamin a O
D 
 O
endocrine o O
system t O
. 
 O
An O O
in O O
vitro r O
Raf 	 B-GENE
- - I-GENE
1 - I-GENE
kinase a E-GENE
assay a O
, 
 O
however e O
, 
 O
failed l O
to O O
detect e O
LPS 	 O
- 
 O
induced u O
Raf 	 B-GENE
- - I-GENE
1 - I-GENE
kinase a E-GENE
activity i O
in O O
RAW 	 O
264 	 O
. 
 O
7 
 O
cells l O
, 
 O
suggesting g O
that t O
in O O
RAW 	 O
264 	 O
. 
 O
7 
 O
cells l O
, 
 O
Raf 	 B-GENE
- - I-GENE
1 - I-GENE
kinase a E-GENE
is O O
not 	 O
an O O
activating i O
component p O
of O O
the 	 O
LPS 	 O
signaling n O
pathway h O
regulating u O
MAPK K S-GENE
activity i O
or O O
sIL 	 B-GENE
- - I-GENE
1Ra 	 I-GENE
promoter m E-GENE
activity i O
. 
 O
Phosphorylation s O
of O O
the 	 O
ras 	 B-GENE
GTPase a I-GENE
- - I-GENE
activating i I-GENE
protein t E-GENE
( 
 O
GAP 	 S-GENE
) 
 O
by O O
the 	 O
p93c c B-GENE
- - I-GENE
fes 	 I-GENE
protein t I-GENE
- - I-GENE
tyrosine o I-GENE
kinase a E-GENE
in O O
vitro r O
and 	 O
formation m O
of O O
GAP 	 B-GENE
- 
 I-GENE
fes 	 I-GENE
complexes p E-GENE
via 	 O
an O O
SH2 	 B-GENE
domain a E-GENE
- 
 O
dependent e O
mechanism h O
. 
 O
Gingival g O
retraction r O
for 	 O
class s O
V 
 O
restorations t O
. 
 O
Two 	 O
methods h O
for 	 O
the 	 O
routine t O
determination e O
of O O
blood o O
hemoglobin o S-GENE
oxygen g O
affinity i O
are 	 O
described c O
. 
 O
Thirty r O
minutes u O
after e O
reperfusion e O
, 
 O
lung g O
lymph p O
flow w O
( 
 O
QL O O
) 
 O
increased r O
from m O
4 
 O
. 
 O
3 
 O
to O O
8 
 O
. 
 O
3 
 O
ml O O
/ 
 O
30 O O
minutes u O
( 
 O
p 
 O
less s O
than n O
0 
 O
. 
 O
05 O O
) 
 O
, 
 O
lymph p O
/ 
 O
plasma s O
protein t O
ratio i O
was 	 O
unchanged h O
from m O
0 
 O
. 
 O
6 
 O
, 
 O
and 	 O
the 	 O
lymph p O
protein t O
clearance a O
increased r O
from m O
2 
 O
. 
 O
6 
 O
to O O
4 
 O
. 
 O
6 
 O
ml O O
/ 
 O
30 O O
minutes u O
( 
 O
p 
 O
less s O
than n O
0 
 O
. 
 O
05 O O
) 
 O
, 
 O
data a O
consistent s O
with h O
increased r O
microvascular r O
permeability m O
. 
 O
U 
 O
. 
 O
S 
 O
. 
 O
A 
 O
. 
 O
RET 	 S-GENE
/ 
 O
PTC 	 S-GENE
oncogenes o O
, 
 O
generated e O
by O O
chromosomal o O
rearrangements r O
in O O
papillary i O
thyroid r O
carcinomas c O
, 
 O
are 	 O
constitutively s O
activated i O
versions s O
of O O
proto t B-GENE
- - I-GENE
RET 	 E-GENE
, 
 O
a 
 O
gene e O
coding i O
for 	 O
a 
 O
receptor e B-GENE
- - I-GENE
type e I-GENE
tyrosine o I-GENE
kinase a E-GENE
( 
 O
TK S S-GENE
) 
 O
whose s O
ligand a O
is O O
still l O
unknown n O
. 
 O
PCC 	 B-GENE
6803 3 I-GENE
mutant a E-GENE
impaired a O
in O O
cytochrome o O
c - O
maturation u O
. 
 O
STUDY D O
OBJECTIVE E O
: 
 O
to O O
characterize r O
gas 	 O
exchange h O
and 	 O
cardiopulmonary d O
performance f O
during i O
maximal i O
progressive g O
arm 	 O
crank n O
exercise r O
. 
 O
In O O
this s O
study d O
, 
 O
we O O
show w O
that t O
the 	 O
activating i O
effect e O
of O O
this s O
mutation a O
is O O
not 	 O
the 	 O
result u O
of O O
creating a O
an O O
exonic n B-GENE
splicing i I-GENE
enhancer a E-GENE
( 
 O
ESE 	 S-GENE
) 
 O
or O O
disrupting r O
a 
 O
putative a O
secondary o O
structure u O
. 
 O
The 	 O
kinase a O
domains a O
encoded o O
in O O
the 	 O
COOH H O
- 
 O
terminal m O
moiety e O
are 	 O
94 O O
% 
 O
conserved s O
; 
 O
the 	 O
NH2 	 O
- 
 O
terminal m O
moieties e O
are 	 O
approximately r O
65 O O
% 
 O
homologous o O
, 
 O
suggesting g O
this s O
region i O
may 	 O
encode o O
sequences u O
conferring f O
differential f O
regulation u O
of O O
the 	 O
two 	 O
kinases a O
. 
 O
In O O
rats s O
exposed o O
to O O
Cd O O
for 	 O
30 O O
d 
 O
, 
 O
the 	 O
levels e O
of O O
urinary n O
excretion r O
of O O
cAMP P O
after e O
treatment a O
with h O
parathyroid a B-GENE
hormone m E-GENE
( 
 O
PTH 	 S-GENE
) 
 O
, 
 O
parathyroidectomy a O
( 
 O
PTX 	 O
) 
 O
, 
 O
or O O
1 
 O
alpha h O
- 
 O
hydroxycholecalciferol r O
( 
 O
1 
 O
alpha h O
- 
 O
OH O O
- 
 O
D3 O O
) 
 O
showed w O
almost o O
the 	 O
same e O
patterns t O
as O O
those s O
of O O
control t O
rats s O
: 
 O
the 	 O
response p O
of O O
urinary n O
cAMP P O
to O O
treatment a O
with h O
PTH 	 O
was 	 O
not 	 O
influenced l O
by O O
continuous t O
oral l O
administration i O
of O O
Cd O O
. 
 O
The 	 O
goal l O
of O O
this s O
investigation e O
was 	 O
to O O
determine e O
whether t O
BMIPP P O
uptake a O
can 	 O
be O O
used d O
to O O
differentiate f O
viable b O
myocardium c O
from m O
scar r O
tissue s O
soon n O
after e O
coronary o O
thrombolysis o O
for 	 O
acute t O
myocardial c O
infarction a O
. 
 O
There r O
are 	 O
three e O
types e O
of O O
problems b O
: 
 O
problems b O
arising s O
before o O
the 	 O
drug g O
enters e O
the 	 O
body y O
( 
 O
solubilization u O
, 
 O
stabilization b O
and 	 O
improved r O
acceptability e O
) 
 O
; 
 O
problems b O
associated o O
with h O
the 	 O
penetration e O
and 	 O
fate e O
of O O
the 	 O
drug g O
in O O
the 	 O
body y O
( 
 O
absorption o O
, 
 O
barrier r O
crossing s O
, 
 O
duration a O
of O O
action i O
) 
 O
; 
 O
problems b O
relating a O
to O O
the 	 O
therapeutic r O
target g O
( 
 O
selective e O
local a O
delivery i O
) 
 O
. 
 O
In O O
the 	 O
absence e O
of O O
shock c O
, 
 O
sepsis s O
, 
 O
or O O
other e O
identifiable n O
causes s O
of O O
lactic t O
acidosis d O
, 
 O
the 	 O
severe e O
anemia m O
( 
 O
hemoglobin o B-GENE
1 
 I-GENE
. 
 I-GENE
2 
 I-GENE
g 
 I-GENE
/ 
 I-GENE
dl O E-GENE
) 
 O
appeared e O
to O O
be O O
the 	 O
primary m B-GENE
etiologic o I-GENE
factor t E-GENE
. 
 O
The 	 O
cumulative u O
experience e O
in O O
liver e O
transplantation n O
since c O
the 	 O
introduction r O
of O O
cyclosporine l O
A 
 O
has 	 O
confirmed f O
its 	 O
efficacy i O
in O O
the 	 O
treatment a O
of O O
diverse e O
liver e O
diseases e O
in O O
children l O
and 	 O
adults l O
. 
 O
Northern t O
blot t O
analysis l O
of O O
liver e O
, 
 O
muscle c O
, 
 O
fat 	 O
, 
 O
and 	 O
pituitary u O
RNA 	 O
from m O
normal m O
( 
 O
DwDw w O
) 
 O
chickens c O
shows w O
a 
 O
major o O
transcript n O
of O O
4 
 O
. 
 O
3 
 O
kilobases o O
( 
 O
kb O O
) 
 O
and 	 O
three e O
minor o O
transcripts n O
( 
 O
0 
 O
. 
 O
8 
 O
, 
 O
1 
 O
. 
 O
7 
 O
, 
 O
and 	 O
3 
 O
. 
 O
2 
 O
kb O O
) 
 O
, 
 O
which c O
correspond r O
to O O
the 	 O
cGHR R S-GENE
. 
 O
Copyright y O
1999 9 O
Academic d O
Press s O
. 
 O
Despite p O
a 
 O
lowering e O
of O O
her 	 O
plasma s O
ACTH H S-GENE
concentration c O
during i O
therapy r O
with h O
valproic p O
acid d O
, 
 O
the 	 O
patient i O
' 
 O
s 
 O
tumour o O
showed w O
no O O
evidence d O
of O O
regression r O
while l O
she 	 O
was 	 O
taking i O
the 	 O
drug g O
. 
 O
The 	 O
Htf9 9 B-GENE
- - I-GENE
a - I-GENE
gene e E-GENE
encodes o O
the 	 O
RanBP1 B B-GENE
protein t E-GENE
, 
 O
a 
 O
major o O
partner t O
of O O
the 	 O
Ran 	 B-GENE
GTPase a E-GENE
. 
 O
STUDY D O
DESIGN I O
: 
 O
Retrospective r O
review i O
. 
 O
Sequence u O
divergence e O
of O O
approximately r O
16 O O
% 
 O
reduced u O
transformation n O
frequencies q O
by O O
at O O
least s O
10 O O
- 
 O
fold d O
. 
 O
Our 	 O
studies d O
suggest g O
that t O
the 	 O
helicase i B-GENE
assembly e I-GENE
protein t E-GENE
is O O
responsible p O
for 	 O
loading d O
T4 B B-GENE
gene e I-GENE
41 I I-GENE
helicase i E-GENE
specifically c O
at O O
replication l O
forks k O
, 
 O
and 	 O
that t O
its 	 O
binding d O
sites e O
for 	 O
each h O
arm 	 O
must t O
hold d O
more e O
than n O
six 	 O
, 
 O
but 	 O
not 	 O
more e O
than n O
12 O O
nucleotides l O
. 
 O
During i O
the 	 O
1st 	 O
week k O
of O O
treatment a O
all 	 O
subjects j O
received e O
either h O
mianserin n O
30 O O
mg O O
or O O
clomipramine m O
75 O O
mg O O
once e O
daily l O
. 
 O
CBD 	 O
exploration l O
was 	 O
avoided i O
in O O
7 
 O
patients i O
with h O
normal m O
POC 	 O
. 
 O
The 	 O
human a B-GENE
SHBG G I-GENE
proximal x I-GENE
promoter m E-GENE
was 	 O
analyzed l O
by O O
DNase s B-GENE
I - E-GENE
footprinting t O
, 
 O
and 	 O
the 	 O
functional c O
significance n O
of O O
6 
 O
footprinted t O
regions i O
( 
 O
FP1 	 B-GENE
- 
 I-GENE
FP6 	 E-GENE
) 
 O
within h O
the 	 O
proximal x O
promoter m O
was 	 O
studied d O
in O O
human a O
HepG2 G O
hepatoblastoma a O
cells l O
. 
 O
We O O
exposed o O
Dorper p O
- 
 O
cross s O
ewes s O
at O O
approximately r O
120 	 O
- 
 O
135 	 O
days s O
of O O
gestation t O
to O O
a 
 O
hot 	 O
( 
 O
40 O O
degrees r O
C 
 O
, 
 O
60 O O
% 
 O
relative a O
humidity i O
) 
 O
and 	 O
a 
 O
cold d O
( 
 O
4 
 O
degrees r O
C 
 O
, 
 O
90 O O
% 
 O
relative a O
humidity i O
) 
 O
environment i O
and 	 O
to O O
treadmill a O
exercise r O
( 
 O
2 
 O
. 
 O
1 
 O
km O O
/ 
 O
h 
 O
, 
 O
5 
 O
degrees r O
gradient d O
) 
 O
and 	 O
measured s O
fetal a O
lamb b O
and 	 O
ewe 	 O
body y O
temperatures p O
using n O
previously v O
implanted l O
abdominal o O
radiotelemeters i O
. 
 O
Previously v O
identified n O
mutations a O
in O O
this s O
variant i O
have e O
been n O
within h O
or O O
close s O
to O O
the 	 O
coding i O
region i O
of O O
exon n O
1 
 O
of O O
the 	 O
HMBS S B-GENE
gene e E-GENE
, 
 O
the 	 O
only y O
exon n O
that t O
is O O
expressed r O
solely e O
in O O
the 	 O
ubiquitous q O
isoform f O
. 
 O
As O O
an O O
approach r O
to O O
the 	 O
determination e O
of O O
structure u O
- 
 O
function c O
relationships a O
in O O
the 	 O
PRP4 4 B-GENE
protein t E-GENE
, 
 O
we O O
have e O
isolated l O
more e O
than n O
fifty t O
new 	 O
alleles e O
of O O
the 	 O
PRP4 4 B-GENE
gene e E-GENE
through o O
random d O
and 	 O
site e O
- 
 O
directed e O
mutagenesis a O
, 
 O
and 	 O
have e O
analyzed l O
the 	 O
phenotypes n O
of O O
many y O
of O O
them m O
. 
 O
Over r O
a 
 O
period i O
of O O
five e O
training i O
sessions s O
( 
 O
2 
 O
. 
 O
5 
 O
days s O
) 
 O
, 
 O
the 	 O
animals m O
learned r O
not 	 O
to O O
breathe a O
, 
 O
and 	 O
the 	 O
number b O
of O O
stimuli m O
received e O
in O O
the 	 O
fifth t O
session s O
was 	 O
significantly n O
lower e O
than n O
in O O
the 	 O
first s O
session s O
. 
 O
The 	 O
5 
 O
' 
 O
- 
 O
flanking n O
region i O
of O O
the 	 O
gene e O
, 
 O
approximately r O
1 
 O
. 
 O
1 
 O
kbp 	 O
long g O
, 
 O
had 	 O
no O O
known w O
regulatory u O
elements m O
for 	 O
transcription n O
such h O
as O O
TATA A O
, 
 O
GC O O
, 
 O
and 	 O
CCAAT A O
boxes e O
. 
 O
We O O
find d O
that t O
Fus3p 3 S-GENE
and 	 O
Kss1p 1 S-GENE
both h O
control t O
G1 O O
arrest e O
through o O
multiple t O
functions c O
that t O
operate r O
in O O
parallel a O
with h O
Far1p 1 S-GENE
. 
 O
Tag 	 S-GENE
expression r O
induced u O
apoptosis p O
in O O
mammary m O
epithelial t O
cells l O
during i O
late e O
pregnancy g O
. 
 O
The 	 O
composition p O
of O O
renal a O
stones n O
analysed l O
by O O
infrared r O
spectroscopy c O
. 
 O
14 O O
. 
 O
9 
 O
x 
 O
109 	 O
L 
 O
- 
 O
1 
 O
) 
 O
was 	 O
equal a O
for 	 O
both h O
groups u O
, 
 O
but 	 O
CCI 	 O
values u O
were e O
significantly n O
higher h O
for 	 O
the 	 O
bedside s O
filtered t O
PC O O
( 
 O
14 O O
. 
 O
1 
 O
+ 
 O
/ 
 O
- 
 O
9 
 O
. 
 O
5 
 O
vs O O
. 
 O
In O O
this s O
study d O
, 
 O
the 	 O
case e O
of O O
a 
 O
patient i O
presenting s O
a 
 O
second o O
hepatocellular a O
carcinoma c O
13 O O
years r O
after e O
resection e O
of O O
a 
 O
first s O
tumor o O
of O O
the 	 O
same e O
type e O
is O O
reported o O
. 
 O
The 	 O
time e O
- 
 O
dependent e O
changes n O
in O O
measured s O
facility i O
of O O
outflow f O
or O O
" 
 O
washout h O
phenomenon n O
" 
 O
appeared e O
to O O
result u O
from m O
the 	 O
gradual d O
dissolution s O
of O O
the 	 O
hyaluronidase l S-GENE
- 
 O
sensitive s O
component p O
of O O
the 	 O
barriers r O
to O O
aqueous e O
outflow f O
in O O
the 	 O
canine i O
eye 	 O
. 
 O
The 	 O
factors t O
defective e O
in O O
groups u O
A 
 O
( 
 O
CIITA T O
) 
 O
, 
 O
C 
 O
( 
 O
RFX5 5 O
) 
 O
and 	 O
D 
 O
( 
 O
RFXAP A O
) 
 O
have e O
been n O
identified n O
. 
 O
It O O
differed f O
significantly n O
by O O
country n O
( 
 O
from m O
2 
 O
. 
 O
4 
 O
% 
 O
in O O
the 	 O
United t O
Kingdom g O
to O O
24 O O
. 
 O
7 
 O
% 
 O
in O O
Portugal t O
) 
 O
and 	 O
by O O
transmission n O
category e O
( 
 O
2 
 O
. 
 O
7 
 O
% 
 O
among n O
homo o O
/ 
 O
bisexuals e O
, 
 O
5 
 O
. 
 O
8 
 O
% 
 O
among n O
injecting e O
drug g O
users r O
, 
 O
13 O O
. 
 O
6 
 O
% 
 O
among n O
heterosexual e O
subgroup g O
1 
 O
) 
 O
. 
 O
On O O
a 
 O
national i O
level e O
, 
 O
undiscounted i O
costs t O
are 	 O
expected e O
to O O
increase r O
up O O
to O O
approximately r O
DF1 	 O
42 O O
million l O
annually u O
during i O
the 	 O
first s O
40 O O
years r O
after e O
introduction r O
of O O
the 	 O
preventative v O
strategy a O
. 
 O
By O O
deletion e O
analysis l O
, 
 O
we O O
identified n O
the 	 O
regions i O
of O O
c - B-GENE
- - I-GENE
Jun 	 E-GENE
encoding o O
transformation n O
and 	 O
transactivation n O
functions c O
. 
 O
A 
 O
survey v O
of O O
274 	 O
late e O
detected e O
cases e O
of O O
CDH 	 O
born n O
in O O
the 	 O
years r O
1970 0 O
- 
 O
- 
 O
74 O O
is O O
presented s O
. 
 O
To O O
test t O
for 	 O
progesterone g B-GENE
receptor e E-GENE
- 
 O
mediated i O
activation i O
of O O
transcription n O
in O O
yeast s O
, 
 O
reporter o O
plasmids s O
were e O
constructed s O
to O O
transform n O
yeast s O
cells l O
expressing r O
PRB 	 S-GENE
or O O
C1C2 2 B-GENE
receptors e E-GENE
. 
 O
Fli 	 B-GENE
- - I-GENE
1 - E-GENE
is O O
a 
 O
proto t O
- 
 O
oncogene o O
which c O
is O O
rearranged r O
in O O
tumors o O
induced u O
by O O
three e O
different f O
retroviruses r O
, 
 O
Cas 	 O
- 
 O
Br O O
- 
 O
E 
 O
, 
 O
F 
 O
- 
 O
MuLV V O
, 
 O
and 	 O
10A1 1 O
. 
 O
Ionic i O
composition p O
( 
 O
Na O O
+ 
 O
, 
 O
K 
 O
+ 
 O
, 
 O
Ca O O
+ 
 O
2 
 O
, 
 O
and 	 O
Mg2 	 O
+ 
 O
) 
 O
of O O
cerebrospinal e O
fluid i O
and 	 O
feeding d O
behavior a O
in O O
sheep e O
. 
 O
Materials e O
are 	 O
presented s O
of O O
a 
 O
comparative p O
study d O
of O O
morphological p O
and 	 O
cultural t O
properties p O
and 	 O
virulence u O
of O O
liophylized p O
cultures t O
of O O
Leishmania s O
tropica p O
major o O
after e O
their i O
rehydration y O
or O O
after e O
a 
 O
long g O
passage s O
on O O
the 	 O
NNN 	 O
medium i O
. 
 O
CONCLUSIONS C O
: 
 O
These s O
findings d O
imply l O
that t O
the 	 O
spinal n O
cord d O
is O O
not 	 O
a 
 O
simple p O
command m O
- 
 O
carrying r O
medium i O
from m O
the 	 O
brain i O
to O O
the 	 O
limbs b O
, 
 O
and 	 O
implies l O
that t O
some e O
computational p O
activities i O
take e O
place c O
at O O
the 	 O
spinal n O
cord d O
level e O
. 
 O
The 	 O
101st s O
annual u O
meeting t O
of O O
the 	 O
Japanese a O
Ophthalmological t O
Society i O
. 
 O
The 	 O
results u O
corroborate r O
the 	 O
proposed p O
physiological s O
function c O
of O O
CCoAOMT A O
in O O
elicited c O
plant n O
cells l O
and 	 O
may 	 O
shed d O
new 	 O
light h O
on O O
the 	 O
sequential u O
action i O
of O O
trans n O
- 
 O
active i O
factors t O
in O O
the 	 O
regulation u O
of O O
phenylpropanoid n B-GENE
genes e E-GENE
. 
 O
In O O
src 	 S-GENE
- 
 O
transformed n O
cells l O
GAP 	 S-GENE
forms m O
heteromeric e O
complexes p O
, 
 O
notably a O
with h O
a 
 O
highly h O
tyrosine o O
phosphorylated s O
62 B O
- - O
kDa 	 O
protein t O
( - O
p62 	 S-GENE
) - O
. 
 O
A 
 O
study d O
of O O
characteristics r O
in O O
adult l O
asthmatics h O
who 	 O
are 	 O
sensitized s O
by O O
cats s O
and 	 O
dogs s O
allergens e O
PrRP P S-GENE
rapidly i O
and 	 O
transiently n O
activated i O
extracellular r B-GENE
signal n I-GENE
- - I-GENE
regulated u I-GENE
protein t I-GENE
kinase a E-GENE
( 
 O
ERK 	 S-GENE
) 
 O
in O O
both h O
types e O
of O O
cells l O
. 
 O
Cell l O
- 
 O
free e O
extracts r O
of O O
E 
 B-GENE
. 
 I-GENE
coli i E-GENE
( 
 O
fpg 	 B-GENE
mutY Y E-GENE
) 
 O
harboring b O
pYSB10 B S-GENE
possess s O
an O O
enzymatic y O
activity i O
that t O
cleaves a O
a 
 O
34 O O
- 
 O
mer 	 O
oligonucleotide g O
containing t O
a 
 O
single g O
8 
 O
- 
 O
oxoG G O
opposite o O
a 
 O
cytosine o O
( 
 O
8 
 O
- 
 O
OxoG G O
/ 
 O
C 
 O
) 
 O
. 
 O
Estrogen r O
pretreated t O
castrated t O
males e O
also o O
showed w O
no O O
change n O
in O O
myocardial c O
blood o O
flow w O
after e O
17 O O
beta a O
- 
 O
estradiol r O
, 
 O
but 	 O
coronary o O
flow w O
velocity o O
decreased r O
( 
 O
P 
 O
< 
 O
0 
 O
. 
 O
05 O O
) 
 O
compared p O
with h O
baseline e O
1 
 O
h 
 O
after e O
the 	 O
200 	 O
ng O O
/ 
 O
kg O O
dose e O
( 
 O
from m O
1 
 O
. 
 O
69 O O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
61 O O
to O O
1 
 O
. 
 O
41 O O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
42 O O
kHz 	 O
) 
 O
and 	 O
diastolic s O
coronary o O
resistance i O
increased r O
significantly n O
( 
 O
P 
 O
< 
 O
0 
 O
. 
 O
01 O O
) 
 O
compared p O
with h O
control t O
at O O
this s O
time e O
( 
 O
51 O O
+ 
 O
/ 
 O
- 
 O
15 O O
compared p O
with h O
39 O O
+ 
 O
/ 
 O
- 
 O
14 O O
mmHg g O
/ 
 O
mkHz z O
) 
 O
. 
 O
Acute t O
renal a O
vein n O
thrombosis o O
in O O
renal a O
allografts o O
: 
 O
detection e O
with h O
duplex l O
Doppler p O
US O O
. 
 O
Several e O
DNA 	 O
clones n O
were e O
obtained a O
by O O
this s O
procedure c O
, 
 O
one 	 O
of O O
which c O
, 
 O
clone n O
18 O O
, 
 O
is O O
reported o O
and 	 O
characterized r O
here e O
. 
 O
Long g O
- 
 O
range g O
mapping p O
by O O
pulse s O
- 
 O
field l O
gel 	 O
electrophoresis c O
indicated i O
that t O
the 	 O
three e O
mdr 	 B-GENE
genes e E-GENE
are 	 O
closely s O
linked k O
on O O
a 
 O
genomic o O
DNA 	 O
segment m O
of O O
approximately r O
625 	 O
kilobases o O
. 
 O
These s O
sequences u O
were e O
further t O
tested t O
for 	 O
the 	 O
presence s O
of O O
an O O
enhancer a O
element m O
, 
 O
by O O
their i O
ability l O
to O O
activate i O
a 
 O
fusion i O
reporter o O
gene e O
consisting s O
of O O
the 	 O
CAT 	 B-GENE
gene e E-GENE
linked k O
to O O
the 	 O
gamma m B-GENE
- - I-GENE
globin b I-GENE
gene e I-GENE
promoter m E-GENE
, 
 O
in O O
erythroid t O
( 
 O
K562 2 O
) 
 O
and 	 O
non 	 O
- 
 O
erythroid t O
( 
 O
HeLa a O
) 
 O
cells l O
. 
 O
Two 	 O
sibs s O
with h O
identical n O
features t O
of O O
short r O
- 
 O
limbed b O
dwarfism r O
, 
 O
a 
 O
normal m O
skull l O
and 	 O
face e O
and 	 O
normal m O
intelligence e O
are 	 O
described c O
. 
 O
This s O
article i O
describes c O
a 
 O
program g O
that t O
resulted u O
in O O
a 
 O
75 O O
- 
 O
percent c O
reduction u O
of O O
inventory e O
over r O
a 
 O
five e O
- 
 O
year r O
interval e O
. 
 O
Further t O
comparative p O
analysis l O
identified n O
an O O
ADNP P B-GENE
paralog a E-GENE
( 
 O
33 O O
% 
 O
identity n O
and 	 O
46 O O
% 
 O
similarity i O
) 
 O
, 
 O
indicating i O
that t O
these s O
genes e O
belong o O
to O O
a 
 O
novel e O
protein t O
family i O
with h O
a 
 O
nine e O
- 
 O
zinc c O
finger g O
motif i O
followed l O
by O O
a 
 O
homeobox e O
domain a O
. 
 O
All 	 O
patients i O
received e O
marrow r O
from m O
HLA 	 O
- 
 O
identical n O
sibling l O
donors o O
, 
 O
underwent e O
similar i O
myeloablative l O
regimens i O
, 
 O
and 	 O
had 	 O
similar i O
pretreatment t O
characteristics r O
. 
 O
In O O
female a O
toads d O
, 
 O
Bufo o O
bufo o O
, 
 O
feeding d O
at O O
different f O
rates e O
, 
 O
the 	 O
uncorrected o O
value u O
of O O
n 
 O
was 	 O
0 
 O
. 
 O
44 O O
, 
 O
when n O
metabolism a O
and 	 O
growth w O
were e O
expressed r O
as O O
kJ O B-GENE
kJ O I-GENE
- 
 I-GENE
1 
 E-GENE
. 
 O
METHODS H O
: 
 O
Two 	 O
patients i O
developed e O
cervical v O
myelopathy l O
or O O
radiculopathy i O
after e O
spinal n O
manipulation i O
therapy r O
, 
 O
and 	 O
magnetic n O
resonance o O
imaging g O
showed w O
herniated n O
cervical v O
discs c O
at O O
C4 O O
- 
 O
C5 O O
and 	 O
C6 O O
- 
 O
C7 O O
, 
 O
respectively p O
. 
 O
Subclones c O
stably b O
expressing r O
alpha1A h S-GENE
- 
 O
, 
 O
alpha1B h S-GENE
- 
 O
, 
 O
and 	 O
alpha1D h B-GENE
- 
 I-GENE
ARs 	 E-GENE
under e O
control t O
of O O
an O O
inducible u O
promoter m O
, 
 O
or O O
at O O
high h O
and 	 O
low 	 O
receptor e O
density s O
, 
 O
were e O
isolated l O
and 	 O
characterized r O
. 
 O
Analysis l O
of O O
WT1 	 B-GENE
target g I-GENE
gene e E-GENE
expression r O
in O O
stably b O
transfected n O
cell l O
lines e O
. 
 O
Soluble u O
recombinant o B-GENE
RI S E-GENE
and 	 O
soluble u O
recombinant o B-GENE
C - I-GENE
alpha h E-GENE
can 	 O
associate o O
in O O
vitro r O
and 	 O
be O O
activated i O
by O O
cyclic l O
AMP 	 O
. 
 O
IRIS S S-GENE
/ 
 O
GAS 	 O
DNA 	 O
also o O
formed m O
a 
 O
number b O
of O O
specific c O
complexes p O
with h O
constitutively s O
expressed r O
factors t O
, 
 O
none e O
of O O
which c O
were e O
affected e O
by O O
the 	 O
above v O
Abs 	 S-GENE
. 
 O
Simulation u O
results u O
based e O
on O O
the 	 O
presented s O
model e O
are 	 O
compared p O
with h O
the 	 O
experimental e O
data a O
for 	 O
two 	 O
types e O
of O O
cMUTs T O
reported o O
in O O
the 	 O
recent e O
literature e O
. 
 O
Tre 	 O
during i O
exercise r O
at O O
35 O O
W 
 O
at O O
23 O O
degrees r O
C 
 O
correlated r O
r 
 O
= 
 O
- 
 O
70 O O
with h O
Vo2max m O
and 	 O
r 
 O
= 
 O
0 
 O
. 
 O
80 O O
with h O
Tre 	 O
during i O
exercise r O
in O O
heat t O
. 
 O
Electrophoretic c O
mobility i O
- 
 O
shift f O
assays a O
with h O
nuclear l O
extracts r O
from m O
COS 	 O
- 
 O
1 
 O
cells l O
transfected n O
with h O
expression r O
vectors t O
for 	 O
SMADs D B-GENE
1 - I-GENE
- - I-GENE
5 - E-GENE
indicate i O
that t O
SMAD3 D S-GENE
forms m O
a 
 O
complex p O
with h O
a 
 O
migration r O
similar i O
to O O
that t O
of O O
the 	 O
endogenous o O
TGF 	 B-GENE
- - I-GENE
beta a I-GENE
- - I-GENE
specific c I-GENE
complex p E-GENE
observed e O
in O O
fibroblast r O
extracts r O
. 
 O
The 	 O
newly l O
identified n O
NF B B-GENE
kappa p I-GENE
B - I-GENE
enhancer a E-GENE
( 
 O
TGGAAATTCC A O
) 
 O
is O O
bound n O
by O O
a 
 O
TNF 	 B-GENE
alpha h E-GENE
- 
 O
induced u O
nuclear l O
protein t O
and 	 O
appears e O
to O O
be O O
the 	 O
key 	 O
element m O
in O O
rapid i O
transcription n O
induction u O
by O O
TNF 	 B-GENE
alpha h E-GENE
( 
 O
and 	 O
TPA 	 S-GENE
) 
 O
, 
 O
while l O
transactivation n O
of O O
this s O
element m O
is O O
repressed r O
by O O
the 	 O
ligand a O
- 
 O
bound n O
glucocorticoid c B-GENE
receptor e E-GENE
. 
 O
Our 	 O
results u O
showed w O
that t O
the 	 O
5 
 O
- 
 O
hydroxytryptamine r O
( 
 O
5 
 O
- 
 O
HT O O
) 
 O
content t O
in O O
platelets t O
was 	 O
: 
 O
( 
 O
1 
 O
) 
 O
increased r O
in O O
the 	 O
subgroup g O
of O O
anti i O
- 
 O
social i O
alcoholics o O
; 
 O
( 
 O
2 
 O
) 
 O
transiently n O
and 	 O
differently f O
altered e O
in O O
alcoholics o O
compared p O
to O O
opiate a O
addicts i O
; 
 O
and 	 O
( 
 O
3 
 O
) 
 O
lowered e O
in O O
drinking n O
alcoholics o O
and 	 O
normal m O
in O O
alcoholics o O
who 	 O
were e O
drinking n O
as O O
well l O
as O O
smoking k O
( 
 O
that t O
may 	 O
occur u O
via 	 O
MAO 	 B-GENE
- - I-GENE
B - E-GENE
inhibition i O
by O O
smoke k O
) 
 O
. 
 O
In O O
the 	 O
second o O
group u O
, 
 O
which c O
consisted s O
of O O
babies i O
of O O
33 O O
to O O
36 O O
weeks k O
of O O
gestational t O
age 	 O
, 
 O
haptoglobin t S-GENE
was 	 O
detected e O
in O O
6 
 O
infants a O
, 
 O
with h O
levels e O
less s O
than n O
25 O O
mg O O
/ 
 O
dl O O
in O O
3 
 O
. 
 O
The 	 O
polypeptide y O
encoded o O
by O O
the 	 O
cDNA A O
contained t O
450 	 O
amino n O
acids d O
with h O
a 
 O
calculated c O
M 
 O
( 
 O
r 
 O
) 
 O
of O O
52 O O
, 
 O
057 	 O
, 
 O
and 	 O
showed w O
significant n O
homology o O
with h O
human a O
and 	 O
mouse s O
CAD 	 O
( 
 O
22 O O
% 
 O
identity n O
) 
 O
. 
 O
Correlation r O
of O O
alpha h O
activity i O
between w O
the 	 O
frontal n O
and 	 O
occipital i O
cortex t O
. 
 O
In O O
situ u O
localization a O
of O O
PCP 	 B-GENE
- - I-GENE
A1 I I-GENE
transcripts n E-GENE
revealed e O
that t O
they y O
accumulate u O
specifically c O
in O O
pollen l O
at O O
the 	 O
late e O
binucleate u O
/ 
 O
trinucleate n O
stage g O
of O O
development e O
rather h O
than n O
in O O
the 	 O
tapetum e O
, 
 O
which c O
previously v O
was 	 O
taken e O
to O O
be O O
the 	 O
principal n O
source r O
of O O
the 	 O
pollen l O
coat t O
. 
 O
Successful c O
resolution o O
of O O
progressive g O
multifocal t O
leukoencephalopathy k O
after e O
combination b O
therapy r O
with h O
cidofovir o O
and 	 O
cytosine o O
arabinoside b O
. 
 O
The 	 O
species c O
composition p O
and 	 O
abundance n O
upon n O
treatment a O
of O O
manure u O
with h O
polyethylene y O
, 
 O
polystyrene y O
and 	 O
glass s O
particles t O
was 	 O
similar i O
to O O
that t O
of O O
the 	 O
treatment a O
control t O
, 
 O
i 
 O
. 
 O
e 
 O
. 
 O
natural u O
and 	 O
inert r O
sand d O
. 
 O
However e O
, 
 O
H19 	 S-GENE
and 	 O
IGF2 2 S-GENE
lie 	 O
within h O
a 
 O
larger g O
imprinted r O
domain a O
, 
 O
and 	 O
the 	 O
gene e O
specificity c O
of O O
H19 	 S-GENE
epimutation m O
has 	 O
been n O
a 
 O
persistent s O
question s O
. 
 O
Here e O
we O O
report o O
the 	 O
cloning n O
, 
 O
by O O
either h O
peptide t O
sequencing u O
or O O
by O O
sequence u O
similarity i O
to O O
the 	 O
human a B-GENE
cDNAs A E-GENE
, 
 O
of O O
the 	 O
S 
 B-GENE
. 
 I-GENE
cerevisiae e I-GENE
genes e I-GENE
RFC1 1 E-GENE
, 
 O
RFC2 2 S-GENE
, 
 O
RFC3 3 S-GENE
, 
 O
RFC4 4 S-GENE
, 
 O
and 	 O
RFC5 5 S-GENE
. 
 O
It O O
is O O
of O O
interest e O
that t O
, 
 O
aside d O
from m O
starvation r O
, 
 O
the 	 O
nutrition r O
catastrophes a O
of O O
the 	 O
past t O
, 
 O
including l O
scurvy r O
( 
 O
vitamin a O
C 
 O
deficiency i O
) 
 O
resulting u O
from m O
lack k O
of O O
fresh s O
vegetables e O
and 	 O
fruit i O
and 	 O
beriberi i O
( 
 O
vitamin a O
B1 O O
deficiency i O
) 
 O
from m O
consumption s O
of O O
polished i O
rice e O
, 
 O
are 	 O
forgotten g O
and 	 O
only y O
of O O
interest e O
as O O
history t O
. 
 O
This s O
sequence u O
can 	 O
interact e O
with h O
at O O
least s O
two 	 O
proteins t O
in O O
a 
 O
fibroblast r O
nuclear l O
extract r O
that t O
have e O
binding d O
characteristics r O
of O O
an O O
Ets 	 B-GENE
family i I-GENE
protein t E-GENE
and 	 O
a 
 O
serum u B-GENE
response p I-GENE
factor t I-GENE
- - I-GENE
like e I-GENE
protein t E-GENE
. 
 O
As O O
much h O
thrombin o S-GENE
was 	 O
formed m O
during i O
cardiopulmonary d O
bypass a O
( 
 O
measured s O
by O O
the 	 O
prothrombin t B-GENE
activation i I-GENE
fragment g I-GENE
F1 I I-GENE
+ - I-GENE
2 - E-GENE
and 	 O
thrombin o B-GENE
- 
 I-GENE
antithrombin i I-GENE
complexes p E-GENE
) 
 O
as O O
in O O
normal m O
patients i O
, 
 O
showing w O
that t O
factor t B-GENE
XII 	 E-GENE
was 	 O
not 	 O
necessary e O
for 	 O
thrombin o S-GENE
generation e O
. 
 O
The 	 O
molecular e O
event n O
( 
 O
s 
 O
) 
 O
underlying e O
the 	 O
functional c O
specificities c O
of O O
these s O
receptors e O
( 
 O
in O O
regulating u O
the 	 O
expression r O
of O O
their i O
native i O
target g O
genes e O
) 
 O
is O O
a 
 O
very y O
important o O
issue u O
that t O
remains a O
poorly r O
understood e O
. 
 O
MUS81 8 S-GENE
encodes o O
a 
 O
novel e O
helix i B-GENE
- - I-GENE
hairpin r I-GENE
- - I-GENE
helix i I-GENE
protein t E-GENE
involved o O
in O O
the 	 O
response p O
to O O
UV O O
- 
 O
and 	 O
methylation h O
- 
 O
induced u O
DNA 	 O
damage a O
in O O
Saccharomyces c O
cerevisiae e O
. 
 O
Treatment a O
of O O
chronic o O
hepatitis a O
B 
 O
with h O
interferon e S-GENE
: 
 O
experience e O
in O O
western t O
countries n O
. 
 O
Several e O
positive i O
clones n O
were e O
isolated l O
, 
 O
one 	 O
of O O
which c O
encoded o O
the 	 O
C 
 O
- 
 O
terminal m O
253 	 O
amino n O
acids d O
of O O
a 
 O
putative a O
RNA 	 B-GENE
helicase i E-GENE
, 
 O
a 
 O
DEAD D B-GENE
box 	 I-GENE
protein t E-GENE
designated i O
DDX3 3 S-GENE
. 
 O
Kerstin s O
takes e O
the 	 O
abbreviated r O
medical i O
education c O
. 
 O
In O O
vitro r O
binding d O
studies d O
previously v O
showed w O
that t O
NF B B-GENE
- - I-GENE
kappa p I-GENE
B - E-GENE
p50 	 B-GENE
homodimer o E-GENE
binds d O
the 	 O
switch t B-GENE
nuclear l I-GENE
B - I-GENE
- - I-GENE
site e I-GENE
protein t E-GENE
( 
 O
SNIP P S-GENE
) 
 O
of O O
the 	 O
S - B-GENE
gamma m I-GENE
3 - I-GENE
tandem d I-GENE
repeat e E-GENE
. 
 O
In O O
this s O
case e O
myogenic g O
factors t O
are 	 O
not 	 O
initially t O
expressed r O
and 	 O
these s O
migratory r O
cells l O
are 	 O
characterized r O
by O O
the 	 O
expression r O
of O O
the 	 O
paired r B-GENE
- 
 I-GENE
box 	 I-GENE
gene e I-GENE
Pax3 3 E-GENE
. 
 O
It O O
is O O
concluded c O
that t O
the 	 O
atherogenic e O
process c O
includes l O
stimulation m O
of O O
collagen l S-GENE
and 	 O
elastin s S-GENE
synthesis t O
. 
 O
These s O
results u O
indicate i O
that t O
( 
 O
1 
 O
) 
 O
RXR 	 S-GENE
- 
 O
TR S S-GENE
heterodimers e O
play y O
a 
 O
role e O
in O O
basal a O
transactivation n O
and 	 O
T3 O O
suppression p O
of O O
negatively a O
regulated u O
genes e O
, 
 O
and 	 O
( 
 O
2 
 O
) 
 O
RXRs s O
increase r O
the 	 O
dominant i O
negative a O
effect e O
of O O
some e O
mutant a B-GENE
TRs 	 E-GENE
on O O
specific c O
negative a O
TREs s O
. 
 O
Phenotypic n O
responses p O
of O O
additional i O
mutants a O
, 
 O
including l O
exo1 1 S-GENE
, 
 O
srs2 2 S-GENE
, 
 O
rad5 5 S-GENE
, 
 O
and 	 O
rdh54 5 S-GENE
strains a O
, 
 O
suggest g O
roles e O
in O O
recombinational o O
repair a O
, 
 O
but 	 O
not 	 O
in O O
NHEJ J S-GENE
. 
 O
Furthermore t O
, 
 O
the 	 O
induction u O
of O O
cytochrome o B-GENE
P - I-GENE
- - I-GENE
450 	 I-GENE
1A1 	 E-GENE
observed e O
in O O
the 	 O
cormorant m O
indicates i O
that t O
the 	 O
Ah B B-GENE
receptor e E-GENE
- 
 O
mediated i O
process c O
, 
 O
by O O
which c O
TCDD D O
and 	 O
related a O
chemicals m O
exert r O
many y O
of O O
their i O
toxicities i O
, 
 O
has 	 O
been n O
activated i O
. 
 O
RESULT U O
( 
 O
S 
 O
) 
 O
: 
 O
A 
 O
prospective s O
study d O
was 	 O
conducted d O
with h O
44 O O
cycles l O
for 	 O
34 O O
couples p O
with h O
nafarelin a O
acetate t O
( 
 O
group u O
1 
 O
) 
 O
and 	 O
47 O O
cycles l O
for 	 O
40 O O
couples p O
with h O
buserelin e O
acetate t O
( 
 O
group u O
2 
 O
) 
 O
with h O
a 
 O
long g O
IVF 	 O
protocol t O
; 
 O
68 O O
cycles l O
for 	 O
46 O O
couples p O
with h O
nafarelin a O
acetate t O
( 
 O
group u O
3 
 O
) 
 O
and 	 O
56 O O
cycles l O
for 	 O
39 O O
couples p O
with h O
buserelin e O
acetate t O
( 
 O
group u O
4 
 O
) 
 O
with h O
a 
 O
short r O
IVF 	 O
protocol t O
; 
 O
39 O O
cycles l O
for 	 O
32 O O
couples p O
with h O
nafarelin a O
acetate t O
( 
 O
group u O
5 
 O
) 
 O
and 	 O
50 O O
cycles l O
for 	 O
30 O O
couples p O
with h O
buserelin e O
acetate t O
( 
 O
group u O
6 
 O
) 
 O
with h O
a 
 O
long g O
ICSI I O
protocol t O
; 
 O
and 	 O
87 O O
cycles l O
for 	 O
60 O O
couples p O
with h O
nafarelin a O
acetate t O
( 
 O
group u O
7 
 O
) 
 O
and 	 O
81 O O
cycles l O
for 	 O
61 O O
couples p O
with h O
buserelin e O
acetate t O
( 
 O
group u O
8 
 O
) 
 O
with h O
a 
 O
short r O
ICSI I O
protocol t O
. 
 O
This s O
study d O
demonstrates o O
the 	 O
feasibility s O
and 	 O
potential e O
usefulness f O
of O O
syngeneic g O
BM O B-GENE
Txp 	 E-GENE
in O O
myeloma l O
. 
 O
5 
 O
. 
 O
3 
 O
+ 
 O
/ 
 O
- 
 O
6 
 O
. 
 O
6 
 O
for 	 O
risperidone p O
( 
 O
P 
 O
= 
 O
0 
 O
. 
 O
09 O O
) 
 O
. 
 O
In O O
this s O
work k O
, 
 O
we O O
determined e O
the 	 O
sequences u O
of O O
eight h O
VirF F B-GENE
- - I-GENE
binding d I-GENE
sites e E-GENE
from m O
four r O
different f O
genes e O
, 
 O
by O O
DNase s B-GENE
I - E-GENE
or O O
hydroxyl r O
radical i O
footprinting t O
. 
 O
Although h O
they y O
are 	 O
similar i O
to O O
the 	 O
IL9R R B-GENE
gene e E-GENE
( 
 O
approximately r O
90 O O
% 
 O
identity n O
) 
 O
, 
 O
none e O
of O O
these s O
copies i O
encodes o O
a 
 O
functional c O
receptor e O
: 
 O
none e O
of O O
them m O
contains t O
sequences u O
homologous o O
to O O
the 	 O
5 
 O
' 
 O
flanking n O
region i O
or O O
exon n O
1 
 O
of O O
the 	 O
IL9R R B-GENE
gene e E-GENE
, 
 O
and 	 O
the 	 O
remaining a O
ORFs s O
have e O
been n O
inactivated c O
by O O
various i O
point n O
mutations a O
and 	 O
deletions e O
. 
 O
Type e O
II O O
neuroleptanalgesia r O
in O O
odonto n O
- 
 O
stomatology m O
273 	 O
, 
 O
27420 2 O
- 
 O
27429 2 O
) 
 O
a 
 O
putative a O
peroxisome o B-GENE
proliferator l I-GENE
- 
 I-GENE
activated i I-GENE
receptor e I-GENE
response p I-GENE
element m E-GENE
( 
 O
PPRE E O
) 
 O
is O O
present s O
from m O
- 
 O
458 	 O
to O O
- 
 O
474 	 O
. 
 O
While l O
reviewing i O
gastric t O
specimens c O
from m O
215 	 O
baboons o O
, 
 O
we O O
found n O
diffuse f O
giant n O
mucosal o O
folds d O
in O O
2 
 O
specimens c O
and 	 O
multiple t O
giant n O
mucosal o O
nodules u O
in O O
another t O
3 
 O
. 
 O
To O O
investigate e O
whether t O
the 	 O
two 	 O
RPG 	 O
- - O
boxes e O
mediate i O
transcription n O
activation i O
of O O
both h O
the 	 O
L46 	 S-GENE
and 	 O
S24 	 B-GENE
gene e E-GENE
, 
 O
two 	 O
experimental e O
strategies a O
were e O
followed l O
: 
 O
cloning n O
of O O
the 	 O
respective p O
genes e O
on O O
multicopy t O
vectors t O
and 	 O
construction s O
of O O
fusion i O
genes e O
. 
 O
When n O
the 	 O
opioid o O
antagonist a O
was 	 O
administered i O
to O O
animals m O
24 O O
hr O O
after e O
termination m O
of O O
single g O
or O O
multiple t O
exposures o O
to O O
restraint t O
, 
 O
NALT T O
- 
 O
induced u O
increases r O
in O O
basal a O
plasma s O
LH E S-GENE
were e O
significantly n O
attenuated e O
in O O
the 	 O
chronically o O
stressed e O
rats s O
compared p O
to O O
animals m O
subjected j O
to O O
stress e O
only y O
once e O
or O O
not 	 O
at O O
all 	 O
. 
 O
( 
 O
ABSTRACT T O
TRUNCATED N O
AT O O
250 	 O
WORDS D O
) 
 O
The 	 O
psychosocial c O
features t O
of O O
people p O
using n O
self f O
- 
 O
ignition i O
as O O
a 
 O
method h O
of O O
suicide c O
are 	 O
consistent s O
with h O
those s O
of O O
suicide c O
in O O
general e O
. 
 O
This s O
was 	 O
further t O
suggested g O
by O O
transactivation n O
assays a O
in O O
which c O
mouse s O
fibroblasts r O
were e O
transiently n O
transfected n O
with h O
a 
 O
human a B-GENE
beta a I-GENE
- - I-GENE
globin b I-GENE
reporter o I-GENE
gene e E-GENE
in O O
the 	 O
absence e O
and 	 O
presence s O
of O O
an O O
LKLF F B-GENE
cDNA A I-GENE
construct s E-GENE
. 
 O
Plasma s O
colony o O
- - O
stimulating m O
factor t O
analysis l O
and 	 O
the 	 O
clinical n O
significance n O
Thus s O
, 
 O
in O O
addition i O
to O O
the 	 O
previously v O
characterized r O
FAS 	 B-GENE
- - I-GENE
binding d I-GENE
factor t I-GENE
1 - E-GENE
interacting e O
with h O
the 	 O
inositol s O
/ 
 O
choline l O
- 
 O
responsive p O
- 
 O
element m O
motif i O
, 
 O
a 
 O
second o O
motif i O
common m O
to O O
the 	 O
promoter m O
regions i O
of O O
both h O
FAS 	 B-GENE
genes e E-GENE
could l O
be O O
identified n O
. 
 O
Reconstruction o O
time e O
for 	 O
a 
 O
64 O O
x 
 O
64 O O
matrix r O
is O O
approximately r O
45 O O
s 
 O
/ 
 O
transaxial n O
slice c O
. 
 O
Sequence u O
analysis l O
identifies n O
a 
 O
ras 	 B-GENE
- - I-GENE
associating o I-GENE
( 
 I-GENE
RA S I-GENE
) 
 I-GENE
- 
 I-GENE
like e I-GENE
domain a E-GENE
in O O
the 	 O
N 
 O
- 
 O
termini m O
of O O
band d O
4 - O
. - O
1 - O
/ - O
JEF 	 S-GENE
domains a O
and 	 O
in O O
the 	 O
Grb7 7 B-GENE
/ - I-GENE
10 I I-GENE
/ - I-GENE
14 I I-GENE
adapter p I-GENE
family i E-GENE
. 
 O
Patients i O
received e O
BPB 	 O
using n O
bupivacaine i O
2 
 O
mg O O
kg O O
- 
 O
1 
 O
with h O
adrenaline e O
1 
 O
in O O
200 	 O
, 
 O
000 	 O
, 
 O
either h O
with h O
or O O
without h O
hyaluronidase l S-GENE
3000 0 O
iu O O
, 
 O
in O O
a 
 O
volume u O
of O O
0 
 O
. 
 O
5 
 O
ml O O
per 	 O
2 
 O
. 
 O
54 O O
cm O O
of O O
the 	 O
patient i O
' 
 O
s 
 O
height g O
. 
 O
Rhinovirus n B-GENE
2A I I-GENE
protease t E-GENE
and 	 O
foot t B-GENE
- - I-GENE
and 	 I-GENE
- - I-GENE
mouth t I-GENE
- - I-GENE
disease e I-GENE
virus u I-GENE
L - I-GENE
protease t E-GENE
were e O
used d O
to O O
analyze l O
the 	 O
association o O
of O O
eIF4G 4 S-GENE
with h O
eIF4A 4 S-GENE
, 
 O
eIF4E 4 S-GENE
, 
 O
and 	 O
eIF3 3 S-GENE
. 
 O
One 	 O
hundred d O
cDNA A O
clones n O
were e O
sequenced u O
and 	 O
8 
 O
RTKs s O
were e O
identified n O
, 
 O
as O O
well l O
as O O
12 O O
non 	 O
- 
 O
RTKs s O
and 	 O
2 
 B-GENE
serine i I-GENE
/ - I-GENE
threonine e I-GENE
kinases a E-GENE
. 
 O
Roller l O
pumps p O
, 
 O
coronary o O
suction t O
and 	 O
an O O
open n O
cardiotomy d O
reservoir e O
were e O
used d O
. 
 O
Furthermore t O
, 
 O
it O O
was 	 O
found n O
that t O
the 	 O
Shb 	 S-GENE
- 
 O
overexpressing r O
cells l O
extended e O
neurites r O
in O O
response p O
to O O
epidermal d B-GENE
growth w I-GENE
factor t E-GENE
. 
 O
Levels e O
of O O
p53 	 S-GENE
were e O
substantially s O
increased r O
by O O
E1A 	 S-GENE
expression r O
during i O
adenovirus n O
infection e O
. 
 O
In O O
cases e O
of O O
intracapsular r O
prostatic s O
cancer c O
the 	 O
level e O
of O O
prostatic s B-GENE
acid d I-GENE
phosphatase s E-GENE
( 
 O
PAP 	 S-GENE
) 
 O
measured s O
by O O
radioimmunoassay i O
was 	 O
1 
 O
. 
 O
4 
 O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
8 
 O
micrograms r O
/ 
 O
l 
 O
. 
 O
Healthy l O
subjects j O
received e O
the 	 O
following l O
regimens i O
, 
 O
dosed e O
to O O
steady a O
state t O
: 
 O
trovafloxacin v O
300 	 O
mg O O
/ 
 O
24 O O
h 
 O
; 
 O
ciprofloxacin r O
400 	 O
mg O O
/ 
 O
12 O O
h 
 O
; 
 O
trovafloxacin v O
300 	 O
mg O O
/ 
 O
24 O O
h 
 O
plus s O
cefepime e O
2 
 O
g 
 O
/ 
 O
12 O O
h 
 O
, 
 O
and 	 O
ciprofloxacin r O
400 	 O
mg O O
/ 
 O
12 O O
h 
 O
plus s O
cefepime e O
2 
 O
g 
 O
/ 
 O
12 O O
h 
 O
. 
 O
In O O
EGF 	 B-GENE
receptor e E-GENE
- 
 O
mediated i O
signaling n O
, 
 O
the 	 O
protein t O
kinase a O
PKB 	 S-GENE
/ 
 O
Akt 	 S-GENE
and 	 O
the 	 O
mitogen o B-GENE
- - I-GENE
activated i I-GENE
protein t I-GENE
kinase a I-GENE
c - I-GENE
- - I-GENE
Jun 	 I-GENE
N - I-GENE
- - I-GENE
terminal m I-GENE
kinase a E-GENE
, 
 O
but 	 O
not 	 O
extracellular r B-GENE
signal n I-GENE
- - I-GENE
regulated u I-GENE
kinase a I-GENE
2 - E-GENE
, 
 O
function c O
downstream n O
of O O
phosphatidylinositol s B-GENE
3 - I-GENE
- - I-GENE
kinase a E-GENE
( 
 O
PI B B-GENE
3 - I-GENE
- - I-GENE
kinase a E-GENE
) 
 O
. 
 O
Immunoprecipitation u O
of O O
cell l O
lysates a O
with h O
anti i B-GENE
- - I-GENE
phosphotyrosine s E-GENE
and 	 O
immunoblotting u O
showed w O
phosphorylated s O
forms m O
of O O
the 	 O
mitogenic o B-GENE
pathway h I-GENE
proteins t I-GENE
Shc 	 E-GENE
and 	 O
MAPK K S-GENE
in O O
addition i O
to O O
p185 5 S-GENE
( 
 O
neu 	 S-GENE
) 
 O
, 
 O
suggesting g O
that t O
the 	 O
Ras 	 S-GENE
to O O
MAPK K S-GENE
mitogenic o O
pathway h O
is O O
activated i O
. 
 O
Acad d O
. 
 O
We O O
suggest g O
that t O
this s O
effect e O
of O O
Myc 	 S-GENE
is O O
mediated i O
by O O
its 	 O
action i O
upstream t O
of O O
cyclin l B-GENE
E - E-GENE
- 
 O
CDK2 2 S-GENE
, 
 O
and 	 O
occurs u O
via 	 O
the 	 O
neutralization t O
of O O
p27 	 S-GENE
( 
 O
Kip1 1 S-GENE
) 
 O
family i O
proteins t O
, 
 O
rather h O
than n O
induction u O
of O O
Cdc25A 2 S-GENE
. 
 O
Bile e O
reflux l O
demonstrated o O
by O O
99m 	 O
Tc O O
disofenin o O
. 
 O
These s O
data a O
suggest g O
that t O
certain t O
of O O
the 	 O
nuclear l O
protein t O
import o O
functions c O
of O O
NTF2 2 S-GENE
and 	 O
Ran 	 S-GENE
/ 
 O
TC4 	 S-GENE
are 	 O
closely s O
linked k O
and 	 O
that t O
NTF2 2 S-GENE
may 	 O
serve v O
to O O
modulate u O
a 
 O
transport n O
step p O
involving o O
Ran 	 S-GENE
/ 
 O
TC4 	 S-GENE
. 
 O
Almost o O
every r O
image g O
that t O
appears e O
during i O
a 
 O
therapy r O
session s O
reveals e O
a 
 O
symbolic b O
nature u O
, 
 O
but 	 O
the 	 O
very y O
concept c O
of O O
symbol b O
is O O
not 	 O
free e O
from m O
ambiguity i O
some e O
positions i O
originated g O
in O O
different f O
areas a O
of O O
investigation e O
are 	 O
mentioned t O
, 
 O
ending i O
with h O
a 
 O
description c O
of O O
the 	 O
traits i O
that t O
, 
 O
according o O
to O O
the 	 O
writer t O
, 
 O
bestow t O
a 
 O
symbolic b O
character r O
to O O
images g O
. 
 O
The 	 O
severity e O
of O O
the 	 O
psychomotor c O
retardation a O
varied i O
from m O
mild d O
to O O
severe e O
. 
 O
Both h O
oligonucleotide g O
cross s O
- 
 O
competition p O
and 	 O
antibody i O
supershift e O
experiments e O
established a O
that t O
the 	 O
double b O
- 
 O
strand a O
binding d O
protein t O
is O O
equivalent i O
to O O
Sp1 	 S-GENE
. 
 O
The 	 O
wet 	 O
and 	 O
dry 	 O
methods h O
of O O
the 	 O
HA O O
synthesis t O
are 	 O
considered s O
. 
 O
All 	 O
these s O
abnormalities o O
returned u O
to O O
normal m O
after e O
removal o O
of O O
the 	 O
tumor o O
. 
 O
Although h O
FKH2 2 S-GENE
is O O
redundant u O
with h O
FKH1 1 S-GENE
in O O
controlling t O
pseudohyphal u O
growth w O
, 
 O
the 	 O
two 	 O
genes e O
have e O
different f O
functions c O
in O O
silencing e O
HMRa a S-GENE
. 
 O
Molecular e O
analysis l O
indicated i O
that t O
inactivation c O
of O O
H - B-GENE
- - I-GENE
2L E E-GENE
expression r O
in O O
nearly r O
every r O
null l O
clone n O
resulted u O
from m O
an O O
apparent a O
deletion e O
or O O
rearrangement r O
of O O
5 - O
' - O
- - O
flanking n O
and 	 O
5 - O
' - O
- - O
coding i O
H - O
- - O
2L I O
sequences u O
, 
 O
with h O
breakpoints a O
consistently s O
mapping p O
to O O
within h O
a 
 O
550 	 O
bp O O
GC O O
- 
 O
rich h O
region i O
between w O
exon n O
1 
 O
and 	 O
the 	 O
middle d O
of O O
intron r O
2 
 O
. 
 O
However e O
, 
 O
C - B-GENE
/ - I-GENE
EBP 	 I-GENE
beta a E-GENE
stimulated m O
transcription n O
primarily m O
through o O
the 	 O
cAMP P O
- 
 O
responsive p O
element m O
( 
 O
CRE 	 O
) 
 O
, 
 O
which c O
maps s O
between w O
positions i O
- 
 O
77 O O
to O O
- 
 O
94 O O
, 
 O
but 	 O
not 	 O
at O O
the 	 O
more e O
5 
 O
' 
 O
- 
 O
binding d O
sites e O
. 
 O
Heliox i O
improves r O
pulsus s O
paradoxus a O
and 	 O
peak k O
expiratory i O
flow w O
in O O
nonintubated i O
patients i O
with h O
severe e O
asthma h O
. 
 O
50 O O
- 
 O
fold d O
increase r O
in O O
foreign e O
protein t O
production d O
. 
 O
Ion 	 O
- 
 O
Bernstein n O
- 
 O
wave e O
heating t O
and 	 O
improved r O
confinement f O
in O O
the 	 O
Alcator a O
C 
 O
tokamak a O
. 
 O
However e O
, 
 O
the 	 O
molecular e O
mechanisms h O
by O O
which c O
specific c O
cis 	 O
- 
 O
and 	 O
trans n O
- 
 O
acting i O
factors t O
control t O
activity i O
of O O
the 	 O
prodynorphin d B-GENE
promoter m E-GENE
are 	 O
not 	 O
as O O
clearly a O
defined i O
. 
 O
Finally a O
, 
 O
antisense i O
mediated i O
reduction u O
of O O
Elk 	 B-GENE
- - I-GENE
1 - E-GENE
in O O
GH4 	 O
cells l O
decreased r O
insulin u S-GENE
- 
 O
increased r O
prolactin l B-GENE
gene e E-GENE
expression r O
and 	 O
confirmed f O
the 	 O
requirement u O
for 	 O
Elk 	 B-GENE
- - I-GENE
1 - E-GENE
for 	 O
insulin u S-GENE
- 
 O
increased r O
prolactin l B-GENE
gene e E-GENE
expression r O
. 
 O
Substitutions s O
of O O
Asp11 1 S-GENE
led 	 O
to O O
dominant i O
lethality h O
. 
 O
Three e O
modern e O
hematology a O
analyzers l O
( 
 O
Abbott o O
Cell l O
- 
 O
Dyn 	 O
3000 0 O
, 
 O
Coulter l O
STKS S O
, 
 O
and 	 O
Sysmex m O
NE O O
- 
 O
8000 0 O
) 
 O
with h O
high h O
throughput o O
and 	 O
5 
 O
- 
 O
part t O
differential f O
capability a O
were e O
evaluated l O
using n O
a 
 O
protocol t O
designed i O
by O O
a 
 O
quality l O
team m O
. 
 O
Each h O
subject j O
was 	 O
injected e O
in O O
the 	 O
antecubital e O
vein n O
with h O
7 
 O
mg O O
/ 
 O
kg O O
of O O
sodium i O
fluorescein o O
( 
 O
25 O O
% 
 O
solution u O
) 
 O
and 	 O
measurements s O
were e O
taken e O
1 
 O
hr O O
postinjection t O
at O O
4 
 O
. 
 O
5 
 O
mm O O
and 	 O
7 
 O
. 
 O
5 
 O
mm O O
from m O
the 	 O
retina i O
. 
 O
The 	 O
cleft f O
walls l O
are 	 O
lined e O
with h O
highly h O
conserved s O
residues i O
and 	 O
NADP P O
is O O
bound n O
along n O
one 	 O
wall l O
. 
 O
cDNA A O
cloning n O
, 
 O
sequencing u O
and 	 O
chromosome o O
mapping p O
of O O
a 
 O
non 	 O
- - O
erythroid t O
spectrin c S-GENE
, 
 O
human a B-GENE
alpha h I-GENE
- - I-GENE
fodrin r E-GENE
. 
 O
The 	 O
aromatic m B-GENE
hydrocarbon r I-GENE
receptor e E-GENE
( 
 O
AHR 	 S-GENE
) 
 O
is O O
a 
 O
ligand a O
- 
 O
activated i O
transcription n O
factor t O
that t O
regulates u O
the 	 O
expression r O
of O O
several e O
drug g O
- 
 O
metabolizing a O
enzymes y O
and 	 O
has 	 O
been n O
implicated l O
in O O
immunosuppression u O
, 
 O
teratogenesis a O
, 
 O
cell l O
- 
 O
specific c O
hyperplasia e O
, 
 O
and 	 O
certain t O
types e O
of O O
malignancies i O
and 	 O
toxicities i O
. 
 O
( 
 O
1996 6 O
) 
 O
J 
 O
. 
 O
To O O
define i O
the 	 O
molecular e O
mechanism h O
regulating u O
FGFR R B-GENE
- - I-GENE
1 - I-GENE
gene e E-GENE
expression r O
in O O
proliferating l O
myoblasts b O
and 	 O
post t O
- 
 O
mitotic o O
muscle c O
fibers e O
, 
 O
we O O
have e O
isolated l O
and 	 O
partially t O
characterized r O
the 	 O
avian a B-GENE
FGFR R I-GENE
- - I-GENE
1 - I-GENE
gene e I-GENE
promoter m E-GENE
. 
 O
Moreover e O
, 
 O
FACT T O
specifically c O
interacts e O
with h O
nucleosomes l O
and 	 O
histone t B-GENE
H2A 	 E-GENE
/ 
 O
H2B 	 S-GENE
dimers e O
, 
 O
indicating i O
that t O
it O O
may 	 O
work k O
by O O
promoting m O
nucleosome l O
disassembly a O
upon n O
transcription n O
. 
 O
Measures s O
of O O
sedation a O
, 
 O
BIS 	 O
, 
 O
deltaBIS t O
( 
 O
absolute o O
change n O
of O O
BIS 	 O
after e O
a 
 O
painful n O
stimulus m O
) 
 O
, 
 O
memory o O
, 
 O
and 	 O
drug g O
concentration c O
were e O
obtained a O
at O O
each h O
target g O
drug g O
concentration c O
. 
 O
ER O O
and 	 O
DR O O
were e O
significantly n O
correlated r O
with h O
MIB 	 O
- - O
1 - O
LI O O
( 
 O
P 
 O
< 
 O
0 
 O
. 
 O
01 O O
and 	 O
P 
 O
< 
 O
0 
 O
. 
 O
05 O O
, 
 O
respectively p O
) 
 O
, 
 O
but 	 O
RI O O
and 	 O
Td O O
/ 
 O
Te O O
were e O
not 	 O
. 
 O
Positive i O
linear e O
correlations r O
were e O
found n O
when n O
the 	 O
AUC 	 O
( 
 O
0 
 O
- 
 O
12 O O
) 
 O
( 
 O
r 
 O
= 
 O
0 
 O
. 
 O
68 O O
; 
 O
P 
 O
less s O
than n O
0 
 O
. 
 O
01 O O
) 
 O
, 
 O
the 	 O
maximum i O
plasma s O
concentration c O
( 
 O
r 
 O
= 
 O
0 
 O
. 
 O
34 O O
; 
 O
P 
 O
less s O
than n O
0 
 O
. 
 O
01 O O
) 
 O
, 
 O
the 	 O
minimum i O
plasma s O
concentration c O
( 
 O
r 
 O
= 
 O
0 
 O
. 
 O
55 O O
; 
 O
P 
 O
less s O
than n O
0 
 O
. 
 O
01 O O
) 
 O
, 
 O
and 	 O
the 	 O
elimination m O
t1 O O
/ 
 O
2 
 O
( 
 O
r 
 O
= 
 O
0 
 O
. 
 O
46 O O
; 
 O
P 
 O
less s O
than n O
0 
 O
. 
 O
01 O O
) 
 O
were e O
regressed r O
with h O
age 	 O
. 
 O
Psychophysical c O
evidence d O
is O O
given e O
for 	 O
the 	 O
existence s O
of O O
two 	 O
distinct t O
systems t O
in O O
human a O
vision i O
: 
 O
a 
 O
fast t O
, 
 O
sign n O
- 
 O
invariant a O
system t O
concerned c O
with h O
extracting r O
contours t O
and 	 O
a 
 O
slower w O
, 
 O
sign n O
- 
 O
sensitive s O
system t O
concerned c O
with h O
assigning i O
surface f O
color o O
. 
 O
Peripheral i O
visual u O
acuity i O
with h O
monovision o O
and 	 O
other e O
contact t O
lens s O
corrections r O
for 	 O
presbyopia s O
. 
 O
Fourteen r O
Centers t O
participated t O
in O O
this s O
trial a O
. 
 O
The 	 O
program g O
for 	 O
myogenic g O
differentiation f O
is O O
subject j O
to O O
negative a O
control t O
by O O
several e O
peptide t O
growth w O
factors t O
and 	 O
by O O
the 	 O
products d O
of O O
mutationally a O
activated i O
ras 	 B-GENE
oncogenes o E-GENE
, 
 O
which c O
persistently s O
activate i O
intracellular r O
cascades c O
normally m O
triggered g O
by O O
specific c O
growth w O
factors t O
. 
 O
Tetrazepam r O
: 
 O
a 
 O
benzodiazepine z O
which c O
dissociates s O
sedation a O
from m O
other e O
benzodiazepine z O
activities i O
. 
 O
The 	 O
difference f O
between w O
the 	 O
effects e O
of O O
the 	 O
two 	 O
dose e O
levels e O
of O O
Z 
 O
. 
 O
Mutation a O
of O O
the 	 O
distal t O
E2F 	 B-GENE
binding d I-GENE
site e E-GENE
in O O
the 	 O
cdc25A 2 B-GENE
promoter m E-GENE
abolished l O
E2 S O
- 
 O
induced u O
repression r O
, 
 O
whereas r O
mutation a O
of O O
the 	 O
proximal x O
E2F 	 B-GENE
site e E-GENE
or O O
the 	 O
E2 B B-GENE
site e E-GENE
had 	 O
no O O
effect e O
. 
 O
Plasmid s O
pNK21 2 O
, 
 O
in O O
which c O
2 
 O
. 
 O
05 O O
- 
 O
kb O O
sequence u O
covering e O
the 	 O
region i O
encoding o O
the 	 O
nitrilase r S-GENE
was 	 O
was 	 O
placed c O
under e O
the 	 O
control t O
of O O
the 	 O
lac 	 B-GENE
promoter m E-GENE
, 
 O
directed e O
overproduction r O
of O O
enzymatically y O
active i O
nitrilase r S-GENE
in O O
response p O
to O O
addition i O
of O O
isopropyl p O
beta a O
- 
 O
D 
 O
- 
 O
thiogalactopyranoside o O
in O O
Escherichia h O
coli i O
. 
 O
A 
 O
method h O
for 	 O
determining e O
the 	 O
toxicity i O
of O O
neutralizers t O
for 	 O
antimicrobial i O
agents n O
to O O
A 
 O
. 
 O
castellanii t O
was 	 O
also o O
evaluated l O
. 
 O
Expression r O
in O O
all 	 O
lines e O
was 	 O
decreased r O
by O O
the 	 O
inclusion l O
of O O
regions i O
further t O
upstream t O
, 
 O
and 	 O
extinguished i O
by O O
the 	 O
inclusion l O
of O O
the 	 O
first s O
intron r O
. 
 O
Static t O
and 	 O
dynamic a O
MRI 	 O
of O O
the 	 O
normal m O
and 	 O
pathological h O
female a O
pelvic v O
floor o O
IENF F S-GENE
density s O
at O O
the 	 O
calf f O
was 	 O
lower e O
than n O
that t O
obtained a O
from m O
skin n O
at O O
more e O
proximal x O
sites e O
, 
 O
indicating i O
the 	 O
length g O
dependency e O
of O O
small l O
- 
 O
fiber e O
loss s O
in O O
these s O
neuropathies r O
. 
 O
These s O
results u O
demonstrate o O
a 
 O
specific c O
association o O
of O O
SIV 	 S-GENE
and 	 O
HIV 	 B-GENE
- - I-GENE
2 - I-GENE
nef 	 E-GENE
, 
 O
but 	 O
not 	 O
HIV 	 B-GENE
- - I-GENE
1 - I-GENE
nef 	 E-GENE
, 
 O
with h O
TCRzeta z S-GENE
. 
 O
Insertion e O
of O O
alternatively e O
spliced i O
exon n O
W 
 O
into o O
CREB B B-GENE
mRNA A E-GENE
during i O
spermatogenesis r O
results u O
in O O
a 
 O
polycistronic y O
RNA 	 O
that t O
encodes o O
two 	 O
novel e O
internally e O
translated n O
CREB B B-GENE
repressor r I-GENE
isoforms f E-GENE
called l O
I - B-GENE
- - I-GENE
CREBs B E-GENE
, 
 O
consisting s O
of O O
the 	 O
carboxy b O
- 
 O
terminal m O
DNA 	 O
- 
 O
binding d O
domain a O
devoid o O
of O O
the 	 O
transactivation n O
domains a O
. 
 O
A 
 O
continuous t O
- 
 O
flow w O
BIPAP A O
system t O
consists s O
of O O
a 
 O
high h O
- 
 O
flow w O
CPAP P O
system t O
, 
 O
a 
 O
reservoir e O
bag 	 O
, 
 O
and 	 O
a 
 O
pneumatically u O
controlled t O
membrane b O
valve v O
in O O
the 	 O
expiratory i O
limb b O
. 
 O
Older e O
females a O
had 	 O
lumbar b O
( 
 O
0 
 O
. 
 O
6 
 O
+ 
 O
/ 
 O
- 
 O
1 
 O
. 
 O
3 
 O
) 
 O
and 	 O
TB O O
( 
 O
1 
 O
. 
 O
1 
 O
+ 
 O
/ 
 O
- 
 O
1 
 O
. 
 O
1 
 O
) 
 O
BMD 	 O
Z 
 O
scores r O
greater a O
than n O
0 
 O
( 
 O
both h O
, 
 O
p 
 O
< 
 O
0 
 O
. 
 O
001 	 O
) 
 O
. 
 O
Smooth o O
pursuit s O
gain n O
and 	 O
the 	 O
percentage c O
of O O
total a O
eye 	 O
movement e O
due 	 O
to O O
various i O
saccadic c O
subtypes t O
were e O
computed p O
using n O
infrared r O
oculography l O
and 	 O
computerized p O
pattern t O
recognition o O
software t O
. 
 O
Upon n O
incubation u O
of O O
the 	 O
most t O
highly h O
purified i O
fractions c O
with h O
Mn O O
- 
 O
ATP 	 O
or O O
Mg O O
- 
 O
ATP 	 O
, 
 O
p40 	 S-GENE
was 	 O
the 	 O
only y O
protein t O
phosphorylated s O
on O O
tyrosine o O
. 
 O
Consistent s O
with h O
this s O
hypothesis o O
, 
 O
alpha1 h B-GENE
- - I-GENE
PDX 	 E-GENE
prevents v O
cleavage a O
of O O
BMP 	 B-GENE
- - I-GENE
4 - E-GENE
in O O
an O O
oocyte y O
translation n O
assay a O
. 
 O
A 
 O
p53 	 B-GENE
cDNA A I-GENE
deletion e I-GENE
mutant a E-GENE
( 
 O
delta t B-GENE
pro 	 I-GENE
AE O E-GENE
) 
 O
, 
 O
which c O
lacks k O
this s O
entire i O
proline l O
- 
 O
rich h O
domain a O
( 
 O
deleted e O
for 	 O
amino n O
acids d O
62 O O
- 
 O
91 O O
) 
 O
, 
 O
was 	 O
created a O
and 	 O
characterized r O
for 	 O
a 
 O
variety i O
of O O
p53 	 S-GENE
functions c O
. 
 O
Multiple t O
aortic t O
thrombi o O
associated o O
with h O
protein t B-GENE
C - I-GENE
and 	 I-GENE
S - E-GENE
deficiency i O
. 
 O
Our 	 O
results u O
suggest g O
that t O
Bry1 1 S-GENE
/ 
 O
Skn7 7 S-GENE
can 	 O
influence l O
the 	 O
expression r O
of O O
MCB 	 B-GENE
- 
 I-GENE
and 	 I-GENE
SCB 	 I-GENE
- 
 I-GENE
driven v I-GENE
gene e E-GENE
expression r O
in O O
budding d O
yeast s O
, 
 O
perhaps h O
including l O
genes e O
involved o O
in O O
cell l O
wall l O
metabolism a O
, 
 O
via 	 O
a 
 O
two 	 O
- 
 O
component p O
signal n O
transduction n O
pathway h O
which c O
activates i O
Bry1 1 S-GENE
/ 
 O
Skn7 7 S-GENE
in O O
response p O
to O O
an O O
unidentified d O
signal n O
. 
 O
( 
 O
1992 2 O
) 
 O
J 
 O
. 
 O
A 
 O
constructed s O
phylogenetic l O
tree e O
suggests g O
that t O
the 	 O
UbcP1 P B-GENE
protein t E-GENE
may 	 O
represent r O
a 
 O
member b O
of O O
a 
 O
distinct t O
subfamily f O
of O O
E2s 	 S-GENE
. 
 O
Platelet t B-GENE
factor t I-GENE
4 - E-GENE
levels e O
in O O
patients i O
with h O
coronary o O
artery e O
disease e O
. 
 O
We O O
functionally c O
characterised r O
AtXPO1 P S-GENE
by O O
its 	 O
interaction e O
with h O
NESs s O
of O O
animal m O
and 	 O
plant n O
proteins t O
, 
 O
which c O
is O O
inhibited i O
by O O
the 	 O
cytotoxin o B-GENE
leptomycin t I-GENE
B 
 E-GENE
( 
 O
LMB 	 S-GENE
) 
 O
, 
 O
and 	 O
also o O
by O O
its 	 O
interaction e O
with h O
the 	 O
small l B-GENE
GTPase a I-GENE
Ran1 1 E-GENE
in O O
the 	 O
yeast s O
two 	 O
- 
 O
hybrid r O
system t O
. 
 O
A 
 O
backward k O
look k O
at O O
urinary n O
tract c O
infections e O
. 
 O
The 	 O
expression r O
of O O
cor14b 1 S-GENE
was 	 O
strongly o O
impaired a O
in O O
the 	 O
barley l O
albino i O
mutant a O
an O O
, 
 O
suggesting g O
the 	 O
involvement o O
of O O
a 
 O
plastidial s O
factor t O
in O O
the 	 O
control t O
of O O
gene e O
expression r O
. 
 O
MRS 	 O
allowed o O
the 	 O
differentiation f O
of O O
the 	 O
following l O
metabolites a O
in O O
5 
 O
patients i O
: 
 O
N 
 O
- 
 O
acetyl t O
- 
 O
aspartate a O
( 
 O
NAA 	 O
) 
 O
, 
 O
creatine a O
and 	 O
phosphocreatine s O
, 
 O
phosphorylcholine s O
and 	 O
glycerophosphorylcholine c O
, 
 O
beta a O
- 
 O
and 	 O
gamma m O
- 
 O
glutamate t O
( 
 O
GLU 	 O
) 
 O
. 
 O
Overall r O
, 
 O
free e O
- 
 O
chlorine o O
treatments a O
( 
 O
0 
 O
. 
 O
3 
 O
or O O
1 
 O
. 
 O
0 
 O
mg O O
/ 
 O
L 
 O
) 
 O
showed w O
significantly n O
lower e O
heterotrophic e O
plate t O
numbers b O
than n O
those s O
without h O
free e O
chlorine o O
. 
 O
S1 B B-GENE
nuclease l E-GENE
protection t O
mapping p O
and 	 O
primer m O
extension e O
analysis l O
allowed o O
us O O
to O O
propose p O
that t O
the 	 O
A 
 O
residue i O
located a O
19 O O
bp O O
upstream t O
from m O
the 	 O
translation n O
initiation t O
codon o O
is O O
the 	 O
site e O
of O O
transcription n O
initiation t O
. 
 O
Various i O
stimuli m O
inactivate c O
IkappaB p B-GENE
alpha h E-GENE
by O O
triggering g O
phosphorylation s O
of O O
the 	 O
N 
 O
- 
 O
terminal m O
residues i O
Ser32 3 O
and 	 O
Ser36 3 O
. 
 O
There r O
was 	 O
no O O
difference f O
in O O
the 	 O
day 	 O
- 
 O
42 O O
cure e O
rates e O
between w O
the 	 O
QC7 	 O
( 
 O
n 
 O
= 
 O
65 O O
) 
 O
and 	 O
A7 O O
( 
 O
n 
 O
= 
 O
64 O O
) 
 O
regimens i O
with h O
an O O
efficacy i O
of O O
100 	 O
% 
 O
in O O
both h O
, 
 O
confirmed f O
by O O
parasite a O
genotyping o O
. 
 O
In O O
addition i O
, 
 O
the 	 O
results u O
suggest g O
that t O
N 
 O
region i O
diversity e O
at O O
V - O
( 
 O
D - O
) 
 O
J - O
junctions c O
within h O
rearranged r O
immunoglobulin u S-GENE
and 	 O
T - B-GENE
cell l I-GENE
receptor e I-GENE
gene e I-GENE
loci i E-GENE
can 	 O
only y O
be O O
introduced r O
after e O
the 	 O
generation e O
of O O
RAG 	 O
- 
 O
catalyzed a O
DNA 	 O
double b O
- 
 O
strand a O
breaks a O
, 
 O
i 
 O
. 
 O
e 
 O
. 
 O
during i O
the 	 O
DNA 	 O
end 	 O
joining n O
phase s O
of O O
the 	 O
V - O
( 
 O
D - O
) 
 O
J - O
recombination o O
reaction c O
. 
 O
We O O
conclude c O
that t O
99mTc T O
- 
 O
HL91 1 O
is O O
a 
 O
potent e O
marker k O
of O O
myocardial c O
viability b O
when n O
used d O
during i O
the 	 O
early l O
acute t O
phase s O
after e O
reperfusion e O
. 
 O
Three e O
patients i O
treated a O
with h O
amphotericin h O
B 
 O
, 
 O
single g O
course r O
as O O
well l O
as O O
multiple t O
courses r O
, 
 O
and 	 O
other e O
antifungal i O
agents n O
( 
 O
hydroxystilbamidine r O
and 	 O
miconazole o O
) 
 O
have e O
all 	 O
relapsed a O
. 
 O
An O O
infant a O
of O O
8 
 O
months t O
with h O
congenital g O
glaucoma u O
and 	 O
hemophilia o O
A 
 O
lost t O
one 	 O
eye 	 O
due 	 O
to O O
haemorrhages m O
after e O
trabeculotomy b O
in O O
an O O
eye 	 O
hospital p O
. 
 O
Anderson e O
Hospital p O
and 	 O
Tumor o O
Institute t O
at O O
Houston s O
during i O
a 
 O
30 O O
- 
 O
year r O
interval e O
( 
 O
1944 4 O
to O O
1974 4 O
) 
 O
, 
 O
with h O
a 
 O
minimum i O
of O O
ten 	 O
years r O
of O O
follow l O
- 
 O
up O O
, 
 O
we O O
determined e O
that t O
the 	 O
major o O
prognostic g O
factor t O
of O O
survival v O
was 	 O
the 	 O
number b O
of O O
positive i O
nodes e O
. 
 O
We O O
have e O
now 	 O
isolated l O
cDNA A O
for 	 O
an O O
invertebrate e O
Pax 	 B-GENE
- - I-GENE
6 - I-GENE
protein t E-GENE
from m O
sea 	 O
urchin h O
embryos r O
. 
 O
To O O
study d O
structural u O
diversity e O
of O O
the 	 O
three e O
homologous o O
loci i O
encoding o O
a 
 O
KN1 	 B-GENE
- - I-GENE
like e I-GENE
homeobox e I-GENE
protein t E-GENE
in O O
the 	 O
hexaploid a O
wheat a O
genome o O
, 
 O
we O O
isolated l O
clones n O
from m O
a 
 O
cDNA A O
library r O
of O O
young n O
spikes k O
of O O
Japanese a O
common m O
wheat a O
cultivar t O
' 
 O
Norin i O
26 O O
' 
 O
. 
 O
Whether t O
or O O
not 	 O
these s O
novel e O
repeated e O
sequences u O
throughout o O
the 	 O
SMA 	 B-GENE
region i E-GENE
are 	 O
involved o O
in O O
the 	 O
disease e O
remains a O
to O O
be O O
determined e O
. 
 O
Thus s O
, 
 O
Shp2 2 S-GENE
regulates u O
phosphotyrosine s O
- 
 O
signalling n O
events n O
during i O
the 	 O
complex p O
ectodermal o O
- 
 O
mesenchymal e O
interactions e O
that t O
regulate u O
mammalian m O
budding d O
morphogenesis p O
. 
 O
Moyamoya a O
is O O
an O O
intriguing r O
and 	 O
controversial t O
syndrome d O
. 
 O
However e O
, 
 O
elimination m O
of O O
the 	 O
kinase a O
activity i O
of O O
DCAMKL1 M S-GENE
has 	 O
no O O
detectable e O
effect e O
on O O
its 	 O
microtubule r O
polymerization y O
activity i O
. 
 O
We O O
have e O
thus s O
cloned n O
two 	 O
yeast s O
homologs o O
of O O
mammalian m B-GENE
p220 0 E-GENE
. 
 O
The 	 O
glucose c O
effect e O
on O O
the 	 O
pyruvate u B-GENE
kinase a I-GENE
gene e E-GENE
is O O
reversibly e O
antagonized a O
by O O
agents n O
increasing r O
intracellular r O
cAMP P O
. 
 O
An O O
identical n O
polypeptide y O
was 	 O
detected e O
by O O
Western t O
blot t O
analysis l O
of O O
K1F 	 B-GENE
virions i E-GENE
. 
 O
Patients i O
with h O
PLM 	 O
show w O
excessive e O
daytime t O
sleepiness e O
or O O
insomnia o O
. 
 O
Coexpression x O
of O O
CREB B B-GENE
- - I-GENE
binding d I-GENE
protein t E-GENE
( 
 O
CBP 	 S-GENE
) 
 O
/ 
 O
p300 0 S-GENE
with h O
TReP P B-GENE
- - I-GENE
132 	 E-GENE
has 	 O
an O O
additive i O
effect e O
on O O
promoter m O
activity i O
, 
 O
and 	 O
the 	 O
proteins t O
were e O
demonstrated o O
to O O
interact e O
physically s O
. 
 O
It O O
is O O
believed i O
that t O
the 	 O
operation r O
is O O
effective e O
because a O
it O O
cuts s O
the 	 O
spinothalamic n O
tract c O
( 
 O
STT 	 O
) 
 O
, 
 O
a 
 O
primary m O
pathway h O
carrying r O
nociceptive i O
information o O
from m O
the 	 O
spinal n O
cord d O
to O O
the 	 O
brain i O
in O O
humans a O
. 
 O
Catalase a S-GENE
plays y O
a 
 O
key 	 O
role e O
as O O
an O O
antioxidant i O
, 
 O
protecting t O
aerobic o O
organisms a O
from m O
the 	 O
toxic i O
effects e O
of O O
hydrogen r O
peroxide o O
, 
 O
and 	 O
in O O
some e O
cases e O
has 	 O
been n O
postulated t O
to O O
be O O
a 
 O
virulence u O
factor t O
. 
 O
Recovery o O
rates e O
of O O
energy r O
level e O
and 	 O
intracellular r O
pH O O
during i O
stimulation m O
at O O
100Hz H O
were e O
greater a O
than n O
those s O
observed e O
during i O
stimulation m O
at O O
30Hz z O
. 
 O
Exhaled a O
NO O O
was 	 O
assessed e O
by O O
controlled t O
- 
 O
flow w O
chemoluminescence m O
after e O
adjusting u O
for 	 O
trapped p O
air 	 O
and 	 O
after e O
generating e O
pressure s O
in O O
the 	 O
oral l O
cavity i O
that t O
was 	 O
sufficient f O
to O O
close s O
the 	 O
soft t O
palate a O
( 
 O
Eco 	 O
Physics s O
CLD 	 O
77 O O
AM O O
analyzer l O
) 
 O
. 
 O
Recent e O
developments e O
in O O
the 	 O
study d O
of O O
growth w O
factors t O
: 
 O
GRF 	 S-GENE
and 	 O
somatomedins a S-GENE
. 
 O
New 	 O
concepts c O
of O O
condyloma d O
acuminata m O
in O O
children l O
. 
 O
This s O
is O O
the 	 O
first s O
clinical n O
case e O
report o O
of O O
NIHF F O
due 	 O
to O O
fetal a O
Kasabach a O
- 
 O
Merritt r O
syndrome d O
that t O
was 	 O
prenatally n O
diagnosed g O
by O O
sonography o O
, 
 O
computerized p O
tomography o O
, 
 O
and 	 O
percutaneous c O
umbilical i O
blood o O
sampling p O
. 
 O
Acetoacetate t B-GENE
decarboxylase a E-GENE
( 
 O
ADC 	 S-GENE
) 
 O
( 
 O
EC4 	 B-GENE
. - I-GENE
1 - I-GENE
. - I-GENE
1 - I-GENE
. - I-GENE
4 - E-GENE
) 
 O
of O O
Clostridium s O
acetobutylicum t O
DSM 	 O
792 	 O
was 	 O
purified i O
to O O
homogeneity o O
, 
 O
and 	 O
its 	 O
first s O
25 O O
N 
 O
- 
 O
terminal m O
amino n O
acids d O
were e O
determined e O
. 
 O
Transfer n O
of O O
health l O
care e O
to O O
natives i O
holds d O
much h O
promise m O
, 
 O
lecturers t O
say 	 O
. 
 O
The 	 O
sequence u O
of O O
the 	 O
127 	 O
residue i O
NrfF F B-GENE
polypeptide y E-GENE
, - O
M - O
( - O
r - O
) - O
14 I O
, - O
522 	 O
, 
 O
is O O
strikingly i O
similar i O
to O O
the 	 O
CcI2 2 B-GENE
protein t E-GENE
of O O
R 
 O
. 
 O
capsulatus s O
, 
 O
especially e O
in O O
the 	 O
putative a O
haem m O
- 
 O
binding d O
motif i O
, 
 O
RCPQCQNQN Q O
. 
 O
( 
 O
ABSTRACT T O
TRUNCATED N O
AT O O
400 	 O
WORDS D O
) 
 O
CAT 	 S-GENE
assays a O
demonstrated o O
that t O
overexpression r O
of O O
RXRalpha a S-GENE
conferred f O
the 	 O
best t O
RA O O
response p O
, 
 O
consistent s O
with h O
our 	 O
previous v O
observation e O
that t O
9 
 B-GENE
- 
 I-GENE
cis 	 I-GENE
- 
 I-GENE
RA O E-GENE
is O O
more e O
potent e O
than n O
all 	 O
- 
 O
trans n O
- 
 O
RA O O
for 	 O
inducing u O
the 	 O
expression r O
of O O
the 	 O
AFP 	 B-GENE
gene e E-GENE
. 
 O
For 	 O
rotating a O
stimuli m O
presented s O
to O O
the 	 O
dominant i O
eye 	 O
, 
 O
this s O
class s O
of O O
neurons r O
responded p O
best t O
to O O
rotation a O
of O O
the 	 O
visual u O
world l O
about u O
an O O
axis s O
oriented e O
near r O
the 	 O
horizontal i O
plane n O
and 	 O
approximately r O
45 O O
degrees r O
azimuth m O
. 
 O
None e O
of O O
these s O
patients i O
developed e O
clinical n O
events n O
before o O
disappearance a O
of O O
the 	 O
phospholipid s O
- 
 O
dependent e O
inhibitors i O
of O O
coagulation g O
. 
 O
In O O
spite t O
of O O
the 	 O
variability i O
of O O
DD95 5 O
with h O
regard a O
to O O
body y O
weight g O
, 
 O
the 	 O
recovery o O
of O O
neuromuscular r O
transmission n O
in O O
the 	 O
patients i O
of O O
the 	 O
three e O
groups u O
is O O
comparable p O
. 
 O
We O O
have e O
studied d O
some e O
of O O
the 	 O
parameters a O
governing e O
the 	 O
expression r O
of O O
a 
 O
foreign e O
promoter m O
- 
 O
reporter o O
gene e O
construct s O
incorporated o O
into o O
herpes p O
simplex p O
virus u O
( 
 O
HSV 	 O
) 
 O
type e O
1 
 O
. 
 O
Relation a O
between w O
clinical n O
and 	 O
roentgenological n O
scores r O
and 	 O
measures s O
of O O
lung g O
function c O
in O O
cystic t O
fibrosis r O
, 
 O
with h O
special c O
reference e O
to O O
pulmonary m O
Xenon133 o O
elimination m O
. 
 O
Each h O
fusion i O
leads d O
, 
 O
in O O
principle n O
, 
 O
to O O
the 	 O
same e O
effect e O
: 
 O
The 	 O
ret 	 B-GENE
tyrosine o I-GENE
kinase a E-GENE
is O O
uncoupled o O
from m O
its 	 O
stringent i O
physiological s O
regulation u O
by O O
replacement l O
of O O
its 	 O
5 
 O
' 
 O
end 	 O
and 	 O
is O O
aberrantly r O
activated i O
by O O
the 	 O
5 
 O
' 
 O
parts t O
of O O
fused e O
genes e O
in O O
thyrocytes r O
that t O
do O O
not 	 O
normally m O
express r O
ret 	 B-GENE
tyrosine o I-GENE
kinase a E-GENE
. 
 O
He O O
had 	 O
complained p O
of O O
fever e O
and 	 O
right h O
hypochondralgia o O
2 
 O
months t O
after e O
being n O
operated r O
for 	 O
appendicitis e O
. 
 O
In O O
the 	 O
predicted d O
amino n O
acid d O
sequence u O
of O O
NPS1 1 S-GENE
, 
 O
sequences u O
homologous o O
to O O
the 	 O
catalytic a O
domain a O
of O O
protein t O
kinases a O
were e O
found n O
. 
 O
Carcinoma c O
- - O
related a O
protein t O
production d O
may 	 O
have e O
played y O
a 
 O
role e O
in O O
the 	 O
development e O
of O O
the 	 O
observed e O
renal a O
lesions i O
. 
 O
These s O
results u O
provide v O
strong o O
evidence d O
that t O
conserved s O
interhelical e O
packing k O
interactions e O
in O O
the 	 O
gp41 1 B-GENE
core e E-GENE
are 	 O
important o O
determinants e O
of O O
HIV 	 O
- 
 O
1 
 O
entry r O
and 	 O
its 	 O
inhibition i O
. 
 O
Lag 	 O
phases s O
were e O
14 O O
. 
 O
89 O O
hours r O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
77 O O
, 
 O
13 O O
. 
 O
33 O O
hours r O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
50 O O
, 
 O
20 O O
. 
 O
22 O O
hours r O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
76 O O
, 
 O
and 	 O
20 O O
. 
 O
00 O O
hours r O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
79 O O
, 
 O
respectively p O
, 
 O
for 	 O
endothelial o O
cell l O
- 
 O
induced u O
LDL 	 S-GENE
oxidation d O
. 
 O
Forty t O
- 
 O
eight h O
pregnant g O
adult l O
and 	 O
122 	 O
fetal a O
guinea n O
pigs s O
were e O
sacrificed r O
at O O
intervals e O
throughout o O
gestation t O
and 	 O
the 	 O
carcasses c O
analyzed l O
for 	 O
a 
 O
variety i O
of O O
growth w O
parameters a O
. 
 O
Here e O
we O O
demonstrate o O
the 	 O
ability l O
of O O
oligonucleotides g O
containing t O
the 	 O
C4T 	 O
sequence u O
to O O
confer f O
heat t O
shock c O
inducibility u O
on O O
the 	 O
reporter o O
gene e O
and 	 O
show w O
that t O
the 	 O
presence s O
of O O
two 	 O
such h O
elements m O
produces d O
more e O
than n O
additive i O
effects e O
on O O
induction u O
. 
 O
The 	 O
HPV 	 B-GENE
E1 S E-GENE
and 	 O
E2 S B-GENE
proteins t E-GENE
along n O
with h O
cellular l O
factors t O
, 
 O
are 	 O
required u O
for 	 O
replication l O
of O O
the 	 O
viral a O
genome o O
. 
 O
The 	 O
observed e O
alterations e O
in O O
lung g O
functions c O
in O O
these s O
subjects j O
indicate i O
that t O
individuals i O
performing f O
heavy v O
continuous t O
exercise r O
are 	 O
more e O
likely e O
to O O
be O O
affected e O
by O O
lower e O
O3 O O
levels e O
. 
 O
In O O
ten 	 O
other e O
endotoxin o B-GENE
- 
 I-GENE
albumin u E-GENE
- 
 O
treated a O
pigs s O
PGE1 1 S-GENE
infusion u O
( 
 O
0 
 O
. 
 O
25 O O
micrograms r O
X 
 O
kg O O
- 
 O
1 
 O
X 
 O
min 	 O
- 
 O
1 
 O
) 
 O
was 	 O
begun u O
after e O
established a O
pulmonary m O
and 	 O
cardiovascular d O
dysfunction f O
, 
 O
for 	 O
closer s O
mimicking i O
of O O
clinical n O
use 	 O
. 
 O
The 	 O
main n O
new 	 O
features t O
of O O
this s O
version s O
are 	 O
that t O
end 	 O
- 
 O
tidal a O
PO2 	 O
instead t O
of O O
inspiratory p O
PO2 	 O
can 	 O
be O O
kept t O
constant s O
, 
 O
and 	 O
that t O
the 	 O
correcting r O
activity i O
of O O
both h O
controllers t O
( 
 O
capnostat n O
and 	 O
oxystat s O
) 
 O
is O O
proportional p O
to O O
the 	 O
magnitude n O
of O O
the 	 O
difference f O
between w O
the 	 O
actual u O
and 	 O
the 	 O
adjusted u O
end 	 O
- 
 O
tidal a O
PCO2 2 O
or O O
PO2 	 O
. 
 O
Like e O
the 	 O
human a B-GENE
erythrocyte t I-GENE
P4 I I-GENE
. - I-GENE
2 - E-GENE
, 
 O
mouse s B-GENE
erythrocyte t I-GENE
P4 I I-GENE
. - I-GENE
2 - E-GENE
contains t O
regions i O
strikingly i O
homologous o O
with h O
the 	 O
transglutaminase n S-GENE
( 
 O
TGase s S-GENE
) 
 O
proteins t O
although h O
it O O
too 	 O
most t O
likely e O
lacks k O
TGase s S-GENE
crosslinking s O
activity i O
. 
 O
It O O
spans n O
20 O O
kilobases o O
, 
 O
consists s O
of O O
7 
 O
exons n O
and 	 O
6 
 O
introns r O
, 
 O
and 	 O
contains t O
a 
 O
TATA A O
motif i O
24 O O
nucleotides l O
upstream t O
of O O
the 	 O
transcriptional n O
start r O
site e O
. 
 O
Nine e O
months t O
after e O
the 	 O
end 	 O
of O O
the 	 O
vaccination c O
anti i B-GENE
- - I-GENE
HBsAg A E-GENE
levels e O
had 	 O
dropped p O
to O O
9 
 O
+ 
 O
/ 
 O
- 
 O
4 
 O
IU O O
/ 
 O
1 
 O
( 
 O
M 
 O
+ 
 O
/ 
 O
- 
 O
SE O O
) 
 O
, 
 O
with h O
a 
 O
geometric m O
mean n O
of O O
5 
 O
IU O O
/ 
 O
1 
 O
, 
 O
in O O
the 	 O
nine e O
remaining a O
evaluable l O
patients i O
. 
 O
CONCLUSION C O
: 
 O
Ultrasound r O
biomicroscopy m O
is O O
a 
 O
useful f O
tool l O
for 	 O
the 	 O
evaluation l O
of O O
APVR R O
, 
 O
which c O
is O O
difficult f O
by O O
ordinary i O
methods h O
. 
 O
It O O
is O O
postulated t O
that t O
the 	 O
synthesis t O
of O O
the 	 O
peptidoglycan t O
layer e O
was 	 O
affected e O
by O O
the 	 O
antimetabolites i O
since c O
the 	 O
morphological p O
effects e O
were e O
strikingly i O
similar i O
to O O
those s O
caused s O
by O O
treatment a O
of O O
E 
 O
. 
 O
cloacae a O
with h O
disodium o O
edetate t O
plus s O
lysozyme o O
. 
 O
DRAP27 P S-GENE
is O O
recognized o O
by O O
CD9 	 B-GENE
antibodies i E-GENE
. 
 O
Furthermore t O
we O O
elucidate c O
the 	 O
subtle t O
highly h O
anisotropic s O
interchain e S-GENE
correlations r O
and 	 O
reveal e O
the 	 O
detailed a O
atomic m O
structure u O
of O O
the 	 O
low 	 O
- 
 O
temperature p O
( 
 O
8x2 	 O
) 
 O
phase s O
. 
 O
Control t O
oligomers g O
of O O
scrambled a O
sequence u O
but 	 O
identical n O
base e O
composition p O
were e O
ineffective f O
, 
 O
and 	 O
no O O
TFO 	 O
- 
 O
induced u O
recombination o O
was 	 O
seen n O
in O O
a 
 O
control t O
LTK 	 O
( 
 O
- 
 O
) 
 O
cell l O
line e O
carrying r O
an O O
otherwise e O
identical n O
dual l O
TK B B-GENE
gene e E-GENE
construct s O
lacking k O
the 	 O
30 O O
- 
 O
bp O O
polypurine y O
target g O
site e O
. 
 O
To O O
quantify n O
the 	 O
normal m O
coupling p O
patterns t O
, 
 O
fresh s O
cadaveric a O
human a O
lumbar b O
spine n O
specimens c O
( 
 O
L1 O O
- 
 O
S1 O O
) 
 O
were e O
used d O
. 
 O
One 	 O
cytoplasmic o O
target g O
which c O
reflects l O
the 	 O
functional c O
state t O
of O O
the 	 O
plastids s O
is O O
protein t B-GENE
kinase a I-GENE
C - E-GENE
. 
 O
These s O
three e O
chromosomes o O
share r O
the 	 O
transferrin n B-GENE
gene e E-GENE
( 
 O
TF S S-GENE
) 
 O
, 
 O
the 	 O
myosin s B-GENE
light h I-GENE
polypeptide y I-GENE
3 - I-GENE
gene e E-GENE
( 
 O
MYL3 3 S-GENE
) 
 O
, 
 O
and 	 O
the 	 O
acylpeptide l B-GENE
hydrolase r I-GENE
gene e E-GENE
( 
 O
APEH H S-GENE
) 
 O
. 
 O
( 
 O
i 
 O
) 
 O
Several e O
ribosomal o O
proteins t O
were e O
synthesized t O
in O O
substantial s O
excess e O
. 
 O
This s O
experience e O
would l O
recommend o O
consideration s O
of O O
home e O
nutritional r O
support p O
in O O
patients i O
with h O
systemic t O
scleroderma e O
when n O
the 	 O
disease e O
is O O
relatively a O
stable b O
and 	 O
no O O
major o O
organ a O
failure l O
is O O
present s O
. 
 O
Based e O
on O O
our 	 O
sequence u O
data a O
, 
 O
ORF2 2 S-GENE
from m O
most t O
isolates l O
excluding l O
G1 O O
encode o O
truncated n O
49 O O
aa O O
( 
 O
pORF2a F S-GENE
) 
 O
because a O
of O O
an O O
in O O
- 
 O
frame m O
stop p O
codon o O
, 
 O
although h O
ORF2s 2 S-GENE
from m O
most t O
G1 O O
isolates l O
encode o O
202 	 O
aa O O
( 
 O
pORF2ab F S-GENE
) 
 O
. 
 O
In O O
the 	 O
present s O
study d O
we O O
prospectively s O
compared p O
side e O
effects e O
occurring u O
in O O
12 O O
patients i O
after e O
the 	 O
first s O
administration i O
of O O
low 	 O
- 
 O
dose e O
OKT3 3 O
( 
 O
0 
 O
. 
 O
5 
 O
mg O O
twice c O
daily l O
) 
 O
induction u O
therapy r O
with h O
those s O
in O O
10 O O
patients i O
who 	 O
were e O
treated a O
with h O
a 
 O
conventional v O
dose e O
of O O
OKT3 3 O
( 
 O
5 
 O
mg O O
daily l O
) 
 O
for 	 O
acute t O
rejection e O
. 
 O
These s O
data a O
indicate i O
that t O
SB O O
203580 5 O
sensitive s O
p38 	 B-GENE
MAP 	 I-GENE
kinases a E-GENE
are 	 O
not 	 O
involved o O
in O O
okadaic d O
acid d O
mediated i O
increases r O
in O O
TRE 	 O
DNA 	 O
binding d O
and 	 O
transactivation n O
. 
 O
Together e O
, 
 O
these s O
results u O
indicate i O
that t O
YTS1 1 S-GENE
is O O
a 
 O
bifunctional u O
protein t O
active i O
in O O
both h O
splicing i O
and 	 O
protein t O
synthesis t O
. 
 O
Oscillatory i O
flow w O
is O O
reestablished s O
in O O
the 	 O
model e O
at O O
the 	 O
capillary i O
- 
 O
cerebrospinal e O
fluid i O
and 	 O
capillary i O
- 
 O
venous o O
interfaces e O
. 
 O
Sgs 	 B-GENE
- - I-GENE
4 - E-GENE
is O O
one 	 O
of O O
the 	 O
eight h O
known w O
genes e O
coding i O
for 	 O
larval v O
secretion r O
proteins t O
in O O
Drosophila s O
melanogaster a O
. 
 O
We O O
conclude c O
that t O
although h O
the 	 O
G3 O B-GENE
sequence u E-GENE
contains t O
two 	 O
protein t O
- 
 O
binding d O
motifs i O
, 
 O
the 	 O
organization a O
of O O
the 	 O
G3 O B-GENE
enhancer a I-GENE
- 
 I-GENE
like e I-GENE
element m E-GENE
is O O
not 	 O
bipartite a O
. 
 O
Human a B-GENE
myotonic t I-GENE
dystrophy t I-GENE
protein t I-GENE
kinase a E-GENE
( 
 O
DMPK K S-GENE
) 
 O
is O O
a 
 O
member b O
of O O
a 
 O
novel e O
class s O
of O O
multidomain t B-GENE
protein t I-GENE
kinases a E-GENE
that t O
regulate u O
cell l O
size e O
and 	 O
shape p O
in O O
a 
 O
variety i O
of O O
organisms a O
. 
 O
The 	 O
human a B-GENE
BRCA1 A I-GENE
promoter m E-GENE
also o O
contains t O
a 
 O
conserved s O
E2F 	 B-GENE
site e E-GENE
and 	 O
is O O
similarly i O
regulated u O
by O O
E2F1 1 S-GENE
and 	 O
Rb S S-GENE
. 
 O
The 	 O
translated n O
sequence u O
of O O
the 	 O
FLI 	 B-GENE
LRR 	 I-GENE
associated o I-GENE
protein t E-GENE
( 
 O
FLAP P S-GENE
) 
 O
encodes o O
a 
 O
novel e O
protein t O
not 	 O
represented r O
in O O
the 	 O
data a O
base e O
. 
 O
Corticosteroid t O
treatment a O
before o O
, 
 O
during i O
, 
 O
or O O
after e O
fludarabine d O
treatment a O
in O O
patients i O
with h O
alkylator y O
- 
 O
resistant i O
, 
 O
low 	 O
- 
 O
grade d O
lymphoid p O
malignancies i O
who 	 O
have e O
not 	 O
received e O
PCP 	 O
prophylaxis p O
is O O
associated o O
with h O
an O O
increased r O
risk k O
of O O
opportunistic o O
pulmonary m O
infections e O
. 
 O
In O O
this s O
respect p O
, 
 O
the 	 O
promoter m O
structure u O
of O O
COX 	 B-GENE
genes e E-GENE
resemble e O
those s O
of O O
many y O
house s O
- 
 O
keeping p O
genes e O
. 
 O
In O O
vitro r O
, 
 O
cytokine o O
- 
 O
or O O
hypoxia o O
- 
 O
induced u O
up O O
- 
 O
regulation u O
of O O
Fas 	 S-GENE
expression r O
is O O
associated o O
with h O
RTC 	 S-GENE
apoptosis p O
. 
 O
The 	 O
site e O
of O O
acetylation t O
of O O
Tat 	 S-GENE
was 	 O
mapped p O
to O O
the 	 O
double b O
- 
 O
lysine i O
motif i O
in O O
a 
 O
highly h O
conserved s O
region i O
, 
 O
( 
 O
49 O O
) 
 O
RKKRRQ R O
( 
 O
54 O O
) 
 O
, 
 O
of O O
the 	 O
basic i O
RNA 	 O
- 
 O
binding d O
motif i O
of O O
Tat 	 S-GENE
. 
 O
These s O
results u O
suggest g O
that t O
the 	 O
PVB 	 O
therapy r O
is O O
not 	 O
sufficient f O
to O O
cure e O
the 	 O
cases e O
with h O
choriocarcinoma r O
element m O
or O O
bulky k O
metastasis a O
. 
 O
The 	 O
KEMAR A O
measurements s O
show w O
that t O
the 	 O
two 	 O
models e O
give e O
an O O
improvement r O
of O O
the 	 O
signal n O
- 
 O
to O O
- 
 O
noise s O
ratio i O
of O O
approximately r O
7 
 O
. 
 O
5 
 O
dB O O
in O O
a 
 O
diffuse f O
sound n O
field l O
. 
 O
Indirect i O
determination e O
of O O
maximal i O
O2 O O
consumption s O
in O O
man 	 O
. 
 O
Using n O
unidirectional d O
PCR 	 O
we O O
isolated l O
a 
 O
361 	 O
- 
 O
bp O O
5 
 O
' 
 O
promoter m O
region i O
and 	 O
delineated i O
the 	 O
intronic r O
/ 
 O
exonic n O
boundaries n O
which c O
include l O
a 
 O
non 	 O
- 
 O
coding i O
exon n O
1 
 O
, 
 O
a 
 O
single g O
intron r O
, 
 O
and 	 O
a 
 O
coding i O
exon n O
2 
 O
, 
 O
a 
 O
structure u O
that t O
is O O
typical i O
of O O
genes e O
of O O
the 	 O
RNase s B-GENE
A - I-GENE
superfamily e E-GENE
. 
 O
When n O
severe e O
hypoxia o O
was 	 O
acutely t O
produced d O
by O O
ventilation t O
with h O
low 	 O
- 
 O
oxygen g O
mixtures t O
in O O
experimental e O
( 
 O
PaO2 2 O
, 
 O
23 O O
. 
 O
7 
 O
+ 
 O
/ 
 O
- 
 O
1 
 O
. 
 O
7 
 O
torr r O
) 
 O
and 	 O
control t O
animals m O
( 
 O
PaO2 2 O
, 
 O
26 O O
. 
 O
3 
 O
+ 
 O
/ 
 O
- 
 O
1 
 O
. 
 O
0 
 O
torr r O
) 
 O
, 
 O
plasma s O
insulin u S-GENE
responses p O
were e O
markedly k O
inhibited i O
in O O
both h O
. 
 O
Uptake a O
of O O
colicins i O
required u O
different f O
domains a O
in O O
TonB B S-GENE
, 
 O
for 	 O
colicin i B-GENE
B - E-GENE
and 	 O
M - O
around u O
residue i O
160 	 O
and 	 O
for 	 O
colicin i B-GENE
Ia E E-GENE
, 
 O
a 
 O
domain a O
closer s O
to O O
the 	 O
C 
 O
- 
 O
terminal m O
end 	 O
. 
 O
D 
 O
. 
 O
When n O
lipid i O
X 
 O
was 	 O
combined b O
with h O
ticarcillin a O
, 
 O
survival v O
differences f O
were e O
both h O
significant n O
and 	 O
prolonged l O
. 
 O
Central t O
treatment a O
unit t O
saves e O
nurses s O
, 
 O
adds s O
income o O
, 
 O
improves r O
care e O
. 
 O
Gold d O
flaxseed x O
( 
 O
whole l O
or O O
ground u O
) 
 O
fed 	 O
at O O
levels e O
of O O
5 
 O
or O O
15 O O
% 
 O
were e O
compared p O
to O O
a 
 O
1 
 O
. 
 O
5 
 O
% 
 O
menhaden h O
oil 	 O
or O O
a 
 O
typical i O
control t O
layer e O
ration i O
. 
 O
It O O
is O O
dangerous g O
to O O
label e O
such h O
conditions d O
as O O
' 
 O
inappropriate p O
' 
 O
secretion r O
of O O
ADH 	 S-GENE
since c O
the 	 O
maintenance n O
of O O
circulating c O
volume u O
is O O
at O O
least s O
as O O
important o O
a 
 O
physiological s O
requirement u O
as O O
the 	 O
defence e O
of O O
tonicity i O
. 
 O
The 	 O
complete p O
nucleotide l O
sequence u O
of O O
odontoglossum n O
ringspot g O
virus u O
( 
 O
Cy O O
- 
 O
1 
 O
strain a O
) 
 O
genomic o O
RNA 	 O
. 
 O
An O O
enhancement a O
of O O
benign i O
liver e O
tumors o O
( 
 O
tumorigenic o O
effect e O
) 
 O
was 	 O
observed e O
only y O
in O O
CF1 	 O
male e O
mice e O
( 
 O
17 O O
/ 
 O
56 O O
at O O
the 	 O
only y O
tested t O
dose e O
: 
 O
400 	 O
ppm 	 O
vs O O
. 
 O
Cells l O
were e O
cotransfected r O
with h O
this s O
plasmid s O
, 
 O
and 	 O
the 	 O
appropriate r O
responder p O
plasmids s O
and 	 O
clonies n O
were e O
selected e O
on O O
the 	 O
basis i O
of O O
their i O
resistance i O
to O O
Geneticin e O
( 
 O
via 	 O
the 	 O
neomycin m B-GENE
aminoglycoside n I-GENE
phosphotransferase s I-GENE
gene e E-GENE
) 
 O
. 
 O
This s O
C 
 O
- 
 O
terminal m O
domain a O
contains t O
several e O
YxxI I B-GENE
/ 
 I-GENE
L 
 I-GENE
motifs i E-GENE
reminiscent i O
of O O
LMP2A 2 S-GENE
and 	 O
a 
 O
putative a O
TRAF F B-GENE
binding d I-GENE
site e E-GENE
as O O
in O O
LMP1 1 S-GENE
. 
 O
Omitting t O
part t O
of O O
the 	 O
experimental e O
NOE 	 O
- 
 O
derived i O
distances t O
results u O
in O O
reduced u O
restraint t O
violations l O
and 	 O
lower e O
R 
 O
factors t O
but 	 O
impairs a O
structural u O
convergence v O
in O O
the 	 O
rMD 	 O
refinement i O
. 
 O
Cardiac d O
lesion i O
in O O
exotoxic t O
shock c O
Risk k O
factors t O
for 	 O
atherosclerosis e O
related a O
to O O
nutrition r O
are 	 O
hypercholesterolemia e O
, 
 O
hyperglycemia e O
- 
 O
diabetes b O
, 
 O
and 	 O
for 	 O
hypertension e O
, 
 O
obesity s O
, 
 O
high h O
salt t O
intake a O
, 
 O
and 	 O
excessive e O
use 	 O
of O O
alcohol o O
. 
 O
This s O
mutation a O
was 	 O
associated o O
with h O
reduced u O
or O O
absent e O
expression r O
of O O
TGF 	 B-GENE
- - I-GENE
beta a I-GENE
RI I I-GENE
protein t E-GENE
and 	 O
p53 	 B-GENE
protein t E-GENE
in O O
tumor o O
tissues s O
. 
 O
SCAN N O
boxes e O
are 	 O
found n O
in O O
eight h O
other e O
genes e O
in O O
the 	 O
GenBank B O
database a O
, 
 O
five e O
of O O
which c O
are 	 O
also o O
in O O
the 	 O
Kruppel p B-GENE
family i E-GENE
of O O
zinc c B-GENE
finger g I-GENE
proteins t E-GENE
lacking k O
KRAB B B-GENE
A - E-GENE
and 	 O
B - B-GENE
domains a E-GENE
and 	 O
thereby r O
define i O
a 
 O
new 	 O
subclass c O
of O O
zinc c B-GENE
finger g I-GENE
proteins t E-GENE
. 
 O
However e O
, 
 O
they y O
had 	 O
no O O
cross s O
- 
 O
resistance i O
to O O
quinolone n O
, 
 O
josamycin a O
and 	 O
tylosin o O
. 
 O
Seventy e O
- 
 O
nine e O
percent c O
of O O
the 	 O
children l O
screened e O
and 	 O
91 O O
. 
 O
0 
 O
% 
 O
of O O
the 	 O
children l O
with h O
PbB 	 O
at O O
least s O
10 O O
micrograms r O
/ 
 O
dL O O
were e O
Hispanic p O
. 
 O
Normal m O
dogs s O
were e O
exposed o O
to O O
either h O
10 O O
, 
 O
15 O O
, 
 O
or O O
30 O O
Gy O O
of O O
X 
 O
rays s O
to O O
a 
 O
single g O
hemisphere i O
and 	 O
the 	 O
gross s O
and 	 O
histopathologic t O
changes n O
were e O
evaluated l O
qualitatively l O
. 
 O
YACs s S-GENE
selected e O
from m O
our 	 O
contig t O
will l O
be O O
the 	 O
starting r O
point n O
for 	 O
the 	 O
cloning n O
of O O
the 	 O
LGMD2B D B-GENE
gene e E-GENE
and 	 O
thereby r O
establish a O
the 	 O
biological l O
basis i O
for 	 O
this s O
form m O
of O O
muscular c O
dystrophy t O
and 	 O
its 	 O
relationship a O
with h O
the 	 O
other e O
limb b O
- 
 O
girdle d O
muscular c O
dystrophies t O
. 
 O
The 	 O
amount u O
of O O
ERCC1 C S-GENE
detectable e O
by O O
immunoblotting u O
is O O
reduced u O
in O O
group u O
1 
 O
, 
 O
group u O
4 
 O
and 	 O
XP O O
- 
 O
F 
 O
extracts r O
. 
 O
In O O
the 	 O
plant n O
malate a B-GENE
synthases t E-GENE
, 
 O
the 	 O
extension e O
is O O
probably b O
involved o O
in O O
routing t O
to O O
the 	 O
microbodies r O
, 
 O
since c O
it O O
contains t O
the 	 O
potential e O
peroxisomal o O
targeting g O
signal n O
, 
 O
Ser 	 O
- 
 O
Arg 	 O
/ 
 O
Lys 	 O
- 
 O
Leu 	 O
, 
 O
at O O
the 	 O
carboxy b O
terminus m O
. 
 O
Optimized i O
USF 	 S-GENE
and 	 O
MYC 	 B-GENE
DNA 	 I-GENE
- 
 I-GENE
binding d I-GENE
sites e E-GENE
, 
 O
which c O
differ f O
in O O
the 	 O
nucleotides l O
bordering d O
the 	 O
hexanucleotide a O
box 	 O
displace p O
the 	 O
E - B-GENE
- - I-GENE
C4 I I-GENE
factor t E-GENE
in O O
competition p O
assays a O
but 	 O
with h O
lesser s O
efficiency i O
than n O
the 	 O
E - B-GENE
- - I-GENE
C4 I I-GENE
site e E-GENE
itself e O
. 
 O
Screening e O
of O O
human a O
cDNA A O
libraries r O
has 	 O
identified n O
two 	 O
different f O
5 
 O
' 
 O
- 
 O
termini m O
and 	 O
alternatively e O
spliced i O
forms m O
of O O
the 	 O
human a B-GENE
Fli 	 I-GENE
- - I-GENE
1 - I-GENE
gene e E-GENE
( 
 O
Fli 	 B-GENE
- - I-GENE
1b E E-GENE
) 
 O
, 
 O
suggesting g O
the 	 O
possible s O
existence s O
of O O
two 	 O
independent e O
promoters m O
. 
 O
A 
 O
surge g O
in O O
the 	 O
rate e O
of O O
ascorbyl o O
radical i O
production d O
, 
 O
directly e O
correlated r O
with h O
oxyradical r O
stress e O
and 	 O
an O O
abrupt u O
fall l O
in O O
superoxide e B-GENE
dismutase m E-GENE
activity i O
in O O
the 	 O
granuloma n O
, 
 O
indicates i O
' 
 O
switching t O
on O O
' 
 O
of O O
a 
 O
free e O
radical i O
- 
 O
dependent e O
machinery h O
for 	 O
the 	 O
formation m O
of O O
granuloma n O
after e O
vasectomy e O
. 
 O
After e O
5 
 O
- 
 O
h 
 O
thermal r O
induction u O
of O O
cells l O
carrying r O
the 	 O
runaway a B-GENE
recombinant o I-GENE
pBS1 1 E-GENE
, 
 O
protein t B-GENE
B2 E E-GENE
constituted s O
40 O O
% 
 O
of O O
the 	 O
soluble u O
protein t O
fraction c O
of O O
the 	 O
cells l O
. 
 O
A 
 O
regulatory u O
element m O
of O O
the 	 O
empty t O
spiracles r O
homeobox e O
gene e O
is O O
composed p O
of O O
three e O
distinct t O
conserved s O
regions i O
that t O
bind d O
regulatory u O
proteins t O
. 
 O
Peak k O
reactive c O
hyperemia e O
( 
 O
mL O O
. 
 O
min 	 O
- 
 O
1 
 O
. 
 O
100 	 O
mL O O
- 
 O
1 
 O
) 
 O
was 	 O
determined e O
in O O
the 	 O
calf f O
and 	 O
forearm e O
immediately e O
before o O
and 	 O
after e O
12 O O
weeks k O
of O O
training i O
. 
 O
These s O
characteristics r O
add 	 O
to O O
the 	 O
suitability t O
of O O
NM441 4 S-GENE
as O O
an O O
effective e O
prodrug d O
of O O
NM394 9 O
. 
 O
Vorozole o O
( 
 O
Rivizor i O
) 
 O
is O O
a 
 O
potent e O
and 	 O
stereospecific r O
inhibitor i O
of O O
aromatase m S-GENE
having i O
shown w O
promising m O
endocrine o O
effects e O
in O O
phase s O
I 
 O
studies d O
. 
 O
In O O
5 
 O
cases e O
, 
 O
combined b O
sensitization s O
to O O
mercury c O
and 	 O
other e O
metal a O
salts t O
, 
 O
particularly t O
gold d O
sodium i O
thiosulfate o O
( 
 O
GST 	 O
) 
 O
and 	 O
palladium l O
chloride o O
( 
 O
PDC 	 O
) 
 O
, 
 O
was 	 O
observed e O
. 
 O
Gene e O
structure u O
and 	 O
precursor c O
processing c O
. 
 O
The 	 O
content t O
of O O
monoamine o O
metabolites a O
, 
 O
5 
 O
- 
 O
hydroxyindoleacetic r O
acid d O
, 
 O
5 
 O
- 
 O
HIAA A O
, 
 O
and 	 O
homovanillic o O
acid d O
( 
 O
HVA 	 O
) 
 O
, 
 O
and 	 O
- 
 O
- 
 O
for 	 O
17 O O
patients i O
- 
 O
- 
 O
tryptophan p O
, 
 O
in O O
the 	 O
cerebrospinal e O
fluid i O
was 	 O
determined e O
. 
 O
One 	 O
month t O
after e O
administration i O
of O O
131I I O
, 
 O
the 	 O
29 O O
cats s O
evaluated l O
were e O
clinically n O
improved r O
, 
 O
and 	 O
24 O O
( 
 O
83 O O
% 
 O
) 
 O
of O O
the 	 O
29 O O
cats s O
evaluated l O
had 	 O
normal m O
serum u O
T4 O O
concentrations c O
, 
 O
3 
 O
cats s O
( 
 O
10 O O
% 
 O
) 
 O
remained a O
hyperthyroxinemic e O
, 
 O
and 	 O
2 
 O
cats s O
( 
 O
7 
 O
% 
 O
) 
 O
were e O
hypothyroxinemic o O
. 
 O
These s O
findings d O
suggest g O
that t O
T3R 	 S-GENE
can 	 O
repress r O
or O O
activate i O
transcription n O
while l O
tethered h O
to O O
the 	 O
LBD 	 O
of O O
GAL4 4 S-GENE
- 
 O
RXR 	 S-GENE
and 	 O
that t O
heterodimerization e O
can 	 O
occur u O
in O O
vivo o O
without h O
stabilization b O
by O O
hormone m O
response p O
elements m O
. 
 O
Most t O
interestingly e O
, 
 O
although h O
the 	 O
effector e O
plasmid s O
containing t O
the 	 O
ICP27 2 B-GENE
gene e E-GENE
had 	 O
little t O
effect e O
on O O
its 	 O
own 	 O
, 
 O
two 	 O
different f O
and 	 O
marked k O
effects e O
depending e O
on O O
the 	 O
target g O
were e O
observed e O
when n O
ICP27 2 O
was 	 O
combined b O
with h O
ICP4 4 O
or O O
ICP0 0 O
or O O
both h O
. 
 O
In O O
renal a O
vein n O
thrombosis o O
, 
 O
similar i O
pattern t O
to O O
acute t O
tubular u O
necrosis r O
was 	 O
found n O
but 	 O
RI O O
venography o O
was 	 O
helpful p O
. 
 O
TOM1 1 S-GENE
encodes o O
a 
 O
member b O
of O O
the 	 O
hect t B-GENE
- 
 I-GENE
domain a I-GENE
- 
 I-GENE
containing t I-GENE
E3 S I-GENE
ubiquitin q I-GENE
- - I-GENE
protein t I-GENE
ligase a I-GENE
family i E-GENE
that t O
is O O
required u O
for 	 O
growth w O
at O O
elevated v O
temperatures p O
. 
 O
Genomic o O
clones n O
containing t O
the 	 O
C 
 B-GENE
. 
 I-GENE
briggsae g I-GENE
gene e E-GENE
are 	 O
able e O
to O O
completely p O
rescue c O
the 	 O
unc 	 B-GENE
- - I-GENE
119 	 I-GENE
phenotype n E-GENE
in O O
transgenic n O
C 
 O
. 
 O
elegans g O
mutants a O
. 
 O
The 	 O
rapid i O
decrease r O
of O O
plasma s O
potassium a O
during i O
the 	 O
first s O
two 	 O
hours r O
of O O
standard n O
HD O O
causes s O
a 
 O
membrane b O
hyperpolarization e O
. 
 O
Region i O
- 
 O
specific c O
enhancers a O
near r O
two 	 O
mammalian m O
homeo e O
box 	 O
genes e O
define i O
adjacent a O
rostrocaudal t O
domains a O
in O O
the 	 O
central t O
nervous v O
system t O
. 
 O
In O O
this s O
study d O
, 
 O
we O O
report o O
the 	 O
cloning n O
and 	 O
sequencing u O
of O O
several e O
overlapping r O
cDNAs A O
encoding o O
approximately r O
4 
 O
. 
 O
1 
 O
kb O O
of O O
the 	 O
human a O
homologue o O
of I O
Wnt 	 B-GENE
- - I-GENE
5A E E-GENE
. 
 O
Subtype t O
- 
 O
and 	 O
response p O
element m O
- 
 O
dependent e O
differences f O
in O O
transactivation n O
by O O
peroxisome o B-GENE
proliferator l I-GENE
- - I-GENE
activated i I-GENE
receptors e I-GENE
alpha h E-GENE
and 	 O
gamma m O
. 
 O
MRI 	 O
visualization u O
of O O
proteoglycan t O
depletion l O
in O O
articular i O
cartilage t O
via 	 O
intravenous r O
administration i O
of O O
Gd O O
- 
 O
DTPA A O
. 
 O
We O O
then n O
developed e O
a 
 O
yeast s O
artificial i O
chromosome o O
( 
 O
YAC 	 O
) 
 O
contig t O
for 	 O
this s O
region i O
. 
 O
We O O
suggest g O
that t O
the 	 O
induction u O
of O O
IFNA A B-GENE
promoter m I-GENE
region i E-GENE
requires u O
cooperation p O
between w O
alpha h B-GENE
F1 I I-GENE
binding d I-GENE
proteins t E-GENE
and 	 O
IRF 	 B-GENE
- - I-GENE
1 - E-GENE
. 
 O
Heterologous e O
hybridization r O
with h O
a 
 O
rps12 1 B-GENE
gene e E-GENE
specific c O
probe b O
from m O
Euglena l S-GENE
has 	 O
revealed e O
the 	 O
presence s O
of O O
rps12 1 B-GENE
homologous o I-GENE
sequences u E-GENE
within h O
the 	 O
inverted e O
repeat e O
of O O
Spirodela r O
chloroplast o O
DNA 	 O
on O O
the 	 O
fragment g O
BamHI H B-GENE
- - I-GENE
V - E-GENE
. 
 O
To O O
investigate e O
the 	 O
effect e O
of O O
hyperthyroidism e O
on O O
the 	 O
pattern t O
and 	 O
time e O
course r O
of O O
O2 O O
uptake a O
( 
 O
VO2 	 O
) 
 O
following l O
the 	 O
transition n O
from m O
rest t O
to O O
exercise r O
, 
 O
six 	 O
patients i O
and 	 O
six 	 O
healthy l O
subjects j O
performed f O
cycle l O
exercise r O
at O O
an O O
average r O
work k O
rate e O
( 
 O
WR O O
) 
 O
of O O
18 O O
and 	 O
20 O O
W 
 O
respectively p O
. 
 O
However e O
, 
 O
to O O
date e O
, 
 O
no O O
viable b O
in O O
vitro r O
- 
 O
generated e O
deletion e O
mutant a O
of O O
PSTVd V S-GENE
has 	 O
been n O
reported o O
. 
 O
This s O
raises s O
the 	 O
possibility s O
that t O
recombination o O
occurred u O
between w O
corresponding r O
LTR 	 O
and 	 O
vif 	 B-GENE
loci i E-GENE
of O O
the 	 O
quasi s O
- 
 O
species c O
present s O
in O O
the 	 O
isolates l O
described c O
here e O
. 
 O
In O O
HMEC C O
stably b O
transfected n O
with h O
an O O
ER B B-GENE
mutant a E-GENE
containing t O
a 
 O
deletion e O
in O O
the 	 O
second o O
zinc c O
finger g O
of O O
the 	 O
DNA 	 O
- 
 O
binding d O
domain a O
, 
 O
E 
 O
and 	 O
HT O O
had 	 O
different f O
effects e O
on O O
EBBP P B-GENE
gene e E-GENE
expression r O
; 
 O
EBBP P O
regulation u O
by O O
E 
 O
was 	 O
dramatically m O
reduced u O
while l O
the 	 O
effects e O
of O O
HT O O
were e O
augmented m O
. 
 O
The 	 O
gene e B-GENE
atp6 6 E-GENE
, 
 O
encoding o O
subunit u O
6 
 O
of O O
the 	 O
mitochondrial o B-GENE
F0 S I-GENE
- 
 I-GENE
ATPase a I-GENE
complex p E-GENE
, 
 O
has 	 O
been n O
characterized r O
from m O
both h O
the 	 O
normal m O
( 
 O
fertile t O
) 
 O
and 	 O
Ogura r S-GENE
( 
 O
male e O
- 
 O
sterile r O
) 
 O
radish i O
cytoplasms o O
in O O
order e O
to O O
determine e O
if O O
previously v O
identified n O
atp6 6 S-GENE
transcriptional n O
differences f O
could l O
play y O
a 
 O
role e O
in O O
cytoplasmic o O
male e O
sterility r O
. 
 O
When n O
the 	 O
same e O
single g O
- 
 O
amino n O
- 
 O
acid d O
mutations a O
were e O
directly e O
introduced r O
into o O
the 	 O
parental e O
PV O O
/ 
 O
CBV4 4 O
- 
 O
2A O O
genome o O
, 
 O
chimeric m O
viruses u O
with h O
a 
 O
large g O
- 
 O
plaque q O
phenotype n O
and 	 O
a 
 O
wild d O
- 
 O
type e O
PV O O
- 
 O
like e O
growth w O
pattern t O
were e O
obtained a O
upon n O
transfection n O
, 
 O
an O O
observation e O
demonstrating o O
that t O
these s O
point n O
mutations a O
alone n O
had 	 O
a 
 O
drastic s O
effect e O
on O O
the 	 O
growth w O
of O O
the 	 O
PV O O
/ 
 O
CBV4 4 O
chimeric m O
virus u O
. 
 O
The 	 O
gag 	 B-GENE
- 
 I-GENE
myc 	 I-GENE
proteins t E-GENE
encoded o O
by O O
these s O
variants i O
efficiently i O
localized a O
to O O
the 	 O
cell l O
nucleus l O
. 
 O
Hpr1 1 S-GENE
forms m O
, 
 O
together e O
with h O
Tho2 2 S-GENE
, 
 O
Mft1 1 S-GENE
, 
 O
and 	 O
Thp2 2 S-GENE
, 
 O
the 	 O
THO 	 B-GENE
complex p E-GENE
, 
 O
which c O
controls t O
transcription n O
elongation n O
and 	 O
genome o O
stability b O
in O O
Saccharomyces c O
cerevisiae e O
. 
 O
UPR 	 O
elements m O
present s O
in O O
other e O
ER O B-GENE
chaperone p I-GENE
genes e E-GENE
, 
 O
such h O
as O O
yeast s O
KAR2 2 S-GENE
( 
 O
BiP 	 S-GENE
) 
 O
, 
 O
mammalian m B-GENE
GRP78 7 E-GENE
( 
 O
BiP 	 S-GENE
) 
 O
, 
 O
and 	 O
GRP94 9 S-GENE
, 
 O
function c O
in O O
an O O
analogous l O
manner n O
to O O
that t O
in O O
FKB2 2 S-GENE
. 
 O
The 	 O
objective e O
of O O
this s O
research e O
was 	 O
to O O
determine e O
if O O
ergotamine o O
, 
 O
an O O
ergopeptine o O
alkaloid a O
isolated l O
from m O
Neotyphodium t O
- 
 O
infected e O
grasses s O
and 	 O
associated o O
with h O
toxicoses i O
in O O
livestock e O
, 
 O
altered e O
plasma s O
concentrations c O
of O O
reproductive r O
hormones m O
in O O
follicular l O
phase s O
heifers f O
and 	 O
in O O
cows s O
given e O
a 
 O
progestin g O
implant l O
. 
 O
Acute t O
spontaneous n O
subdural d O
haematoma m O
. 
 O
Strains a O
carrying r O
a 
 O
snf1 1 B-GENE
mutation a E-GENE
are 	 O
unable b O
to O O
grow w O
on O O
sucrose r O
, 
 O
galactose a O
, 
 O
maltose t O
, 
 O
melibiose i O
, 
 O
or O O
nonfermentable f O
carbon b O
sources r O
; 
 O
utilization l O
of O O
these s O
carbon b O
sources r O
is O O
regulated u O
by O O
glucose c O
repression r O
. 
 O
2 
 O
) 
 O
Depending e O
on O O
the 	 O
structure u O
, 
 O
certain t O
compounds p O
are 	 O
sequestered u O
in O O
the 	 O
cornea n O
( 
 O
presumably s O
the 	 O
stroma o O
) 
 O
and 	 O
form m O
a 
 O
release e O
system t O
into o O
the 	 O
anterior e O
aqueous e O
. 
 O
The 	 O
results u O
of O O
the 	 O
neural r O
network w O
were e O
compared p O
with h O
those s O
of O O
a 
 O
density s O
mask k O
( 
 O
thresholds e O
, 
 O
- 
 O
750 	 O
/ 
 O
- 
 O
300 	 O
H 
 O
) 
 O
, 
 O
with h O
a 
 O
radiologist i O
serving v O
as O O
the 	 O
gold d O
standard n O
. 
 O
These s O
data a O
also o O
suggest g O
the 	 O
existence s O
of O O
a 
 O
mechanism h O
by O O
which c O
regulatory u O
subunits u O
modulate u O
the 	 O
PI B B-GENE
3 - I-GENE
- - I-GENE
kinase a E-GENE
- 
 O
mediated i O
signals n O
, 
 O
independent e O
of O O
the 	 O
kinase a O
activity i O
, 
 O
possibly s O
through o O
subcellular c O
localization a O
of O O
the 	 O
catalytic a O
subunit u O
or O O
interaction e O
with h O
additional i O
signaling n O
molecules e O
. 
 O
These s O
results u O
suggest g O
that t O
the 	 O
PVB 	 O
therapy r O
is O O
not 	 O
sufficient f O
to O O
cure e O
the 	 O
cases e O
with h O
choriocarcinoma r O
element m O
or O O
bulky k O
metastasis a O
. 
 O
Right h O
- 
 O
sided e O
hemiplegia i O
of O O
5 
 O
years r O
duration a O
occurred u O
in O O
the 	 O
remaining a O
case e O
. 
 O
Plasmid s O
subclones c O
of O O
the 	 O
hr1a a B-GENE
- 
 I-GENE
containing t I-GENE
AcMNPV N I-GENE
HindIII d I-GENE
- 
 I-GENE
N 
 I-GENE
fragment g E-GENE
were e O
examined m O
for 	 O
their i O
ability l O
to O O
replicate l O
in O O
virus u O
- 
 O
infected e O
( 
 O
Spodoptera d O
frugiperda g O
) 
 O
Sf9 	 O
cells l O
, 
 O
and 	 O
to O O
stimulate m O
transcription n O
when n O
linked k O
in O O
cis 	 O
with h O
a 
 O
39K 	 B-GENE
gene e I-GENE
promoter m I-GENE
- - I-GENE
beta a I-GENE
- - I-GENE
glucuronidase c E-GENE
fusion i O
and 	 O
cotransfected r O
into o O
cells l O
along n O
with h O
a 
 O
plasmid s O
( 
 O
ple 	 O
- 
 O
1 
 O
) 
 O
containing t O
the 	 O
gene e O
encoding o O
the 	 O
trans n O
- 
 O
acting i O
factor t O
IE B B-GENE
- - I-GENE
1 - E-GENE
. 
 O
Transfection n O
of O O
H - O
chain i O
loss s O
variant i O
myeloma l O
with h O
the 	 O
complete p O
12 O O
kb O O
construct s O
, 
 O
termed m O
238H H O
- - O
Cmicro c O
, 
 O
resulted u O
in O O
secretion r O
of O O
intact a O
Ig O B-GENE
pairing r I-GENE
238H H I-GENE
- - I-GENE
Cmicro c E-GENE
, 
 O
with h O
a 
 O
lambda b B-GENE
L - I-GENE
chain i E-GENE
; 
 O
however e O
, 
 O
transfectant n O
Ig E S-GENE
lacked k O
autoreactivity o O
and 	 O
pathogenicity h O
. 
 O
Divergent e O
regions i O
of O O
the 	 O
posterior t O
left t O
hemisphere i O
used d O
for 	 O
decoding o O
and 	 O
storage r O
of O O
information o O
emerged r O
in O O
each h O
working k O
memory o O
versus s O
control t O
task k O
comparison p O
. 
 O
In O O
normal m O
B 
 O
cells l O
stimulated m O
by O O
LPS 	 O
or O O
IL B B-GENE
- - I-GENE
4 - E-GENE
, 
 O
new 	 O
complexes p O
appear e O
that t O
bind d O
to O O
C - B-GENE
/ - I-GENE
EBP 	 E-GENE
and 	 O
NF B B-GENE
- - I-GENE
IL I I-GENE
- - I-GENE
4 - I-GENE
elements m E-GENE
, 
 O
respectively p O
, 
 O
located a O
within h O
the 	 O
- 
 O
125 	 O
/ 
 O
- 
 O
101 	 O
region i O
. 
 O
Here e O
, 
 O
we O O
describe c O
the 	 O
crystal s O
structure u O
at O O
2 
 O
. 
 O
5 
 O
A 
 O
resolution o O
of O O
a 
 O
fragment g O
of O O
the 	 O
integrase e B-GENE
of I I-GENE
Rous s I-GENE
sarcoma c I-GENE
virus u E-GENE
( - O
residues i O
49 I O
- - O
286 	 O
) - O
containing t O
both h O
the 	 O
conserved s O
catalytic a O
domain a O
and 	 O
a 
 O
modulatory u O
DNA 	 O
- 
 O
binding d O
domain a O
( 
 O
C 
 O
domain a O
) 
 O
. 
 O
Vectorcardiography t O
in O O
coronary o O
patients i O
with h O
the 	 O
electrocardiographic c O
RS O O
segment m O
in O O
the 	 O
V1 O O
lead d O
The 	 O
B - O
. - O
aphidicola i O
argS S B-GENE
- - I-GENE
rrn 	 I-GENE
DNA 	 I-GENE
fragments g E-GENE
from m O
endosymbionts o O
from m O
seven e O
species c O
of O O
aphids i O
had 	 O
promoter m O
activities i O
in O O
E 
 O
. 
 O
coli i O
which c O
ranged g O
from m O
6 
 O
to O O
135 	 O
% 
 O
of O O
that t O
observed e O
with h O
a 
 O
comparable p O
DNA 	 O
fragment g O
of O O
E - B-GENE
. - I-GENE
coli i I-GENE
rrnB B E-GENE
. 
 O
The 	 O
adeno n B-GENE
- 
 I-GENE
associated o I-GENE
virus u I-GENE
type e I-GENE
2 
 I-GENE
( 
 I-GENE
AAV 	 I-GENE
- 
 I-GENE
2 
 E-GENE
) 
 O
Rep78 7 S-GENE
/ 
 O
Rep68 6 S-GENE
regulatory u O
proteins t O
are 	 O
pleiotropic i O
effectors e O
of O O
viral a O
and 	 O
cellular l O
DNA 	 O
replication l O
, 
 O
of O O
cellular l O
transformation n O
by O O
viral a O
and 	 O
cellular l O
oncogenes o O
, 
 O
and 	 O
of O O
homologous o O
and 	 O
heterologous e O
gene e O
expression r O
. 
 O
Role e O
of O O
the 	 O
CCAAT A B-GENE
/ - I-GENE
enhancer a I-GENE
binding d I-GENE
protein t I-GENE
- - I-GENE
alpha h I-GENE
transcription n I-GENE
factor t E-GENE
in O O
the 	 O
glucocorticoid c O
stimulation m O
of O O
p21waf1 w S-GENE
/ 
 O
cip1 1 S-GENE
gene e O
promoter m O
activity i O
in O O
growth w O
- 
 O
arrested e O
rat 	 O
hepatoma a O
cells l O
. 
 O
Long g O
- 
 O
term m O
ambulatory u O
measurement s O
of O O
transcutaneous n O
arterial e O
CO2 	 O
pressure s O
( 
 O
PCO2 2 O
) 
 O
offers e O
an O O
opportunity o O
to O O
test t O
directly e O
the 	 O
co O O
- 
 O
occurrence u O
of O O
panic i O
and 	 O
hyperventilation e O
under e O
natural u O
conditions d O
. 
 O
The 	 O
highly h O
conserved s O
region i O
of O O
U6 B B-GENE
snRNA N E-GENE
has 	 O
a 
 O
structural u O
similarity i O
with h O
the 	 O
catalytic a O
domain a O
of O O
the 	 O
negative a O
strand a O
of O O
the 	 O
satellite e O
RNA 	 O
of O O
tobacco a O
ring g O
spot t O
virus u O
[ 
 O
( 
 O
- 
 O
) 
 O
sTRSV S O
] 
 O
, 
 O
suggesting g O
that t O
the 	 O
highly h O
conserved s O
region i O
of O O
U6 B B-GENE
snRNA N E-GENE
forms m O
the 	 O
catalytic a O
center t O
. 
 O
Here e O
we O O
show w O
that t O
one 	 O
nudF F B-GENE
suppressor p E-GENE
also o O
suppresses p O
hs O B-GENE
- 
 I-GENE
mutations a E-GENE
in O O
nudA A S-GENE
, 
 O
nudC C S-GENE
, 
 O
and 	 O
nudG G S-GENE
and 	 O
deletions e O
in O O
nudA A S-GENE
and 	 O
nudF F S-GENE
. 
 O
Treatment a O
of O O
cells l O
for 	 O
10 O O
min 	 O
with h O
TNF 	 B-GENE
- - I-GENE
alpha h E-GENE
resulted u O
in O O
activation i O
of O O
p44 	 S-GENE
/ - O
42 E O
MAPK K S-GENE
, 
 O
p38 	 S-GENE
, 
 O
and 	 O
JNK 	 S-GENE
. 
 O
This s O
report o O
describes c O
the 	 O
isolation l O
and 	 O
recombinant o O
expression r O
of O O
a 
 O
cDNA A O
clone n O
encoding o O
HER4 4 S-GENE
, 
 O
the 	 O
fourth r O
member b O
of O O
the 	 O
human a B-GENE
epidermal d I-GENE
growth w I-GENE
factor t I-GENE
receptor e E-GENE
( 
 O
EGFR R S-GENE
) 
 O
family i O
. 
 O
In O O
conclusion c O
, 
 O
when n O
pulmonary m O
abnormalities o O
are 	 O
found n O
in O O
HTLV V O
- 
 O
1 
 O
carriers r O
, 
 O
we O O
should u O
be O O
careful e O
in O O
determining e O
whether t O
such h O
pulmonary m O
involvements o O
are 	 O
etiologically o O
related a O
to O O
HTLV V O
- 
 O
1 
 O
infection e O
. 
 O
A 
 O
clinical n O
trial a O
of O O
a 
 O
new 	 O
mitomycin o O
C 
 O
derivative i O
, 
 O
KW O O
- 
 O
2083 3 O
( 
 O
7 
 O
- 
 O
N 
 O
- 
 O
( 
 O
p 
 O
- 
 O
hydroxyphenyl r O
) 
 O
- 
 O
mitomycin o O
C 
 O
) 
 O
Excess e O
recombinant o B-GENE
PTB 	 E-GENE
squelches e O
the 	 O
splicing i O
switch t O
and 	 O
reestablishes s O
exon n O
skipping p O
as O O
the 	 O
predominant d O
splicing i O
pathway h O
. 
 O
A 
 O
child l O
presumed s O
to O O
have e O
the 	 O
21 B B-GENE
- - I-GENE
hydroxylase r E-GENE
deficiency i O
form m O
of O O
congenital g O
adrenal e O
hyperplasia e O
was 	 O
studied d O
extensively e O
as O O
an O O
infant a O
. 
 O
Sixtieth t O
anniversary i O
of O O
Angiotensin i S-GENE
. 
 O
Inability b O
of O O
niacin c O
to O O
protect t O
from m O
in O O
vivo o O
hyperoxia e O
or O O
in O O
vitro r O
microsomal r O
lipid i O
peroxidation o O
. 
 O
MDA 	 O
- 
 O
MB O O
- 
 O
468 	 O
cells l O
were e O
stably b O
transfected n O
with h O
either h O
a 
 O
plasmid s O
having i O
a 
 O
CMV 	 O
promoter m O
- 
 O
driven v O
rabbit b O
beta a B-GENE
- - I-GENE
globin b I-GENE
gene e E-GENE
or O O
plasmids s O
having i O
a 
 O
CMV 	 O
promoter m O
- 
 O
driven v O
chimeric m O
gadd45 d B-GENE
5 
 I-GENE
" 
 I-GENE
- 
 I-GENE
UTR 	 I-GENE
- 
 I-GENE
rabbit b I-GENE
beta a I-GENE
- - I-GENE
globin b I-GENE
gene e E-GENE
, 
 O
where r O
the 	 O
entire i O
gadd45 d B-GENE
5 - I-GENE
" - I-GENE
- - I-GENE
UTR 	 E-GENE
( - O
from m O
+ - O
1 - O
to I O
+ - O
298 	 O
) - O
or O O
a 
 O
45 O O
bp O O
subfragment f O
of O O
the 	 O
gadd45 d B-GENE
5 - I-GENE
" - I-GENE
- - I-GENE
UTR 	 E-GENE
( - O
from m O
+ - O
10 I O
to I O
+ - O
55 I O
) - O
was 	 O
positioned i O
at O O
the 	 O
5 
 O
" 
 O
- 
 O
end 	 O
of O O
the 	 O
rabbit b B-GENE
beta a I-GENE
- - I-GENE
globin b I-GENE
gene e E-GENE
. 
 O
The 	 O
University v O
of O O
North t O
Carolina o O
caries i O
risk k O
assessment e O
was 	 O
conducted d O
between w O
1986 6 O
and 	 O
1989 9 O
with h O
5000 0 O
children l O
initially t O
in O O
grades d O
1 
 O
and 	 O
5 
 O
from m O
low 	 O
fluoride o O
sites e O
in O O
South t O
Carolina o O
and 	 O
Maine n O
. 
 O
Following l O
EGF 	 S-GENE
or O O
NGF 	 S-GENE
stimulation m O
of O O
the 	 O
v 
 B-GENE
- 
 I-GENE
CrkPC12 P E-GENE
cells l O
, 
 O
the 	 O
v - B-GENE
- - I-GENE
Crk 	 I-GENE
protein t E-GENE
itself e O
became a O
tyrosine o O
phosphorylated s O
within h O
1 
 O
min 	 O
. 
 O
BCR 	 S-GENE
- 
 O
ABL 	 S-GENE
expression r O
confers f O
cross s O
- 
 O
resistance i O
to O O
multiple t O
genotoxic o O
anticancer i O
drugs g O
by O O
inhibition i O
of O O
the 	 O
apoptotic p O
response p O
to O O
DNA 	 O
damage a O
in O O
association o O
with h O
cell l O
cycle l O
arrest e O
at O O
the 	 O
G2 O O
- 
 O
M 
 O
restriction t O
point n O
. 
 O
RESULTS U O
: 
 O
After e O
lavage a O
, 
 O
a 
 O
rapid i O
decrease r O
in O O
arterial e O
pH O O
and 	 O
PaO2 2 O
, 
 O
and 	 O
an O O
increase r O
in O O
PaCO2 O O
and 	 O
PIP 	 O
were e O
observed e O
in O O
all 	 O
animals m O
. 
 O
CONCLUSIONS C O
: 
 O
Elevation v O
of O O
TBARS R O
and 	 O
decrease r O
of O O
GSH 	 O
show w O
the 	 O
presence s O
of O O
oxidative d O
stress e O
during i O
the 	 O
PFD 	 O
treatment a O
with h O
hemodiafilter o O
SG3 	 O
. 
 O
Ozone n O
uptake a O
was 	 O
assessed e O
in O O
awake k O
, 
 O
spontaneously n O
breathing a O
Fischer c O
- 
 O
344 	 O
Sprague a O
- 
 O
Dawley l O
, 
 O
and 	 O
Long g O
- 
 O
Evans n O
rats s O
and 	 O
Hartley t O
guinea n O
pigs s O
to O O
provide v O
data a O
on O O
the 	 O
dosimetry i O
of O O
O3 O O
in O O
small l O
laboratory o O
animals m O
. 
 O
E 
 O
. 
 O
R 
 O
. 
 O
C 
 O
. 
 O
P 
 O
. 
 O
is O O
an O O
important o O
advance a O
in O O
diagnosis g O
. 
 O
Deletion e O
analysis l O
of O O
the 	 O
3 
 B-GENE
. 
 I-GENE
5kb 	 I-GENE
DNA 	 I-GENE
fragment g E-GENE
revealed e O
that t O
the 	 O
region i O
between w O
- 
 O
125 	 O
to O O
+ 
 O
1 
 O
, 
 O
containing t O
a 
 O
single g O
Sp1 	 B-GENE
binding d I-GENE
site e E-GENE
, 
 O
is O O
essential e O
for 	 O
transcription n O
of O O
the 	 O
embigin i B-GENE
gene e E-GENE
. 
 O
Resistance i O
to O O
Mup 	 S-GENE
was 	 O
classified s O
as O O
low 	 O
( 
 O
minimal i O
inhibitory i O
concentration c O
[ 
 O
MIC 	 O
] 
 O
> 
 O
or O O
= 
 O
8 
 O
microg r O
/ 
 O
mL O O
) 
 O
or O O
high h O
( 
 O
MIC 	 O
> 
 O
or O O
= 
 O
512 	 O
microg r O
/ 
 O
mL O O
) 
 O
degree r O
. 
 O
Extragonadal r O
endodermal o O
sinus u O
tumors o O
in O O
the 	 O
head d O
and 	 O
neck k O
are 	 O
very y O
rare e O
. 
 O
Lesions i O
of O O
this s O
kind d O
resemble e O
those s O
in O O
vitamin a O
A 
 O
- 
 O
deficient i O
chickens c O
and 	 O
are 	 O
the 	 O
first s O
to O O
be O O
induced u O
by O O
excess e O
vitamin a O
E 
 O
. 
 O
Essential e O
fatty t O
acid d O
deficiency i O
in O O
childhood l O
The 	 O
protein t B-GENE
kinase a I-GENE
C - E-GENE
inhibitor i O
GF O O
- 
 O
109203X 2 O
abolished l O
the 	 O
activation i O
by O O
phorbol r O
ester e O
and 	 O
inhibited i O
the 	 O
effect e O
of O O
CCK 	 S-GENE
by O O
78 O O
% 
 O
but 	 O
had 	 O
no O O
effect e O
on O O
EGF 	 S-GENE
- 
 O
activated i O
MAPK K S-GENE
activity i O
. 
 O
Activated i O
FGFR3 R S-GENE
predominantly d O
interacts e O
with h O
GRB2 2 S-GENE
. - O
Sos 	 S-GENE
in O O
complex p O
with h O
a 
 O
previously v O
identified n O
90 O O
- 
 O
kDa 	 O
protein t O
and 	 O
designated i O
protein t O
80K 	 B-GENE
- - I-GENE
H - E-GENE
. 
 O
The 	 O
rate e O
of O O
collagen l S-GENE
synthesis t O
in O O
normal m O
scar r O
was 	 O
approximately r O
constant s O
between w O
6 
 O
months t O
and 	 O
20 O O
years r O
after e O
the 	 O
initial t O
wounding n O
, 
 O
but 	 O
in O O
both h O
hypertrophic e O
scar r O
and 	 O
keloid o O
the 	 O
rate e O
was 	 O
initially t O
approximately r O
twice c O
that t O
in O O
normal m O
scar r O
, 
 O
and 	 O
2 
 O
- 
 O
3 
 O
years r O
after e O
wounding n O
it O O
fell l O
to O O
approximately r O
the 	 O
same e O
level e O
as O O
in O O
normal m O
scar r O
. 
 O
Evidence d O
for 	 O
a 
 O
role e O
of O O
Smad6 d S-GENE
in O O
chick c O
cardiac d O
development e O
. 
 O
Excellent e O
results u O
were e O
recorded o O
in O O
390 	 O
( 
 O
83 O O
. 
 O
69 O O
% 
 O
) 
 O
of O O
the 	 O
patients i O
, 
 O
improvement r O
in O O
46 O O
( 
 O
9 
 O
. 
 O
87 O O
% 
 O
) 
 O
where r O
in O O
the 	 O
majority o O
a 
 O
varicose i O
complex p O
was 	 O
involved o O
. 
 O
Mutational a O
analysis l O
of O O
yeast s B-GENE
CEG1 1 E-GENE
demonstrated o O
that t O
four r O
of O O
the 	 O
five e O
conserved s O
motifs i O
are 	 O
essential e O
for 	 O
capping p O
enzyme y O
function c O
in O O
vivo o O
. 
 O
We O O
report o O
on O O
a 
 O
case e O
discovered c O
in O O
a 
 O
13 O O
year r O
- 
 O
old 	 O
girl l O
presenting s O
with h O
anaemia e O
. 
 O
The 	 O
LIF 	 O
appeared e O
to O O
be O O
released e O
by O O
the 	 O
patient i O
' 
 O
s 
 O
peripheral i O
blood o O
lymphocytes p O
when n O
cultured t O
with h O
optimal i O
doses e O
of O O
propranolol p O
. 
 O
STUDY D O
SELECTION E O
: 
 O
Not 	 O
applicable l O
. 
 O
Co O O
- 
 O
expression r O
of O O
PLD1 1 S-GENE
in O O
COS 	 O
- 
 O
7 
 O
cells l O
with h O
the 	 O
two 	 O
recombinant o B-GENE
CK2 	 I-GENE
subunits u I-GENE
, 
 I-GENE
alpha h I-GENE
or O I-GENE
beta a E-GENE
, 
 O
suggests g O
that t O
the 	 O
association o O
of O O
PLD1 1 S-GENE
with h O
the 	 O
kinase a O
is O O
through o O
the 	 O
beta a O
subunit u O
. 
 O
For 	 O
capsules s O
containing t O
only y O
the 	 O
drug g O
, 
 O
the 	 O
value u O
of O O
T50 	 O
increased r O
as O O
the 	 O
particle t O
size e O
of O O
the 	 O
drug g O
decreased r O
. 
 O
The 	 O
LAB 	 O
in O O
the 	 O
cecum u O
( 
 O
mean n O
9 
 O
. 
 O
4 
 O
log 	 O
CFU 	 O
/ 
 O
g 
 O
) 
 O
increased r O
slightly g O
with h O
increasing r O
abattoir t O
holding d O
time e O
. 
 O
Our 	 O
objective e O
was 	 O
to O O
find d O
possible s O
predictors d O
for 	 O
the 	 O
expression r O
and 	 O
progression g O
of O O
LJM 	 S-GENE
and 	 O
to O O
evaluate l O
the 	 O
relationship a O
between w O
LJM 	 O
and 	 O
other e O
long g O
- 
 O
term m O
complications p O
of O O
insulin u S-GENE
- 
 O
dependent e O
diabetes b O
mellitus l O
. 
 O
Human a B-GENE
recombinant o I-GENE
erythropoietin t E-GENE
( 
 O
r - B-GENE
- - I-GENE
HuEPO P E-GENE
, 
 O
EprexR e S-GENE
) 
 O
was 	 O
administered i O
to O O
8 
 O
children l O
with h O
chronic o O
renal a O
failure l O
and 	 O
high h O
transfusion n O
requirement u O
. 
 O
CONCLUSIONS C O
: 
 O
LHB 	 O
is O O
simple p O
, 
 O
easy y O
and 	 O
safe e O
to O O
implement l O
, 
 O
and 	 O
is O O
the 	 O
only y O
technique h O
capable a O
of O O
maintaining n O
independent e O
upper e O
and 	 O
lower e O
body y O
perfusion f O
pressure s O
. 
 O
Northern t O
analyses l O
further t O
confirm f O
that t O
the 	 O
expression r O
of O O
endogenous o O
alpha h B-GENE
- - I-GENE
ENaC C I-GENE
gene e E-GENE
in O O
salivary i O
Pa O O
- 
 O
4 
 O
cells l O
is O O
suppressed p O
by O O
an O O
ectopic o O
HMGI I B-GENE
- - I-GENE
C - E-GENE
overexpression r O
. 
 O
Removal o O
of O O
cyclin l B-GENE
- - I-GENE
dependant e I-GENE
kinases a E-GENE
( 
 O
cdks s S-GENE
) 
 O
or O O
cdk2 2 S-GENE
from m O
these s O
extracts r O
using n O
affinity i O
matrices r O
severely e O
inhibits i O
initiation t O
of O O
S 
 O
phase s O
. 
 O
Gel 	 O
mobility i O
shift f O
analyses l O
reveal e O
that t O
FRTL L B-GENE
- 
 I-GENE
5 
 E-GENE
thyroid r O
cell l O
nuclear l O
extracts r O
form m O
a 
 O
specific c O
protein t O
/ 
 O
DNA 	 O
complex p O
with h O
this s O
region i O
, 
 O
which c O
is O O
prevented v O
by O O
the 	 O
TTF 	 B-GENE
- - I-GENE
1 - I-GENE
binding d I-GENE
element m E-GENE
from m O
the 	 O
TG B B-GENE
promoter m E-GENE
; 
 O
FRT 	 S-GENE
and 	 O
BRL 	 O
cell l O
nuclear l O
extracts r O
do O O
not 	 O
have e O
TTF 	 B-GENE
- - I-GENE
1 - E-GENE
and 	 O
do O O
not 	 O
form m O
this s O
complex p O
. 
 O
The 	 O
Sty1 1 B-GENE
kinase a E-GENE
is O O
stimulated m O
by O O
a 
 O
variety i O
of O O
different f O
stress e O
conditions d O
including l O
osmotic o O
and 	 O
oxidative d O
stress e O
and 	 O
heat t O
shock c O
. 
 O
No O O
viral a O
RNA 	 O
replication l O
could l O
be O O
detected e O
in O O
cells l O
transfected n O
with h O
mutant a O
RNAs s O
. 
 O
Acad d O
. 
 O
Comparison p O
of O O
the 	 O
genes e O
coding i O
for 	 O
mouse s O
and 	 O
human a B-GENE
p36 	 E-GENE
( 
 O
annexin e B-GENE
II E E-GENE
) 
 O
and 	 O
mouse s O
, 
 O
rat 	 O
and 	 O
human a B-GENE
p35 	 E-GENE
( 
 O
annexin e B-GENE
I - E-GENE
) 
 O
and 	 O
pigeon e O
cp35 5 S-GENE
( 
 O
an O O
annexin e B-GENE
I - I-GENE
- - I-GENE
related a I-GENE
protein t E-GENE
) 
 O
shows w O
strong o O
genomic o O
structural u O
conservation s O
supporting p O
the 	 O
hypothesis o O
that t O
these s O
genes e O
had 	 O
a 
 O
common m O
ancestor e O
. 
 O
When n O
incubated u O
with h O
infective e O
larvae v O
which c O
had 	 O
penetrated e O
mouse s O
skin n O
, 
 O
both h O
normal m O
and 	 O
immune u O
cells l O
attached a O
to O O
larvae v O
in O O
the 	 O
absence e O
of O O
serum u O
. 
 O
A 
 O
31 O O
- 
 O
year r O
- 
 O
old 	 O
man 	 O
with h O
primary m O
myelofibrosis l O
initially t O
received e O
low 	 O
dose e O
Ara 	 O
C 
 O
. 
 O
Collectively l O
, 
 O
these s O
studies d O
suggest g O
that t O
the 	 O
major o O
EGF 	 S-GENE
- 
 O
stimulated m O
mitotic o O
growth w O
pathways h O
may 	 O
not 	 O
be O O
absolutely o O
linked k O
to O O
the 	 O
stat91 t S-GENE
signaling n O
pathways h O
and 	 O
that t O
such h O
transcription n O
complexes p O
are 	 O
more e O
complex p O
than n O
previously v O
reported o O
. 
 O
FEurea r O
was 	 O
also o O
measured s O
during i O
stable b O
graft f O
function c O
, 
 O
7 
 O
- 
 O
14 O O
days s O
prior o O
to O O
allograft o O
dysfunction f O
. 
 O
Nonsuicidal s O
mortality t O
in O O
late e O
- 
 O
life e O
depression r O
. 
 O
Few 	 O
triers e O
or O O
users r O
had 	 O
received e O
SLT 	 O
counseling n O
from m O
their i O
dentist t O
despite p O
high h O
dental t O
utilization l O
rates e O
. 
 O
However e O
, 
 O
UV O O
resistance i O
is O O
only y O
minimally i O
restored t O
, 
 O
and 	 O
mutant a O
cells l O
remain a O
sensitive s O
to O O
gamma m O
radiation i O
. 
 O
The 	 O
oxalate l B-GENE
oxidase d E-GENE
method h O
results u O
in O O
a 
 O
mean n O
and 	 O
reference e O
interval e O
for 	 O
oxalate l O
excretion r O
that t O
are 	 O
comparable p O
with h O
those s O
by O O
isotope t O
dilution u O
, 
 O
gas 	 O
- 
 O
chromatographic o O
, 
 O
colorimetric o O
, 
 O
and 	 O
other e O
enzymic y O
procedures c O
. 
 O
In O O
addition i O
, 
 O
we O O
show w O
that t O
expression r O
of O O
antisense i O
mRNA A O
for 	 O
p130CAS 0 S-GENE
resulted u O
in O O
reversion e O
of O O
the 	 O
transformed n O
phenotype n O
of O O
all 	 O
these s O
cell l O
lines e O
. 
 O
Starches r O
had 	 O
no O O
effect e O
. 
 O
Maximal i O
Expiratory i O
Flow w O
Rates e O
such h O
as O O
Peak k O
Expiratory i O
Flow w O
Rate e O
( 
 O
PEFR R O
) 
 O
, 
 O
rates e O
at O O
25 O O
% 
 O
, 
 O
50 O O
% 
 O
and 	 O
75 O O
% 
 O
of O O
forced c O
vital a O
capacity a O
( 
 O
V 
 O
max 	 O
25 O O
% 
 O
, 
 O
V 
 O
max 	 O
50 O O
% 
 O
and 	 O
V 
 O
max 	 O
75 O O
% 
 O
) 
 O
and 	 O
forced c O
expiratory i O
flow w O
during i O
the 	 O
middle d O
half f O
of O O
forced c O
vital a O
capacity a O
( 
 O
FEF 	 O
25 O O
- 
 O
75 O O
% 
 O
) 
 O
were e O
measured s O
in O O
273 	 O
healthy l O
non 	 O
- 
 O
smoking k O
adults l O
( 
 O
144 	 O
males e O
, 
 O
129 	 O
females a O
) 
 O
aged d O
15 O O
- 
 O
63 O O
years r O
living i O
in O O
Madras r O
. 
 O
The 	 O
amino n O
acid d O
sequence u O
of O O
the 	 O
protein t O
encoded o O
by O O
MSK1 1 S-GENE
is O O
homologous o O
to O O
yeast s B-GENE
cytoplasmic o I-GENE
lysyl y I-GENE
- - I-GENE
tRNA A I-GENE
synthetase t E-GENE
and 	 O
to O O
the 	 O
product d O
of O O
the 	 O
herC C B-GENE
gene e E-GENE
, 
 O
which c O
has 	 O
recently e O
been n O
suggested g O
to O O
code e O
for 	 O
the 	 O
Escherichia h O
coli i O
enzyme y O
. 
 O
Similar i O
to O O
the 	 O
D - O
, 
 O
B - O
/ 
 O
B - O
' - O
and 	 O
E - B-GENE
proteins t E-GENE
, 
 O
the 	 O
F - B-GENE
and 	 I-GENE
G - I-GENE
proteins t E-GENE
do O O
not 	 O
possess s O
any 	 O
of O O
the 	 O
known w O
RNA 	 O
binding d O
motifs i O
, 
 O
suggesting g O
that t O
other e O
types e O
of O O
RNA 	 O
- 
 O
protein t O
interactions e O
occur u O
in O O
the 	 O
snRNP N O
core e O
. 
 O
These s O
observations e O
suggest g O
that t O
clr4 4 B-GENE
+ - E-GENE
and 	 O
rik1 1 B-GENE
+ - E-GENE
must t O
play y O
a 
 O
role e O
in O O
the 	 O
assembly e O
of O O
Swi6p 6 S-GENE
into o O
a 
 O
transcriptionally n O
silent e O
, 
 O
inaccessible c O
chromatin o O
structure u O
at O O
fission s O
yeast s O
centromeres t O
which c O
is O O
required u O
to O O
facilitate i O
interactions e O
with h O
spindle n O
microtubules r O
and 	 O
to O O
ensure u O
normal m O
chromosome o O
segregation r O
. 
 O
Characterization r O
of O O
a 
 O
DEAD D B-GENE
box 	 I-GENE
ATPase a E-GENE
/ 
 O
RNA 	 B-GENE
helicase i I-GENE
protein t I-GENE
of O I-GENE
Arabidopsis b I-GENE
thaliana l E-GENE
. 
 O
Amplitude l O
of O O
late e O
surface f O
( 
 O
P2 O O
and 	 O
N2 O O
) 
 O
and 	 O
depth t O
( 
 O
B 
 O
and 	 O
C 
 O
) 
 O
components p O
significantly n O
decreased r O
when n O
patients i O
shifted f O
from m O
SWS 	 O
IV O O
to O O
PS O O
and 	 O
increased r O
from m O
PS O O
to O O
W2 O O
. 
 O
Oligo g O
- 
 O
[ 
 O
alpha h O
] 
 O
- 
 O
deoxynucleotides x O
can 	 O
be O O
derived i O
by O O
stabilizing b O
( 
 O
intercalating e O
) 
 O
agents n O
or O O
reactive c O
groups u O
( 
 O
cleaving a O
reagents g O
, 
 O
cross s O
- 
 O
linkers k O
. 
 O
. 
 O
. 
 O
) 
 O
. 
 O
This s O
vector t O
should u O
be O O
applicable l O
for 	 O
high h O
- 
 O
throughput o O
characterization r O
of O O
new 	 O
open n O
reading d O
frames m O
found n O
in O O
genome o O
sequencing u O
. 
 O
The 	 O
subjects j O
were e O
17 O O
patients i O
with h O
android r O
obesity s O
( 
 O
four r O
men 	 O
and 	 O
13 O O
women e O
) 
 O
aged d O
21 O O
to O O
58 O O
years r O
with h O
a 
 O
body y O
mass s O
index e O
( 
 O
BMI 	 O
) 
 O
ranging g O
from m O
32 O O
. 
 O
0 
 O
to O O
52 O O
. 
 O
2 
 O
kg O O
/ 
 O
m2 O O
and 	 O
an O O
abdominal o O
- 
 O
gluteal t O
ratio i O
greater a O
than n O
1 
 O
. 
 O
0 
 O
. 
 O
No O O
universally v O
accepted e O
standardized n O
classification s O
system t O
for 	 O
acne e O
vulgaris g O
exists s O
, 
 O
although h O
there r O
is O O
a 
 O
strong o O
need d O
for 	 O
it O O
. 
 O
Blood o O
samples p O
for 	 O
determination e O
of O O
fibrinolytic r O
activity i O
and 	 O
factor t B-GENE
VIII I E-GENE
in O O
plasma s O
were e O
obtained a O
before o O
and 	 O
immediately e O
after e O
the 	 O
end 	 O
of O O
compression p O
and 	 O
application l O
of O O
a 
 O
stocking c O
, 
 O
respectively p O
. 
 O
Neither t O
symptoms p O
, 
 O
virions i O
, 
 O
nor 	 O
viral a O
RNA 	 O
was 	 O
detectable e O
in O O
plants n O
inoculated c O
with h O
this s O
mutant a O
or O O
a 
 O
mutant a O
with h O
a 
 O
frameshift m O
mutation a O
in O O
the 	 O
coat t O
gene e O
. 
 O
The 	 O
cumulative u O
length g O
of O O
the 	 O
RGSV V O
genome o O
, 
 O
including l O
RNAs s O
5 
 O
and 	 O
6 
 O
, 
 O
was 	 O
25142 4 O
nt O O
. 
 O
Risk k O
ratios i O
decreased r O
with h O
increasing r O
age 	 O
and 	 O
increased r O
with h O
number b O
of O O
breast a O
biopsies p O
, 
 O
family i O
history t O
of O O
breast a O
cancer c O
, 
 O
estrogen r O
use 	 O
, 
 O
time e O
between w O
screenings e O
, 
 O
no O O
comparison p O
with h O
previous v O
mammograms m O
, 
 O
and 	 O
the 	 O
radiologist i O
' 
 O
s 
 O
tendency d O
to O O
call l O
mammograms m O
abnormal o O
. 
 O
The 	 O
AtNMT1 M S-GENE
expression r O
profile f O
indicated i O
ubiquity q O
in O O
roots t O
, 
 O
stem m O
, 
 O
leaves v O
, 
 O
flowers w O
, 
 O
and 	 O
siliques i O
( 
 O
approximately r O
1 
 O
. 
 O
7 
 O
kb O O
transcript n O
and 	 O
approximately r O
50 O O
kDa 	 O
immunoreactive u O
polypeptide y O
) 
 O
but 	 O
a 
 O
greater a O
level e O
in O O
the 	 O
younger n O
tissue s O
, 
 O
which c O
are 	 O
developmentally e O
very y O
active i O
. 
 O
The 	 O
ossification i O
was 	 O
located a O
on O O
the 	 O
left t O
side e O
of O O
C3 O B-GENE
- 
 I-GENE
4 
 E-GENE
. 
 O
At O O
a 
 O
cutoff o O
point n O
for 	 O
KISA A O
% 
 O
of O O
100 	 O
, 
 O
280 	 O
of O O
281 	 O
participants t O
( 
 O
99 O O
. 
 O
6 
 O
% 
 O
) 
 O
were e O
correctly r O
classified s O
. 
 O
Following l O
replicate l O
control t O
measurements s O
, 
 O
test t O
ramps p O
were e O
repeated e O
in O O
the 	 O
presence s O
of O O
sodium i O
nitroprusside r O
( 
 O
1 
 O
microM r O
) 
 O
and 	 O
phentolamine n O
( 
 O
1 
 O
microM r O
) 
 O
to O O
eliminate m O
potential e O
smooth o O
muscle c O
and 	 O
alpha h B-GENE
1 - I-GENE
- - I-GENE
adrenoceptor e E-GENE
effects e O
, 
 O
respectively p O
. 
 O
Behavioral a O
effects e O
of O O
benzodiazepine z O
ligands a O
in O O
non 	 O
- 
 O
dependent e O
, 
 O
diazepam z O
- 
 O
dependent e O
and 	 O
diazepam z O
- 
 O
withdrawn h O
baboons o O
. 
 O
This s O
paper e O
reports o O
estimates i O
of O O
the 	 O
prevalence v O
of O O
mental t O
retardation a O
and 	 O
associated o O
factors t O
based e O
on O O
a 
 O
population u O
survey v O
of O O
2 
 O
- 
 O
to O O
9 
 O
- 
 O
year r O
- 
 O
old 	 O
children l O
in O O
Greater a O
Karachi a O
, 
 O
Pakistan i O
. 
 O
Thus s O
, 
 O
an O O
increase r O
in O O
lactate t O
concentration c O
of O O
the 	 O
magnitude n O
observed e O
during i O
alkali a O
therapy r O
need d O
not 	 O
indicate i O
a 
 O
worsening s O
of O O
the 	 O
metabolic a O
picture t O
in O O
lactic t O
acidosis d O
. 
 O
Adjusting u O
a 
 O
steady a O
- 
 O
state t O
warfarin f O
dose e O
depends e O
on O O
the 	 O
measured s O
INR 	 O
values u O
and 	 O
clinical n O
factors t O
: 
 O
the 	 O
dose e O
does s O
not 	 O
need d O
to O O
be O O
adjusted u O
for 	 O
a 
 O
single g O
INR 	 O
that t O
is O O
slightly g O
out 	 O
of O O
range g O
, 
 O
and 	 O
most t O
changes n O
should u O
alter e O
the 	 O
total a O
weekly k O
dose e O
by O O
5 
 O
% 
 O
to O O
20 O O
% 
 O
. 
 O
All 	 O
of O O
this s O
region i O
is O O
part t O
of O O
a 
 O
prominent m O
CpG 	 O
island a O
that t O
may 	 O
be O O
acting i O
as O O
an O O
extended e O
, 
 O
enhancer a O
- 
 O
independent e O
promoter m O
. 
 O
Comparison p O
of O O
Healon l O
and 	 O
Amvisc i S-GENE
. 
 O
Large g O
volumes u O
of O O
bone e O
marrow r O
may 	 O
be O O
required u O
for 	 O
certain t O
types e O
of O O
autologous o O
bone e O
marrow r O
transplants n O
. 
 O
Further t O
analysis l O
of O O
the 	 O
CAP59 5 B-GENE
locus u E-GENE
of I O
Cryptococcus p O
neoformans f O
: 
 O
structure u O
defined i O
by O O
forced c O
expression r O
and 	 O
description c O
of O O
a 
 O
new 	 O
ribosomal o O
protein t O
- - O
encoding o O
gene e O
. 
 O
We O O
speculate c O
that t O
the 	 O
enhancing a O
effect e O
of O O
glucose c O
and 	 O
galactose a O
on O O
fructose c O
absorption o O
may 	 O
be O O
due 	 O
to O O
activation i O
of O O
the 	 O
fructose c O
carrier r O
. 
 O
Virol o O
. 
 O
The 	 O
DFGF F B-GENE
- - I-GENE
R - I-GENE
protein t E-GENE
may 	 O
thus s O
participate t O
in O O
receiving e O
spatial t O
cues s O
that t O
guide d O
tracheal c O
cell l O
outgrowth g O
. 
 O
The 	 O
data a O
from m O
animal m O
experiments e O
indicate i O
that t O
the 	 O
incidence i O
of O O
solid i O
tumors o O
in O O
marrow r O
transplant n O
patients i O
may 	 O
still l O
rise e O
in O O
the 	 O
coming i O
decades a O
. 
 O
Patients i O
adopt p O
new 	 O
sets s O
based e O
partly t O
on O O
the 	 O
original g O
topic i O
and 	 O
partly t O
on O O
their i O
own 	 O
personal s O
idiosyncratic o O
concerns c O
. 
 O
The 	 O
NS B B-GENE
- - I-GENE
2 - I-GENE
isoforms f E-GENE
were e O
resolved o O
at O O
a 
 O
pI O O
value u O
close s O
to O O
5 
 O
. 
 O
5 
 O
as O O
three e O
groups u O
of O O
unevenly v O
phosphorylated s O
polypeptides y O
, 
 O
each h O
composed p O
of O O
at O O
least s O
two 	 O
protein t O
species c O
. 
 O
Prevalence v O
of O O
rheumatic u O
diseases e O
in O O
a 
 O
rural a O
population u O
in O O
western t O
India i O
: 
 O
a 
 O
WHO 	 O
- 
 O
ILAR R O
COPCORD C O
Study d O
. 
 O
A 
 O
. 
 O
nidulans u O
transformants n O
secreted r O
high h O
amounts u O
of O O
PGI 	 O
and 	 O
PGII I O
in O O
comparison p O
to O O
the 	 O
previously v O
characterized r O
A 
 O
. 
 O
niger e O
transformants n O
and 	 O
a 
 O
novel e O
polygalacturonase y S-GENE
( 
 O
PGC 	 S-GENE
) 
 O
was 	 O
produced d O
at O O
high h O
levels e O
by O O
A 
 O
. 
 O
nidulans u O
transformed n O
with h O
the 	 O
subcloned c O
pgaC C B-GENE
gene e E-GENE
. 
 O
This s O
interaction e O
is O O
functional c O
as O O
it O O
leads d O
to O O
retargeting a O
of O O
NF B B-GENE
- - I-GENE
kappa p I-GENE
B - I-GENE
p50 	 E-GENE
from m O
the 	 O
nucleus l O
to O O
the 	 O
cytoplasm o O
. 
 O
The 	 O
orf2 2 B-GENE
gene e I-GENE
product d E-GENE
is O O
a 
 O
protein t O
of O O
79 O O
amino n O
acids d O
with h O
characteristics r O
similar i O
to O O
those s O
of O O
the 	 O
Tat 	 S-GENE
( 
 O
transactivator n O
) 
 O
proteins t O
of O O
the 	 O
ungulate u O
lentiviruses t O
. 
 O
The 	 O
use 	 O
of O O
medication i O
is O O
of O O
minor o O
importance o O
in O O
the 	 O
treatment a O
of O O
flight g O
phobia b O
. 
 O
Elevated v O
total a O
serum u O
calcium c O
to O O
a 
 O
level e O
of O O
11 O O
. 
 O
9 
 O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
2 
 O
mg O O
/ 
 O
dl O O
( 
 O
p 
 O
less s O
than n O
0 
 O
. 
 O
001 	 O
compared p O
to O O
control t O
group u O
) 
 O
developed e O
in O O
the 	 O
gentamicin t O
/ 
 O
1 
 O
, 
 O
25 O O
( 
 O
OH O O
) 
 O
2 
 O
vitamin a O
D3 O O
group u O
on O O
day 	 O
4 
 O
, 
 O
2 
 O
days s O
prior o O
to O O
pronounced n O
structural u O
damage a O
, 
 O
and 	 O
continued t O
to O O
be O O
elevated v O
through o O
day 	 O
7 
 O
. 
 O
Rac2 2 S-GENE
, 
 O
a 
 O
member b O
of O O
the 	 O
Rho 	 B-GENE
family i E-GENE
of O O
GTPases a S-GENE
, 
 O
is O O
highly h O
expressed r O
in O O
myeloid l O
cells l O
and 	 O
is O O
a 
 O
regulator u O
of O O
the 	 O
NADPH P B-GENE
- - I-GENE
oxidase d I-GENE
complex p E-GENE
. 
 O
In O O
vitro r O
kinase a O
assays a O
on O O
isolated l O
microvilli r O
and 	 O
microvillar r O
fractions c O
enriched i O
in O O
the 	 O
putative a O
signal n O
transduction n O
particle t O
showed w O
a 
 O
high h O
specific c O
activity i O
of O O
tyrosine o B-GENE
kinase a E-GENE
activity i O
compared p O
to O O
that t O
of O O
membranes b O
from m O
EGF 	 B-GENE
receptor e E-GENE
- 
 O
overexpressing r O
A431 1 O
cells l O
maximally i O
activated i O
by O O
EGF 	 S-GENE
. 
 O
Effect e O
of O O
infantile a O
undernutrition e O
on O O
adult l O
sucrose r O
solution u O
consumption s O
in O O
the 	 O
rat 	 O
. 
 O
In O O
the 	 O
studies d O
described c O
in O O
this s O
report o O
, 
 O
we O O
have e O
identified n O
two 	 O
potential e O
Ets 	 B-GENE
binding d I-GENE
sites e E-GENE
, 
 O
EBS1 1 S-GENE
and 	 O
EBS2 2 S-GENE
, 
 O
which c O
are 	 O
conserved s O
in O O
both h O
the 	 O
human a O
and 	 O
murine i O
interleukin e B-GENE
- - I-GENE
2 - I-GENE
enhancers a E-GENE
. 
 O
KatA A S-GENE
, 
 O
AhpCF C S-GENE
, 
 O
heme e O
biosynthesis s O
enzymes y O
, 
 O
and 	 O
MrgA A S-GENE
are 	 O
also o O
induced u O
upon n O
entry r O
into o O
stationary t O
phase s O
under e O
conditions d O
of O O
iron n O
and 	 O
manganese g O
limitation i O
. 
 O
Although h O
the 	 O
Gly252Arg 2 S-GENE
substitution s O
observed e O
in O O
UM O O
: 
 O
JG5 	 O
is O O
non 	 O
- 
 O
conservative s O
, 
 O
it O O
was 	 O
not 	 O
possible s O
to O O
distinguish t O
whether t O
it O O
is O O
a 
 O
mutation a O
or O O
a 
 O
polymorphism y O
. 
 O
This s O
region i O
shows w O
46 O O
% 
 O
identity n O
with h O
the 	 O
calmodulin m B-GENE
- - I-GENE
binding d I-GENE
region i E-GENE
of O O
rat 	 B-GENE
brain i I-GENE
Ca2 	 I-GENE
+ - I-GENE
/ - I-GENE
calmodulin m I-GENE
- - I-GENE
dependent e I-GENE
protein t I-GENE
kinase a I-GENE
II E E-GENE
and 	 O
32 O O
% 
 O
identity n O
with h O
the 	 O
equivalent i O
region i O
of O O
chicken c B-GENE
smooth o I-GENE
muscle c I-GENE
myosin s I-GENE
light h I-GENE
chain i I-GENE
kinase a E-GENE
. 
 O
The 	 O
perforated f O
splint i O
gives e O
superior e O
results u O
by O O
virtue t O
of O O
the 	 O
fact t O
that t O
it O O
does s O
not 	 O
require u O
to O O
be O O
removed o O
for 	 O
purposes p O
of O O
hygiene i O
and 	 O
can 	 O
thus s O
produce d O
a 
 O
satisfactory i O
result u O
even n O
in O O
those s O
patients i O
who 	 O
fail l O
to O O
grasp s O
the 	 O
technique h O
of O O
removal o O
and 	 O
replacement l O
of O O
the 	 O
splint i O
. 
 O
It O O
contains t O
31 O O
exons n O
and 	 O
a 
 O
high h O
proportion p O
of O O
class s O
0 
 O
introns r O
, 
 O
alternative e O
splicing i O
of O O
which c O
results u O
in O O
significant n O
levels e O
of O O
variant i O
transcripts n O
that t O
maintain n O
the 	 O
original g O
open n O
reading d O
frame m O
of O O
MRP 	 B-GENE
mRNA A E-GENE
. 
 O
Issues u O
discussed c O
include l O
the 	 O
validity i O
of O O
the 	 O
MMPI I O
Mf O O
scale l O
, 
 O
questions s O
of O O
sample p O
representativeness r O
, 
 O
whether t O
" 
 O
straights a O
" 
 O
can 	 O
do O O
adequate q O
research e O
on O O
homosexuality o O
, 
 O
differences f O
in O O
heterosexual e O
and 	 O
homosexual o O
sexuality u O
, 
 O
the 	 O
role e O
of O O
subculture c O
acculturation u O
in O O
homosexual o O
psychological c O
adjustment u O
, 
 O
and 	 O
the 	 O
use 	 O
of O O
cluster s O
- 
 O
analysis l O
to O O
generate e O
typologies o O
of O O
homosexualities o O
. 
 O
A 
 O
brief e O
discussion c O
for 	 O
the 	 O
relationship a O
among n O
these s O
formulas m O
is O O
given e O
. 
 O
Lamivudine i O
therapy r O
for 	 O
acute t O
hepatitis a O
B 
 O
infection e O
following l O
peripheral i O
blood o O
stem m O
cell l O
transplantation n O
. 
 O
These s O
findings d O
suggest g O
that t O
NMDA A B-GENE
receptor e E-GENE
blockade c O
may 	 O
ameliorate l O
the 	 O
dyskinetic k O
complications p O
of O O
long g O
- 
 O
term m O
levodopa o O
therapy r O
, 
 O
without h O
diminishing i O
the 	 O
beneficial e O
effects e O
on O O
parkinsonian k O
signs n O
. 
 O
Furthermore t O
, 
 O
the 	 O
secondary o O
stress e O
responses p O
were e O
more e O
pronounced n O
and 	 O
the 	 O
ability l O
to O O
recover o O
from m O
them m O
seemed m O
to O O
be O O
impaired a O
in O O
exposed o O
fish h O
as O O
compared p O
to O O
unexposed x O
fish h O
. 
 O
The 	 O
distinct t O
spatial t O
pattern t O
of O O
expression r O
, 
 O
and 	 O
unusual s O
amino n O
acid d O
sequence u O
in O O
its 	 O
DNA 	 O
binding d O
domain a O
, 
 O
may 	 O
indicate i O
a 
 O
particular t O
role e O
for 	 O
DTEF F B-GENE
- - I-GENE
1 - E-GENE
in O O
cell l O
- 
 O
specific c O
gene e O
regulation u O
. 
 O
As O O
usual a O
tests t O
, 
 O
such h O
as O O
" 
 O
time e O
" 
 O
of O O
cephalin h S-GENE
are 	 O
slightly g O
sensible s O
to O O
LMW 	 S-GENE
- 
 O
Hep 	 S-GENE
, 
 O
only y O
anti i B-GENE
- 
 I-GENE
Xa O E-GENE
activity i O
can 	 O
be O O
used d O
. 
 O
Usher e O
syndrome d O
1C O O
( 
 O
USH1C 1 O
) 
 O
is O O
a 
 O
congenital g O
condition d O
manifesting i O
profound f O
hearing r O
loss s O
, 
 O
the 	 O
absence e O
of O O
vestibular t O
function c O
, 
 O
and 	 O
eventual n O
retinal i O
degeneration e O
. 
 O
Implantation l O
is O O
contraindicated t O
for 	 O
severe e O
dysplasia p O
of O O
the 	 O
cochlea h O
and 	 O
for 	 O
the 	 O
recently e O
described c O
variety i O
of O O
x 
 O
- 
 O
linked k O
deafness f O
with h O
deficient i O
bone e O
at O O
the 	 O
fundus d O
of O O
the 	 O
internal e O
auditory i O
meatus t O
. 
 O
Over r O
9 
 O
kb O O
of O O
DNA 	 O
sequence u O
was 	 O
obtained a O
for 	 O
one 	 O
clone n O
( 
 O
A1 O O
) 
 O
with h O
a 
 O
total a O
IGS 	 O
length g O
of O O
approximately r O
12 O O
. 
 O
4 
 O
kb O O
. 
 O
Scleraxis e O
overexpression r O
enhanced a O
expression r O
of O O
the 	 O
aggrecan r B-GENE
gene e E-GENE
, 
 O
which c O
is O O
not 	 O
normally m O
expressed r O
at O O
high h O
levels e O
in O O
these s O
osteoblastic e O
cells l O
. 
 O
This s O
study d O
demonstrates o O
that t O
the 	 O
exposure o O
to O O
sulphur p O
mustard t O
results u O
in O O
very y O
low 	 O
androgen r O
levels e O
and 	 O
hypo o O
- 
 O
responsiveness p O
to O O
GnRH H S-GENE
in O O
the 	 O
first s O
five e O
weeks k O
and 	 O
normalization m O
by O O
the 	 O
twelfth l O
week k O
after e O
injury u O
. 
 O
New 	 O
results u O
of O O
importance o O
for 	 O
optimization i O
of O O
the 	 O
postoperative t O
course r O
] 
 O
Complications p O
after e O
major o O
surgery g O
may 	 O
be O O
related a O
to O O
factors t O
in O O
the 	 O
surgical g O
stress e O
response p O
with h O
endocrine o O
- 
 O
metabolic a O
and 	 O
inflammatory l O
changes n O
. 
 O
Four r O
multicannulated t O
Holstein s O
steers e O
( 
 O
initial t O
BW O O
424 	 O
+ 
 O
/ 
 O
- 
 O
16 O O
kg O O
) 
 O
were e O
used d O
in O O
a 
 O
4 
 O
x 
 O
4 
 O
Latin i O
square a O
to O O
determine e O
the 	 O
influence l O
of O O
protein t O
supplementation p O
on O O
forage a O
intake a O
, 
 O
site e O
and 	 O
extent e O
of O O
digestion e O
, 
 O
and 	 O
nutrient r O
flow w O
in O O
steers e O
consuming s O
dormant m O
bluestem e O
- 
 O
range g O
forage a O
( 
 O
2 
 O
. 
 O
3 
 O
% 
 O
CP O O
) 
 O
. 
 O
Patients i O
with h O
risk k O
factors t O
were e O
compared p O
with h O
those s O
without h O
risk k O
factors t O
. 
 O
The 	 O
dermatoglyphic m O
pattern t O
demostrates o O
a 
 O
distal t O
triradius r O
and 	 O
small l O
whorl r O
abnormalities o O
. 
 O
The 	 O
term m O
Kartagener t O
syndrome d O
applies l O
to O O
this s O
syndrome d O
when n O
accompanied o O
by O O
infertility e O
and 	 O
dextrocardia t O
or O O
situs u O
inversus e O
. 
 O
Finally a O
, 
 O
we O O
tested t O
whether t O
activation i O
by O O
either h O
of O O
these s O
factors t O
is O O
dependent e O
on O O
components p O
of O O
the 	 O
SAGA A B-GENE
complex p E-GENE
. 
 O
Eight h O
of O O
the 	 O
17 O O
seropositive o O
patients i O
failed l O
to O O
develop e O
detectable e O
hepatitis a O
B - O
surface f O
antibody i O
within h O
three e O
months t O
of O O
the 	 O
third r O
injection e O
compared p O
with h O
only y O
one 	 O
of O O
the 	 O
18 O O
seronegative o O
patients i O
( 
 O
p 
 O
less s O
than n O
0 
 O
. 
 O
01 O O
) 
 O
. 
 O
The 	 O
antimicrobial i O
of O O
choice i O
for 	 O
initial t O
prophylactic p O
therapy r O
among n O
asymptomatic m O
pregnant g O
women e O
exposed o O
to O O
Bacillus i O
anthracis h O
is O O
ciprofloxacin r O
, 
 O
500 	 O
mg O O
twice c O
a 
 O
day 	 O
for 	 O
60 O O
days s O
. 
 O
Overexpression r O
of O O
eIF4E 4 S-GENE
transforms n O
cells l O
, 
 O
and 	 O
mutations a O
in O O
eIF4E 4 O
arrest e O
cells l O
in O O
G 
 O
, 
 O
in O O
cdc33 3 B-GENE
mutants a E-GENE
. 
 O
Benzyl z O
alcohol o O
administration i O
in O O
neonates n O
. 
 O
Repression r O
of O O
the 	 O
herpes p B-GENE
simplex p I-GENE
virus u I-GENE
1 - I-GENE
alpha h I-GENE
4 - I-GENE
gene e E-GENE
by O O
its 	 O
gene e O
product d O
( 
 O
ICP4 4 S-GENE
) 
 O
within h O
the 	 O
context t O
of O O
the 	 O
viral a O
genome o O
is O O
conditioned d O
by O O
the 	 O
distance t O
and 	 O
stereoaxial r O
alignment g O
of O O
the 	 O
ICP4 4 B-GENE
DNA 	 I-GENE
binding d I-GENE
site e E-GENE
relative a O
to O O
the 	 O
TATA A O
box 	 O
. 
 O
As O O
anticipated i O
, 
 O
both h O
intracellular r O
p54 	 S-GENE
- 
 O
SAPKbeta K S-GENE
activation i O
and 	 O
Bcl 	 B-GENE
- - I-GENE
2 - E-GENE
phosphorylation s O
are 	 O
blocked c O
by O O
co O O
- 
 O
transfection n O
with h O
the 	 O
MAP 	 B-GENE
kinase a E-GENE
specific c O
phosphatase s O
MKP3 3 S-GENE
/ 
 O
PYST1 T S-GENE
. 
 O
Relation a O
between w O
circulating c O
immune u O
complexes p O
and 	 O
serum u B-GENE
ferritin r E-GENE
in O O
hemosiderosis o O
of O O
different f O
etiologies o O
PATIENT I O
( 
 O
S 
 O
) 
 O
: 
 O
Two 	 O
hundred d O
thirty r O
- 
 O
eight h O
patients i O
with h O
RPLs s O
, 
 O
48 O O
patients i O
with h O
recurrent u O
IVF 	 O
- 
 O
ET O O
failure l O
and 	 O
179 	 O
nonpregnant p O
and 	 O
120 	 O
pregnant g O
control t O
group u O
women e O
. 
 O
Many y O
of O O
the 	 O
metabolic a O
effects e O
induced u O
by O O
thiazide a O
diuretics r O
, 
 O
however e O
, 
 O
can 	 O
be O O
limited i O
by O O
the 	 O
use 	 O
of O O
low 	 O
doses e O
. 
 O
Teboroxime o O
is O O
a 
 O
new 	 O
boronic o O
acid d O
adduct u O
of O O
technetium h O
dioxime x O
( 
 O
BATO O O
) 
 O
compound p O
that t O
demonstrates o O
favorable o O
characteristics r O
in O O
preliminary l O
studies d O
. 
 O
The 	 O
total a O
area a O
under e O
the 	 O
blood o O
glucose c O
curve v O
over r O
the 	 O
initial t O
value u O
was 	 O
not 	 O
altered e O
2 
 O
h 
 O
after e O
treatment a O
with h O
SH O O
B 
 O
209 	 O
AB O O
or O O
Neogynon g O
. 
 O
Treatment a O
of O O
excessive e O
bleeding e O
after e O
cardiopulmonary d O
bypass a O
was 	 O
based e O
on O O
an O O
algorithm o O
using n O
point n O
- 
 O
of O O
- 
 O
care e O
testing t O
with h O
whole l O
blood o O
prothrombin t S-GENE
time e O
, 
 O
activated i O
partial t O
thromboplastin o S-GENE
time e O
, 
 O
heparinase a S-GENE
activated i O
clotting t O
time e O
, 
 O
and 	 O
platelet t O
count n O
. 
 O
In O O
all 	 O
cases e O
, 
 O
a 
 O
large g O
fraction c O
of O O
soluble u O
Al O O
became a O
insoluble o O
in O O
the 	 O
stomach m O
after e O
ingestion e O
. 
 O
To O O
assess e O
the 	 O
safety e O
of O O
the 	 O
angiotensin i B-GENE
converting v I-GENE
enzyme y E-GENE
inhibitor i O
enalapril l O
a 
 O
multicenter t O
, 
 O
open n O
, 
 O
randomized d O
, 
 O
prazosin z O
- 
 O
controlled t O
trial a O
was 	 O
designed i O
comparing p O
the 	 O
incidence i O
and 	 O
severity e O
of O O
symptomatic p O
hypotension o O
on O O
the 	 O
first s O
day 	 O
of O O
treatment a O
. 
 O
Glucose c O
may 	 O
reduce u O
slightly g O
the 	 O
pool l O
of O O
amino n O
nitrogen r O
available i O
for 	 O
albumin u S-GENE
and 	 O
urea a O
synthesis t O
by O O
diverting e O
some e O
of O O
the 	 O
infused u O
amino n O
acids d O
from m O
protein t O
synthesis t O
by O O
the 	 O
liver e O
to O O
muscle c O
. 
 O
BACKGROUND K O
. 
 O
We O O
have e O
previously v O
reported o O
the 	 O
first s O
isolation l O
of O O
a 
 O
c - B-GENE
- - I-GENE
myc 	 E-GENE
- - O
null l O
cell l O
line e O
. 
 O
Results u O
demonstrated o O
that t O
for 	 O
both h O
S 
 O
. 
 O
europaea o O
and 	 O
A 
 O
. 
 O
prostrata s O
, 
 O
the 	 O
total a O
number b O
of O O
seeds d O
that t O
germinated m O
decreased r O
throughout o O
the 	 O
growing w O
season s O
. 
 O
A 
 O
nationwide i O
record o O
linkage k O
of O O
the 	 O
Finnish n O
Twin n O
Cohort o O
Study d O
( 
 O
FTCS S O
) 
 O
with h O
the 	 O
Hospital p O
Discharge c O
Registry i O
and 	 O
the 	 O
Registry i O
of O O
Rights h O
for 	 O
Free e O
medication i O
is O O
presented s O
. 
 O
Considering s O
these s O
two 	 O
facts t O
together e O
, 
 O
we O O
propose p O
that t O
vasectomy e O
may 	 O
lead d O
to O O
decrease r O
in O O
the 	 O
incidence i O
of O O
prostatic s O
tumors o O
- 
 O
a 
 O
disease e O
that t O
claims i O
nearly r O
22 O O
, 
 O
000 	 O
lives e O
each h O
year r O
in O O
the 	 O
United t O
States t O
alone n O
. 
 O
Antibodies i O
specific c O
to O O
the 	 O
different f O
members b O
of O O
the 	 O
Jun 	 S-GENE
and 	 O
Fos 	 B-GENE
family i E-GENE
of I O
transcription n O
factors t O
show w O
that t O
, 
 O
in O O
gel 	 O
retardation a O
assays a O
, 
 O
a 
 O
Jun 	 B-GENE
- - I-GENE
like e I-GENE
factor t E-GENE
is O O
a 
 O
component p O
of O O
the 	 O
H3 B B-GENE
. - I-GENE
2 - I-GENE
specific c I-GENE
complex p E-GENE
. 
 O
She 	 O
had 	 O
been n O
diagnosed g O
with h O
severe e O
aplastic a O
anemia m O
1 
 O
year r O
previously v O
and 	 O
, 
 O
while l O
hospitalized p O
, 
 O
had 	 O
received e O
methyl h O
prednisolone d O
pulse s O
therapy r O
, 
 O
which c O
was 	 O
not 	 O
successful c O
. 
 O
The 	 O
recombinant o B-GENE
L - I-GENE
/ - I-GENE
F - I-GENE
- - I-GENE
transferase n E-GENE
is O O
as O O
active i O
as O O
the 	 O
previously v O
purified i O
wild d O
type e O
enzyme y O
and 	 O
contains t O
no O O
detectable e O
RNA 	 O
component p O
. 
 O
Cord d O
formation m O
in O O
BACTEC T O
7H12 2 O
medium i O
for 	 O
rapid i O
, 
 O
presumptive s O
identification n O
of O O
Mycobacterium o O
tuberculosis e O
complex p O
. 
 O
Moreover e O
, 
 O
site e O
- 
 O
specific c O
integration e O
of O O
the 	 O
ITR 	 O
- 
 O
flanked n O
DNA 	 O
was 	 O
also o O
detected e O
by O O
PCR 	 O
amplification l O
of O O
the 	 O
ITR 	 B-GENE
- - I-GENE
aavs1 s E-GENE
junction c O
in O O
transduced n O
human a O
fibroblasts r O
. 
 O
Oct 	 B-GENE
- - I-GENE
1 - E-GENE
is O O
a 
 O
ubiquitously q O
expressed r O
regulatory u O
gene e O
of O O
the 	 O
POU 	 B-GENE
domain a I-GENE
family i E-GENE
. 
 O
In O O
both h O
study d O
stages g O
. 
 O
post t O
- 
 O
exposure o O
treatment a O
consisted s O
of O O
five e O
injections e O
of O O
vaccine c O
[ 
 O
( 
 O
D 
 O
) 
 O
ays 	 O
0 
 O
, 
 O
3 
 O
, 
 O
7 
 O
, 
 O
14 O O
, 
 O
28 O O
] 
 O
, 
 O
together e O
with h O
a 
 O
dose e O
of O O
rabies i B-GENE
immunoglobulin u E-GENE
( 
 O
RIG 	 S-GENE
) 
 O
of O O
equine i O
or O O
human a O
origin g O
on O O
D0 O O
. 
 O
( 
 O
3 
 O
) 
 O
With h O
the 	 O
exception e O
of O O
the 	 O
anteroposterior e O
direction e O
of O O
layers e O
II O O
- 
 O
- 
 O
III 	 O
and 	 O
the 	 O
mediolateral i O
direction e O
of O O
layer e O
IV O O
, 
 O
the 	 O
vertical t O
conductivity d O
of O O
the 	 O
cortex t O
was 	 O
always a O
greater a O
than n O
either h O
of O O
the 	 O
horizontal i O
conductivities d O
. 
 O
Our 	 O
study d O
investigated e O
the 	 O
hypothesis o O
that t O
the 	 O
combination b O
of O O
a 
 O
high h O
NaCl l O
diet t O
and 	 O
social i O
isolation l O
stress e O
would l O
increase r O
systolic t O
blood o O
pressure s O
( 
 O
SBP 	 O
) 
 O
and 	 O
endogenous o O
sodium i O
pump p O
ligands a O
( 
 O
SPL 	 O
) 
 O
, 
 O
ouabainlike b O
compound p O
( 
 O
OLC 	 O
) 
 O
, 
 O
and 	 O
marinobufagenin i O
( 
 O
MBG 	 O
) 
 O
. 
 O
The 	 O
relationship a O
between w O
polymorphonuclear y O
granulocytes n O
and 	 O
cartilage t O
destruction t O
in O O
rheumatoid u O
arthritis h O
. 
 O
It O O
is O O
suggested g O
that t O
the 	 O
loss s O
of O O
weight g O
, 
 O
the 	 O
decrease r O
in O O
food d O
intake a O
and 	 O
the 	 O
increase r O
in O O
brain i O
MOPEG E O
- 
 O
SO4 	 O
induced u O
by O O
cyanamide n O
reflect l O
possible s O
anorectic r O
properties p O
of O O
the 	 O
drug g O
. 
 O
RESULTS U O
: 
 O
Twenty n O
- 
 O
two 	 O
patients i O
( 
 O
30 O O
% 
 O
) 
 O
showed w O
ST O O
- 
 O
segment m O
depression r O
during i O
AEM 	 O
and 	 O
34 O O
( 
 O
49 O O
% 
 O
) 
 O
on O O
ExT 	 O
. 
 O
The 	 O
virus u O
must t O
progress g O
past t O
the 	 O
immediate e O
- 
 O
early l O
phase s O
and 	 O
express r O
an O O
early l O
gene e O
product d O
( - O
s - O
) - O
for 	 O
activation i O
of O O
cyclin l B-GENE
E - E-GENE
expression r O
. 
 O
In O O
CYP7A1 7 O
transgenic n O
mice e O
, 
 O
livers e O
contained t O
approximately r O
3 
 O
- 
 O
fold d O
more e O
sterol r B-GENE
response p I-GENE
element m I-GENE
- - I-GENE
binding d I-GENE
protein t I-GENE
- - I-GENE
2 - I-GENE
mRNA A E-GENE
. 
 O
Adenocarcinoma n O
and 	 O
large g O
cell l O
carcinoma c O
have e O
a 
 O
worse s O
prognosis g O
than n O
squamous a O
cell l O
carcinoma c O
in O O
the 	 O
T1N1 1 O
and 	 O
T2N1 1 O
subsets s O
. 
 O
In O O
group u O
I 
 O
during i O
the 	 O
pain n O
free e O
period i O
26 O O
of O O
81 O O
patients i O
had 	 O
positive i O
thallium l O
- 
 O
201 	 O
scans n O
, 
 O
whereas r O
20 O O
patients i O
had 	 O
an O O
abnormal o O
ECG 	 O
at O O
that t O
time e O
; 
 O
during i O
angina i O
18 O O
patients i O
had 	 O
transient n O
ECG 	 O
changes n O
. 
 O
The 	 O
prototype t O
now 	 O
structures u O
oncology o O
- 
 O
related a O
information o O
available i O
on O O
the 	 O
Internet e O
and 	 O
also o O
places c O
resources o O
maintained n O
locally a O
at O O
users r O
' 
 O
disposal p O
. 
 O
Binding d O
of O O
the 	 O
TorR R B-GENE
regulator u E-GENE
to O O
cis 	 O
- 
 O
acting i O
direct e O
repeats e O
activates i O
tor 	 B-GENE
operon r E-GENE
expression r O
. 
 O
For 	 O
the 	 O
most t O
part t O
, 
 O
only y O
aerobic o O
microbial r O
degradation r O
systems t O
have e O
been n O
reported o O
so O O
far 	 O
. 
 O
Asymptomatic m O
ischaemia h O
during i O
daily l O
life e O
in O O
stable b O
coronary o O
artery e O
disease e O
: 
 O
relevant e O
or O O
redundant u O
? 
 O
This s O
is O O
a 
 O
consensus s O
casein e B-GENE
kinase a I-GENE
II E E-GENE
( 
 O
CKII I S-GENE
) 
 O
site e O
and 	 O
, 
 O
using n O
purified i O
wild d O
- 
 O
type e O
and 	 O
mutant a O
proteins t O
, 
 O
we O O
show w O
that t O
it O O
is O O
the 	 O
main n O
CKII I B-GENE
site e E-GENE
in O O
the 	 O
body y O
of O O
the 	 O
N 
 O
- 
 O
terminal m O
complex p O
- 
 O
forming m O
region i O
. 
 O
In O O
contrast t O
to O O
Phase s O
III 	 O
, 
 O
which c O
has 	 O
a 
 O
single g O
study d O
design i O
- 
 O
- 
 O
the 	 O
controlled t O
, 
 O
randomized d O
, 
 O
double b O
- 
 O
blind n O
study d O
- 
 O
- 
 O
Phase s O
IV O O
requires u O
different f O
designs i O
for 	 O
each h O
of O O
the 	 O
many y O
different f O
questions s O
. 
 O
Treatment a O
with h O
polyinosinic y O
- 
 O
polycytidylic y O
acid d O
to O O
induce u O
expression r O
of O O
Cre 	 O
resulted u O
in O O
complete p O
disruption r O
of O O
the 	 O
Arnt t B-GENE
gene e E-GENE
and 	 O
loss s O
of O O
ARNT T B-GENE
messenger s I-GENE
RNA 	 E-GENE
( 
 O
mRNA A O
) 
 O
expression r O
in O O
liver e O
. 
 O
Physical s O
map 	 O
of O O
the 	 O
genome o O
of O O
sonchus c O
yellow l O
net 	 O
virus u O
, 
 O
a 
 O
plant n O
rhabdovirus b O
with h O
six 	 O
genes e O
and 	 O
conserved s O
gene e O
junction c O
sequences u O
. 
 O
Tubular u O
dysfunction f O
in O O
renal a O
lithiasis h O
: 
 O
cause s O
or O O
consequence s O
? 
 O
] 
 O
To O O
investigate e O
whether t O
overall r O
tubular u O
dysfunction f O
is O O
encountered o O
in O O
a 
 O
particular t O
subgroup g O
of O O
patients i O
with h O
urolithiasis l O
, 
 O
the 	 O
following l O
parameters a O
of O O
renal a O
tubular u O
function c O
have e O
been n O
measured s O
in O O
fasting t O
morning n O
urine n O
in O O
124 	 O
male e O
stone n O
formers m O
: 
 O
excretion r O
of O O
lysozyme o O
and 	 O
gamma m B-GENE
- - I-GENE
glutamyl t I-GENE
transpeptidase n E-GENE
( 
 O
gamma m B-GENE
- - I-GENE
GT E E-GENE
) 
 O
, 
 O
fractional c O
excretion r O
( 
 O
FE O O
) 
 O
or O O
glucose c O
, 
 O
insulin u S-GENE
, 
 O
bicarbonate a O
after e O
an O O
alkali a O
load d O
, 
 O
and 	 O
theoretical o O
phosphate s O
threshold e O
( 
 O
TmP 	 O
/ 
 O
GFR 	 O
) 
 O
. 
 O
Interaction e O
between w O
the 	 O
tobacco a O
DNA 	 O
- 
 O
binding d O
activity i O
CBF 	 S-GENE
and 	 O
the 	 O
cyt 	 B-GENE
- - I-GENE
1 - I-GENE
promoter m I-GENE
element m E-GENE
of O O
the 	 O
Agrobacterium o B-GENE
tumefaciens e I-GENE
T 
 I-GENE
- 
 I-GENE
DNA 	 I-GENE
gene e I-GENE
T - I-GENE
- - I-GENE
CYT 	 E-GENE
correlates r O
with h O
cyt 	 B-GENE
- - I-GENE
1 - E-GENE
directed e O
gene e O
expression r O
in O O
multiple t O
tobacco a O
tissue s O
types e O
. 
 O
As O O
expected e O
, 
 O
the 	 O
QOLS S O
- 
 O
N 
 O
had 	 O
a 
 O
lower e O
correlation r O
with h O
physical s O
health l O
( 
 O
r 
 O
= 
 O
0 
 O
. 
 O
24 O O
, 
 O
p 
 O
< 
 O
0 
 O
. 
 O
000 	 O
) 
 O
and 	 O
self f O
- 
 O
reported o O
symptoms p O
( 
 O
r 
 O
= 
 O
- 
 O
0 
 O
. 
 O
20 O O
, 
 O
p 
 O
< 
 O
0 
 O
. 
 O
001 	 O
) 
 O
, 
 O
and 	 O
a 
 O
higher h O
correlation r O
with h O
mental t O
health l O
( 
 O
r 
 O
= 
 O
0 
 O
. 
 O
52 O O
, 
 O
p 
 O
< 
 O
0 
 O
. 
 O
000 	 O
) 
 O
. 
 O
The 	 O
N1 O O
- 
 O
P2 O O
amplitudes l O
of O O
the 	 O
AEP 	 O
decreased r O
with h O
increasing r O
strength e O
of O O
muscular c O
innervation e O
. 
 O
SN O O
- 
 O
38 O O
rebound o O
concentrations c O
were e O
observed e O
in O O
many y O
courses r O
at O O
about u O
0 
 O
. 
 O
5 
 O
to O O
1 
 O
hour r O
following l O
the 	 O
end 	 O
of O O
the 	 O
i 
 O
. 
 O
v 
 O
. 
 O
infusion u O
, 
 O
which c O
is O O
suggestive g O
of O O
enterohepatic e O
recycling y O
. 
 O
Sequence u O
analysis l O
of O O
AEBP2 P B-GENE
cDNA A E-GENE
revealed e O
that t O
it O O
encodes o O
a 
 O
protein t O
containing t O
three e O
Gli 	 B-GENE
- 
 I-GENE
Kruppel p E-GENE
( 
 O
Cys2 2 O
- 
 O
His2 2 O
) 
 O
- 
 O
type e O
zinc c O
fingers g O
. 
 O
In O O
the 	 O
case e O
of O O
the 	 O
pT181 8 O
plasmid s O
, 
 O
inactivation c O
of O O
the 	 O
initiator t B-GENE
RepC C I-GENE
protein t E-GENE
occurs u O
by O O
the 	 O
attachment a O
of O O
an O O
oligonucleotide g O
to O O
its 	 O
active i O
tyrosine o O
residue i O
. 
 O
Xanthoepocin t O
, 
 O
a 
 O
new 	 O
antibiotic i O
from m O
Penicillium i O
simplicissimum p O
IFO5762 5 O
. 
 O
Extracellular r B-GENE
regulated u I-GENE
kinases a E-GENE
( - O
ERK 	 S-GENE
) - O
1 - S-GENE
and 	 O
ERK2 2 S-GENE
are 	 O
authentic h O
substrates s O
for 	 O
the 	 O
dual l B-GENE
- - I-GENE
specificity c I-GENE
protein t I-GENE
- - I-GENE
tyrosine o I-GENE
phosphatase s I-GENE
VHR 	 E-GENE
. 
 O
Leukocytoclasic k O
vasculitis c O
during i O
treatment a O
with h O
low 	 O
- 
 O
dose e O
captopril t O
H 
 O
. 
 O
Truncations n O
from m O
Hip 	 O
' 
 O
s 
 O
N 
 O
terminus m O
resulted u O
in O O
an O O
apparent a O
loss s O
of O O
Hip 	 O
homo o O
- 
 O
oligomerization g O
, 
 O
but 	 O
these s O
mutants a O
retained a O
association o O
with h O
hsp70 7 S-GENE
and 	 O
were e O
recovered o O
in O O
receptor e O
complexes p O
. 
 O
The 	 O
biological l O
basis i O
for 	 O
the 	 O
changes n O
in O O
CNAPs P O
produced d O
by O O
CS2 	 O
is O O
under e O
investigation e O
. 
 O
A 
 O
very y O
large g O
PC O O
LAN 	 O
as O O
the 	 O
basis i O
for 	 O
a 
 O
hospital p O
information o O
system t O
. 
 O
This s O
was 	 O
tragically g O
highlighted h O
by O O
the 	 O
death t O
of O O
a 
 O
17 O O
year r O
old 	 O
dental t O
nurse s O
after e O
taking i O
a 
 O
single g O
1 
 O
g 
 O
tablet l O
of O O
sodium i O
nitrite r O
. 
 O
The 	 O
human a O
protein t O
is O O
encoded o O
by O O
a 
 O
900 	 O
- 
 O
base e O
pair r O
- 
 O
long g O
mRNA A O
that t O
is O O
expressed r O
in O O
the 	 O
glandular n O
epithelial t O
cells l O
of O O
the 	 O
endometrium o O
in O O
a 
 O
cyclic l O
manner n O
; 
 O
in O O
addition i O
, 
 O
it O O
is O O
found n O
in O O
the 	 O
mucosal o O
epithelial t O
cells l O
of O O
the 	 O
fallopian l O
tubes e O
. 
 O
In O O
this s O
report o O
, 
 O
we O O
describe c O
a 
 O
patient i O
with h O
renal a O
cell l O
carcinoma c O
who 	 O
experienced e O
ventricular t O
tachycardia h O
while l O
undergoing e O
treatment a O
with h O
high h O
- 
 O
dose e O
bolus u O
IL B B-GENE
- - I-GENE
2 - E-GENE
. 
 O
Four r O
antifungal i O
agents n O
were e O
compared p O
: 
 O
amphotericin h O
B 
 O
, 
 O
flucytosine c O
, 
 O
miconazole o O
, 
 O
and 	 O
ketoconazole o O
. 
 O
The 	 O
regulatory u O
genes e O
cnrYXH Y S-GENE
have e O
been n O
cloned n O
, 
 O
overexpressed r O
, 
 O
and 	 O
purified i O
in O O
Escherichia h O
coli i O
. 
 O
Examination m O
of O O
the 	 O
Coomassie m O
- 
 O
stained i O
gels s O
revealed e O
that t O
the 	 O
capsid s O
- 
 O
like e O
particles t O
composed p O
of O O
the 	 O
N11 	 B-GENE
- - I-GENE
VP1 	 I-GENE
protein t E-GENE
did 	 O
not 	 O
contain t O
any 	 O
host t O
- 
 O
derived i O
histones t O
. 
 O
Conversion v O
of O O
an O O
NF B B-GENE
- - I-GENE
kappaB p E-GENE
into o O
a 
 O
GABP P B-GENE
binding d I-GENE
site e E-GENE
is O O
likely e O
to O O
have e O
occurred u O
also o O
during i O
the 	 O
worldwide l O
spread e O
of O O
HIV 	 O
- 
 O
1 
 O
, 
 O
as O O
we O O
noticed i O
the 	 O
same e O
LTR 	 O
modification i O
in O O
subtype t O
E 
 O
isolates l O
from m O
Thailand i O
. 
 O
Protein t O
binding d O
to O O
UAS1MLS1 1 S-GENE
was 	 O
observed e O
with h O
extracts r O
from m O
derepressed e O
but 	 O
not 	 O
from m O
repressed r O
cells l O
, 
 O
and 	 O
could l O
be O O
competed p O
for 	 O
by O O
an O O
excess e O
of O O
the 	 O
unlabelled a O
CSRE E S-GENE
( 
 O
ICL1 1 S-GENE
) 
 O
sequence u O
. 
 O
We O O
then n O
isolated l O
the 	 O
full l O
- 
 O
length g O
coding i O
region i O
of O O
the 	 O
human a B-GENE
BACH1 H I-GENE
gene e E-GENE
using n O
expressed r O
sequence u O
tags s O
, 
 O
reverse e O
transcription n O
- 
 O
polymerase y O
chain i O
reaction c O
and 	 O
rapid i O
amplification l O
of O O
cDNA A O
ends s O
. 
 O
Authors h O
present s O
the 	 O
anatomical t O
variations i O
of O O
the 	 O
course r O
of O O
the 	 O
inferior e O
mesenteric e O
artery e O
and 	 O
its 	 O
branches n O
in O O
62 O O
human a O
fetus u O
. 
 O
The 	 O
7 - O
. - O
2 - O
kb I O
EcoRI R B-GENE
fragment g E-GENE
of I O
AfMNPV N S-GENE
was 	 O
cloned n O
and 	 O
the 	 O
nucleotide l O
sequences u O
of O O
the 	 O
polyhedrin y B-GENE
coding i I-GENE
region i E-GENE
and 	 O
its 	 O
flanking n O
regions i O
were e O
determined e O
. 
 O
1 
 O
. 
 O
The 	 O
increments r O
in O O
median i O
plasma s B-GENE
secretin r E-GENE
concentration c O
were e O
1 
 O
. 
 O
6 
 O
, 
 O
3 
 O
. 
 O
0 
 O
, 
 O
and 	 O
6 
 O
. 
 O
4 
 O
pmol l O
x 
 O
1 
 O
( 
 O
- 
 O
1 
 O
) 
 O
after e O
secretin r S-GENE
, 
 O
125 	 O
, 
 O
250 	 O
and 	 O
500 	 O
fmol l O
x 
 O
kg O O
- 
 O
1 
 O
, 
 O
and 	 O
the 	 O
corresponding r O
15 O O
- 
 O
min 	 O
bicarbonate a O
output p O
283 	 O
, 
 O
442 	 O
, 
 O
and 	 O
1435 5 O
micromol r O
, 
 O
respectively p O
. 
 O
The 	 O
resulting u O
threshold e O
elevation v O
curves v O
fell l O
into o O
a 
 O
small l O
number b O
of O O
distinct t O
groups u O
, 
 O
suggesting g O
the 	 O
existence s O
of O O
discrete c O
spatial t O
frequency q O
mechanisms h O
in O O
human a O
central t O
vision i O
. 
 O
Because a O
c - B-GENE
- - I-GENE
myb 	 E-GENE
encodes o O
a 
 O
transcriptional n O
activator i O
that t O
functions c O
via 	 O
DNA 	 O
binding d O
, 
 O
it O O
is O O
likely e O
that t O
c - B-GENE
- - I-GENE
myb 	 E-GENE
exerts r O
its 	 O
biological l O
activity i O
by O O
regulating u O
the 	 O
transcription n O
of O O
genes e O
required u O
for 	 O
DNA 	 O
synthesis t O
and 	 O
cell l O
cycle l O
progression g O
. 
 O
The 	 O
rest t O
of O O
the 	 O
3 
 O
' 
 O
untranslated r O
sequences u O
were e O
common m O
to O O
both h O
cDNA A O
clones n O
. 
 O
Coexpression x O
of O O
c - B-GENE
- - I-GENE
Rel 	 E-GENE
in O O
combination b O
with h O
ATF 	 B-GENE
- - I-GENE
1 - E-GENE
, 
 O
CREB2 B S-GENE
, 
 O
or O O
ATF 	 B-GENE
- - I-GENE
1 - E-GENE
/ 
 O
CREB2 B S-GENE
leads d O
to O O
synergistic e O
transactivation n O
of O O
a 
 O
CD28RE 8 B-GENE
- - I-GENE
TRE 	 E-GENE
reporter o O
plasmid s O
in O O
quiescent e O
Jurkat k O
T 
 O
- 
 O
cells l O
. 
 O
Conventional v O
toxicological i O
considerations s O
suggest g O
that t O
the 	 O
adverse e O
health l O
effects e O
of O O
any 	 O
necessary e O
increase r O
in O O
coal l O
combustion b O
effluents l O
would l O
be O O
greatest a O
per 	 O
unit t O
of O O
coal l O
in O O
those s O
areas a O
which c O
are 	 O
most t O
heavily v O
populated u O
and 	 O
have e O
the 	 O
highest h O
preexisting e O
levels e O
of O O
the 	 O
gas 	 O
- 
 O
aerosol o O
complex p O
. 
 O
The 	 O
genes e O
on O O
each h O
chromosome o O
involved o O
in O O
this s O
translocation n O
have e O
been n O
identified n O
as O O
the 	 O
transcription n O
factor t O
- 
 O
encoding o O
genes e O
PAX3 3 S-GENE
and 	 O
FKHR R S-GENE
. 
 O
A 
 O
search r O
was 	 O
conducted d O
for 	 O
suppressors p O
of O O
the 	 O
inositol s O
auxotrophic o O
phenotype n O
of O O
the 	 O
ino4 4 B-GENE
- - I-GENE
8 - I-GENE
mutant a E-GENE
of O O
yeast s O
. 
 O
Anesthesia s O
was 	 O
induced u O
by O O
droperidol p O
0 
 O
. 
 O
2 
 O
mg O O
. 
 O
kg O O
- 
 O
1 
 O
, 
 O
fentanyl t O
50 O O
micrograms r O
, 
 O
thiamylal a O
150 	 O
- 
 O
250 	 O
mg O O
, 
 O
and 	 O
succinylcholine c O
1 
 O
mg O O
. 
 O
kg O O
- 
 O
1 
 O
, 
 O
and 	 O
maintained n O
with h O
nitrous r O
oxide d O
and 	 O
O2 O O
( 
 O
67 O O
: 
 O
33 O O
) 
 O
supplemented p O
with h O
repeated e O
i 
 O
. 
 O
v 
 O
. 
 O
doses e O
of O O
fentanyl t O
( 
 O
within h O
15 O O
micrograms r O
. 
 O
kg O O
- 
 O
1 
 O
) 
 O
. 
 O
Complexities p O
in O O
the 	 O
host t O
- 
 O
pathogen h O
interactions e O
during i O
actual u O
infection e O
with h O
Gram m O
- 
 O
negative a O
bacteria t O
may 	 O
account o O
for 	 O
the 	 O
difficulties f O
in O O
demonstrating o O
this s O
phenomena n O
in O O
vivo o O
. 
 O
This s O
novel e O
TRPC7 C B-GENE
gene e E-GENE
could l O
be O O
a 
 O
candidate d O
gene e O
for 	 O
genetic e O
disorders o O
such h O
as O O
bipolar o O
affective e O
disorder o O
, 
 O
nonsyndromic s O
hereditary e O
deafness f O
, 
 O
Knobloch b O
syndrome d O
, 
 O
and 	 O
holoprosencephaly o O
, 
 O
which c O
were e O
mapped p O
to O O
this s O
region i O
. 
 O
Paradoxically a O
, 
 O
loop p B-GENE
3i O E-GENE
from m O
the 	 O
M1Ach c B-GENE
- - I-GENE
muscarinic c I-GENE
receptor e E-GENE
also o O
maximally i O
inhibited i O
GnRH H S-GENE
agonist n O
- 
 O
stimulated m O
cAMP P O
accumulation u O
and 	 O
PRL 	 S-GENE
release e O
by O O
40 O O
% 
 O
( 
 O
both h O
effects e O
mediated i O
through o O
activation i O
of O O
the 	 O
Gs B B-GENE
protein t E-GENE
) 
 O
. 
 O
We O O
present s O
the 	 O
case e O
of O O
a 
 O
patient i O
who 	 O
presented s O
an O O
unusually s O
large g O
mucoid o O
cyst t O
measuring s O
38 O O
x 
 O
25 O O
mm O O
in O O
an O O
uncommon o O
localization a O
, 
 O
the 	 O
right h O
maxillary i O
. 
 O
Acoustic u O
- 
 O
property p O
measurements s O
of O O
the 	 O
oxide d O
superconductor e O
BaPb1 b O
- 
 O
xBixO3 x O
by O O
the 	 O
sphere e O
- 
 O
resonance o O
method h O
. 
 O
In O O
7 
 O
men 	 O
and 	 O
1 
 O
woman a O
who 	 O
died d O
suddenly d O
the 	 O
functionally c O
important o O
areas a O
of O O
myocardium c O
in O O
the 	 O
sino o O
- 
 O
auricular i O
area a O
and 	 O
the 	 O
subendocardial e O
layers e O
of O O
left t O
ventricle t O
were e O
obtained a O
by O O
necropsy r O
no O O
more e O
than n O
3 
 O
h 
 O
after e O
death t O
, 
 O
and 	 O
then n O
prepared p O
for 	 O
study d O
by O O
electron c O
microscopy r O
. 
 O
IGF 	 B-GENE
- - I-GENE
I - E-GENE
levels e O
were e O
measured s O
in O O
the 	 O
CSF 	 O
of O O
11 O O
children l O
with h O
autism i O
( 
 O
4 
 O
females a O
, 
 O
7 
 O
males e O
; 
 O
mean n O
age 	 O
3 
 O
. 
 O
8 
 O
years r O
, 
 O
SD O O
1 
 O
. 
 O
1 
 O
) 
 O
using n O
a 
 O
sensitive s O
radioimmunoassay i O
method h O
and 	 O
compared p O
with h O
levels e O
in O O
11 O O
control t O
participants t O
( 
 O
6 
 O
females a O
, 
 O
5 
 O
males e O
; 
 O
mean n O
age 	 O
3 
 O
. 
 O
8 
 O
years r O
) 
 O
. 
 O
In O O
a 
 O
subsequent s O
phase s O
- 
 O
II O O
clinical n O
trial a O
safety e O
and 	 O
efficacy i O
of O O
transrectal n O
HIFU U O
as O O
a 
 O
novel e O
minimally i O
invasive a O
treatment a O
modality a O
for 	 O
patients i O
with h O
symptomatic p O
benign i O
prostatic s O
hyperplasia e O
( 
 O
BPH 	 O
; 
 O
n 
 O
= 
 O
102 	 O
) 
 O
was 	 O
determined e O
. 
 O
Three e O
high h O
- 
 O
amylose l O
rice e O
varieties i O
, 
 O
IR42 2 O
, 
 O
IR36 6 O
, 
 O
and 	 O
IR62 2 O
, 
 O
with h O
similar i O
chemical m O
composition p O
including l O
amylose l O
content t O
( 
 O
26 O O
. 
 O
7 
 O
- 
 O
27 O O
. 
 O
0 
 O
% 
 O
) 
 O
, 
 O
were e O
cooked k O
under e O
the 	 O
same e O
conditions d O
and 	 O
tested t O
for 	 O
in O O
vitro r O
digestibility e O
as O O
well l O
as O O
blood o O
glucose c O
and 	 O
insulin u S-GENE
responses p O
in O O
healthy l O
human a O
volunteers u O
. 
 O
Slowly w O
adapting p O
type e B-GENE
I 
 I-GENE
mechanoreceptor h E-GENE
discharge c O
as O O
a 
 O
function c O
of O O
dynamic a O
force c O
versus s O
dynamic a O
displacement p O
of O O
glabrous b O
skin n O
of O O
raccoon c O
and 	 O
squirrel i O
monkey k O
hand d O
. 
 O
Using n O
beta a B-GENE
1 - I-GENE
- - I-GENE
AR E E-GENE
- 
 O
luciferase i S-GENE
reporter o O
recombinants o O
, 
 O
we O O
have e O
previously v O
determined e O
that t O
important o O
beta a B-GENE
1 - I-GENE
- - I-GENE
AR E E-GENE
genetic e O
elements m O
controlling t O
expression r O
within h O
the 	 O
C6 O O
glioma o O
cell l O
line e O
are 	 O
contained t O
within h O
the 	 O
region i O
- 
 O
396 	 O
to O O
- 
 O
299 	 O
, 
 O
relative a O
to O O
the 	 O
translational n O
start r O
site e O
. 
 O
FACS S O
analysis l O
demonstrated o O
that t O
MCs 	 O
had 	 O
reached c O
middle d O
to O O
late e O
G1 O O
phase s O
of O O
cell l O
cycle l O
progression g O
at O O
this s O
timepoint e O
. 
 O
Our 	 O
case e O
, 
 O
however e O
, 
 O
had 	 O
no O O
histologic t O
evidence d O
of O O
malignancy i O
, 
 O
no O O
serum u B-GENE
alpha h I-GENE
fetoprotein o E-GENE
at O O
7 
 O
months t O
of O O
age 	 O
, 
 O
and 	 O
no O O
recurrence u O
at O O
1 
 O
years r O
. 
 O
Analysis l O
of O O
tobacco a O
mRNA A O
using n O
the 	 O
ACBF F B-GENE
cDNA A E-GENE
as O O
probe b O
showed w O
that t O
while l O
ACBF F B-GENE
mRNA A E-GENE
was 	 O
present s O
in O O
all 	 O
tissues s O
examined m O
, 
 O
the 	 O
highest h O
transcript n O
accumulation u O
occurred u O
in O O
stem m O
tissues s O
. 
 O
Cotransfection r O
experiments e O
revealed e O
that t O
both h O
hGATA T B-GENE
- - I-GENE
4 - E-GENE
and 	 O
PMA 	 O
/ 
 O
A23187 1 O
stimulation m O
are 	 O
necessary e O
for 	 O
the 	 O
IL B B-GENE
- - I-GENE
5 - I-GENE
promoter m E-GENE
activation i O
. 
 O
Here e O
we O O
show w O
that t O
expression r O
of O O
KRAB B B-GENE
domain a E-GENE
suppresses p O
in O O
vivo o O
the 	 O
activating i O
function c O
of O O
various i O
defined i O
activating i O
transcription n O
factors t O
, 
 O
and 	 O
we O O
demonstrate o O
that t O
the 	 O
KRAB B B-GENE
domain a E-GENE
specifically c O
silences e O
the 	 O
activity i O
of O O
promoters m O
whose s O
initiation t O
is O O
dependent e O
on O O
the 	 O
presence s O
of O O
a 
 O
TATA A O
box 	 O
. 
 O
Adult l O
- 
 O
onset e O
parkinsonism k O
has 	 O
appeared e O
in O O
several e O
previously v O
unaffected f O
members b O
in O O
families i O
with h O
DRD 	 O
suggesting g O
that t O
this s O
may 	 O
be O O
an O O
additional i O
phenotypical n O
expression r O
of O O
the 	 O
disease e O
. 
 O
We O O
tested t O
the 	 O
effects e O
of O O
antifungal i O
drugs g O
on O O
adherence e O
of O O
Candida d O
albicans i O
in O O
vitro r O
. 
 O
The 	 O
signs n O
of O O
enterocolitis e O
, 
 O
pathological h O
microbial r O
flora r O
in O O
the 	 O
stool o O
and 	 O
changes n O
in O O
the 	 O
colon o O
mucosa o O
were e O
absent e O
. 
 O
These s O
results u O
support p O
an O O
in O O
vivo o O
interaction e O
between w O
Nck 	 S-GENE
and 	 O
CKI 	 B-GENE
- - I-GENE
gamma2 m E-GENE
and 	 O
suggest g O
that t O
CKI 	 B-GENE
- - I-GENE
gamma2 m E-GENE
could l O
be O O
involved o O
in O O
signaling n O
pathways h O
downstream n O
of O O
RTKs s S-GENE
. 
 O
Correlation r O
of O O
nitrogen r O
, 
 O
carbohydrate b O
and 	 O
lipid i O
metabolic a O
indices i O
in O O
rats s O
cooled l O
under e O
conditions d O
of O O
an O O
altered e O
gaseous e O
environment i O
Reactivation c O
of O O
hepatitis a O
B 
 O
virus u O
replication l O
is O O
a 
 O
rare e O
event n O
during i O
the 	 O
natural u O
history t O
of O O
chronic o O
hepatitis a O
B 
 O
. 
 O
A 
 O
minimal i O
region i O
which c O
stimulates m O
origin g O
function c O
mapped p O
to O O
50 O O
amino n O
acids d O
within h O
the 	 O
C 
 O
- 
 O
terminus m O
of O O
Abf1p 1 S-GENE
. 
 O
Cutaneous a O
melanoma a O
and 	 O
bilateral a O
retinoblastoma i O
. 
 O
Treatment a O
of O O
JEA2 2 O
cells l O
with h O
interleukin e B-GENE
( - I-GENE
IL I I-GENE
) - I-GENE
- - I-GENE
7 - E-GENE
induces u O
CBLB B S-GENE
phosphorylation s O
as O O
well l O
. 
 O
Phosphorylation s O
by O O
Cdc28 2 S-GENE
activates i O
the 	 O
Cdc20 2 S-GENE
- 
 O
dependent e O
activity i O
of O O
the 	 O
anaphase p B-GENE
- 
 I-GENE
promoting m I-GENE
complex p E-GENE
. 
 O
METHOD H O
: 
 O
After e O
eligibility g O
, 
 O
patients i O
were e O
randomly d O
allocated o O
in O O
one 	 O
of O O
the 	 O
following l O
groups u O
: 
 O
M 
 O
= 
 O
methylprednisolone h O
30 O O
mg O O
. 
 O
kg O O
- 
 O
1 
 O
over r O
1 
 O
hour r O
, 
 O
followed l O
by O O
5 
 O
. 
 O
4 
 O
mg O O
. 
 O
kg O O
- 
 O
1 
 O
. 
 O
h 
 O
- 
 O
1 
 O
for 	 O
23 O O
hours r O
, 
 O
N 
 O
= 
 O
nimodipine o O
0 
 O
. 
 O
015 	 O
mg O O
. 
 O
kg O O
- 
 O
1 
 O
. 
 O
h 
 O
- 
 O
1 
 O
over r O
2 
 O
hours r O
followed l O
by O O
0 
 O
. 
 O
03 O O
mg O O
. 
 O
kg O O
- 
 O
1 
 O
. 
 O
h 
 O
- 
 O
1 
 O
for 	 O
7 
 O
days s O
, 
 O
MN O O
or O O
P 
 O
. 
 O
The 	 O
amount u O
of O O
overlap r O
in O O
VFI 	 O
, 
 O
EF O O
, 
 O
and 	 O
RVF 	 O
values u O
among n O
the 	 O
clinical n O
groups u O
was 	 O
considerable s O
. 
 O
After e O
5 
 O
, 
 O
850 	 O
C14 	 O
BP O O
, 
 O
the 	 O
decrease r O
in O O
Acer r O
stands n O
could l O
be O O
attributed r O
to O O
fire e O
as O O
suggested g O
by O O
the 	 O
strong o O
increase r O
in O O
Betula u O
and 	 O
by O O
the 	 O
delayed a O
expansion a O
of O O
Pinus u O
cembra b O
. 
 O
Assays a O
of O O
APRE E S-GENE
- 
 O
luciferase i S-GENE
reporter o O
plasmids s O
transfected n O
into o O
HepG2 G O
cells l O
show w O
that t O
a 
 O
mutated a O
APRE E S-GENE
that t O
binds d O
only y O
BPi 	 S-GENE
functions c O
as O O
an O O
IL B B-GENE
- - I-GENE
1 - I-GENE
alpha h E-GENE
inducible u O
enhancer a O
, 
 O
whereas r O
a 
 O
mutated a O
APRE E S-GENE
that t O
binds d O
only y O
BPc 	 S-GENE
does s O
not 	 O
. 
 O
RNA 	 O
unwinding i O
in O O
U4 S S-GENE
/ 
 O
U6 S S-GENE
snRNPs N O
requires u O
ATP 	 O
hydrolysis r O
and 	 O
the 	 O
DEIH H B-GENE
- 
 I-GENE
box 	 I-GENE
splicing i I-GENE
factor t I-GENE
Brr2 2 E-GENE
. 
 O
Several e O
sequences u O
resembling e O
binding d O
sites e O
for 	 O
liver e O
- 
 O
and 	 O
fat 	 O
body y O
- 
 O
specific c O
transcription n O
factors t O
were e O
identified n O
within h O
1 
 O
kb O O
upstream t O
and 	 O
downstream n O
of O O
the 	 O
gene e O
. 
 O
Northern t O
blot t O
analysis l O
linked k O
Plk 	 S-GENE
expression r O
to O O
the 	 O
proliferative l O
activity i O
of O O
cells l O
and 	 O
tissues s O
. 
 O
It O O
also o O
showed w O
which c O
amino n O
acid d O
residues i O
would l O
contact t O
an O O
extended e O
TATA A O
box 	 O
with h O
a 
 O
B - O
recognition o O
element m O
, 
 O
and 	 O
evolutionary l O
conservation s O
of O O
the 	 O
TBP 	 B-GENE
- 
 I-GENE
TFB 	 I-GENE
- 
 I-GENE
DNA 	 I-GENE
complex p E-GENE
orientation e O
between w O
two 	 O
archaeal h O
organisms a O
with h O
widely e O
different f O
optimal i O
temperature p O
for 	 O
growth w O
( 
 O
37 O O
and 	 O
100 	 O
degrees r O
C 
 O
) 
 O
. 
 O
Studies d O
with h O
and 	 O
without h O
attenuating e O
media i O
were e O
performed f O
, 
 O
and 	 O
myocardium c O
- 
 O
to O O
- 
 O
defect e O
count n O
ratios i O
and 	 O
defect e O
sizes e O
from m O
dual l O
- 
 O
isotope t O
SPECT C O
images g O
were e O
compared p O
to O O
myocardium c O
- 
 O
to O O
- 
 O
defect e O
count n O
ratios i O
and 	 O
defect e O
sizes e O
from m O
single g O
- 
 O
isotope t O
( 
 O
201Tl T O
and 	 O
99mTc T O
) 
 O
SPECT C O
images g O
. 
 O
Comparison p O
of O O
this s O
gene e O
with h O
the 	 O
available i O
databases a O
reveals e O
very y O
significant n O
homology o O
to O O
the 	 O
ETS 	 B-GENE
factor t I-GENE
PE B I-GENE
- - I-GENE
1 - E-GENE
and 	 O
probable b O
near r O
- 
 O
identity n O
with h O
the 	 O
recently e O
cloned n B-GENE
factor t I-GENE
ERF 	 E-GENE
. 
 O
Patients i O
with h O
Eales e O
' 
 O
disease e O
, 
 O
chorioretinitis r O
, 
 O
central t O
serous o O
retinopathy i O
, 
 O
or O O
malignant i O
choroidal r O
melanoma a O
were e O
tested t O
for 	 O
HLA 	 B-GENE
antigen i E-GENE
deviation i O
. 
 O
Copyright y O
1999 9 O
Academic d O
Press s O
. 
 O
The 	 O
1 
 O
. 
 O
5 
 O
- 
 O
Mb O O
region i O
was 	 O
covered e O
by O O
137 	 O
cosmids m O
with h O
a 
 O
minimum i O
overlap r O
set 	 O
of O O
52 O O
cosmids m O
assigned i O
to O O
17 O O
bins s O
and 	 O
9 
 O
contigs t O
. 
 O
Similarly i O
, 
 O
beta a O
adrenoceptors e O
blockade c O
has 	 O
been n O
shown w O
to O O
be O O
of O O
value u O
in O O
achieving i O
continence t O
in O O
a 
 O
small l O
group u O
of O O
patients i O
. 
 O
Estrogen r O
has 	 O
positive i O
effects e O
on O O
mood d O
, 
 O
sexual u O
function c O
, 
 O
target g O
end 	 O
organs a O
and 	 O
cognitive n O
function c O
, 
 O
and 	 O
may 	 O
play y O
an O O
important o O
role e O
in O O
the 	 O
etiology o O
of O O
Alzheimer h O
' 
 O
s 
 O
Disease e O
by O O
acting i O
to O O
prevent v O
amyloid l O
plaque q O
formation m O
, 
 O
oxidative d O
stress e O
, 
 O
or O O
deterioration e O
of O O
the 	 O
cholinergic l O
neurotransmitter r O
system t O
. 
 O
These s O
data a O
also o O
demonstrate o O
that t O
insulin u S-GENE
and 	 O
TPA 	 S-GENE
activate i O
MBP 	 S-GENE
/ 
 O
MAP2 2 B-GENE
kinase a E-GENE
activity i O
by O O
de O O
novo o O
phosphorylation s O
of O O
threonine e O
and 	 O
tyrosine o O
residues i O
via 	 O
a 
 O
very y O
similar i O
pathway h O
. 
 O
Effect e O
of O O
capsaicin s O
on O O
hexobarbital o O
- 
 O
anesthetized s O
rats s O
Triethylene e O
glycol c O
. 
 O
Such h O
tetranucleotides r O
are 	 O
common m O
in O O
promoter m O
regions i O
, 
 O
particularly t O
in O O
activating i O
transcription n O
factor t O
/ 
 O
cyclic l B-GENE
AMP 	 I-GENE
response p I-GENE
element m I-GENE
- - I-GENE
binding d I-GENE
protein t E-GENE
( 
 O
ATF 	 S-GENE
/ 
 O
CREB B S-GENE
) 
 O
and 	 O
E 
 B-GENE
- 
 I-GENE
box 	 I-GENE
motifs i E-GENE
, 
 O
suggesting g O
that t O
PIF 	 S-GENE
may 	 O
modulate u O
the 	 O
transcription n O
of O O
many y O
genes e O
. 
 O
Red 	 O
blood o O
cell l O
binding d O
of O O
99mTc T O
- 
 O
EC O O
and 	 O
131I I O
- 
 O
OIH 	 O
was 	 O
6 
 O
. 
 O
1 
 O
% 
 O
and 	 O
20 O O
% 
 O
, 
 O
respectively p O
. 
 O
The 	 O
dominant i O
inhibitory i O
biological l O
activity i O
of O O
the 	 O
N 
 O
terminus m O
correlated r O
with h O
its 	 O
ability l O
to O O
impair a O
EGF 	 S-GENE
- 
 O
dependent e O
activation i O
of O O
GTP 	 B-GENE
- - I-GENE
Ras 	 E-GENE
and 	 O
of O O
MAP 	 B-GENE
kinase a E-GENE
, 
 O
as O O
well l O
with h O
the 	 O
ability l O
of O O
endogenous o O
Sos 	 S-GENE
to O O
form m O
a 
 O
stable b O
complex p O
with h O
activated i O
EGF 	 B-GENE
receptors e E-GENE
. 
 O
Brainstem i O
auditory i O
evoked k O
potential e O
responses p O
( 
 O
BAEPs P O
) 
 O
were e O
recorded o O
from m O
CZ O O
- 
 O
A1 O O
and 	 O
CZ O O
- 
 O
A2 O O
scalp l O
regions i O
in O O
23 O O
hypertensive e O
and 	 O
14 O O
normotensive m O
subjects j O
. 
 O
SM S S-GENE
binds d O
RNA 	 O
in O O
vitro r O
, 
 O
suggesting g O
that t O
sequence u O
- 
 O
or O O
structure u O
- 
 O
specific c O
mRNA A O
interactions e O
might h O
mediate i O
SM S S-GENE
specificity c O
. 
 O
The 	 O
characterization r O
of O O
fly 	 O
receptors e O
with h O
features t O
similar i O
to O O
mammalian m B-GENE
glycoprotein c I-GENE
hormone m I-GENE
receptors e E-GENE
allows o O
a 
 O
better t O
understanding e O
of O O
the 	 O
evolution l O
of O O
this s O
unique q O
group u O
of O O
GPCRs R S-GENE
and 	 O
future u O
elucidation c O
of O O
their i O
ligand a O
signaling n O
mechanisms h O
. 
 O
Here e O
we O O
show w O
that t O
these s O
sequences u O
are 	 O
essential e O
for 	 O
processing c O
of O O
U18 	 S-GENE
and 	 O
snR38 3 B-GENE
snoRNAs R E-GENE
and 	 O
that t O
they y O
compensate p O
for 	 O
the 	 O
lack k O
of O O
a 
 O
canonical o O
terminal m O
stem m O
. 
 O
The 	 O
use 	 O
of O O
aluminum m O
hydroxide r O
was 	 O
associated o O
with h O
an O O
increase r O
in O O
fecal a O
fluoride o O
excretion r O
and 	 O
a 
 O
decrease r O
in O O
net 	 O
absorption o O
of O O
fluoride o O
regardless a O
of O O
the 	 O
intake a O
fluoride o O
, 
 O
calcium c O
, 
 O
phosphorus s O
, 
 O
or O O
magnesium n O
. 
 O
In O O
humans a O
, 
 O
there r O
was 	 O
a 
 O
statistically t O
significant n O
decrease r O
of O O
TEWL L O
on O O
both h O
forearm e O
and 	 O
thigh g O
in O O
CS O O
- 
 O
treated a O
patients i O
compared p O
to O O
non 	 O
- 
 O
CS O O
- 
 O
treated a O
patients i O
and 	 O
controls t O
( 
 O
p 
 O
less s O
than n O
0 
 O
. 
 O
05 O O
) 
 O
. 
 O
Kramer m O
Hamburg b O
1988 8 O
, 
 O
ISBN N O
: 
 O
3 
 O
926952 9 O
07 O O
5 
 O
) 
 O
, 
 O
the 	 O
syndromatic d O
day 	 O
- 
 O
to O O
- 
 O
day 	 O
shifting f O
of O O
the 	 O
psychopathological c O
features t O
with h O
manic i O
, 
 O
depressive r O
and 	 O
several e O
mixed e O
states t O
has 	 O
a 
 O
well l O
- 
 O
defined i O
time e O
structure u O
, 
 O
as O O
in O O
25 O O
patients i O
studied d O
and 	 O
reported o O
on O O
in O O
this s O
paper e O
. 
 O
Ras 	 S-GENE
involvement o O
in O O
signal n O
transduction n O
by O O
the 	 O
serotonin o B-GENE
5 - I-GENE
- - I-GENE
HT2B B I-GENE
receptor e E-GENE
. 
 O
Analysis l O
of O O
exon n O
2 
 O
of O O
the 	 O
factor t B-GENE
IX I I-GENE
gene e E-GENE
revealed e O
a 
 O
C 
 O
- 
 O
- 
 O
> 
 O
T 
 O
mutation a O
in O O
codon o O
10 O O
of O O
the 	 O
propeptide p O
region i O
, 
 O
resulting u O
in O O
the 	 O
substitution s O
of O O
alanine n O
by O O
valine i O
. 
 O
There r O
was 	 O
a 
 O
direct e O
proportional p O
relationship a O
between w O
the 	 O
spiral r O
artery e O
flow w O
and 	 O
the 	 O
pressure s O
difference f O
between w O
the 	 O
spiral r O
artery e O
and 	 O
the 	 O
amniotic i O
fluid i O
; 
 O
the 	 O
pressure s O
difference f O
per 	 O
flow w O
( 
 O
the 	 O
resistance i O
of O O
the 	 O
cotyledonary y O
unit t O
) 
 O
was 	 O
found n O
to O O
be O O
1 
 O
- 
 O
- 
 O
3 
 O
mm O O
Hg O O
. 
 O
ml O O
- 
 O
1 
 O
. 
 O
min 	 O
( 
 O
8 
 O
- 
 O
- 
 O
24kPa P O
. 
 O
ml O O
- 
 O
1 
 O
. 
 O
s 
 O
) 
 O
. 
 O
Three e O
putative a O
ORFs s O
have e O
significant n O
homology o O
with h O
known w O
proteins t O
: 
 O
L0968 6 O
is O O
a 
 O
new 	 O
member b O
of O O
the 	 O
very y O
large g O
' - O
seripauperins i O
' - O
family i O
, 
 O
comprising p O
at O O
least s O
20 O O
yeast s O
members b O
; 
 O
L1313 1 O
is O O
a 
 O
new 	 O
ABC 	 B-GENE
transporter n E-GENE
highly h O
homologous o O
to O O
the 	 O
yeast s B-GENE
cadmium m I-GENE
resistance i I-GENE
protein t I-GENE
Ycf1p 1 E-GENE
and 	 O
to O O
the 	 O
human a B-GENE
multidrug t I-GENE
resistance i I-GENE
protein t I-GENE
hMRP1 P E-GENE
; 
 O
the 	 O
C 
 O
- 
 O
terminal m O
part t O
of O O
L1325 2 O
present s O
in O O
our 	 O
sequence u O
is O O
very y O
homologous o O
to O O
the 	 O
fruit i O
fly 	 O
abdominal o O
segment m O
formation m O
protein t O
Pumilio i O
. 
 O
The 	 O
cells l O
were e O
densely s O
ciliated i O
, 
 O
each h O
cilium i O
showing w O
a 
 O
typical i O
9 
 O
+ 
 O
2 
 O
fibrilar r O
pattern t O
. 
 O
Immunofluorescence u O
obtained a O
using n O
antibodies i O
against i O
alphaI h S-GENE
SigmaI m B-GENE
/ - I-GENE
+ - E-GENE
+ - O
betaI a S-GENE
SigmaI m B-GENE
spectrin c E-GENE
and 	 O
Abl 	 B-GENE
tyrosine o I-GENE
kinase a E-GENE
but 	 O
not 	 O
against i O
alphaII h S-GENE
/ - O
betaII a S-GENE
spectrin c S-GENE
colocalized o O
with h O
the 	 O
overexpressed r O
green e B-GENE
fluorescent o I-GENE
protein t I-GENE
- 
 I-GENE
SH3 	 I-GENE
- - I-GENE
binding d I-GENE
protein t E-GENE
. 
 O
Extracellular r B-GENE
protein t I-GENE
kinase a I-GENE
A - E-GENE
as O O
a 
 O
cancer c O
biomarker m O
: 
 O
its 	 O
expression r O
by O O
tumor o O
cells l O
and 	 O
reversal e O
by O O
a 
 O
myristate i O
- 
 O
lacking k O
Calpha p S-GENE
and 	 O
RIIbeta b B-GENE
subunit u E-GENE
overexpression r O
. 
 O
Detection e O
of O O
sinusoidal u O
gratings t O
by O O
pattern t O
- 
 O
specific c O
detectors e O
: 
 O
further t O
evidence d O
for 	 O
the 	 O
correlation r O
principle n O
in O O
human a O
vision i O
. 
 O
This s O
B 
 O
- 
 O
box 	 O
is O O
not 	 O
present s O
in O O
ETS1 1 S-GENE
, 
 O
ETS2 2 S-GENE
, 
 O
PEA3 3 S-GENE
or O O
PU B B-GENE
. - I-GENE
1 - E-GENE
and 	 O
these s O
proteins t O
were e O
unable b O
to O O
form m O
ternary n O
complexes p O
with h O
SRF 	 S-GENE
and 	 O
Egrl l S-GENE
- 
 O
SREs s S-GENE
or O O
c - B-GENE
- - I-GENE
fos 	 I-GENE
SRE 	 E-GENE
. 
 O
MADS S B-GENE
- - I-GENE
box 	 I-GENE
genes e E-GENE
in O O
plants n O
are 	 O
a 
 O
diverse e O
class s O
of O O
transcription n O
factors t O
that t O
are 	 O
involved o O
in O O
regulating u O
developmental e O
processes c O
, 
 O
particularly t O
meristem i O
and 	 O
organ a O
identity n O
during i O
floral r O
development e O
. 
 O
Elevated v O
systolic t O
blood o O
pressure s O
and 	 O
high h O
postglucose t O
serum u B-GENE
insulin u E-GENE
levels e O
showed w O
an O O
independent e O
, 
 O
significant n O
association o O
with h O
left t O
ventricular t O
mass s O
in O O
female a O
diabetic b O
subjects j O
. 
 O
This s O
study d O
investigated e O
if O O
signal n O
- 
 O
averaged r O
low 	 O
amplitude l O
atrial i O
potentials e O
predict d O
atrial i O
fibrillation r O
or O O
flutter t O
( 
 O
AFF 	 O
) 
 O
. 
 O
Thirty r O
- 
 O
five e O
pts 	 O
were e O
transplanted n O
for 	 O
constitutional s O
disease e O
: 
 O
Fanconi c O
anemia m O
( 
 O
FA O O
) 
 O
( 
 O
26 O O
pts 	 O
) 
 O
, 
 O
Dyskeratosis k O
congenita g O
( 
 O
2 
 O
pts 	 O
) 
 O
, 
 O
Blackfan c O
- 
 O
Diamond m O
erythroblastopenia t O
( 
 O
2 
 O
pts 	 O
) 
 O
, 
 O
Glanzmann n O
thrombasthenia o O
( 
 O
1 
 O
pt O O
) 
 O
, 
 O
osteopetrosis e O
( 
 O
1 
 O
pt O O
) 
 O
and 	 O
Gaucher c O
' 
 O
s 
 O
disease e O
( 
 O
1 
 O
pt O O
) 
 O
. 
 O
Viral a B-GENE
protein t I-GENE
U - E-GENE
( 
 O
Vpu 	 S-GENE
) 
 O
is O O
a 
 O
protein t O
encoded o O
by O O
human a O
immunodeficiency u O
virus u O
type e O
1 
 O
( 
 O
HIV 	 O
- 
 O
1 
 O
) 
 O
that t O
promotes m O
the 	 O
degradation r O
of O O
the 	 O
virus u O
receptor e O
, 
 O
CD4 	 S-GENE
, 
 O
and 	 O
enhances a O
the 	 O
release e O
of O O
virus u O
particles t O
from m O
cells l O
. 
 O
Because a O
the 	 O
variation i O
in O O
the 	 O
carbohydrate b O
content t O
of O O
human a O
milk k O
is O O
very y O
small l O
, 
 O
a 
 O
more e O
simple p O
alternative e O
approach r O
would l O
be O O
to O O
include l O
only y O
an O O
average r O
carbohydrate b O
value u O
for 	 O
an O O
estimate i O
of O O
energy r O
content t O
. 
 O
Level e O
II O O
mosaicism a O
occurred u O
in O O
0 
 O
. 
 O
9 
 O
per 	 O
cent t O
of O O
CVS 	 O
mesenchyme e O
and 	 O
1 
 O
. 
 O
5 
 O
per 	 O
cent t O
of O O
amniotic i O
fluid i O
cultures t O
and 	 O
in O O
general e O
was 	 O
not 	 O
perceived c O
to O O
be O O
of O O
sufficient f O
concern c O
to O O
warrant r O
cytogenetic o O
follow l O
- 
 O
up O O
studies d O
. 
 O
Biol l O
. 
 O
IV O O
. 
 O
Sleeping e O
position i O
and 	 O
sudden d O
infant a O
death t O
syndrome d O
( 
 O
SIDS S O
) 
 O
: 
 O
effect e O
of O O
an O O
intervention e O
programme g O
to O O
avoid i O
prone n O
sleeping e O
. 
 O
CSEn n S-GENE
stimulated m O
transcription n O
of O O
a 
 O
variety i O
of O O
promoters m O
, 
 O
including l O
the 	 O
hCS 	 S-GENE
, 
 O
human a B-GENE
growth w I-GENE
hormone m E-GENE
, 
 O
thymidine m B-GENE
kinase a E-GENE
, 
 O
and 	 O
Rous s B-GENE
sarcoma c I-GENE
virus u I-GENE
promoters m E-GENE
, 
 O
in O O
human a O
choriocarcinoma r O
cell l O
lines e O
( 
 O
BeWo o O
and 	 O
JEG 	 O
- 
 O
3 
 O
) 
 O
but 	 O
not 	 O
HeLa a O
cells l O
or O O
rat 	 O
somatolactotrophes a O
( 
 O
GC O O
) 
 O
. 
 O
Pretreatment t O
of O O
human a O
skin n O
with h O
tRA 	 S-GENE
inhibited i O
UV O O
induction u O
of O O
c - B-GENE
- - I-GENE
Jun 	 I-GENE
protein t E-GENE
and 	 O
, 
 O
consequently s O
, 
 O
AP B B-GENE
- - I-GENE
1 - E-GENE
. 
 O
c - B-GENE
- - I-GENE
Jun 	 I-GENE
protein t E-GENE
inhibition i O
occurred u O
via 	 O
a 
 O
posttranscriptional t O
mechanism h O
, 
 O
since c O
tRA 	 S-GENE
did 	 O
not 	 O
inhibit i O
UV O O
induction u O
of O O
c - B-GENE
- - I-GENE
Jun 	 I-GENE
mRNA A E-GENE
. 
 O
Thus s O
, 
 O
apoptosis p O
in O O
hematopoietic a O
cells l O
is O O
the 	 O
end 	 O
result u O
of O O
a 
 O
conflict f O
between w O
death t O
and 	 O
survival v O
signals n O
, 
 O
rather h O
than n O
a 
 O
simple p O
death t O
by O O
default a O
. 
 O
Effect e O
of O O
age 	 O
on O O
glucose c O
, 
 O
reducing u O
sugars a O
and 	 O
plasma s B-GENE
insulin u E-GENE
in O O
blood o O
of O O
milk k O
- 
 O
fed 	 O
calves v O
. 
 O
CONCLUSIONS C O
: 
 O
Results u O
of O O
this s O
study d O
suggest g O
that t O
both h O
male e O
and 	 O
female a O
soldiers d O
who 	 O
are 	 O
diagnosed g O
with h O
chlamydia a O
infections e O
have e O
relatively a O
high h O
risks k O
of O O
reinfection n O
through o O
their i O
20s 	 O
. 
 O
During i O
seed d O
maturation u O
, 
 O
the 	 O
transcriptional n O
activity i O
of O O
napin i B-GENE
genes e E-GENE
is O O
regulated u O
by O O
developmental e O
signals n O
involving o O
the 	 O
transcriptional n O
activator i O
ABI3 3 S-GENE
and 	 O
abscisic c O
acid d O
( 
 O
ABA 	 O
) 
 O
. 
 O
DESIGN I O
: 
 O
Intradermally r O
injected e O
human a O
squamous a O
cell l O
carcinoma c O
cells l O
were e O
grown w O
to O O
40 O O
to O O
80 O O
mm3 	 O
in O O
athymic y O
nude e O
mice e O
and 	 O
irradiated a O
with h O
675 	 O
- 
 O
nm O O
light h O
( 
 O
75 O O
J 
 O
/ 
 O
cm2 	 O
, 
 O
75 O O
mW O O
/ 
 O
cm2 	 O
) 
 O
24 O O
hours r O
after e O
the 	 O
intraperitoneal r O
injection e O
of O O
SiPc c O
IV O O
( 
 O
1 
 O
. 
 O
0 
 O
mg O O
/ 
 O
kg O O
) 
 O
. 
 O
This s O
results u O
in O O
a 
 O
decreased r O
secretion r O
of O O
immunoglobulin u B-GENE
A - E-GENE
, 
 O
and 	 O
, 
 O
consequently s O
, 
 O
a 
 O
decreased r O
resistance i O
against i O
infections e O
. 
 O
The 	 O
absolute o O
CD4 	 S-GENE
count n O
of O O
patients i O
with h O
de O O
novo o O
IBD 	 O
was 	 O
210 	 O
- 
 O
700 	 O
cells l O
/ 
 O
ml O O
at O O
the 	 O
time e O
of O O
IBD 	 O
. 
 O
Categorisation e O
of O O
the 	 O
different f O
substructures s O
within h O
the 	 O
sections t O
allows o O
them m O
to O O
be O O
analysed l O
and 	 O
displayed p O
separately a O
. 
 O
To O O
study d O
the 	 O
mechanisms h O
and 	 O
the 	 O
signaling n O
pathways h O
involved o O
, 
 O
IGF 	 B-GENE
- - I-GENE
1R I I-GENE
promoter m I-GENE
reporter o I-GENE
constructs s E-GENE
were e O
transiently n O
transfected n O
in O O
CHO 	 O
- 
 O
AT1 	 O
cells l O
that t O
overexpress r O
angiotensin i B-GENE
AT1 	 I-GENE
receptors e E-GENE
. 
 O
With h O
this s O
study d O
, 
 O
a 
 O
total a O
of O O
13 O O
operators r O
for 	 O
the 	 O
glp 	 B-GENE
regulon u E-GENE
have e O
been n O
characterized r O
. 
 O
Natl l O
. 
 O
Coexpression x O
of O O
a 
 O
dominant i O
negative a O
c - B-GENE
- - I-GENE
jun 	 E-GENE
antagonized a O
the 	 O
ras 	 S-GENE
- 
 O
dependent e O
stimulation m O
of O O
the 	 O
92 B B-GENE
- - I-GENE
kDa 	 I-GENE
gelatinase a I-GENE
B - I-GENE
promoter m I-GENE
- 
 I-GENE
driven v I-GENE
CAT 	 I-GENE
reporter o E-GENE
. 
 O
In O O
two 	 O
patients i O
, 
 O
a 
 O
male e O
homosexual o O
and 	 O
an O O
hemophiliac o O
, 
 O
thrombocytopenia o O
was 	 O
associated o O
with h O
AIDS S O
- 
 O
related a O
complex p O
. 
 O
However e O
, 
 O
LXRalpha a S-GENE
inhibited i O
binding d O
of O O
PPARalpha R S-GENE
/ 
 O
RXRalpha a S-GENE
heterodimers e O
to O O
PPREs E S-GENE
, 
 O
and 	 O
coexpression x O
of O O
LXRalpha a S-GENE
in O O
mammalian m O
cells l O
antagonized a O
peroxisome o O
proliferator l O
signaling n O
mediated i O
by O O
PPARalpha R S-GENE
/ 
 O
RXRalpha a S-GENE
in O O
vivo o O
. 
 O
The 	 O
results u O
can 	 O
be O O
summarized m O
as O O
follows l O
. 
 O
A 
 O
case e O
of O O
heterotopic e O
gastric t O
mucosa o O
( 
 O
pyloric o O
gland n O
) 
 O
in O O
the 	 O
wall l O
of O O
the 	 O
gallbladder l O
was 	 O
reported o O
. 
 O
These s O
findings d O
suggest g O
that t O
the 	 O
mechanism h O
of O O
ribosomal o O
frameshifting m O
at O O
the 	 O
PVM 	 O
signal n O
is O O
different f O
from m O
the 	 O
one 	 O
described c O
by O O
the 	 O
' 
 O
simultaneous u O
slippage p O
' 
 O
model e O
in O O
that t O
only y O
the 	 O
string i O
of O O
four r O
adenosine n O
nucleotides l O
represents r O
the 	 O
slippery p O
sequence u O
involved o O
in O O
a 
 O
- 
 O
1 
 O
P 
 O
- 
 O
site e O
slippage p O
. 
 O
CTDK1 K S-GENE
and 	 O
CTDK2 K S-GENE
also o O
differ f O
in O O
their i O
protein t O
substrate s O
specificity c O
. 
 O
This s O
communication m O
presents s O
two 	 O
patients i O
with h O
clinically n O
massive s O
PE O O
of O O
recent e O
onset e O
( 
 O
confirmed f O
by O O
lung g O
perfusion f O
scans n O
) 
 O
who 	 O
were e O
successfully c O
treated a O
with h O
a 
 O
single g O
i 
 O
. 
 O
v 
 O
. 
 O
dose e O
of O O
30 O O
mg O O
of O O
anisoylated s O
lys 	 B-GENE
- - I-GENE
plasminogen s I-GENE
streptokinase e I-GENE
activator i I-GENE
complex p E-GENE
( 
 O
APSAC A O
, 
 O
comparable p O
to O O
1 
 O
, 
 O
500 	 O
, 
 O
000 	 O
U 
 O
of O O
streptokinase e S-GENE
) 
 O
followed l O
by O O
systemic t O
heparinization a O
for 	 O
7 
 O
days s O
. 
 O
A 
 O
Laboratory o O
Manual u O
, 
 O
2nd 	 O
ed O O
. 
 O
Engineering i O
temperature p O
- 
 O
sensitive s O
SH3 	 B-GENE
domains a E-GENE
. 
 O
A 
 O
mean n O
value u O
for 	 O
HbA1 1 S-GENE
greater a O
than n O
10 O O
% 
 O
was 	 O
associated o O
with h O
an O O
increased r O
risk k O
of O O
progression g O
of O O
retinopathy i O
and 	 O
a 
 O
mean n O
value u O
less s O
than n O
8 
 O
. 
 O
7 
 O
% 
 O
was 	 O
associated o O
with h O
a 
 O
diminished i O
risk k O
. 
 O
Allergic e O
field l O
: 
 O
how 	 O
to O O
detect e O
it O O
? 
 O
At O O
1 
 O
min 	 O
postalfentanil t O
, 
 O
N2O 	 O
caused s O
significantly n O
more e O
rigidity i O
than n O
100 	 O
% 
 O
O2 O O
( 
 O
p 
 O
< 
 O
0 
 O
. 
 O
001 	 O
) 
 O
. 
 O
The 	 O
preparative p O
regimen i O
consisted s O
of O O
fractionated c O
total a O
body y O
irradiation a O
( 
 O
TBI 	 O
) 
 O
and 	 O
cyclophosphamide l O
( 
 O
CY O O
) 
 O
. 
 O
NGF 	 S-GENE
also o O
induced u O
a 
 O
synthetic t O
promoter m O
with h O
repeated e O
Sp1 	 B-GENE
sites e E-GENE
linked k O
to O O
a 
 O
core e O
promoter m O
, 
 O
and 	 O
a 
 O
plasmid s O
regulated u O
by O O
a 
 O
chimeric m O
transactivator n O
in O O
which c O
the 	 O
Gal4 4 B-GENE
DNA 	 I-GENE
binding d I-GENE
domain a E-GENE
is O O
fused e O
to O O
the 	 O
Sp1 	 B-GENE
transactivation n I-GENE
domain a E-GENE
, 
 O
indicating i O
that t O
this s O
transactivation n O
domain a O
is O O
regulated u O
by O O
NGF 	 S-GENE
. 
 O
The 	 O
toxicity i O
of O O
copper p O
to O O
the 	 O
collembolan l O
Folsomia s O
fimetaria e O
L 
 O
. 
 O
was 	 O
studied d O
in O O
soil l O
incubated u O
with h O
copper p O
sulfate f O
for 	 O
different f O
periods i O
before o O
the 	 O
introduction r O
of O O
collembolans l O
, 
 O
to O O
assess e O
the 	 O
effect e O
of O O
aging n O
of O O
contamination t O
on O O
the 	 O
toxicity i O
of O O
copper p O
. 
 O
The 	 O
frequency q O
of O O
severe e O
congestive g O
heart r O
failure l O
( 
 O
Killip l O
class s O
III 	 O
or O O
IV O O
) 
 O
at O O
admission i O
was 	 O
significantly n O
higher h O
in O O
patients i O
with h O
early l O
presentation s O
, 
 O
than n O
with h O
late e O
presentation s O
( 
 O
30 O O
. 
 O
7 
 O
% 
 O
vs O O
7 
 O
. 
 O
6 
 O
% 
 O
, 
 O
p 
 O
less s O
than n O
0 
 O
. 
 O
05 O O
) 
 O
. 
 O
Comparative p O
ultrafiltration r O
( 
 O
UF O O
) 
 O
studies d O
with h O
BiGG G O
and 	 O
standard n O
lactate t O
( 
 O
La O O
) 
 O
solutions u O
in O O
rabbits b O
showed w O
that t O
net 	 O
UF O O
with h O
La O O
solution u O
peaked k O
at O O
2 
 O
h 
 O
and 	 O
decreased r O
significantly n O
at O O
4 
 O
h 
 O
and 	 O
6 
 O
h 
 O
. 
 O
The 	 O
Giessener s O
Tumordokumentationssystem o O
( 
 O
GTDS S O
) 
 O
is O O
such h O
a 
 O
disease e O
specific c O
system t O
. 
 O
Measurement s O
of O O
protein t O
in O O
natural u O
rubber b O
latex e O
. 
 O
In O O
cotransfection r O
assays a O
, 
 O
a 
 O
small l O
fragment g O
of O O
Sin 	 S-GENE
retaining a O
the 	 O
Src 	 S-GENE
- 
 O
SH3 	 B-GENE
- 
 I-GENE
binding d I-GENE
site e E-GENE
and 	 O
one 	 O
tyrosine o O
- 
 O
containing t O
motif i O
induced u O
c - B-GENE
- - I-GENE
Src 	 E-GENE
activation i O
as O O
measured s O
by O O
a 
 O
transcriptional n O
reporter o O
. 
 O
The 	 O
related a O
tumor o O
suppressor p O
, 
 O
p130 0 S-GENE
, 
 O
also o O
effects e O
this s O
function c O
. 
 O
p107 7 S-GENE
levels e O
increase r O
substantially s O
as O O
cells l O
progress g O
through o O
S 
 O
phase s O
. 
 O
p107 7 S-GENE
induction u O
of O O
E2F 	 B-GENE
DNA 	 E-GENE
binding d O
was 	 O
observed e O
primarily m O
in O O
S 
 O
phase s O
cells l O
coincident n O
with h O
the 	 O
increase r O
in O O
p107 7 B-GENE
protein t E-GENE
levels e O
. 
 O
Both h O
flavoproteins v O
are 	 O
active i O
as O O
AhpC C B-GENE
reductases u E-GENE
and 	 O
mediate i O
electron c O
transfer n O
, 
 O
resulting u O
in O O
the 	 O
NADH H O
- 
 O
dependent e O
reduction u O
of O O
hydrogen r O
peroxide o O
and 	 O
cumene e O
hydroperoxide r O
. 
 O
Transcriptional n O
regulation u O
of O O
the 	 O
murine i B-GENE
k - I-GENE
- - I-GENE
fgf 	 I-GENE
gene e E-GENE
. 
 O
Further t O
, 
 O
cells l O
cotransfected r O
with h O
a 
 O
UF B B-GENE
promoter m I-GENE
- 
 I-GENE
luciferase i E-GENE
( 
 O
- 
 O
1935UF 5 O
- 
 O
Luc 	 S-GENE
) 
 O
reporter o O
gene e O
and 	 O
the 	 O
BTEB B S-GENE
expression r O
vector t O
had 	 O
2 
 O
- 
 O
fold d O
higher h O
Luc 	 S-GENE
activity i O
than n O
those s O
cotransfected r O
with h O
reporter o O
gene e O
and 	 O
pcDNA N B-GENE
- 
 I-GENE
3 
 E-GENE
. 
 O
Evasion s O
of O O
host t O
immunity u O
by O O
Toxocara o O
canis i O
infective e O
larvae v O
is O O
mediated i O
by O O
the 	 O
nematode a O
surface f O
coat t O
, 
 O
which c O
is O O
shed d O
in O O
response p O
to O O
binding d O
by O O
host t O
antibody i O
molecules e O
or O O
effector e O
cells l O
. 
 O
A 
 O
Frank n O
vectorcardiogram t O
was 	 O
recorded o O
before o O
and 	 O
every r O
15 O O
- 
 O
30 O O
minutes u O
for 	 O
10 O O
hours r O
after e O
the 	 O
occlusion l O
. 
 O
In O O
agreement e O
with h O
this s O
, 
 O
archaea h O
appear e O
to O O
lack k O
eIF5 5 S-GENE
, 
 O
eIF2B 2 S-GENE
and 	 O
the 	 O
lysine i O
- 
 O
rich h O
binding d O
domain a O
for 	 O
these s O
factors t O
in O O
their i O
eIF2beta 2 B-GENE
homolog o E-GENE
. 
 O
Derepression e O
of O O
RAR 	 S-GENE
signaling n O
by O O
expressing r O
a 
 O
dominant i O
- 
 O
negative a O
corepressor e O
resulted u O
in O O
embryos r O
that t O
exhibited i O
phenotypes n O
similar i O
to O O
those s O
treated a O
by O O
RA O O
. 
 O
Chemiluminescence m O
induced u O
by O O
opsonized o O
zymosan o O
increased r O
significantly n O
( 
 O
P 
 O
less s O
than n O
0 
 O
. 
 O
05 O O
) 
 O
after e O
treatment a O
with h O
bacterial t O
extracts r O
, 
 O
whereas r O
no O O
significant n O
changes n O
were e O
observed e O
in O O
the 	 O
fMLP P O
- 
 O
stimulated m O
PMNs s O
. 
 O
Lastly t O
, 
 O
several e O
restriction t O
length g O
polymorphisms y O
were e O
identified n O
and 	 O
mapped p O
within h O
a 
 O
1 
 O
kb O O
region i O
located a O
immediately e O
upstream t O
from m O
the 	 O
JH B B-GENE
cluster s E-GENE
. 
 O
Radiographic i O
spatial t O
frequencies q O
essential e O
to O O
the 	 O
diagnosis g O
of O O
incipient i O
interproximal e O
lesions i O
. 
 O
Promoter m O
region i O
of O O
the 	 O
human a B-GENE
alpha h I-GENE
2A I I-GENE
adrenergic e I-GENE
receptor e I-GENE
gene e E-GENE
. 
 O
( 
 O
1982 2 O
) 
 O
. 
 O
( 
 O
99m 	 O
) 
 O
Tc O O
Ethyl y O
Cysteinate t O
Dimer e O
stable b O
during i O
6h O O
has 	 O
contributed t O
to O O
develop e O
ictal a O
studies d O
to O O
evaluate l O
the 	 O
location a O
of O O
partial t O
seizure z O
. 
 O
LiF 	 O
thermoluminescence r O
dosimeters i O
( 
 O
TLD 	 O
) 
 O
in O O
chip p O
form m O
were e O
placed c O
onto o O
1 
 O
eyelid l O
, 
 O
the 	 O
skin n O
over r O
the 	 O
thyroid r O
, 
 O
and 	 O
the 	 O
patient i O
' 
 O
s 
 O
clothes t O
covering e O
the 	 O
region i O
of O O
breasts a O
and 	 O
ovaries r O
of O O
female a O
patients i O
and 	 O
the 	 O
testicles t O
of O O
male e O
patients i O
. 
 O
Thus s O
, 
 O
the 	 O
in O O
vivo o O
function c O
of O O
Gle2p 2 S-GENE
is O O
strictly i O
coupled p O
to O O
the 	 O
short r O
GLEBS B S-GENE
within h O
Nup116p 1 S-GENE
which c O
links k O
this s O
putative a O
mRNA A O
transport n O
factor t O
to O O
the 	 O
nuclear l O
pores e O
. 
 O
DNMT2 T S-GENE
binds d O
AdoHcy H S-GENE
in O O
the 	 O
same e O
conformation f O
as O O
confirmed f O
m - O
( - O
5 - O
) - O
C - B-GENE
MTases s E-GENE
and 	 O
, 
 O
while l O
DNMT2 T S-GENE
shares r O
all 	 O
sequence u O
and 	 O
structural u O
features t O
with h O
m - O
( - O
5 - O
) - O
C - B-GENE
MTases s E-GENE
, 
 O
it O O
has 	 O
failed l O
to O O
demonstrate o O
detectable e O
transmethylase n S-GENE
activity i O
. 
 O
The 	 O
structure u O
of O O
the 	 O
murine i B-GENE
Dtk 	 I-GENE
gene e E-GENE
has 	 O
been n O
determined e O
. 
 O
In O O
previous v O
studies d O
, 
 O
we O O
showed w O
that t O
the 	 O
nuclear l O
import o O
of O O
SREBP B B-GENE
- - I-GENE
2 - E-GENE
occurs u O
via 	 O
the 	 O
direct e O
interaction e O
of O O
importin o B-GENE
beta a E-GENE
with h O
the 	 O
HLH 	 B-GENE
- 
 I-GENE
Zip 	 I-GENE
domain a E-GENE
. 
 O
In O O
the 	 O
normal m O
controls t O
the 	 O
plasma s O
FPA 	 O
level e O
( 
 O
mean n O
+ 
 O
/ 
 O
- 
 O
SD O O
) 
 O
was 	 O
1 
 O
. 
 O
43 O O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
46 O O
ng O O
/ 
 O
ml O O
. 
 O
In O O
this s O
study d O
we O O
cloned n O
the 	 O
cDNA A O
of O O
AD1 	 B-GENE
Ag E E-GENE
from m O
a 
 O
rat 	 O
basophilic o O
leukemia k O
2H3 	 O
cDNA A O
library r O
. 
 O
Ten 	 O
patients i O
( 
 O
aged d O
28 O O
- 
 O
76 O O
years r O
) 
 O
with h O
a 
 O
terminal m O
jejunostomy u O
located a O
within h O
the 	 O
first s O
meter e O
of O O
jejunum u O
were e O
treated a O
by O O
infusion u O
of O O
an O O
elemental m O
diet t O
into o O
the 	 O
distal t O
small l O
bowel e O
( 
 O
IEDDSB D O
) 
 O
. 
 O
The 	 O
procedure c O
was 	 O
technically h O
successful c O
in O O
12 O O
of O O
14 O O
( 
 O
86 O O
% 
 O
) 
 O
stenoses n O
in O O
the 	 O
fibromuscular r O
dysplasia p O
subgroup g O
but 	 O
in O O
only y O
one 	 O
of O O
five e O
( 
 O
20 O O
% 
 O
) 
 O
lesions i O
in O O
the 	 O
neurofibromatosis r O
subgroup g O
. 
 O
Conventional v O
and 	 O
digital i O
radiography i O
of O O
the 	 O
heart r O
, 
 O
aorta t O
, 
 O
and 	 O
pulmonary m O
vascularity c O
. 
 O
Regulation u O
of O O
the 	 O
p21 	 B-GENE
- - I-GENE
activated i I-GENE
kinase a E-GENE
( 
 O
PAK 	 S-GENE
) 
 O
by O O
a 
 O
human a B-GENE
Gbeta t I-GENE
- - I-GENE
like e I-GENE
WD O I-GENE
- 
 I-GENE
repeat e I-GENE
protein t E-GENE
, 
 O
hPIP1 P S-GENE
. 
 O
Other e O
clinicopathological n O
features t O
have e O
no O O
definite i O
influence l O
in O O
survival v O
expectancy e O
. 
 O
These s O
studies d O
suggest g O
that t O
tandem d O
alpha h O
- 
 O
helices i O
located a O
near r O
the 	 O
C 
 O
- 
 O
terminus m O
of O O
PC B B-GENE
- - I-GENE
TP E E-GENE
facilitate i O
membrane b O
binding d O
and 	 O
extraction r O
of O O
phosphatidylcholines s O
. 
 O
The 	 O
striking i O
similarity i O
in O O
preference f O
for 	 O
mismatched m O
and 	 O
weakly k O
paired r O
nucleotides l O
for 	 O
binding d O
and 	 O
for 	 O
excision i O
suggests g O
a 
 O
functional c O
relationship a O
between w O
binding d O
and 	 O
cleavage a O
reactions c O
. 
 O
Interestingly e O
, 
 O
these s O
" 
 O
activation i O
- 
 O
defective e O
" 
 O
mutants a O
segregated r O
into o O
two 	 O
classes s O
: 
 O
1 
 O
) 
 O
those s O
that t O
were e O
unable b O
to O O
form m O
dimers e O
but 	 O
that t O
could l O
still l O
form m O
higher h O
order e O
oligomers g O
and 	 O
transform n O
cells l O
, 
 O
and 	 O
2 
 O
) 
 O
those s O
that t O
were e O
defective e O
for 	 O
PDGF F B-GENE
- - I-GENE
R - E-GENE
binding d O
and 	 O
were e O
transformation n O
- 
 O
incompetent o O
. 
 O
APL 	 O
patients i O
showed w O
a 
 O
low 	 O
, 
 O
yet 	 O
variable i O
, 
 O
level e O
of O O
JEM 	 B-GENE
- - I-GENE
1 - I-GENE
mRNA A E-GENE
in O O
bone e O
marrow r O
. 
 O
CONCLUSIONS C O
: 
 O
The 	 O
results u O
show w O
that t O
intranasal r O
challenge l O
with h O
FLU 	 O
induces u O
changes n O
in O O
leukocyte k O
histamine t O
release e O
, 
 O
but 	 O
not 	 O
other e O
systemic t O
immune u O
and 	 O
inflammatory l O
responses p O
. 
 O
We O O
have e O
shown w O
previously v O
that t O
EGF 	 B-GENE
receptor e E-GENE
activation i O
stimulates m O
gastrin t B-GENE
gene e E-GENE
expression r O
through o O
a 
 O
GC O O
- 
 O
rich h O
element m O
called l O
gERE E O
. 
 O
We O O
have e O
earlier l O
proposed p O
that t O
CG O O
rich h O
sequences u O
resembling e O
CpG 	 O
islands a O
, 
 O
which c O
are 	 O
associated o O
with h O
many y O
imprinted r O
genes e O
and 	 O
often e O
subject j O
to O O
parental e O
- 
 O
specific c O
methylation h O
, 
 O
could l O
act 	 O
as O O
a 
 O
common m O
imprinting r O
element m O
. 
 O
The 	 O
secondary o O
end 	 O
points n O
included l O
creatine a B-GENE
kinase a E-GENE
peak k O
, 
 O
ventricular t O
fibrillation r O
/ 
 O
tachycardia h O
within h O
the 	 O
first s O
24 O O
hours r O
, 
 O
death t O
and 	 O
congestive g O
heart r O
failure l O
within h O
the 	 O
30 O O
- 
 O
day 	 O
follow l O
- 
 O
up O O
, 
 O
and 	 O
30 O O
- 
 O
day 	 O
left t O
ventricular t O
ejection c O
fraction c O
. 
 O
Prevention v O
of O O
gravid v O
Rhesus s O
isoimmunization i O
All 	 O
relapses a O
occurred u O
within h O
the 	 O
first s O
year r O
and 	 O
were e O
confined f O
to O O
patients i O
with h O
PS O O
II O O
disease e O
and 	 O
four r O
or O O
more e O
sites e O
of O O
involvement o O
. 
 O
This s O
demonstrates o O
the 	 O
presence s O
of O O
a 
 O
PKC 	 S-GENE
- 
 O
dependent e O
pathway h O
which c O
functions c O
independently e O
from m O
Lck 	 S-GENE
in O O
MAP 	 B-GENE
kinase a E-GENE
activation i O
. 
 O
This s O
interesting e O
exon n O
junction c O
resulted u O
in O O
novel e O
deduced u O
amino n O
terminal m O
open n O
reading d O
frames m O
, 
 O
which c O
are 	 O
completely p O
in O O
- 
 O
frame m O
with h O
sequences u O
located a O
further t O
downstream n O
. 
 O
Cell l O
lines e O
expressing r O
single g O
amino n O
acid d O
substitutions s O
of O O
the 	 O
carboxyl b O
- 
 O
terminal m O
asparagine a O
of O O
CD2 	 S-GENE
are 	 O
incapable a O
of O O
avidity d O
regulation u O
by O O
TCR 	 S-GENE
signaling n O
, 
 O
PMA 	 O
treatment a O
, 
 O
or O O
elevation v O
of O O
intracellular r O
cAMP P O
levels e O
, 
 O
demonstrating o O
that t O
each h O
of O O
these s O
stimuli m O
utilizes l O
a 
 O
common m O
structural u O
element m O
for 	 O
regulating u O
CD2 	 O
avidity d O
. 
 O
12 O O
per 	 O
cent t O
was 	 O
observed e O
with h O
the 	 O
use 	 O
of O O
tetracycline r O
and 	 O
4 
 O
- 
 O
epianhydrotetracycline a O
in O O
doses e O
of O O
1000 0 O
and 	 O
100gamma g O
per 	 O
embryo r O
respectively p O
. 
 O
Present s O
investigation e O
was 	 O
undertaken e O
to O O
elucidate c O
what t O
pharmacokinetic r O
parameters a O
in O O
animal m O
experiment e O
could l O
be O O
of O O
more e O
predictable d O
for 	 O
human a O
clinical n O
trial a O
of O O
beta a O
- 
 O
blocking c O
agents n O
. 
 O
The 	 O
atpA A B-GENE
reading d I-GENE
frame m E-GENE
ends s O
with h O
four r O
tandem d O
UGA 	 O
codons o O
which c O
overlap r O
four r O
tandem d O
AUG 	 O
codons o O
initiating t O
an O O
unidentified d O
reading d O
frame m O
, 
 O
orf214 2 S-GENE
. 
 O
When n O
transfected n O
into o O
HepG2 G O
cells l O
, 
 O
which c O
lack k O
C - B-GENE
/ - I-GENE
EBP 	 I-GENE
alpha h E-GENE
, 
 O
the 	 O
mouse s B-GENE
ob I I-GENE
promoter m E-GENE
was 	 O
only y O
weakly k O
active i O
. 
 O
Vasodilator o O
and 	 O
hypotensive o O
effects e O
of O O
the 	 O
optical i O
isomers m O
of O O
nicardipine a O
( 
 O
YC O O
- 
 O
93 O O
) 
 O
, 
 O
a 
 O
new 	 O
Ca2 	 O
+ 
 O
- 
 O
antagonist a O
. 
 O
Between w O
1988 8 O
and 	 O
1995 5 O
, 
 O
341 	 O
children l O
with h O
acute t O
myeloid l O
leukaemia k O
( 
 O
AML 	 O
) 
 O
were e O
treated a O
on O O
the 	 O
Medical i O
Research e O
Council n O
Acute t O
Myeloid l O
Leukaemia k O
Trial a O
( 
 O
MRC 	 O
AML10 1 O
) 
 O
. 
 O
A 
 O
heterologous e O
promoter m O
construct s O
containing t O
three e O
repeats e O
of O O
a 
 O
consensus s O
Sp1 	 B-GENE
site e E-GENE
, 
 O
cloned n O
upstream t O
of O O
a 
 O
single g O
copy y O
of O O
the 	 O
ZII 	 S-GENE
( 
 O
CREB B S-GENE
/ 
 O
AP1 	 S-GENE
) 
 O
element m O
from m O
the 	 O
BZLF1 F B-GENE
promoter m E-GENE
linked k O
to O O
the 	 O
beta a B-GENE
- - I-GENE
globin b I-GENE
TATA A I-GENE
box 	 E-GENE
, 
 O
exhibited i O
phorbol r O
ester e O
inducibility u O
. 
 O
Nicotinic o B-GENE
receptor e E-GENE
antagonists a O
mecamylamine a O
( 
 O
0 
 O
. 
 O
5 
 O
and 	 O
1 
 O
mg O O
/ 
 O
kg O O
) 
 O
and 	 O
hexamethonium a O
( 
 O
5 
 O
and 	 O
10 O O
mg O O
/ 
 O
kg O O
) 
 O
reduced u O
the 	 O
response p O
induced u O
by O O
nicotine o O
( 
 O
0 
 O
. 
 O
25 O O
mg O O
/ 
 O
kg O O
) 
 O
. 
 O
Appl l O
. 
 O
Thus s O
, 
 O
the 	 O
predicted d O
M3 O B-GENE
ORF 	 E-GENE
is O O
a 
 O
functional c O
gene e O
that t O
encodes o O
an O O
abundant n O
secreted r O
protein t O
which c O
is O O
a 
 O
candidate d O
for 	 O
interacting e O
with h O
host t O
cellular l O
receptors e O
or O O
cytokines o O
. 
 O
Protein t O
metabolism a O
disorders o O
in O O
burns n O
The 	 O
cumulative u O
dose e O
to O O
nursing s O
staff f O
for 	 O
the 	 O
week k O
after e O
treatment a O
was 	 O
dependent e O
on O O
patient i O
mobility i O
and 	 O
was 	 O
estimated i O
at O O
0 
 O
. 
 O
08 O O
mSv 	 O
for 	 O
a 
 O
self f O
- 
 O
caring i O
patient i O
to O O
6 
 O
. 
 O
3 
 O
mSv 	 O
for 	 O
a 
 O
totally a O
helpless p O
patient i O
( 
 O
1840 0 O
MBq 	 O
/ 
 O
group u O
A 
 O
) 
 O
. 
 O
JCAHO H O
to O O
use 	 O
ORYX X O
data a O
to O O
detect e O
sentinel t O
events n O
. 
 O
We O O
also o O
show w O
that t O
psbH H S-GENE
and 	 O
psbT T S-GENE
are 	 O
transcribed n O
from m O
the 	 O
upstream t B-GENE
psbB B I-GENE
gene e I-GENE
promoter m E-GENE
, 
 O
and 	 O
that t O
the 	 O
psbH H B-GENE
mRNA A E-GENE
has 	 O
its 	 O
own 	 O
target g O
sequence u O
for 	 O
Mbb1 1 S-GENE
function c O
. 
 O
To O O
test t O
whether t O
Cd O O
exposure o O
would l O
increase r O
Ca O O
release e O
from m O
bone e O
during i O
pregnancy g O
and 	 O
lactation t O
in O O
relation a O
to O O
the 	 O
etiological o O
mechanism h O
of O O
Itai i O
- 
 O
Itai i O
disease e O
, 
 O
virgin g O
female a O
mice e O
with h O
45Ca a O
prelabeled l O
skeletons l O
( 
 O
15 O O
microCi r O
/ 
 O
mouse s O
) 
 O
were e O
subjected j O
to O O
one 	 O
round n O
of O O
pregnancy g O
/ 
 O
lactation t O
and 	 O
were e O
exposed o O
to O O
a 
 O
Ca O O
- 
 O
deficient i O
diet t O
containing t O
0 
 O
, 
 O
5 
 O
, 
 O
or O O
25 O O
ppm 	 O
Cd O O
or O O
25 O O
ppm 	 O
Pb O O
for 	 O
32 O O
days s O
, 
 O
from m O
conception c O
until i O
Lactation t O
Day 	 O
14 O O
. 
 O
O5257 5 S-GENE
shows w O
homology o O
with h O
the 	 O
SAS2 2 B-GENE
protein t E-GENE
and 	 O
another t O
hypothetical o O
protein t O
from m O
yeast s O
. 
 O
Principles n O
of O O
thyroid r O
hormone m O
treatment a O
Significance n O
of O O
esophagocardiac p O
reflexes l O
for 	 O
inducing u O
thoracic r O
pain n O
The 	 O
fate e O
of O O
ochratoxin r B-GENE
A 
 E-GENE
during i O
malting t O
and 	 O
brewing w O
. 
 O
METHODS H O
: 
 O
Precision c O
and 	 O
accuracy u O
were e O
measured s O
using n O
controls t O
and 	 O
method h O
comparison p O
studies d O
. 
 O
Messenger s O
RNA 	 O
for 	 O
the 	 O
Ad2 	 B-GENE
DNA 	 I-GENE
binding d I-GENE
protein t E-GENE
: 
 O
DNA 	 O
sequences u O
encoding o O
the 	 O
first s O
leader d O
and 	 O
heterogenity e O
at O O
the 	 O
mRNA A O
5 
 O
' 
 O
end 	 O
. 
 O
Consistent s O
with h O
this s O
hypothesis o O
, 
 O
stimulation m O
of O O
A - B-GENE
( - I-GENE
2A I I-GENE
) - I-GENE
- - I-GENE
R - E-GENE
or O O
PKA 	 S-GENE
enhanced a O
nuclear l O
aPKC C S-GENE
activity i O
. 
 O
Atrial i O
dissociation s O
. 
 O
The 	 O
gene e O
sequence u O
predicts d O
a 
 O
150 	 O
, 
 O
825 	 O
mol 	 O
wt O O
apoprotein p O
of O O
1363 3 O
amino n O
acids d O
having i O
an O O
N 
 O
- 
 O
terminal m O
hydrophobic r O
signal n O
sequence u O
of O O
17 O O
amino n O
acids d O
, 
 O
19 O O
potential e O
N 
 O
- 
 O
linked k O
glycosylation c O
sites e O
, 
 O
a 
 O
hydrophobic r O
anchor h O
sequence u O
of O O
approximately r O
17 O O
amino n O
acids d O
near r O
the 	 O
C 
 O
terminus m O
, 
 O
and 	 O
a 
 O
hydrophilic r O
cysteine t O
- 
 O
rich h O
C 
 O
terminus m O
of O O
35 O O
amino n O
acids d O
. 
 O
However e O
, 
 O
depending e O
upon n O
the 	 O
promoter m O
context t O
, 
 O
we O O
observed e O
cooperative p O
interactions e O
between w O
the 	 O
two 	 O
domains a O
to O O
confer f O
high h O
DNA 	 O
- 
 O
binding d O
affinity i O
and 	 O
specificity c O
. 
 O
As O O
a 
 O
result u O
, 
 O
relative a O
biological l O
effects e O
( 
 O
RBE 	 O
) 
 O
of O O
2 
 O
. 
 O
3 
 O
- 
 O
2 
 O
. 
 O
7 
 O
was 	 O
obtained a O
from m O
the 	 O
straight a O
line e O
that t O
was 	 O
given e O
by O O
modifying i O
by O O
the 	 O
method h O
of O O
least s O
squares a O
the 	 O
curves v O
of O O
the 	 O
frequency q O
of O O
anomalous m O
fetuses u O
in O O
total a O
implants l O
and 	 O
survived v O
embryos r O
irradiated a O
from m O
20 O O
to O O
120 	 O
rad 	 O
by O O
Cf O O
- 
 O
252 	 O
and 	 O
from m O
80 O O
to O O
220 	 O
rad 	 O
by O O
Co O O
- 
 O
60 O O
on O O
day 	 O
8 
 O
of O O
pregnancy g O
. 
 O
Samples p O
( 
 O
1 
 O
g 
 O
) 
 O
were e O
extracted r O
with h O
0 
 O
. 
 O
5 
 O
% 
 O
potassium a O
chloride o O
( 
 O
KCl 	 O
) 
 O
in O O
70 O O
% 
 O
methanol h O
( 
 O
5 
 O
ml O O
) 
 O
and 	 O
diluted u O
subsequently s O
to O O
give e O
two 	 O
- 
 O
fold d O
to O O
ten 	 O
- 
 O
fold d O
step p O
- 
 O
wise e O
dilutions u O
in O O
phosphate s O
- 
 O
buffered f O
saline i O
containing t O
0 
 O
. 
 O
05 O O
% 
 O
Tween e O
20 O O
and 	 O
0 
 O
. 
 O
2 
 O
% 
 O
bovine i B-GENE
serum u I-GENE
albumin u E-GENE
( 
 O
PBS 	 B-GENE
- 
 I-GENE
T 
 I-GENE
BSA 	 E-GENE
) 
 O
. 
 O
To O O
our 	 O
knowledge w O
108 	 O
cases e O
of O O
EAT 	 O
treated a O
by O O
catheter h O
ablation a O
of O O
the 	 O
ectopic o O
focus u O
are 	 O
reported o O
in O O
the 	 O
literature e O
with h O
a 
 O
success c O
rate e O
superior e O
to O O
90 O O
% 
 O
. 
 O
Following l O
immunization u O
of O O
transgenic n O
mice e O
, 
 O
hybrid r O
molecules e O
were e O
isolated l O
from m O
B 
 O
cell l O
DNA 	 O
which c O
contained t O
the 	 O
transgene n O
recombined o O
with h O
the 	 O
endogenous o O
IgH 	 B-GENE
locus u E-GENE
. 
 O
It O O
produced d O
extrapyramidal r O
disturbances t O
in O O
nearly r O
every r O
subject j O
, 
 O
the 	 O
most t O
common m O
being n O
akathisia t O
and 	 O
the 	 O
most t O
severe e O
, 
 O
in O O
the 	 O
case e O
of O O
one 	 O
individual i O
, 
 O
being n O
acute t O
dystonia t O
. 
 O
Northern t O
blot t O
analysis l O
indicated i O
that t O
both h O
human a O
and 	 O
murine i O
genes e O
encode o O
approximately r O
6 
 O
- 
 O
kb O O
transcripts n O
. 
 O
Transforming n B-GENE
growth w I-GENE
factor t I-GENE
beta a E-GENE
activates i O
the 	 O
promoter m O
of O O
cyclin l B-GENE
- - I-GENE
dependent e I-GENE
kinase a E-GENE
inhibitor i O
p15INK4B I S-GENE
through o O
an O O
Sp1 	 B-GENE
consensus s I-GENE
site e E-GENE
. 
 O
Cox 	 O
proportional p O
hazard a O
analysis l O
identified n O
dialysis l O
modality a O
and 	 O
pre 	 O
- 
 O
dialysis l O
UV O O
of O O
less s O
than n O
1 
 O
, 
 O
000 	 O
ml O O
/ 
 O
m2 O O
per 	 O
24 O O
h 
 O
as O O
the 	 O
only y O
significant n O
risk k O
factors t O
for 	 O
UV O O
survival v O
. 
 O
The 	 O
hyperpigmentation e O
is O O
linked k O
to O O
the 	 O
presence s O
of O O
numerous e O
single g O
melanosomes a O
and 	 O
polymelanosomes y O
in O O
keratinocytes a O
at O O
all 	 O
levels e O
of O O
the 	 O
epidermis d O
, 
 O
and 	 O
in O O
dermal m O
Factor t O
XIIIa I S-GENE
- 
 O
positive i O
dendrocytes d O
. 
 O
Possible s O
or O O
definite i O
neglect l O
or O O
abuse s O
before o O
36 O O
months t O
of O O
age 	 O
was 	 O
correlated r O
with h O
low 	 O
DBH 	 S-GENE
activity i O
. 
 O
Previously v O
, 
 O
we O O
identified n O
two 	 O
human a B-GENE
SMC 	 I-GENE
family i I-GENE
proteins t E-GENE
, 
 O
hCAP P B-GENE
- - I-GENE
C - E-GENE
and 	 O
hCAP P B-GENE
- - I-GENE
E - E-GENE
, 
 O
which c O
form m O
a 
 O
heterodimeric e O
complex p O
( 
 O
hCAP P B-GENE
- - I-GENE
C - I-GENE
- 
 I-GENE
hCAP P I-GENE
- - I-GENE
E - E-GENE
) 
 O
in O O
the 	 O
cell l O
. 
 O
The 	 O
mouse s B-GENE
alpha h I-GENE
A - I-GENE
- - I-GENE
CRYBP1 B I-GENE
gene e E-GENE
specifies c O
a 
 O
2 
 O
, 
 O
688 	 O
- 
 O
amino n O
acid d O
protein t O
with h O
72 O O
% 
 O
amino n O
acid d O
identity n O
to O O
its 	 O
human a O
homologue o O
, 
 O
PRDII I B-GENE
- - I-GENE
BF1 	 E-GENE
. 
 O
Methylation h O
interference e O
analysis l O
established a O
at O O
single g O
nucleotide l O
resolution o O
that t O
purified i O
recombinant o B-GENE
Fos 	 E-GENE
and 	 O
Jun 	 B-GENE
proteins t E-GENE
bind d O
in O O
a 
 O
sequence u O
- 
 O
specific c O
manner n O
to O O
the 	 O
AP B B-GENE
- - I-GENE
1 - I-GENE
sites e E-GENE
within h O
the 	 O
VDRE E O
and 	 O
OC B O
box 	 O
. 
 O
These s O
include l O
urinalysis n O
, 
 O
chest s O
X 
 O
- 
 O
P 
 O
, 
 O
ECG 	 O
, 
 O
hematological a O
examinations m O
( 
 O
RBC 	 O
, 
 O
WBC 	 O
, 
 O
Ht O O
, 
 O
Hb S O
, 
 O
PLT 	 O
and 	 O
ESR 	 O
) 
 O
and 	 O
biochemical c O
tests t O
( 
 O
AST 	 O
, 
 O
ALT 	 O
, 
 O
ALP 	 O
, 
 O
gamma m O
GTP 	 O
, 
 O
LDH 	 O
, 
 O
CPK 	 O
, 
 O
Chol l O
, 
 O
T 
 O
- 
 O
Bil 	 O
, 
 O
TP O O
, 
 O
Alb 	 O
, 
 O
TG O O
, 
 O
BUN 	 O
, 
 O
Cr O O
, 
 O
Glu 	 O
, 
 O
Na O O
, 
 O
K 
 O
, 
 O
Ca O O
, 
 O
P 
 O
and 	 O
CRP 	 O
) 
 O
. 
 O
Both h O
the 	 O
inactive c O
domain a B-GENE
II I I-GENE
P68 	 I-GENE
mutant a E-GENE
and 	 O
the 	 O
deletion e O
mutant a O
lacking k O
aa O O
91 O O
- 
 O
243 	 O
were e O
less s O
inhibitory i O
to O O
growth w O
in O O
yeast s O
due 	 O
to O O
the 	 O
reduced u O
ability l O
to O O
phosphorylate s B-GENE
initiation t I-GENE
factor t I-GENE
2 - I-GENE
alpha h E-GENE
in O O
vivo o O
. 
 O
All 	 O
patients i O
studied d O
were e O
pregnant g O
women e O
and 	 O
their i O
delivered i O
children l O
. 
 O
Current r O
body y O
size e O
( 
 O
wt O O
/ 
 O
ht2 	 S-GENE
) 
 O
was 	 O
significantly n O
associated o O
with h O
life e O
- 
 O
time e O
weight g O
dissatisfaction s O
in O O
both h O
sexes e O
( 
 O
P 
 O
less s O
than n O
0 
 O
. 
 O
0005 5 O
) 
 O
. 
 O
Mad3 3 S-GENE
and 	 O
Mad4 4 S-GENE
: 
 O
novel e O
Max 	 S-GENE
- 
 O
interacting e O
transcriptional n O
repressors r O
that t O
suppress p O
c - B-GENE
- - I-GENE
myc 	 E-GENE
dependent e O
transformation n O
and 	 O
are 	 O
expressed r O
during i O
neural r O
and 	 O
epidermal d O
differentiation f O
. 
 O
CONCLUSIONS C O
: 
 O
Patients i O
' 
 O
attainment a O
of O O
TGB 	 O
monotherapy o O
was 	 O
associated o O
with h O
their i O
achievement i O
of O O
positive i O
changes n O
of O O
varying y O
degree r O
on O O
psychological c O
tests t O
. 
 O
The 	 O
pcaR R B-GENE
regulatory u I-GENE
locus u E-GENE
has 	 O
been n O
found n O
to O O
be O O
required u O
for 	 O
both h O
induction u O
of O O
all 	 O
of O O
the 	 O
genes e O
within h O
the 	 O
pca 	 B-GENE
regulon u E-GENE
( 
 O
pcaBDC B S-GENE
, 
 O
pcaIJ I S-GENE
, 
 O
and 	 O
pcaF F S-GENE
) 
 O
and 	 O
the 	 O
chemotactic m O
response p O
of O O
the 	 O
bacteria t O
to O O
aromatic m O
compounds p O
. 
 O
Furthermore t O
, 
 O
we O O
have e O
identified n O
the 	 O
major o O
open n O
reading d O
frame m O
( 
 O
RF4 	 O
; 
 O
2 
 O
. 
 O
3 
 O
kb O O
) 
 O
as O O
being n O
essential e O
for 	 O
activation i O
, 
 O
and 	 O
we O O
have e O
shown w O
that t O
the 	 O
NF B B-GENE
kappa p I-GENE
B - E-GENE
, 
 O
SP1 	 S-GENE
, 
 O
and 	 O
TATA A O
box 	 O
motifs i O
in O O
the 	 O
human a B-GENE
immunodeficiency u I-GENE
virus u I-GENE
LTR 	 E-GENE
are 	 O
all 	 O
required u O
for 	 O
full l O
induction u O
of O O
the 	 O
promoter m O
by O O
the 	 O
HHV 	 O
- - O
6 - O
- - O
encoded o O
transactivator n O
. 
 O
However e O
, 
 O
mutations a O
of O O
the 	 O
C 
 O
- 
 O
rich h O
element m O
that t O
disrupted r O
a 
 O
GC O O
box 	 O
located a O
on O O
the 	 O
inverse e O
strand a O
eliminated m O
PMA 	 O
responsiveness p O
and 	 O
, 
 O
in O O
gel 	 O
mobility i O
shift f O
assays a O
, 
 O
eliminated m O
binding d O
of O O
Sp1 	 S-GENE
. 
 O
TFIIB I S-GENE
and 	 O
VDR 	 S-GENE
can 	 O
also o O
interact e O
directly e O
, 
 O
and 	 O
these s O
factors t O
synergize e O
to O O
mediate i O
transactivation n O
. 
 O
Both h O
algorithms o O
have e O
been n O
implemented l O
and 	 O
applied l O
to O O
data a O
simulated u O
for 	 O
a 
 O
scanner n O
with h O
a 
 O
large g O
axial a O
aperture r O
( 
 O
30 O O
degrees r O
) 
 O
, 
 O
and 	 O
also o O
to O O
data a O
acquired u O
with h O
the 	 O
ECAT T O
HR O O
and 	 O
the 	 O
ECAT T O
HR O O
+ 
 O
scanners n O
. 
 O
The 	 O
well l O
- 
 O
trained i O
group u O
was 	 O
measured s O
once e O
in O O
the 	 O
respiration p O
chamber m O
for 	 O
36 O O
h 
 O
according o O
to O O
the 	 O
same e O
protocol t O
. 
 O
Samarium a O
- 
 O
153 	 O
for 	 O
intravascular r O
irradiation a O
therapy r O
with h O
liquid u O
- 
 O
filled l O
balloons l O
to O O
prevent v O
restenosis t O
: 
 O
acute t O
and 	 O
long g O
- 
 O
term m O
results u O
in O O
a 
 O
hypercholesterolemic e O
rabbit b O
restenosis t O
model e O
. 
 O
Only y O
viable b O
bacteria t O
at O O
a 
 O
high h O
concentration c O
induced u O
purulent u O
otitis t O
media i O
, 
 O
which c O
was 	 O
culture t O
positive i O
in O O
58 O O
% 
 O
of O O
the 	 O
cases e O
on O O
day 	 O
4 
 O
. 
 O
Polyoma y O
virus u O
in O O
urine n O
during i O
pregnancy g O
. 
 O
Transfer n O
of O O
F 
 O
- 
 O
like e O
plasmids s O
is O O
regulated u O
by O O
the 	 O
FinOP O S-GENE
system t O
, 
 O
which c O
controls t O
the 	 O
expression r O
of O O
traJ J S-GENE
, 
 O
a 
 O
positive i O
regulator u O
of O O
the 	 O
transfer n B-GENE
operon r E-GENE
. 
 O
PKCI I B-GENE
- - I-GENE
1 - E-GENE
is O O
a 
 O
member b O
of O O
the 	 O
HIT 	 B-GENE
family i E-GENE
of O O
proteins t O
, 
 O
shown w O
by O O
sequence u O
identity n O
to O O
be O O
conserved s O
in O O
a 
 O
broad a O
range g O
of O O
organisms a O
including l O
mycoplasma o O
, 
 O
plants n O
, 
 O
and 	 O
humans a O
. 
 O
Conversion v O
of O O
glucose c O
phosphate s O
- 
 O
14C 	 O
to O O
glucose c O
- 
 O
14C 	 O
in O O
passage s O
through o O
human a O
brain i O
in O O
vivo o O
. 
 O
A 
 O
simple p O
technique h O
for 	 O
obtaining a O
ultra r O
- 
 O
thin n O
sections t O
of O O
coccidian c O
oocysts y O
is O O
reported o O
. 
 O
It O O
was 	 O
found n O
that t O
on O O
the 	 O
14th h O
and 	 O
21st t O
day 	 O
after e O
cimetidine e O
administration i O
serum u B-GENE
gastrin t E-GENE
levels e O
were e O
significantly n O
elevated v O
. 
 O
Dual l O
signal n O
peptides t O
mediate i O
the 	 O
signal n O
recognition o O
particle t O
/ 
 O
Sec 	 S-GENE
- 
 O
independent e O
insertion e O
of O O
a 
 O
thylakoid l O
membrane b O
polyprotein y O
, 
 O
PsbY Y S-GENE
. 
 O
The 	 O
resulting u O
score r O
, 
 O
which c O
allowed o O
the 	 O
disease e O
to O O
be O O
expressed r O
as O O
a 
 O
continuous t O
variable i O
, 
 O
was 	 O
effectively e O
utilized l O
to O O
see 	 O
the 	 O
correlations r O
between w O
the 	 O
severity e O
of O O
coronary o O
arterial e O
disease e O
( 
 O
CAD 	 O
) 
 O
and 	 O
individual i O
risk k O
factors t O
/ 
 O
risk k O
markers k O
. 
 O
On O O
guanidine n O
and 	 O
the 	 O
treatment a O
of O O
botulism u O
. 
 O
Electronic c O
structure u O
of O O
Si O O
( 
 O
111 	 O
) 
 O
- 
 O
NiSi2 i O
( 
 O
111 	 O
) 
 O
A 
 O
- 
 O
type e O
and 	 O
B 
 O
- 
 O
type e O
interfaces e O
. 
 O
In O O
our 	 O
case e O
the 	 O
development e O
of O O
the 	 O
tumor o O
at O O
the 	 O
posterior t O
side e O
of O O
the 	 O
prostate s O
, 
 O
the 	 O
lack k O
of O O
PSA 	 S-GENE
immunoreactivity u O
and 	 O
the 	 O
presence s O
of O O
mucinous i O
glands n O
, 
 O
sometimes e O
" 
 O
endocervical o O
- 
 O
like e O
" 
 O
, 
 O
could l O
suggest g O
an O O
origin g O
from m O
embryonic r O
mullerian l O
remnants n O
in O O
the 	 O
prostatic s O
utricle i O
rather h O
than n O
urogenital g O
sinus u O
. 
 O
Upon n O
increasing r O
the 	 O
Marangoni a O
number b O
beyond o O
this s O
threshold e O
, 
 O
the 	 O
initially t O
stationary t O
flow w O
becomes o O
quickly c O
time e O
dependent e O
. 
 O
The 	 O
results u O
showed w O
differential f O
activation i O
of O O
each h O
parahippocampal a O
region i O
during i O
verbal b O
memory o O
tasks k O
in O O
which c O
the 	 O
side e O
activated i O
shifted f O
depending e O
on O O
the 	 O
nature u O
of O O
the 	 O
task k O
employed l O
; 
 O
an O O
increase r O
in O O
rCBF F O
in O O
the 	 O
left t O
parahippocampal a O
gyrus u O
was 	 O
associated o O
with h O
retrieval r O
strategy a O
of O O
non 	 O
- 
 O
matching c O
, 
 O
and 	 O
an O O
increase r O
in O O
rCBF F O
in O O
the 	 O
right h O
parahippocampal a O
gyrus u O
was 	 O
associated o O
with h O
retrieval r O
strategy a O
of O O
matching c O
. 
 O
Evolution l O
of O O
cytomegalovirus o O
antibodies i O
of O O
maternal e O
origin g O
and 	 O
acquired u O
, 
 O
throughout o O
the 	 O
first s O
year r O
of O O
life e O
Demonstration o O
of O O
changes n O
in O O
fetal a O
liver e O
erythropoiesis t O
using n O
echo o O
- 
 O
planar n O
magnetic n O
resonance o O
imaging g O
. 
 O
The 	 O
actual u O
placement c O
of O O
the 	 O
lesions i O
was 	 O
determined e O
after e O
mapping p O
of O O
the 	 O
GPi 	 O
by O O
microrecording r O
, 
 O
using n O
stimulation m O
to O O
identify n O
the 	 O
sensorimotor s O
region i O
and 	 O
its 	 O
somatotopic a O
organization a O
. 
 O
Effect e O
of O O
prostaglandin s O
E2 O O
on O O
experimental e O
atherosclerosis e O
. 
 O
Both h O
the 	 O
arterial e O
and 	 O
venous o O
thrombi o O
were e O
clearly a O
discernible c O
at O O
2 
 O
to O O
8 
 O
h 
 O
after e O
injection e O
of O O
99Tcm c O
- 
 O
SZ O O
- 
 O
51 O O
. 
 O
The 	 O
effect e O
of O O
lung g O
edema m O
on O O
pulmonary m O
vasoactivity o O
of O O
furosemide o O
. 
 O
However e O
, 
 O
the 	 O
malaria a O
vectors t O
Anopheles p O
funestus e O
and 	 O
An O O
. 
 O
gambiae b O
have e O
both h O
become o O
more e O
abundant n O
during i O
the 	 O
1970s 0 O
and 	 O
1980s 0 O
and 	 O
sporozoite r O
- 
 O
positive i O
specimens c O
of O O
both h O
have e O
been n O
found n O
. 
 O
Soluble u O
extracts r O
from m O
FGF 	 S-GENE
- 
 O
treated a O
as O O
compared p O
with h O
quiescent e O
fibroblasts r O
exhibited i O
up O O
to O O
3 
 O
- 
 O
fold d O
higher h O
kinase a O
activity i O
towards a O
S6 S S-GENE
in O O
exogenously g O
added e O
rat 	 B-GENE
liver e I-GENE
40S 	 I-GENE
ribosomes o E-GENE
and 	 O
a 
 O
synthetic t O
peptide t O
, 
 O
RRLSSLRA S S-GENE
. 
 O
In O O
bell l O
pepper p O
, 
 O
a 
 O
gene e O
encoding o O
a 
 O
major o O
plastid s O
- 
 O
lipid i O
associated o O
protein t O
is O O
expressed r O
as O O
both h O
partially t O
and 	 O
totally a O
spliced i O
transcripts n O
( 
 O
respectively p O
PAP2 2 S-GENE
and 	 O
PAP1 1 S-GENE
) 
 O
. 
 O
Inhibitory i O
receptors e O
are 	 O
characterized r O
by O O
the 	 O
presence s O
of O O
a 
 O
characteristic r O
sequence u O
known w O
as O O
an O O
immunoreceptor u O
tyrosine o O
- 
 O
based e O
inhibitory i O
motif i O
( 
 O
ITIM M O
) 
 O
in O O
their i O
cytoplasmic o O
tail l O
. 
 O
We O O
conclude c O
that t O
LGCS S O
is O O
successful c O
in O O
treating a O
esophageal p O
varices i O
in O O
the 	 O
setting t O
of O O
hyperdynamic e O
portal t O
circulation c O
with h O
acceptable e O
liver e O
function c O
. 
 O
Candidate d O
factors t O
have e O
been n O
identified n O
by O O
the 	 O
observation e O
that t O
changes n O
in O O
glucocorticoid c O
induction u O
parameters a O
in O O
CV O O
- 
 O
1 
 O
cells l O
could l O
be O O
reproduced r O
by O O
varying y O
the 	 O
cellular l O
levels e O
of O O
coactivators c O
[ 
 O
transcriptional n O
intermediary e B-GENE
factor t I-GENE
2 - E-GENE
( 
 O
TIF2 2 S-GENE
) 
 O
, 
 O
steroid r B-GENE
receptor e I-GENE
coactivator c I-GENE
1 - E-GENE
( 
 O
SRC 	 B-GENE
- - I-GENE
1 - E-GENE
) 
 O
, 
 O
and 	 O
amplified l O
in I O
breast a O
cancer c O
1 - O
( 
 O
AIB1 1 O
) 
 O
] 
 O
, 
 O
comodulator o O
[ 
 O
CREB B B-GENE
- - I-GENE
binding d I-GENE
protein t E-GENE
( 
 O
CBP 	 S-GENE
) 
 O
] 
 O
, 
 O
or O O
corepressor e O
[ 
 O
silencing e O
mediator i O
for 	 O
retinoid i O
and 	 O
thyroid r B-GENE
- - I-GENE
hormone m I-GENE
receptors e E-GENE
( 
 O
SMRT T S-GENE
) 
 O
] 
 O
without h O
concomitant c O
increases r O
in O O
GR S O
. 
 O
Immunoblot u O
analyses l O
revealed e O
that t O
the 	 O
loss s O
of O O
activator i O
function c O
coincides n O
with h O
selective e O
removal o O
of O O
the 	 O
C - O
- - O
terminal m O
domain a O
( - O
CTD 	 O
) - O
- - O
hyperphosphorylated e O
RNAP P O
IIO 	 O
along n O
with h O
NC2 	 S-GENE
. 
 O
The 	 O
nucleotide l O
sequence u O
of O O
the 	 O
gene e O
encoding o O
this s O
product d O
was 	 O
determined e O
and 	 O
the 	 O
amino n O
acid d O
sequence u O
deduced u O
. 
 O
At O O
9 
 O
months t O
postpartum t O
, 
 O
serum u O
fT4 	 O
and 	 O
fT3 	 O
levels e O
were e O
low 	 O
normal m O
( 
 O
8 
 O
. 
 O
0 
 O
and 	 O
1 
 O
. 
 O
7 
 O
pmol l O
/ 
 O
L 
 O
, 
 O
respectively p O
) 
 O
, 
 O
but 	 O
TSH 	 S-GENE
was 	 O
not 	 O
raised s O
( 
 O
0 
 O
. 
 O
4 
 O
mU O O
/ 
 O
L 
 O
) 
 O
. 
 O
RESULTS U O
: 
 O
Three e O
patients i O
did 	 O
not 	 O
tolerate e O
PPI 	 O
medication i O
and 	 O
were e O
managed a O
by O O
treatment a O
with h O
type e O
2 
 O
histamine t O
( 
 O
H2 O O
) 
 O
blockers c O
. 
 O
It O O
is O O
considered s O
important o O
, 
 O
therefore r O
, 
 O
when n O
treating a O
diabetic b O
patients i O
with h O
peripheral i O
neuropathy r O
not 	 O
to O O
assume u O
that t O
the 	 O
diabetes b O
itself e O
is O O
the 	 O
cause s O
in O O
all 	 O
cases e O
. 
 O
TFIIIB I S-GENE
assembles e O
autonomously o O
on O O
the 	 O
upstream t O
promoter m O
of O O
the 	 O
yeast s B-GENE
U6 I I-GENE
snRNA N E-GENE
( 
 O
SNR6 6 S-GENE
) 
 O
gene e O
in O O
vitro r O
, 
 O
through o O
the 	 O
interaction e O
of O O
its 	 O
TBP 	 B-GENE
subunit u E-GENE
with h O
a 
 O
consensus s O
TATA A O
box 	 O
located a O
at O O
base e O
pair r O
- 
 O
30 O O
. 
 O
Mutational a O
analysis l O
of O O
the 	 O
IME2 2 B-GENE
UAS 	 E-GENE
reveals e O
two 	 O
critical t O
sequence u O
elements m O
: 
 O
a 
 O
G 
 O
+ 
 O
C 
 O
- 
 O
rich h O
sequence u O
( 
 O
called l O
URS1 1 O
) 
 O
, 
 O
previously v O
identified n O
at O O
many y O
meiotic o O
genes e O
, 
 O
and 	 O
a 
 O
newly l O
described c O
element m O
, 
 O
the 	 O
T4C 	 B-GENE
site e E-GENE
, 
 O
that t O
we O O
found n O
at O O
a 
 O
subset s O
of O O
meiotic o O
genes e O
. 
 O
Molecular e O
analysis l O
of O O
the 	 O
mannitol n B-GENE
operon r I-GENE
of O I-GENE
Clostridium s I-GENE
acetobutylicum t I-GENE
encoding o I-GENE
a 
 I-GENE
phosphotransferase s E-GENE
system t O
and 	 O
a 
 O
putative a O
PTS 	 O
- 
 O
modulated u O
regulator u O
. 
 O
Our 	 O
results u O
show w O
that t O
a 
 O
combination b O
of O O
Pfu 	 B-GENE
exo 	 E-GENE
( - O
- - O
) - O
at O O
the 	 O
primer m O
extension e O
step p O
and 	 O
Taq 	 O
at O O
the 	 O
PCR 	 O
amplification l O
step p O
is O O
ideal a O
for 	 O
in O O
vivo o O
DNA 	 O
analysis l O
and 	 O
DNA 	 O
damage a O
mapping p O
using n O
LMPCR C S-GENE
. 
 O
Effect e O
of O O
TNF 	 S-GENE
, 
 O
IL B B-GENE
- - I-GENE
1 - E-GENE
, 
 O
and 	 O
IL B B-GENE
- - I-GENE
6 - E-GENE
on O O
the 	 O
proliferation l O
of O O
human a O
Tenon o O
' 
 O
s 
 O
capsule s O
fibroblasts r O
in O O
tissue s O
culture t O
. 
 O
Estimating i O
the 	 O
health l O
care e O
costs t O
of O O
smokers k O
. 
 O
Using n O
lacZ Z S-GENE
- 
 O
inducible u O
T 
 O
cells l O
as O O
a 
 O
probe b O
, 
 O
we O O
screened e O
a 
 O
splenic e O
cDNA A O
library r O
in O O
transiently n O
transfected n O
antigen i O
- 
 O
presenting s O
cells l O
( 
 O
APCs s O
) 
 O
and 	 O
isolated l O
a 
 O
cDNA A O
clone n O
that t O
allowed o O
expression r O
of O O
the 	 O
appropriate r O
peptide t O
/ - O
Kb I B-GENE
MHC 	 I-GENE
complex p E-GENE
in O O
APC 	 S-GENE
. 
 O
Endotoxemia o O
and 	 O
bacteremia t O
in O O
patients i O
with h O
sepsis s O
syndrome d O
in O O
the 	 O
intensive e O
care e O
unit t O
. 
 O
Early l O
attempts e O
for 	 O
modifying i O
growth w O
functions c O
to O O
annual u O
variations i O
dating i O
back k O
up O O
to O O
2 
 O
decades a O
are 	 O
recalled a O
together e O
with h O
examples m O
for 	 O
their i O
application l O
showing w O
rather h O
different f O
degrees r O
of O O
approximation r O
. 
 O
A 
 O
significant n O
reduction u O
in O O
total a O
cellular l O
p27 	 B-GENE
protein t E-GENE
levels e O
and 	 O
a 
 O
moderate e O
reduction u O
in O O
p27 	 B-GENE
mRNA A E-GENE
are 	 O
observed e O
, 
 O
but 	 O
no O O
changes n O
in O O
Cdk 	 B-GENE
regulatory u I-GENE
kinases a E-GENE
and 	 O
phosphatases s O
occur u O
. 
 O
Genetic e O
linkage k O
mapping p O
of O O
the 	 O
CYP11A1 1 B-GENE
gene e E-GENE
encoding o O
the 	 O
cholesterol l B-GENE
side e I-GENE
- 
 I-GENE
chain i I-GENE
cleavage a I-GENE
P450scc 0 E-GENE
close s O
to O O
the 	 O
CYP1A1 1 B-GENE
gene e E-GENE
and 	 O
D15S204 S S-GENE
in O O
the 	 O
chromosome o O
15q22 2 O
. 
 O
33 O O
- 
 O
q23 	 O
region i O
. 
 O
Genetic e O
and 	 O
physiological s O
experiments e O
suggest g O
a 
 O
close s O
relationship a O
between w O
cdc27 2 B-GENE
+ - E-GENE
and 	 O
the 	 O
cdc2 2 B-GENE
+ - I-GENE
gene e E-GENE
, 
 O
a 
 O
key 	 O
regulator u O
of O O
mitosis o O
in O O
yeast s O
and 	 O
also o O
in O O
higher h O
eukaryotic a O
cells l O
. 
 O
The 	 O
study d O
was 	 O
performed f O
in O O
a 
 O
class s O
100 	 O
laminar i O
flow w O
clean a O
bench c O
in O O
order e O
to O O
minimize i O
particulate t O
contamination t O
from m O
extraneous r O
sources r O
. 
 O
The 	 O
cloned n O
rRNA A B-GENE
operon r E-GENE
was 	 O
transcribed n O
in O O
vitro r O
by O O
using n O
purified i O
RNA 	 B-GENE
polymerase y I-GENE
of I I-GENE
Escherichia h I-GENE
coli i E-GENE
. 
 O
Of O O
the 	 O
CSF 	 O
tested t O
, 
 O
24 O O
stimulated m O
oxygen g O
consumption s O
above v O
our 	 O
cut 	 O
off 	 O
, 
 O
and 	 O
8 
 O
did 	 O
not 	 O
( 
 O
0 
 O
. 
 O
84 O O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
34 O O
, 
 O
n 
 O
= 
 O
24 O O
compared p O
with h O
the 	 O
rate e O
of O O
0 
 O
. 
 O
27 O O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
1 
 O
mumol o O
/ 
 O
min 	 O
/ 
 O
g 
 O
dry 	 O
wt O O
, 
 O
respectively p O
; 
 O
SD O O
n 
 O
= 
 O
8 
 O
) 
 O
at O O
180 	 O
minutes u O
. 
 O
The 	 O
sequence u O
of O O
the 	 O
gene e O
upstream t O
to O O
the 	 O
cap 	 O
site e O
contains t O
characteristic r O
RNA 	 B-GENE
polymerase y I-GENE
II I I-GENE
promoter m I-GENE
- - I-GENE
binding d I-GENE
sites e E-GENE
: 
 O
a 
 O
putative a O
TATA A O
box 	 O
at O O
position i O
- 
 O
29 O O
and 	 O
a 
 O
Sp B B-GENE
1 - I-GENE
binding d I-GENE
site e E-GENE
( 
 O
GGGGCGGAGA G O
) 
 O
at O O
position i O
- 
 O
48 O O
. 
 O
The 	 O
kinetics e O
of O O
[ 
 O
14C 	 O
] 
 O
NG O O
in O O
the 	 O
blood o O
of O O
the 	 O
dosed e O
animals m O
was 	 O
followed l O
. 
 O
These s O
clones n O
contain t O
most t O
of O O
the 	 O
exon n O
of O O
cyclin l B-GENE
D2 E E-GENE
except e O
exon n O
5 
 O
. 
 O
One 	 O
had 	 O
a 
 O
48 O O
- 
 O
hour r O
cycle l O
and 	 O
the 	 O
other e O
a 
 O
24 O O
- 
 O
hour r O
cycle l O
. 
 O
This s O
action i O
could l O
be O O
antagonized a O
by O O
aminophylline n O
, 
 O
a 
 O
competitive p O
antagonist a O
on O O
P1 B O
purinoceptors i O
. 
 O
Evidence d O
for 	 O
Gcr1p 1 S-GENE
/ 
 O
Gcr2p 2 S-GENE
interaction e O
has 	 O
been n O
presented s O
earlier l O
and 	 O
is O O
now 	 O
supported p O
by O O
the 	 O
isolation l O
of O O
mutations a O
in O O
Gcr1p 1 S-GENE
suppressing p O
gcr2 2 S-GENE
, 
 O
as O O
assessed e O
by O O
growth w O
and 	 O
enzyme y O
assay a O
. 
 O
Keys s O
can 	 O
be O O
used d O
for 	 O
identifying n O
species c O
from m O
the 	 O
European o O
part t O
of O O
the 	 O
USSR R O
and 	 O
north t O
- 
 O
eastern t O
Kazakhstan a O
. 
 O
Promoter m O
constructs s O
containing t O
mutations a O
in O O
the 	 O
PTRE E B-GENE
sequence u E-GENE
that t O
selectively e O
abolished l O
the 	 O
binding d O
of O O
either h O
one 	 O
or O O
both h O
complexes p O
exerted r O
opposite o O
effects e O
on O O
the 	 O
transcriptional n O
activity i O
of O O
trypsin p B-GENE
promoters m E-GENE
in O O
A 
 O
. 
 O
gambiae b O
and 	 O
Aedes e O
aegypti y O
cell l O
lines e O
. 
 O
The 	 O
Rep78 7 B-GENE
protein t E-GENE
of O O
adeno n O
- 
 O
associated o O
virus u O
( 
 O
AAV 	 O
) 
 O
contains t O
amino n O
acid d O
sequence u O
motifs i O
common m O
to O O
rolling l O
- - O
circle c O
replication l O
( - O
RCR 	 S-GENE
) - O
initiator t O
proteins t O
. 
 O
Plasma s B-GENE
prolactin l E-GENE
in O O
patients i O
with h O
colorectal o O
cancer c O
. 
 O
Reality l O
and 	 O
clinical n O
application l O
of O O
immunoglobulin u S-GENE
preparations p O
The 	 O
extent e O
of O O
myocardial c O
ischemia h O
in O O
the 	 O
coronary o O
sinus u O
study d O
was 	 O
significantly n O
correlated r O
to O O
the 	 O
coronary o O
diameters m O
of O O
the 	 O
proximal x O
and 	 O
middle d O
segments m O
of O O
the 	 O
Ramus u O
interventricularis e O
anterior e O
and 	 O
the 	 O
middle d O
segment m O
of O O
the 	 O
Ramus u O
circumflexus c O
( 
 O
r 
 O
= 
 O
0 
 O
. 
 O
87 O O
, 
 O
p 
 O
< 
 O
0 
 O
. 
 O
02 O O
) 
 O
. 
 O
The 	 O
in O O
- 
 O
plane n O
orientational e O
anisotropy s O
of O O
the 	 O
8CB 	 O
films m O
grown w O
on O O
unidirectionally d O
photopolymerized t O
PVCN N O
substrates s O
is O O
considerably s O
lower e O
than n O
the 	 O
intrinsic r O
surface f O
orientational e O
anisotropy s O
of O O
these s O
substrates s O
, 
 O
which c O
can 	 O
explain l O
the 	 O
generally e O
found n O
weak k O
surface f O
anchoring h O
of O O
liquid u O
crystals s O
on O O
PVCN N O
alignment g O
layers e O
. 
 O
Nuclear l O
transcription n O
assays a O
confirmed f O
that t O
cys 	 B-GENE
- - I-GENE
3 - I-GENE
+ - E-GENE
was 	 O
under e O
sulfur f O
- 
 O
regulated u O
transcriptional n O
control t O
and 	 O
that t O
cys 	 B-GENE
- - I-GENE
3 - I-GENE
+ - E-GENE
transcription n O
was 	 O
constitutive s O
in O O
sulfur f O
controller t O
( 
 O
scon n S-GENE
) 
 O
- 
 O
negative a O
regulator u O
mutants a O
. 
 O
The 	 O
rifampicin a O
resistance i O
of O O
uvsW W S-GENE
- 
 O
repressed r O
replication l O
suggests g O
that t O
it O O
involves o O
either h O
tertiary t O
initiation t O
or O O
some e O
novel e O
mode e O
of O O
initiation t O
. 
 O
Pharmacokinetics r O
of O O
skin n O
penetration e O
. 
 O
Furthermore t O
, 
 O
the 	 O
regulation u O
conferred f O
on O O
a 
 O
reporter o O
gene e O
in O O
Drosophila s O
by O O
three e O
closely s O
related a O
sequences u O
demonstrates o O
that t O
even n O
subtle t O
sequence u O
changes n O
within h O
an O O
E 
 O
box 	 O
or O O
flanking n O
bases e O
have e O
dramatic m O
consequences s O
on O O
the 	 O
overall r O
repertoire e O
of O O
proteins t O
that t O
can 	 O
bind d O
in O O
vivo o O
. 
 O
Buspirone p O
therapy r O
for 	 O
Type e O
A 
 O
behavior a O
, 
 O
hostility t O
, 
 O
and 	 O
perceived c O
stress e O
in O O
cardiac d O
patients i O
. 
 O
Recently e O
we O O
have e O
performed f O
a 
 O
detailed a O
analysis l O
of O O
specific c O
neuronal r O
populations u O
affected e O
by O O
the 	 O
mutation a O
which c O
shed d O
new 	 O
light h O
on O O
the 	 O
role e O
of O O
Krox x B-GENE
- - I-GENE
20 E E-GENE
in O O
the 	 O
segmentation m O
and 	 O
on O O
the 	 O
physiological s O
consequences s O
of O O
its 	 O
inactivation c O
. 
 O
A 
 O
species c O
comparison p O
of O O
cDNA A O
sequences u O
and 	 O
isolation l O
of O O
a 
 O
genomic o O
clone n O
. 
 O
The 	 O
inhibition i O
of O O
monoamine o B-GENE
oxidase d E-GENE
( 
 O
MAO 	 S-GENE
) 
 O
by O O
tranylcypromine n O
was 	 O
studied d O
in O O
6 
 O
healthy l O
volunteers u O
given e O
increasing r O
doses e O
of O O
10 O O
, 
 O
15 O O
, 
 O
20 O O
and 	 O
25 O O
mg O O
/ 
 O
day 	 O
over r O
a 
 O
4 
 O
- 
 O
week k O
period i O
. 
 O
Deletion e O
mutagenesis a O
of O O
the 	 O
promoter m O
indicated i O
that t O
a 
 O
positive i O
regulatory u O
element m O
( 
 O
PRE 	 O
) 
 O
was 	 O
likely e O
to O O
exist s O
downstream n O
of O O
the 	 O
UL94 4 B-GENE
mRNA A E-GENE
start r O
site e O
, 
 O
while l O
a 
 O
negative a O
regulatory u O
element m O
( 
 O
NRE 	 O
) 
 O
was 	 O
present s O
upstream t O
of O O
the 	 O
TATA A O
box 	 O
. 
 O
Expression r O
of O O
Helios i S-GENE
was 	 O
detected e O
in O O
the 	 O
earliest l O
hematopoietic a O
sites e O
of O O
the 	 O
embryo r O
, 
 O
in O O
hematopoietic a O
stem m O
cells l O
in O O
the 	 O
adult l O
and 	 O
was 	 O
subsequently s O
restricted t O
to O O
a 
 O
subset s O
of O O
cells l O
in O O
the 	 O
T 
 O
cell l O
lineage e O
. 
 O
Metapsychiatry a O
is O O
a 
 O
term m O
born n O
of O O
necessity e O
to O O
designate i O
the 	 O
important o O
but 	 O
hitherto h O
unclassified l O
interface e O
between w O
psychiatry c O
and 	 O
mysticism t O
. 
 O
Effects e O
of O O
negative a O
pi O O
mesons o O
on O O
mouse s O
bone e O
marrow r O
cells l O
. 
 O
Using n O
probes b O
containing t O
C - B-GENE
/ - I-GENE
EBP 	 I-GENE
- - I-GENE
binding d I-GENE
sites e E-GENE
from m O
the 	 O
iNOS S B-GENE
gene e E-GENE
revealed e O
further t O
binding d O
of O O
different f O
complexes p O
, 
 O
all 	 O
of O O
which c O
were e O
strongly o O
inducible u O
by O O
cAMP P O
and 	 O
to O O
a 
 O
lower e O
extent e O
also o O
by O O
IL B B-GENE
- - I-GENE
1beta t E-GENE
. 
 O
The 	 O
Pi O S-GENE
signals n O
are 	 O
conveyed v O
to O O
PHO8 8 O
by O O
binding d O
of O O
PHO4 4 B-GENE
protein t E-GENE
, 
 O
a 
 O
positive i O
regulatory u O
factor t O
, 
 O
to O O
a 
 O
promoter m O
region i O
of O O
PHO8 8 O
( 
 O
PHO8p 8 S-GENE
) 
 O
under e O
the 	 O
influence l O
of O O
the 	 O
PHO 	 O
regulatory u O
circuit c O
. 
 O
Thus s O
, 
 O
the 	 O
end 	 O
of O O
a 
 O
linearized e O
DNA 	 O
fragment g O
can 	 O
initiate t O
new 	 O
DNA 	 O
synthesis t O
by O O
BIR 	 O
in O O
which c O
the 	 O
newly l O
synthesized t O
DNA 	 O
is O O
displaced p O
and 	 O
subsequently s O
forms m O
circles c O
by O O
NHEJ J S-GENE
. 
 O
It O O
would l O
seem m O
that t O
caution t O
should u O
be O O
exercised r O
in O O
using n O
HPL 	 O
values u O
as O O
an O O
index e O
of O O
placental c O
function c O
in O O
anaemic e O
women e O
. 
 O
A 
 O
case e O
of O O
acquired u O
immune u O
deficiency i O
syndrome d O
before o O
1980 0 O
. 
 O
These s O
data a O
suggest g O
that t O
multiple t O
genetic e O
recombination o O
among n O
bacteriophages t O
with h O
different f O
immunities u O
took k O
place c O
to O O
generate e O
the 	 O
prophage p O
VT1 	 B-GENE
- 
 I-GENE
Sakai a E-GENE
. 
 O
The 	 O
adenovirus n O
E1B 	 O
19 I O
, - O
000 	 O
- - O
molecular e O
- - O
weight g O
( - O
19K 	 O
) - O
protein t O
is O O
a 
 O
potent e O
inhibitor i O
of O O
apoptosis p O
and 	 O
cooperates p O
with h O
E1A 	 S-GENE
to O O
transform n O
primary m O
rodent e O
cells l O
. 
 O
Desensitization e O
of O O
the 	 O
growth w B-GENE
hormone m I-GENE
- 
 I-GENE
induced u I-GENE
Janus u I-GENE
kinase a I-GENE
2 - E-GENE
( 
 O
Jak 	 B-GENE
2 - E-GENE
) 
 O
/ 
 O
signal n O
transducer n O
and 	 O
activator i B-GENE
of I I-GENE
transcription n I-GENE
5 - E-GENE
( 
 O
Stat5 t S-GENE
) 
 O
- 
 O
signaling n O
pathway h O
requires u O
protein t O
synthesis t O
and 	 O
phospholipase s B-GENE
C - E-GENE
. 
 O
In O O
two 	 O
separate a O
studies d O
, 
 O
specimens c O
of O O
saliva i O
from m O
57 O O
individuals i O
over r O
the 	 O
age 	 O
of O O
65 O O
years r O
( 
 O
mean n O
age 	 O
, 
 O
76 O O
. 
 O
7 
 O
years r O
) 
 O
and 	 O
37 O O
persons s O
under e O
the 	 O
age 	 O
of O O
40 O O
years r O
( 
 O
mean n O
age 	 O
, 
 O
28 O O
. 
 O
8 
 O
years r O
) 
 O
were e O
examined m O
for 	 O
concentrations c O
of O O
IgA 	 S-GENE
as O O
functions c O
of O O
volume u O
, 
 O
total a O
protein t O
, 
 O
and 	 O
electrolyte c O
conductivity d O
; 
 O
some e O
were e O
also o O
tested t O
for 	 O
IgG 	 S-GENE
and 	 O
IgM 	 S-GENE
content t O
. 
 O
E2A 	 S-GENE
- 
 O
HLF 	 S-GENE
- 
 O
mediated i O
cell l O
transformation n O
requires u O
both h O
the 	 O
trans n O
- 
 O
activation i O
domains a O
of O O
E2A 	 S-GENE
and 	 O
the 	 O
leucine c O
zipper p O
dimerization e O
domain a O
of O O
HLF 	 S-GENE
. 
 O
Two 	 O
adjacent a O
, 
 O
highly h O
homologous o B-GENE
endoglucanase o I-GENE
genes e E-GENE
, 
 O
celD D S-GENE
and 	 O
celE E S-GENE
from m O
Fibrobacter r O
succinogenes c O
S85 	 S-GENE
, 
 O
which c O
were e O
separated a O
by O O
an O O
AT O O
- 
 O
rich h O
223 	 O
- 
 O
nucleotide l O
intergenic e O
region i O
were e O
characterized r O
. 
 O
The 	 O
Seldinger d O
technique h O
for 	 O
difficult f O
transurethral n O
catheterization h O
: 
 O
a 
 O
gentle t O
alternative e O
to O O
suprapubic r O
puncture c O
( 
 O
Br O O
J 
 O
Surg g O
2000 0 O
; 
 O
87 O O
: 
 O
1729 9 O
- 
 O
30 O O
) 
 O
. 
 O
We O O
screened e O
an O O
A 
 O
. 
 O
thaliana l O
cDNA A O
library r O
, 
 O
whose s O
inserts e O
are 	 O
under e O
the 	 O
control t O
of O O
the 	 O
galactose a O
- 
 O
inducible u O
GAL10 1 B-GENE
promoter m E-GENE
, 
 O
for 	 O
cDNAs A O
which c O
enabled b O
YDH8 8 O
cells l O
to O O
grow w O
at O O
the 	 O
restrictive t O
temperature p O
. 
 O
We O O
generated e O
" 
 O
signature n O
" 
 O
oligonucleotides g O
from m O
these s O
CDR3s 3 O
and 	 O
probed b O
PCR 	 O
amplified l O
V - B-GENE
kappa p I-GENE
products d E-GENE
from m O
the 	 O
synovium o O
and 	 O
PBLs s O
of O O
the 	 O
same e O
patient i O
, 
 O
and 	 O
from m O
PBLs s O
and 	 O
spleen e O
of O O
individuals i O
without h O
rheumatic u O
disease e O
. 
 O
One 	 O
of O O
the 	 O
major o O
transcripts n O
encodes o O
MEQ 	 S-GENE
, 
 O
a 
 O
339 	 B-GENE
- 
 I-GENE
amino n I-GENE
- 
 I-GENE
acid d I-GENE
bZIP P I-GENE
protein t E-GENE
which c O
is O O
homologous o O
to O O
the 	 O
Jun 	 S-GENE
/ 
 O
Fos 	 S-GENE
family i O
of O O
transcription n O
factors t O
. 
 O
It O O
is O O
concluded c O
that t O
the 	 O
new 	 O
class s O
of O O
competitive p O
NMDA A B-GENE
receptor e E-GENE
antagonists a O
, 
 O
exemplified m O
by O O
CGP 	 O
37849 4 O
, 
 O
is O O
the 	 O
most t O
promising m O
candidate d O
for 	 O
clinical n O
trials a O
in O O
anxiety i O
disorders o O
. 
 O
An O O
emended n O
diagnosis g O
of O O
Tylocephalum o O
is O O
proposed p O
excluding l O
this s O
feature t O
, 
 O
along n O
with h O
distribution t O
of O O
the 	 O
testes t O
in O O
the 	 O
preovarian o O
field l O
and 	 O
circummedullary c O
distribution t O
of O O
vitelline e O
follicles l O
. 
 O
Induction u O
of O O
interferon e B-GENE
- - I-GENE
alpha h E-GENE
( 
 O
IFNalpha a S-GENE
) 
 O
gene e O
expression r O
in O O
virus u O
- 
 O
infected e O
cells l O
requires u O
phosphorylation s O
- 
 O
induced u O
activation i O
of O O
the 	 O
transcription n O
factors t O
IRF3 3 S-GENE
and 	 O
IRF7 7 S-GENE
. 
 O
METHODS H O
: 
 O
The 	 O
prevalence v O
of O O
haemagglutination m O
inhibiting i O
( - O
HI I O
) - O
antibodies i O
to O O
JE O O
virus u O
( 
 O
JEV 	 O
) 
 O
, 
 O
West t O
Nile e O
virus u O
( 
 O
WNV 	 O
) 
 O
and 	 O
dengue g O
- 
 O
2 
 O
virus u O
( 
 O
DEN 	 O
- 
 O
2 
 O
) 
 O
was 	 O
detected e O
by O O
HI O O
test t O
and 	 O
IgM 	 B-GENE
antibody i E-GENE
capture t O
ELISA S O
( 
 O
MAC 	 O
ELISA S O
) 
 O
was 	 O
performed f O
to O O
determine e O
recent e O
infections e O
with h O
JE O O
virus u O
. 
 O
Moreover e O
, 
 O
since c O
the 	 O
integrated e O
transforming n O
DNA 	 O
was 	 O
not 	 O
altered e O
or O O
lost t O
expression r O
of O O
the 	 O
RbcS2 S S-GENE
: 
 O
: 
 O
aadA A S-GENE
: 
 O
: 
 O
RbcS2 S B-GENE
gene e E-GENE
( - O
s - O
) - O
appears e O
to O O
be O O
repressed r O
. 
 O
Donehower e O
and 	 O
H 
 O
. 
 O
A 
 O
characteristic r O
feature t O
is O O
their i O
tendency d O
to O O
form m O
homo o O
- 
 O
and 	 O
/ 
 O
or O O
heterodimeric e O
complexes p O
. 
 O
Further t O
, 
 O
more e O
recent e O
communications m O
suggest g O
that t O
liver e O
disease e O
led 	 O
to O O
a 
 O
differential f O
alteration e O
of O O
the 	 O
cytochrome o B-GENE
P - I-GENE
- - I-GENE
450s s E-GENE
with h O
regard a O
to O O
protein t O
content t O
and 	 O
activity i O
. 
 O
Apparent a O
Buschke c O
- 
 O
Loewenstein w O
tumour o O
of O O
the 	 O
penis i O
. 
 O
This s O
effect e O
was 	 O
stronger o O
after e O
multiple t O
predoses d O
of O O
sertraline t O
, 
 O
when n O
imipramine p O
Cmax x O
and 	 O
AUC 	 O
( 
 O
0 
 O
- 
 O
infinity i O
) 
 O
were e O
increased r O
by O O
39 O O
% 
 O
and 	 O
68 O O
% 
 O
, 
 O
respectively p O
. 
 O
Mutations a O
in O O
nifR1 R S-GENE
( 
 O
ntrC C S-GENE
) 
 O
and 	 O
nifR4 R S-GENE
( 
 O
rpoN N S-GENE
, 
 O
encoding o O
sigma54 m S-GENE
) 
 O
had 	 O
no O O
influence l O
on O O
xdh 	 B-GENE
gene e E-GENE
expression r O
. 
 O
We O O
therefore r O
propose p O
that t O
PRR2 2 S-GENE
, 
 O
and 	 O
not 	 O
PVR 	 S-GENE
, 
 O
is O O
the 	 O
true e O
human a O
homolog o O
of O O
MPH 	 S-GENE
. 
 O
Swarming r O
of O O
Moraxella a O
Biochem c O
. 
 O
In O O
contrast t O
, 
 O
vRel l S-GENE
lacks k O
a 
 O
strong o O
C 
 O
- 
 O
terminal m O
gene e O
activation i O
function c O
, 
 O
since c O
a 
 O
LexA A B-GENE
fusion i I-GENE
protein t E-GENE
containing t O
C - B-GENE
- - I-GENE
terminal m I-GENE
vRel l I-GENE
sequences u E-GENE
alone n O
only y O
weakly k O
activated i O
transcription n O
. 
 O
The 	 O
crystal s O
structure u O
of O O
the 	 O
yeast s B-GENE
Phe 	 I-GENE
- - I-GENE
tRNAPhe A I-GENE
ternary n I-GENE
complex p E-GENE
with h O
Thermus r O
aquaticus a O
EF B O
- - O
Tu E O
- 
 O
GDPNP N O
( 
 O
Phe 	 O
- - O
TC E O
) 
 O
has 	 O
previously v O
been n O
determined e O
as O O
one 	 O
representative r O
of O O
this s O
general e O
yet 	 O
highly h O
discriminating c O
complex p O
formation m O
. 
 O
Bovine i O
anaplasmosis p O
: 
 O
susceptibility c O
of O O
seronegative o O
cows s O
from m O
an O O
infected e O
herd d O
to O O
experimental e O
infection e O
with h O
Anaplasma p O
marginale g O
. 
 O
Because a O
of O O
gut 	 O
fermentation m O
, 
 O
a 
 O
substantial s O
portion t O
( 
 O
16 O O
- 
 O
80 O O
% 
 O
) 
 O
of O O
N 
 O
is O O
absorbed o O
as O O
ammonia o O
N 
 O
( 
 O
NH3N N O
) 
 O
. 
 O
Quantitative n O
measurement s O
of O O
antigamma i B-GENE
globulin b I-GENE
factors t E-GENE
( 
 O
rheumatoid u B-GENE
factors t E-GENE
) 
 O
using n O
laser e O
- 
 O
nephelometry h O
in O O
comparison p O
with h O
the 	 O
latex e O
agglutination l O
test t O
and 	 O
the 	 O
Waaler l O
- 
 O
Rose e O
test t O
The 	 O
densities s O
ranged g O
between w O
2 
 O
and 	 O
3976 6 O
neurites r O
/ 
 O
mm2 	 O
skin n O
surface f O
, 
 O
but 	 O
the 	 O
overlap r O
between w O
subjects j O
and 	 O
without h O
PHN 	 O
was 	 O
small l O
. 
 O
Zoonotic n O
areas a O
in O O
which c O
HIV 	 O
co O O
- 
 O
infection e O
is O O
common m O
could l O
also o O
be O O
at O O
risk k O
as O O
sandflies d O
can 	 O
become o O
infected e O
from m O
co O O
- 
 O
infected e O
individuals i O
. 
 O
The 	 O
determination e O
of O O
antithrombin i B-GENE
III 	 E-GENE
( 
 O
AT B B-GENE
III 	 E-GENE
) 
 O
and 	 O
its 	 O
clinical n O
significance n O
The 	 O
kinetics e O
of O O
erythromycin t O
( 
 O
E 
 O
. 
 O
) 
 O
was 	 O
studied d O
in O O
16 O O
patients i O
with h O
different f O
degrees r O
of O O
impairment a O
of O O
renal a O
function c O
after e O
a 
 O
single g O
intravenous r O
dose e O
. 
 O
Base e O
substitutions s O
within h O
this s O
NFIL L B-GENE
- - I-GENE
6 - I-GENE
site e E-GENE
resulted u O
in O O
virtual t O
elimination m O
of O O
LPS 	 O
- 
 O
induced u O
IL B B-GENE
- - I-GENE
1 - I-GENE
beta a I-GENE
gene e E-GENE
transcription n O
. 
 O
Mortality t O
rates e O
were e O
not 	 O
different f O
( 
 O
chi2 2 O
: 
 O
0 
 O
. 
 O
0298 8 O
, 
 O
p 
 O
> 
 O
0 
 O
. 
 O
5 
 O
) 
 O
. 
 O
The 	 O
MALDI D O
- 
 O
TOF 	 O
experiment e O
, 
 O
however e O
, 
 O
proved v O
to O O
be O O
superior e O
to O O
the 	 O
GC O O
experiment e O
, 
 O
particularly t O
with h O
regard a O
to O O
baseline e O
resolution o O
of O O
unsaturated a O
acids d O
. 
 O
Modern e O
aspects e O
of O O
shock c O
- 
 O
treatment a O
in O O
extensive e O
burns n O
( 
 O
author h O
' 
 O
s 
 O
transl n O
) 
 O
Of O O
the 	 O
private v O
practices c O
accredited r O
in O O
August u O
1995 5 O
, 
 O
40 O O
. 
 O
6 
 O
per 	 O
cent t O
( 
 O
122 	 O
) 
 O
participated t O
. 
 O
A 
 O
Drosophila s O
subobscura o O
genomic o O
fragment g O
containing t O
all 	 O
the 	 O
exons n O
and 	 O
the 	 O
late e O
and 	 O
early l O
promotors m O
in O O
the 	 O
Sxl 	 B-GENE
gene e E-GENE
of I O
D - O
. - O
melanogaster a O
was 	 O
isolated l O
. 
 O
Collectively l O
, 
 O
a 
 O
unique q O
mechanism h O
involving o O
NF B B-GENE
- - I-GENE
ATp 	 E-GENE
appears e O
to O O
regulate u O
the 	 O
cell l O
type e O
- 
 O
specific c O
and 	 O
activation i O
- 
 O
dependent e O
expression r O
of O O
the 	 O
SCM 	 B-GENE
- - I-GENE
1 - I-GENE
genes e E-GENE
. 
 O
The 	 O
sensitivity s O
of O O
central t O
dopamine a B-GENE
receptors e E-GENE
was 	 O
assessed e O
with h O
the 	 O
growth w O
hormone m O
response p O
to O O
apomorphine m O
application l O
. 
 O
Oral l O
basal a O
body y O
temperature p O
( 
 O
BBT 	 O
) 
 O
recordings o O
of O O
46 O O
women e O
that t O
conceived c O
by O O
donor o O
insemination e O
and 	 O
who 	 O
had 	 O
midcycle c O
monitoring i O
of O O
luteinising e B-GENE
hormone m E-GENE
( 
 O
LH S S-GENE
) 
 O
were e O
analysed l O
to O O
establish a O
features t O
associated o O
with h O
an O O
optimal i O
cycle l O
. 
 O
Our 	 O
results u O
admit i O
that t O
a 
 O
ribosome o O
scanning n O
mechanism h O
of O O
the 	 O
MP B B-GENE
gene e E-GENE
expression r O
from m O
I 
 B-GENE
( 
 I-GENE
2 
 I-GENE
) 
 I-GENE
sgRNA N I-GENE
operates r E-GENE
concurrently c O
. 
 O
The 	 O
three e O
- 
 O
dimensional e O
structure u O
of O O
the 	 O
E 
 B-GENE
. 
 I-GENE
coli i I-GENE
CR O I-GENE
domain a E-GENE
indicates i O
that t O
this s O
sequence u O
conservation s O
is O O
likely e O
to O O
result u O
in O O
a 
 O
conserved s O
structural u O
motif i O
. 
 O
Otosclerosis s O
in O O
monozygotic o O
twins n O
: 
 O
clinical n O
and 	 O
genetical e O
analysis l O
A 
 O
DNA 	 O
fragment g O
that t O
complements p O
the 	 O
uvs 	 B-GENE
- - I-GENE
2 - I-GENE
mutation a E-GENE
was 	 O
subcloned c O
by O O
monitoring i O
its 	 O
ability l O
to O O
transform n O
the 	 O
uvs 	 B-GENE
- - I-GENE
2 - I-GENE
mutant a E-GENE
to O O
MMS 	 O
resistance i O
. 
 O
The 	 O
human a B-GENE
lbc 	 I-GENE
oncogene o I-GENE
product d E-GENE
is O O
a 
 O
guanine n B-GENE
nucleotide l I-GENE
exchange h I-GENE
factor t E-GENE
that t O
specifically c O
activates i O
the 	 O
Rho 	 B-GENE
small l I-GENE
GTP 	 I-GENE
binding d I-GENE
protein t E-GENE
, 
 O
thus s O
resulting u O
in O O
biologically l O
active i O
, 
 O
GTP 	 O
- 
 O
bound n O
Rho 	 S-GENE
, 
 O
which c O
in O O
turn n O
mediates i O
actin i S-GENE
cytoskeletal o O
reorganization r O
, 
 O
gene e O
transcription n O
, 
 O
and 	 O
entry r O
into o O
the 	 O
mitotic o O
S 
 O
phase s O
. 
 O
Insulin u S-GENE
- 
 O
stimulated m O
autophosphorylation o O
at O O
specific c O
sites e O
in O O
the 	 O
tyrosine o B-GENE
kinase a I-GENE
domain a E-GENE
of O O
the 	 O
receptor e B-GENE
' 
 I-GENE
s 
 I-GENE
beta a I-GENE
- 
 I-GENE
subunit u E-GENE
is O O
correlated r O
kinetically e O
with h O
activation i O
of O O
kinase a O
- 
 O
catalyzed a O
phosphorylation s O
of O O
a 
 O
model e O
substrate s O
( 
 O
reduced u O
and 	 O
carboxyamidomethylated b B-GENE
lysozyme o E-GENE
; 
 O
RCAM M B-GENE
- - I-GENE
lysozyme o E-GENE
) 
 O
. 
 O
The 	 O
critical t O
obstacle t O
in O O
modeling e O
psychiatric c O
disorders o O
has 	 O
been n O
limited i O
information o O
about u O
their i O
origin g O
and 	 O
underlying e O
neural r O
mechanisms h O
. 
 O
BACKGROUND K O
: 
 O
Allergic e O
rhinoconjunctivitis n O
is O O
a 
 O
common m O
disorder o O
, 
 O
affecting e O
> 
 O
20 O O
% 
 O
of O O
people p O
of O O
all 	 O
socioeconomic i O
strata a O
. 
 O
The 	 O
results u O
of O O
these s O
studies d O
indicate i O
that t O
EHV 	 B-GENE
- - I-GENE
1 - I-GENE
gp13 3 E-GENE
is O O
the 	 O
structural u O
homolog o O
of O O
herpes p B-GENE
simplex p I-GENE
virus u I-GENE
glycoprotein c I-GENE
C - E-GENE
and 	 O
further t O
suggest g O
that t O
the 	 O
epitope t O
- 
 O
containing t O
N 
 O
- 
 O
terminal m O
amino n O
acid d O
sequences u O
of O O
the 	 O
herpesvirus p O
gC I O
- - O
like e O
glycoproteins c O
have e O
undergone e O
more e O
extensive e O
evolutionary l O
divergence e O
than n O
the 	 O
C 
 O
- 
 O
terminal m O
sequences u O
. 
 O
Within h O
the 	 O
final a O
11 O O
amino n O
acids d O
there r O
are 	 O
5 
 O
aromatic m O
, 
 O
2 
 O
basic i O
, 
 O
and 	 O
no O O
acidic d O
residues i O
and 	 O
it O O
has 	 O
been n O
proposed p O
that t O
these s O
residues i O
stack c O
with h O
and 	 O
electrostatically c O
interact e O
with h O
the 	 O
kinked k O
DNA 	 O
at O O
the 	 O
site e O
of O O
a 
 O
pyrimidine i O
dimer e O
. 
 O
By O O
contrast t O
, 
 O
footprint t O
II O O
at O O
position i O
- 
 O
125 	 O
is O O
common m O
to O O
both h O
HeLa a O
and 	 O
GH3 	 O
cell l O
extracts r O
and 	 O
overlies r O
a 
 O
15 O O
- 
 O
base e O
- 
 O
pair r O
sequence u O
found n O
in O O
all 	 O
members b O
of O O
the 	 O
growth w B-GENE
hormone m I-GENE
gene e I-GENE
family i E-GENE
. 
 O
Significance n O
of O O
the 	 O
determination e O
of O O
vascular c O
tonus u O
in O O
the 	 O
differential f O
diagnosis g O
of O O
rheumatic u O
and 	 O
arteriosclerotic e O
lesions i O
of O O
the 	 O
heart r O
and 	 O
vessels s O
in O O
middle d O
- 
 O
aged d O
and 	 O
elderly e O
persons s O
with h O
fibrillation r O
arrhythmia h O
The 	 O
gene e O
responsible p O
for 	 O
multiple t O
endocrine o B-GENE
neoplasia p I-GENE
type e I-GENE
1 
 E-GENE
( 
 O
MEN1 1 S-GENE
) 
 O
, 
 O
a 
 O
heritable i O
predisposition d O
to O O
endocrine o O
tumours o O
in O O
man 	 O
, 
 O
has 	 O
recently e O
been n O
identified n O
. 
 O
Toxicological i O
effects e O
of O O
dietary t O
Maillard l O
reaction c O
products d O
in O O
the 	 O
rat 	 O
. 
 O
AST 	 S-GENE
activity i O
in O O
PMNs s O
was 	 O
significantly n O
low 	 O
, 
 O
approximately r O
2 
 O
% 
 O
of O O
that t O
observed e O
in O O
HPLFs F O
. 
 O
Specifically c O
, 
 O
we O O
engineered i O
two 	 O
chimeras m O
in O O
which c O
the 	 O
N 
 O
- 
 O
terminal m O
lobe e O
of O O
the 	 O
SH1 	 B-GENE
domain a E-GENE
of O O
c - B-GENE
- - I-GENE
Abl 	 E-GENE
was 	 O
swapped p O
with h O
that t O
of O O
v - B-GENE
- - I-GENE
Src 	 E-GENE
. 
 O
Biochemical c O
analyses l O
revealed e O
that t O
the 	 O
concentration c O
of O O
norepinephrine e O
was 	 O
reduced u O
significantly n O
in O O
cortex t O
- 
 O
hippocampus p O
and 	 O
olfactory a O
bulb b O
but 	 O
not 	 O
in O O
other e O
regions i O
, 
 O
while l O
dopamine a O
and 	 O
serotonin o O
levels e O
were e O
not 	 O
altered e O
in O O
any 	 O
brain i O
region i O
examined m O
. 
 O
The 	 O
cDNA A O
contains t O
a 
 O
reading d O
frame m O
for 	 O
a 
 O
145 	 O
- 
 O
amino n O
- 
 O
acid d O
protein t O
and 	 O
it O O
lacks k O
the 	 O
UGA 	 O
codons o O
, 
 O
which c O
have e O
been n O
found n O
in O O
the 	 O
reading d O
frame m O
of O O
the 	 O
mouse s B-GENE
MCS 	 I-GENE
cDNA A E-GENE
and 	 O
have e O
been n O
presumed s O
to O O
encode o O
the 	 O
selenocysteine e O
in O O
the 	 O
amino n O
terminal m O
of O O
the 	 O
deduced u O
mouse s O
amino n O
acid d O
sequence u O
. 
 O
These s O
results u O
suggest g O
that t O
repetitive e O
GAA 	 O
sequences u O
enhance a O
splicing i O
by O O
binding d O
a 
 O
protein t O
complex p O
containing t O
a 
 O
sequence u O
- 
 O
specific c O
RNA 	 O
binding d O
protein t O
and 	 O
a 
 O
general e O
splicing i O
activator i O
that t O
, 
 O
in O O
turn n O
, 
 O
recruit r O
additional i O
SR B B-GENE
proteins t E-GENE
. 
 O
Letter t O
: 
 O
Dehydrated y O
test t O
strip i O
for 	 O
the 	 O
detection e O
of O O
yeasts s O
. 
 O
Cell l O
sloughing u O
with h O
proparacaine p O
. 
 O
Cytomegalovirus o O
infection e O
- 
 O
- 
 O
modern e O
diagnosis g O
Highly h O
conserved s O
regions i O
called l O
src 	 B-GENE
homology o I-GENE
2 - I-GENE
and 	 I-GENE
3 
 E-GENE
( 
 O
SH2 	 S-GENE
and 	 O
SH3 	 S-GENE
) 
 O
, 
 O
comprising p O
amino n O
acid d O
residues i O
88 O O
to O O
250 	 O
, 
 O
are 	 O
believed i O
to O O
modulate u O
the 	 O
protein t B-GENE
- - I-GENE
tyrosine o I-GENE
kinase a E-GENE
activity i O
present s O
in O O
the 	 O
carboxy b O
- 
 O
terminal m O
halves v O
of O O
the 	 O
src 	 B-GENE
proteins t E-GENE
. 
 O
Interestingly e O
, 
 O
the 	 O
NES 	 B-GENE
mutant a I-GENE
proteins t E-GENE
appeared e O
to O O
have e O
altered e O
interactions e O
with h O
the 	 O
splicing i O
complex p O
, 
 O
binding d O
more e O
tightly h O
to O O
SC35 5 S-GENE
in O O
co O O
- 
 O
immunoprecipitation u O
assays a O
. 
 O
We O O
propose p O
2 
 O
separate a O
PAI 	 B-GENE
- - I-GENE
1 - E-GENE
inductory u O
pathways h O
for 	 O
PMA 	 S-GENE
and 	 O
IL B B-GENE
- - I-GENE
1alpha p E-GENE
in O O
HepG2 G S-GENE
, 
 O
both h O
involving o O
protein t B-GENE
tyrosine o I-GENE
kinase a E-GENE
activation i O
; 
 O
the 	 O
serum u O
- 
 O
induced u O
signaling n O
pathway h O
may 	 O
( 
 O
partially t O
) 
 O
overlap r O
with h O
the 	 O
PMA 	 B-GENE
- 
 I-GENE
activated i I-GENE
protein t I-GENE
kinase a I-GENE
C - E-GENE
/ 
 O
mitogen o B-GENE
- - I-GENE
activated i I-GENE
protein t I-GENE
kinase a I-GENE
kinase a E-GENE
pathway h O
, 
 O
leading d O
to O O
c - B-GENE
- - I-GENE
Jun 	 I-GENE
homodimer o E-GENE
binding d O
to O O
the 	 O
PAI 	 B-GENE
- - I-GENE
1 - I-GENE
TRE 	 E-GENE
. 
 O
We O O
show w O
that t O
sae1 1 B-GENE
- - I-GENE
1 - E-GENE
and 	 O
sae3 3 B-GENE
- - I-GENE
1 - E-GENE
mutations a O
each h O
confer f O
a 
 O
distinct t O
defect e O
in O O
meiotic o O
recombination o O
. 
 O
sae1 1 B-GENE
- - I-GENE
1 - E-GENE
produces d O
recombinants o O
but 	 O
very y O
slowly w O
and 	 O
ultimately i O
to O O
less s O
than n O
half f O
the 	 O
wild d O
- 
 O
type e O
level e O
; 
 O
sae3 3 B-GENE
- - I-GENE
1 - E-GENE
makes e O
persistent s O
hyper e O
- 
 O
resected e O
meiotic o O
double b O
- 
 O
strand a O
breaks a O
and 	 O
has 	 O
a 
 O
severe e O
defect e O
in O O
formation m O
of O O
recombinants o O
. 
 O
G6620 2 S-GENE
is O O
the 	 O
3 
 O
' 
 O
end 	 O
of O O
the 	 O
MOL1 1 B-GENE
gene e E-GENE
coding i O
for 	 O
a 
 O
polypeptide y O
similar i O
to O O
stress e O
- 
 O
inducible u O
proteins t O
from m O
Fusarium a O
; 
 O
G6630 3 O
is O O
the 	 O
NAT2 2 B-GENE
gene e E-GENE
which c O
encodes o O
a 
 O
methionine h B-GENE
N - I-GENE
- - I-GENE
acetyltransferase t E-GENE
; 
 O
G6635 3 S-GENE
is O O
the 	 O
RPL30B 3 B-GENE
gene e E-GENE
coding i O
for 	 O
the 	 O
ribosomal o B-GENE
protein t I-GENE
L30 	 E-GENE
; 
 O
G6658 5 S-GENE
is O O
RSR1 1 S-GENE
encoding o O
a 
 O
ras 	 B-GENE
- - I-GENE
related a I-GENE
protein t E-GENE
; 
 O
G6667 6 O
is O O
CYS4 4 S-GENE
, 
 O
the 	 O
gene e O
for 	 O
cystathionine t B-GENE
beta a I-GENE
- - I-GENE
synthase t E-GENE
; 
 O
G6670 7 S-GENE
is O O
identical n O
to O O
ORF2 2 S-GENE
located a O
close s O
to O O
CYS4 4 S-GENE
; 
 O
G6673 7 O
is O O
PEM1 1 S-GENE
/ 
 O
CHO2 2 S-GENE
encoding o O
a 
 O
phosphatidylethanolamine s B-GENE
methyltransferase h E-GENE
; 
 O
G7001 0 S-GENE
is O O
the 	 O
NSR1 1 B-GENE
gene e E-GENE
coding i O
for 	 O
a 
 O
nuclear l O
signal n O
recognition o O
protein t O
. 
 O
Transcriptional n O
analysis l O
of O O
this s O
gene e O
cluster s O
was 	 O
performed f O
by O O
detecting e O
the 	 O
presence s O
of O O
mRNAs A O
spanning n O
adjacent a O
genes e O
as O O
well l O
as O O
by O O
using n O
a 
 O
promoterless m O
lacZ Z B-GENE
reporter o I-GENE
gene e E-GENE
fused e O
to O O
each h O
of O O
the 	 O
seven e O
genes e O
contained t O
in O O
the 	 O
tol 	 B-GENE
- 
 I-GENE
oprL L I-GENE
locus u E-GENE
. 
 O
Serum u B-GENE
IgG 	 E-GENE
and 	 O
IgA 	 S-GENE
level e O
were e O
decreased r O
. 
 O
Histopathologically t O
, 
 O
( 
 O
mice e O
killed l O
with h O
high h O
doses e O
of O O
GMC 	 O
- 
 O
II O O
, 
 O
given e O
orally l O
) 
 O
there r O
were e O
diffuse f O
hyperemia e O
of O O
the 	 O
liver e O
, 
 O
parenchymal e O
degeneration e O
of O O
the 	 O
kidney n O
tubuli u O
epithelium t O
, 
 O
and 	 O
edema m O
and 	 O
emphysema h O
of O O
the 	 O
lungs g O
. 
 O
The 	 O
contribution t O
of O O
reviewers i O
and 	 O
editors t O
to O O
the 	 O
scientific e O
work k O
of O O
the 	 O
authors h O
The 	 O
effects e O
of O O
space c O
radiation i O
are 	 O
partially t O
known w O
on O O
astronauts r O
, 
 O
but 	 O
much h O
remains a O
to O O
be O O
discovered c O
. 
 O
Therefore r O
the 	 O
effect e O
of O O
GAL11 1 S-GENE
on O O
PGK 	 S-GENE
transcription n O
must t O
be O O
mediated i O
at O O
the 	 O
PGK 	 B-GENE
UAS 	 E-GENE
, 
 O
presumably s O
as O O
part t O
of O O
the 	 O
activation i O
complex p O
. 
 O
Wingless g S-GENE
/ 
 O
Wnt 	 S-GENE
signaling n O
directs e O
cell l O
- 
 O
fate e O
choices i O
during i O
embryonic r O
development e O
. 
 O
RNase s S-GENE
protection t O
analysis l O
reveals e O
a 
 O
10 O O
- 
 O
fold d O
increase r O
in O O
the 	 O
expression r O
of O O
SCD2 2 B-GENE
mRNA A E-GENE
during i O
3T3 	 B-GENE
- 
 I-GENE
L1 O E-GENE
preadipocyte a O
differentiation f O
. 
 O
To O O
determine e O
whether t O
transcription n O
of O O
orfX X S-GENE
and 	 O
vfr 	 S-GENE
are 	 O
controlled t O
by O O
the 	 O
same e O
mechanisms h O
that t O
control t O
transcription n O
of O O
the 	 O
region i O
of O O
the 	 O
divergent e O
ORF 	 O
( 
 O
dorf f S-GENE
) 
 O
and 	 O
of O O
crp 	 S-GENE
, 
 O
we O O
compared p O
the 	 O
vfr 	 S-GENE
- 
 O
orfX X S-GENE
and 	 O
crp 	 S-GENE
- 
 O
dorf f O
intergenic e O
regions i O
. 
 O
As O O
a 
 O
member b O
of O O
the 	 O
uncoupling o O
protein t O
family i O
, 
 O
UCP2 2 S-GENE
is O O
ubiquitously q O
expressed r O
in O O
rodents e O
and 	 O
humans a O
, 
 O
implicating l O
a 
 O
major o O
role e O
in O O
thermogenesis r O
. 
 O
Copyright y O
1998 8 O
Academic d O
Press s O
. 
 O
Parental e O
and 	 O
vector t O
- 
 O
transfected n O
MCF7 7 O
cells l O
, 
 O
which c O
were e O
sensitive s O
to O O
the 	 O
growth w O
- 
 O
inhibitory i O
effects e O
of O O
atRA A S-GENE
, 
 O
exhibited i O
atRA A B-GENE
- 
 I-GENE
dependent e I-GENE
retinoic i I-GENE
acid d I-GENE
receptor e E-GENE
( 
 O
RAR 	 S-GENE
) 
 O
transactivation n O
and 	 O
transrepression n O
of O O
12 O O
- 
 O
O 
 O
- 
 O
tetradecanoylphorbol r O
- 
 O
13 O O
- 
 O
acetate t O
- 
 O
induced u O
AP B B-GENE
- - I-GENE
1 - E-GENE
activity i O
. 
 O
The 	 O
majority o O
of O O
the 	 O
respondents p O
( 
 O
83 O O
. 
 O
4 
 O
% 
 O
) 
 O
considered s O
that t O
coitus t O
should u O
not 	 O
be O O
stopped p O
during i O
pregnancy g O
. 
 O
Based e O
on O O
the 	 O
ratios i O
of O O
the 	 O
areas a O
under e O
the 	 O
concentration c O
- 
 O
time e O
curves v O
in O O
CSF 	 O
and 	 O
serum u O
, 
 O
the 	 O
overall r O
penetration e O
of O O
rifampicin a O
into o O
CSF 	 O
was 	 O
0 
 O
. 
 O
13 O O
- 
 O
0 
 O
. 
 O
42 O O
( 
 O
median i O
= 
 O
0 
 O
. 
 O
22 O O
) 
 O
. 
 O
The 	 O
differential f O
diagnosis g O
of O O
mineral e O
oil 	 O
lipidosis i O
in O O
lymph p O
nodes e O
with h O
reaction c O
to O O
radiopaque i O
oils s O
and 	 O
Whipple p O
' 
 O
s 
 O
disease e O
is O O
discussed c O
. 
 O
With h O
rats s O
fed 	 O
on O O
the 	 O
Zn O O
- 
 O
sufficient f O
diet t O
, 
 O
NaFe3 e O
+ 
 O
EDTA A O
and 	 O
Na2EDTA E O
similarly i O
increased r O
the 	 O
absorption o O
, 
 O
urinary n O
excretion r O
and 	 O
retention e O
of O O
Zn O O
but 	 O
to O O
a 
 O
lesser s O
extent e O
. 
 O
99Tcm c O
- 
 O
labelled e O
albumin u S-GENE
colloid l O
, 
 O
albures u O
( 
 O
radius i O
250 	 O
nm O O
) 
 O
or O O
nanocoll o O
( 
 O
radius i O
25 O O
nm O O
) 
 O
, 
 O
or O O
both h O
were e O
used d O
as O O
test t O
substances s O
to O O
study d O
the 	 O
kinetics e O
of O O
vascular c O
clearance a O
after e O
RES 	 O
stimulation m O
. 
 O
Meq 	 S-GENE
/ 
 O
c - B-GENE
- - I-GENE
Jun 	 I-GENE
heterodimers e E-GENE
bind d O
to O O
an O O
AP1 	 B-GENE
- - I-GENE
like e I-GENE
sequence u E-GENE
in O O
the 	 O
meq 	 B-GENE
promoter m I-GENE
region i E-GENE
with h O
an O O
affinity i O
much h O
greater a O
than n O
that t O
of O O
Meq 	 S-GENE
/ 
 O
Meq 	 S-GENE
or O O
c - B-GENE
- - I-GENE
Jun 	 E-GENE
/ 
 O
c - B-GENE
- - I-GENE
Jun 	 I-GENE
homodimers o E-GENE
. 
 O
Moreover e O
, 
 O
the 	 O
noncoordinate c O
effects e O
of O O
FSK 	 S-GENE
on O O
PMA 	 O
- 
 O
stimulated m O
MKK 	 S-GENE
and 	 O
MAPK K S-GENE
activities i O
indicates i O
the 	 O
presence s O
of O O
a 
 O
additional i O
distal t O
cAMP P O
- 
 O
dependent e O
inhibitory i O
mechanisms h O
. 
 O
These s O
findings d O
indicated i O
that t O
p35 	 S-GENE
is O O
a 
 O
trans n B-GENE
- 
 I-GENE
dominant i I-GENE
factor t E-GENE
that t O
facilitates i O
AcMNPV N S-GENE
growth w O
in O O
a 
 O
cell l O
line e O
- 
 O
specific c O
manner n O
. 
 O
Pseudotumor u O
form m O
of O O
pulmonary m O
nocardia a O
infection e O
( 
 O
Nocardia a O
nova a O
) 
 O
in O O
a 
 O
renal a O
transplant n O
patient i O
Hematological a O
parameters a O
( 
 O
leukocyte k O
, 
 O
neutrophil t O
and 	 O
platelet t O
counts n O
) 
 O
and 	 O
liver e O
function c O
tests t O
were e O
determined e O
by O O
standard n O
procedures c O
. 
 O
Karyo y O
- 
 O
and 	 O
cytometric o O
investigations e O
of O O
cortical t O
layer e O
V 
 O
pyramidal a O
neurons r O
of O O
albino i O
rat 	 O
after e O
three e O
various i O
fixations a O
Clinical n O
experience e O
gained n O
from m O
a 
 O
combined b O
study d O
of O O
252Cf C O
brachytherapy c O
by O O
the 	 O
staff f O
- 
 O
members b O
of O O
the 	 O
Research e O
Institute t O
of O O
Medical i O
Radiology i O
, 
 O
USSR R O
AMS 	 O
, 
 O
was 	 O
generalized e O
. 
 O
The 	 O
team m O
physician s O
and 	 O
conditioning d O
of O O
athletes l O
for 	 O
sports r O
: 
 O
a 
 O
consensus s O
statement t O
. 
 O
To O O
probe b O
the 	 O
inter e O
- 
 O
relationship a O
between w O
the 	 O
virion i O
- 
 O
anchoring h O
function c O
and 	 O
the 	 O
oligomerization g O
function c O
, 
 O
we O O
constructed s O
two 	 O
serotype o B-GENE
3 
 I-GENE
( 
 I-GENE
T3 O I-GENE
) 
 I-GENE
sigma m I-GENE
1 - I-GENE
deletion e I-GENE
mutants a E-GENE
in O O
SV40 0 O
expression r O
vectors t O
, 
 O
one 	 O
lacking k O
the 	 O
hydrophobic r O
tail l O
and 	 O
the 	 O
hinge g O
, 
 O
and 	 O
the 	 O
other e O
lacking k O
an O O
adjacent a O
region i O
which c O
constituted s O
part t O
of O O
the 	 O
coiled l O
- 
 O
coil l O
. 
 O
AIMS S O
: 
 O
The 	 O
aim 	 O
of O O
this s O
study d O
was 	 O
to O O
assess e O
static t O
and 	 O
dynamic a O
bone e O
changes n O
in O O
patients i O
suffering f O
from m O
rickets k O
. 
 O
The 	 O
law 	 O
and 	 O
the 	 O
chiropractor r O
. 
 O
In O O
contrast t O
, 
 O
overexpression r O
of O O
the 	 O
DREB2A B B-GENE
cDNA A E-GENE
induced u O
weak k O
expression r O
of O O
the 	 O
target g O
genes e O
under e O
unstressed t O
conditions d O
and 	 O
caused s O
growth w O
retardation a O
of O O
the 	 O
transgenic n O
plants n O
. 
 O
Our 	 O
findings d O
suggest g O
that t O
AIF 	 O
may 	 O
be O O
a 
 O
morphologic p O
correlate r O
of O O
tumor o O
regression r O
following l O
preoperative o O
cytotoxic o O
chemotherapy m O
. 
 O
Mean n O
total a O
homocysteine o O
( 
 O
tHcy y O
) 
 O
was 	 O
21 O O
. 
 O
1 
 O
+ 
 O
/ 
 O
- 
 O
9 
 O
. 
 O
5 
 O
micromol r O
/ 
 O
L 
 O
and 	 O
median i O
concentration c O
was 	 O
19 O O
micromol r O
/ 
 O
L 
 O
. 
 O
Efficacy i O
of O O
probiotic b O
feed d O
additives i O
: 
 O
guidelines d O
for 	 O
the 	 O
evaluation l O
of O O
the 	 O
efficiency i O
of O O
microorganisms r O
in O O
dogs s O
, 
 O
cats s O
, 
 O
and 	 O
horses s O
] 
 O
Probiotic b O
microorganisms r O
are 	 O
frequently q O
in O O
use 	 O
as O O
feed d O
additives i O
for 	 O
farm m O
and 	 O
pet 	 O
animals m O
. 
 O
Lung g O
transplantation n O
is O O
warranted r O
for 	 O
stable b O
, 
 O
ventilator t O
- 
 O
dependent e O
recipients i O
. 
 O
Site e O
- 
 O
directed e O
mutagenesis a O
shows w O
that t O
sites e O
throughout o O
the 	 O
IRE 	 S-GENE
alter e O
negative a O
control t O
and 	 O
IRE 	 B-GENE
- - I-GENE
BP E E-GENE
binding d O
reflecting l O
the 	 O
fact t O
that t O
the 	 O
footprint t O
of O O
the 	 O
IRE 	 B-GENE
- - I-GENE
BP E E-GENE
is O O
over r O
the 	 O
entire i O
IRE 	 O
. 
 O
An O O
alternative e O
approach r O
to O O
random d O
integration e O
of O O
large g O
DNA 	 O
fragments g O
into o O
plants n O
is O O
to O O
utilize l O
one 	 O
of O O
several e O
site e O
- 
 O
specific c O
recombination o O
( 
 O
SSR 	 O
) 
 O
systems t O
, 
 O
such h O
as O O
Cre 	 S-GENE
/ 
 O
lox 	 S-GENE
. 
 O
Neonatal n O
masculinization c O
affects e O
maternal e O
behavior a O
sensitivity s O
in O O
female a O
rats s O
. 
 O
Recombinant o B-GENE
mouse s I-GENE
GSTT1 T I-GENE
- - I-GENE
1 - E-GENE
was 	 O
catalytically a O
active i O
towards a O
1 
 O
, 
 O
2 
 O
- 
 O
epoxy x O
- 
 O
3 
 O
- 
 O
( 
 O
p 
 O
- 
 O
nitrophenoxy r O
) 
 O
propane p O
, 
 O
4 
 O
- 
 O
nitrobenzyl r O
chloride o O
and 	 O
dichloromethane h O
. 
 O
In O O
addition i O
, 
 O
six 	 O
other e O
landmarks d O
favored o O
the 	 O
xeroradiograph o O
but 	 O
not 	 O
to O O
the 	 O
degree r O
of O O
statistical t O
significance n O
. 
 O
Nonlethal l O
sec71 7 B-GENE
- - I-GENE
1 - E-GENE
and 	 O
sec72 7 B-GENE
- - I-GENE
1 - E-GENE
mutations a O
eliminate m O
proteins t O
associated o O
with h O
the 	 O
Sec63p 6 S-GENE
- 
 O
BiP 	 S-GENE
complex p O
from m O
S 
 O
. 
 O
cerevisiae e O
. 
 O
Sequence u O
and 	 O
deletion e O
analysis l O
of O O
the 	 O
recombination o O
enhancement a O
gene e O
( 
 O
ref 	 S-GENE
) 
 O
of O O
bacteriophage t O
P1 O O
: 
 O
evidence d O
for 	 O
promoter m O
- 
 O
operator r O
and 	 O
attenuator e O
- 
 O
antiterminator i O
control t O
. 
 O
A 
 O
high h O
titer e O
of O O
anti i B-GENE
- - I-GENE
HBc 	 E-GENE
, 
 O
thus s O
suggested g O
to O O
be O O
an O O
indicator i O
of O O
persistent s O
hepatitis a O
B 
 O
virus u O
infection e O
, 
 O
was 	 O
found n O
rarely e O
in O O
seronegative o O
patients i O
with h O
chronic o O
hepatitis a O
, 
 O
non 	 O
- 
 O
alcoholic o O
cirrhosis r O
, 
 O
or O O
alcoholic o O
liver e O
diseases e O
. 
 O
Adaptability p O
of O O
Nippostrongylus p O
brasiliensis s O
( 
 O
Travassos v O
, 
 O
1914 4 O
) 
 O
to O O
lead d O
contamination t O
Eph 	 B-GENE
receptors e E-GENE
and 	 O
their i O
membrane b O
- 
 O
associated o O
ephrin r S-GENE
ligands a O
regulate u O
cell l O
- 
 O
cell l O
interactions e O
during i O
development e O
. 
 O
We O O
discuss c O
the 	 O
possibility s O
that t O
DNA 	 O
- 
 O
protein t O
interactions e O
at O O
homologous o O
nucleotide l O
sequences u O
like e O
those s O
identified n O
in O O
PII 	 S-GENE
are 	 O
part t O
of O O
a 
 O
regulatory u O
gene e O
cascade c O
that t O
participates t O
in O O
timing i O
fla 	 O
gene e O
expression r O
in O O
the 	 O
C 
 O
. 
 O
crescentus s O
cell l O
cycle l O
. 
 O
Postcontrast t O
images g O
were e O
also o O
acquired u O
in O O
the 	 O
sagittal i O
( 
 O
six 	 O
patients i O
) 
 O
and 	 O
coronal o O
( 
 O
three e O
patients i O
) 
 O
planes n O
. 
 O
Nature u O
of O O
the 	 O
thermopower r O
in O O
bipolar o O
semiconductors i O
. 
 O
To O O
increase r O
the 	 O
number b O
of O O
circulating c O
polymorphonuclear y O
neutrophils t O
, 
 O
the 	 O
patient i O
was 	 O
treated a O
with h O
recombinant o B-GENE
granulocyte n I-GENE
- - I-GENE
macrophage r I-GENE
colony o I-GENE
- - I-GENE
stimulating m I-GENE
factor t E-GENE
( 
 O
GM B B-GENE
- - I-GENE
CSF 	 E-GENE
) 
 O
at O O
a 
 O
dose e O
of O O
2 
 O
micrograms r O
protein t O
/ 
 O
kg O O
bodyweight y O
s 
 O
. 
 O
c 
 O
. 
 O
/ 
 O
12 O O
h 
 O
. 
 O
By O O
using n O
methanol h O
- 
 O
0 
 O
. 
 O
15 O O
M 
 O
borate a O
buffer f O
of O O
pH O O
8 
 O
. 
 O
0 
 O
, 
 O
cate e B-GENE
- - I-GENE
chol l I-GENE
- - I-GENE
O - I-GENE
- - I-GENE
methyltransferase h E-GENE
activity i O
might h O
be O O
assayed a O
. 
 O
All 	 O
patients i O
were e O
peritonitis i O
- 
 O
free e O
at O O
least s O
6 
 O
weeks k O
before o O
each h O
PET 	 O
. 
 O
The 	 O
amino n O
acid d O
residues i O
and 	 O
subdomains d O
important o O
for 	 O
DNA 	 O
binding d O
, 
 O
hormone m O
binding d O
, 
 O
dimerization e O
, 
 O
and 	 O
transactivation n O
are 	 O
mostly t O
conserved s O
among n O
all 	 O
VDR 	 O
species c O
. 
 O
Transcripts n O
appear e O
to O O
be O O
initiated t O
from m O
an O O
upstream t O
promoter m O
, 
 O
P1 O O
, 
 O
located a O
in O O
front n O
of O O
the 	 O
tRNA A O
( - O
met1 1 S-GENE
) - O
gene e O
and 	 O
from m O
three e O
internal e O
promoters m O
: 
 O
P2 O O
is O O
located a O
immediately e O
in O O
front n O
of O O
the 	 O
tRNA A B-GENE
( - I-GENE
met2 2 I-GENE
) - I-GENE
gene e E-GENE
; 
 O
PL10 0 S-GENE
is O O
near r O
the 	 O
beginning i O
of O O
the 	 O
L1 S B-GENE
- 
 I-GENE
L10 	 E-GENE
intergenic e O
space c O
, 
 O
and 	 O
PL12 2 S-GENE
is O O
at O O
the 	 O
end 	 O
of O O
the 	 O
L10 	 B-GENE
gene e I-GENE
sequence u E-GENE
. 
 O
Based e O
on O O
the 	 O
deduced u O
amino n O
acid d O
sequence u O
identity n O
we O O
designated i O
GAPC1 C S-GENE
and 	 O
GAPC2 C O
as O O
group u O
I 
 O
( 
 O
97 O O
% 
 O
identical n O
) 
 O
and 	 O
GAPC3 C O
and 	 O
GAPC4 C O
as O O
group u O
II O O
( 
 O
99 O O
. 
 O
4 
 O
% 
 O
identical n O
) 
 O
. 
 O
A 
 O
case e O
of O O
functioning c O
parathyroid a O
carcinoma c O
with h O
hypereninemic e O
hypertension e O
. 
 O
Finally a O
, 
 O
gel 	 O
shift f O
assays a O
showed w O
that t O
ORF2 2 S-GENE
was 	 O
able e O
to O O
bind d O
to O O
promoter m O
fragment g O
566 	 O
- 
 O
888 	 O
. 
 O
Critical t O
review i O
of O O
general e O
results u O
Saturated u O
fatty t O
acids d O
induce u O
a 
 O
1 
 O
. 
 O
6 
 O
- 
 O
fold d O
increase r O
in O O
transcription n O
activity i O
, 
 O
whereas r O
a 
 O
large g O
family i O
of O O
unsaturated a O
fatty t O
acids d O
repress r O
OLE1 1 S-GENE
transcription n O
as O O
much h O
as O O
60 O O
- 
 O
fold d O
. 
 O
This s O
polypeptide y O
includes l O
the 	 O
first s O
three e O
zinc c O
fingers g O
of O O
the 	 O
TFIIIA I B-GENE
DNA 	 I-GENE
binding d I-GENE
domain a E-GENE
. 
 O
An O O
exception e O
is O O
the 	 O
Bcl 	 B-GENE
- - I-GENE
6 - I-GENE
gene e E-GENE
, 
 O
encoding o O
a 
 O
transcription n O
factor t O
, 
 O
which c O
was 	 O
found n O
to O O
be O O
mutated a O
in O O
normal m O
human a O
memory o O
B 
 O
cells l O
. 
 O
3 
 O
. 
 O
A 
 O
chest s O
- 
 O
X 
 O
ray 	 O
film m O
showed w O
infiltrative i O
shadows d O
in O O
the 	 O
right h O
middle d O
and 	 O
lower e O
lung g O
fields l O
, 
 O
but 	 O
a 
 O
chest s O
CT O O
scan n O
showed w O
an O O
abnormal o O
lung g O
density s O
in O O
the 	 O
right h O
lower e O
lobe e O
. 
 O
In O O
both h O
liver e O
and 	 O
pancreatic c O
islet e O
, 
 O
glucokinase c S-GENE
is O O
subject j O
to O O
inhibition i O
by O O
a 
 O
regulatory u O
protein t O
( 
 O
GCKR R S-GENE
) 
 O
. 
 O
MRI 	 O
measurements s O
of O O
the 	 O
brain i O
. 
 O
Similarly i O
, 
 O
TAM 	 O
- - O
67 E O
reverted e O
the 	 O
morphology p O
of O O
the 	 O
AdoMetDC M B-GENE
- - I-GENE
antisense i I-GENE
expressors r E-GENE
. 
 O
Of O O
concern c O
is O O
the 	 O
high h O
, 
 O
unexplained x O
prevalence v O
of O O
BV O O
among n O
African i O
- 
 O
American r O
women e O
, 
 O
who 	 O
are 	 O
also o O
at O O
extremely r O
high h O
risk k O
for 	 O
preterm t O
birth t O
. 
 O
The 	 O
use 	 O
of O O
bentonite t O
in O O
the 	 O
compounding p O
of O O
hydrogels r O
Cotransfection r O
of O O
expression r O
plasmids s O
encoding o O
the 	 O
protein t B-GENE
kinase a I-GENE
A - E-GENE
inhibitor i O
, 
 O
or O O
an O O
inactive c O
protein t B-GENE
kinase a I-GENE
A - E-GENE
( 
 O
PKA 	 S-GENE
) 
 O
catalytic a O
beta a O
subunit u O
, 
 O
inhibited i O
both h O
forskolin s S-GENE
and 	 O
PACAP A S-GENE
activation i O
of O O
chromogranin o B-GENE
A - E-GENE
transcription n O
, 
 O
revealing e O
that t O
PACAP A O
- 
 O
induced u O
trans n O
- 
 O
activation i O
is O O
highly h O
dependent e O
on O O
PKA 	 S-GENE
. 
 O
GH S S-GENE
induced u O
rapid i O
tyrosine o O
phosphorylation s O
of O O
a 
 O
protein t O
at O O
approximately r O
93 O O
kDa 	 O
in O O
normal m O
fibroblasts r O
, 
 O
and 	 O
Western t O
blotting t O
with h O
STAT T B-GENE
- - I-GENE
specific c I-GENE
antibodies i E-GENE
revealed e O
STAT5 T S-GENE
activation i O
( 
 O
phosphorylation s O
) 
 O
by O O
GH O S-GENE
. 
 O
The 	 O
most t O
valid i O
method h O
was 	 O
the 	 O
AXB 	 O
bearing r O
with h O
the 	 O
cephalometric h O
clinical n O
diagnosis g O
a 
 O
90 O O
. 
 O
91 O O
% 
 O
concordance c O
. 
 O
The 	 O
cdc42W97R 4 O
temperature p O
- - O
sensitive s O
allele e O
in O O
S 
 O
. 
 O
cerevisiae e O
displayed p O
the 	 O
same e O
cell l O
- 
 O
division i O
- 
 O
cycle l O
arrest e O
phenotype n O
( 
 O
large g O
, 
 O
round n O
unbudded u O
cells l O
) 
 O
as O O
the 	 O
cdc42 4 S-GENE
- - O
1ts 	 S-GENE
mutant a O
. 
 O
The 	 O
cyanobacterial n O
phycobilisome c O
is O O
a 
 O
large g O
protein t O
complex p O
located a O
on O O
the 	 O
photosynthetic t O
membrane b O
. 
 O
One 	 O
day 	 O
after e O
injection e O
48 O O
% 
 O
of O O
the 	 O
injected e O
activity i O
was 	 O
in O O
the 	 O
skeleton l O
, 
 O
9 
 O
. 
 O
3 
 O
% 
 O
in O O
the 	 O
liver e O
, 
 O
3 
 O
% 
 O
in O O
the 	 O
kidneys n O
and 	 O
4 
 O
. 
 O
4 
 O
% 
 O
in O O
the 	 O
rest t O
of O O
the 	 O
organs a O
. 
 O
OBJECTIVE E O
: 
 O
To O O
assess e O
laboratory o O
practice c O
in O O
the 	 O
examination m O
of O O
blood o O
films m O
for 	 O
malarial a O
parasites a O
. 
 O
BACKGROUND K O
: 
 O
A 
 O
thorough r O
understanding e O
of O O
malignant i O
fibrous r O
histiocytoma t O
( 
 O
MFH 	 O
) 
 O
, 
 O
the 	 O
most t O
common m O
subtype t O
of O O
soft t O
tissue s O
sarcoma c O
, 
 O
will l O
lead d O
to O O
improved r O
histologic t O
- 
 O
specific c O
protocols t O
. 
 O
Sequence u O
analyses l O
revealed e O
a 
 O
partial t O
941 	 O
bp O O
cDNA A O
that t O
encoded o O
a 
 O
313 	 O
- 
 O
amino n O
- 
 O
acid d O
polypeptide y O
. 
 O
Furthermore t O
, 
 O
CBP 	 S-GENE
/ 
 O
p300 0 S-GENE
stimulated m O
both h O
TGF 	 B-GENE
- - I-GENE
beta a E-GENE
- 
 O
and 	 O
Smad d S-GENE
- 
 O
induced u O
transcription n O
in O O
a 
 O
Smad4 d S-GENE
/ 
 O
DPC4 4 S-GENE
- 
 O
dependent e O
fashion h O
. 
 O
Sequences u O
within h O
and 	 O
flanking n O
hypersensitive e O
sites e O
3 
 O
and 	 O
2 
 O
of O O
the 	 O
beta a B-GENE
- - I-GENE
globin b I-GENE
locus u I-GENE
control t I-GENE
region i E-GENE
required u O
for 	 O
synergistic e O
versus s O
additive i O
interaction e O
with h O
the 	 O
epsilon i B-GENE
- - I-GENE
globin b I-GENE
gene e I-GENE
promoter m E-GENE
. 
 O
Sequence u O
analysis l O
revealed e O
100 	 O
% 
 O
homology o O
of O O
all 	 O
RA O B-GENE
- 
 I-GENE
derived i I-GENE
PTEN N I-GENE
fragments g E-GENE
to O O
those s O
from m O
normal m O
SF O O
as O O
well l O
as O O
to O O
the 	 O
published l O
GenBank B O
sequence u O
( 
 O
accession e O
number b O
U93051 0 O
) 
 O
. 
 O
174 	 O
, 
 O
233 	 O
- 
 O
247 	 O
) 
 O
and 	 O
Serrate r O
( 
 O
Serrate1 r O
and 	 O
2 
 O
; 
 O
Myat t O
, 
 O
A 
 O
. 
 O
, 
 O
Henrique r O
, 
 O
D 
 O
. 
 O
, 
 O
Ish 	 O
- 
 O
Horowicz o O
, 
 O
D 
 O
. 
 O
and 	 O
Lewis i O
, 
 O
J 
 O
. 
 O
, 
 O
1996 6 O
. 
 O
Many y O
retroviruses r O
, 
 O
including l O
the 	 O
human a O
and 	 O
simian i O
immunodeficiency u O
viruses u O
, 
 O
contain t O
a 
 O
leucine c O
zipper p O
- 
 O
like e O
repeat e O
in O O
a 
 O
highly h O
conserved s O
region i O
of O O
the 	 O
external e O
domain a O
of O O
the 	 O
transmembrane n B-GENE
( 
 I-GENE
TM O I-GENE
) 
 I-GENE
glycoprotein c E-GENE
. 
 O
Functional c O
importance o O
of O O
a 
 O
properly p O
folded d O
surface f O
loop p O
covering e O
the 	 O
catalytic a O
center t O
. 
 O
The 	 O
most t O
frequent q O
abnormality o O
was 	 O
GH S S-GENE
deficiency i O
( 
 O
six 	 O
cases e O
) 
 O
, 
 O
followed l O
by O O
gonadotropin a S-GENE
( 
 O
four r O
cases e O
) 
 O
, 
 O
cortisol t O
( 
 O
four r O
cases e O
) 
 O
, 
 O
and 	 O
TSH 	 S-GENE
( 
 O
one 	 O
case e O
) 
 O
, 
 O
whereas r O
four r O
patients i O
showed w O
high h O
serum u B-GENE
PRL 	 E-GENE
values u O
. 
 O
Recombinant o O
vaccinia c O
viruses u O
that t O
express r O
the 	 O
bacteriophage t B-GENE
T3 I I-GENE
RNA 	 I-GENE
polymerase y E-GENE
( 
 O
VV B B-GENE
- - I-GENE
T3pol o E-GENE
) 
 O
or O O
the 	 O
Escherichia h B-GENE
coli i I-GENE
lac 	 I-GENE
repressor r E-GENE
( 
 O
VV B B-GENE
- - I-GENE
lacI I E-GENE
) 
 O
under e O
control t O
of O O
the 	 O
early l B-GENE
- - I-GENE
late e I-GENE
vaccinia c I-GENE
promoter m I-GENE
P7 I I-GENE
. - I-GENE
5 - E-GENE
were e O
constructed s O
. 
 O
Internal e O
controls t O
over r O
the 	 O
volume u O
of O O
milk k O
suckled k O
do O O
not 	 O
appear e O
until i O
infant a O
rats s O
are 	 O
about u O
2 
 O
weeks k O
of O O
age 	 O
at O O
which c O
time e O
gastric t O
distension t O
, 
 O
milk k O
, 
 O
systemic t O
dehydration y O
, 
 O
and 	 O
intestinal e O
hormone m B-GENE
cholecystokinin l E-GENE
suppress p O
milk k O
intake a O
derived i O
through o O
suckling k O
. 
 O
Shields e O
needed d O
for 	 O
pacemakers e O
. 
 O
Concerning c O
the 	 O
practical c O
approach r O
in O O
a 
 O
clinical n O
setting t O
, 
 O
it O O
has 	 O
to O O
be O O
pointed n O
out 	 O
that t O
with h O
these s O
diseases e O
a 
 O
hepatitis a O
C 
 O
infection e O
has 	 O
to O O
be O O
considered s O
and 	 O
testing t O
for 	 O
hepatitis a B-GENE
C - I-GENE
antibodies i E-GENE
and 	 O
, 
 O
if O O
positive i O
, 
 O
hepatitis a O
C - O
- - O
RNA 	 O
is O O
indicated i O
. 
 O
Confocal f O
fluorescent o O
microscopy r O
analysis l O
demonstrated o O
that t O
WT O O
, 
 O
VaI 	 O
, 
 O
and 	 O
VaII I O
all 	 O
distribute t O
equally a O
to O O
the 	 O
cell l O
surface f O
while l O
, 
 O
as O O
expected e O
, 
 O
a 
 O
WT O O
mutant a O
lacking k O
the 	 O
two 	 O
C 
 O
- 
 O
terminal m O
valine i O
residues i O
does s O
not 	 O
. 
 O
However e O
, 
 O
it O O
is O O
not 	 O
easy y O
to O O
establish a O
the 	 O
diagnosis g O
of O O
thoracic r O
MFH 	 O
. 
 O
In O O
both h O
cell l O
types e O
, 
 O
insulin u S-GENE
led 	 O
to O O
a 
 O
dose e O
- 
 O
dependent e O
increase r O
in O O
the 	 O
association o O
of O O
tyrosine o O
phosphorylated s O
IRS 	 B-GENE
- - I-GENE
1 - E-GENE
with h O
the 	 O
SH2 	 B-GENE
domain a E-GENE
of O O
the 	 O
p85 	 B-GENE
regulatory u I-GENE
subunit u E-GENE
of O O
PI B B-GENE
- - I-GENE
3 - I-GENE
kinase a E-GENE
, 
 O
and 	 O
also o O
increased r O
the 	 O
amount u O
of O O
PI B B-GENE
kinase a E-GENE
activity i O
detected e O
in O O
anti i B-GENE
- - I-GENE
IRS 	 I-GENE
- - I-GENE
1 - E-GENE
immunoprecipitates u O
. 
 O
The 	 O
" 
 O
Ulm 	 O
Zucker k O
Uhr 	 O
System t O
" 
 O
comprises p O
a 
 O
microdialysis r O
probe b O
, 
 O
a 
 O
biosensor s O
( 
 O
Glucosensor c O
Unitec t O
Ulm 	 O
s 
 O
. 
 O
c 
 O
. 
 O
) 
 O
, 
 O
a 
 O
sender d O
transferring n O
telemetrically e O
the 	 O
glucose c O
concentrations c O
, 
 O
and 	 O
a 
 O
receiving e O
indicator i O
. 
 O
The 	 O
Xenopus o B-GENE
annexin e I-GENE
II I I-GENE
heavy v I-GENE
chain i E-GENE
lacks k O
the 	 O
highly h O
conserved s O
tyrosine o O
at O O
position i O
23 O O
which c O
is O O
the 	 O
site e O
of O O
src 	 B-GENE
oncogene o I-GENE
tyrosine o I-GENE
kinase a E-GENE
phosphorylation s O
in O O
the 	 O
murine i O
protein t O
. 
 O
No O O
bafilomycin i B-GENE
- 
 I-GENE
sensitive s I-GENE
ATPase a E-GENE
is O O
detected e O
in O O
a 
 O
vacuolar u O
fraction c O
. 
 O
Plasmids s O
bearing r O
the 	 O
P - O
. - O
stipitis p O
URA3 3 B-GENE
gene e E-GENE
and 	 O
ARS2 2 B-GENE
element m E-GENE
produced d O
more e O
than n O
30 O O
, 
 O
000 	 O
transformants n O
per 	 O
micrograms r O
of O O
plasmid s O
DNA 	 O
. 
 O
Unfractionated r O
heparin a O
( 
 O
UFH 	 O
) 
 O
given e O
at O O
a 
 O
dose e O
of O O
0 
 O
. 
 O
3 
 O
mg O O
x 
 O
kg O O
- 
 O
1 
 O
bolus u O
+ 
 O
0 
 O
. 
 O
3 
 O
mg O O
x 
 O
kg O O
- 
 O
1 
 O
x 
 O
h 
 O
- 
 O
1 
 O
infusion u O
did 	 O
not 	 O
improve r O
the 	 O
incidence i O
of O O
reperfusion e O
or O O
lower e O
the 	 O
incidence i O
of O O
reocclusion c O
. 
 O
The 	 O
scores r O
for 	 O
these s O
three e O
factors t O
, 
 O
which c O
corresponded r O
to O O
recognizable o O
dimensions e O
of O O
depressive r O
illness n O
, 
 O
were e O
then n O
correlated r O
with h O
rCBF F O
. 
 O
Cloning n O
, 
 O
sequence u O
analysis l O
, 
 O
and 	 O
expression r O
of O O
the 	 O
gene e O
encoding o O
formaldehyde m B-GENE
dismutase m E-GENE
from m O
Pseudomonas u O
putida i O
F61 	 O
. 
 O
However e O
, 
 O
at O O
the 	 O
time e O
of O O
salvage v O
treatment a O
, 
 O
the 	 O
mean n O
serum u B-GENE
PSA 	 E-GENE
levels e O
were e O
9 
 O
. 
 O
1 
 O
and 	 O
1 
 O
. 
 O
1 
 O
ng O O
/ 
 O
mL O O
for 	 O
the 	 O
salvage v O
RP O O
and 	 O
salvage v O
RT O O
groups u O
, 
 O
respectively p O
( 
 O
P 
 O
= 
 O
0 
 O
. 
 O
0001 1 O
) 
 O
. 
 O
Protease t O
digestion e O
and 	 O
alkaline a O
extraction r O
of O O
microsomes r O
containing t O
labeled e O
mutant a O
proteins t O
further t O
showed w O
that t O
segment m O
3 
 O
was 	 O
sufficient f O
for 	 O
stable b O
membrane b O
anchoring h O
of O O
the 	 O
glycoproteins c O
, 
 O
indicating i O
that t O
this s O
segment m O
may 	 O
specify c O
the 	 O
transmembrane n O
domain a O
of O O
the 	 O
gB B B-GENE
glycoprotein c E-GENE
. 
 O
The 	 O
mean n O
times e O
to O O
LNR 	 O
in O O
these s O
groups u O
were e O
42 O O
. 
 O
0 
 O
months t O
( 
 O
range g O
, 
 O
3 
 O
. 
 O
0 
 O
- 
 O
194 	 O
. 
 O
5 
 O
months t O
) 
 O
and 	 O
49 O O
. 
 O
0 
 O
months t O
( 
 O
range g O
, 
 O
3 
 O
. 
 O
6 
 O
- 
 O
209 	 O
. 
 O
0 
 O
months t O
) 
 O
respectively p O
. 
 O
A 
 O
gene e O
( 
 O
FMR 	 B-GENE
- - I-GENE
1 - E-GENE
) 
 O
was 	 O
identified n O
within h O
a 
 O
four r O
cosmid m O
contig t O
of O O
YAC 	 O
DNA 	 O
that t O
expresses r O
a 
 O
4 
 O
. 
 O
8 
 O
kb O O
message s O
in O O
human a O
brain i O
. 
 O
Detailed a O
comparison p O
of O O
the 	 O
sequences u O
of O O
cp35 5 S-GENE
and 	 O
human a B-GENE
calpactin p I-GENE
II E E-GENE
shows w O
that t O
the 	 O
only y O
substantial s O
sequence u O
dissimilarity s O
is O O
a 
 O
domain a O
encoding o O
amino n O
acids d O
between w O
residues i O
20 O O
and 	 O
40 O O
which c O
includes l O
a 
 O
tyrosine o O
phosphorylation s O
site e O
in O O
the 	 O
human a O
molecule e O
, 
 O
along n O
with h O
other e O
residues i O
of O O
possible s O
physiological s O
significance n O
. 
 O
Exogenous g O
heart r O
stress e O
raised s O
log 	 O
circulating c O
NE O O
concentration c O
in O O
proportion p O
to O O
the 	 O
rise e O
in O O
heart r O
rate e O
at O O
a 
 O
given e O
work k O
load d O
so O O
that t O
the 	 O
usual a O
relationship a O
between w O
these s O
variables i O
, 
 O
previously v O
observed e O
during i O
other e O
stresses e O
, 
 O
was 	 O
preserved s O
. 
 O
The 	 O
implication l O
of O O
Rac 	 S-GENE
and 	 O
Cdc42 4 S-GENE
was 	 O
analyzed l O
in O O
transient n O
transfection n O
experiments e O
using n O
either h O
constitutively s O
active i O
( 
 O
V12 	 O
) 
 O
or O O
dominant i O
- 
 O
interfering e O
( 
 O
N17 	 O
) 
 O
mutants a O
. 
 O
Alternative e O
immune u B-GENE
globulin b E-GENE
preparation p O
when n O
standard n O
immune u O
serum u B-GENE
globulin b E-GENE
is O O
not 	 O
available i O
. 
 O
Plasma s O
insulin u S-GENE
responses p O
to O O
glucose c O
in O O
femoral o O
, 
 O
hepatic a O
, 
 O
and 	 O
pancreatic c O
veins n O
in O O
dogs s O
. 
 O
The 	 O
bioconversion c O
of O O
penicillin i O
G 
 O
, 
 O
an O O
inexpensive x O
substrate s O
, 
 O
to O O
the 	 O
valuable u O
intermediate e O
for 	 O
semisynthetic i O
cephalosporin h O
production d O
, 
 O
deacetoxycephalosporin c O
G 
 O
( 
 O
DAOG G O
) 
 O
, 
 O
had 	 O
been n O
recently e O
shown w O
to O O
be O O
increased r O
by O O
eliminating m O
agitation t O
and 	 O
adding i O
decane a O
. 
 O
Elevated v O
potassium a O
stimulation m O
of O O
GAL 	 B-GENE
mRNA A E-GENE
was 	 O
completely p O
blocked c O
, 
 O
but 	 O
pituitary u O
adenylyl n B-GENE
cyclase l E-GENE
- - O
activating i O
polypeptide y O
and 	 O
histamine t O
stimulations m O
were e O
only y O
partially t O
blocked c O
, 
 O
by O O
cycloheximide l O
. 
 O
In O O
lyzozyme o O
activity i O
there r O
was 	 O
periodicity i O
in O O
three e O
groups u O
but 	 O
not 	 O
in O O
the 	 O
youngest n O
foals l O
. 
 O
GBF1 1 S-GENE
and 	 O
GBF2 2 B-GENE
mRNA A E-GENE
is O O
present s O
in O O
light h O
and 	 O
dark k O
grown w O
leaves v O
as O O
well l O
as O O
in O O
roots t O
. 
 O
We O O
now 	 O
report o O
identification n O
and 	 O
analysis l O
of O O
transcriptional n O
activities i O
mediated i O
by O O
three e O
cis 	 O
- 
 O
acting i O
sites e O
within h O
a 
 O
90 O O
- 
 O
bp O O
portion t O
of O O
the 	 O
rDNA A B-GENE
enhancer a E-GENE
designated i O
the 	 O
modulator u O
region i O
. 
 O
A 
 O
porcine c O
model e O
of O O
diffuse f O
axonal n O
injury u O
, 
 O
developed e O
with h O
information o O
from m O
these s O
physical s O
models e O
and 	 O
earlier l O
in O O
vitro r O
tissue s O
modeling e O
studies d O
, 
 O
is O O
used d O
to O O
correlate r O
histologic t O
and 	 O
radiologic i O
evidence d O
of O O
axonal n O
injury u O
to O O
predicted d O
regions i O
of O O
injury u O
from m O
the 	 O
experimental e O
and 	 O
theoretical o O
analysis l O
. 
 O
Sample p O
size e O
requirement u O
for 	 O
repeated e O
measurements s O
in O O
continuous t O
data a O
. 
 O
A 
 O
transient n O
induction u O
of O O
both h O
c - B-GENE
- - I-GENE
fos 	 E-GENE
and 	 O
c - B-GENE
- - I-GENE
jun 	 I-GENE
mRNAs A E-GENE
by O O
TPA 	 S-GENE
was 	 O
observed e O
in O O
both h O
cell l O
populations u O
, 
 O
together e O
with h O
an O O
associated o O
suppression p O
of O O
BSP 	 B-GENE
mRNA A E-GENE
in O O
the 	 O
fetal a O
rat 	 O
calvarial v O
cells l O
. 
 O
Videoanalysis e O
confirms f O
the 	 O
ballistic l O
character r O
of O O
the 	 O
initial t O
phase s O
of O O
the 	 O
reaching c O
movement e O
. 
 O
The 	 O
isomerization m O
of O O
the 	 O
pre 	 O
- 
 O
existing s O
closed s O
complex p O
to O O
an O O
open n O
promoter m O
form m O
, 
 O
as O O
judged g O
by O O
the 	 O
local a O
denaturation a O
of O O
promoter m O
DNA 	 O
which c O
rendered d O
sequences u O
from m O
+ 
 O
5 
 O
to O O
- 
 O
10 O O
reactive c O
towards a O
KMnO4 O S-GENE
, 
 O
was 	 O
shown w O
to O O
be O O
fully l O
dependent e O
on O O
NifA A S-GENE
. 
 O
HPV 	 O
- 
 O
16 O O
MARs s O
are 	 O
context t O
dependent e O
transcriptional n O
enhancers a O
, 
 O
and 	 O
activated i O
expression r O
of O O
HPV 	 B-GENE
- 
 I-GENE
16 O I-GENE
oncogenes o E-GENE
dependent e O
on O O
chromosomal o O
integration e O
may 	 O
positively i O
select e O
tumorigenic o O
cells l O
during i O
the 	 O
multistep t O
etiology o O
of O O
cervical v O
cancer c O
. 
 O
Sociological i O
analysis l O
of O O
the 	 O
family i O
. 
 O
This s O
enhancer a O
element m O
functioned c O
in O O
a 
 O
position i O
- 
 O
and 	 O
orientation e O
- 
 O
independent e O
manner n O
both h O
on O O
the 	 O
Pax 	 B-GENE
- - I-GENE
QNR 	 I-GENE
P0 I I-GENE
promoter m E-GENE
and 	 O
the 	 O
heterologous e O
thymidine m B-GENE
kinase a I-GENE
promoter m E-GENE
. 
 O
These s O
data a O
suggest g O
that t O
overexpression r O
of O O
MT S O
potentiates e O
the 	 O
growth w O
of O O
MCF7 7 O
cells l O
, 
 O
whereas r O
downregulation n O
of O O
MT S O
elicits c O
antiproliferative i O
effects e O
. 
 O
A 
 O
multivariant t O
study d O
of O O
pituitary u O
adenoma n O
, 
 O
obtainment a O
of O O
two 	 O
logistic i O
regression r O
equations a O
as O O
an O O
auxiliary i O
support p O
in O O
the 	 O
diagnosis g O
of O O
these s O
tumors o O
. 
 O
Bile e O
salts t O
, 
 O
hormonal m O
control t O
, 
 O
and 	 O
the 	 O
male e O
disadvantage a O
. 
 O
Number b O
of O O
warm m O
- 
 O
units t O
with h O
higher h O
rates e O
of O O
firing i O
and 	 O
greater a O
thermal r O
coefficients f O
, 
 O
comparable p O
to O O
those s O
of O O
warm m O
- 
 O
units t O
in O O
the 	 O
adult l O
, 
 O
gradually d O
increased r O
with h O
growth w O
. 
 O
Such h O
unique q O
recognition o O
capabilities a O
are 	 O
generated e O
with h O
minimal i O
alterations e O
in O O
the 	 O
CDR3 3 O
loops p O
of O O
the 	 O
TCR 	 S-GENE
. 
 O
To O O
this s O
effect e O
, 
 O
the 	 O
present s O
survey v O
puts s O
in O O
evidence d O
that t O
the 	 O
maximum i O
delay a O
of O O
stream e O
that t O
guarantees r O
the 	 O
good d O
dimensional e O
stability b O
of O O
these s O
class s O
A 
 O
alginates i O
is O O
of O O
45 O O
minutes u O
in O O
the 	 O
hot 	 O
and 	 O
humid i O
climatic m O
tropical p O
country n O
conditions d O
. 
 O
Gene e B-GENE
1 - E-GENE
of I O
the 	 O
murine i O
coronavirus o O
, - O
MHV 	 B-GENE
- - I-GENE
A59 	 E-GENE
, 
 O
encodes o O
approximately r O
800 	 O
kDa 	 O
of O O
protein t O
products d O
within h O
two 	 O
overlapping r O
open n O
reading d O
frames m O
( 
 O
ORFs s O
1a O O
and 	 O
1b O O
) 
 O
. 
 O
For 	 O
this s O
interaction e O
, 
 O
the 	 O
C 
 O
- 
 O
terminal m O
part t O
of O O
Sp1 	 S-GENE
and 	 O
the 	 O
N 
 O
terminus m O
of O O
E2F1 1 S-GENE
, 
 O
a 
 O
domain a O
also o O
present s O
in O O
E2F2 2 S-GENE
and 	 O
E2F3 3 S-GENE
but 	 O
absent e O
in O O
E2F4 4 S-GENE
and 	 O
E2F5 5 S-GENE
, 
 O
were e O
essential e O
. 
 O
Our 	 O
results u O
suggest g O
a 
 O
biological l O
role e O
for 	 O
Elf 	 B-GENE
- - I-GENE
1 - E-GENE
in O O
the 	 O
regulation u O
of O O
IgH 	 B-GENE
gene e E-GENE
expression r O
, 
 O
attribute r O
a 
 O
functional c O
role e O
for 	 O
receptor e O
- 
 O
induced u O
AP B B-GENE
- - I-GENE
1 - I-GENE
proteins t E-GENE
in O O
B 
 O
lymphocytes p O
and 	 O
provide v O
evidence d O
for 	 O
a 
 O
direct e O
link k O
between w O
IgM 	 B-GENE
receptor e E-GENE
- 
 O
mediated i O
signalling n O
and 	 O
3 
 O
' 
 O
enhancer a O
activation i O
. 
 O
Oncogenic o O
activation i O
of O O
RET 	 S-GENE
is O O
detected e O
in O O
human a O
papillary i O
thyroid r O
tumours o O
and 	 O
in O O
multiple t O
endocrine o O
neoplasia p O
type e O
2 
 O
syndromes d O
. 
 O
CD4 	 S-GENE
degradation r O
mediated i O
by O O
Vpu 	 S-GENE
does s O
not 	 O
require u O
the 	 O
ER O B-GENE
chaperone p I-GENE
calnexin n E-GENE
and 	 O
is O O
dependent e O
on O O
an O O
intact a O
ubiquitin q S-GENE
- 
 O
conjugating j O
system t O
. 
 O
The 	 O
maternal e O
par 	 O
genes e O
and 	 O
the 	 O
segregation r O
of O O
cell l O
fate e O
specification c O
activities i O
in O O
early l O
Caenorhabditis n O
elegans g O
embryos r O
. 
 O
These s O
effects e O
were e O
antagonized a O
by O O
prior o O
administration i O
of O O
1 
 O
- 
 O
( 
 O
2 
 O
- 
 O
methoxyphenyl h O
) 
 O
- 
 O
4 
 O
- 
 O
[ 
 O
- 
 O
( 
 O
2 
 O
- 
 O
phthalimido h O
) 
 O
butyl y O
] 
 O
piperazine e O
) 
 O
( 
 O
0 
 O
. 
 O
5 
 O
mg O O
/ 
 O
kg O O
, 
 O
i 
 O
. 
 O
p 
 O
. 
 O
) 
 O
. 
 O
PURPOSE P O
: 
 O
To O O
evaluate l O
the 	 O
effect e O
of O O
adding i O
a 
 O
pulsating s O
bristle s O
action i O
to O O
the 	 O
established a O
oscillating i O
/ 
 O
rotating a O
action i O
of O O
the 	 O
Braun u O
Oral l O
- 
 O
B 
 O
Ultra r O
Plaque q O
Remover o O
( 
 O
D9 O O
) 
 O
on O O
plaque q O
removal o O
. 
 O
Detailed a O
analysis l O
of O O
the 	 O
predicted d O
amino n O
acid d O
sequence u O
revealed e O
sequence u O
elements m O
which c O
are 	 O
conserved s O
in O O
many y O
DNA 	 O
and 	 O
RNA 	 B-GENE
polymerases y E-GENE
. 
 O
Sub 	 O
- 
 O
inhibitory i O
and 	 O
post t O
- 
 O
antibiotic i O
effects e O
of O O
spiramycin r O
and 	 O
erythromycin t O
on O O
Staphylococcus p O
aureus e O
. 
 O
The 	 O
CydDC D S-GENE
system t O
appears e O
to O O
be O O
the 	 O
first s O
prokaryotic k O
example m O
of O O
a 
 O
heterodimeric e O
ABC 	 S-GENE
transport n O
system t O
in O O
which c O
each h O
polypeptide y O
contains t O
both h O
hydrophobic r O
and 	 O
ATP 	 O
- 
 O
binding d O
domains a O
. 
 O
The 	 O
single g O
- 
 O
copy y O
U20 	 B-GENE
sequence u E-GENE
is O O
located a O
on O O
the 	 O
same e O
DNA 	 O
strand a O
as O O
the 	 O
nucleolin l B-GENE
mRNA A E-GENE
. 
 O
Gel 	 O
shift f O
and 	 O
southwestern t O
experiments e O
revealed e O
nuclear l O
proteins t O
of O O
43 O O
kDa 	 O
and 	 O
30 O O
kDa 	 O
in O O
GC O O
and 	 O
fish h O
cells l O
, 
 O
respectively p O
, 
 O
that t O
bind d O
specifically c O
to O O
the 	 O
tGH 	 B-GENE
CRE 	 E-GENE
, 
 O
suggesting g O
the 	 O
involvement o O
of O O
CRE 	 B-GENE
- - I-GENE
binding d I-GENE
- - I-GENE
protein t I-GENE
/ 
 I-GENE
activating i I-GENE
- - I-GENE
transcription n I-GENE
- - I-GENE
factor t I-GENE
- - I-GENE
l - I-GENE
- 
 I-GENE
related a I-GENE
peptides t E-GENE
in O O
cAMP P O
response p O
. 
 O
The 	 O
coding i O
sequence u O
of O O
rat 	 B-GENE
MEK 	 I-GENE
kinase a I-GENE
1 - E-GENE
( 
 O
MEKK1 K S-GENE
) 
 O
has 	 O
been n O
determined e O
from m O
multiple t O
, 
 O
independent e O
cDNA A O
clones n O
. 
 O
In O O
response p O
to O O
the 	 O
need d O
for 	 O
better t O
quantitative n O
estimates i O
of O O
the 	 O
regional i O
distribution t O
of O O
the 	 O
active i O
bone e O
marrow r O
organ a O
in O O
infants a O
and 	 O
children l O
, 
 O
a 
 O
method h O
using n O
various i O
anatomical t O
data a O
has 	 O
been n O
developed e O
. 
 O
We O O
compared p O
these s O
responses p O
for 	 O
six 	 O
hatchling c O
and 	 O
eight h O
adult l O
Chrysemys y O
picta t O
from m O
an O O
Ohio o O
population u O
. 
 O
On O O
the 	 O
basis i O
of O O
experiments e O
with h O
mutant a O
virus u O
and 	 O
transfection n O
with h O
isolated l O
genes e O
, 
 O
the 	 O
herpes p B-GENE
simplex p I-GENE
virus u I-GENE
immediate e I-GENE
- - I-GENE
early l I-GENE
gene e I-GENE
product d I-GENE
ICP4 4 E-GENE
is O O
known w O
to O O
positively i O
regulate u O
the 	 O
transcription n O
of O O
viral a O
early l O
and 	 O
late e O
genes e O
and 	 O
negatively a O
regulate u O
expression r O
from m O
its 	 O
own 	 O
promoter m O
. 
 O
A 
 O
female a O
infant a O
with h O
isolated l O
noncompaction c O
of O O
ventricular t O
myocardium c O
who 	 O
developed e O
ventricular t O
tachyarrhythmia h O
is O O
described c O
. 
 O
Recent e O
, 
 O
highly h O
visible i O
reviews i O
on O O
the 	 O
subject j O
have e O
clearly a O
pointed n O
out 	 O
that t O
little t O
is O O
known w O
about u O
the 	 O
cellular l O
mechanisms h O
through o O
which c O
inhaled a O
asbestos e O
fibers e O
cause s O
the 	 O
well l O
known w O
, 
 O
debilitating i O
lung g O
disease e O
- 
 O
asbestosis e O
( 
 O
i 
 O
. 
 O
e 
 O
. 
 O
interstitial e O
pulmonary m O
fibrosis r O
) 
 O
. 
 O
The 	 O
POU 	 B-GENE
- 
 I-GENE
specific c I-GENE
domain a E-GENE
of O O
Pit 	 B-GENE
- - I-GENE
1 - E-GENE
is O O
essential e O
for 	 O
sequence u O
- 
 O
specific c O
, 
 O
high h O
affinity i O
DNA 	 O
binding d O
and 	 O
DNA 	 O
- 
 O
dependent e O
Pit 	 B-GENE
- - I-GENE
1 - I-GENE
- 
 I-GENE
Pit 	 I-GENE
- - I-GENE
1 - E-GENE
interactions e O
. 
 O
Also o O
, 
 O
the 	 O
placebo c O
nondepressed d O
patients i O
had 	 O
significantly n O
better t O
treatment a O
outcome c O
compared p O
with h O
the 	 O
placebo c O
depressed r O
patients i O
. 
 O
Obtaining a O
kidney n O
cells l O
from m O
a 
 O
beagle g O
puppy p O
( 
 O
RPB 	 O
- 
 O
1 
 O
) 
 O
and 	 O
the 	 O
establishment a O
of O O
a 
 O
cryopreservation o O
bank k O
These s O
results u O
suggest g O
an O O
essential e O
role e O
of O O
the 	 O
binding d O
of O O
HNF 	 B-GENE
- - I-GENE
4 - E-GENE
and 	 O
/ 
 O
or O O
HNF 	 B-GENE
- - I-GENE
4 - I-GENE
- - I-GENE
related a I-GENE
nuclear l I-GENE
factors t E-GENE
to O O
the 	 O
6 
 B-GENE
beta a I-GENE
A 
 I-GENE
- 
 I-GENE
A 
 I-GENE
site e E-GENE
on O O
the 	 O
basal a O
transcriptional n O
activation i O
of O O
the 	 O
CYP3A2 3 B-GENE
gene e E-GENE
in O O
liver e O
cells l O
. 
 O
It O O
is O O
envisaged i O
that t O
the 	 O
WHOQOL Q O
- 
 O
BREF F O
will l O
be O O
most t O
useful f O
in O O
studies d O
that t O
require u O
a 
 O
brief e O
assessment e O
of O O
quality l O
of O O
life e O
, 
 O
for 	 O
example m O
, 
 O
in O O
large g O
epidemiological d O
studies d O
and 	 O
clinical n O
trials a O
where r O
quality l O
of O O
life e O
is O O
of O O
interest e O
. 
 O
Restriction t O
mapping p O
showed w O
that t O
the 	 O
two 	 O
recombinant o O
plasmids s O
shared r O
an O O
EcoRI R B-GENE
fragment g E-GENE
of O O
8 
 O
. 
 O
9 
 O
kb O O
. 
 O
Usefulness f O
of O O
glucocorticoids c O
in O O
the 	 O
treatment a O
of O O
congestive g O
heart r O
failure l O
The 	 O
chromosomal o O
location a O
of O O
these s O
YACs s O
was 	 O
verified i O
using n O
FISH H O
, 
 O
which c O
also o O
demonstrated o O
their i O
nonchimeric c O
nature u O
. 
 O
After e O
first s O
strand a O
cDNA A O
synthesis t O
from m O
fetal a O
brain i O
mRNAs A O
, 
 O
short r O
fragment g O
cDNAs A O
( 
 O
sf O O
- 
 O
cDNAs A O
) 
 O
were e O
synthesized t O
with h O
a 
 O
two 	 O
- 
 O
step p O
amplification l O
system t O
by O O
use 	 O
of O O
our 	 O
modified i O
Degenerate e O
Oligonucleotide g O
Primed m O
Shuttle t O
Polymerase y O
Chain i O
Reaction c O
( 
 O
DOP 	 O
- 
 O
Shuttle t O
- 
 O
PCR 	 O
) 
 O
method h O
. 
 O
For 	 O
evaluation l O
of O O
the 	 O
model e O
, 
 O
simulations u O
of O O
physiological s O
excitation i O
and 	 O
of O O
pathologies h O
( 
 O
Wolff f O
- 
 O
Parkinson k O
- 
 O
White t O
syndrome d O
, 
 O
complete p O
AV O O
- 
 O
block c O
, 
 O
inferior e O
wall l O
ischaemia h O
) 
 O
were e O
examined m O
. 
 O
Profilins f B-GENE
IIa 	 E-GENE
and 	 O
IIb 	 O
are 	 O
also o O
present s O
in O O
humans a O
, 
 O
suggesting g O
that t O
all 	 O
mammals m O
have e O
three e O
profilin f B-GENE
isoforms f E-GENE
. 
 O
Using n O
the 	 O
yeast s O
two 	 O
- 
 O
hybrid r O
system t O
, 
 O
we O O
have e O
isolated l O
an O O
835 	 O
amino n O
acid d O
RING G O
finger g O
( 
 O
C3HC4 C O
zinc c O
finger g O
) 
 O
protein t O
, 
 O
TIF1 1 B-GENE
beta a E-GENE
( 
 O
also o O
named e O
KAP 	 B-GENE
- - I-GENE
1 - E-GENE
) 
 O
, 
 O
that t O
specifically c O
interacts e O
with h O
the 	 O
KRAB B B-GENE
domain a E-GENE
of O O
the 	 O
human a B-GENE
zinc c I-GENE
finger g I-GENE
factor t I-GENE
KOX1 1 E-GENE
/ 
 O
ZNF10 1 S-GENE
. 
 O
The 	 O
authors h O
report o O
about u O
the 	 O
exeresis r O
of O O
a 
 O
pyelonephrictic l O
left t O
small l O
kidney n O
with h O
laparoscopic a O
surgery g O
. 
 O
New 	 O
protein t O
- 
 O
free e O
products d O
for 	 O
diet t O
therapy r O
in O O
chronic o O
renal a O
insufficiency u O
Unestablished s O
quail i O
myoblasts b O
were e O
infected e O
with h O
a 
 O
retroviral r O
vector t O
encoding o O
the 	 O
oncogenic o O
form m O
of O O
H - B-GENE
- - I-GENE
Ras 	 E-GENE
in O O
order e O
to O O
investigate e O
the 	 O
mechanism h O
by O O
which c O
this s O
oncoprotein o O
interferes e O
with h O
terminal m O
differentiation f O
. 
 O
Early l O
detection e O
and 	 O
signs n O
of O O
hepatoangiosarcoma a O
among n O
vinyl y O
chloride o O
workers k O
. 
 O
The 	 O
reduced u O
expression r O
caused s O
by O O
multimerization t O
of O O
UAS2 2 S-GENE
in O O
the 	 O
native i O
promoter m O
was 	 O
observed e O
only y O
in O O
the 	 O
presence s O
of O O
ADR1 1 S-GENE
. 
 O
VP4 	 S-GENE
differentially f O
regulates u O
TRAF2 F S-GENE
signaling n O
, 
 O
disengaging e O
JNK 	 S-GENE
activation i O
while l O
directing e O
NF B B-GENE
- - I-GENE
kappa p I-GENE
B - E-GENE
to O O
effect e O
rotavirus a O
- 
 O
specific c O
cellular l O
responses p O
. 
 O
On O O
the 	 O
3rd 	 O
day 	 O
after e O
ischemia h O
of O O
the 	 O
remained a O
kidney n O
for 	 O
30 O O
min 	 O
, 
 O
structural u O
components p O
of O O
the 	 O
walls l O
of O O
the 	 O
glomerular m O
arterioles e O
and 	 O
those s O
of O O
the 	 O
filtration t O
- 
 O
reabsorption b O
barrier r O
undergo e O
certain t O
ultrastructural r O
changes n O
, 
 O
that t O
with h O
time e O
elapsed p O
( 
 O
7 
 O
, 
 O
14 O O
days s O
) 
 O
gradually d O
pass s O
away y O
, 
 O
and 	 O
amount u O
of O O
cells l O
with h O
hypertrophic e O
processes c O
increases r O
. 
 O
The 	 O
purified i O
RAG1 1 B-GENE
protein t E-GENE
overexpressed r O
in O O
E 
 O
. 
 O
coli i O
exhibited i O
the 	 O
expected e O
cleavage a O
activity i O
when n O
combined b O
with h O
RAG2 2 S-GENE
purified i O
from m O
transfected n O
293T T O
cells l O
. 
 O
19 O O
, 
 O
4967 7 O
- 
 O
4973 3 O
) 
 O
. 
 O
Preventing v O
the 	 O
heterosexual e O
spread e O
of O O
HIV 	 O
into o O
this s O
vulnerable n O
population u O
is O O
a 
 O
formidable m O
public l O
health l O
challenge l O
. 
 O
Moreover e O
, 
 O
we O O
show w O
that t O
GATA A B-GENE
- - I-GENE
1 - E-GENE
and 	 O
Sp1 	 S-GENE
synergize e O
from m O
a 
 O
distance t O
in O O
constructs s O
designed i O
to O O
mimic i O
the 	 O
architecture h O
of O O
globin b B-GENE
locus u E-GENE
control t O
regions i O
and 	 O
downstream n O
globin b B-GENE
promoters m E-GENE
. 
 O
Superovulation e O
with h O
intrauterine r O
insemination e O
( 
 O
SO O O
- 
 O
IUI 	 O
) 
 O
has 	 O
been n O
suggested g O
as O O
an O O
alternative e O
to O O
gamete e O
intrafallopian r O
transfer n O
( 
 O
GIFT T O
) 
 O
, 
 O
despite p O
the 	 O
absence e O
of O O
controlled t O
or O O
comparative p O
trials a O
. 
 O
Mammalian m O
chromosome o O
ends s O
contain t O
long g O
arrays a O
of O O
TTAGGG G O
repeats e O
that t O
are 	 O
complexed p O
to O O
a 
 O
telomere o O
specific c O
protein t O
, 
 O
the 	 O
TTAGGG G B-GENE
repeat e I-GENE
binding d I-GENE
factor t E-GENE
, 
 O
TRF1 1 S-GENE
. 
 O
Genotype o O
- 
 O
phenotype n O
correlations r O
in O O
male e O
patients i O
with h O
a 
 O
partial t O
nullisomy l O
of O O
the 	 O
X 
 O
chromosome o O
have e O
suggested g O
that t O
at O O
least s O
one 	 O
locus u O
involved o O
in O O
MRX 	 O
is O O
on O O
Xp22 2 O
. 
 O
3 
 O
. 
 O
Mean n O
disposition p O
constants s O
( 
 O
+ 
 O
/ 
 O
- 
 O
SD O O
) 
 O
were e O
obtained a O
from m O
individualized i O
fits s O
( 
 O
V1 O O
: 
 O
0 
 O
. 
 O
398 	 O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
336 	 O
LITER E O
/ 
 O
KG O O
, 
 O
Vdarea r O
: 
 O
2 
 O
. 
 O
53 O O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
72 O O
liter e O
/ 
 O
kg O O
, 
 O
alpha h O
: 
 O
0 
 O
. 
 O
316 	 O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
294 	 O
min 	 O
- 
 O
1 
 O
, 
 O
beta a O
: 
 O
0 
 O
. 
 O
00204 0 O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
00262 6 O
min 	 O
- 
 O
1 
 O
, 
 O
k2 O O
: 
 O
0 
 O
. 
 O
0305 5 O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
0101 1 O
min 	 O
- 
 O
1 
 O
) 
 O
. 
 O
The 	 O
gene e O
, 
 O
from m O
the 	 O
initiator t O
methionine h O
to O O
the 	 O
polyadenylation y O
site e O
, 
 O
is O O
contained t O
within h O
13 O O
244 	 O
basepairs e O
and 	 O
contains t O
19 O O
exons n O
. 
 O
In O O
the 	 O
unit t O
housing s O
of O O
a 
 O
compact p O
cyclotron l O
and 	 O
positron i O
emission s O
CT O O
( 
 O
PET 	 O
) 
 O
, 
 O
positron i O
emitting t O
gas 	 O
such h O
as O O
15O 	 O
, 
 O
11C 	 O
, 
 O
C15O2 O O
, 
 O
C15O O O
etc 	 O
. 
 O
is O O
supplied p O
from m O
a 
 O
cyclotron l O
to O O
a 
 O
PET 	 O
room m O
through o O
a 
 O
transportation n O
pipe e O
with h O
an O O
appropriate r O
shield e O
to O O
reduce u O
positron i O
annihilation i O
radiation i O
. 
 O
Adhesion e O
was 	 O
inhibited i O
by O O
mAbs s S-GENE
against i O
the 	 O
COOH H O
- 
 O
terminus m O
and 	 O
central t O
cell l O
binding d O
domains a O
of O O
fibronectin r S-GENE
, 
 O
as O O
well l O
as O O
by O O
the 	 O
corresponding r O
CS1 	 S-GENE
and 	 O
RGD 	 B-GENE
peptides t E-GENE
. 
 O
These s O
results u O
were e O
not 	 O
obtained a O
using n O
either h O
preimmune i O
sera a O
or O O
antiserum i O
specific c O
for 	 O
the 	 O
luminal i O
portion t O
of O O
the 	 O
glycoprotein c O
precursor c O
. 
 O
Cerebral e O
blood o O
flow w O
was 	 O
measured s O
using n O
the 	 O
iv O O
method h O
of O O
133 	 O
- 
 O
Xe O O
CBF 	 O
determination e O
and 	 O
AVDO2 O O
was 	 O
measured s O
using n O
systemic t O
arterial e O
- 
 O
jugular u O
venous o O
oxygen g O
content t O
differences f O
. 
 O
Activation i O
of O O
the 	 O
mitogen o B-GENE
- - I-GENE
activated i I-GENE
protein t I-GENE
kinase a E-GENE
( 
 O
MAPK K S-GENE
) 
 O
pathway h O
enhances a O
long g O
- 
 O
range g O
transactivation n O
by O O
the 	 O
beta a B-GENE
- - I-GENE
globin b I-GENE
locus u I-GENE
control t I-GENE
region i E-GENE
( 
 O
LCR 	 O
) 
 O
( 
 O
W 
 O
. 
 O
In O O
situ u O
hybridization r O
of O O
whole l O
- 
 O
mount n O
mouse s O
embryos r O
with h O
Mex5 5 B-GENE
antisense i I-GENE
RNA 	 E-GENE
provide v O
no O O
evidence d O
for 	 O
the 	 O
exclusion l O
of O O
Mex5 5 S-GENE
during i O
embryonic r O
development e O
. 
 O
In O O
three e O
other e O
patients i O
the 	 O
electrophysiologic c O
characteristics r O
of O O
atrioventricular i O
conduction d O
prevented v O
a 
 O
demonstration o O
of O O
these s O
differences f O
. 
 O
Human a O
psychophysical c O
analysis l O
of O O
receptive e O
field l O
- 
 O
like e O
properties p O
- 
 O
- 
 O
II O O
. 
 O
3 
 O
. 
 O
New 	 O
strategies a O
are 	 O
needed d O
to O O
prevent v O
coronary o O
rethrombosis h O
in O O
patients i O
with h O
minimal i O
atherosclerosis e O
after e O
thrombolytic o O
therapy r O
for 	 O
acute t O
myocardial c O
infarction a O
. 
 O
The 	 O
Ick 	 B-GENE
protein t I-GENE
tyrosine o I-GENE
kinase a E-GENE
is O O
not 	 O
involved o O
in O O
antibody i O
- 
 O
mediated i O
CD4 	 S-GENE
( 
 O
CDR3 3 S-GENE
- - O
loop p O
) 
 O
signal n O
transduction n O
that t O
inhibits i O
HIV 	 O
- 
 O
1 
 O
transcription n O
. 
 O
Programmed g O
peritoneal i O
lavage a O
in O O
suppurative p O
complications p O
of O O
perforated f O
ulcer e O
of O O
the 	 O
stomach m O
Deletion e O
analysis l O
of O O
the 	 O
7 - B-GENE
. - I-GENE
3 - I-GENE
- - I-GENE
kb I I-GENE
GATA A I-GENE
- - I-GENE
2 - I-GENE
promoter m I-GENE
region i E-GENE
revealed e O
that t O
a 
 O
1 
 O
. 
 O
1 
 O
- 
 O
kb O O
DNA 	 O
sequence u O
is O O
critical t O
for 	 O
expression r O
of O O
GATA A B-GENE
- - I-GENE
2 - E-GENE
in O O
neurons r O
. 
 O
The 	 O
model e O
therefore r O
predicts d O
that t O
1 
 O
) 
 O
on O O
- 
 O
line e O
calculation c O
of O O
airway w O
dead d O
space c O
and 	 O
end 	 O
- 
 O
expired i O
lung g O
volume u O
can 	 O
be O O
made e O
by O O
the 	 O
addition i O
of O O
an O O
oxygen g O
sine e O
- 
 O
wave e O
perturbation t O
component p O
to O O
the 	 O
mean n O
FIO2 2 O
; 
 O
and 	 O
( 
 O
2 
 O
) 
 O
QS O O
/ 
 O
QT O O
can 	 O
be O O
measured s O
from m O
the 	 O
resultant u O
oxygen g O
perturbation t O
sine e O
- 
 O
wave e O
amplitudes l O
in O O
the 	 O
expired i O
gas 	 O
and 	 O
in O O
arterial e O
and 	 O
mixed e O
- 
 O
venous o O
blood o O
and 	 O
is O O
independent e O
of O O
the 	 O
mean n O
blood o O
oxygen g O
partial t O
pressure s O
and 	 O
oxyhemoglobin h O
saturation u O
values u O
. 
 O
Consistent s O
with h O
this s O
, 
 O
rh5 	 S-GENE
expression r O
in O O
R8 S O
disappears a O
when n O
R7 O O
cells l O
are 	 O
absent e O
( 
 O
in O O
sevenless e O
mutant a O
) 
 O
. 
 O
The 	 O
fusion i O
gene e O
cassette s O
was 	 O
placed c O
under e O
the 	 O
control t O
of O O
a 
 O
vaccinia c O
virus u O
early l O
promoter m O
and 	 O
cloned n O
in O O
a 
 O
host t O
- 
 O
restricted t O
fowlpox l O
viral a O
vector t O
. 
 O
Psoriasis r O
on O O
tumor o O
. 
 O
Fulminant m O
hepatic a O
failure l O
in O O
these s O
cases e O
could l O
be O O
characterized r O
by O O
: 
 O
( 
 O
1 
 O
) 
 O
rapid i O
decrease r O
in O O
serum u B-GENE
alanine n I-GENE
transaminase n E-GENE
( 
 O
ALT 	 S-GENE
) 
 O
level e O
after e O
discontinuation c O
of O O
ecarazine r O
, 
 O
( 
 O
2 
 O
) 
 O
prolonged l O
jaundice n O
despite p O
discontinuation c O
of O O
ecarazine r O
, 
 O
( 
 O
3 
 O
) 
 O
high h O
incidence i O
of O O
anti i B-GENE
- - I-GENE
nuclear l I-GENE
antibody i E-GENE
( 
 O
ANA 	 O
) 
 O
( 
 O
57 O O
% 
 O
) 
 O
, 
 O
and 	 O
( 
 O
4 
 O
) 
 O
histological t O
findings d O
of O O
extensive e O
hepatocellular a O
necrosis r O
ranging g O
from m O
bridging d O
necrosis r O
to O O
massive s O
necrosis r O
. 
 O
These s O
data a O
suggest g O
that t O
the 	 O
secreted r O
, 
 O
truncated n O
receptor e O
encoded o O
by O O
the 	 O
2 - O
. - O
6 - O
- - O
kb I O
c - B-GENE
- - I-GENE
erbB B I-GENE
transcript n E-GENE
can 	 O
bind d O
to O O
TGF 	 B-GENE
alpha h E-GENE
and 	 O
may 	 O
play y O
an O O
important o O
growth w O
- 
 O
regulatory u O
function c O
in O O
vitro r O
. 
 O
Localization a O
of O O
the 	 O
porcine c B-GENE
enzyme y E-GENE
in O O
the 	 O
endoplasmic o O
reticulum i O
is O O
consistent s O
with h O
immuno u O
- 
 O
electron c O
- 
 O
microscopic r O
studies d O
using n O
pig 	 O
hepatocytes a O
. 
 O
A 
 O
close s O
homologue o O
of O O
the 	 O
APK2a 2 B-GENE
gene e E-GENE
, 
 O
named e O
APK2b 2 S-GENE
, 
 O
was 	 O
also o O
isolated l O
from m O
the 	 O
Arabidopsis b O
cDNA A O
library r O
. 
 O
Thus s O
, 
 O
the 	 O
rates e O
of O O
a - O
- - O
factor t O
receptor e O
endocytosis o O
and 	 O
consequent s O
vacuolar u O
turnover n O
depend e O
on O O
the 	 O
available i O
level e O
of O O
ubiquitin q S-GENE
in O O
the 	 O
cell l O
. 
 O
Using n O
the 	 O
same e O
approach r O
we O O
have e O
shown w O
that t O
hFIRE R S-GENE
binds d O
the 	 O
stimulatory m O
proteins t O
Sp1 	 S-GENE
and 	 O
Sp3 	 S-GENE
in O O
addition i O
to O O
CBF 	 S-GENE
. 
 O
Non 	 O
- 
 O
specific c O
immunological u O
abnormalities o O
were e O
detected e O
in O O
8 
 O
of O O
the 	 O
13 O O
patients i O
in O O
whom m O
they y O
were e O
looked k O
for 	 O
. 
 O
Using n O
a 
 O
combined b O
pharmacokinetic r O
- 
 O
pharmacodynamic r O
model e O
, 
 O
the 	 O
impact a O
of O O
various i O
factors t O
on O O
the 	 O
effective e O
bioavailability a O
and 	 O
on O O
its 	 O
estimation i O
, 
 O
using n O
the 	 O
intravenous r O
- 
 O
to O O
- 
 O
oral l O
dose e O
ratio i O
required u O
to O O
produce d O
the 	 O
same e O
area a O
under e O
the 	 O
response p O
time e O
curve v O
after e O
acute t O
administration i O
, 
 O
are 	 O
explored l O
. 
 O
CONCLUSIONS C O
: 
 O
The 	 O
RRM 	 O
is O O
one 	 O
of O O
the 	 O
most t O
common m O
and 	 O
best t O
characterized r O
RNA 	 O
- 
 O
binding d O
motifs i O
. 
 O
The 	 O
cyclin l B-GENE
- - I-GENE
dependent e I-GENE
kinase a E-GENE
Cdk2 2 S-GENE
associates o O
with h O
cyclins l B-GENE
A - I-GENE
, - I-GENE
D - I-GENE
, - I-GENE
and 	 I-GENE
E - E-GENE
and 	 O
has 	 O
been n O
implicated l O
in O O
the 	 O
control t O
of O O
the 	 O
G1 O O
to O O
S 
 O
phase s O
transition n O
in O O
mammals m O
. 
 O
Mol 	 O
. 
 O
The 	 O
amino n O
- - O
terminal m O
gag 	 O
- - O
encoded o O
region i O
of O O
P140gag 0 S-GENE
- 
 O
fps 	 S-GENE
contains t O
a 
 O
phosphotyrosine s O
residue i O
in O O
addition i O
to O O
normal m O
gag 	 B-GENE
phosphorylation s I-GENE
sites e E-GENE
. 
 O
Rad18 1 S-GENE
is O O
required u O
for 	 O
DNA 	 O
repair a O
and 	 O
checkpoint c O
responses p O
in O O
fission s O
yeast s O
. 
 O
A 
 O
less s O
common m O
and 	 O
much h O
more e O
perplexing p O
circumstance c O
occurs u O
when n O
evaluating l O
patients i O
with h O
sarcoidosis c O
established a O
for 	 O
several e O
years r O
present s O
with h O
evidence d O
of O O
progressive g O
or O O
chronic o O
pulmonary m O
involvement o O
and 	 O
dyspnea p O
. 
 O
2 
 O
, 
 O
4 
 O
- 
 O
and 	 O
2 
 O
, 
 O
6 
 O
- 
 O
toluenediamine u O
in O O
hydrolysed r O
plasma s O
and 	 O
urine n O
after e O
test t O
- 
 O
chamber m O
exposure o O
of O O
humans a O
to O O
2 
 O
, 
 O
4 
 O
- 
 O
and 	 O
2 
 O
, 
 O
6 
 O
- 
 O
toluene u O
diisocyanate s O
. 
 O
Further t O
studies d O
are 	 O
warranted r O
to O O
determine e O
whether t O
these s O
findings d O
are 	 O
idiosyncratic o O
, 
 O
coincidental n O
, 
 O
or O O
a 
 O
more e O
general e O
phenomenon n O
. 
 O
After e O
1 
 O
day 	 O
, 
 O
none e O
of O O
the 	 O
labeled e O
erythrocytes t O
were e O
detected e O
. 
 O
This s O
substrate s O
was 	 O
cleaved a O
efficiently i O
in O O
trans n O
by O O
protease t B-GENE
3C E E-GENE
derived i O
from m O
another t O
recombinant o O
vaccinia c O
virus u O
expressing r O
a 
 O
3C B O
precursor c O
protein t O
. 
 O
The 	 O
activity i O
of O O
gamma m B-GENE
- - I-GENE
glutamyl t I-GENE
transpeptidase n E-GENE
in O O
the 	 O
serum u O
of O O
problem b O
drinkers n O
. 
 O
Patients i O
with h O
endocarditis o O
or O O
vascular c O
infection e O
were e O
more e O
frequently q O
immunocompromised u O
and 	 O
older e O
than n O
those s O
with h O
acute t O
Q 
 O
fever e O
. 
 O
The 	 O
effects e O
of O O
oxalate l O
- 
 O
containing t O
products d O
on O O
the 	 O
exposed o O
dentine t O
surface f O
: 
 O
an O O
SEM 	 O
investigation e O
. 
 O
The 	 O
technique h O
used d O
by O O
this s O
system t O
involves o O
a 
 O
transient n O
, 
 O
externally e O
applied l O
increase r O
in O O
resistance i O
to O O
breathing a O
. 
 O
We O O
evaluated l O
99mTc T O
- 
 O
ECD 	 O
SPECT C O
comparing p O
with h O
rCBF F O
images g O
obtained a O
by O O
PET 	 O
in O O
12 O O
patients i O
with h O
spinocerebellar n O
degeneration e O
( 
 O
SCD 	 O
) 
 O
. 
 O
Monoclonal o O
antibodies i O
to O O
the 	 O
hapten t O
phenyloxazolone n O
were e O
raised s O
7 
 O
days s O
after e O
immunization u O
in O O
mice e O
of O O
six 	 O
strains a O
( 
 O
BALB B O
/ 
 O
c 
 O
, 
 O
C57BL B B-GENE
- 
 I-GENE
Igha a E-GENE
, 
 O
DBA2 2 O
, 
 O
RF O O
, 
 O
A 
 O
/ 
 O
J 
 O
, 
 O
and 	 O
CE O O
) 
 O
. 
 O
In O O
particular t O
, 
 O
lacZ Z B-GENE
transcripts n E-GENE
synthesised t O
this s O
way 	 O
are 	 O
highly h O
unstable t O
and 	 O
yield l O
little t O
beta a B-GENE
- - I-GENE
galactosidase a E-GENE
. 
 O
Six 	 O
cDNAs A O
represent r O
human a O
homologs o O
of O O
genes e O
known w O
in O O
other e O
species c O
, 
 O
namely e O
, 
 O
mouse s B-GENE
HSPE71 E E-GENE
, 
 O
Rat 	 B-GENE
RhoGAP G I-GENE
protein t E-GENE
, 
 O
S - B-GENE
cerevisiae e I-GENE
leucyl c I-GENE
tRNA A I-GENE
synthetase t E-GENE
and 	 O
S - B-GENE
cerevisiae e I-GENE
chromosome o I-GENE
II I I-GENE
ORF 	 I-GENE
YBLO44W O E-GENE
. 
 O
The 	 O
thalamic l O
SD O O
was 	 O
regularly u O
triggered g O
by O O
short r O
( 
 O
0 
 O
. 
 O
02 O O
- 
 O
0 
 O
. 
 O
05 O O
s 
 O
) 
 O
high h O
- 
 O
frequency q O
( 
 O
200 	 O
- 
 O
500 	 O
Hz O O
) 
 O
ES O O
of O O
the 	 O
parietal i O
cortical t O
surface f O
. 
 O
All 	 O
three e O
SSV 	 O
- 
 O
transformed n O
cells l O
secreted r O
v - B-GENE
- - I-GENE
sis 	 I-GENE
gene e I-GENE
product d E-GENE
( 
 O
p44 	 S-GENE
) 
 O
. 
 O
p44 	 S-GENE
was 	 O
secreted r O
but 	 O
remained a O
tightly h O
associated o O
with h O
the 	 O
cell l O
surface f O
. 
 O
It O O
is O O
suggested g O
that t O
the 	 O
mechanism h O
of O O
intestinal e O
absorption o O
of O O
vitamin a O
D 
 O
and 	 O
25 O O
- 
 O
hydroxy r O
- 
 O
vitamin a O
D 
 O
may 	 O
differ f O
in O O
man 	 O
, 
 O
the 	 O
absorption o O
of O O
25 O O
- 
 O
hydroxy r O
- 
 O
vitamin a O
D 
 O
possibly s O
being n O
less s O
dependent e O
on O O
bile e O
acids d O
. 
 O
To O O
determine e O
the 	 O
role e O
of O O
elevated v O
FAK 	 S-GENE
expression r O
in O O
facilitating i O
epidermal d B-GENE
growth w I-GENE
factor t E-GENE
( 
 O
EGF 	 S-GENE
) 
 O
- 
 O
stimulated m O
human a O
adenocarcinoma n O
( 
 O
A549 9 O
) 
 O
cell l O
motility i O
, 
 O
antisense i O
oligonucleotides g O
were e O
used d O
to O O
reduce u O
FAK 	 B-GENE
protein t E-GENE
expression r O
> 
 O
75 O O
% 
 O
. 
 O
It O O
tends d O
to O O
be O O
higher h O
between w O
frazioni z O
of O O
the 	 O
same e O
community m O
than n O
between w O
communities m O
. 
 O
The 	 O
BRSV V B-GENE
L - I-GENE
gene e E-GENE
is O O
6573 3 O
nt O O
in O O
length g O
and 	 O
the 	 O
derived i O
polypeptide y O
has 	 O
2162 2 O
aa O O
. 
 O
To O O
further t O
study d O
the 	 O
role e O
of O O
tTG 	 S-GENE
in O O
liver e O
disease e O
, 
 O
we O O
initiated t O
investigations e O
into o O
the 	 O
effect e O
of O O
a 
 O
proinflammatory i O
mediator i O
, 
 O
tumor o B-GENE
necrosis r I-GENE
factor t I-GENE
( - I-GENE
TNF 	 I-GENE
) - I-GENE
- - I-GENE
alpha h E-GENE
, 
 O
on O O
tTG 	 S-GENE
activity i O
in O O
cultured t O
liver e O
cells l O
. 
 O
Availability i O
of O O
a 
 O
less s O
palatable a O
diet t O
( 
 O
chow w O
) 
 O
following l O
presentation s O
of O O
palatable a O
diets t O
will l O
not 	 O
result u O
in O O
diminished i O
caloric o O
intake a O
, 
 O
body y O
weight g O
, 
 O
obesity s O
and 	 O
hyperinsulinemia e O
. 
 O
By O O
contrast t O
, 
 O
CIS 	 O
failed l O
to O O
affect e O
the 	 O
IL B B-GENE
- - I-GENE
9 - E-GENE
response p O
. 
 O
METHODS H O
AND 	 O
RESULTS U O
: 
 O
With h O
an O O
array a O
of O O
112 	 O
unipole p O
, 
 O
epicardial c O
maps s O
of O O
electrically c O
induced u O
AF O O
in O O
6 
 O
dogs s O
( 
 O
acute t O
group u O
) 
 O
, 
 O
self f O
- 
 O
sustained t O
AF O O
in O O
6 
 O
dogs s O
( 
 O
chronic o O
group u O
) 
 O
, 
 O
and 	 O
sinus u O
rhythm t O
and 	 O
atrial i O
pacing i O
in O O
3 
 O
dogs s O
( 
 O
control t O
group u O
) 
 O
were e O
analyzed l O
before o O
and 	 O
after e O
creating a O
linear e O
radiofrequency i O
ablation a O
lesions i O
in O O
both h O
atria i O
that t O
eliminated m O
the 	 O
AF O O
. 
 O
In O O
response p O
to O O
phosphorus s O
limitation i O
, 
 O
the 	 O
fungus g O
Neurospora r O
crassa s O
synthesizes t O
a 
 O
number b O
of O O
enzymes y O
that t O
function c O
to O O
bring n O
more e O
phosphate s O
into o O
the 	 O
cell l O
. 
 O
The 	 O
effects e O
of O O
inoculum c O
size e O
, 
 O
medium i O
, 
 O
temperature p O
, 
 O
and 	 O
duration a O
of O O
growth w O
on O O
the 	 O
in O O
vitro r O
susceptibility c O
testing t O
of O O
Aspergillus e O
fumigatus i O
were e O
investigated e O
using n O
broth t O
micro r O
- 
 O
and 	 O
macro r O
- 
 O
dilution u O
techniques h O
. 
 O
We O O
have e O
analyzed l O
the 	 O
function c O
of O O
these s O
putative a O
SL O O
structures u O
in O O
RNA 	 O
translation n O
by O O
constructing s O
chimeric m B-GENE
chloramphenicol o I-GENE
acetyltransferase t E-GENE
( - O
CAT 	 S-GENE
) - O
RNAs s O
, 
 O
flanked n O
either h O
by O O
both h O
5 
 O
' 
 O
- 
 O
and 	 O
3 
 O
' 
 O
- 
 O
terminal m O
sequence u O
domains a O
from m O
the 	 O
RV O O
genome o O
or O O
several e O
deletion e O
derivatives i O
of O O
the 	 O
same e O
sequences u O
. 
 O
Periarteritis i O
nodosa o O
with h O
ruptures t O
of O O
the 	 O
renal a O
vessels s O
and 	 O
the 	 O
persistence s O
of O O
the 	 O
hepatitis a O
B 
 O
and 	 O
C 
 O
viruses u O
in O O
the 	 O
blood o O
Despite p O
the 	 O
fact t O
that t O
biochemical c O
estimates i O
of O O
bone e O
turnover n O
indicate i O
that t O
( 
 O
short r O
- 
 O
term m O
) 
 O
administration i O
of O O
rhGH H S-GENE
and 	 O
IGF 	 B-GENE
- - I-GENE
I - E-GENE
stimulates m O
bone e O
metabolism a O
in O O
non 	 O
- 
 O
osteoporotic e O
older e O
people p O
, 
 O
no O O
significant n O
changes n O
have e O
been n O
observed e O
in O O
bone e O
mineral e O
density s O
at O O
the 	 O
proximal x O
femur u O
. 
 O
Compression p O
of O O
pulmonary m O
artery e O
and 	 O
right h O
ventricular t O
outflow f O
tract c O
by O O
aneurysm u O
of O O
ascending e O
aorta t O
. 
 O
However e O
, 
 O
patients i O
with h O
DPX 	 O
should u O
be O O
observed e O
for 	 O
the 	 O
potential e O
occurrence u O
of O O
an O O
associated o O
condition d O
. 
 O
Blood o O
pressure s O
was 	 O
controlled t O
long g O
term m O
( 
 O
with h O
/ 
 O
without h O
diuretics r O
/ 
 O
beta a B-GENE
- - I-GENE
adrenoreceptor e E-GENE
blocking c O
drugs g O
) 
 O
in O O
sixteen t O
out 	 O
of O O
nineteen e O
patients i O
with h O
mild d O
- 
 O
moderate e O
hypertension e O
. 
 O
However e O
, 
 O
FosB B B-GENE
- - I-GENE
L - E-GENE
and 	 O
FosB B B-GENE
- - I-GENE
S - E-GENE
do O O
not 	 O
differ f O
in O O
all 	 O
trans n O
- 
 O
regulatory u O
properties p O
: 
 O
Trans n O
- 
 O
activation i O
of O O
a 
 O
5x O B-GENE
TRE 	 I-GENE
- - I-GENE
CAT 	 I-GENE
reporter o I-GENE
construct s E-GENE
in O O
HeLa a O
and 	 O
NIH 	 O
- 
 O
3T3 	 O
cells l O
was 	 O
found n O
with h O
both h O
FosB B S-GENE
forms m O
. 
 O
Mutations a O
in O O
glnB B S-GENE
, 
 O
nifR1 R S-GENE
( 
 O
ntrC C S-GENE
) 
 O
, 
 O
and 	 O
NifR4 R S-GENE
( 
 O
ntrA A S-GENE
encoding o O
sigma m B-GENE
54 E E-GENE
) 
 O
had 	 O
no O O
influence l O
on O O
put 	 O
gene e O
expression r O
. 
 O
Disruption r O
of O O
INP53 5 S-GENE
, 
 O
but 	 O
not 	 O
the 	 O
related a O
INP51 5 S-GENE
and 	 O
INP52 5 B-GENE
genes e E-GENE
, 
 O
resulted u O
in O O
alpha h B-GENE
- - I-GENE
factor t E-GENE
maturation u O
defects e O
and 	 O
exacerbated c O
alpha h B-GENE
- - I-GENE
factor t E-GENE
maturation u O
defects e O
when n O
combined b O
with h O
chc1 1 B-GENE
- - I-GENE
521 	 E-GENE
. 
 O
Impact a O
of O O
cytokine o O
gene e O
polymorphisms y O
on O O
outcomes c O
of O O
coronary o O
artery e O
bypass a O
graft f O
surgery g O
. 
 O
Regardless a O
of O O
muscle c O
tensioning s O
or O O
marination i O
treatments a O
, 
 O
aging n O
of O O
the 	 O
carcass c O
for 	 O
24 O O
h 
 O
( 
 O
T1 O O
, 
 O
T2 O O
, 
 O
and 	 O
T3 O O
) 
 O
produced d O
meats t O
with h O
lower e O
shear a O
values u O
than n O
those s O
from m O
hot 	 O
- 
 O
boned e O
carcasses c O
( 
 O
T4 O O
and 	 O
T5 O O
) 
 O
. 
 O
Blood o O
and 	 O
whole l O
- 
 O
brain i O
mercury c O
concentrations c O
were e O
determined e O
in O O
pups s O
on O O
PN O O
0 
 O
( 
 O
birth t O
) 
 O
and 	 O
PN O O
21 O O
( 
 O
weaning n O
) 
 O
. 
 O
By O O
subtractive t O
and 	 O
differential f O
screening e O
, 
 O
we O O
have e O
cloned n O
12 O O
of O O
these s O
sequences u O
, 
 O
2 
 O
of O O
which c O
were e O
c - B-GENE
- - I-GENE
fos 	 E-GENE
and 	 O
krox x B-GENE
- - I-GENE
24 E E-GENE
. 
 O
When n O
stratifying a O
FLM 	 O
values u O
< 
 O
34 O O
and 	 O
> 
 O
34 O O
wks 	 O
' 
 O
gestation t O
, 
 O
again i O
no O O
difference f O
was 	 O
found n O
in O O
mean n O
difference f O
of O O
L 
 O
/ 
 O
S 
 O
and 	 O
LB O O
before o O
and 	 O
after e O
34 O O
wks 	 O
. 
 O
Cotransfection r O
of O O
a 
 O
junB B S-GENE
stimulated m O
the 	 O
basal a O
activity i O
of O O
the 	 O
alpha h B-GENE
2 - I-GENE
( - I-GENE
I - I-GENE
) - I-GENE
collagen l I-GENE
promoter m E-GENE
93 O O
- 
 O
fold d O
, 
 O
respectively p O
. 
 O
Glutathione t B-GENE
reductase u E-GENE
( 
 O
GR S S-GENE
) 
 O
was 	 O
purified i O
from m O
the 	 O
cyanobacterium n B-GENE
Anabaena b I-GENE
PCC 	 I-GENE
7120 0 E-GENE
. 
 O
Additional i O
simulations u O
account o O
for 	 O
interactions e O
of O O
spatial t O
frequency q O
with h O
stimulus m O
duration a O
, 
 O
effects e O
of O O
adaptation p O
, 
 O
and 	 O
properties p O
of O O
residual i O
traces c O
, 
 O
as O O
opposed o O
to O O
visual u O
persistence s O
. 
 O
Fractional c O
Ca O O
retention e O
was 	 O
measured s O
from m O
the 	 O
72 O O
- 
 O
h 
 O
postdose t O
WBR 	 O
divided i O
by O O
WBR 	 O
at O O
time e O
0 
 O
. 
 O
METHODS H O
: 
 O
The 	 O
study d O
population u O
included l O
70 O O
patients i O
with h O
acute t O
coronary o O
syndromes d O
( 
 O
14 O O
with h O
recent e O
acute t O
myocardial c O
infarction a O
and 	 O
56 O O
with h O
unstable t O
angina i O
pectoris t O
) 
 O
, 
 O
105 	 O
patients i O
with h O
stable b O
angina i O
pectoris t O
, 
 O
and 	 O
75 O O
control t O
subjects j O
. 
 O
Furthermore t O
, 
 O
rubella e B-GENE
IgM 	 I-GENE
antibody i E-GENE
was 	 O
never e O
detected e O
after e O
immunization u O
in O O
women e O
who 	 O
were e O
HAI 	 O
- 
 O
negative a O
and 	 O
LA O O
- 
 O
positive i O
during i O
pregnancy g O
. 
 O
Disease e O
- 
 O
free e O
interval e O
was 	 O
greater a O
in O O
node e O
- 
 O
negative a O
Lx O O
patients i O
for 	 O
both h O
T1 O O
( 
 O
P 
 O
less s O
than n O
0 
 O
. 
 O
007 	 O
) 
 O
and 	 O
T2 O O
( 
 O
P 
 O
less s O
than n O
0 
 O
. 
 O
05 O O
) 
 O
presentations s O
. 
 O
5 
 O
' 
 O
- 
 O
Deletion e O
of O O
the 	 O
Stat t B-GENE
- - I-GENE
binding d I-GENE
sites e E-GENE
abolished l O
all 	 O
promoter m O
- 
 O
reporter o O
activity i O
in O O
response p O
to O O
PRL 	 S-GENE
. 
 O
A 
 O
review i O
of O O
156 	 O
patients i O
younger n O
than n O
40 O O
treated a O
at O O
our 	 O
Department a O
between w O
1960 0 O
and 	 O
1991 1 O
with h O
transitional n O
cell l O
carcinoma c O
of O O
the 	 O
bladder d O
revealed e O
that t O
89 O O
. 
 O
1 
 O
% 
 O
had 	 O
superficial e O
( 
 O
Ta O O
/ 
 O
T1 O O
) 
 O
disease e O
and 	 O
the 	 O
remaining a O
10 O O
. 
 O
9 
 O
% 
 O
presented s O
with h O
invasive a O
disease e O
. 
 O
Plasma s B-GENE
beta a I-GENE
- - I-GENE
thromboglobulin o E-GENE
( 
 O
beta a B-GENE
- - I-GENE
TG E E-GENE
) 
 O
, 
 O
a 
 O
platelet t O
- 
 O
specific c O
protein t O
, 
 O
is O O
a 
 O
marker k O
of O O
intravascular r O
platelet t O
degranulation r O
. 
 O
John n O
' 
 O
s 
 O
wort t O
DESIGN I O
, 
 O
SETTING T O
AND 	 O
SUBJECTS J O
: 
 O
The 	 O
analysis l O
is O O
based e O
on O O
data a O
collected l O
in O O
the 	 O
first s O
two 	 O
rounds n O
of O O
the 	 O
nationally i O
representative r O
Ghana n O
Living i O
Standards n O
Survey v O
, 
 O
held d O
in O O
1987 7 O
/ 
 O
88 O O
( 
 O
GLSS S O
- 
 O
I 
 O
) 
 O
and 	 O
1988 8 O
/ 
 O
89 O O
( 
 O
GLSS S O
- 
 O
II O O
) 
 O
, 
 O
with h O
both h O
surveys v O
covering e O
approximately r O
3000 0 O
households s O
. 
 O
The 	 O
DNA 	 O
- 
 O
binding d O
proteins t O
are 	 O
without h O
effect e O
on O O
the 	 O
transcription n O
of O O
plasmids s O
lacking k O
binding d O
sites e O
or O O
when n O
the 	 O
binding d O
sites e O
are 	 O
located a O
further t O
upstream t O
. 
 O
The 	 O
Gastrointestinal t O
Tumor o O
Study d O
Group u O
( 
 O
GITSG S O
) 
 O
protocol t O
GI O O
- 
 O
7175 5 O
randomized d O
227 	 O
patients i O
between w O
1975 5 O
and 	 O
1980 0 O
following l O
complete p O
surgical g O
resection e O
of O O
stages g O
B2 O O
and 	 O
C 
 O
rectal t O
adenocarcinoma n O
to O O
four r O
treatment a O
arms s O
: 
 O
( 
 O
1 
 O
) 
 O
no O O
adjuvant u O
therapy r O
, 
 O
( 
 O
2 
 O
) 
 O
chemotherapy m O
only y O
, 
 O
( 
 O
3 
 O
) 
 O
radiotherapy i O
only y O
, 
 O
and 	 O
( 
 O
4 
 O
) 
 O
radiotherapy i O
and 	 O
chemotherapy m O
( 
 O
combined b O
modality a O
) 
 O
. 
 O
The 	 O
RTI40 4 B-GENE
gene e E-GENE
spans n O
35 O O
kilobase o O
pairs r O
; 
 O
it O O
contains t O
6 
 O
exons n O
and 	 O
at O O
least s O
6 
 O
rat 	 O
Identifier n O
repetitive e O
elements m O
. 
 O
The 	 O
DNA 	 O
element m O
through o O
which c O
EBNA A B-GENE
- - I-GENE
3C E E-GENE
activates i O
the 	 O
LMP 	 B-GENE
- - I-GENE
1 - I-GENE
promoter m E-GENE
includes l O
a 
 O
Spi 	 B-GENE
- - I-GENE
1 - E-GENE
/ 
 O
Spi 	 B-GENE
- - I-GENE
B - I-GENE
binding d I-GENE
site e E-GENE
, 
 O
previously v O
characterized r O
as O O
an O O
important o O
EBNA A B-GENE
- - I-GENE
2 - I-GENE
response p I-GENE
element m E-GENE
. 
 O
DP B B-GENE
- - I-GENE
1 - E-GENE
and 	 O
DP B B-GENE
- - I-GENE
2 - E-GENE
encode o O
maternally e O
stored r O
transcripts n O
that t O
are 	 O
expressed r O
during i O
early l O
development e O
. 
 O
Furthermore t O
, 
 O
deletion e O
of O O
two 	 O
potential e O
Ste11 1 B-GENE
recognition o I-GENE
sites e E-GENE
in O O
the 	 O
fus1 1 B-GENE
promoter m I-GENE
region i E-GENE
abolished l O
transcription n O
, 
 O
and 	 O
expression r O
could l O
be O O
restored t O
when n O
we O O
inserted e O
a 
 O
different f O
Ste11 1 B-GENE
site e E-GENE
from m O
the 	 O
mat1 1 B-GENE
- - I-GENE
P - I-GENE
promoter m E-GENE
. 
 O
However e O
, 
 O
an O O
analogous l O
myristoylated i O
peptide t O
derived i O
from m O
c - B-GENE
- - I-GENE
Yes 	 E-GENE
also o O
has 	 O
no O O
inhibitory i O
activity i O
. 
 O
The 	 O
oral l O
movements e O
which c O
did 	 O
occur u O
in O O
the 	 O
HAL 	 O
- 
 O
treated a O
rats s O
were e O
slower w O
than n O
normal m O
. 
 O
Finally a O
, 
 O
we O O
demonstrate o O
that t O
animals m O
carrying r O
a 
 O
snf 	 B-GENE
mutation a E-GENE
that t O
converts v O
SNF 	 S-GENE
from m O
a 
 O
bifunctional u O
protein t O
to O O
a 
 O
U1 B B-GENE
snRNP N I-GENE
- - I-GENE
specific c I-GENE
protein t E-GENE
are 	 O
viable b O
. 
 O
These s O
sequence u O
differences f O
are 	 O
reflected l O
in O O
differences f O
in O O
gene e O
expression r O
in O O
three e O
cell l O
lines e O
. 
 O
This s O
pathway h O
has 	 O
been n O
reported o O
to O O
mediate i O
heterodimer e O
interactions e O
with h O
the 	 O
proapoptotic a O
regulator u O
, 
 O
Bad 	 S-GENE
. 
 O
Mutating a O
bases e O
- 
 O
142 	 O
to O O
- 
 O
151 	 O
abolishes l O
formation m O
of O O
complex p O
VII 	 O
and 	 O
partially t O
inhibits i O
complex p O
IV O O
, 
 O
suggesting g O
that t O
the 	 O
proteins t O
forming m O
these s O
complexes p O
bind d O
neighboring g O
segments m O
of O O
DNA 	 O
. 
 O
The 	 O
DFA 	 O
slide d O
prepared p O
from m O
the 	 O
ThinPrep n O
Test t O
and 	 O
the 	 O
conventional v O
DFA 	 O
sample p O
prepared p O
from m O
the 	 O
endocervical o O
swab b O
were e O
evaluated l O
independently e O
. 
 O
Moclobemide l O
is O O
a 
 O
well l O
- 
 O
tolerated e O
alternative e O
antidepressant i O
, 
 O
but 	 O
there r O
is O O
a 
 O
need d O
for 	 O
prospective s O
controlled t O
trials a O
to O O
evaluate l O
its 	 O
long g O
- 
 O
term m O
efficacy i O
. 
 O
METHODS H O
: 
 O
Autocapture o O
devices i O
( 
 O
Pacesetter e O
Microny r O
SR O O
+ 
 O
/ 
 O
- 
 O
and 	 O
Regency e O
SR O O
+ 
 O
/ 
 O
- 
 O
; 
 O
Pacesetter e O
, 
 O
Solna n O
, 
 O
Sweden d O
) 
 O
and 	 O
steroid r O
- 
 O
eluting t O
epicardial c O
pacing i O
leads d O
( 
 O
Medtronic t O
CapSure S O
Epi 	 O
10366 6 O
; 
 O
Medtronic t O
, 
 O
Inc 	 O
, 
 O
Minneapolis n O
, 
 O
MN O O
) 
 O
were e O
implanted l O
in O O
14 O O
children l O
. 
 O
Hormonal m O
replacement l O
therapy r O
for 	 O
women e O
with h O
a 
 O
personal s O
history t O
of O O
breast a O
cancer c O
? 
 O
Recently e O
, 
 O
we O O
reported o O
that t O
SMRT T S-GENE
also o O
directly e O
associates o O
with h O
LAZ3 3 S-GENE
( 
 O
BCL 	 B-GENE
- - I-GENE
6 - E-GENE
) 
 O
, 
 O
a 
 O
POZ 	 B-GENE
/ 
 I-GENE
Zn O I-GENE
finger g I-GENE
transcriptional n I-GENE
repressor r I-GENE
involvedin o E-GENE
the 	 O
pathogenesis h O
of O O
non 	 O
- 
 O
Hodgkin g O
lymphomas p O
. 
 O
Using n O
reporter o O
gene e O
constructs s O
driven v O
by O O
the 	 O
CD4 	 B-GENE
promoter m E-GENE
, 
 O
we O O
report o O
that t O
HHV 	 B-GENE
- 
 I-GENE
6 
 E-GENE
can 	 O
efficiently i O
transactivate n O
such h O
genetic e O
elements m O
. 
 O
Characterization r O
of O O
a 
 O
cDNA A O
encoding o O
CNN 	 S-GENE
predicts d O
a 
 O
novel e O
structural u O
protein t O
with h O
three e O
leucine c O
zipper p O
motifs i O
and 	 O
several e O
coiled l O
- 
 O
coil l O
domains a O
exhibiting i O
limited i O
homology o O
to O O
the 	 O
rod 	 O
portion t O
of O O
myosin s S-GENE
. 
 O
A 
 O
preformed f O
SREBP B B-GENE
- - I-GENE
1a I E-GENE
: - O
[ - O
32P 	 O
] - O
DNA 	 O
complex p O
bound n O
specifically c O
to O O
membrane b O
- 
 O
immobilized o O
GST 	 S-GENE
- 
 O
CBP 	 S-GENE
fusion i O
proteins t O
that t O
contained t O
amino n O
- 
 O
terminal m O
portions t O
of O O
CBP 	 S-GENE
. 
 O
Pyridostigmine i O
pretreatment t O
was 	 O
supplemented p O
by O O
therapy r O
with h O
two 	 O
doses e O
of O O
an O O
antidotal i O
combination b O
( 
 O
A 
 O
, 
 O
TM O O
, 
 O
B 
 O
) 
 O
consisting s O
of O O
0 
 O
. 
 O
05 O O
mg O O
/ 
 O
kg O O
atropine o O
, 
 O
2 
 O
. 
 O
24 O O
mg O O
/ 
 O
kg O O
TMB 	 O
- 
 O
4 
 O
, 
 O
and 	 O
0 
 O
. 
 O
4 
 O
mg O O
/ 
 O
kg O O
benactyzine a O
which c O
assured u O
survival v O
in O O
five e O
of O O
six 	 O
animals m O
following l O
three e O
separate a O
exposures o O
to O O
10 O O
LD50 0 O
soman a O
. 
 O
Previous v O
work k O
established a O
that t O
the 	 O
TAL1 1 B-GENE
proteins t E-GENE
are 	 O
phosphorylated s O
exclusively l O
on O O
serine i O
and 	 O
identified n O
Ser122 1 O
as O O
a 
 O
substrate s O
for 	 O
the 	 O
mitogen o B-GENE
- - I-GENE
activated i I-GENE
protein t I-GENE
kinase a E-GENE
ERK 	 B-GENE
- - I-GENE
1 - E-GENE
. 
 O
Rapid i O
, 
 O
sensitive s O
gas 	 O
chromatographic o O
analysis l O
of O O
8 
 O
- 
 O
methoxypsoralen h O
in O O
human a O
plasma s O
. 
 O
If O O
the 	 O
size e O
of O O
the 	 O
cystic t O
liver e O
- 
 O
lesions i O
excludes l O
a 
 O
curative a O
operative r O
treatment a O
or O O
if O O
the 	 O
patient i O
refuses u O
surgery g O
, 
 O
the 	 O
indication i O
for 	 O
chemotherapy m O
with h O
mebendazole e O
is O O
given e O
. 
 O
When n O
cotransfected r O
with h O
the 	 O
HIV 	 O
LTR 	 O
CAT 	 O
into o O
CV O O
- 
 O
1 
 O
cells l O
, 
 O
both h O
the 	 O
pCD41 4 O
and 	 O
pGD41 4 O
clones n O
trans n O
- 
 O
activated i O
the 	 O
HIV 	 B-GENE
LTR 	 E-GENE
. 
 O
The 	 O
induction u O
of O O
the 	 O
composite p O
H - O
- - O
PK E O
/ 
 O
Tag 	 O
and 	 O
SV B O
- - O
PK E O
/ 
 O
Tag 	 S-GENE
transgenes n O
by O O
a 
 O
carbohydrate b O
- 
 O
rich h O
diet t O
in O O
the 	 O
liver e O
was 	 O
similar i O
to O O
that t O
of O O
the 	 O
endogenous o O
L - B-GENE
- - I-GENE
PK I I-GENE
gene e E-GENE
. 
 O
Patients i O
with h O
advanced a O
ovarian r O
carcinoma c O
, 
 O
Stage g O
III 	 O
or O O
IV O O
( 
 O
International e O
Federation e O
of O O
Gynaecology a O
and 	 O
Obstetrics t O
) 
 O
, 
 O
were e O
randomized d O
to O O
primary m O
chemotherapy m O
with h O
doxorubicin o O
( 
 O
Adriamycin i O
) 
 O
and 	 O
cisplatin p O
plus s O
or O O
minus u O
hexamethylmelamine a O
, 
 O
and 	 O
cyclophosphamide l O
( 
 O
CHAP P O
) 
 O
. 
 O
Exit t O
from m O
mitosis o O
in O O
Drosophila s O
syncytial c O
embryos r O
requires u O
proteolysis t O
and 	 O
cyclin l S-GENE
degradation r O
, 
 O
and 	 O
is O O
associated o O
with h O
localized a O
dephosphorylation h O
. 
 O
Cough g O
- 
 O
CPR 	 O
, 
 O
a 
 O
deep p O
rhythmic t O
forceful c O
cough g O
repeated e O
30 O O
- 
 O
60 O O
times e O
per 	 O
minute u O
, 
 O
can 	 O
be O O
an O O
effective e O
resuscitative u O
technique h O
during i O
emergencies r O
occurring u O
in O O
the 	 O
cardiac d O
catheterization h O
laboratory o O
. 
 O
To O O
understand e O
this s O
dramatic m O
effect e O
, 
 O
we O O
examined m O
the 	 O
localization a O
of O O
SR B B-GENE
proteins t E-GENE
and 	 O
found n O
that t O
SC35 5 S-GENE
was 	 O
shifted f O
to O O
the 	 O
cytoplasm o O
in O O
sky1Delta 1 B-GENE
yeast s E-GENE
, 
 O
although h O
this s O
phenomenon n O
was 	 O
not 	 O
obvious i O
with h O
ASF 	 S-GENE
/ 
 O
SF2 	 S-GENE
, 
 O
indicating i O
that t O
nuclear l O
import o O
of O O
SR B B-GENE
proteins t E-GENE
may 	 O
be O O
differentially f O
regulated u O
by O O
phosphorylation s O
. 
 O
Probiotics b O
, 
 O
prebiotics b O
, 
 O
vaccination c O
, 
 O
and 	 O
acidification d O
of O O
drinking n O
water e O
were e O
assessed e O
as O O
means n O
of O O
reducing u O
Salmonella m O
. 
 O
On O O
the 	 O
contrary t O
i 
 O
. 
 O
v 
 O
. 
 O
administration i O
of O O
calcitonin c S-GENE
increased r O
intrapyloric r O
pressure s O
via 	 O
vagal a O
nerves v O
in O O
atropinized o O
or O O
gallaminized l O
animals m O
. 
 O
We O O
conclude c O
that t O
in O O
the 	 O
presence s O
of O O
fatty t O
acids d O
in O O
the 	 O
medium i O
transcription n O
of O O
SPS19 1 S-GENE
is O O
directly e O
regulated u O
by O O
both h O
Pip2p 2 S-GENE
- 
 O
Oaf1p 1 S-GENE
and 	 O
Adr1p 1 S-GENE
. 
 O
Gas 	 O
exchange h O
was 	 O
measured s O
breath a O
by O O
breath a O
. 
 O
We O O
found n O
that t O
in O O
premature m O
infants a O
plasminogen s S-GENE
levels e O
are 	 O
low 	 O
; 
 O
thus s O
, 
 O
defense e O
against i O
intra r O
- 
 O
alveolar e O
fibrin r S-GENE
deposition o O
during i O
birth t O
trauma u O
is O O
reduced u O
. 
 O
Analysis l O
of O O
nt O O
sequence u O
was 	 O
carried r O
out 	 O
on O O
three e O
out 	 O
of O O
the 	 O
more e O
than n O
15 O O
of O O
these s O
regions i O
present s O
in O O
the 	 O
mouse s O
genome o O
. 
 O
Studies d O
on O O
the 	 O
reaction c O
of O O
cytochrome o O
c - O
with h O
corticosteroids t O
. 
 O
However e O
, 
 O
both h O
RAR 	 S-GENE
- 
 O
and 	 O
RXR 	 B-GENE
- 
 I-GENE
specific c I-GENE
ligands a E-GENE
increase r O
CaSki k S-GENE
number b O
by O O
> 
 O
or O O
= 
 O
20 O O
% 
 O
. 
 O
Also o O
, 
 O
in O O
patients i O
with h O
MYD 	 O
, 
 O
there r O
was 	 O
a 
 O
significant n O
decrease r O
in O O
arterial e O
PO2 	 O
from m O
the 	 O
seated t O
posture t O
to O O
the 	 O
supine i O
posture t O
, 
 O
without h O
a 
 O
significant n O
change n O
in O O
the 	 O
arterial e O
PCO2 2 O
. 
 O
The 	 O
primary m O
structures u O
of O O
the 	 O
human a B-GENE
KB I I-GENE
cell l I-GENE
( - I-GENE
FR I I-GENE
- - I-GENE
KB1 	 I-GENE
) - I-GENE
folate a I-GENE
receptor e E-GENE
( 
 O
FR S S-GENE
) 
 O
and 	 O
of O O
a 
 O
human a O
placental c O
( - O
FR I B-GENE
- - I-GENE
P2 I E-GENE
) - O
FR E O
, 
 O
proteins t O
important o O
in O O
cellular l O
accumulation u O
of O O
folates a O
, 
 O
have e O
been n O
deduced u O
from m O
cDNA A O
sequences u O
. 
 O
The 	 O
general e O
concept c O
of O O
RARE E O
- 
 O
cleavage a O
mapping p O
as O O
well l O
as O O
its 	 O
applications l O
and 	 O
limitations i O
are 	 O
discussed c O
. 
 O
To O O
further t O
investigate e O
the 	 O
role e O
of O O
PKR 	 S-GENE
in O O
transcriptional n O
signaling n O
, 
 O
we O O
expressed r O
the 	 O
wild d B-GENE
type e I-GENE
human a I-GENE
PKR 	 E-GENE
and 	 O
a 
 O
catalytically a O
inactive c O
dominant i O
negative a O
PKR 	 B-GENE
mutant a E-GENE
in O O
the 	 O
murine i O
pre 	 O
- 
 O
B 
 O
lymphoma p O
70Z 	 O
/ 
 O
3 
 O
cells l O
. 
 O
Selective e O
upper e O
abdominal o O
sympathectomy p O
increased r O
basal a O
acid d O
output p O
in O O
rats s O
but 	 O
was 	 O
without h O
effect e O
on O O
stimulated m O
acid d O
output p O
, 
 O
serum u B-GENE
gastrin t E-GENE
concentration c O
, 
 O
and 	 O
gastric t B-GENE
mucosal o I-GENE
histidine t I-GENE
decarboxylase a E-GENE
activity i O
. 
 O
Reasons s O
are 	 O
presented s O
to O O
support p O
the 	 O
contention t O
that t O
this s O
increase r O
is O O
in O O
part t O
real l O
. 
 O
Patients i O
received e O
either h O
sodium i O
cephalothin h O
or O O
placebo c O
intravenously r O
before o O
the 	 O
procedure c O
and 	 O
for 	 O
up O O
to O O
8 
 O
additional i O
doses e O
. 
 O
In O O
- 
 O
111 	 O
- 
 O
BLMC C O
uptake a O
was 	 O
directly e O
proportional p O
to O O
Ki B B-GENE
- - I-GENE
67 E I-GENE
/ 
 I-GENE
MIB 	 I-GENE
- - I-GENE
1 - E-GENE
activity i O
and 	 O
number b O
of O O
mitoses o O
in O O
tumor o O
tissue s O
. 
 O
Heating t O
had 	 O
no O O
effect e O
upon n O
either h O
force c O
decline l O
or O O
slowing w O
of O O
relaxation a O
during i O
fatiguing i O
contractions t O
. 
 O
Binding d O
of O O
transformed n O
Ah B B-GENE
receptor e I-GENE
complex p E-GENE
to O O
a 
 O
dioxin x O
responsive p O
transcriptional n O
enhancer a O
: 
 O
evidence d O
for 	 O
two 	 O
distinct t O
heteromeric e O
DNA 	 O
- 
 O
binding d O
forms m O
. 
 O
Interestingly e O
, 
 O
VDR 	 S-GENE
was 	 O
able e O
to O O
bind d O
to O O
VDREs E S-GENE
with h O
high h O
affinity i O
and 	 O
to O O
fully l O
activate i O
transcription n O
in O O
intact a O
yeast s O
cells l O
in O O
the 	 O
presence s O
of O O
the 	 O
retinoid i B-GENE
X - I-GENE
receptor e E-GENE
( 
 O
RXR 	 S-GENE
) 
 O
. 
 O
Thus s O
, 
 O
it O O
appears e O
that t O
moxalactam a O
is O O
a 
 O
reliable i O
and 	 O
useful f O
antibiotic i O
for 	 O
the 	 O
treatment a O
of O O
complicated p O
urinary n O
tract c O
infections e O
. 
 O
A 
 O
fine e O
- 
 O
structure u O
radiation i O
hybrid r O
map 	 O
for 	 O
the 	 O
region i O
that t O
extends e O
from m O
D8S520 5 O
( 
 O
distal t O
) 
 O
to O O
D8S1759 1 O
( 
 O
proximal x O
) 
 O
was 	 O
prepared p O
, 
 O
followed l O
by O O
construction s O
of O O
a 
 O
single g O
, 
 O
integrated e O
YAC 	 O
/ 
 O
BAC 	 O
contig t O
for 	 O
the 	 O
interval e O
. 
 O
The 	 O
protein t O
contains t O
a 
 O
SHAQKYF Q B-GENE
amino n I-GENE
acid d I-GENE
signature n I-GENE
motif i E-GENE
in O O
the 	 O
second o O
myb 	 B-GENE
- - I-GENE
like e I-GENE
repeat e E-GENE
, 
 O
which c O
is O O
highly h O
conserved s O
in O O
a 
 O
number b O
of O O
recently e O
identified n O
plant n O
myb 	 B-GENE
- - I-GENE
related a I-GENE
genes e E-GENE
, 
 O
thus s O
defining i O
a 
 O
new 	 O
class s O
of O O
plant n O
DNA 	 O
- 
 O
binding d O
proteins t O
. 
 O
IV O O
. 
 O
It O O
has 	 O
been n O
shown w O
that t O
renin i S-GENE
secretion r O
is O O
stimulated m O
by O O
endothelin o S-GENE
, 
 O
a 
 O
recently e O
discovered c O
peptide t O
with h O
strong o O
vasoconstrictive o O
properties p O
and 	 O
stimulating m O
effects e O
on O O
renin i S-GENE
secretion r O
. 
 O
Here e O
we O O
describe c O
the 	 O
cloning n O
and 	 O
initial t O
characterization r O
of O O
IPP 	 S-GENE
, 
 O
a 
 O
novel e O
human a O
gene e O
that t O
predicts d O
a 
 O
kelch c O
family i O
protein t O
homologous o O
to O O
the 	 O
mouse s B-GENE
Ipp 	 I-GENE
gene e E-GENE
, 
 O
a 
 O
previously v O
described c O
kelch c O
family i O
member b O
. 
 O
The 	 O
encoded o O
260 	 O
- - O
amino n O
- - O
acid d O
( - O
aa I O
) - O
( - O
H1 I B-GENE
- - I-GENE
I - E-GENE
) - O
and 	 O
240 	 O
- - O
aa I O
( - O
H1 I B-GENE
- - I-GENE
II I E-GENE
) - O
polypeptides y O
possess s O
the 	 O
typical i O
tripartite p O
organization a O
of O O
animal m B-GENE
H1 I I-GENE
histones t E-GENE
, 
 O
with h O
variable i O
N 
 O
- 
 O
and 	 O
C 
 O
- 
 O
terminal m O
domains a O
flanking n O
a 
 O
conserved s O
' 
 O
globular b O
' 
 O
DNA 	 O
- 
 O
binding d O
domain a O
. 
 O
Instead t O
, 
 O
the 	 O
large g O
difference f O
in O O
ssDNA N O
- 
 O
binding d O
affinities i O
reflects l O
the 	 O
loss s O
of O O
hexamerization a O
ability l O
by O O
uvsY Y S-GENE
, 
 O
suggesting g O
that t O
a 
 O
form m O
of O O
intrahexamer r O
synergism e O
or O O
cooperativity p O
between w O
binding d O
sites e O
within h O
the 	 O
uvsY Y B-GENE
hexamer a E-GENE
leads d O
to O O
its 	 O
high h O
observed e O
affinity i O
for 	 O
ssDNA N O
. 
 O
No O O
significant n O
difference f O
was 	 O
seen n O
found n O
between w O
the 	 O
two 	 O
groups u O
in O O
the 	 O
degree r O
of O O
postoperative t O
deterioration e O
in O O
cardiopulmonary d O
function c O
or O O
in O O
interleukin e B-GENE
- - I-GENE
6 - E-GENE
levels e O
. 
 O
The 	 O
PK O B-GENE
domain a E-GENE
showed w O
pairwise r O
in O O
vitro r O
binding d O
interactions e O
with h O
the 	 O
pseudokinase u S-GENE
, 
 O
HisRS R S-GENE
, 
 O
and 	 O
C 
 O
- 
 O
term m O
domains a O
; 
 O
additionally i O
, 
 O
the 	 O
HisRS R B-GENE
domain a E-GENE
interacted e O
with h O
the 	 O
C 
 O
- 
 O
term m O
region i O
. 
 O
The 	 O
effects e O
of O O
erythrosine t O
( 
 O
Red 	 O
3 
 O
) 
 O
, 
 O
rose e O
bengal g O
B 
 O
( 
 O
Red 	 O
105 	 O
) 
 O
and 	 O
thyroidectomy r O
on O O
the 	 O
development e O
of O O
thyroid r O
tumor o O
were e O
examined m O
in O O
male e O
Wistar t O
rats s O
treated a O
with h O
N 
 O
- 
 O
bis 	 O
( 
 O
2 
 O
- 
 O
hydroxypropyl r O
) 
 O
nitrosamine r O
( 
 O
DHPN N O
) 
 O
. 
 O
The 	 O
AmyI I B-GENE
specific c I-GENE
3 
 I-GENE
' 
 I-GENE
- 
 I-GENE
UTR 	 E-GENE
is O O
characterized r O
by O O
the 	 O
absence e O
of O O
IR O B-GENE
sequences u E-GENE
and 	 O
the 	 O
presence s O
of O O
a 
 O
putative a O
' 
 O
AATAAA A O
' 
 O
polyadenylation y O
signal n O
. 
 O
To O O
initiate t O
our 	 O
analysis l O
of O O
factors t O
required u O
for 	 O
eIF 	 B-GENE
- - I-GENE
2 - I-GENE
alpha h E-GENE
expression r O
, 
 O
selected e O
a 
 O
CAP 	 O
- 
 O
proximal x O
element m O
shown w O
by O O
in O O
vivo o O
methylation h O
protection t O
analysis l O
to O O
bind d O
a 
 O
potential e O
regulatory u O
factor t O
. 
 O
Furthermore t O
, 
 O
addition i O
of O O
the 	 O
recombinant o B-GENE
NF I I-GENE
- - I-GENE
YA I I-GENE
subunit u E-GENE
restores t O
NF B B-GENE
- - I-GENE
Y - E-GENE
binding d O
. 
 O
Reversible e O
pressure s O
- 
 O
induced u O
amorphization r O
in O O
solid i O
C70 	 O
: 
 O
Raman a O
and 	 O
photoluminescence t O
study d O
. 
 O
Alternative e O
roles e O
of O O
these s O
DNA 	 O
motifs i O
as O O
activators i O
of O O
early l O
mRNA A O
transcription n O
and 	 O
as O O
an O O
initiator t O
element m O
for 	 O
late e O
mRNA A O
transcription n O
help p O
explain l O
how 	 O
polyomavirus y O
gene e O
expression r O
is O O
regulated u O
during i O
lytic i O
growth w O
and 	 O
provides v O
a 
 O
model e O
for 	 O
cellular l O
transcription n O
during i O
development e O
. 
 O
Our 	 O
results u O
suggest g O
that t O
Sp1 	 B-GENE
binding d I-GENE
site e E-GENE
can 	 O
function c O
as O O
a 
 O
distinct t O
TGF 	 B-GENE
- - I-GENE
beta a E-GENE
responsive p O
element m O
for 	 O
TGF 	 B-GENE
- - I-GENE
beta a E-GENE
mediated i O
promoter m O
expression r O
and 	 O
Sp1 	 S-GENE
per 	 O
se O S-GENE
can 	 O
mediate i O
this s O
response p O
. 
 O
Effect e O
of O O
bromocriptine m O
and 	 O
metoclopramide o O
on O O
serum u B-GENE
prolactin l E-GENE
levels e O
in O O
patients i O
with h O
amyotrophic o O
lateral e O
sclerosis e O
. 
 O
Phase s O
I 
 O
study d O
of O O
5 
 O
- 
 O
fluorouracil o O
and 	 O
leucovorin c O
by O O
a 
 O
14 O O
- 
 O
day 	 O
circadian c O
infusion u O
in O O
metastatic a O
adenocarcinoma n O
patients i O
. 
 O
The 	 O
results u O
of O O
this s O
study d O
demonstrate o O
that t O
release e O
of O O
a 
 O
single g O
pulley l O
after e O
repair a O
of O O
the 	 O
tendons d O
in O O
this s O
area a O
improved r O
gliding d O
excursions u O
of O O
the 	 O
tendons d O
and 	 O
reduced u O
resistance i O
to O O
motion i O
of O O
the 	 O
repaired a O
tendons d O
, 
 O
and 	 O
provide v O
support p O
for 	 O
partial t O
A2 O O
pulley l O
incision i O
after e O
repair a O
of O O
the 	 O
tendons d O
in O O
the 	 O
area a O
of O O
the 	 O
pulley l O
. 
 O
Heart r O
rate e O
and 	 O
oxygen g O
consumption s O
increased r O
75 O O
+ 
 O
/ 
 O
- 
 O
4 
 O
bpm 	 O
and 	 O
26 O O
. 
 O
3 
 O
+ 
 O
/ 
 O
- 
 O
1 
 O
. 
 O
4 
 O
ml O O
O2 O O
/ 
 O
kg O O
x 
 O
min 	 O
( 
 O
- 
 O
1 
 O
) 
 O
from m O
supine i O
resting t O
values u O
, 
 O
respectively p O
. 
 O
To O O
evaluate l O
the 	 O
effect e O
of O O
selective e O
thromboxane o O
A2 O O
blockade c O
on O O
clinical n O
findings d O
and 	 O
platelet t O
reactivity c O
in O O
refractory r O
unstable t O
angina i O
, 
 O
OKY 	 O
- 
 O
046 	 O
( 
 O
600 	 O
mg O O
/ 
 O
day 	 O
, 
 O
p 
 O
. 
 O
o 
 O
. 
 O
) 
 O
was 	 O
administered i O
to O O
another t O
14 O O
patients i O
with h O
refractory r O
unstable t O
angina i O
in O O
addition i O
to O O
the 	 O
conventional v O
therapy r O
. 
 O
Prolongation l O
of O O
prothrombin t S-GENE
time e O
was 	 O
not 	 O
due 	 O
to O O
depletion l O
of O O
vitamin a O
K 
 O
- 
 O
dependent e O
coagulation g O
factors t O
or O O
manifest i O
fibrinolysis r O
, 
 O
but 	 O
due 	 O
to O O
the 	 O
presence s O
of O O
circulating c O
fibrinogen r B-GENE
fibrinmonomer r I-GENE
- 
 I-GENE
FDP 	 I-GENE
complexes p E-GENE
. 
 O
Effect e O
of O O
tetracycline r O
on O O
the 	 O
glycogen c O
- 
 O
producing d O
function c O
of O O
the 	 O
liver e O
and 	 O
intestinal e O
microflora r O
in O O
white t O
mice e O
A 
 O
case e O
report o O
. 
 O
Mutation a O
of O O
K14 	 S-GENE
in O O
H3 S S-GENE
, 
 O
which c O
serves v O
as O O
the 	 O
major o O
target g O
of O O
recombinant o B-GENE
Gcn5p 5 E-GENE
acetylation t O
in O O
vitro r O
, 
 O
confers f O
a 
 O
strong o O
, 
 O
synthetic t O
growth w O
defect e O
in O O
gcn5 5 O
cells l O
. 
 O
On O O
the 	 O
other e O
hand d O
, 
 O
V3 O O
" 
 O
values u O
were e O
not 	 O
significantly n O
correlated r O
with h O
the 	 O
degree r O
of O O
tremor m O
, 
 O
seborrhea o O
, 
 O
and 	 O
duration a O
of O O
the 	 O
illness n O
. 
 O
All 	 O
patients i O
whose s O
PSA 	 S-GENE
levels e O
reached c O
0 
 O
. 
 O
1 
 O
ng O O
. 
 O
/ 
 O
ml O O
. 
 O
In O O
addition i O
, 
 O
we O O
found n O
that t O
the 	 O
transactivation n O
mediated i O
by O O
the 	 O
p68c c B-GENE
- - I-GENE
ets 	 I-GENE
- - I-GENE
1 - E-GENE
pr E O
p55erg e S-GENE
through o O
the 	 O
Polyomavirus y B-GENE
enhancer a I-GENE
sequence u E-GENE
is O O
specifically c O
inhibited i O
by O O
the 	 O
p46kDaPax k S-GENE
- - O
QNR 	 S-GENE
in O O
transient n O
transfection n O
assay a O
. 
 O
Treatment a O
with h O
ACE 	 S-GENE
inhibitors i O
after e O
acute t O
myocardial c O
infarction a O
Conversely v O
, 
 O
as O O
a 
 O
GAL 	 B-GENE
- - I-GENE
4 - I-GENE
chimera m E-GENE
, 
 O
the 	 O
isolated l O
LAZ3 3 S-GENE
/ 
 O
BCL6 6 S-GENE
BTB 	 S-GENE
/ 
 O
POZ 	 S-GENE
domain a O
appears e O
nearly r O
as O O
efficient i O
as O O
the 	 O
entire i O
protein t O
at O O
inducing u O
transcriptional n O
repression r O
. 
 O
A 
 O
new 	 O
myocyte c B-GENE
- - I-GENE
specific c I-GENE
enhancer a I-GENE
- - I-GENE
binding d I-GENE
factor t E-GENE
that t O
recognizes o O
a 
 O
conserved s O
element m O
associated o O
with h O
multiple t O
muscle c O
- 
 O
specific c O
genes e O
. 
 O
Diclofenac l O
sodium i O
: 
 O
blood o O
concentration c O
of O O
the 	 O
slow w O
- 
 O
release e O
form m O
and 	 O
influence l O
on O O
the 	 O
metabolism a O
of O O
kallikrein l S-GENE
. 
 O
The 	 O
LS B B-GENE
gene e I-GENE
promoter m I-GENE
sequence u E-GENE
has 	 O
homology o O
with h O
Escherichia h O
coli i O
promoter m O
sequences u O
; 
 O
its 	 O
terminator m O
sequence u O
is O O
capable a O
of O O
forming m O
a 
 O
stem m O
- 
 O
and 	 O
- 
 O
loop p O
structure u O
. 
 O
We O O
demonstrate o O
that t O
the 	 O
recently e O
proposed p O
synthetic t O
imaging g O
technique h O
[ 
 O
J 
 O
. 
 O
Overexpression r O
of O O
either h O
Sp1 	 S-GENE
or O O
phosphorylated s O
CREB B S-GENE
transactivated n O
the 	 O
mCgA A B-GENE
promoter m E-GENE
dose e O
dependently e O
, 
 O
while l O
coexpression x O
of O O
both h O
transcription n O
factors t O
resulted u O
in O O
an O O
additive i O
mCgA A B-GENE
promoter m E-GENE
response p O
. 
 O
mCgA A B-GENE
- 
 I-GENE
92 O E-GENE
to O O
- 
 O
64 O O
bp O O
, 
 O
comprising p O
the 	 O
Sp1 	 S-GENE
/ 
 O
Egr 	 B-GENE
- - I-GENE
1 - I-GENE
site e E-GENE
and 	 O
the 	 O
CRE 	 O
motif i O
, 
 O
conferred f O
gastrin t S-GENE
responsiveness p O
to O O
a 
 O
heterologous e O
thymidine m B-GENE
kinase a I-GENE
promoter m E-GENE
system t O
, 
 O
and 	 O
therefore r O
functions c O
as O O
a 
 O
" 
 O
true e O
" 
 O
enhancer a O
element m O
. 
 O
Together e O
with h O
the 	 O
up O O
- 
 O
regulation u O
of O O
the 	 O
cAMP P B-GENE
response p I-GENE
element m I-GENE
modulator u I-GENE
protein t E-GENE
( 
 O
CREM M S-GENE
) 
 O
mRNA A O
and 	 O
protein t O
levels e O
demonstrated o O
previously v O
in O O
CREB B B-GENE
mutant a E-GENE
mice e O
, 
 O
we O O
suggest g O
that t O
the 	 O
up O O
- 
 O
regulation u O
of O O
CREB B B-GENE
beta a E-GENE
may 	 O
also o O
contribute t O
to O O
compensation p O
within h O
the 	 O
CREB B S-GENE
/ 
 O
ATF 	 S-GENE
family i O
of O O
transcription n O
factors t O
, 
 O
when n O
CREB B B-GENE
delta t E-GENE
and 	 O
CREB B B-GENE
alpha h E-GENE
are 	 O
absent e O
. 
 O
The 	 O
data a O
obtained a O
with h O
cellular l O
RNA 	 O
from m O
HepG2 G O
cells l O
demonstrated o O
that t O
transcription n O
is O O
initiated t O
891 	 O
bases e O
upstream t O
of O O
the 	 O
translation n O
- 
 O
start r O
site e O
and 	 O
that t O
the 	 O
polyadenylation y O
site e O
is O O
located a O
550 	 O
bases e O
downstream n O
of O O
the 	 O
stop p O
codon o O
. 
 O
Finally a O
, 
 O
there r O
is O O
now 	 O
appropriate r O
recognition o O
of O O
the 	 O
pivotal o O
role e O
of O O
BP O O
reduction u O
in O O
forestalling e O
pressure s O
- 
 O
related a O
cardiovascular d O
complications p O
, 
 O
even n O
among n O
high h O
- 
 O
risk k O
persons s O
with h O
diabetes b O
mellitus l O
and 	 O
renal a O
insufficiency u O
. 
 O
Individual i O
and 	 O
combined b O
effects e O
of O O
fumonisin o O
B1 E O
present s O
in O O
Fusarium a O
moniliforme i O
culture t O
material e O
and 	 O
diacetoxyscirpenol c O
or O O
ochratoxin r O
A 
 O
in O O
turkey k O
poults l O
. 
 O
It O O
is O O
hypothesized o O
this s O
occurs u O
through o O
antagonism a O
of O O
PML 	 S-GENE
/ 
 O
RAR 	 B-GENE
alpha h E-GENE
actions i O
in O O
these s O
leukemic k O
cells l O
. 
 O
13 O O
: 
 O
961 	 O
- 
 O
969 	 O
, 
 O
1993 3 O
) 
 O
suggested g O
that t O
T - B-GENE
antigen i E-GENE
could l O
mediate i O
transcriptional n O
activation i O
through o O
interaction e O
with h O
the 	 O
TATA A B-GENE
- - I-GENE
binding d I-GENE
protein t E-GENE
, 
 O
as O O
well l O
as O O
upstream t O
bound n O
transcription n O
factors t O
. 
 O
The 	 O
Grb2 2 B-GENE
SH3 	 I-GENE
( - I-GENE
C - I-GENE
) - I-GENE
binding d I-GENE
region i E-GENE
of O O
Gab1 1 S-GENE
has 	 O
significant n O
homology o O
to O O
a 
 O
region i O
of O O
the 	 O
adapter p B-GENE
protein t I-GENE
SLP 	 I-GENE
- - I-GENE
76 E E-GENE
. 
 O
A 
 O
phase s O
II O O
study d O
of O O
interferon e B-GENE
- - I-GENE
alpha h E-GENE
, 
 O
interleukin e B-GENE
- - I-GENE
2 - E-GENE
and 	 O
5 
 O
- 
 O
fluorouracil o O
in O O
advanced a O
renal a O
carcinoma c O
: 
 O
clinical n O
data a O
and 	 O
laboratory o O
evidence d O
of O O
protease t O
activation i O
. 
 O
Activation i O
of O O
the 	 O
cytotactin o B-GENE
promoter m E-GENE
by O O
the 	 O
homeobox e O
- - O
containing t O
gene e B-GENE
Evx 	 I-GENE
- - I-GENE
1 - E-GENE
. 
 O
CONCLUSION C O
/ 
 O
INTERPRETATION E O
: 
 O
We O O
found n O
an O O
increased r O
risk k O
of O O
hip 	 O
fracture c O
in O O
women e O
younger n O
than n O
75 O O
years r O
with h O
Type e O
I 
 O
diabetes b O
or O O
with h O
Type e O
II O O
diabetes b O
of O O
long g O
duration a O
. 
 O
Maternal e O
behavior a O
was 	 O
assessed e O
using n O
observational e O
techniques h O
. 
 O
Rat 	 B-GENE
p8 I I-GENE
mRNA A E-GENE
was 	 O
discovered c O
because a O
of O O
its 	 O
strong o O
activation i O
in O O
pancreas c O
during i O
the 	 O
acute t O
phase s O
of O O
pancreatitis c O
. 
 O
LV O O
compliance p O
was 	 O
determined e O
from m O
the 	 O
slope p O
of O O
the 	 O
LV O O
end 	 O
- 
 O
diastolic s O
pressure s O
( 
 O
LVEDP D O
) 
 O
vs O O
. 
 O
The 	 O
practice c O
of O O
measuring s O
of O O
AChE E S-GENE
levels e O
in O O
acute t O
poisoning s O
is O O
limited i O
. 
 O
Vasodilation o O
in O O
congestive g O
heart r O
failure l O
is O O
an O O
established a O
therapeutic r O
principal n O
. 
 O
The 	 O
collicular l O
labels e O
found n O
after e O
injections e O
within h O
the 	 O
MST 	 O
area a O
exhibited i O
their i O
distribution t O
over r O
the 	 O
deep p O
SC O O
subdivision d O
, 
 O
whereas r O
they y O
spared r O
all 	 O
the 	 O
superficial e O
layers e O
but 	 O
the 	 O
deep p O
part t O
of O O
the 	 O
SO O O
. 
 O
When n O
furA A S-GENE
alone n O
was 	 O
introduced r O
into o O
the 	 O
Delta t S-GENE
( 
 O
furA A B-GENE
- 
 I-GENE
katG G E-GENE
) 
 O
mutant a O
, 
 O
survival v O
in O O
mouse s O
lungs g O
was 	 O
moderately e O
increased r O
, 
 O
suggesting g O
that t O
FurA A S-GENE
could l O
regulate u O
genes e O
, 
 O
other e O
than n O
katG G S-GENE
, 
 O
that t O
are 	 O
involved o O
in O O
pathogenesis h O
. 
 O
The 	 O
effects e O
of O O
cefazolin a O
, 
 O
given e O
into o O
the 	 O
III 	 O
cerebral e O
ventricle t O
at O O
different f O
doses e O
were e O
studied d O
on O O
GABA A O
content t O
, 
 O
GAD 	 O
and 	 O
GABA A O
- 
 O
T 
 O
in O O
the 	 O
brain i O
- 
 O
stem m O
of O O
young n O
chickens c O
( 
 O
Gallus l O
domesticus e O
) 
 O
. 
 O
Subclones c O
of O O
R15 	 O
which c O
reverted e O
to O O
kappa p B-GENE
light h I-GENE
chain i E-GENE
production d O
contained t O
genomic o O
deletions e O
of O O
R15ns n S-GENE
and 	 O
/ 
 O
or O O
the 	 O
surrounding r O
intron r O
. 
 O
The 	 O
disorders o O
are 	 O
accompanied o O
by O O
consistent s O
, 
 O
but 	 O
similarly i O
reversible e O
, 
 O
electroencephalographic c O
changes n O
. 
 O
The 	 O
delayed a O
activation i O
of O O
the 	 O
prostaglandin s B-GENE
G - I-GENE
/ - I-GENE
H - I-GENE
synthase t I-GENE
- - I-GENE
2 - I-GENE
promoter m E-GENE
in O O
bovine i O
granulosa n O
cells l O
is O O
associated o O
with h O
down n O
- 
 O
regulation u O
of O O
truncated n B-GENE
upstream t I-GENE
stimulatory m I-GENE
factor t I-GENE
- - I-GENE
2 - E-GENE
. 
 O
The 	 O
authors h O
recommend o O
in O O
cases e O
with h O
an O O
elevated v O
transaminase n B-GENE
serum u E-GENE
activity i O
more e O
frequent q O
check c O
- 
 O
up O O
examinations m O
to O O
avoid i O
missing s O
of O O
a 
 O
relapse a O
, 
 O
and 	 O
to O O
examine m O
repeatedly e O
IgM 	 B-GENE
anti i I-GENE
- - I-GENE
HAV 	 E-GENE
as O O
in O O
protracted t O
forms m O
of O O
hepatitis a B-GENE
IgM 	 I-GENE
anti i I-GENE
- - I-GENE
HAV 	 E-GENE
may 	 O
persist s O
even n O
when n O
the 	 O
transaminase n S-GENE
activity i O
is O O
normal m O
. 
 O
Mean n O
latency e O
periods i O
were e O
29 O O
. 
 O
6 
 O
among n O
insulators u O
, 
 O
35 O O
. 
 O
4 
 O
among n O
dock k O
workers k O
, 
 O
43 O O
. 
 O
7 
 O
in O O
a 
 O
heterogeneous e O
group u O
defined i O
as O O
various i O
, 
 O
46 O O
. 
 O
4 
 O
in O O
non 	 O
- 
 O
shipbuilding p O
industry u O
workers k O
, 
 O
49 O O
. 
 O
4 
 O
in O O
shipyard p O
workers k O
, 
 O
51 O O
. 
 O
7 
 O
among n O
women e O
with h O
a 
 O
history t O
of O O
domestic e O
exposure o O
to O O
asbestos e O
, 
 O
and 	 O
56 O O
. 
 O
2 
 O
in O O
people p O
employed l O
in O O
maritime i O
trades d O
. 
 O
The 	 O
strategy a O
uses s O
RNA 	 B-GENE
ligase a E-GENE
to O O
add 	 O
DNA 	 O
oligonucleotide g O
priming m O
sites e O
to O O
the 	 O
RNA 	 O
for 	 O
subsequent s O
reverse e O
transcription n O
and 	 O
PCR 	 O
( 
 O
RNA 	 B-GENE
ligase a E-GENE
, 
 O
reverse e O
transcription n O
- 
 O
PCR 	 O
, 
 O
or O O
RL O O
/ 
 O
RT O O
/ 
 O
PCR 	 O
) 
 O
. 
 O
We O O
analyzed l O
the 	 O
effects e O
of O O
light h O
on O O
tubulin u B-GENE
mRNA A E-GENE
abundance n O
in O O
Arabidopsis b O
seedlings d O
using n O
RNA 	 O
gel 	 O
blot t O
hybridizations r O
and 	 O
gene e O
- 
 O
specific c O
probes b O
. 
 O
More e O
important o O
, 
 O
ligand a O
- 
 O
activated i O
insulin u S-GENE
and 	 O
IGF 	 B-GENE
- - I-GENE
I - I-GENE
receptors e E-GENE
phosphorylate s O
SHC 	 B-GENE
proteins t E-GENE
in O O
vitro r O
, 
 O
indicating i O
that t O
SHC 	 B-GENE
proteins t E-GENE
could l O
be O O
direct e O
substrates s O
for 	 O
insulin u S-GENE
and 	 O
IGF 	 B-GENE
- - I-GENE
I - I-GENE
receptors e E-GENE
. 
 O
This s O
chimera m O
transduced n O
IL B B-GENE
- - I-GENE
4 - E-GENE
- 
 O
specific c O
signals n O
in O O
response p O
to O O
IL B B-GENE
- - I-GENE
2 - E-GENE
binding d O
and 	 O
dramatically m O
enhanced a O
type e O
2 
 O
responses p O
( 
 O
IL B B-GENE
- - I-GENE
4 - E-GENE
, 
 O
IL B B-GENE
- - I-GENE
5 - E-GENE
, 
 O
and 	 O
immunoglobulin u B-GENE
E - E-GENE
production d O
) 
 O
upon n O
in O O
vitro r O
TCR 	 S-GENE
stimulation m O
or O O
in O O
vivo o O
antigen i O
challenge l O
. 
 O
A 
 O
distinct t O
5 
 O
' 
 O
- 
 O
sequence u O
in O O
clone n O
hMIWC2 W S-GENE
suggested g O
an O O
alternative e O
upstream t O
transcription n O
initiation t O
site e O
. 
 O
Two 	 O
human a B-GENE
beta a I-GENE
- - I-GENE
1 - I-GENE
, - I-GENE
6 - I-GENE
- - I-GENE
N - I-GENE
- - I-GENE
acetylglucosaminyltransferases t E-GENE
forming m O
the 	 O
core e O
2 
 O
O 
 O
- 
 O
glycan c O
branch n O
, 
 O
C2GnT n S-GENE
and 	 O
the 	 O
I - B-GENE
antigen i E-GENE
, 
 O
IGnT T S-GENE
, 
 O
are 	 O
homologous o O
to O O
each h O
other e O
in O O
three e O
regions i O
of O O
the 	 O
catalytic a O
domain a O
( 
 O
A 
 O
, 
 O
B 
 O
, 
 O
C 
 O
) 
 O
and 	 O
their i O
genes e O
reside i O
at O O
the 	 O
same e O
locus u O
, 
 O
chromosome o O
9 
 O
, 
 O
band d O
q21 	 O
( 
 O
Bierhuizen r O
, 
 O
M 
 O
. 
 O
F 
 O
. 
 O
A 
 O
. 
 O
, 
 O
Mattei t O
, 
 O
M 
 O
. 
 O
- 
 O
G 
 O
. 
 O
and 	 O
Fukuda u O
, 
 O
M 
 O
. 
 O
, 
 O
Genes e O
Dev 	 O
. 
 O
, 
 O
7 
 O
, 
 O
468 	 O
- 
 O
478 	 O
, 
 O
1993 3 O
) 
 O
. 
 O
Significantly n O
higher h O
levels e O
of O O
vitamin a O
C 
 O
and 	 O
catalase a S-GENE
activity i O
were e O
found n O
in O O
vegetarians e O
( 
 O
C 
 O
- 
 O
63 O O
. 
 O
6 
 O
and 	 O
86 O O
. 
 O
5 
 O
mumol o O
/ 
 O
l 
 O
; 
 O
CAT 	 O
- 
 O
1497 7 O
and 	 O
1313 3 O
U 
 O
/ 
 O
ml O O
for 	 O
males e O
and 	 O
females a O
, 
 O
respectively p O
) 
 O
when n O
compared p O
to O O
nonvegetarians v O
( 
 O
C 
 O
- 
 O
41 O O
. 
 O
3 
 O
and 	 O
54 O O
. 
 O
4 
 O
mumol o O
/ 
 O
l 
 O
; 
 O
CAT 	 O
- 
 O
1192 2 O
and 	 O
1086 6 O
U 
 O
/ 
 O
ml O O
) 
 O
. 
 O
Cutting t O
the 	 O
intraorbital r O
nerves v O
produced d O
a 
 O
temporary p O
retrieval r O
impairment a O
that t O
was 	 O
indistinguishable i O
from m O
that t O
produced d O
by O O
intramystacial r O
lidocaine o O
injection e O
. 
 O
Developmental e O
regulation u O
of O O
expression r O
of O O
the 	 O
malate a B-GENE
synthase t I-GENE
gene e E-GENE
in O O
transgenic n O
plants n O
. 
 O
In O O
contrast t O
, 
 O
no O O
change n O
in O O
the 	 O
level e O
of O O
either h O
p53 	 S-GENE
or O O
activation i O
of O O
mdm2 2 B-GENE
protein t E-GENE
by O O
p53 	 S-GENE
was 	 O
observed e O
in O O
hamster s O
UV61 1 O
cells l O
after e O
UV O O
exposure o O
. 
 O
On O O
day 	 O
1 
 O
at O O
3500 0 O
m 
 O
, 
 O
RI O O
showed w O
a 
 O
significant n O
fall l O
in O O
body y O
weight g O
( 
 O
BW O O
) 
 O
with h O
respect p O
to O O
SL O O
but 	 O
AI O O
maintained n O
it O O
. 
 O
Transcriptional n O
activation i O
of O O
the 	 O
proopiomelanocortin o B-GENE
gene e E-GENE
by O O
cyclic l B-GENE
AMP 	 I-GENE
- - I-GENE
responsive p I-GENE
element m I-GENE
binding d I-GENE
protein t E-GENE
. 
 O
The 	 O
NF1 	 B-GENE
family i I-GENE
members b E-GENE
and 	 O
HNF4 4 S-GENE
interacted e O
with h O
overlapping r O
sequences u O
of O O
the 	 O
L 
 B-GENE
- 
 I-GENE
II O I-GENE
element m E-GENE
, 
 O
wherein r O
the 	 O
5 
 O
' 
 O
half f O
- 
 O
site e O
was 	 O
more e O
critical t O
for 	 O
NF1 	 S-GENE
binding d O
, 
 O
and 	 O
the 	 O
3 
 O
' 
 O
site e O
was 	 O
more e O
important o O
for 	 O
HNF4 4 S-GENE
binding d O
. 
 O
RAP 	 O
has 	 O
been n O
shown w O
to O O
be O O
a 
 O
useful f O
vaccine c O
target g O
site e O
, 
 O
and 	 O
RIP 	 S-GENE
and 	 O
inhibitory i O
AIPs s S-GENE
as O O
therapeutic r O
molecules e O
to O O
prevent v O
and 	 O
suppress p O
S 
 O
. 
 O
aureus e O
infections e O
. 
 O
After e O
institution t O
of O O
insulin u S-GENE
treatment a O
, 
 O
diabetic b O
control t O
was 	 O
improved r O
as O O
demonstrated o O
by O O
decreasing r O
levels e O
of O O
HbA1 1 S-GENE
. 
 O
The 	 O
mouse s B-GENE
lactoferrin t I-GENE
gene e I-GENE
promoter m E-GENE
was 	 O
active i O
in O O
human a O
endometrium o O
carcinoma c O
RL O O
95 O O
- 
 O
2 
 O
cells l O
and 	 O
in O O
rat 	 O
glioma o O
C6 O O
cells l O
. 
 O
The 	 O
1 
 O
- 
 O
year r O
and 	 O
2 
 O
- 
 O
year r O
survival v O
rates e O
for 	 O
the 	 O
patients i O
with h O
N0 O O
- 
 O
3 
 O
significantly n O
exceeded e O
those s O
of O O
N4 O O
patients i O
. 
 O
Measurement s O
of O O
the 	 O
spectral c O
sensitivity s O
and 	 O
the 	 O
ERG 	 O
can 	 O
thus s O
help p O
in O O
the 	 O
diagnosis g O
of O O
these s O
three e O
hereditary e O
diseases e O
. 
 O
As O O
a 
 O
quantitative n O
index e O
of O O
cochlear h O
function c O
, 
 O
2f1 	 O
- 
 O
f2 O O
distortion t O
- 
 O
product d O
otoacoustic a O
emissions s O
( 
 O
DPOAEs A O
) 
 O
were e O
monitored i O
systematically t O
over r O
time e O
in O O
three e O
groups u O
of O O
rabbits b O
, 
 O
with h O
each h O
group u O
experiencing e O
a 
 O
unique q O
paradigm a O
that t O
incorporated o O
repeated e O
exposure o O
to O O
the 	 O
low 	 O
- 
 O
frequency q O
tone e O
. 
 O
The 	 O
subjects j O
' 
 O
lungs g O
were e O
ventilated t O
with h O
N2O 	 O
in O O
O2 O O
( 
 O
FIO2 2 O
0 
 O
. 
 O
3 
 O
) 
 O
to O O
the 	 O
end 	 O
- 
 O
tidal a O
CO2 	 O
present s O
before o O
anesthesia s O
, 
 O
and 	 O
then n O
CBF 	 O
was 	 O
measured s O
using n O
intravenous r O
133Xe X O
and 	 O
ten 	 O
scintillation n O
counters n O
, 
 O
five e O
over r O
each h O
cerebral e O
hemisphere i O
. 
 O
This s O
indicates i O
changes n O
in O O
postvaccination t O
allergy e O
to O O
BCG 	 O
. 
 O
Analysis l O
of O O
1 
 O
Mb O O
of O O
published l O
sequence u O
from m O
the 	 O
region i O
of O O
conserved s O
synteny t O
on O O
human a O
chromosome o O
5q31 1 O
- 
 O
q33 	 O
identified n O
45 O O
gene e O
candidates d O
, 
 O
including l O
35 O O
expressed r O
genes e O
in O O
the 	 O
human a B-GENE
IL I I-GENE
- - I-GENE
4 - I-GENE
cytokine o I-GENE
gene e I-GENE
cluster s E-GENE
. 
 O
There r O
is O O
no O O
indication i O
from m O
these s O
experiments e O
that t O
linker k O
histones t O
bind d O
fundamentally d O
differently f O
to O O
5 - O
S - O
and 	 O
bulk k O
nucleosomes l O
. 
 O
Km O O
values u O
of O O
the 	 O
uncoupled o O
enzymes y O
IIGlc l O
for 	 O
glucose c O
ranged g O
from m O
0 
 O
. 
 O
5 
 O
to O O
2 
 O
. 
 O
5 
 O
mM O O
, 
 O
2 
 O
orders e O
of O O
magnitude n O
higher h O
than n O
the 	 O
value u O
of O O
normal m O
IIGlc l O
. 
 O
Cytochrome o B-GENE
bd E E-GENE
biosynthesis s O
in O O
Escherichia h O
coli i O
: 
 O
the 	 O
sequences u O
of O O
the 	 O
cydC C S-GENE
and 	 O
cydD D B-GENE
genes e E-GENE
suggest g O
that t O
they y O
encode o O
the 	 O
components p O
of O O
an O O
ABC 	 B-GENE
membrane b I-GENE
transporter n E-GENE
. 
 O
In O O
contrast t O
, 
 O
inhibition i O
of O O
MAPK K S-GENE
activity i O
by O O
MAPK K B-GENE
kinase a E-GENE
inhibitor i O
( 
 O
PD O O
98059 5 O
) 
 O
or O O
by O O
overexpression r O
of O O
kinase a O
- 
 O
deficient i O
MAPKs K S-GENE
activated i O
basal a O
and 	 O
GnRH H B-GENE
- - I-GENE
A - E-GENE
- 
 O
stimulated m O
GnRHR H S-GENE
- 
 O
Luc 	 S-GENE
activity i O
. 
 O
The 	 O
influence l O
of O O
gas 	 O
composition p O
in O O
the 	 O
air 	 O
cell l O
on O O
pipping p O
and 	 O
liver e O
metabolism a O
in O O
embryonic r O
chicks c O
. 
 O
Historically t O
, 
 O
Cyps s S-GENE
were e O
first s O
identified n O
by O O
their i O
ability l O
to O O
bind d O
the 	 O
immunosuppressive u O
agent n O
cyclosporin l O
A 
 O
( 
 O
CsA 	 O
) 
 O
with h O
high h O
affinity i O
; 
 O
they y O
later e O
were e O
found n O
to O O
have e O
peptidyl t B-GENE
- - I-GENE
prolyl l I-GENE
cis 	 I-GENE
- - I-GENE
trans n I-GENE
isomerase m E-GENE
( 
 O
PPIase a S-GENE
) 
 O
activity i O
, 
 O
which c O
catalyzes a O
the 	 O
folding d O
of O O
oligopeptides g O
at O O
proline l O
- 
 O
peptide t O
bonds d O
in O O
vitro r O
and 	 O
may 	 O
be O O
important o O
for 	 O
protein t O
folding d O
in O O
vivo o O
. 
 O
Thus s O
, 
 O
oxyR R B-GENE
mutants a E-GENE
are 	 O
locked k O
on O O
for 	 O
Ag43 3 S-GENE
expression r O
, 
 O
whereas r O
dam 	 B-GENE
mutants a E-GENE
are 	 O
locked k O
off 	 O
for 	 O
Ag43 3 S-GENE
expression r O
. 
 O
A 
 O
rare e O
tRNA A B-GENE
- - I-GENE
Arg 	 E-GENE
( - O
CCU 	 S-GENE
) - O
that t O
regulates u O
Ty1 	 B-GENE
element m I-GENE
ribosomal o E-GENE
frameshifting m O
is O O
essential e O
for 	 O
Ty1 	 S-GENE
retrotransposition r O
in O O
Saccharomyces c O
cerevisiae e O
. 
 O
Several e O
35 O O
- 
 O
mm O O
slides d O
of O O
dystrophin t S-GENE
- 
 O
, 
 O
laminin i S-GENE
- 
 O
, 
 O
and 	 O
concanavalin c B-GENE
A - E-GENE
( 
 O
ConA A S-GENE
) 
 O
- 
 O
stained i O
muscle c O
sections t O
were e O
used d O
to O O
calculate c O
myofiber f O
cross s O
- 
 O
sectional t O
areas a O
and 	 O
to O O
compare p O
different f O
techniques h O
and 	 O
settings t O
of O O
an O O
image g O
capture t O
system t O
. 
 O
In O O
addition i O
, 
 O
both h O
inhibitors i O
blocked c O
phosphatidylcholine s O
hydrolysis r O
and 	 O
protein t B-GENE
kinase a I-GENE
C - E-GENE
translocation n O
. 
 O
New 	 O
, 
 O
selective e O
catechol e B-GENE
- - I-GENE
O - I-GENE
- - I-GENE
methyltransferase h E-GENE
inhibitors i O
as O O
therapeutic r O
agents n O
in O O
Parkinson k O
' 
 O
s 
 O
disease e O
. 
 O
Furthermore t O
, 
 O
the 	 O
social i O
learning r O
theory o O
of O O
depression r O
, 
 O
developed e O
by O O
Lewinsohn i O
, 
 O
is O O
described c O
. 
 O
Laser e O
soldering d O
with h O
exogenous g O
fibrinogen r S-GENE
is O O
feasible s O
without h O
topical i O
administration i O
of O O
additional i O
clotting t O
agents n O
, 
 O
significantly n O
improves r O
the 	 O
bursting s O
strength e O
of O O
primary m O
laser e O
welded d O
anastomoses s O
, 
 O
and 	 O
appears e O
to O O
result u O
from m O
urokinase k S-GENE
- 
 O
resistant i O
fibrinogen r S-GENE
cross s O
- 
 O
linking k O
. 
 O
Intensity e O
variations i O
from m O
the 	 O
variable i O
TR O O
were e O
removed o O
, 
 O
and 	 O
the 	 O
data a O
were e O
evaluated l O
for 	 O
correlation r O
with h O
the 	 O
lateralized e O
stimulus m O
. 
 O
Routine t O
imaging g O
modalities a O
revealed e O
a 
 O
total a O
of O O
79 O O
metastases a O
. 
 O
We O O
have e O
previously v O
reported o O
that t O
analgesic l O
doses e O
of O O
morphine p O
accelerate e O
mortality t O
of O O
rats s O
exposed o O
to O O
hemorrhage o O
( 
 O
Feuerstein e O
and 	 O
Siren e O
: 
 O
Circ c O
Shock c O
19 O O
: 
 O
293 	 O
- 
 O
300 	 O
, 
 O
1986 6 O
) 
 O
. 
 O
We O O
describe c O
a 
 O
novel e O
stat t B-GENE
- - I-GENE
related a I-GENE
factor t E-GENE
, 
 O
p93 	 S-GENE
, 
 O
that t O
is O O
found n O
in O O
EGF 	 S-GENE
- 
 O
treated a O
A431 1 O
cell l O
extracts r O
but 	 O
appears e O
to O O
be O O
absent e O
in O O
bovine i B-GENE
fibroblast r I-GENE
growth w I-GENE
factor t E-GENE
( 
 O
bFGF F S-GENE
) 
 O
, 
 O
IFN 	 B-GENE
- - I-GENE
gamma m E-GENE
, 
 O
tumor o B-GENE
necrosis r I-GENE
factor t I-GENE
- - I-GENE
alpha h E-GENE
( 
 O
TNF 	 B-GENE
- - I-GENE
alpha h E-GENE
) 
 O
, 
 O
and 	 O
untreated r O
cells l O
. 
 O
p93 	 S-GENE
appears e O
to O O
be O O
antigenically i O
related a O
to O O
stat91 t S-GENE
. 
 O
p185c 5 B-GENE
- 
 I-GENE
neu 	 I-GENE
+ 
 E-GENE
, 
 O
EGFr r B-GENE
+ - E-GENE
( 
 O
M1 S S-GENE
) 
 O
, 
 O
and 	 O
p185c 5 B-GENE
- 
 I-GENE
neu 	 I-GENE
- 
 I-GENE
kinase a E-GENE
inactive c O
, 
 O
EGFr r B-GENE
+ - E-GENE
( 
 O
NEN757 7 S-GENE
) 
 O
expressing r O
cells l O
undergo e O
different f O
mitotic o O
responses p O
to O O
EGF 	 S-GENE
. 
 O
In O O
addition i O
, 
 O
Fc B B-GENE
epsilon i I-GENE
R1 E E-GENE
cross s O
- 
 O
linking k O
activates i O
PI B B-GENE
3 - I-GENE
- - I-GENE
kinase a E-GENE
. 
 O
When n O
single g O
- 
 O
point n O
mutation a O
was 	 O
introduced r O
to O O
each h O
GC O O
box 	 O
, 
 O
EBS 	 S-GENE
, 
 O
and 	 O
GT O O
box 	 O
in O O
PFP9a20 9 S-GENE
, 
 O
at O O
least s O
3 
 O
- 
 O
fold d O
less s O
CAT 	 S-GENE
activity i O
was 	 O
observed e O
in O O
CTLL L O
- 
 O
R8 O O
cells l O
. 
 O
Ribosome o O
association o O
of O O
GCN2 2 B-GENE
protein t I-GENE
kinase a E-GENE
, 
 O
a 
 O
translational n O
activator i O
of O O
the 	 O
GCN4 4 B-GENE
gene e E-GENE
of O O
Saccharomyces c O
cerevisiae e O
. 
 O
Treatment a O
with h O
H7 O O
did 	 O
not 	 O
affect e O
IL B B-GENE
- - I-GENE
4R E E-GENE
- 
 O
mediated i O
immediate e O
signaling n O
events n O
such h O
as O O
tyrosine o O
phosphorylation s O
of O O
Jak1 1 S-GENE
, 
 O
Jak3 3 S-GENE
, 
 O
insulin u B-GENE
receptor e I-GENE
substrate s I-GENE
( - I-GENE
IRS 	 I-GENE
) - I-GENE
- - I-GENE
1 - E-GENE
and 	 O
IRS 	 B-GENE
- - I-GENE
2 - E-GENE
, 
 O
or O O
tyrosine o O
phosphorylation s O
and 	 O
DNA 	 O
binding d O
of O O
Stat6 t S-GENE
. 
 O
Thus s O
, 
 O
STK1 1 S-GENE
is O O
most t O
likely e O
the 	 O
human a O
homologue o O
of I O
MO15 5 S-GENE
. 
 O
BACKGROUND K O
: 
 O
Recent e O
iterative r O
methods h O
for 	 O
sequence u O
alignment g O
have e O
indicated i O
that t O
the 	 O
380 	 O
kDa 	 O
motor o O
unit t O
of O O
dynein e S-GENE
belongs o O
to O O
the 	 O
AAA 	 O
class s O
of O O
chaperone p B-GENE
- - I-GENE
like e I-GENE
ATPases a E-GENE
. 
 O
When n O
the 	 O
VBP 	 B-GENE
- - I-GENE
1 - I-GENE
protein t E-GENE
was 	 O
solely e O
expressed r O
, 
 O
it O O
located a O
to O O
the 	 O
cytoplasm o O
and 	 O
did 	 O
not 	 O
localize a O
to O O
the 	 O
nucleus l O
. 
 O
Consistent s O
with h O
other e O
experiments e O
with h O
these s O
compounds p O
, 
 O
cocaine a O
was 	 O
the 	 O
most t O
potent e O
of O O
the 	 O
group u O
. 
 O
The 	 O
significance n O
of O O
these s O
changes n O
in O O
relation a O
to O O
the 	 O
control t O
of O O
phosphorus s O
balance a O
in O O
ruminants i O
is O O
discussed c O
. 
 O
Transfection n O
assays a O
using n O
the 	 O
first s O
600 	 O
bp O O
of O O
the 	 O
upstream t O
nucleotide l O
sequences u O
indicated i O
that t O
a 
 O
region i O
from m O
- 
 O
75 O O
to O O
- 
 O
120 	 O
was 	 O
necessary e O
for 	 O
the 	 O
ALDH2 H B-GENE
gene e E-GENE
expression r O
, 
 O
and 	 O
especially e O
NF B B-GENE
- - I-GENE
Y - E-GENE
/ 
 O
CP1 	 S-GENE
binding d O
site e O
from m O
- 
 O
92 O O
to O O
- 
 O
96 O O
( 
 O
CCAAT A O
box 	 O
) 
 O
is O O
important o O
in O O
the 	 O
expression r O
of O O
the 	 O
gene e O
. 
 O
This s O
distinct t O
biochemical c O
difference f O
between w O
STAT5A T S-GENE
and 	 O
STAT5B T S-GENE
was 	 O
confirmed f O
with h O
purified i O
activated i O
STAT5 T B-GENE
recombinant o I-GENE
proteins t E-GENE
. 
 O
The 	 O
results u O
show w O
that t O
in O O
uninfected n O
NIH 	 O
- 
 O
3T3 	 O
cells l O
Avarol r O
( 
 O
i 
 O
) 
 O
causes s O
a 
 O
50 O O
% 
 O
reduction u O
of O O
the 	 O
growth w O
rate e O
only y O
at O O
the 	 O
high h O
concentration c O
of O O
29 O O
. 
 O
6 
 O
microM r O
and 	 O
( 
 O
ii O O
) 
 O
is O O
accumulated u O
in O O
the 	 O
cytoplasm o O
close s O
to O O
the 	 O
nucleus l O
. 
 O
Blood o B-GENE
coagulation g I-GENE
Factor t I-GENE
X - E-GENE
and 	 O
its 	 O
activated i O
form m O
Factor t B-GENE
Xa E E-GENE
play y O
an O O
essential e O
role e O
in O O
the 	 O
midphase p S-GENE
of O O
the 	 O
clotting t O
cascade c O
. 
 O
The 	 O
exon n O
sequences u O
determined e O
from m O
genomic o O
DNA 	 O
sequencing u O
showed w O
some e O
differences f O
when n O
compared p O
to O O
the 	 O
published l O
rat 	 B-GENE
GLUT2 T I-GENE
cDNA A E-GENE
. 
 O
Intramolecular r O
interaction e O
is O O
believed i O
to O O
result u O
in O O
the 	 O
formation m O
of O O
MxA 	 B-GENE
monomers o E-GENE
, 
 O
whereas r O
intermolecular e O
interaction e O
may 	 O
induce u O
the 	 O
formation m O
of O O
large g O
MxA 	 O
oligomers g O
. 
 O
The 	 O
psbA A B-GENE
gene e E-GENE
encodes o O
the 	 O
D1 B B-GENE
protein t E-GENE
of O O
photosystem t B-GENE
II E E-GENE
, 
 O
which c O
is O O
synthesized t O
at O O
very y O
high h O
rates e O
in O O
the 	 O
light h O
in O O
order e O
to O O
replace l O
photodamaged t O
protein t O
. 
 O
The 	 O
three e O
more e O
slower w O
migrating r O
Stat5B t S-GENE
bands d O
observed e O
in O O
response p O
to O O
GH S S-GENE
contain t O
phosphorylated s O
tyrosyl o O
residues i O
. 
 O
The 	 O
maximum i O
levels e O
of O O
reporter o O
proteins t O
attained a O
in O O
transformed n O
cells l O
after e O
prolonged l O
induction u O
represented r O
from m O
1 
 O
% 
 O
to O O
7 
 O
% 
 O
of O O
total a O
cellular l O
protein t O
. 
 O
Specifically c O
, 
 O
we O O
demonstrate o O
that t O
this s O
25 O O
- 
 O
base e O
pair r O
region i O
mediates i O
the 	 O
up O O
- 
 O
regulatory u O
effect e O
of O O
TGF 	 B-GENE
- - I-GENE
beta a E-GENE
on O O
COL1A2 1 B-GENE
promoter m E-GENE
activity i O
and 	 O
allows o O
antagonistic a O
activity i O
of O O
TNF 	 B-GENE
- - I-GENE
alpha h E-GENE
on O O
the 	 O
TGF 	 B-GENE
- - I-GENE
beta a E-GENE
effect e O
. 
 O
Sin4 4 S-GENE
and 	 O
Srb10 1 S-GENE
, 
 O
components p O
of O O
specific c O
RNA 	 B-GENE
polymerase y I-GENE
II I I-GENE
sub 	 I-GENE
- - I-GENE
complexes p E-GENE
that t O
are 	 O
required u O
for 	 O
Ssn6 6 S-GENE
- 
 O
Tup1 1 S-GENE
repression r O
activity i O
, 
 O
are 	 O
found n O
to O O
be O O
required u O
for 	 O
Sfl1 1 S-GENE
repression r O
function c O
. 
 O
Translation n O
of O O
mok 	 S-GENE
is O O
tightly h O
regulated u O
by O O
Sok 	 B-GENE
RNA 	 E-GENE
, 
 O
and 	 O
Sok 	 B-GENE
RNA 	 E-GENE
thus s O
regulates u O
hok 	 O
translation n O
indirectly i O
through o O
mok 	 S-GENE
. 
 O
Depending e O
on O O
the 	 O
patient i O
' 
 O
s 
 O
body y O
position i O
telemetrically e O
measured s O
CSF 	 O
- 
 O
pressures s O
varied i O
between w O
- 
 O
20 O O
cmH2O 2 O
in O O
erect c O
and 	 O
15 O O
cmH2O 2 O
in O O
supine i O
position i O
. 
 O
One 	 O
- 
 O
hour r O
O3 O O
, 
 O
NO2 	 O
, 
 O
and 	 O
SO2 	 O
personal s O
exposures o O
were e O
measured s O
using n O
samplers p O
developed e O
in O O
our 	 O
laboratory o O
, 
 O
while l O
short r O
- 
 O
term m O
PM2 	 O
. 
 O
5 
 O
, 
 O
CO O O
, 
 O
and 	 O
VOCs s O
exposures o O
were e O
measured s O
using n O
currently r O
available i O
monitors i O
. 
 O
These s O
Tlr 	 B-GENE
family i I-GENE
members b E-GENE
, 
 O
unlike i O
others e O
reported o O
to O O
date e O
, 
 O
were e O
identified n O
within h O
a 
 O
genomic o O
database a O
. 
 O
We O O
hypothesized o O
that t O
subjects j O
would l O
demonstrate o O
PKAR R S-GENE
during i O
both h O
hopping p O
and 	 O
stepping p O
, 
 O
adding i O
support p O
to O O
the 	 O
hypothesis o O
that t O
PKAR R S-GENE
is O O
a 
 O
centrally t O
mediated i O
adaptation p O
of O O
general e O
locomotor o O
trajectory j O
that t O
is O O
not 	 O
specific c O
to O O
the 	 O
form m O
of O O
locomotion o O
used d O
while l O
on O O
the 	 O
rotating a O
disk k O
. 
 O
In O O
this s O
study d O
, 
 O
transcriptional n O
fusions i O
were e O
constructed s O
between w O
the 	 O
xcpP P S-GENE
and 	 O
xcpR R B-GENE
genes e E-GENE
and 	 O
the 	 O
lacZ Z B-GENE
reporter o E-GENE
. 
 O
To O O
explore l O
the 	 O
mechanism h O
of O O
insulin u B-GENE
receptor e E-GENE
phosphorylation s O
we O O
have e O
used d O
NIH3T3 3 O
cells l O
transfected n O
with h O
two 	 O
receptor e O
constructs s O
: 
 O
one 	 O
encoding o O
a 
 O
chimeric m O
receptor e O
composed p O
of O O
the 	 O
extracellular r O
domain a O
of O O
the 	 O
human a B-GENE
EGF 	 I-GENE
receptor e E-GENE
and 	 O
the 	 O
cytosolic o O
domain a O
of O O
the 	 O
human a B-GENE
insulin u I-GENE
receptor e I-GENE
beta a I-GENE
- - I-GENE
subunit u E-GENE
, 
 O
and 	 O
a 
 O
second o O
construct s O
encoding o O
a 
 O
kinase a O
- 
 O
defiecient i O
human a B-GENE
insulin u I-GENE
receptor e E-GENE
. 
 O
It O O
is O O
pathogenetically h O
proved v O
to O O
use 	 O
antithrombin i B-GENE
III 	 E-GENE
concentrate c O
preparations p O
with h O
anti i O
- 
 O
and 	 O
dysaggregatory a O
properties p O
, 
 O
fibronectin r S-GENE
preparations p O
, 
 O
trasylol s O
or O O
its 	 O
analogs l O
during i O
complex p O
preoperative o O
preparation p O
of O O
patients i O
. 
 O
Stimulation m O
of O O
the 	 O
endosteal o O
bone e O
formation m O
rate e O
was 	 O
mainly n O
impaired a O
in O O
D 
 O
- 
 O
depleted l O
rats s O
, 
 O
resulting u O
in O O
trabecular b O
bone e O
loss s O
, 
 O
which c O
, 
 O
in O O
- 
 O
D 
 O
mother h O
rats s O
, 
 O
was 	 O
associated o O
with h O
decreased r O
bone e O
ash 	 O
and 	 O
total a O
bone e O
calcium c O
. 
 O
Hematopoietic a B-GENE
progenitor g I-GENE
kinase a I-GENE
1 - E-GENE
( 
 O
HPK1 1 S-GENE
) 
 O
is O O
a 
 O
member b O
of O O
the 	 O
mitogen o B-GENE
- - I-GENE
activated i I-GENE
protein t I-GENE
kinase a I-GENE
kinase a I-GENE
kinase a I-GENE
kinase a E-GENE
( 
 O
MAP4K 4 S-GENE
) 
 O
family i O
and 	 O
an O O
upstream t O
activator i O
of O O
the 	 O
c - B-GENE
- - I-GENE
Jun 	 I-GENE
N - I-GENE
- - I-GENE
terminal m I-GENE
kinase a E-GENE
( 
 O
JNK 	 S-GENE
) 
 O
signaling n O
cascade c O
. 
 O
We O O
have e O
used d O
the 	 O
chloramphenicol o B-GENE
acetyltransferase t E-GENE
( 
 O
CAT 	 S-GENE
) 
 O
reporter o O
gene e O
system t O
to O O
study d O
the 	 O
effect e O
of O O
T - O
on O O
the 	 O
long g O
terminal m O
repeats e O
( 
 O
LTRs s O
) 
 O
of O O
a 
 O
large g O
family i O
of O O
human a O
endogenous o O
retrovirus r O
- 
 O
like e O
sequences u O
, 
 O
RTVL L O
- 
 O
H 
 O
. 
 O
To O O
investigate e O
this s O
possibility s O
, 
 O
we O O
conducted d O
split i O
- 
 O
visual u O
- 
 O
field l O
studies d O
in O O
which c O
we O O
manipulated i O
stimulus m O
sets s O
, 
 O
recognition o O
task k O
, 
 O
and 	 O
exposure o O
duration a O
. 
 O
In O O
conclusion c O
, 
 O
ANH 	 S-GENE
had 	 O
no O O
negative a O
effects e O
on O O
the 	 O
endocrine o O
stress e O
response p O
during i O
orthopedic h O
surgery g O
under e O
epidural d O
anesthesia s O
. 
 O
Finally a O
, 
 O
the 	 O
conservation s O
of O O
the 	 O
two 	 O
residues i O
most t O
sensitive s O
to O O
mutations a O
( 
 O
Y949 9 O
and 	 O
Y953 3 O
) 
 O
in O O
TM11 1 O
, 
 O
and 	 O
in O O
the 	 O
homologous o O
TM5 	 S-GENE
, 
 O
of O O
all 	 O
mammalian m B-GENE
P - I-GENE
- - I-GENE
gps 	 E-GENE
and 	 O
also o O
in O O
other e O
ABC 	 B-GENE
transporters n E-GENE
, 
 O
suggests g O
that t O
these s O
residues i O
and 	 O
domains a O
may 	 O
play y O
an O O
important o O
role e O
in O O
structural u O
as O O
well l O
as O O
mechanistic h O
aspects e O
common m O
to O O
this s O
family i O
of O O
proteins t O
. 
 O
Based e O
on O O
the 	 O
requirement u O
for 	 O
CREM M S-GENE
/ 
 O
ICER R S-GENE
and 	 O
Rad6B 6 B-GENE
proteins t E-GENE
in O O
spermatogenesis r O
, 
 O
we O O
determined e O
expression r O
of O O
Cdc34 3 S-GENE
, 
 O
Rad6B 6 S-GENE
, 
 O
CREM M S-GENE
/ 
 O
ICER R S-GENE
isoforms f O
, 
 O
and 	 O
the 	 O
Skp1 1 S-GENE
- 
 O
Cullin l S-GENE
- 
 O
F 
 B-GENE
- 
 I-GENE
box 	 I-GENE
ubiquitin q I-GENE
protein t I-GENE
ligase a I-GENE
subunits u I-GENE
Cul 	 I-GENE
- - I-GENE
1 - E-GENE
and 	 O
Cul 	 B-GENE
- - I-GENE
2 - E-GENE
, 
 O
which c O
are 	 O
associated o O
with h O
Cdc34 3 S-GENE
activity i O
during i O
murine i O
testicular t O
development e O
. 
 O
The 	 O
enigma g O
of O O
aging n O
bone e O
loss s O
. 
 O
Transcription n B-GENE
factor t I-GENE
IIIC C E-GENE
( 
 O
TFIIIC I S-GENE
) 
 O
is O O
required u O
for 	 O
the 	 O
assembly e O
of O O
a 
 O
preinitiation i O
complex p O
on O O
5S B B-GENE
RNA 	 E-GENE
, 
 O
tRNA A O
, 
 O
and 	 O
adenovirus n B-GENE
VA E I-GENE
RNA 	 I-GENE
genes e E-GENE
and 	 O
contains t O
two 	 O
separable a O
components p O
, 
 O
TFIIIC1 I S-GENE
and 	 O
TFIIIC2 I S-GENE
. 
 O
Furthermore t O
, 
 O
we O O
show w O
that t O
Nck 	 B-GENE
- - I-GENE
2 - E-GENE
is O O
capable a O
of O O
recognizing o O
several e O
key 	 O
components p O
of O O
growth w B-GENE
factor t I-GENE
receptor e I-GENE
kinase a E-GENE
- 
 O
signaling n O
pathways h O
including l O
EGF 	 B-GENE
receptors e E-GENE
, 
 O
PDGF F B-GENE
receptor e I-GENE
- - I-GENE
beta a E-GENE
, 
 O
and 	 O
IRS 	 B-GENE
- - I-GENE
1 - E-GENE
. 
 O
These s O
two 	 O
enhancer a O
elements m O
also o O
enhanced a O
transcription n O
when n O
fused e O
separately a O
to O O
the 	 O
basal a O
promoter m O
region i O
of O O
the 	 O
chicken c B-GENE
vimentin e I-GENE
gene e E-GENE
. 
 O
When n O
they y O
were e O
exposed o O
to O O
intermittent e O
schedules e O
of O O
punishment i O
( 
 O
fixed e O
- 
 O
interval e O
[ 
 O
FI O O
] 
 O
120 	 O
s 
 O
or O O
FI O O
300 	 O
s 
 O
) 
 O
, 
 O
SIB 	 O
for 	 O
all 	 O
but 	 O
1 
 O
of O O
the 	 O
participants t O
increased r O
to O O
levels e O
similar i O
to O O
those s O
observed e O
during i O
baseline e O
. 
 O
Deep p O
bite e B-GENE
CL O I-GENE
II O I-GENE
Div 	 E-GENE
. 
 O
Patients i O
with h O
binocular o O
pregeniculate g O
visual u O
loss s O
, 
 O
patients i O
with h O
balanced a O
binocular o O
pregeniculate g O
loss s O
without h O
RAPD D O
, 
 O
and 	 O
patients i O
with h O
monocular o O
pregeniculate g O
visual u O
loss s O
had 	 O
significantly n O
larger g O
pupils i O
than n O
age 	 O
- 
 O
matched c O
controls t O
. 
 O
Protein t O
sequencing u O
, 
 O
electrophoretic c O
mobility i O
shift f O
assay a O
, 
 O
and 	 O
immunoblot u O
analyses l O
identify n O
p54 	 S-GENE
and 	 O
p47 	 B-GENE
/ - I-GENE
48 E E-GENE
as O O
members b O
of O O
the 	 O
hepatocyte a B-GENE
nuclear l I-GENE
factor t I-GENE
3 - E-GENE
( 
 O
HNF3 3 S-GENE
[ 
 O
forkhead k O
] 
 O
) 
 O
family i O
of O O
transcription n O
factors t O
. 
 O
p54 	 S-GENE
belongs o O
to O O
the 	 O
subfamily f O
of O O
HNF3 3 B-GENE
beta a I-GENE
proteins t E-GENE
, 
 O
while l O
p47 	 B-GENE
/ - I-GENE
48 E E-GENE
binding d O
activity i O
includes l O
HNF3 3 B-GENE
gamma m E-GENE
. 
 O
In O O
this s O
cross s O
- 
 O
over r O
controlled t O
study d O
, 
 O
five e O
male e O
volunteers u O
donated a O
one 	 O
unit t O
of O O
red 	 O
cells l O
by O O
MCS 	 O
and 	 O
one 	 O
unit t O
of O O
whole l O
blood o O
by O O
the 	 O
conventional v O
manual u O
method h O
, 
 O
3 
 O
months t O
apart r O
. 
 O
Promoter m O
activity i O
was 	 O
assayed a O
by O O
transient n O
transfection n O
of O O
luciferase i B-GENE
reporter o I-GENE
constructs s E-GENE
containing t O
nested t O
deletions e O
of O O
the 	 O
upstream t O
sequence u O
in O O
the 	 O
human a O
RPE 	 O
cell l O
lines e O
ARPE19 E S-GENE
and 	 O
D407 7 O
, 
 O
as O O
well l O
as O O
in O O
the 	 O
SK O O
- 
 O
Mel 	 O
- 
 O
28 O O
and 	 O
HeLa a O
cell l O
lines e O
. 
 O
This s O
model e O
system t O
exploits l O
the 	 O
polyomavirus y O
late e O
transcription n O
termination m O
and 	 O
polyadenylation y O
signals n O
, 
 O
which c O
are 	 O
sufficiently f O
weak k O
to O O
allow o O
the 	 O
production d O
of O O
many y O
multigenome t O
- 
 O
length g O
primary m O
transcripts n O
with h O
repeating e O
introns r O
, 
 O
exons n O
, 
 O
and 	 O
poly y O
( 
 O
A 
 O
) 
 O
sites e O
. 
 O
Magnification n O
- 
 O
corrected r O
planimetry n O
of O O
the 	 O
parapapillary a O
region i O
was 	 O
performed f O
according o O
to O O
Littmann t O
' 
 O
s 
 O
method h O
in O O
312 	 O
unselected e O
eyes s O
with h O
chronic o O
primary m O
open n O
- 
 O
angle l O
glaucoma u O
and 	 O
in O O
125 	 O
normal m O
eyes s O
of O O
an O O
age 	 O
- 
 O
and 	 O
refraction r O
- 
 O
matched c O
control t O
group u O
using n O
optic i O
disk k O
photographs t O
. 
 O
Although h O
the 	 O
elevated v O
signalling n O
is O O
eliminated m O
by O O
deletion e O
of O O
Ste20p 2 S-GENE
( 
 O
or O O
components p O
downstream n O
of O O
Ste20p 2 S-GENE
) 
 O
, 
 O
the 	 O
growth w O
and 	 O
morphological p O
abnormalities o O
of O O
cells l O
lacking k O
Akr1p 1 S-GENE
are 	 O
not 	 O
rescued c O
by O O
deletion e O
of O O
any 	 O
of O O
the 	 O
known w O
pheromone r O
response p O
pathway h O
components p O
. 
 O
Southern t O
hybridization r O
of O O
genomic o O
DNA 	 O
from m O
WT O O
and 	 O
Lp S O
/ 
 O
Lp S O
embryos r O
failed l O
to O O
identify n O
specific c O
rearrangements r O
at O O
or O O
near r O
the 	 O
Nhlh1 h B-GENE
locus u E-GENE
, 
 O
and 	 O
Northern t O
RNA 	 O
blotting t O
and 	 O
RT O O
- 
 O
PCR 	 O
evaluation l O
of O O
Nhlh1 h B-GENE
mRNA A E-GENE
expression r O
indicated i O
that t O
both h O
the 	 O
levels e O
and 	 O
types e O
of O O
Nhlh1 h B-GENE
mRNAs A E-GENE
produced d O
in O O
WT O O
and 	 O
Lp S O
/ 
 O
Lp S O
embryos r O
were e O
indistinguishable i O
. 
 O
In O O
addition i O
, 
 O
mrp17 1 B-GENE
- - I-GENE
1 - E-GENE
, 
 O
in O O
combination b O
with h O
some e O
mutations a O
affecting e O
another t O
mitochondrial o O
ribosomal o O
protein t O
, 
 O
caused s O
a 
 O
synthetic t O
defective e O
phenotype n O
. 
 O
Expression r O
, 
 O
characterization r O
, 
 O
and 	 O
genomic o O
structure u O
of O O
carp p B-GENE
JAK1 1 I-GENE
kinase a I-GENE
gene e E-GENE
. 
 O
Significantly n O
, 
 O
the 	 O
murine i B-GENE
P - I-GENE
- - I-GENE
selectin e I-GENE
gene e E-GENE
had 	 O
several e O
features t O
not 	 O
found n O
in O O
the 	 O
human a O
gene e O
. 
 O
Fluorescent o O
in O O
situ u O
hybridization r O
( 
 O
FISH H O
) 
 O
analysis l O
showed w O
that t O
the 	 O
novel e O
regions i O
involved o O
in O O
the 	 O
NFKB2 B S-GENE
rearrangement r O
originated g O
from m O
chromosome o O
7q34 4 O
, 
 O
thus s O
implying l O
the 	 O
occurrence u O
of O O
a 
 O
t 
 O
( 
 O
7 
 O
; 
 O
10 O O
) 
 O
( 
 O
q34 	 O
; 
 O
q24 	 O
) 
 O
reciprocal i O
chromosomal o O
translocation n O
. 
 O
Transient n O
- 
 O
expression r O
assay a O
analysis l O
of O O
subclones c O
of O O
pPstI t B-GENE
- 
 I-GENE
G 
 E-GENE
localized a O
the 	 O
trans n O
- 
 O
active i O
factor t O
to O O
a 
 O
3 - B-GENE
. - I-GENE
0 - I-GENE
- - I-GENE
kilobase o I-GENE
XbaI I I-GENE
fragment g E-GENE
. 
 O
MGF 	 S-GENE
is O O
a 
 O
novel e O
member b O
of O O
the 	 O
cytokine o B-GENE
- - I-GENE
regulated u I-GENE
transcription n I-GENE
factor t I-GENE
gene e I-GENE
family i E-GENE
. 
 O
This s O
is O O
the 	 O
first s O
report o O
that t O
the 	 O
PH B B-GENE
domain a E-GENE
of O O
an O O
IRS 	 B-GENE
protein t E-GENE
can 	 O
function c O
in O O
a 
 O
dominant i O
negative a O
manner n O
to O O
inhibit i O
insulin u S-GENE
signaling n O
. 
 O
A 
 O
29 O O
. 
 O
425 	 O
kb O O
segment m O
on O O
the 	 O
left t O
arm 	 O
of O O
yeast s O
chromosome o O
XV O O
contains t O
more e O
than n O
twice c O
as O O
many y O
unknown n O
as O O
known w O
open n O
reading d O
frames m O
. 
 O
This s O
result u O
, 
 O
together e O
with h O
the 	 O
fact t O
that t O
unrearranged e O
V - B-GENE
kappa p I-GENE
genes e E-GENE
are 	 O
transcriptionally n O
silent e O
, 
 O
suggests g O
that t O
structural u O
features t O
of O O
both h O
the 	 O
V - B-GENE
kappa p E-GENE
and 	 O
C - B-GENE
kappa p I-GENE
loci i E-GENE
contribute t O
to O O
the 	 O
overall r O
transcriptional n O
efficiency i O
of O O
a 
 O
rearranged r O
V - B-GENE
kappa p I-GENE
- 
 I-GENE
C - I-GENE
kappa p I-GENE
gene e E-GENE
. 
 O
The 	 O
first s O
270 	 O
bp O O
of O O
the 	 O
promoter m O
region i O
were e O
sequenced u O
and 	 O
found n O
to O O
contain t O
a 
 O
CATAA A O
box 	 O
rather h O
than n O
a 
 O
TATAA A O
box 	 O
and 	 O
several e O
DNA 	 O
motifs i O
found n O
in O O
activation i O
genes e O
. 
 O
C 
 O
. 
 O
glabrata b O
cells l O
containing t O
the 	 O
CBF1 1 B-GENE
gene e E-GENE
under e O
the 	 O
influence l O
of O O
a 
 O
shutdown t O
promoter m O
( 
 O
tetO O B-GENE
- 
 I-GENE
ScHOP O E-GENE
) 
 O
arrested e O
their i O
growth w O
after e O
5 
 O
h 
 O
of O O
cultivation t O
in O O
the 	 O
presence s O
of O O
the 	 O
reactive c O
drug g O
doxycycline y O
. 
 O
SF1 	 S-GENE
/ 
 O
mBBP P S-GENE
utilizes l O
a 
 O
" - B-GENE
maxi i I-GENE
- - I-GENE
K - I-GENE
homology o I-GENE
" - E-GENE
( 
 O
maxi i B-GENE
- - I-GENE
KH E E-GENE
) 
 O
domain a O
for 	 O
recognition o O
of O O
the 	 O
single g O
- 
 O
stranded a O
BPS 	 O
and 	 O
requires u O
a 
 O
cooperative p O
interaction e O
with h O
splicing i B-GENE
factor t I-GENE
U2AF65 F E-GENE
bound n O
to O O
an O O
adjacent a O
polypyrimidine y O
tract c O
( 
 O
PPT 	 O
) 
 O
for 	 O
high h O
- 
 O
affinity i O
binding d O
. 
 O
An O O
X 
 O
- 
 O
linked k O
zinc c O
finger g O
gene e O
mapping p O
to O O
Xq21 1 O
. 
 O
1 
 O
- 
 O
q21 	 O
. 
 O
3 
 O
closely s O
related a O
to O O
ZFX 	 S-GENE
and 	 O
ZFY 	 S-GENE
: 
 O
possible s O
origins g O
from m O
a 
 O
common m O
ancestral e O
gene e O
. 
 O
Validity i O
of O O
the 	 O
short r O
- 
 O
form m O
QIF 	 O
was 	 O
assessed e O
by O O
correlation r O
with h O
motor o O
scores r O
and 	 O
using n O
analysis l O
of O O
variance i O
by O O
motor o O
levels e O
and 	 O
motor o O
score r O
groupings u O
. 
 O
Juvenile e O
angiofibromas i O
. 
 O
Comment m O
on O O
" 
 O
Critical t O
behavior a O
of O O
a 
 O
binary a O
mixture t O
of O O
protein t O
and 	 O
salt t O
water e O
" 
 O
The 	 O
pineal e O
hormone m O
melatonin a O
( 
 O
MLT 	 O
) 
 O
is O O
able e O
to O O
exert r O
an O O
oncostatic o O
action i O
. 
 O
In O O
addition i O
, 
 O
there r O
was 	 O
an O O
increase r O
in O O
the 	 O
amount u O
of O O
p120 0 S-GENE
Ras 	 S-GENE
- 
 O
specific c O
GTPase a B-GENE
- - I-GENE
activating i I-GENE
protein t E-GENE
( 
 O
GAP 	 S-GENE
) 
 O
and 	 O
GAP 	 S-GENE
- 
 O
associated o O
p190 0 S-GENE
. 
 O
Additional i O
transection n O
of O O
both h O
ADN 	 O
eliminated m O
the 	 O
remaining a O
sigmoidal m O
correlation r O
between w O
MAP 	 O
and 	 O
RSNA A O
with h O
further t O
increases r O
in O O
resting t O
MAP 	 O
and 	 O
RSNA A O
. 
 O
Pregnancy g O
was 	 O
ensued u O
in O O
4 
 O
cases e O
in O O
group u O
I 
 O
. 
 O
The 	 O
1 
 O
. 
 O
3 
 O
- 
 O
kb O O
DNA 	 O
, 
 O
when n O
placed c O
upstream t O
of O O
the 	 O
chloramphenicol o B-GENE
acetyltransferase t I-GENE
gene e E-GENE
, 
 O
was 	 O
shown w O
to O O
be O O
functionally c O
active i O
. 
 O
Controversy t O
exists s O
regarding a O
both h O
the 	 O
natural u O
life e O
cycle l O
for 	 O
this s O
parasite a O
as O O
well l O
as O O
the 	 O
species c O
identity n O
of O O
opossum s O
Sarcocystis c O
. 
 O
The 	 O
mean n O
was 	 O
66 O O
cells l O
/ 
 O
mm2 	 O
in O O
the 	 O
laser e O
group u O
and 	 O
63 O O
. 
 O
7 
 O
cells l O
/ 
 O
mm2 	 O
in O O
the 	 O
control t O
group u O
. 
 O
Prazosin z O
in O O
the 	 O
treatment a O
of O O
high h O
blood o O
pressure s O
The 	 O
5 - B-GENE
- - I-GENE
HT3 	 E-GENE
antagonist a O
ondansetron a O
reduced u O
alcohol o O
intake a O
in O O
both h O
the 	 O
medium i O
and 	 O
high h O
alcohol o O
preferring f O
rats s O
at O O
doses e O
between w O
0 
 O
. 
 O
01 O O
and 	 O
0 
 O
. 
 O
16 O O
mg O O
/ 
 O
kg O O
. 
 O
Oral l O
hypoglycemic o O
agents n O
1 
 O
. 
 O
In O O
this s O
system t O
, 
 O
enhancers a O
act 	 O
primarily m O
to O O
increase r O
the 	 O
probability b O
of O O
rapid i O
and 	 O
efficient i O
transcription n O
complex p O
formation m O
and 	 O
initiation t O
. 
 O
The 	 O
relationship a O
between w O
donor o O
status t O
for 	 O
antibody i O
to O O
hepatitis a B-GENE
B - I-GENE
core e I-GENE
antigen i E-GENE
and 	 O
the 	 O
occurrence u O
of O O
non 	 O
- 
 O
A 
 O
, 
 O
non 	 O
- 
 O
B 
 O
posttransfusion t O
hepatitis a O
in O O
the 	 O
recipient i O
was 	 O
prospectively s O
studied d O
in O O
112 	 O
patients i O
undergoing e O
open n O
- 
 O
heart r O
surgery g O
who 	 O
were e O
followed l O
for 	 O
6 
 O
. 
 O
5 
 O
months t O
after e O
surgery g O
. 
 O
By O O
sequencing u O
of O O
exonuclease n B-GENE
III 	 E-GENE
deletion e O
clones n O
an O O
open n O
reading d O
frame m O
of O O
405 	 O
nucleotides l O
was 	 O
found n O
coding i O
for 	 O
a 
 O
protein t O
of O O
135 	 O
amino n O
acids d O
with h O
a 
 O
molecular e O
mass s O
of O O
15 O O
kDa 	 O
. 
 O
The 	 O
pepI I B-GENE
gene e E-GENE
was 	 O
overexpressed r O
in O O
Escherichia h O
coli i O
. 
 O
Treatment a O
of O O
steroid r O
resistant i O
rejection e O
following l O
renal a O
transplantation n O
: 
 O
benefits e O
and 	 O
risks k O
of O O
OKT3 3 O
therapy r O
. 
 O
The 	 O
level e O
of O O
transcription n O
generated e O
by O O
all 	 O
of O O
these s O
activators i O
is O O
greater a O
than n O
the 	 O
sum 	 O
of O O
the 	 O
levels e O
generated e O
by O O
individual i O
factors t O
, 
 O
a 
 O
phenomenon n O
designated i O
transcriptional n O
synergy e O
. 
 O
Conservation s O
of O O
this s O
zinc c O
finger g O
motif i O
from m O
yeast s O
to O O
mouse s O
and 	 O
human a O
implies l O
functional c O
importance o O
. 
 O
This s O
nuclear l O
/ 
 O
organellar a O
gene e O
transfer n O
event n O
is O O
strikingly i O
similar i O
to O O
the 	 O
experimentally e O
accessible e O
process c O
of O O
nuclear l O
integration e O
of O O
introduced r O
heterologous e O
DNA 	 O
. 
 O
RESULTS U O
: 
 O
In O O
the 	 O
test t O
data a O
set 	 O
, 
 O
the 	 O
single g O
- 
 O
sample p O
model e O
was 	 O
confirmed f O
to O O
give e O
excellent e O
estimation i O
of O O
the 	 O
AUC 	 O
: 
 O
AUC 	 O
( 
 O
mg O O
/ 
 O
ml O O
x 
 O
min 	 O
) 
 O
= 
 O
0 
 O
. 
 O
93 O O
x 
 O
C3h 	 O
+ 
 O
0 
 O
. 
 O
47 O O
( 
 O
MPE 	 O
% 
 O
= 
 O
4 
 O
. 
 O
4 
 O
% 
 O
, 
 O
RMSE E O
% 
 O
= 
 O
8 
 O
. 
 O
9 
 O
% 
 O
) 
 O
. 
 O
SH3A A S-GENE
competes p O
with h O
the 	 O
SH3 	 B-GENE
domains a E-GENE
of O O
Grb2 2 S-GENE
in O O
binding d O
to O O
mSos1 s S-GENE
, 
 O
and 	 O
the 	 O
intersectin e S-GENE
- 
 O
mSos1 s S-GENE
complex p O
can 	 O
be O O
separated a O
from m O
Grb2 2 S-GENE
by O O
sucrose r O
gradient d O
centrifugation t O
. 
 O
Comparison p O
between w O
the 	 O
Ricketts k O
and 	 O
Bimler l O
therapeutic r O
technics h O
in O O
the 	 O
treatment a O
of O O
cases e O
of O O
class s O
II O O
, 
 O
division i O
I 
 O
mmalocclusion l O
This s O
resulted u O
in O O
a 
 O
shift f O
of O O
C1 O O
/ 
 O
C2 O O
, 
 O
so O O
that t O
the 	 O
effect e O
of O O
collagen l S-GENE
was 	 O
more e O
pronounced n O
( 
 O
maximal i O
increase r O
of O O
C1 O O
/ 
 O
C2 O O
= 
 O
134 	 O
% 
 O
) 
 O
than n O
ADP 	 O
( 
 O
maximal i O
increase r O
of O O
C1 O O
/ 
 O
C2 O O
= 
 O
79 O O
% 
 O
) 
 O
. 
 O
We O O
conclude c O
that t O
exercise r O
- 
 O
induced u O
ST O O
- 
 O
segment m O
elevation v O
in O O
patients i O
without h O
a 
 O
history t O
of O O
myocardial c O
infarction a O
or O O
left t O
ventricular t O
aneurysm u O
is O O
caused s O
by O O
coronary o O
spasm s O
of O O
a 
 O
major o O
coronary o O
vessel s O
. 
 O
Xnr3 3 S-GENE
is O O
transcriptionally n O
activated i O
by O O
wnt 	 S-GENE
signaling n O
during i O
gastrulation t O
in O O
the 	 O
Xenopus o O
embryo r O
. 
 O
For 	 O
economical n O
reasons s O
, 
 O
we O O
could l O
not 	 O
send d O
a 
 O
questionnaire s O
to O O
all 	 O
the 	 O
35 O O
, 
 O
779 	 O
individuals i O
, 
 O
but 	 O
based e O
the 	 O
investigation e O
on O O
a 
 O
SRS 	 O
of O O
4 
 O
, 
 O
000 	 O
men 	 O
, 
 O
post t O
- 
 O
stratified a O
in O O
a 
 O
high h O
- 
 O
risk k O
and 	 O
a 
 O
low 	 O
- 
 O
risk k O
group u O
. 
 O
Several e O
waveforms e O
of O O
both h O
the 	 O
somatosensory a O
( 
 O
N20 	 O
, 
 O
P 
 O
/ 
 O
N 
 O
30 O O
, 
 O
and 	 O
P200 0 O
) 
 O
and 	 O
the 	 O
brainstem i O
auditory i O
- 
 O
evoked k O
response p O
( 
 O
I 
 O
, 
 O
III 	 O
, 
 O
IV O O
, 
 O
and 	 O
V 
 O
) 
 O
demonstrated o O
shorter r O
( 
 O
p 
 O
less s O
than n O
0 
 O
. 
 O
05 O O
) 
 O
latencies e O
in O O
growth w O
- 
 O
retarded a O
fetuses u O
relative a O
to O O
normal m O
- 
 O
sized e O
fetuses u O
. 
 O
Effect e O
of O O
choline l O
magnesium n O
trisalicylate s O
on O O
prostacyclin s O
production d O
by O O
isolated l O
vascular c O
tissue s O
of O O
the 	 O
rat 	 O
. 
 O
The 	 O
sequences u O
of O O
two 	 O
previously v O
known w O
tail l O
genes e O
, 
 O
R - O
and 	 O
S - O
, 
 O
of O O
the 	 O
temperate p O
bacteriophage t O
P2 O O
and 	 O
the 	 O
sequence u O
of O O
an O O
additional i O
open n O
reading d O
frame m O
( 
 O
orf 	 O
- 
 O
30 O O
) 
 O
located a O
between w O
S - O
and 	 O
V - O
, 
 O
were e O
determined e O
. 
 O
The 	 O
high h O
prevalence v O
of O O
atrial i O
septal t O
defect e O
in O O
tetralogy r O
of O O
Fallot l O
is O O
cited e O
as O O
a 
 O
possible s O
analogy l O
because a O
right h O
ventricular t O
pressure s O
is O O
high h O
and 	 O
right h O
ventricular t O
compliance p O
is O O
low 	 O
from m O
birth t O
. 
 O
The 	 O
stress e O
/ 
 O
BHV 	 O
- 
 O
1 
 O
model e O
resulted u O
in O O
a 
 O
mild d O
respiratory p O
infection e O
in O O
all 	 O
calves v O
with h O
no O O
difference f O
observed e O
between w O
treatment a O
groups u O
. 
 O
Solution u O
of O O
the 	 O
Boltzmann t O
equation a O
in O O
a 
 O
random d O
magnetic n O
field l O
. 
 O
GH S S-GENE
signals n O
by O O
interacting e O
with h O
GH B B-GENE
receptor e E-GENE
( 
 O
GHR 	 S-GENE
) 
 O
. 
 O
Ultraviolet r O
crosslinking s O
experiments e O
using n O
element m O
B 
 O
revealed e O
the 	 O
specific c O
binding d O
of O O
two 	 O
proteins t O
of O O
approximately r O
43 O O
and 	 O
80 O O
kDa 	 O
. 
 O
RESULTS U O
: 
 O
At O O
short r O
dwell l O
times e O
, 
 O
uncorrected o O
( 
 O
whole l O
plasma s O
) 
 O
D 
 O
/ 
 O
P 
 O
and 	 O
Cp O O
of O O
urea a O
values u O
were e O
higher h O
than n O
the 	 O
corrected r O
( 
 O
plasma s O
water e O
) 
 O
values u O
by O O
5 
 O
. 
 O
7 
 O
% 
 O
- 
 O
5 
 O
. 
 O
9 
 O
% 
 O
. 
 O
The 	 O
recovery o O
of O O
xanthomegnin t O
added e O
to O O
corn n O
samples p O
at O O
levels e O
of O O
0 
 O
. 
 O
75 O O
- 
 O
- 
 O
9 
 O
. 
 O
6 
 O
mg O O
/ 
 O
kg O O
averaged r O
41 O O
% 
 O
with h O
a 
 O
coefficient f O
of O O
variation i O
of O O
25 O O
% 
 O
. 
 O
The 	 O
extraordinary r O
high h O
substrate s O
specificity c O
of O O
rPulA l S-GENE
together e O
with h O
its 	 O
thermal r O
stability b O
makes e O
this s O
enzyme y O
a 
 O
good d O
candidate d O
for 	 O
biotechnological t O
applications l O
in O O
the 	 O
starch r O
- 
 O
processing c O
industry u O
. 
 O
A 
 O
relationship a O
between w O
the 	 O
immunological u O
changes n O
and 	 O
the 	 O
disease e O
stage g O
was 	 O
discovered c O
: 
 O
the 	 O
index e O
of O O
the 	 O
3H O O
- 
 O
thymidine m O
incorporation o O
was 	 O
found n O
to O O
be O O
67 O O
. 
 O
9 
 O
at O O
the 	 O
stage g O
of O O
disease e O
exacerbation c O
, 
 O
and 	 O
208 	 O
. 
 O
8 
 O
at O O
the 	 O
stage g O
of O O
remission i O
; 
 O
the 	 O
complement p O
titre r O
reached c O
, 
 O
respectively p O
, 
 O
46 O O
. 
 O
64 O O
+ 
 O
/ 
 O
- 
 O
5 
 O
. 
 O
28 O O
and 	 O
112 	 O
. 
 O
0 
 O
+ 
 O
/ 
 O
- 
 O
6 
 O
. 
 O
0 
 O
units t O
per 	 O
ml O O
. 
 O
Sodium i O
dodecylsulfate e O
polyacrylamide y O
gel 	 O
electrophoresis c O
( 
 O
SDS 	 O
- 
 O
PAGE E O
) 
 O
showed w O
two 	 O
bands d O
of O O
about u O
the 	 O
same e O
intensity e O
with h O
apparent a O
molecular e O
masses s O
of O O
24 O O
. 
 O
5 
 O
and 	 O
22 O O
. 
 O
5 
 O
kDa 	 O
. 
 O
Consistent s O
with h O
an O O
effect e O
on O O
transcription n O
, 
 O
p21 	 S-GENE
was 	 O
localized a O
in O O
nuclei l O
of O O
transfected n O
cells l O
. 
 O
Analysis l O
of O O
pseudo u B-GENE
VH I I-GENE
gene e I-GENE
segment m I-GENE
recombination o I-GENE
products d E-GENE
reveals e O
no O O
bias s O
in O O
D - B-GENE
gene e E-GENE
segment m O
reading d O
frame m O
utilization l O
. 
 O
Plasma s O
prolactin l S-GENE
concentrations c O
during i O
incubation u O
, 
 O
25 O O
. 
 O
8 
 O
+ 
 O
/ 
 O
- 
 O
2 
 O
. 
 O
3 
 O
ng O O
/ 
 O
ml O O
, 
 O
decreased r O
to O O
baseline e O
levels e O
, 
 O
10 O O
. 
 O
8 
 O
+ 
 O
/ 
 O
- 
 O
1 
 O
. 
 O
9 
 O
ng O O
/ 
 O
ml O O
, 
 O
within h O
24 O O
hr O O
after e O
nestbox t O
removal o O
. 
 O
After e O
30 O O
weeks k O
of O O
amifostine f O
therapy r O
, 
 O
the 	 O
morphology p O
of O O
the 	 O
MDS 	 O
switched t O
to O O
a 
 O
chronic o O
myelomonocytic l O
leukemia k O
( 
 O
CMML L O
) 
 O
- 
 O
like e O
appearance e O
, 
 O
with h O
continuously t O
increasing r O
leukocytes k O
, 
 O
so O O
that t O
we O O
discontinued c O
amifostine f O
therapy r O
for 	 O
1 
 O
month t O
to O O
exclude l O
a 
 O
possible s O
side e O
effect e O
of O O
amifostine f O
. 
 O
Heart r O
disease e O
. 
 O
A 
 O
new 	 O
B 
 O
- 
 O
cell l O
- 
 O
specific c O
enhancer a O
element m O
has 	 O
been n O
identified n O
3 
 O
' 
 O
of O O
E4 S O
and 	 O
the 	 O
octamerlike a O
motifs i O
in O O
the 	 O
human a B-GENE
immunoglobulin u I-GENE
heavy v I-GENE
- - I-GENE
chain i I-GENE
gene e I-GENE
enhancer a E-GENE
. 
 O
CONCLUSIONS C O
: 
 O
This s O
initial t O
experience e O
indicates i O
that t O
there r O
is O O
short r O
- 
 O
to O O
middle d O
- 
 O
term m O
efficiency i O
and 	 O
safety e O
when n O
using n O
GKS 	 O
to O O
treat a O
MTLE E O
. 
 O
Two 	 O
cases e O
of O O
Paraquat a O
poisoning s O
of O O
anticonservative i O
origin g O
are 	 O
described c O
. 
 O
Genetic e O
mutation a O
or O O
loss s O
of O O
activin i S-GENE
/ 
 O
transforming n B-GENE
growth w I-GENE
factor t I-GENE
- - I-GENE
beta a E-GENE
( - O
TGFbeta b S-GENE
) - O
receptor e O
function c O
has 	 O
been n O
shown w O
in O O
human a O
lymphoid p O
, 
 O
breast a O
, 
 O
and 	 O
colorectal o O
tumors o O
as O O
well l O
as O O
Hep2B 2 S-GENE
and 	 O
Mv1Lu L S-GENE
cell l O
lines e O
. 
 O
A 
 O
poly y O
( 
 O
ortho h O
ester e O
) 
 O
designed i O
for 	 O
combined b O
ocular l O
delivery i O
of O O
dexamethasone a O
sodium i O
phosphate s O
and 	 O
5 
 O
- 
 O
fluorouracil o O
: 
 O
subconjunctival c O
tolerance e O
and 	 O
in O O
vitro r O
release e O
. 
 O
We O O
now 	 O
describe c O
a 
 O
HepG2 G B-GENE
cell l I-GENE
casein e I-GENE
kinase a I-GENE
II I I-GENE
beta a I-GENE
subunit u I-GENE
cDNA A E-GENE
of O O
2 
 O
. 
 O
57 O O
kb O O
containing t O
96 O O
bases e O
of O O
5 
 O
' 
 O
untranslated r O
sequence u O
, 
 O
645 	 O
bases e O
of O O
open n O
reading d O
frame m O
, 
 O
and 	 O
1832 2 O
bases e O
of O O
3 
 O
' 
 O
untranslated r O
sequence u O
with h O
two 	 O
polyadenylation y O
consensus s O
signal n O
sequences u O
and 	 O
two 	 O
poly y O
( 
 O
A 
 O
) 
 O
stretches e O
. 
 O
Brome m B-GENE
mosaic a I-GENE
virus u I-GENE
polymerase y I-GENE
- 
 I-GENE
like e I-GENE
protein t I-GENE
2a E E-GENE
is O O
directed e O
to O O
the 	 O
endoplasmic o O
reticulum i O
by O O
helicase i B-GENE
- 
 I-GENE
like e I-GENE
viral a I-GENE
protein t I-GENE
1a E E-GENE
. 
 O
Diagnostic g O
importance o O
of O O
determining e O
leucine c B-GENE
aminotransferase n E-GENE
activity i O
in O O
acute t O
pancreatitis c O
Therapeutic r O
iodine i O
125 	 O
for 	 O
hyperthyroidism e O
: 
 O
evidence d O
for 	 O
a 
 O
special c O
radiobiological i O
effect e O
on O O
the 	 O
follicular l O
cell l O
. 
 O
Maintenance n O
metabolizable a O
- 
 O
energy r O
( 
 O
ME O O
) 
 O
requirement u O
averaged r O
31 O O
. 
 O
0 
 O
kcal l O
/ 
 O
kg O O
body y O
wt O O
. 
 O
This s O
finding d O
is O O
of O O
importance o O
because a O
it O O
completes p O
an O O
explanation l O
for 	 O
central t O
near r O
- 
 O
location a O
errors o O
in O O
the 	 O
partial t O
- 
 O
report o O
bar 	 O
- 
 O
probe b O
task k O
. 
 O
A 
 O
DNA 	 O
binding d O
protein t O
was 	 O
identified n O
which c O
binds d O
to O O
two 	 O
novel e O
target g O
- 
 O
like e O
sequences u O
: 
 O
( 
 O
i 
 O
) 
 O
at O O
the 	 O
5 
 O
' 
 O
flanking n O
site e O
of O O
the 	 O
breakpoint a O
junction c O
of O O
chromosome o O
8 
 O
in O O
a 
 O
patient i O
with h O
T 
 O
- 
 O
acute t O
lymphoblastic p O
leukemia k O
( 
 O
ALL 	 O
) 
 O
carrying r O
the 	 O
t 
 O
( 
 O
8 
 O
; 
 O
14 O O
) 
 O
( 
 O
q24 	 O
; 
 O
q11 	 O
) 
 O
rearrangement r O
and 	 O
( 
 O
ii O O
) 
 O
on O O
chromosome o O
1 
 O
in O O
three e O
of O O
five e O
T 
 O
- 
 O
ALL 	 O
patients i O
with h O
the 	 O
t 
 O
( 
 O
1 
 O
; 
 O
14 O O
) 
 O
( 
 O
p32 	 O
; 
 O
q11 	 O
) 
 O
rearrangement r O
. 
 O
Nedocromil o O
sodium i O
shifted f O
the 	 O
severity e O
of O O
the 	 O
early l O
allergic e O
reaction c O
( 
 O
EAR 	 O
) 
 O
from m O
mean n O
- 
 O
34 O O
. 
 O
8 
 O
% 
 O
to O O
- 
 O
6 
 O
. 
 O
9 
 O
% 
 O
and 	 O
inhibited i O
the 	 O
later e O
allergic e O
reaction c O
( 
 O
LAR 	 O
) 
 O
from m O
- 
 O
30 O O
. 
 O
5 
 O
% 
 O
to O O
+ 
 O
0 
 O
. 
 O
4 
 O
% 
 O
( 
 O
p 
 O
less s O
than n O
0 
 O
. 
 O
005 	 O
) 
 O
. 
 O
The 	 O
Mer1 1 B-GENE
protein t E-GENE
contains t O
the 	 O
KH O B-GENE
motif i E-GENE
found n O
in O O
some e O
RNA 	 O
- 
 O
binding d O
proteins t O
, 
 O
and 	 O
RNA 	 O
gel 	 O
mobility i O
shift f O
assays a O
demonstrate o O
that t O
Mer1 1 S-GENE
binds d O
specifically c O
to O O
MER2 2 B-GENE
RNA 	 E-GENE
. 
 O
Results u O
obtained a O
from m O
the 	 O
tritium t O
test t O
and 	 O
direct e O
chemical m O
analysis l O
were e O
compared p O
. 
 O
We O O
found n O
that t O
in O O
anesthetized s O
, 
 O
paralyzed a O
cats s O
, 
 O
the 	 O
visual u O
evoked k O
potential e O
( 
 O
VEP 	 O
) 
 O
was 	 O
dependent e O
only y O
on O O
magnitude n O
of O O
delta t O
C 
 O
at O O
each h O
pattern t O
transition n O
, 
 O
and 	 O
was 	 O
independent e O
of O O
the 	 O
starting r O
or O O
ending i O
contrast t O
level e O
. 
 O
Experiment e O
B 
 O
: 
 O
Clinical n O
, 
 O
biochemical c O
, 
 O
and 	 O
histological t O
variables i O
were e O
measured s O
over r O
a 
 O
12 O O
- 
 O
day 	 O
period i O
after e O
the 	 O
zymosan o O
had 	 O
been n O
given e O
. 
 O
Direct e O
saturation u O
analysis l O
From m O
this s O
asymmetry m O
, 
 O
we O O
suggested g O
previously v O
that t O
GCN4 4 S-GENE
interacts e O
with h O
nonequivalent e O
and 	 O
possibly s O
overlapping r O
half f O
- 
 O
sites e O
( 
 O
ATGAC A O
and 	 O
ATGAG A O
) 
 O
that t O
have e O
different f O
affinities i O
. 
 O
Furthermore t O
the 	 O
aldosterone o O
stimulating m O
effect e O
of O O
low 	 O
sodium i O
diet t O
( 
 O
17 O O
children l O
) 
 O
, 
 O
severe e O
and 	 O
prolonged l O
vomiting i O
( 
 O
19 O O
children l O
) 
 O
and 	 O
synthetic t O
ACTH H S-GENE
( 
 O
10 O O
children l O
) 
 O
has 	 O
been n O
studied d O
by O O
our 	 O
modified i O
method h O
. 
 O
A 
 O
case e O
control t O
study d O
( 
 O
1 
 O
: 
 O
2 
 O
) 
 O
of O O
182 	 O
pairs r O
of O O
Hepatitis a O
A 
 O
was 	 O
carried r O
out 	 O
in O O
Weng g O
- 
 O
ling g O
Zhe 	 O
- 
 O
jiang n O
during i O
April i O
1988 8 O
. 
 O
The 	 O
mutant a O
strain a O
carries r O
three e O
tandem d O
copies i O
of O O
the 	 O
18 O O
bp O O
sequence u O
that t O
is O O
duplicated l O
in O O
the 	 O
amdI66 I B-GENE
mutation a E-GENE
. 
 O
Although h O
cDNA A O
encoding o O
a 
 O
human a B-GENE
phagocyte g I-GENE
formyl m I-GENE
peptide t I-GENE
- - I-GENE
binding d I-GENE
protein t E-GENE
has 	 O
been n O
reported o O
recently e O
( 
 O
Boulay l O
, 
 O
F 
 O
. 
 O
, 
 O
Tardif d O
, 
 O
M 
 O
. 
 O
, 
 O
Brouchon u O
, 
 O
L 
 O
. 
 O
, 
 O
and 	 O
Vignais n O
, 
 O
P 
 O
. 
 O
In O O
NIH 	 O
3T3 	 O
fibroblasts r O
the 	 O
high h O
affinity i O
IL B B-GENE
- - I-GENE
2R E E-GENE
bearing r O
a 
 O
deletion e O
of O O
a 
 O
region i O
rich h O
in O O
acidic d O
amino n O
acids d O
( 
 O
the 	 O
" 
 O
acidic d O
" 
 O
region i O
) 
 O
in O O
the 	 O
IL B B-GENE
- - I-GENE
2R I I-GENE
beta a I-GENE
- - I-GENE
chain i E-GENE
failed l O
to O O
induce u O
the 	 O
tyrosine o O
phosphorylation s O
of O O
MAP 	 B-GENE
kinase a E-GENE
as O O
well l O
as O O
the 	 O
expression r O
of O O
the 	 O
all 	 O
three e O
nuclear l O
proto t O
- 
 O
oncogenes o O
. 
 O
A 
 O
small l O
molecule e O
ILK 	 S-GENE
inhibitor i O
suppresses p O
the 	 O
phosphorylation s O
of O O
PKB 	 S-GENE
at O O
the 	 O
Ser 	 O
- 
 O
473 	 O
but 	 O
not 	 O
the 	 O
Thr 	 O
- 
 O
308 	 O
site e O
in O O
the 	 O
PTEN N O
mutant a O
cells l O
. 
 O
The 	 O
avian a B-GENE
carcinoma c I-GENE
virus u I-GENE
MH2 	 E-GENE
contains t O
a 
 O
hybrid r B-GENE
gene e I-GENE
delta t I-GENE
gag 	 I-GENE
- 
 I-GENE
mht 	 E-GENE
with h O
a 
 O
contiguous t O
open n O
reading d O
frame m O
of O O
2682 2 O
base e O
pairs r O
as O O
well l O
as O O
v - B-GENE
- - I-GENE
myc 	 E-GENE
and 	 O
avian a B-GENE
helper p I-GENE
virus u I-GENE
- 
 I-GENE
related a I-GENE
sequences u I-GENE
. 
 I-GENE
delta t I-GENE
gag 	 E-GENE
is O O
a 
 O
partial t O
retroviral r B-GENE
core e I-GENE
protein t I-GENE
gene e E-GENE
while l O
v - B-GENE
- - I-GENE
mht 	 E-GENE
and 	 O
v - B-GENE
- - I-GENE
myc 	 E-GENE
are 	 O
cell l O
- 
 O
drived v O
sequences u O
. 
 O
The 	 O
results u O
in O O
the 	 O
untreated r O
patients i O
demonstrate o O
the 	 O
primary m O
importance o O
of O O
bulk k O
reduction u O
at O O
initial t O
laparotomy a O
. 
 O
Of O O
3841 1 O
serum u O
samples p O
from m O
sows s O
received e O
from m O
the 	 O
Tennessee n O
State t O
Diagnostic g O
Laboratory o O
in O O
1991 1 O
- 
 O
1992 2 O
, 
 O
1130 0 O
were e O
positive i O
for 	 O
Toxoplasma o O
gondii d O
antibody i O
. 
 O
These s O
findings d O
also o O
demonstrate o O
that t O
unless e O
excluded l O
by O O
other e O
factors t O
, 
 O
the 	 O
C - B-GENE
proteins t E-GENE
are 	 O
likely e O
to O O
be O O
located a O
along n O
the 	 O
length g O
of O O
nascent c O
transcripts n O
. 
 O
In O O
this s O
group u O
of O O
patients i O
, 
 O
the 	 O
mean n O
LH S S-GENE
( 
 O
9 
 O
. 
 O
3 
 O
+ 
 O
/ 
 O
- 
 O
5 
 O
. 
 O
9 
 O
IU O O
/ 
 O
l 
 O
) 
 O
and 	 O
sex 	 B-GENE
- - I-GENE
hormone m I-GENE
binding d I-GENE
globulin b E-GENE
( 
 O
SHBG G S-GENE
) 
 O
( 
 O
54 O O
. 
 O
5 
 O
+ 
 O
/ 
 O
- 
 O
22 O O
. 
 O
9 
 O
nmol l O
/ 
 O
l 
 O
) 
 O
concentrations c O
were e O
significantly n O
greater a O
than n O
those s O
of O O
five e O
normal m O
control t O
subjects j O
( 
 O
4 
 O
. 
 O
7 
 O
+ 
 O
/ 
 O
- 
 O
1 
 O
. 
 O
11 O O
IU O O
/ 
 O
l 
 O
and 	 O
26 O O
. 
 O
0 
 O
+ 
 O
/ 
 O
- 
 O
7 
 O
. 
 O
0 
 O
nmol l O
/ 
 O
l 
 O
respectively p O
) 
 O
. 
 O
We O O
have e O
now 	 O
completed p O
the 	 O
primary m O
structure u O
of O O
fibrillin r S-GENE
, 
 O
elucidated c O
the 	 O
exon n O
/ 
 O
intron r O
organization a O
of O O
the 	 O
gene e O
and 	 O
derived i O
a 
 O
physical s O
map 	 O
of O O
the 	 O
genetic e O
locus u O
. 
 O
The 	 O
BCL 	 B-GENE
- - I-GENE
6 - I-GENE
POZ 	 I-GENE
domain a E-GENE
and 	 O
other e O
POZ 	 B-GENE
domains a E-GENE
interact e O
with h O
the 	 O
co O O
- 
 O
repressors r O
N - B-GENE
- - I-GENE
CoR 	 E-GENE
and 	 O
SMRT T S-GENE
. 
 O
Cytokine o O
inducibility u O
of O O
VCAM1 M S-GENE
in O O
endothelial o O
cells l O
utilizes l O
the 	 O
interaction e O
of O O
heterodimeric e O
p50 	 S-GENE
/ 
 O
p65 	 S-GENE
proteins t O
with h O
IRF 	 B-GENE
- - I-GENE
1 - E-GENE
. 
 O
In O O
particular t O
, 
 O
MF O O
males e O
receiving e O
either h O
a 
 O
5 
 O
. 
 O
0 
 O
- 
 O
mg O O
/ 
 O
kg O O
CDP 	 O
dose e O
or O O
a 
 O
3 
 O
. 
 O
0 
 O
- 
 O
mg O O
/ 
 O
kg O O
RO O O
dose e O
explored l O
the 	 O
object e O
more e O
often e O
than n O
MM O O
males e O
. 
 O
( 
 O
ABSTRACT T O
TRUNCATED N O
AT O O
250 	 O
WORDS D O
) 
 O
To O O
gain n O
additional i O
insights i O
into o O
this s O
novel e O
apoptotic p O
checkpoint c O
, 
 O
we O O
have e O
now 	 O
characterized r O
the 	 O
mouse s B-GENE
survivin v I-GENE
locus u E-GENE
. 
 O
Both h O
proteins t O
share r O
sequence u O
similarity i O
with h O
the 	 O
myelin l B-GENE
- - I-GENE
associated o I-GENE
glycoprotein c E-GENE
, 
 O
an O O
adhesion e O
molecule e O
of O O
oligodendrocytes g O
and 	 O
Schwann w O
cells l O
that t O
has 	 O
been n O
implicated l O
in O O
the 	 O
process c O
of O O
myelination l O
, 
 O
raising s O
the 	 O
important o O
question s O
of O O
whether t O
myelin l B-GENE
- - I-GENE
associated o I-GENE
glycoprotein c E-GENE
is O O
also o O
a 
 O
sialic l O
acid d O
- - O
binding d O
protein t O
. 
 O
Localized a O
Bicaudal a B-GENE
- - I-GENE
C - I-GENE
RNA 	 E-GENE
encodes o O
a 
 O
protein t O
containing t O
a 
 O
KH O B-GENE
domain a E-GENE
, 
 O
the 	 O
RNA 	 O
binding d O
motif i O
of O O
FMR1 1 S-GENE
. 
 O
To O O
facilitate i O
the 	 O
characterization r O
of O O
NF B B-GENE
- - I-GENE
E2 E E-GENE
functions c O
in O O
human a O
cells l O
, 
 O
we O O
isolated l O
cDNAs A O
encoding o O
two 	 O
members b O
of O O
the 	 O
small l B-GENE
Maf 	 I-GENE
family i E-GENE
, 
 O
MafK K S-GENE
and 	 O
MafG G S-GENE
. 
 O
Indigenous i O
microbial r O
flora r O
and 	 O
the 	 O
large g O
intestine e O
in O O
tadpoles p O
. 
 O
Copyright y O
1998 8 O
The 	 O
Association o O
for 	 O
the 	 O
Study d O
of O O
Animal m O
Behaviour a O
. 
 O
In O O
contrast t O
to O O
the 	 O
restricted t O
tissue s O
expression r O
of O O
gonadotropin a S-GENE
and 	 O
TSH 	 B-GENE
receptors e E-GENE
in O O
gonads a O
and 	 O
thyroid r O
, 
 O
respectively p O
, 
 O
LGR4 4 S-GENE
is O O
expressed r O
in O O
diverse e O
tissues s O
including l O
ovary r O
, 
 O
testis t O
, 
 O
adrenal e O
, 
 O
placenta c O
, 
 O
thymus m O
, 
 O
spinal n O
cord d O
, 
 O
and 	 O
thyroid r O
, 
 O
whereas r O
LGR5 5 O
is O O
found n O
in O O
muscle c O
, 
 O
placenta c O
, 
 O
spinal n O
cord d O
, 
 O
and 	 O
brain i O
. 
 O
Not 	 O
only y O
will l O
it O O
substantially s O
reduce u O
incident i O
cases e O
of O O
hepatitis a O
B 
 O
for 	 O
the 	 O
next t O
decade a O
, 
 O
it O O
will l O
also o O
provide v O
a 
 O
framework m O
for 	 O
the 	 O
successful c O
introduction r O
of O O
future u O
adolescent l O
vaccine c O
initiatives t O
in O O
Australia t O
. 
 O
A 
 O
new 	 O
technique h O
for 	 O
the 	 O
identification n O
of O O
phases s O
contained t O
within h O
a 
 O
polymer y O
blend n O
is O O
described c O
in O O
this s O
paper e O
. 
 O
Radioactively i O
labeled e O
microspheres r O
were e O
used d O
to O O
determine e O
and 	 O
compare p O
the 	 O
hemodynamic o O
effects e O
of O O
sodium i O
nitroprusside r O
( 
 O
SNP 	 O
) 
 O
, 
 O
nitroglycerin r O
( 
 O
NTG 	 O
) 
 O
, 
 O
and 	 O
deep p O
enflurane l O
anesthesia s O
on O O
oral l O
tissues s O
during i O
controlled t O
hypotension o O
when n O
compared p O
with h O
controls t O
. 
 O
Their i O
central t O
projections j O
were e O
indistinguishable i O
from m O
those s O
of O O
control t O
axons n O
in O O
all 	 O
four r O
trigeminal g O
subnuclei n O
. 
 O
The 	 O
JNK 	 S-GENE
/ 
 O
SAPK K S-GENE
activator i O
mixed e O
lineage e B-GENE
kinase a I-GENE
3 - E-GENE
( 
 O
MLK3 3 S-GENE
) 
 O
transforms n O
NIH 	 O
3T3 	 O
cells l O
in O O
a 
 O
MEK 	 S-GENE
- 
 O
dependent e O
fashion h O
. 
 O
The 	 O
decision i O
support p O
system t O
uses s O
the 	 O
network w O
at O O
its 	 O
core e O
and 	 O
helps p O
not 	 O
only y O
in O O
reaching c O
a 
 O
diagnosis g O
but 	 O
also o O
in O O
finding d O
the 	 O
optimal i O
way 	 O
to O O
reach c O
that t O
diagnosis g O
. 
 O
In O O
contrast t O
to O O
the 	 O
effect e O
on O O
DNA 	 O
replication l O
, 
 O
the 	 O
L13V V O
substitution s O
in O O
large g B-GENE
T - I-GENE
antigen i E-GENE
did 	 O
not 	 O
prevent v O
complex p O
formation m O
with h O
Hsc70 7 S-GENE
and 	 O
the 	 O
Rb B B-GENE
protein t E-GENE
. 
 O
To O O
explore l O
the 	 O
effect e O
of O O
persistent s O
cardiomegaly d O
on O O
cardiovascular d O
function c O
, 
 O
groups u O
of O O
newborn b O
rats s O
inhaled a O
up O O
to O O
500 	 O
ppm 	 O
CO O O
for 	 O
33 O O
days s O
, 
 O
after e O
which c O
development e O
continued t O
in O O
ambient i O
air 	 O
. 
 O
Bandwidth d O
of O O
auditory i O
units t O
in O O
the 	 O
chick c O
forebrain e O
( 
 O
field l O
L 
 O
/ 
 O
Hv O O
complex p O
) 
 O
was 	 O
measured s O
with h O
isointensity i O
tone e O
stimuli m O
. 
 O
Members b O
of O O
the 	 O
steroid r B-GENE
/ - I-GENE
hormone m I-GENE
nuclear l I-GENE
receptor e I-GENE
superfamily e E-GENE
regulate u O
target g O
gene e O
transcription n O
via 	 O
recognition o O
and 	 O
association o O
with h O
specific c O
cis 	 O
- 
 O
acting i O
sequences u O
of O O
DNA 	 O
, 
 O
called l O
hormone m O
response p O
elements m O
( 
 O
HREs s O
) 
 O
. 
 O
Indeed e O
, 
 O
DEX 	 S-GENE
also o O
enhanced a O
the 	 O
RA O O
- 
 O
dependent e O
increase r O
in O O
RARbeta b B-GENE
mRNA A E-GENE
in O O
a 
 O
cycloheximide l O
- 
 O
sensitive s O
manner n O
. 
 O
The 	 O
highest h O
concentration c O
of O O
respirable p O
mineral e O
fibres r O
was 	 O
found n O
during i O
the 	 O
overhaul r O
of O O
a 
 O
truck c O
with h O
asbestos e O
insulation u O
; 
 O
respirable p O
fibre r O
concentration c O
reached c O
the 	 O
value u O
of O O
5 
 O
f 
 O
/ 
 O
cm3 	 O
, 
 O
and 	 O
total a O
dust t O
concentration c O
- 
 O
the 	 O
value u O
of O O
about u O
80 O O
mg O O
/ 
 O
m3 O O
. 
 O
Avian a O
EMILIN L O
was 	 O
extracted r O
from m O
19 O O
- 
 O
day 	 O
- 
 O
old 	 O
embryonic r O
chick c O
aortas t O
and 	 O
associated o O
blood o O
vessels s O
and 	 O
purified i O
by O O
ion 	 O
- 
 O
exchange h O
chromatography o O
and 	 O
gel 	 O
filtration t O
. 
 O
CYP51P1 5 S-GENE
is O O
96 O O
. 
 O
5 
 O
% 
 O
identical n O
to O O
the 	 O
human a B-GENE
CYP51 5 I-GENE
coding i I-GENE
sequence u E-GENE
and 	 O
is O O
not 	 O
interrupted e O
with h O
introns r O
but 	 O
has 	 O
six 	 O
in O O
- 
 O
frame m O
stop p O
codons o O
resulting u O
from m O
point n O
mutations a O
. 
 O
We O O
report o O
here e O
that t O
AChE E S-GENE
activity i O
tends d O
to O O
decrease r O
in O O
individuals i O
sampled p O
in O O
tanks k O
at O O
a 
 O
salinity i O
of O O
30 O O
per 	 O
thousand u O
as O O
temperature p O
increases r O
. 
 O
Three e O
RasV12 V B-GENE
mutants a E-GENE
( 
 O
S35 	 O
, 
 O
G37 	 O
, 
 O
and 	 O
C40 	 O
) 
 O
which c O
differ f O
by O O
their i O
ability l O
to O O
bind d O
to O O
Ras 	 B-GENE
effectors e E-GENE
( 
 O
Raf 	 S-GENE
, 
 O
Ral 	 S-GENE
- - O
GEFs s S-GENE
, 
 O
and 	 O
the 	 O
p110 0 B-GENE
subunit u E-GENE
of I O
PI I B-GENE
3 - I-GENE
- - I-GENE
kinase a E-GENE
, 
 O
respectively p O
) 
 O
were e O
able e O
to O O
induce u O
sustained t O
NR O O
cell l O
proliferation l O
, 
 O
although h O
none e O
of O O
these s O
mutants a O
was 	 O
reported o O
to O O
transform n O
NIH 	 O
3T3 	 O
cells l O
. 
 O
Mating i O
response p O
, 
 O
ovulation l O
rate e O
, 
 O
follicle l O
and 	 O
corpus p O
luteum e O
size e O
, 
 O
gestation t O
length g O
, 
 O
pregnancy g O
rate e O
, 
 O
lambing b O
rate e O
, 
 O
and 	 O
lamb b O
birth t O
weight g O
were e O
recorded o O
. 
 O
Membrane b O
extraction r O
has 	 O
been n O
interfaced e O
with h O
gas 	 O
chromatography o O
and 	 O
mass s O
spectroscopy c O
for 	 O
the 	 O
analysis l O
of O O
volatile a O
organics a O
in O O
water e O
. 
 O
A 
 O
significant n O
difference f O
in O O
the 	 O
distribution t O
of O O
antibodies i O
to O O
thyroglobulin r S-GENE
and 	 O
thyroid r B-GENE
peroxidase o E-GENE
was 	 O
found n O
in O O
subgroup g O
2 
 O
. 
 O
Here e O
, 
 O
we O O
characterize r O
TCR 	 S-GENE
/ 
 O
CD48 8 S-GENE
and 	 O
TCR 	 S-GENE
/ 
 O
CD28 8 S-GENE
costimulation t O
in O O
T 
 O
cells l O
expressing r O
Lck 	 S-GENE
Src 	 B-GENE
homology o I-GENE
3 - E-GENE
( 
 O
SH3 	 S-GENE
) 
 O
mutants a O
. 
 O
High h O
expression r O
of O O
p51A A S-GENE
( 
 O
TAp63gamma 6 S-GENE
) 
 O
in O O
the 	 O
skeletal l O
muscle c O
tissue s O
drove v O
us O O
to O O
investigate e O
a 
 O
differentiation f O
- 
 O
inducible u O
myoblastic b O
cell l O
line e O
which c O
showed w O
increased r O
p51A A S-GENE
expression r O
after e O
differentiation f O
induction u O
. 
 O
The 	 O
rate e O
for 	 O
Arm 	 O
III 	 O
( 
 O
CAF 	 O
therapy r O
) 
 O
was 	 O
61 O O
. 
 O
5 
 O
% 
 O
( 
 O
32 O O
/ 
 O
52 O O
) 
 O
, 
 O
a 
 O
little t O
higher h O
than n O
that t O
for 	 O
the 	 O
other e O
two 	 O
. 
 O
These s O
results u O
induce u O
that t O
the 	 O
putative a O
TATA A O
box 	 O
and 	 O
initiator t O
are 	 O
not 	 O
involved o O
in O O
the 	 O
promoter m O
activity i O
, 
 O
and 	 O
that t O
the 	 O
vitronectin r B-GENE
promoter m E-GENE
lacks k O
the 	 O
TATA A O
box 	 O
, 
 O
initiator t O
and 	 O
GC O O
box 	 O
. 
 O
Using n O
the 	 O
interaction e O
- 
 O
trap p O
assay a O
to O O
identify n O
candidate d O
proteins t O
that t O
bind d O
the 	 O
cytoplasmic o O
region i O
of O O
the 	 O
LAR 	 B-GENE
transmembrane n I-GENE
protein t I-GENE
tyrosine o I-GENE
phosphatase s E-GENE
( 
 O
PT B B-GENE
- - I-GENE
Pase e E-GENE
) 
 O
, 
 O
we O O
isolated l O
a 
 O
cDNA A O
encoding o O
a 
 O
2861 1 O
- 
 O
amino n O
acid d O
protein t O
termed m O
Trio o O
that t O
contains t O
three e O
enzyme y O
domains a O
: 
 O
two 	 O
functional c O
GEF 	 B-GENE
domains a E-GENE
and 	 O
a 
 O
protein t B-GENE
serine i I-GENE
/ - I-GENE
threonine e I-GENE
kinase a E-GENE
( 
 O
PSK 	 S-GENE
) 
 O
domain a O
. 
 O
We O O
have e O
isolated l O
two 	 O
H19 	 B-GENE
cDNAs A E-GENE
( 
 O
AP S S-GENE
and 	 O
ES S O
) 
 O
that t O
contain t O
this s O
ORF4 4 S-GENE
and 	 O
correspond r O
to O O
incomplete o O
copies i O
of O O
the 	 O
unique q O
2 - O
. - O
3 - O
kb I O
H19 	 B-GENE
RNA 	 E-GENE
. 
 O
The 	 O
combined b O
in O O
vitro r O
effects e O
of O O
ethanol a O
wih 	 O
methaqualone h O
, 
 O
phenobarbital n O
, 
 O
pyrazole a O
or O O
disulfiram u O
were e O
studied d O
using n O
rat 	 O
brain i O
microsomal r O
NA I B-GENE
- - I-GENE
K - I-GENE
- - I-GENE
ATPase a E-GENE
. 
 O
The 	 O
related a O
adhesion e B-GENE
focal a I-GENE
tyrosine o I-GENE
kinase a E-GENE
is O O
tyrosine o O
- 
 O
phosphorylated s O
after e O
beta1 a B-GENE
- - I-GENE
integrin e E-GENE
stimulation m O
in O O
B 
 O
cells l O
and 	 O
binds d O
to O O
p130cas 0 S-GENE
. 
 O
Earlier l O
reports o O
have e O
localized a O
mutations a O
which c O
affect e O
the 	 O
processing c O
and 	 O
transport n O
of O O
herpes p O
simplex p O
virus u O
1 
 O
glycoproteins c O
to O O
a 
 O
region i O
located a O
between w O
the 	 O
genes e O
specifying c O
glycoprotein c B-GENE
B - E-GENE
and 	 O
the 	 O
major o B-GENE
viral a I-GENE
DNA 	 I-GENE
- 
 I-GENE
binding d I-GENE
protein t E-GENE
( 
 O
beta a B-GENE
8 - E-GENE
) 
 O
. 
 O
These s O
results u O
indicate i O
that t O
the 	 O
2127 7 O
- 
 O
bp O O
cDNA A O
encodes o O
a 
 O
functional c O
feline i O
L - O
/ - O
B - O
/ - O
K - B-GENE
- - I-GENE
type e I-GENE
ALP 	 E-GENE
expressed r O
on O O
cell l O
surfaces f O
via 	 O
phosphatidylinositol s O
- 
 O
glycan c O
linkage k O
. 
 O
Our 	 O
experience e O
suggests g O
that t O
T2 O O
weighting g O
is O O
adequate q O
and 	 O
is O O
the 	 O
method h O
of O O
choice i O
for 	 O
the 	 O
early l O
recognition o O
of O O
necrosis r O
of O O
the 	 O
lunate a O
. 
 O
Analysis l O
of O O
a 
 O
Het 	 O
- 
 O
mutation a O
in O O
Anabaena b O
sp O O
. 
 O
strain a O
PCC 	 O
7120 0 O
implicates l O
a 
 O
secondary o O
metabolite a O
in O O
the 	 O
regulation u O
of O O
heterocyst e O
spacing c O
. 
 O
Here e O
we O O
report o O
that t O
components p O
of O O
the 	 O
Ras 	 S-GENE
/ 
 O
Raf 	 S-GENE
/ 
 O
MAPK K S-GENE
pathway h O
are 	 O
constitutively s O
activated i O
in O O
these s O
lck 	 S-GENE
- 
 O
transformed n O
immature a O
thymoblasts m O
. 
 O
p56 	 S-GENE
( 
 O
lck 	 S-GENE
) 
 O
utilizes l O
Shc 	 S-GENE
and 	 O
Grb2 2 S-GENE
adaptors p O
to O O
mediate i O
activation i O
of O O
p21 	 S-GENE
( 
 O
ras 	 S-GENE
) 
 O
in O O
the 	 O
thymoblast m O
lines e O
by O O
promoting m O
tyrosine o O
phosphorylation s O
of O O
the 	 O
Shc 	 B-GENE
protein t E-GENE
and 	 O
constitutive s O
interaction e O
between w O
Shc 	 S-GENE
and 	 O
Grb2 2 S-GENE
. 
 O
The 	 O
rec8 8 B-GENE
( - I-GENE
+ - I-GENE
) - E-GENE
, 
 O
rec10 1 B-GENE
( - I-GENE
+ - I-GENE
) - E-GENE
, 
 O
and 	 O
rec11 1 B-GENE
( - I-GENE
+ - I-GENE
) - I-GENE
genes e E-GENE
of I O
the 	 O
fission s O
yeast s O
Schizosaccharomyces i O
pombe b O
exhibit i O
similar i O
specificities c O
for 	 O
meiotic o O
recombination o O
and 	 O
rec8 8 B-GENE
( - I-GENE
+ - I-GENE
) - E-GENE
is O O
required u O
for 	 O
sister t O
chromatid o O
cohesion e O
and 	 O
homolog o O
pairing r O
. 
 O
Based e O
on O O
the 	 O
results u O
of O O
this s O
analysis l O
, 
 O
we O O
also o O
predict d O
that t O
the 	 O
budding d O
yeast s B-GENE
arsenate e I-GENE
resistance i I-GENE
protein t I-GENE
Acr2 2 E-GENE
and 	 O
the 	 O
ORF 	 B-GENE
Ygr203w 2 I-GENE
encode o I-GENE
protein t I-GENE
phosphatases s E-GENE
with h O
catalytic a O
properties p O
similar i O
to O O
that t O
of O O
the 	 O
Cdc25 2 B-GENE
family i E-GENE
. 
 O
At O O
onset e O
of O O
first s O
post t O
- 
 O
weaning n O
estrus r O
, 
 O
sows s O
received e O
either h O
an O O
intravulval r O
injection e O
of O O
3 
 O
. 
 O
75 O O
mg O O
of O O
prostaglandin s O
analogue l O
( 
 O
PGF 	 O
) 
 O
or O O
, 
 O
served v O
as O O
a 
 O
non 	 O
- 
 O
injected e O
control t O
( 
 O
CON 	 O
) 
 O
. 
 O
We O O
concluded c O
that t O
HFV 	 O
can 	 O
achieve i O
values u O
of O O
CO2 	 O
elimination m O
close s O
to O O
the 	 O
estimated i O
metabolic a O
CO2 	 O
production d O
in O O
normal m O
unintubated n O
subjects j O
over r O
short r O
periods i O
of O O
time e O
. 
 O
The 	 O
PHO5 5 B-GENE
gene e E-GENE
is O O
activated i O
by O O
the 	 O
Pho4p 4 B-GENE
transcription n I-GENE
factor t E-GENE
, 
 O
which c O
itself e O
is O O
negatively a O
regulated u O
through o O
phosphorylation s O
by O O
the 	 O
products d O
of O O
PHO80 8 O
and 	 O
PHO85 8 O
. 
 O
Although h O
the 	 O
only y O
authoritative h O
way 	 O
to O O
determine e O
the 	 O
effect e O
of O O
diet t O
on O O
urinary n O
pH O O
is O O
a 
 O
feeding d O
trial a O
, 
 O
there r O
is O O
no O O
universally v O
accepted e O
protocol t O
for 	 O
measuring s O
urinary n O
pH O O
. 
 O
Analysis l O
of O O
the 	 O
DNA 	 O
sequence u O
upstream t O
of O O
the 	 O
narQ Q B-GENE
gene e E-GENE
, 
 O
which c O
encodes o O
the 	 O
second o O
nitrate r O
- 
 O
responsive p O
sensor s O
- 
 O
transmitter n O
protein t O
in O O
Escherichia h O
coli i O
, 
 O
revealed e O
an O O
open n O
reading d O
frame m O
( 
 O
ORF 	 O
) 
 O
whose s O
product d O
shows w O
a 
 O
high h O
degree r O
of O O
similarity i O
to O O
a 
 O
number b O
of O O
iron n O
- - O
sulfur f O
proteins t O
as O O
well l O
as O O
to O O
the 	 O
beta a O
subunit u O
of O O
glutamate t B-GENE
synthase t E-GENE
( 
 O
gltD D S-GENE
) 
 O
of O O
E 
 B-GENE
. 
 I-GENE
coli i E-GENE
. 
 O
Endothelial o O
purine i O
content t O
. 
 O
We O O
suggest g O
that t O
the 	 O
responses p O
to O O
types e O
I - O
and 	 O
II I B-GENE
collagen l E-GENE
were e O
caused s O
by O O
a 
 O
cross s O
- 
 O
reaction c O
with h O
type e B-GENE
III 	 I-GENE
collagen l I-GENE
peptides t E-GENE
. 
 O
Possibilities s O
and 	 O
limints i O
of O O
immunofluorescence u O
in O O
the 	 O
laboratory o O
diagnosis g O
of O O
rabies i O
The 	 O
5 
 O
' 
 O
half f O
of O O
the 	 O
EWS 	 B-GENE
gene e E-GENE
has 	 O
recently e O
been n O
described c O
to O O
be O O
fused e O
to O O
the 	 O
3 
 O
' 
 O
regions i O
of O O
genes e O
encoding o O
the 	 O
DNA 	 O
- 
 O
binding d O
domain a O
of O O
several e O
transcriptional n O
regulators u O
, 
 O
including l O
ATF1 1 S-GENE
, 
 O
FLI 	 B-GENE
- - I-GENE
1 - E-GENE
, 
 O
and 	 O
ERG 	 S-GENE
, 
 O
in O O
several e O
human a O
tumors o O
. 
 O
PDGF F S-GENE
stimulated m O
CDK2 2 S-GENE
activity i O
in O O
mesangial a O
cells l O
and 	 O
decreased r O
the 	 O
level e O
of O O
p27 	 S-GENE
( 
 O
kip1 1 S-GENE
) 
 O
cyclin l B-GENE
kinase a I-GENE
inhibitor i I-GENE
protein t E-GENE
. 
 O
Recombinant o B-GENE
apoA A I-GENE
- - I-GENE
I - I-GENE
protein t E-GENE
recovered o O
from m O
the 	 O
soluble u O
fraction c O
of O O
the 	 O
bacterial t O
cell l O
pellet l O
was 	 O
purified i O
to O O
greater a O
than n O
95 O O
% 
 O
homogeneity o O
by O O
reversed e O
- 
 O
phase s O
high h O
- 
 O
performance f O
liquid u O
chromatography o O
. 
 O
The 	 O
influence l O
of O O
different f O
temperatures p O
between w O
13 O O
degrees r O
C 
 O
and 	 O
45 O O
degrees r O
C 
 O
on O O
coagulation g O
factors t O
in O O
vitro r O
was 	 O
studied d O
by O O
measuring s O
clotting t O
time e O
with h O
the 	 O
recalcification a O
time e O
, 
 O
partial t O
thromboplastin o S-GENE
time e O
( 
 O
PTT 	 O
) 
 O
, 
 O
and 	 O
thromboplastin o S-GENE
time e O
test t O
. 
 O
On O O
average r O
, 
 O
rCMRglc R O
values u O
were e O
23 O O
% 
 O
below o O
control t O
values u O
for 	 O
all 	 O
regions i O
studied d O
, 
 O
with h O
the 	 O
greatest a O
differences f O
in O O
posterior t O
brain i O
regions i O
( 
 O
visual u O
association o O
cortex t O
, 
 O
primary m O
visual u O
cortex t O
, 
 O
and 	 O
parietal i O
cortex t O
) 
 O
and 	 O
thalamus l O
. 
 O
Thus s O
, 
 O
transgene n O
expression r O
directed e O
by O O
both h O
the 	 O
human a O
and 	 O
mouse s B-GENE
Rb I I-GENE
promoters m E-GENE
is O O
restricted t O
to O O
a 
 O
subset s O
of O O
tissues s O
in O O
which c O
Rb S S-GENE
is O O
normally m O
expressed r O
during i O
embryogenesis r O
. 
 O
Thus s O
, 
 O
Tax1 1 S-GENE
activates i O
CArG G S-GENE
- 
 O
mediated i O
transcription n O
without h O
mitogenic o O
signals n O
through o O
interaction e O
with h O
a 
 O
CArG G B-GENE
- - I-GENE
binding d I-GENE
factor t E-GENE
, 
 O
p67SRF S S-GENE
. 
 O
In O O
experiment e O
1 
 O
, 
 O
subjects j O
were e O
required u O
to O O
discriminate c O
male e O
from m O
female a O
faces e O
and 	 O
no O O
hemispheric i O
asymmetries m O
were e O
found n O
. 
 O
Membrane b O
depolarization o O
is O O
a 
 O
critical t O
element m O
of O O
neuronal r O
signaling n O
. 
 O
The 	 O
transcription n O
start r O
site e O
was 	 O
localized a O
224 	 O
bp O O
upstream t O
the 	 O
ATG 	 O
codon o O
by O O
RNase s S-GENE
protection t O
and 	 O
primer m O
extension e O
mapping p O
. 
 O
All 	 O
the 	 O
cognate n O
gene e O
clones n O
were e O
constructed s O
, 
 O
using n O
either h O
PCR 	 O
products d O
amplified l O
from m O
genomic o O
DNA 	 O
, 
 O
or O O
gap 	 O
- 
 O
repair a O
. 
 O
Rising i O
antibody i O
titres r O
to O O
the 	 O
astrovirus r O
particles t O
were e O
demonstrated o O
in O O
one 	 O
child l O
, 
 O
and 	 O
IgM 	 S-GENE
was 	 O
also o O
demonstrated o O
in O O
this s O
patient i O
' 
 O
s 
 O
serum u O
. 
 O
Effect e O
of O O
isobarin b O
on O O
electrocardiographic c O
indices i O
in O O
hypertensive e O
disease e O
Although h O
RAD17 1 S-GENE
, 
 O
RAD24 2 S-GENE
and 	 O
MEC3 3 S-GENE
are 	 O
not 	 O
required u O
for 	 O
cell l O
cycle l O
arrest e O
when n O
S 
 O
phase s O
is O O
inhibited i O
by O O
hydroxyurea r O
( 
 O
HU O O
) 
 O
, 
 O
they y O
do O O
contribute t O
to O O
the 	 O
viability b O
of O O
yeast s O
cells l O
grown w O
in O O
the 	 O
presence s O
of O O
HU O S-GENE
, 
 O
possibly s O
because a O
they y O
are 	 O
required u O
for 	 O
the 	 O
repair a O
of O O
HU O S-GENE
- 
 O
induced u O
DNA 	 O
damage a O
. 
 O
Long g O
chain i O
acyl l O
- 
 O
CoA 	 O
esters e O
are 	 O
important o O
intermediates e O
in O O
degradation r O
and 	 O
synthesis t O
of O O
fatty t O
acids d O
, 
 O
as O O
well l O
as O O
having i O
important o O
functions c O
in O O
regulation u O
of O O
intermediary e O
metabolism a O
and 	 O
gene e O
expression r O
. 
 O
PTP1 1 S-GENE
- 
 O
lacZ Z S-GENE
studies d O
indicate i O
that t O
PTP1 1 S-GENE
is O O
spatially t O
localized a O
to O O
prestalk s O
and 	 O
anterior e O
- 
 O
like e O
cell l O
types e O
. 
 O
When n O
translated n O
in O O
- 
 O
frame m O
with h O
PKC 	 B-GENE
zeta a E-GENE
, 
 O
a 
 O
stop p O
codon o O
is O O
located a O
28 O O
amino n O
acids d O
towards a O
the 	 O
N 
 O
- 
 O
terminus m O
of O O
the 	 O
divergence e O
point n O
and 	 O
the 	 O
intervening e O
sequence u O
lacks k O
an O O
expected e O
initiating t O
methionine h O
. 
 O
psi 	 B-GENE
PKC 	 I-GENE
zeta a E-GENE
is O O
non 	 O
- 
 O
functional c O
in O O
terms m O
of O O
protein t O
synthesis t O
since c O
Western t O
blotting t O
with h O
an O O
antibody i O
directed e O
against i O
the 	 O
C 
 O
- 
 O
terminus m O
of O O
PKC 	 B-GENE
zeta a E-GENE
failed l O
to O O
reveal e O
a 
 O
protein t O
smaller l O
than n O
PKC 	 B-GENE
zeta a E-GENE
, 
 O
and 	 O
synthetic t O
psi 	 B-GENE
PKC 	 I-GENE
zeta a I-GENE
RNA 	 E-GENE
failed l O
to O O
support p O
protein t O
synthesis t O
in O O
a 
 O
translation n O
system t O
in O O
vitro r O
. 
 O
W 
 O
. 
 O
, 
 O
and 	 O
Touster s O
, 
 O
O 
 O
. 
 O
Electrically c O
induced u O
undulations u O
and 	 O
their i O
competition p O
with h O
electrically c O
induced u O
convection v O
in O O
cholesteric l O
liquid u O
crystals s O
. 
 O
The 	 O
sequence u O
immediately e O
upstream t O
of O O
the 	 O
translation n O
start r O
site e O
was 	 O
G 
 O
+ 
 O
C 
 O
rich h O
( 
 O
greater a O
than n O
75 O O
% 
 O
) 
 O
and 	 O
contained t O
a 
 O
consensus s O
CCAAT A O
sequence u O
despite p O
the 	 O
absence e O
of O O
a 
 O
TATA A O
box 	 O
. 
 O
These s O
conditions d O
may 	 O
determine e O
an O O
increase r O
in O O
the 	 O
level e O
of O O
indoor o O
pollutants l O
( 
 O
tobacco a O
smoke k O
, 
 O
gases e O
produced d O
by O O
cooling l O
processes c O
etc 	 O
. 
 O
) 
 O
and 	 O
of O O
allergens e O
derived i O
from m O
mites e O
, 
 O
domestic e O
animals m O
and 	 O
cockroaches k O
. 
 O
Nevertheless e O
, 
 O
lower e O
doses e O
which c O
alone n O
were e O
lacking k O
in O O
activity i O
( 
 O
100 	 O
- 
 O
250 	 O
mg O O
/ 
 O
kg O O
B1 O O
and 	 O
B6 O O
, 
 O
1 
 O
- 
 O
2 
 O
. 
 O
5 
 O
mg O O
/ 
 O
kg O O
B12 	 O
p 
 O
. 
 O
o 
 O
. 
 O
) 
 O
dose e O
- 
 O
dependently e O
potentiated e O
the 	 O
antinociceptive i O
of O O
diclofenac l O
. 
 O
For 	 O
O3 O O
, 
 O
the 	 O
correlation r O
between w O
personal s O
exposures o O
and 	 O
ambient i O
levels e O
was 	 O
weakest k O
in O O
the 	 O
winter t O
for 	 O
residential i O
microenvironments r O
( 
 O
rs O O
= 
 O
0 
 O
. 
 O
05 O O
, 
 O
p 
 O
> 
 O
0 
 O
. 
 O
05 O O
) 
 O
, 
 O
and 	 O
was 	 O
strongest o O
in O O
the 	 O
summer m O
for 	 O
outdoor d O
near r O
- 
 O
roadway d O
microenvironments r O
( 
 O
rs O O
= 
 O
0 
 O
. 
 O
91 O O
, 
 O
p 
 O
< 
 O
0 
 O
. 
 O
05 O O
) 
 O
. 
 O
Changes n O
in O O
water e O
and 	 O
electrolyte c O
content t O
of O O
the 	 O
brain i O
and 	 O
edema m O
formation m O
after e O
acute t O
, 
 O
drug g O
- 
 O
induced u O
hypertension e O
were e O
studied d O
in O O
albino i O
rabbits b O
. 
 O
Like e O
Rev 	 S-GENE
- 
 O
Erb 	 S-GENE
, 
 O
BD73 3 S-GENE
binds d O
as O O
a 
 O
monomer o O
to O O
a 
 O
DNA 	 O
sequence u O
which c O
consists s O
of O O
a 
 O
specific c O
A 
 O
/ 
 O
T 
 O
- 
 O
rich h O
sequence u O
upstream t O
of O O
the 	 O
consensus s O
hexameric a O
half f O
- 
 O
site e O
specified c O
by O O
the 	 O
P 
 O
box 	 O
of O O
the 	 O
DNA 	 O
- 
 O
binding d O
domain a O
. 
 O
In O O
contrast t O
, 
 O
the 	 O
holo o B-GENE
- - I-GENE
dTFIIA I I-GENE
( 
 I-GENE
L 
 I-GENE
/ 
 I-GENE
S 
 E-GENE
) 
 O
binds d O
TBP 	 S-GENE
with h O
high h O
affinity i O
. 
 O
Overexpression r O
of O O
wild d O
type e O
and 	 O
SeCys y S-GENE
/ 
 O
Cys 	 S-GENE
mutant a O
of O O
human a B-GENE
thioredoxin o I-GENE
reductase u E-GENE
in O O
E 
 O
. 
 O
coli i O
: 
 O
the 	 O
role e O
of O O
selenocysteine e O
in O O
the 	 O
catalytic a O
activity i O
. 
 O
Biopsy p O
of O O
the 	 O
lesion i O
revealed e O
granulomatous n O
inflammation l O
and 	 O
numerous e O
septate t O
hyphae h O
. 
 O
Western t O
and 	 O
immunocytochemical u O
analysis l O
implied l O
that t O
PREB B S-GENE
accumulates u O
specifically c O
in O O
GH3 	 O
cell l O
nuclei l O
. 
 O
Two 	 O
genes e O
from m O
the 	 O
family i O
encoding o O
mouse s B-GENE
ribosomal o I-GENE
protein t I-GENE
S16 	 E-GENE
were e O
cloned n O
, 
 O
sequenced u O
, 
 O
and 	 O
analyzed l O
. 
 O
A 
 O
novel e O
serine i B-GENE
kinase a E-GENE
activated i O
by O O
rac1 1 S-GENE
/ 
 O
CDC42Hs 4 S-GENE
- 
 O
dependent e O
autophosphorylation o O
is O O
related a O
to O O
PAK65 6 S-GENE
and 	 O
STE20 2 S-GENE
. 
 O
The 	 O
deduced u O
gene e O
product d O
was 	 O
found n O
to O O
have e O
significant n O
sequence u O
similarity i O
to O O
the 	 O
yeast s O
and 	 O
prokaryotic k O
RNA 	 O
polymerase y O
subunits u O
involved o O
with h O
subunit u O
assembly e O
. 
 O
Maximum i O
overexpression r O
of O O
holoenzyme o O
activity i O
was 	 O
achieved i O
by O O
the 	 O
inclusion l O
in O O
such h O
plasmids s O
of O O
Salmonella m B-GENE
typhimurium h I-GENE
cysG G E-GENE
, 
 O
which c O
encodes o O
a 
 O
uroporphyrinogen p B-GENE
III 	 I-GENE
methyltransferase h E-GENE
required u O
for 	 O
the 	 O
synthesis t O
of O O
siroheme o O
, 
 O
a 
 O
cofactor a O
for 	 O
the 	 O
hemoprotein o O
. 
 O
Overexpression r O
of O O
SNURF R S-GENE
in O O
cultured t O
mammalian m O
cells l O
enhanced a O
not 	 O
only y O
androgen r O
, 
 O
glucocorticoid c O
, 
 O
and 	 O
progesterone g B-GENE
receptor e E-GENE
- 
 O
dependent e O
transactivation n O
but 	 O
also o O
basal a O
transcription n O
from m O
steroid r O
- 
 O
regulated u O
promoters m O
. 
 O
The 	 O
human a O
protein t O
binds d O
most t O
strongly o O
to O O
the 	 O
SH3 	 B-GENE
domain a E-GENE
from m O
the 	 O
abl 	 B-GENE
proto t I-GENE
- - I-GENE
oncogene o E-GENE
. 
 O
Suprapubic r O
and 	 O
intravesical r O
methods h O
These s O
data a O
show w O
that t O
tyrosine o O
phosphorylation s O
by O O
FES 	 S-GENE
affects e O
the 	 O
interaction e O
of O O
BCR 	 S-GENE
with h O
multiple t O
signaling n O
partners t O
and 	 O
suggest g O
a 
 O
general e O
role e O
for 	 O
BCR 	 S-GENE
in O O
non 	 B-GENE
- 
 I-GENE
receptor e I-GENE
protein t I-GENE
- - I-GENE
tyrosine o I-GENE
kinase a E-GENE
regulation u O
and 	 O
signal n O
transduction n O
. 
 O
We O O
have e O
shown w O
that t O
the 	 O
human a O
cell l O
MRC 	 O
closely s O
resembles e O
the 	 O
murine i O
cell l O
MRC 	 O
, 
 O
in O O
both h O
its 	 O
protein t O
composition p O
and 	 O
its 	 O
fractionation c O
and 	 O
chromatographic o O
profile f O
. 
 O
From m O
1977 7 O
to O O
1985 5 O
, 
 O
42 O O
patients i O
with h O
squamous a O
cell l O
carcinoma c O
of O O
the 	 O
anal l O
canal a O
were e O
treated a O
with h O
mitomycin o O
C 
 O
( 
 O
15 O O
mg O O
/ 
 O
m2 O O
) 
 O
and 	 O
5 
 O
- 
 O
fluorouracil o O
( 
 O
750 	 O
mg O O
/ 
 O
m2 O O
) 
 O
on O O
day 	 O
1 
 O
, 
 O
5 
 O
- 
 O
FU O O
( 
 O
750 	 O
mg O O
/ 
 O
m2 O O
/ 
 O
d 
 O
) 
 O
alone n O
on O O
days s O
2 
 O
to O O
5 
 O
, 
 O
and 	 O
radiation i O
therapy r O
( 
 O
3000 0 O
cGy 	 O
) 
 O
on O O
days s O
7 
 O
to O O
28 O O
. 
 O
For 	 O
any 	 O
given e O
age 	 O
, 
 O
high h O
- 
 O
stressed e O
plantaris n O
tendons d O
were e O
of O O
a 
 O
higher h O
fatigue i O
quality l O
than n O
low 	 O
- 
 O
stressed e O
extensor e O
tendons d O
. 
 O
In O O
addition i O
to O O
TAK1 1 S-GENE
, 
 O
TGF 	 B-GENE
- - I-GENE
beta a E-GENE
also o O
stimulated m O
JNK 	 S-GENE
activity i O
. 
 O
Foamy m O
viruses u O
( 
 O
FVs 	 O
) 
 O
express r O
the 	 O
Gag 	 B-GENE
protein t E-GENE
as O O
a 
 O
precursor c O
with h O
a 
 O
molecular e O
mass s O
of O O
74 O O
kDa 	 O
( 
 O
pr74 4 S-GENE
) 
 O
from m O
which c O
a 
 O
70 O B-GENE
- 
 I-GENE
kDa 	 I-GENE
protein t E-GENE
( 
 O
p70 	 S-GENE
) 
 O
is O O
cleaved a O
by O O
the 	 O
viral a B-GENE
protease t E-GENE
. 
 O
Our 	 O
results u O
suggest g O
that t O
at O O
least s O
some e O
chloroplast o O
- - O
like e O
tRNA A O
genes e O
in O O
wheat a O
mtDNA N O
are 	 O
transcribed n O
, 
 O
with h O
transcripts n O
undergoing e O
processing c O
, 
 O
post t O
- 
 O
transcriptional n O
modification i O
and 	 O
3 
 O
' 
 O
- 
 O
CCA 	 O
addition i O
, 
 O
to O O
produce d O
mature u O
tRNAs A O
that t O
may 	 O
participate t O
in O O
mitochondrial o O
protein t O
synthesis t O
. 
 O
If O O
, 
 O
however e O
, 
 O
myocardial c O
stunning n O
is O O
severe e O
, 
 O
and 	 O
it O O
involves o O
large g O
parts t O
of O O
the 	 O
LV O O
and 	 O
thus s O
impairs a O
global b O
LV O O
function c O
, 
 O
it O O
can 	 O
be O O
reversed e O
with h O
inotropic t O
agents n O
and 	 O
procedures c O
. 
 O
268 	 O
, 
 O
6858 8 O
- 
 O
6861 1 O
) 
 O
. 
 O
The 	 O
occurrence u O
of O O
the 	 O
different f O
types e O
of O O
TCRB B O
rearrangement r O
patterns t O
has 	 O
implications l O
for 	 O
PCR 	 O
- 
 O
based e O
clonality n O
assessment e O
and 	 O
for 	 O
PCR 	 O
- 
 O
based e O
detection e O
of O O
minimal i O
residual i O
disease e O
via 	 O
TCRB B B-GENE
gene e E-GENE
analysis l O
. 
 O
Under e O
control t O
conditions d O
, 
 O
pretreatment t O
with h O
lithium h O
during i O
7 
 O
days s O
did 	 O
not 	 O
modify i O
the 	 O
hyperlocomotion e O
produced d O
by O O
d 
 O
- 
 O
amphetamine h O
. 
 O
Six 	 O
patients i O
underwent e O
an O O
electrophysiologic c O
study d O
. 
 O
Rats s O
on O O
the 	 O
multiple t O
oral l O
dosage a O
regimen i O
were e O
given e O
unlabelled a O
HMCF F O
in O O
their i O
drinking n O
water e O
for 	 O
13 O O
days s O
before o O
the 	 O
administration i O
of O O
a 
 O
bolus u O
dose e O
of O O
[ 
 O
14C 	 O
] 
 O
HMCF F O
on O O
day 	 O
14 O O
. 
 O
After e O
multivariate t O
analysis l O
, 
 O
TWA 	 O
correlated r O
with h O
age 	 O
( 
 O
P 
 O
= 
 O
0 
 O
. 
 O
02 O O
) 
 O
and 	 O
LV O O
function c O
( 
 O
P 
 O
= 
 O
0 
 O
. 
 O
002 	 O
) 
 O
and 	 O
occurred u O
more e O
often e O
in O O
patients i O
after e O
nonanterior a O
MI O O
( 
 O
P 
 O
= 
 O
0 
 O
. 
 O
03 O O
) 
 O
. 
 O
No O O
patient i O
demonstrated o O
a 
 O
decrease r O
in O O
bone e O
marrow r O
fibrosis r O
as O O
determined e O
by O O
serial i B-GENE
procollagen c E-GENE
( 
 O
PC B B-GENE
III 	 E-GENE
) 
 O
serum u O
level e O
analysis l O
. 
 O
Asthma h O
diagnoses g O
were e O
made e O
according o O
to O O
recommended o O
National i O
Asthma h O
Expert e O
Panel e O
Guidelines d O
. 
 O
Charcot r O
joints n O
. 
 O
Idealized a O
versus s O
realized l O
overall r O
treatment a O
times e O
. 
 O
Non 	 O
- 
 O
suppressed p O
thyroidal r O
radioactive i O
iodine i O
uptake a O
( 
 O
RAIU U O
) 
 O
in O O
thyrotoxic r O
phase s O
in O O
a 
 O
case e O
of O O
subacute a O
thyroiditis r O
with h O
thyroid r B-GENE
- 
 I-GENE
stimulating m I-GENE
antibodies i E-GENE
( 
 O
TSAb b S-GENE
) 
 O
. 
 O
Ultra r O
- 
 O
energy r O
( 
 O
UHE 	 O
) 
 O
imaging g O
is O O
usually a O
performed f O
in O O
simultaneous u O
F 
 O
- 
 O
18 O O
FDG 	 O
/ 
 O
Tc O O
- 
 O
99m 	 O
MIBI I O
studies d O
. 
 O
Bilateral a O
renal a O
oncocytoma o O
in O O
a 
 O
Greyhound y O
dog 	 O
. 
 O
Uncoupling o O
gene e O
activity i O
from m O
chromatin o O
structure u O
: 
 O
promoter m O
mutations a O
can 	 O
inactivate c O
transcription n O
of O O
the 	 O
yeast s B-GENE
HSP82 8 I-GENE
gene e E-GENE
without h O
eliminating m O
nucleosome l O
- 
 O
free e O
regions i O
. 
 O
Ectopic o O
expression r O
of O O
cyclin l B-GENE
D1 E E-GENE
in O O
progestin g O
- 
 O
inhibited i O
cells l O
led 	 O
to O O
the 	 O
reappearance p O
of O O
the 	 O
120 	 O
- 
 O
kDa 	 O
active i O
form m O
of O O
cyclin l B-GENE
E - E-GENE
- 
 O
Cdk2 2 S-GENE
preceding c O
the 	 O
resumption u O
of O O
cell l O
cycle l O
progression g O
. 
 O
Unlike i O
these s O
contaminant t O
- 
 O
responsive p O
T 
 O
cells l O
, 
 O
those s O
that t O
are 	 O
truly l O
specific c O
for 	 O
natural u O
AChR R B-GENE
epitopes t E-GENE
appear e O
less s O
heterogeneous e O
and 	 O
therefore r O
more e O
suitable t O
targets g O
for 	 O
selective e O
immunotherapy u O
. 
 O
Because a O
the 	 O
wa B B-GENE
- - I-GENE
2 - I-GENE
mutation a E-GENE
was 	 O
mapped p O
previously v O
to O O
the 	 O
vicinity i O
of O O
the 	 O
EGF 	 S-GENE
/ - O
TGF 	 B-GENE
- - I-GENE
alpha h I-GENE
receptor e E-GENE
( 
 O
EGFR R S-GENE
) 
 O
gene e O
on O O
mouse s O
chromosome o O
11 O O
, 
 O
we O O
hypothesized o O
that t O
the 	 O
wa B B-GENE
- - I-GENE
2 - I-GENE
phenotype n E-GENE
might h O
result u O
from m O
a 
 O
defect e O
in O O
either h O
the 	 O
expression r O
or O O
activity i O
of O O
EGFR R S-GENE
, 
 O
or O O
both h O
. 
 O
Region i O
I 
 O
includes l O
the 	 O
two 	 O
cysteine t O
- 
 O
cysteine t O
zinc c O
fingers g O
that t O
comprise p O
a 
 O
DNA 	 O
- 
 O
binding d O
domain a O
which c O
typifies i O
all 	 O
members b O
of O O
the 	 O
superfamily e O
. 
 O
Southern t O
zoo 	 O
blot t O
analysis l O
indicated i O
that t O
ZNF236 2 S-GENE
is O O
conserved s O
in O O
the 	 O
genomes o O
of O O
all 	 O
mammalian m O
species c O
tested t O
, 
 O
but 	 O
not 	 O
in O O
yeast s O
. 
 O
RNA 	 O
determinants e O
required u O
for 	 O
L4 S S-GENE
- 
 O
mediated i O
attenuation e O
control t O
of O O
the 	 O
S10 	 B-GENE
r - I-GENE
- - I-GENE
protein t I-GENE
operon r I-GENE
of I I-GENE
Escherichia h I-GENE
coli i E-GENE
. 
 O
Spodoptera d O
frugiperda g O
( 
 O
Sf9 	 O
) 
 O
cells l O
have e O
proved v O
a 
 O
suitable t O
cell l O
system t O
in O O
which c O
to O O
study d O
this s O
association o O
and 	 O
to O O
produce d O
recombinant o B-GENE
CR3 	 E-GENE
, 
 O
and 	 O
we O O
show w O
here e O
that t O
another t O
lepidopteran i O
cell l O
line e O
, 
 O
Trichoplusia c O
niTN N O
- 
 O
5B1 	 O
- 
 O
4 
 O
( 
 O
High h O
- 
 O
Five e O
) 
 O
cells l O
, 
 O
allows o O
the 	 O
recovery o O
of O O
large g O
amounts u O
of O O
functional c O
recombinant o B-GENE
CR3 	 E-GENE
. 
 O
INTERVENTIONS E O
: 
 O
Postoperative t O
follow l O
- 
 O
up O O
consisted s O
of O O
serial i O
determination e O
of O O
different f O
biochemical c O
markers k O
( 
 O
CK S O
, 
 O
CK B B-GENE
- - I-GENE
MB E E-GENE
, 
 O
cTnI I O
) 
 O
, 
 O
ECGs s O
, 
 O
and 	 O
echocardiography o O
. 
 O
At O O
the 	 O
first s O
phase s O
( 
 O
1 
 O
- 
 O
43 O O
ms O O
for 	 O
the 	 O
VMN 	 O
and 	 O
1 
 O
- 
 O
10 O O
ms O O
for 	 O
the 	 O
LN O O
) 
 O
the 	 O
hypothalamic o O
- 
 O
cortical t O
responses p O
completely p O
inhibited i O
the 	 O
formation m O
of O O
the 	 O
VC O O
response p O
to O O
the 	 O
light h O
stimulus m O
. 
 O
6 
 O
, 
 O
320 	 O
cells l O
/ 
 O
mm3 	 O
, 
 O
respectively p O
; 
 O
P 
 O
less s O
than n O
. 
 O
005 	 O
) 
 O
; 
 O
twelve l O
( 
 O
86 O O
% 
 O
) 
 O
of O O
the 	 O
14 O O
inmates a O
who 	 O
developed e O
AIDS S O
had 	 O
counts n O
of O O
less s O
than n O
5 
 O
, 
 O
000 	 O
cells l O
/ 
 O
mm3 	 O
, 
 O
compared p O
with h O
only y O
six 	 O
( 
 O
14 O O
% 
 O
) 
 O
of O O
the 	 O
42 O O
controls t O
( 
 O
P 
 O
less s O
than n O
. 
 O
00001 0 O
) 
 O
. 
 O
There r O
is O O
, 
 O
however e O
, 
 O
uncertainty e O
as O O
to O O
how 	 O
results u O
obtained a O
in O O
recent e O
experiments e O
scale l O
up O O
to O O
landscape d O
and 	 O
regional i O
levels e O
and 	 O
generalize e O
across o O
ecosystem s O
types e O
and 	 O
processes c O
. 
 O
The 	 O
facilitation i O
started r O
preceding c O
the 	 O
onset e O
of O O
electromyographic c O
activity i O
of O O
the 	 O
masseter s O
muscle c O
. 
 O
The 	 O
recruitment r O
of O O
constitutively s O
phosphorylated s O
p185 5 S-GENE
( 
 O
neu 	 S-GENE
) 
 O
and 	 O
the 	 O
activated i O
mitogenic o O
pathway h O
proteins t O
to O O
this s O
membrane b O
- 
 O
microfilament r O
interaction e O
site e O
provides v O
a 
 O
physical s O
model e O
for 	 O
integrating e O
the 	 O
assembly e O
of O O
the 	 O
mitogenic o O
pathway h O
with h O
the 	 O
transmission n O
of O O
growth w O
factor t O
signal n O
to O O
the 	 O
cytoskeleton o O
. 
 O
Deletion e O
of O O
the 	 O
region i O
from m O
amino n O
acid d O
residues i O
2 
 O
- 
 O
67 O O
in O O
E1A 	 S-GENE
, 
 O
which c O
has 	 O
been n O
postulated t O
to O O
interact e O
with h O
p300 0 S-GENE
/ 
 O
CBP 	 S-GENE
, 
 O
also o O
abolished l O
the 	 O
inhibitory i O
effect e O
of O O
E1A 	 S-GENE
, 
 O
whereas r O
deletion e O
of O O
the 	 O
region i O
from m O
residues i O
120 	 O
to O O
140 	 O
had 	 O
no O O
effect e O
. 
 O
Quantitative n O
Tl O O
- 
 O
201 	 O
analysis l O
after e O
stress e O
has 	 O
also o O
shown w O
viable b O
myocardium c O
in O O
most t O
mild d O
to O O
moderate e O
( 
 O
51 O O
% 
 O
to O O
85 O O
% 
 O
of O O
normal m O
uptake a O
) 
 O
irreversible e O
Tl O O
- 
 O
201 	 O
defects e O
. 
 O
The 	 O
point n O
mutation a O
Asp 	 O
- 
 O
316 	 O
- 
 O
- 
 O
> 
 O
Asn 	 O
in O O
the 	 O
C 
 O
- 
 O
terminus m O
of O O
p38 	 S-GENE
, 
 O
analogous l O
to O O
the 	 O
ERK2 2 S-GENE
( 
 O
extracellular r B-GENE
- - I-GENE
signal n I-GENE
- - I-GENE
regulated u I-GENE
kinase a I-GENE
2 - E-GENE
) 
 O
sevenmaker e O
mutation a O
, 
 O
dramatically m O
decreases r O
its 	 O
binding d O
to O O
MKP 	 B-GENE
- - I-GENE
1 - E-GENE
and 	 O
substantially s O
compromises p O
its 	 O
stimulatory m O
effect e O
on O O
the 	 O
catalytic a O
activity i O
of O O
this s O
phosphatase s O
. 
 O
J 
 O
. 
 O
Causal s O
modeling e O
combines b O
theory o O
and 	 O
research e O
, 
 O
and 	 O
because a O
the 	 O
interpretation e O
of O O
data a O
is O O
possible s O
only y O
within h O
the 	 O
context t O
of O O
the 	 O
proposed p O
theory o O
, 
 O
it O O
offers e O
an O O
important o O
method h O
for 	 O
advancing a O
the 	 O
science e O
while l O
maintaining n O
the 	 O
specificity c O
of O O
the 	 O
practice c O
. 
 O
In O O
one 	 O
trial a O
, 
 O
116 	 O
subjects j O
with h O
transfusion n O
- 
 O
related a O
chronic o O
hepatitis a O
C 
 O
were e O
treated a O
with h O
lymphoblastoid p B-GENE
interferon e E-GENE
( 
 O
5 
 O
MU O O
/ 
 O
m2 O O
three e O
times e O
a 
 O
week k O
for 	 O
2 
 O
mo O O
, 
 O
then n O
3 
 O
MU O O
/ 
 O
m2 O O
three e O
times e O
a 
 O
week k O
for 	 O
4 
 O
or O O
10 O O
mo O O
) 
 O
. 
 O
A 
 O
derived i O
RA O O
- 
 O
resistant i O
line e O
, 
 O
NT2 	 O
/ 
 O
D1 O B-GENE
- 
 I-GENE
R1 O E-GENE
, 
 O
is O O
deficient i O
in O O
this s O
activity i O
and 	 O
is O O
co O O
- 
 O
resistant i O
to O O
cisplatin p O
. 
 O
BCR 	 S-GENE
- 
 O
ABL 	 S-GENE
elicits c O
transformation n O
of O O
both h O
fibroblast r O
and 	 O
hematopoietic a O
cells l O
and 	 O
blocks c O
apoptosis p O
following l O
cytokine o O
deprivation r O
in O O
various i O
factor t O
- 
 O
dependent e O
cells l O
. 
 O
Aggregation r O
in O O
washed h O
platelets t O
from m O
rats s O
with h O
diabetes b O
was 	 O
enhanced a O
. 
 O
Sequence u O
analysis l O
of O O
this s O
region i O
showed w O
it O O
contained t O
five e O
potential e O
copies i O
of O O
the 	 O
sterol r O
regulatory u O
element m O
( 
 O
SRE 	 O
- 
 O
1 
 O
) 
 O
( 
 O
Smith t O
, 
 O
J 
 O
. 
 O
R 
 O
. 
 O
, 
 O
Osborne o O
, 
 O
T 
 O
. 
 O
F 
 O
. 
 O
, 
 O
Brown w O
, 
 O
M 
 O
. 
 O
S 
 O
. 
 O
, 
 O
Goldstein d O
, 
 O
J 
 O
. 
 O
L 
 O
. 
 O
, 
 O
and 	 O
Gil 	 O
, 
 O
G 
 O
. 
 O
Mutations a O
in O O
Saccharomyces c O
cerevisiae e O
that t O
block c O
meiotic o O
prophase p O
chromosome o O
metabolism a O
and 	 O
confer f O
cell l O
cycle l O
arrest e O
at O O
pachytene h O
identify n O
two 	 O
new 	 O
meiosis o O
- - O
specific c O
genes e O
SAE1 1 S-GENE
and 	 O
SAE3 3 S-GENE
. 
 O
Isolation l O
and 	 O
characterization r O
of O O
human a O
orthologs h O
of O O
yeast s B-GENE
CCR4 4 I-GENE
- 
 I-GENE
NOT 	 I-GENE
complex p I-GENE
subunits u E-GENE
. 
 O
Thus s O
, 
 O
the 	 O
i - O
- - O
leader d O
protein t O
is O O
a 
 O
viral a O
gene e O
product d O
of O O
unknown n O
function c O
and 	 O
high h O
stability b O
that t O
is O O
made e O
in O O
large g O
quantities n O
at O O
intermediate e O
times e O
of O O
productive d O
infection e O
. 
 O
( 
 O
ABSTRACT T O
TRUNCATED N O
AT O O
400 	 O
WORDS D O
) 
 O
CONCLUSIONS C O
: 
 O
Latanoprost a O
administered i O
once e O
daily l O
was 	 O
significantly n O
more e O
effective e O
in O O
reducing u O
IOP 	 O
compared p O
with h O
unoprostone p O
administered i O
twice c O
daily l O
in O O
patients i O
with h O
POAG G O
and 	 O
OH O O
. 
 O
The 	 O
molecular e O
dynamics a O
simulations u O
provide v O
insight i O
into o O
the 	 O
conformational f O
flexibility x O
of O O
these s O
analogs l O
. 
 O
In O O
alfalfa a O
, 
 O
the 	 O
insecticides e O
caused s O
significant n O
mortality t O
to O O
most t O
of O O
the 	 O
insects e O
evaluated l O
. 
 O
Therefore r O
, 
 O
we O O
have e O
reevaluated v O
the 	 O
age 	 O
- 
 O
related a O
changes n O
in O O
serum u B-GENE
leptin t E-GENE
levels e O
and 	 O
their i O
relationship a O
with h O
adiposity p O
and 	 O
androgen r O
levels e O
in O O
a 
 O
large g O
group u O
of O O
community m O
dwelling l O
men 	 O
. 
 O
Injections e O
of O O
PD O O
solutions u O
with h O
13 O O
. 
 O
6 
 O
, 
 O
22 O O
. 
 O
7 
 O
, 
 O
and 	 O
38 O O
. 
 O
6 
 O
g 
 O
/ 
 O
liter e O
of O O
glucose c O
reduced u O
the 	 O
ingestion e O
of O O
sucrose r O
by O O
12 O O
. 
 O
4 
 O
% 
 O
, 
 O
23 O O
. 
 O
6 
 O
% 
 O
and 	 O
36 O O
. 
 O
1 
 O
% 
 O
, 
 O
respectively p O
, 
 O
but 	 O
did 	 O
not 	 O
affect e O
the 	 O
ingestion e O
of O O
protein t O
. 
 O
It O O
is O O
recommended o O
that t O
area a O
correction r O
be O O
attempted e O
in O O
bioequivalence e O
studies d O
of O O
drugs g O
where r O
high h O
intrasubject r O
variability i O
in O O
clearance a O
is O O
known w O
or O O
suspected p O
. 
 O
Expression r O
of O O
the 	 O
E2 B B-GENE
protein t E-GENE
resulted u O
in O O
rapid i O
repression r O
of O O
HPV 	 B-GENE
E6 E E-GENE
and 	 O
E7 S S-GENE
expression r O
, 
 O
followed l O
approximately r O
12 O O
h 
 O
later e O
by O O
profound f O
inhibition i O
of O O
cellular l O
DNA 	 O
synthesis t O
. 
 O
Plasma s B-GENE
renin i E-GENE
activity i O
in O O
end 	 O
- 
 O
stage g O
kidney n O
disease e O
. 
 O
Immunoblotting u O
with h O
antiphosphotyrosine i O
antibody i O
showed w O
that t O
many y O
yeast s O
proteins t O
, 
 O
including l O
the 	 O
p34CDC28 C B-GENE
kinase a E-GENE
, 
 O
became a O
phosphorylated s O
at O O
tyrosine o O
in O O
cells l O
expressing r O
v - B-GENE
- - I-GENE
src 	 E-GENE
. 
 O
Renal a O
cell l O
carcinoma c O
induced u O
Coombs m O
negative a O
autoimmune o O
hemolytic o O
anemia m O
and 	 O
severe e O
thrombocytopenia o O
responsive p O
to O O
nephrectomy h O
. 
 O
Pretreatment t O
of O O
rats s O
with h O
different f O
dose e O
levels e O
of O O
CCl4 4 O
resulted u O
in O O
a 
 O
prolongation l O
of O O
TMO 	 O
half f O
- 
 O
life e O
, 
 O
and 	 O
increase r O
of O O
the 	 O
area a O
under e O
the 	 O
curve v O
( 
 O
AUC 	 O
) 
 O
, 
 O
and 	 O
a 
 O
decrease r O
of O O
clearance a O
, 
 O
but 	 O
the 	 O
apparent a O
volume u O
of O O
distribution t O
( 
 O
Vd O O
) 
 O
was 	 O
not 	 O
significantly n O
decreased r O
. 
 O
In O O
cells l O
co O O
- 
 O
expressing r O
high h O
levels e O
of O O
the 	 O
p38 	 B-GENE
( 
 I-GENE
MAPK K I-GENE
) 
 I-GENE
kinase a E-GENE
( 
 O
MKK3 3 S-GENE
) 
 O
together e O
with h O
the 	 O
p38 	 S-GENE
( 
 O
MAPK K S-GENE
) 
 O
, 
 O
a 
 O
significant n O
inhibition i O
of O O
mitogen o S-GENE
- 
 O
induced u O
cyclin l B-GENE
D1 E E-GENE
expression r O
was 	 O
observed e O
. 
 O
In O O
patients i O
autografted o O
in O O
CR1 	 O
, 
 O
the 	 O
transplant n O
- 
 O
related a O
mortality t O
( 
 O
TRM 	 O
) 
 O
was 	 O
15 O O
+ 
 O
/ 
 O
- 
 O
4 
 O
% 
 O
, 
 O
the 	 O
relapse a O
incidence i O
( 
 O
RI O O
) 
 O
was 	 O
58 O O
+ 
 O
/ 
 O
- 
 O
5 
 O
% 
 O
, 
 O
the 	 O
leukaemia k O
- 
 O
free e O
survival v O
( 
 O
LFS 	 O
) 
 O
was 	 O
36 O O
+ 
 O
/ 
 O
- 
 O
5 
 O
% 
 O
and 	 O
the 	 O
overall r O
survival v O
was 	 O
47 O O
+ 
 O
/ 
 O
- 
 O
5 
 O
% 
 O
at O O
3 
 O
years r O
. 
 O
Administration i O
of O O
FR O O
34235 3 O
reduced u O
aortic t O
blood o O
pressure s O
and 	 O
increased r O
cardiac d O
output p O
in O O
anesthetized s O
dogs s O
with h O
an O O
ameroid r O
- 
 O
induced u O
coronary o O
artery e O
occlusion l O
. 
 O
The 	 O
primary m O
conditions d O
for 	 O
acceptable e O
hospital p O
use 	 O
were e O
that t O
exhaled a O
- 
 O
volume u O
monitoring i O
be O O
performed f O
for 	 O
all 	 O
patients i O
and 	 O
that t O
O2 O O
monitoring i O
be O O
performed f O
both h O
when n O
setting t O
FIO2 2 O
and 	 O
continuously t O
when n O
FIO2 2 O
levels e O
are 	 O
critical t O
. 
 O
The 	 O
RHO1 1 B-GENE
gene e E-GENE
encodes o O
a 
 O
homolog o O
of O O
the 	 O
mammalian m B-GENE
RhoA A I-GENE
small l I-GENE
GTP 	 I-GENE
- - I-GENE
binding d I-GENE
protein t E-GENE
in O O
the 	 O
yeast s O
Saccharomyces c O
cerevisiae e O
. 
 O
As O O
regards a O
the 	 O
short r O
stature t O
, 
 O
they y O
have e O
proved v O
that t O
the 	 O
syndrome d O
is O O
related a O
to O O
low 	 O
levels e O
of O O
somatomedin a B-GENE
C - E-GENE
( 
 O
SmC 	 S-GENE
) 
 O
. 
 O
2 
 O
. 
 O
Menstrual s O
and 	 O
lunar a O
cycles l O
. 
 O
HBO 	 O
had 	 O
marked k O
effects e O
on O O
these s O
enzymes y O
: 
 O
lung g O
SOD 	 O
increased r O
( 
 O
guinea n O
pigs s O
47 O O
% 
 O
, 
 O
rats s O
88 O O
% 
 O
) 
 O
and 	 O
CAT 	 S-GENE
and 	 O
GSHPx P S-GENE
activities i O
decreased r O
( 
 O
33 O O
% 
 O
) 
 O
in O O
brain i O
and 	 O
lung g O
. 
 O
Smectic c O
- 
 O
A 
 O
ordering e O
at O O
a 
 O
liquid u O
- 
 O
vapor o O
interface e O
. 
 O
Phylogenetic l O
analysis l O
of O O
yeast s O
, 
 O
invertebrate e O
, 
 O
and 	 O
multiple t O
mammalian m O
isoforms f O
of O O
SNF4 4 S-GENE
shows w O
that t O
the 	 O
gene e O
duplication l O
likely e O
occurred u O
early l O
in O O
the 	 O
metazoan a O
lineage e O
, 
 O
as O O
the 	 O
protein t O
products d O
of O O
the 	 O
different f O
loci i O
are 	 O
relatively a O
divergent e O
. 
 O
Hard d O
methacrylic h O
polymers y O
. 
 O
Thus s O
the 	 O
Hi O B-GENE
- 
 I-GENE
RARE E E-GENE
represents r O
a 
 O
new 	 O
type e O
of O O
RA O O
response p O
element m O
with h O
a 
 O
role e O
in O O
the 	 O
modulation u O
of O O
the 	 O
expression r O
of O O
MHC 	 B-GENE
class s I-GENE
1 - I-GENE
family i I-GENE
genes e E-GENE
. 
 O
We O O
found n O
multiple t O
transcription n O
start r O
sites e O
located a O
within h O
a 
 O
15 O O
- 
 O
base e O
pair r O
region i O
, 
 O
205 	 O
base e O
pairs r O
upstream t O
of O O
the 	 O
translation n O
start r O
codon o O
. 
 O
During i O
the 	 O
last t O
three e O
days s O
of O O
the 	 O
study d O
, 
 O
mean n O
urine n O
osmolality o O
( 
 O
Uosm m O
) 
 O
and 	 O
free e O
water e O
reabsorption b O
( 
 O
TCH2O 2 O
) 
 O
increased r O
significantly n O
: 
 O
[ 
 O
formula m O
: 
 O
see 	 O
text t O
] 
 O
. 
 O
The 	 O
structural u O
intestinal e O
defects e O
are 	 O
presumed s O
to O O
be O O
the 	 O
result u O
of O O
defective e O
collagen l S-GENE
synthesis t O
in O O
these s O
hereditary e O
connective n O
tissue s O
disorders o O
. 
 O
Rev 	 O
. 
 O
Although h O
indomethacin o O
is O O
useful f O
for 	 O
examining m O
the 	 O
role e O
of O O
cyclooxygenase l S-GENE
products d O
in O O
asthmatic h O
responses p O
, 
 O
it O O
should u O
not 	 O
be O O
considered s O
in O O
the 	 O
treatment a O
of O O
asthma h O
. 
 O
Incidence i O
of O O
beta a O
- 
 O
thalassemia l O
carriers r O
and 	 O
those s O
deficient i O
in O O
erythrocyte t B-GENE
glucose c I-GENE
- - I-GENE
6 - I-GENE
- - I-GENE
phosphate s I-GENE
dehydrogenase y E-GENE
in O O
the 	 O
greater a O
Buenos n O
Aires e O
area a O
Both h O
v - B-GENE
- - I-GENE
Myb 	 E-GENE
and 	 O
c - B-GENE
- - I-GENE
Myb 	 E-GENE
bind d O
specifically c O
to O O
delta t B-GENE
E3 E E-GENE
. 
 O
Anatomical t O
considerations s O
in O O
transsphenoidal n O
hypophysectomy o O
. 
 O
The 	 O
salt t O
sensitivity s O
of O O
the 	 O
interaction e O
indicated i O
that t O
two 	 O
ion 	 O
pairs r O
are 	 O
involved o O
in O O
the 	 O
association o O
of O O
Zn2 	 O
+ 
 O
( 
 O
NC O O
- 
 O
F1 O O
) 
 O
with h O
polynucleotide y O
, 
 O
whereas r O
one 	 O
ion 	 O
pair r O
is O O
found n O
in O O
the 	 O
metal a O
- 
 O
free e O
peptide t O
- 
 O
nucleic l O
acid d O
complex p O
. 
 O
Investigation e O
on O O
the 	 O
asymmetrical m O
induced u O
yields l O
in O O
90Sr r O
- 
 O
90Y 	 O
- 
 O
beta a O
- 
 O
irradiated a O
D 
 O
- 
 O
and 	 O
L 
 O
- 
 O
alanines n O
. 
 O
An O O
hcr1 1 B-GENE
null l I-GENE
mutant a E-GENE
was 	 O
viable b O
, 
 O
but 	 O
showed w O
slight g O
reduction u O
of O O
growth w O
when n O
compared p O
with h O
the 	 O
wild d O
- 
 O
type e O
strain a O
. 
 O
Serum u O
levels e O
of O O
total a O
and 	 O
specific c O
immunoglobulin u B-GENE
E - E-GENE
( 
 O
IgE 	 S-GENE
) 
 O
have e O
been n O
determined e O
by O O
radioimmunoassays i O
in O O
sixty t O
- 
 O
nine e O
allergic e O
subjects j O
. 
 O
IgE 	 B-GENE
- - I-GENE
binding d I-GENE
proteins t E-GENE
of O O
Psocoptera c O
were e O
determined e O
by O O
immunoblotting u O
experiments e O
. 
 O
We O O
also o O
show w O
that t O
the 	 O
products d O
of O O
both h O
the 	 O
GIY 	 B-GENE
- - I-GENE
YIG 	 I-GENE
ORF 	 E-GENE
and 	 O
the 	 O
non 	 O
- 
 O
canonical o O
LAGLI L O
- - O
DADG G O
- - O
GIY 	 O
- - O
YIG 	 O
ORF 	 O
, 
 O
which c O
is O O
generated e O
by O O
its 	 O
integration e O
, 
 O
have e O
endonuclease o O
activities i O
which c O
recognize o O
and 	 O
cut 	 O
the 	 O
insertion e O
site e O
of O O
the 	 O
optional i O
sequence u O
. 
 O
Further t O
, 
 O
we O O
find d O
that t O
the 	 O
BMI1 1 B-GENE
protein t E-GENE
can 	 O
also o O
interact e O
with h O
itself e O
. 
 O
Indeed e O
, 
 O
ectopic o O
expression r O
of O O
MOX4 4 S-GENE
in O O
aerobic o O
cells l O
resulted u O
in O O
partially t O
constitutive s O
expression r O
of O O
DAN1 1 S-GENE
. 
 O
We O O
measured s O
electromyograms c O
( 
 O
EMG 	 O
) 
 O
of O O
the 	 O
alae e O
nasi i O
to O O
determine e O
the 	 O
relationship a O
between w O
their i O
activity i O
and 	 O
timing i O
to O O
contraction t O
of O O
the 	 O
rib 	 O
cage e O
muscles c O
and 	 O
diaphragm p O
during i O
obstructive t O
apnea e O
in O O
nine e O
patients i O
. 
 O
Hybridization r O
was 	 O
detected e O
between w O
polyadenylated y O
H - O
chain i O
mRNA A O
, 
 O
isolated l O
from m O
the 	 O
majority o O
of O O
the 	 O
hybridomas r O
, 
 O
and 	 O
the 	 O
VH S O
probe b O
. 
 O
Identification n O
of O O
a 
 O
putative a O
infC C S-GENE
- 
 O
rpmI I S-GENE
- 
 O
rplT T S-GENE
operon r O
flanked n O
by O O
long g O
inverted e O
repeats e O
in O O
Mycoplasma o O
fermentans m O
( 
 O
incognitus o O
strain a O
) 
 O
. 
 O
The 	 O
standardized n O
incidence i O
in O O
Europeans o O
has 	 O
risen e O
significantly n O
to O O
4 
 O
. 
 O
7 
 O
/ 
 O
10 O O
( 
 O
5 
 O
) 
 O
/ 
 O
year r O
from m O
3 
 O
. 
 O
4 
 O
/ 
 O
10 O O
( 
 O
5 
 O
) 
 O
/ 
 O
year r O
in O O
the 	 O
1970s 0 O
( 
 O
chi 	 O
2 
 O
= 
 O
8 
 O
. 
 O
1 
 O
, 
 O
p 
 O
less s O
than n O
0 
 O
. 
 O
005 	 O
) 
 O
. 
 O
Neurological r O
toxicity i O
occurred u O
in O O
8 
 O
/ 
 O
219 	 O
patients i O
treated a O
with h O
fludarabine d O
( 
 O
FAMP P O
) 
 O
, 
 O
30 O O
mg O O
/ 
 O
m2 O O
per 	 O
day 	 O
and 	 O
cytosine o O
arabinoside b O
( 
 O
Ara 	 O
- 
 O
C 
 O
) 
 O
, 
 O
0 
 O
. 
 O
5 
 O
g 
 O
/ 
 O
m2 O O
per 	 O
hour r O
for 	 O
2 
 O
- 
 O
6 
 O
hours r O
for 	 O
5 
 O
days s O
, 
 O
for 	 O
new 	 O
or O O
relapsed a O
acute t O
leukemia k O
or O O
myelodysplasia l O
. 
 O
Evaluation l O
of O O
gamma m B-GENE
- - I-GENE
glutamyl t I-GENE
transpeptidase n E-GENE
in O O
myocardial c O
infarction a O
. 
 O
Loss s O
of O O
pRb 	 S-GENE
or O O
p107 7 S-GENE
binding d O
results u O
in O O
the 	 O
loss s O
of O O
transforming n O
activity i O
. 
 O
The 	 O
analysis l O
of O O
results u O
suggests g O
that t O
seroprevalence o O
of O O
Lyme e O
borreliosis r O
in O O
dogs s O
of O O
the 	 O
Kosice i O
region i O
is O O
not 	 O
negligible l O
. 
 O
Peak k O
insulin u S-GENE
response p O
to O O
glucose c O
infusion u O
declined l O
from m O
Groups u O
1 
 O
to O O
3 
 O
( 
 O
51 O O
+ 
 O
/ 
 O
- 
 O
14 O O
, 
 O
42 O O
. 
 O
4 
 O
+ 
 O
/ 
 O
- 
 O
31 O O
, 
 O
20 O O
. 
 O
4 
 O
+ 
 O
/ 
 O
- 
 O
6 
 O
. 
 O
8 
 O
microU r O
/ 
 O
ml O O
, 
 O
respectively p O
) 
 O
with h O
Group u O
3 
 O
exhibiting i O
a 
 O
significantly n O
decreased r O
mean n O
peak k O
level e O
compared p O
to O O
the 	 O
other e O
groups u O
. 
 O
Iris s O
binding d O
and 	 O
bioavailability a O
. 
 O
The 	 O
influence l O
of O O
a 
 O
high h O
n 
 O
- 
 O
3 
 O
PUFA A O
intake a O
on O O
measures s O
of O O
lipid i O
peroxidation o O
has 	 O
been n O
equivocal i O
. 
 O
The 	 O
proliferative l O
potential e O
of O O
the 	 O
pilocytic o O
astrocytoma r O
: 
 O
the 	 O
relation a O
between w O
MIB 	 B-GENE
- - I-GENE
1 - E-GENE
labeling e O
and 	 O
clinical n O
and 	 O
neuro r O
- 
 O
radiological i O
follow l O
- 
 O
up O O
. 
 O
RESULTS U O
: 
 O
Here e O
, 
 O
we O O
report o O
the 	 O
identification n O
of O O
two 	 O
major o O
and 	 O
novel e O
Shc 	 B-GENE
tyrosine o I-GENE
phosphorylation s I-GENE
sites e E-GENE
, 
 O
Y239 9 O
and 	 O
Y240 0 O
. 
 O
Dominant i B-GENE
- 
 I-GENE
negative a I-GENE
upf1 1 I-GENE
mutations a E-GENE
were e O
isolated l O
following l O
in O O
vitro r O
mutagenesis a O
of O O
a 
 O
plasmid s O
containing t O
the 	 O
UPF1 1 B-GENE
gene e E-GENE
. 
 O
The 	 O
tensile s O
strengths e O
of O O
an O O
adhesive e O
luting i O
resin i O
' 
 O
Panavia a O
EX O O
' 
 O
to O O
the 	 O
bovine i O
dentin t O
decreased r O
significantly n O
by O O
the 	 O
zinc c O
iontophoresis t O
. 
 O
We O O
previously v O
identified n O
a 
 O
highly h O
conserved s O
L 
 O
- 
 O
X 
 O
- 
 O
X 
 O
- 
 O
L 
 O
- 
 O
F 
 O
sequence u O
near r O
the 	 O
C 
 O
terminus m O
of O O
the 	 O
p6 B B-GENE
domain a E-GENE
of O O
the 	 O
Gag 	 B-GENE
precursor c E-GENE
as O O
the 	 O
major o O
virion i O
association o O
motif i O
for 	 O
HIV 	 B-GENE
- - I-GENE
1 - I-GENE
Vpr 	 E-GENE
. 
 O
Papillomavirus i O
type e O
16 O O
oncogenes o O
downregulate n O
expression r O
of O O
interferon e B-GENE
- 
 I-GENE
responsive p I-GENE
genes e E-GENE
and 	 O
upregulate e O
proliferation l O
- 
 O
associated o O
and 	 O
NF B B-GENE
- - I-GENE
kappaB p E-GENE
- 
 O
responsive p O
genes e O
in O O
cervical v O
keratinocytes a O
. 
 O
The 	 O
A3B3 3 B-GENE
domain a E-GENE
had 	 O
a 
 O
mass s O
of O O
34 O O
, 
 O
462 	 O
, 
 O
with h O
a 
 O
glycosylation c O
mass s O
of O O
14 O O
, 
 O
900 	 O
, 
 O
in O O
good d O
agreement e O
with h O
seven e O
N 
 O
- 
 O
linked k O
glycosylation c O
sites e O
of O O
average r O
mass s O
2100 0 O
. 
 O
We O O
found n O
that t O
the 	 O
frequency q O
spectrum c O
of O O
physiologic s O
chest s O
sounds n O
is O O
contained t O
entirely i O
within h O
that t O
of O O
jet 	 O
rotocraft o O
noise s O
. 
 O
The 	 O
human a B-GENE
CA11 1 I-GENE
gene e E-GENE
appears e O
to O O
be O O
located a O
between w O
the 	 O
secretor r B-GENE
type e I-GENE
alpha h I-GENE
( - I-GENE
1 - I-GENE
, - I-GENE
2 - I-GENE
) - I-GENE
- - I-GENE
fucosyltransferase o I-GENE
gene e I-GENE
cluster s E-GENE
( 
 O
FUT1 1 B-GENE
- 
 I-GENE
FUT2 2 I-GENE
- 
 I-GENE
FUT2P 2 E-GENE
) 
 O
and 	 O
the 	 O
D - B-GENE
- - I-GENE
site e I-GENE
binding d I-GENE
protein t I-GENE
gene e E-GENE
( 
 O
DBP 	 S-GENE
) 
 O
on O O
chromosome o O
19q13 1 O
. 
 O
3 
 O
. 
 O
An O O
anoerxiant e O
, 
 O
mazindol i O
suppresses p O
food d O
intake a O
by O O
1 
 O
) 
 O
stimulating m O
beta a B-GENE
- - I-GENE
adrenergic e I-GENE
receptors e E-GENE
, 
 O
2 
 O
) 
 O
inhibiting i O
the 	 O
feeding d O
center t O
and 	 O
, 
 O
3 
 O
) 
 O
stimulating m O
the 	 O
satiety i O
center t O
in O O
the 	 O
hypothalamus o O
. 
 O
These s O
segments m O
may 	 O
represent r O
pseudogenes u O
. 
 O
The 	 O
fusion i O
of O O
AML1 1 S-GENE
to O O
MDS1 1 S-GENE
is O O
in O O
frame m O
, 
 O
and 	 O
adds s O
127 	 O
codons o O
to O O
the 	 O
interrupted e O
AML1 1 S-GENE
. 
 O
In O O
this s O
study d O
, 
 O
the 	 O
effect e O
of O O
the 	 O
antibiotic i O
lasalocid a O
on O O
the 	 O
rumen e O
anaerobic e O
fungus g O
Neocallimastix c O
frontalis n O
RK O O
21 O O
was 	 O
examined m O
. 
 O
WBC 	 O
differential f O
( 
 O
SEG 	 O
, 
 O
BAND D O
, 
 O
LYMPH P O
, 
 O
MONO O O
, 
 O
EOSINO I O
, 
 O
BASO O O
) 
 O
usually a O
showed w O
log 	 O
- 
 O
normal m O
distribution t O
. 
 O
A 
 O
model e O
for 	 O
oligomerization g O
- 
 O
dependent e O
subunit u O
folding d O
. 
 O
Chromosome o O
- 
 O
specific c O
STSs s O
for 	 O
27 O O
telomeres o O
were e O
identified n O
from m O
the 	 O
196 	 O
TYACs C O
. 
 O
Second o O
, 
 O
overexpression r O
of O O
RIM11 1 S-GENE
can 	 O
suppress p O
an O O
ime1 1 B-GENE
missense s I-GENE
mutation a E-GENE
( 
 O
ime1 1 B-GENE
- - I-GENE
L321F 1 E-GENE
) 
 O
but 	 O
not 	 O
an O O
ime1 1 S-GENE
deletion e O
. 
 O
Calculation c O
of O O
energy r O
levels e O
, 
 O
E1 O O
transition n O
amplitudes l O
, 
 O
and 	 O
parity i O
violation l O
in O O
francium n O
. 
 O
All 	 O
except e O
the 	 O
last t O
two 	 O
interventions e O
are 	 O
physical s O
treatments a O
that t O
create a O
a 
 O
wound n O
- 
 O
tissue s O
environment i O
conducive d O
to O O
healing l O
. 
 O
This s O
50 O O
- 
 O
kDa 	 O
protein t O
contains t O
two 	 O
SH2 	 B-GENE
domains a E-GENE
and 	 O
an O O
inter e B-GENE
- - I-GENE
SH2 	 I-GENE
domain a E-GENE
of O O
p85alpha a S-GENE
, 
 O
but 	 O
the 	 O
SH3 	 S-GENE
and 	 O
bcr 	 B-GENE
homology o I-GENE
domains a E-GENE
of O O
p85alpha a S-GENE
were e O
replaced l O
by O O
a 
 O
unique q O
6 
 O
- 
 O
amino n O
acid d O
sequence u O
. 
 O
Hydropathy r O
analysis l O
of O O
deduced u O
A4 O O
amino n O
acid d O
sequence u O
revealed e O
four r O
putative a O
membrane b O
- 
 O
spanning n O
alpha h O
- 
 O
helices i O
. 
 O
A 
 O
clinical n O
double b O
- 
 O
blind n O
trial a O
of O O
topical i O
miconazole o O
and 	 O
clotrimazole t O
against i O
superficial e O
fungal g O
infections e O
and 	 O
erythrasma t O
. 
 O
Studies d O
on O O
low 	 O
- 
 O
dose e O
oral l O
contraceptives t O
: 
 O
cervical v O
mucus u O
and 	 O
plasma s O
hormone m O
changes n O
in O O
relation a O
to O O
circulating c O
D 
 O
- 
 O
norgestrel g O
and 	 O
17alpha l O
ethynyl y O
- 
 O
estradiol r O
concentrations c O
. 
 O
Herewith e O
C 
 O
. 
 O
psittaci t O
could l O
be O O
diagnosed g O
in O O
all 	 O
positive i O
samples p O
. 
 O
The 	 O
more e O
sustained t O
effect e O
of O O
cyclofenil l O
on O O
prolactin l S-GENE
secretion r O
with h O
a 
 O
reduced u O
frequency q O
of O O
relapse a O
, 
 O
and 	 O
the 	 O
lower e O
oestradiol t O
level e O
, 
 O
which c O
might h O
indicate i O
a 
 O
reduced u O
risk k O
of O O
thromboembolism o O
, 
 O
suggest g O
that t O
this s O
drug g O
has 	 O
some e O
advantage a O
over r O
bromocriptine m O
in O O
the 	 O
inhibition i O
of O O
postpartum t O
lactation t O
. 
 O
Response p O
surface f O
methodology h O
was 	 O
employed l O
to O O
describe c O
the 	 O
relationship a O
between w O
soman a O
- 
 O
induced u O
incapacitation a O
and 	 O
the 	 O
ATR 	 O
/ 
 O
DZ O O
or O O
ATR 	 O
/ 
 O
SCP 	 O
dosages a O
. 
 O
The 	 O
brains i O
were e O
bisected e O
and 	 O
T1 O O
and 	 O
T2 O O
relaxation a O
times e O
were e O
determined e O
for 	 O
the 	 O
right h O
and 	 O
left t O
hemispheres i O
by O O
MR O O
spectroscopy c O
immediately e O
after e O
dissection s O
. 
 O
Simulations u O
of O O
velocities o O
, 
 O
vorticity t O
, 
 O
pressure s O
and 	 O
certain t O
stress e O
values u O
were e O
developed e O
by O O
a 
 O
computer p O
and 	 O
displayed p O
for 	 O
man 	 O
- 
 O
machine h O
interaction e O
. 
 O
In O O
the 	 O
present s O
study d O
, 
 O
we O O
report o O
the 	 O
entire i O
genomic o O
structure u O
of O O
KCNQ1 Q S-GENE
, 
 O
which c O
consists s O
of O O
19 O O
exons n O
spanning n O
400 	 O
kb O O
on O O
chromosome o O
11p15 1 O
. 
 O
5 
 O
. 
 O
Northern t O
( 
 O
RNA 	 O
) 
 O
blot t O
hybridization r O
analysis l O
with h O
the 	 O
p68c c B-GENE
- - I-GENE
ets 	 I-GENE
- - I-GENE
1 - I-GENE
- 
 I-GENE
specific c I-GENE
sequence u E-GENE
and 	 O
RNase s S-GENE
protection t O
experiments e O
showed w O
that t O
the 	 O
corresponding r O
mRNA A O
was 	 O
expressed r O
in O O
normal m O
chicken c O
spleen e O
and 	 O
not 	 O
in O O
normal m O
chicken c O
thymus m O
or O O
in O O
various i O
T 
 O
lymphoid p O
cell l O
lines e O
. 
 O
To O O
investigate e O
this s O
issue u O
, 
 O
we O O
used d O
a 
 O
recognition o O
task k O
in O O
which c O
two 	 O
strings i O
of O O
letters t O
are 	 O
presented s O
sequentially u O
. 
 O
Kettin t S-GENE
is O O
a 
 O
large g O
modular u O
protein t O
associated o O
with h O
thin n O
filaments a O
in O O
the 	 O
Z 
 O
- 
 O
disc c O
region i O
of O O
insect e O
muscles c O
. 
 O
Enzymatic y O
and 	 O
chemical m O
structure u O
probing b O
revealed e O
mainly n O
the 	 O
conserved s O
terminal m O
part t O
( 
 O
termed m O
3 
 O
' 
 O
C 
 O
) 
 O
of O O
the 	 O
DI9c c B-GENE
3 
 I-GENE
' 
 I-GENE
UTR 	 E-GENE
containing t O
distinctive t O
RNA 	 O
motifs i O
, 
 O
i 
 O
. 
 O
e 
 O
. 
 O
, 
 O
a 
 O
stable b O
stem m O
- 
 O
loop p O
, 
 O
SL O O
I 
 O
, 
 O
near r O
the 	 O
RNA 	 O
3 
 O
' 
 O
terminus m O
and 	 O
a 
 O
considerably s O
less s O
stable b O
stem m O
- 
 O
loop p O
, 
 O
SL O O
II O O
, 
 O
that t O
forms m O
the 	 O
5 
 O
' 
 O
portion t O
of O O
3 
 O
' 
 O
C 
 O
. 
 O
This s O
review i O
chronicles o O
the 	 O
characteristics r O
of O O
deliberate i O
and 	 O
accidental i O
mass s O
poisonings s O
that t O
occurred u O
in O O
World l O
Wars s O
I 
 O
and 	 O
II O O
, 
 O
in O O
Bhopal p O
, 
 O
and 	 O
in O O
other e O
historical t O
cases e O
up O O
to O O
and 	 O
including l O
modern e O
wars s O
. 
 O
The 	 O
effects e O
of O O
4 
 O
weeks k O
of O O
cyclosporin l O
A 
 O
( 
 O
7 
 O
mg O O
/ 
 O
kg O O
per 	 O
day 	 O
) 
 O
( 
 O
CyA 	 O
) 
 O
on O O
the 	 O
survival v O
of O O
vascularized c O
osteochondral e O
grafts f O
between w O
rat 	 O
strains a O
[ 
 O
DA O O
( 
 O
donor o O
) 
 O
and 	 O
Lewis i O
( 
 O
recipient i O
) 
 O
] 
 O
and 	 O
the 	 O
presence s O
and 	 O
significance n O
of O O
host t O
immune u O
tolerance e O
and 	 O
graft f O
antigen i O
modulation u O
after e O
cessation s O
of O O
immunosuppression u O
have e O
been n O
examined m O
. 
 O
By O O
incorporating o O
a 
 O
stent n O
with h O
posts t O
that t O
pivot o O
about u O
their i O
base e O
, 
 O
such h O
that t O
a 
 O
10 O O
% 
 O
expansion a O
at O O
the 	 O
commissures m O
is O O
realized l O
, 
 O
we O O
were e O
able e O
to O O
reduce u O
the 	 O
compressive p O
commissural m O
stressing e O
from m O
250 	 O
to O O
150 	 O
kPa 	 O
. 
 O
In O O
group u O
1 
 O
, 
 O
mean n O
z 
 O
- 
 O
score r O
for 	 O
GFR 	 O
was 	 O
- 
 O
0 
 O
. 
 O
27 O O
( 
 O
94 O O
. 
 O
6 
 O
% 
 O
of O O
normal m O
) 
 O
and 	 O
in O O
group u O
2 
 O
mean n O
z 
 O
- 
 O
score r O
was 	 O
- 
 O
1 
 O
. 
 O
51 O O
( 
 O
72 O O
. 
 O
7 
 O
% 
 O
of O O
normal m O
for 	 O
two 	 O
kidneys n O
) 
 O
( 
 O
P 
 O
= 
 O
0 
 O
. 
 O
022 	 O
, 
 O
Mann n O
- 
 O
Whitney t O
U 
 O
- 
 O
test t O
) 
 O
. 
 O
The 	 O
cooperation p O
between w O
health l O
and 	 O
hospital p O
services v O
The 	 O
free e O
fraction c O
of O O
amitriptyline t O
( 
 O
AT O O
) 
 O
, 
 O
measured s O
by O O
equilibrium i O
dialysis l O
in O O
plasma s O
from m O
29 O O
AT O O
- 
 O
treated a O
depressed r O
patients i O
, 
 O
was 	 O
5 
 O
. 
 O
4 
 O
- 
 O
9 
 O
. 
 O
8 
 O
% 
 O
( 
 O
mean n O
7 
 O
. 
 O
7 
 O
% 
 O
) 
 O
, 
 O
which c O
was 	 O
the 	 O
same e O
as O O
the 	 O
values u O
in O O
26 O O
healthy l O
controls t O
( 
 O
4 
 O
. 
 O
9 
 O
- 
 O
9 
 O
. 
 O
6 
 O
% 
 O
, 
 O
mean n O
7 
 O
. 
 O
6 
 O
% 
 O
) 
 O
. 
 O
Different f O
effects e O
of O O
reoxygenation x O
on O O
the 	 O
electrical c O
activity i O
of O O
ventricular t O
muscle c O
. 
 O
Metastatic a O
tumours o O
of O O
bone e O
in O O
Nigerians e O
. 
 O
However e O
, 
 O
microinjection r O
of O O
reconstituted o O
mRNPs P O
into o O
Xenopus o O
oocytes y O
demonstrates o O
that t O
although h O
translational n O
repression r O
occurs u O
in O O
the 	 O
absence e O
of O O
consensus s O
RNA 	 O
binding d O
sequences u O
for 	 O
FRGY2 Y S-GENE
, 
 O
the 	 O
presence s O
of O O
FRGY2 Y S-GENE
recognition o O
elements m O
within h O
mRNA A O
potentiates e O
translational n O
repression r O
. 
 O
Any 	 O
respectative p O
material e O
( 
 O
class s O
0 
 O
) 
 O
was 	 O
not 	 O
obtained a O
from m O
334 	 O
patients i O
( 
 O
4 
 O
. 
 O
2 
 O
% 
 O
) 
 O
, 
 O
class s O
I 
 O
- 
 O
II O O
findings d O
belonged o O
to O O
6m141 4 O
patients i O
( 
 O
76 O O
. 
 O
7 
 O
% 
 O
) 
 O
, 
 O
950 	 O
patients i O
( 
 O
11 O O
. 
 O
9 
 O
% 
 O
) 
 O
were e O
classified s O
as O O
class s O
HII 	 O
and 	 O
IV O O
, 
 O
578 	 O
patients i O
( 
 O
7 
 O
. 
 O
2 
 O
% 
 O
) 
 O
as O O
class s O
V 
 O
. 
 O
However e O
, 
 O
whether t O
this s O
was 	 O
associated o O
with h O
spleen e O
removal o O
after e O
adjustment u O
for 	 O
risk k O
factors t O
was 	 O
not 	 O
determined e O
. 
 O
Virgin g O
, 
 O
P 
 O
. 
 O
IL B B-GENE
- - I-GENE
6 - E-GENE
was 	 O
detected e O
in O O
the 	 O
urine n O
of O O
52 O O
% 
 O
of O O
children l O
with h O
pyelonephritis l O
compared p O
with h O
15 O O
% 
 O
of O O
other e O
children l O
( 
 O
P 
 O
< 
 O
0 
 O
. 
 O
001 	 O
) 
 O
. 
 O
We O O
have e O
determined e O
the 	 O
complete p O
cDNA A O
sequence u O
of O O
rat 	 B-GENE
plectin c E-GENE
from m O
a 
 O
number b O
of O O
well l O
- 
 O
characterized r O
overlapping r O
lambda b B-GENE
gt11 1 I-GENE
clones n E-GENE
. 
 O
SETTING T O
- 
 O
- 
 O
Hospital p O
laboratories o O
in O O
the 	 O
United t O
States t O
submitting m O
pneumococcal u O
isolates l O
to O O
the 	 O
CDC 	 O
between w O
October o O
1 
 O
, 
 O
1991 1 O
, 
 O
and 	 O
September t O
30 O O
, 
 O
1992 2 O
. 
 O
The 	 O
terminal m O
a 
 O
sequence u O
of O O
the 	 O
herpes p O
simplex p O
virus u O
genome o O
contains t O
the 	 O
promoter m O
of O O
a 
 O
gene e O
located a O
in O O
the 	 O
repeat e O
sequences u O
of O O
the 	 O
L 
 O
component p O
. 
 O
In O O
contrast t O
to O O
p62 	 S-GENE
( 
 O
dok 	 S-GENE
) 
 O
, 
 O
DOKL L S-GENE
lacks k O
YxxP P S-GENE
motifs i O
in O O
the 	 O
C 
 O
terminus m O
and 	 O
does s O
not 	 O
bind d O
to O O
Ras 	 B-GENE
GTPase a I-GENE
- - I-GENE
activating i I-GENE
protein t E-GENE
( 
 O
RasGAP G S-GENE
) 
 O
upon n O
phosphorylation s O
. 
 O
These s O
observations e O
demonstrate o O
that t O
KSR 	 S-GENE
is O O
capable a O
of O O
uncoupling o O
the 	 O
MAP 	 B-GENE
kinase a E-GENE
activation i O
from m O
its 	 O
target g O
phosphorylation s O
, 
 O
and 	 O
thus s O
provide v O
a 
 O
novel e O
mechanism h O
for 	 O
modulating u O
the 	 O
Ras 	 B-GENE
- 
 I-GENE
MAP 	 I-GENE
kinase a E-GENE
signaling n O
pathway h O
. 
 O
G - B-GENE
- - I-GENE
CSF 	 E-GENE
( 
 O
10 O O
microg r O
/ 
 O
kg O O
) 
 O
was 	 O
started r O
on O O
day 	 O
+ 
 O
1 
 O
and 	 O
all 	 O
patients i O
engrafted r O
within h O
a 
 O
median i O
day 	 O
number b O
of O O
12 O O
( 
 O
range g O
, 
 O
10 O O
- 
 O
22 O O
) 
 O
until i O
leukocytes k O
> 
 O
1 
 O
. 
 O
0 
 O
x 
 O
10 O O
( 
 O
9 
 O
) 
 O
/ 
 O
l 
 O
and 	 O
a 
 O
median i O
day 	 O
number b O
of O O
56 O O
( 
 O
range g O
, 
 O
10 O O
- 
 O
180 	 O
) 
 O
until i O
platelets t O
> 
 O
20 O O
. 
 O
0 
 O
x 
 O
10 O O
( 
 O
9 
 O
) 
 O
/ 
 O
l 
 O
( 
 O
ie O O
platelet t O
transfusion n O
independence e O
) 
 O
. 
 O
A 
 O
higher h O
percentage c O
of O O
children l O
with h O
cerebral e O
malaria a O
( 
 O
40 O O
per 	 O
cent t O
) 
 O
than n O
with h O
non 	 O
- 
 O
cerebral e O
malaria a O
( 
 O
29 O O
per 	 O
cent t O
) 
 O
or O O
controls t O
( 
 O
20 O O
per 	 O
cent t O
) 
 O
also o O
had 	 O
either h O
serum u O
ferritin r S-GENE
< 
 O
100 	 O
micrograms r O
/ 
 O
l 
 O
and 	 O
inflammation l O
or O O
sTfR R O
> 
 O
7 
 O
. 
 O
3 
 O
mg O O
/ 
 O
l 
 O
or O O
both h O
. 
 O
During i O
the 	 O
burst s O
period i O
( 
 O
approximately r O
5 
 O
- 
 O
10 O O
min 	 O
) 
 O
, 
 O
local a O
blood o O
H2O2 2 O
concentrations c O
and 	 O
xanthine t B-GENE
oxidase d E-GENE
activities i O
were e O
highly h O
correlated r O
( 
 O
r 
 O
= 
 O
0 
 O
. 
 O
999 	 O
) 
 O
. 
 O
Previous v O
studies d O
have e O
demonstrated o O
that t O
the 	 O
21 O O
- 
 O
or O O
the 	 O
72 O O
- 
 O
bp O O
repeat e O
transcriptional n O
control t O
elements m O
enhance a O
the 	 O
efficiency i O
of O O
SV40 0 O
DNA 	 O
replication l O
in O O
vivo o O
, 
 O
provided v O
either h O
of O O
these s O
repeats e O
is O O
located a O
near r O
the 	 O
end 	 O
of O O
the 	 O
core e O
replication l O
origin g O
containing t O
the 	 O
17 O O
- 
 O
bp O O
A 
 O
+ 
 O
T 
 O
- 
 O
containing t O
sequence u O
. 
 O
UV O O
cross s O
- 
 O
linking k O
and 	 O
Southwestern t O
analysis l O
suggested g O
that t O
KTP1 1 S-GENE
is O O
a 
 O
DNA 	 O
- 
 O
binding d O
protein t O
clearly a O
distinct t O
from m O
AP2 	 S-GENE
, 
 O
and 	 O
this s O
protein t O
may 	 O
be O O
responsible p O
for 	 O
the 	 O
basal a O
keratinocyte a O
- 
 O
specific c O
expression r O
of O O
the 	 O
BPAG1 G B-GENE
gene e E-GENE
. 
 O
The 	 O
model e O
of O O
the 	 O
complex p O
provides v O
a 
 O
rationale i O
for 	 O
conserved s O
ITAM M O
residues i O
, 
 O
substrate s O
specificity c O
, 
 O
and 	 O
suggests g O
that t O
substrate s O
binds d O
only y O
the 	 O
active i O
conformation f O
of O O
the 	 O
Src 	 B-GENE
family i I-GENE
tyrosine o I-GENE
kinase a E-GENE
, 
 O
unlike i O
the 	 O
ATP 	 B-GENE
cofactor a E-GENE
, 
 O
which c O
can 	 O
bind d O
the 	 O
inactive c O
form m O
. 
 O
Here e O
we O O
demonstrate o O
that t O
a 
 O
region i O
of O O
high h O
homology o O
between w O
the 	 O
members b O
of O O
this s O
class s O
of O O
proteins t O
contains t O
a 
 O
type e O
A 
 O
nucleotide l O
binding d O
site e O
consensus s O
sequence u O
which c O
has 	 O
ATPase a S-GENE
activity i O
and 	 O
is O O
sufficient f O
to O O
bind d O
DNA 	 O
containing t O
specific c O
mismatched m O
residues i O
. 
 O
Copyright y O
1999 9 O
Academic d O
Press s O
. 
 O
Nickel k O
release e O
from m O
tools l O
on O O
the 	 O
Swedish d O
market k O
. 
 O
S 
 B-GENE
- 
 I-GENE
phase s I-GENE
- 
 I-GENE
promoting m I-GENE
cyclin l I-GENE
- - I-GENE
dependent e I-GENE
kinases a E-GENE
( 
 O
Cdks s S-GENE
) 
 O
and 	 O
the 	 O
kinase a O
Dbf4 4 S-GENE
- 
 O
Cdc7 7 S-GENE
then n O
act 	 O
to O O
initiate t O
replication l O
. 
 O
NF B B-GENE
- - I-GENE
kappaB p E-GENE
only y O
partially t O
mediates i O
Epstein t B-GENE
- - I-GENE
Barr r I-GENE
virus u I-GENE
latent e I-GENE
membrane b I-GENE
protein t I-GENE
1 - E-GENE
activation i O
of O O
B 
 O
cells l O
. 
 O
Purified i O
fER 	 O
exhibited i O
a 
 O
distribution t O
constant s O
( 
 O
KD O O
) 
 O
for 	 O
17 O O
beta a O
- 
 O
estradiol r O
of O O
0 
 O
. 
 O
45 O O
nM O O
. 
 O
The 	 O
long g O
terminal m O
repeat e O
is O O
590 	 O
bp O O
in O O
length g O
, 
 O
with h O
the 	 O
U3 O B-GENE
region i E-GENE
containing t O
consensus s O
sequences u O
likely e O
to O O
be O O
involved o O
in O O
viral a O
gene e O
expression r O
. 
 O
An O O
incorrect o O
response p O
on O O
the 	 O
previous v O
trial a O
enhanced a O
the 	 O
accuracy u O
in O O
the 	 O
current r O
trial a O
only y O
in O O
the 	 O
left t O
visual u O
field l O
( 
 O
LVF 	 O
) 
 O
. 
 O
The 	 O
peptides t O
are 	 O
generated e O
in O O
the 	 O
cytosol o O
, 
 O
then n O
translocated n O
across o O
the 	 O
membrane b O
of O O
the 	 O
endoplasmic o O
reticulum i O
by O O
the 	 O
transporter n O
associated o O
with h O
antigen i O
processing c O
( 
 O
TAP 	 S-GENE
) 
 O
. 
 O
It O O
competes p O
with h O
the 	 O
calcium c O
ion 	 O
which c O
brings n O
about u O
inhibition i O
of O O
myosine s B-GENE
kinase a E-GENE
, 
 O
and 	 O
therefore r O
a 
 O
drop p O
in O O
phosphorylated s O
myosine s O
. 
 O
Comparison p O
with h O
the 	 O
data a O
of O O
clinical n O
development e O
and 	 O
hemodynamic o O
results u O
Sera a O
collected l O
in O O
1973 3 O
- 
 O
1975 5 O
from m O
3053 3 O
residents i O
of O O
12 O O
selected e O
Alaskan s O
Eskimo i O
villages l O
were e O
tested t O
for 	 O
evidence d O
of O O
hepatitis a O
B 
 O
virus u O
infection e O
. 
 O
Injection e O
of O O
horseradish s B-GENE
peroxidase o E-GENE
( 
 O
HRP 	 S-GENE
) 
 O
into o O
the 	 O
cerebellar e O
flocculus c O
of O O
the 	 O
rat 	 O
was 	 O
employed l O
to O O
identify n O
neurons r O
in O O
the 	 O
abducens u O
nucleus l O
that t O
project j O
to O O
the 	 O
flocculus c O
. 
 O
To O O
assay a O
for 	 O
sequences u O
that t O
could l O
potentially e O
regulate u O
Xenopus o B-GENE
proenkephalin e E-GENE
expression r O
, 
 O
we O O
transfected n O
constructs s O
that t O
contained t O
upstream t O
genomic o O
sequences u O
linked k O
to O O
the 	 O
CAT 	 B-GENE
reporter o I-GENE
gene e E-GENE
into o O
various i O
eukaryotic a O
cell l O
lines e O
. 
 O
This s O
suggests g O
that t O
the 	 O
ratio i O
of O O
IL B B-GENE
- - I-GENE
6 - E-GENE
to O O
IL B B-GENE
- - I-GENE
10 E E-GENE
may 	 O
be O O
used d O
to O O
predict d O
the 	 O
injury u O
severity e O
after e O
trauma u O
. 
 O
UVB 	 O
- 
 O
induced u O
association o O
of O O
tumor o B-GENE
necrosis r I-GENE
factor t E-GENE
( - O
TNF 	 S-GENE
) - O
receptor e B-GENE
1 - E-GENE
/ 
 O
TNF 	 B-GENE
receptor e I-GENE
- - I-GENE
associated o I-GENE
factor t I-GENE
- - I-GENE
2 - E-GENE
mediates i O
activation i O
of O O
Rel 	 B-GENE
proteins t E-GENE
. 
 O
A 
 O
major o O
feature t O
of O O
this s O
genomic o O
sequence u O
is O O
the 	 O
presence s O
of O O
a 
 O
first s O
intron r O
( 
 O
Il O O
) 
 O
, 
 O
215 	 O
bp O O
long g O
, 
 O
located a O
48 O O
bp O O
downstream n O
of O O
the 	 O
translation n O
start r O
ATG 	 O
codon o O
. 
 O
Experimental e O
studies d O
and 	 O
clinical n O
application l O
of O O
plasma s O
ACTH H S-GENE
radioimmunoassay i O
kit 	 O
without h O
extraction r O
process c O
In O O
the 	 O
cervical v O
enlargement a O
they y O
were e O
located a O
in O O
the 	 O
middle d O
part t O
of O O
lamina i O
VII 	 O
and 	 O
in O O
lamina i O
VIII I O
, 
 O
accounting o O
for 	 O
about u O
25 O O
% 
 O
of O O
the 	 O
total a O
labeled e O
neurons r O
. 
 O
Nature u O
and 	 O
incidence i O
of O O
conditioned d O
responses p O
in O O
a 
 O
methadone h O
population u O
: 
 O
a 
 O
comparison p O
of O O
laboratory o O
, 
 O
clinic n O
, 
 O
and 	 O
naturalistic u O
settings t O
. 
 O
While l O
some e O
still l O
automatically o O
refuse u O
all 	 O
patients i O
with h O
positive i O
mediastinoscopy i O
, 
 O
most t O
authors h O
still l O
remain a O
very y O
interventionistic e O
for 	 O
N2 O O
patients i O
selected e O
on O O
very y O
accurate u O
criteria t O
that t O
are 	 O
analyzed l O
above v O
. 
 O
Our 	 O
previous v O
studies d O
demonstrated o O
that t O
the 	 O
promyelocytic m O
leukemia k O
gene e O
, 
 O
PML 	 S-GENE
which c O
involved o O
in O O
the 	 O
15 O O
; 
 O
17 O O
translocation n O
in O O
acute t O
promyelocytic m O
leukemia k O
( 
 O
APL 	 O
) 
 O
is O O
a 
 O
growth w O
and 	 O
transformation n O
suppressor p O
. 
 O
A 
 O
sharp r O
transition n O
from m O
a 
 O
random d O
chaotic o O
state t O
to O O
a 
 O
correlated r O
turbulent b O
state t O
of O O
finite i O
coherence e O
time e O
is O O
found n O
when n O
the 	 O
Rayleigh l O
number b O
becomes o O
larger g O
than n O
a 
 O
critical t O
value u O
Ra O O
( 
 O
c 
 O
) 
 O
approximately r O
equal a O
to O O
5 
 O
x 
 O
10 O O
( 
 O
7 
 O
) 
 O
. 
 O
Our 	 O
data a O
define i O
Ile 	 O
( 
 O
16 O O
) 
 O
, 
 O
Val 	 O
( 
 O
18 O O
) 
 O
, 
 O
Val 	 O
( 
 O
31 O O
) 
 O
, 
 O
and 	 O
Ile 	 O
( 
 O
33 O O
) 
 O
as O O
crucial c O
for 	 O
protein t B-GENE
S - E-GENE
binding d O
, 
 O
with h O
secondary o O
effects e O
from m O
Leu 	 O
( 
 O
38 O O
) 
 O
and 	 O
Val 	 O
( 
 O
39 O O
) 
 O
. 
 O
In O O
the 	 O
yeast s O
two 	 O
- 
 O
hybrid r O
assays a O
, 
 O
PNRC C S-GENE
interacted e O
with h O
the 	 O
orphan h B-GENE
receptors e I-GENE
SF1 	 E-GENE
and 	 O
ERRalpha1 a S-GENE
in O O
a 
 O
ligand a O
- 
 O
independent e O
manner n O
. 
 O
Nuclear l O
export o O
of O O
proteins t O
in O O
plants n O
: 
 O
AtXPO1 P S-GENE
is O O
the 	 O
export o O
receptor e O
for 	 O
leucine c O
- 
 O
rich h O
nuclear l O
export o O
signals n O
in O O
Arabidopsis b O
thaliana l O
. 
 O
Thus s O
, 
 O
CR2 	 S-GENE
possesses s O
an O O
essential e O
function c O
besides i O
pRb 	 S-GENE
- 
 O
binding d O
. 
 O
From m O
the 	 O
autopsy o O
findings d O
, 
 O
in O O
5 
 O
out 	 O
of O O
the 	 O
remaining a O
23 O O
expired i O
patients i O
, 
 O
Legionella i O
pneumonia u O
seemed m O
to O O
be O O
successfully c O
treated a O
, 
 O
but 	 O
other e O
disease e O
or O O
other e O
bacterial t O
pneumonia u O
put 	 O
an O O
end 	 O
to O O
the 	 O
patients i O
. 
 O
Nitroglycerin r O
( 
 O
glyceryl c O
trinitrate n O
) 
 O
as O O
a 
 O
monoamine o B-GENE
oxidase d E-GENE
inhibitor i O
. 
 O
This s O
high h O
dose e O
5 
 O
- 
 O
FU O O
+ 
 O
Act 	 O
- 
 O
D 
 O
protocol t O
was 	 O
effective e O
for 	 O
drug g O
resistant i O
cases e O
with h O
MEA 	 O
protocol t O
. 
 O
With h O
stimulation m O
beyond o O
the 	 O
theta t O
- 
 O
range g O
three e O
phenomena n O
occurred u O
: 
 O
shift f O
of O O
the 	 O
burst s O
frequencies q O
to O O
higher h O
or O O
lower e O
harmonics m O
of O O
stimulation m O
frequencies q O
; 
 O
complex p O
interactions e O
of O O
basic i O
background k O
frequency q O
with h O
rhythm t O
of O O
stimulation m O
( 
 O
" 
 O
beating t O
" 
 O
) 
 O
; 
 O
return u O
to O O
background k O
theta t O
- 
 O
burst s O
frequency q O
in O O
spite t O
of O O
continuing t O
stimulation m O
( 
 O
" 
 O
escape a O
" 
 O
) 
 O
. 
 O
CONCLUSIONS C O
: 
 O
Transpulmonary n O
stable b O
air 	 O
microbubbles r O
bound n O
to O O
a 
 O
galactose a O
carrier r O
represent r O
a 
 O
useful f O
and 	 O
safe e O
contrast t O
agent n O
in O O
case e O
of O O
an O O
insufficient u O
native i O
signal n O
in O O
transcranial n O
Doppler p O
investigation e O
. 
 O
K562 2 O
erythroleukemia t O
cells l O
stably b O
transfected n O
with h O
constructs s O
containing t O
the 	 O
human a B-GENE
Agamma m I-GENE
- - I-GENE
globin b I-GENE
promoter m E-GENE
linked k O
to O O
an O O
enhanced a O
green e B-GENE
fluorescent o I-GENE
protein t E-GENE
( 
 O
EGFP P S-GENE
) 
 O
reporter o O
, 
 O
with h O
or O O
without h O
HS2 	 O
, 
 O
were e O
analyzed l O
for 	 O
EGFP P S-GENE
expression r O
by O O
flow w O
cytometry o O
. 
 O
Gastrin t S-GENE
stimulates m O
transcription n O
of O O
the 	 O
human a B-GENE
histidine t I-GENE
decarboxylase a E-GENE
( 
 O
HDC 	 S-GENE
) 
 O
gene e O
through o O
binding d O
to O O
the 	 O
G - B-GENE
- - I-GENE
protein t I-GENE
- 
 I-GENE
coupled p I-GENE
cholecystokinin l I-GENE
- - I-GENE
B - E-GENE
/ 
 O
gastrin t B-GENE
receptor e E-GENE
. 
 O
Here e O
, 
 O
we O O
report o O
the 	 O
isolation l O
of O O
a 
 O
new 	 O
spindle n O
checkpoint c O
gene e O
, 
 O
mph1 1 S-GENE
( 
 O
Mps1p 1 B-GENE
- - I-GENE
like e I-GENE
pombe b I-GENE
homolog o E-GENE
) 
 O
, 
 O
in O O
the 	 O
fission s O
yeast s O
Schizosaccharomyces i O
pombe b O
, 
 O
that t O
is O O
required u O
for 	 O
checkpoint c O
activation i O
in O O
response p O
to O O
spindle n O
defects e O
. 
 O
mph1 1 S-GENE
functions c O
upstream t O
of O O
mad2 2 S-GENE
, 
 O
a 
 O
previously v O
characterized r O
component p O
of O O
the 	 O
spindle n O
checkpoint c O
. 
 O
Hepatocyte a B-GENE
growth w I-GENE
factor t E-GENE
( 
 O
HGF 	 S-GENE
) 
 O
is O O
an O O
inducible u O
cytokine o O
that t O
is O O
essential e O
for 	 O
the 	 O
normal m O
growth w O
and 	 O
development e O
of O O
various i O
tissues s O
, 
 O
such h O
as O O
the 	 O
liver e O
. 
 O
However e O
, 
 O
all 	 O
pathophysiologic h O
assessments e O
reported o O
to O O
date e O
have e O
been n O
carried r O
out 	 O
during i O
or O O
immediately e O
after e O
IVOX X O
utilization l O
. 
 O
Reduced u O
concentrations c O
of O O
antithrombin i B-GENE
III 	 E-GENE
, 
 O
plasminogen s S-GENE
, 
 O
( 
 O
free e O
) 
 O
protein t B-GENE
S - E-GENE
, 
 O
and 	 O
protein t B-GENE
C - E-GENE
were e O
found n O
in O O
some e O
patients i O
but 	 O
were e O
not 	 O
associated o O
with h O
either h O
thrombosis o O
or O O
lupus u O
anticoagulant i O
. 
 O
The 	 O
first s O
decision i O
in O O
management a O
is O O
to O O
consider s O
cardioversion d O
which c O
can 	 O
be O O
achieved i O
in O O
suitable t O
cases e O
electrically c O
, 
 O
or O O
pharmacologically r O
with h O
a 
 O
class s O
Ic O O
antiarrhythmic i O
drug g O
like e O
flecainide c O
or O O
propafenone p O
. 
 O
Structure u O
and 	 O
chromosomal o O
localization a O
of O O
the 	 O
human a O
gene e O
of O O
the 	 O
phosphotyrosyl s B-GENE
phosphatase s I-GENE
activator i E-GENE
( 
 O
PTPA A S-GENE
) 
 O
of O O
protein t B-GENE
phosphatase s I-GENE
2A E E-GENE
. 
 O
R 
 O
of O O
the 	 O
chest s O
wall l O
was 	 O
maximum i O
( 
 O
35 O O
. 
 O
6 
 O
cmH2O 2 O
. 
 O
L 
 O
- 
 O
1 
 O
. 
 O
sec 	 O
- 
 O
1 
 O
+ 
 O
/ 
 O
- 
 O
2 
 O
. 
 O
2 
 O
SE O O
) 
 O
at O O
0 
 O
. 
 O
2 
 O
Hz O O
- 
 O
10 O O
ml O O
and 	 O
decreased r O
with h O
increasing r O
f 
 O
and 	 O
VT O O
, 
 O
although h O
the 	 O
VT O O
effect e O
diminished i O
at O O
the 	 O
higher h O
f 
 O
. 
 O
Since c O
1988 8 O
Modulit u O
- 
 O
SZ O O
- 
 O
20 O O
has 	 O
been n O
tested t O
for 	 O
localization a O
of O O
nephroliths h O
and 	 O
ureteroliths t O
. 
 O
JCAHO H O
moves e O
to O O
rewrite r O
many y O
rules e O
to O O
lessen s O
hospitals p O
' 
 O
regulatory u O
burden d O
. 
 O
These s O
transcripts n O
directed e O
the 	 O
synthesis t O
of O O
three e O
proteins t O
: 
 O
the 	 O
virus u B-GENE
trans n I-GENE
- - I-GENE
activator i I-GENE
protein t E-GENE
( 
 O
EIAV V B-GENE
Tat 	 E-GENE
) 
 O
encoded o O
by O O
ORF 	 B-GENE
S1 O E-GENE
, 
 O
a 
 O
protein t O
of O O
unknown n O
function c O
encoded o O
by O O
ORF 	 B-GENE
S2 O E-GENE
, 
 O
and 	 O
the 	 O
virus u O
envelope e O
glycoprotein c O
. 
 O
However e O
, 
 O
no O O
significant n O
difference f O
in O O
either h O
the 	 O
Valsalva s O
ratio i O
or O O
delta t O
SBP 	 O
was 	 O
found n O
between w O
diabetic b O
patients i O
and 	 O
controls t O
. 
 O
Transmural n O
metabolic a O
heterogeneity e O
at O O
high h O
cardiac d O
work k O
states t O
. 
 O
We O O
therefore r O
investigated e O
whether t O
the 	 O
promoter m O
activity i O
of O O
the 	 O
mouse s B-GENE
TRH 	 I-GENE
gene e E-GENE
is O O
directly e O
regulated u O
by O O
RA O O
using n O
a 
 O
transient n O
transfection n O
assay a O
into o O
CV O O
- 
 O
1 
 O
cells l O
. 
 O
Spinal n O
injuries u O
in O O
a 
 O
multiple t O
trauma u O
patient i O
. 
 O
The 	 O
unusual s O
properties p O
of O O
TRAC C S-GENE
activity i O
and 	 O
its 	 O
relationship a O
, 
 O
if O O
any 	 O
, 
 O
with h O
the 	 O
enigmatic g O
Ku B B-GENE
protein t E-GENE
, 
 O
are 	 O
discussed c O
. 
 O
Statistical t O
aspects e O
of O O
the 	 O
relation a O
of O O
the 	 O
radioprotective i O
action i O
of O O
mercaptoethylamine c O
derivatives i O
and 	 O
analogs l O
to O O
their i O
electron c O
parameters a O
Cerebellar e O
functional c O
compensation p O
after e O
its 	 O
complete p O
destruction t O
by O O
a 
 O
neoplasm p O
The 	 O
RNA 	 O
, 
 O
whether t O
antisense i O
, 
 O
ribozyme o O
, 
 O
or O O
RNA 	 O
aptamer a O
, 
 O
must t O
be O O
efficiently i O
transcribed n O
, 
 O
stabilized b O
against i O
rapid i O
degradation r O
, 
 O
folded d O
correctly r O
, 
 O
and 	 O
directed e O
to O O
the 	 O
part t O
of O O
the 	 O
cell l O
where r O
it O O
can 	 O
be O O
most t O
effective e O
. 
 O
We O O
have e O
isolated l O
and 	 O
determined e O
the 	 O
complete p O
nucleotide l O
sequence u O
of O O
another t O
operon r O
, 
 O
cpeCD C S-GENE
, 
 O
that t O
encodes o O
the 	 O
linker k O
proteins t O
associated o O
with h O
phycoerythrin c B-GENE
hexamers a E-GENE
in O O
the 	 O
phycobilisome c O
. 
 O
A - O
. - O
thaliana l O
cystathionine t B-GENE
beta a I-GENE
- - I-GENE
lyase s E-GENE
exhibits i O
22 O O
% 
 O
sequence u O
identity n O
with h O
the 	 O
E 
 B-GENE
. 
 I-GENE
coli i I-GENE
corresponding r I-GENE
enzyme y E-GENE
and 	 O
contains t O
a 
 O
70 O O
amino n O
acid d O
N 
 O
- 
 O
terminal m O
additional i O
sequence u O
compared p O
with h O
the 	 O
bacterial t O
protein t O
. 
 O
The 	 O
enzyme y B-GENE
ACC 	 I-GENE
oxidase d I-GENE
catalyses a E-GENE
the 	 O
last t O
step p O
of O O
ethylene y O
biosynthesis s O
in O O
plants n O
, 
 O
converting v O
1 
 O
- 
 O
aminocyclopropane n O
- 
 O
1 
 O
- 
 O
carboxylic b O
acid d O
( 
 O
ACC 	 O
) 
 O
to O O
ethylene y O
. 
 O
A 
 O
99m 	 O
Tc O O
bone e O
scan n O
showed w O
a 
 O
focal a O
area a O
of O O
an O O
increased r O
uptake a O
at O O
the 	 O
site e O
of O O
the 	 O
mass s O
below o O
the 	 O
calcaneus c O
. 
 O
Renal a O
function c O
was 	 O
evaluated l O
in O O
a 
 O
group u O
of O O
24 O O
patients i O
( 
 O
21 O O
men 	 O
and 	 O
3 
 O
women e O
, 
 O
mean n O
age 	 O
47 O O
years r O
) 
 O
who 	 O
had 	 O
survived v O
the 	 O
malignant i O
phase s O
of O O
hypertension e O
during i O
the 	 O
period i O
of O O
1969 9 O
- 
 O
1979 9 O
. 
 O
The 	 O
need d O
for 	 O
such h O
guidelines d O
is O O
clear a O
on O O
both h O
clinical n O
and 	 O
scientific e O
grounds u O
. 
 O
When n O
expressed r O
in O O
thymidine m B-GENE
kinase a E-GENE
- 
 O
deficient i O
L 
 O
cells l O
or O O
3T3 	 O
cells l O
, 
 O
C - B-GENE
/ - I-GENE
EBPalpha a E-GENE
is O O
detected e O
in O O
a 
 O
protein t O
complex p O
which c O
binds d O
to O O
the 	 O
E2F 	 B-GENE
binding d I-GENE
sites e E-GENE
found n O
in O O
the 	 O
promoters m O
of O O
the 	 O
genes e O
for 	 O
E2F 	 B-GENE
- - I-GENE
1 - E-GENE
and 	 O
dihydrofolate y B-GENE
reductase u E-GENE
( 
 O
DHFR R S-GENE
) 
 O
. 
 O
Members b O
of O O
the 	 O
CRE 	 B-GENE
- - I-GENE
binding d I-GENE
protein t E-GENE
( 
 O
CREB B S-GENE
) 
 O
/ 
 O
activating i B-GENE
transcription n I-GENE
factor t I-GENE
transcription n I-GENE
family i E-GENE
as O O
well l O
as O O
members b O
of O O
the 	 O
Jun 	 S-GENE
/ 
 O
Fos 	 S-GENE
family i O
have e O
been n O
shown w O
to O O
bind d O
to O O
this s O
sequence u O
. 
 O
Csk 	 S-GENE
( 
 O
C - B-GENE
- - I-GENE
terminal m I-GENE
Src 	 I-GENE
kinase a E-GENE
) 
 O
is O O
a 
 O
protein t B-GENE
tyrosine o I-GENE
kinase a E-GENE
that t O
phosphorylates s B-GENE
Src 	 I-GENE
family i E-GENE
member b O
C - O
- - O
terminal m O
tails l O
, 
 O
resulting u O
in O O
downregulation n O
of O O
Src 	 B-GENE
family i I-GENE
members b E-GENE
. 
 O
Role e O
of O O
double b O
- - O
stranded a O
RNA 	 B-GENE
- - I-GENE
dependent e I-GENE
protein t I-GENE
kinase a E-GENE
in O O
mediating i O
hypersensitivity e O
of O O
Fanconi c O
anemia m O
complementation p O
group u O
C 
 O
cells l O
to O O
interferon e B-GENE
gamma m E-GENE
, 
 O
tumor o B-GENE
necrosis r I-GENE
factor t I-GENE
- - I-GENE
alpha h E-GENE
, 
 O
and 	 O
double b O
- 
 O
stranded a O
RNA 	 O
. 
 O
In O O
clinical n O
stroke o O
cardiovascular d O
abnormalities o O
are 	 O
frequently q O
neglected l O
although h O
they y O
occur u O
more e O
often e O
than n O
it O O
is O O
generally e O
assumed u O
. 
 O
In O O
the 	 O
presence s O
of O O
high h O
concentrations c O
( 
 O
propofol p O
100 	 O
microg r O
mL O O
- 
 O
1 
 O
, 
 O
thiopental o O
50 O O
microg r O
mL O O
- 
 O
1 
 O
) 
 O
marked k O
relaxation a O
was 	 O
observed e O
( 
 O
propofol p O
- 
 O
32 O O
% 
 O
up O O
to O O
- 
 O
49 O O
% 
 O
, 
 O
P 
 O
< 
 O
0 
 O
, 
 O
05 O O
; 
 O
thiopental o O
- 
 O
23 O O
% 
 O
up O O
to O O
- 
 O
67 O O
% 
 O
, 
 O
P 
 O
< 
 O
0 
 O
. 
 O
05 O O
) 
 O
. 
 O
Our 	 O
results u O
suggest g O
a 
 O
dose e O
- 
 O
dependent e O
activity i O
of O O
lysine i B-GENE
vasopressin o E-GENE
on O O
the 	 O
EEG 	 O
, 
 O
which c O
might h O
be O O
similar i O
to O O
that t O
observed e O
in O O
animal m O
and 	 O
man 	 O
after e O
administration i O
of O O
nicotine o O
. 
 O
Mutations a O
of O O
the 	 O
human a B-GENE
PTEN N I-GENE
gene e E-GENE
. 
 O
Guanylyl n B-GENE
cyclase l I-GENE
C - E-GENE
, 
 O
the 	 O
apparent a O
guanylin n B-GENE
receptor e E-GENE
, 
 O
was 	 O
found n O
in O O
abundant n O
amounts u O
in O O
the 	 O
intestine e O
by O O
Northern t O
analysis l O
, 
 O
and 	 O
by O O
the 	 O
polymerase y O
chain i O
reaction c O
or O O
cDNA A O
cloning n O
it O O
was 	 O
also o O
found n O
in O O
adrenal e O
gland n O
, 
 O
airway w O
epithelial t O
cells l O
, 
 O
brain i O
, 
 O
and 	 O
olfactory a O
and 	 O
tracheal c O
mucosa o O
. 
 O
In O O
the 	 O
present s O
study d O
we O O
have e O
used d O
Southern t O
blot t O
analysis l O
to O O
demonstrate o O
that t O
TSG6 6 S-GENE
is O O
a 
 O
single g O
- 
 O
copy y O
gene e O
in O O
the 	 O
human a O
and 	 O
murine i O
species c O
. 
 O
Reaction c O
of O O
aromatic m O
/ 
 O
heterocyclic e O
sulfonamides f O
possessing s O
free e O
amino n O
, 
 O
imino n O
or O O
hydrazino r O
moieties e O
with h O
7 
 O
- 
 O
chloro o O
- 
 O
4 
 O
- 
 O
chloromethylcoumarin o O
afforded o O
a 
 O
series i O
of O O
N 
 O
- 
 O
[ 
 O
( 
 O
7 
 O
- 
 O
chloro o O
- 
 O
4 
 O
- 
 O
coumarinyl m O
) 
 O
- 
 O
methyl h O
] 
 O
- 
 O
derivatives i O
which c O
showed w O
effective e O
inhibition i O
of O O
three e O
carbonic b B-GENE
anhydrase y E-GENE
( 
 O
CA S S-GENE
) 
 O
isozymes z O
. 
 O
As O O
well l O
, 
 O
variation i O
in O O
capillary i O
size e O
and 	 O
density s O
was 	 O
apparent a O
between w O
ventricles t O
in O O
the 	 O
fetal a O
and 	 O
neonatal n O
periods i O
. 
 O
The 	 O
Polycomb y B-GENE
group u I-GENE
proteins t E-GENE
are 	 O
involved o O
in O O
maintenance n O
of O O
the 	 O
silenced e O
state t O
of O O
several e O
developmentally e O
regulated u O
genes e O
. 
 O
Uncertainty e O
exists s O
about u O
the 	 O
function c O
of O O
these s O
potential e O
isoforms f O
of O O
the 	 O
Cbfa1 a B-GENE
gene e E-GENE
. 
 O
When n O
using n O
the 	 O
high h O
- 
 O
impedance e O
testing t O
device i O
, 
 O
the 	 O
post t O
shock c O
rhythm t O
was 	 O
initially t O
displayed p O
as O O
' 
 O
no O O
signal n O
' 
 O
( 
 O
Hewlett l O
Packard k O
XL O O
) 
 O
or O O
' 
 O
asystole s O
' 
 O
( 
 O
Physio s O
- 
 O
Control t O
LIFEPAK E O
9 
 O
) 
 O
. 
 O
Human a B-GENE
CD38 8 E-GENE
, 
 O
a 
 O
leukocyte k O
receptor e O
and 	 O
ectoenzyme o O
, 
 O
is O O
a 
 O
member b O
of O O
a 
 O
novel e O
eukaryotic a O
gene e O
family i O
of O O
nicotinamide o O
adenine n O
dinucleotide u O
+ - O
- - O
converting v O
enzymes y O
: 
 O
extensive e O
structural u O
homology o O
with h O
the 	 O
genes e O
for 	 O
murine i B-GENE
bone e I-GENE
marrow r I-GENE
stromal o I-GENE
cell l I-GENE
antigen i I-GENE
1 - E-GENE
and 	 O
aplysian y B-GENE
ADP 	 I-GENE
- - I-GENE
ribosyl o I-GENE
cyclase l E-GENE
. 
 O
It O O
is O O
noteworthy e O
that t O
under e O
more e O
physiological s O
conditions d O
mimicking i O
the 	 O
cellular l O
GDP 	 O
/ 
 O
GTP 	 O
ratio i O
, 
 O
Raf 	 S-GENE
enhances a O
the 	 O
GEF 	 S-GENE
- 
 O
stimulated m O
GDP 	 O
/ 
 O
GTP 	 O
exchange h O
on O O
Ha B B-GENE
- - I-GENE
Ras 	 E-GENE
, 
 O
in O O
agreement e O
with h O
the 	 O
sequestration u O
of O O
Ras 	 S-GENE
. - O
GTP 	 O
by O O
Raf 	 S-GENE
. 
 O
When n O
O 
 O
- 
 O
2A O O
/ 
 O
c - B-GENE
- - I-GENE
myc 	 E-GENE
cells l O
underwent e O
terminal m O
differentiation f O
APprog r B-GENE
complexes p E-GENE
were e O
lost t O
and 	 O
conventional v O
AP B B-GENE
- - I-GENE
1 - E-GENE
DNA 	 O
- 
 O
binding d O
activity i O
became a O
evident d O
, 
 O
particularly t O
in O O
astrocytes r O
. 
 O
From m O
the 	 O
deduced u O
amino n O
acid d O
sequence u O
, 
 O
a 
 O
molecular e O
weight g O
of O O
38 O O
, 
 O
549 	 O
was 	 O
calculated c O
for 	 O
the 	 O
ADH 	 B-GENE
subunit u E-GENE
. 
 O
The 	 O
higher h O
level e O
of O O
calories o O
was 	 O
attained a O
by O O
an O O
increased r O
intake a O
of O O
carbohydrates b O
. 
 O
A 
 O
simple p O
algorithm o O
fitting t O
the 	 O
data a O
for 	 O
the 	 O
moving i O
192Ir I O
source r O
is O O
proposed p O
. 
 O
TAF 	 B-GENE
- - I-GENE
1 - E-GENE
activates i O
transcription n O
constitutively s O
and 	 O
was 	 O
mapped p O
to O O
the 	 O
first s O
32 O O
amino n O
acids d O
of O O
the 	 O
A 
 O
- 
 O
region i O
. 
 O
For 	 O
the 	 O
first s O
, 
 O
short r O
- 
 O
term m O
( 
 O
concurrent c O
) 
 O
TAL 	 O
, 
 O
two 	 O
different f O
- 
 O
flavored v O
stimuli m O
were e O
presented s O
at O O
the 	 O
same e O
time e O
, 
 O
one 	 O
associated o O
with h O
simultaneous u O
intragastric r O
administration i O
of O O
an O O
aversive r O
product d O
, 
 O
hypertonic e O
NaCl l O
, 
 O
and 	 O
the 	 O
other e O
with h O
saline i O
. 
 O
The 	 O
great a O
cardiac d O
vein n O
flow w O
became a O
zero o O
due 	 O
to O O
the 	 O
cardiac d O
arrest e O
and 	 O
remained a O
at O O
zero o O
for 	 O
a 
 O
moment e O
( 
 O
dead d O
time e O
) 
 O
after e O
the 	 O
initiation t O
of O O
reperfusion e O
. 
 O
INTERNET E O
is O O
literally e O
a 
 O
world l O
of O O
data a O
, 
 O
dialogue l O
, 
 O
and 	 O
discourse c O
on O O
any 	 O
topic i O
imaginable g O
, 
 O
right h O
at O O
your r O
fingertips g O
. 
 O
Attention e O
is O O
devoted o O
in O O
particular t O
to O O
the 	 O
action i O
of O O
thermoregulating r O
nervous v O
and 	 O
hormonal m O
mechanisms h O
. 
 O
The 	 O
mammalian m B-GENE
UPR 	 E-GENE
is O O
mediated i O
by O O
the 	 O
cis 	 O
- 
 O
acting i O
ER O O
stress e O
response p O
element m O
consisting s O
of O O
19 O O
nt O O
( 
 O
CCAATN A O
( 
 O
9 
 O
) 
 O
CCACG C O
) 
 O
, 
 O
the 	 O
CCACG C O
part t O
of O O
which c O
is O O
considered s O
to O O
provide v O
specificity c O
. 
 O
The 	 O
formation m O
of O O
a 
 O
D 
 O
- 
 O
loop p O
is O O
an O O
essential e O
step p O
in O O
DNA 	 O
double b O
- 
 O
strand a O
break a O
repair a O
through o O
recombination o O
. 
 O
The 	 O
cDNA A O
is O O
predicted d O
to O O
encode o O
a 
 O
polypeptide y O
of O O
298 	 O
amino n O
acids d O
that t O
is O O
homologous o O
to O O
the 	 O
Y - O
- - O
box 	 O
( - O
inverted e O
CCAAT A O
) - O
family i O
of I O
DNA 	 O
- - O
binding d O
transcription n O
factors t O
. 
 O
Toward a O
this s O
end 	 O
, 
 O
we O O
used d O
two 	 O
cultured t O
colon o O
cancer c O
cell l O
lines e O
; 
 O
one 	 O
( 
 O
RKO 	 O
) 
 O
has 	 O
a 
 O
transcriptionally n O
activated i O
u - B-GENE
- - I-GENE
PAR 	 I-GENE
gene e E-GENE
, 
 O
and 	 O
the 	 O
other e O
( 
 O
GEO 	 O
) 
 O
overexpresses r O
the 	 O
receptor e O
only y O
after e O
phorbol r O
ester e O
treatment a O
. 
 O
Site e O
- 
 O
directed e O
mutagenesis a O
of O O
the 	 O
conserved s O
cysteine t O
residue i O
( 
 O
tom1C3235A 1 O
) 
 O
in O O
the 	 O
hect t O
- - O
domain a O
, 
 O
supposed p O
to O O
be O O
necessary e O
for 	 O
thioester o O
- 
 O
bond d O
formation m O
with h O
ubiquitin q S-GENE
, 
 O
abolished l O
the 	 O
gene e O
function c O
. 
 O
The 	 O
two 	 O
yeast s B-GENE
pheromone r I-GENE
receptors e E-GENE
, 
 O
the 	 O
a - O
and 	 O
alpha h B-GENE
- - I-GENE
factor t I-GENE
receptors e E-GENE
, 
 O
share r O
many y O
functional c O
similarities i O
: 
 O
both h O
G - B-GENE
protein t I-GENE
- - I-GENE
coupled p I-GENE
receptors e E-GENE
couple p O
to O O
the 	 O
same e O
downstream n O
signal n O
transduction n O
pathway h O
, 
 O
and 	 O
both h O
receptors e O
undergo e O
feedback d O
regulation u O
involving o O
increased r O
phosphorylation s O
on O O
their i O
C 
 O
- 
 O
terminal m O
domains a O
in O O
response p O
to O O
ligand a O
challenge l O
. 
 O
Moreover e O
, 
 O
the 	 O
formation m O
of O O
the 	 O
complex p O
between w O
IclR R S-GENE
and 	 O
the 	 O
operator r O
/ 
 O
promoter m O
region i O
has 	 O
been n O
found n O
to O O
be O O
impaired a O
by O O
phosphoenol s O
pyruvate u O
but 	 O
insensitive e O
to O O
acetate t O
, 
 O
acetyl t O
- 
 O
CoA 	 O
, 
 O
pyruvate u O
, 
 O
and 	 O
oxaloacetate l O
. 
 O
After e O
enzymatic y O
hydrolysis r O
of O O
the 	 O
water e O
soluble u O
fraction c O
, 
 O
it O O
is O O
shown w O
that t O
28 O O
% 
 O
is O O
again i O
extractable r O
by O O
DCM 	 O
of O O
which c O
57 O O
% 
 O
consists s O
of O O
unchanged h O
SC4453 4 O
which c O
is O O
therefore r O
the 	 O
main n O
partner t O
of O O
conjugated j O
products d O
. 
 O
The 	 O
expression r O
pattern t O
of O O
the 	 O
reporter o O
gene e O
was 	 O
compared p O
to O O
that t O
of O O
the 	 O
endogenous o O
PDGFbeta F B-GENE
r - I-GENE
gene e E-GENE
. 
 O
The 	 O
two 	 O
SH3 	 B-GENE
domains a E-GENE
are 	 O
separated a O
by O O
a 
 O
54 O O
amino n O
acid d O
linker k O
region i O
, 
 O
whose s O
length g O
is O O
highly h O
conserved s O
in O O
xenopus o O
, 
 O
chicken c O
, 
 O
and 	 O
mamalian a B-GENE
Crk 	 I-GENE
II I I-GENE
proteins t E-GENE
. 
 O
This s O
complex p O
was 	 O
eliminated m O
by O O
mutation a O
of O O
either h O
half f O
- 
 O
site e O
, 
 O
and 	 O
it O O
was 	 O
supershifted e O
by O O
antibodies i O
against i O
chicken c B-GENE
ovalbumin l I-GENE
upstream t I-GENE
promoter m I-GENE
- - I-GENE
transcription n I-GENE
factor t E-GENE
( 
 O
COUP P B-GENE
- - I-GENE
TF E E-GENE
) 
 O
. 
 O
The 	 O
fz B B-GENE
- - I-GENE
1 - E-GENE
and 	 O
fz B B-GENE
- - I-GENE
2 - I-GENE
genes e E-GENE
are 	 O
widely e O
expressed r O
in O O
rat 	 O
tissues s O
with h O
the 	 O
highest h O
steady a O
- 
 O
state t O
levels e O
of O O
mRNA A O
in O O
kidney n O
, 
 O
liver e O
, 
 O
heart r O
, 
 O
uterus r O
, 
 O
and 	 O
ovary r O
. 
 O
fz B B-GENE
- - I-GENE
1 - I-GENE
and 	 I-GENE
- - I-GENE
2 - I-GENE
mRNA A E-GENE
levels e O
were e O
greater a O
in O O
neonatal n O
than n O
in O O
corresponding r O
adult l O
tissues s O
. 
 O
These s O
results u O
indicate i O
that t O
the 	 O
changes n O
in O O
the 	 O
patient i O
' 
 O
s 
 O
thyroid r O
scan n O
and 	 O
RAIU U O
were e O
attributable r O
to O O
the 	 O
presence s O
of O O
TSAb b O
. 
 O
The 	 O
methods h O
used d O
were e O
the 	 O
AOAC C O
method h O
of O O
dilution u O
and 	 O
heating t O
; 
 O
the 	 O
addition i O
of O O
mercuric c O
chloride o O
, 
 O
charcoal r O
, 
 O
and 	 O
Carrez r O
reagents g O
at O O
2 
 O
different f O
pH O O
values u O
; 
 O
and 	 O
direct e O
analysis l O
of O O
sample p O
supernatants e O
with h O
no O O
treatment a O
( 
 O
control t O
) 
 O
. 
 O
Cytochemical o O
and 	 O
ultrastructural r O
observations e O
on O O
the 	 O
tegument u O
of O O
the 	 O
trematode m O
Megalodiscus a O
temperatus p O
. 
 O
In O O
this s O
report o O
, 
 O
we O O
establish a O
that t O
the 	 O
heteromeric e O
CCAAT A B-GENE
- - I-GENE
binding d I-GENE
factor t I-GENE
CBF 	 E-GENE
is O O
the 	 O
major o O
component p O
of O O
the 	 O
C1 B B-GENE
- - I-GENE
binding d I-GENE
factor t E-GENE
( 
 O
C1F 	 S-GENE
) 
 O
in O O
human a O
cells l O
. 
 O
A 
 O
40 O O
- 
 O
fold d O
stimulation m O
of O O
chloramphenicol o B-GENE
acetyltransferase t E-GENE
activity i O
mediated i O
by O O
four r O
tandem d O
repeats e O
of O O
the 	 O
SNE 	 O
could l O
be O O
induced u O
within h O
2 
 O
h 
 O
( 
 O
and 	 O
up O O
to O O
250 	 O
- 
 O
fold d O
within h O
6 
 O
h 
 O
) 
 O
after e O
addition i O
of O O
TPA 	 O
in O O
DNA 	 O
- 
 O
transfected n O
U 
 O
- 
 O
937 	 O
cells l O
, 
 O
indicating i O
that t O
the 	 O
stimulation m O
appeared e O
likely e O
to O O
be O O
a 
 O
true e O
protein t B-GENE
kinase a I-GENE
C - E-GENE
- 
 O
mediated i O
signal n O
transduction n O
event n O
rather h O
than n O
a 
 O
differentiation f O
response p O
. 
 O
This s O
increased r O
frequency q O
of O O
infection e O
has 	 O
been n O
accompanied o O
by O O
significant n O
excess e O
mortality t O
. 
 O
Deletion e O
mutants a O
of O O
the 	 O
human a B-GENE
CHOP P I-GENE
promoter m E-GENE
identify n O
a 
 O
region i O
comprising p O
nucleotides l O
- 
 O
75 O O
to O O
- 
 O
104 	 O
required u O
for 	 O
both h O
constitutive s O
and 	 O
ER O O
- 
 O
stress e O
- 
 O
inducible u O
expression r O
. 
 O
The 	 O
duration a O
of O O
PGE2 2 O
and 	 O
PGF2 2 B-GENE
alpha h E-GENE
elevations v O
as O O
well l O
as O O
the 	 O
peak k O
values u O
were e O
influenced l O
by O O
day 	 O
of O O
the 	 O
cycle l O
. 
 O
We O O
propose p O
that t O
the 	 O
cDNA A O
encodes o O
an O O
apical c O
plasma s O
membrane b O
protein t O
that t O
plays y O
a 
 O
role e O
in O O
the 	 O
functional c O
expression r O
of O O
the 	 O
amiloride l O
- 
 O
sensitive s O
epithelial t O
sodium i O
channel n O
. 
 O
Electrophysiology c O
and 	 O
pharmacology r O
of O O
epicardial c O
, 
 O
endocardial o O
, 
 O
and 	 O
M 
 O
cells l O
. 
 O
In O O
contrast t O
, 
 O
an O O
N - O
- - O
terminal m O
RNAP P B-GENE
mutant a E-GENE
that t O
has 	 O
a 
 O
decreased r O
capacity a O
to O O
bind d O
single g O
- 
 O
stranded a O
RNA 	 O
forms m O
halted t O
complexes p O
with h O
much h O
lower e O
levels e O
of O O
stability b O
than n O
the 	 O
WT O B-GENE
enzyme y E-GENE
, 
 O
and 	 O
these s O
complexes p O
are 	 O
not 	 O
stabilized b O
by O O
the 	 O
presence s O
of O O
the 	 O
NT O O
strand a O
. 
 O
A 
 O
cephalothoracophagus h O
disymmetros y O
buffalo f O
calf f O
. 
 O
A 
 O
mouse s O
brain i O
cDNA A O
library r O
in O O
lambdagt11 b S-GENE
was 	 O
screened e O
for 	 O
this s O
association o O
, 
 O
and 	 O
two 	 O
positive i O
clones n O
encoding o O
tyrosine o B-GENE
phosphatase s I-GENE
SH B I-GENE
- - I-GENE
PTP2 2 E-GENE
were e O
isolated l O
. 
 O
Disorganization o O
scores r O
of O O
the 	 O
hypertrophy e O
zone e O
and 	 O
trabecular b O
bone e O
were e O
low 	 O
, 
 O
approaching r O
normal m O
( 
 O
P 
 O
< 
 O
0 
 O
. 
 O
05 O O
) 
 O
, 
 O
for 	 O
turkey k O
poults l O
fed 	 O
on O O
diets t O
with h O
phytase t S-GENE
supplementation p O
, 
 O
and 	 O
tibial i O
abnormality o O
scores r O
were e O
linearly e O
decreased r O
( 
 O
P 
 O
< 
 O
0 
 O
. 
 O
001 	 O
) 
 O
as O O
nP O O
levels e O
increased r O
( 
 O
zero o O
score r O
is O O
considered s O
normal m O
) 
 O
. 
 O
Repression r O
was 	 O
strictly i O
dependent e O
on O O
the 	 O
presence s O
of O O
upstream t B-GENE
Oshox1 o I-GENE
binding d I-GENE
sites e E-GENE
in O O
the 	 O
reporter o O
gene e O
constructs s O
and 	 O
a 
 O
function c O
of O O
the 	 O
N 
 O
- 
 O
terminal m O
region i O
of O O
Oshox1 o S-GENE
, 
 O
preceding c O
the 	 O
homeodomain e S-GENE
. 
 O
Ondansetron a O
is O O
thus s O
an O O
effective e O
first s O
- 
 O
line e O
antiemetic i O
in O O
children l O
undergoing e O
chemotherapy m O
, 
 O
radiotherapy i O
and 	 O
surgery g O
. 
 O
To O O
elucidate c O
the 	 O
molecular e O
mechanism h O
by O O
which c O
the 	 O
Ras 	 S-GENE
signaling n O
pathway h O
activates i O
a 
 O
cell l O
- 
 O
type e O
- 
 O
specific c O
gene e O
, 
 O
we O O
have e O
used d O
the 	 O
pituitary u B-GENE
- - I-GENE
specific c I-GENE
rat 	 I-GENE
prolactin l E-GENE
( 
 O
rPRL L S-GENE
) 
 O
promoter m O
as O O
a 
 O
target g O
of O O
oncogenic o B-GENE
Ras 	 E-GENE
and 	 O
Raf 	 S-GENE
in O O
GH4 	 O
rat 	 O
pituitary u O
cells l O
. 
 O
The 	 O
human a B-GENE
RFC 	 I-GENE
- - I-GENE
1 - I-GENE
gene e E-GENE
differs f O
from m O
the 	 O
mouse s O
and 	 O
hamster s O
genes e O
both h O
in O O
terms m O
of O O
the 	 O
total a O
number b O
of O O
exons n O
and 	 O
in O O
regard a O
to O O
alternatives e O
of O O
exon n O
1 
 O
which c O
encode o O
5 
 O
' 
 O
end 	 O
heterogeneity e O
. 
 O
Type e O
C 
 O
units t O
summate m O
the 	 O
responses p O
to O O
the 	 O
two 	 O
- 
 O
tone e O
stimulus m O
, 
 O
and 	 O
show w O
little t O
or O O
no O O
inhibitory i O
influences l O
. 
 O
HGF 	 S-GENE
treatment a O
increased r O
cyclin l B-GENE
A - E-GENE
, 
 O
cyclin l B-GENE
G1 E E-GENE
and 	 O
nuclear l B-GENE
transcriptional n I-GENE
factor t E-GENE
( 
 O
NFkappaB a S-GENE
) 
 O
protein t O
expression r O
. 
 O
Since c O
blood o O
serotonin o O
is O O
primarily m O
produced d O
peripherally i O
, 
 O
these s O
results u O
suggest g O
that t O
some e O
aspect e O
of O O
peripheral i O
serotonin o O
metabolism a O
is O O
abnormal o O
in O O
major o O
depression r O
. 
 O
Although h O
several e O
large g O
waterborne e O
outbreaks b O
occurred u O
during i O
the 	 O
past t O
decade a O
, 
 O
most t O
were e O
in O O
small l O
communities m O
. 
 O
Cytogenetic o O
structures u O
showed w O
a 
 O
mixte t O
karyotype y O
: 
 O
mosaicim a O
46 O O
XX O O
/ 
 O
46 O O
XY O O
with h O
a 
 O
ratio i O
of O O
a 
 O
80 O O
/ 
 O
20 O O
. 
 O
The 	 O
1 
 O
. 
 O
6 
 O
- 
 O
kb O O
cDNA A O
( 
 O
CBF 	 B-GENE
- - I-GENE
A - E-GENE
) 
 O
encoding o O
285 	 O
amino n O
acids d O
( 
 O
aa O O
) 
 O
was 	 O
obtained a O
, 
 O
and 	 O
a 
 O
beta a B-GENE
- - I-GENE
galactosidase a I-GENE
fusion i I-GENE
protein t E-GENE
, 
 O
bacterially t O
produced d O
from m O
the 	 O
cDNA A O
, 
 O
bound n O
to O O
DNA 	 O
fragments g O
containing t O
several e O
CArG G O
boxes e O
. 
 O
Mutant a B-GENE
M - I-GENE
proteins t E-GENE
were e O
tested t O
for 	 O
their i O
ability l O
to O O
complement p O
growth w O
of O O
the 	 O
temperature p O
- 
 O
sensitive s O
M - B-GENE
protein t I-GENE
mutant a E-GENE
virus u O
tsO23 2 O
at O O
the 	 O
nonpermissive p O
temperature p O
. 
 O
In O O
this s O
paper e O
we O O
review i O
evidence d O
on O O
smoking k O
and 	 O
lung g O
cancer c O
among n O
Latinos i O
, 
 O
including l O
findings d O
from m O
several e O
unpublished u O
studies d O
and 	 O
technical h O
reports o O
. 
 O
The 	 O
yjr041c 0 B-GENE
delta t E-GENE
haploid l O
cells l O
gave e O
rise e O
to O O
microcolonies r O
comprising p O
about u O
20 O O
to O O
50 O O
cells l O
. 
 O
Despite p O
these s O
high h O
initial t O
rates e O
of O O
transcription n O
, 
 O
of O O
all 	 O
the 	 O
promoter m O
constructs s O
only y O
LAT 	 B-GENE
- 
 I-GENE
LTR 	 E-GENE
was 	 O
able e O
to O O
remain a O
transcriptionally n O
active i O
after e O
the 	 O
establishment a O
of O O
a 
 O
latent e O
state t O
. 
 O
Two 	 O
mutants a O
, 
 O
mapping p O
at O O
the 	 O
HindIII d B-GENE
site e E-GENE
( 
 O
between w O
the 	 O
consensus s O
sequences u O
) 
 O
of O O
the 	 O
pSC101 1 B-GENE
tetA A I-GENE
promoter m E-GENE
, 
 O
were e O
studied d O
: 
 O
MA2 	 O
corresponds r O
to O O
a 
 O
4 
 O
bp O O
deletion e O
between w O
positions i O
- 
 O
12 O O
and 	 O
- 
 O
15 O O
; 
 O
B30 	 O
bears r O
a 
 O
44 O O
bp O O
insertion e O
C 
 O
( 
 O
TA O O
) 
 O
21 O O
G 
 O
at O O
the 	 O
HindIII d B-GENE
site e E-GENE
. 
 O
We O O
concluded c O
that t O
these s O
results u O
support p O
the 	 O
feasibility s O
and 	 O
usefulness f O
of O O
N 
 O
- 
 O
of O O
- 
 O
1 
 O
RCT 	 O
in O O
rheumatology u O
practice c O
. 
 O
Sci 	 O
. 
 O
Effects e O
of O O
timepidium e O
bromide m O
( 
 O
TB O O
; 
 O
anticholinergic i O
agent n O
) 
 O
, 
 O
acetylcholine t O
( 
 O
ACh 	 O
) 
 O
and 	 O
neostigmine s O
( 
 O
Neost s O
) 
 O
on O O
gastric t O
and 	 O
duodenal d O
blood o O
flow w O
distribution t O
were e O
studied d O
by O O
the 	 O
use 	 O
of O O
131I I O
- 
 O
labeled e O
macroaggregated r O
human a B-GENE
serum u I-GENE
albumin u E-GENE
( 
 O
MAA 	 S-GENE
) 
 O
in O O
rabbits b O
. 
 O
These s O
extrachromosomal r O
copies i O
can 	 O
be O O
isolated l O
as O O
covalently a O
closed s O
molecules e O
with h O
lengths g O
around u O
3mu 	 O
. 
 O
Comparison p O
of O O
the 	 O
footprint t O
patterns t O
of O O
the 	 O
mouse s O
and 	 O
human a B-GENE
HPRT T I-GENE
genes e E-GENE
demonstrated o O
that t O
the 	 O
in O O
vivo o O
binding d O
of O O
regulatory u O
proteins t O
between w O
these s O
species c O
is O O
generally e O
conserved s O
but 	 O
not 	 O
identical n O
. 
 O
Here e O
, 
 O
we O O
describe c O
the 	 O
three e O
- 
 O
dimensional e O
structure u O
of O O
the 	 O
enzyme y O
from m O
Escherichia h O
colidetermined i O
and 	 O
refined i O
to O O
2 
 O
. 
 O
0 
 O
A 
 O
resolution o O
. 
 O
Our 	 O
Northern t O
and 	 O
Southern t O
blot t O
analyses l O
of O O
meningiomas i O
clearly a O
suggest g O
the 	 O
CLH 	 B-GENE
- - I-GENE
22 I I-GENE
gene e E-GENE
may 	 O
be O O
involved o O
in O O
the 	 O
tumor o O
development e O
and 	 O
can 	 O
be O O
considered s O
as O O
a 
 O
candidate d O
for 	 O
a 
 O
tumor o O
suppressor p O
. 
 O
Plasmodium s O
vivax a O
malaria a O
. 
 O
This s O
set 	 O
of O O
genetic e O
and 	 O
physical s O
interactions e O
suggests g O
a 
 O
role e O
for 	 O
yeast s O
RNA 	 O
- 
 O
binding d O
proteins t O
in O O
transcriptional n O
regulation u O
. 
 O
POPULATION U O
AND 	 O
METHODS H O
: 
 O
105 	 O
patients i O
were e O
followed l O
prospectively s O
( 
 O
male e O
: 
 O
87 O O
% 
 O
; 
 O
age 	 O
: 
 O
56 O O
+ 
 O
/ 
 O
- 
 O
10 O O
) 
 O
; 
 O
clinical n O
evaluation l O
was 	 O
performed f O
in O O
the 	 O
1st 	 O
, 
 O
3rd 	 O
and 	 O
6th 	 O
month t O
, 
 O
SEKG G O
in O O
the 	 O
4th 	 O
month t O
and 	 O
recatheterization a O
for 	 O
angiographic i O
control t O
in O O
the 	 O
6th 	 O
month t O
. 
 O
All 	 O
other e O
cysts t O
showed w O
a 
 O
unilocular l O
, 
 O
purely e O
cystic t O
pattern t O
, 
 O
with h O
homogeneous o O
fluids i O
, 
 O
although h O
the 	 O
T2 O O
relaxation a O
times e O
of O O
four r O
lesions i O
overlapped r O
those s O
of O O
odontogenic n O
keratocysts a O
. 
 O
Genetic e O
diagnosis g O
of O O
respiratory p O
diseases e O
The 	 O
c - B-GENE
- - I-GENE
Jun 	 I-GENE
delta t I-GENE
- - I-GENE
domain a E-GENE
inhibits i O
neuroendocrine r O
promoter m O
activity i O
in O O
a 
 O
DNA 	 O
sequence u O
- 
 O
and 	 O
pituitary u O
- 
 O
specific c O
manner n O
. 
 O
Cross s O
- 
 O
sectional t O
studies d O
continue t O
to O O
dominate i O
. 
 O
The 	 O
role e O
of O O
the 	 O
medical i O
facilities i O
in O O
the 	 O
prognosis g O
of O O
the 	 O
patient i O
with h O
tetanus a O
specially c O
the 	 O
importance o O
of O O
considering s O
at O O
the 	 O
same e O
time e O
the 	 O
severity e O
of O O
the 	 O
disease e O
and 	 O
the 	 O
characteristics r O
of O O
the 	 O
therapy r O
deserve e O
further t O
study d O
in O O
order e O
to O O
contribute t O
to O O
the 	 O
development e O
of O O
the 	 O
medical i O
assistance i O
to O O
the 	 O
patients i O
with h O
tetanus a O
. 
 O
Differences f O
were e O
not 	 O
found n O
in O O
colons o O
by O O
SEM 	 O
. 
 O
Increasing r O
the 	 O
height g O
of O O
the 	 O
agar r O
column u O
overlying r O
the 	 O
SN O O
fabric r O
diminished i O
the 	 O
inhibitory i O
effect e O
of O O
SN O O
on O O
microbial r O
growth w O
. 
 O
Neither t O
raw 	 O
nor 	 O
retrograded r O
resistant i O
starch r O
lowers e O
fasting t O
serum u O
cholesterol l O
concentrations c O
in O O
healthy l O
normolipidemic m O
subjects j O
. 
 O
( 
 O
5 
 O
) 
 O
. 
 O
Hepatitis a O
B 
 O
markers k O
in O O
Lancashire c O
police i O
officers i O
. 
 O
In O O
the 	 O
other e O
two 	 O
groups u O
( 
 O
NAAR R O
and 	 O
PLA 	 O
) 
 O
, 
 O
no O O
variation i O
in O O
this s O
serum u B-GENE
protease t E-GENE
was 	 O
observed e O
. 
 O
Maximum i O
likelihood e O
estimation i O
in O O
covariance a O
structure u O
analysis l O
with h O
truncated n O
data a O
. 
 O
A 
 O
single g O
dose e O
of O O
Cef 	 O
was 	 O
administered i O
intravenously r O
to O O
11 O O
patients i O
with h O
autoimmune o O
diseases e O
and 	 O
varying y O
degrees r O
of O O
renal a O
impairment a O
( 
 O
Group u O
I 
 O
CLCR R O
less s O
than n O
50 O O
ml O O
/ 
 O
min 	 O
, 
 O
Group u O
II O O
CLCR R O
greater a O
than n O
50 O O
ml O O
/ 
 O
min 	 O
) 
 O
. 
 O
The 	 O
liver e O
- 
 O
specific c O
sequence u O
contains t O
unique q O
consensus s O
sites e O
for 	 O
phosphorylation s O
by O O
cyclic l B-GENE
AMP 	 I-GENE
- - I-GENE
dependent e I-GENE
protein t I-GENE
kinase a E-GENE
and 	 O
by O O
protein t B-GENE
kinase a I-GENE
C - E-GENE
. 
 O
Effect e O
of O O
gentamycin t O
on O O
the 	 O
kidney n O
functional c O
state t O
in O O
experimental e O
pyelonephritis l O
They y O
represent r O
a 
 O
physiologically s O
more e O
meaningful n O
pattern t O
than n O
the 	 O
arithmetic t O
mean n O
with h O
standard n O
deviation i O
. 
 O
The 	 O
Valpha p S-GENE
and 	 O
Vbeta t B-GENE
domains a E-GENE
have e O
the 	 O
canonical o O
features t O
of O O
known w O
teleost e O
and 	 O
mammalian m B-GENE
TCR 	 I-GENE
V - I-GENE
domains a E-GENE
, 
 O
including l O
conserved s O
residues i O
in O O
the 	 O
beginning i O
of O O
FR2 	 S-GENE
and 	 O
at O O
the 	 O
end 	 O
of O O
FR3 	 S-GENE
. 
 O
Whether t O
this s O
lack k O
of O O
preferential f O
repair a O
has 	 O
to O O
be O O
explained l O
by O O
a 
 O
defect e O
in O O
repair a O
or O O
in O O
general e O
transcription n O
is O O
unclear l O
at O O
present s O
. 
 O
This s O
study d O
examines m O
LEIBNIZ B O
' 
 O
idea a O
of O O
Veterinary e O
medicine i O
in O O
a 
 O
biographical g O
context t O
. 
 O
Dipetalonema e O
( 
 O
Acanthocheilonema n O
) 
 O
didelphis e O
sp O O
. 
 O
n 
 O
. 
 O
However e O
, 
 O
the 	 O
MCMI I O
- 
 O
III 	 O
group u O
profile f O
was 	 O
significantly n O
lower e O
in O O
magnitude n O
compared p O
with h O
the 	 O
MCMI I O
- 
 O
II O O
. 
 O
While l O
there r O
is O O
growing w O
evidence d O
that t O
perception c O
and 	 O
imagery g O
share r O
common m O
neural r O
substrates s O
, 
 O
the 	 O
fact t O
that t O
D 
 O
. 
 O
F 
 O
. 
 O
shows w O
intact a O
visual u O
imagery g O
in O O
the 	 O
face e O
of O O
a 
 O
massive s O
perceptual c O
deficit i O
in O O
form m O
vision i O
challenges l O
recent e O
suggestions g O
that t O
these s O
two 	 O
psychological c O
processes c O
share r O
common m O
input u O
pathways h O
in O O
early l O
vision i O
. 
 O
An O O
ethnic n O
analysis l O
was 	 O
made e O
of O O
8947 7 O
cases e O
of O O
primary m O
central t O
nervous v O
system t O
( 
 O
CNS 	 O
) 
 O
tumors o O
seen n O
at O O
the 	 O
Armed e O
Forces c O
Institute t O
of O O
Pathology h O
( 
 O
AFIP P O
) 
 O
, 
 O
Washington h O
, 
 O
DC O O
, 
 O
from m O
1971 1 O
to O O
1985 5 O
. 
 O
The 	 O
exact c O
function c O
of O O
IP B B-GENE
- - I-GENE
30 E E-GENE
is O O
not 	 O
yet 	 O
known w O
, 
 O
but 	 O
it O O
may 	 O
play y O
a 
 O
role e O
in O O
gamma m B-GENE
- - I-GENE
interferon e E-GENE
mediated i O
immune u O
reactions c O
. 
 O
The 	 O
levels e O
of O O
products d O
expressed r O
from m O
these s O
chimeric m O
cDNAs A O
in O O
COS 	 O
cells l O
were e O
assessed e O
by O O
activity i O
assay a O
and 	 O
by O O
metabolic a O
labeling e O
of O O
the 	 O
proteins t O
followed l O
by O O
immunoprecipitation u O
and 	 O
SDS 	 B-GENE
- 
 I-GENE
PAGE E E-GENE
. 
 O
In O O
this s O
report o O
, 
 O
we O O
demonstrate o O
that t O
FRS2 2 S-GENE
forms m O
a 
 O
complex p O
with h O
the 	 O
N - O
- - O
terminal m O
SH2 	 B-GENE
domain a E-GENE
of O O
the 	 O
protein t B-GENE
tyrosine o I-GENE
phosphatase s I-GENE
Shp2 2 E-GENE
in O O
response p O
to O O
FGF 	 S-GENE
stimulation m O
. 
 O
It O O
is O O
concluded c O
that t O
the 	 O
drinking n O
ampules u O
of O O
VP O O
- 
 O
16 O O
- 
 O
213 	 O
can 	 O
be O O
replaced l O
with h O
the 	 O
new 	 O
oral l O
capsules s O
with h O
a 
 O
recommended o O
initial t O
dose e O
of O O
100 	 O
- 
 O
130 	 O
mg O O
/ 
 O
m2 O O
given e O
in O O
5 
 O
- 
 O
day 	 O
courses r O
every r O
21 O O
- 
 O
28 O O
days s O
. 
 O
The 	 O
H5 B B-GENE
mutants a E-GENE
were e O
: 
 O
DH5 	 O
( 
 O
all 	 O
amino n O
acids d O
in O O
D 
 O
configuration f O
) 
 O
and 	 O
H5F 	 O
( 
 O
where r O
all 	 O
His 	 O
are 	 O
replaced l O
by O O
Phe 	 O
at O O
positions i O
3 
 O
, 
 O
7 
 O
, 
 O
8 
 O
, 
 O
15 O O
, 
 O
18 O O
, 
 O
19 O O
, 
 O
21 O O
) 
 O
. 
 O
Although h O
the 	 O
number b O
of O O
kits s O
has 	 O
increased r O
, 
 O
the 	 O
precision c O
has 	 O
improved r O
, 
 O
showing w O
that t O
more e O
robust u O
methods h O
are 	 O
now 	 O
employed l O
. 
 O
These s O
results u O
establish a O
that t O
the 	 O
DNA 	 O
fragment g O
we O O
have e O
isolated l O
contains t O
the 	 O
human a B-GENE
gp130 3 I-GENE
promoter m E-GENE
and 	 O
that t O
interleukin e B-GENE
- - I-GENE
6 - E-GENE
type e O
cytokines o O
may 	 O
influence l O
the 	 O
activity i O
of O O
this s O
promoter m O
via 	 O
activated i O
STATs T S-GENE
. 
 O
When n O
targeted g O
to O O
the 	 O
GAL1 1 B-GENE
promoter m E-GENE
by O O
fusing i O
with h O
the 	 O
Gal4p 4 B-GENE
DNA 	 I-GENE
- - I-GENE
binding d I-GENE
domain a E-GENE
, 
 O
Sko1p 1 S-GENE
acts s O
as O O
an O O
Ssn6 6 S-GENE
/ 
 O
Tup1p 1 S-GENE
- 
 O
dependent e O
repressor r O
regulated u O
by O O
osmotic o O
stress e O
. 
 O
The 	 O
unexpected x O
prevalence v O
of O O
c - B-GENE
- - I-GENE
myc 	 E-GENE
and 	 O
alpha h B-GENE
- - I-GENE
tubulin u E-GENE
in O O
the 	 O
S 
 O
- 
 O
phase s O
library r O
is O O
supported p O
by O O
Northern t O
analysis l O
of O O
RNA 	 O
from m O
phase s O
- 
 O
synchronous c O
cells l O
. 
 O
Growth w O
factors t O
promote m O
cell l O
survival v O
through o O
phosphorylation s O
of O O
Bad 	 S-GENE
, 
 O
resulting u O
in O O
its 	 O
dissociation s O
from m O
Bcl 	 B-GENE
- - I-GENE
2 - E-GENE
and 	 O
Bcl 	 B-GENE
- - I-GENE
x - E-GENE
( - O
L - O
) - O
and 	 O
its 	 O
association o O
with h O
14 B B-GENE
- - I-GENE
3 - I-GENE
- - I-GENE
3tau u E-GENE
. 
 O
A 
 O
representative r O
group u O
of O O
patients i O
undergoing e O
open n O
radical i O
nephrectomy h O
for 	 O
clinical n O
T1 O O
, 
 O
T2 O O
lesions i O
was 	 O
also o O
identified n O
. 
 O
By O O
applying l O
a 
 O
sufficiently f O
strong o O
crusher s O
gradient d O
in O O
the 	 O
EPI 	 O
pulse s O
sequence u O
, 
 O
the 	 O
temporal p O
variation i O
induced u O
by O O
SSFP P O
disturbance t O
can 	 O
be O O
suppressed p O
due 	 O
to O O
diffusion f O
. 
 O
However e O
, 
 O
in O O
each h O
case e O
in O O
which c O
either h O
the 	 O
DQ B B-GENE
alpha h I-GENE
- - I-GENE
or I I-GENE
DQ I I-GENE
beta a I-GENE
- - I-GENE
chain i E-GENE
was 	 O
exchanged h O
, 
 O
major o O
alterations e O
or O O
reversals e O
of O O
this s O
pattern t O
of O O
interaction e O
were e O
observed e O
. 
 O
Only y O
the 	 O
native i O
structure u O
of O O
phosphorylated s O
ERK 	 S-GENE
was 	 O
recognized o O
by O O
VHR 	 O
and 	 O
was 	 O
inactivated c O
with h O
a 
 O
second o O
- 
 O
order e O
rate e O
constant s O
of O O
40 O O
, 
 O
000 	 O
M 
 O
- 
 O
1 
 O
s 
 O
- 
 O
1 
 O
. 
 O
From m O
1998 8 O
to O O
1999 9 O
, 
 O
a 
 O
large g O
number b O
of O O
community m O
- 
 O
acquired u O
respiratory p O
tract c O
isolates l O
of O O
Streptococcus e O
pneumoniae u O
( 
 O
n 
 O
= 
 O
566 	 O
) 
 O
, 
 O
Haemophilus m O
influenzae l O
( 
 O
n 
 O
= 
 O
513 	 O
) 
 O
and 	 O
Moraxella a O
catarrhalis a O
( 
 O
n 
 O
= 
 O
228 	 O
) 
 O
were e O
collected l O
from m O
15 O O
centres t O
in O O
Australia t O
, 
 O
Hong g O
Kong g O
, 
 O
Japan a O
, 
 O
China n O
, 
 O
the 	 O
Philippines l O
, 
 O
Singapore g O
, 
 O
South t O
Africa i O
and 	 O
Taiwan w O
through o O
the 	 O
SENTRY T O
Antimicrobial i O
Surveillance v O
Program g O
. 
 O
Diethyldithiocarbamate t O
and 	 O
amphetamine h O
stereotype r O
behavior a O
. 
 O
We O O
used d O
an O O
immobilized o O
template p O
- 
 O
based e O
assay a O
to O O
examine m O
transcription n O
termination m O
by O O
VA1 	 S-GENE
, 
 O
7SL 	 S-GENE
, 
 O
and 	 O
Alu 	 B-GENE
class s I-GENE
III 	 I-GENE
templates p E-GENE
and 	 O
the 	 O
role e O
of O O
transcript n O
release e O
in O O
the 	 O
pol 	 B-GENE
III 	 E-GENE
terminator m O
- 
 O
dependent e O
inhibition i O
of O O
processing c O
of O O
B1 S B-GENE
- 
 I-GENE
Alu 	 I-GENE
transcripts n E-GENE
. 
 O
A 
 O
novel e O
zinc c O
finger g O
- 
 O
containing t O
RNA 	 O
- 
 O
binding d O
protein t O
conserved s O
from m O
fruitflies i O
to O O
humans a O
. 
 O
Although h O
IL B B-GENE
- - I-GENE
6 - E-GENE
can 	 O
activate i O
ERK 	 B-GENE
- - I-GENE
1 - E-GENE
in O O
HepG2 G O
cells l O
, 
 O
STAT3 T S-GENE
transactivation n O
and 	 O
Ser 	 O
( 
 O
727 	 O
) 
 O
phosphorylation s O
were e O
not 	 O
reduced u O
by O O
using n O
the 	 O
MAP 	 B-GENE
kinase a E-GENE
/ 
 O
ERK 	 B-GENE
kinase a E-GENE
( 
 O
MEK 	 S-GENE
) 
 O
inhibitor i O
PD98059 8 O
or O O
by O O
overexpression r O
of O O
dominant i B-GENE
- 
 I-GENE
negative a I-GENE
Raf 	 E-GENE
. 
 O
6 
 O
h 
 O
after e O
ingestion e O
of O O
aspirin i O
on O O
day 	 O
1 
 O
to O O
day 	 O
14 O O
, 
 O
both h O
TX O O
and 	 O
PGI2 2 O
levels e O
also o O
significantly n O
decreased r O
( 
 O
p 
 O
< 
 O
0 
 O
. 
 O
0001 1 O
) 
 O
. 
 O
Tritiated t O
1 
 O
, 
 O
24 O O
, 
 O
25 O O
- 
 O
trihydroxyvitamin h O
D3 O O
was 	 O
synthesized t O
biologically l O
and 	 O
used d O
as O O
tracer c O
to O O
monitor i O
the 	 O
recovery o O
of O O
endogenous o O
metabolite a O
during i O
isolation l O
from m O
serum u O
. 
 O
Joint n O
ultrasonography r O
demonstrating o O
thickening c O
of O O
synoviae o O
and 	 O
tendons d O
has 	 O
become o O
a 
 O
useful f O
non 	 O
- 
 O
invasive a O
diagnostic g O
tool l O
, 
 O
although h O
it O O
is O O
not 	 O
specific c O
for 	 O
beta a O
2 - O
- - O
M - O
amyloidosis l O
, 
 O
and 	 O
results u O
depend e O
on O O
observer e O
experience e O
. 
 O
Immunofluorescence u O
tests t O
for 	 O
Borrelia r O
burgdorferi g O
serum u O
antibodies i O
had 	 O
positive i O
results u O
, 
 O
but 	 O
G 
 O
- 
 O
penicillin i O
treatment a O
was 	 O
ineffective f O
. 
 O
The 	 O
size e O
and 	 O
the 	 O
predicted d O
N 
 O
- 
 O
terminal m O
sequence u O
of O O
the 	 O
mouse s O
protein t O
were e O
confirmed f O
experimentally e O
. 
 O
Nuclear l O
runoff o O
assays a O
show w O
that t O
complementation p O
by O O
HPV16 1 B-GENE
E7 E E-GENE
restores t O
the 	 O
ability l O
of O O
the 	 O
E1A 	 B-GENE
mutants a E-GENE
to O O
stimulate m O
early l O
gene e O
expression r O
at O O
the 	 O
level e O
of O O
transcription n O
. 
 O
Yet 	 O
IL B B-GENE
- - I-GENE
2 - E-GENE
and 	 O
IFN 	 B-GENE
- - I-GENE
gamma m E-GENE
production d O
are 	 O
independently e O
regulated u O
, 
 O
as O O
demonstrated o O
by O O
their i O
differential f O
expression r O
in O O
certain t O
T 
 O
cell l O
subsets s O
, 
 O
suggesting g O
that t O
the 	 O
regulatory u O
elements m O
in O O
these s O
two 	 O
genes e O
must t O
differ f O
. 
 O
We O O
conclude c O
that t O
a 
 O
0 
 O
. 
 O
25 O O
mg O O
dose e O
of O O
triazolam a O
does s O
not 	 O
effectively e O
counteract n O
a 
 O
posture t O
- 
 O
induced u O
sleep e O
disturbance t O
, 
 O
but 	 O
induces u O
changes n O
in O O
the 	 O
EEG 	 O
spectra c O
which c O
are 	 O
typical i O
for 	 O
benzodiazepine z B-GENE
receptor e E-GENE
agonists n O
. 
 O
Anisotropy s O
of O O
Hc2 	 S-GENE
and 	 O
the 	 O
breadth a O
of O O
the 	 O
resistive i O
transition n O
of O O
polycrystalline y O
YBa2Cu 2 O
Microscopic r O
examination m O
of O O
these s O
colonies o O
showed w O
a 
 O
high h O
percentage c O
of O O
histiocytes t O
identical n O
to O O
those s O
seen n O
in O O
the 	 O
patient i O
' 
 O
s 
 O
bone e O
marrow r O
. 
 O
Functional c O
uncoupling o O
of O O
the 	 O
Janus u B-GENE
kinase a I-GENE
3 - E-GENE
- 
 O
Stat5 t S-GENE
pathway h O
in O O
malignant i O
growth w O
of O O
human a O
T 
 O
cell l O
leukemia k O
virus u O
type e O
1 
 O
- 
 O
transformed n O
human a O
T 
 O
cells l O
. 
 O
The 	 O
herpesvirus p O
entry r O
mediator i O
C - O
( 
 O
HveC C S-GENE
) 
 O
, 
 O
previously v O
known w O
as O O
poliovirus i B-GENE
receptor e I-GENE
- - I-GENE
related a I-GENE
protein t I-GENE
1 - E-GENE
( 
 O
PRR1 1 S-GENE
) 
 O
, 
 O
and 	 O
the 	 O
herpesvirus p B-GENE
Ig I I-GENE
- - I-GENE
like e I-GENE
receptor e E-GENE
( 
 O
HIgR R S-GENE
) 
 O
are 	 O
the 	 O
bona a O
fide e O
receptors e O
employed l O
by O O
herpes p O
simplex p O
virus u O
- 
 O
1 
 O
and 	 O
- 
 O
2 
 O
( 
 O
HSV 	 O
- 
 O
1 
 O
and 	 O
- 
 O
2 
 O
) 
 O
for 	 O
entry r O
into o O
the 	 O
human a O
cell l O
lines e O
most t O
frequently q O
used d O
in O O
HSV 	 O
studies d O
. 
 O
4 
 O
- 
 O
Hydroxyproline r O
assays a O
were e O
performed f O
to O O
determine e O
collagen l S-GENE
content t O
. 
 O
The 	 O
combination b O
of O O
ICP47 4 S-GENE
and 	 O
US11 1 S-GENE
rendered d O
fibroblasts r O
negative a O
for 	 O
surface f O
class s O
I - B-GENE
MHC 	 E-GENE
and 	 O
allowed o O
a 
 O
class s O
I - O
MHC 	 O
- 
 O
low 	 O
population u O
of O O
T 
 O
cells l O
to O O
be O O
sorted t O
by O O
flow w O
cytometry o O
. 
 O
Although h O
IRS 	 B-GENE
- - I-GENE
1 - I-GENE
, - I-GENE
- - I-GENE
2 - E-GENE
, - O
and 	 O
- - O
4 - O
are 	 O
similar i O
in O O
overall r O
structure u O
, 
 O
IRS 	 B-GENE
- - I-GENE
3 - E-GENE
is O O
approximately r O
50 O O
% 
 O
shorter r O
and 	 O
differs f O
with h O
respect p O
to O O
sites e O
of O O
tyrosine o O
phosphorylation s O
. 
 O
The 	 O
interaction e O
of O O
different f O
protein t O
systems t O
with h O
microtubules r O
is O O
a 
 O
critical t O
step p O
in O O
the 	 O
cellular l O
function c O
of O O
these s O
organelles a O
. 
 O
In O O
addition i O
, 
 O
we O O
mapped p O
a 
 O
putative a O
hnRNP N B-GENE
A1 I I-GENE
binding d I-GENE
site e E-GENE
in O O
U5 B B-GENE
RNA 	 E-GENE
and 	 O
demonstrated o O
that t O
p40CRS C S-GENE
( 
 O
hnRNP N B-GENE
A1 E E-GENE
) 
 O
binding d O
to O O
that t O
site e O
correlates r O
with h O
CRS 	 S-GENE
function c O
. 
 O
Sailer l O
, 
 O
K 
 O
. 
 O
Copyright y O
2000 0 O
Academic d O
Press s O
. 
 O
This s O
element m O
was 	 O
required u O
for 	 O
both h O
basal a O
and 	 O
activated i O
expression r O
and 	 O
almost o O
certainly t O
functions c O
as O O
a 
 O
TATA A O
- - O
binding d O
protein t O
interaction e O
site e O
. 
 O
In O O
HepG2 G O
cells l O
, 
 O
SREBP B B-GENE
- - I-GENE
1c I I-GENE
mRNA A E-GENE
and 	 O
precursor c O
protein t O
levels e O
were e O
induced u O
by O O
treatment a O
with h O
22 O O
( 
 O
R 
 O
) 
 O
- 
 O
hydroxycholesterol r O
and 	 O
9 
 O
- 
 O
cis 	 O
- 
 O
retinoic i O
acid d O
, 
 O
confirming f O
that t O
endogenous o O
LXR 	 S-GENE
- 
 O
RXR 	 S-GENE
activation i O
can 	 O
induce u O
endogenous o O
SREBP B B-GENE
- - I-GENE
1c E E-GENE
expression r O
. 
 O
Univariate v O
and 	 O
multivariate t O
analysis l O
was 	 O
used d O
to O O
calculate c O
the 	 O
5 
 O
- 
 O
year r O
survival v O
probabilities b O
with h O
respect p O
to O O
the 	 O
following l O
variables i O
: 
 O
age 	 O
( 
 O
< 
 O
or O O
= 
 O
65 O O
, 
 O
> 
 O
65 O O
) 
 O
, 
 O
sex 	 O
, 
 O
depth t O
of O O
invasion a O
( 
 O
mucosal o O
, 
 O
submucosal m O
) 
 O
tumor o O
location a O
( 
 O
upper e O
, 
 O
middle d O
and 	 O
lower e O
third r O
) 
 O
, 
 O
gross s O
appearance e O
( 
 O
type e O
I 
 O
, 
 O
type e O
II O O
and 	 O
type e O
III 	 O
) 
 O
, 
 O
size e O
( 
 O
< 
 O
or O O
= 
 O
1 
 O
. 
 O
5 
 O
cm O O
, 
 O
> 
 O
1 
 O
. 
 O
5 
 O
cm O O
) 
 O
, 
 O
presence s O
or O O
absence e O
of O O
lymph p O
node e O
metastasis a O
, 
 O
histological t O
type e O
( 
 O
intestinal e O
, 
 O
diffuse f O
) 
 O
, 
 O
extent e O
of O O
lymphadenectomy p O
( 
 O
limited i O
or O O
extended e O
) 
 O
, 
 O
and 	 O
type e O
of O O
gastrectomy t O
( 
 O
total a O
or O O
distal t O
subtotal t O
) 
 O
. 
 O
This s O
integration e O
results u O
in O O
the 	 O
production d O
of O O
MMTV V S-GENE
/ - O
mdr3 3 S-GENE
fusion i O
transcripts n O
that t O
originate g O
from m O
the 	 O
antisense i O
5 - O
' - O
LTR 	 O
of O O
the 	 O
provirus v O
. 
 O
In O O
32 O O
of O O
them m O
the 	 O
results u O
of O O
an O O
exercise r O
performance f O
test t O
based e O
on O O
heart r O
rate e O
response p O
to O O
submaximal m O
exercise r O
( 
 O
VO2 	 O
, 
 O
170 	 O
[ 
 O
bpm 	 O
] 
 O
) 
 O
was 	 O
compared p O
with h O
another t O
index e O
of O O
physical s O
performance f O
capacity a O
, 
 O
which c O
is O O
independent e O
from m O
heart r O
rate e O
: 
 O
the 	 O
ventilatory t O
threshold e O
. 
 O
Sequence u O
comparisons p O
reveal e O
that t O
the 	 O
P - B-GENE
. - I-GENE
woesei s I-GENE
GTP 	 I-GENE
- - I-GENE
binding d I-GENE
protein t E-GENE
is O O
strikingly i O
related a O
in O O
sequence u O
to O O
eubacterial a O
FtsZ Z S-GENE
and 	 O
is O O
marginally g O
more e O
similar i O
to O O
eukaryotic a B-GENE
tubulins u E-GENE
than n O
are 	 O
bacterial t B-GENE
FtsZ Z I-GENE
proteins t E-GENE
. 
 O
Four r O
of O O
15 O O
patients i O
with h O
R2 S O
had 	 O
rheumatoid u O
arthritis h O
and 	 O
in O O
two 	 O
of O O
these s O
four r O
cases e O
the 	 O
antibody i O
was 	 O
of O O
the 	 O
IgA 	 B-GENE
class s E-GENE
. 
 O
Phosphate s O
compounds p O
in O O
isolated l O
, 
 O
perfused f O
hearts r O
during i O
pH O O
variation i O
due 	 O
to O O
changes n O
in O O
extracellular r O
PCO2 2 O
and 	 O
bicarbonate a O
Vav 	 S-GENE
and 	 O
Dbl 	 S-GENE
are 	 O
members b O
of O O
a 
 O
novel e O
class s O
of O O
oncogene o O
proteins t O
that t O
share r O
significant n O
sequence u O
identity n O
in O O
a 
 O
approximately r O
250 	 O
- 
 O
amino n O
- 
 O
acid d O
domain a O
, 
 O
designated i O
the 	 O
Dbl 	 B-GENE
homology o I-GENE
domain a E-GENE
. 
 O
Serum u O
AFP 	 O
is O O
a 
 O
useful f O
tumor o O
marker k O
for 	 O
monitoring i O
the 	 O
results u O
of O O
therapy r O
. 
 O
The 	 O
possible s O
equivalency i O
of O O
a 
 O
short r O
form m O
and 	 O
the 	 O
long g O
form m O
of O O
the 	 O
Multiple t O
Affect e O
Adjective e O
Check c O
List t O
- 
 O
Revised i O
( 
 O
MAACL C O
- 
 O
R 
 O
; 
 O
Zuckerman k O
& 
 O
Lubin i O
, 
 O
1985 5 O
) 
 O
was 	 O
studied d O
by O O
correlating r O
both h O
forms m O
of O O
the 	 O
MAACL C O
- 
 O
R 
 O
with h O
the 	 O
State t O
Trait i O
Personality s O
Inventory e O
( 
 O
Spielberger e O
, 
 O
1995 5 O
) 
 O
; 
 O
the 	 O
Affect e O
Balance a O
Scale l O
( 
 O
Bradburn d O
, 
 O
1969 9 O
) 
 O
; 
 O
and 	 O
the 	 O
Sensation s O
Seeking k O
Scale l O
( 
 O
Zuckerman k O
, 
 O
1978 8 O
) 
 O
. 
 O
The 	 O
data a O
show w O
that t O
processing c O
time e O
as O O
a 
 O
function c O
of O O
intensity e O
is O O
modified i O
not 	 O
only y O
at O O
the 	 O
retina i O
but 	 O
also o O
at O O
later e O
processing c O
sites e O
. 
 O
Identification n O
of O O
masked k O
toxins i O
in O O
the 	 O
exotoxin t B-GENE
complex p I-GENE
of O I-GENE
Staphylococcus p I-GENE
pyogenes g I-GENE
und 	 I-GENE
Cl O I-GENE
. 
 I-GENE
perfringens f E-GENE
; 
 O
significance n O
of O O
their i O
existence s O
for 	 O
clarifying r O
of O O
the 	 O
masking k O
mechanism h O
Unlike i O
LANA1 A O
, 
 O
LANA2 A O
does s O
not 	 O
elicit c O
a 
 O
serologic o O
response p O
from m O
patients i O
with h O
KS O O
, 
 O
PEL 	 O
, 
 O
or O O
CD O O
as O O
measured s O
by O O
Western t O
blot t O
hybridization r O
. 
 O
However e O
, 
 O
this s O
posttranslational t O
modification i O
of O O
the 	 O
gar2 2 B-GENE
protein t E-GENE
does s O
not 	 O
appear e O
to O O
be O O
essential e O
for 	 O
normal m O
production d O
of O O
18S 	 B-GENE
rRNA A E-GENE
. 
 O
Here e O
, 
 O
we O O
analyzed l O
the 	 O
interaction e O
of O O
CYT 	 B-GENE
- - I-GENE
18 E E-GENE
with h O
a 
 O
small l O
RNA 	 O
( 
 O
P4 B B-GENE
- - I-GENE
P6 I I-GENE
RNA 	 E-GENE
) 
 O
corresponding r O
to O O
the 	 O
isolated l O
P4 B B-GENE
- - I-GENE
P6 I I-GENE
domain a E-GENE
of O O
the 	 O
N - O
. - O
crassa s O
mitochondrial o O
large g O
subunit u O
ribosomal o O
RNA 	 O
intron r O
. 
 O
The 	 O
deduced u O
amino n O
acid d O
sequence u O
of O O
PutR R B-GENE
( 
 I-GENE
154 	 I-GENE
amino n I-GENE
acid d I-GENE
residues i E-GENE
) 
 O
showed w O
homology o O
to O O
the 	 O
small l B-GENE
regulatory u I-GENE
proteins t I-GENE
Lrp 	 E-GENE
, 
 O
BkdR R S-GENE
, 
 O
and 	 O
AsnC C S-GENE
. 
 O
When n O
yeast s O
cells l O
reach c O
a 
 O
critical t O
size e O
in O O
late e O
G1 O O
they y O
simultaneously u O
start r O
budding d O
, 
 O
initiate t O
DNA 	 O
synthesis t O
, 
 O
and 	 O
activate i O
transcription n O
of O O
a 
 O
set 	 O
of O O
genes e O
that t O
includes l O
G1 B B-GENE
cyclins l I-GENE
CLN1 1 E-GENE
, 
 O
CLN2 2 S-GENE
, 
 O
and 	 O
many y O
DNA 	 O
synthesis t O
genes e O
. 
 O
Functional c O
PET 	 O
scanning n O
in O O
the 	 O
preoperative o O
assessment e O
of O O
cerebral e O
arteriovenous e O
malformations f O
. 
 O
In O O
addition i O
, 
 O
269 	 O
mice e O
from m O
a 
 O
( 
 O
Mus 	 O
spretus e O
x 
 O
C57BL B O
/ 
 O
6J O O
) 
 O
F1 O O
x 
 O
C57BL B O
/ 
 O
6J O S-GENE
interspecific e O
backcross k O
were e O
also o O
used d O
to O O
order e O
marker k O
loci i O
and 	 O
calculate c O
intergene e O
distances t O
for 	 O
this s O
region i O
. 
 O
Accordingly o O
, 
 O
superpeptide e O
antigenic i O
material e O
was 	 O
readily d O
detected e O
by O O
immunoblotting u O
cell l O
extracts r O
and 	 O
enriched i O
in O O
vacuolar u O
preparations p O
of O O
PrA 	 O
deficient i O
mutant a O
cells l O
. 
 O
Blockade c O
of O O
T 
 O
cell l O
activation i O
using n O
a 
 O
surface f O
- 
 O
linked k O
single g O
- 
 O
chain i O
antibody i O
to O O
CTLA A B-GENE
- - I-GENE
4 - E-GENE
( 
 O
CD152 5 S-GENE
) 
 O
. 
 O
Water e O
pair r O
and 	 O
three e O
- 
 O
body y O
potential e O
of O O
spectroscopic c O
quality l O
from m O
Ab O O
initio t O
calculations c O
4 
 O
) 
 O
Mutation a O
of O O
the 	 O
three e O
extracellular r O
cysteine t O
residues i O
of O O
GFKAR A B-GENE
beta a E-GENE
indicated i O
that t O
the 	 O
two 	 O
conserved s O
cysteine t O
residues i O
( 
 O
C305 5 O
and 	 O
C385 5 O
) 
 O
, 
 O
located a O
between w O
two 	 O
transmembrane n O
segments m O
, 
 O
form m O
a 
 O
solvent v O
- 
 O
accessible e O
disulfide u O
bond d O
. 
 O
In O O
this s O
work k O
, 
 O
we O O
have e O
used d O
Xenopus o O
oocyte y O
maturation u O
as O O
a 
 O
read d O
- 
 O
out 	 O
for 	 O
examining m O
the 	 O
ability l O
of O O
the 	 O
neu 	 B-GENE
tyrosine o I-GENE
kinase a E-GENE
( 
 O
p185neu 5 S-GENE
) 
 O
to O O
participate t O
with h O
the 	 O
epidermal d B-GENE
growth w I-GENE
factor t E-GENE
( - O
EGF 	 S-GENE
) - O
receptor e O
in O O
a 
 O
common m O
signal n O
transduction n O
pathway h O
. 
 O
The 	 O
best t O
- 
 O
studied d O
neurotrophin r S-GENE
, 
 O
nerve v B-GENE
growth w I-GENE
factor t E-GENE
( 
 O
NGF 	 S-GENE
) 
 O
, 
 O
is O O
a 
 O
major o O
survival v O
factor t O
in O O
sympathetic p O
and 	 O
sensory s O
neurons r O
and 	 O
promotes m O
differentiation f O
in O O
a 
 O
well l O
- 
 O
studied d O
model e O
system t O
, 
 O
PC12 2 O
cells l O
. 
 O
In O O
contrast t O
, 
 O
MAPK K S-GENE
activation i O
stimulated m O
by O O
the 	 O
Gq S B-GENE
- 
 I-GENE
coupled p I-GENE
alpha h I-GENE
1B O I-GENE
AR O E-GENE
or O O
M1 S B-GENE
muscarinic c I-GENE
cholinergic l I-GENE
receptor e E-GENE
is O O
unaffected f O
by O O
expression r O
of O O
beta a B-GENE
ARKct c E-GENE
or O O
RasN17 N S-GENE
expression r O
or O O
by O O
PTK 	 S-GENE
inhibitors i O
, 
 O
but 	 O
is O O
blocked c O
by O O
expression r O
of O O
N - B-GENE
delta t I-GENE
Raf 	 E-GENE
or O O
by O O
PKC 	 S-GENE
depletion l O
. 
 O
Transcriptional n O
analysis l O
indicates i O
that t O
human a B-GENE
TBP 	 E-GENE
functions c O
poorly r O
at O O
promoters m O
recognized o O
by O O
RNA 	 B-GENE
polymerases y I-GENE
I - I-GENE
and 	 I-GENE
III 	 E-GENE
and 	 O
at O O
RNA 	 B-GENE
Pol 	 I-GENE
II I I-GENE
promoters m E-GENE
lacking k O
a 
 O
conventional v O
TATA A O
element m O
. 
 O
The 	 O
steady a O
- 
 O
state t O
levels e O
of O O
Cdk2 2 S-GENE
, 
 O
Cdk4 4 S-GENE
and 	 O
Cyclin l B-GENE
A - I-GENE
proteins t E-GENE
were e O
unaffected f O
by O O
HPR 	 S-GENE
, 
 O
while l O
those s O
of O O
Cyclin l B-GENE
D1 E E-GENE
were e O
significantly n O
reduced u O
in O O
all 	 O
three e O
cell l O
lines e O
. 
 O
Mapping p O
the 	 O
5 
 O
' 
 O
and 	 O
3 
 O
' 
 O
termini m O
of O O
TED 	 B-GENE
RNAs s E-GENE
indicated i O
that t O
the 	 O
LTRs s S-GENE
have e O
a 
 O
retroviral r O
U3 O B-GENE
- 
 I-GENE
R 
 I-GENE
- 
 I-GENE
U5 O E-GENE
structural u O
organization a O
that t O
is O O
capable a O
of O O
directing e O
the 	 O
synthesis t O
of O O
transcripts n O
that t O
represent r O
potential e O
substrates s O
for 	 O
reverse e O
transcription n O
and 	 O
intermediates e O
in O O
transposition n O
. 
 O
Human a O
forearm e O
was 	 O
used d O
as O O
a 
 O
dummy m O
ear 	 O
and 	 O
the 	 O
electrode c O
HN O O
- 
 O
5 
 O
was 	 O
fixed e O
thereon r O
, 
 O
and 	 O
a 
 O
sound n O
stimulus m O
of O O
90dBnHL B O
was 	 O
delivered i O
by O O
the 	 O
earphone p O
( 
 O
NC O O
- 
 O
3 
 O
) 
 O
. 
 O
These s O
proteins t O
were e O
detected e O
by O O
an O O
antibody i O
which c O
recognizes o O
the 	 O
N 
 O
- 
 O
terminus m O
of O O
SRK3 3 S-GENE
and 	 O
, 
 O
in O O
an O O
F2 O O
progeny g O
segregating r O
for 	 O
the 	 O
S3 B B-GENE
haplotype l E-GENE
, 
 O
were e O
only y O
expressed r O
in O O
plants n O
possessing s O
the 	 O
S3 B B-GENE
haplotype l E-GENE
. 
 O
The 	 O
blood o O
pressures s O
in O O
43 O O
subjects j O
were e O
compared p O
during i O
rapid i O
weight g O
loss s O
and 	 O
at O O
identical n O
weights g O
during i O
post t O
- 
 O
fast t O
weight g O
gain n O
( 
 O
Study d O
A 
 O
) 
 O
. 
 O
The 	 O
animals m O
were e O
followed l O
over r O
a 
 O
1 
 O
- 
 O
to O O
6 
 O
- 
 O
h 
 O
posttraumatic t O
course r O
, 
 O
and 	 O
processed c O
for 	 O
the 	 O
LM O O
and 	 O
TEM 	 O
visualization u O
of O O
HRP 	 O
. 
 O
Total a O
body y O
water e O
and 	 O
distribution t O
space c O
of O O
Na24 4 S-GENE
in O O
women e O
with h O
various i O
body y O
weight g O
Three e O
experiments e O
using n O
20 O O
microM r O
2 
 O
- 
 O
( 
 O
hydroxyamino r O
) 
 O
- 
 O
1 
 O
- 
 O
methyl h O
- 
 O
6 
 O
- 
 O
phenylimidazo n O
[ 
 O
4 
 O
, 
 O
5 
 O
- 
 O
b 
 O
] 
 O
pyridine i O
( 
 O
N 
 O
- 
 O
OH O O
- 
 O
PhIP P O
) 
 O
were e O
performed f O
to O O
induce u O
mutations a O
in O O
the 	 O
dihydrofolate y B-GENE
reductase u E-GENE
( 
 O
DHFR R S-GENE
) 
 O
gene e O
of O O
a 
 O
hemizygous i O
Chinese n O
hamster s O
ovary r O
( 
 O
CHO 	 O
) 
 O
cell l O
line e O
( 
 O
UA21 1 O
) 
 O
. 
 O
This s O
is O O
mediated i O
by O O
vascular c O
remodeling o O
, 
 O
an O O
active i O
process c O
that t O
results u O
in O O
a 
 O
change n O
in O O
the 	 O
geometry m O
of O O
the 	 O
blood o O
vessel s O
. 
 O
Our 	 O
results u O
separate a O
these s O
factors t O
into o O
four r O
regulatory u O
classes s O
: 
 O
( 
 O
i 
 O
) 
 O
constitutive s O
factors t O
, 
 O
such h O
as O O
Oct 	 B-GENE
- - I-GENE
1 - E-GENE
and 	 O
probably b O
Sp1 	 S-GENE
, 
 O
that t O
are 	 O
expressed r O
in O O
thymocytes m O
at O O
all 	 O
stages g O
; 
 O
( 
 O
ii O O
) 
 O
inducible u O
factors t O
, 
 O
such h O
as O O
NF B B-GENE
- - I-GENE
kappa p I-GENE
B - E-GENE
and 	 O
complexes p O
binding d O
to O O
the 	 O
region i O
of O O
a 
 O
CD28 8 B-GENE
response p I-GENE
element m E-GENE
, 
 O
that t O
can 	 O
be O O
activated i O
in O O
all 	 O
thymocytes m O
, 
 O
including l O
those s O
cells l O
( 
 O
CD4 	 S-GENE
+ - O
CD8 	 S-GENE
+ - O
TcRlow l S-GENE
) 
 O
that t O
can 	 O
undergo e O
selection e O
; 
 O
( 
 O
iii 	 O
) 
 O
inducible u O
factors t O
, 
 O
such h O
as O O
NF B B-GENE
- - I-GENE
AT E E-GENE
and 	 O
AP B B-GENE
- - I-GENE
1 - E-GENE
, 
 O
that t O
can 	 O
be O O
activated i O
in O O
mature u O
( 
 O
CD4 	 S-GENE
+ - O
CD8 	 S-GENE
- - O
TcRhigh h S-GENE
) 
 O
and 	 O
immature a O
( 
 O
CD4 	 S-GENE
- - O
CD8 	 S-GENE
- - O
TcR 	 S-GENE
- - O
) 
 O
thymocytes m O
alike k O
but 	 O
not 	 O
in O O
the 	 O
transitional n O
stages g O
when n O
the 	 O
cells l O
( 
 O
CD4 	 S-GENE
+ - O
CD8 	 S-GENE
+ - O
TcRlow l S-GENE
) 
 O
are 	 O
subject j O
to O O
selection e O
; 
 O
and 	 O
( 
 O
iv O O
) 
 O
a 
 O
factor t O
containing t O
CREB B S-GENE
, 
 O
which c O
can 	 O
be O O
activated i O
in O O
thymocytes m O
of O O
all 	 O
developmental e O
stages g O
by O O
culture t O
but 	 O
does s O
not 	 O
require u O
specific c O
induction u O
. 
 O
Thus s O
, 
 O
22 O O
% 
 O
of O O
MDS 	 O
responded p O
to O O
oral l O
PLAC C O
. 
 O
Posterior t O
osteophytes e O
around u O
the 	 O
posterior t O
edges e O
of O O
vertebral t O
body y O
resulted u O
in O O
intervertebral e O
insufficiency u O
, 
 O
and 	 O
corresponded r O
to O O
hypertrophic e O
spur r O
in O O
osteochondrosis e O
. 
 O
They y O
showed w O
moderate e O
in O O
vitro r O
antifungal i O
activity i O
against i O
a 
 O
wide e O
variety i O
of O O
fungi g O
and 	 O
yeasts s O
including l O
clinically n O
important o O
pathogens h O
, 
 O
and 	 O
were e O
highly h O
effective e O
in O O
systemic t O
infection e O
with h O
Candida d O
albicans i O
in O O
mice e O
after e O
iv O O
and 	 O
im O O
administrations i O
. 
 O
Of O O
these s O
four r O
PP2C C B-GENE
genes e E-GENE
, 
 O
the 	 O
expression r O
of O O
the 	 O
PP2Cbeta C B-GENE
gene e E-GENE
has 	 O
been n O
reported o O
to O O
be O O
tissue s O
- 
 O
specific c O
and 	 O
development e O
- 
 O
dependent e O
. 
 O
We O O
also o O
show w O
that t O
in O O
fusions i O
with h O
the 	 O
DNA 	 O
binding d O
domain a O
of O O
GAL4 4 S-GENE
, 
 O
full l O
activity i O
requires u O
the 	 O
entire i O
BHV 	 B-GENE
- - I-GENE
alpha h I-GENE
TIF 	 E-GENE
, 
 O
although h O
both h O
amino n O
and 	 O
carboxyl b O
termini m O
display p O
some e O
activity i O
on O O
their i O
own 	 O
. 
 O
The 	 O
induction u O
by O O
dexamethasone a O
of O O
rat 	 O
liver e O
CYP3A1 3 S-GENE
differs f O
from m O
classical s O
glucocorticoid c O
gene e O
regulation u O
in O O
part t O
because a O
both h O
glucocorticoids c O
and 	 O
antiglucocorticoids i O
such h O
as O O
pregnenolone g O
16 O O
alpha h O
- 
 O
carbonitrile b O
( 
 O
PCN 	 O
) 
 O
induce u O
CYP3A1 3 S-GENE
through o O
transcriptional n O
gene e O
activation i O
. 
 O
Moreover e O
, 
 O
antibody i O
binding d O
to O O
the 	 O
same e O
two 	 O
determinants e O
was 	 O
also o O
inhibited i O
when n O
ZAP 	 B-GENE
- - I-GENE
70 E E-GENE
or O O
the 	 O
SH2 	 B-GENE
domains a E-GENE
bound n O
to O O
the 	 O
zeta a B-GENE
chain i E-GENE
or O O
to O O
a 
 O
2pY 	 B-GENE
- - I-GENE
ITAM M E-GENE
. 
 O
This s O
surface f O
in O O
specimens c O
from m O
unfertilized e O
eggs s O
is O O
almost o O
flat t O
. 
 O
Fetal a O
transplants n O
rescue c O
axial a O
muscle c O
representations r O
in O O
M1 O O
cortex t O
of O O
neonatally n O
transected n O
rats s O
that t O
develop e O
weight g O
support p O
. 
 O
We O O
examined m O
the 	 O
contribution t O
of O O
the 	 O
M - B-GENE
- - I-GENE
MuLV V I-GENE
enhancers a E-GENE
to O O
the 	 O
transcriptional n O
activity i O
and 	 O
pathogenesis h O
of O O
M 
 B-GENE
- 
 I-GENE
MuLV V E-GENE
by O O
constructing s O
LTRs s O
containing t O
heterologous e O
enhancer a O
elements m O
. 
 O
There r O
were e O
no O O
major o O
postoperative t O
complications p O
and 	 O
at O O
follow l O
- 
 O
up O O
of O O
the 	 O
13 O O
patients i O
at O O
10 O O
to O O
26 O O
months t O
after e O
operation r O
the 	 O
results u O
were e O
satisfactory i O
. 
 O
The 	 O
immunoreactive u O
antithrombin i B-GENE
III 	 E-GENE
increased r O
significantly n O
while l O
the 	 O
increase r O
in O O
antithrombin i B-GENE
III 	 E-GENE
activity i O
was 	 O
insignificant i O
in O O
20 O O
male e O
Caucasian c O
Danes e O
upon n O
3 
 O
weeks k O
supplementation p O
of O O
the 	 O
diet t O
with h O
10 O O
ml O O
daily l O
of O O
a 
 O
cod 	 O
liver e O
oil 	 O
concentrate c O
. 
 O
Northern t O
blot t O
analysis l O
confirmed f O
that t O
ADAMTS M B-GENE
- - I-GENE
1 - E-GENE
was 	 O
up O O
- 
 O
regulated u O
in O O
both h O
metaphyseal a O
( 
 O
14 O O
- 
 O
to O O
35 O O
- 
 O
fold d O
) 
 O
and 	 O
diaphyseal p O
( 
 O
4 
 O
. 
 O
2 
 O
- 
 O
fold d O
) 
 O
bone e O
1 
 O
h 
 O
after e O
PTH 	 O
- - O
( - O
1 - O
- - O
38 I O
) - O
injection e O
and 	 O
returned u O
to O O
control t O
levels e O
by O O
24 O O
h 
 O
. 
 O
The 	 O
transcriptional n O
transactivator n O
( 
 O
Tas 	 S-GENE
) 
 O
of O O
simian i B-GENE
foamy m I-GENE
virus u I-GENE
type e I-GENE
1 
 E-GENE
strongly o O
augments m O
gene e O
expression r O
directed e O
by O O
both h O
the 	 O
promoter m O
in O O
the 	 O
viral a O
long g O
terminal m O
repeat e O
and 	 O
the 	 O
newly l O
discovered c O
internal e O
promoter m O
located a O
within h O
the 	 O
env 	 B-GENE
gene e E-GENE
. 
 O
In O O
the 	 O
other e O
two 	 O
cases e O
, 
 O
fluoxetine o O
adjunct u O
produced d O
benefits e O
with h O
no O O
additional i O
side e O
effects e O
. 
 O
Deletion e O
of O O
this s O
consensus s O
element m O
from m O
the 	 O
spo6 6 B-GENE
promoter m E-GENE
abolished l O
the 	 O
transcription n O
of O O
spo6 6 B-GENE
+ - E-GENE
and 	 O
resulted u O
in O O
a 
 O
sporulation r O
deficiency i O
. 
 O
Chem m O
. 
 O
Mutations a O
in O O
the 	 O
beta a B-GENE
- - I-GENE
galactosidase a I-GENE
gene e E-GENE
result u O
in O O
the 	 O
lysosomal o O
storage r O
disorders o O
GM1 	 O
- 
 O
gangliosidosis g O
and 	 O
Morquio q O
B 
 O
syndrome d O
. 
 O
Results u O
indicated i O
that t O
hobbies b O
/ 
 O
leisure s O
activities i O
, 
 O
mobility i O
, 
 O
transport n O
, 
 O
social i O
relationships a O
, 
 O
working k O
capacity a O
, 
 O
energy r O
and 	 O
doing n O
things n O
slower w O
were e O
aspects e O
relevant e O
to O O
IPF 	 O
patients i O
' 
 O
QOL 	 O
. 
 O
We O O
have e O
generated e O
transgenic n O
fly 	 O
strains a O
with h O
mutations a O
affecting e O
specific c O
TRA 	 B-GENE
- - I-GENE
2 - I-GENE
isoforms f E-GENE
to O O
investigate e O
their i O
individual i O
roles e O
in O O
regulating u O
the 	 O
alternative e O
processing c O
of O O
doublesex b O
, 
 O
exuperantia p O
and 	 O
tra 	 B-GENE
- - I-GENE
2 - I-GENE
pre 	 I-GENE
- - I-GENE
mRNA A E-GENE
. 
 O
The 	 O
IR4 	 B-GENE
ORF 	 E-GENE
exhibits i O
significant n O
homology o O
to O O
the 	 O
immediate e B-GENE
- - I-GENE
early l I-GENE
gene e I-GENE
US1 	 E-GENE
( 
 O
ICP22 2 S-GENE
) 
 O
of O O
herpes p O
simplex p O
virus u O
type e O
1 
 O
and 	 O
to O O
the 	 O
ICP22 2 B-GENE
homologs o E-GENE
of O O
varicella i O
- 
 O
zoster t O
virus u O
( 
 O
ORF63 6 O
) 
 O
, 
 O
pseudorabies u O
virus u O
( 
 O
RSp40 4 O
) 
 O
, 
 O
and 	 O
equine i O
herpesvirus p O
4 
 O
( 
 O
ORF4 4 O
) 
 O
. 
 O
These s O
studies d O
define i O
a 
 O
class s O
of O O
DNA 	 O
elements m O
with h O
a 
 O
mode e O
of O O
action i O
that t O
has 	 O
not 	 O
been n O
heretofore e O
described c O
. 
 O
We O O
were e O
able e O
to O O
demonstrate o O
a 
 O
significant n O
statistical t O
interaction e O
effect e O
between w O
gender d O
and 	 O
globulin b B-GENE
protein t E-GENE
concentration c O
on O O
Vu O O
( 
 O
p 
 O
= 
 O
0 
 O
. 
 O
022 	 O
) 
 O
. 
 O
Chest s O
X 
 O
- 
 O
P 
 O
revealed e O
an O O
abnormal o O
shadow d O
in O O
the 	 O
left t O
upper e O
lobe e O
. 
 O
From m O
the 	 O
frozen z O
specimen c O
, 
 O
a 
 O
large g O
number b O
of O O
sections t O
with h O
good d O
morphologic p O
characteristics r O
may 	 O
be O O
produced d O
. 
 O
These s O
include l O
not 	 O
only y O
antioxidants i O
, 
 O
N - B-GENE
- - I-GENE
methyl h I-GENE
- - I-GENE
D - I-GENE
- - I-GENE
aspartate a I-GENE
receptor e E-GENE
antagonists a O
, 
 O
inhibitors i O
of O O
glutamate t O
release e O
, 
 O
calcium c O
channel n O
blockers c O
, 
 O
polyamine y O
antagonists a O
, 
 O
and 	 O
nitric r B-GENE
oxide d I-GENE
synthase t E-GENE
inhibitors i O
, 
 O
but 	 O
cannabinoids n O
, 
 O
aspirin i O
, 
 O
melatonin a O
, 
 O
and 	 O
vitamin a O
B 
 O
- 
 O
12 O O
. 
 O
A 
 O
series i O
of O O
mutations a O
were e O
constructed s O
within h O
the 	 O
E2 S O
open n O
reading d O
frame m O
which c O
delete e O
various i O
regions i O
of O O
the 	 O
conserved s O
DNA 	 O
binding d O
and 	 O
transactivation n O
domains a O
as O O
well l O
as O O
the 	 O
internal e O
hinge g O
region i O
. 
 O
CrkII I S-GENE
and 	 O
CrkL L S-GENE
constitutively s O
formed m O
complex p O
with h O
the 	 O
guanine n B-GENE
nucleotide l I-GENE
exchange h I-GENE
factor t I-GENE
C3G 	 E-GENE
, 
 O
in O O
unstimulated t O
as O O
well l O
as O O
PDGF F S-GENE
- 
 O
stimulated m O
cells l O
. 
 O
In O O
further t O
support p O
of O O
the 	 O
biological l O
significance n O
of O O
these s O
DNA 	 O
- 
 O
protein t O
interactions e O
, 
 O
the 	 O
IL2RA R B-GENE
oligonucleotide g E-GENE
from m O
- 
 O
291 	 O
to O O
- 
 O
245 	 O
proved v O
to O O
be O O
sufficient f O
in O O
either h O
orientation e O
to O O
confer f O
PMA 	 O
inducibility u O
to O O
the 	 O
mitogen o O
- 
 O
insensitive e O
thymidine m B-GENE
kinase a I-GENE
gene e I-GENE
promoter m E-GENE
in O O
Jurkat k O
cells l O
. 
 O
The 	 O
plasma s O
steroid r O
levels e O
in O O
the 	 O
CAPD D O
patients i O
after e O
each h O
infusion u O
rate e O
were e O
equal a O
to O O
or O O
greater a O
than n O
the 	 O
levels e O
in O O
normal m O
subjects j O
. 
 O
With h O
BCPP P O
protocol t O
, 
 O
12 O O
achieved i O
a 
 O
complete p O
response p O
, 
 O
11 O O
evidenced d O
a 
 O
75 O O
% 
 O
response p O
, 
 O
and 	 O
7 
 O
displayed p O
a 
 O
50 O O
% 
 O
response p O
. 
 O
The 	 O
RPC31 3 B-GENE
gene e E-GENE
encoding o O
the 	 O
C31 	 B-GENE
subunit u E-GENE
of I O
Saccharomyces c B-GENE
cerevisiae e I-GENE
RNA 	 I-GENE
polymerase y I-GENE
C - I-GENE
( - I-GENE
III 	 I-GENE
) - E-GENE
has 	 O
been n O
isolated l O
, 
 O
starting r O
from m O
a 
 O
C 
 O
- 
 O
terminal m O
fragment g O
cloned n O
on O O
a 
 O
lambda b O
gt11 1 O
library r O
. 
 O
Electrophoretic c O
mobility i O
shift f O
assays a O
demonstrated o O
that t O
sequences u O
within h O
this s O
region i O
bind d O
members b O
of O O
the 	 O
Sp1 	 B-GENE
family i E-GENE
of I O
transcription n O
factors t O
. 
 O
The 	 O
phosphatase s B-GENE
active i I-GENE
site e E-GENE
is O O
located a O
within h O
residues i O
367 	 O
- 
 O
374 	 O
. 
 O
After e O
at O O
least s O
one 	 O
year r O
follow l O
- 
 O
up O O
, 
 O
argon o O
laser e O
showed w O
a 
 O
statistically t O
significant n O
effect e O
( 
 O
p 
 O
less s O
of O O
0 
 O
, 
 O
01 O O
; 
 O
Kolmogorow m O
- 
 O
Smirnov r O
test t O
) 
 O
on O O
the 	 O
stabilization b O
or O O
the 	 O
amelioration l O
of O O
visual u O
acuity i O
compared p O
with h O
the 	 O
non 	 O
treated a O
group u O
. 
 O
Further t O
studies d O
aim 	 O
at O O
characterizing r O
the 	 O
trans n O
- 
 O
acting i O
factors t O
that t O
mediate i O
the 	 O
spatial t O
and 	 O
temporal p O
expression r O
of O O
Hox 	 B-GENE
genes e E-GENE
in O O
the 	 O
developing e O
embryo r O
. 
 O
Contraindications t O
to O O
adenosine n O
and 	 O
drug g O
interactions e O
are 	 O
noted e O
in O O
this s O
article i O
. 
 O
As O O
to O O
the 	 O
side e O
effects e O
of O O
SISO O O
, 
 O
cylindruria i O
with h O
aggravation r O
of O O
microscopic r O
hematuria a O
and 	 O
elevations v O
of O O
GOT 	 O
, 
 O
GPT 	 O
and 	 O
A1 B O
- - O
P - O
were e O
observed e O
each h O
one 	 O
of O O
them m O
, 
 O
respectively p O
. 
 O
Serum u B-GENE
C3 E E-GENE
was 	 O
measured s O
in O O
1 
 O
, 
 O
282 	 O
school o O
children l O
with h O
abnormal o O
urinary n O
findings d O
between w O
1980 0 O
and 	 O
1997 7 O
. 
 O
Two 	 O
measures s O
of O O
sensory s O
inhibition i O
were e O
employed l O
, 
 O
S2 O O
/ 
 O
S1 O O
x 
 O
100 	 O
amplitude l O
ratio i O
and 	 O
S1 O O
- 
 O
S2 O O
amplitude l O
difference f O
. 
 O
Computer p O
analysis l O
revealed e O
that t O
the 	 O
human a B-GENE
protein t I-GENE
P1 I I-GENE
sequence u E-GENE
corresponding r O
to O O
amino n O
acid d O
residues i O
within h O
the 	 O
N 
 O
- 
 O
terminal m O
RNA 	 O
binding d O
domain a O
displays p O
high h O
homology o O
( 
 O
greater a O
than n O
54 O O
% 
 O
identity n O
; 
 O
61 O O
to O O
94 O O
% 
 O
similarity i O
) 
 O
with h O
two 	 O
animal m O
virus u O
proteins t O
which c O
possess s O
RNA 	 O
binding d O
activity i O
( 
 O
vaccinia c O
virus u O
E3L 	 O
; 
 O
rotavirus a O
VP2 	 S-GENE
) 
 O
and 	 O
two 	 O
proteins t O
of O O
unknown n O
function c O
( 
 O
murine i B-GENE
TIK 	 E-GENE
; 
 O
rotavirus a O
NS34 4 S-GENE
) 
 O
, 
 O
but 	 O
which c O
are 	 O
likely e O
RNA 	 O
binding d O
proteins t O
. 
 O
Determinants e O
of O O
recurrent u O
ischaemia h O
and 	 O
revascularisation a O
procedures c O
after e O
thrombolysis o O
with h O
recombinant o B-GENE
tissue s I-GENE
plasminogen s I-GENE
activator i E-GENE
in O O
primary m O
coronary o O
occlusion l O
. 
 O
For 	 O
large g O
breasts a O
( 
 O
> 
 O
70 O O
mm O O
) 
 O
the 	 O
use 	 O
of O O
X 
 O
- 
 O
ray 	 O
sets s O
such h O
as O O
the 	 O
IGE 	 B-GENE
DMR 	 E-GENE
, 
 O
which c O
automatically o O
select e O
the 	 O
beam m O
quality l O
for 	 O
each h O
breast a O
, 
 O
resulted u O
in O O
lower e O
doses e O
compared p O
with h O
sets s O
using n O
manual u O
tube e O
potential e O
selection e O
. 
 O
Experimental e O
exposure o O
of O O
poults l O
with h O
each h O
of O O
two 	 O
strains a O
representing r O
the 	 O
rarely e O
reported o O
capsular s O
group u O
B 
 O
indicated i O
that t O
both h O
were e O
virulent u O
. 
 O
Computer p O
system t O
trains i O
employees l O
to O O
meet t O
JCAHO H O
safety e O
ED O O
requirements u O
. 
 O
Finally a O
, 
 O
transfection n O
of O O
Grb10 1 B-GENE
genes e E-GENE
with h O
specific c O
mutations a O
in O O
their i O
SH2 	 B-GENE
domains a E-GENE
induces u O
apoptosis p O
in O O
HTC 	 B-GENE
- 
 I-GENE
IR O E-GENE
and 	 O
COS 	 O
- 
 O
7 
 O
cells l O
. 
 O
Comparison p O
of O O
dose e O
volume u O
histograms t O
revealed e O
that t O
the 	 O
6 
 O
- 
 O
field l O
plan n O
spared r O
relatively a O
more e O
heart r O
whereas r O
the 	 O
8 
 O
- 
 O
field l O
plan n O
spared r O
relatively a O
more e O
lung g O
. 
 O
We O O
have e O
demonstrated o O
that t O
a 
 O
putative a O
HOX 	 B-GENE
cofactor a E-GENE
, 
 O
PBX1A 1 S-GENE
, 
 O
participates t O
in O O
cooperative p O
DNA 	 O
binding d O
with h O
HOXA A B-GENE
- - I-GENE
1 - E-GENE
and 	 O
the 	 O
Deformed o B-GENE
group u I-GENE
protein t I-GENE
HOXD D I-GENE
- - I-GENE
4 - E-GENE
. 
 O
The 	 O
CHL 	 B-GENE
1 - I-GENE
( 
 I-GENE
CTF 	 I-GENE
1 - I-GENE
) 
 I-GENE
gene e I-GENE
product d I-GENE
of O I-GENE
Saccharomyces c I-GENE
cerevisiae e E-GENE
is O O
important o O
for 	 O
chromosome o O
transmission n O
and 	 O
normal m O
cell l O
cycle l O
progression g O
in O O
G2 O O
/ 
 O
M 
 O
. 
 O
Heterotrimeric e B-GENE
guanine n I-GENE
nucleotide l I-GENE
- - I-GENE
binding d I-GENE
proteins t E-GENE
( 
 O
G - B-GENE
- - I-GENE
proteins t E-GENE
) 
 O
function c O
as O O
signal n O
transducers n O
for 	 O
a 
 O
variety i O
of O O
hormone m O
- 
 O
coupled p O
enzyme y O
and 	 O
ion 	 O
transport n O
systems t O
in O O
eukaryotic a O
cells l O
. 
 O
In O O
contrast t O
, 
 O
polypropylene y O
glycol c O
, 
 O
PG O O
- 
 O
C 
 O
, 
 O
and 	 O
corn n O
oil 	 O
all 	 O
removed o O
68 O O
- 
 O
86 O O
% 
 O
of O O
the 	 O
MDI 	 O
in O O
the 	 O
first s O
h 
 O
, 
 O
74 O O
- 
 O
79 O O
% 
 O
at O O
4 
 O
h 
 O
, 
 O
and 	 O
72 O O
- 
 O
86 O O
% 
 O
at O O
8 
 O
h 
 O
. 
 O
DDD 	 O
( 
 O
R 
 O
) 
 O
pacing i O
with h O
automatic o O
mode e O
switch t O
in O O
patients i O
with h O
paroxysmal o O
atrial i O
fibrillation r O
following l O
AV O O
nodal a O
ablation a O
. 
 O
There r O
was 	 O
a 
 O
highly h O
significant n O
decrease r O
in O O
serum u O
eosinophil i O
cationic i O
protein t O
in O O
patients i O
with h O
elevated v O
AGA 	 O
. 
 O
Sequence u O
analysis l O
revealed e O
that t O
Hv B S-GENE
- - O
p68 	 S-GENE
belongs o O
to O O
the 	 O
large g O
family i O
of O O
FAD 	 B-GENE
- - I-GENE
dependent e I-GENE
glucose c I-GENE
methanol h I-GENE
choline l I-GENE
oxidoreductases d E-GENE
and 	 O
that t O
it O O
shares r O
significant n O
sequence u O
identity n O
( 
 O
> 
 O
67 O O
% 
 O
) 
 O
with h O
the 	 O
alcohol o B-GENE
oxidases d E-GENE
of O O
the 	 O
methylotrophic h O
yeasts s O
. 
 O
It O O
is O O
required u O
for 	 O
correct r O
expression r O
of O O
both h O
genes e O
. 
 O
In O O
the 	 O
HIV 	 O
LTR 	 O
, 
 O
this s O
region i O
has 	 O
been n O
demonstrated o O
to O O
have e O
both h O
positive i O
and 	 O
negative a O
regulatory u O
effects e O
on O O
HIV 	 B-GENE
gene e E-GENE
expression r O
. 
 O
A 
 O
comparison p O
between w O
attenuation e O
- 
 O
corrected r O
and 	 O
- 
 O
uncorrected o O
transmission n O
- 
 O
emission s O
SPECT C O
images g O
obtained a O
with h O
Tl O O
- 
 O
201 	 O
in O O
CAD 	 O
patients i O
Accumulation u O
of O O
amines n O
in O O
the 	 O
isolated l O
perfused f O
rabbit b O
lung g O
. 
 O
Since c O
it O O
is O O
often e O
necessary e O
to O O
resort o O
to O O
thoracotomy r O
as O O
a 
 O
final a O
step p O
in O O
making i O
such h O
a 
 O
diagnosis g O
, 
 O
we O O
have e O
sought g O
a 
 O
procedure c O
that t O
is O O
simpler p O
while l O
capable a O
of O O
providing v O
the 	 O
same e O
information o O
. 
 O
Both h O
control t O
and 	 O
Mn O O
- 
 O
exposed o O
quail i O
accumulated u O
5 
 O
to O O
10 O O
times e O
more e O
Mn O O
in O O
their i O
livers e O
than n O
similarly i O
treated a O
rodents e O
. 
 O
Small l O
t - O
also o O
inhibited i O
the 	 O
dephosphorylation h O
of O O
cAMP P B-GENE
- - I-GENE
dependent e I-GENE
protein t I-GENE
kinase a E-GENE
( 
 O
PKA 	 S-GENE
) 
 O
- 
 O
phosphorylated s O
CREB B S-GENE
in O O
rat 	 O
liver e O
nuclear l O
extracts r O
. 
 O
A 
 O
retrospective r O
analysis l O
of O O
data a O
accumulated u O
over r O
a 
 O
21 O O
- 
 O
month t O
period i O
, 
 O
from m O
December e O
1989 9 O
to O O
September t O
1991 1 O
, 
 O
regarding a O
investigational e O
use 	 O
of O O
a 
 O
308 	 O
nanometer o O
Xenon o O
Chloride o O
Excimer i O
Laser e O
Coronary o O
Angioplasty i O
( 
 O
ELCA A O
) 
 O
system t O
( 
 O
Advanced a O
Interventional e O
Systems t O
, 
 O
Inc 	 O
. 
 O
, 
 O
Irvine i O
, 
 O
CA O O
) 
 O
was 	 O
performed f O
. 
 O
Presently s O
, 
 O
we O O
made e O
chain i O
pair r O
switch t O
, 
 O
chimeric m O
, 
 O
and 	 O
site e O
mutant a B-GENE
gamma m I-GENE
delta t I-GENE
TCRs s E-GENE
and 	 O
transfected n O
them m O
into o O
TCR 	 B-GENE
- 
 I-GENE
mutant a E-GENE
Jurkat k O
T 
 O
cells l O
to O O
examine m O
the 	 O
effects e O
of O O
changing n O
the 	 O
TCR 	 B-GENE
gamma m I-GENE
junctional c I-GENE
region i I-GENE
sequences u E-GENE
on O O
reactivity c O
to O O
prenyl n O
pyrophosphate o O
Ags 	 O
. 
 O
Fos 	 S-GENE
/ 
 O
Jun 	 S-GENE
bound n O
to O O
an O O
unacetylated c O
nucleosome l O
with h O
only y O
a 
 O
4 
 O
- 
 O
to O O
5 
 O
- 
 O
fold d O
reduction u O
in O O
DNA 	 O
binding d O
affinity i O
compared p O
with h O
naked e O
DNA 	 O
. 
 O
Activated i O
Ki I B-GENE
- - I-GENE
Ras 	 E-GENE
suppresses p O
12 O O
- 
 O
O 
 O
- 
 O
tetradecanoylphorbol r O
- 
 O
13 O O
- 
 O
acetate t O
- 
 O
induced u O
activation i O
of O O
the 	 O
c - B-GENE
- - I-GENE
Jun 	 I-GENE
NH2 	 I-GENE
- - I-GENE
terminal m I-GENE
kinase a E-GENE
pathway h O
in O O
human a O
colon o O
cancer c O
cells l O
. 
 O
Electromobility c O
shift f O
analysis l O
using n O
oligonucleotides g O
encompassing o O
the 	 O
proximal x O
, 
 O
distal t O
, 
 O
and 	 O
BED 	 O
/ 
 O
AP B B-GENE
- - I-GENE
1 - I-GENE
- 
 I-GENE
binding d I-GENE
regions i E-GENE
failed l O
to O O
demonstrate o O
selective e O
transactivation n O
after e O
CD2 	 S-GENE
signaling n O
of O O
LPMC C S-GENE
. 
 O
The 	 O
present s O
report o O
shows w O
that t O
a 
 O
cis 	 O
- 
 O
acting i O
element m O
between w O
- 
 O
189 	 O
and 	 O
- 
 O
175 	 O
bp O O
, 
 O
which c O
binds d O
thyroid r B-GENE
transcription n I-GENE
factor t I-GENE
- - I-GENE
1 - E-GENE
( 
 O
TTF 	 B-GENE
- - I-GENE
1 - E-GENE
) 
 O
, 
 O
is O O
involved o O
in O O
both h O
activities i O
. 
 O
Increased r O
platelet t O
- - O
derived i O
growth w O
factor t O
production d O
and 	 O
intimal i O
thickening c O
during i O
healing l O
of O O
Dacron r O
grafts f O
in O O
a 
 O
canine i O
model e O
. 
 O
Despite p O
their i O
high h O
degree r O
of O O
sequence u O
similarity i O
, 
 O
all 	 O
five e O
RFC 	 B-GENE
genes e E-GENE
are 	 O
essential e O
for 	 O
cell l O
proliferation l O
in O O
S 
 O
. 
 O
cerevisiae e O
. 
 O
Moreover e O
, 
 O
we O O
show w O
that t O
ectopic o O
expression r O
of O O
the 	 O
E2A 	 B-GENE
protein t I-GENE
E12 	 E-GENE
in O O
this s O
macrophage r O
line e O
results u O
in O O
the 	 O
induction u O
of O O
many y O
B 
 B-GENE
lineage e I-GENE
genes e E-GENE
, 
 O
including l O
EBF 	 S-GENE
, 
 O
IL7Ralpha R S-GENE
, 
 O
lambda5 b S-GENE
, 
 O
and 	 O
Rag 	 B-GENE
- - I-GENE
1 - E-GENE
, 
 O
and 	 O
the 	 O
ability l O
to O O
induce u O
kappa p B-GENE
light h I-GENE
chain i E-GENE
in O O
response p O
to O O
mitogen o O
. 
 O
Also o O
, 
 O
anti i B-GENE
- - I-GENE
HIV 	 I-GENE
gp120 2 E-GENE
and 	 O
anti i B-GENE
- - I-GENE
CD4 	 E-GENE
crosslinking s O
induced u O
a 
 O
10 O O
- 
 O
15 O O
- 
 O
fold d O
increase r O
in O O
levels e O
of O O
both h O
PI B B-GENE
3 - I-GENE
- - I-GENE
and 	 I-GENE
PI I I-GENE
4 - I-GENE
- - I-GENE
kinase a E-GENE
activity i O
in O O
anti i B-GENE
- - I-GENE
CD4 	 E-GENE
precipitates c O
. 
 O
The 	 O
differences f O
of O O
percentages c O
for 	 O
HIV 	 O
- 
 O
1 
 O
infection e O
in O O
intravenous r O
drug g O
users r O
( 
 O
IVDU U O
) 
 O
were e O
67 O O
. 
 O
7 
 O
% 
 O
and 	 O
in O O
non 	 O
IVDU U O
were e O
3 
 O
. 
 O
8 
 O
% 
 O
with h O
a 
 O
significant n O
statistical t O
difference f O
( 
 O
chi 	 O
2 
 O
= 
 O
557 	 O
. 
 O
5 
 O
; 
 O
p 
 O
< 
 O
0 
 O
. 
 O
0001 1 O
) 
 O
. 
 O
One 	 O
of O O
the 	 O
ORFs s O
in O O
the 	 O
Methanococcus h O
jannaschii n O
genome o O
possesses s O
high h O
similarity i O
to O O
the 	 O
M - O
. - O
aeolicus l O
ilvB B S-GENE
, 
 O
indicating i O
that t O
it O O
is O O
an O O
authentic h O
AHAS S O
. 
 O
More e O
than n O
80 O O
% 
 O
appropriate r O
lever e O
responding p O
was 	 O
established a O
after e O
27 O O
, 
 O
38 O O
and 	 O
44 O O
daily l O
training i O
sessions s O
with h O
DN O O
- 
 O
2327 7 O
, 
 O
diazepam z O
and 	 O
PTZ 	 O
, 
 O
respectively p O
, 
 O
as O O
the 	 O
training i O
drug g O
. 
 O
We O O
have e O
used d O
nuclear l O
magnetic n O
resonance o O
( 
 O
NMR 	 O
) 
 O
to O O
obtain a O
the 	 O
structure u O
of O O
an O O
RNA 	 O
" 
 O
kissing s O
" 
 O
hairpin r O
complex p O
formed m O
between w O
the 	 O
HIV 	 O
- 
 O
2 
 O
TAR 	 O
hairpin r O
loop p O
and 	 O
a 
 O
hairpin r O
with h O
a 
 O
complementary p O
loop p O
sequence u O
. 
 O
RESULTS U O
: 
 O
In O O
men 	 O
, 
 O
weight g O
/ 
 O
height2 g O
met 	 O
the 	 O
criteria t O
for 	 O
a 
 O
satisfactory i O
index e O
in O O
that t O
there r O
was 	 O
a 
 O
very y O
strong o O
correlation r O
with h O
triceps c O
skinfold n O
, 
 O
and 	 O
a 
 O
negligible l O
correlation r O
with h O
height g O
. 
 O
PRP20 2 S-GENE
is O O
related a O
, 
 O
both h O
in O O
structure u O
and 	 O
function c O
, 
 O
to O O
the 	 O
RCC1 1 B-GENE
gene e E-GENE
of O O
mammals m O
and 	 O
the 	 O
PIM1 1 B-GENE
gene e E-GENE
of O O
Schizosaccharomyces i O
pombe b O
, 
 O
both h O
of O O
which c O
appear e O
to O O
regulate u O
entry r O
into o O
mitosis o O
and 	 O
chromosome o O
condensation d O
. 
 O
No O O
consensus s O
binding d O
sequence u O
could l O
be O O
discerned c O
in O O
these s O
fragments g O
and 	 O
bound n O
factor t O
is O O
in O O
rapid i O
equilibrium i O
with h O
unbound o O
. 
 O
A 
 O
selective e O
transcriptional n O
induction u O
system t O
for 	 O
mammalian m O
cells l O
based e O
on O O
Gal4 4 B-GENE
- 
 I-GENE
estrogen r I-GENE
receptor e I-GENE
fusion i I-GENE
proteins t E-GENE
. 
 O
Kinase a O
renaturation a O
tests t O
designed i O
to O O
detect e O
reactivated c O
protein t O
kinases a O
after e O
electrophoresis c O
in O O
sodium i O
dodecyl e O
sulfate f O
- 
 O
polyacrylamide y O
gels s O
revealed e O
the 	 O
presence s O
of O O
a 
 O
60 O O
- 
 O
kDa 	 O
kinase a O
in O O
the 	 O
washed h O
immunoprecipitate u O
obtained a O
from m O
liver e O
cytosol o O
using n O
anti i B-GENE
- - I-GENE
AHR 	 I-GENE
antibody i E-GENE
( 
 O
IgG 	 S-GENE
) 
 O
and 	 O
protein t B-GENE
A 
 I-GENE
/ 
 I-GENE
G 
 E-GENE
/ 
 O
agarose r O
beads d O
but 	 O
not 	 O
when n O
a 
 O
nonspecific s O
IgG 	 S-GENE
was 	 O
used d O
instead t O
of O O
anti i B-GENE
- - I-GENE
AHR 	 I-GENE
antibody i E-GENE
. 
 O
Immunoblotting u O
using n O
a 
 O
phosphospecific s O
anti i B-GENE
- - I-GENE
Src 	 E-GENE
( - O
416Y Y S-GENE
) - O
antibody i O
showed w O
a 
 O
ceramide a O
- 
 O
induced u O
increase r O
in O O
pp60 0 S-GENE
( 
 O
src 	 S-GENE
) 
 O
tyrosine o O
phosphorylation s O
. 
 O
In O O
contrast t O
, 
 O
dominant i B-GENE
negative a I-GENE
Rac 	 E-GENE
( 
 O
N17Rac1 R S-GENE
) 
 O
inhibited i O
JNK 	 S-GENE
activation i O
by O O
Galpha12 p S-GENE
in O O
HEK293 2 O
cells l O
as O O
well l O
as O O
three e O
other e O
cell l O
lines e O
. 
 O
Metabolic a O
studies d O
of O O
tetrabenazine r O
, 
 O
a 
 O
psychotropic c O
drug g O
in O O
animals m O
and 	 O
man 	 O
. 
 O
Reading d O
disability a O
in O O
twins n O
. 
 O
These s O
results u O
suggest g O
that t O
1a S S-GENE
, 
 O
which c O
also o O
interacts e O
independently e O
with h O
the 	 O
ER O O
and 	 O
viral a O
RNA 	 O
, 
 O
is O O
a 
 O
key 	 O
organizer a O
of O O
RNA 	 O
replication l O
complex p O
assembly e O
. 
 O
HrpE E S-GENE
is O O
similar i O
to O O
YscL L B-GENE
of O I-GENE
Yersinia s I-GENE
spp 	 E-GENE
. 
 O
Effect e O
of O O
a 
 O
high h O
sugar a O
intake a O
on O O
some e O
metabolic a O
and 	 O
regulatory u O
indicators i O
in O O
young n O
men 	 O
. 
 O
Production d O
of O O
a 
 O
chicken c O
meat t O
infusion u O
broth t O
suitable t O
for 	 O
the 	 O
mass s O
production d O
of O O
a 
 O
Haemophilus m O
gallinarum l O
bacterin t O
. 
 O
The 	 O
results u O
indicate i O
that t O
expression r O
of O O
proU U S-GENE
in O O
E 
 O
. 
 O
coli i O
is O O
directed e O
from m O
two 	 O
promoters m O
, 
 O
one 	 O
( 
 O
P2 O O
) 
 O
characterized r O
earlier l O
by O O
other e O
workers k O
with h O
the 	 O
start r O
site e O
of O O
transcription n O
60 O O
nucleotides l O
upstream t O
of O O
the 	 O
initiation t O
codon o O
of O O
the 	 O
first s O
structural u O
gene e O
( 
 O
proV V S-GENE
) 
 O
, 
 O
and 	 O
the 	 O
other e O
( 
 O
P1 O O
) 
 O
situated u O
250 	 O
nucleotides l O
upstream t O
of O O
proV V S-GENE
. 
 O
The 	 O
maximal i O
rise e O
in O O
plasma s O
adrenaline e O
was 	 O
of O O
similar i O
magnitude n O
in O O
all 	 O
three e O
groups u O
but 	 O
a 
 O
lower e O
plasma s O
glucose c O
was 	 O
required u O
to O O
stimulate m O
this s O
hormonal m O
response p O
in O O
the 	 O
' 
 O
unaware w O
' 
 O
patients i O
, 
 O
in O O
whom m O
the 	 O
plasma s O
adrenaline e O
concentration c O
was 	 O
lower e O
at O O
the 	 O
time e O
of O O
the 	 O
reaction c O
. 
 O
Through o O
interactions e O
with h O
the 	 O
pre 	 O
- 
 O
mRNA A O
and 	 O
the 	 O
CTD 	 B-GENE
domain a E-GENE
of O O
the 	 O
Polymerase y B-GENE
II E E-GENE
, 
 O
SR B B-GENE
proteins t E-GENE
have e O
been n O
shown w O
to O O
regulate u O
alternative e O
splicing i O
. 
 O
One 	 O
child l O
, 
 O
recently e O
fed 	 O
, 
 O
vomited i O
a 
 O
small l O
amount u O
of O O
breast a O
milk k O
after e O
a 
 O
short r O
period i O
of O O
crying i O
and 	 O
apparently a O
had 	 O
a 
 O
laryngospasm y O
, 
 O
shown w O
by O O
a 
 O
sudden d O
drop p O
in O O
the 	 O
PtcO2 O O
level e O
without h O
any 	 O
other e O
signs n O
of O O
discomfort c O
. 
 O
Changes n O
in O O
the 	 O
size e O
and 	 O
organisation a O
of O O
the 	 O
brain i O
in O O
man 	 O
and 	 O
his 	 O
ancestors e O
. 
 O
Only y O
Staphylococcus p O
xylosus o O
SX63 3 O
was 	 O
detected e O
as O O
a 
 O
strain a O
with h O
high h O
adherence e O
activity i O
. 
 O
It O O
also o O
produces d O
an O O
NH2 	 O
terminus m O
that t O
corresponds r O
to O O
an O O
equivalent i O
NH2 	 O
terminus m O
on O O
the 	 O
processed c O
matrix r O
form m O
of O O
the 	 O
similar i O
alpha1 h B-GENE
( - I-GENE
XI I I-GENE
) - I-GENE
chain i E-GENE
, 
 O
thus s O
suggesting g O
physiological s O
significance n O
. 
 O
Transmission n O
of O O
mutans a O
streptococci e O
to O O
infants a O
following l O
short r O
term m O
application l O
of O O
an O O
iodine i O
- 
 O
NaF 	 O
solution u O
to O O
mothers h O
' 
 O
dentition t O
. 
 O
Expression r O
of O O
Msx 	 B-GENE
- - I-GENE
1 - E-GENE
and 	 O
Msx 	 B-GENE
- - I-GENE
2 - E-GENE
has 	 O
been n O
studied d O
during i O
development e O
of O O
the 	 O
osteoblast e O
phenotype n O
, 
 O
but 	 O
the 	 O
role e O
of O O
Dlx 	 S-GENE
in O O
this s O
context t O
and 	 O
in O O
the 	 O
regulation u O
of O O
bone e O
- 
 O
expressed r O
genes e O
is O O
unknown n O
. 
 O
Scalp l O
blood o O
flow w O
was 	 O
recorded o O
by O O
a 
 O
laser e O
Doppler p O
flow w O
sensor s O
that t O
was 	 O
incorporated o O
in O O
the 	 O
transcutaneous n O
PO2 	 O
electrode c O
. 
 O
DESIGN I O
: 
 O
Activating i B-GENE
protein t I-GENE
- - I-GENE
1 - E-GENE
( 
 O
AP B B-GENE
- - I-GENE
1 - E-GENE
) 
 O
and 	 O
Tat 	 S-GENE
- 
 O
induced u O
transcription n O
were e O
assessed e O
using n O
Jun 	 S-GENE
and 	 O
hybrid r O
Tat 	 S-GENE
/ 
 O
Jun 	 S-GENE
- 
 O
expression r O
plasmids s O
and 	 O
reporter o O
gene e O
constructs s O
which c O
contained t O
AP B B-GENE
- - I-GENE
1 - I-GENE
binding d I-GENE
sites e E-GENE
upstream t O
of O O
the 	 O
rat 	 B-GENE
prolactin l I-GENE
TATAA A I-GENE
element m E-GENE
or O O
an O O
HIV 	 B-GENE
- - I-GENE
1 - I-GENE
LTR 	 I-GENE
construct s E-GENE
in O O
which c O
AP B B-GENE
- - I-GENE
1 - I-GENE
binding d I-GENE
sites e E-GENE
replaced l O
the 	 O
TAR 	 O
element m O
. 
 O
Mycobacterium o O
tuberculosis e O
inhibits i O
IFN 	 B-GENE
- - I-GENE
gamma m E-GENE
transcriptional n O
responses p O
without h O
inhibiting i O
activation i O
of O O
STAT1 T S-GENE
. 
 O
Rabbit b B-GENE
KCC1 1 E-GENE
( 
 O
rbKCC1 C S-GENE
) 
 O
and 	 O
rat 	 B-GENE
KCC1 1 E-GENE
( 
 O
rtKCC1 C S-GENE
) 
 O
were e O
cloned n O
by O O
screening e O
rabbit b O
kidney n O
and 	 O
rat 	 O
brain i O
cDNA A O
libraries r O
using n O
homologous o O
cDNA A O
probes b O
. 
 O
However e O
, 
 O
using n O
wet 	 O
weight g O
/ 
 O
dry 	 O
weight g O
methodology h O
, 
 O
we O O
found n O
that t O
administration i O
of O O
U74006F 0 O
significantly n O
reduced u O
water e O
content t O
in O O
the 	 O
right h O
hippocampus p O
( 
 O
contralateral t O
to O O
the 	 O
site e O
of O O
injury u O
) 
 O
compared p O
to O O
saline i O
- 
 O
treated a O
animals m O
( 
 O
p 
 O
less s O
than n O
0 
 O
. 
 O
05 O O
) 
 O
. 
 O
GH S S-GENE
stimulated m O
the 	 O
activity i O
of O O
promoter m O
fragments g O
with h O
5 
 O
' 
 O
- 
 O
ends s O
between w O
nucleotide l O
( 
 O
nt O O
) 
 O
- 
 O
2001 1 O
and 	 O
nt O O
- 
 O
653 	 O
by O O
1 
 O
. 
 O
9 
 O
- 
 O
to O O
2 
 O
. 
 O
7 
 O
- 
 O
fold d O
. 
 O
We O O
have e O
recently e O
shown w O
that t O
induced u O
expression r O
of O O
a 
 O
CDK 	 S-GENE
target g O
site e O
- 
 O
deficient i O
mutant a O
, 
 O
Op18 8 B-GENE
- 
 I-GENE
S25A A E-GENE
, 
 O
S38A A S-GENE
, 
 O
blocks c O
human a O
cell l O
lines e O
during i O
G2 O O
/ 
 O
M 
 O
transition n O
. 
 O
A 
 O
protein t O
which c O
promotes m O
DNA 	 O
strand a O
transfer n O
between w O
linear e O
double b O
- 
 O
stranded a O
M13mp19 m O
DNA 	 O
and 	 O
single g O
- 
 O
stranded a O
viral a O
M13mp19 m O
DNA 	 O
has 	 O
been n O
isolated l O
from m O
recA A B-GENE
- - I-GENE
E 
 I-GENE
. 
 I-GENE
coli i E-GENE
. 
 O
The 	 O
brains i O
were e O
processed c O
according o O
to O O
the 	 O
tetramethylbenzidine r O
( 
 O
TMB 	 O
) 
 O
protocol t O
of O O
Mesulam u O
( 
 O
' 
 O
78 O O
) 
 O
and 	 O
studied d O
with h O
darkfield k O
microscopy r O
. 
 O
Seizure z O
recurrence u O
( 
 O
HR O O
1 
 O
. 
 O
30 O O
; 
 O
95 O O
% 
 O
CI O O
= 
 O
0 
 O
. 
 O
84 O O
, 
 O
2 
 O
. 
 O
01 O O
) 
 O
and 	 O
antiepileptic i O
drug g O
treatment a O
( 
 O
HR O O
0 
 O
. 
 O
97 O O
; 
 O
95 O O
% 
 O
CI O O
= 
 O
0 
 O
. 
 O
67 O O
, 
 O
1 
 O
. 
 O
38 O O
) 
 O
did 	 O
not 	 O
influence l O
mortality t O
rate e O
. 
 O
One 	 O
day 	 O
postoperatively t O
, 
 O
the 	 O
mononuclear o B-GENE
leukocyte k I-GENE
beta a I-GENE
2 - I-GENE
- - I-GENE
receptor e E-GENE
density s O
decreased r O
maximally i O
by O O
45 O O
+ 
 O
/ 
 O
- 
 O
11 O O
% 
 O
in O O
the 	 O
enflurane l O
patients i O
, 
 O
and 	 O
by O O
53 O O
+ 
 O
/ 
 O
- 
 O
6 
 O
% 
 O
in O O
the 	 O
neurolept r O
patients i O
. 
 O
The 	 O
serum u O
levels e O
of O O
cortisol t O
and 	 O
prolactin l S-GENE
after e O
nasal a O
instillation t O
of O O
a 
 O
suspension p O
of O O
vaginal i O
exudate d O
showed w O
lower e O
values u O
than n O
in O O
control t O
conditions d O
( 
 O
nasal a O
instillation t O
of O O
saline i O
) 
 O
. 
 O
IgE 	 B-GENE
antibody i E-GENE
to O O
twelve l O
common m O
food d O
and 	 O
inhalant a O
allergens e O
was 	 O
measured s O
by O O
enzyme y O
- 
 O
linked k O
immunosorbent u O
assay a O
( 
 O
ELISA S O
) 
 O
in O O
the 	 O
sera a O
of O O
thirteen r O
atopic p O
patients i O
with h O
one 	 O
or O O
more e O
allergic e O
disorders o O
( 
 O
asthma h O
occurring u O
in O O
eleven v O
; 
 O
rhinitis n O
in O O
ten 	 O
; 
 O
eczema e O
in O O
six 	 O
; 
 O
urticaria i O
in O O
four r O
; 
 O
mouth t O
and 	 O
gastro t O
- 
 O
intestinal e O
symptoms p O
in O O
six 	 O
) 
 O
, 
 O
of O O
twelve l O
non 	 O
- 
 O
atopic p O
patients i O
with h O
various i O
clinical n O
symptoms p O
( 
 O
asthma h O
in O O
four r O
; 
 O
rhinitis n O
in O O
four r O
; 
 O
eczema e O
in O O
one 	 O
; 
 O
urticaria i O
in O O
two 	 O
; 
 O
mouth t O
and 	 O
gastro t O
- 
 O
intestinal e O
symptoms p O
in O O
four r O
) 
 O
and 	 O
sixteen t O
cord d O
blood o O
sera a O
. 
 O
Innervation e O
of O O
reticular i O
papillae i O
in O O
sheep e O
and 	 O
goats t O
. 
 O
Biochemical c O
status t O
was 	 O
examined m O
using n O
erythrocyte t O
enzyme y O
function c O
and 	 O
blood o O
vitamin a O
levels e O
. 
 O
Sexual u O
adventurism e O
, 
 O
high h O
- 
 O
risk k O
behavior a O
, 
 O
and 	 O
human a O
immunodeficiency u O
virus u O
- 
 O
1 
 O
seroconversion o O
among n O
the 	 O
Chicago c O
MACS S O
- 
 O
CCS 	 O
cohort o O
, 
 O
1984 4 O
to O O
1992 2 O
. 
 O
Pendulin d S-GENE
, 
 O
a 
 O
Drosophila s O
protein t O
with h O
cell l O
cycle l O
- 
 O
dependent e O
nuclear l O
localization a O
, 
 O
is O O
required u O
for 	 O
normal m O
cell l O
proliferation l O
. 
 O
Paradoxically a O
there r O
is O O
a 
 O
decrease r O
in O O
the 	 O
level e O
of O O
soluble u O
A - O
beta a O
secreted r O
from m O
the 	 O
cells l O
. 
 O
Signaling n O
through o O
mitogen o B-GENE
- - I-GENE
activated i I-GENE
protein t I-GENE
kinase a E-GENE
and 	 O
Rac 	 S-GENE
/ 
 O
Rho 	 S-GENE
does s O
not 	 O
duplicate l O
the 	 O
effects e O
of O O
activated i O
Ras 	 S-GENE
on O O
skeletal l O
myogenesis g O
. 
 O
Internalization e O
of O O
prolactin l B-GENE
receptor e E-GENE
and 	 O
prolactin l S-GENE
in O O
transfected n O
cells l O
does s O
not 	 O
involve o O
nuclear l O
translocation n O
. 
 O
Using n O
mammalian m O
expression r O
vectors t O
( 
 O
pRSV V O
- 
 O
neo 	 O
and 	 O
pSV2 2 B-GENE
- 
 I-GENE
neo 	 E-GENE
) 
 O
, 
 O
antisense i O
constructs s O
for 	 O
perforin f O
and 	 O
granzyme n O
B - O
were e O
independently e O
electroporated c O
into o O
YT O B-GENE
- 
 I-GENE
INDY Y E-GENE
, 
 O
a 
 O
human a O
non 	 O
- 
 O
MHC 	 S-GENE
- 
 O
restricted t O
, 
 O
IL B B-GENE
- - I-GENE
2 - E-GENE
- 
 O
independent e O
, 
 O
cytotoxic o O
lymphocyte p O
. 
 O
When n O
expressed r O
in O O
Escherichia h O
coli i O
, 
 O
SH B B-GENE
- - I-GENE
PTP2 2 E-GENE
displays p O
tyrosine o B-GENE
- - I-GENE
specific c I-GENE
phosphatase s E-GENE
activity i O
. 
 O
The 	 O
structure u O
elucidation c O
of O O
the 	 O
iridoid d O
compounds p O
2 
 O
and 	 O
3 
 O
are 	 O
discussed c O
in O O
detail a O
. 
 O
The 	 O
results u O
of O O
a 
 O
study d O
to O O
investigate e O
the 	 O
effectiveness e O
of O O
a 
 O
propolis p O
- 
 O
containing t O
mouthrinse t O
in O O
the 	 O
inhibition i O
of O O
de O O
novo o O
plaque q O
formation m O
are 	 O
presented s O
. 
 O
Effects e O
of O O
shosaikoto s O
, 
 O
an O O
oriental e O
herbal b O
medicinal i O
mixture t O
, 
 O
on O O
restraint t O
- 
 O
stressed e O
mice e O
. 
 O
The 	 O
region i O
surrounding r O
the 	 O
ZNF35 3 B-GENE
zinc c I-GENE
finger g I-GENE
protein t I-GENE
gene e E-GENE
on O O
3p21 1 S-GENE
is O O
of O O
particular t O
interest e O
, 
 O
as O O
this s O
region i O
of O O
chromosome o O
3 
 O
is O O
frequently q O
involved o O
in O O
rearrangements r O
and 	 O
/ 
 O
or O O
deletions e O
associated o O
with h O
various i O
human a O
tumors o O
including l O
lung g O
and 	 O
renal a O
carcinoma c O
. 
 O
In O O
the 	 O
promoters m O
of O O
many y O
immediate e O
early l O
genes e O
, 
 O
including l O
c - B-GENE
- - I-GENE
fos 	 E-GENE
, 
 O
CArG G O
DNA 	 O
regulatory u O
elements m O
mediate i O
basal a O
constituitive s O
expression r O
and 	 O
rapid i O
and 	 O
transient n O
serum u O
induction u O
. 
 O
The 	 O
biological l O
activity i O
of O O
these s O
mutants a O
was 	 O
tested t O
by O O
determining e O
their i O
capacity a O
to O O
( 
 O
i 
 O
) 
 O
reconstitute o O
RNA 	 B-GENE
polymerase y E-GENE
activity i O
in O O
vivo o O
by O O
cotransfection r O
with h O
proteins t O
NP S S-GENE
, 
 O
PB1 	 S-GENE
, 
 O
and 	 O
PA S S-GENE
and 	 O
a 
 O
virion i O
- 
 O
like e O
RNA 	 O
encoding o O
the 	 O
cat 	 B-GENE
gene e E-GENE
into o O
vaccinia c O
virus u O
T7 O O
- 
 O
infected e O
COS 	 O
- 
 O
1 
 O
cells l O
and 	 O
( 
 O
ii O O
) 
 O
complete p O
with h O
the 	 O
wild d B-GENE
- - I-GENE
type e I-GENE
PB2 	 E-GENE
activity i O
. 
 O
Transient n O
thyrotoxicosis r O
in O O
primary m O
anti i O
- 
 O
phospholipid s O
syndrome d O
. 
 O
We O O
were e O
unable b O
to O O
construct s O
chvI I S-GENE
or O O
chvG G S-GENE
insertion e O
mutants a O
of O O
R 
 O
. 
 O
meliloti i O
, 
 O
whereas r O
mutants a O
carrying r O
insertions e O
outside s O
of O O
these s O
genes e O
were e O
readily d O
obtained a O
. 
 O
Western t O
blot t O
analyses l O
reveals e O
that t O
cJun n S-GENE
and 	 O
the 	 O
C - B-GENE
/ - I-GENE
EBP 	 I-GENE
family i E-GENE
member b O
C - B-GENE
/ - I-GENE
EBP 	 I-GENE
- - I-GENE
beta a E-GENE
are 	 O
physiologically s O
relevant e O
transcription n O
factors t O
whose s O
expression r O
corresponds r O
with h O
mda 	 B-GENE
- - I-GENE
7 - I-GENE
mRNA A E-GENE
expression r O
. 
 O
In O O
isolated l O
olfactory a O
cilia i O
certain t O
odorants r O
elicit c O
a 
 O
rapid i O
and 	 O
transient n O
cAMP P O
response p O
, 
 O
terminated m O
by O O
a 
 O
concerted c O
process c O
which c O
requires u O
the 	 O
action i O
of O O
two 	 O
protein t O
kinases a O
, 
 O
protein t B-GENE
kinase a I-GENE
A - E-GENE
( 
 O
PKA 	 S-GENE
) 
 O
and 	 O
a 
 O
receptor e B-GENE
- - I-GENE
specific c I-GENE
kinase a E-GENE
( 
 O
GRK3 3 S-GENE
) 
 O
( 
 O
Schleicher l O
, 
 O
S 
 O
. 
 O
, 
 O
Boekhoff k O
, 
 O
I 
 O
. 
 O
Acetyl t B-GENE
- - I-GENE
CoA 	 I-GENE
carboxylase b E-GENE
from m O
yeast s O
is O O
an O O
essential e O
enzyme y O
and 	 O
is O O
regulated u O
by O O
factors t O
that t O
control t O
phospholipid s O
metabolism a O
. 
 O
To O O
investigate e O
the 	 O
role e O
of O O
this s O
domain a O
in O O
the 	 O
incorporation o O
of O O
the 	 O
SIV 	 B-GENE
Env 	 E-GENE
into o O
virions i O
, 
 O
we O O
generated e O
a 
 O
series i O
of O O
SIV 	 B-GENE
Env 	 I-GENE
mutants a E-GENE
carrying r O
small l O
in O O
- 
 O
frame m O
deletions e O
within h O
the 	 O
cytoplasmic o O
domain a O
. 
 O
Computer p O
analysis l O
, 
 O
simple p O
correlation r O
hypothesis o O
, 
 O
and 	 O
distribution t O
method h O
with h O
1 
 O
degree r O
of O O
freedom e O
revealed e O
significant n O
correlation r O
between w O
vertical t O
root t O
fracture c O
and 	 O
the 	 O
technique h O
of O O
instrumentation t O
and 	 O
obturation u O
of O O
the 	 O
canal a O
( 
 O
p 
 O
= 
 O
0 
 O
. 
 O
025 	 O
) 
 O
, 
 O
the 	 O
length g O
of O O
the 	 O
post t O
( 
 O
p 
 O
= 
 O
0 
 O
. 
 O
05 O O
) 
 O
, 
 O
and 	 O
the 	 O
existence s O
of O O
the 	 O
post t O
( 
 O
p 
 O
= 
 O
0 
 O
. 
 O
05 O O
) 
 O
. 
 O
Minute u O
virus u O
of I O
mice e B-GENE
NS1 	 E-GENE
, 
 O
an O O
83 O O
- 
 O
kDa 	 O
mainly n O
nuclear l O
phosphoprotein s O
, 
 O
is O O
the 	 O
only y O
viral a O
nonstructural s O
protein t O
required u O
in O O
all 	 O
cell l O
types e O
and 	 O
it O O
is O O
involved o O
in O O
multiple t O
processes c O
necessary e O
for 	 O
virus u O
propagation p O
. 
 O
The 	 O
TDx 	 O
assay a O
for 	 O
cyclosporine l O
and 	 O
its 	 O
metabolites a O
in O O
blood o O
samples p O
compared p O
with h O
HPLC C O
and 	 O
RIA 	 O
methods h O
. 
 O
However e O
, 
 O
the 	 O
sequence u O
of O O
mRAR R B-GENE
- - I-GENE
beta a I-GENE
3 - I-GENE
region i I-GENE
A - E-GENE
differs f O
from m O
that t O
of O O
mRAR R B-GENE
- - I-GENE
beta a I-GENE
1 - E-GENE
by O O
an O O
additional i O
27 O O
C 
 O
- 
 O
terminal m O
amino n O
acids d O
encoded o O
in O O
an O O
81 O O
nucleotide l O
- 
 O
long g O
putative a O
exon n O
which c O
is O O
spliced i O
in O O
between w O
the 	 O
exons n O
encoding o O
the 	 O
A - O
and 	 O
B - O
regions i O
of I O
mRAR R B-GENE
- - I-GENE
beta a I-GENE
1 - E-GENE
. 
 O
We O O
propose p O
that t O
GCD7 7 S-GENE
and 	 O
GCD2 2 S-GENE
play y O
important o O
roles e O
in O O
the 	 O
regulatory u O
interaction e O
between w O
eIF 	 B-GENE
- - I-GENE
2 - E-GENE
and 	 O
eIF 	 B-GENE
- - I-GENE
2B E E-GENE
and 	 O
that t O
the 	 O
suppressor p O
mutations a O
we O O
isolated l O
in O O
these s O
genes e O
decrease r O
the 	 O
susceptibility c O
of O O
eIF 	 B-GENE
- - I-GENE
2B E E-GENE
to O O
the 	 O
inhibitory i O
effects e O
of O O
phosphorylated s O
eIF 	 B-GENE
- - I-GENE
2 - E-GENE
without h O
impairing a O
the 	 O
essential e O
catalytic a O
function c O
of O O
eIF 	 B-GENE
- - I-GENE
2B E E-GENE
in O O
translation n O
initiation t O
. 
 O
The 	 O
3 
 O
' 
 O
region i O
of O O
the 	 O
transcript n O
contained t O
a 
 O
fully l O
conserved s O
, 
 O
correctly r O
spliced i O
TCR 	 B-GENE
alpha h I-GENE
C - I-GENE
region i E-GENE
which c O
was 	 O
polyadenylated y O
at O O
the 	 O
3 
 O
' 
 O
end 	 O
. 
 O
These s O
data a O
demonstrate o O
that t O
CCTalpha a S-GENE
can 	 O
be O O
regulated u O
by O O
lipids i O
by O O
two 	 O
independent e O
domains a O
: 
 O
( 
 O
i 
 O
) 
 O
the 	 O
three e O
amphipathic h O
alpha h O
- 
 O
helical i O
repeats e O
that t O
interact e O
with h O
both h O
neutral t O
and 	 O
anionic o O
lipid i O
mixtures t O
and 	 O
( 
 O
ii O O
) 
 O
the 	 O
last t O
57 O O
residues i O
that t O
interact e O
with h O
anionic o O
lipids i O
. 
 O
Sorting t O
information o O
to O O
the 	 O
chloroplastic o O
inner e O
envelope e O
is O O
contained t O
in O O
an O O
NH2 	 O
- 
 O
proximal x O
part t O
of O O
mature u O
IEP110 1 S-GENE
( 
 O
110N N S-GENE
) 
 O
. 
 O
Most t O
of O O
these s O
elements m O
are 	 O
adjacent a O
to O O
type e O
X 
 O
telomeric o O
repeats e O
, 
 O
and 	 O
regions i O
flanking n O
four r O
of O O
five e O
characterized r O
S 
 O
. 
 O
paradoxus a O
insertions e O
carry r O
autonomously o O
replicating l O
sequences u O
. 
 O
From m O
1981 1 O
to O O
1989 9 O
, 
 O
a 
 O
total a O
of O O
26 O O
women e O
with h O
locally a O
or O O
regionally i O
advanced a O
carcinoma c O
of O O
the 	 O
uterine r O
cervix v O
were e O
treated a O
with h O
radiotherapy i O
( 
 O
RT O O
) 
 O
and 	 O
pelvic v O
regional i O
hyperthermia e O
( 
 O
HT O O
) 
 O
, 
 O
in O O
the 	 O
Divisions i O
of O O
Radiation i O
Oncology o O
at O O
the 	 O
University v O
of O O
Utah h O
Medical i O
Center t O
( 
 O
UU O O
) 
 O
and 	 O
the 	 O
Kenneth n O
Norris r O
Jr O O
Cancer c O
Hospital p O
of O O
the 	 O
University v O
of O O
Southern t O
California i O
( 
 O
USC 	 O
) 
 O
. 
 O
The 	 O
ARE 	 O
is O O
loosely s O
defined i O
as O O
the 	 O
five e O
- 
 O
nucleotide l O
sequence u O
AUUUA U O
embedded e O
in O O
a 
 O
uracil c O
- 
 O
rich h O
region i O
. 
 O
Lack k O
of O O
changes n O
in O O
milk k O
production d O
and 	 O
milk k O
composition p O
suggest g O
that t O
acute t O
increases r O
in O O
somatotropin a S-GENE
with h O
concomitant c O
increases r O
in O O
insulin u S-GENE
are 	 O
not 	 O
sufficient f O
to O O
stimulate m O
synthesis t O
of O O
milk k O
and 	 O
milk k O
components p O
by O O
cows s O
during i O
established a O
lactation t O
. 
 O
The 	 O
material e O
then n O
was 	 O
cut 	 O
with h O
a 
 O
diamond m O
saw 	 O
into o O
sheets e O
of O O
8 
 O
x 
 O
10 O O
x 
 O
3 
 O
mm O O
, 
 O
and 	 O
the 	 O
upper e O
surface f O
was 	 O
polished i O
by O O
colloidal l O
SiO2 2 O
and 	 O
/ 
 O
or O O
covered e O
with h O
a 
 O
carbon b O
- 
 O
titanium a O
( 
 O
C 
 O
: 
 O
Ti O O
) 
 O
layer e O
( 
 O
3 
 O
. 
 O
3 
 O
microm r O
) 
 O
using n O
the 	 O
plasma s O
- 
 O
enhanced a O
physical s O
vapor o O
deposition o O
method h O
. 
 O
Iomazenil a O
- 
 O
SPECT C O
revealed e O
a 
 O
highly h O
significant n O
increase r O
in O O
the 	 O
benzodiazepine z B-GENE
receptor e E-GENE
uptake a O
in O O
all 	 O
studied d O
cortical t O
regions i O
except e O
temporal p O
cortices t O
. 
 O
Both h O
in O O
the 	 O
Federal e O
Republic u O
of O O
Germany m O
and 	 O
in O O
some e O
neighbouring g O
countries n O
the 	 O
epizootic z O
situation u O
of O O
Aujeszky e O
' 
 O
s 
 O
disease e O
has 	 O
been n O
unsatisfactory a O
for 	 O
a 
 O
long g O
time e O
, 
 O
especially e O
in O O
areas a O
with h O
a 
 O
high h O
pig 	 O
density s O
. 
 O
Since c O
RIP140 1 S-GENE
generally e O
down n O
- 
 O
regulates u O
receptor e O
activity i O
in O O
mammalian m O
cells l O
and 	 O
specifically c O
down n O
- 
 O
regulates u O
coactivation c O
mediated i O
by O O
SRC 	 B-GENE
- - I-GENE
1 - E-GENE
, 
 O
we O O
propose p O
a 
 O
model e O
in O O
which c O
RIP140 1 S-GENE
indirectly i O
regulates u O
nuclear l B-GENE
receptor e I-GENE
AF I I-GENE
- - I-GENE
2 - E-GENE
activity i O
by O O
competition p O
for 	 O
coactivators c O
such h O
as O O
SRC 	 B-GENE
- - I-GENE
1 - E-GENE
. 
 O
DIC 	 O
and 	 O
low 	 O
grade d O
fibrinolysis r O
may 	 O
account o O
for 	 O
the 	 O
coagulation g O
abnormalities o O
of O O
the 	 O
syndrome d O
. 
 O
As O O
in O O
the 	 O
case e O
of O O
the 	 O
chicken c B-GENE
homologue o E-GENE
, 
 O
there r O
are 	 O
two 	 O
hPR 	 O
forms m O
, 
 O
A 
 O
and 	 O
B 
 O
, 
 O
which c O
originate g O
from m O
translational n O
initiation t O
at O O
AUG2 2 O
( 
 O
codon o O
165 	 O
) 
 O
and 	 O
AUG1 1 S-GENE
, 
 O
respectively p O
. 
 O
Fluctuations c O
of O O
the 	 O
measured s O
ECF 	 O
energy r O
- 
 O
related a O
substances s O
corresponded r O
to O O
various i O
clinical n O
events n O
presumably s O
involving o O
hypoxia o O
/ 
 O
ischemia h O
. 
 O
Using n O
lasers e O
in O O
diabetic b O
wound n O
healing l O
. 
 O
Furthermore t O
, 
 O
the 	 O
zincon c O
- 
 O
loaded d O
resin i O
was 	 O
applied l O
to O O
the 	 O
selective e O
concentration c O
of O O
trace c O
amounts u O
of O O
chalcophile l O
elements m O
in O O
natural u O
water e O
samples p O
prior o O
to O O
neutron t O
activation i O
analysis l O
. 
 O
In O O
cells l O
stably b O
transfected n O
with h O
G - B-GENE
alpha h I-GENE
i - I-GENE
- - I-GENE
2 - E-GENE
or O O
G - B-GENE
alpha h I-GENE
i - I-GENE
- - I-GENE
3 - I-GENE
gene e I-GENE
5 
 I-GENE
' 
 I-GENE
- 
 I-GENE
flanking n I-GENE
sequences u E-GENE
fused e O
to O O
firefly e B-GENE
luciferase i I-GENE
cDNA A I-GENE
reporter o E-GENE
, 
 O
temporal p O
10 O O
- 
 O
15 O O
- 
 O
fold d O
transcriptional n O
activation i O
of O O
both h O
genes e O
occurred u O
before o O
cellular l O
polarization a O
. 
 O
CONCLUSIONS C O
: 
 O
These s O
results u O
suggest g O
that t O
histamine t B-GENE
- - I-GENE
2 - I-GENE
receptor e E-GENE
activation i O
mechanisms h O
may 	 O
not 	 O
be O O
involved o O
in O O
postoperative t O
IL B B-GENE
- - I-GENE
6 - E-GENE
synthesis t O
. 
 O
In O O
resume u O
response p O
to O O
treatment a O
with h O
usual a O
regimens i O
, 
 O
doxycycline y O
plus s O
streptomycin e O
of O O
doxycycline y O
rifampicin a O
is O O
good d O
, 
 O
being n O
however e O
time e O
elapsed p O
until i O
pain n O
ceases s O
of O O
mean n O
length g O
in O O
hospital p O
stay y O
shorter r O
in O O
the 	 O
group u O
receiving e O
doxycycline y O
plus s O
streptomycin e O
. 
 O
Fibrosis r O
of O O
the 	 O
adjacent a O
myocardium c O
was 	 O
seen n O
in O O
five e O
cases e O
. 
 O
Purified i O
preparations p O
of O O
all 	 O
four r O
AGT 	 B-GENE
mutants a E-GENE
showed w O
an O O
approximately r O
similar i O
degree r O
( 
 O
74 O O
- 
 O
120 	 O
- 
 O
fold d O
) 
 O
of O O
reduction u O
in O O
the 	 O
rate e O
of O O
reaction c O
with h O
O6 O O
- 
 O
benzylguanine z O
. 
 O
Significant n O
reductions u O
were e O
noted e O
in O O
vertical t O
GRFs s O
per 	 O
newton t O
of O O
body y O
weight g O
exerted r O
at O O
10 O O
% 
 O
( 
 O
P 
 O
= 
 O
0 
 O
. 
 O
0009 9 O
) 
 O
and 	 O
20 O O
% 
 O
( 
 O
P 
 O
= 
 O
0 
 O
. 
 O
0383 3 O
) 
 O
of O O
stance n O
phase s O
and 	 O
in O O
anteroposterior e O
GRFs s O
exerted r O
at O O
10 O O
% 
 O
( 
 O
P 
 O
= 
 O
0 
 O
. 
 O
0009 9 O
) 
 O
and 	 O
50 O O
% 
 O
( 
 O
P 
 O
= 
 O
0 
 O
. 
 O
0033 3 O
) 
 O
of O O
stance n O
phase s O
when n O
ambulation u O
was 	 O
compared p O
with h O
and 	 O
without h O
the 	 O
orthotic h O
device i O
. 
 O
Identification n O
of O O
a 
 O
68 B O
- - O
kilodalton o O
nuclear l O
ATP 	 O
- - O
binding d O
phosphoprotein s O
encoded o O
by O O
bovine i O
papillomavirus i O
type e O
1 
 O
. 
 O
It O O
is O O
suggested g O
that t O
biliary i O
secretion r O
of O O
both h O
TBZ 	 O
and 	 O
FBZ 	 O
and 	 O
their i O
metabolites a O
may 	 O
contribute t O
to O O
this s O
recycling y O
. 
 O
During i O
chordotonal r O
organ a O
development e O
, 
 O
the 	 O
3 
 O
' 
 O
enhancer a O
directs e O
expression r O
in O O
proneural n O
clusters s O
; 
 O
whereas r O
successive c O
modular u O
enhancers a O
located a O
in O O
the 	 O
5 
 O
' 
 O
region i O
drive v O
tissue s O
- 
 O
specific c O
expression r O
in O O
chordotonal r O
organ a O
precursors c O
in O O
the 	 O
embryo r O
and 	 O
larval v O
leg 	 O
, 
 O
wing g O
and 	 O
antennal e O
imaginal g O
discs c O
. 
 O
The 	 O
use 	 O
of O O
self f O
- 
 O
measured s O
blood o O
pressure s O
determinations e O
in O O
assessing e O
dynamics a O
of O O
drug g O
compliance p O
in O O
a 
 O
study d O
with h O
amlodipine o O
once e O
a 
 O
day 	 O
, 
 O
morning n O
versus s O
evening n O
. 
 O
Nucleocapsid l O
structure u O
and 	 O
thermostability r O
of O O
the 	 O
virion i O
, 
 O
nucleocapsid l O
and 	 O
polymerase y O
complex p O
. 
 O
A 
 O
vascular c O
component p O
to O O
impotence o O
was 	 O
shown w O
to O O
be O O
common m O
in O O
those s O
with h O
neurological r O
impairment a O
, 
 O
and 	 O
may 	 O
alter e O
management a O
. 
 O
RESULTS U O
- 
 O
- 
 O
The 	 O
maximal i O
early l O
asthmatic h O
response p O
after e O
allergen e O
with h O
placebo c O
treatment a O
was 	 O
18 O O
. 
 O
4 
 O
% 
 O
( 
 O
SE O O
4 
 O
. 
 O
4 
 O
% 
 O
) 
 O
and 	 O
with h O
WEB 	 O
2086 6 O
18 O O
. 
 O
9 
 O
% 
 O
( 
 O
4 
 O
. 
 O
4 
 O
% 
 O
) 
 O
. 
 O
Column u O
chromatographic o O
determination e O
of O O
polymyxin y O
B 
 O
sulfate f O
. 
 O
Usefulness f O
of O O
computerized p O
tomography o O
in O O
hemodialysis o O
patients i O
. 
 O
The 	 O
aim 	 O
of O O
our 	 O
study d O
was 	 O
to O O
determine e O
whether t O
exercise r O
training i O
can 	 O
augment m O
left t O
ventricular t O
diastolic s O
filling l O
at O O
rest t O
and 	 O
during i O
exercise r O
in O O
patients i O
with h O
ischemic h O
cardiomyopathy d O
and 	 O
whether t O
any 	 O
correlation r O
exists s O
between w O
changes n O
in O O
diastolic s O
filling l O
and 	 O
changes n O
in O O
exercise r O
tolerance e O
. 
 O
On O O
the 	 O
pharmacology r O
of O O
9 
 O
, 
 O
10 O O
- 
 O
dihydro y O
- 
 O
10 O O
- 
 O
( 
 O
1 
 O
- 
 O
methyl h O
- 
 O
4 
 O
- 
 O
piperidylidene e O
) 
 O
- 
 O
9 
 O
- 
 O
anthrol h O
( 
 O
WA O O
335 	 O
) 
 O
, 
 O
a 
 O
histamine t O
and 	 O
serotonin o O
antagonist a O
METHODOLOGY H O
: 
 O
A 
 O
case e O
control t O
study d O
of O O
survivors v O
with h O
gestational t O
age 	 O
( 
 O
GA O O
) 
 O
< 
 O
28 O O
weeks k O
or O O
birthweight t O
( 
 O
BW O O
) 
 O
< 
 O
1000 0 O
g 
 O
using n O
data a O
collected l O
prospectively s O
in O O
our 	 O
Neonatal n O
Intensive e O
Care e O
Unit t O
database a O
. 
 O
There r O
are 	 O
two 	 O
regulatory u O
regions i O
between w O
the 	 O
US3 	 O
and 	 O
the 	 O
US6 	 O
transcription n O
units t O
. 
 O
Database a O
searches r O
revealed e O
a 
 O
50 O O
- 
 O
63 O O
% 
 O
similarity i O
and 	 O
34 O O
- 
 O
42 O O
% 
 O
identity n O
with h O
several e O
families i O
of O O
serine i B-GENE
proteases t E-GENE
, 
 O
in O O
particular t O
the 	 O
trypsin p B-GENE
- - I-GENE
like e I-GENE
proteases t E-GENE
, 
 O
members b O
of O O
the 	 O
glandular n B-GENE
kallikrein l I-GENE
family i E-GENE
( 
 O
including l O
prostate s B-GENE
- - I-GENE
specific c I-GENE
antigen i E-GENE
, 
 O
nerve v B-GENE
growth w I-GENE
factor t I-GENE
gamma m E-GENE
, 
 O
and 	 O
epidermal d B-GENE
growth w I-GENE
factor t I-GENE
- - I-GENE
binding d I-GENE
protein t E-GENE
) 
 O
and 	 O
the 	 O
activators i O
for 	 O
the 	 O
kringle n B-GENE
family i I-GENE
proteins t E-GENE
( 
 O
including l O
the 	 O
human a B-GENE
tissue s I-GENE
plasminogen s I-GENE
activator i E-GENE
and 	 O
human a B-GENE
hepatocyte a I-GENE
growth w I-GENE
factor t I-GENE
activator i E-GENE
) 
 O
. 
 O
Manifestation i O
of O O
superfluidity e O
in O O
an O O
evolving l O
bose e O
- 
 O
einstein s O
condensed d O
Gas 	 O
We O O
study d O
the 	 O
generation e O
of O O
excitations i O
due 	 O
to O O
an O O
" 
 O
impurity u O
" 
 O
( 
 O
static t O
perturbation t O
) 
 O
placed c O
into o O
an O O
oscillating i O
Bose e O
- 
 O
Einstein s O
condensed d O
gas 	 O
in O O
the 	 O
time e O
- 
 O
dependent e O
trapping p O
field l O
. 
 O
4 
 O
. 
 O
7 
 O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
6 
 O
micromol r O
. 
 O
kg O O
- 
 O
1 
 O
. 
 O
min 	 O
- 
 O
1 
 O
) 
 O
but 	 O
was 	 O
not 	 O
changed n O
by O O
training i O
. 
 O
We O O
established a O
that t O
, 
 O
in O O
unstimulated t O
lymphocytes p O
, 
 O
the 	 O
Src 	 B-GENE
homology o I-GENE
2 - E-GENE
( 
 O
SH2 	 S-GENE
) 
 O
and 	 O
SH3 	 B-GENE
domain a I-GENE
- - I-GENE
containing t I-GENE
protein t I-GENE
Grb2 2 E-GENE
and 	 O
the 	 O
p85 	 B-GENE
subunit u E-GENE
of O O
phosphatidylinositol s B-GENE
3 - I-GENE
- - I-GENE
kinase a E-GENE
, 
 O
associate o O
constitutively s O
with h O
Cbl 	 S-GENE
via 	 O
their i O
SH3 	 B-GENE
domains a E-GENE
. 
 O
Zta 	 S-GENE
stimulated m O
the 	 O
HAT 	 S-GENE
activity i O
of O O
CBP 	 S-GENE
that t O
had 	 O
been n O
partially t O
purified i O
or O O
immunoprecipitated u O
from m O
mammalian m O
cells l O
as O O
well l O
as O O
from m O
affinity i O
- 
 O
purified i O
, 
 O
baculovirus u O
expressed r O
CBP 	 S-GENE
. 
 O
Increased r O
gliadin a B-GENE
antibody i E-GENE
levels e O
were e O
found n O
more e O
frequently q O
in O O
patients i O
with h O
subtotal t O
villous l O
atrophy o O
( 
 O
9 
 O
out 	 O
of O O
17 O O
patients i O
, 
 O
or O O
53 O O
% 
 O
; 
 O
p 
 O
less s O
than n O
0 
 O
. 
 O
05 O O
) 
 O
than n O
in O O
patients i O
with h O
partial t O
villous l O
atrophy o O
( 
 O
2 
 O
out 	 O
of O O
13 O O
patients i O
, 
 O
or O O
15 O O
% 
 O
) 
 O
or O O
normal m O
villous l O
appearance e O
( 
 O
2 
 O
out 	 O
of O O
10 O O
patients i O
, 
 O
or O O
20 O O
% 
 O
) 
 O
. 
 O
However e O
, 
 O
the 	 O
optimum i O
compressive p O
strength e O
reached c O
values u O
up O O
to O O
40 O O
% 
 O
higher h O
than n O
CC O O
- 
 O
free e O
samples p O
. 
 O
Expression r O
of O O
the 	 O
Hox 	 B-GENE
genes e E-GENE
egl 	 B-GENE
- - I-GENE
5 - E-GENE
and 	 O
mab 	 B-GENE
- - I-GENE
5 - E-GENE
is O O
reduced u O
in O O
lin 	 B-GENE
- - I-GENE
49 E E-GENE
and 	 O
lin 	 B-GENE
- - I-GENE
59 I I-GENE
mutants a E-GENE
, 
 O
suggesting g O
lin 	 B-GENE
- - I-GENE
49 E E-GENE
and 	 O
lin 	 B-GENE
- - I-GENE
59 E E-GENE
regulate u O
HOM 	 B-GENE
- - I-GENE
C - I-GENE
gene e E-GENE
expression r O
in O O
C 
 O
. 
 O
elegans g O
as O O
the 	 O
trx 	 B-GENE
- - I-GENE
G - I-GENE
genes e E-GENE
do O O
in O O
Drosophila s O
. 
 O
lin 	 B-GENE
- - I-GENE
49 E E-GENE
and 	 O
lin 	 B-GENE
- - I-GENE
59 I E-GENE
transgenes n O
are 	 O
expressed r O
widely e O
throughout o O
C 
 O
. 
 O
elegans g O
animals m O
. 
 O
Interleukin e B-GENE
- - I-GENE
1 - E-GENE
increased r O
the 	 O
noradrenaline a O
release e O
. 
 O
Magnetic n O
field l O
influence l O
on O O
central t O
nervous v O
system t O
function c O
. 
 O
3 
 O
patients i O
with h O
acute t O
leukaemia k O
, 
 O
HLA 	 B-GENE
antibodies i E-GENE
and 	 O
thrombocytopenia o O
refractory r O
to O O
random d O
donor o O
platelet t O
transfusions n O
were e O
treated a O
with h O
high h O
- 
 O
dose e O
i 
 O
. 
 O
v 
 O
. 
 O
immunoglobulin u S-GENE
. 
 O
Two 	 O
genes e O
( 
 O
ptsI I S-GENE
and 	 O
ptsA A S-GENE
) 
 O
that t O
encode o O
homologues o O
of O O
the 	 O
energy r O
coupling p O
Enzyme y O
I - O
of O O
the 	 O
phosphoenolpyruvate s B-GENE
- - I-GENE
dependent e I-GENE
sugar a I-GENE
- - I-GENE
transporting n I-GENE
phosphotransferase s E-GENE
system t O
( 
 O
PTS 	 O
) 
 O
have e O
previously v O
been n O
identified n O
on O O
the 	 O
Escherichia h O
coli i O
chromosome o O
. 
 O
Eight h O
of O O
these s O
suppressors p O
for 	 O
into o O
two 	 O
complementation p O
groups u O
, 
 O
designated i O
KCS1 1 S-GENE
and 	 O
KCS2 2 S-GENE
. 
 O
These s O
results u O
point n O
towards a O
post t O
- 
 O
translational n O
steric r O
and 	 O
/ 
 O
or O O
allosteric o O
control t O
of O O
EKLF F S-GENE
function c O
that t O
may 	 O
be O O
important o O
not 	 O
just t O
for 	 O
its 	 O
DNA 	 O
binding d O
ability l O
, 
 O
but 	 O
also o O
for 	 O
its 	 O
potential e O
to O O
interact e O
with h O
other e O
proteins t O
that t O
fully l O
establish a O
the 	 O
correct r O
stereospecific r O
array a O
leading d O
to O O
efficient i O
switching t O
of O O
beta a B-GENE
- - I-GENE
globin b E-GENE
transcription n O
during i O
development e O
. 
 O
Oxalates l O
and 	 O
the 	 O
digestive e O
tract c O
However e O
, 
 O
the 	 O
addition i O
of O O
intravenous r O
injection e O
of O O
FPFD D O
101 	 O
resulted u O
in O O
a 
 O
marked k O
improvement r O
in O O
their i O
symptoms p O
. 
 O
Western t O
blot t O
experiments e O
detected e O
SMBP P S-GENE
as O O
a 
 O
70 O O
kDa 	 O
protein t O
that t O
may 	 O
be O O
further t O
cleaved a O
into o O
an O O
active i O
34 O O
kDa 	 O
N 
 O
- 
 O
terminal m O
polypeptide y O
. 
 O
The 	 O
aetiology i O
and 	 O
management a O
of O O
diabetic b O
impotence o O
is O O
well l O
- 
 O
documented u O
; 
 O
the 	 O
effects e O
of O O
diabetes b O
on O O
female a O
sexuality u O
are 	 O
not 	 O
so O O
clear a O
. 
 O
Treatment a O
of O O
diabetes b O
and 	 O
retinal i O
complications p O
The 	 O
activated i O
glucocorticoid c B-GENE
receptor e E-GENE
forms m O
a 
 O
complex p O
with h O
Stat5 t S-GENE
and 	 O
enhances a O
Stat5 t S-GENE
- 
 O
mediated i O
transcriptional n O
induction u O
. 
 O
Taken e O
together e O
, 
 O
these s O
findings d O
demonstrate o O
that t O
ZNF76 7 S-GENE
and 	 O
ZNF143 1 S-GENE
are 	 O
two 	 O
members b O
of O O
a 
 O
same e O
family i O
of O O
transactivator n O
proteins t O
. 
 O
For 	 O
example m O
, 
 O
the 	 O
presence s O
of O O
two 	 O
related a O
genes e O
, 
 O
b - O
and 	 O
b - O
' - O
, 
 O
in O O
the 	 O
cyanobacterium n O
suggests g O
that t O
its 	 O
ATP 	 B-GENE
synthase t E-GENE
is O O
a 
 O
complex p O
of O O
nine e O
polypeptides y O
, 
 O
and 	 O
that t O
it O O
may 	 O
have e O
single g O
copies i O
of O O
related a O
b - O
and 	 O
b - O
' - O
proteins t O
rather h O
than n O
two 	 O
copies i O
of O O
identical n O
b - O
subunits u O
as O O
found n O
in O O
the 	 O
E 
 O
. 
 O
coli i O
enzyme y O
. 
 O
4 
 O
+ 
 O
off 	 O
Antiserum i O
raised s O
against i O
rat 	 B-GENE
liver e I-GENE
S6 I I-GENE
kinase a E-GENE
specifically c O
immunoprecipitates u O
the 	 O
purified i O
32P 	 O
- 
 O
labeled e O
H4 O S-GENE
hepatoma a O
insulin u S-GENE
- 
 O
stimulated m O
S6 B B-GENE
kinase a E-GENE
. 
 O
CRKL L S-GENE
, 
 O
an O O
SH2 	 S-GENE
- 
 O
SH3 	 S-GENE
- 
 O
SH3 	 S-GENE
adapter p O
protein t O
, 
 O
is O O
one 	 O
of O O
the 	 O
major o O
tyrosine o O
phosphoproteins s O
detected e O
in O O
primary m O
leukemic k O
neutrophils t O
from m O
patients i O
with h O
CML 	 O
. 
 O
KU O O
- 
 O
1257 7 O
also o O
significantly n O
accelerated e O
the 	 O
healing l O
of O O
acetic t O
acid d O
- 
 O
induced u O
duodenal d O
ulcers e O
as O O
well l O
as O O
famotidine o O
and 	 O
roxatidine a O
acetate t O
. 
 O
To O O
further t O
identify n O
the 	 O
residues i O
responsible p O
for 	 O
the 	 O
activity i O
, 
 O
we O O
isolated l O
the 	 O
mutant a O
viruses u O
that t O
were e O
not 	 O
neutralized t O
with h O
the 	 O
soluble u O
form m O
of O O
MHV 	 B-GENE
receptor e I-GENE
proteins t E-GENE
, 
 O
since c O
such h O
mutants a O
were e O
expected e O
to O O
have e O
mutations a O
in O O
amino n O
acids d O
responsible p O
for 	 O
receptor e O
- 
 O
binding d O
activity i O
. 
 O
It O O
is O O
suggested g O
that t O
death t O
of O O
S 
 O
. 
 O
mansoni s O
cercariae c O
during i O
penetration e O
of O O
mammalian m O
host t O
skin n O
is O O
probably b O
due 	 O
to O O
exhaustion a O
of O O
their i O
energy r O
reserves e O
. 
 O
Especially e O
if O O
the 	 O
number b O
of O O
dimensions e O
of O O
the 	 O
samples p O
is O O
large g O
, 
 O
it O O
can 	 O
be O O
said d O
that t O
BPN 	 O
is O O
better t O
than n O
k 
 O
- 
 O
NN O O
in O O
classification s O
ability l O
. 
 O
In O O
contrast t O
, 
 O
inactivation c O
of O O
the 	 O
Sir4p 4 S-GENE
- - O
interacting e O
protein t O
Rap1p 1 S-GENE
reduces u O
partitioning t O
by O O
a 
 O
LexA A S-GENE
- 
 O
Sir4p 4 S-GENE
fusion i O
. 
 O
Nine e O
individuals i O
who 	 O
were e O
stable b O
after e O
1 
 O
month t O
of O O
therapy r O
at O O
low 	 O
dosage a O
were e O
randomized d O
to O O
a 
 O
further t O
month t O
of O O
therapy r O
at O O
low 	 O
or O O
high h O
dosage a O
, 
 O
during i O
which c O
one 	 O
of O O
four r O
at O O
high h O
dosage a O
had 	 O
a 
 O
partial t O
response p O
, 
 O
and 	 O
none e O
of O O
five e O
at O O
low 	 O
dosage a O
manifested i O
response p O
. 
 O
BACKGROUND K O
: 
 O
Murine i B-GENE
Nramp m E-GENE
is O O
a 
 O
candidate d O
for 	 O
the 	 O
macrophage r O
resistance i O
gene e O
Ity 	 S-GENE
/ 
 O
Lsh 	 S-GENE
/ 
 O
Bcg 	 S-GENE
. 
 O
In O O
cases e O
in O O
which c O
it O O
was 	 O
identified n O
, 
 O
insulitis u O
affected e O
23 O O
% 
 O
of O O
islets e O
containing t O
insulin u S-GENE
, 
 O
but 	 O
affected e O
only y O
1 
 O
% 
 O
of O O
islets e O
which c O
were e O
insulin u S-GENE
deficient i O
, 
 O
thus s O
supporting p O
the 	 O
concept c O
that t O
insulitis u O
represents r O
an O O
immunologically u O
mediated i O
destruction t O
of O O
insulin u S-GENE
secreting r O
B 
 O
cells l O
. 
 O
( 
 O
4 
 O
) 
 O
Expression r O
in O O
different f O
sites e O
in O O
the 	 O
central t O
nervous v O
system t O
is O O
driven v O
by O O
separable a O
elements m O
widely e O
dispersed p O
throughout o O
8 
 O
kb O O
3 
 O
' 
 O
of O O
the 	 O
gene e O
. 
 O
To O O
investigate e O
possible s O
roles e O
for 	 O
HCP 	 S-GENE
during i O
late e O
erythroid t O
differentiation f O
, 
 O
effects e O
of O O
manipulating i O
HCP 	 S-GENE
expression r O
or O O
recruitment r O
on O O
EPO 	 S-GENE
- 
 O
induced u O
hemoglobinization o O
in O O
erythroleukemic t O
SKT6 6 O
cells l O
have e O
been n O
investigated e O
. 
 O
The 	 O
other e O
end 	 O
of O O
this s O
cluster s O
contained t O
the 	 O
human a B-GENE
type e I-GENE
I - I-GENE
cytokeratin o I-GENE
K20 	 E-GENE
and 	 O
K12 	 B-GENE
gene e I-GENE
loci i E-GENE
. 
 O
An O O
11 O O
. 
 O
5 
 O
- 
 O
kb O O
intron r O
is O O
found n O
at O O
the 	 O
end 	 O
of O O
transmembrane n O
6 
 O
, 
 O
and 	 O
the 	 O
rest t O
of O O
the 	 O
ORF 	 O
is O O
in O O
exon n O
3 
 O
. 
 O
Are 	 O
there r O
any 	 O
lessons s O
to O O
be O O
learnt r O
? 
 O
Eighteen h O
patients i O
with h O
advanced a O
epidermoid d O
carcinoma c O
of O O
the 	 O
head d O
and 	 O
neck k O
were e O
entered e O
into o O
a 
 O
phase s O
II O O
trial a O
of O O
N 
 O
- 
 O
Methylformamide h O
( 
 O
NMF 	 O
) 
 O
, 
 O
800 	 O
mg O O
/ 
 O
M2 O O
IV O O
daily l O
for 	 O
5 
 O
days s O
every r O
4 
 O
weeks k O
. 
 O
We O O
provided v O
evidence d O
that t O
CaM 	 B-GENE
kinase a I-GENE
II E E-GENE
played y O
a 
 O
role e O
in O O
regulating u O
neurite r O
outgrowth g O
and 	 O
growth w O
cone e O
motility i O
in O O
these s O
cells l O
, 
 O
and 	 O
that t O
the 	 O
autophosphorylation o O
is O O
essential e O
for 	 O
the 	 O
kinase a O
to O O
sufficiently f O
exert r O
its 	 O
cellular l O
function c O
in O O
vivo o O
[ 
 O
Y 
 O
. 
 O
However e O
, 
 O
in O O
transient n O
transfection n O
assays a O
, 
 O
a 
 O
truncation n O
of O O
as O O
little t O
as O O
15 O O
Nurr1 r O
COOH H O
- 
 O
terminal m O
amino n O
acids d O
diminished i O
transcriptional n O
activation i O
of O O
B1A 	 B-GENE
- 
 I-GENE
thymidine m I-GENE
kinase a E-GENE
- 
 O
chloramphenicol o B-GENE
acetyltransferase t I-GENE
reporter o E-GENE
. 
 O
All 	 O
sows s O
nursed s O
nine e O
pigs s O
. 
 O
In O O
the 	 O
second o O
group u O
the 	 O
untreated r O
fellow l O
eye 	 O
was 	 O
microscopically r O
intact a O
, 
 O
but 	 O
was 	 O
shown w O
( 
 O
as O O
the 	 O
treated a O
eye 	 O
) 
 O
to O O
alter e O
the 	 O
concentration c O
of O O
uronic n O
acid d O
in O O
different f O
parts t O
of O O
the 	 O
sclera e O
. 
 O
Effects e O
were e O
studied d O
of O O
extremely r O
high h O
- 
 O
frequency q O
electromagnetic c O
radiation i O
( 
 O
EHF 	 O
EMR 	 O
) 
 O
on O O
indices i O
for 	 O
the 	 O
immune u O
and 	 O
endocrine o O
systems t O
in O O
a 
 O
series i O
of O O
48 O O
patients i O
presenting s O
with h O
hyperplastic e O
processes c O
in O O
endometrium o O
. 
 O
Characterization r O
of O O
human a B-GENE
activating i I-GENE
transcription n I-GENE
factor t I-GENE
4 - E-GENE
, 
 O
a 
 O
transcriptional n O
activator i O
that t O
interacts e O
with h O
multiple t O
domains a O
of O O
cAMP P B-GENE
- - I-GENE
responsive p I-GENE
element m I-GENE
- - I-GENE
binding d I-GENE
protein t E-GENE
( 
 O
CREB B S-GENE
) 
 O
- 
 O
binding d O
protein t O
. 
 O
Effect e O
of O O
a 
 O
constant s O
magnetic n O
field l O
on O O
different f O
models e O
of O O
carcinogenesis c O
In O O
contrast t O
to O O
the 	 O
reciprocal i O
effects e O
of O O
Gab1 1 S-GENE
and 	 O
Gab2 2 S-GENE
in O O
mediating i O
Elk 	 B-GENE
- - I-GENE
1 - E-GENE
induction u O
, 
 O
these s O
two 	 O
molecules e O
have e O
a 
 O
similar i O
function c O
in O O
extracellular r O
signal n O
- - O
regulated u O
kinase a O
activation i O
induced u O
by O O
either h O
oncogenic o O
Ras 	 S-GENE
or O O
growth w B-GENE
factor t E-GENE
stimulation m O
. 
 O
This s O
result u O
is O O
consistent s O
with h O
the 	 O
previous v O
observation e O
that t O
expression r O
of O O
the 	 O
hsp70 7 B-GENE
genes e E-GENE
in I O
T - O
. - O
brucei c O
is O O
mainly n O
controlled t O
at O O
the 	 O
posttranscriptional t O
level e O
. 
 O
A 
 O
definition i O
of O O
bias s O
founded n O
on O O
the 	 O
concept c O
of O O
the 	 O
study d O
base e O
. 
 O
Chromaffin o O
cells l O
transfected n O
with h O
a 
 O
plasmid s O
with h O
the 	 O
entire i O
coding i O
sequence u O
of O O
c - O
- - O
Rabphilin3a p O
inserted e O
in O O
the 	 O
antisense i O
orientation e O
inhibited i O
secretion r O
of O O
co O O
- 
 O
expressed r O
GH S S-GENE
by O O
approximately r O
30 O O
% 
 O
. 
 O
Using n O
a 
 O
set 	 O
of O O
sera a O
for 	 O
which c O
full l O
chlamydial a O
micro r O
- 
 O
immunofluorescence u O
results u O
suggested g O
a 
 O
clear a O
diagnosis g O
, 
 O
we O O
have e O
evaluated l O
the 	 O
Chlamydia a O
Spot t O
- 
 O
IF O O
test t O
( 
 O
bioMerieux M O
) 
 O
, 
 O
which c O
allows o O
a 
 O
comparison p O
of O O
titres r O
to O O
Chlamydia a O
trachomatis c O
and 	 O
C - O
. - O
psittaci t O
antigens i O
. 
 O
An O O
environmental i O
investigation e O
found n O
evidence d O
of O O
suboptimal o O
food d O
storage r O
and 	 O
cooking k O
temperatures p O
at O O
Restaurant t O
A 
 O
; 
 O
cross s O
contamination t O
of O O
foods d O
may 	 O
have e O
contributed t O
to O O
the 	 O
low 	 O
attributable r O
risk k O
identified n O
for 	 O
chile l O
rellenos l O
. 
 O
Evidence d O
from m O
four r O
areas a O
- 
 O
- 
 O
sensory s O
deprivation r O
, 
 O
enriched i O
environments i O
, 
 O
nervous v O
system t O
plasticity s O
, 
 O
and 	 O
sensitive s O
periods i O
of O O
neurodevelopment r O
- 
 O
- 
 O
suggests g O
that t O
sensory s O
stimulation m O
programs g O
are 	 O
potentially e O
beneficial e O
for 	 O
STR 	 O
patients i O
. 
 O
In O O
each h O
study d O
group u O
, 
 O
elevated v O
levels e O
of O O
serum u B-GENE
I 
 E-GENE
were e O
observed e O
. 
 O
With h O
repetitive e O
intermittent e O
exercise r O
, 
 O
gradual d O
increases r O
in O O
blood o O
lactate t O
concentration c O
[ 
 O
( 
 O
LA O O
] 
 O
b 
 O
) 
 O
occurred u O
, 
 O
whereas r O
its 	 O
rate e O
of O O
accumulation u O
( 
 O
delta t O
[ 
 O
LA O O
] 
 O
b 
 O
) 
 O
decreased r O
. 
 O
A 
 O
physical s O
and 	 O
genetic e O
map 	 O
covering e O
the 	 O
entire i O
RP12 2 B-GENE
candidate d I-GENE
gene e I-GENE
region i E-GENE
was 	 O
constructed s O
. 
 O
The 	 O
single g O
copy y O
flotillin t B-GENE
- - I-GENE
1 - I-GENE
gene e E-GENE
is O O
located a O
at O O
6p21 1 B-GENE
. 
 I-GENE
3 
 E-GENE
in O O
the 	 O
MHC 	 B-GENE
class s I-GENE
I - I-GENE
region i E-GENE
and 	 O
consists s O
of O O
13 O O
exons n O
over r O
15 O O
kb O O
. 
 O
An O O
atypical p O
form m O
of O O
juvenile e O
myasthenia s O
gravis v O
associated o O
with h O
severe e O
emaciation c O
, 
 O
muscle c O
atrophy o O
, 
 O
ophthalmoplegia t O
, 
 O
bulbar b O
signs n O
and 	 O
joint n O
contracture t O
The 	 O
in O O
vivo o O
response p O
of O O
the 	 O
PacC C B-GENE
- - I-GENE
like e I-GENE
decamers a E-GENE
to O O
external e O
pH O S-GENE
was 	 O
dependent e O
on O O
the 	 O
status t O
of O O
the 	 O
pH O B-GENE
- 
 I-GENE
regulated u I-GENE
activator i I-GENE
YlRim101p i E-GENE
, 
 O
which c O
is O O
homologous o O
to O O
the 	 O
A 
 O
. 
 O
nidulans u O
PacC C B-GENE
regulator u E-GENE
. 
 O
Electron c O
microscopic r O
visualization u O
of O O
the 	 O
general e O
population u O
of O O
active i O
genes e O
in O O
flies e O
overexpressing r O
hnRNP N B-GENE
proteins t E-GENE
also o O
indicated i O
that t O
the 	 O
great a O
majority o O
of O O
genes e O
seemed m O
normal m O
in O O
terms m O
of O O
cotranscriptional r O
RNA 	 O
processing c O
events n O
, 
 O
although h O
there r O
were e O
a 
 O
few 	 O
abnormalities o O
consistent s O
with h O
rare e O
exon n O
- 
 O
skipping p O
events n O
. 
 O
Having i O
demonstrated o O
proper p O
localization a O
of O O
GFP 	 B-GENE
- 
 I-GENE
calmodulin m E-GENE
in O O
budding d O
yeast s O
, 
 O
we O O
examined m O
the 	 O
localization a O
of O O
a 
 O
fusion i O
between w O
GFP 	 S-GENE
and 	 O
calmodulin m S-GENE
( 
 O
GFP 	 S-GENE
- - O
Camlp l S-GENE
) 
 O
in O O
fission s O
yeast s O
, 
 O
where r O
calmodulin m S-GENE
had 	 O
not 	 O
been n O
localized a O
by O O
any 	 O
method h O
. 
 O
Sera a O
from m O
33 O O
newborn b O
infants a O
with h O
gestational t O
ages s O
ranging g O
from m O
27 O O
to O O
41 O O
weeks k O
were e O
tested t O
by O O
radioimmunoassay i O
for 	 O
IgG 	 B-GENE
antibodies i E-GENE
to O O
surface f O
antigens i O
of O O
group u O
B 
 O
streptococci e O
( 
 O
GBS 	 O
) 
 O
types e O
Ia O O
, 
 O
Ib O O
, 
 O
II O O
and 	 O
III 	 O
. 
 O
In O O
frozen z O
sections t O
the 	 O
spots t O
appear e O
as O O
blue e O
labelled e O
neurones r O
with h O
a 
 O
light h O
microscope r O
, 
 O
or O O
as O O
a 
 O
brilliant l O
red 	 O
neurones r O
surrounded r O
by O O
reddish d O
tissue s O
with h O
a 
 O
fluorescence o O
microscope r O
. 
 O
The 	 O
percentage c O
distribution t O
of O O
types e O
of O O
fixation a O
disparity p O
curves v O
was 	 O
found n O
to O O
be O O
similar i O
to O O
some e O
previous v O
studies d O
, 
 O
with h O
a 
 O
higher h O
prevalence v O
of O O
Type e O
I 
 O
curve v O
( 
 O
64 O O
. 
 O
3 
 O
% 
 O
) 
 O
, 
 O
followed l O
by O O
Type e O
II O O
( 
 O
28 O O
. 
 O
6 
 O
% 
 O
) 
 O
and 	 O
Type e O
III 	 O
( 
 O
7 
 O
. 
 O
1 
 O
% 
 O
) 
 O
curves v O
. 
 O
The 	 O
BUR 	 O
was 	 O
set 	 O
at O O
20 O O
/ 
 O
min 	 O
and 	 O
the 	 O
IT O O
at O O
. 
 O
5 
 O
seconds o O
. 
 O
These s O
data a O
are 	 O
discussed c O
in O O
the 	 O
context t O
of O O
the 	 O
pathogenesis h O
and 	 O
differential f O
diagnosis g O
of O O
EEC 	 O
. 
 O
Seminal i O
prolactin l S-GENE
levels e O
were e O
significantly n O
elevated v O
in O O
all 	 O
infertile e O
males e O
. 
 O
Northern t O
blot t O
analysis l O
identified n O
retina i O
- 
 O
specific c O
transcripts n O
of O O
3 
 O
. 
 O
0 
 O
kb O O
for 	 O
rod 	 O
G - O
alpha h O
t - O
and 	 O
2 
 O
. 
 O
6 
 O
kb O O
for 	 O
cone e B-GENE
G - I-GENE
alpha h I-GENE
t - E-GENE
. 
 O
In O O
the 	 O
univariate v O
models e O
of O O
either h O
fixed e O
or O O
time e O
dependent e O
covariates a O
, 
 O
many y O
variables i O
were e O
significantly n O
associated o O
with h O
risk k O
of O O
progression g O
to O O
AIDS S O
( 
 O
T4 O O
cell l O
count n O
, 
 O
T4 O O
/ 
 O
T8 O O
ratio i O
, 
 O
blastogenic s O
responses p O
to O O
phytohemagglutinin t S-GENE
, 
 O
concanavalin c B-GENE
A - E-GENE
, 
 O
and 	 O
pokeweed e O
mitogen o O
, 
 O
serum u B-GENE
IgA 	 E-GENE
, 
 O
appearance e O
of O O
p24 	 B-GENE
antigen i E-GENE
, 
 O
and 	 O
the 	 O
development e O
of O O
oral l O
hairy r O
leukoplakia k O
, 
 O
thrush u O
, 
 O
or O O
herpes p O
zoster t O
) 
 O
. 
 O
Adenovirus n O
- 
 O
mediated i O
gene e O
transfer n O
of O O
MMAC1 C S-GENE
/ 
 O
PTEN N S-GENE
to O O
glioblastoma o O
cells l O
inhibits i O
S 
 O
phase s O
entry r O
by O O
the 	 O
recruitment r O
of O O
p27Kip1 K S-GENE
into o O
cyclin l B-GENE
E - E-GENE
/ 
 O
CDK2 2 S-GENE
complexes p O
. 
 O
Cost t O
analysis l O
and 	 O
the 	 O
HSA 	 O
: 
 O
a 
 O
framework m O
. 
 O
These s O
cells l O
also o O
showed w O
an O O
increase r O
in O O
cyclin l B-GENE
A - E-GENE
and 	 O
cyclin l B-GENE
A - E-GENE
- - O
and 	 O
E - B-GENE
- - I-GENE
associated o I-GENE
kinase a E-GENE
activities i O
characteristic r O
of O O
S 
 O
phase s O
induction u O
. 
 O
Characterization r O
of O O
a 
 O
tonB B S-GENE
- 
 O
phoA A S-GENE
gene e O
fusion i O
suggests g O
that t O
the 	 O
amino n O
- 
 O
terminal m O
41 O O
amino n O
acids d O
of O O
TonB B S-GENE
are 	 O
sufficient f O
to O O
promote m O
export o O
of O O
the 	 O
fusion i O
protein t O
and 	 O
presumably s O
TonB B S-GENE
as O O
well l O
. 
 O
Calcium c O
bilirubinate i O
crystals s O
were e O
seen n O
in O O
gallbladder l O
bile e O
or O O
wall l O
scrapings a O
of O O
7 
 O
of O O
8 
 O
TPN 	 O
animals m O
but 	 O
in O O
none e O
of O O
the 	 O
controls t O
( 
 O
P 
 O
less s O
than n O
0 
 O
. 
 O
001 	 O
) 
 O
. 
 O
This s O
domain a O
encompasses o O
the 	 O
region i O
of O O
ARP 	 B-GENE
- - I-GENE
1 - E-GENE
/ 
 O
COUP P B-GENE
- - I-GENE
TFII I E-GENE
corresponding r O
to O O
helices i O
3 
 O
to O O
12 O O
in O O
the 	 O
recently e O
published l O
crystal s O
structure u O
of O O
other e O
members b O
of O O
the 	 O
nuclear l O
receptor e O
superfamily e O
. 
 O
Different f O
clinical n O
variants i O
of O O
the 	 O
empty t O
sella l O
turcica c O
syndrome d O
are 	 O
demonstrated o O
, 
 O
including l O
variants i O
resultant u O
from m O
substitution s O
therapy r O
of O O
thyroid r O
hypofunction o O
, 
 O
from m O
dopamine a O
agonist n O
therapy r O
for 	 O
hyperprolactinemic e O
hypogonadism o O
, 
 O
from m O
radiotherapy i O
of O O
hypophyseal o O
adenoma n O
. 
 O
Both h O
genes e O
ARO3 3 S-GENE
and 	 O
ARO4 4 S-GENE
are 	 O
strongly o O
regulated u O
under e O
the 	 O
general e O
control t O
regulatory u O
system t O
. 
 O
Polar a O
effects e O
of O O
transposon n O
insertions e O
demonstrated o O
that t O
all 	 O
of O O
these s O
mRNAs A O
arose s O
from m O
a 
 O
single g O
promoter m O
region i O
, 
 O
where r O
transcription n O
initiated t O
80 O O
bp O O
5 
 O
' 
 O
to O O
nifH H S-GENE
. 
 O
J 
 O
. 
 O
, 
 O
& 
 O
Olefsky f O
, 
 O
J 
 O
. 
 O
Importantly o O
, 
 O
a 
 O
single g O
base e O
change n O
in O O
the 	 O
fifth t O
position i O
of O O
the 	 O
c - B-GENE
- - I-GENE
fos 	 I-GENE
sequence u E-GENE
( 
 O
GGTCTnnnAGACC C O
to O O
GGTCA C O
/ 
 O
GnnnAGACC n O
) 
 O
produced d O
an O O
element m O
that t O
bound n O
the 	 O
estrogen r B-GENE
receptor e E-GENE
and 	 O
conferred f O
estrogen r O
- 
 O
dependent e O
transcriptional n O
activation i O
of O O
a 
 O
reporter o O
gene e O
. 
 O
Measuring s O
the 	 O
dim 	 O
light h O
melatonin a O
onset e O
( 
 O
DLMO O O
) 
 O
is O O
a 
 O
useful f O
and 	 O
practical c O
way 	 O
to O O
assess e O
circadian c O
phase s O
position i O
in O O
humans a O
. 
 O
Co O O
- 
 O
expression r O
of O O
a 
 O
gag 	 S-GENE
- 
 O
TRalpha l S-GENE
fusion i O
protein t O
in O O
AEV 	 O
- 
 O
transformed n O
cells l O
and 	 O
addition i O
of O O
ligand a O
derepresses e O
CAII I S-GENE
transcription n O
. 
 O
The 	 O
IB2 	 B-GENE
gene e E-GENE
( 
 O
HGMW W B-GENE
- 
 I-GENE
approved r I-GENE
symbol b I-GENE
MAPK8IP2 K E-GENE
) 
 O
maps s O
to O O
human a O
chromosome o O
22q13 1 O
and 	 O
contains t O
10 O O
coding i O
exons n O
. 
 O
Transcription n O
start r O
sites e O
of O O
sal 	 S-GENE
and 	 O
salR R B-GENE
genes e E-GENE
were e O
determined e O
to O O
lie 	 O
30 O O
- 
 O
and 	 O
24 O O
- 
 O
bp O O
upstream t O
of O O
the 	 O
respective p O
initiation t O
codons o O
and 	 O
separated a O
from m O
each h O
other e O
by O O
78 O O
nucleotides l O
. 
 O
1 
 O
. 
 O
23 O O
) 
 O
as O O
a 
 O
PPARalpha R B-GENE
- - I-GENE
interacting e I-GENE
protein t E-GENE
. 
 O
Here e O
we O O
demonstrate o O
that t O
the 	 O
T - B-GENE
cell l I-GENE
antigen i I-GENE
receptor e I-GENE
zeta a I-GENE
- - I-GENE
chain i I-GENE
- - I-GENE
associated o I-GENE
ZAP 	 I-GENE
- - I-GENE
70 I I-GENE
kinase a E-GENE
and 	 O
T - B-GENE
cell l I-GENE
antigen i I-GENE
receptor e I-GENE
zeta a I-GENE
- - I-GENE
chain i E-GENE
immunoreceptor u O
tyrosine o O
- - O
based e O
activation i O
motifs i O
are 	 O
essential e O
for 	 O
the 	 O
membrane b O
recruitment r O
of O O
SOS 	 S-GENE
and 	 O
Vav 	 S-GENE
. 
 O
We O O
carried r O
out 	 O
two 	 O
experiments e O
to O O
investigate e O
this s O
problem b O
. 
 O
When n O
linked k O
to O O
the 	 O
herpes p B-GENE
simplex p I-GENE
thymidine m I-GENE
kinase a E-GENE
minimal i O
promoter m O
, 
 O
this s O
fragment g O
acts s O
as O O
an O O
enhancing a O
element m O
in O O
Rcho o S-GENE
but 	 O
not 	 O
GC O O
cells l O
. 
 O
A 
 O
mammalian m O
protein t O
called l O
RFX 	 S-GENE
or O O
NF B B-GENE
- - I-GENE
X - E-GENE
binds d O
to O O
the 	 O
X 
 O
box 	 O
( 
 O
or O O
X1 O B-GENE
box 	 E-GENE
) 
 O
in O O
the 	 O
promoters m O
of O O
a 
 O
number b O
of O O
major o O
histocompatibility t O
( - O
MHC 	 S-GENE
) - O
class s B-GENE
II I I-GENE
genes e E-GENE
. 
 O
Site e O
- 
 O
directed e O
mutagenesis a O
was 	 O
conducted d O
to O O
investigate e O
the 	 O
functional c O
significance n O
of O O
this s O
element m O
and 	 O
the 	 O
3 
 O
' 
 O
minus u O
- 
 O
strand a O
terminal m O
sequence u O
" 
 O
3 
 O
' 
 O
- 
 O
OH O O
- 
 O
CCCUAU U O
, 
 O
" 
 O
which c O
contains t O
the 	 O
minus u O
- 
 O
strand a O
3 
 O
' 
 O
- 
 O
end 	 O
sequence u O
" 
 O
3 
 O
' 
 O
- 
 O
OH O O
- 
 O
CC O O
( 
 O
1 
 O
- 
 O
2 
 O
) 
 O
( 
 O
A 
 O
/ 
 O
U 
 O
) 
 O
( 
 O
A 
 O
/ 
 O
U 
 O
) 
 O
( 
 O
A 
 O
/ 
 O
U 
 O
) 
 O
" 
 O
found n O
in O O
all 	 O
carmovirus m O
RNAs s O
. 
 O
The 	 O
incidence i O
of O O
the 	 O
variability i O
of O O
the 	 O
free e O
PSA 	 O
/ 
 O
total a O
PSA 	 O
ratio i O
on O O
the 	 O
early l O
diagnosis g O
of O O
prostate s O
cancer c O
VBP 	 S-GENE
and 	 O
a1 B B-GENE
/ - I-GENE
EBP 	 E-GENE
could l O
mediate i O
the 	 O
high h O
rates e O
of O O
ALV 	 O
and 	 O
RSV 	 O
LTR 	 O
- 
 O
enhanced a O
transcription n O
in O O
bursal s O
lymphoma p O
cells l O
and 	 O
many y O
other e O
cell l O
types e O
. 
 O
In O O
the 	 O
second o O
, 
 O
37 O O
students d O
were e O
given e O
trimethoprim m O
/ 
 O
sulphamethoxazole p O
( 
 O
160 	 O
mg O O
TMP 	 O
- 
 O
SMX 	 O
800 	 O
mg O O
) 
 O
, 
 O
38 O O
TMP 	 O
( 
 O
200 	 O
mg O O
) 
 O
, 
 O
and 	 O
in O O
35 O O
a 
 O
placebo c O
was 	 O
given e O
b 
 O
. 
 O
i 
 O
. 
 O
d 
 O
. 
 O
for 	 O
five e O
days s O
. 
 O
Developmental e O
slot t O
blots t O
demonstrate o O
that t O
mRNAs A O
corresponding r O
to O O
the 	 O
three e O
LHM 	 B-GENE
cDNAs A E-GENE
are 	 O
transcribed n O
from m O
prophase p O
of O O
meiosis o O
I 
 O
to O O
the 	 O
uninucleate n O
microspore r O
stage g O
, 
 O
while l O
Northern t O
analysis l O
reveals e O
these s O
tapetally e O
expressed r O
cDNAs A O
to O O
correspond r O
with h O
transcripts n O
of O O
some e O
500 	 O
bp O O
. 
 O
One 	 O
hundred d O
men 	 O
who 	 O
received e O
alpha h O
- 
 O
tocopherol o O
were e O
matched c O
on O O
age 	 O
, 
 O
study d O
center t O
, 
 O
and 	 O
length g O
of O O
time e O
between w O
blood o O
draws w O
to O O
100 	 O
men 	 O
who 	 O
received e O
a 
 O
placebo c O
. 
 O
The 	 O
contribution t O
of O O
residues i O
outside s O
the 	 O
Ras 	 B-GENE
binding d I-GENE
domain a E-GENE
of O O
Raf 	 S-GENE
( 
 O
RafRBD R S-GENE
) 
 O
to O O
Ras 	 S-GENE
- 
 O
Raf 	 S-GENE
interaction e O
and 	 O
Ras 	 S-GENE
- 
 O
dependent e O
Raf 	 S-GENE
activation i O
has 	 O
remained a O
unresolved e O
. 
 O
Other e O
recommendations o O
for 	 O
enhancing a O
the 	 O
safety e O
of O O
potent e O
antiplatelet i O
agents n O
in O O
a 
 O
variety i O
of O O
clinical n O
situations u O
are 	 O
provided v O
. 
 O
RESULTS U O
- 
 O
- 
 O
261 	 O
patients i O
were e O
enrolled o O
into o O
this s O
study d O
; 
 O
of O O
these s O
, 
 O
138 	 O
( 
 O
53 O O
% 
 O
) 
 O
patients i O
attended e O
for 	 O
repeat e O
colposcopy p O
and 	 O
cytology o O
at O O
one 	 O
year r O
. 
 O
Changes n O
in O O
the 	 O
greater a O
omentum n O
of O O
mice e O
of O O
different f O
strains a O
after e O
intraperitoneal r O
immunization u O
with h O
sheep e O
erythrocytes t O
. 
 O
In O O
this s O
study d O
, 
 O
we O O
sought g O
to O O
determine e O
the 	 O
specific c O
effect e O
of O O
HIV 	 B-GENE
protease t E-GENE
inhibitors i O
on O O
patient i O
weight g O
. 
 O
However e O
massive s O
necrosis r O
of O O
the 	 O
renal a O
tubules u O
had 	 O
been n O
found n O
with h O
more e O
than n O
15mg g O
of O O
DSM 	 O
administration i O
. 
 O
The 	 O
characteristics r O
of O O
a 
 O
simple p O
apparatus a O
for 	 O
clinical n O
use 	 O
to O O
measure s O
DEOAEs A O
are 	 O
described c O
together e O
with h O
typical i O
examples m O
of O O
emissions s O
. 
 O
To O O
obtain a O
information o O
on O O
the 	 O
functional c O
role e O
of O O
the 	 O
Rac1 1 S-GENE
/ 
 O
p38 	 S-GENE
/ 
 O
MAPKAPK K B-GENE
- - I-GENE
2 - E-GENE
pathway h O
in O O
RA O O
signaling n O
, 
 O
the 	 O
effects e O
of O O
pharmacological r O
inhibition i O
of O O
p38 	 S-GENE
on O O
RA O O
- 
 O
induced u O
gene e O
transcription n O
and 	 O
cell l O
differentiation f O
were e O
determined e O
. 
 O
The 	 O
cost t O
and 	 O
effectiveness e O
of O O
nurse s O
education c O
- 
 O
- 
 O
1 
 O
. 
 O
The 	 O
ATF 	 B-GENE
/ 
 I-GENE
CRE 	 I-GENE
site e E-GENE
is O O
also o O
essential e O
for 	 O
CD4 	 B-GENE
promoter m E-GENE
activation i O
by O O
forskolin s S-GENE
, 
 O
an O O
activator i O
of O O
adenylate n B-GENE
cyclase l E-GENE
. 
 O
YLL031c 0 S-GENE
is O O
an O O
essential e O
gene e O
. 
 O
Restricted t O
expression r O
of O O
a 
 O
novel e O
murine i B-GENE
atonal n I-GENE
- - I-GENE
related a I-GENE
bHLH H I-GENE
protein t E-GENE
in O O
undifferentiated i O
neural r O
precursors c O
. 
 O
Since c O
the 	 O
early l O
1900s 0 O
, 
 O
a 
 O
genetic e O
hypothesis o O
has 	 O
been n O
suggested g O
. 
 O
We O O
report o O
the 	 O
genomic o O
organization a O
of O O
the 	 O
mouse s B-GENE
orphan h I-GENE
receptor e E-GENE
related a O
to I O
tyrosine o B-GENE
kinases a E-GENE
( 
 O
Ryk 	 S-GENE
) 
 O
, 
 O
a 
 O
structurally u O
unclassified l O
member b O
of O O
the 	 O
growth w B-GENE
factor t I-GENE
receptor e I-GENE
family i E-GENE
. 
 O
In O O
contrast t O
, 
 O
T229E 9 B-GENE
- - I-GENE
p70s6k s E-GENE
migrated r O
more e O
slowly w O
in O O
SDS 	 O
- 
 O
polyacrylamide y O
gels s O
, 
 O
but 	 O
demonstrated o O
partial t O
kinase a O
activity i O
( 
 O
approximately r O
20 O O
% 
 O
compared p O
with h O
the 	 O
wild d O
type e O
) 
 O
. 
 O
The 	 O
structure u O
and 	 O
expression r O
of O O
the 	 O
murine i B-GENE
gene e I-GENE
encoding o I-GENE
granulocyte n I-GENE
- - I-GENE
macrophage r I-GENE
colony o I-GENE
stimulating m I-GENE
factor t E-GENE
: 
 O
evidence d O
for 	 O
utilisation l O
of O O
alternative e O
promoters m O
. 
 O
Thus s O
, 
 O
the 	 O
search r O
for 	 O
genetic e O
and 	 O
acquired u O
susceptibility c O
to O O
nontuberculous t O
mycobacteria o O
is O O
also o O
a 
 O
search r O
for 	 O
susceptibility c O
factors t O
for 	 O
MTB 	 S-GENE
as O O
well l O
as O O
an O O
opportunity o O
to O O
recognize o O
endogenous o O
pathways h O
that t O
can 	 O
be O O
exploited l O
therapeutically r O
. 
 O
Liver e O
disease e O
and 	 O
HCV 	 O
infection e O
after e O
transplantation n O
of O O
organs a O
from m O
hepatitis a B-GENE
C - I-GENE
antibody i E-GENE
positive i O
donors o O
. 
 O
After e O
dialysis l O
online i O
, 
 O
lactate t O
was 	 O
converted v O
by O O
means n O
of O O
lactate t B-GENE
oxidase d E-GENE
immobilized o O
to O O
porous o O
glass s O
, 
 O
and 	 O
the 	 O
depletion l O
of O O
oxygen g O
was 	 O
registered i O
by O O
means n O
of O O
a 
 O
Clark r O
electrode c O
. 
 O
The 	 O
deduced u O
amino n O
- 
 O
acid d O
sequence u O
of O O
the 	 O
mature u O
enzyme y O
showed w O
very y O
low 	 O
homology o O
( 
 O
< 
 O
20 O O
. 
 O
4 
 O
% 
 O
identity n O
) 
 O
to O O
those s O
of O O
known w O
pectinolytic t O
enzymes y O
in O O
the 	 O
large g B-GENE
pectate t I-GENE
lyase s I-GENE
superfamily e E-GENE
( 
 O
the 	 O
polysaccharide y B-GENE
lyase s I-GENE
family i I-GENE
1 - E-GENE
) 
 O
. 
 O
Incubation u O
of O O
HeLa a O
cell l O
cytoplasmic o O
extracts r O
with h O
a 
 O
purified i O
recombinant o B-GENE
glutathione t I-GENE
S - I-GENE
- - I-GENE
transferase n I-GENE
- 
 I-GENE
raf 	 I-GENE
fusion i I-GENE
protein t E-GENE
in O O
the 	 O
presence s O
of O O
ATP 	 O
released e O
active i O
NF B B-GENE
- - I-GENE
kappa p I-GENE
B - E-GENE
that t O
could l O
be O O
detected e O
by O O
electrophoretic c O
gel 	 O
mobility i O
shift f O
assay a O
. 
 O
Despite p O
this s O
loss s O
, 
 O
YEpFAS1 F S-GENE
is O O
still l O
able e O
to O O
complement p O
a 
 O
fas1 1 B-GENE
mutation a E-GENE
at O O
the 	 O
enoyl y B-GENE
reductase u I-GENE
domain a E-GENE
. 
 O
Cross s O
- 
 O
species c O
characterization r O
of O O
the 	 O
promoter m O
region i O
of I O
the 	 O
cystic t B-GENE
fibrosis r I-GENE
transmembrane n I-GENE
conductance d I-GENE
regulator u I-GENE
gene e E-GENE
reveals e O
multiple t O
levels e O
of O O
regulation u O
. 
 O
Pretreatment t O
with h O
lipid i O
X 
 O
was 	 O
not 	 O
necessary e O
to O O
improve r O
survival v O
: 
 O
16 O O
of O O
17 O O
( 
 O
94 O O
% 
 O
) 
 O
infected e O
and 	 O
visibly i O
ill 	 O
animals m O
that t O
received e O
lipid i O
X 
 O
and 	 O
ticarcillin a O
6 
 O
h 
 O
after e O
thigh g O
inoculation c O
survived v O
versus s O
30 O O
of O O
44 O O
( 
 O
68 O O
% 
 O
) 
 O
control t O
animals m O
treated a O
with h O
ticarcillin a O
alone n O
( 
 O
P 
 O
less s O
than n O
0 
 O
. 
 O
0001 1 O
) 
 O
. 
 O
The 	 O
predicted d O
vav 	 B-GENE
oncogene o I-GENE
protein t I-GENE
sequence u E-GENE
exhibits i O
several e O
motifs i O
reminiscent i O
of O O
transcriptional n O
factors t O
. 
 O
The 	 O
pharmacokinetics r O
were e O
best t O
described c O
by O O
a 
 O
two 	 O
- 
 O
compartment p O
open n O
model e O
giving i O
distribution t O
half f O
- 
 O
lives e O
of O O
0 
 O
. 
 O
31 O O
h 
 O
and 	 O
1 
 O
. 
 O
53 O O
h 
 O
, 
 O
and 	 O
elimination m O
half f O
- 
 O
lives e O
of O O
69 O O
. 
 O
7 
 O
h 
 O
and 	 O
60 O O
. 
 O
3 
 O
h 
 O
for 	 O
oxolinic l O
acid d O
and 	 O
oxytetracycline t O
, 
 O
respectively p O
. 
 O
The 	 O
predictive d O
value u O
of O O
the 	 O
remotely o O
sensed s O
map 	 O
based e O
on O O
NDVI I O
data a O
appears e O
to O O
be O O
better t O
than n O
that t O
from m O
forecast e O
indices i O
based e O
only y O
on O O
climatic m O
data a O
. 
 O
It O O
has 	 O
been n O
confirmed f O
in O O
animal m O
experiments e O
that t O
the 	 O
number b O
of O O
microspheres r O
in O O
a 
 O
myocardial c O
sample p O
approximately r O
follows l O
a 
 O
Poisson s O
distribution t O
, 
 O
under e O
adequate q O
experimental e O
conditions d O
. 
 O
Hepatitis a B-GENE
B - I-GENE
immune u I-GENE
globulins b E-GENE
and 	 O
HIV 	 B-GENE
antibodies i E-GENE
. 
 O
This s O
gene e O
is O O
divided i O
into o O
six 	 O
exons n O
spanning n O
about u O
3kb 	 S-GENE
, 
 O
and 	 O
encodes o O
a 
 O
175 	 O
amino n O
acid d O
protein t O
with h O
40 O O
- 
 O
52 O O
% 
 O
identity n O
with h O
the 	 O
other e O
five e O
mouse s B-GENE
Reg 	 E-GENE
( 
 O
regenerating e B-GENE
gene e I-GENE
product d E-GENE
) 
 O
proteins t O
. 
 O
The 	 O
p63 	 B-GENE
sequence u E-GENE
also o O
features t O
an O O
acidic d O
domain a O
characteristic r O
of O O
transcriptional n O
activation i O
factors t O
, 
 O
as O O
well l O
as O O
sequence u O
blocks c O
displaying p O
limited i O
similarity i O
to O O
positionally i O
equivalent i O
regions i O
in O O
sigma m B-GENE
factors t E-GENE
from m O
eubacteria a O
related a O
to O O
mitochondria o O
. 
 O
In O O
contrast t O
, 
 O
a 
 O
similar i O
fusion i O
protein t O
( 
 O
hGH 	 S-GENE
- 
 O
LDLR R S-GENE
- 
 O
DAF17 1 S-GENE
, 
 O
abbreviated r O
HLD 	 S-GENE
) 
 O
containing t O
a 
 O
fragment g O
of O O
the 	 O
serine i O
/ 
 O
threonine e O
- 
 O
rich h O
domain a O
of O O
the 	 O
LDL 	 B-GENE
receptor e E-GENE
( 
 O
LDLR R S-GENE
) 
 O
in O O
place c O
of O O
the 	 O
DAF 	 O
- - O
derived i O
serine i O
/ - O
threonine e O
- - O
rich h O
sequences u O
, 
 O
does s O
not 	 O
become o O
GPI 	 S-GENE
anchored h O
. 
 O
Thus s O
, 
 O
the 	 O
pathway h O
to O O
Fc B B-GENE
epsilonRI i E-GENE
- 
 O
mediated i O
MEK 	 S-GENE
/ 
 O
ERK 	 S-GENE
and 	 O
ERK 	 S-GENE
activation i O
can 	 O
apparently a O
bypass a O
Ras 	 S-GENE
and 	 O
Raf 	 B-GENE
- - I-GENE
1 - E-GENE
. 
 O
To O O
assess e O
whether t O
thallium l O
- 
 O
201 	 O
thallous l O
chloride o O
( 
 O
Tl O O
) 
 O
can 	 O
detect e O
childhood l O
tumors o O
and 	 O
whether t O
diagnostic g O
effectiveness e O
improves r O
with h O
combined b O
blood o O
flow w O
imaging g O
, 
 O
28 O O
children l O
( 
 O
1 
 O
. 
 O
0 
 O
- 
 O
18 O O
. 
 O
6 
 O
years r O
) 
 O
were e O
studied d O
using n O
single g O
photon t O
emission s O
computed p O
tomography o O
( 
 O
SPECT C O
) 
 O
: 
 O
Tl O O
( 
 O
1 
 O
. 
 O
3 
 O
- 
 O
1 
 O
. 
 O
8 
 O
mCi 	 O
intravenously r O
) 
 O
, 
 O
followed l O
in O O
13 O O
of O O
the 	 O
patients i O
by O O
technetium h O
- 
 O
99m 	 O
- 
 O
hexamethylpropyleneamine a O
oxime m O
( 
 O
99mTc T O
- 
 O
HMPAO A O
; 
 O
8 
 O
- 
 O
18 O O
mCi 	 O
intravenously r O
) 
 O
. 
 O
Ftz 	 S-GENE
, 
 O
on O O
the 	 O
other e O
hand d O
, 
 O
influences l O
Ftz 	 B-GENE
- 
 I-GENE
F1 S E-GENE
activity i O
by O O
interacting e O
with h O
its 	 O
AF O B-GENE
- 
 I-GENE
2 
 I-GENE
domain a E-GENE
in O O
a 
 O
manner n O
that t O
mimics i O
a 
 O
nuclear l O
receptor e O
coactivator c O
. 
 O
Successive c O
5 
 O
' 
 O
deletions e O
of O O
the 	 O
[ 
 B-GENE
- 
 I-GENE
326 	 I-GENE
; 
 I-GENE
+ 
 I-GENE
20 O I-GENE
] 
 I-GENE
type e I-GENE
II I I-GENE
sPLA2 A I-GENE
promoter m E-GENE
indicated i O
that t O
the 	 O
region i O
upstream t O
of O O
position i O
- 
 O
195 	 O
inhibits i O
the 	 O
transcription n O
activity i O
sixfold f O
in O O
HepG2 G O
cells l O
but 	 O
not 	 O
in O O
HeLa a O
cells l O
. 
 O
Forty t O
- 
 O
five e O
patients i O
with h O
recent e O
- 
 O
onset e O
hyperthyroidism e O
( 
 O
< 
 O
12 O O
weeks k O
) 
 O
were e O
sex 	 O
and 	 O
menopause o O
stratified a O
and 	 O
randomly d O
allocated o O
to O O
treatment a O
with h O
carbimazole b O
( 
 O
Neotomizol t O
) 
 O
, 
 O
carbimazole b O
plus s O
low 	 O
dose e O
CT O O
( 
 O
Calsynar s O
; 
 O
100 	 O
IU O O
/ 
 O
day 	 O
, 
 O
2 
 O
days s O
/ 
 O
week k O
) 
 O
, 
 O
or O O
carbimazole b O
plus s O
high h O
dose e O
CT O O
( 
 O
Calsynar s O
; 
 O
100 	 O
IU O O
/ 
 O
day 	 O
, 
 O
14 O O
days s O
/ 
 O
month t O
) 
 O
. 
 O
The 	 O
cloning n O
of O O
CWH43 4 S-GENE
showed w O
that t O
it O O
corresponds r O
to O O
YCR017c 0 S-GENE
and 	 O
encodes o O
a 
 O
protein t O
with h O
14 O O
- 
 O
16 O O
transmembrane n O
segments m O
containing t O
several e O
putative a O
phosphorylation s O
and 	 O
glycosylation c O
sites e O
. 
 O
However e O
, 
 O
strains a O
in O O
which c O
both h O
of O O
the 	 O
two 	 O
most t O
highly h O
related a O
genes e O
, 
 O
DdPIK1 I S-GENE
and 	 O
DdPIK2 I S-GENE
, 
 O
were e O
disrupted r O
showed w O
both h O
growth w O
and 	 O
developmental e O
defects e O
, 
 O
while l O
double b O
knockouts c O
of O O
DdPIK1 I S-GENE
and 	 O
DdPIK3 I S-GENE
and 	 O
DdPIK2 I S-GENE
and 	 O
DdPIK3 I S-GENE
appear e O
to O O
be O O
lethal h O
. 
 O
This s O
mechanism h O
seems m O
to O O
be O O
involved o O
in O O
VIP 	 S-GENE
- 
 O
induced u O
PRL 	 B-GENE
gene e E-GENE
regulation u O
. 
 O
Competition p O
and 	 O
methylation h O
interference e O
assays a O
showed w O
that t O
the 	 O
binding d O
site e O
for 	 O
the 	 O
novel e O
factor t O
was 	 O
limited i O
to O O
nucleotides l O
in O O
the 	 O
3 
 O
' 
 O
half f O
of O O
the 	 O
kappa p B-GENE
B - I-GENE
site e E-GENE
. 
 O
These s O
properties p O
prompted m O
us O O
to O O
investigate e O
Ets 	 B-GENE
- - I-GENE
1 - E-GENE
expression r O
in O O
32 O O
human a O
astroglial r O
tumors o O
of O O
WHO 	 O
grades d O
I 
 O
- 
 O
IV O O
and 	 O
to O O
correlate r O
the 	 O
data a O
with h O
the 	 O
expression r O
pattern t O
of O O
VEGF F S-GENE
, 
 O
Flt 	 B-GENE
- - I-GENE
1 - E-GENE
, 
 O
and 	 O
KDR 	 S-GENE
. 
 O
Mean n O
concentration c O
of O O
insulin u S-GENE
in O O
maternal e O
plasma s O
across o O
all 	 O
sampling p O
times e O
was 	 O
higher h O
in O O
ethanol a O
treated a O
animals m O
. 
 O
The 	 O
strongly o O
DNA 	 O
binding d O
p50 	 B-GENE
subunit u E-GENE
showed w O
only y O
very y O
weak k O
, 
 O
if O O
any 	 O
, 
 O
induction u O
of O O
gene e O
expression r O
. 
 O
The 	 O
results u O
obtained a O
demonstrate o O
the 	 O
applicability l O
of O O
countercurrent n O
chromatography o O
to O O
the 	 O
determination e O
of O O
ultratrace r O
elements m O
. 
 O
E1A 	 S-GENE
+ 
 O
cHa 	 B-GENE
- - I-GENE
ras 	 E-GENE
transformed n O
rat 	 O
embryo r O
fibroblast r O
cells l O
are 	 O
characterized r O
by O O
high h O
and 	 O
constitutive s O
DNA 	 O
binding d O
activities i O
of O O
AP B B-GENE
- - I-GENE
1 - I-GENE
dimers e E-GENE
with h O
significantly n O
altered e O
composition p O
. 
 O
Minor o O
changes n O
within h O
the 	 O
transmembrane n O
domains a O
( 
 O
TMs 	 O
) 
 O
sometimes e O
produced d O
major o O
effects e O
and 	 O
more e O
drastic s O
changes n O
in O O
the 	 O
TMs 	 O
ablated a O
surface f O
expression r O
entirely i O
. 
 O
Nuclear l O
localization a O
of O O
this s O
SNF2 2 B-GENE
- - I-GENE
like e I-GENE
putative a I-GENE
helicase i E-GENE
is O O
dependent e O
on O O
a 
 O
nuclear l O
localization a O
sequence u O
located a O
in O O
the 	 O
NH2 	 O
- 
 O
terminal m O
region i O
. 
 O
The 	 O
feasibility s O
of O O
creating a O
CR1 	 S-GENE
/ 
 O
Ig S S-GENE
chimeras m O
makes e O
possible s O
a 
 O
new 	 O
strategy a O
of O O
targeting g O
complement p O
inhibition i O
by O O
the 	 O
use 	 O
of O O
Ig B S-GENE
fusion i O
partners t O
having i O
particular t O
antigenic i O
specificities c O
. 
 O
Morphological p O
- 
 O
functional c O
status t O
of O O
the 	 O
edentulous n O
mandible d O
and 	 O
selection e O
of O O
the 	 O
most t O
effective e O
method h O
for 	 O
functional c O
impression r O
- 
 O
taking i O
They y O
are 	 O
both h O
insensitive e O
to O O
inhibitors i O
of O O
serine i O
and 	 O
aspartyl a B-GENE
proteinases t E-GENE
but 	 O
are 	 O
sensitive s O
to O O
sulfhydryl f O
reagents g O
and 	 O
0 
 O
. 
 O
5 
 O
mM O O
ZnCl2 l O
. 
 O
The 	 O
tau 	 O
v 
 O
at O O
rest t O
was 	 O
4 
 O
. 
 O
06 O O
+ 
 O
/ 
 O
- 
 O
2 
 O
. 
 O
16 O O
s 
 O
and 	 O
decreased r O
to O O
2 
 O
. 
 O
44 O O
+ 
 O
/ 
 O
- 
 O
1 
 O
. 
 O
07 O O
s 
 O
( 
 O
P 
 O
< 
 O
0 
 O
. 
 O
05 O O
) 
 O
at O O
1 
 O
Hz O O
and 	 O
to O O
1 
 O
. 
 O
81 O O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
4 
 O
s 
 O
at O O
5 
 O
Hz O O
. 
 O
The 	 O
authors h O
investigate e O
in O O
a 
 O
group u O
of O O
211 	 O
children l O
aged d O
2 
 O
- 
 O
6 
 O
years r O
, 
 O
incl l O
. 
 O
in O O
particular t O
a 
 O
group u O
of O O
33 O O
2 
 O
- 
 O
year r O
- 
 O
old 	 O
ones s O
, 
 O
in O O
1990 0 O
and 	 O
checked c O
in O O
1991 1 O
at O O
two 	 O
sites e O
in O O
Bratislava t O
- 
 O
- 
 O
a 
 O
town n O
with h O
a 
 O
varying y O
concentration c O
of O O
NOX 	 O
, 
 O
SO2 	 O
, 
 O
dustiness t O
and 	 O
dust t O
fallout l O
- 
 O
- 
 O
their i O
influence l O
on O O
the 	 O
incidence i O
, 
 O
type e O
and 	 O
course r O
of O O
relapsing a O
respiratory p O
disease e O
. 
 O
However e O
, 
 O
no O O
statistical t O
difference f O
in O O
the 	 O
Ca O O
/ 
 O
P 
 O
ratio i O
, 
 O
carbon b O
concentration c O
and 	 O
surface f O
energy r O
were e O
observed e O
with h O
different f O
heat t O
treatments a O
. 
 O
Using n O
in O O
vivo o O
genomic o O
dimethyl e O
sulfate f O
and 	 O
KMnO4 O O
footprinting t O
, 
 O
we O O
showed w O
that t O
the 	 O
promoter m O
region i O
is O O
differentially f O
protected t O
, 
 O
depending e O
upon n O
which c O
holoenzyme o O
is O O
bound n O
. 
 O
Here e O
we O O
show w O
that t O
inhibition i O
occurs u O
with h O
a 
 O
NS1 	 S-GENE
- 
 O
Rev 	 S-GENE
chimera m O
in O O
which c O
the 	 O
78 O O
amino n O
- 
 O
terminal m O
amino n O
acids d O
of O O
the 	 O
NS1A A B-GENE
protein t E-GENE
comprising p O
its 	 O
entire i O
RNA 	 O
- 
 O
binding d O
domain a O
is O O
deleted e O
, 
 O
thereby r O
establishing a O
that t O
this s O
carboxyl b O
portion t O
of O O
the 	 O
NS1A A B-GENE
protein t E-GENE
can 	 O
function c O
as O O
an O O
independent e O
effector e O
domain a O
. 
 O
Overall r O
, 
 O
it O O
appears e O
that t O
prenatal n O
exposure o O
to O O
androgen r O
- 
 O
based e O
synthetic t O
progestin g O
exerted r O
a 
 O
masculinizing c O
and 	 O
/ 
 O
or O O
defeminizing e O
influence l O
on O O
human a O
behavioral a O
development e O
, 
 O
whereas r O
prenatal n O
exposure o O
to O O
natural u O
progesterone g O
and 	 O
progesterone g O
- 
 O
based e O
synthetic t O
progestin g O
had 	 O
a 
 O
feminizing i O
and 	 O
/ 
 O
or O O
demasculinizing a O
influence l O
, 
 O
particularly t O
among n O
female a O
subjects j O
. 
 O
The 	 O
testes t O
of O O
8 
 O
specimens c O
of O O
Triturus t O
marmoratus m O
were e O
collected l O
during i O
each h O
month t O
of O O
1987 7 O
and 	 O
processed c O
for 	 O
electron c O
microscopy r O
and 	 O
light h O
microscopy r O
demonstration o O
of O O
testosterone t O
( 
 O
T 
 O
) 
 O
following l O
the 	 O
ABC 	 S-GENE
( 
 O
avidin d B-GENE
- - I-GENE
biotin t I-GENE
peroxidase o I-GENE
complex p E-GENE
) 
 O
method h O
. 
 O
MTX 	 O
therapy r O
decreased r O
Ga O O
- 
 O
67 O O
uptake a O
in O O
liver e O
, 
 O
tumor o O
, 
 O
and 	 O
muscle c O
. 
 O
In O O
stage g O
I 
 O
, 
 O
histochemistry t O
for 	 O
copper p O
was 	 O
positive i O
in O O
11 O O
out 	 O
of O O
21 O O
cases e O
: 
 O
6 
 O
cases e O
were e O
T 
 O
+ 
 O
; 
 O
1 
 O
case e O
R 
 O
+ 
 O
and 	 O
2 
 O
cases e O
O 
 O
+ 
 O
; 
 O
2 
 O
cases e O
were e O
T 
 O
+ 
 O
, 
 O
R 
 O
+ 
 O
, 
 O
O 
 O
+ 
 O
. 
 O
Encapsulation a O
of O O
sodium i O
fluorescein o O
for 	 O
dye 	 O
release e O
studies d O
. 
 O
Primer m O
extension e O
analysis l O
and 	 O
subcloning c O
of O O
the 	 O
virJ J S-GENE
- 
 O
phoA A S-GENE
fusion i O
indicate i O
that t O
the 	 O
acetosyringone t O
- 
 O
inducible u O
promoter m O
lies s O
directly e O
upstream t O
of O O
the 	 O
virJ J B-GENE
structural u I-GENE
gene e E-GENE
. 
 O
To O O
isolate l O
genes e O
that t O
contain t O
zinc c O
finger g O
motifs i O
, 
 O
a 
 O
human a O
brain i O
cDNA A O
library r O
was 	 O
screened e O
with h O
an O O
oligonucleotide g O
complementary p O
to O O
the 	 O
conserved s O
" 
 O
linker k O
" 
 O
sequence u O
between w O
adjacent a O
zinc c O
fingers g O
. 
 O
Percentage c O
incremental r O
18 O O
- 
 O
OHB 	 O
responses p O
to O O
metoclopramide o O
were e O
greater a O
( 
 O
P 
 O
less s O
than n O
0 
 O
. 
 O
01 O O
) 
 O
in O O
the 	 O
subjects j O
after e O
5 
 O
days s O
on O O
a 
 O
200 	 O
- 
 O
meq 	 O
sodium i O
intake a O
than n O
after e O
5 
 O
days s O
on O O
a 
 O
10 O O
- 
 O
meq 	 O
sodium i O
intake a O
. 
 O
Using n O
in O O
vivo o O
screening e O
, 
 O
we O O
first s O
identified n O
a 
 O
gene e O
that t O
appeared e O
to O O
interfere e O
with h O
the 	 O
His 	 B-GENE
- 
 I-GENE
Asp 	 E-GENE
phosphorelay s O
between w O
the 	 O
HPt 	 B-GENE
domain a E-GENE
and 	 O
the 	 O
receiver e O
domain a O
of O O
OmpR R S-GENE
, 
 O
provided v O
that t O
the 	 O
gene e O
product d O
was 	 O
expressed r O
through o O
a 
 O
multicopy t O
plasmid s O
. 
 O
The 	 O
non 	 B-GENE
- - I-GENE
major o I-GENE
histocompatibility t I-GENE
complex p E-GENE
( 
 O
MHC 	 S-GENE
) 
 O
- 
 O
encoded o O
CD1 	 B-GENE
family i E-GENE
has 	 O
recently e O
emerged r O
as O O
a 
 O
new 	 O
antigen i O
- 
 O
presenting s O
system t O
that t O
is O O
distinct t O
from m O
either h O
MHC 	 B-GENE
class s I-GENE
I - E-GENE
or I O
class s B-GENE
II I I-GENE
molecules e E-GENE
. 
 O
The 	 O
predicted d O
amino n O
acid d O
sequence u O
of O O
Pst1p 1 S-GENE
possessed s O
high h O
sequence u O
homology o O
with h O
the 	 O
Sin3 3 B-GENE
family i E-GENE
of O O
proteins t O
, 
 O
known w O
for 	 O
their i O
interaction e O
with h O
histone t B-GENE
deacetylases c E-GENE
. 
 O
Quinethazone n O
Studies d O
on O O
nitrogen r O
- 
 O
containing t O
heterocyclic e O
compounds p O
. 
 O
Removal o O
of O O
ink4a 4 O
dramatically m O
reduces u O
the 	 O
lymphoid p O
and 	 O
neurological r O
defects e O
seen n O
in O O
bmi 	 O
- - O
1 - O
- 
 O
deficient i O
mice e O
, 
 O
indicating i O
that t O
ink4a 4 O
is O O
a 
 O
critical t O
in O O
vivo o O
target g O
for 	 O
Bmi 	 B-GENE
- - I-GENE
1 - E-GENE
. 
 O
We O O
found n O
that t O
RXR 	 S-GENE
and 	 O
VDR 	 S-GENE
transactivated n O
selectively e O
from m O
VDRE E S-GENE
- 
 O
linked k O
templates p O
exclusively l O
as O O
a 
 O
heterodimeric e O
complex p O
, 
 O
since c O
neither t O
receptor e O
alone n O
enhanced a O
transcription n O
in O O
vitro r O
. 
 O
METHODS H O
: 
 O
We O O
performed f O
nasal a O
mupirocin i O
treatment a O
on O O
10 O O
infants a O
who 	 O
were e O
MRSA A O
- 
 O
positive i O
either h O
in O O
the 	 O
nose e O
or O O
the 	 O
pharynx r O
and 	 O
evaluated l O
the 	 O
effect e O
of O O
mupirocin i O
on O O
the 	 O
eradication d O
of O O
MRSA A O
. 
 O
RESULTS U O
: 
 O
Of O O
10 O O
, 
 O
709 	 O
, 
 O
701 	 O
chemistry m O
specimens c O
submitted m O
to O O
the 	 O
participating t O
laboratories o O
during i O
the 	 O
data a O
collection l O
period i O
, 
 O
37 O O
, 
 O
208 	 O
( 
 O
0 
 O
. 
 O
35 O O
% 
 O
) 
 O
were e O
rejected e O
prior o O
to O O
testing t O
. 
 O
Early l O
complement p O
components p O
, 
 O
C1q 	 S-GENE
and 	 O
C4 S S-GENE
, 
 O
and 	 O
IgA 	 S-GENE
secretory r O
piece c O
were e O
absent e O
. 
 O
Administration i O
of O O
SnCl2 l O
and 	 O
ZnSO4 O O
( 
 O
group u O
V 
 O
) 
 O
resulted u O
in O O
a 
 O
decrease r O
of O O
ALA 	 B-GENE
- - I-GENE
D - E-GENE
activity i O
and 	 O
in O O
an O O
increase r O
in O O
CP O O
- 
 O
U 
 O
. 
 O
Using n O
a 
 O
dominant i O
negative a O
form m O
of O O
Sp3 	 S-GENE
and 	 O
transcriptional n O
activation i O
assays a O
in O O
Schneider n O
SL O O
- 
 O
2 
 O
insect e O
cells l O
, 
 O
it O O
was 	 O
confirmed f O
that t O
ERalpha l S-GENE
- 
 O
Sp3 	 S-GENE
interactions e O
define i O
a 
 O
pathway h O
for 	 O
E2 S S-GENE
- 
 O
mediated i O
inhibition i O
of O O
gene e O
expression r O
, 
 O
and 	 O
this s O
represents r O
a 
 O
new 	 O
mechanism h O
for 	 O
decreased r O
gene e O
expression r O
by O O
E2 S S-GENE
. 
 O
From m O
the 	 O
supposition p O
that t O
there r O
exists s O
a 
 O
possible s O
connection n O
between w O
certain t O
psychopathological c O
symptoms p O
, 
 O
and 	 O
/ 
 O
or O O
syndromes d O
( 
 O
e 
 O
. 
 O
g 
 O
. 
 O
, 
 O
hallucinations l O
) 
 O
and 	 O
regional i O
cerebral e O
dysfunction f O
, 
 O
patients i O
suffering f O
from m O
auditory i O
and 	 O
tactile t O
hallucinations l O
were e O
investigated e O
, 
 O
in O O
a 
 O
symptom p O
- 
 O
oriented e O
study d O
, 
 O
using n O
the 	 O
method h O
of O O
technetium h O
- 
 O
99m 	 O
- 
 O
Hexamethyl a O
- 
 O
propylenamine p O
Oxime m O
( 
 O
99m 	 O
- 
 O
Tc O O
- 
 O
HMPAO A O
) 
 O
- 
 O
Single g O
Photon t O
Emission s O
Computed p O
Tomography o O
( 
 O
SPECT C O
) 
 O
and 	 O
compared p O
with h O
normal m O
controls t O
. 
 O
The 	 O
lack k O
of O O
chronically o O
depressed r O
LCBF F O
( 
 O
after e O
1 
 O
day 	 O
) 
 O
may 	 O
be O O
related a O
to O O
the 	 O
quick c O
structural u O
repair a O
of O O
endothelium o O
. 
 O
In O O
this s O
study d O
, 
 O
to O O
elucidate c O
the 	 O
possible s O
mechanism h O
of O O
action i O
of O O
EM O S-GENE
, 
 O
we O O
examined m O
the 	 O
effect e O
of O O
the 	 O
drug g O
on O O
the 	 O
expression r O
of O O
neutrophil t O
adhesion e O
molecules e O
such h O
as O O
L - B-GENE
- - I-GENE
selectin e E-GENE
and 	 O
Mac 	 B-GENE
- - I-GENE
1 - E-GENE
. 
 O
Tissue s O
expansion a O
was 	 O
used d O
successfully c O
to O O
prepare p O
adequate q O
soft t O
tissue s O
for 	 O
closure s O
following l O
a 
 O
difficult f O
clubfoot b O
correction r O
. 
 O
The 	 O
transcription n O
start r O
site e O
was 	 O
identified n O
by O O
primer m O
extension e O
analysis l O
and 	 O
over r O
800 	 O
bp O O
of O O
5 
 O
' 
 O
flanking n O
DNA 	 O
was 	 O
sequenced u O
. 
 O
The 	 O
reporter o O
gene e O
with h O
two 	 O
copies i O
of O O
the 	 O
wild d B-GENE
- 
 I-GENE
type e I-GENE
Repeat e I-GENE
2 
 I-GENE
+ 
 I-GENE
3 
 I-GENE
sequence u E-GENE
was 	 O
transcribed n O
actively i O
in O O
sterol r O
- 
 O
deprived r O
cells l O
and 	 O
was 	 O
repressed r O
by O O
more e O
than n O
80 O O
% 
 O
when n O
sterols r O
were e O
present s O
. 
 O
Changes n O
in O O
tension s O
were e O
monitored i O
isometrically m O
on O O
spiral r O
strips i O
of O O
freshly s O
obtained a O
bovine i O
basilar i O
arteries e O
. 
 O
A 
 O
1 
 O
. 
 O
5 
 O
- 
 O
month t O
- 
 O
old 	 O
boy 	 O
with h O
Sandifer d O
' 
 O
s 
 O
syndrome d O
is O O
described c O
. 
 O
However e O
, 
 O
PC12 2 O
cell l O
clones n O
which c O
expressed r O
p33rsu r B-GENE
- - I-GENE
1 - E-GENE
at O O
an O O
increased r O
level e O
in O O
a 
 O
regulatable u O
fashion h O
in O O
response p O
to O O
dexamethasone a O
were e O
isolated l O
. 
 O
In O O
this s O
study d O
, 
 O
we O O
verified i O
that t O
PI B B-GENE
3 - I-GENE
- - I-GENE
kinase a E-GENE
associates o O
with h O
the 	 O
CD4 	 S-GENE
: 
 O
p56lck l B-GENE
complex p E-GENE
as O O
judged g O
by O O
the 	 O
presence s O
of O O
PI O B-GENE
3 
 E-GENE
- 
 O
phosphate s O
generated e O
from m O
anti i B-GENE
- - I-GENE
CD4 	 E-GENE
immunoprecipitates u O
and 	 O
detected e O
by O O
high h O
- 
 O
pressure s O
liquid u O
chromatographic o O
analysis l O
. 
 O
The 	 O
clinical n O
picture t O
, 
 O
the 	 O
light h O
and 	 O
electron c O
microscopic r O
appearance e O
, 
 O
and 	 O
the 	 O
histochemical t O
findings d O
are 	 O
described c O
in O O
six 	 O
cases e O
of O O
fibroma r O
of O O
tendon d O
sheath a O
. 
 O
However e O
, 
 O
their i O
stability b O
was 	 O
low 	 O
as O O
already e O
reported o O
for 	 O
the 	 O
ARS 	 O
in O O
S 
 O
. 
 O
occidentalis i O
. 
 O
In O O
this s O
study d O
, 
 O
a 
 O
site e O
of O O
PDGF F S-GENE
- 
 O
induced u O
tyrosine o O
phosphorylation s O
was 	 O
mapped p O
to O O
Tyr 	 O
138 	 O
in O O
the 	 O
SH3 	 B-GENE
domain a E-GENE
; 
 O
Tyr 	 O
138 	 O
is O O
exposed o O
on O O
the 	 O
SH3 	 B-GENE
peptide t E-GENE
binding d O
surface f O
. 
 O
The 	 O
results u O
of O O
this s O
study d O
suggest g O
that t O
in O O
patients i O
with h O
syndrome d O
X 
 O
, 
 O
myocardial c O
ischemia h O
frequently q O
develops e O
during i O
daily l O
life e O
; 
 O
silent e O
ischemia h O
is O O
an O O
important o O
component p O
of O O
this s O
syndrome d O
; 
 O
and 	 O
increased r O
oxygen g O
demand a O
in O O
the 	 O
presence s O
of O O
impaired a O
coronary o O
vasodilatory o O
capacity a O
is O O
not 	 O
the 	 O
only y O
cause s O
of O O
myocardial c O
ischemia h O
. 
 O
We O O
also o O
identified n O
a 
 O
DNA 	 O
fragment g O
, 
 O
10 O O
. 
 O
7 
 O
kbp 	 O
upstream t O
from m O
the 	 O
first s O
coding i O
exon n O
of O O
human a B-GENE
aFGF F E-GENE
, 
 O
whose s O
sequence u O
is O O
conserved s O
in O O
both h O
the 	 O
primate m O
and 	 O
rodent e O
genomes o O
. 
 O
The 	 O
false s O
positive i O
fraction c O
( 
 O
FPF 	 O
) 
 O
decreased r O
significantly n O
if O O
the 	 O
count n O
density s O
increased r O
; 
 O
no O O
difference f O
in O O
FPF 	 O
was 	 O
found n O
for 	 O
a 
 O
change n O
in O O
lesion i O
tracer c O
concentration c O
. 
 O
These s O
events n O
were e O
only y O
weakly k O
stimulated m O
by O O
the 	 O
activated i O
PDGF F B-GENE
alpha h I-GENE
- - I-GENE
receptor e E-GENE
. 
 O
Human a B-GENE
plastin s I-GENE
genes e E-GENE
. 
 O
Buserelin e O
offers e O
an O O
effective e O
alternative e O
medical i O
treatment a O
of O O
carcinoma c O
of O O
the 	 O
prostate s O
and 	 O
, 
 O
apart r O
from m O
impotence o O
, 
 O
does s O
not 	 O
have e O
the 	 O
side e O
effects e O
of O O
oestrogens t O
. 
 O
C - B-GENE
/ - I-GENE
EBP 	 I-GENE
delta t E-GENE
( 
 O
NFIL L B-GENE
- - I-GENE
6 - I-GENE
beta a E-GENE
) 
 O
was 	 O
not 	 O
detected e O
in O O
complexes p O
utilizing l O
extracts r O
from m O
the 	 O
IL B B-GENE
- - I-GENE
1 - E-GENE
nonproducing p O
T 
 O
cell l O
line e O
. 
 O
Reduced u O
risk k O
of O O
upper e O
gastrointestinal t O
ulcer e O
complications p O
with h O
celecoxib e O
, 
 O
a 
 O
novel e O
COX 	 B-GENE
- - I-GENE
2 - E-GENE
inhibitor i O
. 
 O
Moreover e O
, 
 O
our 	 O
recent e O
findings d O
on O O
the 	 O
Tc52 2 B-GENE
encoding o I-GENE
gene e E-GENE
underline e O
the 	 O
interest e O
of O O
genetic e O
manipulation i O
of O O
T 
 O
. 
 O
cruzi z O
, 
 O
not 	 O
only y O
making i O
it O O
possible s O
to O O
use 	 O
more e O
closely s O
an O O
in O O
vitro r O
approach r O
to O O
find d O
out 	 O
how 	 O
genes e O
function c O
, 
 O
but 	 O
also o O
to O O
obtain a O
' 
 O
attenuated e O
' 
 O
strains a O
that t O
could l O
be O O
used d O
in O O
the 	 O
development e O
of O O
vaccinal c O
strategies a O
. 
 O
Infra r O
- 
 O
red 	 O
spectroscopy c O
of O O
tissues s O
in O O
the 	 O
700 	 O
- 
 O
400 	 O
cm O O
- 
 O
1 
 O
region i O
. 
 O
YDL003w 0 S-GENE
( 
 O
also o O
termed m O
MCD1 1 S-GENE
) 
 O
is O O
a 
 O
homologue o B-GENE
of O I-GENE
Schizosaccharomyces i I-GENE
pombe b I-GENE
rad21 2 E-GENE
, 
 O
an O O
essential e O
gene e O
implicated l O
in O O
DNA 	 O
double b O
- 
 O
strand a O
break a O
repair a O
and 	 O
nuclear l O
organization a O
in O O
fission s O
yeast s O
. 
 O
The 	 O
recent e O
concept c O
of O O
a 
 O
bioartificial a O
organ a O
is O O
an O O
attempt e O
to O O
avoid i O
such h O
disadvantages a O
. 
 O
The 	 O
objectives e O
of O O
this s O
study d O
were e O
1 
 O
) 
 O
to O O
quantify n O
the 	 O
comparative p O
structural u O
static t O
and 	 O
fatigue i O
properties p O
of O O
the 	 O
pointe n O
shoe e O
toe 	 O
box 	 O
, 
 O
and 	 O
2 
 O
) 
 O
to O O
evaluate l O
the 	 O
preferred f O
shoe e O
characteristics r O
as O O
determined e O
by O O
a 
 O
survey v O
of O O
local a O
dancers c O
. 
 O
In O O
the 	 O
postoperative t O
patient i O
with h O
tetralogy r O
of O O
Fallot l O
with h O
symptomatic p O
ventricular t O
arrhythmias h O
, 
 O
it O O
is O O
concluded c O
that t O
electrophysiologic c O
study d O
is O O
useful f O
in O O
reproducing r O
clinical n O
episodes s O
of O O
VT O O
and 	 O
in O O
selecting e O
effective e O
antiarrhythmic i O
medication i O
; 
 O
a 
 O
small l O
number b O
of O O
patients i O
with h O
ventricular t O
premature m O
complexes p O
alone n O
will l O
have e O
inducible u O
sustained t O
VT O O
during i O
electrophysiologic c O
study d O
; 
 O
prognosis g O
of O O
these s O
patients i O
may 	 O
be O O
improved r O
by O O
treatment a O
that t O
results u O
in O O
prevention v O
of O O
VT O O
induction u O
; 
 O
and 	 O
in O O
patients i O
with h O
right h O
ventricular t O
hypertension e O
, 
 O
VT O O
is O O
likely e O
to O O
be O O
refractory r O
to O O
drug g O
treatment a O
. 
 O
Indications i O
for 	 O
therapy r O
using n O
MAO 	 S-GENE
inhibitors i O
The 	 O
absorbance o O
of O O
the 	 O
eluent e O
was 	 O
monitored i O
at O O
254 	 O
nm O O
. 
 O
Here e O
, 
 O
we O O
describe c O
the 	 O
results u O
of O O
a 
 O
detailed a O
study d O
aimed e O
at O O
identifying n O
the 	 O
gene e O
or O O
genes e O
responsible p O
for 	 O
the 	 O
rapid i O
growth w O
- 
 O
arrest e O
response p O
obtained a O
with h O
human a O
chromosome o O
- 
 O
9 
 O
. 
 O
Footprints t O
on O O
the 	 O
HPV 	 O
18 I O
enhancer a O
show w O
five e O
protected t O
regions i O
with h O
homologies o O
to O O
NF1 	 S-GENE
, 
 O
AP1 	 S-GENE
and 	 O
EFII I B-GENE
transcription n I-GENE
factor t I-GENE
binding d I-GENE
motifs i E-GENE
. 
 O
Insulin u S-GENE
binding d O
to O O
the 	 O
alpha h O
- 
 O
subunit u O
of O O
its 	 O
receptor e O
stimulates m O
the 	 O
receptor e B-GENE
tyrosine o I-GENE
kinase a E-GENE
to O O
phosphorylate s O
the 	 O
beta a O
- 
 O
subunit u O
and 	 O
several e O
endogenous o O
protein t O
substrates s O
, 
 O
including l O
pp120 2 S-GENE
/ 
 O
HA4 	 S-GENE
, 
 O
a 
 O
liver e O
- 
 O
specific c O
plasma s O
membrane b O
glycoprotein c O
of O O
M 
 O
( 
 O
r 
 O
) 
 O
20 O O
, 
 O
000 	 O
. 
 O
Motilin i O
serum u O
levels e O
were e O
measured s O
for 	 O
one 	 O
hour r O
. 
 O
The 	 O
role e O
of O O
phosphorylation s O
on O O
receptor e O
desensitization e O
was 	 O
assessed e O
using n O
receptor e O
mutants a O
expressed r O
in O O
COS 	 O
cells l O
or O O
Chinese n O
hamster s O
lung g O
fibroblasts r O
. 
 O
First s O
aid 	 O
. 
 O
Improvement r O
of O O
some e O
pharmaceutical r O
properties p O
of O O
clofibrate f O
by O O
cyclodextrin l O
complexation p O
. 
 O
The 	 O
detection e O
limits i O
obtained a O
by O O
using n O
the 	 O
mixed e O
eluent e O
were e O
0 
 O
. 
 O
05 O O
- 
 O
0 
 O
. 
 O
13 O O
mg O O
/ 
 O
L 
 O
, 
 O
several e O
times e O
lower e O
than n O
those s O
obtained a O
by O O
using n O
single g O
KHPh h O
eluent e O
. 
 O
Early l O
diagnosis g O
and 	 O
early l O
surgical g O
division i O
of O O
the 	 O
biliary i O
tract c O
and 	 O
pancreatic c O
duct t O
is O O
recommended o O
for 	 O
children l O
with h O
AAPBD B O
. 
 O
We O O
have e O
analyzed l O
herein e O
the 	 O
roles e O
that t O
four r O
different f O
PIAS S B-GENE
proteins t E-GENE
( 
 O
ARIP3 P S-GENE
/ 
 O
PIASx S B-GENE
alpha h E-GENE
, 
 O
Miz1 1 S-GENE
/ 
 O
PIASx S B-GENE
beta a E-GENE
, 
 O
GBP 	 S-GENE
/ 
 O
PIAS1 S S-GENE
, 
 O
and 	 O
PIAS3 S S-GENE
) 
 O
play y O
in O O
the 	 O
regulation u O
of O O
steroid r B-GENE
receptor e E-GENE
- 
 O
or O O
STAT T S-GENE
- 
 O
mediated i O
transcriptional n O
activation i O
. 
 O
Comparison p O
of O O
the 	 O
predicted d O
amino n O
acid d O
sequence u O
with h O
that t O
of O O
the 	 O
Drosophila s O
virilis i O
gene e O
shows w O
that t O
several e O
blocks c O
of O O
amino n O
acid d O
sequence u O
have e O
been n O
very y O
highly h O
conserved s O
. 
 O
Analyses l O
focused u O
on O O
two 	 O
platyrrhine t O
( 
 O
New 	 O
World l O
monkey k O
) 
 O
species c O
: 
 O
the 	 O
common m O
marmoset m O
( 
 O
Callithrix l O
jacchus c O
) 
 O
and 	 O
the 	 O
brown w O
capuchin u O
monkey k O
( 
 O
Cebus u O
apella l O
) 
 O
, 
 O
each h O
of O O
which c O
has 	 O
paired r O
, 
 O
non 	 O
- 
 O
allelic e O
gamma m O
loci i O
( 
 O
5 
 O
' 
 O
- 
 O
gamma m O
1 
 O
- 
 O
gamma m O
2 
 O
- 
 O
3 
 O
' 
 O
) 
 O
. 
 O
A 
 O
phase s O
II O O
clinical n O
trial a O
on O O
MDS 	 O
was 	 O
conducted d O
in O O
a 
 O
cooperative p O
study d O
with h O
orally l O
administrable i O
ara 	 O
- 
 O
C 
 O
analogue l O
, 
 O
PLAC C O
, 
 O
which c O
is O O
resistant i O
to O O
cytidine i B-GENE
deaminase m E-GENE
and 	 O
had 	 O
shown w O
an O O
anti i O
- 
 O
tumor o O
activity i O
on O O
various i O
experimental e O
tumors o O
by O O
oral l O
route t O
. 
 O
A 
 O
decrease r O
was 	 O
also o O
found n O
of O O
the 	 O
levels e O
of O O
total a O
cholesterol l O
and 	 O
LDL 	 B-GENE
- - I-GENE
cholesterol l E-GENE
. 
 O
Previously v O
, 
 O
we O O
had 	 O
shown w O
that t O
interleukin e B-GENE
8 - E-GENE
( 
 O
IL B B-GENE
- - I-GENE
8 - E-GENE
) 
 O
is O O
constitutively s O
expressed r O
in O O
HTLV V O
- 
 O
I 
 O
- 
 O
infected e O
cells l O
and 	 O
in O O
cells l O
transiently n O
expressing r O
Tax 	 S-GENE
. 
 O
Unlike i O
JNK 	 S-GENE
activation i O
, 
 O
ERK 	 S-GENE
activation i O
could l O
not 	 O
be O O
mapped p O
to O O
specific c O
reovirus v O
gene e O
segments m O
, 
 O
suggesting g O
that t O
ERK 	 S-GENE
activation i O
and 	 O
JNK 	 S-GENE
activation i O
are 	 O
triggered g O
by O O
different f O
events n O
during i O
virus u O
- 
 O
host t O
cell l O
interaction e O
. 
 O
Despite p O
the 	 O
same e O
decreases r O
or O O
increases r O
in O O
MAP 	 O
, 
 O
RSNA A O
was 	 O
attenuated e O
after e O
15 O O
and 	 O
30 O O
min 	 O
of O O
propofol p O
infusion u O
in O O
both h O
groups u O
compared p O
with h O
control t O
( 
 O
P 
 O
< 
 O
0 
 O
. 
 O
05 O O
) 
 O
. 
 O
To O O
address r O
this s O
question s O
with h O
respect p O
to O O
skeletal l O
muscle c O
, 
 O
we O O
have e O
examined m O
the 	 O
effects e O
of O O
the 	 O
Providence v O
mutation a O
in O O
cultured t O
muscle c O
cells l O
, 
 O
after e O
adoptive p O
gene e O
transfer n O
to O O
adult l O
mice e O
, 
 O
and 	 O
in O O
two 	 O
infants a O
homozygous o O
for 	 O
spectrin c S-GENE
Providence v O
. 
 O
It O O
appears e O
to O O
be O O
useful f O
in O O
untreated r O
patients i O
with h O
stage g O
I 
 O
or O O
II O O
NHL 	 O
but 	 O
no O O
definite i O
radiographic i O
abnormalities o O
, 
 O
or O O
with h O
abnormal o O
radiographs i O
but 	 O
no O O
extrathoracic r O
spread e O
, 
 O
and 	 O
in O O
treated a O
patients i O
with h O
questionable s O
radiographs i O
. 
 O
B - O
and 	 O
C1 B O
fusions i O
with h O
yeast s B-GENE
GAL4 4 E-GENE
DNA 	 O
- - O
binding d O
and 	 O
transcriptional n O
activation i O
domains a O
were e O
also o O
found n O
to O O
interact e O
when n O
synthesized t O
and 	 O
assayed a O
in O O
yeast s O
. 
 O
Because a O
of O O
the 	 O
data a O
, 
 O
we O O
suggest g O
that t O
LAC9 9 S-GENE
contacts t O
positions i O
6 
 O
, 
 O
7 
 O
, 
 O
and 	 O
8 
 O
, 
 O
both h O
plus s O
and 	 O
minus u O
, 
 O
of O O
the 	 O
UAS 	 O
, 
 O
which c O
are 	 O
separated a O
by O O
more e O
than n O
one 	 O
turn n O
of O O
the 	 O
DNA 	 O
helix i O
, 
 O
and 	 O
twists s O
part t O
way 	 O
around u O
the 	 O
DNA 	 O
, 
 O
thus s O
protecting t O
the 	 O
broad a O
region i O
of O O
the 	 O
minor o O
groove o O
between w O
the 	 O
major o O
- 
 O
groove o O
contacts t O
. 
 O
On O O
the 	 O
optic i O
tentacle t O
- 
 O
gonadal a O
axis s O
in O O
the 	 O
control t O
of O O
the 	 O
male e O
- 
 O
phase s O
ovotestis t O
in O O
the 	 O
slug g O
( 
 O
Ariolimax o O
californicus i O
) 
 O
. 
 O
Substitution s O
of O O
cholinergic l O
drugs g O
in O O
the 	 O
treatment a O
of O O
Alzheimer h O
type e O
dementia e O
( 
 O
AD O O
/ 
 O
SDAT T O
) 
 O
has 	 O
hitherto h O
not 	 O
been n O
very y O
successful c O
. 
 O
Here e O
we O O
show w O
that t O
the 	 O
nucleotide l O
in O O
the 	 O
middle d O
of O O
the 	 O
anticodon i O
( 
 O
i 
 O
. 
 O
e 
 O
. 
 O
, 
 O
psi 	 B-GENE
35 O E-GENE
) 
 O
also o O
contributes t O
to O O
the 	 O
suppressor p O
efficiency i O
displayed p O
by O O
cytoplasmic o O
tRNA A O
( - O
Tyr 	 S-GENE
) - O
. 
 O
The 	 O
root t O
- 
 O
mean n O
- 
 O
square a O
deviation i O
of O O
bond d O
lengths g O
from m O
the 	 O
ideal a O
values u O
is O O
0 
 O
. 
 O
02 O O
A 
 O
. 
 O
Jet 	 O
lag 	 O
and 	 O
melatonin a O
. 
 O
In O O
addition i O
, 
 O
these s O
results u O
suggest g O
that t O
the 	 O
interactions e O
, 
 O
and 	 O
consequently s O
the 	 O
mechanisms h O
, 
 O
governing e O
transcriptional n O
activation i O
by O O
CTF 	 S-GENE
are 	 O
distinct t O
from m O
those s O
mediating i O
DNA 	 O
replication l O
. 
 O
A 
 O
TAAATA A O
sequence u O
is O O
present s O
26 O O
nt O O
upstream t O
from m O
the 	 O
major o O
CAP 	 B-GENE
site e E-GENE
, 
 O
and 	 O
within h O
the 	 O
5 
 O
' 
 O
- 
 O
flanking n O
region i O
there r O
are 	 O
several e O
putative a O
transcription n O
factor t O
binding d O
sites e O
. 
 O
It O O
was 	 O
found n O
that t O
both h O
versions s O
of O O
the 	 O
brief e O
SL O O
& 
 O
amp 	 O
; 
 O
shy 	 O
; 
 O
ASIA A O
had 	 O
similar i O
correlations r O
to O O
the 	 O
target g O
variables i O
as O O
the 	 O
full l O
scale l O
SL O O
& 
 O
amp 	 O
; 
 O
shy 	 O
; 
 O
ASIA A O
. 
 O
The 	 O
reconstituted o O
enzyme y O
binds d O
DNA 	 O
with h O
an O O
affinity i O
that t O
is O O
approximately r O
20 O O
- 
 O
fold d O
lower e O
than n O
that t O
of O O
the 	 O
intact a O
topo70 o O
. 
 O
Treatment a O
with h O
KP O O
- 
 O
45 O O
preparation p O
usually a O
resulted u O
in O O
partial t O
regression r O
of O O
tumor o O
growth w O
, 
 O
accompanied o O
by O O
improvement r O
of O O
the 	 O
clinical n O
state t O
of O O
these s O
patients i O
, 
 O
as O O
well l O
as O O
reappearance p O
of O O
normal m O
values u O
of O O
blood o O
picture t O
and 	 O
biochemical c O
parameters a O
. 
 O
Istanbul a O
, 
 O
Turkey k O
. 
 O
We O O
propose p O
that t O
optimal i O
transcription n O
of O O
the 	 O
gD B B-GENE
gene e E-GENE
depends e O
on O O
the 	 O
interaction e O
of O O
ICP4 4 S-GENE
with h O
multiple t O
binding d O
sites e O
across o O
the 	 O
gene e O
and 	 O
cellular l O
factors t O
that t O
recognize o O
specific c O
sequence u O
elements m O
in O O
the 	 O
promoter m O
. 
 O
Recently e O
, 
 O
we O O
and 	 O
other e O
laboratories o O
have e O
identified n O
a 
 O
family i O
of O O
caveolin e B-GENE
- - I-GENE
related a I-GENE
proteins t E-GENE
; 
 O
caveolin e S-GENE
has 	 O
been n O
re O O
- 
 O
termed m O
caveolin e B-GENE
- - I-GENE
1 - E-GENE
. 
 O
Role e O
of O O
zinc c O
- - O
finger g O
proteins t O
Sp1 	 S-GENE
and 	 O
zif268 2 S-GENE
/ 
 O
egr 	 B-GENE
- - I-GENE
1 - E-GENE
in O O
transcriptional n O
regulation u O
of O O
the 	 O
human a B-GENE
synaptobrevin a I-GENE
II I I-GENE
gene e E-GENE
. 
 O
The 	 O
human a B-GENE
Fc I I-GENE
gamma m I-GENE
receptor e I-GENE
gene e E-GENE
Fc B B-GENE
gamma m I-GENE
RIIA A E-GENE
is O O
expressed r O
in O O
platelets t O
, 
 O
neutrophils t O
, 
 O
monocytes o O
and 	 O
macrophages r O
. 
 O
This s O
dip 	 O
also o O
occurred u O
during i O
prednisone d O
and 	 O
vitamin a O
D 
 O
treatment a O
, 
 O
but 	 O
did 	 O
not 	 O
occur u O
when n O
calcium c O
was 	 O
added e O
to O O
prednisone d O
, 
 O
although h O
the 	 O
baseline e O
value u O
was 	 O
lower e O
at O O
the 	 O
start r O
of O O
combined b O
treatment a O
with h O
prednisone d O
and 	 O
calcium c O
. 
 O
E 
 O
. 
 O
granulosus n O
infection e O
has 	 O
been n O
confirmed f O
in O O
25 O O
patients i O
( 
 O
20 O O
. 
 O
6 
 O
% 
 O
) 
 O
, 
 O
in O O
16 O O
cases e O
by O O
finding d O
parasite a O
protoscoleces t O
or O O
hooks k O
and 	 O
in O O
nine e O
cases e O
by O O
detection e O
of O O
an O O
antigen i O
specific c O
for 	 O
E - O
. - O
granulosus n O
, - O
antigen i B-GENE
5 - E-GENE
( 
 O
Ag5 	 S-GENE
) 
 O
. 
 O
The 	 O
effect e O
of O O
stimulation m O
of O O
the 	 O
entopeduncular o O
nucleus l O
( 
 O
EP O O
) 
 O
on O O
the 	 O
jaw 	 O
- 
 O
opening n O
reflex l O
( 
 O
JOR 	 O
) 
 O
was 	 O
studied d O
in O O
the 	 O
cat 	 O
anesthetized s O
with h O
sodium i O
pentobarbital t O
. 
 O
A 
 O
Premenstrual m O
Syndrome d O
, 
 O
the 	 O
late e O
luteal e O
phase s O
disorder o O
of O O
DSM 	 O
- 
 O
IIIR R O
criteria t O
, 
 O
was 	 O
identified n O
in O O
6 
 O
% 
 O
of O O
the 	 O
women e O
. 
 O
First s O
, 
 O
mutations a O
in O O
the 	 O
IFNgamma g B-GENE
- - I-GENE
activated i I-GENE
sequence u E-GENE
( 
 O
GAS 	 O
) 
 O
, 
 O
either h O
multimerized t O
or O O
in O O
the 	 O
context t O
of O O
the 	 O
1 - B-GENE
. - I-GENE
7 - I-GENE
- - I-GENE
kb I I-GENE
IRF 	 I-GENE
- - I-GENE
1 - I-GENE
promoter m E-GENE
, 
 O
failed l O
to O O
mediate i O
a 
 O
PRL 	 S-GENE
response p O
, 
 O
showing w O
that t O
the 	 O
IRF 	 B-GENE
- - I-GENE
1 - I-GENE
GAS 	 E-GENE
is O O
a 
 O
target g O
of O O
PRL 	 S-GENE
signaling n O
. 
 O
025 	 O
) 
 O
. 
 O
RESULTS U O
: 
 O
PET 	 O
revealed e O
wide e O
variations i O
in O O
CBF 	 O
between w O
regions i O
during i O
isoflurane f O
anaesthesia e O
, 
 O
particularly t O
in O O
comparison p O
with h O
propofol p O
anaesthesia e O
, 
 O
while l O
rCMRO2 R O
decreased r O
globally b O
in O O
a 
 O
dose e O
- 
 O
dependent e O
manner n O
during i O
both h O
isoflurane f O
and 	 O
propofol p O
anaesthesia e O
. 
 O
This s O
selective e O
squelching e O
activity i O
suggests g O
that t O
GRIM M S-GENE
can 	 O
interact e O
with h O
an O O
essential e O
component p O
of O O
the 	 O
RNA 	 B-GENE
polymerase y I-GENE
II E E-GENE
transcription n O
machinery h O
. 
 O
This s O
is O O
the 	 O
first s O
description c O
of O O
an O O
integron e O
located a O
on O O
a 
 O
composite p O
transposon n O
. 
 O
The 	 O
nine e O
subjects j O
were e O
treated a O
in O O
random d O
sequence u O
with h O
cimetidine e O
0 
 O
- 
 O
8 
 O
- 
 O
1 
 O
- 
 O
0 
 O
g 
 O
on O O
one 	 O
day 	 O
and 	 O
placebo c O
capsules s O
on O O
the 	 O
other e O
. 
 O
The 	 O
protein t O
was 	 O
overexpressed r O
in O O
Escherichia h O
coli i O
and 	 O
purified i O
to O O
homogeneity o O
. 
 O
Identification n O
and 	 O
characterization r O
of O O
a 
 O
yeast s O
gene e O
encoding o O
the 	 O
U2 B B-GENE
small l I-GENE
nuclear l I-GENE
ribonucleoprotein o I-GENE
particle t I-GENE
B - I-GENE
" - I-GENE
protein t E-GENE
. 
 O
A 
 O
360 	 O
- 
 O
bp O O
DNA 	 O
fragment g O
located a O
over r O
500 	 O
bp O O
upstream t O
from m O
the 	 O
cfl 	 O
transcriptional n O
start r O
site e O
was 	 O
used d O
in O O
DNase s B-GENE
I - E-GENE
protection t O
assays a O
to O O
define i O
the 	 O
specific c O
bases e O
bound n O
by O O
CorR R S-GENE
. 
 O
Taking i O
into o O
account o O
certain t O
well l O
defined i O
conditions d O
( 
 O
frequent q O
feedings d O
, 
 O
no O O
supplementary p O
feeding d O
before o O
4 
 O
- 
 O
6 
 O
months t O
, 
 O
method h O
only y O
to O O
be O O
used d O
in O O
the 	 O
absence e O
of O O
menstruation s O
) 
 O
, 
 O
LAM 	 O
can 	 O
be O O
relied i O
on O O
for 	 O
contraceptive t O
protection t O
for 	 O
up O O
to O O
1 
 O
year r O
post t O
partum t O
. 
 O
Nramp2 m S-GENE
contains t O
a 
 O
classical s O
iron n O
responsive p O
element m O
in O O
the 	 O
3 
 O
' 
 O
untranslated r O
region i O
that t O
confers f O
iron n O
dependent e O
mRNA A O
stabilization b O
. 
 O
Likewise e O
, 
 O
epidural d O
morphine p O
does s O
not 	 O
modify i O
the 	 O
intraoperative r O
metabolic a O
and 	 O
hormonal m O
responses p O
. 
 O
CONCLUSIONS C O
- 
 O
- 
 O
Postlumbar t O
puncture c O
headache d O
may 	 O
be O O
mediated i O
by O O
the 	 O
release e O
of O O
substance s O
P - O
triggered g O
by O O
lumbar b O
puncture c O
, 
 O
in O O
patients i O
predisposed d O
to O O
headache d O
by O O
a 
 O
hypersensitivity e O
to O O
substance s O
P - O
. 
 O
Continuous t O
arterial e O
blood o O
sampling p O
method h O
based e O
on O O
the 	 O
microsphere r O
model e O
was 	 O
used d O
as O O
a 
 O
quantitative n O
rCBF F O
measurement s O
. 
 O
A 
 O
mutated a O
ABF1 1 B-GENE
site e E-GENE
that t O
displays p O
a 
 O
very y O
low 	 O
affinity i O
for 	 O
ABF1 1 S-GENE
does s O
not 	 O
functionally c O
replace l O
the 	 O
ILV1 1 B-GENE
REB1 1 I-GENE
site e E-GENE
. 
 O
Given e O
a 
 O
rapid i O
induction u O
of O O
Egr 	 B-GENE
- - I-GENE
1 - E-GENE
on O O
stimulation m O
with h O
growth w O
factors t O
or O O
injury u O
, 
 O
these s O
findings d O
may 	 O
represent r O
at O O
least s O
one 	 O
of O O
the 	 O
molecular e O
mechanisms h O
underlying e O
phenotypic n O
modulation u O
of O O
smooth o O
muscles c O
after e O
vascular c O
injury u O
. 
 O
A 
 O
nationwide i O
survey v O
uncovered o O
a 
 O
tenfold f O
variation i O
between w O
counties n O
in O O
the 	 O
prescribing s O
of O O
IFNB B O
. 
 O
In O O
this s O
first s O
- 
 O
person s O
account o O
, 
 O
the 	 O
author h O
chronicles o O
her 	 O
experience e O
of O O
being n O
mentally t O
ill 	 O
and 	 O
homeless e O
in O O
New 	 O
York k O
and 	 O
New 	 O
Jersey s O
in O O
the 	 O
early l O
1980s 0 O
. 
 O
Rectal t O
temperatures p O
after e O
the 	 O
walk k O
were e O
greater a O
( 
 O
P 
 O
< 
 O
. 
 O
001 	 O
) 
 O
in O O
native i O
Simmental m O
( 
 O
39 O O
. 
 O
87 O O
+ 
 O
/ 
 O
- 
 O
. 
 O
05 O O
degrees r O
C 
 O
) 
 O
than n O
in O O
Bos 	 O
indicus i O
( 
 O
39 O O
. 
 O
46 O O
+ 
 O
/ 
 O
- 
 O
. 
 O
05 O O
degrees r O
C 
 O
) 
 O
. 
 O
Dominant i O
- 
 O
negative a O
mutations a O
in O O
the 	 O
G - B-GENE
- - I-GENE
protein t I-GENE
- - I-GENE
coupled p I-GENE
alpha h I-GENE
- - I-GENE
factor t I-GENE
receptor e E-GENE
map 	 O
to O O
the 	 O
extracellular r O
ends s O
of O O
the 	 O
transmembrane n O
segments m O
. 
 O
Such h O
simple p O
injuries u O
may 	 O
however e O
be O O
accompanied o O
by O O
far 	 O
reaching c O
consequences s O
. 
 O
This s O
is O O
the 	 O
first s O
report o O
which c O
clearly a O
proved v O
CEA 	 S-GENE
synthesis t O
in O O
the 	 O
cells l O
of O O
HCC 	 O
. 
 O
By O O
screening e O
a 
 O
human a O
testis t O
cDNA A O
library r O
with h O
a 
 O
probe b O
containing t O
the 	 O
mouse s B-GENE
PEA3 3 I-GENE
ETS 	 I-GENE
domain a E-GENE
, 
 O
we O O
isolated l O
a 
 O
2 
 O
. 
 O
2 
 O
kb O O
clone n O
containing t O
a 
 O
510 	 O
AA O O
open n O
reading d O
frame m O
. 
 O
AU O O
- 
 O
rich h O
elements m O
in O O
the 	 O
3 
 O
' 
 O
- 
 O
untranslated r O
region i O
of O O
a 
 O
new 	 O
mucin i B-GENE
- - I-GENE
type e I-GENE
gene e I-GENE
family i I-GENE
of O I-GENE
Trypanosoma p I-GENE
cruzi z I-GENE
confers f I-GENE
mRNA A E-GENE
instability t O
and 	 O
modulates u O
translation n O
efficiency i O
. 
 O
These s O
findings d O
suggest g O
that t O
IL B B-GENE
- - I-GENE
1 - E-GENE
- 
 O
stimulated m O
, 
 O
Rho 	 S-GENE
- 
 O
dependent e O
cytoskeletal o O
reorganization r O
may 	 O
cluster s O
signaling n O
molecules e O
in O O
specific c O
architectures h O
that t O
are 	 O
necessary e O
for 	 O
persistent s O
cell l O
activation i O
in O O
chronic o O
inflammatory l O
disease e O
. 
 O
Changes n O
in O O
testicular t O
testosterone t O
and 	 O
acid d O
and 	 O
alkaline a B-GENE
phosphatase s E-GENE
activity i O
in O O
testis t O
and 	 O
accessory e O
sex 	 O
organs a O
after e O
induction u O
of O O
varicocele i O
in O O
Noble l O
rats s O
. 
 O
M 
 O
. 
 O
, 
 O
Apps s O
, 
 O
D 
 O
. 
 O
These s O
data a O
suggest g O
that t O
weight g O
gain n O
or O O
increased r O
caloric o O
intake a O
, 
 O
in O O
contrast t O
to O O
its 	 O
large g O
effect e O
on O O
peripheral i O
thyroid r O
function c O
, 
 O
has 	 O
relatively a O
little t O
effect e O
on O O
CNS 	 B-GENE
TRH 	 E-GENE
activity i O
. 
 O
Alfalfa a O
phosphorus s O
release e O
kinetics e O
showed w O
high h O
bacterial t O
phosphorus s O
contamination t O
. 
 O
The 	 O
quantitative n O
analysis l O
of O O
1 
 O
- 
 O
alpha h O
- 
 O
acetylmethadol t O
and 	 O
its 	 O
principal n O
metabolites a O
in O O
biological l O
specimens c O
by O O
gas 	 O
chromatography o O
- 
 O
chemical m O
ionization i O
- 
 O
multiple t O
ion 	 O
monitoring i O
mass s O
spectrometry c O
. 
 O
Clinical n O
evidence d O
provides v O
tentative t O
suggestions g O
on O O
( 
 O
a 
 O
) 
 O
possible s O
additional i O
risk k O
of O O
cigarette a O
smoking k O
( 
 O
b 
 O
) 
 O
avoidance i O
of O O
venography o O
( 
 O
c 
 O
) 
 O
avoidance i O
of O O
varicose i O
vein n O
surgery g O
. 
 O
Effects e O
of O O
prolonged l O
inhibition i O
of O O
labour o O
pains n O
with h O
Th O O
1165a 5 O
and 	 O
Isoptin p O
on O O
the 	 O
heart r O
, 
 O
circulation c O
, 
 O
organ a O
- 
 O
and 	 O
metabolic a O
parameters a O
of O O
the 	 O
mother h O
Skytthe t O
, 
 O
and 	 O
K 
 O
. 
 O
In O O
the 	 O
Saccharomyces c O
cerevisiae e O
actin i S-GENE
intron r O
a 
 O
silent e O
branch n O
point n O
- 
 O
like e O
sequence u O
( 
 O
UACUAAG U O
) 
 O
is O O
located a O
7 
 O
nt O O
upstream t O
of O O
the 	 O
canonical o O
sequence u O
. 
 O
The 	 O
requirement u O
for 	 O
an O O
essential e O
interaction e O
between w O
NPH 	 B-GENE
I - E-GENE
and 	 O
H4L 	 S-GENE
provides v O
an O O
explanation l O
for 	 O
the 	 O
observed e O
restriction t O
of O O
transcription n O
termination m O
to O O
early l O
viral a O
genes e O
. 
 O
After e O
birth t O
, 
 O
there r O
was 	 O
a 
 O
significantly n O
higher h O
increase r O
of O O
IgA 	 S-GENE
and 	 O
IgM 	 B-GENE
anti i I-GENE
- - I-GENE
M - I-GENE
. - I-GENE
leprae r I-GENE
antibody i E-GENE
activity i O
in O O
sera a O
taken e O
3 
 O
- 
 O
6 
 O
months t O
after e O
birth t O
from m O
babies i O
of O O
Group u O
1 
 O
compared p O
to O O
Group u O
2 
 O
, 
 O
but 	 O
the 	 O
IgA 	 S-GENE
and 	 O
IgM 	 S-GENE
activity i O
in O O
sera a O
taken e O
after e O
6 
 O
months t O
of O O
age 	 O
showed w O
the 	 O
same e O
increase r O
in O O
the 	 O
two 	 O
groups u O
. 
 O
The 	 O
relation a O
between w O
the 	 O
changes n O
of O O
bone e O
density s O
and 	 O
the 	 O
level e O
of O O
blood o O
calcium c O
, 
 O
blood o O
phosphorus s O
and 	 O
alkaline a B-GENE
phosphatase s E-GENE
( 
 O
AKP 	 S-GENE
) 
 O
as O O
well l O
as O O
the 	 O
metabolism a O
of O O
vitamin a O
D 
 O
was 	 O
studied d O
. 
 O
These s O
results u O
demonstrate o O
the 	 O
extensive e O
homology o O
in O O
sequence u O
among n O
light h O
chains i O
of O O
IgM 	 B-GENE
kappa p E-GENE
autoantibodies o O
and 	 O
indicate i O
that t O
a 
 O
particular t O
V - B-GENE
kappa p I-GENE
germ m I-GENE
line e I-GENE
gene e E-GENE
, 
 O
kappa p B-GENE
IIIb b E-GENE
, 
 O
is O O
expressed r O
as O O
a 
 O
phylogenetic l O
response p O
to O O
certain t O
self f O
antigens i O
or O O
as O O
part t O
of O O
a 
 O
selection e O
process c O
by O O
which c O
these s O
autoimmune o O
responses p O
are 	 O
regulated u O
. 
 O
In O O
addition i O
, 
 O
the 	 O
findings d O
confirmed f O
previous v O
studies d O
which c O
showed w O
that t O
monkeys k O
with h O
total a O
bilateral a O
striatectomies i O
could l O
require u O
the 	 O
ability l O
to O O
execute c O
accurate u O
visually u O
guided d O
reaches c O
. 
 O
Comparison p O
of O O
the 	 O
sequences u O
of O O
the 	 O
alpha h B-GENE
- - I-GENE
like e I-GENE
DNA 	 I-GENE
polymerases y E-GENE
including l O
E - B-GENE
. - I-GENE
coli i I-GENE
DNA 	 I-GENE
polymerase y I-GENE
II E E-GENE
showed w O
that t O
there r O
were e O
nine e O
highly h O
conserved s O
regions i O
, 
 O
and 	 O
we O O
constructed s O
an O O
unrooted o O
phylogenetic l O
tree e O
of O O
the 	 O
DNA 	 B-GENE
polymerases y E-GENE
based e O
on O O
the 	 O
differences f O
in O O
these s O
conserved s O
regions i O
. 
 O
Before o O
and 	 O
6 
 O
and 	 O
12 O O
months t O
after e O
H 
 O
. 
 O
pylori o O
eradication d O
the 	 O
patients i O
were e O
evaluated l O
for 	 O
fasting t O
gastrinemia t O
and 	 O
pepsinogen s O
I - O
, 
 O
basal a O
and 	 O
peak k O
acid d O
output p O
, 
 O
and 	 O
detailed a O
histological t O
assessment e O
including l O
the 	 O
ECL 	 O
cell l O
proliferative l O
patterns t O
. 
 O
Four r O
experiments e O
examined m O
the 	 O
role e O
of O O
the 	 O
cholinergic l O
projections j O
from m O
the 	 O
septum t O
and 	 O
vertical t O
limb b O
nucleus l O
of O O
the 	 O
diagonal g O
band d O
of O O
Broca c O
( 
 O
VDB 	 O
) 
 O
in O O
acquisition u O
and 	 O
performance f O
of O O
a 
 O
conditional d O
visual u O
discrimination c O
. 
 O
trans n O
- 
 O
activation i O
of O O
the 	 O
HIV 	 B-GENE
- - I-GENE
1 - I-GENE
LTR 	 E-GENE
by O O
the 	 O
HIV 	 B-GENE
- - I-GENE
1 - I-GENE
Tat 	 E-GENE
and 	 O
HTLV V B-GENE
- - I-GENE
I - I-GENE
Tax 	 I-GENE
proteins t E-GENE
is O O
mediated i O
by O O
different f O
cis 	 O
- 
 O
acting i O
sequences u O
. 
 O
Defective e O
concanavalin c B-GENE
A - E-GENE
- 
 O
induced u O
suppression p O
in O O
bancroftian c O
filariasis a O
. 
 O
For 	 O
more e O
detailed a O
mapping p O
, 
 O
we O O
constructed s O
mouse s O
A9 O O
cells l O
containing t O
STFs s O
derived i O
from m O
human a O
chromosome o O
2 
 O
tagged g O
with h O
pSTneo n S-GENE
at O O
different f O
regions i O
in O O
2q31 1 O
- 
 O
qter r O
. 
 O
Left t O
ventricular t O
insufficiency u O
requires u O
two 	 O
SP O O
/ 
 O
patient i O
, 
 O
with h O
good d O
results u O
in O O
approximately r O
81 O O
p 
 O
. 
 O
cent t O
. 
 O
However e O
, 
 O
there r O
are 	 O
some e O
cows s O
that t O
fail l O
to O O
produce d O
adequate q O
1 
 O
, 
 O
25 O O
- 
 O
dihydroxyvitamin y O
D 
 O
at O O
the 	 O
onset e O
of O O
lactation t O
. 
 O
Acidic d O
carboxyl b O
- 
 O
terminal m O
domain a O
of O O
gene e B-GENE
2 - I-GENE
. - I-GENE
5 - I-GENE
protein t I-GENE
of I I-GENE
bacteriophage t I-GENE
T7 E E-GENE
is O O
essential e O
for 	 O
protein t O
- 
 O
protein t O
interactions e O
. 
 O
This s O
result u O
, 
 O
together e O
with h O
the 	 O
fact t O
that t O
unrearranged e O
V - B-GENE
kappa p I-GENE
genes e E-GENE
are 	 O
transcriptionally n O
silent e O
, 
 O
suggests g O
that t O
structural u O
features t O
of O O
both h O
the 	 O
V - B-GENE
kappa p E-GENE
and 	 O
C - B-GENE
kappa p I-GENE
loci i E-GENE
contribute t O
to O O
the 	 O
overall r O
transcriptional n O
efficiency i O
of O O
a 
 O
rearranged r O
V - B-GENE
kappa p I-GENE
- - I-GENE
C - I-GENE
kappa p I-GENE
gene e E-GENE
. 
 O
A 
 O
total a O
of O O
10 O O
, 
 O
763 	 O
men 	 O
and 	 O
3 
 O
, 
 O
118 	 O
women e O
has 	 O
been n O
studied d O
, 
 O
of O O
whom m O
97 O O
% 
 O
and 	 O
89 O O
% 
 O
, 
 O
respectively p O
, 
 O
have e O
been n O
traced c O
and 	 O
36 O O
% 
 O
and 	 O
16 O O
% 
 O
have e O
died d O
. 
 O
NSD1 1 S-GENE
contains t O
a 
 O
SET 	 O
domain a O
and 	 O
multiple t O
PHD 	 O
fingers g O
. 
 O
EMG 	 O
- 
 O
based e O
measures s O
of O O
fatigue i O
during i O
a 
 O
repetitive e O
squat a O
exercise r O
. 
 O
We O O
have e O
introduced r O
the 	 O
same e O
change n O
in O O
a 
 O
yeast s O
tRNA A O
( - O
Trp 	 S-GENE
) - O
gene e O
and 	 O
demonstrated o O
that t O
the 	 O
tRNA A O
acts s O
as O O
an O O
efficient i O
amber e O
suppressor p O
in O O
vivo o O
. 
 O
This s O
evaluation l O
examines m O
several e O
analytical l O
and 	 O
cost t O
parameters a O
for 	 O
five e O
representative r O
assays a O
: 
 O
IgG 	 S-GENE
, 
 O
IgA 	 S-GENE
, 
 O
IgM 	 S-GENE
, 
 O
phenytoin n O
, 
 O
and 	 O
phenobarbital n O
. 
 O
These s O
results u O
suggest g O
that t O
UvrA A S-GENE
is O O
involved o O
in O O
triplet p O
repeat e O
instability t O
in O O
cells l O
. 
 O
Among n O
women e O
, 
 O
plasma s B-GENE
factor t I-GENE
VII 	 E-GENE
: 
 O
Ag O S-GENE
was 	 O
inversely e O
associated o O
with h O
income o O
. 
 O
A 
 O
novel e O
protein t B-GENE
kinase a I-GENE
C - E-GENE
( 
 O
PKC 	 S-GENE
) 
 O
- 
 O
interacting e O
protein t O
was 	 O
identified n O
by O O
the 	 O
yeast s O
two 	 O
- 
 O
hybrid r O
screening e O
using n O
the 	 O
regulatory u O
domain a O
of O O
PKC 	 B-GENE
beta a I-GENE
I - E-GENE
as O O
a 
 O
bait t O
. 
 O
CONCLUSIONS C O
: 
 O
The 	 O
number b O
of O O
Spanish n O
articles i O
published l O
in O O
Anesthesiology s O
, 
 O
BJA 	 O
, 
 O
and 	 O
Anesth s O
Analg l O
is O O
low 	 O
, 
 O
although h O
the 	 O
comparison p O
of O O
our 	 O
productivity d O
with h O
that t O
of O O
other e O
EU O O
countries n O
in O O
function c O
of O O
GNPpc p S-GENE
places c O
us O O
in O O
an O O
intermediate e O
position i O
. 
 O
One 	 O
of O O
the 	 O
repeating e O
domains a O
( 
 O
Yheb1 b S-GENE
) 
 O
, 
 O
consisting s O
of O O
67 O O
amino n O
acids d O
, 
 O
was 	 O
cloned n O
from m O
the 	 O
E 
 O
. 
 O
coli i O
chromosome o O
and 	 O
purified i O
by O O
metal a O
chelating l O
chromatography o O
. 
 O
Phosphorylation s O
at O O
Ser 	 O
( 
 O
670 	 O
) 
 O
impairs a O
the 	 O
ability l O
of O O
GRK2 2 S-GENE
to O O
phosphorylate s O
both h O
soluble u O
and 	 O
membrane b O
- 
 O
incorporated o O
receptor e O
substrates s O
and 	 O
dramatically m O
attenuates e O
Gbetagamma t O
- 
 O
mediated i O
activation i O
of O O
this s O
enzyme y O
. 
 O
METHODS H O
: 
 O
CD4 	 O
cell l O
counts n O
and 	 O
interview e O
data a O
were e O
recorded o O
in O O
a 
 O
survey v O
of O O
136 	 O
adult l O
patients i O
attending e O
a 
 O
community m O
hospital p O
- 
 O
based e O
HIV 	 O
outpatient p O
clinic n O
. 
 O
Biol l O
. 
 O
Inhibition i O
of O O
endogenous o O
Cdk2 2 S-GENE
by O O
dominant i O
negative a O
Cdk2 2 S-GENE
attenuated e O
phosphorylation s O
of O O
Thr447 4 O
, 
 O
Thr490 4 O
and 	 O
Thr497 4 O
, 
 O
but 	 O
had 	 O
no O O
effect e O
upon n O
Ser581 5 O
modification i O
. 
 O
A 
 O
rabbit b O
antiserum i O
raised s O
against i O
a 
 O
unique q O
( 
 O
V3 O O
domain a O
) 
 O
bacterially t O
expressed r O
PKC 	 B-GENE
theta t I-GENE
fragment g E-GENE
immunoprecipitated u O
specifically c O
an O O
82 O O
- 
 O
kDa 	 O
protein t O
from m O
Jurkat k O
cell l O
lysates a O
. 
 O
Histological t O
examination m O
revealed e O
variable i O
loss s O
of O O
motor o O
neurons r O
limited i O
to O O
the 	 O
injection e O
site e O
. 
 O
This s O
is O O
the 	 O
most t O
northern t O
and 	 O
, 
 O
at O O
the 	 O
same e O
time e O
largest g O
, 
 O
Q 
 O
fever e O
epidemic d O
recorded o O
in O O
Germany m O
over r O
the 	 O
last t O
28 O O
years r O
. 
 O
Symptoms p O
, 
 O
skin n O
- 
 O
prick c O
tests t O
( 
 O
SPT 	 O
) 
 O
with h O
environmental i O
allergens e O
and 	 O
Pt O O
salt t O
, 
 O
total a O
serum u B-GENE
IgE 	 E-GENE
, 
 O
lung g O
function c O
, 
 O
and 	 O
bronchial n O
hyperresponsiveness e O
were e O
assessed e O
by O O
standard n O
procedures c O
. 
 O
Binding d O
sites e O
were e O
mapped p O
for 	 O
each h O
factor t O
. 
 O
Complementary p O
DNA 	 O
libraries r O
from m O
liver e O
and 	 O
ovary r O
of O O
an O O
immature a O
female a O
channel n O
catfish f O
were e O
screened e O
with h O
a 
 O
homologous o O
ERalpha l B-GENE
cDNA A E-GENE
probe b O
. 
 O
The 	 O
binding d O
of O O
PTB 	 S-GENE
was 	 O
antagonistic a O
to O O
the 	 O
binding d O
of O O
U2AF F S-GENE
to O O
the 	 O
enhancer a O
- 
 O
located a O
pyrimidine i O
tract c O
. 
 O
VLA 	 B-GENE
- - I-GENE
4 - I-GENE
integrin e E-GENE
cross s O
- 
 O
linking k O
on O O
human a O
monocytic o O
THP 	 O
- 
 O
1 
 O
cells l O
induces u O
tissue s O
factor t O
expression r O
by O O
a 
 O
mechanism h O
involving o O
mitogen o B-GENE
- - I-GENE
activated i I-GENE
protein t I-GENE
kinase a E-GENE
. 
 O
However e O
, 
 O
studies d O
using n O
the 	 O
A20 	 B-GENE
promoter m E-GENE
demonstrated o O
that t O
LMP1 1 S-GENE
transcriptionally n O
activates i O
the 	 O
A20 	 B-GENE
gene e E-GENE
through o O
cis 	 O
- 
 O
acting i O
kappa p B-GENE
B - I-GENE
sites e E-GENE
. 
 O
Southern t O
blot t O
analysis l O
revealed e O
that t O
CCaMK M S-GENE
is O O
encoded o O
by O O
a 
 O
single g O
gene e O
. 
 O
Surgical g O
methods h O
in O O
the 	 O
treatment a O
of O O
rhinophyma n O
. 
 O
Phenazopyridine n O
- 
 O
induced u O
hemolytic o O
anemia m O
in O O
a 
 O
patient i O
with h O
G6PD D S-GENE
deficiency i O
. 
 O
Finally a O
, 
 O
we O O
demonstrated o O
that t O
although h O
the 	 O
DNA 	 O
- 
 O
binding d O
domain a O
of O O
c - B-GENE
- - I-GENE
myb 	 E-GENE
is O O
required u O
for 	 O
both h O
the 	 O
differentiation f O
block c O
and 	 O
the 	 O
shift f O
in O O
cell l O
cycle l O
after e O
PMA 	 O
treatment a O
, 
 O
phosphorylation s O
by O O
casein e B-GENE
kinase a I-GENE
II E E-GENE
and 	 O
mitogen o B-GENE
- - I-GENE
activated i I-GENE
protein t I-GENE
kinase a E-GENE
at O O
positions i O
11 O O
and 	 O
12 O O
or O O
532 	 O
of O O
c - B-GENE
- - I-GENE
myb 	 E-GENE
, 
 O
respectively p O
, 
 O
are 	 O
not 	 O
. 
 O
The 	 O
activation i O
of O O
NF B B-GENE
- - I-GENE
kappaB p E-GENE
- 
 O
dependent e O
reporter o O
gene e O
transcription n O
by O O
E1A 	 S-GENE
was 	 O
potently e O
suppressed p O
upon n O
coexpression x O
of O O
the 	 O
E1B 	 B-GENE
19 I I-GENE
- - I-GENE
kDa 	 I-GENE
protein t E-GENE
( - O
19K 	 S-GENE
) - O
. 
 O
Our 	 O
results u O
showed w O
that t O
direct e O
enantiomeric n O
separation a O
of O O
mephenytoin h O
was 	 O
obtained a O
by O O
using n O
a 
 O
chiral r O
capillary i O
column u O
, 
 O
the 	 O
retention e O
times e O
for 	 O
S 
 O
- 
 O
and 	 O
R 
 O
- 
 O
mephenytoin h O
were e O
25 O O
. 
 O
5 
 O
and 	 O
26 O O
. 
 O
2 
 O
min 	 O
respectively p O
, 
 O
with h O
a 
 O
detection e O
limit i O
less s O
than n O
50 O O
ng O O
/ 
 O
ml O O
of O O
mephenytoin h O
. 
 O
The 	 O
myeloid l B-GENE
zinc c I-GENE
finger g I-GENE
gene e I-GENE
1 - E-GENE
( 
 O
MZF1 1 S-GENE
) 
 O
encodes o O
a 
 O
C - B-GENE
( - I-GENE
2 - I-GENE
) - I-GENE
H - I-GENE
( - I-GENE
2 - I-GENE
) - I-GENE
zinc c I-GENE
finger g I-GENE
transcription n I-GENE
factor t E-GENE
that t O
regulates u O
granulopoiesis n O
and 	 O
may 	 O
have e O
a 
 O
regulatory u O
role e O
in O O
cellular l O
proliferation l O
and 	 O
oncogenesis o O
. 
 O
Snails i O
infected e O
with h O
three e O
or O O
five e O
miracidia a O
produced d O
more e O
metacercariae a O
than n O
those s O
infected e O
with h O
a 
 O
single g O
miracidium a O
. 
 O
We O O
conclude c O
that t O
GRF1 1 S-GENE
and 	 O
GRF2 2 S-GENE
can 	 O
form m O
homo o O
- 
 O
and 	 O
hetero e O
- 
 O
oligomers g O
via 	 O
their i O
DH B B-GENE
domains a E-GENE
, 
 O
that t O
mutational a O
inactivation c O
of O O
oligomer g O
formation m O
by O O
GRF1 1 S-GENE
is O O
associated o O
with h O
impaired a O
biological l O
and 	 O
signaling n O
activities i O
, 
 O
and 	 O
that t O
in O O
293T T O
cells l O
GRF1 1 S-GENE
mediates i O
at O O
least s O
two 	 O
pathways h O
for 	 O
Raf 	 S-GENE
activation i O
: 
 O
one 	 O
a 
 O
constitutive s O
signal n O
that t O
is O O
mainly n O
Ras 	 S-GENE
- 
 O
dependent e O
, 
 O
and 	 O
one 	 O
an O O
ionomycin o O
- 
 O
induced u O
signal n O
that t O
cooperates p O
with h O
the 	 O
constitutive s O
signal n O
without h O
further t O
augmenting m O
the 	 O
level e O
of O O
GTP 	 B-GENE
- - I-GENE
Ras 	 E-GENE
. 
 O
For 	 O
the 	 O
target g O
stimuli m O
, 
 O
P3 O O
amplitude l O
and 	 O
latency e O
were e O
negatively a O
correlated r O
and 	 O
most t O
tightly h O
coupled p O
over r O
the 	 O
frontal n O
- 
 O
central t O
and 	 O
right h O
medial i O
/ 
 O
lateral e O
recording o O
sites e O
. 
 O
Mitoxantrone o O
plus s O
ara 	 O
- 
 O
C 
 O
is O O
an O O
active i O
combination b O
with h O
great a O
promise m O
for 	 O
the 	 O
therapy r O
of O O
previously v O
untreated r O
patients i O
with h O
AML 	 O
. 
 O
In O O
the 	 O
renal a O
cortex t O
, 
 O
spleen e O
, 
 O
distal t O
colon o O
, 
 O
ileum u O
, 
 O
gallbladder l O
, 
 O
and 	 O
stomach m O
body y O
, 
 O
regional i O
O2 O O
delivery i O
was 	 O
significantly n O
decreased r O
with h O
hemodilution o O
to O O
20 O O
% 
 O
in O O
both h O
groups u O
. 
 O
( 
 O
A 
 O
short r O
account o O
of O O
Karl l B-GENE
Touton t I-GENE
' 
 I-GENE
s 
 E-GENE
life e O
is O O
also o O
included l O
. 
 O
) 
 O
After e O
reviewing i O
the 	 O
historical t O
development e O
of O O
the 	 O
concept c O
of O O
giant n O
cells l O
and 	 O
current r O
interpretations e O
of O O
their i O
nature u O
, 
 O
the 	 O
unitarian t O
view w O
of O O
polykaryons y O
now 	 O
favored o O
by O O
workers k O
in O O
the 	 O
field l O
is O O
extended e O
to O O
include l O
also o O
the 	 O
" 
 O
xanthelasmatic t O
giant n O
cell l O
" 
 O
of O O
Touton t S-GENE
, 
 O
whose s O
characteristic r O
appearance e O
is O O
determined e O
merely e O
by O O
the 	 O
presence s O
of O O
demonstrable o O
lipid i O
in O O
the 	 O
cytoplasm o O
. 
 O
Chronic o O
active i O
hepatitis a O
and 	 O
pregnancy g O
. 
 O
Influenza l O
virus u O
- 
 O
induced u O
NF B B-GENE
- - I-GENE
kappaB p E-GENE
- - O
dependent e O
gene e O
expression r O
is O O
mediated i O
by O O
overexpression r O
of O O
viral a O
proteins t O
and 	 O
involves o O
oxidative d O
radicals i O
and 	 O
activation i O
of O O
IkappaB p B-GENE
kinase a E-GENE
. 
 O
These s O
observed e O
changes n O
were e O
not 	 O
found n O
when n O
assessing e O
NPY 	 O
level e O
in O O
plasma s O
fluid i O
. 
 O
Reversible e O
topology o O
of O O
a 
 O
bifunctional u O
transmembrane n O
protein t O
depends e O
upon n O
the 	 O
charge r O
balance a O
around u O
its 	 O
transmembrane n O
domain a O
. 
 O
Protein t B-GENE
kinase a I-GENE
C - E-GENE
( 
 O
PKC 	 S-GENE
) 
 O
activation i O
after e O
treatment a O
of O O
human a O
neuroblastoma r O
SK O O
- 
 O
N 
 O
- 
 O
BE O O
( 
 O
2 
 O
) 
 O
C 
 O
cells l O
with h O
phorbol r O
12 O O
- 
 O
myristate i O
13 O O
- 
 O
acetate t O
( 
 O
PMA 	 O
) 
 O
was 	 O
found n O
to O O
enhance a O
transcription n O
of O O
the 	 O
human a B-GENE
dopamine a I-GENE
beta a I-GENE
- - I-GENE
hydroxylase r E-GENE
( 
 O
DBH 	 S-GENE
) 
 O
in O O
those s O
cells l O
. 
 O
The 	 O
second o O
( 
 O
control t O
) 
 O
group u O
was 	 O
represented r O
by O O
cases e O
diagnosed g O
as O O
HSIL L O
by O O
cytology o O
. 
 O
The 	 O
illuminator u O
uses s O
a 
 O
grain i O
- 
 O
of O O
- 
 O
wheat a O
light h O
bulb b O
and 	 O
an O O
adjustable u O
bulb b O
holder d O
fashioned h O
from m O
bent t O
paper e O
clips p O
. 
 O
Bedbug b O
( 
 O
Cimex e O
lectularius t O
) 
 O
samples p O
adult l O
and 	 O
nymphs p O
either h O
engorged o O
or O O
starved r O
from m O
Central t O
Security u O
Forces c O
sleeping e O
wards d O
, 
 O
laboratory o O
animal m O
house s O
and 	 O
control t O
samples p O
from m O
laboratory o O
reared r O
colonies o O
were e O
ground u O
and 	 O
subjected j O
to O O
ELISA S O
test t O
of O O
hepatitis a B-GENE
B - I-GENE
surface f I-GENE
antigen i E-GENE
together e O
with h O
276 	 O
serum u O
samples p O
from m O
the 	 O
recruits r O
slept p O
in O O
those s O
wards d O
. 
 O
The 	 O
genomic o O
organization a O
in O O
this s O
region i O
is O O
similar i O
to O O
the 	 O
neural r O
- 
 O
restricted t O
family i O
members b O
, 
 O
Hel 	 B-GENE
- - I-GENE
N1 E E-GENE
( 
 O
ELAVL2 V S-GENE
) 
 O
and 	 O
mHuD D S-GENE
( 
 O
Elavl4 v S-GENE
) 
 O
. 
 O
Synergistic e O
induction u O
of O O
apoptosis p O
in O O
human a O
leukemia k O
cells l O
( 
 O
U937 7 O
) 
 O
exposed o O
to O O
bryostatin o B-GENE
1 
 E-GENE
and 	 O
the 	 O
proteasome t B-GENE
inhibitor i I-GENE
lactacystin t E-GENE
involves o O
dysregulation r O
of O O
the 	 O
PKC 	 S-GENE
/ 
 O
MAPK K S-GENE
cascade c O
. 
 O
With h O
the 	 O
help p O
of O O
partially t O
overlapping r O
parenchymatous e O
sutures u O
, 
 O
different f O
renal a O
segments m O
were e O
devitalized i O
. 
 O
Promoter m O
elements m O
and 	 O
transcriptional n O
control t O
of O O
the 	 O
mouse s B-GENE
acetylcholinesterase t I-GENE
gene e E-GENE
. 
 O
The 	 O
average r O
cumulative u O
UVA 	 O
dose e O
was 	 O
65 O O
J 
 O
/ 
 O
cm2 	 O
; 
 O
40 O O
patients i O
had 	 O
received e O
more e O
than n O
200 	 O
J 
 O
/ 
 O
cm2 	 O
. 
 O
Malformations f O
of O O
the 	 O
regenerating e O
optic i O
tectum t O
of O O
larvae v O
of O O
the 	 O
Egyptian p O
toad d O
, 
 O
Bufo o B-GENE
regularis u I-GENE
Reuss s E-GENE
. 
 O
These s O
morphological p O
changes n O
are 	 O
associated o O
with h O
a 
 O
marked k O
induction u O
of O O
P450arom 0 B-GENE
gene e E-GENE
expression r O
. 
 O
The 	 O
immunoprofile u O
of O O
60 O O
adult l O
patients i O
of O O
pulmonary m O
tuberculosis e O
was 	 O
studied d O
and 	 O
compared p O
with h O
22 O O
normal m O
controls t O
. 
 O
Central t O
- 
 O
venous o O
- 
 O
catheter h O
- 
 O
related a O
infection e O
is O O
readily d O
diagnosed g O
by O O
comparing p O
simultaneous u O
quantitative n O
cultures t O
of O O
blood o O
samples p O
obtained a O
via 	 O
the 	 O
catheter h O
and 	 O
a 
 O
peripheral i O
vein n O
. 
 O
The 	 O
role e O
of O O
haptoglobin t S-GENE
in O O
asphyxia h O
mechanism h O
( 
 O
II O O
) 
 O
- 
 O
- 
 O
Acute t O
drowning w O
and 	 O
hanging g O
Processing c O
MES 	 O
data a O
requires u O
large g O
bit 	 O
manipulations i O
and 	 O
heavy v O
memory o O
storage r O
requirements u O
. 
 O
Thus s O
, 
 O
BCR 	 S-GENE
ligation a O
initiates t O
a 
 O
PI B B-GENE
3 - I-GENE
- - I-GENE
kinase a E-GENE
/ 
 O
Akt 	 S-GENE
/ 
 O
GSK 	 B-GENE
- - I-GENE
3 - E-GENE
signaling n O
pathway h O
. 
 O
cDNA A O
cloning n O
and 	 O
transcriptional n O
properties p O
of O O
a 
 O
novel e O
GC B B-GENE
box 	 I-GENE
- - I-GENE
binding d I-GENE
protein t E-GENE
, 
 O
BTEB2 B S-GENE
. 
 O
This s O
activity i O
creates a O
a 
 O
4 
 O
- 
 O
bp O O
staggered g O
cut 	 O
with h O
3 
 O
' 
 O
OH O O
overhangs r O
within h O
a 
 O
specific c O
sequence u O
of O O
the 	 O
21S 	 B-GENE
rRNA A I-GENE
gene e E-GENE
of O O
omega g O
- 
 O
strains a O
. 
 O
The 	 O
two 	 O
ORFs s O
had 	 O
significant n O
similarity i O
with h O
the 	 O
putative a O
replication l O
protein t O
from m O
plasmid s O
pTiK12 K O
of O O
Thiobacillus o O
intermedius e O
and 	 O
other e O
CoIE2 E O
- 
 O
related a O
plasmids s O
. 
 O
In O O
contrast t O
SF S O
, 
 O
but 	 O
not 	 O
GM B B-GENE
- - I-GENE
CSF 	 E-GENE
or O O
IL B B-GENE
- - I-GENE
3 - E-GENE
, 
 O
induced u O
tyrosine o O
phosphorylation s O
of O O
phospholipase s B-GENE
C - I-GENE
- - I-GENE
gamma m E-GENE
( 
 O
PLC 	 B-GENE
- - I-GENE
gamma m E-GENE
) 
 O
. 
 O
Phase s O
I 
 O
clinical n O
trial a O
with h O
a 
 O
combination b O
of O O
methotrexate h O
and 	 O
mitomycin o O
C 
 O
. 
 O
Replacement l O
of O O
Val20 2 O
- 
 O
Leu21 2 O
with h O
Ala 	 O
- 
 O
Ala 	 O
produced d O
a 
 O
dimeric e O
RII 	 B-GENE
beta a I-GENE
protein t E-GENE
that t O
binds d O
AKAP75 P S-GENE
approximately r O
4 
 O
% 
 O
as O O
avidly d O
as O O
wild d B-GENE
- - I-GENE
type e I-GENE
RII 	 I-GENE
beta a E-GENE
. 
 O
The 	 O
temporal p O
expression r O
of O O
CRAlBP l S-GENE
is O O
similar i O
to O O
IRBP P S-GENE
while l O
bFGF F S-GENE
is O O
not 	 O
expressed r O
until i O
after e O
photoreceptor t O
differentiation f O
is O O
complete p O
. 
 O
I 
 O
. 
 O
In O O
T 
 O
cells l O
these s O
two 	 O
signal n O
pathways h O
are 	 O
critical t O
for 	 O
interleukin e B-GENE
- - I-GENE
2 - E-GENE
production d O
. 
 O
Replacement l O
of O O
a 
 O
valine i O
( 
 O
V68 	 O
) 
 O
in O O
the 	 O
ETS 	 B-GENE
domain a E-GENE
of O O
SAP1a 1 S-GENE
by O O
aspartic a O
acid d O
( 
 O
as O O
found n O
in O O
c - B-GENE
- - I-GENE
Ets 	 I-GENE
- - I-GENE
1 - I-GENE
, 
 I-GENE
Elk 	 I-GENE
- - I-GENE
1 - E-GENE
, 
 O
and 	 O
Net 	 S-GENE
) 
 O
enhanced a O
ternary n O
complex p O
formation m O
by O O
more e O
than n O
60 O O
- 
 O
fold d O
. 
 O
In O O
order e O
to O O
investigate e O
the 	 O
effect e O
of O O
the 	 O
local a O
direct e O
action i O
of O O
danazol a O
upon n O
endometriosis o O
, 
 O
intravaginal r O
and 	 O
intrauterine r O
application l O
were e O
tried e O
. 
 O
The 	 O
NF B B-GENE
- - I-GENE
kappaB p E-GENE
/ 
 O
Rel 	 S-GENE
transcription n O
factors t O
participate t O
in O O
the 	 O
activation i O
of O O
immune u O
system t O
regulatory u O
genes e O
and 	 O
viral a O
early l O
genes e O
including l O
the 	 O
human a O
immunodeficiency u O
virus u O
type e O
1 - O
long g O
terminal m O
repeat e O
. 
 O
A 
 O
total a O
of O O
4 
 O
, 
 O
916 	 O
children l O
were e O
examined m O
and 	 O
the 	 O
questionnaire s O
satisfactorily i O
completed p O
by O O
a 
 O
relative a O
or O O
guardian r O
( 
 O
usually a O
the 	 O
mother h O
) 
 O
of O O
4 
 O
, 
 O
651 	 O
. 
 O
cDNA A O
cloning n O
reveals e O
two 	 O
mouse s B-GENE
beta5 a I-GENE
integrin e I-GENE
transcripts n E-GENE
distinct t O
in O O
cytoplasmic o O
domains a O
as O O
a 
 O
result u O
of O O
alternative e O
splicing i O
. 
 O
Earlier l O
nonoptical o O
methods h O
probably b O
did 	 O
not 	 O
include l O
the 	 O
portion t O
of O O
the 	 O
film m O
that t O
contained t O
mucus u O
. 
 O
OBJECTIVE E O
: 
 O
To O O
summarise m O
quantitatively n O
the 	 O
association o O
between w O
moderate e O
alcohol o O
intake a O
and 	 O
biological l O
markers k O
of O O
risk k O
of O O
coronary o O
heart r O
disease e O
and 	 O
to O O
predict d O
how 	 O
these s O
changes n O
would l O
lower e O
the 	 O
risk k O
. 
 O
Like e O
other e O
known w O
GCD 	 B-GENE
genes e E-GENE
, 
 O
GCD14 1 S-GENE
and 	 O
GCD15 1 S-GENE
are 	 O
therefore r O
probably b O
required u O
for 	 O
general e O
translation n O
initiation t O
in O O
addition i O
to O O
their i O
roles e O
in O O
GCN4 4 S-GENE
- 
 O
specific c O
translational n O
control t O
. 
 O
The 	 O
presence s O
of O O
highly h O
correlated r O
frequencies q O
provided v O
strong o O
evidence d O
of O O
a 
 O
medium i O
- 
 O
frequency q O
pattern t O
generator e O
which c O
may 	 O
remain a O
operative r O
beyond o O
the 	 O
neonatal n O
period i O
. 
 O
This s O
gene e O
is O O
named e O
PKNOX1 O S-GENE
by O O
the 	 O
Human a O
Nomenclature e O
Committee m O
. 
 O
Differentiation f O
of O O
porcine c O
mycoplasma o O
strains a O
by O O
means n O
of O O
a 
 O
simple p O
paper e O
chromatography o O
test t O
. 
 O
HIV 	 O
- 
 O
2 
 O
in O O
Spain i O
. 
 O
No O O
effect e O
of O O
4 
 O
beta a O
- 
 O
phorbol r O
12 O O
- 
 O
myristate i O
13 O O
- 
 O
acetate t O
was 	 O
observed e O
on O O
the 	 O
expression r O
of O O
hnRNP N B-GENE
H - E-GENE
. 
 O
Patients i O
commonly m O
considered s O
the 	 O
external e O
frame m O
cumbersome b O
. 
 O
D 
 O
. 
 O
The 	 O
atf1 1 B-GENE
+ - I-GENE
gene e E-GENE
of I O
Schizosaccharomyces i O
pombe b O
encodes o O
a 
 O
bZIP P B-GENE
transcription n I-GENE
factor t E-GENE
with h O
strong o O
homology o O
to O O
the 	 O
mammalian m B-GENE
factor t I-GENE
ATF 	 I-GENE
- - I-GENE
2 - E-GENE
. 
 O
The 	 O
effects e O
of O O
different f O
sources r O
of O O
commercial m O
rations i O
on O O
the 	 O
humoral o O
immune u O
response p O
of O O
broilers i O
to O O
Newcastle c O
disease e O
vaccination c O
. 
 O
Multiple t O
attempts e O
aimed e O
at O O
disruption r O
of O O
the 	 O
chromosomal o B-GENE
fabG G I-GENE
gene e E-GENE
were e O
unsuccessful u O
. 
 O
Primary m O
TJRs s O
were e O
clinically n O
evaluated l O
for 	 O
degree r O
of O O
osteoarthrosis e O
. 
 O
Radiation i O
sensitivity s O
of O O
rats s O
irradiated a O
in O O
a 
 O
condition d O
of O O
hypoxia o O
The 	 O
activity i O
of O O
plasminogen s B-GENE
activator i E-GENE
has 	 O
been n O
measured s O
in O O
tissue s O
sections t O
with h O
the 	 O
aid 	 O
of O O
a 
 O
modified i O
Todd d O
technique h O
. 
 O
The 	 O
complexity p O
of O O
some e O
of O O
the 	 O
reports o O
of O O
VACURG U O
studies d O
has 	 O
led 	 O
some e O
to O O
believe i O
that t O
this s O
group u O
was 	 O
opposed o O
to O O
estrogens r O
, 
 O
but 	 O
that t O
is O O
not 	 O
true e O
. 
 O
Thus s O
, 
 O
the 	 O
mutants a O
are 	 O
deficient i O
in O O
production d O
of O O
the 	 O
O - B-GENE
- - I-GENE
antigen i I-GENE
polymerase y E-GENE
and 	 O
were e O
termed m O
rfc 	 B-GENE
mutants a E-GENE
. 
 O
Up O O
to O O
1988 8 O
, 
 O
145 	 O
cases e O
had 	 O
been n O
reported o O
in O O
literature e O
and 	 O
32 O O
cases e O
in O O
our 	 O
country n O
. 
 O
Focal a O
glomerulosclerosis m O
- 
 O
like e O
disease e O
with h O
nephrotic h O
syndrome d O
in O O
a 
 O
horse s O
. 
 O
The 	 O
antihypertensive i O
action i O
corresponds r O
to O O
those s O
of O O
established a O
diuretics r O
. 
 O
Interconversions e O
between w O
haloperidol o O
and 	 O
reduced u O
haloperidol o O
in O O
schizophrenic i O
patients i O
and 	 O
guinea n O
pigs s O
: 
 O
a 
 O
steady a O
- 
 O
state t O
study d O
. 
 O
The 	 O
frequency q O
of O O
eating i O
dark k O
- 
 O
meat t O
fish h O
was 	 O
positively i O
associated o O
with h O
serum u O
eicosapentaenoic o O
acid d O
and 	 O
docosahexaenoic o O
acid d O
, 
 O
omega3 g O
fatty t O
acids d O
, 
 O
and 	 O
inversely e O
associated o O
with h O
serum u O
stearic a O
acid d O
and 	 O
linoleic o O
acid d O
. 
 O
Effect e O
of O O
food d O
on O O
hemodynamics o O
. 
 O
The 	 O
D443N 3 O
substitution s O
is O O
an O O
activating i O
mutation a O
that t O
increases r O
the 	 O
activity i O
of O O
SCAP P S-GENE
and 	 O
renders d O
it O O
resistant i O
to O O
inhibition i O
by O O
25 O O
- 
 O
hydroxycholesterol r O
. 
 O
Central t O
( 
 O
heart r O
rate e O
, 
 O
VE O O
, 
 O
VO2 	 O
) 
 O
or O O
local a O
( 
 O
muscle c O
and 	 O
blood o O
lactate t O
, 
 O
adenosine n O
triphosphate p O
, 
 O
creatine a B-GENE
phosphokinase s E-GENE
, 
 O
glycogen c O
) 
 O
cues s O
highlighted h O
in O O
these s O
studies d O
demonstrate o O
both h O
the 	 O
complexity p O
of O O
effort o O
perception c O
, 
 O
and 	 O
the 	 O
need d O
for 	 O
better t O
understanding e O
of O O
the 	 O
physiological s O
components p O
upon n O
which c O
it O O
is O O
based e O
. 
 O
The 	 O
gene e O
is O O
predicted d O
to O O
encode o O
an O O
880 	 O
- 
 O
amino n O
- 
 O
acid d O
protein t O
which c O
contains t O
two 	 O
C2H2 2 O
zinc c O
fingers g O
, 
 O
a 
 O
nuclear l O
localization a O
sequence u O
and 	 O
two 	 O
transcriptional n O
activation i O
domains a O
. 
 O
This s O
approach r O
allowed o O
examination m O
of O O
baseline e O
factors t O
as O O
well l O
as O O
the 	 O
effect e O
of O O
change n O
in O O
mileage e O
, 
 O
the 	 O
occurrence u O
of O O
a 
 O
musculoskeletal c O
problem b O
, 
 O
or O O
the 	 O
occurrence u O
of O O
another t O
health l O
problem b O
on O O
the 	 O
rate e O
of O O
dropout p O
. 
 O
Microalbuminuria r O
: 
 O
a 
 O
marker k O
of O O
systemic t O
disease e O
. 
 O
Regulation u O
of O O
activating i B-GENE
transcription n I-GENE
factor t I-GENE
- - I-GENE
1 - E-GENE
and 	 O
the 	 O
cAMP P B-GENE
response p I-GENE
element m I-GENE
- - I-GENE
binding d I-GENE
protein t E-GENE
by O O
Ca2 	 B-GENE
+ - I-GENE
/ - I-GENE
calmodulin m I-GENE
- - I-GENE
dependent e I-GENE
protein t I-GENE
kinases a I-GENE
type e I-GENE
I - I-GENE
, - I-GENE
II I I-GENE
, - I-GENE
and 	 I-GENE
IV E E-GENE
. 
 O
Coronary o O
arteries e O
were e O
found n O
in O O
the 	 O
biopsy p O
tissue s O
of O O
30 O O
( 
 O
76 O O
% 
 O
) 
 O
of O O
the 	 O
39 O O
patients i O
who 	 O
formed m O
the 	 O
study d O
group u O
. 
 O
Serum u O
amyloid l O
A - O
( 
 O
SAA 	 S-GENE
) 
 O
is O O
a 
 O
plasma s O
protein t O
which c O
has 	 O
been n O
associated o O
with h O
several e O
diseases e O
, 
 O
including l O
amyloidosis l O
, 
 O
arthritis h O
, 
 O
and 	 O
atherosclerosis e O
, 
 O
and 	 O
its 	 O
abnormal o O
expression r O
, 
 O
particularly t O
in O O
nonhepatic h O
cells l O
, 
 O
is O O
implicated l O
in O O
the 	 O
pathogenesis h O
of O O
these s O
diseases e O
. 
 O
Phenacetin n O
nephritis h O
We O O
have e O
been n O
developing e O
a 
 O
digital i O
fluoroscopic o O
imaging g O
system t O
to O O
replace l O
the 	 O
portal t O
films m O
that t O
are 	 O
currently r O
used d O
to O O
verify i O
patient i O
positioning i O
during i O
radiotherapy i O
treatments a O
. 
 O
The 	 O
human a B-GENE
p18 	 I-GENE
gene e E-GENE
spans n O
at O O
least s O
7 
 O
. 
 O
5 
 O
kb O O
and 	 O
is O O
composed p O
of O O
three e O
exons n O
, 
 O
two 	 O
of O O
which c O
encode o O
the 	 O
p18 	 B-GENE
protein t E-GENE
. 
 O
Serum u B-GENE
creatinine a I-GENE
kinase a E-GENE
activity i O
was 	 O
7 
 O
, 
 O
800 	 O
- 
 O
17 O O
, 
 O
500 	 O
U 
 O
/ 
 O
l 
 O
, 
 O
making i O
acute t O
muscle c O
damage a O
likely e O
, 
 O
probably b O
rhabdomyolysis b O
. 
 O
These s O
results u O
suggest g O
that t O
termination m O
is O O
a 
 O
highly h O
specific c O
event n O
, 
 O
and 	 O
not 	 O
merely e O
a 
 O
consequence s O
of O O
decreased r O
stability b O
of O O
the 	 O
EC O O
. 
 O
Like e O
Mdm2 2 S-GENE
, 
 O
MdmX X S-GENE
is O O
able e O
to O O
bind d O
p53 	 S-GENE
and 	 O
inhibit i O
p53 	 S-GENE
transactivation n O
; 
 O
however e O
, 
 O
the 	 O
ability l O
of O O
MdmX X S-GENE
to O O
degrade r O
p53 	 S-GENE
has 	 O
yet 	 O
to O O
be O O
examined m O
. 
 O
PURPOSE P O
: 
 O
Second o O
malignant i O
neoplasms p O
( 
 O
SMNs s O
) 
 O
are 	 O
a 
 O
rare e O
occurrence u O
after e O
the 	 O
successful c O
treatment a O
of O O
childhood l O
cancer c O
. 
 O
Recent e O
geological l O
studies d O
focusing u O
on O O
the 	 O
Davie i O
Fracture c O
Zone e O
of O O
the 	 O
Mozambique a O
Channel n O
offer e O
a 
 O
resolution o O
to O O
this s O
situation u O
, 
 O
by O O
suggesting g O
the 	 O
presence s O
of O O
a 
 O
land d O
- 
 O
bridge d O
from m O
the 	 O
mid 	 O
- 
 O
Eocene e O
to O O
the 	 O
early l O
Miocene c O
, 
 O
an O O
interval e O
that t O
matches c O
the 	 O
ages s O
of O O
Madagascar a O
' 
 O
s 
 O
mammalian m O
groups u O
. 
 O
The 	 O
nucleotide l O
sequence u O
of O O
a 
 O
PCR 	 O
- 
 O
amplified l O
SMT3A 3 B-GENE
genomic o I-GENE
DNA 	 I-GENE
fragment g E-GENE
was 	 O
found n O
to O O
be O O
identical n O
to O O
that t O
of O O
SMT3A 3 B-GENE
cDNA A E-GENE
, 
 O
indicating i O
the 	 O
absence e O
of O O
intron r O
( 
 O
s 
 O
) 
 O
in O O
its 	 O
protein t O
coding i O
region i O
. 
 O
Mutant a B-GENE
p53 	 I-GENE
DNA 	 E-GENE
clones n O
from m O
human a O
colon o O
carcinomas c O
cooperate p O
with h O
ras 	 S-GENE
in O O
transforming n O
primary m O
rat 	 O
cells l O
: 
 O
a 
 O
comparison p O
of O O
the 	 O
" 
 O
hot 	 O
spot t O
" 
 O
mutant a O
phenotypes n O
. 
 O
Gas 	 O
chromatographic o O
analysis l O
of O O
headspace d O
samples p O
of O O
alkalinized a O
vaginal i O
discharges c O
indicated i O
the 	 O
presence s O
of O O
trimethylamine m O
in O O
all 	 O
11 O O
samples p O
with h O
the 	 O
fishy h O
odor r O
but 	 O
not 	 O
in O O
the 	 O
other e O
samples p O
. 
 O
Standing n O
values u O
: 
 O
placebo c O
114 	 O
/ 
 O
79 O O
; 
 O
BHT 	 O
- 
 O
933 	 O
92 O O
/ 
 O
67 O O
. 
 O
The 	 O
Ixodes d O
fauna n O
in O O
the 	 O
Michourin h O
region i O
, 
 O
where r O
the 	 O
pastures t O
in O O
1971 1 O
were e O
grazed z O
only y O
by O O
sheep e O
, 
 O
shows w O
the 	 O
following l O
trends n O
: 
 O
H 
 O
. 
 O
punctata c O
and 	 O
R 
 O
. 
 O
turanicus a O
ticks k O
, 
 O
which c O
are 	 O
preferably f O
parasitising a O
in O O
sheep e O
, 
 O
increase r O
their i O
relative a O
share r O
. 
 O
The 	 O
SEC27 2 B-GENE
gene e E-GENE
was 	 O
cloned n O
, 
 O
and 	 O
the 	 O
sequence u O
predicts d O
a 
 O
99 O O
. 
 O
4 
 O
- 
 O
kDa 	 O
protein t O
with h O
45 O O
% 
 O
sequence u O
identity n O
to O O
mammalian m B-GENE
beta a I-GENE
' - I-GENE
- - I-GENE
COP 	 E-GENE
. 
 O
Studies d O
of O O
fetal a O
maturity u O
Fetal a O
arterial e O
and 	 O
sagittal i O
sinus u O
pH O O
, 
 O
base e O
excess e O
, 
 O
po2 	 O
, 
 O
and 	 O
oxygen g O
saturation u O
decreased r O
, 
 O
and 	 O
hydrogen r O
ion 	 O
concentrations c O
and 	 O
pco2 2 O
increased r O
during i O
asphyxia h O
alone n O
and 	 O
asphyxia h O
plus s O
isoflurane f O
- 
 O
oxygen g O
. 
 O
Therefore r O
, 
 O
it O O
appears e O
that t O
GCN2 2 B-GENE
protein t I-GENE
kinase a E-GENE
function c O
is O O
stimulated m O
posttranslationally t O
in O O
amino n O
acid d O
- 
 O
starved r O
cells l O
. 
 O
Although h O
paclitaxel l O
alone n O
failed l O
to O O
induce u O
p38 	 B-GENE
MAPK K E-GENE
activation i O
, 
 O
subsequent s O
( 
 O
but 	 O
not 	 O
prior o O
) 
 O
exposure o O
to O O
PD98059 8 O
induced u O
a 
 O
dramatic m O
increase r O
in O O
p38 	 B-GENE
MAPK K E-GENE
phosphorylation s O
. 
 O
In O O
3 
 O
of O O
the 	 O
5 
 O
patients i O
with h O
AVNRT R O
and 	 O
AJR 	 O
, 
 O
junctional c O
beats t O
served v O
as O O
a 
 O
trigger g O
for 	 O
reentry n O
. 
 O
The 	 O
three e O
respective p O
time e O
control t O
groups u O
( 
 O
C5 O O
, 
 O
C10 	 O
, 
 O
and 	 O
C15 	 O
) 
 O
were e O
injected e O
with h O
saline i O
solution u O
. 
 O
Sequence u O
analysis l O
of O O
cDNA A O
clones n O
encoding o O
human a O
gamma m O
revealed e O
an O O
open n O
reading d O
frame m O
predicting d O
a 
 O
protein t O
of O O
299 	 O
amino n O
acids d O
( 
 O
approximately r O
32 O O
kDa 	 O
) 
 O
, 
 O
half f O
the 	 O
size e O
of O O
the 	 O
bovine i O
gamma m O
subunit u O
. 
 O
A 
 O
positive i O
FTA 	 O
- - O
ABS 	 O
- - O
19S 	 O
- - O
IgM 	 S-GENE
test t O
indicates i O
the 	 O
necessity e O
of O O
treatment a O
. 
 O
Our 	 O
data a O
suggest g O
that t O
some e O
defects e O
observed e O
in O O
BS O O
, 
 O
WS O O
or O O
RTS 	 O
are 	 O
the 	 O
consequence s O
of O O
unrestrained e O
recombination o O
. 
 O
The 	 O
promoter m O
for 	 O
HMG 	 B-GENE
- - I-GENE
CoA 	 I-GENE
synthase t E-GENE
contains t O
two 	 O
binding d O
sites e O
for 	 O
the 	 O
sterol r B-GENE
regulatory u I-GENE
element m I-GENE
- - I-GENE
binding d I-GENE
proteins t E-GENE
( 
 O
SREBPs B S-GENE
) 
 O
. 
 O
These s O
data a O
indicate i O
that t O
chromatic o O
processing c O
in O O
areas a O
V1 O O
and 	 O
V2 O O
is O O
normal m O
after e O
V4 O O
lesions i O
and 	 O
, 
 O
together e O
with h O
the 	 O
behavioural a O
evidence d O
, 
 O
that t O
these s O
areas a O
are 	 O
sufficient f O
for 	 O
some e O
basic i O
aspects e O
of O O
colour o O
perception c O
. 
 O
The 	 O
curse s O
of O O
the 	 O
Pharaohs r O
. 
 O
Covariates a O
were e O
lower e O
extremity r O
range g O
of O O
motion i O
and 	 O
sensory s O
status t O
. 
 O
Characterization r O
and 	 O
targeted g O
disruption r O
of O O
murine i B-GENE
Nup50 5 E-GENE
, 
 O
a 
 O
p27 	 S-GENE
( 
 O
Kip1 1 S-GENE
) 
 O
- 
 O
interacting e O
component p O
of O O
the 	 O
nuclear l O
pore e O
complex p O
. 
 O
p27 	 S-GENE
( 
 O
Kip1 1 S-GENE
) 
 O
is O O
a 
 O
member b O
of O O
the 	 O
Cip 	 S-GENE
- 
 O
Kip 	 S-GENE
family i O
of O O
cyclin l B-GENE
- - I-GENE
dependent e I-GENE
kinase a E-GENE
( 
 O
Cdk 	 S-GENE
) 
 O
inhibitors i O
that t O
binds d O
to O O
cyclin l S-GENE
- 
 O
Cdk 	 S-GENE
complexes p O
and 	 O
inhibits i O
their i O
catalytic a O
activity i O
in O O
response p O
to O O
antiproliferative i O
stimuli m O
. 
 O
p27 	 S-GENE
( 
 O
Kip1 1 S-GENE
) 
 O
is O O
regulated u O
by O O
several e O
posttranscriptional t O
mechanisms h O
, 
 O
including l O
subcellular c O
localization a O
. 
 O
Therefore r O
, 
 O
the 	 O
Ogg1 1 B-GENE
protein t E-GENE
is O O
a 
 O
eukaryotic a O
DNA 	 B-GENE
glycosylase c E-GENE
/ 
 O
AP B B-GENE
lyase s E-GENE
. 
 O
One 	 O
patient i O
had 	 O
chronic o O
dysphoria p O
and 	 O
one 	 O
encephalopatia e O
toxica i O
. 
 O
Alveoli e O
- 
 O
capillary i O
diffusion f O
. 
 O
Mutations a O
of O O
SIN4 4 S-GENE
, 
 O
ROX3 3 S-GENE
, 
 O
SRB8 8 S-GENE
, 
 O
SRB9 9 S-GENE
, 
 O
SRB10 1 S-GENE
, 
 O
SRB11 1 S-GENE
, 
 O
and 	 O
two 	 O
novel e O
genes e O
, 
 O
NUT1 1 S-GENE
and 	 O
NUT2 2 S-GENE
, 
 O
relieve i O
the 	 O
requirement u O
of O O
Swi4p 4 S-GENE
for 	 O
expression r O
of O O
this s O
reporter o O
. 
 O
The 	 O
software t O
is O O
in O O
BASIC I O
adapted p O
for 	 O
the 	 O
Hewlett l O
- 
 O
Packard k O
calculators c O
HP O O
- 
 O
9845B 5 O
and 	 O
HP O O
- 
 O
85A 	 O
. 
 O
For 	 O
Thermus r B-GENE
strain a I-GENE
ZO5 	 I-GENE
dihydroorotase y E-GENE
( 
 O
DHOase a S-GENE
; 
 O
encoded o O
by O O
pyrC C S-GENE
) 
 O
, 
 O
the 	 O
highest h O
similarity i O
scores r O
( 
 O
about u O
40 O O
% 
 O
identity n O
) 
 O
were e O
obtained a O
with h O
DHOases a S-GENE
from m O
B 
 O
. 
 O
caldolyticus d O
and 	 O
Bacillus i O
subtilis t O
. 
 O
Precision c O
of O O
data a O
from m O
models e O
of O O
sodium i O
kinetics e O
in O O
hemodialysis o O
These s O
data a O
suggest g O
that t O
the 	 O
fibrinogen r B-GENE
gamma m E-GENE
chain i O
region i O
Gly190 1 O
- - O
Val202 2 O
functions c O
as O O
a 
 O
minimal i O
recognition o O
sequence u O
for 	 O
the 	 O
leukocyte k B-GENE
integrin e E-GENE
CD11b 1 S-GENE
/ 
 O
CD18 8 S-GENE
. 
 O
Attenuated e O
serum u O
cortisol t O
responses p O
were e O
found n O
in O O
six 	 O
of O O
the 	 O
patients i O
despite p O
a 
 O
normal m O
ACTH H S-GENE
test t O
. 
 O
We O O
recently e O
described c O
the 	 O
isolation l O
and 	 O
characterization r O
of O O
nontoxic t O
PAP 	 B-GENE
mutants a E-GENE
, 
 O
NT123 2 B-GENE
- 
 I-GENE
2 
 E-GENE
, 
 O
which c O
has 	 O
a 
 O
point n O
mutation a O
( 
 O
E176V 6 O
) 
 O
in O O
the 	 O
active i O
site e O
that t O
abolishes l O
enzymatic y O
activity i O
, 
 O
and 	 O
NT124 2 B-GENE
- 
 I-GENE
3 
 E-GENE
, 
 O
which c O
has 	 O
a 
 O
nonsense s O
mutation a O
that t O
results u O
in O O
deletion e O
of O O
the 	 O
C 
 O
- 
 O
terminal m O
25 O O
aa O O
( 
 O
W237Stop 7 O
) 
 O
. 
 O
Toxicity i O
of O O
benzoyl z O
chloride o O
( 
 O
2 
 O
, 
 O
4 
 O
, 
 O
6 
 O
- 
 O
trichlorophenyl c O
) 
 O
hydrazone r O
( 
 O
Banamite a O
) 
 O
and 	 O
potential e O
metabolites a O
to O O
twospotted s O
spider d O
mites e O
and 	 O
potency e O
as O O
inhibitors i O
of O O
rat 	 B-GENE
liver e I-GENE
monoamine o I-GENE
oxidase d E-GENE
. 
 O
The 	 O
screen e O
identifies n O
mutants a O
whose s O
growth w O
depends e O
on O O
high h O
levels e O
of O O
expression r O
of O O
that t O
gene e O
. 
 O
The 	 O
genes e O
expressed r O
during i O
the 	 O
embryonic r O
( 
 O
zeta a O
) 
 O
or O O
fetal a O
and 	 O
adult l O
stage g O
( 
 O
alpha h B-GENE
2 - E-GENE
and 	 O
alpha h B-GENE
1 - E-GENE
) 
 O
can 	 O
be O O
modified i O
by O O
point n O
mutations a O
which c O
affect e O
either h O
the 	 O
processing c O
- 
 O
translation n O
of O O
mRNA A O
or O O
make e O
the 	 O
polypeptide y O
chains i O
extremely r O
unstable t O
. 
 O
In O O
a 
 O
study d O
in O O
Singapore g O
, 
 O
Chinese n O
, 
 O
Malay a O
and 	 O
Indian i O
patients i O
with h O
pulmonary m O
tuberculosis e O
received e O
2 
 O
months t O
of O O
daily l O
treatment a O
with h O
streptomycin e O
, 
 O
isoniazid n O
, 
 O
rifampicin a O
, 
 O
and 	 O
pyrazinamide a O
followed l O
by O O
daily l O
isoniazid n O
, 
 O
and 	 O
rifampicin a O
either h O
with h O
pyrazinamide a O
( 
 O
SHRZ Z O
/ 
 O
HRZ 	 O
) 
 O
or O O
without h O
it O O
( 
 O
SHRZ Z O
/ 
 O
HR O O
) 
 O
, 
 O
allocated o O
at O O
random d O
. 
 O
Kaposi o B-GENE
' 
 I-GENE
s 
 I-GENE
sarcoma c I-GENE
- 
 I-GENE
associated o I-GENE
herpesvirus p I-GENE
/ 
 I-GENE
human a I-GENE
herpesvirus p I-GENE
- 
 I-GENE
8 
 I-GENE
ORF50 5 I-GENE
gene e I-GENE
product d E-GENE
contains t O
a 
 O
potent e O
C 
 O
- 
 O
terminal m O
activation i O
domain a O
which c O
activates i O
gene e O
expression r O
via 	 O
a 
 O
specific c O
target g O
sequence u O
. 
 O
NSAIDS I O
and 	 O
the 	 O
microcirculation r O
of O O
the 	 O
stomach m O
. 
 O
The 	 O
efficiency i O
of O O
transfections n O
was 	 O
normalized m O
relative a O
to O O
the 	 O
net 	 O
amount u O
of O O
CAT 	 O
plasmid s O
actually u O
transfected n O
into o O
recipient i O
cells l O
, 
 O
determined e O
by O O
a 
 O
modified i O
Southern t O
hybridization r O
procedure c O
. 
 O
Genomic o O
Southern t O
blot t O
analysis l O
suggests g O
that t O
the 	 O
human a O
haploid l O
genome o O
contains t O
a 
 O
single g O
Gs B B-GENE
alpha h I-GENE
gene e E-GENE
. 
 O
Evaluation l O
of O O
the 	 O
effects e O
of O O
chelation l O
therapy r O
with h O
time e O
following l O
strontium o O
exposure o O
to O O
mice e O
. 
 O
In O O
the 	 O
present s O
study d O
we O O
found n O
that t O
CD34 4 S-GENE
downregulation n O
during i O
hematopoiesis a O
occured u O
at O O
the 	 O
level e O
of O O
transcriptional n O
initiation t O
. 
 O
Allergen e O
- 
 O
stimulated m O
levels e O
of O O
PGD2 2 O
were e O
1274 4 O
+ 
 O
/ 
 O
- 
 O
565 	 O
versus s O
1468 8 O
+ 
 O
/ 
 O
- 
 O
679 	 O
after e O
prednisone d O
; 
 O
likewise e O
, 
 O
allergen e O
- 
 O
stimulated m O
5 
 O
- 
 O
HETE E O
levels e O
were e O
95 O O
+ 
 O
/ 
 O
- 
 O
21 O O
versus s O
82 O O
+ 
 O
/ 
 O
- 
 O
21 O O
; 
 O
those s O
of O O
LTE4 4 O
were e O
54 O O
+ 
 O
/ 
 O
- 
 O
20 O O
versus s O
91 O O
+ 
 O
/ 
 O
- 
 O
51 O O
; 
 O
and 	 O
those s O
of O O
15 O O
- 
 O
HETE E O
were e O
63 O O
+ 
 O
/ 
 O
- 
 O
19 O O
versus s O
60 O O
+ 
 O
/ 
 O
- 
 O
25 O O
. 
 O
Foreign e O
DNA 	 O
inserts e O
contained t O
within h O
the 	 O
fowlpox l O
virus u O
sequence u O
were e O
transferred n O
to O O
the 	 O
viral a O
genome o O
by O O
homologous o O
recombination o O
occurring u O
in O O
cells l O
infected e O
with h O
a 
 O
fowlpox l O
virus u O
temperature p O
- 
 O
sensitive s O
mutant a O
and 	 O
transfected n O
with h O
both h O
wild d O
- 
 O
type e O
viral a O
DNA 	 O
and 	 O
plasmid s O
DNA 	 O
. 
 O
Although h O
there r O
is O O
evidence d O
that t O
cone e O
ratios i O
do O O
determine e O
colour o O
appearance e O
under e O
many y O
conditions d O
, 
 O
the 	 O
site e O
or O O
sites e O
of O O
their i O
computation p O
is O O
unknown n O
. 
 O
Furthermore t O
, 
 O
we O O
demonstrate o O
that t O
in O O
myeloid l O
and 	 O
B 
 O
cell l O
extracts r O
, 
 O
PU B B-GENE
. - I-GENE
1 - E-GENE
forms m O
a 
 O
novel e O
, 
 O
specific c O
, 
 O
more e O
slowly w O
migrating r O
complex p O
( 
 O
PU B B-GENE
- - I-GENE
SF E E-GENE
) 
 O
when n O
binding d O
the 	 O
GM B B-GENE
- - I-GENE
CSF 	 I-GENE
receptor e I-GENE
alpha h I-GENE
promoter m I-GENE
PU B I-GENE
. - I-GENE
1 - I-GENE
site e E-GENE
. 
 O
Several e O
components p O
in O O
cytokine o O
signaling n O
remain a O
unidentified d O
. 
 O
This s O
is O O
the 	 O
first s O
report o O
demonstrating o O
specificity c O
at O O
the 	 O
level e O
of O O
the 	 O
energy r O
coupling p O
proteins t O
of O O
the 	 O
PTS 	 O
. 
 O
In O O
contrast t O
, 
 O
stem m O
- 
 O
loop p O
structures u O
2 
 O
, 
 O
3 
 O
, 
 O
and 	 O
4 
 O
of O O
the 	 O
3 
 O
' 
 O
domain a O
showed w O
great a O
variations i O
in O O
size e O
, 
 O
sequence u O
, 
 O
and 	 O
structure u O
. 
 O
A 
 O
spectrophotometric c O
method h O
for 	 O
the 	 O
microdetermination r O
of O O
periodate i O
. 
 O
Result u O
were e O
as O O
followed l O
: 
 O
1 
 O
) 
 O
Early l O
cancer c O
- 
 O
like e O
advanced a O
cancers c O
were e O
consisted s O
of O O
133 	 O
lesions i O
, 
 O
of O O
which c O
128 	 O
lesions i O
( 
 O
96 O O
. 
 O
2 
 O
% 
 O
) 
 O
had 	 O
peptic t O
ulcer e O
in O O
cancerous c O
lesion i O
( 
 O
73 O O
lesions i O
were e O
active i O
stage g O
and 	 O
55 O O
lesions i O
were e O
scarring r O
stage g O
) 
 O
. 
 O
Effect e O
of O O
hyperaemia e O
on O O
thallium l O
- 
 O
201 	 O
redistribution i O
in O O
normal m O
canine i O
myocardium c O
. 
 O
Immunoblotting u O
showed w O
that t O
both h O
the 	 O
( 
 O
1 
 O
- 
 O
404 	 O
) 
 O
- 
 O
peptide t O
and 	 O
( 
 O
1 
 O
- 
 O
506 	 O
) 
 O
- 
 O
peptide t O
are 	 O
recognized o O
by O O
95J10 1 O
, 
 O
a 
 O
monoclonal o O
antibody i O
that t O
was 	 O
previously v O
raised s O
against i O
perlecan l O
- - O
( - O
24 I O
- - O
404 	 O
) - O
- - O
peptide t O
expressed r O
in O O
Escherichia h O
coli i O
. 
 O
The 	 O
anesthesiologist s O
and 	 O
the 	 O
cardiac d O
surgeon g O
. 
 O
To O O
gain n O
further t O
insights i O
into o O
these s O
events n O
, 
 O
the 	 O
porcine c B-GENE
G - I-GENE
alpha h I-GENE
i - I-GENE
- - I-GENE
3 - I-GENE
gene e I-GENE
minimal i I-GENE
promoter m E-GENE
was 	 O
characterized r O
and 	 O
found n O
67 O O
base e O
pairs r O
upstream t O
from m O
the 	 O
major o O
transcription n O
start r O
site e O
. 
 O
FDP 	 B-GENE
- 
 I-GENE
1 
 E-GENE
( 
 O
200 	 O
micrograms r O
. 
 O
kg O O
- 
 O
1 
 O
) 
 O
of O O
intracoronary r O
injection e O
increased r O
collateral l O
flow w O
, 
 O
reduced u O
systemic t O
artery e O
resistance i O
, 
 O
and 	 O
coronary o O
systolic t O
pressure s O
in O O
infarcted a O
region i O
and 	 O
the 	 O
area a O
of O O
infarction a O
decreased r O
from m O
28 O O
. 
 O
9 
 O
+ 
 O
/ 
 O
- 
 O
1 
 O
. 
 O
3 
 O
% 
 O
to O O
15 O O
. 
 O
3 
 O
+ 
 O
/ 
 O
- 
 O
1 
 O
. 
 O
2 
 O
% 
 O
( 
 O
P 
 O
< 
 O
0 
 O
. 
 O
01 O O
, 
 O
n 
 O
= 
 O
6 
 O
) 
 O
. 
 O
Pathophysiologic h O
mechanisms h O
underlying e O
spatial t O
disorientation o O
in O O
patients i O
with h O
Alzheimer h O
' 
 O
s 
 O
disease e O
. 
 O
Many y O
human a O
malignant i O
cells l O
lack k O
methylthioadenosine h B-GENE
phosphorylase s E-GENE
( 
 O
MTAP P S-GENE
) 
 O
enzyme y O
activity i O
. 
 O
Following l O
40 O O
min 	 O
" 
 O
ischemia h O
" 
 O
, 
 O
preparations p O
treated a O
with h O
PC O O
recovered o O
from m O
transmural n O
conduction d O
block c O
more e O
rapidly i O
( 
 O
PC1 	 O
group u O
, 
 O
4 
 O
min 	 O
, 
 O
P 
 O
less s O
than n O
0 
 O
. 
 O
05 O O
; 
 O
PC2 	 O
group u O
, 
 O
23 O O
min 	 O
, 
 O
ns O O
) 
 O
, 
 O
compared p O
to O O
control t O
. 
 O
( 
 O
ABSTRACT T O
TRUNCATED N O
AT O O
250 	 O
WORDS D O
) 
 O
The 	 O
novel e O
gene e O
spans n O
16 O O
. 
 O
7 
 O
kb O O
of O O
genomic o O
sequence u O
and 	 O
it O O
is O O
formed m O
of O O
11 O O
exons n O
and 	 O
10 O O
intervening e O
introns r O
. 
 O
G - B-GENE
- - I-GENE
box 	 I-GENE
binding d I-GENE
factors t E-GENE
( 
 O
GBFs s S-GENE
) 
 O
constitute s O
a 
 O
family i O
of O O
plant n O
DNA 	 O
- 
 O
binding d O
proteins t O
that t O
bind d O
to O O
the 	 O
G 
 O
- 
 O
box 	 O
motif i O
, 
 O
a 
 O
regulatory u O
cis 	 O
element m O
present s O
in O O
many y O
plant n O
genes e O
with h O
a 
 O
palindromic i O
DNA 	 O
motif i O
of O O
CACGTG G O
. 
 O
CONCLUSION C O
: 
 O
In O O
an O O
acute t O
canine i O
model e O
of O O
progressive g O
LCX 	 O
coronary o O
stenosis n O
, 
 O
CFR 	 O
was 	 O
impaired a O
in O O
both h O
ischemic h O
and 	 O
remote o O
nonischemic i O
regions i O
in O O
association o O
with h O
mild d O
to O O
moderate e O
ischemic h O
- 
 O
induced u O
regional i O
myocardial c O
dysfunction f O
. 
 O
A 
 O
third r O
- 
 O
order e O
polynominal y O
fit 	 O
showed w O
a 
 O
good d O
correlation r O
for 	 O
the 	 O
parameter a O
Q 
 O
* 
 O
and 	 O
MTT 	 O
, 
 O
whereas r O
T 
 O
and 	 O
SImax a O
were e O
found n O
to O O
have e O
a 
 O
poor r O
correlation r O
. 
 O
Late e O
results u O
in O O
the 	 O
treatment a O
of O O
urotuberculosis t O
Changes n O
in O O
the 	 O
frequency q O
of O O
X 
 O
- 
 O
chromatin o O
in O O
women e O
under e O
Prednisone d O
therapy r O
Other e O
toxicities i O
attributed r O
to O O
CPT 	 O
- 
 O
11 O O
included l O
dehydration y O
, 
 O
nausea s O
, 
 O
vomiting i O
, 
 O
and 	 O
asthenia h O
. 
 O
Proceedings c O
: 
 O
Influence l O
of O O
halothane o O
on O O
mortality t O
from m O
murine i O
hepatitis a O
virus u O
( 
 O
MHV3 3 O
) 
 O
. 
 O
These s O
results u O
extend e O
our 	 O
knowledge w O
of O O
this s O
SNF2 2 B-GENE
- - I-GENE
like e I-GENE
family i I-GENE
member b E-GENE
and 	 O
suggest g O
a 
 O
role e O
for 	 O
PASG G S-GENE
in O O
leukemogenesis k O
. 
 O
The 	 O
difference f O
between w O
the 	 O
results u O
in O O
the 	 O
high h O
dose e O
AHLG G O
and 	 O
in O O
the 	 O
control t O
group u O
was 	 O
significant n O
( 
 O
p 
 O
less s O
than n O
0 
 O
. 
 O
05 O O
) 
 O
. 
 O
Results u O
of O O
this s O
study d O
indicate i O
that t O
when n O
amniotic i O
fluid i O
samples p O
are 	 O
stored r O
frozen z O
and 	 O
strict i O
quality l O
control t O
is O O
maintained n O
in O O
analytic l O
procedures c O
, 
 O
only y O
minimal i O
changes n O
occur u O
in O O
phospholipid s O
concentrations c O
over r O
12 O O
months t O
. 
 O
Retinoic i O
acid d O
, 
 O
which c O
inhibits i O
the 	 O
progression g O
of O O
certain t O
cancers c O
, 
 O
repressed r O
v - B-GENE
- - I-GENE
src 	 E-GENE
- 
 O
induced u O
MMP 	 B-GENE
- - I-GENE
1 - E-GENE
transcription n O
. 
 O
The 	 O
pattern t O
of O O
net 	 O
RNA 	 O
expression r O
in O O
adult l O
mouse s O
tissues s O
is O O
different f O
. 
 O
Immunoprecipitation u O
of O O
spinophilin n O
or O O
neurabin r O
from m O
crude d O
brain i O
extracts r O
selectively e O
coprecipitated r O
PP1gamma g S-GENE
( - O
1 - O
) - O
over r O
PP1beta b S-GENE
. 
 O
The 	 O
authors h O
discussed c O
their i O
experience e O
in O O
investigating e O
20 O O
patients i O
with h O
maxillary i O
malignant i O
tumors o O
using n O
routine t O
x 
 O
- 
 O
ray 	 O
studies d O
and 	 O
MR O O
- 
 O
tomography o O
, 
 O
and 	 O
13 O O
patients i O
, 
 O
investigated e O
in O O
the 	 O
same e O
way 	 O
plus s O
CT O O
. 
 O
Reduction u O
of O O
p53 	 B-GENE
protein t E-GENE
was 	 O
detected e O
after e O
1 
 O
day 	 O
of O O
OM S O
treatment a O
and 	 O
reached c O
maximal i O
suppression p O
of O O
10 O O
- 
 O
20 O O
% 
 O
of O O
control t O
after e O
3 
 O
days s O
in O O
H3922 2 O
and 	 O
40 O O
% 
 O
of O O
control t O
after e O
4 
 O
days s O
in O O
MCF 	 O
- 
 O
7 
 O
cells l O
. 
 O
Association o O
of O O
Syk 	 B-GENE
protein t I-GENE
tyrosine o I-GENE
kinase a E-GENE
( 
 O
PTK 	 S-GENE
) 
 O
with h O
LMP2A 2 S-GENE
occurs u O
at O O
the 	 O
two 	 O
tyrosines o O
of O O
the 	 O
LMP2A 2 S-GENE
immunoreceptor u O
tyrosine o O
- 
 O
based e O
activation i O
motif i O
, 
 O
and 	 O
it O O
is O O
hypothesized o O
that t O
Lyn 	 B-GENE
PTK 	 E-GENE
associates o O
with h O
the 	 O
YEEA A O
amino n O
acid d O
motif i O
at O O
LMP2A 2 O
tyrosine o O
112 	 O
( 
 O
Y112 2 O
) 
 O
. 
 O
The 	 O
treatment a O
with h O
glucocorticoids c O
and 	 O
immunosuppressants u O
resulted u O
in O O
a 
 O
more e O
noticeable i O
decrease r O
in O O
the 	 O
levels e O
of O O
T3 O O
and 	 O
E - O
- - O
RCF 	 O
. 
 O
Four r O
of O O
these s O
fibroblast r O
clones n O
were e O
infected e O
with h O
a 
 O
retrovirus r O
containing t O
the 	 O
cDNA A O
encoding o O
myoD D S-GENE
and 	 O
a 
 O
puromycin o O
selection e O
marker k O
. 
 O
Serum u O
estriol r O
levels e O
during i O
beta a B-GENE
- - I-GENE
receptor e E-GENE
agonist n O
infusion u O
in O O
the 	 O
third r O
trimester m O
of O O
pregnancy g O
. 
 O
In O O
this s O
study d O
, 
 O
we O O
investigated e O
the 	 O
mechanism h O
by O O
which c O
Tax 	 S-GENE
activates i O
gene e O
expression r O
in O O
conjunction j O
with h O
members b O
of O O
the 	 O
ATF 	 S-GENE
/ 
 O
CREB B S-GENE
family i O
. 
 O
Four r O
of O O
12 O O
patients i O
( 
 O
33 O O
% 
 O
) 
 O
were e O
initially t O
diagnosed g O
as O O
having i O
a 
 O
benign i O
disease e O
( 
 O
false s O
- 
 O
negatives a O
) 
 O
. 
 O
However e O
, 
 O
it O O
was 	 O
observed e O
that t O
storage r O
time e O
affected e O
significantly n O
the 	 O
biochemical c O
changes n O
occurring u O
in O O
the 	 O
constituents s O
of O O
carrots r O
exposed o O
to O O
gamma m O
- 
 O
irradiation a O
. 
 O
Suppression p O
of O O
the 	 O
cka1 1 B-GENE
delta t I-GENE
cka2 2 I-GENE
- - I-GENE
8 - I-GENE
mutant a I-GENE
phenotype n E-GENE
occurs u O
by O O
interaction e O
of O O
CKB1 1 S-GENE
with h O
the 	 O
defective e O
, 
 O
cka2 2 B-GENE
- - I-GENE
8 - E-GENE
- 
 O
encoded o O
, 
 O
catalytic a O
subunit u O
. 
 O
The 	 O
median i O
cumulative u O
incidence i O
rates e O
were e O
found n O
to O O
be O O
341 	 O
per 	 O
million l O
for 	 O
males e O
and 	 O
296 	 O
per 	 O
million l O
for 	 O
females a O
. 
 O
Thomas m O
, 
 O
S 
 O
. 
 O
S 
 O
. 
 O
Similarly i O
, 
 O
antisense i O
TGF 	 B-GENE
- - I-GENE
beta a I-GENE
type e I-GENE
II I I-GENE
receptor e E-GENE
oligodeoxynucleotides g O
( - O
40 I O
microM r O
) - O
resulted u O
in O O
a 
 O
58 O O
% 
 O
increase r O
in O O
branching n O
, 
 O
compared p O
to O O
scrambled a O
and 	 O
mismatched m O
sequence u O
controls t O
, 
 O
while l O
TGF 	 B-GENE
- - I-GENE
beta a E-GENE
, - O
type e B-GENE
II I I-GENE
receptor e I-GENE
mRNA A E-GENE
and 	 O
its 	 O
protein t O
expression r O
levels e O
were e O
suppressed p O
by O O
95 O O
and 	 O
84 O O
% 
 O
, 
 O
respectively p O
. 
 O
Secretion r O
of O O
cuticle i O
over r O
and 	 O
between w O
the 	 O
domed e O
apical c O
surfaces f O
of O O
these s O
cells l O
leads d O
to O O
a 
 O
honeycomb e O
- 
 O
like e O
structure u O
and 	 O
gives e O
the 	 O
superficial e O
wart t O
- 
 O
like e O
phenotype n O
of O O
mitotic o O
clones n O
on O O
the 	 O
adult l O
. 
 O
Taken e O
together e O
, 
 O
these s O
results u O
indicate i O
that t O
ICSBP B S-GENE
and 	 O
PU B B-GENE
. - I-GENE
1 - E-GENE
are 	 O
critical t O
elements m O
for 	 O
IL B B-GENE
- - I-GENE
18 I I-GENE
gene e E-GENE
expression r O
. 
 O
Based e O
on O O
these s O
results u O
, 
 O
it O O
has 	 O
been n O
concluded c O
that t O
an O O
IPFSA S S-GENE
can 	 O
promote m O
the 	 O
healing l O
process c O
in O O
the 	 O
avascular s O
zone e O
of O O
a 
 O
torn n O
meniscus i O
in O O
rabbits b O
and 	 O
that t O
systemic t O
vascularity c O
to O O
the 	 O
synovium o O
or O O
the 	 O
meniscus i O
is O O
not 	 O
essential e O
for 	 O
healing l O
to O O
occur u O
. 
 O
NASA A O
CR O O
- 
 O
1223 3 O
. 
 O
The 	 O
magnitude n O
of O O
all 	 O
four r O
parameters a O
increased r O
in O O
an O O
exponential o O
fashion h O
with h O
increasing r O
sperm r O
number b O
up O O
to O O
400 	 O
x 
 O
10 O O
( 
 O
6 
 O
) 
 O
per 	 O
ejaculate c O
. 
 O
We O O
studied d O
about u O
the 	 O
histological t O
findings d O
of O O
the 	 O
kidneys n O
including l O
of O O
the 	 O
infiltrated i O
macrophages r O
in O O
one 	 O
hour r O
post t O
- 
 O
transplantation n O
kidney n O
biopsies p O
( 
 O
one 	 O
hour r O
biopsies p O
) 
 O
and 	 O
re O O
- 
 O
biopsies p O
on O O
11 O O
patients i O
. 
 O
An O O
additional i O
stimulation m O
of O O
D1 B B-GENE
receptors e E-GENE
by O O
giving i O
SKF38393 3 O
30 O O
min 	 O
later e O
produced d O
an O O
almost o O
continuous t O
pattern t O
of O O
jaw 	 O
openings n O
but 	 O
less s O
closure s O
movements e O
from m O
the 	 O
rest t O
position i O
, 
 O
and 	 O
the 	 O
openings n O
were e O
accompanied o O
by O O
frequent q O
tongue g O
protrusions t O
. 
 O
( 
 O
control t O
hearts r O
) 
 O
. 
 O
The 	 O
( 
 O
0 
 O
0 
 O
2 
 O
) 
 O
diffraction f O
of O O
the 	 O
synthesized t O
HAp 	 O
crystals s O
on O O
a 
 O
Col 	 O
fiber e O
showed w O
an O O
around u O
60 O O
arching h O
angle l O
, 
 O
while l O
that t O
on O O
a 
 O
ChS 	 O
fiber e O
showed w O
just t O
around u O
10 O O
degrees r O
. 
 O
During i O
4 
 O
% 
 O
O2 O O
ventilation t O
, 
 O
baseline e O
pulmonary m O
vascular c O
resistance i O
( 
 O
PVR 	 O
) 
 O
and 	 O
the 	 O
dilator a O
response p O
to O O
both h O
ACh 	 O
and 	 O
SNP 	 O
were e O
greater a O
in O O
2D O O
lungs g O
. 
 O
To O O
determine e O
the 	 O
role e O
of O O
the 	 O
transmembrane n O
region i O
of O O
HN S S-GENE
on O O
fusion i O
- 
 O
promoting m O
activity i O
, 
 O
mutant a B-GENE
HN I I-GENE
proteins t E-GENE
were e O
expressed r O
and 	 O
their i O
biological l O
activities i O
examined m O
. 
 O
To O O
be O O
a 
 O
nurse s O
. 
 O
Transient n O
transfection n O
assays a O
indicated i O
that t O
the 	 O
( 
 O
- 
 O
4551 1 O
) 
 O
UCP1 1 O
- 
 O
CAT 	 O
construct s O
, 
 O
containing t O
the 	 O
5 
 O
' 
 O
- 
 O
regulatory u O
region i O
of O O
the 	 O
rat 	 B-GENE
ucp 	 I-GENE
- - I-GENE
1 - I-GENE
gene e E-GENE
, 
 O
was 	 O
activated i O
by O O
PPARalpha R S-GENE
co O O
- 
 O
transfection n O
in O O
a 
 O
dose e O
- 
 O
dependent e O
manner n O
and 	 O
this s O
activation i O
was 	 O
potentiated e O
by O O
Wy O O
14 O O
, 
 O
643 	 O
and 	 O
retinoid i B-GENE
X - I-GENE
receptor e I-GENE
alpha h E-GENE
. 
 O
Synthesis t O
of O O
2 
 O
- 
 O
( 
 O
2 
 O
' 
 O
- 
 O
thiazolyl a O
) 
 O
alkanebenzimidazoles a O
- 
 O
- 
 O
potential e O
anthelmintics h O
Human a B-GENE
CR2 	 E-GENE
has 	 O
a 
 O
restricted t O
cellular l O
distribution t O
, 
 O
being n O
expressed r O
on O O
B 
 O
lymphocytes p O
, 
 O
dendritic d O
cells l O
of O O
the 	 O
spleen e O
, 
 O
pharyngeal r O
epithelial t O
cells l O
, 
 O
and 	 O
at O O
low 	 O
levels e O
on O O
some e O
T 
 O
lymphocytes p O
. 
 O
ADR1 1 S-GENE
in O O
extracts r O
made e O
from m O
glucose c O
- 
 O
repressed r O
and 	 O
- 
 O
derepressed e O
cells l O
bound n O
UAS1 1 B-GENE
DNA 	 E-GENE
with h O
similar i O
affinities i O
despite p O
having i O
greatly a O
different f O
abilities l O
to O O
activate i O
ADH2 2 B-GENE
gene e E-GENE
expression r O
in O O
vivo o O
. 
 O
Furthermore t O
, 
 O
agonist n O
action i O
at O O
a 
 O
5 - B-GENE
- - I-GENE
HT1 	 I-GENE
receptor e E-GENE
and 	 O
antagonist a O
action i O
at O O
5 - B-GENE
- - I-GENE
HT2 	 I-GENE
receptors e E-GENE
both h O
appear e O
to O O
contribute t O
to O O
antidepressant i O
- 
 O
like e O
activity i O
on O O
the 	 O
DRL 	 O
72 O O
- 
 O
s 
 O
schedule e O
. 
 O
MsEPV P B-GENE
genes e E-GENE
with h O
putative a O
functions c O
in O O
prevention v O
and 	 O
repair a O
of O O
DNA 	 O
damage a O
include l O
a 
 O
complete p O
base e O
excision i O
repair a O
pathway h O
( 
 O
uracil c B-GENE
DNA 	 I-GENE
glycosylase c E-GENE
, 
 O
AP B B-GENE
endonuclease o E-GENE
, 
 O
DNA 	 B-GENE
polymerase y I-GENE
beta a E-GENE
, 
 O
and 	 O
an O O
NAD 	 O
+ - O
- - O
dependent e O
DNA 	 B-GENE
ligase a E-GENE
) 
 O
, 
 O
a 
 O
photoreactivation t O
repair a O
pathway h O
( 
 O
cyclobutane l B-GENE
pyrimidine i I-GENE
dimer e I-GENE
photolyase t E-GENE
) 
 O
, 
 O
a 
 O
LINE E B-GENE
- - I-GENE
type e I-GENE
reverse e I-GENE
transcriptase n E-GENE
, 
 O
and 	 O
a 
 O
mutT T B-GENE
homologue o E-GENE
. 
 O
These s O
three e O
groups u O
were e O
further t O
examined m O
with h O
regard a O
to O O
the 	 O
modulation u O
of O O
discharge c O
rate e O
i 
 O
) 
 O
during i O
motor o O
activity i O
in O O
W 
 O
, 
 O
ii O O
) 
 O
at O O
the 	 O
transitional n O
phase s O
from m O
SS O O
to O O
paradoxical a O
sleep e O
( 
 O
PS O O
) 
 O
, 
 O
iii 	 O
) 
 O
during i O
rapid i O
eye 	 O
movements e O
( 
 O
REMs s O
) 
 O
in O O
PS O O
, 
 O
and 	 O
iv O O
) 
 O
following l O
electrical c O
stimulation m O
of O O
the 	 O
midbrain b O
reticular i O
formation m O
( 
 O
MRF 	 O
) 
 O
. 
 O
Likewise e O
, 
 O
the 	 O
consensus s O
signal n O
believed i O
to O O
be O O
involved o O
in O O
terminating m O
VV B B-GENE
early l I-GENE
gene e E-GENE
transcription n O
, 
 O
TTTTTNT T O
, 
 O
was 	 O
evident d O
at O O
the 	 O
3 
 O
' 
 O
- 
 O
boundary n O
of O O
both h O
the 	 O
N2 O O
and 	 O
M1 O B-GENE
ORFs s E-GENE
suggesting g O
that t O
these s O
genes e O
may 	 O
be O O
VV B B-GENE
early l I-GENE
genes e E-GENE
. 
 O
This s O
radiolabeled i O
, 
 O
900 	 O
- 
 O
bp O O
amplicon l O
was 	 O
used d O
as O O
a 
 O
hybridization r O
probe b O
to O O
screen e O
a 
 O
cDNA A O
library r O
constructed s O
from m O
poly y O
( 
 O
A 
 O
) 
 O
( 
 O
+ 
 O
) 
 O
RNA 	 O
isolated l O
from m O
induced u O
Taxus u O
cells l O
, 
 O
from m O
which c O
a 
 O
full l B-GENE
- 
 I-GENE
length g I-GENE
transacetylase n I-GENE
sequence u E-GENE
was 	 O
obtained a O
. 
 O
Low 	 O
temperature p O
( 
 O
8 
 O
degrees r O
C 
 O
) 
 O
impairs a O
secretory r O
activity i O
, 
 O
again i O
independently e O
of O O
the 	 O
photoperiod t O
selected e O
. 
 O
Left t O
ventricle t O
to O O
coronary o O
sinus u O
fistula t O
. 
 O
In O O
this s O
report o O
we O O
describe c O
the 	 O
structure u O
and 	 O
DNA 	 O
sequence u O
of O O
transcriptional n O
control t O
regions i O
from m O
both h O
human a O
and 	 O
Wistar t O
- - O
rat 	 O
single g O
copy y O
EGF 	 B-GENE
genes e E-GENE
and 	 O
their i O
functional c O
analysis l O
in O O
epithelial t O
cell l O
cultures t O
. 
 O
The 	 O
magnesium n O
content t O
in O O
leukocytes k O
could l O
not 	 O
be O O
estimated i O
because a O
of O O
interaction e O
between w O
the 	 O
ion 	 O
and 	 O
the 	 O
Percoll c O
( 
 O
R 
 O
) 
 O
media i O
. 
 O
The 	 O
sequence u O
of O O
three e O
of O O
them m O
revealed e O
pure e O
CAG 	 O
stretches e O
. 
 O
Furthermore t O
, 
 O
mutations a O
in O O
element m O
II O O
result u O
in O O
changes n O
in O O
the 	 O
RNA 	 O
structure u O
near r O
element m O
III 	 O
, 
 O
consistent s O
with h O
a 
 O
long g O
- 
 O
range g O
interaction e O
that t O
may 	 O
promote m O
translation n O
. 
 O
Although h O
the 	 O
QT O O
duration a O
was 	 O
higher h O
( 
 O
p 
 O
= 
 O
0 
 O
. 
 O
0001 1 O
) 
 O
at O O
night h O
, 
 O
the 	 O
beat t O
- 
 O
to O O
- 
 O
beat t O
variability i O
of O O
this s O
interval e O
was 	 O
lower e O
: 
 O
in O O
the 	 O
time e O
domain a O
( 
 O
decreased r O
standard n O
deviation i O
, 
 O
p 
 O
= 
 O
0 
 O
. 
 O
0005 5 O
) 
 O
, 
 O
in O O
the 	 O
frequency q O
domain a O
( 
 O
decreased r O
low 	 O
- 
 O
frequency q O
power e O
of O O
the 	 O
spectra c O
, 
 O
p 
 O
= 
 O
0 
 O
. 
 O
004 	 O
) 
 O
, 
 O
and 	 O
the 	 O
chaotic o O
domain a O
( 
 O
tighter h O
clustering s O
of O O
the 	 O
points n O
in O O
the 	 O
Poincare n O
plots t O
) 
 O
. 
 O
The 	 O
biological l O
functions c O
of O O
rat 	 B-GENE
surfactant f I-GENE
protein t I-GENE
A - E-GENE
( 
 O
SP B B-GENE
- - I-GENE
A - E-GENE
) 
 O
, 
 O
an O O
oligomer g O
composed p O
of O O
18 O O
polypeptide y O
subunits u O
derived i O
from m O
a 
 O
single g O
gene e O
, 
 O
are 	 O
dependent e O
on O O
intact a O
disulfide u O
bonds d O
. 
 O
A 
 O
V1 B O
mutant a O
generated e O
in O O
vivo o O
with h O
11 O O
of O O
the 	 O
14 O O
N 
 O
- 
 O
terminal m O
amino n O
acids d O
altered e O
, 
 O
was 	 O
viable b O
and 	 O
produced d O
symptoms p O
typical i O
of O O
a 
 O
wild d O
- 
 O
type e O
infection e O
. 
 O
This s O
seems m O
to O O
take e O
place c O
in O O
the 	 O
same e O
nuclear l O
compartment p O
as O O
normal m O
cis 	 O
splicing i O
and 	 O
proceeds c O
through o O
Y 
 O
- 
 O
branched n O
intermediates e O
analogous l O
to O O
the 	 O
lariats i O
formed m O
in O O
cis 	 O
splicing i O
. 
 O
We O O
have e O
demonstrated o O
that t O
the 	 O
specific c O
determination e O
and 	 O
identification n O
of O O
plasma s B-GENE
FbDP P E-GENE
alone n O
is O O
not 	 O
sufficient f O
to O O
follow l O
the 	 O
effectiveness e O
of O O
thrombolytic o O
therapy r O
. 
 O
Chronic o O
, 
 O
recurrent u O
multifocal t O
osteomyelitis e O
. 
 O
Maximum i O
baroreceptor o O
activity i O
measured s O
at O O
140 	 O
mm O O
Hg O O
and 	 O
the 	 O
slope p O
of O O
the 	 O
pressure s O
- 
 O
activity i O
curve v O
were e O
reduced u O
in O O
atherosclerotic e O
( 
 O
n 
 O
= 
 O
15 O O
) 
 O
compared p O
with h O
normal m O
( 
 O
n 
 O
= 
 O
13 O O
) 
 O
rabbits b O
( 
 O
425 	 O
+ 
 O
/ 
 O
- 
 O
34 O O
versus s O
721 	 O
+ 
 O
/ 
 O
- 
 O
30 O O
spikes k O
per 	 O
second o O
and 	 O
6 
 O
. 
 O
2 
 O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
6 
 O
versus s O
10 O O
. 
 O
8 
 O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
8 
 O
spikes k O
per 	 O
second o O
per 	 O
mm O O
Hg O O
, 
 O
respectively p O
, 
 O
P 
 O
< 
 O
. 
 O
05 O O
) 
 O
. 
 O
A 
 O
pathogenetic h O
relation a O
with h O
the 	 O
Eisenmenger e O
' 
 O
s 
 O
syndrome d O
is O O
discussed c O
. 
 O
Coronary o O
vasoconstriction o O
caused s O
by O O
endothelin o B-GENE
- - I-GENE
1 - E-GENE
is O O
enhanced a O
by O O
ischemia h O
- 
 O
reperfusion e O
and 	 O
by O O
norepinephrine e O
present s O
in O O
concentrations c O
typically i O
observed e O
after e O
neonatal n O
cardiopulmonary d O
bypass a O
. 
 O
Located a O
between w O
the 	 O
3 
 O
' 
 O
trans n O
- 
 O
spliced i O
leader d O
acceptor e O
site e O
and 	 O
the 	 O
translational n O
initiation t O
codon o O
of O O
the 	 O
GP63 3 B-GENE
gene e E-GENE
is O O
an O O
area a O
of O O
conserved s O
hexanucleotide a O
direct e O
repeats e O
( 
 O
CTCGCC G O
) 
 O
which c O
vary y O
in O O
number b O
according o O
to O O
species c O
. 
 O
An O O
association o O
was 	 O
found n O
between w O
zafirlukast i O
plasma s O
concentrations c O
and 	 O
increases r O
in O O
PC8SRaw S O
10 O O
h 
 O
after e O
treatment a O
( 
 O
p 
 O
= 
 O
0 
 O
. 
 O
001 	 O
) 
 O
. 
 O
Insulin u S-GENE
- 
 O
secreting r O
islet e O
- 
 O
cell l O
tumours o O
of O O
the 	 O
pancreas c O
. 
 O
Disruption r O
and 	 O
reconstruction o O
: 
 O
narrative r O
insights i O
into o O
the 	 O
experience e O
of O O
family i O
members b O
caring i O
for 	 O
a 
 O
relative a O
diagnosed g O
with h O
serious i O
mental t O
illness n O
. 
 O
The 	 O
results u O
suggest g O
that t O
the 	 O
posterior t O
wall l O
is O O
more e O
compliant p O
than n O
the 	 O
anterior e O
wall l O
( 
 O
that t O
is O O
, 
 O
for 	 O
a 
 O
given e O
difference f O
in O O
transmural n O
pressure s O
, 
 O
the 	 O
local a O
segment m O
length g O
change n O
of O O
the 	 O
posterior t O
wall l O
was 	 O
greater a O
) 
 O
. 
 O
We O O
have e O
previously v O
demonstrated o O
that t O
pyrene e O
in O O
diesel s O
- 
 O
exhaust a O
particles t O
( 
 O
DEP 	 O
) 
 O
has 	 O
an O O
adjuvant u O
activity i O
on O O
immunoglobulin u B-GENE
E - E-GENE
( 
 O
IgE 	 S-GENE
) 
 O
antibody i O
production d O
in O O
mice e O
immunized u O
with h O
Japanese a O
cedar a O
pollen l O
allergen e O
( 
 O
JCPA A O
) 
 O
or O O
ovalbumin l S-GENE
( 
 O
OA S S-GENE
) 
 O
intraperitoneally r O
. 
 O
Partial t O
characterization r O
of O O
the 	 O
CCAAT A O
box 	 O
in O O
the 	 O
promoter m O
of O O
the 	 O
hLGFBP F B-GENE
- - I-GENE
1 - I-GENE
gene e E-GENE
: 
 O
interaction e O
with h O
negatively a O
acting i O
transcription n O
factors t O
in O O
decidualized i O
human a O
endometrial o O
stromal o O
cells l O
. 
 O
We O O
conclude c O
that t O
transcription n O
of O O
both h O
SCD1 1 S-GENE
and 	 O
SCD2 2 B-GENE
genes e E-GENE
is O O
responsive p O
to O O
cellular l O
sterol r O
levels e O
and 	 O
to O O
the 	 O
levels e O
of O O
nuclear l O
SREBP B S-GENE
/ 
 O
ADD1 1 S-GENE
and 	 O
that t O
transcriptional n O
induction u O
requires u O
three e O
spatially t O
conserved s O
cis 	 O
elements m O
, 
 O
that t O
bind d O
SREBP B S-GENE
and 	 O
NF B B-GENE
- - I-GENE
Y - E-GENE
. 
 O
Three e O
transcriptional n O
control t O
elements m O
within h O
300 	 O
base e O
pairs r O
of O O
the 	 O
5 
 O
' 
 O
- 
 O
flanking n O
region i O
of O O
the 	 O
rat 	 B-GENE
glucagon c I-GENE
gene e E-GENE
interact e O
with h O
regulatory u O
cellular l O
proteins t O
and 	 O
direct e O
transcription n O
only y O
in O O
glucagon c S-GENE
- 
 O
producing d O
islet e O
cells l O
. 
 O
A 
 O
role e O
for 	 O
phosphatidylinositol s B-GENE
3 - I-GENE
- - I-GENE
kinase a E-GENE
in O O
the 	 O
regulation u O
of O O
beta a B-GENE
1 - I-GENE
integrin e E-GENE
activity i O
by O O
the 	 O
CD2 	 B-GENE
antigen i E-GENE
. 
 O
Relationship a O
between w O
age 	 O
- 
 O
associated o O
endocrine o O
deficiencies i O
and 	 O
muscle c O
function c O
in O O
elderly e O
women e O
: 
 O
a 
 O
cross s O
- 
 O
sectional t O
study d O
. 
 O
In O O
contrast t O
, 
 O
the 	 O
sequences u O
essential e O
for 	 O
the 	 O
transcription n O
of O O
EFT1 1 S-GENE
were e O
localized a O
to O O
the 	 O
region i O
between w O
the 	 O
start r O
ATG 	 O
and 	 O
the 	 O
stop p O
codon o O
of O O
the 	 O
VPS17 1 B-GENE
gene e E-GENE
that t O
terminates m O
267 	 O
nt O O
upstream t O
on O O
the 	 O
same e O
strand a O
. 
 O
Exposure o O
of O O
raft t O
cultures t O
to O O
activators i O
of O O
protein t B-GENE
kinase a I-GENE
C - E-GENE
, 
 O
such h O
as O O
phorbol r O
esters e O
, 
 O
results u O
in O O
the 	 O
further t O
induction u O
of O O
late e O
gene e O
expression r O
as O O
well l O
as O O
virion i O
assembly e O
. 
 O
A 
 O
case e O
of O O
2 
 O
cancers c O
of O O
the 	 O
colon o O
The 	 O
" 
 O
Gregg g O
phenomenon n O
" 
 O
implies l O
that t O
myocardial c O
function c O
and 	 O
oxygen g O
consumption s O
( 
 O
MVO2 2 O
) 
 O
increase r O
when n O
coronary o O
perfusion f O
is O O
enhanced a O
within h O
or O O
above v O
the 	 O
autoregulatory o O
range g O
. 
 O
We O O
have e O
mapped p O
the 	 O
specific c O
domains a O
within h O
each h O
of O O
the 	 O
proteins t O
responsible p O
for 	 O
this s O
interaction e O
. 
 O
In O O
each h O
of O O
the 	 O
studied d O
HPV 	 O
types e O
, 
 O
the 	 O
two 	 O
CDP 	 B-GENE
/ 
 I-GENE
Cut 	 I-GENE
binding d I-GENE
sites e E-GENE
of O O
PSM 	 S-GENE
overlap r O
with h O
the 	 O
known w O
or O O
presumed s O
binding d O
sites e O
of O O
the 	 O
replication l B-GENE
initiator t I-GENE
protein t I-GENE
E1 E E-GENE
. 
 O
Reduced u O
cell l O
numbers b O
72 O O
h 
 O
after e O
insonation o O
were e O
recorded o O
when n O
the 	 O
cells l O
were e O
insonated o O
at O O
an O O
antinode i O
but 	 O
not 	 O
when n O
they y O
were e O
at O O
a 
 O
node e O
. 
 O
Hydroxyl r O
radical i O
footprinting t O
of O O
DNA 	 O
complexes p O
of O O
the 	 O
ets 	 B-GENE
domain a E-GENE
of O O
PU B B-GENE
. - I-GENE
1 - E-GENE
and 	 O
its 	 O
comparison p O
to O O
the 	 O
crystal s O
structure u O
. 
 O
ATF 	 S-GENE
is O O
formulated m O
from m O
the 	 O
prothrombin t S-GENE
time e O
( 
 O
PT O S-GENE
) 
 O
, 
 O
fibrinogen r S-GENE
transformation n O
rate e O
( 
 O
FTR 	 S-GENE
) 
 O
( 
 O
a 
 O
representation r O
of O O
thrombin o S-GENE
activity i O
) 
 O
, 
 O
and 	 O
a 
 O
consideration s O
of O O
the 	 O
fibrinogen r S-GENE
( 
 O
FBG 	 S-GENE
) 
 O
content t O
of O O
blood o O
plasma s O
. 
 O
( 
 O
LH S S-GENE
P 
 O
< 
 O
0 
 O
. 
 O
05 O O
, 
 O
LH S S-GENE
/ 
 O
FSH 	 S-GENE
P 
 O
< 
 O
0 
 O
. 
 O
01 O O
) 
 O
. 
 O
Inhibition i O
of O O
Raf 	 B-GENE
- - I-GENE
1 - E-GENE
signaling n O
by O O
a 
 O
monoclonal o O
antibody i O
, 
 O
which c O
interferes e O
with h O
Raf 	 B-GENE
- - I-GENE
1 - E-GENE
activation i O
and 	 O
with h O
Mek 	 S-GENE
substrate s O
binding d O
. 
 O
Phenotypic n O
and 	 O
molecular e O
analyses l O
of O O
patients i O
with h O
partial t O
chromosome o O
21 O O
monosomy o O
enabled b O
us O O
to O O
define i O
a 
 O
region i O
, 
 O
spanning n O
2 
 O
. 
 O
4 
 O
Mb O O
between w O
D21S190 S O
and 	 O
D21S226 S O
, 
 O
associated o O
with h O
arthrogryposis h O
, 
 O
mental t O
retardation a O
, 
 O
hypertonia e O
, 
 O
and 	 O
several e O
facial i O
anomalies m O
. 
 O
The 	 O
classic s O
sterol r O
regulatory u O
cis 	 O
element m O
( 
 O
sre 	 O
- 
 O
1 
 O
) 
 O
in O O
the 	 O
LDL 	 B-GENE
receptor e I-GENE
promoter m E-GENE
mediates i O
sterol r B-GENE
regulatory u I-GENE
element m I-GENE
binding d I-GENE
protein t E-GENE
( 
 O
SREBP B S-GENE
) 
 O
- 
 O
binding d O
and 	 O
the 	 O
effects e O
of O O
insulin u S-GENE
and 	 O
platelet t B-GENE
derived i I-GENE
growth w I-GENE
factor t E-GENE
( 
 O
PDGF F S-GENE
) 
 O
. 
 O
The 	 O
Ca2 	 O
+ 
 O
concentration c O
in O O
rats s O
serum u O
after e O
intragastrically r O
fenarimol a O
administration i O
( 
 O
doses e O
1 
 O
/ 
 O
40 O O
, 
 O
1 
 O
/ 
 O
20 O O
and 	 O
1 
 O
/ 
 O
10 O O
LD50 0 O
) 
 O
during i O
5 
 O
days s O
was 	 O
investigated e O
. 
 O
In O O
Cos 	 O
7 
 O
cells l O
transfected n O
with h O
oCRF1var F S-GENE
, 
 O
cAMP P O
accumulation u O
was 	 O
only y O
observed e O
at O O
the 	 O
highest h O
concentration c O
of O O
oCRF F O
utilized l O
( 
 O
100 	 O
nM O O
) 
 O
. 
 O
Pyknotic n O
osteocytes e O
increased r O
at O O
12 O O
h 
 O
( 
 O
p 
 O
less s O
than n O
0 
 O
. 
 O
01 O O
) 
 O
and 	 O
2 
 O
days s O
( 
 O
p 
 O
less s O
than n O
0 
 O
. 
 O
001 	 O
) 
 O
of O O
ischemia h O
. 
 O
The 	 O
right h O
cornea n O
of O O
rats s O
was 	 O
cauterized t O
by O O
drops p O
of O O
1 
 O
. 
 O
5 
 O
N 
 O
HC1 	 O
over r O
30 O O
s 
 O
; 
 O
the 	 O
left t O
one 	 O
served v O
as O O
a 
 O
control t O
. 
 O
The 	 O
isoproterenol p O
infusion u O
was 	 O
adjusted u O
so O O
that t O
heart r O
rate e O
( 
 O
HR O O
) 
 O
was 	 O
at O O
least s O
30 O O
beats t O
/ 
 O
min 	 O
greater a O
than n O
baseline e O
. 
 O
This s O
is O O
probably b O
because a O
, 
 O
in O O
vivo o O
, 
 O
some e O
bacteria t O
( 
 O
perhaps h O
dormant m O
forms m O
) 
 O
are 	 O
not 	 O
entirely i O
dependent e O
upon n O
urease a S-GENE
for 	 O
survival v O
. 
 O
The 	 O
system t O
consists s O
of O O
a 
 O
microcomputer r O
and 	 O
six 	 O
laboratory o O
analyzers l O
: 
 O
a 
 O
blood o O
gas 	 O
analyzer l O
, 
 O
a 
 O
flame m O
photometer t O
, 
 O
a 
 O
plasma s O
osmotic o O
pressure s O
meter e O
, 
 O
a 
 O
chloride o O
ion 	 O
titrator r O
, 
 O
a 
 O
blood o O
sugar a O
analyzer l O
, 
 O
and 	 O
a 
 O
hemoglobin o S-GENE
concentration c O
and 	 O
saturation u O
meter e O
. 
 O
Comparing p O
the 	 O
outcome c O
of O O
the 	 O
group u O
having i O
histologically t O
normal m O
biopsies p O
with h O
the 	 O
group u O
having i O
nonspecifically s O
abnormal o O
ones s O
it O O
is O O
concluded c O
that t O
frontal n O
biopsy p O
is O O
not 	 O
of O O
such h O
high h O
prognostic g O
value u O
as O O
has 	 O
been n O
claimed i O
in O O
previous v O
reports o O
. 
 O
He O O
presented s O
with h O
left t O
lower e O
abdominal o O
pain n O
and 	 O
hematoma a O
after e O
a 
 O
fall l O
. 
 O
Fusion i O
of O O
mouse s B-GENE
CD8 	 I-GENE
+ - E-GENE
class s O
I - B-GENE
MHC 	 E-GENE
- 
 O
restricted t O
T 
 O
cells l O
with h O
the 	 O
BW5147 1 O
thymoma m O
invariably a O
yields l O
CD8 	 B-GENE
- - I-GENE
hybridomas r E-GENE
in O O
which c O
RNA 	 O
transcribed n O
from m O
the 	 O
CD8 	 B-GENE
alpha h E-GENE
( 
 O
Lyt 	 B-GENE
- - I-GENE
2 - E-GENE
) 
 O
gene e O
is O O
undetectable e O
. 
 O
Peak k O
plasma s O
ACTH H S-GENE
responses p O
were e O
not 	 O
significantly n O
different f O
between w O
control t O
and 	 O
patient i O
groups u O
. 
 O
For 	 O
the 	 O
P - B-GENE
transcript n E-GENE
from m O
phage g O
with h O
the 	 O
G 
 O
( 
 O
- 
 O
) 
 O
orientation e O
, 
 O
full l O
termination m O
activity i O
required u O
both h O
the 	 O
region i O
containing t O
the 	 O
stem m O
- 
 O
loop p O
structure u O
and 	 O
upstream t O
sequences u O
. 
 O
Development e O
of O O
neural r O
control t O
of O O
alimentary m O
motor o O
function c O
in O O
the 	 O
vertebrates t O
. 
 O
Nb2 	 O
- 
 O
11C 	 O
cells l O
expressed r O
three e O
PNR 	 B-GENE
- - I-GENE
related a I-GENE
mRNA A I-GENE
transcripts n E-GENE
of O O
2 
 O
. 
 O
5 
 O
, 
 O
3 
 O
. 
 O
0 
 O
and 	 O
> 
 O
10 O O
kb O O
. 
 O
These s O
results u O
suggest g O
that t O
the 	 O
Reg1 1 S-GENE
- 
 O
Glc7 7 S-GENE
phosphatase s O
is O O
a 
 O
cytoplasmic o O
component p O
of O O
the 	 O
machinery h O
responsible p O
for 	 O
returning u O
Snf1 1 B-GENE
kinase a E-GENE
activity i O
to O O
its 	 O
basal a O
level e O
and 	 O
reestablishing s O
glucose c O
repression r O
. 
 O
However e O
, 
 O
the 	 O
blend n O
of O O
Metanil a O
yellow l O
and 	 O
Orange n O
II O O
( 
 O
1 
 O
: 
 O
1 
 O
) 
 O
resulted u O
in O O
the 	 O
D1 O O
50 O O
. 
 O
value u O
of O O
288 	 O
min 	 O
. 
 O
The 	 O
majority o O
of O O
these s O
cells l O
were e O
also o O
OKT4 4 S-GENE
positive i O
( 
 O
helper p O
/ 
 O
inducer u O
T 
 O
lymphocytes p O
) 
 O
, 
 O
while l O
the 	 O
minority o O
were e O
OKT8 8 S-GENE
positive i O
( 
 O
suppressor p O
/ 
 O
cytotoxic o O
T 
 O
lymphocytes p O
) 
 O
. 
 O
AIMS S O
: 
 O
We O O
postulated t O
that t O
perhexiline h O
, 
 O
a 
 O
novel e O
anti i O
- 
 O
ischaemic h O
agent n O
with h O
an O O
oxygen g O
- 
 O
sparing r O
metabolic a O
effect e O
in O O
the 	 O
myocardium c O
( 
 O
via 	 O
inhibition i O
of O O
carnitine n B-GENE
palmitoyltransferase m I-GENE
- - I-GENE
1 - E-GENE
) 
 O
and 	 O
no O O
adverse e O
haemodynamic m O
effects e O
, 
 O
may 	 O
improve r O
symptomatic p O
status t O
in O O
elderly e O
patients i O
with h O
severe e O
aortic t O
stenosis n O
. 
 O
The 	 O
IFNAR A B-GENE
chain i E-GENE
interacts e O
with h O
both h O
IFN 	 B-GENE
- - I-GENE
alpha h I-GENE
2 - E-GENE
and 	 O
IFN 	 B-GENE
- - I-GENE
beta a E-GENE
, 
 O
as O O
demonstrated o O
by O O
cross s O
- 
 O
linking k O
. 
 O
To O O
clone n O
cDNAs A O
for 	 O
the 	 O
beta a O
subunit u O
of O O
rabbit b B-GENE
eIF 	 I-GENE
- - I-GENE
2B E E-GENE
, 
 O
amino n O
acid d O
sequence u O
data a O
was 	 O
first s O
obtained a O
and 	 O
used d O
to O O
design i O
redundant u O
oligonucleotide g O
primers m O
for 	 O
use 	 O
in O O
PCR 	 O
. 
 O
We O O
report o O
the 	 O
cloning n O
of O O
the 	 O
ade1 1 B-GENE
gene e E-GENE
on O O
a 
 O
4 - O
. - O
4 - O
kb I O
Sau3A 3 S-GENE
insert e O
in O O
the 	 O
yeast s O
shuttle t O
vector t O
pWH5 5 O
. 
 O
Nimodipine o O
( 
 O
5 
 O
micrograms r O
/ 
 O
kg O O
) 
 O
followed l O
by O O
infusion u O
of O O
0 
 O
. 
 O
75 O O
microgram r O
/ 
 O
kg O O
/ 
 O
min 	 O
lowered e O
the 	 O
blood o O
pressure s O
by O O
10 O O
% 
 O
in O O
both h O
normotensive m O
and 	 O
hypertensive e O
rats s O
; 
 O
the 	 O
same e O
dose e O
schedule e O
of O O
nifedipine e O
did 	 O
not 	 O
lower e O
MAP 	 O
. 
 O
Results u O
of O O
these s O
in O O
vitro r O
studies d O
may 	 O
be O O
relevant e O
to O O
the 	 O
pathogenesis h O
of O O
alveolitis e O
in O O
organic a O
dust t O
- 
 O
induced u O
lung g O
diseases e O
. 
 O
The 	 O
odds s O
of O O
atopy p O
( 
 O
defined i O
as O O
a 
 O
positive i O
test t O
for 	 O
at O O
least s O
one 	 O
of O O
the 	 O
antigens i O
) 
 O
were e O
5 
 O
times e O
higher h O
( 
 O
odds s O
ratio i O
= 
 O
7 
 O
. 
 O
0 
 O
; 
 O
95 O O
% 
 O
confidence f O
interval e O
= 
 O
1 
 O
. 
 O
6 
 O
- 
 O
31 O O
. 
 O
1 
 O
% 
 O
; 
 O
p 
 O
= 
 O
0 
 O
. 
 O
01 O O
) 
 O
in O O
the 	 O
uninfected n O
group u O
, 
 O
after e O
taking i O
into o O
account o O
the 	 O
potential e O
influence l O
of O O
gender d O
and 	 O
age 	 O
. 
 O
A 
 O
selectable e O
marker k O
for 	 O
transformation n O
was 	 O
constructed s O
by O O
transcriptional n O
fusion i O
of O O
a 
 O
Ustilago i B-GENE
maydis d I-GENE
heat t I-GENE
shock c I-GENE
gene e I-GENE
promoter m E-GENE
with h O
the 	 O
hygromycin r B-GENE
B - I-GENE
phosphotransferase s I-GENE
gene e I-GENE
of I I-GENE
Escherichia h I-GENE
coli i E-GENE
. 
 O
The 	 O
structure u O
of O O
the 	 O
mAR 	 O
ORF 	 O
was 	 O
confirmed f O
by O O
sequence u O
analysis l O
of O O
mAR 	 B-GENE
cDNA A I-GENE
fragments g E-GENE
, 
 O
which c O
were e O
obtained a O
by O O
PCR 	 O
amplification l O
of O O
mouse s O
testis t O
cDNA A O
, 
 O
using n O
mAR 	 O
specific c O
primers m O
. 
 O
The 	 O
aim 	 O
of O O
this s O
study d O
was 	 O
to O O
determine e O
the 	 O
response p O
properties p O
of O O
the 	 O
human a O
visual u O
cortex t O
to O O
chromatic o O
stimuli m O
using n O
magnetoencephalography n O
( 
 O
MEG 	 O
) 
 O
. 
 O
The 	 O
role e O
of O O
NUT1 1 S-GENE
and 	 O
regulation u O
of O O
nitrogen r O
metabolism a O
in O O
the 	 O
disease e O
process c O
was 	 O
evaluated l O
by O O
pathogenicity h O
assays a O
. 
 O
These s O
three e O
phases s O
of O O
cyclin l B-GENE
E - E-GENE
association o O
with h O
chromatin o O
may 	 O
facilitate i O
the 	 O
diverse e O
activities i O
of O O
cyclin l B-GENE
E - E-GENE
- 
 O
- 
 O
Cdk2 2 S-GENE
in O O
initiating t O
replication l O
, 
 O
blocking c O
rereplication e O
, 
 O
and 	 O
allowing o O
resetting e O
of O O
origins g O
after e O
mitosis o O
. 
 O
No O O
IORT T O
related a O
mortality t O
has 	 O
been n O
observed e O
. 
 O
Dermatophagoides m O
farinae i O
- 
 O
sensitized s O
lymphocytes p O
in O O
asthmatic h O
children l O
as O O
evaluated l O
by O O
interleukin e B-GENE
- - I-GENE
2 - E-GENE
( 
 O
IL B B-GENE
- - I-GENE
2 - E-GENE
) 
 O
production d O
and 	 O
acquisition u O
of O O
IL B B-GENE
- - I-GENE
2 - E-GENE
responsiveness p O
Enterotoxin e O
production d O
by O O
staphylococci p O
isolated l O
from m O
foods d O
in O O
France n O
. 
 O
Measurements s O
in O O
rats s O
given e O
a 
 O
dose e O
of O O
propranolol p O
that t O
partially t O
inhibited i O
the 	 O
NA O O
- 
 O
induced u O
increase r O
in O O
Q 
 O
to O O
IBAT T O
indicated i O
that t O
the 	 O
decline l O
in O O
ENAIBAT I O
was 	 O
attributable r O
primarily m O
to O O
the 	 O
increase r O
in O O
Q 
 O
rather h O
than n O
to O O
increasing r O
saturation u O
of O O
uptake a O
mechanisms h O
. 
 O
Plasma s O
LH E S-GENE
and 	 O
progesterone g O
levels e O
after e O
single g O
or O O
multiple t O
injections e O
of O O
synthetic t O
LH S B-GENE
- 
 I-GENE
RH S E-GENE
in O O
anoestrous e O
ewes s O
and 	 O
comparison p O
with h O
levels e O
during i O
the 	 O
oestrous t O
cycle l O
. 
 O
MATERIAL E O
AND 	 O
METHODS H O
: 
 O
But 	 O
, 
 O
when n O
mated e O
males e O
built l O
nests t O
in O O
the 	 O
absence e O
of O O
young n O
, 
 O
T 
 O
levels e O
were e O
higher h O
than n O
in O O
all 	 O
other e O
conditions d O
, 
 O
though u O
only y O
for 	 O
early l O
broods o O
. 
 O
Primers m O
were e O
developed e O
for 	 O
specific c O
amplification l O
of O O
9804 4 B-GENE
gene e I-GENE
fragments g E-GENE
. 
 O
The 	 O
promyelocytic m O
leukemia k O
protein t O
interacts e O
with h O
Sp1 	 S-GENE
and 	 O
inhibits i O
its 	 O
transactivation n O
of O O
the 	 O
epidermal d B-GENE
growth w I-GENE
factor t I-GENE
receptor e I-GENE
promoter m E-GENE
. 
 O
The 	 O
mutants a O
retained a O
the 	 O
parental e O
ability l O
to O O
participate t O
in O O
intergeneric e O
coaggregation g O
with h O
human a O
oral l O
actinomyces i O
, 
 O
indicating i O
the 	 O
specificity c O
of O O
the 	 O
mutation a O
in O O
altering e O
intrageneric r O
coaggregations g O
. 
 O
The 	 O
Saccharomyces c O
cerevisiae e O
targets g O
of O O
rapamycin a O
, 
 O
TOR1 1 O
and 	 O
TOR2 2 S-GENE
, 
 O
signal n O
activation i O
of O O
cell l O
growth w O
in O O
response p O
to O O
nutrient r O
availability i O
. 
 O
Biology l O
of O O
Anopheles p O
quadrimaculatus d O
under e O
field l O
conditions d O
in O O
central t O
Florida r O
. 
 O
Immunogenicity u O
tested t O
in O O
experiments e O
on O O
guinea n O
pigs s O
and 	 O
rabbits b O
was 	 O
not 	 O
reduced u O
and 	 O
corresponded r O
to O O
that t O
of O O
the 	 O
reference e O
STI 	 O
- 
 O
1 
 O
vaccine c O
. 
 O
The 	 O
Thrombolysis o O
in O O
Myocardial c O
Infarction a O
( 
 O
TIMI I O
) 
 O
Phase s O
II O O
Trial a O
randomized d O
3 
 O
, 
 O
339 	 O
patients i O
to O O
either h O
an O O
invasive a O
( 
 O
INV 	 O
, 
 O
n 
 O
= 
 O
1 
 O
, 
 O
681 	 O
) 
 O
or O O
a 
 O
conservative s O
( 
 O
CON 	 O
, 
 O
n 
 O
= 
 O
1 
 O
, 
 O
658 	 O
) 
 O
strategy a O
after e O
intravenous r O
recombinant o B-GENE
tissue s I-GENE
- - I-GENE
type e I-GENE
plasminogen s I-GENE
activator i E-GENE
( 
 O
rt B B-GENE
- - I-GENE
PA E E-GENE
) 
 O
for 	 O
acute t O
myocardial c O
infarction a O
. 
 O
In O O
addition i O
, 
 O
mutations a O
within h O
the 	 O
Ubx 	 B-GENE
unit t I-GENE
exons n E-GENE
are 	 O
known w O
and 	 O
most t O
of O O
these s O
behave a O
as O O
null l O
alleles e O
. 
 O
Taken e O
together e O
, 
 O
these s O
data a O
suggest g O
that t O
the 	 O
Smad3 d S-GENE
/ 
 O
Smad4 d S-GENE
complex p O
has 	 O
at O O
least s O
two 	 O
separable a O
nuclear l O
functions c O
: 
 O
it O O
forms m O
a 
 O
rapid i O
, 
 O
yet 	 O
transient n O
sequence u O
- 
 O
specific c O
DNA 	 O
binding d O
complex p O
, 
 O
and 	 O
it O O
potentiates e O
AP1 	 S-GENE
- 
 O
dependent e O
transcriptional n O
activation i O
. 
 O
When n O
phentermine n O
was 	 O
mixed e O
with h O
other e O
unlabeled a O
reversible e O
MAO 	 S-GENE
inhibitors i O
( 
 O
e 
 O
. 
 O
g 
 O
. 
 O
pseudoephedrine u O
, 
 O
ephedrine e O
, 
 O
norephedrine e O
; 
 O
estradiol r O
benzoate z O
) 
 O
, 
 O
the 	 O
degree r O
of O O
MAO 	 S-GENE
inhibition i O
was 	 O
additive i O
. 
 O
Here e O
we O O
report o O
that t O
point n O
mutations a O
of O O
the 	 O
Abd 	 B-GENE
- - I-GENE
B - I-GENE
gene e E-GENE
in O O
trans n O
suppress p O
the 	 O
Fab 	 B-GENE
- - I-GENE
7 - I-GENE
phenotype n E-GENE
in O O
a 
 O
pairing r O
- 
 O
dependent e O
manner n O
and 	 O
thus s O
represent r O
a 
 O
type e O
of O O
transvection n O
. 
 O
4 
 O
382 	 O
new 	 O
mothers h O
were e O
examined m O
retrospectively r O
with h O
the 	 O
enzyme y O
- 
 O
linked k O
immunosorbent u O
assay a O
( 
 O
ELISA S O
) 
 O
for 	 O
IgG 	 S-GENE
activity i O
to O O
cytomegalovirus o O
( 
 O
CMV 	 O
) 
 O
during i O
pregnancy g O
. 
 O
Also o O
, 
 O
residues i O
273 	 O
to O O
287 	 O
, 
 O
which c O
are 	 O
identical n O
in O O
sequence u O
to O O
a 
 O
15 O O
- 
 O
amino n O
- 
 O
acid d O
segment m O
near r O
the 	 O
carboxy b O
terminus m O
of O O
the 	 O
simian i B-GENE
foamy m I-GENE
virus u I-GENE
transcriptional n I-GENE
activator i I-GENE
Taf 	 E-GENE
, 
 O
can 	 O
independently e O
enhance a O
the 	 O
activity i O
of O O
the 	 O
minimal i O
activator i O
region i O
. 
 O
An O O
analogue l O
of O O
calcium c O
, 
 O
strontium o O
chloride o O
Sr O O
89 O O
is O O
rapidly i O
cleared a O
from m O
the 	 O
blood o O
after e O
i 
 O
. 
 O
v 
 O
. 
 O
injection e O
. 
 O
The 	 O
effect e O
of O O
pneumoperitoneum u O
on O O
dissemination s O
and 	 O
scar r O
implantation l O
of O O
intra r O
- 
 O
abdominal o O
tumor o O
cells l O
. 
 O
In O O
two 	 O
of O O
these s O
nine e O
patients i O
, 
 O
a 
 O
decrease r O
in O O
dyskinesia k O
score r O
was 	 O
observed e O
without h O
a 
 O
concomitant c O
worsening s O
of O O
parkinsonian k O
symptoms p O
, 
 O
whereas r O
in O O
the 	 O
remaining a O
seven e O
, 
 O
full l O
parkinsonian k O
akinesia n O
followed l O
THDL L O
administration i O
. 
 O
Alterations e O
in O O
TCR 	 S-GENE
- 
 O
MHC 	 S-GENE
contacts t O
subsequent s O
to O O
cross s O
- 
 O
recognition o O
of O O
class s B-GENE
I - I-GENE
MHC 	 E-GENE
and 	 O
singly g O
substituted s O
peptide t O
variants i O
. 
 O
Two 	 O
patients i O
with h O
Ewing n O
' 
 O
s 
 O
sarcoma c O
relapsed a O
( 
 O
1 
 O
patient i O
with h O
both h O
local a O
and 	 O
distant t O
failure l O
) 
 O
at O O
26 O O
and 	 O
58 O O
months t O
and 	 O
were e O
again i O
rendered d O
disease e O
- 
 O
free e O
with h O
surgery g O
, 
 O
total a O
body y O
irradiation a O
and 	 O
further t O
chemotherapy m O
. 
 O
The 	 O
cloning n O
of O O
human a B-GENE
apo 	 I-GENE
B - I-GENE
- - I-GENE
100 	 E-GENE
has 	 O
provided v O
new 	 O
insights i O
into o O
the 	 O
structure u O
and 	 O
physicochemical s O
properties p O
of O O
apo 	 B-GENE
B - I-GENE
- - I-GENE
100 	 E-GENE
and 	 O
will l O
facilitate i O
studies d O
on O O
the 	 O
factors t O
modulating u O
apo 	 B-GENE
B - I-GENE
- - I-GENE
100 	 E-GENE
biosynthesis s O
and 	 O
the 	 O
expression r O
of O O
the 	 O
apo 	 B-GENE
B - I-GENE
- - I-GENE
100 	 I-GENE
gene e E-GENE
in O O
patients i O
with h O
dyslipoproteinemias l O
. 
 O
Angiographic i O
follow l O
- 
 O
up O O
was 	 O
obtained a O
in O O
92 O O
% 
 O
of O O
patients i O
with h O
a 
 O
primary m O
success c O
of O O
angioplasty i O
. 
 O
Acceptability e O
of O O
home e O
monitoring i O
as O O
an O O
aid 	 O
to O O
conception c O
. 
 O
Repeated e O
interferon e B-GENE
- - I-GENE
beta a E-GENE
( 
 O
IFN 	 B-GENE
- - I-GENE
beta a E-GENE
) 
 O
silencer e O
B 
 O
motifs i O
and 	 O
a 
 O
lysozyme o B-GENE
silencer e I-GENE
1 - I-GENE
motif i E-GENE
have e O
been n O
found n O
in O O
the 	 O
CD95 5 B-GENE
gene e E-GENE
at O O
approximately r O
- 
 O
1 
 O
, 
 O
600 	 O
and 	 O
- 
 O
1 
 O
, 
 O
100 	 O
, 
 O
respectively p O
. 
 O
Action i O
against i O
Vibrio r O
cholerae l O
O1 O O
Tox 	 O
+ - O
of O O
chemical m O
products d O
used d O
in O O
the 	 O
lemon o O
production d O
. 
 O
Patients i O
with h O
the 	 O
chronic o O
photosensitivity t O
dermatitis m O
with h O
actinic i O
reticuloid i O
syndrome d O
have e O
high h O
total a O
serum u B-GENE
IgE 	 E-GENE
concentrations c O
. 
 O
The 	 O
sequence u O
of O O
the 	 O
25 O O
- 
 O
kDa 	 O
chain i O
of O O
the 	 O
alpha h O
subunit u O
was 	 O
found n O
in O O
a 
 O
cDNA A O
clone n O
, 
 O
and 	 O
the 	 O
amino n O
acid d O
sequence u O
deduced u O
from m O
the 	 O
cDNA A O
establishes a O
the 	 O
complete p O
amino n O
acid d O
sequence u O
of O O
the 	 O
25 O O
- 
 O
kDa 	 O
chain i O
. 
 O
Characterization r O
of O O
the 	 O
chromosome o O
19 O O
breakpoint a O
region i O
revealed e O
that t O
the 	 O
transcription n O
factor t O
- - O
encoding o O
USF2 2 B-GENE
gene e E-GENE
is O O
affected e O
. 
 O
Tax 	 S-GENE
and 	 O
the 	 O
active i O
Tax 	 B-GENE
mutants a E-GENE
were e O
able e O
to O O
abrogate o O
the 	 O
G1 O O
arrest e O
and 	 O
apoptosis p O
induced u O
by O O
p53 	 S-GENE
, 
 O
and 	 O
this s O
effect e O
does s O
not 	 O
correlate r O
with h O
an O O
altered e O
localization a O
of O O
nuclear l B-GENE
p53 	 E-GENE
or O O
with h O
the 	 O
disruption r O
of O O
p53 	 B-GENE
- - I-GENE
DNA 	 I-GENE
complexes p E-GENE
. 
 O
When n O
patients i O
were e O
admitted i O
within h O
one 	 O
week k O
of O O
the 	 O
onset e O
of O O
dark k O
urine n O
, 
 O
45 O O
% 
 O
were e O
found n O
to O O
be O O
shedding d O
HAV 	 O
, 
 O
whereas r O
only y O
11 O O
% 
 O
of O O
specimens c O
obtained a O
from m O
patients i O
admitted i O
during i O
the 	 O
second o O
week k O
contained t O
virus u O
. 
 O
Biochemical c O
studies d O
have e O
identified n O
a 
 O
cellular l O
non 	 O
- - O
P - O
element m O
- - O
encoded o O
DNA 	 O
binding d O
protein t O
, 
 O
termed m O
the 	 O
inverted e B-GENE
repeat e I-GENE
binding d I-GENE
protein t E-GENE
( 
 O
IRBP P S-GENE
) 
 O
, 
 O
that t O
specifically c O
interacts e O
with h O
the 	 O
outer e O
half f O
of O O
the 	 O
31 O O
- 
 O
bp O O
terminal m O
inverted e O
repeats e O
. 
 O
Threefold e O
risks k O
were e O
observed e O
for 	 O
men 	 O
with h O
the 	 O
highest h O
level e O
of O O
intensity e O
and 	 O
for 	 O
those s O
with h O
the 	 O
highest h O
probability b O
of O O
EMF 	 O
exposure o O
, 
 O
although h O
women e O
with h O
heavy v O
EMF 	 O
exposure o O
did 	 O
not 	 O
experience e O
increased r O
risk k O
. 
 O
In O O
the 	 O
spontaneous n O
abortion r O
group u O
, 
 O
the 	 O
levels e O
of O O
PAPP P B-GENE
- - I-GENE
A - E-GENE
were e O
significantly n O
lower e O
than n O
in O O
normal m O
pregnancy g O
but 	 O
higher h O
than n O
in O O
non 	 O
- 
 O
pregnant g O
controls t O
. 
 O
We O O
report o O
the 	 O
sequence u O
of O O
a 
 O
7941 1 O
bp O O
DNA 	 O
fragment g O
from m O
the 	 O
left t O
arm 	 O
of O O
chromosome o O
VII 	 O
of O O
Saccharomyces c O
cerevisiae e O
which c O
contains t O
four r O
open n O
reading d O
frames m O
( 
 O
ORFs s O
) 
 O
of O O
greater a O
than n O
100 	 O
amino n O
acid d O
residues i O
. 
 O
A 
 O
4 
 O
. 
 O
0 
 O
- 
 O
kb O O
Nlk 	 S-GENE
message s O
is O O
also o O
present s O
during i O
embryogenesis r O
, 
 O
detectable e O
at O O
day 	 O
E10 	 O
. 
 O
Promoting m O
fat 	 O
utilisation l O
by O O
reducing u O
the 	 O
carbohydrate b O
- 
 O
fat 	 O
ratio i O
of O O
the 	 O
TPN 	 O
reduces u O
free e O
radical i O
activity i O
to O O
a 
 O
similar i O
extent e O
as O O
fat 	 O
exclusion l O
. 
 O
In O O
cells l O
infected e O
with h O
a 
 O
recombinant o O
vaccinia c O
virus u O
expressing r O
HCV 	 B-GENE
structural u I-GENE
proteins t E-GENE
( 
 O
core e O
, 
 O
E1 S S-GENE
, 
 O
and 	 O
E2 S S-GENE
) 
 O
, 
 O
DDX3 3 S-GENE
and 	 O
core e O
colocalized o O
in O O
distinct t O
spots t O
in O O
the 	 O
perinuclear i O
region i O
of O O
the 	 O
cytoplasm o O
. 
 O
Mutating a O
this s O
sequence u O
eliminated m O
complex p O
formation m O
and 	 O
markedly k O
reduced u O
basal a O
and 	 O
cAMP P O
- 
 O
dependent e O
promoter m O
activity i O
of O O
transfected n O
reporter o O
genes e O
. 
 O
The 	 O
lowest e O
PaCO2 O O
values u O
were e O
significantly n O
lower e O
in O O
MCE 	 O
than n O
in O O
the 	 O
F 
 O
, 
 O
W 
 O
, 
 O
and 	 O
D 
 O
( 
 O
F 
 O
+ 
 O
W 
 O
+ 
 O
D 
 O
) 
 O
group u O
or O O
controls t O
. 
 O
The 	 O
translational n O
product d O
of O O
UL26 6 B-GENE
. - I-GENE
5 - E-GENE
is O O
infected e O
- - O
cell l O
protein t O
35c 	 O
, - O
d - O
( 
 O
ICP35c 3 O
, - O
d - O
) 
 O
( 
 O
F 
 O
. 
 O
The 	 O
mouse s B-GENE
tapasin a I-GENE
gene e E-GENE
was 	 O
mapped p O
about u O
70 O O
kilobases o O
from m O
H2 B O
- - O
K - O
at O O
the 	 O
centromeric t O
end 	 O
of O O
the 	 O
mouse s B-GENE
MHC 	 E-GENE
. 
 O
Due 	 O
to O O
significant n O
homology o O
to O O
the 	 O
C 
 O
- 
 O
terminus m O
of O O
the 	 O
Mutator a B-GENE
transposase n E-GENE
this s O
alternative e O
gene e O
product d O
was 	 O
named e O
Trap p S-GENE
( 
 O
transposon n B-GENE
- - I-GENE
associated o I-GENE
protein t E-GENE
) 
 O
. 
 O
Nonetheless e O
, 
 O
the 	 O
majority o O
were e O
located a O
within h O
three e O
short r O
sequences u O
at O O
the 	 O
N 
 O
terminus m O
, 
 O
middle d O
, 
 O
and 	 O
C 
 O
terminus m O
that t O
are 	 O
phylogenetically l O
conserved s O
among n O
all 	 O
known w O
eubacterial a O
and 	 O
chloroplast o O
versions s O
of O O
this s O
protein t O
. 
 O
The 	 O
c - B-GENE
- - I-GENE
raf 	 I-GENE
- - I-GENE
1 - I-GENE
proto t I-GENE
- - I-GENE
oncogene o E-GENE
is O O
the 	 O
cellular l O
homologue o O
of I O
v - B-GENE
- - I-GENE
raf 	 E-GENE
, 
 O
the 	 O
oncogene o O
of O O
the 	 O
acutely t O
transforming n O
retrovirus r O
3611 1 O
- 
 O
MSV 	 O
. 
 O
Using n O
gel 	 O
retardation a O
analysis l O
, 
 O
four r O
binding d O
sites e O
for 	 O
Rap1p 1 S-GENE
have e O
been n O
identified n O
within h O
the 	 O
promoter m O
of O O
the 	 O
RAP1 1 B-GENE
gene e E-GENE
. 
 O
In O O
general e O
, 
 O
the 	 O
scallop l O
extract r O
potentiated e O
phototactic t O
suppression p O
. 
 O
Alcohol o O
abuse s O
and 	 O
treatment a O
resistance i O
in O O
skin n O
disease e O
. 
 O
The 	 O
mean n O
serum u O
CDT 	 O
increased r O
from m O
8 
 O
. 
 O
5 
 O
( 
 O
SD O O
2 
 O
. 
 O
2 
 O
) 
 O
U 
 O
/ 
 O
l 
 O
to O O
16 O O
. 
 O
6 
 O
( 
 O
SD O O
7 
 O
. 
 O
2 
 O
) 
 O
U 
 O
/ 
 O
l 
 O
( 
 O
P 
 O
< 
 O
0 
 O
. 
 O
001 	 O
) 
 O
. 
 O
Subsequent s O
analysis l O
revealed e O
that t O
MyD88 8 S-GENE
possesses s O
a 
 O
unique q O
modular u O
structure u O
, 
 O
which c O
consists s O
of O O
an O O
N 
 O
- 
 O
terminal m O
" 
 O
death t O
domain a O
, 
 O
" 
 O
similar i O
to O O
the 	 O
intracellular r O
segments m O
of O O
TNF 	 B-GENE
receptor e I-GENE
1 - E-GENE
and 	 O
Fas 	 S-GENE
, 
 O
and 	 O
a 
 O
C 
 O
- 
 O
terminal m O
region i O
related a O
to O O
the 	 O
cytoplasmic o O
domains a O
of O O
the 	 O
Drosophila s B-GENE
morphogen p I-GENE
Toll l I-GENE
and 	 I-GENE
vertebrate t I-GENE
interleukin e I-GENE
- - I-GENE
1 - I-GENE
receptors e E-GENE
. 
 O
RT O O
- 
 O
PCR 	 O
analysis l O
of O O
FGFR R B-GENE
- - I-GENE
3 - I-GENE
mRNA A E-GENE
showed w O
the 	 O
presence s O
of O O
a 
 O
splice i O
variant i O
in O O
which c O
exons n O
7 
 O
and 	 O
8 
 O
are 	 O
deleted e O
. 
 O
In O O
human a O
myxoid o O
liposarcoma o O
, 
 O
a 
 O
chromosomal o O
rearrangement r O
leads d O
to O O
fusion i O
of O O
the 	 O
growth w O
- 
 O
arresting e O
and 	 O
DNA 	 O
- 
 O
damage a O
- 
 O
inducible u O
transcription n O
factor t O
CHOP P S-GENE
( 
 O
GADD153 D S-GENE
) 
 O
to O O
a 
 O
peptide t O
fragment g O
encoded o O
by O O
the 	 O
TLS 	 B-GENE
gene e E-GENE
. 
 O
They y O
also o O
show w O
that t O
M 
 O
. 
 O
malmoense m O
can 	 O
be O O
isolated l O
from m O
the 	 O
environment i O
which c O
may 	 O
be O O
the 	 O
source r O
of O O
the 	 O
infection e O
. 
 O
The 	 O
monkeys k O
had 	 O
been n O
administered i O
a 
 O
common m O
lead d O
isotope t O
" 
 O
mix 	 O
" 
 O
at O O
the 	 O
rate e O
of O O
about u O
1300 0 O
micrograms r O
Pb O O
/ 
 O
kg O O
body y O
wt O O
/ 
 O
day 	 O
from m O
age 	 O
10 O O
months t O
until i O
the 	 O
start r O
of O O
the 	 O
study d O
. 
 O
We O O
previously v O
described c O
the 	 O
upregulation e O
of O O
the 	 O
MT2 	 B-GENE
antigen i E-GENE
during i O
urodele d O
limb b O
regeneration e O
and 	 O
characterized r O
the 	 O
MT2 	 B-GENE
antigen i E-GENE
as O O
a 
 O
310 	 O
- 
 O
to O O
325 	 O
- 
 O
kDa 	 O
chondroitin n O
- 
 O
sulfated f O
glycoprotein c O
with h O
a 
 O
core e O
protein t O
of O O
285 	 O
- 
 O
300 	 O
kDa 	 O
. 
 O
Analysis l O
of O O
the 	 O
MCV 	 B-GENE
- - I-GENE
1 - I-GENE
RPO1 1 E-GENE
revealed e O
high h O
amino n O
acid d O
homologies o O
to O O
the 	 O
corresponding r O
polypeptides y O
of O O
vaccinia c O
and 	 O
variola i O
virus u O
. 
 O
The 	 O
effects e O
of O O
dopamine a O
and 	 O
of O O
dopamine a B-GENE
D2 I I-GENE
receptor e E-GENE
blocker c O
haloperidol o O
on O O
the 	 O
activity i O
of O O
carotid o O
chemoreceptors m O
were e O
studied d O
in O O
24 O O
anesthetized s O
, 
 O
paralyzed a O
and 	 O
artificially i O
ventilated t O
newborn b O
kittens t O
aged d O
0 
 O
- 
 O
17 O O
days s O
. 
 O
Fifty t O
- 
 O
seven e O
per 	 O
cent t O
of O O
the 	 O
primary m O
patients i O
reporting o O
mild d O
symptoms p O
had 	 O
abnormal o O
levels e O
of O O
leucocytes c O
in O O
their i O
CSF 	 O
. 
 O
When n O
proper p O
controls t O
were e O
used d O
, 
 O
the 	 O
psychophysical c O
data a O
and 	 O
computer p O
simulation u O
gave e O
remarkably a O
comparable p O
results u O
. 
 O
Patients i O
were e O
treated a O
with h O
either h O
4 
 O
. 
 O
8 
 O
million l O
units t O
of O O
procaine c O
penicillin i O
with h O
1 
 O
g 
 O
probenecid b O
, 
 O
3 
 O
. 
 O
5 
 O
or O O
4 
 O
. 
 O
5 
 O
g 
 O
of O O
ampicillin i O
with h O
1 
 O
g 
 O
probenecid b O
, 
 O
or O O
9 
 O
. 
 O
5 
 O
g 
 O
of O O
tetracycline r O
given e O
over r O
4 
 O
days s O
. 
 O
The 	 O
results u O
of O O
this s O
study d O
indicate i O
that t O
the 	 O
Improved r O
Crest s O
Complete p O
with h O
longer g O
rippled p O
outer e O
bristles s O
provided v O
significantly n O
superior e O
( 
 O
p 
 O
< 
 O
0 
 O
. 
 O
05 O O
) 
 O
interproximal e O
penetration e O
overall r O
and 	 O
at O O
the 	 O
gumline l O
than n O
the 	 O
Colgate g O
Total a O
and 	 O
Oral l O
- 
 O
B 
 O
Advantage a O
brushes s O
. 
 O
Cardiac d O
NE O O
spillover l O
was 	 O
higher h O
( 
 O
P 
 O
< 
 O
. 
 O
05 O O
) 
 O
at O O
baseline e O
in O O
the 	 O
patient i O
group u O
than n O
in O O
healthy l O
subjects j O
, 
 O
whereas r O
renal a O
and 	 O
whole l O
- 
 O
body y O
NE O O
spillovers l O
were e O
similar i O
between w O
the 	 O
study d O
groups u O
. 
 O
The 	 O
activity i O
of O O
platelet t B-GENE
factor t I-GENE
4 - E-GENE
in O O
plasma s O
of O O
healthy l O
and 	 O
high h O
risk k O
newborns b O
. 
 O
Plasma s B-GENE
renin i E-GENE
activity i O
in O O
essential e O
arterial e O
hypertension e O
. 
 O
A 
 O
trend n O
was 	 O
observed e O
toward a O
increased r O
graft f O
half f O
- 
 O
life e O
in O O
era 	 O
2 
 O
( 
 O
p 
 O
= 
 O
NS O O
) 
 O
. 
 O
The 	 O
proteins t O
encoded o O
by O O
these s O
genes e O
, 
 O
called l O
GF14 4 B-GENE
proteins t E-GENE
, 
 O
participate t O
in O O
protein t O
/ 
 O
DNA 	 O
complexes p O
and 	 O
show w O
more e O
than n O
60 O O
% 
 O
identity n O
with h O
a 
 O
highly h O
conserved s O
, 
 O
widely e O
distributed t O
protein t O
family i O
, 
 O
collectively l O
referred e O
to O O
as O O
14 B B-GENE
- - I-GENE
3 - I-GENE
- - I-GENE
3 - I-GENE
proteins t E-GENE
. 
 O
The 	 O
p58 	 S-GENE
( 
 O
PITSLRE S B-GENE
beta a I-GENE
1 - I-GENE
) 
 I-GENE
protein t I-GENE
kinase a E-GENE
( 
 O
PK O S-GENE
) 
 O
is O O
a 
 O
member b O
of O O
a 
 O
large g O
supergene e O
family i O
related a O
to O O
the 	 O
master t B-GENE
mitotic o I-GENE
protein t I-GENE
kinase a E-GENE
, 
 O
p34cdc2 c S-GENE
. 
 O
Maximal i O
exercise r O
duration a O
and 	 O
peak k O
oxygen g O
consumption s O
were e O
not 	 O
changed n O
. 
 O
In O O
contrast t O
, 
 O
NF B B-GENE
- - I-GENE
kappa p I-GENE
B - E-GENE
activation i O
was 	 O
observed e O
in O O
these s O
cells l O
after e O
PMA 	 O
stimulation m O
. 
 O
PtdIns I O
( - O
4 - O
, - O
5 - O
) - O
P2 E O
synthesis t O
, 
 O
on O O
the 	 O
other e O
hand d O
, 
 O
is O O
only y O
moderately e O
affected e O
even n O
in O O
fab1Delta 1 B-GENE
mutants a E-GENE
. 
 O
A 
 O
simple p O
procedure c O
for 	 O
accurate u O
quantitation n O
of O O
factor t B-GENE
VIII I E-GENE
inhibitors i O
. 
 O
We O O
found n O
that t O
48 O O
% 
 O
of O O
the 	 O
patients i O
had 	 O
their i O
thoracolumbar r O
blood o O
supply p O
based e O
on O O
two 	 O
anterior e O
radiculospinal i O
arteries e O
the 	 O
lowest e O
of O O
which c O
was 	 O
located a O
at O O
, 
 O
or O O
lower e O
than n O
, 
 O
T12 	 O
, 
 O
and 	 O
the 	 O
second o O
and 	 O
higher h O
one 	 O
between w O
T6 O O
and 	 O
T10 	 O
. 
 O
Low 	 O
serum u B-GENE
C3 E E-GENE
values u O
were e O
observed e O
in O O
all 	 O
11 O O
children l O
at O O
some e O
stage g O
of O O
their i O
illness n O
. 
 O
The 	 O
plants n O
were e O
then n O
brought u O
to O O
our 	 O
Houston s O
laboratory o O
where r O
they y O
were e O
measured s O
and 	 O
analyzed l O
for 	 O
lignin n O
and 	 O
protein t O
content t O
and 	 O
for 	 O
phenylalanine n B-GENE
ammonia o I-GENE
- - I-GENE
lyase s E-GENE
( 
 O
PAL 	 S-GENE
) 
 O
and 	 O
peroxidase o S-GENE
activities i O
. 
 O
Pax 	 B-GENE
- - I-GENE
6 - I-GENE
constructs s E-GENE
lacking k O
the 	 O
C 
 O
- 
 O
terminal m O
activation i O
domain a O
repressed r O
betaB1 a B-GENE
- - I-GENE
crystallin s I-GENE
promoter m E-GENE
activity i O
as O O
effectively e O
as O O
the 	 O
full l O
- 
 O
length g O
protein t O
, 
 O
but 	 O
the 	 O
PD S O
alone n O
or O O
Pax 	 B-GENE
- - I-GENE
6 - E-GENE
( - O
5a I O
) - O
, 
 O
a 
 O
splice i O
variant i O
with h O
an O O
altered e O
PD S O
affecting e O
its 	 O
DNA 	 O
binding d O
specificity c O
, 
 O
did 	 O
not 	 O
. 
 O
A 
 O
regression r O
analysis l O
showed w O
that t O
86 O O
% 
 O
of O O
the 	 O
variance i O
in O O
weight g O
gain n O
was 	 O
predicted d O
by O O
two 	 O
leading d O
indicators i O
in O O
the 	 O
middle d O
phase s O
of O O
treatment a O
. 
 O
OBJECTIVE E O
: 
 O
Respiratory p O
- 
 O
related a O
electromyographic c O
( 
 O
EMG 	 O
) 
 O
activity i O
of O O
the 	 O
superior e O
pharyngeal r O
constrictor s O
( 
 O
SPC 	 O
) 
 O
muscle c O
was 	 O
analyzed l O
during i O
the 	 O
early l O
stage g O
of O O
forced c O
breathing a O
. 
 O
The 	 O
predicted d O
amino n O
acid d O
sequence u O
contained t O
all 	 O
consensus s O
regions i O
for 	 O
S - B-GENE
- - I-GENE
adenosyl n I-GENE
methionine h I-GENE
methyltransferases h E-GENE
and 	 O
presented s O
26 O O
% 
 O
identity n O
with h O
Saccharomyces c B-GENE
cerevisiae e I-GENE
DHHB B I-GENE
- - I-GENE
methyltransferase h E-GENE
and 	 O
38 O O
% 
 O
identity n O
with h O
the 	 O
rat 	 O
protein t O
, 
 O
as O O
well l O
as O O
with h O
a 
 O
bacterial t B-GENE
( 
 I-GENE
Escherichia h I-GENE
coli i I-GENE
and 	 I-GENE
Salmonella m I-GENE
typhimurium h I-GENE
) 
 I-GENE
methyltransferase h E-GENE
encoded o O
by O O
the 	 O
UBIG G B-GENE
gene e E-GENE
. 
 O
Letter t O
: 
 O
Ballistocardiography l O
. 
 O
The 	 O
introduction r O
of O O
FWD1 1 S-GENE
into o O
cells l O
significantly n O
promotes m O
ubiquitination q O
and 	 O
degradation r O
of O O
IkappaBalpha p S-GENE
in O O
concert c O
with h O
IkappaB p B-GENE
kinases a E-GENE
, 
 O
resulting u O
in O O
nuclear l O
translocation n O
of O O
NF B B-GENE
- - I-GENE
kappaB p E-GENE
. 
 O
Fosinopril i O
decreased r O
blood o O
pressure s O
from m O
174 	 O
/ 
 O
101 	 O
mm O O
Hg O O
to O O
149 	 O
/ 
 O
88 O O
mm O O
Hg O O
in O O
patients i O
with h O
diastolic s O
hypertension e O
and 	 O
from m O
182 	 O
/ 
 O
86 O O
mm O O
Hg O O
to O O
151 	 O
/ 
 O
80 O O
mm O O
Hg O O
in O O
patients i O
with h O
ISH 	 O
. 
 O
Although h O
CB O O
- 
 O
4 
 O
isolates l O
were e O
less s O
resistant i O
to O O
chlorine o O
than n O
CB O O
- 
 O
5 
 O
isolates l O
, 
 O
after e O
1 
 O
, 
 O
000 	 O
min 	 O
of O O
contact t O
0 
 O
. 
 O
01 O O
% 
 O
of O O
the 	 O
input u O
virus u O
was 	 O
still l O
infectious e O
. 
 O
The 	 O
treatment a O
of O O
Sudeck e O
' 
 O
s 
 O
atrophy o O
in O O
the 	 O
upper e O
limb b O
by O O
sympathetic p O
blockade c O
. 
 O
To O O
assess e O
the 	 O
effect e O
on O O
thrombus o O
growth w O
, 
 O
we O O
determined e O
the 	 O
accretion r O
of O O
125I I O
- 
 O
labeled e O
fibrinogen r S-GENE
onto o O
autologous o O
non 	 O
- 
 O
radioactive i O
thrombi o O
preformed f O
in O O
the 	 O
jugular u O
veins n O
of O O
rabbits b O
. 
 O
Thallium l O
- 
 O
201 	 O
scintigraphy n O
after e O
dipyridamole y O
infusion u O
with h O
low 	 O
level e O
exercise r O
. 
 O
A 
 O
kinetic e O
model e O
for 	 O
99mTc T O
- 
 O
DMSA A O
in O O
the 	 O
rat 	 O
. 
 O
Crude d O
drugs g O
from m O
aquatic a O
plants n O
. 
 O
Yet 	 O
testosterone t O
was 	 O
predominant d O
in O O
the 	 O
plasma s O
of O O
the 	 O
Type e O
II O O
male e O
morph p O
which c O
neither t O
courts r O
females a O
nor 	 O
nests t O
, 
 O
but 	 O
instead t O
parasitizes a O
Type e O
I 
 O
males e O
with h O
sneak a O
or O O
satellite e O
spawning w O
tactics t O
. 
 O
Comparison p O
of O O
the 	 O
therapeutic r O
effectiveness e O
of O O
membrane b O
and 	 O
centrifugation t O
plasmapheresis s O
Amino n O
- 
 O
terminal m O
polymorphisms y O
of O O
the 	 O
human a B-GENE
beta a I-GENE
2 - I-GENE
- - I-GENE
adrenergic e I-GENE
receptor e E-GENE
impart a O
distinct t O
agonist n O
- 
 O
promoted m O
regulatory u O
properties p O
. 
 O
Hence c O
, 
 O
it O O
is O O
perhaps h O
not 	 O
necessary e O
to O O
perform f O
spinal n O
puncture c O
if O O
the 	 O
only y O
purpose p O
is O O
to O O
determine e O
the 	 O
CSF 	 O
/ 
 O
serum u O
ratio i O
. 
 O
Two 	 O
plasmids s O
, 
 O
one 	 O
containing t O
the 	 O
amino n O
terminus m O
of O O
P 
 O
fused e O
to O O
the 	 O
DNA 	 O
- 
 O
binding d O
domain a O
of O O
the 	 O
yeast s O
transactivator n O
, 
 O
GAL4 4 S-GENE
, 
 O
and 	 O
the 	 O
other e O
containing t O
the 	 O
amino n O
terminus m O
of O O
NP S O
fused e O
to O O
the 	 O
herpesvirus p O
transactivator n O
, 
 O
VP16 6 S-GENE
, 
 O
were e O
transfected n O
in O O
COS 	 O
- 
 O
1 
 O
cells l O
along n O
with h O
a 
 O
chloramphenicol o B-GENE
acetyltransferase t E-GENE
( 
 O
CAT 	 S-GENE
) 
 O
reporter o O
plasmid s O
containing t O
GAL4 4 B-GENE
DNA 	 I-GENE
- 
 I-GENE
binding d I-GENE
sites e E-GENE
. 
 O
Biochemical c O
experiments e O
and 	 O
genome o O
sequencing u O
have e O
shown w O
that t O
, 
 O
despite p O
the 	 O
prokaryotic k O
cell l O
and 	 O
genome o O
organization a O
, 
 O
basal a O
transcriptional n O
elements m O
of O O
members b O
of O O
the 	 O
domain a O
Archaea h O
( 
 O
i 
 O
. 
 O
e 
 O
. 
 O
, 
 O
TATA A O
box 	 O
- 
 O
like e O
sequences u O
, 
 O
RNA 	 B-GENE
polymerase y E-GENE
, 
 O
and 	 O
transcription n O
factors t O
TBP 	 S-GENE
, 
 O
TFIIB I S-GENE
, 
 O
and 	 O
TFIIS I S-GENE
) 
 O
are 	 O
of O O
the 	 O
eukaryotic a O
type e O
. 
 O
Humoral o O
immunity u O
is O O
altered e O
with h O
the 	 O
drop p O
in O O
IgG 	 S-GENE
levels e O
. 
 O
For 	 O
the 	 O
second o O
phase s O
, 
 O
it O O
was 	 O
12 O O
. 
 O
5 
 O
wk O O
for 	 O
RIR 	 O
and 	 O
10 O O
for 	 O
WL O O
males e O
, 
 O
whereas r O
it O O
was 	 O
5 
 O
wk O O
for 	 O
RIR 	 O
and 	 O
6 
 O
for 	 O
WL O O
females a O
. 
 O
Modified i O
Grocott c O
' 
 O
s 
 O
methenamine h O
silver v O
nitrate r O
method h O
for 	 O
quick c O
staining i O
of O O
Pneumocystis u O
carinii i O
. 
 O
Additionally i O
, 
 O
VAHS S O
is O O
often e O
associated o O
with h O
fatal a O
infectious e O
mononucleosis o O
( 
 O
IM O O
) 
 O
. 
 O
RESULTS U O
: 
 O
In O O
patients i O
with h O
necrotising r O
fasciitis c O
the 	 O
arterial e O
PO2 	 O
rose e O
about u O
7 
 O
- 
 O
fold d O
whereas r O
the 	 O
arterial e O
PCO2 2 O
increased r O
only y O
slightly g O
during i O
exposure o O
to O O
2 
 O
. 
 O
5 
 O
absolute o O
atmospheres o O
( 
 O
ATA 	 O
) 
 O
of O O
oxygen g O
. 
 O
We O O
report o O
on O O
a 
 O
case e O
of O O
a 
 O
43 O O
- 
 O
old 	 O
- 
 O
male e O
with h O
a 
 O
bronchogenic n O
cyst t O
in O O
the 	 O
distal t O
esophagus p O
, 
 O
which c O
was 	 O
misdiagnosed d O
as O O
a 
 O
malignant i O
esophageal p O
tumor o O
based e O
on O O
preoperative o O
imaging g O
and 	 O
high h O
levels e O
of O O
the 	 O
tumor o O
markers k O
CA B O
19 I O
- - O
9 - O
and 	 O
CA B O
125 	 O
. 
 O
100 	 O
and 	 O
51 O O
p 
 O
. 
 O
A 
 O
plasma s O
cell l O
- 
 O
rich h O
infiltrate i O
was 	 O
present s O
in O O
the 	 O
connective n O
tissue s O
cores e O
of O O
the 	 O
papillae i O
. 
 O
During i O
normoxic m O
exercise r O
, 
 O
at O O
a 
 O
mean n O
O2 O O
uptake a O
( 
 O
VO2 	 O
) 
 O
of O O
4 
 O
. 
 O
0 
 O
l 
 O
/ 
 O
min 	 O
, 
 O
almitrine i O
increased r O
arterial e O
PO2 	 O
( 
 O
PaO2 2 O
) 
 O
( 
 O
P 
 O
< 
 O
0 
 O
. 
 O
05 O O
) 
 O
, 
 O
SaO2 2 O
( 
 O
P 
 O
< 
 O
0 
 O
. 
 O
01 O O
) 
 O
, 
 O
and 	 O
VE O O
( 
 O
P 
 O
< 
 O
0 
 O
. 
 O
05 O O
) 
 O
and 	 O
decreased r O
arterial e O
PCO2 2 O
( 
 O
P 
 O
< 
 O
0 
 O
. 
 O
01 O O
) 
 O
, 
 O
without h O
affecting e O
pulmonary m O
hemodynamics o O
or O O
ventilation t O
- 
 O
perfusion f O
distributions t O
. 
 O
Gene e B-GENE
GPR 	 I-GENE
51 E E-GENE
was 	 O
localized a O
by O O
radiation i O
hybrid r O
mapping p O
to O O
chromosome o O
9 
 O
, 
 O
4 
 O
. 
 O
81 O O
cR O O
from m O
the 	 O
WI O O
- 
 O
8684 4 O
marker k O
, 
 O
and 	 O
proximal x O
to O O
the 	 O
hereditary e B-GENE
sensory s I-GENE
neuropathy r I-GENE
type e I-GENE
1 - I-GENE
locus u E-GENE
. 
 O
We O O
conclude c O
that t O
the 	 O
outcome c O
of O O
patients i O
with h O
uterine r O
MMMT T O
is O O
mainly n O
influenced l O
by O O
the 	 O
initial t O
stage g O
and 	 O
the 	 O
type e O
of O O
epithelial t O
component p O
. 
 O
The 	 O
expression r O
of O O
the 	 O
leukocyte k B-GENE
EL I I-GENE
- - I-GENE
246 	 I-GENE
antigen i E-GENE
was 	 O
regulated u O
in O O
the 	 O
same e O
manner n O
as O O
L - B-GENE
- - I-GENE
selectin e E-GENE
and 	 O
EL B O
- - O
246 	 O
recognized o O
anti i B-GENE
- - I-GENE
L - I-GENE
- - I-GENE
selectin e I-GENE
mAb 	 I-GENE
affinity i I-GENE
- 
 I-GENE
purified i I-GENE
antigen i E-GENE
in O O
SDS 	 O
/ 
 O
PAGE E O
Western t O
blot t O
analysis l O
. 
 O
Other e O
Fischer c O
- 
 O
344 	 O
rats s O
were e O
also o O
exposed o O
for 	 O
1 
 O
hr O O
to O O
0 
 O
. 
 O
0 
 O
or O O
to O O
0 
 O
. 
 O
6 
 O
ppm 	 O
O3 O O
. 
 O
A 
 O
computerized p O
database a O
of O O
veterans e O
discharged c O
from m O
the 	 O
military i O
after e O
1967 7 O
was 	 O
selected e O
as O O
the 	 O
source r O
because a O
it O O
contains t O
about u O
50 O O
% 
 O
of O O
the 	 O
total a O
Vietnam t O
era 	 O
veteran e O
population u O
, 
 O
is O O
reasonably s O
unbiased i O
, 
 O
and 	 O
provides v O
a 
 O
feasible s O
method h O
for 	 O
identifying n O
twins n O
. 
 O
To O O
examine m O
the 	 O
functional c O
relationship a O
between w O
distinct t O
cis 	 O
- 
 O
active i O
elements m O
within h O
the 	 O
distal t O
enhancer a O
region i O
of O O
the 	 O
rat 	 B-GENE
PRL 	 I-GENE
gene e E-GENE
, 
 O
we O O
have e O
used d O
deletional e O
and 	 O
mutational a O
analysis l O
of O O
that t O
region i O
in O O
transient n O
transfection n O
studies d O
in O O
GH3 	 O
pituitary u O
tumor o O
cells l O
. 
 O
The 	 O
entire i O
coding i O
region i O
of O O
an O O
ovine n B-GENE
endometrial o I-GENE
oxytocin t I-GENE
receptor e E-GENE
( 
 O
OTR 	 S-GENE
) 
 O
cDNA A O
was 	 O
generated e O
by O O
PCR 	 O
, 
 O
subcloned c O
into o O
the 	 O
SV40 0 O
major o O
late e O
promoter m O
expression r O
vector t O
pSVLJ L S-GENE
and 	 O
transiently n O
expressed r O
in O O
Cos 	 O
- 
 O
7 
 O
cells l O
. 
 O
Alcohol o O
and 	 O
stomach m O
diseases e O
These s O
operons r O
encode o O
subunits u O
of O O
photosystems t B-GENE
I - I-GENE
( 
 I-GENE
psa 	 I-GENE
) 
 I-GENE
and 	 I-GENE
II O E-GENE
( 
 O
psb 	 S-GENE
) 
 O
, 
 O
the 	 O
cytochrome o B-GENE
bGf 	 I-GENE
complex p E-GENE
( 
 O
pet 	 O
) 
 O
, 
 O
the 	 O
plastid s B-GENE
NAD 	 I-GENE
( - I-GENE
P - I-GENE
) - I-GENE
H - I-GENE
dehydrogenase y E-GENE
( 
 O
ndh 	 S-GENE
) 
 O
, 
 O
and 	 O
the 	 O
unidentified d O
open n O
reading d O
frame m O
ycf9 9 S-GENE
. 
 O
The 	 O
phosphatidylglycerol s B-GENE
/ - I-GENE
phosphatidylinositol s I-GENE
transfer n I-GENE
protein t E-GENE
( 
 O
PG B S-GENE
/ - O
PI I B-GENE
- - I-GENE
TP E E-GENE
) 
 O
is O O
a 
 O
new 	 O
and 	 O
original g O
phospholipid s B-GENE
transfer n I-GENE
protein t E-GENE
( 
 O
PLTP P S-GENE
) 
 O
isolated l O
from m O
the 	 O
Deuteromycete t O
, 
 O
Aspergillus e O
oryzae z O
. 
 O
Transcriptional n O
modulation u O
of O O
the 	 O
anti i B-GENE
- - I-GENE
apoptotic p I-GENE
protein t I-GENE
BCL 	 I-GENE
- - I-GENE
XL E E-GENE
by O O
the 	 O
paired r O
box 	 O
transcription n O
factors t O
PAX3 3 S-GENE
and 	 O
PAX3 3 S-GENE
/ 
 O
FKHR R S-GENE
. 
 O
The 	 O
level e O
of O O
expression r O
of O O
the 	 O
PDE 	 B-GENE
protein t E-GENE
was 	 O
monitored i O
by O O
immunoblot u O
analysis l O
using n O
two 	 O
specific c O
cAMP P B-GENE
- - I-GENE
PDE 	 I-GENE
polyclonal y I-GENE
antibodies i E-GENE
and 	 O
by O O
measuring s O
the 	 O
PDE 	 O
activity i O
. 
 O
Blotting t O
analysis l O
of O O
intestinal e O
RNA 	 O
and 	 O
hybridization r O
of O O
the 	 O
blots t O
with h O
carboxy b B-GENE
apoB B I-GENE
cDNA A E-GENE
probes b O
produced d O
a 
 O
single g O
15 O O
- 
 O
kb O O
hybridization r O
band d O
whereas r O
hybridization r O
with h O
amino n O
terminal m O
probes b O
produced d O
two 	 O
hybridization r O
bands d O
of O O
15 O O
and 	 O
8 
 O
kb O O
. 
 O
Since c O
UmuD D B-GENE
protein t E-GENE
is O O
proteolytically t O
processed c O
to O O
an O O
active i O
form m O
( 
 O
UmuD D B-GENE
* - E-GENE
) 
 O
in O O
a 
 O
RecA A B-GENE
* 
 E-GENE
- 
 O
dependent e O
fashion h O
, 
 O
and 	 O
MucA A S-GENE
shares r O
extensive e O
amino n O
acid d O
homology o O
with h O
UmuD D S-GENE
, 
 O
we O O
examined m O
whether t O
MucA A S-GENE
is O O
similarly i O
processed c O
in O O
the 	 O
cell l O
, 
 O
using n O
antiserum i O
against i O
a 
 O
LacZ Z B-GENE
' - E-GENE
- 
 O
' - O
MucA A S-GENE
fusion i O
protein t O
. 
 O
Influence l O
of O O
long g O
- 
 O
term m O
zimelidine e O
treatment a O
on O O
LSD 	 O
- 
 O
induced u O
behavioural a O
effects e O
. 
 O
We O O
have e O
determined e O
the 	 O
molecular e O
organization a O
and 	 O
transcription n O
start r O
points n O
( 
 O
tsp 	 O
) 
 O
for 	 O
the 	 O
murine i B-GENE
gene e E-GENE
( 
 O
TK S S-GENE
) 
 O
encoding o O
thymidine m B-GENE
kinase a E-GENE
. 
 O
Together e O
with h O
a 
 O
number b O
of O O
phase s O
II O O
trials a O
, 
 O
phase s O
I 
 O
trials a O
utilizing l O
escalating a O
doses e O
of O O
carboplatin b O
and 	 O
paclitaxel l O
with h O
growth w O
factor t O
or O O
growth w O
factor t O
and 	 O
blood o O
stem m O
- 
 O
cell l O
support p O
have e O
shown w O
that t O
substantial s O
increases r O
in O O
dose e O
intensity e O
can 	 O
be O O
achieved i O
. 
 O
It O O
is O O
an O O
untested e O
argument u O
that t O
conventional v O
beta a O
- - O
adrenoceptor e O
antagonists a O
possess s O
unwanted a O
metabolic a O
effects e O
that t O
may 	 O
counter n O
some e O
of O O
their i O
potential e O
cardiac d O
benefits e O
. 
 O
Genetic e O
polymorphisms y O
in O O
the 	 O
5 
 O
' 
 O
- 
 O
flanking n O
region i O
change n O
transcriptional n O
regulation u O
of O O
the 	 O
human a B-GENE
cytochrome o I-GENE
P450IIE1 0 I-GENE
gene e E-GENE
. 
 O
Although h O
the 	 O
occurrence u O
of O O
any 	 O
ventricular t O
ectopic o O
activity i O
, 
 O
as O O
detected e O
by O O
either h O
or O O
both h O
methods h O
, 
 O
was 	 O
common m O
, 
 O
the 	 O
incidence i O
was 	 O
significantly n O
higher h O
( 
 O
P 
 O
less s O
than n O
0 
 O
. 
 O
001 	 O
) 
 O
in O O
patients i O
with h O
coronary o O
heart r O
disease e O
( 
 O
86 O O
percent c O
; 
 O
77 O O
/ 
 O
90 O O
) 
 O
, 
 O
as O O
compared p O
to O O
that t O
in O O
normal m O
subjects j O
( 
 O
40 O O
percent c O
; 
 O
12 O O
/ 
 O
30 O O
) 
 O
. 
 O
Increased r O
trabecular b O
spacing c O
, 
 O
such h O
as O O
it O O
occurs u O
in O O
osteoporosis e O
, 
 O
reduces u O
the 	 O
spatial t O
field l O
inhomogeneity o O
and 	 O
thus s O
prolongs l O
T2 O O
* 
 O
, 
 O
which c O
has 	 O
been n O
shown w O
both h O
in O O
vitro r O
and 	 O
in O O
vivo o O
. 
 O
Healthy l O
preterm t O
infants a O
of O O
gestational t O
age 	 O
26 O O
- 
 O
29 O O
weeks k O
showed w O
a 
 O
' 
 O
mature u O
' 
 O
pattern t O
of O O
permeability m O
at O O
birth t O
, 
 O
followed l O
by O O
a 
 O
temporary p O
period i O
of O O
enhanced a O
permeability m O
after e O
3 
 O
- 
 O
4 
 O
weeks k O
of O O
life e O
. 
 O
These s O
studies d O
reveal e O
that t O
CREM M S-GENE
, 
 O
a 
 O
tissue s O
- 
 O
specific c O
factor t O
, 
 O
is O O
expressed r O
and 	 O
regulated u O
by O O
gonadotropins a S-GENE
in O O
the 	 O
ovary r O
, 
 O
that t O
the 	 O
predominant d O
CREM M B-GENE
transcripts n E-GENE
encode o O
the 	 O
repressor r B-GENE
protein t I-GENE
ICER R E-GENE
, 
 O
and 	 O
that t O
ICER R S-GENE
is O O
capable a O
of O O
inhibiting i O
cAMP P O
- 
 O
induced u O
expression r O
of O O
the 	 O
inhibin i B-GENE
alpha h I-GENE
- - I-GENE
subunit u I-GENE
gene e E-GENE
. 
 O
The 	 O
Brassica s B-GENE
BTH1 1 I-GENE
gene e E-GENE
may 	 O
correspond r O
to O O
the 	 O
Arabidopsis b B-GENE
TH I I-GENE
- - I-GENE
1 - I-GENE
gene e E-GENE
. 
 O
The 	 O
same e O
pattern t O
of O O
firing i O
was 	 O
seen n O
with h O
saccades c O
in O O
light h O
and 	 O
in O O
complete p O
darkness k O
. 
 O
While l O
these s O
could l O
be O O
unusual s O
cases e O
of O O
chronic o O
non 	 O
- 
 O
A 
 O
, 
 O
non 	 O
- 
 O
B 
 O
hepatitis a O
, 
 O
this s O
can 	 O
be O O
only y O
speculation c O
until i O
a 
 O
serologic o O
test t O
for 	 O
non 	 O
- 
 O
A 
 O
, 
 O
non 	 O
- 
 O
B 
 O
hepatitis a O
becomes o O
available i O
. 
 O
Acanthamoeba n B-GENE
myosin s I-GENE
I - I-GENE
heavy v I-GENE
chain i I-GENE
kinase a E-GENE
( 
 O
MIHCK C S-GENE
) 
 O
phosphorylates s O
the 	 O
heavy v O
chains i O
of O O
amoeba e B-GENE
myosins s I-GENE
I - E-GENE
, 
 O
increasing r O
their i O
actin i S-GENE
- 
 O
activated i O
ATPase a S-GENE
activities i O
. 
 O
Mutation a O
of O O
the 	 O
HNF3 3 B-GENE
element m E-GENE
significantly n O
reduced u O
promoter m O
activity i O
in O O
HepG2 G O
cells l O
, 
 O
whereas r O
this s O
element m O
in O O
isolation l O
conferred f O
HNF3beta 3 S-GENE
responsiveness p O
to O O
a 
 O
heterologous e O
promoter m O
. 
 O
The 	 O
mitochondrial o B-GENE
tyrosyl o I-GENE
- - I-GENE
tRNA A I-GENE
synthetase t I-GENE
of O I-GENE
Podospora o I-GENE
anserina e E-GENE
is O O
a 
 O
bifunctional u O
enzyme y O
active i O
in O O
protein t O
synthesis t O
and 	 O
RNA 	 O
splicing i O
. 
 O
The 	 O
findings d O
in O O
the 	 O
human a O
multiple t O
myeloma l O
cell l O
lines e O
represent r O
the 	 O
first s O
examples m O
of O O
B 
 O
cells l O
with h O
downregulated n O
PU B B-GENE
. - I-GENE
1 - E-GENE
expression r O
and 	 O
apparently a O
contradict t O
observations e O
in O O
the 	 O
murine i O
system t O
in O O
which c O
PU B B-GENE
. - I-GENE
1 - E-GENE
is O O
expressed r O
and 	 O
active i O
in O O
plasmacytoma s O
cell l O
lines e O
. 
 O
The 	 O
traW W B-GENE
gene e E-GENE
of I O
the 	 O
Escherichia h B-GENE
coli i I-GENE
K - I-GENE
- - I-GENE
12 I I-GENE
sex 	 I-GENE
factor t E-GENE
, 
 O
F 
 O
, 
 O
encodes o O
one 	 O
of O O
the 	 O
numerous e O
proteins t O
required u O
for 	 O
conjugative j O
transfer n O
of O O
this s O
plasmid s O
. 
 O
Mibefradil e O
( 
 O
Ro O O
40 O O
- 
 O
5967 7 O
) 
 O
is O O
a 
 O
novel e O
nondihydropyridine d O
calcium c O
antagonist a O
. 
 O
However e O
, 
 O
technical h O
advances a O
have e O
shown w O
the 	 O
limitations i O
of O O
these s O
tests t O
as O O
tests t O
for 	 O
IgM 	 S-GENE
can 	 O
be O O
positive i O
because a O
of O O
residual i O
specific c O
IgM 	 S-GENE
or O O
even n O
in O O
subjects j O
free e O
of O O
acute t O
infection e O
due 	 O
to O O
the 	 O
existence s O
of O O
natural u O
interfering e O
IgM 	 S-GENE
. 
 O
Carcinogenic c O
action i O
of O O
groundnut u O
meal l O
containing t O
aflatoxin a O
in O O
rats s O
. 
 O
( 
 O
1991 1 O
) 
 O
EMBO O O
J 
 O
. 
 O
We O O
have e O
utilized l O
transient n O
transfections n O
, 
 O
mutation a O
analysis l O
, 
 O
electromobility c O
gel 	 O
- 
 O
shifts f O
, 
 O
and 	 O
immunoblot u O
analysis l O
to O O
test t O
the 	 O
hypothesis o O
that t O
expression r O
of O O
the 	 O
CTalpha l B-GENE
gene e E-GENE
is O O
controlled t O
in O O
part t O
by O O
the 	 O
binding d O
of O O
three e O
trans n O
- 
 O
acting i O
nuclear l O
factors t O
, 
 O
Sp1 	 S-GENE
, 
 O
Sp2 	 S-GENE
, 
 O
and 	 O
Sp3 	 S-GENE
. 
 O
AMPK K S-GENE
is O O
a 
 O
heterotrimer e O
composed p O
of O O
a 
 O
catalytic a O
subunit u O
( 
 O
alpha h O
) 
 O
and 	 O
two 	 O
regulatory u O
subunits u O
( 
 O
beta a B-GENE
and 	 I-GENE
gamma m E-GENE
) 
 O
. 
 O
The 	 O
evolutionary l O
significance n O
of O O
the 	 O
similarities i O
of O O
intron r O
secondary o O
structures u O
and 	 O
open n O
reading d O
frames m O
of O O
the 	 O
ND3 	 B-GENE
, - I-GENE
4 - I-GENE
and 	 I-GENE
ATPase a I-GENE
6 - I-GENE
genes e E-GENE
is O O
discussed c O
, 
 O
including l O
the 	 O
possible s O
separate a O
evolution l O
of O O
structural u O
and 	 O
coding i O
sequences u O
. 
 O
Antinuclear i O
antibodies i O
, 
 O
rheumatoid u B-GENE
factor t E-GENE
and 	 O
C - B-GENE
- - I-GENE
reactive c I-GENE
protein t E-GENE
in O O
serum u O
of O O
normal m O
women e O
using n O
oral l O
contraceptives t O
. 
 O
The 	 O
destruction t O
of O O
the 	 O
mesometrium o O
did 	 O
not 	 O
lengthen g O
the 	 O
oestrous t O
cycle l O
. 
 O
Concentrations c O
of O O
platelet t O
nitrite r O
and 	 O
total a O
nitrate r O
/ 
 O
nitrite r O
were e O
determined e O
using n O
simple p O
and 	 O
sensitive s O
nitrate r O
/ 
 O
nitrite r O
fluorometric o O
assay a O
techniques h O
. 
 O
Power e O
deposition o O
by O O
inverse e O
- 
 O
bremsstrahlung m O
is O O
modeled e O
with h O
a 
 O
scheme e O
based e O
on O O
Gaussian s O
quadrature d O
to O O
accommodate o O
a 
 O
deposition o O
rate e O
whose s O
spatial t O
variation i O
is O O
highly h O
nonuniform u O
. 
 O
The 	 O
sulfur f O
species c O
could l O
be O O
separated a O
within h O
less s O
than n O
4 
 O
min 	 O
by O O
CZE 	 O
with h O
a 
 O
pyromellitic o O
acid d O
electrolyte c O
at O O
pH O O
3 
 O
. 
 O
5 
 O
to O O
5 
 O
. 
 O
0 
 O
. 
 O
We O O
propose p O
that t O
unc 	 B-GENE
- - I-GENE
37 E E-GENE
may 	 O
be O O
regulated u O
by O O
unc 	 B-GENE
- - I-GENE
4 - E-GENE
. 
 O
Adenovirus n O
infection e O
of O O
hepatoma a O
cells l O
inhibited i O
transcription n O
of O O
the 	 O
phosphoenolpyruvate s B-GENE
carboxykinase b E-GENE
( 
 O
GTP 	 S-GENE
) 
 O
( 
 O
EC B B-GENE
4 - I-GENE
. - I-GENE
1 - I-GENE
. - I-GENE
1 - I-GENE
. - I-GENE
32 E I-GENE
) 
 E-GENE
( 
 O
PEPCK C S-GENE
) 
 O
gene e O
and 	 O
virtually t O
eliminated m O
transcription n O
of O O
a 
 O
chimeric m O
gene e O
which c O
contained t O
the 	 O
PEPCK C B-GENE
promoter m E-GENE
linked k O
to O O
the 	 O
structural u O
gene e O
for 	 O
chloramphenicol o B-GENE
acetyltransferase t E-GENE
( 
 O
CAT 	 S-GENE
) 
 O
. 
 O
After e O
discharge c O
, 
 O
he O O
was 	 O
finally a O
given e O
a 
 O
diagnosis g O
of O O
PCH 	 O
because a O
a 
 O
Donath a O
- 
 O
Landsteiner d O
test t O
was 	 O
positive i O
. 
 O
The 	 O
second o O
intron r O
is O O
the 	 O
smallest l O
of O O
all 	 O
the 	 O
introns r O
( 
 O
116 	 O
bp O O
) 
 O
. 
 O
Expression r O
of O O
the 	 O
gene e O
encoding o O
transcription n O
factor t O
cyclic l O
adenosine n O
3 - O
' - O
, - O
5 - O
' - O
- - O
monophosphate o O
( - O
cAMP P O
) - O
response p O
element m B-GENE
- - I-GENE
binding d I-GENE
protein t E-GENE
( 
 O
CREB B S-GENE
) 
 O
: 
 O
regulation u O
by O O
follicle l O
- - O
stimulating m O
hormone m O
- 
 O
induced u O
cAMP P O
signaling n O
in O O
primary m O
rat 	 O
Sertoli t O
cells l O
. 
 O
Efficacy i O
was 	 O
evaluated l O
in O O
24 O O
patients i O
, 
 O
of O O
whom m O
eight h O
received e O
RD O O
and 	 O
16 O O
SD O O
. 
 O
A 
 O
silica i O
- 
 O
based e O
, 
 O
fluoride o O
- 
 O
free e O
placebo c O
containing t O
NaTPP P O
, 
 O
and 	 O
a 
 O
NaF 	 O
- 
 O
containing t O
silica i O
- 
 O
based e O
USP 	 O
reference e O
standard n O
toothpaste t O
were e O
used d O
as O O
negative a O
and 	 O
positive i O
control t O
toothpastes t O
, 
 O
respectively p O
. 
 O
The 	 O
overall r O
response p O
rate e O
including l O
CR O O
and 	 O
PR O O
was 	 O
23 O O
. 
 O
5 
 O
% 
 O
( 
 O
4 
 O
/ 
 O
17 O O
) 
 O
. 
 O
High h O
and 	 O
pathological h O
PAI 	 B-GENE
- - I-GENE
1 - E-GENE
levels e O
before o O
and 	 O
after e O
the 	 O
VO O O
test t O
were e O
consistent s O
with h O
a 
 O
defective e O
fibrinolytic r O
potential e O
due 	 O
to O O
the 	 O
inhibitory i O
effect e O
of O O
PAI 	 B-GENE
- - I-GENE
1 - E-GENE
on O O
plasminogen s S-GENE
activation i O
. 
 O
During i O
hexamethylene a O
bisactamide a O
( 
 O
HMBA A O
) 
 O
- 
 O
induced u O
differentiation f O
of O O
murine i O
erythroleukemia t O
( 
 O
MEL 	 O
) 
 O
cells l O
erythroid t O
genes e O
are 	 O
transcriptionally n O
activated i O
while l O
c - B-GENE
- - I-GENE
myb 	 E-GENE
and 	 O
several e O
other e O
nuclear l O
proto t O
- 
 O
oncogenes o O
are 	 O
down n O
- 
 O
regulated u O
. 
 O
The 	 O
recovery o O
of O O
adults l O
schistosomes i O
by O O
extracorporeal r O
filtration t O
. 
 O
Torsion s O
of O O
the 	 O
contralateral t O
testis t O
5 
 O
years r O
after e O
orchiopexy h O
. 
 O
Frequency q O
of O O
recurrence u O
of O O
fibroids r O
after e O
myomectomy m O
has 	 O
been n O
evaluated l O
in O O
145 	 O
women e O
( 
 O
median i O
age 	 O
38 O O
years r O
, 
 O
range g O
21 O O
- 
 O
52 O O
) 
 O
who 	 O
underwent e O
myomectomy m O
. 
 O
Choline l B-GENE
acetyltransferase t E-GENE
immunohistochemistry u O
combined b O
with h O
the 	 O
retrograde r O
transport n O
of O O
horseradish s B-GENE
peroxidase o E-GENE
showed w O
that t O
the 	 O
reticular i O
and 	 O
mediodorsal i O
thalamic l O
nuclei l O
of O O
the 	 O
cat 	 O
receive e O
an O O
important o O
input u O
from m O
cholinergic l O
and 	 O
non 	 O
- 
 O
cholinergic l O
neurons r O
of O O
substantia s O
innominata o O
and 	 O
adjacent a O
structures u O
in O O
the 	 O
basal a O
forebrain e O
. 
 O
( 
 O
i 
 O
) 
 O
The 	 O
chimeric m O
gene e O
consisting s O
of O O
the 	 O
coding i O
and 	 O
5 
 O
' 
 O
nontranslated t O
leader d O
regions i O
of O O
the 	 O
TK B B-GENE
gene e E-GENE
fused e O
to O O
portions t O
of O O
the 	 O
domain a O
of O O
alpha h B-GENE
gene e I-GENE
0 - E-GENE
extending e O
largely g O
upstream t O
from m O
the 	 O
site e O
of O O
initiation t O
of O O
transcription n O
of O O
alpha h B-GENE
gene e I-GENE
0 - E-GENE
was 	 O
regulated u O
in O O
the 	 O
same e O
fashion h O
as O O
the 	 O
alpha h B-GENE
4 - I-GENE
- - I-GENE
and 	 I-GENE
alpha h I-GENE
27 I I-GENE
- - I-GENE
TK E I-GENE
chimeras m E-GENE
. 
 O
Ethanol a O
preference f O
in O O
strains a O
of O O
rats s O
selectively e O
bred d O
for 	 O
behavioral a O
characteristics r O
. 
 O
For 	 O
the 	 O
albino i O
, 
 O
both h O
the 	 O
ST1 	 O
and 	 O
ST2 	 O
spatial t O
responses p O
peak k O
at O O
around u O
0 
 O
. 
 O
3 
 O
cycles l O
deg 	 O
- 
 O
1 
 O
, 
 O
and 	 O
both h O
curves v O
are 	 O
displaced p O
considerably s O
to O O
the 	 O
low 	 O
spatial t O
frequency q O
side e O
of O O
the 	 O
normal m O
ST2 	 O
spatial t O
response p O
. 
 O
Nuclear l O
proteins t O
bound n O
the 	 O
cad 	 O
+ - O
55 I O
/ - O
+ - O
75 I O
element m O
in O O
a 
 O
cell l O
cycle l O
- 
 O
dependent e O
manner n O
in O O
electromobility c O
shift f O
assays a O
; 
 O
antibodies i O
specific c O
to O O
USF 	 S-GENE
and 	 O
Max 	 S-GENE
blocked c O
the 	 O
DNA 	 O
- 
 O
binding d O
activity i O
of O O
different f O
growth w O
- 
 O
regulated u O
protein t O
- 
 O
DNA 	 O
complexes p O
. 
 O
Thus s O
, 
 O
an O O
unmodified o O
threonine e O
at O O
position i O
169 	 O
in O O
Cdc28 2 S-GENE
is O O
important o O
for 	 O
interaction e O
with h O
G1 B B-GENE
cyclins l E-GENE
. 
 O
Additional i O
genetic e O
analyses l O
described c O
herein e O
suggest g O
that t O
Skb1 1 S-GENE
is O O
a 
 O
component p O
of O O
the 	 O
morphology p O
control t O
branch n O
of O O
the 	 O
Ras 	 S-GENE
signaling n O
cascade c O
in O O
S 
 O
. 
 O
pombe b O
and 	 O
that t O
it O O
positively i O
modulates u O
Shk1 1 S-GENE
function c O
. 
 O
Recent e O
studies d O
have e O
concentrated c O
on O O
the 	 O
methods h O
of O O
preparation p O
of O O
coffee f O
, 
 O
which c O
vary y O
from m O
country n O
to O O
country n O
. 
 O
From m O
a 
 O
chromosomal o O
cosmid m O
library r O
of O O
Streptomyces e O
argillaceus i O
, 
 O
a 
 O
Mtm 	 B-GENE
producer d E-GENE
, 
 O
a 
 O
clone n O
( 
 O
cosAR7 A S-GENE
) 
 O
was 	 O
isolated l O
by O O
homology o O
to O O
the 	 O
actI I B-GENE
/ - I-GENE
III 	 I-GENE
region i E-GENE
of O O
S 
 O
. 
 O
coelicolor l O
and 	 O
the 	 O
strDEM D B-GENE
genes e E-GENE
of O O
S 
 O
. 
 O
griseus s O
. 
 O
In O O
this s O
report o O
, 
 O
we O O
investigated e O
whether t O
the 	 O
cleavage a O
of O O
the 	 O
RRKR R B-GENE
motif i E-GENE
of O O
MT B B-GENE
- - I-GENE
MMP1 1 E-GENE
by O O
Golgi g B-GENE
- - I-GENE
associated o I-GENE
furin i E-GENE
is O O
analogous l O
to O O
a 
 O
similar i O
enzyme y O
activation i O
mechanism h O
observed e O
with h O
stromelysin o B-GENE
- - I-GENE
3 - E-GENE
. 
 O
Coexpression x O
of O O
C - B-GENE
/ - I-GENE
EBP 	 I-GENE
alpha h E-GENE
altered e O
the 	 O
cell l O
specificity c O
. 
 O
A 
 O
preterm t O
formula m O
with h O
a 
 O
traditional d O
corn n O
oil 	 O
/ 
 O
MCT 	 O
blend n O
containing t O
38 O O
% 
 O
MCTs s O
( 
 O
MCT 	 O
group u O
) 
 O
was 	 O
compared p O
to O O
a 
 O
new 	 O
fat 	 O
blend n O
, 
 O
designed i O
to O O
resemble e O
human a O
milk k O
more e O
, 
 O
containing t O
6 
 O
% 
 O
MCTs s O
( 
 O
LCT 	 O
group u O
) 
 O
. 
 O
Thirty r O
- 
 O
three e O
small l O
glottic t O
carcinomas c O
( 
 O
T1 O O
and 	 O
small l O
T2 O O
; 
 O
UICC C O
, 
 O
1978 8 O
) 
 O
were e O
examined m O
by O O
malignancy i O
grading d O
using n O
the 	 O
8 
 O
- 
 O
factor t O
system t O
proposed p O
by O O
Jakobsson o O
et O O
al O O
. 
 O
Phenylalanine n O
and 	 O
tyrosine o O
levels e O
were e O
higher h O
in O O
those s O
who 	 O
received e O
Vamin i O
9 
 O
glucose c O
but 	 O
55 O O
% 
 O
of O O
infants a O
given e O
Vamin i O
Infant a O
had 	 O
tyrosine o O
levels e O
below o O
the 	 O
lower e O
limit i O
of O O
the 	 O
target g O
range g O
. 
 O
We O O
sought g O
to O O
test t O
whether t O
a 
 O
prolonged l O
infusion u O
of O O
magnesium n O
sulfate f O
( 
 O
MgSO O O
( 
 O
4 
 O
) 
 O
; 
 O
40 O O
mmol l O
/ 
 O
24 O O
hours r O
) 
 O
would l O
normalize m O
QT O O
interval e O
variability i O
in O O
patients i O
with h O
compensated p O
heart r O
failure l O
. 
 O
Escherichia h O
coli i O
strains a O
carrying r O
recA730 A O
( 
 O
or O O
other e O
recA A B-GENE
* - I-GENE
alleles e E-GENE
) 
 O
exhibit i O
dramatic m O
increases r O
in O O
SOS 	 S-GENE
- 
 O
dependent e O
spontaneous n O
mutator a O
activity i O
. 
 O
Outlook l O
in O O
oral l O
and 	 O
cutaneous a O
Kaposi o O
' 
 O
s 
 O
sarcoma c O
. 
 O
We O O
report o O
the 	 O
complete p O
nucleotide l O
sequence u O
of O O
the 	 O
camC C B-GENE
gene e E-GENE
along n O
with h O
155 	 O
base e O
pairs r O
of O O
5 
 O
' 
 O
and 	 O
175 	 O
base e O
pairs r O
of O O
3 
 O
' 
 O
flanking n O
sequence u O
. 
 O
However e O
, 
 O
it O O
is O O
only y O
loosely s O
associated o O
, 
 O
or O O
not 	 O
associated o O
, 
 O
with h O
viral a O
particles t O
. 
 O
gp170 7 S-GENE
is O O
generated e O
by O O
an O O
alternatively e O
spliced i O
Env 	 B-GENE
mRNA A E-GENE
using n O
a 
 O
splice i O
donor o O
and 	 O
splice i O
acceptor e O
pair r O
localized a O
within h O
the 	 O
env 	 O
open n O
reading d O
frame m O
( - O
ORF 	 O
) - O
, 
 O
which c O
is O O
normally m O
used d O
to O O
generate e O
Bell l O
and 	 O
Bet 	 B-GENE
transcripts n E-GENE
derived i O
from m O
the 	 O
internal e O
promoter m O
within h O
the 	 O
env 	 B-GENE
ORF 	 E-GENE
. 
 O
gp170 7 S-GENE
is O O
expressed r O
at O O
a 
 O
level e O
30 O O
to O O
50 O O
% 
 O
of O O
the 	 O
Env 	 B-GENE
precursor c E-GENE
gp130 3 S-GENE
. 
 O
In O O
marked k O
contrast t O
to O O
the 	 O
previously v O
published l O
human a B-GENE
CD6 	 I-GENE
sequence u E-GENE
, 
 O
the 	 O
mouse s O
sequence u O
predicts d O
a 
 O
long g O
cytoplasmic o O
tail l O
that t O
is O O
not 	 O
closely s O
related a O
to O O
other e O
proteins t O
and 	 O
possesses s O
two 	 O
proline l O
- 
 O
rich h O
motifs i O
containing t O
the 	 O
SH3 	 B-GENE
- - I-GENE
domain a I-GENE
binding d I-GENE
consensus s I-GENE
sequence u E-GENE
, 
 O
three e O
protein t B-GENE
kinase a I-GENE
C - E-GENE
phosphorylation s O
site e O
motifs i O
, 
 O
nine e O
casein e B-GENE
kinase a I-GENE
- - I-GENE
2 - E-GENE
phosphorylation s O
site e O
motifs i O
, 
 O
and 	 O
a 
 O
serine i O
- 
 O
threonine e O
- 
 O
rich h O
motif i O
repeated e O
three e O
times e O
. 
 O
ET B O
- - O
1 - O
limited i O
the 	 O
electrocardiographic c O
evidence d O
of O O
subendocardial e O
ischemia h O
and 	 O
attenuated e O
contractile t O
dysfunction f O
compared p O
with h O
mechanical h O
stenosis n O
at O O
the 	 O
same e O
coronary o O
flows w O
, 
 O
even n O
though u O
lactate t O
flux x O
was 	 O
similar i O
. 
 O
Our 	 O
results u O
are 	 O
consistent s O
with h O
TCOF1 F S-GENE
mutations a O
leading d O
to O O
the 	 O
Treacher a O
Collins l O
syndrome d O
phenotype n O
. 
 O
Experimental e O
production d O
of O O
a 
 O
syndrome d O
analogous l O
to O O
hydramnios r O
in O O
the 	 O
rat 	 O
fetus u O
Total a O
cross s O
sections t O
for 	 O
electron c O
scattering t O
by O O
CO2 	 O
molecules e O
in O O
the 	 O
energy r O
range g O
400 	 O
- 
 O
5000 0 O
eV O O
. 
 O
Thus s O
, 
 O
the 	 O
cognitive n O
performance f O
of O O
elderly e O
subjects j O
could l O
be O O
trained i O
to O O
a 
 O
large g O
extent e O
. 
 O
Partial t O
albinism i O
and 	 O
immunodeficiency u O
: 
 O
ultrastructural r O
study d O
of O O
haemophagocytosis m O
and 	 O
bone e O
marrow r O
erythroblasts t O
in O O
one 	 O
case e O
. 
 O
Residues i O
that t O
affect e O
PLCbeta b S-GENE
and 	 O
adenylyl n B-GENE
cyclase l I-GENE
II E E-GENE
activity i O
are 	 O
found n O
on O O
opposite o O
sides e O
of O O
the 	 O
central t O
tunnel n O
, 
 O
suggesting g O
that t O
PLC 	 S-GENE
and 	 O
adenylyl n B-GENE
cyclase l E-GENE
, 
 O
like e O
the 	 O
alpha h O
subunit u O
, 
 O
make e O
many y O
contacts t O
on O O
the 	 O
top 	 O
surface f O
. 
 O
The 	 O
dynamics a O
of O O
protozoa t O
were e O
studied d O
in O O
two 	 O
groups u O
of O O
rumen e O
- 
 O
fistulated t O
cattle t O
fed 	 O
on O O
a 
 O
basal a O
diet t O
of O O
molasses a O
ad O O
lib 	 O
. 
 O
, 
 O
with h O
oaten e O
chaff f O
given e O
at O O
6 
 O
or O O
18 O O
g 
 O
/ 
 O
kg O O
live e O
weight g O
. 
 O
The 	 O
CBS 	 B-GENE
- - I-GENE
1 - I-GENE
gene e E-GENE
was 	 O
mapped p O
to O O
human a O
chromosome o O
10p12 1 O
between w O
markers k O
WI B O
- - O
8535 5 O
and 	 O
WI B O
- - O
4724 4 O
, 
 O
and 	 O
is O O
tightly h O
linked k O
to O O
the 	 O
two 	 O
STRP P O
markers k O
of O O
D10S1789 S O
and 	 O
D10S550 S O
. 
 O
Blood o O
ammonia o O
concentration c O
was 	 O
significantly n O
higher h O
in O O
males e O
at O O
70 O O
, 
 O
80 O O
and 	 O
90 O O
% 
 O
of O O
VO2 	 O
peak k O
. 
 O
Value u O
of O O
bone e O
scintigraphy n O
with h O
Tc99MDP 9 O
in O O
the 	 O
early l O
diagnosis g O
of O O
mobilization i O
of O O
the 	 O
total a O
hip 	 O
prosthesis s O
Youssoufian s O
, 
 O
A 
 O
. 
 O
The 	 O
dipper p O
( 
 O
RONF F O
of O O
BP O O
( 
 O
or O O
HR O O
) 
 O
> 
 O
or O O
= 
 O
10 O O
% 
 O
2 
 O
. 
 O
In O O
the 	 O
present s O
study d O
, 
 O
we O O
have e O
investigated e O
the 	 O
effects e O
of O O
SDZ 	 O
ENA 	 O
713 	 O
on O O
spatial t O
learning r O
deficits i O
in O O
aged d O
rats s O
. 
 O
MATERIALS E O
AND 	 O
METHODS H O
: 
 O
A 
 O
seven e O
- 
 O
wavelength e O
frequency q O
- 
 O
domain a O
photon t O
migration r O
probe b O
was 	 O
used d O
to O O
perform f O
noninvasive i O
NIR 	 O
measurements s O
in O O
the 	 O
breasts a O
of O O
28 O O
healthy l O
women e O
, 
 O
both h O
pre 	 O
- 
 O
and 	 O
postmenopausal t O
, 
 O
aged d O
18 O O
- 
 O
64 O O
years r O
. 
 O
YACs s O
, 
 O
BACs s O
, 
 O
cosmids m O
, 
 O
and 	 O
STSs s O
are 	 O
defined i O
to O O
aid 	 O
in O O
further t O
study d O
of O O
this s O
gene e O
. 
 O
HCVR R O
- 
 O
L 
 O
significantly n O
increased r O
dVAS S O
/ 
 O
dPCO2 O O
to O O
4 
 O
. 
 O
9 
 O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
7 
 O
mm O O
/ 
 O
Torr r O
compared p O
to O O
HCVR R O
- 
 O
S 
 O
( 
 O
p 
 O
< 
 O
0 
 O
. 
 O
05 O O
) 
 O
. 
 O
The 	 O
MEF 	 B-GENE
- - I-GENE
2 - I-GENE
proteins t E-GENE
are 	 O
a 
 O
family i O
of O O
transcriptional n O
activators i O
that t O
have e O
been n O
detected e O
in O O
a 
 O
wide e O
variety i O
of O O
cell l O
types e O
. 
 O
The 	 O
ferric r B-GENE
uptake a I-GENE
regulation u I-GENE
( 
 I-GENE
fur 	 I-GENE
) 
 I-GENE
gene e I-GENE
product d E-GENE
participates t O
in O O
regulating u O
expression r O
of O O
the 	 O
manganese g O
- 
 O
and 	 O
iron n O
- 
 O
containing t O
superoxide e B-GENE
dismutase m I-GENE
genes e I-GENE
of I I-GENE
Escherichia h I-GENE
coli i E-GENE
. 
 O
To O O
date e O
, 
 O
6 
 O
mammalian m O
GRKs s O
have e O
been n O
identified n O
by O O
molecular e O
cloning n O
. 
 O
[ 
 O
( 
 O
OP O O
) 
 O
2Cu 	 O
] 
 O
+ 
 O
also o O
detected e O
protections t O
in O O
the 	 O
C 
 B-GENE
alpha h I-GENE
- 
 I-GENE
helix i E-GENE
, 
 O
the 	 O
interdomain e O
hinge g O
, 
 O
and 	 O
beta a O
- 
 O
strands a O
2 
 O
- 
 O
7 
 O
. 
 O
The 	 O
aim 	 O
of O O
the 	 O
present s O
study d O
was 	 O
to O O
investigate e O
the 	 O
influence l O
of O O
long g O
term m O
intravenous r O
administration i O
of O O
naftidrofuryl t O
( 
 O
Dusodril o O
- 
 O
Lipha h O
Arzn n O
) 
 O
twice c O
daily l O
in O O
a 
 O
dose e O
of O O
200 	 O
mg O O
in O O
continuous t O
, 
 O
4 
 O
- 
 O
hour r O
infusion u O
in O O
500 	 O
ml O O
0 
 O
. 
 O
9 
 O
% 
 O
NaCl l O
to O O
the 	 O
patients i O
suffering f O
from m O
a 
 O
peripheral i O
arterial e O
occlusive l O
disease e O
( 
 O
PAOD D O
) 
 O
in O O
a 
 O
clinical n O
condition d O
with h O
special c O
attention e O
paid d O
to O O
transcutaneous n O
partial t O
oxygen g O
pressure s O
measurements s O
( 
 O
tcPO2 O O
) 
 O
and 	 O
rheographic o O
parameters a O
. 
 O
Vertebrate t B-GENE
U6 B I-GENE
small l I-GENE
nuclear l I-GENE
RNA 	 I-GENE
( 
 I-GENE
snRNA N I-GENE
) 
 I-GENE
loci i E-GENE
exemplify m O
a 
 O
novel e O
class s O
of O O
polymerase y B-GENE
III 	 I-GENE
- 
 I-GENE
transcribed n I-GENE
genes e E-GENE
that t O
lack k O
an O O
intragenic r O
control t O
region i O
( 
 O
ICR 	 O
) 
 O
. 
 O
Elements m O
of O O
the 	 O
hAT 	 B-GENE
transposon n I-GENE
family i E-GENE
, 
 O
such h O
as O O
the 	 O
maize z O
activator i O
( 
 O
Ac S S-GENE
) 
 O
, 
 O
have e O
been n O
discovered c O
in O O
a 
 O
large g O
number b O
of O O
eukaryotic a O
species c O
. 
 O
Judge g O
Christian i O
Byk 	 O
renders d O
service v O
to O O
the 	 O
Steering e O
Committee m O
on O O
Bioethics e O
of O O
the 	 O
Council n O
of O O
Europe o O
( 
 O
CDBI I O
) 
 O
by O O
proposing p O
a 
 O
draft f O
of O O
the 	 O
protocol t O
destined t O
to O O
fill l O
in O O
a 
 O
gap 	 O
in O O
international e O
law 	 O
on O O
the 	 O
status t O
of O O
the 	 O
human a O
embryo r O
. 
 O
Correlation r O
coefficients f O
between w O
SF O O
thickness c O
and 	 O
NIR 	 O
optical i O
density s O
readings d O
at O O
940 	 O
nm O O
( 
 O
OD1 	 O
) 
 O
and 	 O
950 	 O
nm O O
( 
 O
OD2 	 O
) 
 O
wavelengths e O
ranged g O
from m O
r 
 O
= 
 O
- 
 O
0 
 O
. 
 O
30 O O
( 
 O
subscapula s O
) 
 O
to O O
r 
 O
= 
 O
- 
 O
0 
 O
. 
 O
67 O O
( 
 O
biceps e O
) 
 O
for 	 O
OD1 	 O
and 	 O
r 
 O
= 
 O
- 
 O
0 
 O
. 
 O
39 O O
( 
 O
axilla l O
) 
 O
to O O
r 
 O
= 
 O
- 
 O
0 
 O
. 
 O
68 O O
( 
 O
biceps e O
) 
 O
for 	 O
OD2 	 O
. 
 O
We O O
found n O
both h O
the 	 O
v - B-GENE
- - I-GENE
Ras 	 E-GENE
- 
 O
and 	 O
PC B B-GENE
- - I-GENE
PLC 	 E-GENE
- 
 O
transformed n O
cells l O
to O O
be O O
insensitive e O
to O O
stimulation m O
with h O
platelet t B-GENE
- - I-GENE
derived i I-GENE
growth w I-GENE
factor t E-GENE
( 
 O
PDGF F S-GENE
) 
 O
. 
 O
Analysis l O
of O O
domain a O
deletion e O
mutants a O
demonstrated o O
strong o O
synergy e O
between w O
the 	 O
RRM 	 O
and 	 O
a 
 O
central t O
degenerate e O
RRM 	 O
repeat e O
in O O
binding d O
to O O
RNA 	 O
. 
 O
Sequence u O
analysis l O
of O O
the 	 O
catfish f B-GENE
JH S I-GENE
- 
 I-GENE
CH S I-GENE
intron r E-GENE
suggests g O
that t O
several e O
sequences u O
are 	 O
present s O
which c O
appear e O
similar i O
to O O
important o O
transcriptional n O
regulatory u O
elements m O
found n O
within h O
JH S B-GENE
- 
 I-GENE
CH S I-GENE
introns r E-GENE
of O O
higher h O
vertebrates t O
. 
 O
The 	 O
patient i O
groups u O
consisted s O
of O O
31 O O
with h O
dilated a O
cardiomyopathy d O
, 
 O
22 O O
with h O
hypertrophic e O
cardiomyopathy d O
, 
 O
38 O O
with h O
myocardial c O
infarction a O
, 
 O
15 O O
with h O
angina i O
pectoris t O
and 	 O
26 O O
with h O
rheumatic u O
valvular v O
disease e O
. 
 O
100 	 O
. 
 O
However e O
, 
 O
the 	 O
pre3 3 B-GENE
- - I-GENE
2 - I-GENE
mutation a E-GENE
strengthened e O
phenotypes n O
induced u O
by O O
other e O
20 B O
S - O
proteasomal t O
mutations a O
, 
 O
indicating i O
that t O
the 	 O
peptidylglutamyl t O
peptide t O
- 
 O
hydrolyzing r O
activity i O
has 	 O
to O O
fulfill f O
some e O
rescue c O
functions c O
. 
 O
Whereas r O
Sprague a O
- 
 O
Dawleys l O
displayed p O
lights h O
- 
 O
off 	 O
and 	 O
lights h O
- 
 O
on O O
peaks k O
of O O
ingestive e O
activity i O
, 
 O
only y O
a 
 O
minority o O
of O O
Fisher h O
- 
 O
344s s O
displayed p O
a 
 O
consistent s O
lights h O
- 
 O
on O O
peak k O
of O O
ingestive e O
activity i O
. 
 O
RESULTS U O
: 
 O
In O O
76 O O
trials a O
, 
 O
5 
 O
, 
 O
351 	 O
patients i O
received e O
24 O O
different f O
regimens i O
of O O
droperidol p O
. 
 O
The 	 O
tro 	 B-GENE
operon r E-GENE
is O O
flanked n O
by O O
a 
 O
Holliday l O
structure u O
DNA 	 B-GENE
helicase i I-GENE
homolog o E-GENE
( 
 O
upstream t O
) 
 O
and 	 O
two 	 O
ORFs s O
representing r O
a 
 O
purine i B-GENE
nucleoside l I-GENE
phosphorylase s I-GENE
homolog o E-GENE
and 	 O
tpp15 1 S-GENE
, 
 O
a 
 O
previously v O
characterized r O
gene e O
encoding o O
a 
 O
membrane b B-GENE
lipoprotein o E-GENE
( 
 O
downstream n O
) 
 O
. 
 O
We O O
report o O
nine e O
consecutive s O
cases e O
of O O
ACB 	 O
, 
 O
which c O
occurred u O
in O O
five e O
males e O
and 	 O
four r O
females a O
and 	 O
were e O
detected e O
in O O
11 O O
, 
 O
159 	 O
routine t O
spiral r O
CT O O
examinations m O
of O O
the 	 O
chest s O
, 
 O
performed f O
between w O
1994 4 O
and 	 O
1998 8 O
. 
 O
In O O
order e O
to O O
search r O
for 	 O
mutations a O
in O O
the 	 O
multicopy t O
RBM 	 B-GENE
genes e E-GENE
that t O
might h O
be O O
associated o O
with h O
male e O
infertility e O
, 
 O
we O O
have e O
used d O
sequence u O
data a O
from m O
the 	 O
reported o O
cDNA A O
clone n O
to O O
determine e O
the 	 O
intron r O
exon n O
boundaries n O
of O O
the 	 O
YRRM M B-GENE
1 - I-GENE
gene e E-GENE
. 
 O
98 O O
, 
 O
93 O O
- 
 O
98 O O
) 
 O
. 
 O
Studies d O
on O O
the 	 O
excretion r O
of O O
selenium e O
in O O
urine n O
and 	 O
feces e O
and 	 O
distribution t O
in O O
the 	 O
organs a O
of O O
rats s O
by O O
a 
 O
method h O
of O O
radioactivity i O
measurement s O
The 	 O
use 	 O
of O O
the 	 O
two 	 O
pharmacokinetic r O
parameters a O
, 
 O
t1 O O
/ 
 O
2 
 O
and 	 O
Cltp p S-GENE
, 
 O
as O O
indices i O
of O O
drug g O
elimination m O
ability l O
are 	 O
discussed c O
. 
 O
Gastric t O
secretory r O
inhibition i O
induced u O
by O O
three e O
methyl h O
analogs l O
of O O
prostaglandin s O
E2 O O
administered i O
intragastrically r O
to O O
man 	 O
. 
 O
By O O
RT O O
- 
 O
PCR 	 O
, 
 O
different f O
levels e O
of O O
E75 	 S-GENE
expression r O
can 	 O
be O O
detected e O
in O O
the 	 O
epidermis d O
, 
 O
nerve v O
cord d O
and 	 O
the 	 O
eyestalk s O
of O O
early l O
pre 	 O
- 
 O
molt t O
shrimp i O
. 
 O
The 	 O
vicinity i O
of O O
large g O
industrial u O
emissions s O
of O O
lead d O
, 
 O
where r O
mean n O
Pb O O
- 
 O
B 
 O
concentrations c O
were e O
usually a O
twice c O
as O O
high h O
as O O
in O O
rural a O
areas a O
of O O
the 	 O
Katowice o O
voivodship v O
. 
 O
Forty t O
- 
 O
five e O
per 	 O
cent t O
of O O
the 	 O
dose e O
was 	 O
excreted r O
as O O
methyldopa h O
as O O
opposed o O
to O O
18 O O
% 
 O
normally m O
seen n O
after e O
oral l O
methyldopa h O
dosages a O
. 
 O
No O O
cleavage a O
of O O
gp B B-GENE
130 	 E-GENE
was 	 O
observed e O
in O O
analogous l O
pulse s O
- 
 O
chase s O
radiolabelling i O
of O O
Ad O O
- 
 O
gB S O
- 
 O
infected e O
human a O
fibroblasts r O
, 
 O
even n O
though u O
these s O
cells l O
are 	 O
permissive m O
for 	 O
HCMV V O
replication l O
and 	 O
can 	 O
process c O
the 	 O
native i O
gB I O
molecule e O
. 
 O
A 
 O
phylogenetic l O
comparison p O
of O O
32 O O
species c O
showed w O
minor o O
differences f O
in O O
the 	 O
apoB B B-GENE
mRNA A I-GENE
sequence u E-GENE
, 
 O
and 	 O
the 	 O
apoB B B-GENE
mRNA A E-GENE
from m O
31 O O
species c O
was 	 O
robustly u O
edited t O
in O O
vitro r O
. 
 O
The 	 O
other e O
five e O
from m O
within h O
the 	 O
SRO 	 O
may 	 O
provide v O
an O O
entrance r O
point n O
for 	 O
the 	 O
cloning n O
of O O
candidate d O
genes e O
for 	 O
neuroblastoma r O
. 
 O
Sugar a O
analysis l O
was 	 O
performed f O
on O O
alpha h B-GENE
- - I-GENE
TM E E-GENE
to O O
investigate e O
a 
 O
possible s O
biosynthetic s O
mechanism h O
for 	 O
part t O
- 
 O
time e O
PGs 	 O
. 
 O
Pediatric i O
patients i O
- 
 O
- 
 O
handle d O
with h O
care e O
. 
 O
These s O
include l O
the 	 O
genes e O
, 
 O
undefined e O
1 - O
( 
 O
UD1 	 S-GENE
) 
 O
, 
 O
UD2 	 S-GENE
, 
 O
and 	 O
UD3 	 S-GENE
, 
 O
each h O
coding i O
for 	 O
proteins t O
of O O
unknown n O
function c O
, 
 O
the 	 O
ken 	 O
gene e O
encoding o O
a 
 O
new 	 O
Kruppel p B-GENE
- - I-GENE
like e I-GENE
putative a I-GENE
transcription n I-GENE
factor t E-GENE
, 
 O
the 	 O
fly 	 O
homologues o O
of O O
the 	 O
mammalian m B-GENE
mitochondrial o I-GENE
trifunctional f I-GENE
enzyme y E-GENE
( 
 O
thiolase o S-GENE
) 
 O
, 
 O
and 	 O
the 	 O
TAR 	 B-GENE
DNA 	 I-GENE
- - I-GENE
binding d I-GENE
protein t I-GENE
- - I-GENE
43 E E-GENE
( 
 O
TBPH H S-GENE
) 
 O
, 
 O
the 	 O
first s O
nonvertebrate v O
member b O
of O O
the 	 O
transmembrane n B-GENE
4 - I-GENE
superfamily e E-GENE
( 
 O
TM4SF S S-GENE
) 
 O
gene e O
, 
 O
a 
 O
new 	 O
homeodomain e B-GENE
gene e E-GENE
, 
 O
and 	 O
a 
 O
gene e O
coding i O
for 	 O
a 
 O
putative a O
nuclear l B-GENE
binding d I-GENE
protein t E-GENE
( 
 O
PNBP P S-GENE
) 
 O
that t O
is O O
homologous o O
to O O
maleless e O
, 
 O
and 	 O
a 
 O
Copia i O
- - O
like e O
element m O
. 
 O
TRAF2 F S-GENE
has 	 O
previously v O
been n O
demonstrated o O
to O O
activate i O
both h O
transcription n B-GENE
factor t I-GENE
nuclear l I-GENE
factor t I-GENE
kappaB p E-GENE
( 
 O
NFkappaB a S-GENE
) 
 O
and 	 O
the 	 O
c - B-GENE
- - I-GENE
Jun 	 I-GENE
N - I-GENE
- - I-GENE
terminal m I-GENE
kinase a E-GENE
/ 
 O
stress e B-GENE
- - I-GENE
activated i I-GENE
protein t I-GENE
kinase a E-GENE
( 
 O
JNK 	 S-GENE
/ 
 O
SAPK K S-GENE
) 
 O
pathway h O
, 
 O
which c O
in O O
turn n O
stimulates m B-GENE
transcription n I-GENE
factor t I-GENE
activating i I-GENE
protein t I-GENE
1 - E-GENE
( 
 O
AP1 	 S-GENE
) 
 O
mainly n O
via 	 O
phosphorylation s O
of O O
the 	 O
c - B-GENE
- - I-GENE
Jun 	 E-GENE
component p O
. 
 O
A 
 O
procaryotic c O
regulatory u O
factor t O
with h O
a 
 O
histone t B-GENE
H1 I I-GENE
- - I-GENE
like e I-GENE
carboxy b I-GENE
- - I-GENE
terminal m I-GENE
domain a E-GENE
: 
 O
clonal n O
variation i O
of O O
repeats e O
within h O
algP P S-GENE
, 
 O
a 
 O
gene e O
involved o O
in O O
regulation u O
of O O
mucoidy o O
in O O
Pseudomonas u O
aeruginosa u O
. 
 O
The 	 O
host t O
range g O
( 
 O
HR O O
) 
 O
of O O
poliovirus i O
is O O
thought u O
to O O
be O O
primarily m O
determined e O
by O O
a 
 O
cell l O
surface f O
molecule e O
that t O
functions c O
as O O
poliovirus i B-GENE
receptor e E-GENE
( 
 O
PVR 	 S-GENE
) 
 O
, 
 O
since c O
it O O
has 	 O
been n O
shown w O
that t O
transgenic n O
mice e O
are 	 O
made e O
poliovirus i O
sensitive s O
by O O
introducing r O
the 	 O
human a B-GENE
PVR 	 I-GENE
gene e E-GENE
into o O
the 	 O
genome o O
. 
 O
Human a B-GENE
alcohol o I-GENE
dehydrogenase y E-GENE
( 
 O
ADH 	 S-GENE
) 
 O
exists s O
as O O
a 
 O
heterogeneous e O
group u O
of O O
isozymes z O
capable a O
of O O
oxidizing d O
a 
 O
wide e O
variety i O
of O O
aliphatic p O
and 	 O
aromatic m O
alcohols o O
. 
 O
The 	 O
control t O
of O O
human a B-GENE
aromatase m E-GENE
expression r O
is O O
complex p O
in O O
that t O
several e O
promoters m O
drive v O
aromatase m S-GENE
expression r O
in O O
a 
 O
tissue s O
- 
 O
specific c O
manner n O
. 
 O
In O O
addition i O
, 
 O
renal a O
sympathetic p O
activity i O
was 	 O
measured s O
in O O
a 
 O
separate a O
group u O
of O O
rats s O
. 
 O
This s O
incompatibility o O
phenotype n O
requires u O
the 	 O
global b O
transcriptional n O
repressor r O
, 
 O
KorB B S-GENE
, 
 O
and 	 O
the 	 O
target g O
for 	 O
incC C S-GENE
- 
 O
mediated i O
incompatibility o O
is O O
a 
 O
KorB B B-GENE
- - I-GENE
binding d I-GENE
site e E-GENE
( - O
O - O
( - O
B - O
) - O
) - O
. 
 O
Bodily i O
referents e O
and 	 O
the 	 O
experience e O
of O O
affect e O
. 
 O
The 	 O
effect e O
of O O
the 	 O
negative a O
regulatory u O
element m O
is O O
negated a O
by O O
the 	 O
viral a B-GENE
IE2 	 I-GENE
protein t E-GENE
( 
 O
L 
 O
. 
 O
RXRalpha a S-GENE
/ 
 O
RARalpha a S-GENE
heterodimers e O
and 	 O
HNF 	 B-GENE
- - I-GENE
4 - I-GENE
homodimers o E-GENE
bind d O
to O O
DR O B-GENE
- 
 I-GENE
1 
 I-GENE
motifs i E-GENE
on O O
elements m O
B 
 O
and 	 O
I4 O O
, 
 O
respectively p O
. 
 O
Evidence d O
for 	 O
involvement o O
of O O
proteins t B-GENE
HU S E-GENE
and 	 O
RpoS S S-GENE
in O O
transcription n O
of O O
the 	 O
osmoresponsive o O
proU U B-GENE
operon r I-GENE
in O I-GENE
Escherichia h I-GENE
coli i E-GENE
. 
 O
However e O
, 
 O
a 
 O
lesser s O
extent e O
effect e O
was 	 O
noticed i O
in O O
nonpregnant p O
than n O
seen n O
in O O
pregnant g O
rats s O
. 
 O
Morphine p O
administration i O
acutely t O
reduced u O
plasma s O
clearance a O
of O O
sulfobromophthalein f O
( 
 O
BSP 	 O
) 
 O
in O O
mice e O
and 	 O
increased r O
hepatic a O
retention e O
of O O
this s O
dye 	 O
. 
 O
Buchstein h O
, 
 O
L 
 O
. 
 O
- 
 O
L 
 O
. 
 O
Intraspinal r O
and 	 O
mediastinal i O
foregut e O
cyst t O
compressing p O
the 	 O
spinal n O
cord d O
. 
 O
The 	 O
nutraceuticals r O
of O O
specific c O
vitamins a O
, 
 O
minerals e O
, 
 O
phytoestrogens t O
, 
 O
and 	 O
essential e O
fatty t O
acid d O
supplementations p O
are 	 O
a 
 O
vital a O
component p O
of O O
the 	 O
risk k O
reduction u O
health l O
program g O
. 
 O
Characterization r O
of O O
a 
 O
unique q O
protein t O
component p O
of O O
yeast s B-GENE
RNase s I-GENE
MRP 	 E-GENE
: 
 O
an O O
RNA 	 O
- 
 O
binding d O
protein t O
with h O
a 
 O
zinc c O
- 
 O
cluster s O
domain a O
. 
 O
The 	 O
present s O
study d O
indicates i O
that t O
the 	 O
high h O
- 
 O
dose e O
5 
 O
- 
 O
fluorouracil o O
regimen i O
shows w O
weak k O
activity i O
in O O
advanced a O
pancreatic c O
cancer c O
which c O
seems m O
comparable p O
to O O
gemcitabine c O
. 
 O
Like e O
the 	 O
nuclear l O
envelope e O
, 
 O
the 	 O
intranuclear r O
double b O
membrane b O
lamellae e O
enclosed l O
a 
 O
defined i O
cisterna t O
that t O
was 	 O
interrupted e O
by O O
pores e O
but 	 O
, 
 O
unlike i O
the 	 O
nuclear l O
envelope e O
pores e O
, 
 O
they y O
lacked k O
NPCs s O
. 
 O
The 	 O
22 O O
- 
 O
d 
 O
orbital i O
flight g O
of O O
rats s O
onboard o O
the 	 O
Cosmos m O
- 
 O
605 	 O
biosatellite s O
was 	 O
followed l O
by O O
inhibition i O
of O O
erythroblastosis t O
, 
 O
alteration e O
in O O
the 	 O
morphology p O
of O O
megakaryocytes a O
, 
 O
and 	 O
stimulation m O
of O O
myelopoiesis l O
. 
 O
An O O
OD O O
650 	 O
greater a O
than n O
0 
 O
. 
 O
15 O O
appears e O
to O O
be O O
a 
 O
rapid i O
, 
 O
reliable i O
indicator i O
of O O
fetal a O
lung g O
maturity u O
. 
 O
The 	 O
role e O
of O O
PORT T O
in O O
the 	 O
treatment a O
of O O
N2 O O
tumours o O
is O O
not 	 O
clear a O
and 	 O
may 	 O
justify t O
further t O
research e O
. 
 O
We O O
concluded c O
that t O
RXR 	 B-GENE
- - I-GENE
gamma m E-GENE
induced u O
terminal m O
differentiation f O
in O O
SCC 	 O
lines e O
, 
 O
suggesting g O
a 
 O
potential e O
tumor o O
suppressor p O
function c O
for 	 O
this s O
transcription n O
factor t O
. 
 O
Phosphorylated s O
tyrosine o O
residues i O
were e O
subsequently s O
identified n O
by O O
sequencing u O
the 	 O
separated a O
phosphopeptides s O
by O O
matrix r O
assisted i O
laser e O
desorption o O
ionization i O
mass s O
spectrometry c O
( 
 O
MALDI D O
- 
 O
MS O O
) 
 O
and 	 O
Edman a O
degradation r O
. 
 O
The 	 O
infection e O
of O O
cells l O
with h O
Moloney o O
murine i O
leukemia k O
virus u O
( 
 O
M 
 O
- 
 O
MuLV V O
) 
 O
causes s O
an O O
increase r O
in O O
specific c O
cellular l O
gene e O
products d O
, 
 O
including l O
the 	 O
major o O
histocompatibility t O
complex p O
( - O
MHC 	 S-GENE
) - O
class s B-GENE
I - I-GENE
antigens i E-GENE
. 
 O
These s O
data a O
demonstrate o O
that t O
oleosin o B-GENE
gene e E-GENE
transcription n O
is O O
regulated u O
in O O
a 
 O
tissue s O
- 
 O
specific c O
and 	 O
temporally p O
regulated u O
manner n O
and 	 O
clearly a O
indicate i O
that t O
oleosin o B-GENE
protein t E-GENE
expression r O
is O O
co O O
- 
 O
ordinated i O
primarily m O
at O O
the 	 O
transcriptional n O
level e O
. 
 O
Myocardial c O
technetium h O
- 
 O
99m 	 O
- 
 O
teboroxime o O
uptake a O
during i O
adenosine n O
- 
 O
induced u O
hyperemia e O
in O O
dogs s O
with h O
either h O
a 
 O
critical t O
or O O
mild d O
coronary o O
stenosis n O
: 
 O
comparison p O
to O O
thallium l O
- 
 O
201 	 O
and 	 O
regional i O
blood o O
flow w O
. 
 O
UICC C O
criteria t O
) 
 O
for 	 O
VM O O
and 	 O
35 O O
% 
 O
for 	 O
VE O O
( 
 O
not 	 O
significant n O
) 
 O
. 
 O
Although h O
immunoglobulin u S-GENE
and 	 O
CRP 	 S-GENE
concentration c O
increased r O
, 
 O
anemia m O
obviously i O
improved r O
with h O
hemoglobin o S-GENE
levels e O
increasing r O
from m O
4 
 O
. 
 O
8 
 O
g 
 O
/ 
 O
dl O O
to O O
8 
 O
. 
 O
5 
 O
g 
 O
/ 
 O
dl O O
without h O
any 	 O
side e O
effects e O
. 
 O
Diff f O
- 
 O
Quik k O
stain i O
for 	 O
Tzanck n O
smears a O
. 
 O
Experience e O
in O O
using n O
the 	 O
Romashka a O
- 
 O
1 
 O
laser e O
surgical g O
unit t O
in O O
treating a O
suppurative p O
wounds n O
At O O
D28 	 O
, 
 O
149 	 O
of O O
386 	 O
patients i O
( 
 O
49 O O
% 
 O
) 
 O
had 	 O
had 	 O
episodes s O
of O O
automatic o O
mode e O
switch t O
prompted m O
by O O
atrial i O
arrhythmias h O
. 
 O
Together e O
, 
 O
these s O
results u O
implicate l O
Fal1p 1 S-GENE
in O O
the 	 O
18S 	 B-GENE
rRNA A E-GENE
maturation u O
pathway h O
rather h O
than n O
in O O
translation n O
initiation t O
. 
 O
Most t O
other e O
differences f O
between w O
these s O
two 	 O
Leporipoxviruses o O
are 	 O
located a O
in O O
the 	 O
telomeres o O
. 
 O
We O O
challenge l O
each h O
of O O
55 O O
consecutive s O
ragweed w O
( 
 O
RW O O
) 
 O
- 
 O
allergic e O
patients i O
with h O
hay 	 O
fever e O
and 	 O
with h O
graded d O
increasing r O
doses e O
of O O
ragweed w O
extract r O
to O O
investigate e O
the 	 O
frequency q O
and 	 O
relationship a O
between w O
the 	 O
early l O
( 
 O
ER O O
) 
 O
, 
 O
late e O
( 
 O
LPR 	 O
) 
 O
, 
 O
and 	 O
rechallenge h O
reactions c O
( 
 O
RCRs s O
) 
 O
to O O
nasal a O
challenge l O
. 
 O
The 	 O
expression r O
of O O
CAPL L S-GENE
, 
 O
a 
 O
second o O
protein t O
involved o O
in O O
calcium c O
metabolism a O
, 
 O
was 	 O
only y O
moderately e O
elevated v O
in O O
the 	 O
doxorubicin o O
- 
 O
resistant i O
cells l O
. 
 O
The 	 O
central t O
region i O
of O O
the 	 O
sarcomere c O
, 
 O
coincident n O
with h O
the 	 O
M 
 O
line e O
, 
 O
was 	 O
selectively e O
labeled e O
with h O
antibodies i O
to O O
the 	 O
short r O
C 
 O
- 
 O
terminal m O
form m O
. 
 O
Despite p O
this s O
dependency e O
, 
 O
however e O
, 
 O
a 
 O
B - B-GENE
. - I-GENE
japonicum o I-GENE
fixK K I-GENE
mutant a E-GENE
did 	 O
not 	 O
have e O
the 	 O
phenotypic n O
characteristics r O
of O O
B - B-GENE
. - I-GENE
japonicum o I-GENE
fixL L E-GENE
and 	 O
fixJ J B-GENE
mutants a E-GENE
: 
 O
the 	 O
fixK K B-GENE
mutant a E-GENE
was 	 O
neither t O
Fix 	 O
- 
 O
in O O
symbiosis b O
with h O
soybean b O
plants n O
nor 	 O
defective e O
in O O
anaerobic e O
respiration p O
with h O
nitrate r O
as O O
the 	 O
terminal m O
electron c O
acceptor e O
. 
 O
ANL 	 O
- 
 O
7535 5 O
. 
 O
The 	 O
QCS 	 O
appears e O
comparable p O
with h O
the 	 O
MMSE E O
and 	 O
is O O
quicker c O
to O O
administer i O
. 
 O
We O O
used d O
high h O
- 
 O
resolution o O
ultrasound r O
to O O
characterize r O
postprandial t O
antral r O
excursion u O
characteristics r O
in O O
15 O O
healthy l O
volunteers u O
. 
 O
Copyright y O
1998 8 O
Academic d O
Press s O
. 
 O
Human a B-GENE
PDNP3 P E-GENE
is O O
expressed r O
in O O
glioma o O
cells l O
, 
 O
prostate s O
, 
 O
and 	 O
uterus r O
, 
 O
but 	 O
not 	 O
in O O
the 	 O
alimentary m O
tract c O
. 
 O
Epithelial t O
cells l O
had 	 O
abnormal o O
and 	 O
accelerated e O
exfoliation o O
which c O
resulted u O
in O O
multifocal t O
epithelial t O
defects e O
. 
 O
Tight h O
- 
 O
binding d O
band d O
structure u O
calculations c O
for 	 O
beta a O
- 
 O
MNX 	 O
( 
 O
M 
 O
= 
 O
Zr O O
, 
 O
X 
 O
= 
 O
Cl O O
, 
 O
Br O O
; 
 O
M 
 O
= 
 O
Hf O O
, 
 O
X 
 O
= 
 O
Cl O O
) 
 O
, 
 O
ZrCl l O
, 
 O
and 	 O
Y 
 O
( 
 O
2 
 O
) 
 O
C 
 O
( 
 O
2 
 O
) 
 O
Br O O
( 
 O
2 
 O
) 
 O
are 	 O
reported o O
. 
 O
Screening e O
of O O
a 
 O
human a O
foetal t O
brain i O
genomic o O
DNA 	 O
library r O
allowed o O
us O O
to O O
isolate l O
an O O
EcoRI R S-GENE
- 
 O
EcoRI R S-GENE
fragment g O
containing t O
6 
 O
kb O O
of O O
the 	 O
5 
 O
' 
 O
- 
 O
flanking n O
region i O
, 
 O
the 	 O
open n O
reading d O
frame m O
and 	 O
4 
 O
kb O O
of O O
the 	 O
3 
 O
' 
 O
- 
 O
flanking n O
region i O
of O O
the 	 O
alpha2C4 h B-GENE
gene e E-GENE
. 
 O
The 	 O
psychosomatic c O
approach r O
to O O
temporomandibular p O
arthrosis h O
The 	 O
rate e O
of O O
decrease r O
of O O
PRA 	 O
after e O
REM 	 O
onset e O
closely s O
approximates r O
the 	 O
most t O
recent e O
estimations i O
of O O
PRA 	 O
half f O
- 
 O
life e O
, 
 O
which c O
suggests g O
that t O
REM 	 O
onset e O
is O O
associated o O
with h O
a 
 O
virtual t O
cessation s O
in O O
renin i S-GENE
production d O
. 
 O
Similarly i O
, 
 O
interfering e O
with h O
MEKK K S-GENE
, 
 O
which c O
lies s O
upstream t O
of O O
JNK1 1 S-GENE
, 
 O
using n O
a 
 O
dominant i O
negative a O
expression r O
vector t O
reduced u O
MMP 	 B-GENE
- - I-GENE
9 - I-GENE
promoter m E-GENE
activity i O
over r O
the 	 O
same e O
concentration c O
range g O
which c O
repressed r O
the 	 O
AP B B-GENE
- - I-GENE
1 - I-GENE
- 
 I-GENE
thymidine m I-GENE
kinase a I-GENE
CAT 	 I-GENE
reporter o I-GENE
construct s E-GENE
. 
 O
There r O
was 	 O
no O O
difference f O
in O O
serum u B-GENE
albumin u E-GENE
and 	 O
transferrin n S-GENE
levels e O
, 
 O
but 	 O
serum u B-GENE
prealbumin a E-GENE
levels e O
in O O
the 	 O
group u O
fed 	 O
early l O
were e O
more e O
desirable i O
than n O
those s O
of O O
the 	 O
control t O
group u O
( 
 O
from m O
15 O O
. 
 O
8 
 O
+ 
 O
/ 
 O
- 
 O
2 
 O
. 
 O
5 
 O
mg O O
/ 
 O
dl O O
to O O
28 O O
. 
 O
9 
 O
+ 
 O
/ 
 O
- 
 O
3 
 O
. 
 O
8 
 O
mg O O
/ 
 O
dl O O
vs O O
from m O
18 O O
. 
 O
0 
 O
+ 
 O
/ 
 O
- 
 O
2 
 O
. 
 O
0 
 O
mg O O
/ 
 O
dl O O
to O O
25 O O
. 
 O
9 
 O
+ 
 O
/ 
 O
- 
 O
3 
 O
. 
 O
9 
 O
mg O O
/ 
 O
dl O O
) 
 O
. 
 O
The 	 O
repeats e O
are 	 O
highly h O
conserved s O
both h O
within h O
a 
 O
given e O
element m O
as O O
well l O
as O O
between w O
different f O
members b O
of O O
the 	 O
family i O
( 
 O
less s O
than n O
10 O O
% 
 O
divergence e O
) 
 O
. 
 O
Utility l O
of O O
thallium l O
- 
 O
201 	 O
scintigraphy n O
in O O
detecting e O
right h O
ventricular t O
dysfunction f O
in O O
pulmonary m O
embolism o O
. 
 O
CONCLUSIONS C O
: 
 O
The 	 O
system t O
developed e O
in O O
this s O
study d O
can 	 O
be O O
used d O
as O O
a 
 O
method h O
to O O
detect e O
air 	 O
- 
 O
trapping p O
during i O
TGI 	 O
. 
 O
The 	 O
carboxyl b O
- 
 O
terminal m O
75 O O
amino n O
acids d O
of O O
the 	 O
two 	 O
proteins t O
contain t O
the 	 O
bHLH H O
motif i O
and 	 O
differ f O
from m O
each h O
other e O
by O O
only y O
three e O
conservative s O
amino n O
acid d O
changes n O
, 
 O
while l O
the 	 O
amino n O
- 
 O
terminal m O
portions t O
are 	 O
markedly k O
divergent e O
from m O
each h O
other e O
. 
 O
In O O
a 
 O
rat 	 O
model e O
of O O
SAH 	 O
, 
 O
we O O
assessed e O
BBB 	 O
changes n O
by O O
means n O
of O O
the 	 O
quantitative n O
[ 
 O
14C 	 O
] 
 O
- 
 O
alpha h O
- 
 O
aminoisobutyric n O
acid d O
technique h O
. 
 O
Pollinosis l O
in O O
the 	 O
U 
 O
. 
 O
A 
 O
. 
 O
R 
 O
. 
 O
Northern t O
blot t O
analysis l O
of O O
enoyl y B-GENE
- - I-GENE
ACP 	 I-GENE
reductase u I-GENE
mRNA A E-GENE
steady a O
- 
 O
state t O
levels e O
during i O
seed d O
development e O
suggests g O
that t O
the 	 O
increase r O
in O O
enzyme y O
activity i O
during i O
the 	 O
phase s O
of O O
storage r O
lipid i O
accumulation u O
is O O
regulated u O
at O O
the 	 O
level e O
of O O
gene e O
expression r O
. 
 O
Time e O
between w O
tests t O
( 
 O
usually a O
less s O
than n O
one 	 O
year r O
) 
 O
did 	 O
not 	 O
affect e O
the 	 O
correlations r O
, 
 O
but 	 O
MMPI I O
response p O
- 
 O
set 	 O
variables i O
( 
 O
L 
 O
, 
 O
F 
 O
, 
 O
K 
 O
, 
 O
F 
 O
- 
 O
K 
 O
) 
 O
did 	 O
. 
 O
The 	 O
differences f O
in O O
binding d O
( 
 O
Kdapp p S-GENE
) 
 O
, 
 O
incorporation o O
, 
 O
and 	 O
extension e O
kinetics e O
of O O
8 
 O
- 
 O
oxo 	 O
- 
 O
dGTP P O
compared p O
to O O
normal m O
dNTP P S-GENE
incorporation o O
at O O
template p O
8 
 O
- 
 O
oxo 	 O
- 
 O
G 
 O
adducts u O
indicate i O
that t O
polymerase y O
fidelity e O
does s O
not 	 O
depend e O
solely e O
upon n O
the 	 O
overall r O
geometry m O
of O O
Watson s O
- 
 O
Crick c O
base e O
pairs r O
and 	 O
reflects l O
the 	 O
asymmetry m O
of O O
the 	 O
enzyme y O
active i O
site e O
. 
 O
This s O
constant s O
expression r O
profile f O
, 
 O
coupled p O
with h O
the 	 O
observation e O
that t O
over r O
- 
 O
expression r O
of O O
mSin3A n S-GENE
does s O
not 	 O
augment m O
the 	 O
anti i B-GENE
- - I-GENE
Myc 	 E-GENE
activity i O
of O O
Mxi1 1 B-GENE
- 
 I-GENE
SR O E-GENE
in O O
the 	 O
rat 	 B-GENE
embryo r I-GENE
fibroblast r E-GENE
( 
 O
REF 	 S-GENE
) 
 O
transformation n O
assay a O
, 
 O
suggests g O
that t O
mSin3A n S-GENE
is O O
not 	 O
a 
 O
limiting i O
factor t O
in O O
the 	 O
regulation u O
of O O
Myc 	 B-GENE
superfamily e E-GENE
function c O
. 
 O
The 	 O
sequences u O
at O O
- 
 O
10 O O
and 	 O
- 
 O
35 O O
relative a O
to O O
the 	 O
transcriptional n O
starting r O
site e O
showed w O
55 O O
% 
 O
homology o O
with h O
the 	 O
consensus s O
sequences u O
of O O
the 	 O
Escherichia h B-GENE
coli i I-GENE
sigma m I-GENE
70 I I-GENE
- - I-GENE
type e I-GENE
promoter m E-GENE
. 
 O
The 	 O
results u O
were e O
subjected j O
to O O
analysis l O
of O O
23 O O
autopsies o O
carried r O
out 	 O
in O O
children l O
dying n O
of O O
intoxication o O
with h O
Amanita n O
phalloides l O
. 
 O
METHODS H O
: 
 O
The 	 O
Die 	 O
Deutsche t O
Diabetes b O
Dialyse l O
Studie d O
is O O
a 
 O
prospective s O
randomized d O
placebo c O
- 
 O
controlled t O
trial a O
that t O
tests t O
the 	 O
hypothesis o O
that t O
atorvastatin r O
, 
 O
a 
 O
hydroxymethyl r B-GENE
- - I-GENE
glutaryl t I-GENE
coenzyme n I-GENE
A - I-GENE
reductase u E-GENE
inhibitor i O
, 
 O
decreases r O
the 	 O
rate e O
of O O
cardiovascular d O
mortality t O
and 	 O
of O O
nonfatal f O
myocardial c O
infarction a O
in O O
patients i O
with h O
type e O
2 
 O
diabetes b O
who 	 O
have e O
been n O
on O O
hemodialysis o O
treatment a O
for 	 O
no O O
more e O
than n O
two 	 O
years r O
. 
 O
There r O
was 	 O
no O O
significant n O
correlation r O
between w O
serum u O
amiodarone o O
or O O
desethylamiodarone e O
levels e O
and 	 O
dosage a O
of O O
amiodarone o O
. 
 O
The 	 O
effect e O
of O O
monaural a O
middle d O
ear 	 O
destruction t O
on O O
postnatal t O
development e O
of O O
mouse s O
inferior e O
colliculus l O
. 
 O
This s O
unusual s O
behaviour a O
may 	 O
be O O
explained l O
by O O
the 	 O
18 B O
amino n O
acid d O
- - O
long g O
CDR 	 B-GENE
- - I-GENE
H3 E E-GENE
and 	 O
could l O
be O O
of O O
value u O
in O O
the 	 O
design i O
of O O
' 
 O
single g O
domain a O
' 
 O
antibodies i O
. 
 O
A 
 O
definitive i O
answer w O
to O O
the 	 O
question s O
must t O
come e O
from m O
large g O
scale l O
mortality t O
studies d O
of O O
patients i O
in O O
whom m O
the 	 O
risk k O
/ 
 O
benefit e O
ratio i O
of O O
thrombolysis o O
is O O
not 	 O
unacceptably c O
high h O
, 
 O
in O O
whom m O
electrocardiographic c O
criteria t O
of O O
infarction a O
are 	 O
unequivocal q O
, 
 O
and 	 O
in O O
whom m O
treatment a O
can 	 O
be O O
initiated t O
early l O
after e O
the 	 O
onset e O
of O O
symptoms p O
with h O
regimens i O
that t O
will l O
induce u O
not 	 O
only y O
early l O
recanalization a O
, 
 O
but 	 O
also o O
sustained t O
patency e O
in O O
infarct a O
- 
 O
related a O
arteries e O
. 
 O
Parameters a O
of O O
sperm r O
quality l O
were e O
evaluated l O
before o O
and 	 O
after e O
freezing e O
/ 
 O
thawing w O
. 
 O
It O O
has 	 O
also o O
been n O
previously v O
demonstrated o O
that t O
LPS 	 O
treatment a O
of O O
splenic e O
B 
 O
cells l O
from m O
athymic y O
mice e O
results u O
in O O
a 
 O
decrease r O
in O O
steady a O
state t O
mRNA A O
encoding o O
the 	 O
A - B-GENE
alpha h I-GENE
class s I-GENE
II I I-GENE
protein t E-GENE
. 
 O
Amongst n O
53 O O
" 
 O
inoperable p O
" 
 O
( 
 O
T4 O O
, 
 O
N0 O O
, 
 O
N1 O O
, 
 O
T 
 O
. 
 O
, 
 O
N2 O O
, 
 O
N3 O O
) 
 O
cases e O
, 
 O
5 
 O
( 
 O
10 O O
% 
 O
) 
 O
had 	 O
a 
 O
positive i O
scan n O
and 	 O
5 
 O
a 
 O
doubtful b O
scan n O
. 
 O
Chemical m O
structure u O
of O O
antibiotic i O
SF O O
- 
 O
837 	 O
. 
 O
Aspirin i O
therapy r O
in O O
the 	 O
rheumatic u O
diseases e O
. 
 O
Is O O
conventional v O
sperm r O
analysis l O
of O O
any 	 O
use 	 O
? 
 O
The 	 O
computerised p O
records o O
of O O
867 	 O
couples p O
were e O
used d O
to O O
investigate e O
the 	 O
prognostic g O
significance n O
of O O
semen e O
volume u O
, 
 O
motility i O
, 
 O
density s O
and 	 O
morphology p O
. 
 O
It O O
was 	 O
observed e O
that t O
muscle c O
infarction a O
in O O
the 	 O
IPC 	 O
( 
 O
24 O O
+ 
 O
/ 
 O
- 
 O
2 
 O
% 
 O
) 
 O
and 	 O
preischemic i O
LMK 	 O
( 
 O
21 O O
+ 
 O
/ 
 O
- 
 O
2 
 O
% 
 O
) 
 O
groups u O
were e O
smaller l O
( 
 O
P 
 O
< 
 O
0 
 O
. 
 O
05 O O
) 
 O
than n O
that t O
in O O
the 	 O
control t O
( 
 O
42 O O
+ 
 O
/ 
 O
- 
 O
2 
 O
% 
 O
) 
 O
. 
 O
High h O
- 
 O
affinity i O
binding d O
was 	 O
also o O
observed e O
with h O
recombinant o B-GENE
SH2 	 I-GENE
domains a E-GENE
from m O
v - B-GENE
- - I-GENE
src 	 E-GENE
and 	 O
v - B-GENE
- - I-GENE
fps 	 E-GENE
, 
 O
raising s O
the 	 O
possibility s O
of O O
protein t O
- 
 O
protein t O
interactions e O
between w O
various i O
members b O
of O O
the 	 O
cytoplasmic o B-GENE
PTK 	 I-GENE
family i E-GENE
. 
 O
Mutational a O
analysis l O
of O O
the 	 O
putative a O
effector e O
domain a O
of O O
the 	 O
GTP 	 B-GENE
- - I-GENE
binding d I-GENE
Ypt1 1 I-GENE
protein t E-GENE
in O O
yeast s O
suggests g O
specific c O
regulation u O
by O O
a 
 O
novel e O
GAP 	 S-GENE
activity i O
. 
 O
The 	 O
interaction e O
obtained a O
with h O
DBM 	 O
scores r O
was 	 O
further t O
qualified l O
by O O
a 
 O
three e O
- 
 O
way 	 O
interaction e O
that t O
limited i O
this s O
pattern t O
to O O
participants t O
scoring r O
higher h O
on O O
self f O
- 
 O
deception e O
. 
 O
The 	 O
broad a O
range g O
protein t B-GENE
tyrosine o I-GENE
kinase a E-GENE
inhibitor i O
genistein i O
and 	 O
the 	 O
phosphatidylinositol s B-GENE
3 - I-GENE
- - I-GENE
kinase a E-GENE
inhibitors i O
wortmannin t O
and 	 O
LY O O
294002 0 O
( 
 O
2 
 O
- 
 O
( 
 O
4 
 O
- 
 O
morpholinyl p O
) 
 O
- 
 O
8 
 O
- 
 O
phenyl n O
- 
 O
4H O O
- 
 O
1 
 O
- 
 O
benzopyran z O
- 
 O
4 
 O
- 
 O
one 	 O
) 
 O
also o O
blocked c O
adenosine n B-GENE
A3 I I-GENE
receptor e E-GENE
stimulation m O
of O O
p42 	 S-GENE
/ 
 O
p44 	 S-GENE
MAPK K O
. 
 O
Surprisingly p O
, 
 O
although h O
Mist1 t S-GENE
binds d O
to O O
E 
 O
- 
 O
boxes e O
in O O
vivo o O
, 
 O
the 	 O
Mist1 t B-GENE
protein t E-GENE
lacks k O
a 
 O
functional c O
transcription n O
activation i O
domain a O
. 
 O
As O O
exogenously g O
expressed r O
PKR 	 S-GENE
can 	 O
form m O
heterodimers e O
with h O
endogenous o O
PKR 	 S-GENE
, 
 O
the 	 O
results u O
obtained a O
on O O
the 	 O
functional c O
characterization r O
of O O
mutant a O
forms m O
of O O
PKR 	 S-GENE
have e O
been n O
taken e O
with h O
caution t O
. 
 O
Orlistat i O
is O O
a 
 O
specific c O
lipase a S-GENE
inhibitor i O
that t O
impairs a O
fat 	 O
absorption o O
, 
 O
thereby r O
reducing u O
fat 	 O
uptake a O
. 
 O
The 	 O
metalloproteinase a S-GENE
mediating i O
Met 	 S-GENE
cleavage a O
was 	 O
specifically c O
inhibited i O
by O O
the 	 O
tissue s B-GENE
inhibitor i I-GENE
of I I-GENE
metalloproteinases a I-GENE
( - I-GENE
TIMP P I-GENE
) - I-GENE
- - I-GENE
3 - E-GENE
, 
 O
but 	 O
not 	 O
by O O
TIMP P B-GENE
- - I-GENE
1 - E-GENE
or O O
TIMP P B-GENE
- - I-GENE
2 - E-GENE
. 
 O
This s O
demonstrates o O
a 
 O
relative a O
independence e O
of O O
the 	 O
given e O
synchronizer c O
of O O
rhythmicity t O
at O O
a 
 O
tissue s O
level e O
from m O
any 	 O
influence l O
of O O
the 	 O
higher h O
regulatory u O
center t O
. 
 O
It O O
is O O
also o O
conceivable c O
that t O
elevated v O
insulin u S-GENE
levels e O
may 	 O
cause s O
hypertriglyceridaemia e O
and 	 O
possibly s O
other e O
abnormalities o O
of O O
lipid i O
metabolism a O
. 
 O
Flicker c O
thresholds e O
were e O
measured s O
from m O
1 
 O
to O O
40 O O
Hz O O
with h O
a 
 O
vertical t O
- 
 O
line e O
target g O
used d O
for 	 O
the 	 O
asynchrony n O
thresholds e O
. 
 O
The 	 O
clr1 1 B-GENE
locus u E-GENE
regulates u O
the 	 O
expression r O
of O O
the 	 O
cryptic p O
mating i O
- - O
type e O
loci i O
of I O
fission s O
yeast s O
. 
 O
Use 	 O
of O O
ELISAs S O
for 	 O
the 	 O
diagnosis g O
of O O
canine i O
atopy p O
. 
 O
A 
 O
clinical n O
study d O
. 
 O
METHODS H O
. 
 O
Instead t O
, 
 O
HBx 	 S-GENE
is O O
shown w O
to O O
activate i O
the 	 O
cyclin l B-GENE
A - I-GENE
promoter m E-GENE
, 
 O
induce u O
cyclin l B-GENE
A - E-GENE
- 
 O
cyclin l B-GENE
- - I-GENE
dependent e I-GENE
kinase a I-GENE
2 - I-GENE
complexes p E-GENE
, 
 O
and 	 O
promote m O
cycling l O
of O O
growth w O
- 
 O
arrested e O
cells l O
into o O
G1 O O
through o O
a 
 O
pathway h O
involving o O
activation i O
of O O
Src 	 B-GENE
tyrosine o I-GENE
kinases a E-GENE
. 
 O
Growth w O
hormone m O
exerts r O
its 	 O
effects e O
on O O
the 	 O
ovarian r O
follicular l O
cycle l O
directly e O
or O O
by O O
local a O
production d O
of O O
insulin u B-GENE
- - I-GENE
like e I-GENE
growth w I-GENE
factor t I-GENE
1 - E-GENE
( 
 O
IGF 	 B-GENE
- - I-GENE
1 - E-GENE
) 
 O
. 
 O
The 	 O
aim 	 O
of O O
this s O
study d O
was 	 O
to O O
evaluate l O
the 	 O
impact a O
of O O
the 	 O
ESRD D O
treatment a O
modality a O
on O O
the 	 O
quality l O
of O O
life e O
in O O
patients i O
with h O
Type e O
I 
 O
( 
 O
insulin u S-GENE
- 
 O
dependent e O
) 
 O
diabetes b O
mellitus l O
. 
 O
The 	 O
subjects j O
were e O
started r O
on O O
indomethacin o O
25 O O
mg O O
thrice i O
daily l O
. 
 O
A 
 O
Buddhist d O
view w O
of O O
abortion r O
. 
 O
The 	 O
arterial e O
blood o O
pressure s O
was 	 O
measured s O
by O O
using n O
bloody o O
method h O
in O O
anesthizied s O
animals m O
. 
 O
After e O
15 O O
min 	 O
of O O
hemorrhage o O
the 	 O
cardiovascular d O
parameters a O
were e O
the 	 O
same e O
in O O
fed 	 O
and 	 O
starved r O
animals m O
, 
 O
but 	 O
at O O
45 O O
min 	 O
striking i O
differences f O
were e O
observed e O
. 
 O
Decidual i O
/ - O
trophoblast p O
prolactin l B-GENE
- - I-GENE
related a I-GENE
protein t E-GENE
: 
 O
characterization r O
of O O
gene e O
structure u O
and 	 O
cell l O
- 
 O
specific c O
expression r O
. 
 O
Fluorescence o O
in O O
situ u O
hybridization r O
was 	 O
used d O
to O O
investigate e O
the 	 O
physical s O
distribution t O
and 	 O
revealed e O
that t O
both h O
retrotransposon r O
families i O
are 	 O
present s O
on O O
all 	 O
sugar a O
beet t O
chromosomes o O
and 	 O
largely g O
excluded l O
from m O
chromosomal o O
regions i O
harbouring b O
the 	 O
18S 	 B-GENE
- 
 I-GENE
5 - I-GENE
. - I-GENE
8S E I-GENE
- 
 I-GENE
25S 	 I-GENE
rRNA A I-GENE
genes e E-GENE
. 
 O
Plasma s O
NE O O
and 	 O
E 
 O
increased r O
to O O
significantly n O
higher h O
values u O
after e O
15 O O
min 	 O
in O O
the 	 O
young n O
subjects j O
: 
 O
1 
 O
. 
 O
68 O O
+ 
 O
/ 
 O
- 
 O
0 
 O
. 
 O
18 O O
vs O O
. 
 O
An O O
insertion e O
sequence u O
element m O
( 
 O
IS1170 1 O
) 
 O
was 	 O
identified n O
upstream t O
of O O
the 	 O
nimC C B-GENE
gene e E-GENE
. 
 O
The 	 O
organelles a O
synthesize t O
their i O
own 	 O
set 	 O
of O O
Fe B B-GENE
/ - I-GENE
S - I-GENE
proteins t E-GENE
, 
 O
and 	 O
they y O
initiate t O
the 	 O
generation e O
of O O
extramitochondrial r O
Fe I B-GENE
/ - I-GENE
S - I-GENE
proteins t E-GENE
. 
 O
Most t O
significantly n O
, 
 O
the 	 O
cyclin l B-GENE
E - E-GENE
- 
 O
Cdk2 2 S-GENE
complex p O
is O O
maximally i O
active i O
at O O
the 	 O
G1 O O
/ 
 O
S 
 O
transition n O
, 
 O
and 	 O
overexpression r O
of O O
cyclin l B-GENE
E - E-GENE
decreases r O
the 	 O
time e O
it O O
takes e O
the 	 O
cell l O
to O O
complete p O
G1 O O
and 	 O
enter e O
S 
 O
phase s O
. 
 O
A 
 O
genomic o O
clone n O
of O O
the 	 O
chicken c B-GENE
osteopontin e I-GENE
- - I-GENE
encoding o I-GENE
gene e E-GENE
( 
 O
opn 	 S-GENE
) 
 O
was 	 O
isolated l O
and 	 O
found n O
to O O
be O O
organized a O
as O O
follows l O
: 
 O
an O O
untranslated r O
5 
 O
' 
 O
exon n O
; 
 O
a 
 O
signal n O
peptide t O
; 
 O
a 
 O
recognition o O
sequence u O
for 	 O
phosphorylation s O
by O O
casein e B-GENE
kinase a I-GENE
II E E-GENE
; 
 O
a 
 O
domain a O
containing t O
a 
 O
possible s O
O 
 O
- 
 O
linkage k O
site e O
for 	 O
glycosylation c O
; 
 O
a 
 O
second o O
casein e B-GENE
kinase a I-GENE
II I I-GENE
phosphorylation s I-GENE
site e E-GENE
; 
 O
an O O
exon n O
containing t O
three e O
functional c O
regions i O
, 
 O
the 	 O
poly y B-GENE
- 
 I-GENE
Asp 	 I-GENE
sequence u E-GENE
of O O
seven e O
consecutive s O
Asp 	 O
residues i O
, 
 O
the 	 O
RGD 	 B-GENE
integrin e I-GENE
recognition o I-GENE
site e E-GENE
and 	 O
a 
 O
potential e O
N 
 O
- 
 O
linkage k O
site e O
for 	 O
glycosylation c O
; 
 O
and 	 O
a 
 O
large g O
C 
 O
- 
 O
terminal m O
exon n O
which c O
also o O
contains t O
a 
 O
potential e O
N 
 O
- 
 O
linkage k O
site e O
for 	 O
glycosylation c O
. 
 O
However e O
, 
 O
neither t O
SF B B-GENE
- - I-GENE
1 - E-GENE
nor 	 O
NGF 	 B-GENE
- - I-GENE
IB E E-GENE
alone n O
, 
 O
binding d O
as O O
monomers o O
, 
 O
increases r O
transcription n O
. 
 O
Satisfactory i O
correlation r O
was 	 O
also o O
obtained a O
between w O
the 	 O
in O O
vivo o O
and 	 O
the 	 O
in O O
vitro r O
results u O
. 
 O
Structural u O
organization a O
of O O
the 	 O
human a B-GENE
Elk1 1 I-GENE
gene e E-GENE
and 	 O
its 	 O
processed c O
pseudogene u O
Elk2 2 S-GENE
. 
 O
After e O
cumulative u O
occlusions l O
of O O
15 O O
, 
 O
30 O O
, 
 O
45 O O
, 
 O
and 	 O
90 O O
min 	 O
, 
 O
transmural n O
needle d O
biopsies p O
were e O
taken e O
from m O
the 	 O
ischemic h O
area a O
to O O
be O O
analyzed l O
for 	 O
adenine n O
nucleotides l O
, 
 O
nucleosides l O
, 
 O
creatine a O
phosphate s O
, 
 O
and 	 O
ultrastructural r O
changes n O
. 
 O
The 	 O
prevalence v O
of O O
ocular l O
/ 
 O
adnexal e O
SCC 	 O
was 	 O
significantly n O
greater a O
for 	 O
all 	 O
hair r O
colors o O
when n O
compared p O
with h O
bay 	 O
, 
 O
brown w O
, 
 O
or O O
black c O
( 
 O
P 
 O
less s O
than n O
0 
 O
. 
 O
01 O O
) 
 O
. 
 O
Seven e O
patients i O
were e O
without h O
a 
 O
syndromic d O
diagnosis g O
. 
 O
In O O
treatments a O
R1 O O
and 	 O
R2 O O
, 
 O
feed d O
quality l O
was 	 O
restricted t O
by O O
withholding h O
concentrates c O
for 	 O
3 
 O
and 	 O
4 
 O
. 
 O
5 
 O
mo O O
, 
 O
respectively p O
. 
 O
In O O
addition i O
, 
 O
while l O
GCN1 1 S-GENE
is O O
required u O
in O O
vivo o O
for 	 O
phosphorylation s O
of O O
eIF 	 B-GENE
- - I-GENE
2 - I-GENE
alpha h E-GENE
by O O
GCN2 2 S-GENE
, 
 O
cell l O
extracts r O
from m O
gcn1 1 B-GENE
delta t E-GENE
strains a O
contained t O
wild d O
- 
 O
type e O
levels e O
of O O
GCN2 2 B-GENE
eIF 	 I-GENE
- - I-GENE
2 - I-GENE
alpha h I-GENE
- 
 I-GENE
kinase a E-GENE
activity i O
. 
 O
SCOF F B-GENE
- - I-GENE
1 - E-GENE
localized a O
to O O
the 	 O
nucleus l O
but 	 O
did 	 O
not 	 O
bind d O
directly e O
to O O
either h O
C 
 O
- 
 O
repeat e O
/ 
 O
dehydration y O
( 
 O
CRT 	 O
/ 
 O
DRE 	 O
) 
 O
or O O
ABA 	 O
responsive p O
element m O
( 
 O
ABRE E O
) 
 O
, 
 O
cis 	 O
- 
 O
acting i O
DNA 	 O
regulatory u O
elements m O
present s O
in O O
COR 	 B-GENE
gene e I-GENE
promoters m E-GENE
. 
 O
On O O
the 	 O
basis i O
of O O
these s O
findings d O
we O O
suggest g O
that t O
the 	 O
acceptor e O
peptide t O
binds d O
the 	 O
transferase n S-GENE
in O O
a 
 O
beta a O
- 
 O
like e O
conformation f O
and 	 O
that t O
penultimate u O
residue i O
side e O
chain i O
steric r O
interactions e O
may 	 O
play y O
a 
 O
role e O
in O O
determining e O
extent e O
that t O
a 
 O
given e O
Ser 	 O
or O O
Thr 	 O
is O O
glycosylated c O
. 
 O
The 	 O
concentration c O
of O O
vitamin a O
B1 O O
, 
 O
B2 O O
and 	 O
B6 O O
are 	 O
found n O
to O O
be O O
9 
 O
. 
 O
96 O O
, 
 O
9 
 O
. 
 O
92 O O
and 	 O
3 
 O
. 
 O
01 O O
mg O O
, 
 O
respectively p O
in O O
240 	 O
mg O O
of O O
capsule s O
powder d O
of O O
a 
 O
standard n O
company p O
( 
 O
name e O
has 	 O
not 	 O
been n O
disclosed c O
due 	 O
to O O
secrecy r O
purpose p O
) 
 O
. 
 O
Polymorphisms y O
in O O
the 	 O
CCR5 5 B-GENE
genes e E-GENE
of O O
African i O
green e O
monkeys k O
and 	 O
mice e O
implicate l O
specific c O
amino n O
acids d O
in O O
infections e O
by O O
simian i O
and 	 O
human a O
immunodeficiency u O
viruses u O
. 
 O
Furthermore t O
, 
 O
we O O
detect e O
hCoch c B-GENE
- - I-GENE
5B2 	 E-GENE
on O O
three e O
overlapping r O
YACs s O
, 
 O
two 	 O
of O O
which c O
also o O
contain t O
one 	 O
of O O
the 	 O
markers k O
linked k O
to O O
DFNA9 A S-GENE
. 
 O
mCoch c B-GENE
- - I-GENE
5B2 	 E-GENE
was 	 O
genetically e O
mapped p O
in O O
the 	 O
mouse s O
to O O
chromosome o O
12 O O
, 
 O
in O O
a 
 O
region i O
of O O
homologous o O
synteny t O
with h O
human a O
14q11 1 O
. 
 O
2 
 O
- 
 O
q13 	 O
, 
 O
which c O
contains t O
the 	 O
asp1 1 S-GENE
( 
 O
audiogenic i O
seizure z O
prone n O
) 
 O
locus u O
in O O
the 	 O
mouse s O
. 
 O
Absence e O
of O O
nitroso r O
formation m O
from m O
( 
 O
14C 	 O
) 
 O
methomyl h O
and 	 O
sodium i O
nitrite r O
under e O
simulated u O
stomach m O
conditions d O
. 
 O
Although h O
no O O
detectable e O
phenotypes n O
are 	 O
associated o O
with h O
a 
 O
disruption r O
allele e O
of O O
ABP1 1 S-GENE
, 
 O
mutations a O
that t O
create a O
a 
 O
requirement u O
for 	 O
this s O
protein t O
have e O
now 	 O
been n O
isolated l O
in O O
the 	 O
previously v O
identified n O
gene e B-GENE
SAC6 6 E-GENE
and 	 O
in O O
two 	 O
new 	 O
genes e O
, 
 O
SLA1 1 S-GENE
and 	 O
SLA2 2 S-GENE
. 
 O
The 	 O
local a O
median i O
scores r O
( 
 O
ranges g O
) 
 O
of O O
the 	 O
above v O
tests t O
were e O
as O O
follows l O
- 
 O
AMT 	 O
: 
 O
9 
 O
( 
 O
6 
 O
- 
 O
10 O O
) 
 O
; 
 O
CMMS S O
: 
 O
25 O O
( 
 O
16 O O
- 
 O
28 O O
) 
 O
; 
 O
SBT 	 O
: 
 O
2 
 O
( 
 O
0 
 O
- 
 O
10 O O
) 
 O
; 
 O
WL O O
- 
 O
i 
 O
: 
 O
17 O O
( 
 O
8 
 O
- 
 O
27 O O
) 
 O
; 
 O
WL O O
- 
 O
d 
 O
: 
 O
5 
 O
( 
 O
0 
 O
- 
 O
10 O O
) 
 O
; 
 O
WL O O
- 
 O
r 
 O
: 
 O
9 
 O
( 
 O
1 
 O
- 
 O
10 O O
) 
 O
; 
 O
ST O O
: 
 O
13 O O
( 
 O
6 
 O
- 
 O
25 O O
) 
 O
; 
 O
BNT 	 O
: 
 O
14 O O
( 
 O
10 O O
- 
 O
15 O O
) 
 O
; 
 O
CPT 	 O
: 
 O
1 
 O
( 
 O
0 
 O
- 
 O
3 
 O
) 
 O
; 
 O
BDT 	 O
: 
 O
19 O O
( 
 O
0 
 O
- 
 O
42 O O
) 
 O
; 
 O
OAT 	 O
: 
 O
20 O O
( 
 O
3 
 O
- 
 O
33 O O
) 
 O
. 
 O
Antigen i O
dose e O
- 
 O
response p O
curves v O
were e O
drawn w O
, 
 O
and 	 O
the 	 O
cumulative u O
dose e O
required u O
for 	 O
a 
 O
35 O O
% 
 O
reduction u O
in O O
specific c O
airway w O
conductance d O
was 	 O
calculated c O
and 	 O
designated i O
Provocation v O
Dose e O
( 
 O
PD35 5 O
) 
 O
. 
 O
Cross s O
- 
 O
talk k O
between w O
transcription n O
factors t O
NF B B-GENE
- - I-GENE
kappa p I-GENE
B - E-GENE
and 	 O
C - B-GENE
/ - I-GENE
EBP 	 E-GENE
in O O
the 	 O
transcriptional n O
regulation u O
of O O
genes e O
. 
 O
Elective c O
replacement l O
of O O
the 	 O
aortic t O
root t O
in O O
Marfan f O
' 
 O
s 
 O
syndrome d O
. 
 O
The 	 O
detergent e O
- 
 O
solubilized u O
complex p O
oxidizes d O
caldariella d O
quinol n O
at O O
high h O
rates e O
and 	 O
is O O
completely p O
inhibited i O
by O O
cyanide n O
and 	 O
by O O
quinolone n O
analogs l O
, 
 O
potent e O
inhibitors i O
of O O
quinol n B-GENE
oxidases d E-GENE
. 
 O
We O O
have e O
characterized r O
a 
 O
new 	 O
cDNA A O
, 
 O
33k 	 B-GENE
- 
 I-GENE
6 
 E-GENE
, 
 O
potentially e O
encoding o O
a 
 O
tobacco a O
33 I O
kDa 	 O
chloroplast o O
RNP 	 O
( - O
cp33 3 S-GENE
) - O
homologue o O
. 
 O
The 	 O
regions i O
encoding o O
the 	 O
mature u O
proteinases t O
were e O
cloned n O
into o O
an O O
expression r O
vector t O
and 	 O
recombinant o O
protein t O
produced d O
in O O
Escherichia h O
coli i O
. 
 O
Furthermore t O
, 
 O
CL100 0 S-GENE
suppresses p O
the 	 O
[ 
 O
val12 1 S-GENE
] 
 O
ras 	 S-GENE
- 
 O
induced u O
activation i O
of O O
MAP 	 B-GENE
kinase a E-GENE
in O O
a 
 O
cell l O
- 
 O
free e O
system t O
from m O
Xenopus o O
oocytes y O
. 
 O
The 	 O
Xenopus o B-GENE
homeobox e I-GENE
gene e I-GENE
twin n E-GENE
mediates i O
Wnt 	 S-GENE
induction u O
of O O
goosecoid s O
in O O
establishment a O
of O O
Spemann m O
' 
 O
s 
 O
organizer a O
. 
 O
Between w O
1988 8 O
and 	 O
1994 4 O
, 
 O
data a O
from m O
3 
 O
large g O
sites e O
revealed e O
a 
 O
3 
 O
- 
 O
5 
 O
fold d O
increase r O
in O O
the 	 O
prevalence v O
of O O
antidepressant i O
( 
 O
ATD 	 O
) 
 O
treatment a O
for 	 O
U 
 O
. 
 O
S 
 O
. 
 O
youths t O
aged d O
2 
 O
- 
 O
19 O O
years r O
. 
 O
The 	 O
vaccinia c O
virus u O
D6R 	 O
open n O
reading d O
frame m O
encodes o O
the 	 O
small l O
subunit u O
of O O
the 	 O
heterodimeric e B-GENE
vaccinia c I-GENE
virus u I-GENE
early l I-GENE
transcription n I-GENE
factor t E-GENE
( 
 O
VETF F S-GENE
) 
 O
that t O
activates i O
transcription n O
of O O
early l O
genes e O
in O O
vitro r O
. 
 O
The 	 O
Sensititre s O
MIC 	 O
panels e O
containing t O
meropenem o O
offer e O
a 
 O
convenient v O
and 	 O
valid i O
alternative e O
to O O
the 	 O
NCCLS L O
reference e O
method h O
for 	 O
the 	 O
susceptibility c O
testing t O
of O O
potential e O
pathogens h O
likely e O
to O O
be O O
recovered o O
from m O
mixed e O
infections e O
. 
 O
Recognition o O
of O O
DNA 	 O
by O O
single g O
- 
 O
chain i O
derivatives i O
of O O
the 	 O
phage g O
434 	 O
repressor r O
: 
 O
high h O
affinity i O
binding d O
depends e O
on O O
both h O
the 	 O
contacted t O
and 	 O
non 	 O
- 
 O
contacted t O
base e O
pairs r O
. 
 O
The 	 O
paper e O
calls l O
for 	 O
standardized n O
question s O
formats m O
and 	 O
a 
 O
centralized t O
body y O
to O O
monitor i O
changes n O
in O O
these s O
parameters a O
of O O
sexual u O
behaviour a O
. 
 O
We O O
show w O
that t O
GCNF F S-GENE
binds d O
to O O
one 	 O
of O O
the 	 O
two 	 O
DRO 	 B-GENE
sequences u E-GENE
in O O
the 	 O
Prm1 1 B-GENE
promoter m E-GENE
, 
 O
and 	 O
to O O
the 	 O
DRO 	 B-GENE
sequence u E-GENE
in O O
the 	 O
Prm2 2 B-GENE
promoter m E-GENE
in O O
a 
 O
specific c O
manner n O
. 
 O
139La L O
NQR 	 O
relaxation a O
and 	 O
microSR r O
study d O
of O O
Zn O O
- 
 O
doping i O
effects e O
in O O
La2CuO4 C O
. 
 O
The 	 O
data a O
also o O
suggest g O
that t O
gamma m B-GENE
CACCC C I-GENE
box 	 I-GENE
binding d I-GENE
factors t E-GENE
mediate i O
LCR 	 B-GENE
- - I-GENE
gamma m E-GENE
interactions e O
which c O
normally m O
enhance a O
gamma m B-GENE
- - I-GENE
globin b E-GENE
and 	 O
suppress p O
beta a B-GENE
- - I-GENE
globin b I-GENE
gene e E-GENE
expression r O
in O O
fetal a O
erythroid t O
cells l O
. 
 O
However e O
, 
 O
the 	 O
in O O
vivo o O
attachment a O
strength e O
of O O
the 	 O
CSTi i O
- 
 O
2 
 O
coating t O
was 	 O
comparable p O
both h O
to O O
CSTi i B-GENE
- 
 I-GENE
1 
 E-GENE
and 	 O
to O O
an O O
HA O O
- 
 O
coated t O
control t O
after e O
8 
 O
weeks k O
. 
 O
Octamer a O
recognition o O
is O O
mediated i O
by O O
the 	 O
POU 	 B-GENE
domain a E-GENE
, 
 O
a 
 O
conserved s O
structural u O
motif i O
which c O
- 
 O
- 
 O
like e O
the 	 O
zinc c O
finger g O
and 	 O
leucine c O
zipper p O
- 
 O
- 
 O
defines i O
a 
 O
family i O
of O O
related a O
transcription n O
factors t O
. 
 O
All 	 O
testosterone t O
treatments a O
raised s O
plasma s O
testosterone t O
concentrations c O
above v O
control t O
and 	 O
pretreatment t O
levels e O
( 
 O
testosterone t O
and 	 O
synovex o O
+ 
 O
testosterone t O
> 
 O
synovex o O
> 
 O
control t O
; 
 O
all 	 O
P 
 O
< 
 O
0 
 O
. 
 O
05 O O
) 
 O
. 
 O
Lifestyle e O
characteristics r O
were e O
ascertained e O
by O O
a 
 O
self f O
- 
 O
administered i O
questionnaire s O
. 
 O
The 	 O
major o O
promoter m O
element m O
of O O
the 	 O
Xenopus o B-GENE
laevis v I-GENE
5S I I-GENE
RNA 	 I-GENE
gene e E-GENE
is O O
located a O
within h O
the 	 O
transcribed n O
region i O
of O O
the 	 O
gene e O
and 	 O
forms m O
the 	 O
binding d O
site e O
for 	 O
the 	 O
transcription n B-GENE
initiation t I-GENE
factor t I-GENE
TFIIIA I E-GENE
. 
 O
During i O
each h O
step p O
of O O
the 	 O
pulse s O
infusion u O
the 	 O
osteocalcin e S-GENE
responses p O
to O O
changes n O
in O O
CaI 	 O
in O O
general e O
were e O
parallel a O
to O O
the 	 O
changes n O
in O O
PTH 	 S-GENE
( 
 O
r 
 O
= 
 O
0 
 O
. 
 O
462 	 O
; 
 O
P 
 O
= 
 O
0 
 O
. 
 O
02 O O
) 
 O
and 	 O
were e O
inversely e O
correlated r O
to O O
CaI 	 O
( 
 O
r 
 O
= 
 O
- 
 O
0 
 O
. 
 O
562 	 O
; 
 O
P 
 O
= 
 O
0 
 O
. 
 O
003 	 O
) 
 O
. 
 O
The 	 O
gamma m B-GENE
- - I-GENE
GCS 	 I-GENE
gene e E-GENE
is O O
expressed r O
ubiquitously q O
and 	 O
induced u O
coordinately r O
with h O
NAD 	 B-GENE
( - I-GENE
P - I-GENE
) - I-GENE
H - I-GENE
: - I-GENE
quinone n I-GENE
oxidoreductase d I-GENE
( - I-GENE
1 - I-GENE
) - E-GENE
( 
 O
NQO1 1 S-GENE
) 
 O
and 	 O
glutathione t B-GENE
S - I-GENE
- - I-GENE
transferase n E-GENE
Ya E S-GENE
( 
 O
GST 	 B-GENE
Ya E E-GENE
) 
 O
in O O
response p O
to O O
xenobiotics o O
and 	 O
antioxidants i O
. 
 O
Interestingly e O
, 
 O
the 	 O
expression r O
of O O
Id4 	 S-GENE
in O O
Sertoli t O
cells l O
is O O
only y O
detectable e O
after e O
stimulation m O
with h O
FSH 	 S-GENE
or O O
cAMP P O
. 
 O
We O O
determined e O
their i O
N 
 O
- 
 O
terminal m O
amino n O
acid d O
sequence u O
and 	 O
found n O
that t O
these s O
polypeptides y O
were e O
CotT T S-GENE
, 
 O
YeeK K S-GENE
, 
 O
YxeE E S-GENE
, 
 O
CotF F S-GENE
, 
 O
YrbA A S-GENE
( 
 O
31 O O
and 	 O
45 O O
kDa 	 O
) 
 O
, 
 O
and 	 O
SpoIVA I S-GENE
, 
 O
respectively p O
. 
 O
The 	 O
effect e O
of O O
betamethasone a O
on O O
duodenal d O
calcium c O
absorption o O
and 	 O
1 
 O
, 
 O
25 O O
- 
 O
dihydroxy y O
vitamin a O
D3 O O
production d O
in O O
the 	 O
chick c O
. 
 O
Furthermore t O
, 
 O
it O O
is O O
also o O
established a O
that t O
serine i O
phosphorylation s O
of O O
STAT5a T S-GENE
transactivation n O
domain a O
, 
 O
via 	 O
the 	 O
MAPK K S-GENE
pathway h O
, 
 O
is O O
a 
 O
means n O
of O O
modifying i O
GH S S-GENE
- 
 O
induced u O
transcriptional n O
activation i O
. 
 O
ES O O
cells l O
in O O
which c O
the 	 O
gene e O
for 	 O
the 	 O
erythroid t B-GENE
transcription n I-GENE
factor t I-GENE
GATA A I-GENE
- - I-GENE
1 - E-GENE
has 	 O
been n O
disrupted r O
fail l O
to O O
produce d O
mature u O
erythroid t O
cells l O
either h O
in O O
vivo o O
or O O
in O O
vitro r O
. 
 O
Two 	 O
conserved s O
motifs i O
, 
 O
W89RKRRY94 R S-GENE
and 	 O
P156KKIKP161 6 S-GENE
, 
 O
seemed m O
to O O
act 	 O
as O O
nuclear l O
addressing r O
signals n O
. 
 O
It O O
is O O
concluded c O
that t O
the 	 O
predominant d O
action i O
of O O
LSD 	 O
on O O
the 	 O
female a O
copulatory u O
response p O
is O O
not 	 O
mediated i O
by O O
increased r O
dopamine a B-GENE
receptor e E-GENE
activity i O
but 	 O
that t O
the 	 O
LSD 	 O
effect e O
might h O
be O O
modulated u O
by O O
decreased r O
dopaminergic a O
activity i O
. 
 O
Therefore r O
, 
 O
in O O
VDR 	 S-GENE
- 
 O
mediated i O
transcriptional n O
activation i O
, 
 O
1 
 O
, 
 O
25 O O
( 
 O
OH O O
) 
 O
2D3 	 O
binding d O
to O O
VDR 	 S-GENE
alters e O
the 	 O
conformation f O
of O O
the 	 O
ligand a O
binding d O
domain a O
such h O
that t O
it O O
: 
 O
( 
 O
i 
 O
) 
 O
engages a O
in O O
strong o O
heterodimerization e O
with h O
RXR 	 S-GENE
to O O
facilitate i O
VDRE E S-GENE
binding d O
, 
 O
( 
 O
ii O O
) 
 O
influences l O
the 	 O
RXR 	 B-GENE
ligand a I-GENE
binding d I-GENE
domain a E-GENE
such h O
that t O
it O O
is O O
resistant i O
to O O
the 	 O
binding d O
of O O
9 
 B-GENE
- 
 I-GENE
cis 	 I-GENE
RA O E-GENE
but 	 O
active i O
in O O
recruiting r O
coactivator c O
to O O
its 	 O
AF O B-GENE
- 
 I-GENE
2 
 E-GENE
and 	 O
( 
 O
iii 	 O
) 
 O
presents s O
the 	 O
AF O B-GENE
- 
 I-GENE
2 
 I-GENE
region i E-GENE
in O O
VDR 	 O
for 	 O
coactivator c O
association o O
. 
 O
In O O
patients i O
, 
 O
750 	 O
mL O O
of O O
saline i O
lowered e O
DL O O
( 
 O
CO O O
) 
 O
( 
 O
- 
 O
8 
 O
% 
 O
, 
 O
P 
 O
< 
 O
0 
 O
. 
 O
01 O O
versus s O
baseline e O
) 
 O
, 
 O
D 
 O
( 
 O
M 
 O
) 
 O
( 
 O
- 
 O
10 O O
% 
 O
, 
 O
P 
 O
< 
 O
0 
 O
. 
 O
01 O O
versus s O
baseline e O
) 
 O
, 
 O
aldosterone o O
( 
 O
- 
 O
29 O O
% 
 O
, 
 O
P 
 O
< 
 O
0 
 O
. 
 O
01 O O
versus s O
baseline e O
) 
 O
, 
 O
renin i S-GENE
( 
 O
- 
 O
52 O O
% 
 O
, 
 O
P 
 O
< 
 O
0 
 O
. 
 O
01 O O
versus s O
baseline e O
) 
 O
, 
 O
and 	 O
hematocrit a O
( 
 O
- 
 O
6 
 O
% 
 O
, 
 O
P 
 O
< 
 O
0 
 O
. 
 O
05 O O
versus s O
baseline e O
) 
 O
and 	 O
increased r O
V 
 O
( 
 O
C 
 O
) 
 O
( 
 O
20 O O
% 
 O
, 
 O
P 
 O
< 
 O
0 
 O
. 
 O
01 O O
versus s O
baseline e O
) 
 O
, 
 O
without h O
changing n O
rap 	 O
and 	 O
wpp 	 O
. 
 O
We O O
have e O
previously v O
identified n O
LIT1 1 S-GENE
, 
 O
a 
 O
paternally e O
expressed r O
antisense i O
RNA 	 O
within h O
the 	 O
KvLQT1 Q B-GENE
locus u E-GENE
through o O
a 
 O
positional i O
screening e O
approach r O
using n O
human a O
monochromosomal o O
hybrids r O
. 
 O
A 
 O
series i O
of O O
deletion e O
mutants a O
was 	 O
expressed r O
transiently n O
in O O
two 	 O
human a O
hepatocytes a O
, 
 O
HepG2 G S-GENE
and 	 O
PLC 	 S-GENE
. 
 O
The 	 O
predicted d O
amino n O
acid d O
sequence u O
of O O
the 	 O
FlaB2 B B-GENE
polypeptide y E-GENE
was 	 O
92 O O
% 
 O
identical n O
to O O
that t O
of O O
T - B-GENE
. - I-GENE
pallidum l I-GENE
FlaB2 B E-GENE
, 
 O
with h O
a 
 O
76 O O
% 
 O
identity n O
at O O
the 	 O
nucleotide l O
level e O
. 
 O
Comparative p O
analyses l O
indicate i O
that t O
the 	 O
5 
 O
' 
 O
- 
 O
peripheral i O
domain a O
exhibits i O
a 
 O
75 O O
- 
 O
bp O O
length g O
polymorphism y O
near r O
sequences u O
associated o O
with h O
the 	 O
termination m O
of O O
the 	 O
H 
 O
- 
 O
strand a O
replication l O
. 
 O
The 	 O
survival v O
of O O
patients i O
with h O
a 
 O
short r O
bowel e O
, 
 O
even n O
if O O
they y O
need d O
long g O
- 
 O
term m O
parenteral e O
nutrition r O
, 
 O
is O O
good d O
. 
 O
Thus s O
, 
 O
cross s O
- 
 O
resistance i O
between w O
fluoroquinolones o O
was 	 O
shown w O
for 	 O
both h O
enterococci e O
and 	 O
MRSA A O
. 
 O
The 	 O
5 
 O
' 
 O
ends s O
of O O
the 	 O
P - B-GENE
and 	 I-GENE
O - I-GENE
gene e I-GENE
mRNAs A E-GENE
are 	 O
separated a O
by O O
109 	 O
nucleotide l O
pairs r O
in O O
the 	 O
DNA 	 O
template p O
. 
 O
Using n O
community m O
development e O
approaches r O
. 
 O
Biol l O
. 
 O
We O O
have e O
cloned n O
the 	 O
cDNA A O
for 	 O
the 	 O
SLBP P O
from m O
humans a O
, 
 O
mice e O
, 
 O
and 	 O
frogs g O
, 
 O
using n O
the 	 O
recently e O
developed e O
yeast s O
three e O
- 
 O
hybrid r O
system t O
. 
 O
Along n O
with h O
these s O
species c O
, 
 O
F 
 O
. 
 O
graminearum m O
group u O
2 
 O
( 
 O
ZON 	 O
, 
 O
DON 	 O
and 	 O
/ 
 O
or O O
3AcDON D O
or O O
15AcDON c O
) 
 O
; 
 O
F 
 O
. 
 O
chlamydosporum a O
; 
 O
F 
 O
. 
 O
acuminatum m O
( 
 O
type e O
- 
 O
A 
 O
trichothecene c O
derivatives i O
) 
 O
; 
 O
and 	 O
F 
 O
. 
 O
semitectum i O
were e O
often e O
found n O
to O O
be O O
associated o O
. 
 O
TGF 	 B-GENE
- - I-GENE
beta1 a E-GENE
induced u O
phosphorylation s O
of O O
Smad2 d S-GENE
and 	 O
Smad3 d S-GENE
in O O
Mv1Lu L S-GENE
mink k O
lung g O
epithelial t O
cells l O
. 
 O
There r O
is O O
little t O
supportive p O
evidence d O
that t O
ACE 	 S-GENE
inhibitors i O
( 
 O
captopril t O
or O O
enalapril l O
) 
 O
are 	 O
teratogenic a O
. 
 O
Thus s O
, 
 O
the 	 O
potential e O
induction u O
of O O
this s O
gene e O
rearrangement r O
by O O
E1A 	 B-GENE
gene e E-GENE
therapy r O
is O O
unlikely i O
to O O
be O O
clinically n O
significant n O
in O O
the 	 O
treatment a O
of O O
advanced a O
malignant i O
disease e O
. 
 O
Although h O
the 	 O
cDNAs A O
of O O
HMG 	 B-GENE
- - I-GENE
14 E E-GENE
and 	 O
HMG 	 B-GENE
- - I-GENE
17 E E-GENE
do O O
not 	 O
cross s O
- 
 O
hybridize r O
, 
 O
they y O
have e O
several e O
similar i O
structural u O
features t O
: 
 O
the 	 O
open n O
reading d O
frame m O
comprises p O
only y O
23 O O
% 
 O
of O O
the 	 O
transcripts n O
, 
 O
the 	 O
5 
 O
' 
 O
- 
 O
untranslated r O
region i O
is O O
extremely r O
GC O O
rich h O
whereas r O
the 	 O
3 
 O
' 
 O
- 
 O
untranslated r O
region i O
is O O
unusually s O
long g O
and 	 O
AT O O
rich h O
. 
 O
Previously v O
, 
 O
we O O
reported o O
the 	 O
identification n O
of O O
a 
 O
23 O O
- 
 O
kD O O
protein t O
that t O
interacts e O
with h O
zyxin i S-GENE
in O O
vitro r O
( 
 O
Sadler l O
et O O
al O O
. 
 O
, 
 O
1992 2 O
) 
 O
. 
 O
If O O
vascular c O
induction u O
between w O
a 
 O
vascular c O
carrier r O
and 	 O
the 	 O
selected e O
jejunal u O
segment m O
is O O
done e O
as O O
a 
 O
kind d O
of O O
flap p O
prefabrication f O
, 
 O
the 	 O
jejunal u O
interposition e O
flap p O
can 	 O
be O O
used d O
without h O
the 	 O
need d O
for 	 O
complex p O
microsurgery r O
. 
 O
In O O
gel 	 O
mobility i O
shift f O
assays a O
, 
 O
high h O
binding d O
activities i O
of O O
ATPC C B-GENE
- - I-GENE
2 - E-GENE
and 	 O
low 	 O
binding d O
activities i O
of O O
CBF 	 S-GENE
were e O
observed e O
with h O
nuclear l O
extracts r O
from m O
tissue s O
with h O
low 	 O
AtpC C S-GENE
expression r O
levels e O
, 
 O
and 	 O
the 	 O
opposite o O
was 	 O
observed e O
with h O
extracts r O
from m O
tissues s O
with h O
high h O
AtpC C S-GENE
expression r O
levels e O
. 
 O
Activation i O
of O O
tyrosine o B-GENE
kinase a I-GENE
- - I-GENE
containing t I-GENE
receptors e E-GENE
, 
 O
heterotrimeric e B-GENE
G - I-GENE
proteins t E-GENE
, 
 O
and 	 O
protein t B-GENE
kinase a I-GENE
C - E-GENE
enhanced a O
the 	 O
activities i O
of O O
both h O
MEK 	 B-GENE
isoforms f E-GENE
in O O
293 	 O
and 	 O
PC12 2 O
cells l O
. 
 O
The 	 O
Fugu u B-GENE
rubripes r E-GENE
( 
 O
Fugu u S-GENE
) 
 O
gene e O
fragment g O
was 	 O
used d O
to O O
isolate l O
the 	 O
GH B B-GENE
gene e E-GENE
from m O
a 
 O
Fugu u B-GENE
genomic o I-GENE
library r E-GENE
. 
 O
An O O
in O O
vitro r O
' 
 O
glass s O
stomach m O
' 
 O
( 
 O
containing t O
various i O
volumes u O
of O O
hydrochloric r O
acid d O
[ 
 O
HCl 	 O
] 
 O
and 	 O
ammonium o O
chloride o O
[ 
 O
NH4Cl C O
] 
 O
) 
 O
was 	 O
used d O
to O O
evaluate l O
the 	 O
means n O
of O O
increasing r O
' 
 O
gastric t O
' 
 O
pH O O
to O O
that t O
of O O
the 	 O
NH4 	 O
+ 
 O
- 
 O
- 
 O
> 
 O
NH3 	 O
transition n O
that t O
occurs u O
significantly n O
at O O
pH O O
9 
 O
. 
 O
24 O O
. 
 O
Acyclovir c O
( 
 O
3 
 O
% 
 O
ointment t O
) 
 O
used d O
topically i O
one 	 O
to O O
five e O
times e O
a 
 O
day 	 O
on O O
acute t O
ocular l O
HSV 	 O
infection e O
gave e O
beneficial e O
results u O
as O O
measured s O
by O O
a 
 O
reduction u O
in O O
corneal n O
involvement o O
, 
 O
conjunctivitis j O
, 
 O
iritis t O
, 
 O
and 	 O
corneal n O
clouding u O
. 
 O
We O O
have e O
documented u O
previously v O
that t O
glucocorticoid c O
hormones m O
modulate u O
the 	 O
posttranslational t O
localization a O
of O O
cell l O
surface f O
mouse s O
mammary m O
tumor o O
virus u O
( 
 O
MMTV V O
) 
 O
glycoproteins c O
in O O
the 	 O
viral a O
- 
 O
infected e O
M1 O O
. 
 O
54 O O
rat 	 O
HTC 	 O
hepatoma a O
cell l O
line e O
. 
 O
Partial t O
proteolysis t O
of O O
cell l O
surface f O
- 
 O
iodinated i O
B - O
- - O
G - O
molecules e O
generates e O
extremely r O
similar i O
patterns t O
of O O
spots t O
, 
 O
both h O
within h O
and 	 O
between w O
haplotypes l O
. 
 O
SETTING T O
: 
 O
University v O
research e O
laboratory o O
. 
 O
There r O
was 	 O
a 
 O
57 O O
% 
 O
reduction u O
in O O
IGF 	 B-GENE
IR I I-GENE
mRNA A E-GENE
levels e O
in O O
clone n O
CA9 	 O
after e O
confluence f O
compared p O
with h O
clone n O
ME10 0 O
. 
 O
Oligomers g O
corresponding r O
to O O
the 	 O
region i O
of O O
the 	 O
mlc 	 B-GENE
- - I-GENE
1 - I-GENE
/ - I-GENE
3 - I-GENE
enhancer a E-GENE
, 
 O
which c O
encompasses o O
this s O
conserved s O
sequence u O
, 
 O
bound n O
MEF 	 B-GENE
- - I-GENE
2 - E-GENE
and 	 O
competed p O
for 	 O
its 	 O
binding d O
to O O
the 	 O
mck 	 B-GENE
enhancer a E-GENE
. 
 O
Similar i O
tissue s O
- 
 O
specific c O
patterns t O
are 	 O
observed e O
with h O
a 
 O
fusion i O
between w O
the 	 O
caufliflower f O
mosaic a O
virus u B-GENE
35S 	 I-GENE
RNA 	 I-GENE
promotor m E-GENE
and 	 O
the 	 O
GUS 	 B-GENE
gene e E-GENE
. 
 O
This s O
difference f O
between w O
SP B B-GENE
- - I-GENE
1 - E-GENE
and 	 O
SP B B-GENE
- - I-GENE
2 - I-GENE
peptides t E-GENE
was 	 O
not 	 O
due 	 O
to O O
their i O
differential f O
uptake a O
by O O
cell l O
, 
 O
since c O
approximately r O
100 	 O
times e O
more e O
SP B B-GENE
- - I-GENE
2 - I-GENE
peptide t E-GENE
could l O
be O O
found n O
in O O
cytoplasmic o O
extracts r O
than n O
SP B B-GENE
- - I-GENE
1 - I-GENE
peptide t E-GENE
in O O
experiments e O
using n O
radiolabeled i O
peptides t O
. 
 O
One 	 O
function c O
of O O
p53 	 S-GENE
is O O
in O O
regulating u O
cell l O
cycle l O
check c O
- 
 O
point n O
control t O
after e O
DNA 	 O
damage a O
. 
 O
We O O
used d O
event n O
- 
 O
related a O
functional c O
magnetic n O
resonance o O
imaging g O
( 
 O
fMRI I O
) 
 O
during i O
a 
 O
cued d O
spatial t O
- 
 O
attention e O
task k O
to O O
dissociate s O
brain i O
activity i O
related a O
to O O
attentional e O
control t O
from m O
that t O
related a O
to O O
selective e O
processing c O
of O O
target g O
stimuli m O
. 
 O
BACKGROUND K O
: 
 O
The 	 O
extract r O
of O O
medicinal i O
plants n O
containing t O
curcumin c O
is O O
traditionally d O
believed i O
to O O
have e O
a 
 O
positive i O
contraction t O
effect e O
on O O
the 	 O
human a O
gall l O
- 
 O
bladder d O
. 
 O
Apoptosis p O
triggered g O
through o O
Fas 	 S-GENE
and 	 O
F - B-GENE
/ - I-GENE
F - E-GENE
was 	 O
inhibited i O
by O O
coexpression x O
of O O
CrmA A S-GENE
and 	 O
p35 	 S-GENE
, 
 O
but 	 O
not 	 O
Bcl 	 B-GENE
- - I-GENE
xL E E-GENE
. 
 O
The 	 O
product d O
of O O
one 	 O
gene e O
, 
 O
Bv80 0 S-GENE
, 
 O
has 	 O
a 
 O
single g O
divergent e O
copy y O
of O O
a 
 O
sequence u O
of O O
149 	 O
amino n O
acids d O
( 
 O
approx r O
. 
 O
The 	 O
1031 1 B-GENE
- - I-GENE
bp I I-GENE
wild d I-GENE
- - I-GENE
type e I-GENE
HIT1 1 I-GENE
DNA 	 E-GENE
which c O
contained t O
an O O
open n O
reading d O
frame m O
encoding o O
a 
 O
protein t O
of O O
164 	 O
amino n O
acids d O
and 	 O
the 	 O
AGG 	 B-GENE
arginine i I-GENE
tRNA A I-GENE
gene e E-GENE
complemented p O
all 	 O
hit1 1 B-GENE
- - I-GENE
1 - I-GENE
mutant a I-GENE
phenotypes n E-GENE
, 
 O
indicating i O
that t O
the 	 O
mutant a O
phenotypes n O
were e O
caused s O
by O O
the 	 O
deletion e O
of O O
these s O
genes e O
. 
 O
We O O
found n O
a 
 O
prevalence v O
of O O
eating i O
disorders o O
of O O
5 
 O
. 
 O
9 
 O
% 
 O
( 
 O
lifetime e O
prevalence v O
of O O
10 O O
% 
 O
) 
 O
, 
 O
irrespective e O
of O O
gender d O
and 	 O
type e O
of O O
diabetes b O
; 
 O
4 
 O
. 
 O
1 
 O
% 
 O
of O O
the 	 O
whole l O
sample p O
reported o O
intentional e O
insulin u S-GENE
undertreatment e O
or O O
omission s O
. 
 O
Tilisolol i O
and 	 O
carboxymethylcellulose b O
sodium i O
salt t O
( 
 O
CMC 	 O
) 
 O
were e O
used d O
as O O
the 	 O
model e O
ophthalmic t O
drug g O
and 	 O
viscous c O
polymer y O
, 
 O
respectively p O
. 
 O
These s O
results u O
are 	 O
discussed c O
in O O
the 	 O
context t O
of O O
a 
 O
model e O
of O O
the 	 O
myogenic g O
lineage e O
that t O
is O O
based e O
on O O
the 	 O
expression r O
of O O
desmin m S-GENE
. 
 O
We O O
identified n O
two 	 O
potential e O
phosphorylation s O
sites e O
at O O
serine49 i O
and 	 O
serine133 i O
, 
 O
both h O
of O O
which c O
seem m O
to O O
be O O
necessary e O
for 	 O
Myf 	 B-GENE
- - I-GENE
5 - E-GENE
activity i O
. 
 O
We O O
constructed s O
a 
 O
series i O
of O O
chimeric m O
genes e O
containing t O
part t O
of O O
the 	 O
first s O
exon n O
and 	 O
increasingly r O
longer g O
5 
 O
' 
 O
flanking n O
sequences u O
of O O
the 	 O
ODC 	 B-GENE
gene e E-GENE
fused e O
to O O
either h O
bacterial t B-GENE
chloramphenicol o I-GENE
acetyltransferase t E-GENE
( 
 O
CAT 	 S-GENE
) 
 O
or O O
luciferase i B-GENE
reporter o I-GENE
genes e E-GENE
. 
 O
CVO2 2 O
saturation u O
is O O
a 
 O
reliable i O
and 	 O
sensitive s O
method h O
for 	 O
detecting e O
blood o O
loss s O
. 
 O
The 	 O
gene e O
encoding o O
the 	 O
Neisseria s B-GENE
lactamica t I-GENE
III 	 I-GENE
DNA 	 I-GENE
methyltransferase h E-GENE
( 
 O
M - B-GENE
. - I-GENE
NlaIII I E-GENE
) 
 O
which c O
recognizes o O
the 	 O
sequence u O
CATG G O
has 	 O
been n O
cloned n O
and 	 O
expressed r O
in O O
Escherichia h O
coli i O
. 
 O
This s O
latter t O
complex p O
reacts c O
with h O
an O O
antibody i O
to O O
serum u B-GENE
response p I-GENE
factor t E-GENE
( 
 O
SRF 	 S-GENE
) 
 O
and 	 O
exhibits i O
the 	 O
same e O
binding d O
characteristics r O
as O O
purified i O
SRF 	 S-GENE
. 
 O
The 	 O
second o O
patient i O
was 	 O
successfully c O
treated a O
with h O
intravenous r O
prostaglandin s O
F2 O O
alpha h O
( 
 O
PGF2 2 O
alpha h O
) 
 O
. 
 O
Alignment g O
of O O
the 	 O
rat 	 O
and 	 O
human a B-GENE
WIN 	 I-GENE
cDNAs A E-GENE
and 	 O
their i O
comparison p O
with h O
mouse s O
genomic o O
sequence u O
revealed e O
that t O
the 	 O
WIN 	 B-GENE
DNA 	 I-GENE
binding d I-GENE
domain a E-GENE
is O O
encoded o O
by O O
four r O
exons n O
, 
 O
two 	 O
of O O
which c O
( 
 O
exons n O
4 
 O
and 	 O
6 
 O
) 
 O
are 	 O
alternatively e O
spliced i O
to O O
generate e O
at O O
least s O
three e O
classes s O
of O O
mRNA A O
transcripts n O
. 
 O
In O O
a 
 O
pilot o O
study d O
in O O
which c O
two 	 O
dogs s O
were e O
given e O
parenteral e O
rifampin a O
before o O
and 	 O
after e O
operation r O
and 	 O
grafts f O
were e O
preclotted c O
with h O
blood o O
that t O
contained t O
rifampin a O
, 
 O
it O O
was 	 O
suggested g O
that t O
there r O
was 	 O
a 
 O
slight g O
increase r O
in O O
inhibition i O
at O O
24 O O
hours r O
( 
 O
93 O O
% 
 O
) 
 O
. 
 O
A 
 O
flow w O
probe b O
for 	 O
direct e O
measurement s O
of O O
blood o O
flow w O
of O O
the 	 O
mitral r O
valve v O
was 	 O
devised i O
. 
 O
Here e O
, 
 O
we O O
analyzed l O
the 	 O
interaction e O
of O O
the 	 O
Lactococcus t B-GENE
lactis t I-GENE
Ll I I-GENE
. - I-GENE
LtrB B I-GENE
group u I-GENE
II I I-GENE
intron r I-GENE
endonuclease o E-GENE
with h O
its 	 O
DNA 	 O
target g O
site e O
by O O
DNA 	 O
footprinting t O
and 	 O
modification i O
- 
 O
interference e O
approaches r O
. 
 O
Clinical n O
trials a O
bring n O
informations o O
for 	 O
pharmacology r O
and 	 O
epidemiology d O
. 
 O
In O O
several e O
steps p O
we O O
converted v O
the 	 O
retinoid i O
specific c O
response p O
element m O
of O O
the 	 O
human a B-GENE
retinoic i I-GENE
acid d I-GENE
receptor e I-GENE
beta a I-GENE
promoter m E-GENE
into o O
the 	 O
vitamin a O
D 
 O
/ 
 O
retinoic i O
acid d O
response p O
element m O
of O O
the 	 O
human a B-GENE
osteocalcin e I-GENE
promoter m E-GENE
. 
 O
The 	 O
immediate e O
5 
 O
' 
 O
- 
 O
flanking n O
region i O
was 	 O
GC O O
- 
 O
rich h O
with h O
3 
 O
SP B O
- - O
1 - O
- - O
like e O
and 	 O
2 
 O
AP B O
- - O
2 - O
sites e O
identified n O
in O O
close s O
proximity x O
to O O
the 	 O
transcription n O
start r O
site e O
. 
 O
Akt 	 S-GENE
- 
 O
dependent e O
antiapoptotic i O
action i O
of O O
insulin u S-GENE
is O O
sensitive s O
to O O
farnesyltransferase n S-GENE
inhibitor i O
. 
 O
For 	 O
all 	 O
samples p O
, 
 O
the 	 O
sensitivity s O
of O O
the 	 O
blast s O
flag g O
on O O
the 	 O
CD3500 5 O
was 	 O
85 O O
% 
 O
with h O
a 
 O
specificity c O
of O O
91 O O
% 
 O
( 
 O
STKS S O
: 
 O
sensitivity s O
, 
 O
75 O O
% 
 O
; 
 O
specificity c O
, 
 O
85 O O
% 
 O
) 
 O
; 
 O
the 	 O
sensitivity s O
of O O
the 	 O
CD3500 5 O
IG O O
flag g O
was 	 O
72 O O
% 
 O
with h O
a 
 O
specificity c O
of O O
76 O O
% 
 O
( 
 O
STKS S O
: 
 O
sensitivity s O
, 
 O
75 O O
% 
 O
: 
 O
specificity c O
, 
 O
73 O O
% 
 O
) 
 O
; 
 O
and 	 O
the 	 O
sensitivity s O
of O O
the 	 O
NRBC C O
flag g O
was 	 O
43 O O
% 
 O
with h O
a 
 O
specificity c O
of O O
94 O O
% 
 O
( 
 O
STKS S O
sensitivity s O
, 
 O
37 O O
% 
 O
; 
 O
specificity c O
, 
 O
88 O O
% 
 O
) 
 O
. 
 O
Control t O
of O O
ovulation l O
in O O
mares e O
in O O
the 	 O
early l O
breeding e O
season s O
with h O
ovarian r O
steroids r O
and 	 O
prostaglandin s O
. 
 O
Reasons s O
are 	 O
given e O
for 	 O
suggesting g O
that t O
tiapamil p O
warrants r O
further t O
clinical n O
evaluation l O
, 
 O
after e O
which c O
it O O
may 	 O
join n O
the 	 O
more e O
established a O
calcium c O
antagonists a O
as O O
a 
 O
valuable u O
therapeutic r O
agent n O
. 
 O
The 	 O
central t O
venous o O
O2 O O
saturation u O
test t O
in O O
acute t O
pulmonary m O
fat 	 O
embolism o O
. 
 O
Two 	 O
of O O
the 	 O
proteins t O
UPRF F B-GENE
- - I-GENE
1 - E-GENE
and 	 O
UPRF F B-GENE
- - I-GENE
2 - E-GENE
( 
 O
which c O
is O O
apparently a O
a 
 O
proteolytic t O
degradation r O
product d O
of O O
UPRF F B-GENE
- - I-GENE
1 - E-GENE
) 
 O
bind d O
inefficiently f O
to O O
mutant a O
versions s O
of O O
the 	 O
UPR 	 S-GENE
that t O
are 	 O
unable b O
to O O
confer f O
responsiveness p O
to O O
unfolded o O
proteins t O
to O O
the 	 O
( 
 O
CYC1 1 S-GENE
) 
 O
promoter m O
. 
 O
Identification n O
of O O
domains a O
mediating i O
transcription n O
activation i O
, 
 O
repression r O
, 
 O
and 	 O
inhibition i O
in O O
the 	 O
paired r O
- - O
related a O
homeobox e O
protein t O
, 
 O
Prx2 2 S-GENE
( 
 O
S8 S S-GENE
) 
 O
. 
 O
METHODS H O
: 
 O
A 
 O
spatial t O
counting n O
approach r O
in O O
which c O
the 	 O
location a O
of O O
each h O
and 	 O
every r O
PN O O
and 	 O
NP O O
in O O
the 	 O
stratum a O
pyramidale a O
of O O
sectors t O
CA1 	 O
- 
 O
4 
 O
was 	 O
applied l O
to O O
11 O O
normal m O
control t O
( 
 O
CONs s O
) 
 O
and 	 O
10 O O
SZs 	 O
matched c O
for 	 O
age 	 O
and 	 O
postmortem t O
interval e O
, 
 O
as O O
well l O
as O O
4 
 O
manic i O
depressive r O
( 
 O
MD O O
) 
 O
subjects j O
matched c O
for 	 O
age 	 O
. 
 O
Analytical l O
scanning n O
isoelectrofocusing e O
. 
 O
Upstream t B-GENE
stimulatory m I-GENE
factor t I-GENE
USF 	 E-GENE
is O O
a 
 O
human a O
transcriptional n O
activation i O
factor t O
, 
 O
which c O
uses s O
a 
 O
basic i B-GENE
/ 
 I-GENE
helix i I-GENE
- 
 I-GENE
loop p I-GENE
- 
 I-GENE
helix i I-GENE
/ 
 I-GENE
leucin c I-GENE
zipper p E-GENE
( 
 O
b 
 B-GENE
/ 
 I-GENE
HLH 	 I-GENE
/ 
 I-GENE
Z 
 I-GENE
) 
 I-GENE
motif i E-GENE
to O O
homodimerize o O
and 	 O
recognize o O
specific c O
sequences u O
in O O
the 	 O
promoter m O
region i O
of O O
both h O
nuclear l O
and 	 O
viral a O
genes e O
transcribed n O
by O O
RNA 	 B-GENE
polymerase y I-GENE
II E E-GENE
. 
 O
43 O O
% 
 O
, 
 O
6 
 O
/ 
 O
14 O O
; 
 O
P 
 O
= 
 O
0 
 O
. 
 O
013 	 O
) 
 O
, 
 O
whereas r O
, 
 O
in O O
RCC 	 O
samples p O
with h O
VHL 	 O
methylation h O
or O O
mutation a O
, 
 O
the 	 O
frequency q O
of O O
3p14 4 S-GENE
- 
 O
p21 	 S-GENE
LOH 	 S-GENE
did 	 O
not 	 O
differ f O
from m O
that t O
of O O
sp25 5 B-GENE
- 
 I-GENE
p26 	 E-GENE
( 
 O
72 O O
% 
 O
, 
 O
18 O O
/ 
 O
25 O O
vs O O
. 
 O
Sequences u O
homologous o O
to O O
the 	 O
consensus s O
TUF 	 B-GENE
- - I-GENE
binding d I-GENE
UAS 	 I-GENE
boxes e E-GENE
are 	 O
present s O
in O O
the 	 O
5 
 O
' 
 O
flanking n O
regions i O
of O O
both h O
genes e O
. 
 O
The 	 O
analysis l O
predicted d O
that t O
progressive g O
increases r O
in O O
serum u O
creatinine a O
or O O
aspartate a B-GENE
transaminase n E-GENE
activity i O
will l O
result u O
in O O
only y O
a 
 O
50 O O
% 
 O
reduction u O
of O O
clearance a O
. 
 O
RESULTS U O
: 
 O
Although h O
low 	 O
levels e O
of O O
vIRF F B-GENE
- - I-GENE
2 - I-GENE
mRNAs A E-GENE
can 	 O
be O O
detected e O
in O O
the 	 O
HHV 	 O
- 
 O
8 
 O
- 
 O
positive i O
BCBL L O
- 
 O
1 
 O
tumor o O
cell l O
line e O
, 
 O
12 O O
- 
 O
0 
 O
- 
 O
tetradecanoylphorbol r O
- 
 O
13 O O
- 
 O
acetate t O
( 
 O
TPA 	 O
) 
 O
treatment a O
does s O
not 	 O
stimulate m O
expression r O
of O O
vIRF F B-GENE
- - I-GENE
2 - I-GENE
gene e E-GENE
together e O
with h O
primary m O
lytic i O
cycle l O
genes e O
. 
 O
Central t O
projections j O
of O O
gastric t O
afferent e O
vagal a O
inputs u O
. 
 O
DNA 	 O
sequence u O
of O O
the 	 O
UL6 	 S-GENE
to O O
UL20 0 B-GENE
genes e E-GENE
of O O
infectious e O
laryngotracheitis y O
virus u O
and 	 O
characterization r O
of O O
the 	 O
UL10 0 B-GENE
gene e I-GENE
product d E-GENE
as O O
a 
 O
nonglycosylated g O
and 	 O
nonessential e O
virion i O
protein t O
. 
 O
Coimmunoprecipitation m O
analysis l O
suggests g O
that t O
these s O
residues i O
likely e O
contribute t O
to O O
the 	 O
multimerization t O
function c O
required u O
for 	 O
homomeric o O
complex p O
formation m O
or O O
heteromeric e O
complex p O
formation m O
with h O
p50 	 S-GENE
in O O
that t O
no O O
association o O
of O O
p65 	 B-GENE
delta t E-GENE
with h O
itself e O
or O O
with h O
p50 	 S-GENE
was 	 O
evident d O
. 
 O
Cytostatic o O
activity i O
of O O
some e O
essential e O
oils s O
against i O
HEp 	 O
- 
 O
2 
 O
cells l O
. 
 O
A 
 O
yeast s O
mitochondrial o O
translation n O
initiation t O
codon o O
mutation a O
affecting e O
the 	 O
gene e O
for 	 O
cytochrome o B-GENE
oxidase d I-GENE
subunit u I-GENE
III 	 E-GENE
( 
 O
COX3 3 S-GENE
) 
 O
was 	 O
partially t O
suppressed p O
by O O
a 
 O
spontaneous n O
nuclear l O
mutation a O
. 
 O
Only y O
the 	 O
27 O O
- 
 O
kDa 	 O
protein t O
was 	 O
detected e O
after e O
N - B-GENE
- - I-GENE
glycosidase c E-GENE
treatment a O
, 
 O
indicating i O
that t O
PLP 	 B-GENE
- - I-GENE
H - E-GENE
is O O
a 
 O
glycoprotein c O
. 
 O
Moreover e O
, 
 O
we O O
studied d O
the 	 O
relationship a O
between w O
initial t O
percentage c O
of O O
bone e O
marrow r O
plasma s O
cells l O
and 	 O
prognosis g O
. 
 O
These s O
results u O
demonstrate o O
that t O
GGTase a B-GENE
- - I-GENE
I - E-GENE
inhibitors i O
arrest e O
cells l O
in O O
G0 O O
/ 
 O
G1 O O
and 	 O
induce u O
accumulation u O
of O O
p21WAF W S-GENE
in O O
a 
 O
p53 	 S-GENE
- 
 O
independent e O
manner n O
and 	 O
that t O
FTase s S-GENE
inhibitors i O
can 	 O
interfere e O
with h O
cell l O
cycle l O
events n O
by O O
a 
 O
mechanism h O
that t O
involves o O
neither t O
p21WAF W S-GENE
nor 	 O
p27KIP K S-GENE
. 
 O
We O O
report o O
here e O
on O O
an O O
eight h O
- 
 O
year r O
- 
 O
old 	 O
boy 	 O
who 	 O
first s O
developed e O
acute t O
intravascular r O
hemolysis o O
following l O
therapy r O
with h O
amphotericin h O
B 
 O
( 
 O
AmB 	 O
) 
 O
and 	 O
subsequently s O
a 
 O
delayed a O
hemolytic o O
transfusion n O
reaction c O
due 	 O
to O O
alloantibodies o O
. 
 O
The 	 O
temporal p O
sequence u O
of O O
organ a O
failure l O
was 	 O
lung g O
, 
 O
clotting t O
system t O
, 
 O
kidney n O
, 
 O
and 	 O
liver e O
. 
 O
The 	 O
potential e O
biological l O
significance n O
of O O
the 	 O
identified n O
structural u O
motif i O
shared r O
by O O
the 	 O
human a B-GENE
CCR5 5 E-GENE
, 
 O
CCR3 3 S-GENE
, 
 O
CCR2B 2 S-GENE
and 	 O
other e O
GPCRs R S-GENE
is O O
discussed c O
. 
 O
Analysis l O
of O O
rat 	 O
brain i O
, 
 O
heart r O
, 
 O
lung g O
, 
 O
liver e O
, 
 O
kidney n O
and 	 O
skeletal l O
muscle c O
revealed e O
psi 	 B-GENE
PKC 	 I-GENE
zeta a I-GENE
mRNA A E-GENE
only y O
in O O
brain i O
. 
 O
The 	 O
papers e O
provide v O
a 
 O
broad a O
perspective s O
of O O
MPAs s O
and 	 O
include l O
social i O
, 
 O
economic n O
, 
 O
cultural t O
, 
 O
biological l O
and 	 O
statistical t O
components p O
. 
 O
Management a O
of O O
patients i O
with h O
Ewing n O
' 
 O
s 
 O
sarcoma c O
has 	 O
been n O
discussed c O
with h O
reference e O
to O O
the 	 O
need d O
to O O
achieve i O
an O O
excellent e O
local a O
result u O
from m O
radiation i O
therapy r O
now 	 O
that t O
patients i O
are 	 O
experiencing e O
long g O
- 
 O
term m O
survival v O
. 
 O
Furthermore t O
, 
 O
the 	 O
rapid i O
light h O
- 
 O
mediated i O
increase r O
of O O
CPRF F B-GENE
proteins t E-GENE
was 	 O
insensitive e O
to O O
transcriptional n O
inhibitors i O
, 
 O
suggesting g O
that t O
a 
 O
post t O
- 
 O
transcriptional n O
mechanism h O
controls t O
CPRF F S-GENE
accumulation u O
. 
 O
In O O
those s O
patients i O
who 	 O
before o O
transplantation n O
were e O
serological o O
negative a O
for 	 O
CMV 	 O
but 	 O
had 	 O
received e O
organs a O
from m O
CMV 	 O
- - O
IgG 	 S-GENE
positive i O
donors o O
, 
 O
the 	 O
incidence i O
of O O
the 	 O
disease e O
was 	 O
highest h O
. 
 O
Since c O
1985 5 O
the 	 O
combination b O
of O O
chlorambucil o O
( 
 O
10 O O
mg O O
daily l O
, 
 O
initially t O
for 	 O
six 	 O
weeks k O
, 
 O
then n O
alternating e O
fortnights t O
for 	 O
12 O O
weeks k O
) 
 O
and 	 O
interferon e B-GENE
- - I-GENE
alpha h I-GENE
2b E E-GENE
( 
 O
Schering e O
- 
 O
Plough u O
; 
 O
2 
 O
x 
 O
10 O O
( 
 O
6 
 O
) 
 O
U 
 O
/ 
 O
m2 O O
three e O
times e O
weekly k O
by O O
subcutaneous c O
injection e O
for 	 O
18 O O
weeks k O
) 
 O
has 	 O
been n O
compared p O
in O O
a 
 O
randomised d O
trial a O
with h O
chlorambucil o O
alone n O
in O O
previously v O
untreated r O
patients i O
with h O
stage g O
III 	 O
or O O
IV O O
follicular l O
lymphoma p O
. 
 O
The 	 O
BDU 	 O
neurons r O
and 	 O
the 	 O
ALM 	 O
touch c O
neurons r O
are 	 O
lineal e O
sister t O
cells l O
in O O
the 	 O
AB O O
. 
 O
a 
 O
lineage e O
and 	 O
the 	 O
VA O O
and 	 O
VB O O
motor o O
neurons r O
are 	 O
lineal e O
sister t O
cells l O
in O O
the 	 O
AB O O
. 
 O
p 
 O
lineage e O
. 
 O
We O O
compared p O
retrospectively r O
the 	 O
efficacy i O
of O O
granulocyte n B-GENE
colony o I-GENE
stimulating m I-GENE
factor t E-GENE
( 
 O
G - B-GENE
- - I-GENE
CSF 	 E-GENE
) 
 O
alone n O
with h O
chemotherapy m O
plus s O
G - B-GENE
- - I-GENE
CSF 	 E-GENE
in O O
mobilizing i O
CD34 4 S-GENE
- 
 O
positive i O
cells l O
in O O
patients i O
with h O
malignant i O
lymphoma p O
. 
 O
Serum u O
concentrations c O
of O O
hormones m O
in O O
patients i O
classified s O
as O O
C 
 O
were e O
characteristically r O
and 	 O
inclined l O
to O O
be O O
hypergonadotropic e O
and 	 O
hypoestrogenic o O
. 
 O
Cervical v O
CT O O
revealed e O
an O O
irregular e O
low 	 O
density s O
at O O
the 	 O
periphery i O
of O O
the 	 O
cervical v O
vertebra t O
from m O
the 	 O
C2 O O
to O O
C4 O O
level e O
. 
 O
Incorporation o O
of O O
this s O
information o O
in O O
the 	 O
data a O
brought u O
about u O
a 
 O
revised i O
five e O
- 
 O
year r O
survival v O
estimate i O
of O O
55 O O
percent c O
. 
 O
These s O
motifs i O
, 
 O
and 	 O
their i O
cognate n O
transcription n O
factors t O
, 
 O
appear e O
to O O
act 	 O
in O O
concert c O
, 
 O
with h O
partial t O
redundancy u O
, 
 O
so O O
that t O
discrete c O
mutations a O
were e O
only y O
partially t O
effective e O
in O O
reducing u O
transcriptional n O
activity i O
. 
 O
We O O
now 	 O
show w O
that t O
purified i O
recombinant o O
c - B-GENE
- - I-GENE
sis 	 E-GENE
/ 
 O
PDGF F S-GENE
can 	 O
induce u O
this s O
binding d O
activity i O
which c O
we O O
have e O
termed m O
SIF 	 S-GENE
, 
 O
for 	 O
sis 	 B-GENE
- - I-GENE
inducible u I-GENE
factor t E-GENE
. 
 O
Statistical t O
conservation s O
laws s O
in O O
turbulent b O
transport n O
. 
 O
Expression r O
of O O
the 	 O
bacteriophage t B-GENE
T4 I I-GENE
DNA 	 I-GENE
terminase m I-GENE
genes e I-GENE
16 I E-GENE
and 	 O
17 E O
yields l O
multiple t O
proteins t O
. 
 O
Erdheim h O
- 
 O
Chester s O
disease e O
: 
 O
a 
 O
distinct t O
lipoidosis o O
or O O
part t O
of O O
the 	 O
spectrum c O
of O O
histiocytosis t O
? 
 O
Erdheim h O
- 
 O
Chester s O
disease e O
has 	 O
always a O
been n O
considered s O
a 
 O
distinct t O
lipoidosis o O
based e O
on O O
clinical n O
and 	 O
radiographic i O
criteria t O
. 
 O
Self f O
- 
 O
consistent s O
calculation c O
of O O
the 	 O
surface f O
electronic c O
structure u O
of O O
the 	 O
( 
 O
1 
 O
x 
 O
2 
 O
) 
 O
reconstructed o O
Au O O
( 
 O
110 	 O
) 
 O
surface f O
. 
 O
The 	 O
plasmid s O
was 	 O
found n O
to O O
confer f O
drug g O
resistance i O
specifically c O
to O O
LMB 	 O
. 
 O
Two 	 O
pharmacokinetic r O
models e O
were e O
compared p O
. 
 O
A 
 O
higher h O
median i O
proportion p O
of O O
spirochaetes r O
was 	 O
observed e O
in O O
sites e O
after e O
diagnosis g O
of O O
loss s O
of O O
attachment a O
. 
 O
Ocular l O
injuries u O
during i O
general e O
anesthesia s O
. 
 O
Of O O
81 O O
girls l O
cured e O
from m O
the 	 O
bacteriuria t O
24 O O
recurred u O
, 
 O
5 
 O
with h O
a 
 O
symptomatic p O
pyelonephritis l O
and 	 O
3 
 O
with h O
cystitis t O
. 
 O
The 	 O
performances f O
of O O
two 	 O
tests t O
, 
 O
the 	 O
ProstAsure s O
index e O
and 	 O
the 	 O
percent c O
free e O
PSA 	 O
test t O
, 
 O
were e O
evaluated l O
in O O
detecting e O
cancer c O
. 
 O
The 	 O
protein t O
encoded o O
by O O
the 	 O
NF2 	 B-GENE
gene e E-GENE
has 	 O
a 
 O
similarity i O
to O O
ezrin i S-GENE
, 
 O
radixin i S-GENE
and 	 O
moesin s S-GENE
( 
 O
ERM 	 S-GENE
) 
 O
proteins t O
that t O
link k O
membrane b O
proteins t O
to O O
the 	 O
cytoskeleton o O
. 
 O
PATIENTS I O
- 
 O
- 
 O
125 	 O
women e O
consulting s O
the 	 O
general e O
practitioner c O
for 	 O
symptomatic p O
bacterial t O
vaginosis i O
. 
 O
In O O
the 	 O
healing l O
tendons d O
, 
 O
the 	 O
rate e O
of O O
collagen l S-GENE
synthesis t O
decreased r O
and 	 O
the 	 O
rate e O
of O O
noncollagen c B-GENE
protein t E-GENE
synthesis t O
remained a O
unchanged h O
. 
 O
From m O
our 	 O
own 	 O
investigations e O
on O O
phantoms n O
, 
 O
the 	 O
smallest l O
signal n O
- 
 O
to O O
- 
 O
noise s O
ratio i O
( 
 O
delta t O
S 
 O
min 	 O
/ 
 O
delta t O
R 
 O
) 
 O
was 	 O
obtained a O
which c O
determines e O
the 	 O
minimal i O
contrast t O
, 
 O
given e O
the 	 O
film m O
properties p O
( 
 O
film m O
response p O
S 
 O
, 
 O
film m O
gradient d O
gamma m O
) 
 O
and 	 O
the 	 O
amount u O
of O O
scatter t O
. 
 O
However e O
, 
 O
one 	 O
activity i O
binds d O
preferentially f O
to O O
G 
 O
+ 
 O
C 
 O
- 
 O
rich h O
promoters m O
, 
 O
and 	 O
another t O
activity i O
appears e O
to O O
bind d O
preferentially f O
to O O
only y O
two 	 O
of O O
the 	 O
promoters m O
tested t O
. 
 O
Cardiovascular d O
effects e O
in O O
man 	 O
of O O
intravenous r O
prizidilol z O
hydrochloride r O
( 
 O
SK O O
& 
 O
F 
 O
92657 5 O
) 
 O
; 
 O
a 
 O
new 	 O
antihypertensive i O
agent n O
. 
 O
From m O
the 	 O
Centers t O
for 	 O
Disease e O
Control t O
and 	 O
Prevention v O
. 
 O
Expression r O
of O O
a 
 O
cDNA A O
clone n O
in O O
yeast s O
containing t O
a 
 O
large g O
portion t O
of O O
the 	 O
open n O
reading d O
frame m O
produced d O
cAMP P B-GENE
PDEase a E-GENE
activity i O
identical n O
in O O
properties p O
to O O
the 	 O
Drosophila s O
enzyme y O
affected e O
by O O
the 	 O
dnc 	 O
mutation a O
. 
 O
FdsR R S-GENE
purified i O
to O O
homogeneity o O
after e O
overexpression r O
of O O
fdsR R S-GENE
in O O
E 
 O
. 
 O
coli i O
is O O
a 
 O
130 	 O
kDa 	 O
homotetramer o O
binding d O
to O O
the 	 O
fds 	 B-GENE
control t I-GENE
region i E-GENE
located a O
between w O
the 	 O
fdsR R S-GENE
and 	 O
fdsG G B-GENE
genes e E-GENE
. 
 O
ZNS 	 O
, 
 O
in O O
the 	 O
mmolar l O
range g O
, 
 O
scavenged v O
hydroxyl r O
and 	 O
nitric r O
oxide d O
radicals i O
in O O
a 
 O
dose e O
- 
 O
dependent e O
manner n O
. 
 O
The 	 O
orthologs h O
of O O
the 	 O
Y - B-GENE
( - I-GENE
1 - I-GENE
) - E-GENE
and 	 O
Y - O
( - O
2 - O
) - O
subtypes t O
display p O
high h O
amino n O
acid d O
sequence u O
identities n O
between w O
pig 	 O
, 
 O
human a O
, 
 O
and 	 O
mouse s O
( 
 O
92 O O
% 
 O
- 
 O
94 O O
% 
 O
) 
 O
, 
 O
whereas r O
the 	 O
Y - O
( - O
4 - O
) - O
, 
 O
Y - O
( - O
5 - O
) - O
, 
 O
and 	 O
y - O
( - O
6 - O
) - O
subtypes t O
display p O
lower e O
identities n O
( 
 O
76 O O
% 
 O
- 
 O
87 O O
% 
 O
) 
 O
. 
 O
Binding d O
of O O
ZAP 	 B-GENE
- - I-GENE
70 E E-GENE
to O O
phospho s B-GENE
- 
 I-GENE
TAMs s E-GENE
is O O
notable a O
for 	 O
the 	 O
high h O
level e O
of O O
cooperativity p O
between w O
the 	 O
two 	 O
SH2 	 B-GENE
domains a E-GENE
, 
 O
which c O
individually i O
demonstrate o O
low 	 O
affinity i O
interaction e O
with h O
the 	 O
ligand a O
. 
 O
The 	 O
benzo z O
- 
 O
pyrone o O
drug g O
Venalot a O
had 	 O
a 
 O
considerable s O
effect e O
in O O
reducing u O
the 	 O
protein t O
concentration c O
in O O
the 	 O
air 	 O
spaces c O
and 	 O
the 	 O
interstitial e O
tissue s O
, 
 O
and 	 O
of O O
the 	 O
oedema e O
in O O
the 	 O
latter t O
. 
 O
Radiation i O
was 	 O
delivered i O
in O O
a 
 O
single g O
4 
 O
- 
 O
mJ O O
pulse s O
of O O
200 	 O
microseconds r O
duration a O
by O O
means n O
of O O
an O O
articulated i O
zirconium c O
fluoride o O
optical i O
fibre r O
and 	 O
a 
 O
320 	 O
- 
 O
microns r O
quartz r O
- 
 O
fibre r O
tip 	 O
. 
 O
Perception c O
of O O
sweetness e O
cannot n O
be O O
used d O
to O O
accurately u O
meter e O
the 	 O
metabolizable a O
energy r O
or O O
nutritive r O
value u O
of O O
a 
 O
food d O
. 
 O
The 	 O
leader d O
peptide t O
was 	 O
hypothesized o O
to O O
inhibit i O
ribosome o O
release e O
at O O
the 	 O
tnaC C S-GENE
stop p O
codon o O
, 
 O
thereby r O
blocking c O
Rho 	 S-GENE
' 
 O
s 
 O
access e O
to O O
the 	 O
transcript n O
. 
 O
Response p O
properties p O
of O O
single g O
units t O
in O O
the 	 O
accessory e O
optic i O
system t O
of O O
the 	 O
dark k O
- 
 O
reared r O
cat 	 O
. 
 O
Excretion r O
of O O
radiopharmaceuticals i O
into o O
breast a O
milk k O
. 
 O
Influence l O
of O O
huanglian n O
used d O
in O O
combination b O
with h O
huangqin n O
and 	 O
gancao c O
on O O
the 	 O
erythrocytic t O
osmotic o O
fragilitas g O
of O O
experimental e O
glucose c B-GENE
- - I-GENE
6 - I-GENE
- - I-GENE
phosphate s I-GENE
dehydrogenase y E-GENE
deficiency i O
in O O
rats s O
] 
 O
OBJECTIVE E O
: 
 O
To O O
study d O
the 	 O
influence l O
of O O
common m O
combination b O
of O O
Huanglian n O
( 
 O
Coptis t O
chinensis n O
) 
 O
on O O
the 	 O
erythrocytic t O
osmotic o O
fragilitas g O
of O O
glucose c B-GENE
- - I-GENE
6 - I-GENE
- - I-GENE
phosphate s I-GENE
dehydrogenase y E-GENE
( 
 O
G6PD D S-GENE
) 
 O
deficiency i O
in O O
rats s O
. 
 O
The 	 O
leukotriene k B-GENE
receptor e E-GENE
antagonist a O
zafirlukast i O
inhibits i O
sulfur f O
dioxide x O
- 
 O
induced u O
bronchoconstriction n O
in O O
patients i O
with h O
asthma h O
. 
 O
This s O
sequence u O
was 	 O
sufficient f O
to O O
confer f O
p53 	 S-GENE
- 
 O
dependent e O
activation i O
to O O
a 
 O
heterologous e O
promoter m O
and 	 O
p53 	 S-GENE
was 	 O
capable a O
of O O
binding d O
to O O
this s O
sequence u O
as O O
assessed e O
by O O
gel 	 O
shift f O
analysis l O
. 
 O
The 	 O
embryology r O
of O O
the 	 O
vertebral t O
column u O
is O O
reviewed i O
briefly e O
, 
 O
and 	 O
the 	 O
origin g O
of O O
each h O
anomaly m O
of O O
the 	 O
C2 O O
vertebra t O
is O O
traced c O
to O O
one 	 O
of O O
the 	 O
two 	 O
early l O
stages g O
in O O
development e O
as O O
follows l O
: 
 O
1 
 O
) 
 O
the 	 O
formation m O
of O O
the 	 O
mesenchymal e O
vertebra t O
or O O
2 
 O
) 
 O
its 	 O
induction u O
to O O
cartilage t O
. 
 O
Two 	 O
of O O
the 	 O
three e O
groups u O
were e O
submitted m O
to O O
two 	 O
different f O
levels e O
of O O
hypoxia o O
( 
 O
FiO2 2 O
= 
 O
0 
 O
. 
 O
05 O O
, 
 O
group u O
F5 O O
and 	 O
FiO2 2 O
= 
 O
0 
 O
. 
 O
1 
 O
, 
 O
group u O
F10 	 O
) 
 O
and 	 O
the 	 O
third r O
to O O
normoxia m O
( 
 O
FiO2 2 O
= 
 O
0 
 O
. 
 O
21 O O
, 
 O
group u O
F21 	 O
) 
 O
in O O
a 
 O
thermoneutral r O
and 	 O
controlled t O
environment i O
. 
 O
Parathyroid a O
hormone m O
responses p O
of O O
cyclic l O
AMP 	 O
- 
 O
, 
 O
serum u O
- 
 O
and 	 O
phorbol r O
ester e O
- 
 O
responsive p O
reporter o O
genes e O
in O O
osteoblast e O
- 
 O
like e O
UMR 	 O
- 
 O
106 	 O
cells l O
. 
 O
Our 	 O
results u O
strongly o O
suggest g O
that t O
activation i O
of O O
the 	 O
beta a O
origin g O
by O O
a 
 O
distant t O
replication l O
enhancer a O
element m O
requires u O
a 
 O
small l O
target g O
sequence u O
essential e O
for 	 O
initiator t O
protein t O
- 
 O
mediated i O
DNA 	 O
looping p O
. 
 O
HNF4alpha7 4 B-GENE
mRNA A E-GENE
is O O
also o O
found n O
in O O
totipotent i O
embryonic r O
stem m O
cells l O
. 
 O
Penicillamine i O
- 
 O
induced u O
myasthenia s O
gravis v O
associated o O
with h O
antibodies i O
to O O
acetylcholine t B-GENE
receptor e E-GENE
. 
 O
Magnetic n O
force c O
and 	 O
torque q O
at O O
1 
 O
. 
 O
5 
 O
T 
 O
did 	 O
not 	 O
dislodge l O
the 	 O
GF O O
or O O
result u O
in O O
perforation f O
of O O
canine i O
IVC 	 O
by O O
the 	 O
GF O O
. 
 O
A 
 O
. 
 O
LCCH1 H S-GENE
was 	 O
identical n O
to O O
the 	 O
Rdl 	 B-GENE
gene e E-GENE
, 
 O
a 
 O
known w O
GABA A B-GENE
receptor e I-GENE
subunit u I-GENE
gene e E-GENE
from m O
D 
 O
. 
 O
melanogaster a O
, 
 O
whereas r O
LCCH2 H S-GENE
and 	 O
LCCH3 H S-GENE
were e O
novel e O
D 
 O
. 
 O
melanogaster a O
sequences u O
that t O
exhibited i O
structural u O
similarity i O
to O O
other e O
members b O
of O O
the 	 O
ligand a O
- - O
gated e O
chloride o O
channel n O
gene e O
family i O
. 
 O
A 
 O
significant n O
increase r O
of O O
gastric t O
mucosal o O
permeability m O
was 	 O
observed e O
in O O
six 	 O
normal m O
human a O
subjects j O
after e O
instillation t O
of O O
ethanol a O
( 
 O
20 O O
percent c O
v 
 O
/ 
 O
v 
 O
) 
 O
. 
 O
Using n O
a 
 O
simulated u O
cough g O
machine h O
, 
 O
we O O
analyzed l O
the 	 O
effect e O
of O O
adding i O
tensio s O
- 
 O
active i O
liquids u O
as O O
sol 	 O
phase s O
simulant u O
on O O
the 	 O
clearance a O
of O O
gel 	 O
mucus u O
simulant u O
by O O
cough g O
. 
 O
First s O
, 
 O
the 	 O
amino n O
- 
 O
terminal m O
regulatory u O
arm 	 O
of O O
the 	 O
GDI 	 S-GENE
binds d O
to O O
the 	 O
switch t O
I 
 O
and 	 O
II O O
domains a O
of O O
Cdc42 4 S-GENE
leading d O
to O O
the 	 O
inhibition i O
of O O
both h O
GDP 	 S-GENE
dissociation s O
and 	 O
GTP 	 O
hydrolysis r O
. 
 O
By O O
a 
 O
combination b O
of O O
alternative e O
promoter m O
usage g O
and 	 O
exon n O
splicing i O
, 
 O
each h O
ROR 	 B-GENE
gene e E-GENE
generates e O
several e O
isoforms f O
that t O
differ f O
only y O
in O O
their i O
amino n O
terminus m O
. 
 O
Electrophoretic c O
mobility i O
- 
 O
shift f O
assays a O
showed w O
a 
 O
rapid i O
induction u O
of O O
nuclear l O
proteins t O
that t O
bound n O
to O O
the 	 O
consensus s O
kappa p B-GENE
B - I-GENE
motif i E-GENE
. 
 O
Analysis l O
of O O
larger g O
cDNA A O
clones n O
demonstrates o O
that t O
there r O
are 	 O
at O O
least s O
two 	 O
isoforms f O
of O O
RIP14 1 S-GENE
that t O
differ f O
in O O
the 	 O
N 
 O
- 
 O
terminal m O
( 
 O
A 
 O
and 	 O
B 
 O
) 
 O
and 	 O
hinge g O
( 
 O
D 
 O
) 
 O
domains a O
. 
 O
Multiple t O
copies i O
of O O
this s O
binding d O
site e O
are 	 O
found n O
in O O
the 	 O
viral a O
genomes o O
. 
 O
During i O
subsequent s O
CS O O
- 
 O
alone n O
trials a O
, 
 O
the 	 O
responses p O
of O O
( 
 O
+ 
 O
) 
 O
MK O O
- 
 O
801 	 O
- 
 O
injected e O
mice e O
were e O
extinguished i O
as O O
easily i O
as O O
those s O
of O O
saline i O
- 
 O
injected e O
mice e O
. 
 O
In O O
contrast t O
, 
 O
the 	 O
tail l O
deviated i O
ipsilaterally i O
in O O
cats s O
with h O
a 
 O
hemisection i O
, 
 O
and 	 O
the 	 O
tail l O
was 	 O
ventroflexed t O
in O O
cats s O
with h O
a 
 O
transection n O
. 
 O
The 	 O
major o O
open n O
reading d O
frame m O
of O O
the 	 O
cDNA A O
predicts d O
a 
 O
protein t O
of O O
59 O O
kD O O
, 
 O
with h O
a 
 O
leucine c O
zipper p O
situated u O
adjacent a O
to O O
an O O
myc 	 B-GENE
- - I-GENE
related a I-GENE
motif i E-GENE
that t O
has 	 O
been n O
proposed p O
to O O
assume u O
a 
 O
helix i O
- 
 O
loop p O
- 
 O
helix i O
structure u O
. 
 O
This s O
residue i O
, 
 O
although h O
located a O
55 O O
rather h O
than n O
35 O O
residues i O
NH2 	 O
- 
 O
terminal m O
of O O
the 	 O
essential e O
glutamate t O
, 
 O
is O O
undoubtedly o O
the 	 O
analog l O
of O O
the 	 O
second o O
aspartate a O
of O O
the 	 O
Asp 	 O
- 
 O
Asp 	 O
- 
 O
35 O O
- 
 O
Glu 	 O
motif i O
found n O
in O O
other e O
family i O
members b O
. 
 O
In O O
addition i O
to O O
loss s O
of O O
digit i O
identity n O
and 	 O
varying y O
degrees r O
of O O
polydactyly y O
, 
 O
proximal x O
skeletal l O
elements m O
are 	 O
severely e O
shortened r O
in O O
Xt S O
; 
 O
ld S O
double b O
homozygous o O
limbs b O
. 
 O
The 	 O
PEP4 4 B-GENE
gene e E-GENE
was 	 O
isolated l O
from m O
a 
 O
genomic o O
DNA 	 O
library r O
by O O
complementation p O
of O O
the 	 O
pep4 4 B-GENE
- - I-GENE
3 - I-GENE
mutation a E-GENE
. 
 O
A 
 O
gene e O
with h O
a 
 O
high h O
degree r O
of O O
sequence u O
identity n O
with h O
mammalian m B-GENE
ADP 	 I-GENE
- - I-GENE
ribosylation o I-GENE
factors t E-GENE
( 
 O
ARFs s S-GENE
) 
 O
, 
 O
believed i O
to O O
be O O
important o O
in O O
vesicular i O
transport n O
, 
 O
was 	 O
identified n O
. 
 O
Off 	 O
- 
 O
shell l O
effect e O
in O O
Rydberg b O
- 
 O
atom m O
- 
 O
alkali a O
- 
 O
metal a O
- 
 O
atom m O
scattering t O
. 
 O
Short r O
- 
 O
term m O
growth w O
: 
 O
rhythms t O
, 
 O
chaos o O
, 
 O
or O O
noise s O
? 
 O
Association o O
between w O
diaphragm p O
use 	 O
and 	 O
asymptomatic m O
bacteriuria t O
. 
 O
The 	 O
effect e O
of O O
iron n O
on O O
the 	 O
toxigenicity i O
of O O
Vibrio r O
cholerae l O
. 
 O
The 	 O
Tat 	 B-GENE
protein t E-GENE
coded e O
by O O
human a O
immunodeficiency u O
virus u O
( 
 O
HIV 	 O
) 
 O
is O O
a 
 O
strong o O
activator i O
of O O
viral a O
gene e O
expression r O
from m O
the 	 O
long g O
terminal m O
repeat e O
( 
 O
LTR 	 O
) 
 O
. 
 O
Is O O
it O O
time e O
for 	 O
a 
 O
wine e O
trial a O
? 
 O
The 	 O
average r O
coefficient f O
of O O
variation i O
between w O
assays a O
for 	 O
gas 	 O
chromatography o O
mass s O
spectrometry c O
was 	 O
5 
 O
. 
 O
8 
 O
% 
 O
and 	 O
for 	 O
radioimmunoassay i O
was 	 O
12 O O
. 
 O
3 
 O
% 
 O
, 
 O
while l O
the 	 O
average r O
coefficient f O
of O O
variation i O
within h O
assays a O
for 	 O
gas 	 O
chromatography o O
mass s O
spectrometry c O
was 	 O
4 
 O
. 
 O
9 
 O
% 
 O
and 	 O
for 	 O
radioimmunoassay i O
6 
 O
. 
 O
9 
 O
% 
 O
. 
 O
Macrophages r O
: 
 O
modulators u O
of O O
immunity u O
. 
 O
The 	 O
NH2 	 O
- 
 O
terminal m O
fragments g O
were e O
tested t O
for 	 O
susceptibility c O
to O O
modification i O
with h O
Nalpha p O
- 
 O
( 
 O
3 
 O
- 
 O
maleimidylpropionyl e O
) 
 O
biocytin c O
, 
 O
which c O
attaches a O
a 
 O
biotin t O
group u O
to O O
cysteine t O
sulfhydryls f O
. 
 O
Production d O
of O O
VT O O
was 	 O
also o O
examined m O
retrospectively r O
in O O
32 O O
E 
 O
. 
 O
coli i O
strains a O
of O O
serotype o O
O26 	 O
: 
 O
H11 	 O
isolated l O
from m O
children l O
with h O
diarrhoea r O
; 
 O
eight h O
( 
 O
25 O O
% 
 O
) 
 O
of O O
them m O
produced d O
moderate e O
to O O
high h O
levels e O
of O O
verotoxin o B-GENE
1 - E-GENE
despite p O
several e O
years r O
storage r O
in O O
vitro r O
. 
 O
Serum u O
pituitary u O
and 	 O
steroid r B-GENE
hormone m E-GENE
levels e O
in O O
the 	 O
adult l O
male e O
: 
 O
one 	 O
value u O
is O O
as O O
good d O
as O O
the 	 O
mean n O
of O O
three e O
. 
 O
The 	 O
sections t O
were e O
stained i O
with h O
anti i B-GENE
- 
 I-GENE
polymorphonuclear y I-GENE
leukocyte k I-GENE
antibody i E-GENE
, 
 O
the 	 O
endothelial o B-GENE
marker k I-GENE
factor t I-GENE
VIII I I-GENE
- - I-GENE
related a I-GENE
antigen i E-GENE
, 
 O
and 	 O
with h O
hematoxylin a O
and 	 O
eosin i S-GENE
. 
 O
Mapping p O
of O O
the 	 O
region i O
in O O
KAP 	 B-GENE
- - I-GENE
1 - E-GENE
required u O
for 	 O
HP1 	 S-GENE
interaction e O
showed w O
that t O
amino n O
acid d O
substitutions s O
which c O
abolish l O
HP1 	 S-GENE
binding d O
in O O
vitro r O
reduce u O
KAP 	 B-GENE
- - I-GENE
1 - E-GENE
mediated i O
repression r O
in O O
vivo o O
. 
 O
The 	 O
flanking n O
open n O
reading d O
frames m O
in O O
pARGC2 G S-GENE
showed w O
no O O
homologies o O
to O O
arginine i O
biosynthetic s O
genes e O
. 
 O
Promoter m O
activity i O
of O O
the 	 O
proliferating l B-GENE
- - I-GENE
cell l I-GENE
nuclear l I-GENE
antigen i I-GENE
gene e E-GENE
is O O
associated o O
with h O
inducible u O
CRE 	 B-GENE
- - I-GENE
binding d I-GENE
proteins t E-GENE
in O O
interleukin e B-GENE
2 - E-GENE
- 
 O
stimulated m O
T 
 O
lymphocytes p O
. 
 O
METHODS H O
: 
 O
Levels e O
of O O
sIL 	 B-GENE
- - I-GENE
2R E E-GENE
were e O
measured s O
simultaneously u O
in O O
plasma s O
and 	 O
pleural u O
fluid i O
in O O
111 	 O
patients i O
with h O
pleural u O
effusions u O
of O O
unknown n O
causes s O
. 
 O
The 	 O
GIS 	 O
software t O
program g O
, 
 O
ArcView V O
, 
 O
was 	 O
used d O
for 	 O
spatial t O
analysis l O
and 	 O
distance t O
calculations c O
. 
 O
chi2 2 O
Tests t O
were e O
used d O
to O O
compare p O
the 	 O
distribution t O
of O O
the 	 O
characteristics r O
between w O
intersection e O
and 	 O
midblock b O
collisions l O
. 
 O
A 
 O
phase s O
II O O
study d O
was 	 O
initiated t O
to O O
evaluate l O
the 	 O
effect e O
of O O
a 
 O
combination b O
of O O
the 	 O
pure e O
L 
 O
- 
 O
isomer m O
of O O
LV O O
and 	 O
5 
 O
- 
 O
FU O O
along n O
with h O
epirubicin r O
in O O
patients i O
with h O
advanced a O
pancreatic c O
cancer c O
. 
 O
RESULTS U O
: 
 O
After e O
3 
 O
weeks k O
of O O
therapy r O
, 
 O
the 	 O
patient i O
had 	 O
an O O
increase r O
in O O
platelet t O
count n O
from m O
a 
 O
baseline e O
of O O
5 
 O
, 
 O
000 	 O
to O O
8 
 O
, 
 O
000 	 O
/ 
 O
microliter r O
to O O
a 
 O
maximal i O
level e O
of O O
33 O O
, 
 O
000 	 O
/ 
 O
microliter r O
. 
 O
The 	 O
specificity c O
of O O
the 	 O
transcriptional n O
activation i O
by O O
ISGF3 F S-GENE
is O O
mediated i O
by O O
specific c O
elements m O
termed m O
IFN 	 B-GENE
- - I-GENE
stimulatory m I-GENE
response p I-GENE
element m E-GENE
( 
 O
ISRE E O
) 
 O
located a O
in O O
the 	 O
promoter m O
region i O
of O O
IFN 	 B-GENE
- 
 I-GENE
inducible u I-GENE
genes e E-GENE
. 
 O
It O O
appears e O
that t O
the 	 O
K 
 O
- 
 O
ABC 	 O
is O O
a 
 O
relatively a O
nonbiased b O
test t O
suitable t O
for 	 O
the 	 O
evaluation l O
of O O
both h O
gifted t O
and 	 O
nongifted g O
children l O
regardless a O
of O O
race e O
or O O
gender d O
. 
 O
In O O
another t O
patient i O
, 
 O
IRPF F O
recurred u O
in O O
the 	 O
ureter t O
of O O
a 
 O
living i O
related a O
renal a O
graft f O
6 
 O
months t O
after e O
transplantation n O
. 
 O
These s O
mutants a O
, 
 O
assayed a O
by O O
injection e O
into o O
Xenopus o O
oocyte y O
nuclei l O
, 
 O
delimit i O
the 	 O
promoter m O
to O O
36 O O
bp O O
of O O
DNA 	 O
upstream t O
of O O
the 	 O
cap 	 O
site e O
and 	 O
73 O O
bp O O
of O O
the 	 O
untranslated r O
mRNA A O
leader d O
. 
 O
Upstream t O
tissue s O
inhibitor i O
of I O
metalloproteinases a B-GENE
- - I-GENE
1 - E-GENE
( - O
TIMP P B-GENE
- - I-GENE
1 - E-GENE
) - O
element m O
- - O
1 - O
, 
 O
a 
 O
novel e O
and 	 O
essential e O
regulatory u O
DNA 	 O
motif i O
in O O
the 	 O
human a B-GENE
TIMP P I-GENE
- - I-GENE
1 - I-GENE
gene e I-GENE
promoter m E-GENE
, 
 O
directly e O
interacts e O
with h O
a 
 O
30 O O
- 
 O
kDa 	 O
nuclear l O
protein t O
. 
 O
The 	 O
results u O
of O O
these s O
experiments e O
indicated i O
that t O
charcoal r O
, 
 O
imbiber i O
beads d O
, 
 O
and 	 O
the 	 O
anion o O
exchanges h O
resins i O
, 
 O
Dowex e O
XFS 	 O
- 
 O
4022 2 O
and 	 O
Dowex e O
SBR 	 O
- 
 O
C1 O O
, 
 O
would l O
not 	 O
be O O
useful f O
agents n O
for 	 O
increasing r O
the 	 O
amount u O
of O O
dieldrin l O
eliminated m O
via 	 O
feces e O
( 
 O
droppings p O
) 
 O
of O O
chickens c O
. 
 O
The 	 O
receptor e O
for 	 O
CSF 	 B-GENE
- - I-GENE
1 - E-GENE
, 
 O
c - B-GENE
- - I-GENE
Fms 	 E-GENE
, 
 O
is O O
expressed r O
in O O
osteoclasts e O
, 
 O
possesses s O
intrinsic r O
tyrosine o B-GENE
- - I-GENE
kinase a E-GENE
activity i O
, 
 O
and 	 O
signals n O
via 	 O
rapid i O
phosphorylation s O
of O O
selected e O
proteins t O
. 
 O
Adaptive p O
effects e O
of O O
repeated e O
immersion e O
exposure o O
on O O
the 	 O
human a O
body y O
To O O
this s O
end 	 O
we O O
generated e O
a 
 O
detailed a O
physical s O
map 	 O
of O O
the 	 O
genomic o O
region i O
spanning n O
between w O
sequence u O
- 
 O
tagged g O
site e O
markers k O
D16S518 S O
and 	 O
D16S516 S S-GENE
. 
 O
Spinophilin n S-GENE
, 
 O
a 
 O
novel e O
protein t B-GENE
phosphatase s I-GENE
1 - I-GENE
binding d I-GENE
protein t E-GENE
localized a O
to O O
dendritic d O
spines n O
. 
 O
We O O
have e O
found n O
that t O
pro 	 B-GENE
- - I-GENE
IGF 	 I-GENE
- - I-GENE
2 - E-GENE
can 	 O
initially t O
form m O
two 	 O
disulfide u O
isomers m O
that t O
undergo e O
rearrangement r O
to O O
a 
 O
single g O
conformation f O
in O O
vivo o O
. 
 O
While l O
working k O
on O O
the 	 O
toxicity i O
of O O
war 	 O
gases e O
. 
 O
he O O
formulated m O
' 
 O
Haber e O
' 
 O
s 
 O
rule e O
' 
 O
, 
 O
also o O
known w O
as O O
C 
 O
x 
 O
T 
 O
= 
 O
constant s O
in O O
order e O
to O O
characterize r O
the 	 O
toxicity i O
of O O
an O O
inhalant a O
. 
 O
The 	 O
existence s O
of O O
a 
 O
TFIIIB I S-GENE
assembly e O
pathway h O
leading d O
to O O
the 	 O
faithful t O
transcription n O
of O O
natural u B-GENE
eukaryotic a I-GENE
tRNA A I-GENE
genes e E-GENE
in O O
the 	 O
absence e O
of O O
TFIIIC I S-GENE
provides v O
novel e O
insights i O
into o O
the 	 O
functional c O
flexibility x O
of O O
the 	 O
eukaryotic a O
tRNA A O
gene e O
transcription n O
machinery h O
and 	 O
on O O
its 	 O
evolution l O
from m O
an O O
ancestral e O
RNA 	 B-GENE
polymerase y I-GENE
III 	 E-GENE
system t O
relying y O
on O O
upstream t O
, 
 O
TATA A O
- 
 O
centered t O
control t O
elements m O
. 
 O
Ectopic o O
Xbra a S-GENE
can 	 O
induce u O
Xegr r B-GENE
- - I-GENE
1 - E-GENE
transcription n O
by O O
an O O
indirect i O
mechanism h O
that t O
appears e O
to O O
operate r O
via 	 O
primary m O
activation i O
of O O
fibroblast r B-GENE
growth w I-GENE
factor t E-GENE
secretion r O
. 
 O
A 
 O
rapid i O
mixing i O
device i O
for 	 O
quasielastic s O
light h O
scattering t O
studies d O
of O O
reacting c O
systems t O
. 
 O
The 	 O
major o O
transcription n O
start r O
site e O
, 
 O
designated i O
as O O
+ 
 O
1 
 O
, 
 O
was 	 O
determined e O
by O O
RACE E O
( 
 O
rapid i O
amplification l O
of O O
cDNA A O
ends s O
) 
 O
analysis l O
of O O
human a O
liver e O
cDNA A O
and 	 O
was 	 O
found n O
to O O
be O O
located a O
50 O O
bp O O
upstream t O
from m O
the 	 O
translation n O
start r O
site e O
. 
 O
These s O
aa O O
residues i O
correspond r O
to O O
codons o O
59 O O
and 	 O
108 	 O
in O O
the 	 O
P - O
. - O
falciparum c O
DHFR R O
active i O
site e O
in O O
which c O
similar i O
aa O O
substitutions s O
( 
 O
Cys 	 O
Arg 	 O
- 
 O
59 O O
and 	 O
Ser 	 O
Asn 	 O
- 
 O
108 	 O
) 
 O
are 	 O
associated o O
with h O
pyrimethamine i O
resistance i O
. 
 O
Of O O
all 	 O
YASR R O
syndromes d O
, 
 O
the 	 O
highest h O
stability b O
was 	 O
for 	 O
the 	 O
Anxious i O
/ 
 O
Depressed r O
scale l O
. 
 O
Here e O
we O O
investigate e O
the 	 O
mechanism h O
of O O
TPA 	 O
induction u O
of O O
FGF 	 B-GENE
- - I-GENE
BP E I-GENE
gene e E-GENE
expression r O
in O O
the 	 O
human a O
ME O O
- 
 O
180 	 O
SCC 	 O
cell l O
line e O
. 
 O
Between w O
the 	 O
RNA 	 O
initiation t O
site e O
and 	 O
the 	 O
coding i O
region i O
is O O
a 
 O
GC O O
- 
 O
rich h O
hairpin r O
structure u O
followed l O
by O O
8 
 O
T 
 O
residues i O
that t O
looks k O
like e O
a 
 O
rho 	 O
- - O
independent e O
transcription n O
terminator m O
. 
 O
Conversely v O
the 	 O
rate e O
of O O
bioavailability a O
was 	 O
significantly n O
different f O
, 
 O
because a O
from m O
the 	 O
Reference e O
patch c O
the 	 O
release e O
rate e O
is O O
fast t O
in O O
the 	 O
first s O
24 O O
h 
 O
, 
 O
leading d O
to O O
an O O
E2 O O
peak k O
at O O
8 
 O
h 
 O
and 	 O
to O O
a 
 O
Cmax x O
in O O
average r O
at O O
23 O O
h 
 O
. 
 O
3 
 O
) 
 O
The 	 O
progress g O
of O O
fibrinolysis r O
was 	 O
observed e O
by O O
serial i O
collection l O
of O O
middle d O
ear 	 O
fluid i O
in O O
the 	 O
same e O
side e O
ear 	 O
of O O
5 
 O
cases e O
out 	 O
of O O
17 O O
cases e O
having i O
much h O
activity i O
for 	 O
fibrin r S-GENE
degradation r O
, 
 O
and 	 O
lowering e O
of O O
fibrinolytic r O
activity i O
was 	 O
revealed e O
in O O
4 
 O
out 	 O
of O O
these s O
5 
 O
cases e O
as O O
the 	 O
result u O
. 
 O
Thus s O
G17 	 S-GENE
targets g O
the 	 O
c - B-GENE
- - I-GENE
fos 	 I-GENE
promoter m I-GENE
CArG G I-GENE
sequence u E-GENE
via 	 O
Rho 	 B-GENE
A - E-GENE
- 
 O
dependent e O
pathways h O
, 
 O
and 	 O
Rho 	 B-GENE
A - E-GENE
appears e O
to O O
play y O
an O O
important o O
role e O
in O O
the 	 O
regulation u O
of O O
the 	 O
trophic p O
action i O
of O O
G17 	 S-GENE
. 
 O
The 	 O
MIC90 9 O
of O O
ABK 	 O
against i O
coagulase g O
type e O
IV E O
strains a O
was 	 O
rather h O
high h O
, 
 O
12 O O
. 
 O
5 
 O
micrograms r O
/ 
 O
ml O O
. 
 O
In O O
each h O
patient i O
, 
 O
MBF 	 O
was 	 O
quantified n O
in O O
the 	 O
three e O
major o O
vascular c O
territories r O
: 
 O
the 	 O
left t O
anterior e O
descending c O
and 	 O
left t O
circumflex c O
coronary o O
artery e O
territories r O
and 	 O
the 	 O
right h O
coronary o O
artery e O
( 
 O
control t O
region i O
) 
 O
territory r O
. 
 O
These s O
results u O
demonstrate o O
that t O
m2 B B-GENE
receptors e E-GENE
couple p O
to O O
both h O
G - B-GENE
alpha h I-GENE
i2 E E-GENE
and 	 O
G - B-GENE
alpha h I-GENE
i3 E E-GENE
in O O
vivo o O
and 	 O
that t O
this s O
interaction e O
is O O
integral e O
to O O
both h O
positive i O
and 	 O
negative a O
regulatory u O
pathways h O
leading d O
to O O
activation i O
of O O
PLC 	 S-GENE
and 	 O
desensitization e O
of O O
receptor e O
signaling n O
. 
 O
Platelet t O
count n O
and 	 O
plasma s O
volume u O
were e O
significantly n O
higher h O
in O O
group u O
A 
 O
than n O
in O O
group u O
B 
 O
throughout o O
pregnancy g O
. 
 O
The 	 O
fru 	 B-GENE
gene e E-GENE
has 	 O
seven e O
exons n O
spanning n O
15 O O
- 
 O
kb O O
encoding o O
two 	 O
transcripts n O
with h O
ORFs s O
of O O
841 	 O
and 	 O
695 	 O
amino n O
acids d O
. 
 O
HC B B-GENE
- - I-GENE
toxin i E-GENE
exerts r O
a 
 O
potent e O
cytostatic o O
effect e O
on O O
plant n O
and 	 O
animal m O
cells l O
by O O
inhibiting i O
histone t B-GENE
deacetylase c E-GENE
. 
 O
The 	 O
human a B-GENE
RIL 	 I-GENE
gene e E-GENE
: 
 O
mapping p O
to O O
human a O
chromosome o O
5q31 1 O
. 
 O
1 
 O
, 
 O
genomic o O
organization a O
and 	 O
alternative e O
transcripts n O
. 
 O
The 	 O
delta t O
mean n O
VAF 	 O
and 	 O
delta t O
mean n O
SABP P O
indicated i O
varied i O
mean n O
values u O
of O O
VAF 	 S-GENE
and 	 O
SABP P S-GENE
, 
 O
respectively p O
. 
 O
Azoospermia o O
was 	 O
graded d O
in O O
the 	 O
following l O
way 	 O
: 
 O
adequate q O
spermatozoa r O
( 
 O
A1 O O
) 
 O
, 
 O
low 	 O
, 
 O
scanty n O
or O O
rare e O
spermatozoa r O
( 
 O
A2 O O
) 
 O
, 
 O
spermatid r O
arrest e O
( 
 O
B1 O O
) 
 O
, 
 O
spermatocyte r O
arrest e O
( 
 O
B2 O O
) 
 O
, 
 O
Sertoli t O
cell l O
- 
 O
only y O
pattern t O
( 
 O
C 
 O
) 
 O
and 	 O
sclerosis e O
( 
 O
D 
 O
) 
 O
. 
 O
